PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Huang, X; Britto, MD; Kear-Scott, JL; Boone, CD; Rocca, JR; Simmerling, C; Mckenna, R; Bieri, M; Gooley, PR; Dunn, BM; Fanucci, GE				Huang, Xi; Britto, Manuel D.; Kear-Scott, Jamie L.; Boone, Christopher D.; Rocca, James R.; Simmerling, Carlos; Mckenna, Robert; Bieri, Michael; Gooley, Paul R.; Dunn, Ben M.; Fanucci, Gail E.			The Role of Select Subtype Polymorphisms on HIV-1 Protease Conformational Sampling and Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; DRUG-RESISTANCE MUTATIONS; VIRUS TYPE-1 PROTEASE; MOLECULAR-DYNAMICS; STRUCTURAL-CHARACTERIZATION; CRYSTAL-STRUCTURES; NMR-SPECTROSCOPY; EPR SPECTROSCOPY; LARGER PROTEINS	HIV-1 protease is an essential enzyme for viral particle maturation and is a target in the fight against HIV-1 infection world-wide. Several natural polymorphisms are also associated with drug resistance. Here, we utilized both pulsed electron double resonance, also called double electron-electron resonance, and NMR 15N relaxation measurements to characterize equilibrium conformational sampling and backbone dynamics of an HIV-1 protease construct containing four specific natural polymorphisms commonly found in subtypes A, F, and CRF_01 A/E. Results show enhanced backbone dynamics, particularly in the flap region, and the persistence of a novel conformational ensemble that we hypothesize is an alternative flap orientation of a curled open state or an asymmetric configuration when interacting with inhibitors.	[Huang, Xi; Britto, Manuel D.; Kear-Scott, Jamie L.; Fanucci, Gail E.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Boone, Christopher D.; Mckenna, Robert; Dunn, Ben M.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Rocca, James R.] Univ Florida, McKnight Brain Inst, Adv Magnet Resonance Imaging & Spect Facil, Gainesville, FL 32610 USA; [Simmerling, Carlos] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Bieri, Michael; Gooley, Paul R.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Melbourne	Fanucci, GE (corresponding author), Univ Florida, Dept Chem, POB 117200, Gainesville, FL 32611 USA.	fanucci@chem.ufl.edu		Gooley, Paul/0000-0002-0323-449X	National Institutes of Health [S10 RR031603, R01 GM105409, R37 AI28571]; National Science Foundation from the University of Florida Center for AIDS Research [MBC-0746533]; National High Magnetic Field Laboratory user program; National High Magnetic Field Laboratory-In-House Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028571, R37AI028571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105409] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1329467] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation from the University of Florida Center for AIDS Research; National High Magnetic Field Laboratory user program; National High Magnetic Field Laboratory-In-House Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grants S10 RR031603, R01 GM105409 (to G. E. F.), and R37 AI28571 (to B. M. D.). This work was also supported by National Science Foundation Grant MBC-0746533 from the University of Florida Center for AIDS Research, National High Magnetic Field Laboratory user program, and National High Magnetic Field Laboratory-In-House Research Program.	Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P2819, DOI 10.1021/bi2018317; Alteri C, 2013, J ANTIMICROB CHEMOTH, V68, P2205, DOI 10.1093/jac/dkt173; Bandaranayake RM, 2010, J VIROL, V84, P9995, DOI 10.1128/JVI.00505-10; Batista PR, 2006, CELL BIOCHEM BIOPHYS, V44, P395, DOI 10.1385/CBB:44:3:395; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; Bieri M, 2011, J BIOMOL NMR, V50, P147, DOI 10.1007/s10858-011-9509-1; Blackburn M. E, 2010, THESIS U FLORIDA GAI; Blackburn ME, 2009, BIOCHEMISTRY-US, V48, P8765, DOI 10.1021/bi901201q; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Cai YF, 2012, J CHEM THEORY COMPUT, V8, P3452, DOI 10.1021/ct300076y; Chang MW, 2011, J MOL BIOL, V410, P756, DOI 10.1016/j.jmb.2011.03.038; Charpentier C, 2011, ANTIVIR THER, V16, P429, DOI 10.3851/IMP1754; Clemente JC, 2003, BIOCHEMISTRY-US, V42, P15029, DOI 10.1021/bi035701y; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Coman RM, 2008, BIOCHEMISTRY-US, V47, P731, DOI 10.1021/bi7018332; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P121, DOI 10.1007/s10858-007-9213-3; d'Auvergne EJ, 2008, J BIOMOL NMR, V40, P107, DOI 10.1007/s10858-007-9214-2; de Vera I. M. S., 2013, CURR PROTOC PROTEIN, P74; de Vera IMS, 2013, BIOCHEMISTRY-US, V52, P3278, DOI 10.1021/bi400109d; de Vera IMS, 2012, BIOCHEMISTRY-US, V51, P7813, DOI 10.1021/bi301010z; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding F, 2008, J AM CHEM SOC, V130, P7184, DOI 10.1021/ja800893d; Freedberg DI, 2002, PROTEIN SCI, V11, P221, DOI 10.1110/ps.33202; Galiano L, 2009, J PHYS CHEM B, V113, P1673, DOI 10.1021/jp8057788; Galiano L, 2009, J AM CHEM SOC, V131, P430, DOI 10.1021/ja807531v; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hemelaar J, 2012, TRENDS MOL MED, V18, P182, DOI 10.1016/j.molmed.2011.12.001; Hoffmann C, 2009, EUR BIOPHYS J BIOPHY, V38, P557, DOI 10.1007/s00249-009-0404-6; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Huang X, 2013, BIOMOL NMR ASSIGN, V7, P199, DOI 10.1007/s12104-012-9409-7; Huang X, 2012, J PHYS CHEM B, V116, P14235, DOI 10.1021/jp308207h; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Ishima R, 1999, STRUCTURE, V7, P1047, DOI 10.1016/S0969-2126(99)80172-5; Ishima R, 1998, J AM CHEM SOC, V120, P10534, DOI 10.1021/ja981546c; Ishima R, 2007, J BIOL CHEM, V282, P17190, DOI 10.1074/jbc.M701304200; Jeschke G, 2004, APPL MAGN RESON, V26, P223, DOI 10.1007/BF03166574; Jeschke G, 2006, PHYS CHEM CHEM PHYS, V8, P4095, DOI 10.1039/b607826e; Kantor R, 2002, ANTIMICROB AGENTS CH, V46, P1086, DOI 10.1128/AAC.46.4.1086-1092.2002; Sadiq SK, 2010, PROTEINS, V78, P2873, DOI 10.1002/prot.22806; Kear J. L., 2011, J BIOPHYS CHEM, V2, P137; Kear J. L., 2010, THESIS U FLORIDA GAI; Kear JL, 2009, J AM CHEM SOC, V131, P14650, DOI 10.1021/ja907088a; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Mahalingam B, 2002, PROTEINS, V48, P107, DOI 10.1002/prot.10140; Mcgee D., 2010, THESIS U FLORIDA GAI; Meiselbach H, 2007, J MOL MODEL, V13, P297, DOI 10.1007/s00894-006-0121-3; MILDNER AM, 1994, BIOCHEMISTRY-US, V33, P9405, DOI 10.1021/bi00198a005; Miller JF, 2006, BIOORG MED CHEM LETT, V16, P1788, DOI 10.1016/j.bmcl.2006.01.035; Mo HM, 2007, ANTIMICROB AGENTS CH, V51, P732, DOI 10.1128/AAC.00690-06; Morin S, 2009, J BIOMOL NMR, V45, P361, DOI 10.1007/s10858-009-9381-4; Muzammil S, 2007, J VIROL, V81, P5144, DOI 10.1128/JVI.02706-06; Naicker P, 2013, J BIOMOL STRUCT DYN, V31, P1370, DOI 10.1080/07391102.2012.736774; Oelrichs RB, 2003, CURR HIV RES, V1, P239, DOI 10.2174/1570162033485302; Sanches M, 2007, J MOL BIOL, V369, P1029, DOI 10.1016/j.jmb.2007.03.049; Sayer JM, 2008, J BIOL CHEM, V283, P13459, DOI 10.1074/jbc.M708506200; Sayer JM, 2009, PROTEINS, V75, P556, DOI 10.1002/prot.22271; SPINELLI S, 1991, BIOCHIMIE, V73, P1391, DOI 10.1016/0300-9084(91)90169-2; Swanson MA, 2009, J AM CHEM SOC, V131, P15978, DOI 10.1021/ja9059816; Torbeev VY, 2011, P NATL ACAD SCI USA, V108, P20982, DOI 10.1073/pnas.1111202108; Torbeev VY, 2009, J AM CHEM SOC, V131, P884, DOI 10.1021/ja806526z; Tsvetkov YD, 2009, INSTRUM EXP TECH+, V52, P615, DOI 10.1134/S0020441209050017; Velaquez-Campoy Adrian, 2003, AIDS Reviews, V5, P165; Velazquez-Campoy A, 2002, BIOCHEMISTRY-US, V41, P8613, DOI 10.1021/bi020160i; Velazquez-Campoy A, 2001, P NATL ACAD SCI USA, V98, P6062, DOI 10.1073/pnas.111152698; Weber IT, 2012, ADV PROTEIN CHEM STR, V87, P57, DOI 10.1016/B978-0-12-398312-1.00003-2; Weber IT, 2009, VIRUSES-BASEL, V1, P1110, DOI 10.3390/v1031110; WENIGER BG, 1994, AIDS, V8, pS13; Wilson SI, 1997, BBA-PROTEIN STRUCT M, V1339, P113, DOI 10.1016/S0167-4838(96)00224-5; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	71	36	36	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					17203	17214		10.1074/jbc.M114.571836	http://dx.doi.org/10.1074/jbc.M114.571836			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24742668	Green Published, hybrid			2022-12-25	WOS:000338016200053
J	Agarwal, V; Sroka, M; Fulde, M; Bergmann, S; Riesbeck, K; Blom, AM				Agarwal, Vaibhav; Sroka, Magdalena; Fulde, Marcus; Bergmann, Simone; Riesbeck, Kristian; Blom, Anna M.			Binding of Streptococcus pneumoniae Endopeptidase O (PepO) to Complement Component C1q Modulates the Complement Attack and Promotes Host Cell Adherence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Complement System; Host-Pathogen Interaction; Innate Immunity; Streptococcus; c1q; Complement Activation; Host Cell Adherence; Pneumococci	PNEUMOCOCCAL SURFACE PROTEIN; FACTOR-H; C4B-BINDING PROTEIN; INNATE IMMUNITY; EVASION; PSPC; COLONIZATION; PATHOGENS; INVASION; PHAGOCYTOSIS	The Gram-positive species Streptococcus pneumoniae is a human pathogen causing severe local and life-threatening invasive diseases associated with high mortality rates and death. We demonstrated recently that pneumococcal endopeptidase O (PepO) is a ubiquitously expressed, multifunctional plasminogen and fibronectin-binding protein facilitating host cell invasion and evasion of innate immunity. In this study, we found that PepO interacts directly with the complement C1q protein, thereby attenuating the classical complement pathway and facilitating pneumococcal complement escape. PepO binds both free C1q and C1 complex in a dose-dependent manner based on ionic interactions. Our results indicate that recombinant PepO specifically inhibits the classical pathway of complement activation in both hemolytic and complement deposition assays. This inhibition is due to direct interaction of PepO with C1q, leading to a strong activation of the classical complement pathway, and results in consumption of complement components. In addition, PepO binds the classical complement pathway inhibitor C4BP, thereby regulating downstream complement activation. Importantly, pneumococcal surface-exposed PepO-C1q interaction mediates bacterial adherence to host epithelial cells. Taken together, PepO facilitates C1q-mediated bacterial adherence, whereas its localized release consumes complement as a result of its activation following binding of C1q, thus representing an additional mechanism of human complement escape by this versatile pathogen.	[Agarwal, Vaibhav; Sroka, Magdalena; Blom, Anna M.] Lund Univ, Dept Lab Med Malmo, Div Med Prot Chem, S-20502 Malmo, Sweden; [Riesbeck, Kristian] Lund Univ, Dept Lab Med Malmo, Div Med Microbiol, S-20502 Malmo, Sweden; [Fulde, Marcus] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-30625 Hannover, Germany; [Bergmann, Simone] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany	Lund University; Lund University; Hannover Medical School; Braunschweig University of Technology	Blom, AM (corresponding author), Lund Univ, Dept Lab Med Malmo, Wallenberg Lab, Floor 4,Inga Marie Nilssons St 53, S-20502 Malmo, Sweden.	anna.blom@med.lu.se	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; Riesbeck, Kristian/0000-0001-6274-6965; Sroka, Magdalena/0000-0003-0962-6707	Swedish Research Council [K2012-66X-14928-09-5]; Foundations of Torsten Soderberg, Osterlund; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Foundations of Torsten Soderberg, Osterlund; Royal Physiographic Society in Lund; Skane University Hospital; Swedish Society for Medical Research	This work was supported by Swedish Research Council Grants K2012-66X-14928-09-5), the Foundations of Torsten Soderberg, Osterlund, Greta and Johan Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg, the Royal Physiographic Society in Lund, and a grant from the Skane University Hospital.; The recipient of a postdoctoral stipend from the Swedish Society for Medical Research.	Agarwal V, 2013, J IMMUNOL, V191, P4235, DOI 10.4049/jimmunol.1300279; Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Agarwal V, 2012, J IMMUNOL, V189, P3575, DOI 10.4049/jimmunol.1102934; Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Bergmann S, 2009, J CELL SCI, V122, P256, DOI 10.1242/jcs.035600; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Domenech M, 2013, INFECT IMMUN, V81, P2606, DOI 10.1128/IAI.00491-13; Forsgren A, 2001, J IMMUNOL, V167, P2112, DOI 10.4049/jimmunol.167.4.2112; Hackel M, 2013, VACCINE, V31, P4881, DOI 10.1016/j.vaccine.2013.07.054; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Laarman A, 2010, J MOL MED, V88, P115, DOI 10.1007/s00109-009-0572-y; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LAURELL CB, 1983, J CHROMATOGR, V278, P53, DOI 10.1016/S0378-4347(00)84755-6; Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ogunniyi AD, 2009, FASEB J, V23, P731, DOI 10.1096/fj.08-119537; Pracht D, 2005, INFECT IMMUN, V73, P2680, DOI 10.1128/IAI.73.5.2680-2689.2005; Quin LR, 2007, INFECT IMMUN, V75, P2067, DOI 10.1128/IAI.01727-06; Rennemeier C, 2007, FASEB J, V21, P3118, DOI 10.1096/fj.06-7992com; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; TENNER AJ, 1981, J IMMUNOL, V127, P648; Terrasse R, 2012, J BIOL CHEM, V287, P42620, DOI 10.1074/jbc.M112.423731; Tu AHT, 1999, INFECT IMMUN, V67, P4720, DOI 10.1128/IAI.67.9.4720-4724.1999; Voss S, 2012, MOL ORAL MICROBIOL, V27, P246, DOI 10.1111/j.2041-1014.2012.00654.x; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222	35	44	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15833	15844		10.1074/jbc.M113.530212	http://dx.doi.org/10.1074/jbc.M113.530212			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24739385	Green Published, hybrid			2022-12-25	WOS:000337465400062
J	Suckow, AT; Polidori, D; Yan, W; Chon, S; Ma, JY; Leonard, J; Briscoe, CP				Suckow, Arthur T.; Polidori, David; Yan, Wen; Chon, Suhyoun; Ma, Jing Ying; Leonard, James; Briscoe, Celia P.			Alteration of the Glucagon Axis in GPR120 (FFAR4) Knockout Mice A ROLE FOR GPR120 IN GLUCAGON SECRETION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fatty Acid; G Protein-coupled Receptor (GPCR); Lipid; Pancreatic Islet; Polyunsaturated Fatty Acid (PUFA); GPR120; GPR40; Long Chain Fatty Acids; Alpha Cell; Glucagon	ACID RECEPTOR GPR40; SECRETION IN-VIVO; FATTY-ACID; INSULIN-SECRETION; HUMAN ISLETS; ALPHA-CELLS; BETA-CELLS; STIMULATION; MOUSE; INVOLVEMENT	GPR40 (FFAR1) and GPR120 (FFAR4) are G-protein-coupled receptors (GPCRs) that are activated by long chain fatty acids (LCFAs). GPR40 is expressed at high levels in islets and mediates the ability of LCFAs to potentiate glucose-stimulated insulin secretion (GSIS). GPR120 is expressed at high levels in colon, adipose, and pituitary, and at more modest levels in pancreatic islets. The role of GPR120 in islets has not been explored extensively. Here, we confirm that saturated (e.g. palmitic acid) and unsaturated (e.g. docosahexaenoic acid (DHA)) LCFAs engage GPR120 and demonstrate that palmitate- and DHA-potentiated glucagon secretion are greatly reduced in isolated GPR120 KO islets. Remarkably, LCFA potentiated glucagon secretion is similarly reduced in GPR40 KO islets. Compensatory changes in mRNA expression of GPR120 in GPR40 KO islets, and vice versa, do not explain that LCFA potentiated glucagon secretion seemingly involves both receptors. LCFA-potentiated GSIS remains intact in GPR120 KO islets. Consistent with previous reports, GPR120 KO mice are hyperglycemic and glucose intolerant; however, our KO mice display evidence of a hyperactive counter-regulatory response rather than insulin resistance during insulin tolerance tests. An arginine stimulation test and a glucagon challenge confirmed both increases in glucagon secretion and liver glucagon sensitivity in GPR120 KO mice relative to WT mice. Our findings demonstrate that GPR120 is a nutrient sensor that is activated endogenously by both saturated and unsaturated long chain fatty acids and that an altered glucagon axis likely contributes to the impaired glucose homeostasis observed in GPR120 KO mice.	[Suckow, Arthur T.; Polidori, David; Yan, Wen; Chon, Suhyoun; Ma, Jing Ying; Leonard, James; Briscoe, Celia P.] Janssen Res & Dev LLC, San Diego, CA 92121 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Suckow, AT (corresponding author), MedImmune, One Med Immune Way, Gaithersburg, MD 20878 USA.	suckowa@medimmune.com						Alcazar O, 1997, DIABETES, V46, P1153, DOI 10.2337/diabetes.46.7.1153; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; De Marinis YZ, 2010, CELL METAB, V11, P543, DOI 10.1016/j.cmet.2010.04.007; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Flodgren E, 2007, BIOCHEM BIOPH RES CO, V354, P240, DOI 10.1016/j.bbrc.2006.12.193; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hong J, 2005, METABOLISM, V54, P1329, DOI 10.1016/j.metabol.2005.04.022; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kebede MA, 2009, DIABETES OBES METAB, V11, P10, DOI 10.1111/j.1463-1326.2009.01114.x; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kharouta M, 2009, DIABETES RES CLIN PR, V85, P252, DOI 10.1016/j.diabres.2009.06.021; Lan H, 2008, DIABETES, V57, P2999, DOI 10.2337/db08-0596; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046300; Matsumura S, 2009, NEUROSCI LETT, V450, P186, DOI 10.1016/j.neulet.2008.11.056; Morgan NG, 2009, BIOCHEM PHARMACOL, V78, P1419, DOI 10.1016/j.bcp.2009.07.020; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olofsson CS, 2004, DIABETES, V53, P2836, DOI 10.2337/diabetes.53.11.2836; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Raptis DA, 2014, J HEPATOL, V60, P625, DOI 10.1016/j.jhep.2013.11.006; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Rezania A, 2011, DIABETES, V60, P239, DOI 10.2337/db10-0573; Salehi A, 2005, CELL TISSUE RES, V322, P207, DOI 10.1007/s00441-005-0017-z; Steneberg R, 2005, CELL METAB, V1, P245, DOI 10.1016/j.cmet.2005.03.007; Suckow AT, 2008, ENDOCRINOLOGY, V149, P6006, DOI 10.1210/en.2008-0274; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Wang L, 2011, J ENDOCRINOL, V210, P173, DOI 10.1530/JOE-11-0132; WARNOTTE C, 1994, DIABETES, V43, P703, DOI 10.2337/diabetes.43.5.703; Watson SJ, 2012, MOL PHARMACOL, V81, P631, DOI 10.1124/mol.111.077388; Yashiro H, 2012, J PHARMACOL EXP THER, V340, P483, DOI 10.1124/jpet.111.187708; Zhang C., PLOS ONE, V8	34	59	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15751	15763		10.1074/jbc.M114.568683	http://dx.doi.org/10.1074/jbc.M114.568683			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742677	hybrid, Green Published			2022-12-25	WOS:000337465400055
J	Peter, F; Berens, DG; Farwig, N				Peter, Franziska; Berens, Dana G.; Farwig, Nina			Effects of Local Tree Diversity on Herbivore Communities Diminish with Increasing Forest Fragmentation on the Landscape Scale	PLOS ONE			English	Article							INSECT HERBIVORY; HABITAT FRAGMENTATION; SPECIES-DIVERSITY; SPATIAL SCALE; BODY-SIZE; ABUNDANCE; ASSEMBLAGES; EVOLUTION; RESPONSES	Forest fragmentation and plant diversity have been shown to play a crucial role for herbivorous insects (herbivores, hereafter). In turn, herbivory-induced leaf area loss is known to have direct implications for plant growth and reproduction as well as long-term consequences for ecosystem functioning and forest regeneration. So far, previous studies determined diverging responses of herbivores to forest fragmentation and plant diversity. Those inconsistent results may be owed to complex interactive effects of both co-occurring environmental factors albeit they act on different spatial scales. In this study, we investigated whether forest fragmentation on the landscape scale and tree diversity on the local habitat scale show interactive effects on the herbivore community and leaf area loss in subtropical forests in South Africa. We applied standardized beating samples and a community-based approach to estimate changes in herbivore community composition, herbivore abundance, and the effective number of herbivore species on the tree species-level. We further monitored leaf area loss to link changes in the herbivore community to the associated process of herbivory. Forest fragmentation and tree diversity interactively affected the herbivore community composition, mainly by a species turnover within the family of Curculionidae. Furthermore, herbivore abundance increased and the number of herbivore species decreased with increasing tree diversity in slightly fragmented forests whereas the effects diminished with increasing forest fragmentation. Surprisingly, leaf area loss was neither affected by forest fragmentation or tree diversity, nor by changes in the herbivore community. Our study highlights the need to consider interactive effects of environmental changes across spatial scales in order to draw reliable conclusions for community and interaction patterns. Moreover, forest fragmentation seems to alter the effect of tree diversity on the herbivore community, and thus, has the potential to jeopardize ecosystem functioning and forest regeneration.	[Peter, Franziska; Berens, Dana G.; Farwig, Nina] Univ Marburg, Fac Biol, Dept Ecol Conservat Ecol, Marburg, Germany	Philipps University Marburg	Peter, F (corresponding author), Univ Marburg, Fac Biol, Dept Ecol Conservat Ecol, Marburg, Germany.	franziska.peter@biologie.uni-marburg.de			Robert Bosch Stiftung	Robert Bosch Stiftung	The study was funded by the Robert Bosch Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arun P R, 2004, ScientificWorldJournal, V4, P381; Baayen RH, 2011, LANGUAGER DATA SETS; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; Bates D, 2012, LME4 LINEAR MIXED EF; BERENBAUM MR, 1989, EXPERIENTIA, V45, P229, DOI 10.1007/BF01951808; Bonte D, 2010, OIKOS, V119, P560, DOI 10.1111/j.1600-0706.2009.17943.x; Boon, 2010, POOLEYS TREES E S AF; Braschler B, 2009, ECOL ENTOMOL, V34, P321, DOI 10.1111/j.1365-2311.2008.01080.x; de Sassi C, 2012, ECOLOGY, V93, P1892, DOI 10.1890/11-1839.1; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; Dray, 2011, PACKFOR FORWARD SELE, P46; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Ezemvelo KZN Wildlife, 2011, KWAZULU NAT LAND COV; Ezemvelo KZN Wildlife, 2009, OR GORG NAT RES INT; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fischer C, 2013, J INSECT CONSERV, V17, P1027, DOI 10.1007/s10841-013-9586-4; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Giffard B, 2012, BASIC APPL ECOL, V13, P458, DOI 10.1016/j.baae.2012.08.004; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Holland JD, 2005, OIKOS, V110, P101, DOI 10.1111/j.0030-1299.2005.13638.x; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jactel H, 2007, ECOL LETT, V10, P835, DOI 10.1111/j.1461-0248.2007.01073.x; Jelaska LS, 2009, ANN SOC ENTOMOL FR, V45, P327, DOI 10.1080/00379271.2009.10697618; Lawes MJ, 2007, J BIOGEOGR, V34, P1246, DOI 10.1111/j.1365-2699.2007.01696.x; Maron JL, 2006, P R SOC B, V273, P2575, DOI 10.1098/rspb.2006.3587; Maser GL, 2007, J THEOR BIOL, V247, P337, DOI 10.1016/j.jtbi.2007.03.003; Mody K, 2007, ECOLOGY, V88, P1012, DOI 10.1890/06-1338; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; da Silva NAP, 2011, REV BRAS ENTOMOL, V55, P79, DOI 10.1590/S0085-56262011000100013; R Development Core Team, 2012, R LANG ENV STAT COMP; Rao M, 2001, CONSERV BIOL, V15, P624, DOI 10.1046/j.1523-1739.2001.015003624.x; Rosch V, 2013, J APPL ECOL, V50, P387, DOI 10.1111/1365-2664.12056; Ruiz-Guerra B, 2010, OIKOS, V119, P317, DOI 10.1111/j.1600-0706.2009.17614.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Santo-Silva EE, 2013, BIOTROPICA, V45, P386, DOI 10.1111/btp.12013; Scholtz C.H., 2008, INSECTS SO AFRICA, V2; Schuldt A, 2010, J ECOL, V98, P917, DOI 10.1111/j.1365-2745.2010.01659.x; Shipley B, 2009, ECOLOGY, V90, P363, DOI 10.1890/08-1034.1; Smith AC, 2009, LANDSCAPE ECOL, V24, P1271, DOI 10.1007/s10980-009-9383-3; Sobek S, 2009, ECOL ENTOMOL, V34, P772, DOI 10.1111/j.1365-2311.2009.01132.x; Thies C, 2003, OIKOS, V101, P18, DOI 10.1034/j.1600-0706.2003.12567.x; Tischendorf L, 2003, LANDSCAPE ECOL, V18, P41, DOI 10.1023/A:1022908109982; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; Valladares G, 2006, CONSERV BIOL, V20, P212, DOI 10.1111/j.1523-1739.2006.00337.x; Vehvilainen H, 2007, OECOLOGIA, V152, P287, DOI 10.1007/s00442-007-0673-7; Wamser S, 2012, INSECT CONSERV DIVER, V5, P9, DOI 10.1111/j.1752-4598.2010.00110.x; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782	51	9	10	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95551	10.1371/journal.pone.0095551	http://dx.doi.org/10.1371/journal.pone.0095551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743315	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100137
J	Wu, L; Herman, JG; Brock, MV; Wu, KM; Mao, GP; Yan, WJ; Nie, Y; Liang, H; Zhan, QM; Li, W; Guo, MZ				Wu, Liang; Herman, James G.; Brock, Malcolm V.; Wu, Kongming; Mao, Gaoping; Yan, Wenji; Nie, Yan; Liang, Hao; Zhan, Qimin; Li, Wen; Guo, Mingzhou			Silencing DACH1 Promotes Esophageal Cancer Growth by Inhibiting TGF-beta Signaling	PLOS ONE			English	Article							FATE DETERMINATION FACTOR; CYCLIN D1; METHYLATION; PROGRESSION; PATHWAY; EXPRESSION; CARCINOMA; RECEPTOR; BINDING; SOX17	Human Dachshund homologue 1 (DACH1) is a major component of the Retinal Determination Gene Network. Loss of DACH1 expression was found in breast, prostate, lung, endometrial, colorectal and hepatocellular carcinoma. To explore the expression, regulation and function of DACH1 in human esophageal cancer, 11 esophageal cancer cell lines, 10 cases of normal esophageal mucosa, 51 cases of different grades of dysplasia and 104 cases of primary esophageal squamous cancer were employed. Methylation specific PCR, immunohistochemistry, western blot, flow cytometry, small interfering RNAs, colony formation techniques and xenograft mice model were used. We found that DACH1 expression was regulated by promoter region hypermethylation in esophageal cancer cell lines. 18.8% (6 of 32) of grade 1, 42.1% (8 of 19) of grade 2 and grade 3 dysplasia (ED2,3), and 61.5% (64 of 104) of esophageal cancer were methylated, but no methylation was found in 10 cases of normal esophageal mucosa. The methylation was increased in progression tendency during esophageal carcinogenesis (P < 0.01). DACH1 methylation was associated with poor differentiation (P < 0.05) and late tumor stage (P < 0.05). Restoration of DACH1 expression inhibited cell growth and activated TGF-beta signaling in KYSE150 and KYSE510 cells. DACH1 suppressed human esophageal cancer cell tumor growth in xenograft mice. In conclusion, DACH1 is frequently methylated in human esophageal cancer and methylation of DACH1 is involved in the early stage of esophageal carcinogenesis. DACH1 expression is regulated by promoter region hypermethylation. DACH1 suppresses esophageal cancer growth by activating TGF-beta signaling.	[Wu, Liang; Yan, Wenji; Liang, Hao; Li, Wen; Guo, Mingzhou] Chinese Peoples Liberat Army Gen Hosp, Dept Gastroenterol & Hepatol, Beijing, Peoples R China; [Herman, James G.; Brock, Malcolm V.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Wu, Kongming] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan 430074, Peoples R China; [Mao, Gaoping] Gen Air Force Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Nie, Yan] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hainan Hosp, Dept Gastroenterol & Hepatol, Hai Tang Wan, Sanya, Peoples R China; [Zhan, Qimin] Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese People's Liberation Army General Hospital; Johns Hopkins University; Johns Hopkins Medicine; Huazhong University of Science & Technology; Chinese People's Liberation Army General Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhan, QM (corresponding author), Chinese Acad Med Sci, Canc Inst & Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China.	zhanqimin@pumc.edu.cn; liwen2000@yahoo.com; mzguo1@gmail.com			National Basic Research Program (973 Program) [2012CB934002, 2010CB912802]; National High-tech R&D Program (863 Program) [SS2012AA020314, SS2012AA020821, SS2012AA020303]; National Key Scientific Instrument Special Programme of China [2011YQ03013405]; National Science Foundation of China [81121004, 81071953, 81161120432, 81072169, 81172422, 81261120395]	National Basic Research Program (973 Program)(National Basic Research Program of China); National High-tech R&D Program (863 Program)(National High Technology Research and Development Program of China); National Key Scientific Instrument Special Programme of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from: the National Basic Research Program (973 Program No. 2012CB934002, 2010CB912802), National High-tech R&D Program (863 Program No. SS2012AA020314, SS2012AA020821, SS2012AA020303), National Key Scientific Instrument Special Programme of China (Grant No. 2011YQ03013405) and National Science Foundation of China (Grant No. 81121004, 81071953, 81161120432, 81072169, 81172422, 81261120395). The URLs of funder's websites are: National Basic Research Program: http://www.973.gov.cn/Default_3.aspx; National High-tech R&D Program: http://www.863.gov.cn/; National Key Scientific Instrument Special Programme of China: http://www.most.gov.cn/index.htm; National Science Foundation of China: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen K, 2013, ONCOTARGET, V4, P923, DOI 10.18632/oncotarget.1094; Chen K, 2013, CANCER RES, V73, P3262, DOI 10.1158/0008-5472.CAN-12-3191; Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Deng Xin-Chao, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P263; Elston Rebecca, 2012, J Signal Transduct, V2012, P294097, DOI 10.1155/2012/294097; Guo M, 2007, INT J CANCER, V121, P1219, DOI 10.1002/ijc.22828; Guo MZ, 2006, CLIN CANCER RES, V12, P4515, DOI 10.1158/1078-0432.CCR-05-2858; Guo MZ, 2008, EPIGENETICS-US, V3, P336, DOI 10.4161/epi.3.6.7158; Guo MZ, 2006, CANCER BIOL THER, V5, P152, DOI 10.4161/cbt.5.2.2318; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inman GJ, 2011, CURR OPIN GENET DEV, V21, P93, DOI 10.1016/j.gde.2010.12.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jia Y, 2012, J MOL DIAGN, V14, P577, DOI 10.1016/j.jmoldx.2012.06.004; Jia Y, 2012, EPIGENOMICS-UK, V4, P135, DOI [10.2217/EPI.12.11, 10.2217/epi.12.11]; Jia Y, 2010, EPIGENETICS-US, V5, P743, DOI 10.4161/epi.5.8.13104; Kuwano H, 2005, SURG TODAY, V35, P7, DOI 10.1007/s00595-004-2885-3; Liang F, 2012, INT J GYNECOL CANCER, V22, P386, DOI 10.1097/IGC.0b013e31824311e6; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meulmeester E, 2011, J PATHOL, V223, P205, DOI 10.1002/path.2785; Nan FF, 2009, CANCER BIOL THER, V8, P1534, DOI 10.4161/cbt.8.16.8963; Pardali K, 2005, J CELL PHYSIOL, V204, P260, DOI 10.1002/jcp.20304; Sato F, 2006, CANCER-AM CANCER SOC, V106, P483, DOI 10.1002/cncr.21657; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Talukdar FR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060996; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Wu KM, 2003, J BIOL CHEM, V278, P51673, DOI 10.1074/jbc.M310021200; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06; Wu KM, 2009, CANCER RES, V69, P3347, DOI 10.1158/0008-5472.CAN-08-3821; Yan W, 2013, EPIGENETICS, V8; Zhu HB, 2013, HEPATOLOGY, V58, P2012, DOI 10.1002/hep.26587; Zu XY, 2012, CELL TISSUE RES, V347, P73, DOI 10.1007/s00441-011-1225-3	36	35	41	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95509	10.1371/journal.pone.0095509	http://dx.doi.org/10.1371/journal.pone.0095509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743895	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100132
J	Zhong, SY; Chen, YX; Fang, M; Zhu, XL; Zhao, YX; Liu, XY				Zhong, Shi-Ying; Chen, Yong-Xing; Fang, Min; Zhu, Xiao-Long; Zhao, Yan-Xin; Liu, Xue-Yuan			Low-Dose Levodopa Protects Nerve Cells from Oxidative Stress and Up-Regulates Expression of pCREB and CD39	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; AMP-RESPONSIVE ELEMENT; LONG-TERM POTENTIATION; L-DOPA; PARKINSONS-DISEASE; TRANSCRIPTION FACTORS; SYNAPTIC PLASTICITY; STRIATAL DOPAMINE; CYCLIC-AMP; RAT STRIATUM	Objective: This study aimed to investigate the influence of low-dose levodopa (L-DOPA) on neuronal cell death under oxidative stress. Methods: PC12 cells were treated with L-DOPA at different concentrations. We detected the L-DOPA induced reactive oxygen species (ROS). Meanwhile, MTT and LDH assay were performed to determine the proliferation and growth of PC12 cells with or without ROS scavenger. In addition, after pretreatment with L-DOPA at different concentrations alone or in combination with CD39 inhibitor, PC12 cells were incubated with hydrogen peroxide (H2O2) and the cell viability was evaluated by MTT and LDH assay. In addition, the expression of pCREB and CD39 was detected by immunofluorescence staining and Western blot assay in both cells and rat's brain after L-DOPA treatment. Results: After treatment with L-DOPA for 3 days, the cell proliferation and growth were promoted when the L-DOPA concentration was <30 mu M, while cell proliferation was comparable to that in control group when the L-DOPA concentration was >30 mu M. Low dose L-DOPA could protect the PC12 cells from H2O2 induced oxidative stress, which was compromised by CD39 inhibitor. In addition, the expression of CD39 and pCREB increased in both PC12 cells and rats' brain after L-DOPA treatment. Conclusions: L-DOPA at different concentrations has distinct influence on proliferation and growth of PC12 cells, and low dose (<30 mu M) L-DOPA protects PC12 cells against oxidative stress which might be related to the up-regulation of CD39 and pCREB expression.	[Zhong, Shi-Ying; Chen, Yong-Xing; Fang, Min; Zhu, Xiao-Long; Zhao, Yan-Xin; Liu, Xue-Yuan] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Neurol, Shanghai 200092, Peoples R China	Tongji University	Zhao, YX (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Neurol, Shanghai 200092, Peoples R China.	zhao_yanxin@126.com; liu1304@yeah.net			Shanghai Science and Technology Committee [11DZ1920903]; Shanghai Municipal Health Bureau [20114319]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Municipal Health Bureau	The study was supported by the Combined Program of Shanghai Science and Technology Committee (No. 11DZ1920903) and Program of Shanghai Municipal Health Bureau (20114319). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnauld E, 1998, MOL BRAIN RES, V60, P127, DOI 10.1016/S0169-328X(98)00192-2; Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Barth AL, 2000, J NEUROSCI, V20, P4206; Brown P, 2006, J COMP NEUROL, V498, P415, DOI 10.1002/cne.21034; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Calon F, 2002, J NEUROPATH EXP NEUR, V61, P186, DOI 10.1093/jnen/61.2.186; Calon F, 2000, TRENDS NEUROSCI, V23, pS92, DOI 10.1016/S1471-1931(00)00026-4; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Cenci MA, 1999, NEUROSCIENCE, V94, P515, DOI 10.1016/S0306-4522(99)00294-8; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Chase TN, 2000, TRENDS NEUROSCI, V23, pS86, DOI 10.1016/S1471-1931(00)00018-5; Dombrowski KE, 1998, IMMUNOL REV, V161, P111, DOI 10.1111/j.1600-065X.1998.tb01575.x; Dragunow M, 2004, FRONT BIOSCI, V9, P100, DOI 10.2741/1197; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; Gerfen CR, 2000, ANN NEUROL, V47, pS42; Gerlo S, 2006, CELL MOL LIFE SCI, V63, P92, DOI 10.1007/s00018-005-5433-4; Han SK, 1996, J NEUROCHEM, V66, P501; HASHIMOTO N, 1994, BRAIN RES BULL, V33, P281, DOI 10.1016/0361-9230(94)90195-3; HolgadoMadruga M, 1997, P NATL ACAD SCI USA, V94, P12419, DOI 10.1073/pnas.94.23.12419; Hoyt KR, 1997, EXP NEUROL, V143, P269, DOI 10.1006/exnr.1996.6374; Hyman MC, 2009, J CLIN INVEST, V119, P1136, DOI 10.1172/JCI36433; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; JACKSON DM, 1994, PHARMACOL THERAPEUT, V64, P291, DOI 10.1016/0163-7258(94)90041-8; Kim DS, 2006, NEUROSCIENCE, V137, P1381, DOI 10.1016/j.neuroscience.2005.10.054; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; LANGEVELD CH, 1995, NEUROSCI LETT, V192, P13, DOI 10.1016/0304-3940(95)11596-O; Langston HP, 2003, J IMMUNOL, V170, P2962, DOI 10.4049/jimmunol.170.6.2962; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; Liu F C, 1998, Adv Pharmacol, V42, P682; Liu FC, 1998, P NATL ACAD SCI USA, V95, P4708, DOI 10.1073/pnas.95.8.4708; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lyras L, 2002, J NEURAL TRANSM, V109, P53, DOI 10.1007/s702-002-8236-2; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574; Marcus A J, 2001, Ital Heart J, V2, P824; Marcus AJ, 2005, SEMIN THROMB HEMOST, V31, P234, DOI 10.1055/s-2005-869528; Marcus AJ, 2003, J THROMB HAEMOST, V1, P2497, DOI 10.1111/j.1538-7836.2003.00479.x; Marcus AJ, 2003, J PHARMACOL EXP THER, V305, P9, DOI 10.1124/jpet.102.043729; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Mena MA, 1997, J NEUROCHEM, V69, P1398; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Oh JD, 2003, J NEUROSCI RES, V72, P768, DOI 10.1002/jnr.10629; Oh JD, 1997, NEUROSCI LETT, V228, P5, DOI 10.1016/S0304-3940(97)00355-8; Olanow CW, 2004, MOVEMENT DISORD, V19, P997, DOI 10.1002/mds.20243; Papadeas ST, 2004, J NEUROSCI, V24, P5863, DOI 10.1523/JNEUROSCI.0528-04.2004; PARDO B, 1995, BRAIN RES, V682, P133, DOI 10.1016/0006-8993(95)00341-M; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Pittenger C, 1998, CR ACAD SCI III-VIE, V321, P91, DOI 10.1016/S0764-4469(97)89807-1; Riccio A, 2002, NAT NEUROSCI, V5, P389, DOI 10.1038/nn0502-389; Robinson SW, 1997, MOL PHARMACOL, V52, P508, DOI 10.1124/mol.52.3.508; ROGUE P, 1994, CELL SIGNAL, V6, P725, DOI 10.1016/0898-6568(94)00044-1; Shao JY, 2004, J BIOL CHEM, V279, P14287, DOI 10.1074/jbc.M313276200; Shin JY, 2009, J NEUROCHEM, V111, P1042, DOI 10.1111/j.1471-4159.2009.06381.x; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SPENCER JPE, 1995, NEUROREPORT, V6, P1480, DOI 10.1097/00001756-199507310-00004; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Viola HE, 2000, J NEUROSCI, V20; Wang HM, 2006, PROG NEUROBIOL, V79, P123, DOI 10.1016/j.pneurobio.2006.06.004; Zhao W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065860; Zhen XC, 1998, MOL PHARMACOL, V54, P453, DOI 10.1124/mol.54.3.453; ZIMMERMANN H, 1992, BIOCHEM J, V285, P345, DOI 10.1042/bj2850345	68	8	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95387	10.1371/journal.pone.0095387	http://dx.doi.org/10.1371/journal.pone.0095387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743653	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100115
J	Dasgupta, MG; George, BS; Bhatia, A; Sidhu, OP				Dasgupta, Modhumita Ghosh; George, Blessan Santhosh; Bhatia, Anil; Sidhu, Om Prakash			Characterization of Withania somnifera Leaf Transcriptome and Expression Analysis of Pathogenesis - Related Genes during Salicylic Acid Signaling	PLOS ONE			English	Article							TIME RT-PCR; SYSTEMIC ACQUIRED-RESISTANCE; HAIRY ROOT CULTURES; RNA-SEQ ANALYSIS; ORYZA-SATIVA L.; EST-SSR MARKERS; DEFENSE RESPONSES; METHYL JASMONATE; DISEASE RESISTANCE; PROTEIN GENES	Withania somnifera (L.) Dunal is a valued medicinal plant with pharmaceutical applications. The present study was undertaken to analyze the salicylic acid induced leaf transcriptome of W. somnifera. A total of 45.6 million reads were generated and the de novo assembly yielded 73,523 transcript contig with average transcript contig length of 1620 bp. A total of 71,062 transcripts were annotated and 53,424 of them were assigned GO terms. Mapping of transcript contigs to biological pathways revealed presence of 182 pathways. Seventeen genes representing 12 pathogenesis-related (PR) families were mined from the transcriptome data and their pattern of expression post 17 and 36 hours of salicylic acid treatment was documented. The analysis revealed significant up-regulation of all families of PR genes by 36 hours post treatment except WsPR10. The relative fold expression of transcripts ranged from 1 fold to 6,532 fold. The two families of peroxidases including the lignin-forming anionic peroxidase (WsL-PRX) and suberization-associated anionic peroxidase (WsS-PRX) recorded maximum expression of 377 fold and 6532 fold respectively, while the expression of WsPR10 was down-regulated by 14 fold. Additionally, the most stable reference gene for normalization of qRT-PCR data was also identified. The effect of SA on the accumulation of major secondary metabolites of W. somnifera including withanoside V, withaferin A and withanolide A was also analyzed and an increase in content of all the three metabolites were detected. This is the first report on expression patterns of PR genes during salicylic acid signaling in W. somnifera.	[Dasgupta, Modhumita Ghosh; George, Blessan Santhosh] Inst Forest Genet & Tree Breeding, Div Plant Biotechnol, Coimbatore, Tamil Nadu, India; [Bhatia, Anil; Sidhu, Om Prakash] CSIR Natl Bot Res Inst, Lucknow, Uttar Pradesh, India	Indian Council of Forestry Research & Education (ICFRE); Institute of Forest Genetics & Tree Breeding (IFGTB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI)	Dasgupta, MG (corresponding author), Inst Forest Genet & Tree Breeding, Div Plant Biotechnol, Coimbatore, Tamil Nadu, India.	ghoshm@icfre.org	Bhatia, Anil/G-4566-2015; Dasgupta, Modhumita Ghosh/AAX-9028-2020	Bhatia, Anil/0000-0001-8286-5574; Dasgupta, Modhumita Ghosh/0000-0001-8878-5911; Ranganathan, Shoba/0000-0002-8290-813X	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/PR/12597/PBD/16/867/2009]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The authors thank the Department of Biotechnology, Ministry of Science and Technology, Government of India, for the financial support (Project ID: BT/PR/12597/PBD/16/867/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime S, 2013, MOL PLANT MICROBE IN, V26, P918, DOI 10.1094/MPMI-12-12-0290-R; An CF, 2011, J INTEGR PLANT BIOL, V53, P412, DOI 10.1111/j.1744-7909.2011.01043.x; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Annadurai RS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-663; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Bharti SK, 2011, MAGN RESON CHEM, V49, P659, DOI 10.1002/mrc.2817; Blanco F, 2009, PLANT MOL BIOL, V70, P79, DOI 10.1007/s11103-009-9458-1; Blanco-Ulate B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00142; Bovie Catherine, 2004, BMC Plant Biology, V4, P15, DOI 10.1186/1471-2229-4-15; BOWLING SA, 1994, PLANT CELL, V6, P1845, DOI 10.1105/tpc.6.12.1845; Breda C, 1996, MOL PLANT MICROBE IN, V9, P713, DOI 10.1094/MPMI-9-0713; Burketova L, 1999, BIOL PLANTARUM, V42, P423, DOI 10.1023/A:1002473404578; Busam G, 1997, PLANT PHYSIOL, V115, P1029, DOI 10.1104/pp.115.3.1029; Cag S, 2009, PAK J BOT, V41, P2297; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chen SF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067974, 10.1371/journal.pone.0054659]; Ciddi Veeresham, 2006, Indian Journal of Pharmaceutical Sciences, V68, P490; Clarke JD, 1998, PLANT CELL, V10, P557, DOI 10.1105/tpc.10.4.557; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Cordeiro GM, 2001, PLANT SCI, V160, P1115, DOI 10.1016/S0168-9452(01)00365-X; CROWELL DN, 1992, PLANT MOL BIOL, V18, P459, DOI 10.1007/BF00040662; Datta R, 2013, J BIOSCIENCES, V38, P317, DOI 10.1007/s12038-013-9308-9; Davis JM, 2002, MOL PLANT MICROBE IN, V15, P380, DOI 10.1094/MPMI.2002.15.4.380; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; DELANEY TP, 1995, P NATL ACAD SCI USA, V92, P6602, DOI 10.1073/pnas.92.14.6602; Delaure SL, 2008, PLANT SCI, V174, P375, DOI 10.1016/j.plantsci.2008.01.008; Derckel JP, 1998, PHYSIOL PLANTARUM, V104, P56, DOI 10.1034/j.1399-3054.1998.1040108.x; Ding CK, 2002, PLANTA, V214, P895, DOI 10.1007/s00425-001-0698-9; Doma M, 2012, INDIAN J EXP BIOL, V50, P484; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Ee SF, 2013, MOL BIOL REP, V40, P2231, DOI 10.1007/s11033-012-2286-4; Fernandes CF, 2006, J PLANT PHYSIOL, V163, P1040, DOI 10.1016/j.jplph.2005.06.021; Gao LL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-340; [高丽娟 Gao Lijuan], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P41; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Ghosh Dasgupta M, 2013, SILVAE GENE IN PRESS; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gorlach J, 1996, PLANT CELL, V8, P629, DOI 10.1105/tpc.8.4.629; Goswami RS, 2013, J CLIN ONCOL, V31, P2903, DOI 10.1200/JCO.2012.45.3050; Gupta P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062714; Gupta P, 2013, PROTOPLASMA, V250, P285, DOI 10.1007/s00709-012-0410-x; Gupta P, 2011, PLANT GROWTH REGUL, V65, P93, DOI 10.1007/s10725-011-9578-x; Gupta PK, 2003, MOL GENET GENOMICS, V270, P315, DOI 10.1007/s00438-003-0921-4; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; Han QM, 2013, PROTOPLASMA, V250, P471, DOI 10.1007/s00709-012-0430-6; Harfouche AL, 2008, J PLANT PHYSIOL, V165, P734, DOI 10.1016/j.jplph.2007.03.010; Hatfield R, 2001, PLANT PHYSIOL, V126, P1351, DOI 10.1104/pp.126.4.1351; Holuigue L., 2007, Salicylic acid: a plant hormone, P197, DOI 10.1007/1-4020-5184-0_8; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Hwang HJ, 2003, PLANT SCI, V165, P1297, DOI 10.1016/S0168-9452(03)00341-8; Hwang SH, 2008, PLANTA, V227, P1141, DOI 10.1007/s00425-007-0687-8; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Jayaraj J, 2004, BIOL PLANTARUM, V48, P425, DOI 10.1023/B:BIOP.0000041097.03177.2d; JUNG JL, 1993, PLANT PHYSIOL, V101, P873, DOI 10.1104/pp.101.3.873; Jwa NS, 2001, BIOCHEM BIOPH RES CO, V286, P973, DOI 10.1006/bbrc.2001.5507; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Ketchum REB, 1999, BIOTECHNOL BIOENG, V62, P97, DOI 10.1002/(SICI)1097-0290(19990105)62:1&lt;97::AID-BIT11&gt;3.0.CO;2-C; Khedgikar V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.294; Klarzynski O, 2000, PLANT PHYSIOL, V124, P1027, DOI 10.1104/pp.124.3.1027; KOGEL KH, 1994, PLANT PHYSIOL, V106, P1269, DOI 10.1104/pp.106.4.1269; KOMBRINK E, 1988, P NATL ACAD SCI USA, V85, P782, DOI 10.1073/pnas.85.3.782; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; Kumar S, 2014, PLANT CELL REP, V33, P905, DOI 10.1007/s00299-014-1569-8; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; LAWTON KA, 1994, MOL PLANT MICROBE IN, V7, P48, DOI 10.1094/MPMI-7-0048; Lee BL, 2013, ELIFE, V2, DOI [10.7554/eLife.00291, 10.1155/2013/961957]; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Liu JJ, 2003, PHYSIOL PLANTARUM, V119, P544, DOI 10.1046/j.1399-3054.2003.00200.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lu H, 2009, PLANT SIGNAL BEHAV, V4, P713, DOI 10.4161/psb.4.8.9173; Ma BC, 2009, J AM SOC HORTIC SCI, V134, P379, DOI 10.21273/JASHS.134.3.379; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Maleck K, 2002, GENETICS, V160, P1661; Martinelli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038039; Mateo A, 2006, J EXP BOT, V57, P1795, DOI 10.1093/jxb/erj196; McGhee JD, 2001, MOL PLANT MICROBE IN, V14, P877, DOI 10.1094/MPMI.2001.14.7.877; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Minamiyama Y, 2006, MOL BREEDING, V18, P157, DOI 10.1007/s11032-006-9024-3; Mir BA, 2011, AFR J BIOTECHNOL, V10, P14746, DOI 10.5897/AJB09.980; Mishra L C, 2000, Altern Med Rev, V5, P334; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morris SW, 1998, MOL PLANT MICROBE IN, V11, P643, DOI 10.1094/MPMI.1998.11.7.643; Naidoo R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00043; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Neuhaus JM, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P77; Ng GN, 2011, GENETICS, V189, P851, DOI 10.1534/genetics.111.132332; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; NIDERMAN T, 1995, PLANT PHYSIOL, V108, P17, DOI 10.1104/pp.108.1.17; Orlowska E, 2012, PLANT CELL REP, V31, P187, DOI 10.1007/s00299-011-1155-2; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Passos MAN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-78; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Portis E, 2007, PLANT SCI, V172, P640, DOI 10.1016/j.plantsci.2006.11.016; Radman R, 2003, BIOTECHNOL APPL BIOC, V37, P91, DOI 10.1042/BA20020118; Rastogi R. P., 1998, COMPENDIUM INDIAN ME, V5, P589; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rodrigues CM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-676; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Salzman RA, 2005, PLANT PHYSIOL, V138, P352, DOI 10.1104/pp.104.058206; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shah J, 1997, MOL PLANT MICROBE IN, V10, P69, DOI 10.1094/MPMI.1997.10.1.69; Singh NK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083963, 10.1371/journal.pone.0073005]; Singhal VK, 2008, COMP CYTOGENET, V2, P85; Siriwardane A S, 2013, Pak J Biol Sci, V16, P141, DOI 10.3923/pjbs.2013.141.144; Sivanandhan G, 2012, IND CROP PROD, V37, P124, DOI 10.1016/j.indcrop.2011.11.022; Sivanandhan G, 2013, PLANT CELL TISS ORG, V114, P121, DOI 10.1007/s11240-013-0297-z; Sivanandhan G, 2012, APPL BIOCHEM BIOTECH, V168, P681, DOI 10.1007/s12010-012-9809-2; Socquet-Juglard D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054196; Soh HC, 2012, EUR J PLANT PATHOL, V132, P37, DOI 10.1007/s10658-011-9846-7; Somssich IE, 1998, TRENDS PLANT SCI, V3, P86, DOI 10.1016/S1360-1385(98)01199-6; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Taheri P., 2012, J BOT, V2012, P6, DOI DOI 10.1155/2012/137037; Takeuchi K, 2011, PLANT CELL PHYSIOL, V52, P1686, DOI 10.1093/pcp/pcr105; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thi THD, 2009, PLANT PHYSIOL BIOCH, V47, P146, DOI 10.1016/j.plaphy.2008.10.001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tripathi N., 2012, J MED AROM PLANT SCI, V6, P33; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Udayakumar R., 2013, European Journal of Medicinal Plants, V3, P266; Van der Does D, 2013, PLANT CELL, V25, P744, DOI 10.1105/tpc.112.108548; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Veluthakkal R, 2012, FOREST PATHOL, V42, P467, DOI 10.1111/j.1439-0329.2012.00781.x; Veluthakkal R, 2010, TREES-STRUCT FUNCT, V24, P993, DOI 10.1007/s00468-010-0489-7; Verma SK., 2011, ASIAN J PHARM CLIN R, V4, P1; Vidal S, 1997, PLANT J, V11, P115, DOI 10.1046/j.1365-313X.1997.11010115.x; Vidya K. M., 2013, Asian Journal of Horticulture, V8, P97; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wachholtz M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-613; Walter MH, 1996, EUR J BIOCHEM, V239, P281, DOI 10.1111/j.1432-1033.1996.0281u.x; Wan HJ, 2011, BIOCHEM BIOPH RES CO, V416, P24, DOI 10.1016/j.bbrc.2011.10.105; Wang YY, 2011, SCI HORTIC-AMSTERDAM, V129, P183, DOI 10.1016/j.scienta.2011.03.021; Wang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-650; WARD ER, 1991, PLANT PHYSIOL, V96, P390, DOI 10.1104/pp.96.2.390; WARNER SAJ, 1994, PLANT J, V6, P31, DOI 10.1046/j.1365-313X.1994.6010031.x; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Xu XB, 2008, POSTHARVEST BIOL TEC, V49, P379, DOI 10.1016/j.postharvbio.2008.02.003; XU Y, 1994, PLANT CELL, V6, P1077, DOI 10.1105/tpc.6.8.1077; Yao HJ, 2005, POSTHARVEST BIOL TEC, V35, P253, DOI 10.1016/j.postharvbio.2004.09.001; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Yu Z, 2010, P NATL ACAD SCI USA, V107, P17809, DOI 10.1073/pnas.1000852107; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Jiyu, 2010, BMC Res Notes, V3, P208, DOI 10.1186/1756-0500-3-208; Zhang LY, 2003, ACTA BOT SIN, V45, P802; Zhou N, 1998, PLANT CELL, V10, P1021, DOI 10.1105/tpc.10.6.1021; ZHU BL, 1995, PLANT MOL BIOL, V28, P17, DOI 10.1007/BF00042034; Zhu QH, 2013, GENE, V512, P259, DOI 10.1016/j.gene.2012.10.036	163	17	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94803	10.1371/journal.pone.0094803	http://dx.doi.org/10.1371/journal.pone.0094803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739900	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900068
J	Hedreville, M; Charlot, K; Waltz, X; Sinnapah, S; Lemonne, N; Etienne-Julan, M; Soter, V; Hue, O; Hardy-Dessources, MD; Barthelemy, JC; Connes, P				Hedreville, Mona; Charlot, Keyne; Waltz, Xavier; Sinnapah, Stephane; Lemonne, Nathalie; Etienne-Julan, Maryse; Soter, Valerie; Hue, Olivier; Hardy-Dessources, Marie-Dominique; Barthelemy, Jean-Claude; Connes, Philippe			Acute Moderate Exercise Does Not Further Alter the Autonomic Nervous System Activity in Patients with Sickle Cell Anemia	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; SYMPATHOVAGAL BALANCE; AGGREGATE STRENGTH; CLINICAL SEVERITY; MENSTRUAL-CYCLE; DYSFUNCTION; BLOOD; CHILDREN; DISEASE; ADULTS	A decreased global autonomic nervous system (ANS) activity and increased sympathetic activation in patients with sickle cell anemia (SCA) seem to worsen the clinical severity and could play a role in the pathophysiology of the disease, notably by triggering vaso-occlusive crises. Because exercise challenges the ANS activity in the general population, we sought to determine whether a short (<15 min) and progressive moderate exercise session conducted until the first ventilatory threshold had an effect on the ANS activity of a group of SCA patients and a group of healthy individuals (CONT group). Temporal and spectral analyses of the nocturnal heart rate variability were performed before and on the 3 nights following the exercise session. Standard deviation of all normal RR intervals (SDNN), total power, low frequencies (LF) and high frequencies powers (HF) were lower but LF/HF was higher in SCA patients than in the CONT group. Moderate exercise did not modify ANS activity in both groups. In addition, no adverse clinical events occurred during the entire protocol. These results imply that this kind of short and moderate exercise is not detrimental for SCA patients.	[Hedreville, Mona; Charlot, Keyne; Waltz, Xavier; Sinnapah, Stephane; Hue, Olivier; Connes, Philippe] French West Indies & Guiana Univ, Dept Physiol, EA 3596, Lab ACTES, Pointe A Pitre, Guadeloupe, France; [Hedreville, Mona] Acad Hosp Pointe A Pitre, Emergency Care Dept, Pointe A Pitre, Guadeloupe, France; [Charlot, Keyne; Waltz, Xavier; Etienne-Julan, Maryse; Hardy-Dessources, Marie-Dominique; Connes, Philippe] French West Indies & Guiana Univ, INSERM, U1134, UMR, Pointe A Pitre, Guadeloupe, France; [Charlot, Keyne; Waltz, Xavier; Hardy-Dessources, Marie-Dominique] PRES Sorbonne, Lab Excellence Globule Rouge LABEX GR Ex, Paris, France; [Lemonne, Nathalie; Etienne-Julan, Maryse] Acad Hosp Pointe A Pitre, Sickle Cell Ctr, Pointe A Pitre, Guadeloupe, France; [Soter, Valerie] Acad Hosp Pointe A Pitre, Direct Res & Innovat, Pointe A Pitre, Guadeloupe, France; [Barthelemy, Jean-Claude] Univ St Etienne, PRES Lyon, Lab SNA EPIS EA4607, St Etienne, France; [Connes, Philippe] IUF, Paris, France	CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Guadeloupe; CHU Guadeloupe; Universite Jean Monnet	Connes, P (corresponding author), French West Indies & Guiana Univ, Dept Physiol, EA 3596, Lab ACTES, Pointe A Pitre, Guadeloupe, France.	pconnes@yahoo.fr	HEDREVILLE, MONA/R-7705-2019; Barthelemy, Jean-Claude/AAE-7180-2019; , Hardy-dessources/K-9189-2017; WALTZ, Xavier/M-3606-2016; Connes, Philippe/J-7835-2019	, Hardy-dessources/0000-0003-0861-3648; WALTZ, Xavier/0000-0002-0838-290X; Connes, Philippe/0000-0002-9232-0268; Hue, Olivier/0000-0002-2155-0816; Philippe, Connes/0000-0001-8449-7998; ETIENNE-JULAN, Maryse/0000-0003-1339-6545	Contrat Plan Etat Region (CPER) grant; Inserm; Region Guadeloupe; Contrat Plan Etat Region (CPER) grant; Inserm; Region Guadeloupe	Contrat Plan Etat Region (CPER) grant; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Guadeloupe; Contrat Plan Etat Region (CPER) grant; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Guadeloupe	KC is funded by a Contrat Plan Etat Region (CPER) grant and XW was supported by a grant from Inserm and the Region Guadeloupe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Haddad H, 2009, INT J SPORT PHYSIOL, V4, P435, DOI 10.1123/ijspp.4.4.435; Al J, 2007, NEUROSCIENCE, V149, P845, DOI 10.1016/j.neuroscience.2007.07.062; Balayssac-Siransy E, 2011, BRIT J HAEMATOL, V154, P398, DOI 10.1111/j.1365-2141.2011.08728.x; Barbeau P, 2001, ENDOTHELIUM-NEW YORK, V8, P147, DOI 10.3109/10623320109165323; Billman GE, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00086; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Boyd A, 2012, ALLERGY ASTHMA CL IM, V8, DOI 10.1186/1710-1492-8-13; Callahan LA, 2002, AM J RESP CRIT CARE, V165, P1309, DOI 10.1164/rccm.2002036; Camm AJ, 1996, EUR HEART J, V17, P354; Chirico EN, 2012, IUBMB LIFE, V64, P72, DOI 10.1002/iub.584; Connes P, 2014, BRIT J HAEMATOL, V165, P564, DOI 10.1111/bjh.12786; Connes P, 2013, CR BIOL, V336, P142, DOI 10.1016/j.crvi.2012.09.003; Connes P, 2011, CLIN HEMORHEOL MICRO, V49, P151, DOI 10.3233/CH-2011-1465; Etienne-Julan M, 2004, HAEMATOLOGICA, V89, P863; Ettinger SM, 1998, J APPL PHYSIOL, V85, P2075, DOI 10.1152/jappl.1998.85.6.2075; Faes C, 2013, BR J HAEMAT IN PRESS; Fortrat JO, 1999, AM J PHYSIOL-HEART C, V277, pH261, DOI 10.1152/ajpheart.1999.277.1.H261; Fronzoni F, 2004, HAEMATOLOGICA, V89, P233; FURLAN R, 1993, CARDIOVASC RES, V27, P482, DOI 10.1093/cvr/27.3.482; Hautala A, 2001, CLIN PHYSIOL, V21, P238, DOI 10.1046/j.1365-2281.2001.00309.x; Inamo J, 2009, AM J HEMATOL, V84, P311, DOI 10.1002/ajh.21377; Jouven X, 2005, NEW ENGL J MED, V352, P1951, DOI 10.1056/NEJMoa043012; Knight-Madden JM, 2013, CLIN HEMORHEOL MICRO, V53, P231, DOI 10.3233/CH-2012-1545; Lamarre Y, 2013, CLIN HEMORHEOL MICRO; Leicht AS, 2003, EXP PHYSIOL, V88, P441, DOI 10.1113/eph8802535; MARTIN GJ, 1987, AM J CARDIOL, V60, P86, DOI 10.1016/0002-9149(87)90990-8; Moheeb H, 2007, AM J HEMATOL, V82, P91, DOI 10.1002/ajh.20755; Myllymaki T, 2012, EUR J APPL PHYSIOL, V112, P801, DOI 10.1007/s00421-011-2034-9; Nebor D, 2011, HAEMATOL-HEMATOL J, V96, P1589, DOI 10.3324/haematol.2011.047365; O'Hagan C, 2013, SPORTS MED, V43, P39, DOI 10.1007/s40279-012-0004-y; Oguanobi NI, 2012, ACTA CARDIOL, V67, P169, DOI 10.1080/AC.67.2.2154207; Pearson SR, 2005, CLIN AUTON RES, V15, P400, DOI 10.1007/s10286-005-0300-9; Pepin JL, 2002, REV NEUROL-FRANCE, V158, P785; Princi Tanja, 2005, V41, P340; Ries AL, 2007, CHEST, V131, p4S, DOI 10.1378/chest.06-2418; ROMPELMAN O, 1977, MED BIOL ENG COMPUT, V15, P233, DOI 10.1007/BF02441043; Sangkatumvong S, 2011, AM J RESP CRIT CARE, V184, P474, DOI 10.1164/rccm.201103-0537OC; SAYERS BM, 1973, ERGONOMICS, V16, P17; Tripette J, 2009, HAEMATOL-HEMATOL J, V94, P1060, DOI 10.3324/haematol.2008.005371; Vaya A, 2013, CLIN HEMORHEOL MICRO; Vent-Schmidt J, 2013, CLIN HEMORHEOL MICRO; Waltz X, 2013, HAEMATOLOGICA, V98, P1039, DOI 10.3324/haematol.2013.083576; Waltz X, 2012, CLIN HEMORHEOL MICRO, V52, P15, DOI 10.3233/CH-2012-1540	43	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95563	10.1371/journal.pone.0095563	http://dx.doi.org/10.1371/journal.pone.0095563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740295	gold, Green Published			2022-12-25	WOS:000336863900155
J	Kizima, L; Rodriguez, A; Kenney, J; Derby, N; Mizenina, O; Menon, R; Seidor, S; Zhang, SM; Levendosky, K; Jean-Pierre, N; Pugach, P; Villegas, G; Ford, BE; Gettie, A; Blanchard, J; Piatak, M; Lifson, JD; Paglini, G; Teleshova, N; Zydowsky, TM; Robbiani, M; Fernandez-Romero, JA				Kizima, Larisa; Rodriguez, Aixa; Kenney, Jessica; Derby, Nina; Mizenina, Olga; Menon, Radhika; Seidor, Samantha; Zhang, Shimin; Levendosky, Keith; Jean-Pierre, Ninochka; Pugach, Pavel; Villegas, Guillermo; Ford, Brian E.; Gettie, Agegnehu; Blanchard, James; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Paglini, Gabriela; Teleshova, Natalia; Zydowsky, Thomas M.; Robbiani, Melissa; Fernandez-Romero, Jose A.			A Potent Combination Microbicide that Targets SHIV-RT, HSV-2 and HPV	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; PLACEBO-CONTROLLED TRIAL; CARRAGUARD VAGINAL GEL; ANTI-HIV MICROBICIDES; REVERSE-TRANSCRIPTASE; IN-VITRO; GENITAL HERPES; ANIMAL-MODELS; PREEXPOSURE PROPHYLAXIS	Prevalent infection with human herpes simplex 2 (HSV-2) or human papillomavirus (HPV) is associated with increased human immunodeficiency virus (HIV) acquisition. Microbicides that target HIV as well as these sexually transmitted infections (STIs) may more effectively limit HIV incidence. Previously, we showed that a microbicide gel (MZC) containing (M) under bar IV-150, zinc acetate ((Z) under barA) and carrageenan ((C) under barG) protected macaques against simian-human immunodeficiency virus (SHIV-RT) infection and that a ZC gel protected mice against HSV-2 infection. Here we evaluated a modified MZC gel (containing different buffers, co-solvents, and preservatives suitable for clinical testing) against both vaginal and rectal challenge of animals with SHIV-RT, HSV-2 or HPV. MZC was stable and safe in vitro (cell viability and monolayer integrity) and in vivo (histology). MZC protected macaques against vaginal (p<0.0001) SHIV-RT infection when applied up to 8 hours (h) prior to challenge. When used close to the time of challenge, MZC prevented rectal SHIV-RT infection of macaques similar to the CG control. MZC significantly reduced vaginal (p<0.0001) and anorectal (p = 0.0187) infection of mice when 10(6) pfu HSV-2 were applied immediately after vaginal challenge and also when 5x10(3) pfu were applied between 8 h before and 4 h after vaginal challenge (p<0.0248). Protection of mice against 8x10(6) HPV16 pseudovirus particles (HPV16 PsV) was significant for MZC applied up to 24 h before and 2 h after vaginal challenge (p<0.0001) and also if applied 2 h before or after anorectal challenge (p<0.0006). MZC provides a durable window of protection against vaginal infection with these three viruses and, against HSV-2 and HPV making it an excellent candidate microbicide for clinical use.	[Kizima, Larisa; Rodriguez, Aixa; Kenney, Jessica; Derby, Nina; Mizenina, Olga; Menon, Radhika; Seidor, Samantha; Zhang, Shimin; Levendosky, Keith; Jean-Pierre, Ninochka; Pugach, Pavel; Villegas, Guillermo; Ford, Brian E.; Teleshova, Natalia; Zydowsky, Thomas M.; Robbiani, Melissa; Fernandez-Romero, Jose A.] Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA; [Blanchard, James] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Frederick Natl Lab, Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick, MD USA; [Paglini, Gabriela; Fernandez-Romero, Jose A.] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol JM Vanella, RA-5000 Cordoba, Argentina	Population Council; Rockefeller University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National University of Cordoba	Fernandez-Romero, JA (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	jromero@popcouncil.org	Ford, Brian E/G-5875-2010	Ford, Brian E/0000-0003-0543-4978	United States Agency for International Development (USAID), Bureau for Global Health, Office of Population and Reproductive Health [GPO-A-00-04-00019]; Swedish Ministry of Foreign Affairs; Swedish International Development Cooperation Agency; TNPRC National Institutes of Health (NIH) [RR00164]; National Cancer Institute, NIH [HHSN261200800001E]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	United States Agency for International Development (USAID), Bureau for Global Health, Office of Population and Reproductive Health(United States Agency for International Development (USAID)); Swedish Ministry of Foreign Affairs; Swedish International Development Cooperation Agency; TNPRC National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was made possible by the generous support of the American people through the United States Agency for International Development (USAID), Bureau for Global Health, Office of Population and Reproductive Health, under the terms of Award No. GPO-A-00-04-00019. This work was also supported by the Swedish Ministry of Foreign Affairs, the Swedish International Development Cooperation Agency, the TNPRC National Institutes of Health (NIH) base grant RR00164, and with federal funds from the National Cancer Institute, NIH, under contract HHSN261200800001E. The contents of this paper are the sole responsibility of the Population Council and do not necessarily reflect the views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MR is a 2002 Elizabeth Glaser Scientist.	Alexander TH, 2006, LARYNGOSCOPE, V116, P217, DOI 10.1097/01.mlg.0000191549.17796.13; Aravantinou M, 2012, AIDS RES HUM RETROV, V28, P1467, DOI [10.1089/aid.2012.0080, 10.1089/AID.2012.0080]; Ashley R, 1995, DIAGNOSTIC PROCEDURE, P383; Begay O, 2011, AIDS RES HUM RETROV, V27, P1019, DOI [10.1089/aid.2010.0252, 10.1089/AID.2010.0252]; Bernstein DI, 2003, ANTIMICROB AGENTS CH, V47, P3784, DOI 10.1128/AAC.47.12.3784-3788.2003; Bourne N, 2005, ANTIMICROB AGENTS CH, V49, P1181, DOI 10.1128/AAC.49.3.1181-1183.2005; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Catalone BJ, 2004, ANTIMICROB AGENTS CH, V48, P1837, DOI 10.1128/AAC.48.5.1837-1847.2004; Chateau M, 2013, J VIROL, V87, P1274, DOI 10.1128/JVI.01777-12; CHVAPIL M, 1979, J BIOMED MATER RES, V13, P1, DOI 10.1002/jbm.820130103; Cline AN, 2005, J MED PRIMATOL, V34, P303; Corey L, 2007, J INFECT DIS, V195, P1242, DOI 10.1086/513570; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; Delbello A, 2010, ACTA DERMATOVEN ALP, V19, P13; Derby N, 2013, EXPERT REV ANTI-INFE, V11, P5, DOI [10.1586/ERI.12.155, 10.1586/eri.12.155]; Fahim MS, 1996, CONTRACEPTION, V53, P231, DOI 10.1016/0010-7824(96)00042-X; Fernandez-Romero JA, 2007, SEX TRANSM DIS, V34, P9, DOI 10.1097/01.olq.0000223287.46097.4b; Fernandez-Romero JA, 2012, ANTIMICROB AGENTS CH, V56, P358, DOI 10.1128/AAC.05461-11; Fetherston SM, 2013, EUR J PHARM SCI, V48, P406, DOI 10.1016/j.ejps.2012.12.002; Fletcher PS, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-46; Geitmann M, 2006, J MED CHEM, V49, P2367, DOI 10.1021/jm0504048; Handisurya A, 2012, VIROLOGY, V433, P385, DOI 10.1016/j.virol.2012.08.035; Herrera C, 2011, AIDS, V25, P1971, DOI 10.1097/QAD.0b013e32834b3629; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Hurt CB, 2011, CLIN INFECT DIS, V53, P1265, DOI 10.1093/cid/cir684; Jin XW, 2013, CLEV CLIN J MED, V80, P49, DOI 10.3949/ccjm.80a.12084; Johnson KM, 2009, J VIROL, V83, P2067, DOI 10.1128/JVI.02190-08; Johnson TJ, 2010, EUR J PHARM SCI, V39, P203, DOI 10.1016/j.ejps.2009.11.007; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kenney J, 2012, AIDS RES HUM RETROV, V28, P1476, DOI [10.1089/aid.2012.0087, 10.1089/AID.2012.0087]; Kenney J, 2013, ANTIMICROB AGENTS CH, V57, P4001, DOI 10.1128/AAC.00796-13; Kenney J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015835; Kilmarx PH, 2008, SEX TRANSM DIS, V35, P226, DOI 10.1097/OLQ.0b013e31815d6e0d; Kilmarx PH, 2006, JAIDS-J ACQ IMM DEF, V43, P327, DOI 10.1097/01.qai.0000243056.59860.c1; Marais D, 2011, ANTIVIR THER, V16, P1219, DOI 10.3851/IMP1890; Martin S, 2010, J WOMENS HEALTH, V19, P1561, DOI 10.1089/jwh.2009.1362; McGowan I, 2011, AIDS BEHAV, V15, pS66, DOI 10.1007/s10461-011-9899-9; McLean CA, 2010, AIDS, V24, P717, DOI 10.1097/QAD.0b013e328333bf89; Mocchegiani E, 2000, TRENDS PHARMACOL SCI, V21, P205, DOI 10.1016/S0165-6147(00)01476-0; Mocchegiani E, 2000, MECH AGEING DEV, V121, P21; Mocchegiani E, 2000, BIOGERONTOLOGY, V1, P133, DOI 10.1023/A:1010095930854; Moench TR, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-331; Moncla BJ, 2012, J MICROBIOL METH, V88, P292, DOI 10.1016/j.mimet.2011.12.013; National Research Council, 2010, GUIDE CARE USE LAB A; Nel AM, 2010, AIDS RES HUM RETROV, V26, P1181, DOI 10.1089/aid.2009.0227; Nel AM, 2010, JAIDS-J ACQ IMM DEF, V55, P161, DOI 10.1097/QAI.0b013e3181e3293a; Nixon B, 2013, J VIROL, V87, P6257, DOI 10.1128/JVI.00012-13; Rink L, 2000, J NUTR, V130, p1407S, DOI 10.1093/jn/130.5.1407S; Roberts JN, 2007, NAT MED, V13, P857, DOI 10.1038/nm1598; Roberts JN, 2011, JNCI-J NATL CANCER I, V103, P737, DOI 10.1093/jnci/djr061; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Schader SM, 2011, AIDS, V25, P1585, DOI 10.1097/QAD.0b013e3283491f89; Segarra TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027675; Singer R, 2011, J VIROL, V85, P5504, DOI 10.1128/JVI.02422-10; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Smith SM, 1999, AIDS RES HUM RETROV, V15, P1691, DOI 10.1089/088922299309739; Spinazzi M, 2009, NEUROLOGY, V73, P76, DOI 10.1212/01.wnl.0000349696.89948.b7; Tien D, 2005, AIDS RES HUM RETROV, V21, P845, DOI 10.1089/aid.2005.21.845; Trkola A, 1999, J VIROL, V73, P8966, DOI 10.1128/JVI.73.11.8966-8974.1999; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Veazey RS, 2013, CURR OPIN HIV AIDS, V8, P295, DOI 10.1097/COH.0b013e328361d096; Veazey RS, 2012, CURR HIV RES, V10, P79, DOI 10.2174/157016212799304715; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Whitehead SJ, 2006, AIDS, V20, P2141, DOI 10.1097/QAD.0b013e32801086c9; Whitehead SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014831; Wilson SS, 2009, ANTIVIR THER, V14, P1113, DOI 10.3851/IMP1463; ZAK O, 1991, ANTIMICROB AGENTS CH, V35, P1527, DOI 10.1128/AAC.35.8.1527	69	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94547	10.1371/journal.pone.0094547	http://dx.doi.org/10.1371/journal.pone.0094547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740100	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900053
J	Tikhonenkov, DV; Janouskovec, J; Mylnikov, AP; Mikhailov, KV; Simdyanov, TG; Aleoshin, VV; Keeling, PJ				Tikhonenkov, Denis V.; Janouskovec, Jan; Mylnikov, Alexander P.; Mikhailov, Kirill V.; Simdyanov, Timur G.; Aleoshin, Vladimir V.; Keeling, Patrick J.			Description of Colponema vietnamica sp.n. and Acavomonas peruviana n. gen. n. sp., Two New Alveolate Phyla (Colponemidia nom. nov and Acavomonidia nom. nov.) and Their Contributions to Reconstructing the Ancestral State of Alveolates and Eukaryotes	PLOS ONE			English	Article							PERKINSUS-MARINUS; MITOCHONDRIAL GENOME; OXYRRHIS-MARINA; ALGAL ORIGIN; FLAGELLATE; ULTRASTRUCTURE; APICOMPLEXAN; MORPHOLOGY; PHYLOGENY; DINOFLAGELLATE	The evolutionary and ecological importance of predatory flagellates are too often overlooked. This is not only a gap in our understanding of microbial diversity, but also impacts how we interpret their better-studied relatives. A prime example of these problems is found in the alveolates. All well-studied species belong to three large clades (apicomplexans, dinoflagellates, and ciliates), but the predatory colponemid flagellates are also alveolates that are rare in nature and seldom cultured, but potentially important to our understanding of alveolate evolution. Recently we reported the first cultivation and molecular analysis of several colponemid-like organisms representing two novel clades in molecular trees. Here we provide ultrastructural analysis and formal species descriptions for both new species, Colponema vietnamica n. sp. and Acavomonas peruviana n. gen. n. sp. Morphological and feeding characteristics concur with molecular data that both species are distinct members of alveolates, with Acavomonas lacking the longitudinal phagocytotic groove, a defining feature of Colponema. Based on ultrastructure and molecular phylogenies, which both provide concrete rationale for a taxonomic reclassification of Alveolata, we establish the new phyla Colponemidia nom. nov. for the genus Colponema and its close relatives, and Acavomonidia nom. nov. for the genus Acavomonas and its close relatives. The morphological data presented here suggests that colponemids are central to our understanding of early alveolate evolution, and suggest they also retain features of the common ancestor of all eukaryotes.	[Tikhonenkov, Denis V.; Janouskovec, Jan; Keeling, Patrick J.] Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada; [Tikhonenkov, Denis V.; Mylnikov, Alexander P.] Russian Acad Sci, Inst Biol Inland Waters, Borok, Yaroslavl Prove, Russia; [Mikhailov, Kirill V.; Aleoshin, Vladimir V.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Simdyanov, Timur G.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Papanin Institute for Biology of Inland Waters; Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University	Tikhonenkov, DV (corresponding author), Univ British Columbia, Canadian Inst Adv Res, Dept Bot, Vancouver, BC, Canada.	tikho-denis@yandex.ru	Tikhonenkov, Denis/ABA-4225-2020; Simdyanov, Timur G/H-8279-2012; Aleoshin, Vladimir/AAE-9707-2022; Aleoshin, Vladimir/AFE-8409-2022; Mylnikov, Alexander/J-2929-2016; Janouškovec, Jan/ABA-2568-2021; Tikhonenkov, Denis/E-9449-2014	Tikhonenkov, Denis/0000-0002-4882-2148; Simdyanov, Timur G/0000-0003-2478-9301; Aleoshin, Vladimir/0000-0002-3299-9950; Mylnikov, Alexander/0000-0003-3746-2797; Janouškovec, Jan/0000-0001-6547-749X; Tikhonenkov, Denis/0000-0002-4882-2148; Mikhailov, Kirill/0000-0002-0457-9625; Keeling, Patrick/0000-0002-7644-0745	Russian Foundation for Basic Research [11-04-00084-a, 12-04-33067-mol_a-ved, 11-04-00077-a, 14-04-00554-a]; Canadian Institutes for Health Research [MOP-42517]; John Simon Guggenheim Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); John Simon Guggenheim Foundation	The work was supported by the Russian Foundation for Basic Research (No 11-04-00084-a, 12-04-33067-mol_a-ved, 11-04-00077-a and 14-04-00554-a to DVT and APM); and a grant from the Canadian Institutes for Health Research (MOP-42517) to PJK. PJK is a Fellow of the Canadian Institute for Advanced Research and was supported by a Fellowship from the John Simon Guggenheim Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Blanc L, 2000, J BIOGEOGR, V27, P141, DOI 10.1046/j.1365-2699.2000.00347.x; BOVEE E C, 1979, University of Kansas Science Bulletin, V51, P615; BROERS CAM, 1990, EUR J PROTISTOL, V25, P369, DOI 10.1016/S0932-4739(11)80130-6; Brugerolle G, 2003, EUR J PROTISTOL, V39, P101, DOI 10.1078/0932-4739-00910; Brugerolle G, 2002, EUR J PROTISTOL, V37, P379, DOI 10.1078/0932-4739-00837; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavalier-Smith T, 2004, EUR J PROTISTOL, V40, P185, DOI 10.1016/j.ejop.2004.01.002; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; CHADEFAUD M., 1944, REV SCI [PARIS], V82, P43; DODGE J D, 1971, Protistologica, V7, P399; DODGE J D, 1971, Protistologica, V7, P295; Faria G. de, 1922, Memorias do Instituto Oswaldo Cruz, V15, P186; Feagin JE, 1997, NUCLEIC ACIDS RES, V25, P438, DOI 10.1093/nar/25.2.438; Fernandez I, 1999, EUR J PROTISTOL, V35, P55, DOI 10.1016/S0932-4739(99)80022-4; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Janouskovec J, 2013, CURR BIOL, V23, P2546, DOI 10.1016/j.cub.2013.10.062; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keeling PJ, 2009, J EUKARYOT MICROBIOL, V56, P1, DOI 10.1111/j.1550-7408.2008.00371.x; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Kohler S, 1997, SCIENCE, V275, P1485, DOI 10.1126/science.275.5305.1485; Kuvardina ON, 2002, J EUKARYOT MICROBIOL, V49, P498, DOI 10.1111/j.1550-7408.2002.tb00235.x; Leander BS, 2003, J EUKARYOT MICROBIOL, V50, P334, DOI 10.1111/j.1550-7408.2003.tb00145.x; Lemmermann E, 1914, SUSSWASERFLORA DEUTS, P28; Lim L, 2010, PHILOS T R SOC B, V365, P749, DOI 10.1098/rstb.2009.0273; Masuda I, 2010, NUCLEIC ACIDS RES, V38, P6186, DOI 10.1093/nar/gkq449; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; McFadden GI, 2001, J PHYCOL, V37, P951, DOI 10.1046/j.1529-8817.2001.01126.x; MIGNOT J P, 1975, Protistologica, V11, P429; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Myl'nikov AP, 2006, ZOOL ZH, V85, P1164; MYL'NIKOV A P, 1989, Botanicheskii Zhurnal (St. Petersburg), V74, P184; Myl'nikov AP, 2000, ZOOL ZH, V79, P261; Myl'nikova ZM, 2010, INLAND WATER BIOL, V3, P21, DOI 10.1134/S1995082910010037; Mylnikov A.P., 2007, Zoosystematica Rossica, V16, P1; Mylnikov AP, 2009, ZOOL ZH, V88, P1163; Mylnikov AP, 2009, BIOL BULL+, V36, P582, DOI 10.1134/S1062359009060065; MYLNIKOV AP, 1991, ZOOL ZH, V70, P5; Nash EA, 2007, MOL BIOL EVOL, V24, P1528, DOI 10.1093/molbev/msm074; Noren F, 1999, EUR J PROTISTOL, V35, P233, DOI 10.1016/S0932-4739(99)80001-7; O'Kelly CJ, 1999, PROTIST, V150, P149, DOI 10.1016/S1434-4610(99)70018-0; Obornik M, 2012, PROTIST, V163, P306, DOI 10.1016/j.protis.2011.09.001; OKELLY CJ, 1993, J EUKARYOT MICROBIOL, V40, P627, DOI 10.1111/j.1550-7408.1993.tb06120.x; PERKINS FO, 1976, J PARASITOL, V62, P959, DOI 10.2307/3279192; Perkins FO, 1996, J SHELLFISH RES, V15, P67; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Sandon H, 1927, BIOL MONOGRAPHS MANU, V7, P239; Shatilovich AV, 2010, ZOOL ZH, V89, P387; Shatilovich Anastassia V., 2009, V16, P97; Siddall Mark E., 2001, American Museum Novitates, V3314, P1, DOI 10.1206/0003-0082(2001)314<0001:MDOTPP>2.0.CO;2; Siddall ME, 1997, PARASITOLOGY, V115, P165, DOI 10.1017/S0031182097001157; Silberman JD, 2004, J EUKARYOT MICROBIOL, V51, P246, DOI 10.1111/j.1550-7408.2004.tb00555.x; Simpson AGB, 1996, SYST PARASITOL, V33, P187, DOI 10.1007/BF01531200; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stein FR, 1878, ORG FLAGELLATEN 1 OR, VIII; Tikhonenkov DV, 2008, ZH OBSHCH BIOL, V69, P57; Tikhonenkov DV, 2012, ACTA PROTOZOOL, V51, P65, DOI 10.4467/16890027AP.12.006.0389; VORS N, 1992, OPHELIA, V36, P1; Yubuki N, 2013, PLANT J, V75, P230, DOI 10.1111/tpj.12145; Zhukov B., 1979, BIOL INLAND WATER IN, V42, P9; Zhukov BF, 1987, FAUNA BIOL PRESNOVOD, P70	65	33	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95467	10.1371/journal.pone.0095467	http://dx.doi.org/10.1371/journal.pone.0095467			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740116	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900146
J	Peng, Y; Liu, YM; Li, LC; Wang, LL; Wu, XL				Peng, Yang; Liu, Yan-Min; Li, Lu-Chun; Wang, Lu-Lu; Wu, Xiao-Ling			MicroRNA-338 Inhibits Growth, Invasion and Metastasis of Gastric Cancer by Targeting NRP1 Expression	PLOS ONE			English	Article							FACTOR VEGF; MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; TUMOR-CELLS; TGF-BETA; NEUROPILIN-1; RECEPTOR; ANGIOGENESIS; MECHANISMS; PATHWAYS	NRP1 as multifunctional non-tyrosine-kinase receptors play critical roles in tumor progression. MicroRNAs (miRNAs) are an important class of pervasive genes that are involved in a variety of biological functions, particularly cancer. It remains unclear whether miRNAs can regulate the expression of NRP1. The goal of this study was to identify miRNAs that could inhibit the growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. We found that miR-338 expression was reduced in gastric cancer cell lines and in gastric cancer tissues. Moreover, we found that miR-338 inhibited gastric cancer cell migration, invasion, proliferation and promoted apoptosis by targeting NRP1 expression. As an upstream regulator of NRP1, miR-338 directly targets NRP1. The forced expression of miR-338 inhibited the phosphorylation of Erk1/2, P38 MAPK and Akt; however, the expression of phosphorylated Erk1/2, P38 MAPK and Akt was restored by the overexpression of NRP1. In AGS cells infected with miR-338 or transfected with SiNRP1, the protein levels of fibronectin, vimentin, N-cadherin and SNAIL were decreased, but the expression of E-cadherin was increased. The expression of mesenchymal markers in miR-338-expressing cells was restored to normal levels by the restoration of NRP1 expression. In vivo, miR-338 also decreased tumor growth and suppressed D-MVA by targeting NRP1. Therefore, we conclude that miR-338 acts as a novel tumor suppressor gene in gastric cancer. miR-338 can decrease migratory, invasive, proliferative and apoptotic behaviors, as well as gastric cancer EMT, by attenuating the expression of NRP1.	[Peng, Yang; Liu, Yan-Min; Li, Lu-Chun; Wang, Lu-Lu; Wu, Xiao-Ling] Chongqing Med Univ, Dept Gastroenterol & Hepatol, Affiliated Hosp 2, Chongqing, Peoples R China	Chongqing Medical University	Wu, XL (corresponding author), Chongqing Med Univ, Dept Gastroenterol & Hepatol, Affiliated Hosp 2, Chongqing, Peoples R China.	mars008520@sina.cn			Science and Technology Committee in Shapingba district of Chongqing [201302]	Science and Technology Committee in Shapingba district of Chongqing	This work was supported by project of Science and Technology Committee in Shapingba district of Chongqing (201302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi M, 2003, BRIT J CANCER, V88, P796, DOI 10.1038/sj.bjc.6600811; Broholm H, 2004, APMIS, V112, P257, DOI 10.1111/j.1600-0463.2004.apm11204-0505.x; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Dallas NA, 2008, CLIN CANCER RES, V14, P8052, DOI 10.1158/1078-0432.CCR-08-1520; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Glinka Y, 2011, CARCINOGENESIS, V32, P613, DOI 10.1093/carcin/bgq281; Gluzman-Poltorak Z, 2000, J BIOL CHEM, V275, P18040, DOI 10.1074/jbc.M909259199; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Huang XH, 2011, J PATHOL, V225, P463, DOI 10.1002/path.2877; Kong Xia, 2010, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V18, P1292; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo HC, 2009, CHINESE J CANCER RES, V21, P74, DOI 10.1007/s11670-009-0074-z; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Murga M, 2005, BLOOD, V105, P1992, DOI 10.1182/blood-2004-07-2598; Pellet-Many C, 2011, BIOCHEM J, V435, P609, DOI 10.1042/BJ20100580; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rossignol M, 2003, J CELL BIOCHEM, V88, P744, DOI 10.1002/jcb.10384; Ruffini F, 2013, INT J ONCOL, V43, P297, DOI 10.3892/ijo.2013.1948; Salikhova A, 2008, CIRC RES, V103, pE71, DOI 10.1161/CIRCRESAHA.108.183327; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Staton CA, 2013, HISTOPATHOLOGY, V62, P908, DOI 10.1111/his.12098; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang L, 2003, J BIOL CHEM, V278, P48848, DOI 10.1074/jbc.M310047200; Wey JS, 2005, BRIT J CANCER, V93, P233, DOI 10.1038/sj.bjc.6602663; Wu YY, 2014, ANGIOGENESIS, V17, P247, DOI 10.1007/s10456-013-9394-1; Yu DCW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-276; Zhang ZP, 2011, CANCER GENET-NY, V204, P486, DOI 10.1016/j.cancergen.2011.07.004	32	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94422	10.1371/journal.pone.0094422	http://dx.doi.org/10.1371/journal.pone.0094422			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736504	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600065
J	Sabapathy, V; Sundaram, B; Sreelakshmi, VM; Mankuzhy, P; Kumar, S				Sabapathy, Vikram; Sundaram, Balasubramanian; Sreelakshmi, V. M.; Mankuzhy, Pratheesh; Kumar, Sanjay			Human Wharton's Jelly Mesenchymal Stem Cells Plasticity Augments Scar-Free Skin Wound Healing with Hair Growth	PLOS ONE			English	Article							HUMAN BONE-MARROW; INDOCYANINE GREEN; STROMAL CELLS; TRYPAN BLUE; IN-VITRO; CULTURE; TISSUE; ADULT; FETAL; MSC	Human mesenchymal stem cells (MSCs) are a promising candidate for cell-based transplantation and regenerative medicine therapies. Thus in the present study Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs) have been derived from extra embryonic umbilical cord matrix following removal of both arteries and vein. Also, to overcome the clinical limitations posed by fetal bovine serum (FBS) supplementation because of xenogeneic origin of FBS, usual FBS cell culture supplement has been replaced with human platelet lysate (HPL). Apart from general characteristic features of bone marrow-derived MSCs, wharton jelly-derived MSCs have the ability to maintain phenotypic attributes, cell growth kinetics, cell cycle pattern, in vitro multilineage differentiation plasticity, apoptotic pattern, normal karyotype-like intrinsic mesenchymal stem cell properties in long-term in vitro cultures. Moreover, the WJ-MSCs exhibited the in vitro multilineage differentiation capacity by giving rise to differentiated cells of not only mesodermal lineage but also to the cells of ectodermal and endodermal lineage. Also, WJ-MSC did not present any aberrant cell state upon in vivo transplantation in SCID mice and in vitro soft agar assays. The immunomodulatory potential assessed by gene expression levels of immunomodulatory factors upon exposure to inflammatory cytokines in the fetal WJ-MSCs was relatively higher compared to adult bone marrow-derived MSCs. WJ-MSCs seeded on decellularized amniotic membrane scaffold transplantation on the skin injury of SCID mice model demonstrates that combination of WJ-MSCs and decellularized amniotic membrane scaffold exhibited significantly better wound-healing capabilities, having reduced scar formation with hair growth and improved biomechanical properties of regenerated skin compared to WJ-MSCs alone. Further, our experimental data indicate that indocyanin green (ICG) at optimal concentration can be resourcefully used for labeling of stem cells and in vivo tracking by near infrared fluorescence non-invasive live cell imaging of labelled transplanted cells, thus proving its utility for therapeutic applications.	[Sabapathy, Vikram; Sundaram, Balasubramanian; Mankuzhy, Pratheesh; Kumar, Sanjay] CMC, CSCR, Vellore, Tamil Nadu, India; [Sreelakshmi, V. M.] VIT Univ, Sch Biosci & Technol, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore; Vellore Institute of Technology	Kumar, S (corresponding author), CMC, CSCR, Vellore, Tamil Nadu, India.	skumar@cmcvellore.ac.in			Department of Biotechnology (DBT), Government of India [BT/PR/15420/MED/31/122/2011]	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	We deeply value Department of Biotechnology (DBT), Government of India, for Ramalingaswami Fellowship and research support grant (DBT Grant # BT/PR/15420/MED/31/122/2011) to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulrazzak H, 2010, J R SOC INTERFACE, V7, pS689, DOI 10.1098/rsif.2010.0347.focus; Anzalone R, 2010, STEM CELLS DEV, V19, P423, DOI 10.1089/scd.2009.0299; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Battula VL, 2007, DIFFERENTIATION, V75, P279, DOI 10.1111/j.1432-0436.2006.00139.x; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Boddington SE, 2010, CELL TRANSPLANT, V19, P55, DOI [10.3727/096368909X478579, 10.3727/096368909X]; Can A, 2011, METHODS MOL BIOL, V698, P51, DOI 10.1007/978-1-60761-999-4_5; Dell'Era P., 2013, ISRN STEM CELLS, V2013, DOI 10.1155/2013/674671; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Du T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt215; English K, 2013, IMMUNOL CELL BIOL, V91, P19, DOI 10.1038/icb.2012.56; Gale JS, 2004, AM J OPHTHALMOL, V138, P64, DOI 10.1016/j.ajo.2004.02.061; Guillot PV, 2007, STEM CELLS, V25, P646, DOI 10.1634/stemcells.20060208; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Horn P, 2010, CYTOTHERAPY, V12, P888, DOI 10.3109/14653249.2010.501788; Jonak C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023972; Kim DW, 2013, INT J MOL SCI, V14, P11692, DOI 10.3390/ijms140611692; Kodjikian L, 2005, GRAEF ARCH CLIN EXP, V243, P917, DOI 10.1007/s00417-004-1121-6; Kuroda Y, 2011, OPEN TISSUE ENG REGE, P54; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lo Iacono M, 2011, OPEN TISSUE ENG REGE, V4, P72, DOI DOI 10.2174/1875043501104010072; Maxson S, 2012, STEM CELL TRANSL MED, V1, P142, DOI 10.5966/sctm.2011-0018; MCELREAVEY KD, 1991, BIOCHEM SOC T, V19, pS29, DOI 10.1042/bst019029s; Moodley Y, 2009, AM J PATHOL, V175, P303, DOI 10.2353/ajpath.2009.080629; Murata M, 2005, RETINA-J RET VIT DIS, V25, P75, DOI 10.1097/00006982-200501000-00011; OWEN M, 1988, CIBA F SYMP, V136, P42, DOI 10.1002/9780470513637.ch4; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Sabapathy V, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/174328; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; SCHEERS I, 2011, OPEN TISSUE ENG REGE, V4, P48; Singer AJ, 2000, ACAD EMERG MED, V7, P1083, DOI 10.1111/j.1553-2712.2000.tb01256.x; Stute N, 2004, EXP HEMATOL, V32, P1212, DOI 10.1016/j.exphem.2004.09.003; Tam K, 2013, J CELL BIOCH; Tamura M., 2011, OPEN TISSUE ENG REGE, V4, P39, DOI DOI 10.2174/1875043501104010039; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wilshaw SP, 2006, TISSUE ENG, V12, P2117, DOI 10.1089/ten.2006.12.2117; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Zhang YJ, 2012, INT J LOW EXTR WOUND, V11, P264, DOI 10.1177/1534734612463577; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	40	85	92	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93726	10.1371/journal.pone.0093726	http://dx.doi.org/10.1371/journal.pone.0093726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736473	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600024
J	Johswich, A; Longuet, C; Pawling, J; Rahman, AA; Ryczko, M; Drucker, DJ; Dennis, JW				Johswich, Anita; Longuet, Christine; Pawling, Judy; Rahman, Anas Abdel; Ryczko, Michael; Drucker, Daniel J.; Dennis, James W.			N-Glycan Remodeling on Glucagon Receptor Is an Effector of Nutrient Sensing by the Hexosamine Biosynthesis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KNOCKOUT MICE; ACETYLGLUCOSAMINYLTRANSFERASE V; TRANSCRIPTIONAL REGULATION; PLASMA-MEMBRANE; QUALITY-CONTROL; O-GLCNAC; GLUCOSE; GLYCOSYLATION; OBESITY; METABOLISM	Glucose homeostasis in mammals is dependent on the opposing actions of insulin and glucagon. The Golgi N-acetylglucos-aminyltransferases encoded by Mgat1, Mgat2, Mgat4a/b/c, and Mgat5 modify the N-glycans on receptors and solute transporter, possibly adapting activities in response to the metabolic environment. Herein we report that Mgat5(-/-) mice display diminished glycemic response to exogenous glucagon, together with increased insulin sensitivity. Glucagon receptor signaling and gluconeogenesis in Mgat5(-/-) cultured hepatocytes was impaired. In HEK293 cells, signaling by ectopically expressed glucagon receptor was increased by Mgat5 expression and GlcNAc supplementation to UDP-GlcNAc, the donor substrate shared by Mgat branching enzymes. The mobility of glucagon receptor in primary hepatocytes was reduced by galectin-9 binding, and the strength of the interaction was dependent on Mgat5 and UDP-GlcNAc levels. Finally, oral GlcNAc supplementation rescued the glucagon response in Mgat5(-/-) hepatocytes and mice, as well as glycolytic metabolites and UDP-GlcNAc levels in liver. Our results reveal that the hexosamine biosynthesis pathway and GlcNAc salvage contribute to glucose homeostasis through N-glycan branching on glucagon receptor.	[Johswich, Anita; Longuet, Christine; Pawling, Judy; Rahman, Anas Abdel; Ryczko, Michael; Drucker, Daniel J.; Dennis, James W.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Ryczko, Michael; Dennis, James W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5R 0A3, Canada; [Dennis, James W.] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON M5R 0A3, Canada; [Drucker, Daniel J.; Dennis, James W.] Univ Toronto, Dept Med, Toronto, ON M5R 0A3, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto	Dennis, JW (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave,R988, Toronto, ON M5G 1X5, Canada.	dennis@lunenfeld.ca	Drucker, Daniel J/A-4092-2010; Dennis, James/E-7268-2013; Longuet, Christine/ABC-2556-2020; Abdel Rahman, Anas/AEC-1515-2022	Abdel Rahman, Anas/0000-0002-9527-9424	Ontario Research Fund Grant [GL-2]; Canadian Institutes for Health Research [MOP-79405, MOP-62975, MOP-93749, MOP-123391]; Canada Research Chairs Program; Banting & Best Diabetes Centre (BBDC)-Novo Nordisk Chair in Incretin Biology; Canadian Liver Foundation	Ontario Research Fund Grant; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Banting & Best Diabetes Centre (BBDC)-Novo Nordisk Chair in Incretin Biology; Canadian Liver Foundation	This work was supported by Ontario Research Fund Grant GL-2, Canadian Institutes for Health Research Grants MOP-79405 and MOP-62975, Grant s from the Canada Research Chairs Program (to J. W. D. and D. J. D.), Canadian Institutes for Health Research Grants MOP-93749 and MOP-123391 (to D. J. D.), the Banting & Best Diabetes Centre (BBDC)-Novo Nordisk Chair in Incretin Biology (to D. J. D.), and Canadian Liver Foundation Graduate Studentship (to M. R.).	Abbott KL, 2008, J PROTEOME RES, V7, P1470, DOI 10.1021/pr700792g; Ali S, 2009, AM J PHYSIOL-ENDOC M, V296, pE415, DOI 10.1152/ajpendo.90887.2008; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Bishop JR, 2010, J BIOL CHEM, V285, P14658, DOI 10.1074/jbc.M110.112391; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; CAMPBELL RM, 1995, GLYCOBIOLOGY, V5, P535, DOI 10.1093/glycob/5.5.535; Cheung P, 2007, GLYCOBIOLOGY, V17, P828, DOI 10.1093/glycob/cwm048; Cho YM, 2012, PHARMACOL THERAPEUT, V135, P247, DOI 10.1016/j.pharmthera.2012.05.009; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Conarello SL, 2007, DIABETOLOGIA, V50, P142, DOI 10.1007/s00125-006-0481-3; Cooksey RC, 2002, ANN NY ACAD SCI, V967, P102; Dennis JW, 2013, MOL CELL PROTEOMICS, V12, P913, DOI 10.1074/mcp.R112.026989; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; Flock G, 2007, DIABETES, V56, P3006, DOI 10.2337/db07-0697; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Goren HJ, 2004, ENDOCRINOLOGY, V145, P3307, DOI 10.1210/en.2003-1400; Granovsky M, 2000, NAT MED, V6, P306; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian A, 2011, J BIOL CHEM, V286, P40133, DOI 10.1074/jbc.M111.277814; Haga Y, 2011, J BIOL CHEM, V286, P31320, DOI 10.1074/jbc.M111.253955; Hancock AS, 2010, MOL ENDOCRINOL, V24, P1605, DOI 10.1210/me.2010-0120; Harikumar KG, 2012, P NATL ACAD SCI USA, V109, P18607, DOI 10.1073/pnas.1205227109; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Kang R, 1996, J BIOL CHEM, V271, P26706, DOI 10.1074/jbc.271.43.26706; KITAGAWA T, 1995, J CELL SCI, V108, P3735; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee Y, 2012, P NATL ACAD SCI USA, V109, P14972, DOI 10.1073/pnas.1205983109; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Metallo CM, 2010, GENE DEV, V24, P2717, DOI 10.1101/gad.2010510; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Ohtsubo K, 2011, NAT MED, V17, P1067, DOI 10.1038/nm.2414; Pagano M, 2009, AM J PHYSIOL-CELL PH, V296, pC607, DOI 10.1152/ajpcell.00488.2008; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shang J, 2007, J CELL BIOL, V176, P605, DOI 10.1083/jcb.200607007; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Sorensen H, 2006, DIABETES, V55, P3463, DOI 10.2337/db06-0307; Thevelein JM, 2009, MOL BIOL EVOL, V26, P2407, DOI 10.1093/molbev/msp168; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; UNSON CG, 1995, J BIOL CHEM, V270, P27720, DOI 10.1074/jbc.270.46.27720; Unson CG, 1996, P NATL ACAD SCI USA, V93, P310, DOI 10.1073/pnas.93.1.310; Veerababu G, 2000, DIABETES, V49, P2070, DOI 10.2337/diabetes.49.12.2070; von Meyenn F, 2013, CELL METAB, V17, P436, DOI 10.1016/j.cmet.2013.01.014; Vuguin PM, 2006, ENDOCRINOLOGY, V147, P3995, DOI 10.1210/en.2005-1410; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; Williams R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086088; Wu GC, 2001, J BIOL CHEM, V276, P35450, DOI 10.1074/jbc.M009704200; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yang JX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-281; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Youk H, 2009, NATURE, V462, P875, DOI 10.1038/nature08653; Yu CE, 2004, GENOMICS, V84, P600, DOI 10.1016/j.ygeno.2004.06.003	66	32	33	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15927	15941		10.1074/jbc.M114.563734	http://dx.doi.org/10.1074/jbc.M114.563734			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742675	Green Published, hybrid			2022-12-25	WOS:000337965700004
J	Brzeska, H; Pridham, K; Chery, G; Titus, MA; Korn, ED				Brzeska, Hanna; Pridham, Kevin; Chery, Godefroy; Titus, Margaret A.; Korn, Edward D.			The Association of Myosin IB with Actin Waves in Dictyostelium Requires Both the Plasma Membrane-Binding Site and Actin-Binding Region in the Myosin Tail	PLOS ONE			English	Article							ACANTHAMOEBA MYOSIN; FLUORESCENT PROTEIN; CELL LOCOMOTION; DISCOIDEUM; DYNAMICS; MUTANTS; PHOSPHORYLATION; TRANSFORMATION; OSCILLATIONS; MARKER	F-actin structures and their distribution are important determinants of the dynamic shapes and functions of eukaryotic cells. Actin waves are F-actin formations that move along the ventral cell membrane driven by actin polymerization. Dictyostelium myosin IB is associated with actin waves but its role in the wave is unknown. Myosin IB is a monomeric, non-filamentous myosin with a globular head that binds to F-actin and has motor activity, and a non-helical tail comprising a basic region, a glycine-proline-glutamine-rich region and an SH3-domain. The basic region binds to acidic phospholipids in the plasma membrane through a short basic-hydrophobic site and the Gly-Pro-Gln region binds F-actin. In the current work we found that both the basic-hydrophobic site in the basic region and the Gly-Pro-Gln region of the tail are required for the association of myosin IB with actin waves. This is the first evidence that the Gly-Pro-Gln region is required for localization of myosin IB to a specific actin structure in situ. The head is not required for myosin IB association with actin waves but binding of the head to F-actin strengthens the association of myosin IB with waves and stabilizes waves. Neither the SH3-domain nor motor activity is required for association of myosin IB with actin waves. We conclude that myosin IB contributes to anchoring actin waves to the plasma membranes by binding of the basic-hydrophobic site to acidic phospholipids in the plasma membrane and binding of the Gly-Pro-Gln region to F-actin in the wave.	[Brzeska, Hanna; Pridham, Kevin; Chery, Godefroy; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; [Titus, Margaret A.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Minnesota System; University of Minnesota Twin Cities	Brzeska, H (corresponding author), NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	brzeskah@mail.nih.gov		Korn, Edward/0000-0003-3867-6295; Pridham, Kevin/0000-0002-2636-9688	National Institutes of Health (NIH) intramural program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006019, ZIAHL006035] Funding Source: NIH RePORTER	National Institutes of Health (NIH) intramural program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research was funded by National Institutes of Health (NIH) intramural program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CG, 2011, NAT CELL BIOL, V13, P779, DOI 10.1038/ncb2262; Asano Y, 2008, CELL MOTIL CYTOSKEL, V65, P923, DOI 10.1002/cm.20314; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; Bretschneider T, 2004, CURR BIOL, V14, P1, DOI 10.1016/j.cub.2003.12.005; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; BRZESKA H, 1989, J BIOL CHEM, V264, P19340; Brzeska H, 1996, J BIOL CHEM, V271, P16983, DOI 10.1074/jbc.271.29.16983; Brzeska H, 2008, J BIOL CHEM, V283, P32014, DOI 10.1074/jbc.M804828200; Brzeska H, 2012, J BIOL CHEM, V287, P14923, DOI 10.1074/jbc.M111.318667; Brzeska H, 2010, J BIOL CHEM, V285, P5738, DOI 10.1074/jbc.M109.066910; Carlsson AE, 2010, ANNU REV BIOPHYS, V39, P91, DOI 10.1146/annurev.biophys.093008.131207; Carlsson AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.228102; Case LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026631; Crawley SW, 2006, J BIOL CHEM, V281, P6307, DOI 10.1074/jbc.M508670200; de la Roche MA, 2001, BBA-GEN SUBJECTS, V1525, P245, DOI 10.1016/S0304-4165(01)00110-6; Doubrovinski K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.258103; Falk DL, 2003, J CELL SCI, V116, P3985, DOI 10.1242/jcs.00696; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Friedman AL, 1998, BIOCHEMISTRY-US, V37, P9679, DOI 10.1021/bi973143f; Gaudet P, 2007, NAT PROTOC, V2, P1317, DOI 10.1038/nprot.2007.179; Gerisch G, 2004, BIOPHYS J, V87, P3493, DOI 10.1529/biophysj.104.047589; Gerisch G, 2012, BIOPHYS J, V103, P1170, DOI [10.1016/j.bpj.2012.08.004, 10.1016/j.bpj.2012.05.00.4]; Gerisch G, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-42; Gerisch G, 2009, CELL ADHES MIGR, V3, P373, DOI 10.4161/cam.3.4.9708; Gerisch Gunther, 2010, PMC Biophys, V3, P7, DOI 10.1186/1757-5036-3-7; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1990, J CELL BIOL, V110, P1955, DOI 10.1083/jcb.110.6.1955; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Khamviwath V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064272; LEE SF, 1993, J BIOL CHEM, V268, P20923; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Liu X, 2001, P NATL ACAD SCI USA, V98, P9122, DOI 10.1073/pnas.161285698; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; Novak KD, 1997, J CELL BIOL, V136, P633, DOI 10.1083/jcb.136.3.633; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; Ostap EM, 1996, J CELL BIOL, V133, P221, DOI 10.1083/jcb.133.2.221; PETERSON MD, 1994, J EUKARYOT MICROBIOL, V41, P652, DOI 10.1111/j.1550-7408.1994.tb01529.x; POLLARD TD, 1973, J BIOL CHEM, V248, P4691; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; ROSENFELD SS, 1994, BIOCHEMISTRY-US, V33, P2322, DOI 10.1021/bi00174a045; Ruppel KM, 1996, MOL BIOL CELL, V7, P1123, DOI 10.1091/mbc.7.7.1123; Schroth-Diez B, 2009, HFSP J, V3, P412, DOI 10.2976/1.3239407; Shimada T, 1997, BIOCHEMISTRY-US, V36, P14037, DOI 10.1021/bi971837i; SUSSMAN M, 1987, METHOD CELL BIOL, V28, P9; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; Taniguchi D, 2013, P NATL ACAD SCI USA, V110, P5016, DOI 10.1073/pnas.1218025110; Tsiavaliaris G, 2008, J BIOL CHEM, V283, P4520, DOI 10.1074/jbc.M708113200; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; Vicker MG, 2002, FEBS LETT, V510, P5, DOI 10.1016/S0014-5793(01)03207-0; Vicker MG, 2002, EXP CELL RES, V275, P54, DOI 10.1006/excr.2001.5466; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Whitelam S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198103	55	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94306	10.1371/journal.pone.0094306	http://dx.doi.org/10.1371/journal.pone.0094306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747353	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500023
J	Sarmiento-Ramirez, JM; van der Voort, M; Raaijmakers, JM; Dieguez-Uribeondo, J				Sarmiento-Ramirez, Jullie M.; van der Voort, Menno; Raaijmakers, Jos M.; Dieguez-Uribeondo, Javier			Unravelling the Microbiome of Eggs of the Endangered Sea Turtle Eretmochelys imbricata Identifies Bacteria with Activity against the Emerging Pathogen Fusarium falciforme	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; CARETTA-CARETTA; GUT MICROBIOTA; DNA-SEQUENCES; DISEASES; STREPTOMYCES; COMMUNITY; FUNGAL	Habitat bioaugmentation and introduction of protective microbiota have been proposed as potential conservation strategies to rescue endangered mammals and amphibians from emerging diseases. For both strategies, insight into the microbiomes of the endangered species and their habitats is essential. Here, we sampled nests of the endangered sea turtle species Eretmochelys imbricata that were infected with the fungal pathogen Fusarium falciforme. Metagenomic analysis of the bacterial communities associated with the shells of the sea turtle eggs revealed approximately 16,664 operational taxonomic units, with Proteobacteria, Actinobacteria, Firmicutes and Bacteroidetes as the most dominant phyla. Subsequent isolation of Actinobacteria from the eggshells led to the identification of several genera ( Streptomyces, Amycolaptosis, Micromomospora Plantactinospora and Solwaraspora) that inhibit hyphal growth of the pathogen F. falciforme. These bacterial genera constitute a first set of microbial indicators to evaluate the potential role of microbiota in conservation of endangered sea turtle species.	[Sarmiento-Ramirez, Jullie M.; Dieguez-Uribeondo, Javier] Real Jardin Bot CSIC, Dept Micol, Madrid, Spain; [van der Voort, Menno; Raaijmakers, Jos M.] Wageningen Univ, Phytopathol Lab, NL-6700 AP Wageningen, Netherlands; [Raaijmakers, Jos M.] Netherlands Inst Ecol NIOO KNAW, Dept Microbial Ecol, Wageningen, Netherlands	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Real Jardin Botanico de Madrid; Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW)	Dieguez-Uribeondo, J (corresponding author), Real Jardin Bot CSIC, Dept Micol, Madrid, Spain.	dieguez@rjb.csic.es	Diéguez-Uribeondo, Javier/ABF-1130-2021; Raaijmakers, Jos M/D-1574-2014; dieguez-uribeondo, javier/I-2178-2015; KNAW, NIOO-KNAW/A-4320-2012	Diéguez-Uribeondo, Javier/0000-0002-4488-0658; Raaijmakers, Jos M/0000-0003-1608-6614; dieguez-uribeondo, javier/0000-0002-4488-0658; KNAW, NIOO-KNAW/0000-0002-3835-159X	Ministerio de Economia y Competitividad, Spain [CGL2012-39357]; Ms-Ph D program on Biodiversity and Conservation of Tropical Areas, CSIC-UIMP; Dutch government; Consejo Superior de Investigaciones Cientificas, CSIC [JAEPre 0901804]	Ministerio de Economia y Competitividad, Spain; Ms-Ph D program on Biodiversity and Conservation of Tropical Areas, CSIC-UIMP; Dutch government; Consejo Superior de Investigaciones Cientificas, CSIC	This work was supported by grants of Ministerio de Economia y Competitividad, Spain (CGL2012-39357) and by Ms-Ph D program on Biodiversity and Conservation of Tropical Areas, CSIC-UIMP. The Dutch government funded program BE-Basic supported JMSR and MV, JMSR was supported by grant of Consejo Superior de Investigaciones Cientificas, CSIC (JAEPre 0901804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bahry S, 2009, MAR POLLUT BULL, V58, P720, DOI 10.1016/j.marpolbul.2008.12.018; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AVANISSAGHAJANI E, 1994, BIOTECHNIQUES, V17, P144; Awong-Taylor J, 2008, J APPL MICROBIOL, V104, P1244, DOI 10.1111/j.1365-2672.2007.03650.x; Baillie J.E.M., 2004, IUCN RED LIST THREAT; Bautista-Banos S, 2013, CROP PROT, V49, P8, DOI 10.1016/j.cropro.2013.02.011; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Craven Kathryn S., 2007, Marine Turtle Newsletter, P9; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; D'Aversa F, 2013, INTERN EMERG MED, V8, pS11, DOI 10.1007/s11739-013-0916-z; Daskin HJ, 2012, P ROYAL SOC B, V279; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Doumbou CL, 2001, PHYTOPROTECTION, V82, P85, DOI 10.7202/706219ar; ELABYAD MS, 1993, PLANT SOIL, V149, P185, DOI 10.1007/BF00016608; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Girondot M, 1990, NMFSSEFC278 NOAA; GLAZEBROOK JS, 1993, DIS AQUAT ORGAN, V16, P133, DOI 10.3354/dao016133; Gnanamanickam SS, 2002, BIOL CONTROL CROP DI; Goodfellow M, 2010, ANTON LEEUW INT J G, V98, P119, DOI 10.1007/s10482-010-9460-2; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Head IM, 1998, MICROB ECOL, V35, P1, DOI 10.1007/s002489900056; Hernandez-Divers SJ, 2009, J WILDLIFE DIS, V45, P637, DOI 10.7589/0090-3558-45.3.637; Honarvar S, 2011, J EXP MAR BIOL ECOL, V409, P339, DOI 10.1016/j.jembe.2011.09.015; Kim W, 2012, J BACTERIOLOGY VIROL, V42, P262; Koberl M, 2013, FEMS MICROBIOL LETT, V342, P168, DOI 10.1111/1574-6968.12089; KOGAN SC, 1987, NEW ENGL J MED, V317, P985, DOI 10.1056/NEJM198710153171603; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Mo CL, 1990, 10 ANN WORKSH SEA TU, P249; Nachtigall J, 2011, J ANTIBIOT, V64, P775, DOI 10.1038/ja.2011.96; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Rademaker JLW, 1997, MOL MICROBIAL ECOLOG, P1; Rambaut A, 2002, SE AL SEQUENCE ALIGN; Santoro M, 2006, REV BIOL TROP, V54, P43; Sarmiento-Ramirez JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085853; Sarmiento-Ramirez JM, 2010, FEMS MICROBIOL LETT, V312, P192, DOI 10.1111/j.1574-6968.2010.02116.x; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka Y., 1990, ACTINOMYCETOLOGICA, V4, P13, DOI [10.3209/saj.4_13, DOI 10.3209/SAJ.4_13, DOI 10.3209/saj.4_13]; Tendulkar SR, 2003, BIOTECHNOL LETT, V25, P1941, DOI 10.1023/B:BILE.0000003990.27624.04; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Viladomiu M, 2013, J NUTR BIOCHEM, V24, P929, DOI 10.1016/j.jnutbio.2013.01.006; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Weller DM, 2002, ANNU REV PHYTOPATHOL, V40, P309, DOI 10.1146/annurev.phyto.40.030402.110010; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8; WYNEKEN J, 1988, J HERPETOL, V22, P88, DOI 10.2307/1564360; Xu J, 2013, EVID-BASED COMPL ALT, V2013, P9; Yang CH, 2001, FEMS MICROBIOL ECOL, V35, P129, DOI 10.1111/j.1574-6941.2001.tb00796.x; Yang MM, 2012, EUR J PLANT PATHOL, V134, P811, DOI 10.1007/s10658-012-0057-7	52	34	34	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95206	10.1371/journal.pone.0095206	http://dx.doi.org/10.1371/journal.pone.0095206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743166	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100086
J	Yan, F; Yu, Y; Chow, DC; Palzkill, T; Madoux, F; Hodder, P; Chase, P; Griffin, PR; O'Malley, BW; Lonard, DM				Yan, Fei; Yu, Yang; Chow, Dar-Chone; Palzkill, Timothy; Madoux, Franck; Hodder, Peter; Chase, Peter; Griffin, Patrick R.; O'Malley, Bert W.; Lonard, David M.			Identification of Verrucarin A as a Potent and Selective Steroid Receptor Coactivator-3 Small Molecule Inhibitor	PLOS ONE			English	Article							CANCER CELL-PROLIFERATION; TRAIL-INDUCED APOPTOSIS; BREAST-CANCER; TRANSCRIPTIONAL COACTIVATOR; HISTONE ACETYLTRANSFERASE; PROGESTERONE-RECEPTOR; TAMOXIFEN RESISTANCE; GROWTH-INHIBITION; P160 COACTIVATORS; OVARIAN-CANCER	Members of the steroid receptor coactivator (SRC) family are overexpressed in numerous types of cancers. In particular, steroid receptor coactivator 3 (SRC-3) has been recognized as a critical coactivator associated with tumor initiation, progression, recurrence, metastasis, and chemoresistance where it interacts with multiple nuclear receptors and other transcription factors to enhance their transcriptional activities and facilitate cross-talk between pathways that stimulate cancer progression. Because of its central role as an integrator of growth signaling pathways, development of small molecule inhibitors (SMIs) against SRCs have the potential to simultaneously disrupt multiple signal transduction networks and transcription factors involved in tumor progression. Here, high-throughput screening was performed to identify compounds able to inhibit the intrinsic transcriptional activities of the three members of the SRC family. Verrucarin A was identified as a SMI that can selectively promote the degradation of the SRC-3 protein, while affecting SRC-1 and SRC-2 to a lesser extent and having no impact on CARM-1 and p300 protein levels. Verrucarin A was cytotoxic toward multiple types of cancer cells at low nanomolar concentrations, but not toward normal liver cells. Moreover, verrucarin A was able to inhibit expression of the SRC-3 target genes MMP2 and MMP13 and attenuated cancer cell migration. We found that verrucarin A effectively sensitized cancer cells to treatment with other anti-cancer drugs. Binding studies revealed that verrucarin A does not bind directly to SRC-3, suggesting that it inhibits SRC-3 through its interaction with an upstream effector. In conclusion, unlike other SRC SMIs characterized by our laboratory that directly bind to SRCs, verrucarin A is a potent and selective SMI that blocks SRC-3 function through an indirect mechanism.	[Yan, Fei; Yu, Yang; O'Malley, Bert W.; Lonard, David M.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Chow, Dar-Chone; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Madoux, Franck; Hodder, Peter; Chase, Peter; Griffin, Patrick R.] Scripps Florida, Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA	Baylor College of Medicine; Baylor College of Medicine; Scripps Research Institute; State University System of Florida; University of Florida	Lonard, DM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	dlonard@bcm.edu			Susan G. Komen Foundation [PG12221410]; Prostate Cancer Foundation; Clayton Foundation; Dunn Foundation; Cancer Prevention and Research Institute of Texas [RP100348, RP101251]; National Institutes of Health [HD076596, DK059820]; National Institutes of Health Molecular Libraries Program [U54 MH084512]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD007857, U01HD076596, R01HD008188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Prostate Cancer Foundation; Clayton Foundation; Dunn Foundation; Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Molecular Libraries Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was performed using funding from the Susan G. Komen Foundation (PG12221410), the Prostate Cancer Foundation, the Clayton Foundation and the Dunn Foundation to BWO, Cancer Prevention and Research Institute of Texas (RP100348 and RP101251 to BWO) and from the National Institutes of Health (HD076596 to DML) and (DK059820 to BWO). High throughput screening was supported through the National Institutes of Health Molecular Libraries Program (U54 MH084512 to PH and FM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bautista S, 1998, CLIN CANCER RES, V4, P2925; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; Bouras T, 2001, CANCER RES, V61, P903; Brown K, 2003, J BIOL CHEM, V278, P39402, DOI 10.1074/jbc.M307832200; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chen SL, 2000, GENE DEV, V14, P1209; Ciruelos E, 2013, ANTI-CANCER DRUG, V24, P769, DOI 10.1097/CAD.0b013e328363adc5; Coulthard VH, 2003, J BIOL CHEM, V278, P10942, DOI 10.1074/jbc.M212950200; Ghadimi BM, 1999, AM J PATHOL, V154, P525, DOI 10.1016/S0002-9440(10)65298-4; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Han SJ, 2006, MOL ENDOCRINOL, V20, P45, DOI 10.1210/me.2005-0310; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; JARVIS BB, 1978, CANCER TREAT REP, V62, P1585; Jayasooriya RGPT, 2013, FOOD CHEM TOXICOL, V55, P1, DOI 10.1016/j.fct.2012.12.045; Jayasooriya RGPT, 2013, ENVIRON TOXICOL PHAR, V36, P303, DOI 10.1016/j.etap.2013.04.008; JIMENEZ A, 1975, EUR J BIOCHEM, V54, P483, DOI 10.1111/j.1432-1033.1975.tb04160.x; Johnson AB, 2012, MOL CELL ENDOCRINOL, V348, P430, DOI 10.1016/j.mce.2011.04.021; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Li B, 2008, CANCER LETT, V261, P64, DOI 10.1016/j.canlet.2007.11.013; Liao L, 2008, MOL CELL BIOL, V28, P2460, DOI 10.1128/MCB.01163-07; Liu PY, 2006, FEBS J, V273, P2172, DOI 10.1111/j.1742-4658.2006.05231.x; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Lonard DM, 2012, NAT REV ENDOCRINOL, V8, P598, DOI 10.1038/nrendo.2012.100; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Long WW, 2010, MOL CELL, V37, P321, DOI 10.1016/j.molcel.2010.01.004; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Lydon JP, 2011, ENDOCRINOLOGY, V152, P19, DOI 10.1210/en.2010-1012; Ma H, 1999, MOL CELL BIOL, V19, P6164; Mc Ilroy M, 2006, ENDOCR-RELAT CANCER, V13, P1135, DOI 10.1677/erc.1.01222; Moon DO, 2013, TOXICOL IN VITRO, V27, P257, DOI 10.1016/j.tiv.2012.09.001; Mussi P, 2006, MOL ENDOCRINOL, V20, P3105, DOI 10.1210/me.2005-0522; ONATE SA, 1995, SCIENCE, V270, P1354; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Palanivel K, 2013, BIOTECHNOL LETT, V35, P1395, DOI 10.1007/s10529-013-1238-y; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Roy A, 2010, CURR PHARM BIOTECHNO, V11, P764, DOI 10.2174/138920110792927757; Sakakura C, 2000, INT J CANCER, V89, P217; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Suen CS, 1998, J BIOL CHEM, V273, P27645, DOI 10.1074/jbc.273.42.27645; Tan JA, 2000, ENDOCRINOLOGY, V141, P3440, DOI 10.1210/en.141.9.3440; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Torres-Arzayus MI, 2010, CANCER RES, V70, P4102, DOI 10.1158/0008-5472.CAN-09-4080; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang Y, 2002, CANCER-AM CANCER SOC, V95, P2346, DOI 10.1002/cncr.10963; Wang Y., 2014, CANC RES; Wang Y, 2011, MOL ENDOCRINOL, V25, P2041, DOI 10.1210/me.2011-1222; Wu RC, 2002, MOL CELL BIOL, V22, P3549, DOI 10.1128/MCB.22.10.3549-3561.2002; Wu SF, 2010, LEUKEMIA, V24, P544, DOI 10.1038/leu.2009.280; Wu SF, 2012, MOL CELL BIOL, V32, P4821, DOI 10.1128/MCB.00851-12; Xu FP, 2007, CANCER LETT, V245, P69, DOI 10.1016/j.canlet.2005.12.030; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Yan F, 2010, J MED CHEM, V53, P5502, DOI 10.1021/jm1001698; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955; Yan J, 2006, CANCER RES, V66, P11039, DOI 10.1158/0008-5472.CAN-06-2442; Ying H, 2005, MOL CELL BIOL, V25, P7687, DOI 10.1128/MCB.25.17.7687-7695.2005; Zhou HJ, 2005, CANCER RES, V65, P7976, DOI 10.1158/0008-5472.CAN-04-4076	63	27	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95243	10.1371/journal.pone.0095243	http://dx.doi.org/10.1371/journal.pone.0095243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743578	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100095
J	Chen, WX; Liu, XM; Lv, MM; Chen, L; Zhao, JH; Zhong, SL; Ji, MH; Hu, Q; Luo, Z; Wu, JZ; Tang, JH				Chen, Wei-xian; Liu, Xue-min; Lv, Meng-meng; Chen, Lin; Zhao, Jian-hua; Zhong, Shan-liang; Ji, Ming-hua; Hu, Qing; Luo, Zhou; Wu, Jian-zhong; Tang, Jin-hai			Exosomes from Drug-Resistant Breast Cancer Cells Transmit Chemoresistance by a Horizontal Transfer of MicroRNAs	PLOS ONE			English	Article							ACQUIRED MULTIDRUG-RESISTANCE; INTERCELLULAR COMMUNICATION; MESSENGER-RNAS; MECHANISM; GENES	Adriamycin and docetaxel are two agents commonly used in treatment of breast cancer, but their efficacy is often limited by the emergence of chemoresistance. Recent studies indicate that exosomes act as vehicles for exchange of genetic cargo between heterogeneous populations of tumor cells, engendering a transmitted drug resistance for cancer development and progression. However, the specific contribution of breast cancer-derived exosomes is poorly understood. Here we reinforced other's report that human breast cancer cell line MCF-7/S could acquire increased survival potential from its resistant variants MCF-7/Adr and MCF-7/Doc. Additionally, exosomes of the latter, A/exo and D/exo, significantly modulated the cell cycle distribution and drug-induced apoptosis with respect to S/exo. Exosomes pre-treated with RNase were unable to regulate cell cycle and apoptosis resistance, suggesting an RNA-dependent manner. Microarray and polymerase chain reaction for the miRNA expression profiles of A/exo, D/exo, and S/exo demonstrated that they loaded selective miRNA patterns. Following A/exo and D/exo transfer to recipient MCF-7/S, the same miRNAs were significantly increased in acquired cells. Target gene prediction and pathway analysis showed the involvement of miR-100, miR-222, and miR-30a in pathways implicated in cancer pathogenesis, membrane vesiculation and therapy failure. Furthermore, D/exo co-culture assays and miRNA mimics transfection experiments indicated that miR-222-rich D/exo could alter target gene expression in MCF-7/S. Our results suggest that drug-resistant breast cancer cells may spread resistance capacity to sensitive ones by releasing exosomes and that such effects could be partly attributed to the intercellular transfer of specific miRNAs.	[Chen, Wei-xian; Liu, Xue-min; Lv, Meng-meng; Luo, Zhou] Nanjing Med Univ, Clin Sch 4, Nanjing, Jiangsu, Peoples R China; [Chen, Wei-xian; Liu, Xue-min; Lv, Meng-meng; Chen, Lin; Hu, Qing; Luo, Zhou; Tang, Jin-hai] Nanjing Med Univ, Affiliated Canc Hosp, Dept Gen Surg, Canc Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Chen, Lin; Hu, Qing] Xuzhou Med Coll, Grad Sch, Xuzhou, Jiangsu, Peoples R China; [Zhao, Jian-hua; Zhong, Shan-liang] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Ctr Clin Lab, Nanjing, Jiangsu, Peoples R China; [Ji, Ming-hua] Nanjing Med Univ, Affiliated Canc Hosp, Canc Inst Jiangsu Prov, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China; [Wu, Jian-zhong] Nanjing Med Univ, Affiliated Canc Hosp, Ctr Clin Oncol, Canc Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Xuzhou Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Tang, JH (corresponding author), Nanjing Med Univ, Affiliated Canc Hosp, Dept Gen Surg, Canc Inst Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.	jhtangnj@126.com	Wu, Jian/AAU-5221-2020; Chen, Wei-xian/ABF-9972-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Zhong, Shanliang/0000-0001-8200-0511	National Natural Science Foundation of China [81272470]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81272470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Chen W, 2013, TUMOUR BIOL; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chiba M, 2012, ONCOL REP, V28, P1551, DOI 10.3892/or.2012.1967; Corcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Fonsato V, 2012, STEM CELLS, V30, P1985, DOI 10.1002/stem.1161; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hannafon BN, 2013, INT J MOL SCI, V14, P14240, DOI 10.3390/ijms140714240; Harburg GC, 2011, J MAMMARY GLAND BIOL, V16, P257, DOI 10.1007/s10911-011-9225-1; Herve JC, 2013, CELL TISSUE RES, V352, P21, DOI 10.1007/s00441-012-1485-6; Imagawa W, 2002, J STEROID BIOCHEM, V80, P213, DOI 10.1016/S0960-0760(01)00188-1; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Knaust E, 2000, HAEMATOLOGICA, V85, P124; Kogure T, 2011, HEPATOLOGY, V54, P1237, DOI 10.1002/hep.24504; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kucharzewska P, 2013, P NATL ACAD SCI USA, V110, P7312, DOI 10.1073/pnas.1220998110; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li WJ, 2013, MOL BIOL REP, V40, P6143, DOI 10.1007/s11033-013-2725-x; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Miot S, 2010, TISSUE ENG PART C-ME, V16, P11, DOI [10.1089/ten.tec.2008.0698, 10.1089/ten.TEC.2008.0698]; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morel L, 2013, J BIOL CHEM, V288, P7105, DOI 10.1074/jbc.M112.410944; O'Brien K, 2013, EUR J CANCER, V49, P1845, DOI 10.1016/j.ejca.2013.01.017; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pasquier J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-5; Reis LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044092; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SINGER SJ, 1992, SCIENCE, V255, P1671, DOI 10.1126/science.1313187; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zhong SL, 2013, GENE, V531, P8, DOI 10.1016/j.gene.2013.08.062	43	279	295	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95240	10.1371/journal.pone.0095240	http://dx.doi.org/10.1371/journal.pone.0095240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740415	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900122
J	Comstock, SS; Lewis, MM; Pathak, DR; Hortos, K; Kovan, B; Fenton, JI				Comstock, Sarah S.; Lewis, Markita M.; Pathak, Dorothy R.; Hortos, Kari; Kovan, Bruce; Fenton, Jenifer I.			Cross-Sectional Analysis of Obesity and Serum Analytes in Males Identifies sRAGE as a Novel Biomarker Inversely Associated with Diverticulosis	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; NECROSIS-FACTOR-ALPHA; WAIST CIRCUMFERENCE; SOLUBLE RECEPTOR; METABOLIC SYNDROME; DISEASE; ADIPONECTIN; RISK; DIAGNOSIS; INCREASES	Diverticulosis can lead to diverticulitis, a colon condition involving inflammation and other complications. Diverticulosis can result from biological, behavioral, or genetic causes. However, the etiology of diverticulosis is unknown. Although diet is associated with diverticulosis, recent studies suggest other factors influence risk. We sought to identify anthropometric or serum markers that were associated with the presence of diverticulosis. To determine these associations, 126 asymptomatic men (48-65 yr) were recruited at the time of preventative screening colonoscopy. Anthropometric measures were taken, and blood was collected for serum protein analysis. Data were analyzed by logistic regression and factor analysis. Obese individuals (BMI >30) were 7.8 (CI: 2.3-26.3) times more likely than normal weight (BMI <25) individuals to have diverticulosis. The relationship was similar for waist circumference. Individuals with a waist circumference >45 inches were 8.1 (CI: 2.8-23.8) times more likely to have diverticulosis than those with a waist circumference <38 inches. Leptin was also positively associated with diverticulosis (OR = 5.5, CI: 2.0-14.7). Both low molecular weight adiponectin (LMW, OR = 0.50; CI: 0.3-0.8) and the soluble receptor for advanced glycation end products (sRAGE, OR = 0.4, CI: 0.3-0.7) were inversely related to the presence of diverticulosis. sRAGE levels were not correlated with leptin or C-peptide concentrations. The pattern of high BMI, waist circumference, leptin and C-peptide increased the odds of diverticulosis while the pattern of high levels of sRAGE and LMW adiponectin decreased the odds of diverticulosis. Associations between diverticulosis and anthropometric or serum markers may elucidate the origins of diverticulosis and may enable physicians to identify individuals at risk for diverticulitis.	[Comstock, Sarah S.; Lewis, Markita M.; Fenton, Jenifer I.] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA; [Pathak, Dorothy R.] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Hortos, Kari; Kovan, Bruce; Fenton, Jenifer I.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Kovan, Bruce] Professional Corp, Tricty Gastroenterol, Clinton Township, MI USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University College of Osteopathic Medicine	Fenton, JI (corresponding author), Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.	imigjeni@msu.edu			National Cancer Institute [1R03CA142000]; Clinical and Translational Sciences Institute at Michigan State University; NATIONAL CANCER INSTITUTE [R03CA142000] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Clinical and Translational Sciences Institute at Michigan State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research supported in part by the National Cancer Institute 1R03CA142000 and the Clinical and Translational Sciences Institute at Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DIV DIS; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Chavakis T, 2004, MICROBES INFECT, V6, P1219, DOI 10.1016/j.micinf.2004.08.004; Choi KM, 2012, J CLIN ENDOCR METAB, V97, P3751, DOI 10.1210/jc.2012-1951; Comstock SS, 2014, PLOS ONE, V9; GEAR JSS, 1979, LANCET, V1, P511; Hinchey E J, 1978, Adv Surg, V12, P85; Hjern F, 2012, AM J GASTROENTEROL, V107, P296, DOI 10.1038/ajg.2011.352; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Karmiris K, 2008, MOL NUTR FOOD RES, V52, P855, DOI 10.1002/mnfr.200700050; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Kohler L, 1999, SURG ENDOSC-ULTRAS, V13, P430, DOI 10.1007/s004649901007; Kopylov U, 2012, DIGESTION, V86, P201, DOI 10.1159/000339881; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maillard-Lefebvre H, 2009, RHEUMATOLOGY, V48, P1190, DOI 10.1093/rheumatology/kep199; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; Ness-Abramof R, 2008, NUTR CLIN PRACT, V23, P397, DOI 10.1177/0884533608321700; Peery AF, 2013, CLIN GASTROENTEROL H, V11, P1622, DOI 10.1016/j.cgh.2013.06.033; Rogler G, 1998, WORLD J SURG, V22, P382, DOI 10.1007/s002689900401; Ruhl CE, 2008, BURDEN DIGESTIVE DIS, P137; Schober F, 2007, BIOCHEM BIOPH RES CO, V361, P968, DOI 10.1016/j.bbrc.2007.07.106; Shahedi K, 2013, CLIN GASTROENTEROL H; Shen W, 2006, OBESITY, V14, P727, DOI 10.1038/oby.2006.83; Strate LL, 2012, AM J GASTROENTEROL, V107, P1486, DOI 10.1038/ajg.2012.194; Strate LL, 2012, DIGEST DIS, V30, P35, DOI 10.1159/000335707; Strate LL, 2009, GASTROENTEROLOGY, V136, P115, DOI 10.1053/j.gastro.2008.09.025; Sung JY, 2013, TOHOKU J EXP MED, V230, P59, DOI 10.1620/tjem.230.59; Tursi A, 2012, NEUROGASTROENT MOTIL, V24, P836, DOI 10.1111/j.1365-2982.2012.01946.x; Tursi A, 2012, COLORECTAL DIS, V14, pe258, DOI 10.1111/j.1463-1318.2012.02926.x; Uchida T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070200; Van Arendonk KJ, 2013, JAMA SURG, V148, P316, DOI 10.1001/jamasurg.2013.1010; Ye JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE466, DOI 10.1152/ajpendo.00266.2012; Yehuda-Shnaidman E, 2012, OBES REV; Yuan Y, 2011, J STAT SOFTWARE, V45	36	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95232	10.1371/journal.pone.0095232	http://dx.doi.org/10.1371/journal.pone.0095232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740401	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900121
J	Mesquita, M; Resende, P; Marttorelli, A; Machado, V; Sacramento, CQ; Fintelman-Rodrigues, N; Abrantes, JL; Tavares, R; Schirmer, M; Siqueira, MM; Souza, TML				Mesquita, Milene; Resende, Paola; Marttorelli, Andressa; Machado, Viviane; Sacramento, Carolina Q.; Fintelman-Rodrigues, Natalia; Abrantes, Juliana L.; Tavares, Rita; Schirmer, Marcelo; Siqueira, Marilda M.; Souza, Thiago Moreno L.			Detection of the Influenza A(H1N1)pdm09 Virus Carrying the K-15E, P83S and Q293H Mutations in Patients Who Have Undergone Bone Marrow Transplant	PLOS ONE			English	Article							H1N1; INFECTION; EMERGENCE	The 2009 pandemic influenza A(H1N1)pdm09 virus emerged and caused considerable morbidity and mortality in the third world, especially in Brazil. Although circulating strains of A(H1N1) pdm09 are A/California/04/2009-like (CA-04-like) viruses, various studies have suggested that some mutations in the viral hemagglutinin (HA) may be associated with enhanced severity and fatality. This phenomenon is particularly challenging for immunocompromised individuals, such as those who have undergone bone marrow transplant (BMT), because they are more likely to display worse clinical outcomes to influenza infection than non-immunocompromised individuals. We studied the clinical and viral aspects of post-BMT patients with confirmed A(H1N1) pdm09 diagnosis in the largest cancer hospital in Brazil. We found a viral strain with K-15E, P83S and Q293H polymorphisms in the HA, which is presumably more virulent, in these individuals. Despite that, these patients showed only mild symptoms of infection. Our findings complement the discovery of mild cases of infection with the A(H1N1) pdm09 virus with the K-15E, P83S and Q293H mutations in Brazil and oppose other studies that have linked these changes with increased disease severity. These results could be important for a better comprehension of the impact of the pandemic influenza in the context of BMT.	[Mesquita, Milene; Resende, Paola; Marttorelli, Andressa; Machado, Viviane; Sacramento, Carolina Q.; Fintelman-Rodrigues, Natalia; Abrantes, Juliana L.; Siqueira, Marilda M.; Souza, Thiago Moreno L.] Fiocruz MS, Inst Oswaldo Cruz, WHO NIC, Measles & Resp Viruses Lab, BR-21045900 Rio De Janeiro, RJ, Brazil; [Tavares, Rita; Schirmer, Marcelo] Natl Canc Inst INCa, Ctr Bone Marrow Transplantat CEMO, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; National Cancer Institute (Inca)	Souza, TML (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, WHO NIC, Measles & Resp Viruses Lab, BR-21045900 Rio De Janeiro, RJ, Brazil.	tmoreno@ioc.fiocruz.br	Miranda, Milene/ABD-8472-2021; Resende, Paola Cristina/P-5002-2015; Souza, Thiago Moreno L./G-2900-2012	Miranda, Milene/0000-0003-0037-059X; Resende, Paola Cristina/0000-0002-2884-3662; Souza, Thiago Moreno L./0000-0003-2212-3899; Machado de Mello Andrade, Viviane/0000-0002-5056-298X	Instituto Oswaldo Cruz/Fiocruz; Brazilian Ministry of Health/Decit and SVS; CNPq; FAPERJ; IOC/Fiocruz	Instituto Oswaldo Cruz/Fiocruz; Brazilian Ministry of Health/Decit and SVS; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); IOC/Fiocruz	The work was supported by Instituto Oswaldo Cruz/Fiocruz (www.ioc.fiocruz.br) and Brazilian Ministry of Health/Decit and SVS (http://portal2.saude.gov.br/sisct/?). Dr. Siqueira was supported in part by individual research grants from CNPq (www.cnpq.br). Dr. Siqueira and Souza used, in part, individual research grants from FAPERJ (www.faperj.br) and CNPq. Thanks are also due to IOC/Fiocruz for providing PCR and NFR fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P21; Brockwell-Staats C, 2009, INFLUENZA OTHER RESP, V3, P207, DOI 10.1111/j.1750-2659.2009.00096.x; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Casper C, 2010, BLOOD, V115, P1331, DOI 10.1182/blood-2009-11-255455; Cordero E, 2012, EUR J CLIN MICROBIOL, V31, P547, DOI 10.1007/s10096-011-1346-3; Cordero Elisa, 2012, Enferm Infecc Microbiol Clin, V30 Suppl 4, P38, DOI 10.1016/S0213-005X(12)70103-9; Dean A, 2014, OPENEPI OPEN SOURCE; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; Goni N, 2011, ARCH VIROL, V156, P87, DOI 10.1007/s00705-010-0825-7; Graham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016087; Kilander A, 2010, EUROSURVEILLANCE, V15, P1, DOI DOI 10.1128/JVI.01136-10; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lapinsky SE, 2010, CRIT CARE MED, V38, pE52, DOI 10.1097/CCM.0b013e3181c85d5f; Lee RTC, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-297; Liu Y, 2010, J VIROL, V84, P12069, DOI 10.1128/JVI.01639-10; Ministry of Health Republic of Indonesia, 2010, B ELETRONICO EPIDEMI, V2, P1; Mohty B, 2012, BONE MARROW TRANSPL, V47, P236, DOI 10.1038/bmt.2011.57; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Piralla A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028332; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; Redelman-Sidi G, 2010, J INFECTION, V60, P257, DOI 10.1016/j.jinf.2010.01.009; Scales DC, 2008, CRIT CARE, V12, DOI 10.1186/cc6923; Seville MTA, 2010, TRANSPLANTATION, V90, P571, DOI 10.1097/TP.0b013e3181e86af0; Souza TML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014158; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Velasco RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030333; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; WHO Global Influenza Surveillance Network, 2011, MAN LAB DIAGN VIR SU; World Health Organization, 2009, WHO CDC PROT REALT R; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94822	10.1371/journal.pone.0094822	http://dx.doi.org/10.1371/journal.pone.0094822			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740088	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900071
J	Rocha, LO; Tralamazza, SM; Reis, GM; Rabinovitch, L; Barbosa, CB; Correa, B				Rocha, Liliana O.; Tralamazza, Sabina Moser; Reis, Gabriela M.; Rabinovitch, Leon; Barbosa, Cynara B.; Correa, Benedito			Multi-Method Approach for Characterizing the Interaction between Fusarium verticillioides and Bacillus thuringiensis Subsp Kurstaki	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; BIOCONTROL AGENTS; HEAD BLIGHT; CYTOCHEMICAL ASPECTS; IN-VITRO; MYCOTOXINS; STRAINS; GROWTH; GENE; GERMINATION	Bacterial antagonists used as biocontrol agents represent part of an integrated management program to reduce pesticides in the environment. Bacillus thuringiensis is considered a good alternative as a biocontrol agent for suppressing plant pathogens such as Fusarium. In this study, we used microscopy, flow cytometry, indirect immunofluorescence, and high performance liquid chromatography to determine the interaction between B. thuringiensis subsp. kurstaki LFB-FIOCRUZ (CCGB) 257 and F. verticillioides MRC 826, an important plant pathogen frequently associated with maize. B. thuringiensis showed a strong in vitro suppressive effect on F. verticillioides growth and inhibited fumonisin production. Flow cytometry analysis was found to be adequate for characterizing the fungal cell oscillations and death during these interactions. Further studies of the antagonistic effect of this isolate against other fungi and in vivo testing are necessary to determine the efficacy of B. thuringiensis subsp. kurstaki in controlling plant pathogens. This is the first report on the use of flow cytometry for quantifying living and apoptotic F. verticillioides cells and the B. thuringiensis Cry 1Ab toxin.	[Rocha, Liliana O.; Tralamazza, Sabina Moser; Reis, Gabriela M.; Barbosa, Cynara B.; Correa, Benedito] Univ Sao Paulo, Dept Microbiol, Lab Mycotoxins & Toxigen Fungi, Sao Paulo, Brazil; [Rabinovitch, Leon] Fiocruz MS, Inst Oswaldo Cruz, Dept Bacteriol, Lab Bacterial Physiol, BR-21045900 Rio De Janeiro, Brazil	Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Rocha, LO (corresponding author), Univ Sao Paulo, Dept Microbiol, Lab Mycotoxins & Toxigen Fungi, Sao Paulo, Brazil.	liliana_rocha@ymail.com	Tralamazza, Sabina M/E-8212-2015; Rocha, Liliana/AAG-3993-2019; Rocha, Liliana/N-7269-2015	Rocha, Liliana/0000-0003-2820-4470; Correa, Benedito/0000-0003-4314-0751	State of Sao Paulo Research Foundation	State of Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was funded by the State of Sao Paulo Research Foundation (http://www.fapesp.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez DF, 2010, AM J PHYSIOL-LUNG C, V298, P127, DOI DOI 10.1152/AJPLUNG.00313.2009; Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; Arora N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066603; Bacon CW, 2002, BIOL CONTROL, V23, P274, DOI 10.1006/bcon.2001.1016; Bacon CW, 2001, ENVIRON HEALTH PERSP, V109, P325, DOI 10.2307/3435026; Baysal O, 2008, PHYSIOL MOL PLANT P, V73, P25, DOI 10.1016/j.pmpp.2008.11.002; Baysal O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053182; Benhamou N, 1999, PHYTOPATHOLOGY, V89, P506, DOI 10.1094/PHYTO.1999.89.6.506; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Braghini R, 2009, APPL RADIAT ISOTOPES, V67, P1622, DOI 10.1016/j.apradiso.2009.03.004; Carroll J, 1997, J CELL SCI, V110, P3099; Cavaglieri L, 2005, RES MICROBIOL, V156, P748, DOI 10.1016/j.resmic.2005.03.001; Cherif M, 2002, J PLANT PATHOL, V84, P83; Chitarra GS, 2003, J APPL MICROBIOL, V94, P159, DOI 10.1046/j.1365-2672.2003.01819.x; CHU FS, 1994, APPL ENVIRON MICROB, V60, P847, DOI 10.1128/AEM.60.3.847-852.1994; Crickmore N, 1998, MICROBIOL MOL BIOL R, V62, P807, DOI 10.1128/MMBR.62.3.807-813.1998; de la Vega LM, 2006, CAN J MICROBIOL, V52, P651, DOI 10.1139/W06-019; de Oliveira KM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-107; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dong YH, 2005, J MICROBIOL, V43, P101; Dubois T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002629; El-Ghaouth A, 1998, PHYTOPATHOLOGY, V88, P282, DOI 10.1094/PHYTO.1998.88.4.282; Etcheverry MG, 2009, MYCOPATHOLOGIA, V167, P287, DOI 10.1007/s11046-008-9177-1; FDAS E Silva, 2006, COMP AGR NAT RES P 4, P393; Yamamoto-Ribeiro MMG, 2013, FOOD CHEM, V141, P3147, DOI 10.1016/j.foodchem.2013.05.144; Gilbert J, 2013, CAN J PLANT PATHOL, V35, P149, DOI 10.1080/07060661.2013.772921; Granjo CA, 2007, MYCOPATHOLOGIA, V164, P119, DOI 10.1007/s11046-007-9035-6; Hendriksen NB, 2002, CAN J MICROBIOL, V48, P256, DOI [10.1139/w02-009, 10.1139/W02-009]; Jurado M, 2008, APPL ENVIRON MICROB, V74, P2032, DOI 10.1128/AEM.02337-07; Larson TM, 2011, CURR GENET, V57, P177, DOI 10.1007/s00294-011-0334-6; Lee K, 2009, FEMS MICROBIOL LETT, V299, P31, DOI 10.1111/j.1574-6968.2009.01719.x; Leslie J. F., 2006, FUSARIUM LAB MANUAL, DOI 10.1002/9780470278376; Marasas WFO, 2001, ENVIRON HEALTH PERSP, V109, P239, DOI 10.2307/3435014; Missmer SA, 2006, ENVIRON HEALTH PERSP, V114, P237, DOI 10.1289/ehp.8221; Monnerat RG, 2007, BIOL CONTROL, V41, P291, DOI 10.1016/j.biocontrol.2006.11.008; Munro CA, 2001, MED MYCOL, V39, P41, DOI 10.1080/744118878; Nicholson WL, 2002, CELL MOL LIFE SCI, V59, P410, DOI 10.1007/s00018-002-8433-7; O'Donnell Erika A, 2013, Immune Netw, V13, P43, DOI 10.4110/in.2013.13.2.43; Odell ID, 2013, J INVEST DERMATOL, V133, pE1, DOI 10.1038/jid.2012.455; Palazzinia JM, 2007, CROP PROT, V26, P1702, DOI 10.1016/j.cropro.2007.03.004; Pereira P, 2007, BIOL CONTROL, V42, P281, DOI 10.1016/j.biocontrol.2007.05.015; Pereira P, 2010, BIOL CONTROL, V53, P258, DOI 10.1016/j.biocontrol.2010.02.001; Picot A, 2010, CRIT REV MICROBIOL, V36, P221, DOI 10.3109/10408411003720209; Proctor RH, 2002, EUR J PLANT PATHOL, V108, P691, DOI 10.1023/A:1020637832371; Reyes-Ramirez A, 2004, J FOOD SCI, V69, pM131, DOI 10.1111/j.1365-2621.2004.tb10721.x; Sadfi N., 2001, Journal of Plant Pathology, V83, P101; Schmidt-Heydt M, 2008, FEMS MICROBIOL LETT, V284, P142, DOI 10.1111/j.1574-6968.2008.01182.x; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; SHEPHARD GS, 1990, J LIQ CHROMATOGR, V13, P2077, DOI 10.1080/01483919008049014; Snook ME, 2009, J AGR FOOD CHEM, V57, P4287, DOI 10.1021/jf900164h; Sparks ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061190; STABB EV, 1994, APPL ENVIRON MICROB, V60, P4404, DOI 10.1128/AEM.60.12.4404-4412.1994; SYDENHAM EW, 1990, J AGR FOOD CHEM, V38, P1900, DOI 10.1021/jf00100a004; Tilquin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003432; Vidal-Quist JC, 2013, FEMS MICROBIOL ECOL, V86, P474, DOI [10.1111/1574-6941.12175, 10.1111/]; Xue AG, 2009, CAN J PLANT PATHOL, V31, P169; Yang H, 2012, APPL ENVIRON MICROB, V78, P6466, DOI 10.1128/AEM.01229-12; Zhang YP, 2011, FUNGAL GENET BIOL, V48, P71, DOI 10.1016/j.fgb.2010.09.004; Zhou Y, 2008, APPL MICROBIOL BIOT, V80, P563, DOI 10.1007/s00253-008-1610-3	59	8	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e92189	10.1371/journal.pone.0092189	http://dx.doi.org/10.1371/journal.pone.0092189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739804	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900010
J	Burkovetskaya, M; Karpuk, N; Xiong, J; Bosch, M; Boska, MD; Takeuchi, H; Suzumura, A; Kielian, T				Burkovetskaya, Maria; Karpuk, Nikolay; Xiong, Juan; Bosch, Megan; Boska, Michael D.; Takeuchi, Hideyuki; Suzumura, Akio; Kielian, Tammy			Evidence for Aberrant Astrocyte Hemichannel Activity in Juvenile Neuronal Ceroid Lipofuscinosis (JNCL)	PLOS ONE			English	Article							JUNCTION INTERCELLULAR COMMUNICATION; MAGNETIC-RESONANCE SPECTROSCOPY; MITOCHONDRIAL ATP SYNTHASE; KNOCK-IN MICE; MOUSE MODEL; BATTEN-DISEASE; GAP-JUNCTIONS; FLUORESCENT DYES; SUBUNIT-C; BRAIN	Juvenile Neuronal Ceroid Lipofuscinosis (JNCL) is a lysosomal storage disease caused by an autosomal recessive mutation in CLN3 that leads to vision loss, progressive cognitive and motor decline, and premature death. Morphological evidence of astrocyte activation occurs early in the disease process and coincides with regions where neuronal loss eventually ensues. However, the consequences of CLN3 mutation on astrocyte function remain relatively ill-defined. Astrocytes play a critical role in CNS homeostasis, in part, by their ability to regulate the extracellular milieu via the formation of extensive syncytial networks coupled by gap junction (GJ) channels. In contrast, unopposed hemichannels (HCs) have been implicated in CNS pathology by allowing the non-discriminant passage of molecules between the intracellular and extracellular milieus. Here we examined acute brain slices from CLN3 mutant mice (CLN3(Delta ex7/8)) to determine whether CLN3 loss alters the balance of GJ and HC activity. CLN3(Delta ex7/8) mice displayed transient increases in astrocyte HC opening at postnatal day 30 in numerous brain regions, compared to wild type (WT) animals; however, HC activity steadily decreased at postnatal days 60 and 90 in CLN3(Delta ex7/8) astrocytes to reach levels lower than WT cells. This suggested a progressive decline in astrocyte function, which was supported by significant reductions in glutamine synthetase, GLAST, and connexin expression in CLN3(Delta ex7/8) mice compared to WT animals. Based on the early increase in astrocyte HC activity, CLN3(Delta ex7/8) mice were treated with the novel carbenoxolone derivative INI-0602 to inhibit HCs. Administration of INI-0602 for a one month period significantly reduced lysosomal ceroid inclusions in the brains of CLN3(Delta ex7/8) mice compared to WT animals, which coincided with significant increases in astrocyte GJ communication and normalization of astrocyte resting membrane potential to WT levels. Collectively, these findings suggest that alterations in astrocyte communication may impact the progression of JNCL and could offer a potential therapeutic target.	[Burkovetskaya, Maria; Karpuk, Nikolay; Xiong, Juan; Kielian, Tammy] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Burkovetskaya, Maria; Karpuk, Nikolay; Xiong, Juan; Kielian, Tammy] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE USA; [Bosch, Megan] Univ Nebraska Med Ctr, Dept Pharmacol, Omaha, NE USA; [Bosch, Megan] Univ Nebraska Med Ctr, Dept Expt Neurosci, Omaha, NE USA; [Boska, Michael D.] Univ Nebraska Med Ctr, Dept Radiol, Omaha, NE USA; [Takeuchi, Hideyuki; Suzumura, Akio] Nagoya Univ, Environm Med Res Inst, Dept Neuroimmunol, Nagoya, Aichi 464, Japan	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Nagoya University	Kielian, T (corresponding author), Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA.	tkielian@unmc.edu		Kielian, Tammy/0000-0001-7624-670X; Takeuchi, Hideyuki/0000-0001-5912-7581	National Institutes of Health National Institute of Neurological Disorders and Stroke [R21NS084392]; Batten Disease Support and Research Administration (BDSRA); Bee For Battens - The Saoirse Foundation; UNMC Dean's Pediatric Research Fund; UNMC-Chinese Scholarship Council fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084392] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Batten Disease Support and Research Administration (BDSRA); Bee For Battens - The Saoirse Foundation; UNMC Dean's Pediatric Research Fund; UNMC-Chinese Scholarship Council fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health National Institute of Neurological Disorders and Stroke (R21NS084392), Batten Disease Support and Research Administration (BDSRA), Bee For Battens - The Saoirse Foundation, and the UNMC Dean's Pediatric Research Fund (to T. K.). J.X. is supported by a UNMC-Chinese Scholarship Council fellowship. The development of INI-0602 was supported by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan (to H. T. and A. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg L, 2000, NEUROLOGY, V54, P1069, DOI 10.1212/WNL.54.5.1069; Anderson CM, 2000, GLIA, V32, P1; Anderson GW, 2012, BIOCH BIOPHYS ACTA; BASTIAANSE EML, 1993, J MEMBRANE BIOL, V136, P135, DOI 10.1007/BF02505758; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; Braak E, 2001, ACTA NEUROPATHOL, V101, P195; Bramley JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022721; Bras J, 2012, HUM MOL GENET, V21, P2646, DOI 10.1093/hmg/dds089; Brockmann K, 1996, NEUROPEDIATRICS, V27, P242, DOI 10.1055/s-2007-973772; Chatziioannou Arion F, 2005, Proc Am Thorac Soc, V2, P533, DOI 10.1513/pats.200508-079DS; Corns LF, 2013, NEUROSCI LETT, V553, P57, DOI 10.1016/j.neulet.2013.07.007; Cotman SL, 2002, HUM MOL GENET, V11, P2709, DOI 10.1093/hmg/11.22.2709; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; Esen N, 2007, GLIA, V55, P104, DOI 10.1002/glia.20438; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Eugenin EA, 2012, J NEUROIMMUNE PHARM, V7, P499, DOI 10.1007/s11481-012-9352-5; Finn R, 2011, NEUROCHEM INT, V58, P648, DOI 10.1016/j.neuint.2011.02.003; Fossale E, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-57; Garg S, 2005, J NEUROCHEM, V95, P475, DOI 10.1111/j.1471-4159.2005.03384.x; Giaume C, 2009, BRAIN RES REV; Groh J, 2013, BRAIN, V136, P1083, DOI 10.1093/brain/awt020; HAGOPIAN K, 1995, AM J MED GENET, V57, P272, DOI 10.1002/ajmg.1320570232; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Herrmann P, 2008, J NEUROSCI RES, V86, P1857, DOI 10.1002/jnr.21630; Iglesias R, 2009, J NEUROSCI, V29, P7092, DOI 10.1523/JNEUROSCI.6062-08.2009; Jalanko A, 2005, NEUROBIOL DIS, V18, P226, DOI 10.1016/j.nbd.2004.08.013; JOHNSON DW, 1995, AM J MED GENET, V57, P350, DOI 10.1002/ajmg.1320570250; Karpuk N, 2012, J NEUROPHYSIOL, V108, P112, DOI 10.1152/jn.01182.2011; Karpuk N, 2011, J NEUROSCI, V31, P414, DOI 10.1523/JNEUROSCI.5247-10.2011; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Kovacs AD, 2012, NEUROPHARMACOLOGY, V63, P769, DOI 10.1016/j.neuropharm.2012.05.040; Kovacs AD, 2011, NEUROPHARMACOLOGY, V60, P405, DOI 10.1016/j.neuropharm.2010.10.010; Kuhl TG, 2013, J CHILD NEUROL, V28, P1117, DOI 10.1177/0883073813494479; LERNER TJ, 1995, CELL, V82, P949, DOI 10.1016/0092-8674(95)90274-0; Li AF, 2003, INVEST OPHTH VIS SCI, V44, P5376, DOI 10.1167/iovs.03-0360; Locke D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-52; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Micsenyi MC, 2013, J NEUROSCI, V33, P10815, DOI 10.1523/JNEUROSCI.0987-13.2013; Mink JW, 2013, J CHILD NEUROL, V28, P1101, DOI 10.1177/0883073813494268; Miyasaka N, 2006, MAGNET RESON MED, V55, P198, DOI 10.1002/mrm.20731; Moriyama Y, 2013, NEUROSCI LETT, V543, P152, DOI 10.1016/j.neulet.2013.03.053; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Munroe PB, 1997, AM J HUM GENET, V61, P310, DOI 10.1086/514846; Nagasawa K, 2006, J CELL PHYSIOL, V208, P123, DOI 10.1002/jcp.20647; Nagy JI, 2011, EUR J NEUROSCI, V34, P263, DOI 10.1111/j.1460-9568.2011.07741.x; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Oliveira VC, 2010, HISTOL HISTOPATHOL, V25, P1017, DOI 10.14670/HH-25.1017; Orellana J. A., 2013, J NEUROCHEM; Orellana JA, 2011, CNS NEUROL DISORD DR; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Pautler RG, 2004, PHYSIOLOGY, V19, P168, DOI 10.1152/physiol.00016.2004; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pears MR, 2005, J BIOL CHEM, V280, P42508, DOI 10.1074/jbc.M507380200; Pontikis CC, 2005, NEUROBIOL DIS, V20, P823, DOI 10.1016/j.nbd.2005.05.018; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Qiao X, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-95; Rakheja D, 2007, CURR MOL MED, V7, P603, DOI 10.2174/156652407781695729; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Ransom BR, 2000, PROG BRAIN RES, V125, P217; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Ratiney H, 2004, MAGN RESON MATER PHY, V16, P284, DOI 10.1007/s10334-004-0037-9; Riga D, 2006, ANN NY ACAD SCI, V1067, P158, DOI 10.1196/annals.1354.019; Rose CF, 2013, BIOCHEM SOC T, V41, P1518, DOI 10.1042/BST20130237; Rouach N, 2003, J PHYSIOL-LONDON, V553, P729, DOI 10.1113/jphysiol.2003.053439; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Salek RM, 2011, J BIOMOL NMR, V49, P175, DOI 10.1007/s10858-011-9491-7; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Sebastia J, 2003, CYTOM PART A, V51A, P16, DOI 10.1002/cyto.a.10003; Seehafer SS, 2006, NEUROBIOL AGING, V27, P576, DOI 10.1016/j.neurobiolaging.2005.12.006; Shestopalov VI, 2008, CELL MOL LIFE SCI, V65, P376, DOI 10.1007/s00018-007-7200-1; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Staropoli JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038310; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; Takahashi DK, 2010, NEUROBIOL DIS, V40, P573, DOI 10.1016/j.nbd.2010.07.018; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takeuchi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021108; Tauskela JS, 2000, GLIA, V30, P329, DOI 10.1002/(SICI)1098-1136(200006)30:4<329::AID-GLIA20>3.3.CO;2-I; TAYLOR RM, 1988, ACTA NEUROPATHOL, V75, P627, DOI 10.1007/BF00686209; Tecedor L, 2013, J NEUROSCI, V33, P18065, DOI 10.1523/JNEUROSCI.0498-13.2013; Tovar KR, 2009, J NEUROPHYSIOL, V102, P974, DOI 10.1152/jn.00060.2009; TSAI GC, 1995, PROG NEUROBIOL, V46, P531, DOI 10.1016/0301-0082(95)00014-M; Tyynela J, 2004, BRAIN PATHOL, V14, P349; Valenzuela MJ, 2001, NEUROLOGY, V56, P592, DOI 10.1212/WNL.56.5.592; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Wang SY, 2012, ADV EXP MED BIOL, V724, P138, DOI 10.1007/978-1-4614-0653-2_11; Weimer JM, 2009, BRAIN RES, V1266, P93, DOI 10.1016/j.brainres.2009.02.009; Weissenbock H, 1997, J COMP PATHOL, V117, P17, DOI 10.1016/S0021-9975(97)80063-1; Wolfe DM, 2011, DIS MODEL MECH, V4, P120, DOI 10.1242/dmm.006114; Xiong J, 2013, J NEUROCHEM; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	94	36	37	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95023	10.1371/journal.pone.0095023	http://dx.doi.org/10.1371/journal.pone.0095023			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736558	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600127
J	Lyon, D; Castillejo, MA; Staudinger, C; Weckwerth, W; Wienkoop, S; Egelhofer, V				Lyon, David; Castillejo, Maria Angeles; Staudinger, Christiana; Weckwerth, Wolfram; Wienkoop, Stefanie; Egelhofer, Volker			Automated Protein Turnover Calculations from N-15 Partial Metabolic Labeling LC/MS Shotgun Proteomics Data	PLOS ONE			English	Article							QUANTIFICATION; IDENTIFICATION; STABILITY	Protein turnover is a well-controlled process in which polypeptides are constantly being degraded and subsequently replaced with newly synthesized copies. Extraction of composite spectral envelopes from complex LC/MS shotgun proteomics data can be a challenging task, due to the inherent complexity of biological samples. With partial metabolic labeling experiments this complexity increases as a result of the emergence of additional isotopic peaks. Automated spectral extraction and subsequent protein turnover calculations enable the analysis of gigabytes of data within minutes, a prerequisite for systems biology high throughput studies. Here we present a fully automated method for protein turnover calculations from shotgun proteomics data. The approach enables the analysis of complex shotgun LC/MS N-15 partial metabolic labeling experiments. Spectral envelopes of 1419 peptides can be extracted within an hour. The method quantifies turnover by calculating the Relative Isotope Abundance (RIA), which is defined as the ratio between the intensity sum of all heavy (N-15) to the intensity sum of all light (N-14) and heavy peaks. To facilitate this process, we have developed a computer program based on our method, which is freely available to download at http://promex.pph.univie.ac.at/protover.	[Lyon, David; Castillejo, Maria Angeles; Staudinger, Christiana; Weckwerth, Wolfram; Wienkoop, Stefanie; Egelhofer, Volker] Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria	University of Vienna	Egelhofer, V (corresponding author), Univ Vienna, Dept Ecogen & Syst Biol, Vienna, Austria.	volker.egelhofer@univie.ac.at	Weckwerth, Wolfram/G-5811-2010; Wienkoop, Stefanie/H-7509-2014; Castillejo, Maria Angeles/AAD-2248-2020; Egelhofer, Volker/B-9988-2014	Wienkoop, Stefanie/0000-0003-3575-813X; Castillejo, Maria Angeles/0000-0003-2017-1029; Lyon, David/0000-0001-5794-0456; Staudinger, Christiana/0000-0003-0606-9407; Egelhofer, Volker/0000-0003-2109-941X; Weckwerth, Wolfram/0000-0002-9719-6358	FWF [P23441-B20]; Spanish Ministry of Education [2010-0236]; Austrian Science Fund (FWF) [P 23441] Funding Source: researchfish	FWF(Austrian Science Fund (FWF)); Spanish Ministry of Education(Spanish Government); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by FWF, Project Number: P23441-B20 (Austrian Science Fund), and Spanish Ministry of Education, through the Mobility Program R-D + I 2008-2011, code 2010-0236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Castillejo MA, 2014, METHODS MOL BIOL, V1072, P303, DOI 10.1007/978-1-62703-631-3_22; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Gustavsson N, 2005, PROTEOMICS, V5, P3563, DOI 10.1002/pmic.200401193; Hebeler R, 2008, MOL CELL PROTEOMICS, V7, P108, DOI 10.1074/mcp.M700340-MCP200; Hoehenwarter W, 2010, RAPID COMMUN MASS SP, V24, P3609, DOI 10.1002/rcm.4818; Li L, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010025, 10.1074/mcp.M111.014209]; Maier T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.38; Martin SF, 2012, J PROTEOME RES, V11, P476, DOI 10.1021/pr2009302; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park SK, 2008, NAT METHODS, V5, P319, DOI [10.1038/NMETH.1195, 10.1038/nmeth.1195]; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Price JC, 2010, PNAS, V2010, DOI [10.1073/pnas.1006551107/2/DCSupplemental, DOI 10.1073/PNAS.1006551107/2/DCSUPPLEMENTAL]; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Schwanhausser B, 2013, NATURE, V495, P126, DOI 10.1038/nature11848; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Singh DK, 2011, TRENDS PLANT SCI, V16, P432, DOI 10.1016/j.tplants.2011.03.014; Singh Upasana, 2011, BMC Res Notes, V4, P18, DOI 10.1186/1756-0500-4-18; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang YY, 2011, ANAL CHEM, V83, P1665, DOI 10.1021/ac102755n	22	5	5	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94692	10.1371/journal.pone.0094692	http://dx.doi.org/10.1371/journal.pone.0094692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736476	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600084
J	Rorabaugh, JM; Stratford, JM; Zahniser, NR				Rorabaugh, Jacki M.; Stratford, Jennifer M.; Zahniser, Nancy R.			A Relationship between Reduced Nucleus Accumbens Shell and Enhanced Lateral Hypothalamic Orexin Neuronal Activation in Long-Term Fructose Bingeing Behavior	PLOS ONE			English	Article							RECEPTOR ANTAGONIST SB-334867; MESOLIMBIC DOPAMINE; FLAVOR PREFERENCES; PROTEIN DISTRIBUTION; VENTRAL PALLIDUM; FOOD-CONSUMPTION; REWARD-SEEKING; FOS EXPRESSION; RAT-BRAIN; GLUCOSE	Fructose accounts for 10% of daily calories in the American diet. Fructose, but not glucose, given intracerebroventricularly stimulates homeostatic feeding mechanisms within the hypothalamus; however, little is known about how fructose affects hedonic feeding centers. Repeated ingestion of sucrose, a disaccharide of fructose and glucose, increases neuronal activity in hedonic centers, the nucleus accumbens (NAc) shell and core, but not the hypothalamus. Rats given glucose in the intermittent access model (IAM) display signatures of hedonic feeding including bingeing and altered DA receptor (R) numbers within the NAc. Here we examined whether substituting fructose for glucose in this IAM produces bingeing behavior, alters DA Rs and activates hedonic and homeostatic feeding centers. Following long-term (21-day) exposure to the IAM, rats given 8-12% fructose solutions displayed fructose bingeing but unaltered DA D1R or D2R number. Fructose bingeing rats, as compared to chow bingeing controls, exhibited reduced NAc shell neuron activation, as determined by c-Fos-immunoreactivity (Fos-IR). This activation was negatively correlated with orexin (Orx) neuron activation in the lateral hypothalamus/perifornical area (LH/PeF), a brain region linking homeostatic to hedonic feeding centers. Following short-term (2-day) access to the IAM, rats exhibited bingeing but unchanged Fos-IR, suggesting only long-term fructose bingeing increases Orx release. In long-term fructose bingeing rats, pretreatment with the Ox1R antagonist SB-334867 (30 mg/kg; i.p.) equally reduced fructose bingeing and chow intake, resulting in a 50% reduction in calories. Similarly, in control rats, SB-334867 reduced chow/caloric intake by 60%. Thus, in the IAM, Ox1Rs appear to regulate feeding based on caloric content rather than palatability. Overall, our results, in combination with the literature, suggest individual monosaccharides activate distinct neuronal circuits to promote feeding behavior. Specifically, long-term fructose bingeing activates a hyperphagic circuit composed in part of NAc shell and LH/PeF Orx neurons.	[Rorabaugh, Jacki M.; Zahniser, Nancy R.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80309 USA; [Stratford, Jennifer M.] Univ Colorado, Sch Med, Dept Cell & Dev Biol, Rocky Mt Taste & Smell Ctr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Rorabaugh, JM (corresponding author), Univ Colorado, Sch Med, Dept Pharmacol, Anschutz Med Campus, Aurora, CO 80309 USA.	jacki.rorabaugh@ucdenver.edu			Rocky Mountain Taste and Smell Center [P30 DC04657];  [T32 GM007635];  [F32 DC012025];  [K05 DA015050];  [R01 DA004216]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC012025, P30DC004657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA015050, R01DA004216] Funding Source: NIH RePORTER	Rocky Mountain Taste and Smell Center; ; ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	J.M. Rorabaugh was supported in part by T32 GM007635. J.M. Stratford was supported by F32 DC012025. N.R. Zahniser was supported in part by K05 DA015050. R01 DA004216 supported this study, with additional support from the Rocky Mountain Taste and Smell Center P30 DC04657. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackroff K, 2001, PHYSIOL BEHAV, V72, P691, DOI 10.1016/S0031-9384(01)00442-5; Angeles-Castellanos M, 2004, AM J PHYSIOL-REG I, V286, pR158, DOI 10.1152/ajpregu.00216.2003; Aston-Jones G, 2010, BRAIN RES, V1314, P74, DOI 10.1016/j.brainres.2009.09.106; Avena NM, 2008, PHYSIOL BEHAV, V94, P309, DOI 10.1016/j.physbeh.2008.01.008; Avena NM, 2006, CURR PROTOC NEUROSCI; Backberg M, 2002, EUR J NEUROSCI, V15, P315, DOI 10.1046/j.0953-816x.2001.01859.x; Balcita-Pedicino JJ, 2007, J COMP NEUROL, V503, P668, DOI 10.1002/cne.21420; Baldo BA, 2004, EUR J NEUROSCI, V19, P376, DOI 10.1111/j.1460-9568.2004.03093.x; Berthoud HR, 2011, PHYSIOL BEHAV, V104, P29, DOI 10.1016/j.physbeh.2011.04.051; Boggiano MA, 2005, BEHAV NEUROSCI, V119, P1207, DOI 10.1037/0735-7044.119.5.1207; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Cason AM, 2012, PSYCHOPHARMACOLOGY B; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; Cha SH, 2009, BIOCHEM BIOPH RES CO, V386, P212, DOI 10.1016/j.bbrc.2009.06.017; Chao J, 2004, ANNU REV MED, V55, P113, DOI 10.1146/annurev.med.55.091902.103730; Choi DL, 2012, NEUROSCIENCE, V210, P243, DOI 10.1016/j.neuroscience.2012.02.036; Cluderay JE, 2002, REGUL PEPTIDES, V104, P131, DOI 10.1016/S0167-0115(01)00357-3; Colantuoni C, 2001, NEUROREPORT, V12, P3549, DOI 10.1097/00001756-200111160-00035; Cutler DJ, 1999, PEPTIDES, V20, P1455, DOI 10.1016/S0196-9781(99)00157-6; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dugovic C, 2009, J PHARMACOL EXP THER, V330, P142, DOI 10.1124/jpet.109.152009; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Gonzalez JA, 2008, DIABETES, V57, P2569, DOI 10.2337/db08-0548; GROENEWEGEN HJ, 1993, NEUROSCIENCE, V57, P113, DOI 10.1016/0306-4522(93)90115-V; Harris GC, 2006, TRENDS NEUROSCI, V29, P571, DOI 10.1016/j.tins.2006.08.002; Haynes AC, 2000, REGUL PEPTIDES, V96, P45, DOI 10.1016/S0167-0115(00)00199-3; Hervieu GJ, 2001, NEUROSCIENCE, V103, P777, DOI 10.1016/S0306-4522(01)00033-1; Ho CY, 2013, NEUROPSYCHOPHARMACOL, V38, P1655, DOI 10.1038/npp.2013.62; Ishii Y, 2005, BEHAV BRAIN RES, V160, P11, DOI 10.1016/j.bbr.2004.11.011; Ishii Y, 2004, PHYSIOL BEHAV, V81, P129, DOI 10.1016/j.physbeh.2004.01.009; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Kay K, 2013, PSYCHOPHARMACOLOGY B; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; KIROUAC GJ, 1995, NEUROSCIENCE, V67, P625, DOI 10.1016/0306-4522(95)00013-9; Korotkova TM, 2003, J NEUROSCI, V23, P7; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Ma XS, 2007, J NEUROSCI, V27, P1529, DOI 10.1523/JNEUROSCI.3583-06.2007; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; McCaughey SA, 2008, NEUROSCI BIOBEHAV R, V32, P1024, DOI 10.1016/j.neubiorev.2008.04.002; Mitra A, 2011, NEUROSCIENCE, V192, P459, DOI 10.1016/j.neuroscience.2011.06.033; Moran TH, 2009, J NUTR, V139, pS1253, DOI 10.3945/jn.108.097956; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; Newman S, 2013, BIOL PSYCHIAT, V73, P843, DOI 10.1016/j.biopsych.2012.11.027; Otsubo H, 2011, NEUROSCIENCE, V196, P97, DOI 10.1016/j.neuroscience.2011.09.003; Page KA, 2013, JAMA-J AM MED ASSOC, V309, P63, DOI 10.1001/jama.2012.116975; Patyal R, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00082; PERIS J, 1990, J PHARMACOL EXP THER, V253, P38; Peyron C, 1998, J NEUROSCI, V18, P9996; Piccoli L, 2012, NEUROPSYCHOPHARMACOL, V37, P1999, DOI 10.1038/npp.2012.48; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Ren XY, 2010, J NEUROSCI, V30, P8012, DOI 10.1523/JNEUROSCI.5749-09.2010; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T, 2011, TRENDS PHARMACOL SCI, V32, P451, DOI 10.1016/j.tips.2011.03.007; Sano H, 2007, J NEUROSCI, V27, P6948, DOI 10.1523/JNEUROSCI.0514-07.2007; Scheggi S, 2013, NEUROSCIENCE, V236, P320, DOI 10.1016/j.neuroscience.2013.01.027; SCLAFANI A, 1994, PHYSIOL BEHAV, V56, P399, DOI 10.1016/0031-9384(94)90213-5; SCLAFANI A, 1993, AM J PHYSIOL, V265, pR320, DOI 10.1152/ajpregu.1993.265.2.R320; Sclafani A, 2011, PHYSIOL BEHAV, V104, P64, DOI 10.1016/j.physbeh.2011.04.039; Sharf R, 2008, BIOL PSYCHIAT, V64, P175, DOI 10.1016/j.biopsych.2008.03.006; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Smith JC, 2002, APPETITE, V38, P155, DOI 10.1006/appe.2001.0467; Smith MI, 2003, NEUROSCI LETT, V341, P256, DOI 10.1016/S0304-3940(03)00066-1; Stratford TR, 2012, BEHAV BRAIN RES, V226, P548, DOI 10.1016/j.bbr.2011.10.014; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Thorpe AJ, 2006, BRAIN RES, V1125, P60, DOI 10.1016/j.brainres.2006.09.075; Thorpe AJ, 2005, BRAIN RES, V1050, P156, DOI 10.1016/j.brainres.2005.05.045; Urstadt KR, 2013, NEUROPHARMACOLOGY, V67, P176, DOI 10.1016/j.neuropharm.2012.10.027; van den Top M, 2004, NAT NEUROSCI, V7, P493, DOI 10.1038/nn1226; Venner A, 2011, J PHYSIOL-LONDON, V589, P5701, DOI 10.1113/jphysiol.2011.217000; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Zheng HY, 2003, AM J PHYSIOL-REG I, V284, pR1436, DOI 10.1152/ajpregu.00781.2002; Zhou LY, 2012, J PHARMACOL EXP THER, V340, P801, DOI 10.1124/jpet.111.187567; Zukerman S, 2013, AM J PHYSIOL-REG I, V305, pR840, DOI 10.1152/ajpregu.00297.2013	77	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95019	10.1371/journal.pone.0095019	http://dx.doi.org/10.1371/journal.pone.0095019			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736531	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600126
J	Rota, CT; Millspaugh, JJ; Rumble, MA; Lehman, CP; Kesler, DC				Rota, Christopher T.; Millspaugh, Joshua J.; Rumble, Mark A.; Lehman, Chad P.; Kesler, Dylan C.			The Role of Wildfire, Prescribed Fire, and Mountain Pine Beetle Infestations on the Population Dynamics of Black-Backed Woodpeckers in the Black Hills, South Dakota	PLOS ONE			English	Article							HABITAT ASSOCIATIONS; PICOIDES-ARCTICUS; BURNED FORESTS; COMMUNITIES; ABUNDANCE; DISTURBANCES; SEVERITY; GROWTH; DEER; TIME	Wildfire and mountain pine beetle infestations are naturally occurring disturbances in western North American forests. Black-backed woodpeckers (Picoides arcticus) are emblematic of the role these disturbances play in creating wildlife habitat, since they are strongly associated with recently-killed forests. However, management practices aimed at reducing the economic impact of natural disturbances can result in habitat loss for this species. Although black-backed woodpeckers occupy habitats created by wildfire, prescribed fire, and mountain pine beetle infestations, the relative value of these habitats remains unknown. We studied habitat-specific adult and juvenile survival probabilities and reproductive rates between April 2008 and August 2012 in the Black Hills, South Dakota. We estimated habitat-specific adult and juvenile survival probability with Bayesian multi-state models and habitat-specific reproductive success with Bayesian nest survival models. We calculated asymptotic population growth rates from estimated demographic rates with matrix projection models. Adult and juvenile survival and nest success were highest in habitat created by summer wildfire, intermediate in MPB infestations, and lowest in habitat created by fall prescribed fire. Mean posterior distributions of population growth rates indicated growing populations in habitat created by summer wildfire and declining populations in fall prescribed fire and mountain pine beetle infestations. Our finding that population growth rates were positive only in habitat created by summer wildfire underscores the need to maintain early post-wildfire habitat across the landscape. The lower growth rates in fall prescribed fire and MPB infestations may be attributed to differences in predator communities and food resources relative to summer wildfire.	[Rota, Christopher T.; Millspaugh, Joshua J.; Kesler, Dylan C.] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA; [Rumble, Mark A.] US Forest Serv, Forest & Grassland Res Lab, Rocky Mt Res Stn, Rapid City, SD USA; [Lehman, Chad P.] South Dakota Dept Game Fish & Pk, Custer, SD USA	University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); United States Forest Service	Rota, CT (corresponding author), Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA.	rotact@missouri.edu	Rota, Christopher/H-5189-2019	Rota, Christopher/0000-0001-9272-4687	United States Forest Service Rocky Mountain Research Station [07-JV-11221609-211]; National Fire Plan [10-JV-11221632-178]; South Dakota Department of Game, Fish and Parks [08-CO-11221632-111]; South Dakota Department of Game, Fish, and Parks [T-39-R-1, 2439]; Missouri Chapter of the Wildlife Society; University of Missouri ORG; James D. Chambers Memorial Scholarship; Judy Southern Fellowship; TransWorld Airlines Scholarship	United States Forest Service Rocky Mountain Research Station; National Fire Plan; South Dakota Department of Game, Fish and Parks; South Dakota Department of Game, Fish, and Parks; Missouri Chapter of the Wildlife Society; University of Missouri ORG; James D. Chambers Memorial Scholarship; Judy Southern Fellowship; TransWorld Airlines Scholarship	Funding for this project was provided by the United States Forest Service Rocky Mountain Research Station agreement 07-JV-11221609-211 and the National Fire Plan agreement 10-JV-11221632-178. The South Dakota Department of Game, Fish and Parks provided funding through agreement number 08-CO-11221632-111 and the Wildlife Diversity Small Grants Program. This study was also made possible through State Wildlife Grant T-39-R-1, Study #2439, provided by the South Dakota Department of Game, Fish, and Parks. CTR was also supported by the Missouri Chapter of the Wildlife Society, the University of Missouri ORG, the James D. Chambers Memorial Scholarship, the Judy Southern Fellowship, and a TransWorld Airlines Scholarship administered by the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KK, 2001, EVALUATION MOUNTAIN; [Anonymous], 2009, JFSP SYNTHESIS REPOR; Baker WL, 2007, J BIOGEOGR, V34, P251, DOI 10.1111/j.1365-2699.2006.01592.x; Bonnot TW, 2008, CONDOR, V110, P450, DOI 10.1525/cond.2008.8460; Bonnot TW, 2009, FOREST ECOL MANAG, V259, P220, DOI 10.1016/j.foreco.2009.10.021; Brown PM, 1996, INT J WILDLAND FIRE, V6, P97, DOI 10.1071/WF9960097; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Cilimburg A, 2006, NO REGION LANDBIRD M; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dinsmore SJ, 2002, ECOLOGY, V83, P3476, DOI 10.1890/0012-9658(2002)083[3476:ATFMAN]2.0.CO;2; Drever MC, 2009, ECOLOGY, V90, P1095, DOI 10.1890/08-0575.1; Dudley JG, 2007, WEST N AM NATURALIST, V67, P593, DOI 10.3398/1527-0904(2007)67[593:HRSOBW]2.0.CO;2; Dudley JG, 2012, CONDOR, V114, P348, DOI 10.1525/cond.2012.110020; Edworthy AB, 2011, FOREST ECOL MANAG, V261, P203, DOI 10.1016/j.foreco.2010.10.006; Fair J., 2010, ORNITHOLOGICAL COUNC; Federal Register, 2013, FED REGISTER, V68, P21086; Ferrenberg SM, 2006, FIRE ECOL, V2, P79, DOI DOI 10.4996/fireecology.0202079; GOGGANS R, 1989, 87302 OR DEP FISH WI; Graham R.T., 2004, SCI BASIS CHANGING F; Hanson CT, 2008, CONDOR, V110, P777, DOI 10.1525/cond.2008.8611; Hoffman GR, 1987, RMRP276 USDA FOR SER; Hoyt JS, 2002, CAN J FOREST RES, V32, P1881, DOI [10.1139/x02-109, 10.1139/X02-109]; Huebner DP, 2007, J FIELD ORNITHOL, V78, P87, DOI 10.1111/j.1557-9263.2006.00089.x; Hutto RL, 2006, CONDOR, V108, P817, DOI 10.1650/0010-5422(2006)108[817:TEOPSL]2.0.CO;2; Hutto RL, 2008, ECOL APPL, V18, P1827, DOI 10.1890/08-0895.1; HUTTO RL, 1995, CONSERV BIOL, V9, P1041, DOI [10.1046/j.1523-1739.1995.9051041.x, 10.1046/j.1523-1739.1995.9051033.x-i1]; Ibarzabal J, 2006, ANN ZOOL FENN, V43, P235; Johnson SD, 2008, SOUTHWEST NAT, V53, P137, DOI 10.1894/0038-4909(2008)53[137:TOPBAA]2.0.CO;2; KEAY JA, 1980, J WILDLIFE MANAGE, V44, P372, DOI 10.2307/3807967; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Lehman CP, 2011, J FIELD ORNITHOL, V82, P430, DOI 10.1111/j.1557-9263.2011.00347.x; Mohren SR, 2002, THESIS U WYOMING LAR; Murphy EC, 1998, J WILDLIFE MANAGE, V62, P1359, DOI 10.2307/3802002; Nappi A, 2011, CAN J FOREST RES, V41, P994, DOI [10.1139/X11-028, 10.1139/x11-028]; Nappi A, 2009, BIOL CONSERV, V142, P1381, DOI 10.1016/j.biocon.2009.01.022; National Interagency Fire Council, 2013, TOT WILDL FIR ACR 19; Proudfoot GA, 1996, WILDLIFE SOC B, V24, P528; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Rota CT, 2014, FOREST ECOL MANAG, V313, P161, DOI 10.1016/j.foreco.2013.10.048; Rota Christopher T., 2013, THESIS U MISSOURI CO; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Saab VA, 2007, CONDOR, V109, P97, DOI 10.1650/0010-5422(2007)109[97:NDOCBI]2.0.CO;2; Saint-Germain M, 2004, ENVIRON ENTOMOL, V33, P1703, DOI 10.1603/0046-225X-33.6.1703; Schutz S, 1999, NATURE, V398, P298, DOI 10.1038/18585; Setterington MA, 2000, J WILDLIFE MANAGE, V64, P335, DOI 10.2307/3803231; Shinneman DJ, 1997, CONSERV BIOL, V11, P1276, DOI 10.1046/j.1523-1739.1997.96198.x; Smucker KM, 2005, ECOL APPL, V15, P1535, DOI 10.1890/04-1353; South Dakota Department of Game Fish and Parks, 2006, 200609 S DAK DEP GAM; Squires J. R., 1997, BIRDS N AM ONLINE; Stanley TR, 2004, WILSON BULL, V116, P267, DOI 10.1676/04-042; Tremblay JA, 2009, AVIAN CONSERV ECOL, V4; USDA Forest Service Rocky Mountain Region Forest Health Management, 2009, ANN AER DET OV SURV; USDA Forest Service Rocky Mountain Region Forest Health Management, 2010, ANN AER DET OV SURV; Wisdom MJ, 2000, ECOLOGY, V81, P628, DOI 10.1890/0012-9658(2000)081[0628:LSSAEV]2.0.CO;2; Zimmerman TJ, 2006, J MAMMAL, V87, P598, DOI 10.1644/05-mamm-A-356R1.1; [No title captured]	57	27	29	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94700	10.1371/journal.pone.0094700	http://dx.doi.org/10.1371/journal.pone.0094700			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736502	Green Published, gold			2022-12-25	WOS:000336922600085
J	Yokota, T; Shiraishi, R; Aida, T; Iwai, K; Liu, NM; Yokoyama, U; Minamisawa, S				Yokota, Tomohiro; Shiraishi, Ryosuke; Aida, Takashi; Iwai, Kenji; Liu, Norika Mengchia; Yokoyama, Utako; Minamisawa, Susumu			Thromboxane A(2) Receptor Stimulation Promotes Closure of the Rat Ductus Arteriosus through Enhancing Neointima Formation	PLOS ONE			English	Article							VASCULAR-TONE; INDOMETHACIN; PATHOGENESIS; INFANTS; DIFFERENTIATION; PROLIFERATION; FIBRONECTIN; HYALURONAN; EXPRESSION; MATURATION	Ductus arteriosus (DA) closure follows constriction and remodeling of the entire vessel wall. Patent ductus arteriosus occurs when the DA does not close after birth, and this condition is currently treated using cyclooxygenase inhibitors. However, the efficacy of cyclooxygenase inhibitors is often limited. Our previous study demonstrated that low-dose thromboxane A(2) receptor (TP) stimulation constricted the DA with minimal adverse effects in rat neonates. However, its effect on DA remodeling remains unknown. In this study, we focused on the impact of the exogenous TP stimulation on the DA remodeling, especially intimal thickening. Using DA explants from rat fetuses at embryonic day 19 as a ex vivo model and primary cultured rat DA smooth muscle cells from embryonic day 21 as a in vitro model, we evaluated the effect of TP stimulation on the DA remodeling. The selective TP agonists U46619 and I-BOP promoted neointima formation in the ex vivo DA explants, and TP stimulation increased DA SMC migration in a dose-dependent manner. Both effects were inhibited by the selective TP antagonist SQ29548 or the siRNA against TP. TP stimulation also increased DA SMC proliferation in the presence of 10% fetal bovine serum. LC/MS/MS analysis revealed that TP stimulation increased secretion of several extracellular matrix proteins that may contribute to an increase in neointima formation. In conclusion, we uncovered that exogenous administration of TP agonist promotes neointima formation through the induction of migration and proliferation of DA SMC, which could contribute to DA closure and also to its vasoconstrictive action.	[Yokota, Tomohiro; Shiraishi, Ryosuke; Aida, Takashi; Iwai, Kenji; Liu, Norika Mengchia; Minamisawa, Susumu] Waseda Univ, Dept Life Sci & Med Biosci, Grad Sch Adv Sci & Engn, Tokyo, Japan; [Shiraishi, Ryosuke; Minamisawa, Susumu] Jikei Univ, Dept Cell Physiol, Sch Med, Tokyo, Japan; [Yokoyama, Utako] Yokohama City Univ, Cardiovasc Res Inst, Grad Sch Med, Yokohama, Kanagawa, Japan	Waseda University; Jikei University; Yokohama City University	Minamisawa, S (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Grad Sch Adv Sci & Engn, Tokyo, Japan.	sminamis@jikei.ac.jp	Yokoyama, Utako/AAD-1404-2022	Yokoyama, Utako/0000-0003-1803-0155; Minamisawa, Susumu/0000-0003-4728-2116; Yokota, Tomohiro/0000-0003-2540-3810; Liu, Norika/0000-0002-0033-9253	Ministry of Education, Culture, Sports, Science and Technology of Japan; Foundation for Growth Science; Yokohama Foundation for Advanced Medical Science; "High-Tech Research Center" Project for Private Universities: MEXT; Vehicle Racing Commemorative Foundation; Construction of Labo-exchange Type Health & Biomedical Science Research Consortium; Miyata Cardiology Research Promotion Foundation; Takeda Science Foundation; Japan Heart Foundation; Kowa Life Science Foundation; Sumitomo Foundation; Japan Cardiovascular Research Foundation; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [25293236, 24659100] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Growth Science; Yokohama Foundation for Advanced Medical Science; "High-Tech Research Center" Project for Private Universities: MEXT; Vehicle Racing Commemorative Foundation; Construction of Labo-exchange Type Health & Biomedical Science Research Consortium; Miyata Cardiology Research Promotion Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Heart Foundation; Kowa Life Science Foundation; Sumitomo Foundation; Japan Cardiovascular Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (UY, SM), Foundation for Growth Science (SM), the Yokohama Foundation for Advanced Medical Science (UY, SM), the "High-Tech Research Center" Project for Private Universities: MEXT (SM), the Vehicle Racing Commemorative Foundation (SM), Construction of Labo-exchange Type Health & Biomedical Science Research Consortium (TY), Miyata Cardiology Research Promotion Foundation (UY, SM), Takeda Science Foundation (UY, SM), the Japan Heart Foundation Research Grant (UY), the Kowa Life Science Foundation (UY), the Sumitomo Foundation (UY), Japan Cardiovascular Research Foundation (SM), and the Uehara Memorial Foundation (UY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hady H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/676192; Ballinger ML, 2010, J CELL MOL MED, V14, P1408, DOI 10.1111/j.1582-4934.2009.00902.x; Bokenkamp R, 2010, NEONATOLOGY, V98, P6, DOI 10.1159/000262481; BOUDREAU N, 1991, DEV BIOL, V143, P235, DOI 10.1016/0012-1606(91)90074-D; Chen XY, 2009, PHARMACOLOGY, V83, P67, DOI 10.1159/000178814; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; CHERVU A, 1990, SURG GYNECOL OBSTET, V171, P433; Clyman RI, 2006, BIOL NEONATE, V89, P330, DOI 10.1159/000092870; Cyrus T, 2010, ATHEROSCLEROSIS, V208, P376, DOI 10.1016/j.atherosclerosis.2009.08.008; D'Antoni ML, 2012, MATRIX BIOL, V31, P101, DOI 10.1016/j.matbio.2011.11.001; FINEMAN JR, 1992, AM J PHYSIOL, V262, pH1365, DOI 10.1152/ajpheart.1992.262.5.H1365; Gao YL, 2001, J PHARMACOL EXP THER, V296, P426; GITTENBERGERDEGROOT AC, 1980, J PEDIATR-US, V96, P88, DOI 10.1016/S0022-3476(80)80337-4; GITTENBERGERDEGROOT AC, 1985, J AM COLL CARDIOL, V6, P394, DOI 10.1016/S0735-1097(85)80178-9; Gustafsson M, 2007, CIRC RES, V101, P777, DOI 10.1161/CIRCRESAHA.107.149666; Hamrick SEG, 2010, PEDIATRICS, V125, P1020, DOI 10.1542/peds.2009-3506; Hermes-DeSantis ER, 2006, J PERINATOL, V26, pS14, DOI 10.1038/sj.jp.7211465; Kabra NS, 2007, J PEDIATR-US, V150, P229, DOI 10.1016/j.jpeds.2006.11.039; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Leonhardt A, 2003, BRIT J PHARMACOL, V138, P655, DOI 10.1038/sj.bjp.0705092; Li CH, 2000, CELL SIGNAL, V12, P435, DOI 10.1016/S0898-6568(00)00096-6; Little DC, 2003, J PEDIATR SURG, V38, P492, DOI 10.1053/jpsu.2003.50086; Liu NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073685; Loftin CD, 2002, J CLIN INVEST, V110, P549, DOI 10.1172/JCI200214924; Mason CAE, 1999, NAT MED, V5, P176, DOI 10.1038/5538; Minamisawa S, 2003, J BIOL CHEM, V278, P9570, DOI 10.1074/jbc.M213132200; Murphy-Ullrich JE, 2001, J CLIN INVEST, V107, P785, DOI 10.1172/JCI12609; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; PALDER SB, 1987, J PEDIATR SURG, V22, P1171, DOI 10.1016/S0022-3468(87)80730-3; Rabinovitch M, 1996, SEMIN PERINATOL, V20, P531, DOI 10.1016/S0146-0005(96)80067-X; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; SACHINIDIS A, 1995, HYPERTENSION, V26, P771, DOI 10.1161/01.HYP.26.5.771; Slomp J, 1997, ARTERIOSCL THROM VAS, V17, P1003, DOI 10.1161/01.ATV.17.5.1003; SLOMP J, 1992, ATHEROSCLEROSIS, V93, P25, DOI 10.1016/0021-9150(92)90197-O; Smith GCS, 1998, PHARMACOL REV, V50, P35; Smyth EM, 2010, CLIN LIPIDOL, V5, P209, DOI 10.2217/CLP.10.11; TADA T, 1985, ACTA PATHOL JAPON, V35, P23; Tufvesson E, 2003, J CELL SCI, V116, P4857, DOI 10.1242/jcs.00808; van der Sterren S, 2011, COMP BIOCHEM PHYS A, V159, P436, DOI 10.1016/j.cbpa.2011.04.010; Van Overmeire B, 2000, NEW ENGL J MED, V343, P674, DOI 10.1056/NEJM200009073431001; Van Overmeire B, 2004, LANCET, V364, P1945, DOI 10.1016/S0140-6736(04)17477-1; Yokota T, 2012, PEDIATR RES, V72, P129, DOI 10.1038/pr.2012.68; Yokoyama U, 2006, AM J PHYSIOL-HEART C, V290, pH1660, DOI 10.1152/ajpheart.00100.2004; Yokoyama U, 2007, PHYSIOL GENOMICS, V31, P139, DOI 10.1152/physiolgenomics.00007.2006; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; Yokoyama U, 2010, CIRC RES, V106, P1882, DOI 10.1161/CIRCRESAHA.109.214924; Yokoyama Utako, 2010, Journal of Smooth Muscle Research, V46, P77; Yuhki K, 2011, PHARMACOL THERAPEUT, V129, P195, DOI 10.1016/j.pharmthera.2010.09.004; Yun DH, 2009, EXP MOL MED, V41, P17, DOI 10.3858/emm.2009.41.1.003; Zuccollo A, 2005, CIRCULATION, V112, P3001, DOI 10.1161/CIRCULATIONAHA.105.581892	50	4	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94895	10.1371/journal.pone.0094895	http://dx.doi.org/10.1371/journal.pone.0094895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736499	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600104
J	Cho, Y; Di Liberto, V; Carlin, D; Abe, N; Li, KH; Burlingame, AL; Guan, S; Michaelevski, I; Cavalli, V				Cho, Yongcheol; Di Liberto, Valentina; Carlin, Dan; Abe, Namiko; Li, Kathy H.; Burlingame, Alma L.; Guan, Shenheng; Michaelevski, Izhak; Cavalli, Valeria			Syntaxin13 Expression Is Regulated by Mammalian Target of Rapamycin (mTOR) in Injured Neurons to Promote Axon Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Axon; mTOR; Proteomics; Regeneration; SNARE Proteins	LOCAL PROTEIN-SYNTHESIS; NEURITE OUTGROWTH; MESSENGER-RNA; GROWTH; TRANSPORT; MEMBRANE; TRANSLATION; TRAFFICKING; ENDOSOMES; NERVE	Injured peripheral neurons successfully activate intrinsic signaling pathways to enable axon regeneration. We have previously shown that dorsal root ganglia (DRG) neurons activate the mammalian target of rapamycin (mTOR) pathway following injury and that this activity enhances their axon growth capacity. mTOR plays a critical role in protein synthesis, but the mTOR-dependent proteins enhancing the regenerative capacity of DRG neurons remain unknown. To identify proteins whose expression is regulated by injury in an mTOR-dependent manner, we analyzed the protein composition of DRGs from mice in which we genetically activated mTOR and from mice with or without a prior nerve injury. Quantitative label-free mass spectrometry analyses revealed that the injury effects were correlated with mTOR activation. We identified a member of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) family of proteins, syntaxin13, whose expression was increased by injury in an mTOR-dependent manner. Increased syntaxin13 levels in injured nerves resulted from local protein synthesis and not axonal transport. Finally, knockdown of syntaxin13 in cultured DRG neurons prevented axon growth and regeneration. Together, these data suggest that syntaxin13 translation is regulated by mTOR in injured neurons to promote axon regeneration.	[Cho, Yongcheol; Di Liberto, Valentina; Carlin, Dan; Abe, Namiko; Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Li, Kathy H.; Burlingame, Alma L.; Guan, Shenheng] Univ Calif San Francisco, Dept Pharmaceut Chem, Mass Spectrometry Facil, San Francisco, CA 94158 USA; [Michaelevski, Izhak] Tel Aviv Univ, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Washington University (WUSTL); University of California System; University of California San Francisco; Tel Aviv University	Cavalli, V (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	cavalli@pcg.wustl.edu	Di+Liberto, Valentina/ACL-0264-2022; Michaelevski, Izhak/G-8940-2018	Di Liberto, Valentina/0000-0002-8574-0061; Michaelevski, Izhak/0000-0002-0783-1443	National Institutes of Health from NIGMS Biomedical Technology Research Centers Program [8P41GM103481]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082446] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS Biomedical Technology Research Centers Program; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Karen O'Malley and Vitaly Klyachko for critical reading of the manuscript. The mass spectrometry instrumentation access was provided by the Bio-Organic Biomedical Mass Spectrometry Resource at the University of California at San Francisco (A. L. Burlingame, Director) and is supported by National Institutes of Health Grant 8P41GM103481 from NIGMS Biomedical Technology Research Centers Program.	Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Abe N, 2009, J BIOL CHEM, V284, P34628, DOI 10.1074/jbc.M109.035022; Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; CRAGG BG, 1970, BRAIN RES, V23, P1, DOI 10.1016/0006-8993(70)90345-8; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Futerman AH, 1996, TRENDS NEUROSCI, V19, P144, DOI 10.1016/S0166-2236(96)80025-7; Gracias NG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4506; Guan SH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010728; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Hirling H, 2000, EUR J NEUROSCI, V12, P1913, DOI 10.1046/j.1460-9568.2000.00076.x; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jimenez-Diaz L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001961; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Kopp MA, 2012, CELL TISSUE RES, V349, P119, DOI 10.1007/s00441-012-1334-7; Leung LC, 2013, NAT NEUROSCI, V16, P166, DOI 10.1038/nn.3290; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; Liu K, 2011, ANNU REV NEUROSCI, V34, P131, DOI 10.1146/annurev-neuro-061010-113723; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Mackay D. J., 2003, INFORM THEORY INFERE, P284, DOI [10.2277/0521642981, DOI 10.2277/0521642981]; Merianda TT, 2013, J CELL SCI, V126, P90, DOI 10.1242/jcs.107268; Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Prager-Khoutorsky M, 2009, BRAIN RES, V1251, P65, DOI 10.1016/j.brainres.2008.10.049; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Prekeris R, 1999, J NEUROSCI, V19, P10324; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Rishal I, 2014, NAT REV NEUROSCI, V15, P32, DOI 10.1038/nrn3609; Salvador S, 2004, PROC INT C TOOLS ART, P576; Sann S, 2009, TRENDS CELL BIOL, V19, P317, DOI 10.1016/j.tcb.2009.05.001; SCHREYER DJ, 1993, J NEUROBIOL, V24, P959, DOI 10.1002/neu.480240709; Shin JE, 2012, NEURON, V74, P1015, DOI 10.1016/j.neuron.2012.04.028; Skalski M, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-62; Spencer GE, 2000, J NEUROBIOL, V44, P72, DOI 10.1002/1097-4695(200007)44:1<72::AID-NEU7>3.0.CO;2-#; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tuck Elizabeth, 2010, Commun Integr Biol, V3, P209; Vance JE, 2000, BBA-MOL CELL BIOL L, V1486, P84, DOI 10.1016/S1388-1981(00)00050-0; VANDERZEE CEEM, 1989, J NEUROSCI, V9, P3505; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; WATSON WE, 1969, J PHYSIOL-LONDON, V201, pP80; WATSON WE, 1968, J PHYSIOL-LONDON, V196, P655, DOI 10.1113/jphysiol.1968.sp008528; Wildonger J, 2008, GENE DEV, V22, P2447, DOI 10.1101/gad.1724108; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Winckler B, 2011, TRAFFIC, V12, P1099, DOI 10.1111/j.1600-0854.2011.01213.x; Wu KY, 2005, NATURE, V436, P1020, DOI 10.1038/nature03885; Yoo S, 2013, J NEUROCHEM, V126, P792, DOI 10.1111/jnc.12266	59	21	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15820	15832		10.1074/jbc.M113.536607	http://dx.doi.org/10.1074/jbc.M113.536607			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737317	Green Published, hybrid			2022-12-25	WOS:000337465400061
J	Sullivan, SE; Dillon, GM; Sullivan, JM; Ho, A				Sullivan, Sarah E.; Dillon, Gregory M.; Sullivan, Josefa M.; Ho, Angela			Mint Proteins Are Required for Synaptic Activity-dependent Amyloid Precursor Protein (APP) Trafficking and Amyloid beta Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Protein; Alzheimer Disease; Amyloid; Amyloid Precursor Protein (APP); Trafficking; Mint; X11; Synaptic Activity	ALZHEIMERS-DISEASE; IN-VIVO; RELEASE; PATHWAY; SECRETASE; AUTOINHIBITION; ENDOCYTOSIS; BINDING; OCCURS; ALPHA	Background: Activity-dependent amyloid (A) generation requires endosomal proteolytic cleavage of the amyloid precursor protein (APP). Results: Mints are adaptor proteins that regulate APP endocytosis and insertion at the plasma membrane upon activity induction or inhibition. Conclusion: Mints are necessary for activity-induced APP trafficking and A generation. Significance: Insight into the cell biology and molecules controlling APP trafficking is essential in understanding A pathogenesis. Aberrant amyloid (A) production plays a causal role in Alzheimer disease pathogenesis. A major cellular pathway for A generation is the activity-dependent endocytosis and proteolytic cleavage of the amyloid precursor protein (APP). However, the molecules controlling activity-dependent APP trafficking in neurons are less defined. Mints are adaptor proteins that directly interact with the endocytic sorting motif of APP and are functionally important in regulating APP endocytosis and A production. We analyzed neuronal cultures from control and Mint knockout neurons that were treated with either glutamate or tetrodotoxin to stimulate an increase or decrease in neuronal activity, respectively. We found that neuronal activation by glutamate increased APP endocytosis, followed by elevated APP insertion into the cell surface, stabilizing APP at the plasma membrane. Conversely, suppression of neuronal activity by tetrodotoxin decreased APP endocytosis and insertion. Interestingly, we found that activity-dependent APP trafficking and A generation were blocked in Mint knockout neurons. We showed that wild-type Mint1 can rescue APP internalization and insertion in Mint knockout neurons. In addition, we found that Mint overexpression increased excitatory synaptic activity and that APP was internalized predominantly to endosomes associated with APP processing. We demonstrated that presenilin 1 (PS1) endocytosis requires interaction with the PDZ domains of Mint1 and that this interaction facilitates activity-dependent colocalization of APP and PS1. These findings demonstrate that Mints are necessary for activity-induced APP and PS1 trafficking and provide insight into the cellular fate of APP in endocytic pathways essential for A production.	[Sullivan, Sarah E.; Dillon, Gregory M.; Sullivan, Josefa M.; Ho, Angela] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Ho, A (corresponding author), Boston Univ, Dept Biol, 24 Cummington Mall, Boston, MA 02215 USA.	aho1@bu.edu			National Institute of Health [K01 AG027311, R01 AG044499]; Alzheimer's Association [IIRG-09-130591]; NATIONAL INSTITUTE ON AGING [R01AG044499, K01AG027311] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institute of Health Grants K01 AG027311 and R01 AG044499 (to A. H.). This work was also supported by Alzheimer's Association Grant IIRG-09-130591 (to A. H.).	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Back S, 2007, J NEUROSCI RES, V85, P2580, DOI 10.1002/jnr.21239; Beffert U, 2012, J NEUROSCI, V32, P13906, DOI 10.1523/JNEUROSCI.2108-12.2012; Biederer T, 2002, J NEUROSCI, V22, P7340; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Chaufty J, 2012, J NEUROSCI, V32, P9613, DOI 10.1523/JNEUROSCI.0602-12.2012; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Cirrito JR, 2005, J CLIN INVEST, V115, P3285, DOI 10.1172/JCI25247; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; Good RL, 2011, NEUROTOXICOLOGY, V32, P751, DOI 10.1016/j.neuro.2011.07.005; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Gross GG, 2013, J NEUROSCI, V33, P8575, DOI 10.1523/JNEUROSCI.5749-12.2013; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAASS C, 1994, J BIOL CHEM, V269, P17741; Ho A, 2003, P NATL ACAD SCI USA, V100, P1409, DOI 10.1073/pnas.252774899; Ho A, 2008, J NEUROSCI, V28, P14392, DOI 10.1523/JNEUROSCI.2481-08.2008; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Jacobs EH, 2006, NEUROSCIENCE, V138, P511, DOI 10.1016/j.neuroscience.2005.11.017; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lau KF, 2000, NEUROREPORT, V11, P3607, DOI 10.1097/00001756-200011090-00041; Long JF, 2005, NAT STRUCT MOL BIOL, V12, P722, DOI 10.1038/nsmb958; Matos MF, 2012, P NATL ACAD SCI USA, V109, P3802, DOI 10.1073/pnas.1119075109; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Pawson T, 2007, CURR OPIN CELL BIOL, V19, P112, DOI 10.1016/j.ceb.2007.02.013; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Rhinn H, 2013, NATURE, V500, P45, DOI 10.1038/nature12415; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Scorza CA, 2003, EPILEPSY RES, V57, P49, DOI 10.1016/j.eplepsyres.2003.10.010; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Xie H, 2013, P NATL ACAD SCI USA, V110, P7904, DOI 10.1073/pnas.1217938110	38	24	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15374	15383		10.1074/jbc.M113.541003	http://dx.doi.org/10.1074/jbc.M113.541003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742670	Green Published, hybrid			2022-12-25	WOS:000337465400021
J	Barton, M; Sunnucks, P; Norgate, M; Murray, N; Kearney, M				Barton, Madeleine; Sunnucks, Paul; Norgate, Melanie; Murray, Neil; Kearney, Michael			Co-Gradient Variation in Growth Rate and Development Time of a Broadly Distributed Butterfly	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; BODY-SIZE; CLIMATE-CHANGE; EVOLUTIONARY SIGNIFICANCE; HETERONYMPHA-MEROPE; TEMPERATURE; COUNTERGRADIENT; LEPIDOPTERA; ADAPTATION; ECTOTHERMS	Widespread species often show geographic variation in thermally-sensitive traits, providing insight into how species respond to shifts in temperature through time. Such patterns may arise from phenotypic plasticity, genetic adaptation, or their interaction. In some cases, the effects of genotype and temperature may act together to reduce, or to exacerbate, phenotypic variation in fitness-related traits across varying thermal environments. We find evidence for such interactions in life-history traits of Heteronympha merope, a butterfly distributed across a broad latitudinal gradient in south-eastern Australia. We show that body size in this butterfly is negatively related to developmental temperature in the laboratory, in accordance with the temperature-size rule, but not in the field, despite very strong temperature gradients. A common garden experiment on larval thermal responses, spanning the environmental extremes of H. merope's distribution, revealed that butterflies from low latitude (warmer climate) populations have relatively fast intrinsic growth and development rates compared to those from cooler climates. These synergistic effects of genotype and temperature across the landscape (co-gradient variation) are likely to accentuate phenotypic variation in these traits, and this interaction must be accounted for when predicting how H. merope will respond to temperature change through time. These results highlight the importance of understanding how variation in life-history traits may arise in response to environmental change. Without this knowledge, we may fail to detect whether organisms are tracking environmental change, and if they are, whether it is by plasticity, adaptation or both.	[Barton, Madeleine; Kearney, Michael] Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia; [Sunnucks, Paul; Norgate, Melanie] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Murray, Neil] La Trobe Univ, Dept Genet, Melbourne, Vic, Australia	University of Melbourne; Monash University; La Trobe University	Barton, M (corresponding author), Univ Melbourne, Dept Zool, Parkville, Vic 3052, Australia.	mbarton@sun.ac.za	Kearney, Michael/R-3404-2017	Kearney, Michael/0000-0002-3349-8744; Sunnucks, Paul/0000-0002-8139-7059	Australian Research Council [DP0772837]	Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council Discovery Grant: DP0772837 to PS and MK. Specimens were collected under permits of SA, NSW, VIC and QLD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2004, INTEGR COMP BIOL, V44, P498, DOI 10.1093/icb/44.6.498; [Anonymous], 2007, CONTRIBUTION WORKING; [Anonymous], 1847, GOTTINGERSTUDIEN, V1, P595; Anthes N, 2008, J INSECT CONSERV, V12, P3, DOI 10.1007/s10841-007-9084-7; Arendt JD, 1997, Q REV BIOL, V72, P149, DOI 10.1086/419764; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Atkinson D, 1997, TRENDS ECOL EVOL, V12, P235, DOI 10.1016/S0169-5347(97)01058-6; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; Blanckenhorn WU, 1997, OECOLOGIA, V109, P342, DOI 10.1007/s004420050092; Bonebrake TC, 2010, OIKOS, V119, P927, DOI 10.1111/j.1600-0706.2009.17759.x; Boulard T, 2002, AGR FOREST METEOROL, V110, P159, DOI 10.1016/S0168-1923(01)00292-1; Braby MF, 2000, BUTTERFLIES AUSTR TH; Bradshaw WE, 2010, ANNU REV PHYSIOL, V72, P147, DOI 10.1146/annurev-physiol-021909-135837; Briscoe NJ, 2012, OIKOS, V121, P1464, DOI 10.1111/j.1600-0706.2011.20049.x; Campbell GS, 1998, INTRO EVNRONMENTAL B; Carter JO, 2000, APPL SEASONAL CLIMAT; Chown SL, 1999, BIOL REV, V74, P87, DOI 10.1017/S000632319800526X; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; EDWARDS E D, 1973, Journal of the Australian Entomological Society, V12, P92; Endler J.A., 1986, Monographs in Population Biology, pviii; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Gibbs M, 2011, ECOGRAPHY, V34, P336, DOI 10.1111/j.1600-0587.2010.06573.x; Gotthard K, 2004, INTEGR COMP BIOL, V44, P471, DOI 10.1093/icb/44.6.471; GOTTHARD K, 1994, OECOLOGIA, V99, P281, DOI 10.1007/BF00627740; Helliker BR, 2008, NATURE, V454, P511, DOI 10.1038/nature07031; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Jones DA, 2009, AUST METEOROL OCEAN, V58, P233, DOI 10.22499/2.5804.003; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; KOOIJMAN SALM, 1986, J THEOR BIOL, V121, P269, DOI 10.1016/S0022-5193(86)80107-2; Laugen AT, 2003, J EVOLUTION BIOL, V16, P906; MASAKI S, 1978, OECOLOGIA, V35, P343, DOI 10.1007/BF00345141; MASAKI S, 1967, EVOLUTION, V21, P725, DOI 10.1111/j.1558-5646.1967.tb03430.x; Miller DG, 2009, ENTOMOL EXP APPL, V132, P126, DOI 10.1111/j.1570-7458.2009.00880.x; Mousseau TA, 1997, EVOLUTION, V51, P630, DOI [10.2307/2411138, 10.1111/j.1558-5646.1997.tb02453.x]; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Norgate M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007950; Nygren GH, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.4701; NYLIN S, 1991, HOLARCTIC ECOL, V14, P192; PARK O, 1949, PHYSIOL ZOOL, V22, P359, DOI 10.1086/physzool.22.4.30152061; PEARSE FK, 1981, AUST J ZOOL, V29, P631; Poykko H, 2010, J EVOLUTION BIOL, V23, P1278, DOI 10.1111/j.1420-9101.2010.01990.x; ROFF D, 1980, OECOLOGIA, V45, P202, DOI 10.1007/BF00346461; Steigenga MJ, 2007, ENTOMOL EXP APPL, V125, P195, DOI 10.1111/j.1570-7458.2007.00610.x; Tammaru T, 2002, OECOLOGIA, V133, P430, DOI 10.1007/s00442-002-1057-7; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Tobin PC, 2008, GLOBAL CHANGE BIOL, V14, P951, DOI 10.1111/j.1365-2486.2008.01561.x; Turlure C, 2010, GLOBAL CHANGE BIOL, V16, P1883, DOI 10.1111/j.1365-2486.2009.02133.x; vanderHave TM, 1996, J THEOR BIOL, V183, P329, DOI 10.1006/jtbi.1996.0224; Vandewoestijne S, 2011, ECOGRAPHY, V34, P876, DOI 10.1111/j.1600-0587.2010.06458.x; WEISS SB, 1988, ECOLOGY, V69, P1486, DOI 10.2307/1941646	52	23	24	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95258	10.1371/journal.pone.0095258	http://dx.doi.org/10.1371/journal.pone.0095258			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743771	Green Published, gold			2022-12-25	WOS:000335309100098
J	Hinc, K; Stasilojc, M; Piatek, I; Peszynska-Sularz, G; Isticato, R; Ricca, E; Obuchowski, M; Iwanicki, A				Hinc, Krzysztof; Stasilojc, Malgorzata; Piatek, Iwona; Peszynska-Sularz, Grazyna; Isticato, Rachele; Ricca, Ezio; Obuchowski, Michal; Iwanicki, Adam			Mucosal Adjuvant Activity of IL-2 Presenting Spores of Bacillus subtilis in a Murine Model of Helicobacter pylori Vaccination	PLOS ONE			English	Article							SURFACE-DISPLAY; ORAL IMMUNIZATION; UREASE-B; COAT; PROTEIN; MICE; INFECTION; DELIVERY; COTC; IMMUNOGENICITY	The endospores of Bacillus subtilis are now widely used as a platform for presentation of heterologous proteins and due to their safety record and high resistance to harsh environmental conditions can be considered as potential vehicles for oral vaccination. In this research we show that recombinant B. subtilis spores presenting a fragment of the Helicobacter acinonychis UreB protein and expressing the ureB gene under vegetative promoter elicit a strong cellular immune response in orally immunized mice when co-administered with spores presenting IL-2. We show for the first time the successful application of two types of recombinant spores, one carrying an antigen and the other an adjuvant, in a single oral immunization.	[Hinc, Krzysztof; Obuchowski, Michal; Iwanicki, Adam] Med Univ Gdansk, Intercoll Fac Biotechnol UG MUG, Dept Med Biotechnol, Gdansk, Poland; [Stasilojc, Malgorzata; Piatek, Iwona] Univ Gdansk, Intercoll Fac Biotechnol UG MUG, Dept Med Biotechnol, PL-80952 Gdansk, Poland; [Peszynska-Sularz, Grazyna] Med Univ Gdansk, Tricity Anim Lab, Gdansk, Poland; [Isticato, Rachele; Ricca, Ezio] Univ Naples Federico II, Dept Biol, Naples, Italy	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; University of Naples Federico II	Iwanicki, A (corresponding author), Med Univ Gdansk, Intercoll Fac Biotechnol UG MUG, Dept Med Biotechnol, Gdansk, Poland.	aiwanicki@gumed.edu.pl	Isticato, Rachele/J-3476-2012; Peszyńska-Sularz, Grażyna/AAL-1601-2021; Hinc, Krzysztof/B-9543-2014; Iwanicki, Adam/R-1767-2017; ISTICATO, Rachele/AAX-9972-2021; Ricca, Ezio/AAG-2998-2020; Obuchowski, Michał/F-5836-2011; Obuchowski, Michał/N-1118-2019; Hinc, Krzysztof/F-5967-2011	Peszyńska-Sularz, Grażyna/0000-0002-5436-397X; Hinc, Krzysztof/0000-0002-6067-7852; Iwanicki, Adam/0000-0001-7882-5529; ISTICATO, Rachele/0000-0001-9141-4038; Ricca, Ezio/0000-0002-7355-0332; Obuchowski, Michał/0000-0001-5410-2350; Obuchowski, Michał/0000-0001-5410-2350; Stasilojc, Malgorzata/0000-0003-4221-5803	Polish Ministry of Science and Higher Education [23/MOB/2007/0]; Polish National Science Center [N401 2794 39]; EU FP7 project MOBI4Health [GA. 316094]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish National Science Center; EU FP7 project MOBI4Health	The research was supported by the Polish Ministry of Science and Higher Education on the Support for International Mobility of Scientists Program (project no. 23/MOB/2007/0) and Polish National Science Center grant no. N401 2794 39. Publication costs were covered by the EU FP7 project MOBI4Health, GA. 316094. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTOPOULOS C, 1961, P NATL ACAD SCI USA, V47, P378, DOI 10.1073/pnas.47.3.378; Baluna R, 1997, IMMUNOPHARMACOLOGY, V37, P117, DOI 10.1016/S0162-3109(97)00041-6; Barnes AGC, 2007, EUR J IMMUNOL, V37, P1538, DOI 10.1002/eji.200636875; Bumann D, 2001, VACCINE, V20, P845, DOI 10.1016/S0264-410X(01)00391-7; CALIGIURI MA, 1993, J CLIN INVEST, V91, P123, DOI 10.1172/JCI116161; Chen JS, 2012, MICROBIOL IMMUNOL, V56, P85, DOI 10.1111/j.1348-0421.2011.00409.x; CLEMENTS JD, 1988, VACCINE, V6, P269, DOI 10.1016/0264-410X(88)90223-X; Corthesy B, 2005, J INFECT DIS, V192, P1441, DOI 10.1086/444425; Cutting SM, 2009, INT REV IMMUNOL, V28, P487, DOI 10.3109/08830180903215605; DiPetrillo MD, 1999, VACCINE, V18, P449, DOI 10.1016/S0264-410X(99)00246-7; Duc L, 2003, INFECT IMMUN, V71, P2810, DOI 10.1128/IAI.71.5.2810-2818.2003; Duc LH, 2003, VACCINE, V21, P4215, DOI 10.1016/S0264-410X(03)00492-4; Ermak TH, 1998, J EXP MED, V188, P2277, DOI 10.1084/jem.188.12.2277; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Hinc K, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-22; Hinc K, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-2; Hoang TH, 2008, INFECT IMMUN, V76, P5257, DOI 10.1128/IAI.00686-08; Hong HA, 2005, FEMS MICROBIOL REV, V29, P813, DOI 10.1016/j.femsre.2004.12.001; Imamura D, 2011, J BACTERIOL, V193, P4075, DOI 10.1128/JB.05310-11; Isticato R, 2004, J BACTERIOL, V186, P1129, DOI 10.1128/JB.186.4.1129-1135.2004; Isticato R, 2001, J BACTERIOL, V183, P6294, DOI 10.1128/JB.183.21.6294-6301.2001; Isticato R, 2008, J BACTERIOL, V190, P1267, DOI 10.1128/JB.01425-07; Isticato R, 2007, BIOTECHNIQUES, V42, P149, DOI 10.2144/000112329; Julkowska D, 2005, J BACTERIOL, V187, P65, DOI 10.1128/JB.187.1.65-76.2005; Knecht LD, 2011, ANAL BIOANAL CHEM, V400, P977, DOI 10.1007/s00216-011-4835-4; Lee S, 2010, CLIN VACCINE IMMUNOL, V17, P1647, DOI 10.1128/CVI.00135-10; Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9; Liu KY, 2011, VACCINE, V29, P6679, DOI 10.1016/j.vaccine.2011.06.099; MARQUSEE S, 1989, P NATL ACAD SCI USA, V86, P5286, DOI 10.1073/pnas.86.14.5286; Mauriello EMF, 2004, VACCINE, V22, P1177, DOI 10.1016/j.vaccine.2003.09.031; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; McKenney PT, 2010, CURR BIOL, V20, P934, DOI 10.1016/j.cub.2010.03.060; Monroe A, 2006, J BACTERIOL, V188, P7609, DOI 10.1128/JB.01116-06; Moss SF, 2011, VACCINE, V29, P2085, DOI 10.1016/j.vaccine.2010.12.130; Negri A, 2013, J MED MICROBIOL, V62, P1379, DOI 10.1099/jmm.0.057372-0; Nguyen QU, 2007, VACCINE, V25, P356; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; OGASAWARA N, 1983, J BACTERIOL, V154, P50, DOI 10.1128/JB.154.1.50-57.1983; Permpoonpattana P, 2011, INFECT IMMUN, V79, P2295, DOI 10.1128/IAI.00130-11; Rizos K, 2003, INFECT IMMUN, V71, P6320, DOI 10.1128/IAI.71.11.6320-6328.2003; Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009; Sambrook J., 2002, MOL CLONING LAB MANU; Shi T, 2005, HELICOBACTER, V10, P71, DOI 10.1111/j.1523-5378.2005.00293.x; Song M, 2012, VACCINE, V30, P3266, DOI 10.1016/j.vaccine.2012.03.016; Suerbaum S, 1999, MOL MED TODAY, V5, P32, DOI 10.1016/S1357-4310(98)01390-2; Wu CH, 2008, TRENDS MICROBIOL, V16, P181, DOI 10.1016/j.tim.2008.01.003; YUAN G, 1995, J BACTERIOL, V177, P5427, DOI 10.1128/jb.177.19.5427-5433.1995	49	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95187	10.1371/journal.pone.0095187	http://dx.doi.org/10.1371/journal.pone.0095187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743850	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100084
J	Melaku, YA; Zeleke, EG				Melaku, Yohannes Adama; Zeleke, Ejigu Gebeye			Contraceptive Utilization and Associated Factors among HIV Positive Women on Chronic Follow Up Care in Tigray Region, Northern Ethiopia: A Cross Sectional Study	PLOS ONE			English	Article							TRANSMISSION; MEN	Background: In sub-Sahara Africa, more than 60% of all new HIV infections are occurring in women, infants and young children. Maternal to child transmission is responsible for 90% of childhood HIV infection. Preventing unwanted pregnancy among HIV positive women is imperative to reduce maternal and infant morbidity and mortality. Methods: A cross-sectional survey was conducted among 964 HIV positive women in selected 12 health centers of Tigray region. In this paper, analysis was restricted only for 847 women who were sexually active and non-pregnant. In each health center the number of study participants was allocated proportionally to the load of HIV positive women in chronic care clinics. The data were entered into EpiData version 3.1, and cleaned and analyzed using Stata version 11.1. Descriptive summary of data and logistic regression were used to identify possible predictors using odds ratio with 95% confidence interval and P-value of 0.05. Findings: Three hundred ninety four (46.5%) of all HIV positive women had intension to have more children. Three hundred seventy five (44.3%) were using contraceptive methods at time of survey. Injectable (70.7%) and male condom (47.6%) were most commonly used type of contraceptives. In the multivariable analysis, women who were urban dwellers (AOR = 2.55; 95% CI: 1.27, 5.02), completed primary education (AOR = 2.27; 95% CI: 1.12, 2.86) and those openly discussed about contraceptive methods with their husbands or sexual partners (AOR = 6.3; 95% CI: 3.42, 11.76) were more likely to use contraceptive. Women who have one or more living children were also more likely to use contraceptive compared with women with no child. Conclusion: Less than half of women used contraceptive methods. The use of condoms could impact unintended pregnancies and reduced risks of vertical and sexual transmission. Efforts to increase contraceptive utilization focusing on the barrier methods should be strengthen in HIV/AIDS chronic care units.	[Melaku, Yohannes Adama] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia; [Zeleke, Ejigu Gebeye] Univ Gondar, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	Mekelle University; University of Gondar	Melaku, YA (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia.	adamayohannes@gmail.com	Melaku, Yohannes Adama/S-2451-2019	Melaku, Yohannes Adama/0000-0002-3051-7313	United States Agency for International Development (USAID) through Management Sciences for Health (MSH) [AID-663-A-11-00006]	United States Agency for International Development (USAID) through Management Sciences for Health (MSH)(United States Agency for International Development (USAID))	This study is made possible by the generous support of the United States Agency for International Development (USAID) through Management Sciences for Health (MSH) under cooperative agreement No. AID-663-A-11-00006. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, FACT SHEET GLOB AIDS; Berhane Y, 2013, ISRN AIDS, V10; Beyeza-Kashesya J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-144; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency [Ethiopia], 2007, ETH CENS REP 2007; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Crede S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-197; Dube ALN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051861; Ethiopia HIV/AIDS Prevention & Control Office (HAPCO) and Global HIV/AIDS Monitoring and Evaluation Team (GAMET), 2012, HIV AIDS ETH EP SYNT; Ethiopian Health and Nutrition Research Institute (EHNRI), 2011, ROUND REP 2009 ANT C; Harries J, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-282; Hladik W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007691; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; Kaida A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013868; King R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-530; Kipp W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-27; Kirshenbaum SB, 2004, PERSPECT SEX REPRO H, V36, P106, DOI 10.1111/j.1931-2393.2004.tb00198.x; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; Mmbaga EJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-86; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Nattabi B, 2011, CONFLICT HLTH, V5; Obare F, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-34; Oraka CO, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-S1-P78; Pagano M., 2018, PRINCIPLES BIOSTATIS; Paiva V, 2003, REPROD HEALTH MATTER, V11, P91, DOI 10.1016/S0968-8080(03)02293-6; Stuart GS, 2009, CONTRACEPTION, V80, P412, DOI 10.1016/j.contraception.2009.03.014; The United Nations' Division for the Advancement of Women, 1979, CONV EL ALL FORMS DI; Tigray Regional Health Bureau, 2012, TIGR HLTH PROF 2010; UN, 2007, WORLD CONTR US; UNAIDS, 2011, AIDS EP UPD UN NAT J; USAID Tigray Health Bureau, 2012, TIGR REG STAT SYNTH, P3; Van Ness PH, 2007, 10531 SUGI 31, P1; Wanyenze RK, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-35; Wanyenze RK, 2013, BMC PUBLIC HLTH, V13; Warren EC, 2013, BMC PREGNANCY CHILDB, V13; WHO, 2003, WHO M 20 22 MARCH 20; Wilcher R, 2009, AIDS, V23, pS1, DOI 10.1097/01.aids.0000363772.45635.35	39	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94682	10.1371/journal.pone.0094682	http://dx.doi.org/10.1371/journal.pone.0094682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743241	Green Submitted, gold, Green Published			2022-12-25	WOS:000335309100040
J	Quinn, A; Kashimada, K; Davidson, TL; Ng, ET; Chawengsaksophak, K; Bowles, J; Koopman, P				Quinn, Alexander; Kashimada, Kenichi; Davidson, Tara-Lynne; Ng, Ee Ting; Chawengsaksophak, Kallayanee; Bowles, Josephine; Koopman, Peter			A Site-Specific, Single-Copy Transgenesis Strategy to Identify 5 ' Regulatory Sequences of the Mouse Testis-Determining Gene Sry	PLOS ONE			English	Article							SEX-DETERMINING REGION; RT-PCR ANALYSIS; Y-CHROMOSOME; EXPRESSION; SOX9; DIFFERENTIATION; SERTOLI; MICE; PATTERNS; XX	The Y-chromosomal gene SRY acts as the primary trigger for male sex determination in mammalian embryos. Correct regulation of SRY is critical: aberrant timing or level of Sry expression is known to disrupt testis development in mice and we hypothesize that mutations that affect regulation of human SRY may account for some of the many cases of XY gonadal dysgenesis that currently remain unexplained. However, the cis-sequences involved in regulation of Sry have not been identified, precluding a test of this hypothesis. Here, we used a transgenic mouse approach aimed at identifying mouse Sry 5' flanking regulatory sequences within 8 kb of the Sry transcription start site (TSS). To avoid problems associated with conventional pronuclear injection of transgenes, we used a published strategy designed to yield single-copy transgene integration at a defined, transcriptionally open, autosomal locus, Col1a1. None of the Sry transgenes tested was expressed at levels compatible with activation of Sox9 or XX sex reversal. Our findings indicate either that the Col1a1 locus does not provide an appropriate context for the correct expression of Sry transgenes, or that the cis-sequences required for Sry expression in the developing gonads lie beyond 8 kb 5' of the TSS.	[Quinn, Alexander; Davidson, Tara-Lynne; Ng, Ee Ting; Chawengsaksophak, Kallayanee; Bowles, Josephine; Koopman, Peter] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Kashimada, Kenichi] Tokyo Med & Dent Univ, Dept Pediat & Dev Biol, Bunkyo Ku, Tokyo, Japan	University of Queensland; Tokyo Medical & Dental University (TMDU)	Quinn, A (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	a.quinn@imb.uq.edu.au	Bowles, Josephine/B-6583-2013; Koopman, Peter A/C-9416-2009; Chawengsaksophak, Kallayanee/G-4427-2014; Bowles, Josephine/AAG-4903-2020	Bowles, Josephine/0000-0003-2867-7438; Koopman, Peter A/0000-0001-6939-0914; Chawengsaksophak, Kallayanee/0000-0001-9401-2122; Bowles, Josephine/0000-0003-2867-7438; Kashimada, Kenichi/0000-0003-2505-5932	Australian Research Council (ARC) [DP120104534]; National Health and Medical Research Council (NHMRC) (Australia) [546517]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	Support was provided by the Australian Research Council (ARC) Discovery Grant No. DP120104534 [www.arc.gov.au] and the National Health and Medical Research Council (NHMRC) (Australia) Program Grant No. 546517 [www.nhmrc.gov.au]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bogani D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000196; Bouma GJ, 2004, GENE EXPR PATTERNS, V5, P141, DOI 10.1016/j.modgep.2004.05.001; Bowles J, 1999, NAT GENET, V22, P405, DOI 10.1038/11981; Bowles J, 2014, DEV BIOL, V386, P25, DOI 10.1016/j.ydbio.2013.12.008; Bradford ST, 2009, HUM MOL GENET, V18, P3429, DOI 10.1093/hmg/ddp283; Bullejos M, 2005, DEV BIOL, V278, P473, DOI 10.1016/j.ydbio.2004.11.030; Bullejos M, 2001, DEV DYNAM, V221, P201, DOI 10.1002/dvdy.1134; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; EICHER EM, 1982, SCIENCE, V217, P535, DOI 10.1126/science.7089579; Fujimoto Y, 2013, DEV CELL, V26, P416, DOI 10.1016/j.devcel.2013.06.018; Gierl MS, 2012, DEV CELL, V23, P1032, DOI 10.1016/j.devcel.2012.09.014; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HACKER A, 1995, DEVELOPMENT, V121, P1603; HAWKINS JR, 1992, HUM GENET, V88, P471, DOI 10.1007/BF00215684; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; Jasin M, 1996, P NATL ACAD SCI USA, V93, P8804, DOI 10.1073/pnas.93.17.8804; JESKE YWA, 1995, NAT GENET, V10, P480, DOI 10.1038/ng0895-480; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kato T, 2013, SCI REPORTS, V3, P1; Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482; Kidokoro T, 2005, DEV BIOL, V278, P511, DOI 10.1016/j.ydbio.2004.11.006; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; Koopman P, 2001, J EXP ZOOL, V290, P463, DOI 10.1002/jez.1089; Kuroki S, 2013, SCIENCE, V341, P1106, DOI 10.1126/science.1239864; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; McFarlane L, 2013, SEX DEV, V7, P207, DOI 10.1159/000348677; Nov D, 2007, CURR OPIN BIOTECH, V18, P411, DOI 10.1016/j.copbio.2007.07.013; Ohtsuka M, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq860; Pitetti JL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003160; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Svingen T, 2009, SEX DEV, V3, P194, DOI 10.1159/000228720; Tevosian SG, 2002, DEVELOPMENT, V129, P4627; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039	42	3	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94813	10.1371/journal.pone.0094813	http://dx.doi.org/10.1371/journal.pone.0094813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743337	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100044
J	Rosenthal, SL; Barmada, MM; Wang, XB; Demirci, FY; Kamboh, MI				Rosenthal, Samantha L.; Barmada, M. Michael; Wang, Xingbin; Demirci, F. Yesim; Kamboh, M. Ilyas			Connecting the Dots: Potential of Data Integration to Identify Regulatory SNPs in Late-Onset Alzheimer's Disease GWAS Findings	PLOS ONE			English	Article							COMMON VARIANTS; ASSOCIATION; IDENTIFICATION; ANNOTATION; CANCER; CD2AP; EPHA1; CD33	Late-onset Alzheimer's disease (LOAD) is a multifactorial disorder with over twenty loci associated with disease risk. Given the number of genome-wide significant variants that fall outside of coding regions, it is possible that some of these variants alter some function of gene expression rather than tagging coding variants that alter protein structure and/or function. RegulomeDB is a database that annotates regulatory functions of genetic variants. In this study, we utilized RegulomeDB to investigate potential regulatory functions of lead single nucleotide polymorphisms (SNPs) identified in five genome-wide association studies (GWAS) of risk and age-at onset (AAO) of LOAD, as well as SNPs in LD (r(2)>= 0.80) with the lead GWAS SNPs. Of a total 614 SNPs examined, 394 returned RegulomeDB scores of 1-6. Of those 394 variants, 34 showed strong evidence of regulatory function (RegulomeDB score <3), and only 3 of them were genome-wide significant SNPs (ZCWPW1/rs1476679, CLU/rs1532278 and ABCA7/rs3764650). This study further supports the assumption that some of the non-coding GWAS SNPs are true associations rather than tagged associations and demonstrates the application of RegulomeDB to GWAS data.	[Rosenthal, Samantha L.; Barmada, M. Michael; Wang, Xingbin; Demirci, F. Yesim; Kamboh, M. Ilyas] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; [Kamboh, M. Ilyas] Univ Pittsburgh, Alzheimers Dis Res Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kamboh, MI (corresponding author), Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA.	kamboh@pitt.edu		Demirci, F. Yesim/0000-0001-6907-9843; Barmada, M Michael/0000-0002-3604-6460; Kamboh, M. Ilyas/0000-0002-3453-1438; Manna, Samantha/0000-0002-5593-7656	National Institute on Aging [AG041718, AG030653, AG005133]; NATIONAL INSTITUTE ON AGING [P50AG005133, R01AG041718, R01AG030653] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institute on Aging grants AG041718, AG030653 and AG005133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Lounis A, 2010, DIABETES, V59, P1674, DOI 10.2337/db09-0986; Alinikula J, 2010, EUR J IMMUNOL, V40, P2599, DOI 10.1002/eji.200940002; Benadiba C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002606; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; Driver JA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1442; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Ganguli M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1662; Genin E, 2011, MOL PSYCHIATR, V16, P903, DOI 10.1038/mp.2011.52; Gonzalez N, 2008, CURR OPIN ENDOCRINOL, V15, P58, DOI 10.1097/MED.0b013e3282f3709b; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kamboh MI, 2012, MOL PSYCHIATR, V17, P1340, DOI 10.1038/mp.2011.135; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Li Q, 2011, CANCER LETT, V308, P203, DOI 10.1016/j.canlet.2011.05.005; Majumdar ID, 2011, CURR OPIN ENDOCRINOL, V18, P68, DOI 10.1097/MED.0b013e328340ff93; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	21	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95152	10.1371/journal.pone.0095152	http://dx.doi.org/10.1371/journal.pone.0095152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743338	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000335309100075
J	Zhang, J; Zou, D; Li, Y; Sun, X; Wang, NN; Gong, SY; Zheng, Y; Li, XB				Zhang, Jie; Zou, Dan; Li, Yang; Sun, Xiang; Wang, Na-Na; Gong, Si-Ying; Zheng, Yong; Li, Xue-Bao			GhMPK17, a Cotton Mitogen-Activated Protein Kinase, Is Involved in Plant Response to High Salinity and Osmotic Stresses and ABA Signaling	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; MAP KINASES; SALT STRESS; TRANSCRIPTION FACTORS; GENOMIC ORGANIZATION; DISEASE RESISTANCE; HYDROGEN-PEROXIDE; CELL-SUSPENSIONS; ABSCISIC-ACID; METAL STRESS	Mitogen-activated protein kinase (MAPK) cascades play pivotal roles in mediating biotic and abiotic stress responses. Cotton (Gossypium hirsutum) is the most important textile crop in the world, and often encounters abiotic stress during its growth seasons. In this study, a gene encoding a mitogen-activated protein kinase (MAPK) was isolated from cotton, and designated as GhMPK17. The open reading frame (ORF) of GhMPK17 gene is 1494 bp in length and encodes a protein with 497 amino acids. Quantitative RT-PCR analysis indicated that GhMPK17 expression was up-regulated in cotton under NaCl, mannitol and ABA treatments. The transgenic Arabidopsis plants expressing GhMPK17 gene showed higher seed germination, root elongation and cotyledon greening/expansion rates than those of the wild type on MS medium containing NaCl, mannitol and exogenous ABA, suggesting that overexpression of GhMPK17 in Arabidopsis increased plant ABA-insensitivity, and enhanced plant tolerance to salt and osmotic stresses. Furthermore, overexpression of GhMPK17 in Arabidopsis reduced H2O2 level and altered expression of ABA- and abiotic stress-related genes in the transgenic plants. Collectively, these data suggested that GhMPK17 gene may be involved in plant response to high salinity and osmotic stresses and ABA signaling.	[Zhang, Jie; Zou, Dan; Li, Yang; Sun, Xiang; Wang, Na-Na; Gong, Si-Ying; Zheng, Yong; Li, Xue-Bao] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China	Central China Normal University	Zheng, Y (corresponding author), Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, Wuhan, Peoples R China.	zhengyong@mail.ccnu.edu.cn; xbli@mail.ccnu.edu.cn			Ministry of Agriculture of China for transgenic research [2014ZX08009-027B, 2014ZX08009-003-004]; National Natural Sciences Foundation of China [31171174]	Ministry of Agriculture of China for transgenic research; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the projects from the Ministry of Agriculture of China for transgenic research (Grant No. 2014ZX08009-027B, 2014ZX08009-003-004) and National Natural Sciences Foundation of China (Grant No. 31171174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAOGRE L, 1999, PLANT CELL, V11, P5; Champion A, 2004, TRENDS PLANT SCI, V9, P123, DOI 10.1016/j.tplants.2004.01.005; Cheong YH, 2003, PLANT PHYSIOL, V132, P1961, DOI 10.1104/pp.103.023176; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Droillard MJ, 2004, FEBS LETT, V574, P42, DOI 10.1016/j.febslet.2004.08.001; Droillard MJ, 2002, FEBS LETT, V527, P43, DOI 10.1016/S0014-5793(02)03162-9; Frugoli JA, 1996, PLANT PHYSIOL, V112, P327, DOI 10.1104/pp.112.1.327; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Ghawana S, 2010, MOL BIOL REP, V37, P933, DOI 10.1007/s11033-009-9726-9; He CZ, 1999, MOL PLANT MICROBE IN, V12, P1064, DOI 10.1094/MPMI.1999.12.12.1064; Hong YY, 2010, PLANT CELL ENVIRON, V33, P627, DOI 10.1111/j.1365-3040.2009.02087.x; Ichimura K, 2002, TRENDS PLANT SCI, V7, P301, DOI 10.1016/S1360-1385(02)02302-6; Ichimura K, 2000, PLANT J, V24, P655, DOI 10.1046/j.1365-313x.2000.00913.x; Ichimura K, 1998, BIOCHEM BIOPH RES CO, V253, P532, DOI 10.1006/bbrc.1998.9796; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Jonak C, 2004, PLANT PHYSIOL, V136, P3276, DOI 10.1104/pp.104.045724; Jonak C, 2002, CURR OPIN PLANT BIOL, V5, P415, DOI 10.1016/S1369-5266(02)00285-6; Khan MN, 2012, NITRIC OXIDE-BIOL CH, V27, P210, DOI 10.1016/j.niox.2012.07.005; Kiegerl S, 2000, PLANT CELL, V12, P2247, DOI 10.1105/tpc.12.11.2247; Kim SH, 2011, BIOCHEM BIOPH RES CO, V412, P150, DOI 10.1016/j.bbrc.2011.07.064; Kumar KRR, 2009, MOL GENET GENOMICS, V282, P65, DOI 10.1007/s00438-009-0446-6; Laohavisit Anuphon, 2012, Methods Mol Biol, V913, P163, DOI 10.1007/978-1-61779-986-0_10; Li DD, 2009, GENE, V438, P26, DOI 10.1016/j.gene.2009.02.023; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Liu YB, 2010, PLANT PHYSIOL BIOCH, V48, P836, DOI 10.1016/j.plaphy.2010.07.001; Matsuoka D, 2002, PLANT J, V29, P637, DOI 10.1046/j.0960-7412.2001.01246.x; Mikolajczyk M, 2000, PLANT CELL, V12, P165, DOI 10.1105/tpc.12.1.165; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mizoguchi T, 1996, P NATL ACAD SCI USA, V93, P765, DOI 10.1073/pnas.93.2.765; Munnik T, 1999, PLANT J, V20, P381, DOI 10.1046/j.1365-313x.1999.00610.x; Mutalik VK, 2006, BIOSYSTEMS, V85, P144, DOI 10.1016/j.biosystems.2006.01.001; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Nicole MC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-223; Opdenakker K, 2012, INT J MOL SCI, V13, P7828, DOI 10.3390/ijms13067828; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Ouaked F, 2003, EMBO J, V22, P1282, DOI 10.1093/emboj/cdg131; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; Rasmussen MW, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00169; Ren DT, 2006, PLANT PHYSIOL, V141, P1482, DOI 10.1104/pp.106.080697; Reyna NS, 2006, MOL PLANT MICROBE IN, V19, P530, DOI 10.1094/MPMI-19-0530; Samajova O, 2013, TRENDS PLANT SCI, V18, P140, DOI 10.1016/j.tplants.2012.11.004; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; Seo S, 1999, PLANT CELL, V11, P289, DOI 10.1105/tpc.11.2.289; Shi J, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-22; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; Teige M, 2004, MOL CELL, V15, P141, DOI 10.1016/j.molcel.2004.06.023; Wang XJ, 2010, PLANT CELL PHYSIOL, V51, P754, DOI 10.1093/pcp/pcq037; Xing Y, 2008, PLANT J, V54, P440, DOI 10.1111/j.1365-313X.2008.03433.x; Xiong LZ, 2003, PLANT CELL, V15, P745, DOI 10.1105/tpc.008714; Yadav S, 2011, J ENVIRON BIOL, V32, P667; Yu LJ, 2010, NEW PHYTOL, V188, P762, DOI 10.1111/j.1469-8137.2010.03422.x; Zhang L, 2011, PLANT MOL BIOL, V77, P17, DOI 10.1007/s11103-011-9788-7; Zhang MY, 2012, J PLANT PHYSIOL, V169, P1501, DOI 10.1016/j.jplph.2012.06.008; Zong XJ, 2009, PLANTA, V229, P485, DOI 10.1007/s00425-008-0848-4	55	33	35	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95642	10.1371/journal.pone.0095642	http://dx.doi.org/10.1371/journal.pone.0095642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743296	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100152
J	Gademan, MGJ; Vermeulen, M; Oostvogels, AJJM; Roseboom, TJ; Visscher, TLS; van Eijsden, M; Twickler, MTB; Vrijkotte, TGM				Gademan, Maaike G. J.; Vermeulen, Marloes; Oostvogels, Adriette J. J. M.; Roseboom, Tessa J.; Visscher, Tommy L. S.; van Eijsden, Manon; Twickler, Marcel T. B.; Vrijkotte, Tanja G. M.			Maternal Prepregancy BMI and Lipid Profile during Early Pregnancy Are Independently Associated with Offspring's Body Composition at Age 5-6 Years: The ABCD Study	PLOS ONE			English	Article							NONFASTING TRIGLYCERIDES; PHYSICAL-ACTIVITY; NEWBORN WEIGHT; OBESITY; CHILDHOOD; RISK; DIET; OVERWEIGHT; ADIPOSITY; RATS	Background: There is growing evidence that disturbances in maternal metabolism and, subsequently, intrauterine conditions affect foetal metabolism. Whether this has metabolic consequences in offspring later in life is not fully elucidated. We investigated whether maternal pre-pregnancy body mass index (pBMI) is associated with offspring's adiposity at age 5-6 years and whether this association is mediated by the mother's lipid profile during early pregnancy. Methods: Data were derived from a multi-ethnic birth cohort, the Amsterdam Born Children and their Development (ABCD) study (inclusion 2003-2004). During early gestation mothers completed a questionnaire during pregnancy (pBMI) and random non-fasting blood samples were analysed for total cholesterol (TC), triglycerides (TG), apolipoprotein A1 (ApoA1), apolipoprotein B (ApoB) and total free fatty acids (FFA) in early gestation. At age 5-6 years, child's BMI, waist-to-height-ratio (WHtR) and fat% were assessed. Results: Only non-diabetic mothers with at term-born children were included(n = 1727). Of all women, 15.1% were overweight(BMI: 25-29.9 kg/m2) and 4.3% were obese(BMI >= 30 kg/m2). After adjustments for confounders, every unit increase in pBMI was linearly associated with various offspring variables: BMI(beta 0.10; 95% CI 0.08-0.12), WHtR* 100(beta 0.13; 95% CI 0.09-0.17), fat%(beta 0.21; 95% CI 0.13-0.29) and increased risk for overweight(OR: 1.15; 95% CI 1.10-1.20). No convincing proof for mediation by maternal lipid profile during early gestation was found. Moreover, maternal FFA was associated with the child's fat percentage, BMI and risk for overweight. Maternal ApoB and TC were positively associated with the offspring's fat percentage and maternal TG was positively associated with their children's WHtR. Conclusions: Both pBMI and maternal lipids during early pregnancy are independently related to offspring adiposity.	[Gademan, Maaike G. J.; Vermeulen, Marloes; Oostvogels, Adriette J. J. M.; Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, NL-1105 AZ Amsterdam, Netherlands; [Roseboom, Tessa J.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynaecol, NL-1105 AZ Amsterdam, Netherlands; [Roseboom, Tessa J.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Visscher, Tommy L. S.] Windesheim, Res Ctr Prevent Overweight, Zwolle Amsterdam, Netherlands; [Visscher, Tommy L. S.] Vrije Univ Amsterdam, EMGO, Zwolle Amsterdam, Netherlands; [Visscher, Tommy L. S.; van Eijsden, Manon] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [van Eijsden, Manon] Publ Hlth Serv Amsterdam GGD, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands; [Twickler, Marcel T. B.] Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab Dis, Antwerp, Belgium	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Public Health Service Amsterdam; University of Antwerp	Gademan, MGJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Publ Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.g.gademan@amc.uva.nl	Visscher, Tommy/AHE-5878-2022; Akkal, Maureen/P-6919-2014	Roseboom, Tessa/0000-0003-0564-5994; Vrijkotte, Tanja/0000-0003-3641-4048	Netherlands Organization for Health Research and Development (ZonMW) [40-00812-98-11010]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This study was financially supported by the Netherlands Organization for Health Research and Development (ZonMW, TOPgrant: 40-00812-98-11010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMRI EZ, 1994, J LIPID RES, V35, P930; [Anonymous], 2001, MISSING DATA; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Chang GQ, 2008, J NEUROSCI, V28, P12107, DOI 10.1523/JNEUROSCI.2642-08.2008; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Beer M, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-23; Di Cianni G, 2005, DIABETIC MED, V22, P21, DOI 10.1111/j.1464-5491.2004.01336.x; Donahue SMA, 2011, AM J CLIN NUTR, V93, P780, DOI 10.3945/ajcn.110.005801; Dutman AE, 2011, PUBLIC HEALTH NUTR, V14, P410, DOI 10.1017/S1368980010002119; Hills AP, 2011, BRIT J SPORT MED, V45, P866, DOI 10.1136/bjsports-2011-090199; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Kitajima M, 2001, OBSTET GYNECOL, V97, P776, DOI 10.1016/S0029-7844(01)01328-X; Kosti Rena I., 2006, Central European Journal of Public Health, V14, P151; Laitinen J, 2001, AM J CLIN NUTR, V74, P287; Lawlor DA, 2012, NAT REV ENDOCRINOL, V8, P679, DOI 10.1038/nrendo.2012.176; Lawlor DA, 2012, EUR HEART J, V33, P335, DOI 10.1093/eurheartj/ehr300; Lee EB, 2012, J CLIN INVEST, V122, P22, DOI 10.1172/JCI61562; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; Mighiu PI, 2012, DIABETES, V61, P1350, DOI 10.2337/db12-0330; Milanski M, 2012, DIABETES, V61, P1455, DOI 10.2337/db11-0390; Nicolaou M, 2012, EUR J PUBLIC HEALTH, V22, P859, DOI 10.1093/eurpub/ckr155; Nivoit P, 2009, DIABETOLOGIA, V52, P1133, DOI 10.1007/s00125-009-1316-9; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; O'Dwyer MV, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-117; OLIVERIA SA, 1992, AM J CLIN NUTR, V56, P593, DOI 10.1093/ajcn/56.3.593; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Salsberry PJ, 2005, PEDIATRICS, V116, P1329, DOI 10.1542/peds.2004-2583; Sebire NJ, 2001, INT J OBESITY, V25, P1175, DOI 10.1038/sj.ijo.0801670; Soria A, 1996, J NUTR, V126, P2481, DOI 10.1093/jn/126.10.2481; Steur M, 2011, INT J PEDIATR OBES, V6, pE170, DOI 10.3109/17477166.2010.519389; STEWART AW, 1987, AM J EPIDEMIOL, V125, P122, DOI 10.1093/oxfordjournals.aje.a114494; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Vollebregt KC, 2008, BJOG-INT J OBSTET GY, V115, P607, DOI 10.1111/j.1471-0528.2008.01665.x; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; Vrijkotte TGM, 2011, J PEDIATR-US, V159, P736, DOI 10.1016/j.jpeds.2011.05.001; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; Wardle J, 2008, AM J CLIN NUTR, V87, P398, DOI 10.1093/ajcn/87.2.398; WHO, 2000, OB PREV MAN GLOB EP	45	50	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94594	10.1371/journal.pone.0094594	http://dx.doi.org/10.1371/journal.pone.0094594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740157	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900056
J	Muli, E; Patch, H; Frazier, M; Frazier, J; Torto, B; Baumgarten, T; Kilonzo, J; Kimani, JN; Mumoki, F; Masiga, D; Tumlinson, J; Grozinger, C				Muli, Elliud; Patch, Harland; Frazier, Maryann; Frazier, James; Torto, Baldwyn; Baumgarten, Tracey; Kilonzo, Joseph; Kimani, James Ng'ang'a; Mumoki, Fiona; Masiga, Daniel; Tumlinson, James; Grozinger, Christina			Evaluation of the Distribution and Impacts of Parasites, Pathogens, and Pesticides on Honey Bee (Apis mellifera) Populations in East Africa	PLOS ONE			English	Article							COLONY COLLAPSE DISORDER; VARROA-DESTRUCTOR; PARALYSIS VIRUS; NOSEMA-CERANAE; MOLECULAR DIAGNOSIS; DIVERSITY; WINTER; MITES; BROOD; SUSCEPTIBILITY	In East Africa, honey bees (Apis mellifera) provide critical pollination services and income for small-holder farmers and rural families. While honey bee populations in North America and Europe are in decline, little is known about the status of honey bee populations in Africa. We initiated a nationwide survey encompassing 24 locations across Kenya in 2010 to evaluate the numbers and sizes of honey bee colonies, assess the presence of parasites (Varroa mites and Nosema microsporidia) and viruses, identify and quantify pesticide contaminants in hives, and assay for levels of hygienic behavior. Varroa mites were present throughout Kenya, except in the remote north. Levels of Varroa were positively correlated with elevation, suggesting that environmental factors may play a role in honey bee host-parasite interactions. Levels of Varroa were negatively correlated with levels of hygienic behavior: however, while Varroa infestation dramatically reduces honey bee colony survival in the US and Europe, in Kenya Varroa presence alone does not appear to impact colony size. Nosema apis was found at three sites along the coast and one interior site. Only a small number of pesticides at low concentrations were found. Of the seven common US/European honey bee viruses, only three were identified but, like Varroa, were absent from northern Kenya. The number of viruses present was positively correlated with Varroa levels, but was not correlated with colony size or hygienic behavior. Our results suggest that Varroa, the three viruses, and Nosema have been relatively recently introduced into Kenya, but these factors do not yet appear to be impacting Kenyan bee populations. Thus chemical control for Varroa and Nosema are not necessary for Kenyan bees at this time. This study provides baseline data for future analyses of the possible mechanisms underlying resistance to and the long-term impacts of these factors on African bee populations.	[Muli, Elliud; Torto, Baldwyn; Kilonzo, Joseph; Kimani, James Ng'ang'a; Mumoki, Fiona; Masiga, Daniel] Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya; [Muli, Elliud] South Eastern Kenya Univ SEKU, Dept Biol Sci, Kitui, Kenya; [Patch, Harland; Frazier, Maryann; Frazier, James; Baumgarten, Tracey; Tumlinson, James; Grozinger, Christina] Penn State Univ, Dept Entomol, Ctr Pollinator Res, University Pk, PA 16802 USA	International Centre of Insect Physiology & Ecology (ICIPE); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Patch, H (corresponding author), Penn State Univ, Dept Entomol, Ctr Pollinator Res, University Pk, PA 16802 USA.	hmpatch@psu.edu	Mumoki, Fiona/AFT-1425-2022	Masiga, Daniel/0000-0001-7513-0887; Mumoki, Fiona Nelima/0000-0002-0796-1598	NSF-BREAD grant [0965441]; Direct For Biological Sciences [0965441] Funding Source: National Science Foundation	NSF-BREAD grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by an NSF-BREAD grant (0965441)(http://www.nsf.gov/bio/bread/index.jsp) to J. Tumlinson, M. Frazier, J. Frazier, C. Grozinger, D. Masiga, E. Muli, H. Patch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Akinwade KL, 2012, J APICULT RES, V15, P369; Allsopp Mike, 2004, International Journal of Tropical Insect Science, V24, P87, DOI 10.1079/IJT20041; Arias MC, 1996, MOL PHYLOGENET EVOL, V5, P557, DOI 10.1006/mpev.1996.0050; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Nguyen BK, 2011, J APICULT RES, V50, P195, DOI 10.3896/IBRA.1.50.3.03; Benjeddou M, 2001, APPL ENVIRON MICROB, V67, P2384, DOI 10.1128/AEM.67.5.2384-2387.2001; Bhattacharya A, 2004, ANN BOT FENN, V41, P385; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Calderone NW, 2005, J ECON ENTOMOL, V98, P645, DOI 10.1603/0022-0493-98.3.645; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chauzat MP, 2010, J APICULT RES, V49, P31, DOI 10.3896/IBRA.1.49.1.05; Chen YP, 2010, APIDOLOGIE, V41, P364, DOI 10.1051/apido/2010021; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Ciarlo TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040848; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crane E, 1999, WORLD HIST BEEKEEPIN; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Delaplane KS, 1997, J APICULT RES, V36, P125, DOI 10.1080/00218839.1997.11100938; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2011, J GEN VIROL, V92, P151, DOI 10.1099/vir.0.023853-0; Eilers EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021363; Ellis MD, 2001, G01 1430 USING SUGAR; Faucon JP, 2002, BEE WORLD, V83, P14, DOI 10.1080/0005772X.2002.11099532; Fazier M, 2010, APIDOLOGIE, V41, P463, DOI 10.1051/apido/2009073; Fries I, 2003, APIDOLOGIE, V34, P389, DOI 10.1051/apido:2003032; Fries I, 2003, J APICULT RES, V42, P13, DOI 10.1080/00218839.2003.11101080; Fries I, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.14; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2008, J VERBRAUCH LEBENSM, V3, P429, DOI 10.1007/s00003-008-0379-8; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Gregorc A, 2012, J INSECT PHYSIOL, V58, P1042, DOI 10.1016/j.jinsphys.2012.03.015; Guzman-Novoa E, 1999, APIDOLOGIE, V30, P173, DOI 10.1051/apido:19990207; Hepburn RH, 1998, HONEYBEES AFRICA; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Kajobe R, 2010, J INVERTEBR PATHOL, V104, P153, DOI 10.1016/j.jip.2010.02.007; Kasina M, 2009, J APICULT RES, V48, P134, DOI 10.3896/IBRA.1.48.2.08; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Klein AM, 2003, P ROY SOC B-BIOL SCI, V270, P955, DOI 10.1098/rspb.2002.2306; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Mbae R.M., 1999, P 1 INT WORKSHOP CON, P103; Meixner MD, 2011, APIDOLOGIE, V42, P425, DOI 10.1007/s13592-011-0007-y; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; National Beekeeping Station, 2007, HIV POP PROD KEN 200; National Institute for Health and Clinical Excellence, 2010, FIN APPR DET BORT TH, P1; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pirk CWW, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.13; Ribiere M, 2002, APIDOLOGIE, V33, P339, DOI 10.1051/apido:2002020; Roubik DW, 2002, NATURE, V417, P708, DOI 10.1038/417708a; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; RUTTNER F, 1992, NATURGESCHICHTE HONI; Ruttner F, 1987, BIOGEOGRAPHY TAXONOM; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Schoning C, 2012, J EXP BIOL, V215, P264, DOI 10.1242/jeb.062562; Spivak M, 1998, AM BEE J, V138, P283; Spivak M, 2001, J ECON ENTOMOL, V94, P326, DOI 10.1603/0022-0493-94.2.326; Stoltz D, 1995, J APICULT RES, V34, P153, DOI 10.1080/00218839.1995.11100900; Swart DJ, 2003, OCCURENCE NOSEMA API; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traver BE, 2011, J INVERTEBR PATHOL, V107, P43, DOI 10.1016/j.jip.2011.02.003; UNCTAD/WTO ITC, 2004, KEN SUPPL SUV AP HOR; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wei S, 2001, GENETIC VARIATION CO; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; Wu JY, 2012, J INVERTEBR PATHOL, V109, P326, DOI 10.1016/j.jip.2012.01.005; Zhu W, CHRONIC ORAL T UNPUB	77	79	84	2	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94459	10.1371/journal.pone.0094459	http://dx.doi.org/10.1371/journal.pone.0094459			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740399	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900047
J	Spate, LD; Brown, AN; Redel, BK; Whitworth, KM; Murphy, CN; Prather, RS				Spate, Lee D.; Brown, Alana N.; Redel, Bethany K.; Whitworth, Kristin M.; Murphy, Clifton N.; Prather, Randall S.			Dickkopf-Related Protein 1 Inhibits the WNT Signaling Pathway and Improves Pig Oocyte Maturation	PLOS ONE			English	Article							DEVELOPMENTAL COMPETENCE; EXPRESSION; EMBRYOS; GENES; STAGE	The ability to mature oocytes in vitro provides a tool for creating embryos by parthenogenesis, fertilization, and cloning. Unfortunately the quality of oocytes matured in vitro falls behind that of in vivo matured oocytes. To address this difference, transcriptional profiling by deep sequencing was conducted on pig oocytes that were either matured in vitro or in vivo. Alignment of over 18 million reads identified 1,316 transcripts that were differentially represented. One pathway that was overrepresented in the oocytes matured in vitro was for Wingless-type MMTV integration site (WNT) signaling. In an attempt to inhibit the WNT pathway, Dickkopf-related protein 1 was added to the in vitro maturation medium. Addition of Dickkopf-related protein 1 improved the percentage of oocytes that matured to the metaphase II stage, increased the number of nuclei in the resulting blastocyst stage embryos, and reduced the amount of disheveled segment polarity protein 1 protein in oocytes. It is concluded that transcriptional profiling is a powerful method for detecting differences between in vitro and in vivo matured oocytes, and that the WNT signaling pathway is important for proper oocyte maturation.	[Spate, Lee D.; Brown, Alana N.; Redel, Bethany K.; Whitworth, Kristin M.; Murphy, Clifton N.; Prather, Randall S.] Anim Sci Res Ctr, Div Anim Sci, Columbia, MO 65201 USA	University of Missouri System; University of Missouri Columbia	Prather, RS (corresponding author), Anim Sci Res Ctr, Div Anim Sci, Columbia, MO 65201 USA.	PratherR@Missouri.Edu		Prather, Randall/0000-0002-6012-4035; Redel, Bethany/0000-0002-6444-9064	Food for the 21st Century at the University of Missouri; University of Missouri from the Missouri Life Science Research Board [13321]	Food for the 21st Century at the University of Missouri; University of Missouri from the Missouri Life Science Research Board	Funding from Food for the 21st Century at the University of Missouri, and by the University of Missouri grant 13321 from the Missouri Life Science Research Board via Dr. Jerry Taylor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeydeera LR, 1997, THERIOGENOLOGY, V48, P537, DOI 10.1016/S0093-691X(97)00270-7; Abrams EW, 2009, CURR OPIN GENET DEV, V19, P396, DOI 10.1016/j.gde.2009.06.002; Bauer BK, 2010, BIOL REPROD, V83, P791, DOI 10.1095/biolreprod.110.085936; Brown NL, 2003, DEV GROWTH DIFFER, V45, P153; Denicol AC, 2013, SCI REP-UK, V3, DOI 10.1038/srep01266; Fragouli E, 2011, CYTOGENET GENOME RES, V133, P107, DOI 10.1159/000323801; Guder C, 2006, DEVELOPMENT, V133, P901, DOI 10.1242/dev.02265; HAGEN DR, 1991, J ANIM SCI, V69, P1147; Harwood BN, 2008, DEV DYNAM, V237, P1099, DOI 10.1002/dvdy.21491; Hirao Y, 2011, ANIM SCI J, V82, P187, DOI 10.1111/j.1740-0929.2010.00870.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Im GS, 2004, THERIOGENOLOGY, V61, P1125, DOI 10.1016/j.theriogenology.2003.06.006; Jones KT, 2012, EXP CELL RES, V318, P1394, DOI 10.1016/j.yexcr.2012.02.012; Alvarez GM, 2009, BIOCELL, V33, P167; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Paczkowski M, 2011, J ANIM SCI, V89, P3561, DOI 10.2527/jas.2011-4193; Redel BK, 2012, MOL REPROD DEV, V79, P262, DOI 10.1002/mrd.22017; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Whitworth KM, 2005, BIOL REPROD, V72, P1437, DOI 10.1095/biolreprod.104.037952; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339; Yoshioka K, 2011, J REPROD DEVELOP, V57, P9, DOI 10.1262/jrd.10-196E; Yuan Y, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099952; Yuan Y, 2011, MOL REPROD DEV, V78, P565, DOI 10.1002/mrd.21351; Zheng P, 2006, MOL REPROD DEV, V73, P667, DOI 10.1002/mrd.20428	27	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95114	10.1371/journal.pone.0095114	http://dx.doi.org/10.1371/journal.pone.0095114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739947	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900105
J	Toyjanova, J; Bar-Kochba, E; Lopez-Fagundo, C; Reichner, J; Hoffman-Kim, D; Franck, C				Toyjanova, Jennet; Bar-Kochba, Eyal; Lopez-Fagundo, Cristina; Reichner, Jonathan; Hoffman-Kim, Diane; Franck, Christian			High Resolution, Large Deformation 3D Traction Force Microscopy	PLOS ONE			English	Article							FOCAL ADHESIONS; CELL; LOCOMOTION; MOMENTS; FIELDS	Traction Force Microscopy (TFM) is a powerful approach for quantifying cell-material interactions that over the last two decades has contributed significantly to our understanding of cellular mechanosensing and mechanotransduction. In addition, recent advances in three-dimensional (3D) imaging and traction force analysis (3D TFM) have highlighted the significance of the third dimension in influencing various cellular processes. Yet irrespective of dimensionality, almost all TFM approaches have relied on a linear elastic theory framework to calculate cell surface tractions. Here we present a new high resolution 3D TFM algorithm which utilizes a large deformation formulation to quantify cellular displacement fields with unprecedented resolution. The results feature some of the first experimental evidence that cells are indeed capable of exerting large material deformations, which require the formulation of a new theoretical TFM framework to accurately calculate the traction forces. Based on our previous 3D TFM technique, we reformulate our approach to accurately account for large material deformation and quantitatively contrast and compare both linear and large deformation frameworks as a function of the applied cell deformation. Particular attention is paid in estimating the accuracy penalty associated with utilizing a traditional linear elastic approach in the presence of large deformation gradients.	[Toyjanova, Jennet; Bar-Kochba, Eyal; Hoffman-Kim, Diane; Franck, Christian] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Lopez-Fagundo, Cristina; Hoffman-Kim, Diane] Brown Univ, Ctr Biomed Engn, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Reichner, Jonathan] Rhode Isl Hosp, Dept Surg, Providence, RI USA; [Reichner, Jonathan] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Hoffman-Kim, Diane] Brown Inst Brain Sci, Providence, RI USA	Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Brown University	Franck, C (corresponding author), Brown Univ, Sch Engn, Providence, RI 02912 USA.	franck@brown.edu	Franck, Christian/C-6077-2012	Franck, Christian/0000-0002-2347-620X; Reichner, Jonathan/0000-0002-7349-6321	NIH [R21 AI101469-01]; NIH IMSD [765 R25GM083270-01]; NSF CBET [1134166]; NSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM083270] Funding Source: NIH RePORTER; Directorate For Engineering [1134166] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH IMSD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF CBET(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work is in part supported by NIH R21 AI101469-01 to C. F. and J.S.R.; by NIH IMSD 765 R25GM083270-01 to C. L. F.; by NSF CBET 1134166 to D. H. K., and an NSF Graduate Research Fellowship to E. B. K. and C. L. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Kochba E, 2014, EXPT MECH, V53; Bower A. F., 2011, APPL MECH SOLIDS; Bruck HA, 1989, EXPT MECH; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; del Alamo JC, 2013, ARXIV13064374; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; del Alamo JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069850; Delanoe-Ayari H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248103; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; DErrico J., 2005, SURFACE FITTING USIN; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Farid H, 2004, IEEE T IMAGE PROCESS, V13, P496, DOI 10.1109/TIP.2004.823819; Franck C, 2007, EXP MECH, V47, P427, DOI 10.1007/s11340-007-9037-9; Franck C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017833; Gates M, 2011, EXP MECH, V51, P491, DOI 10.1007/s11340-010-9445-0; Hur SS, 2012, P NATL ACAD SCI USA, V109, P11110, DOI 10.1073/pnas.1207326109; Hur SS, 2009, CELL MOL BIOENG, V2, P425, DOI 10.1007/s12195-009-0082-6; Jacobson K, 1996, PROG BIOPHYS MOL BIO, V65, pSF301; Jannat RA, 2011, BIOPHYS J, V101, P575, DOI 10.1016/j.bpj.2011.05.040; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Legant WR, 2013, P NATL ACAD SCI USA, V110, P881, DOI 10.1073/pnas.1207997110; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Long R, 2011, BIOPHYS J, V101, P643, DOI 10.1016/j.bpj.2011.06.049; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Mitchel JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024316; Nogueira J, 2005, EXP FLUIDS, V39, P305, DOI 10.1007/s00348-005-1016-2; Oakes PW, 2009, BLOOD, V114, P1387, DOI 10.1182/blood-2008-11-191445; OLIVER T, 1995, CELL MOTIL CYTOSKEL, V31, P225, DOI 10.1002/cm.970310306; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Scarano F, 2002, MEAS SCI TECHNOL, V13, pR1, DOI 10.1088/0957-0233/13/1/201; Scarano F, 2000, EXP FLUIDS, V29, pS51, DOI 10.1007/s003480070007; Schoen I, 2010, NANO LETT, V10, P1823, DOI 10.1021/nl100533c; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Trichet L, 2012, PNAS EARLY EDITION, P1; Wang JHC, 2007, BIOMECH MODEL MECHAN, V6, P361, DOI 10.1007/s10237-006-0068-4; Yang ZC, 2006, J THEOR BIOL, V242, P607, DOI 10.1016/j.jtbi.2006.05.005	42	54	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e90976	10.1371/journal.pone.0090976	http://dx.doi.org/10.1371/journal.pone.0090976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740435	Green Published, gold			2022-12-25	WOS:000336863900005
J	Yin, HF; Jin, CF; Fang, XY; Miao, Q; Zhao, YY; Chen, ZQ; Su, ZA; Ye, PP; Wang, Y; Yin, JF				Yin, Houfa; Jin, Chongfei; Fang, Xiaoyun; Miao, Qi; Zhao, Yingying; Chen, Zhiqing; Su, Zhaoan; Ye, Panpan; Wang, Yao; Yin, Jinfu			Molecular Analysis and Phenotypic Study in 14 Chinese Families with Bietti Crystalline Dystrophy	PLOS ONE			English	Article							CORNEO-RETINAL DYSTROPHY; CHOROIDAL NEOVASCULARIZATION; FUNDUS DYSTROPHY; CYP4V2 MUTATIONS; RETINOPATHY; GENE; TIMP3	Purpose: To investigate the clinical features and cytochrome P450 family 4 subfamily V polypeptide 2 (CYP4V2) gene mutations in 14 Chinese families with Bietti crystalline dystrophy (BCD). Methods: Seventeen patients from 14 unrelated Chinese families with BCD were recruited for complete clinical ophthalmic examination and genetic study. The 11 exons of CYP4V2 were amplified from genomic DNA of all patients and their family members by polymerase chain reaction (PCR) and then sequenced. Exons of TIMP3 were also sequenced in BCD patient associated with choroidal neovascularization (CNV). One hundred and seventy unrelated healthy Chinese subjects were screened for mutations in CYP4V2. Results: All 17 patients with BCD had mutations in CYP4V2; one of these mutations was novel (c.219T>A, p.F73L) and four other mutations had been reported. The p.F73L mutation was a commonly detected mutation in our study (seven out of 34 alleles), either in the homozygous state or in the heterozygous state. Among the patients, considerable phenotypic variability was detected, both within and between families. Screening of TIMP3 did not find any mutation in the BCD patient associated with CNV. Conclusion: The novel CYP4V2 c.219T>A (p.F73L) mutation may be another recurrent mutation in Chinese patients with BCD. Our study expands the mutation spectrum of CYP4V2 and characterizes novel genotype-phenotype associations in Chinese patients with BCD.	[Yin, Houfa; Jin, Chongfei; Fang, Xiaoyun; Miao, Qi; Zhao, Yingying; Chen, Zhiqing; Su, Zhaoan; Ye, Panpan; Wang, Yao; Yin, Jinfu] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China; [Yin, Houfa; Fang, Xiaoyun; Miao, Qi; Zhao, Yingying; Chen, Zhiqing; Su, Zhaoan; Ye, Panpan; Wang, Yao; Yin, Jinfu] Zhejiang Prov Key Lab Ophthalmol, Hangzhou, Zhejiang, Peoples R China; [Jin, Chongfei] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA	Zhejiang University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Fang, XY (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou 310003, Zhejiang, Peoples R China.	xiaoyun.fang88@gmail.com	zhao, yingying/HHC-8693-2022	zhao, yingying/0000-0002-6566-1841	Qianjiang Talents Project of Zhejiang province [2010R10067]; Zhejiang Key Innovation Team Project of China [2009R50039]; Zhejiang Key Laboratory Fund of China [2011E10006]; National Natural Science Foundation of China [81100640]; Public Welfare Technology Project of Science Technology Department of Zhejiang Province [2012C23068]	Qianjiang Talents Project of Zhejiang province; Zhejiang Key Innovation Team Project of China; Zhejiang Key Laboratory Fund of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Technology Project of Science Technology Department of Zhejiang Province	This work was supported by the Qianjiang Talents Project of Zhejiang province (Grant No. 2010R10067), Zhejiang Key Innovation Team Project of China (Grant No. 2009R50039), Zhejiang Key Laboratory Fund of China (Grant No. 2011E10006), National Natural Science Foundation of China (Grant No. 81100640) and Public Welfare Technology Project of Science Technology Department of Zhejiang Province (Grant No. 2012C23068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmaca LS, 2007, EYE, V21, P839, DOI 10.1038/sj.eye.6702673; Bietti G., 1937, KLIN MBL AUGENHEILK, V99, P737; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Fu Q, 2013, INVEST OPHTH VIS SCI, V54, P4158, DOI 10.1167/iovs.13-11672; Ganesh A, 2011, CURR OPIN OPHTHALMOL, V22, P332, DOI 10.1097/ICU.0b013e328349229e; Garcia-Garcia GP, 2013, CORNEA, V32, P1002, DOI 10.1097/ICO.0b013e31828a27bc; Gupta B., 2011, International Ophthalmology, V31, P59, DOI 10.1007/s10792-010-9406-8; Haddad NMN, 2012, MOL VIS, V18, P1182; Halford S, 2014, OPHTHALMOLOGY; Iriyama Aya, 2013, Retina, V33, P1462, DOI 10.1097/IAE.0b013e31828221ae; Ji Shu-Xing, 2009, Retin Cases Brief Rep, V3, P361, DOI 10.1097/ICB.0b013e3181780832; Jiao XD, 2000, AM J HUM GENET, V67, P1309; KAISERKUPFER MI, 1994, AM J OPHTHALMOL, V118, P569, DOI 10.1016/S0002-9394(14)76572-9; Kojima H, 2012, BRIT J OPHTHALMOL, V96, P390, DOI 10.1136/bjo.2010.199356; Lai TYY, 2007, INVEST OPHTH VIS SCI, V48, P5212, DOI 10.1167/iovs.07-0660; Lai TYY, 2010, INVEST OPHTH VIS SCI, V51, P1092, DOI 10.1167/iovs.09-3665; Le Tien V, 2010, EYE, V24, P1728, DOI 10.1038/eye.2010.116; Lee KYC, 2005, INVEST OPHTH VIS SCI, V46, P3812, DOI 10.1167/iovs.05-0378; Li AR, 2004, AM J HUM GENET, V74, P817, DOI 10.1086/383228; Mackay DS, 2012, EXP EYE RES, V102, P111, DOI 10.1016/j.exer.2011.06.019; Mamatha G, 2011, MOL VIS, V17, P1970; Marano F, 2000, GRAEF ARCH CLIN EXP, V238, P760, DOI 10.1007/s004170000186; Mataftsi A, 2004, RETINA-J RET VIT DIS, V24, P416, DOI 10.1097/00006982-200406000-00013; Nakano M, 2012, MOL PHARMACOL, V82, P679, DOI 10.1124/mol.112.080085; Nakano M, 2009, DRUG METAB DISPOS, V37, P2119, DOI 10.1124/dmd.109.028530; Rossi S, 2013, BRIT J OPHTHALMOL, V97, P174, DOI 10.1136/bjophthalmol-2012-302469; Rossi S, 2011, OPHTHALMIC GENET, V32, P118, DOI 10.3109/13816810.2011.559653; Saatci AO, 1997, OPHTHALMIC GENET, V18, P139, DOI 10.3109/13816819709057127; Schoenberger SD, 2013, RETINA-J RET VIT DIS, V33, P429, DOI 10.1097/IAE.0b013e318263d3b4; Song YP, 2013, INT OPHTHALMOL, V33, P269, DOI 10.1007/s10792-012-9686-2; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; WILSON DJ, 1989, ARCH OPHTHALMOL-CHIC, V107, P213, DOI 10.1001/archopht.1989.01070010219026; Xiao XS, 2011, BIOCHEM BIOPH RES CO, V409, P181, DOI 10.1016/j.bbrc.2011.04.112; Yokoi Y, 2011, CASE REP OPHTHALM, V2, P296, DOI 10.1159/000331885; YUZAWA M, 1986, OPHTHALMIC PAED GEN, V7, P9, DOI 10.3109/13816818609058037; Zweifel SA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1596, DOI 10.1001/archophthalmol.2009.326	36	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94960	10.1371/journal.pone.0094960	http://dx.doi.org/10.1371/journal.pone.0094960			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739949	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900088
J	Akimoto-Tomiyama, C; Furutani, A; Ochiai, H				Akimoto-Tomiyama, Chiharu; Furutani, Ayako; Ochiai, Hirokazu			Real Time Live Imaging of Phytopathogenic Bacteria Xanthomonas campestris pv. campestris MAFF106712 in 'Plant Sweet Home'	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; PSEUDOMONAS-SYRINGAE; ARABIDOPSIS-THALIANA; RALSTONIA-SOLANACEARUM; CELL SIGNAL; HOST-RANGE; VIRULENCE; ORYZAE; PATHOGENICITY; RICE	Xanthomonas is one of the most widespread phytobacteria, causing diseases on a variety of agricultural plants. To develop novel control techniques, knowledge of bacterial behavior inside plant cells is essential. Xanthomonas campestris pv. campestris, a vascular pathogen, is the causal agent of black rot on leaves of Brassicaceae, including Arabidopsis thaliana. Among the X. campestris pv. campestris stocks in the MAFF collection, we selected XccMAFF106712 as a model compatible pathogen for the A. thaliana reference ecotype Columbia (Col-0). Using modified green fluorescent protein (AcGFP) as a reporter, we observed real time XccMAFF106712 colonization in planta with confocal microscopy. AcGFP-expressing bacteria colonized the inside of epidermal cells and the apoplast, as well as the xylem vessels of the vasculature. In the case of the type III mutant, bacteria colonization was never detected in the xylem vessel or apoplast, though they freely enter the xylem vessel through the wound. After 9 days post inoculation with XccMAFF106712, the xylem vessel became filled with bacterial aggregates. This suggests that Xcc colonization can be divided into main four steps, (1) movement in the xylem vessel, (2) movement to the next cell, (3) adhesion to the host plant cells, and (4) formation of bacterial aggregates. The type III mutant abolished at least steps (1) and (2). Better understanding of Xcc colonization is essential for development of novel control techniques for black rot.	[Akimoto-Tomiyama, Chiharu; Ochiai, Hirokazu] Natl Inst Agrobiol Sci, Div Plant Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki, Japan; [Furutani, Ayako] Ibaraki Univ, Ctr Gene Res, Inashiki, Ibaraki, Japan	National Institute of Agrobiological Sciences - Japan; Ibaraki University	Akimoto-Tomiyama, C (corresponding author), Natl Inst Agrobiol Sci, Div Plant Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki, Japan.	akimotoc@affrc.go.jp			NIAS Strategic Research Fund	NIAS Strategic Research Fund	This study was supported by the NIAS Strategic Research Fund, no number, http://www.nias.affrc.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto-Tomiyama C, 2012, MOL PLANT MICROBE IN, V25, P505, DOI 10.1094/MPMI-06-11-0167; Aparna G, 2009, PLANT CELL, V21, P1860, DOI 10.1105/tpc.109.066886; Bolot S, 2013, GENOME ANNOUNC, V1; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; BONAS U, 1991, MOL PLANT MICROBE IN, V4, P81, DOI 10.1094/MPMI-4-081; BOUCHER CA, 1987, J BACTERIOL, V169, P5626, DOI 10.1128/jb.169.12.5626-5632.1987; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Das A, 2009, MOL PLANT MICROBE IN, V22, P73, DOI 10.1094/MPMI-22-1-0073; Digonnet C, 2012, PLANTA, V236, P1419, DOI 10.1007/s00425-012-1694-y; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; Dow JM, 1994, MOL CELLULAR MECH BA, V192., P29; Fujie M, 2010, J BIOSCI BIOENG, V109, P153, DOI 10.1016/j.jbiosc.2009.07.012; Garavaglia BS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-51; Genin S, 2010, NEW PHYTOL, V187, P920, DOI 10.1111/j.1469-8137.2010.03397.x; Gonzalez ET, 2003, MOL PLANT MICROBE IN, V16, P536, DOI 10.1094/MPMI.2003.16.6.536; Gudesblat GE, 2009, PLANT PHYSIOL, V149, P1017, DOI 10.1104/pp.108.126870; Guy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073469; Guy E, 2013, MBIO, V4, DOI 10.1128/mBio.00538-12; Han SW, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-164; Henty-Ridilla JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003290; INNES RW, 1988, J BACTERIOL, V170, P3793, DOI 10.1128/jb.170.9.3793-3802.1988; Jha G, 2007, MOL PLANT MICROBE IN, V20, P31, DOI 10.1094/MPMI-20-0031; KAMOUN S, 1990, J BACTERIOL, V172, P5165, DOI 10.1128/jb.172.9.5165-5172.1990; Kover PX, 2007, NEW PHYTOL, V174, P172, DOI 10.1111/j.1469-8137.2007.01985.x; Lagopodi AL, 2002, MOL PLANT MICROBE IN, V15, P172, DOI 10.1094/MPMI.2002.15.2.172; Lee SJ, 2013, PLANTA, V238, P307, DOI 10.1007/s00425-013-1889-x; Lindeberg M, 2009, TRENDS MICROBIOL, V17, P304, DOI 10.1016/j.tim.2009.04.001; Meyer D, 2005, MOL PLANT PATHOL, V6, P327, DOI 10.1111/j.1364-3703.2005.00287.x; Misas-Villamil JC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003281; Misas-Villamil JC, 2011, PLANT J, V67, P774, DOI 10.1111/j.1365-313X.2011.04632.x; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Rajeshwari R, 2005, MOL PLANT MICROBE IN, V18, P830, DOI 10.1094/MPMI-18-0830; Ray SK, 2000, MOL PLANT MICROBE IN, V13, P394, DOI 10.1094/MPMI.2000.13.4.394; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Silipo A, 2008, CHEMBIOCHEM, V9, P896, DOI 10.1002/cbic.200700693; Sinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075867; Stuurman N, 2000, MOL PLANT MICROBE IN, V13, P1163, DOI 10.1094/MPMI.2000.13.11.1163; Torres PS, 2007, ENVIRON MICROBIOL, V9, P2101, DOI 10.1111/j.1462-2920.2007.01332.x; Verena B, 2009, MOL PLANT MICROBE IN, V22, P655; Vorhoelter FJ, 2008, J BIOTECHNOL, V134, P33, DOI 10.1016/j.jbiotec.2007.12.013; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu XL, 2013, P NATL ACAD SCI USA, V110, pE425, DOI 10.1073/pnas.1221892110; Yun MH, 2006, PLANT PHYSIOL, V141, P178, DOI 10.1104/pp.105.074542; Zhang S, 2013, SAUDI J BIOL SCI, V20, P23, DOI 10.1016/j.sjbs.2012.11.001	49	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94386	10.1371/journal.pone.0094386	http://dx.doi.org/10.1371/journal.pone.0094386			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736478	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600064
J	Chan, KH; Simpson, PJL; Yong, AS; Dunn, LL; Chawantanpipat, C; Hsu, CJ; Yu, Y; Keech, AC; Celermajer, DS; Ng, MKC				Chan, Kim H.; Simpson, Philippa J. L.; Yong, Andy S.; Dunn, Louise L.; Chawantanpipat, Chirapan; Hsu, Chijen; Yu, Young; Keech, Anthony C.; Celermajer, David S.; Ng, Martin K. C.			The Relationship between Endothelial Progenitor Cell Populations and Epicardial and Microvascular Coronary Disease-A Cellular, Angiographic and Physiologic Study	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; COLONY-FORMING CELLS; CARDIAC SYNDROME-X; E-KNOCKOUT MICE; BONE-MARROW; ARTERY-DISEASE; ANGIOGENIC PROPERTIES; CARDIOVASCULAR RISK; MONONUCLEAR-CELLS; FLOW RESERVE	Background: Endothelial progenitor cells (EPCs) are implicated in protection against vascular disease. However, studies using angiography alone have reported conflicting results when relating EPCs to epicardial coronary artery disease (CAD) severity. Moreover, the relationship between different EPC types and the coronary microcirculation is unknown. We therefore investigated the relationship between EPC populations and coronary epicardial and microvascular disease. Methods: Thirty-three patients with a spectrum of isolated left anterior descending artery disease were studied. The coronary epicardial and microcirculation were physiologically interrogated by measurement of fractional flow reserve (FFR), index of microvascular resistance (IMR) and coronary flow reserve (CFR). Two distinct EPC populations (early EPC and late outgrowth endothelial cells [OECs]) were isolated from these patients and studied ex vivo. Results: There was a significant inverse relationship between circulating OEC levels and epicardial CAD severity, as assessed by FFR and angiography (r = 0.371, p = 0.04; r = -0.358, p = 0.04; respectively). More severe epicardial CAD was associated with impaired OEC migration and tubulogenesis (r = 0.59, p = 0.005; r = 0.589, p = 0.004; respectively). Patients with significant epicardial CAD (FFR, 0.75) had lower OEC levels and function compared to those without hemodynamically significant stenoses (p<0.05). In contrast, no such relationship was seen for early EPC number and function, nor was there a relationship between IMR and EPCs. There was a significant relationship between CFR and OEC function. Conclusions: EPC populations differ in regards to their associations with CAD severity. The number and function of OECs, but not early EPCs, correlated significantly with epicardial CAD severity. There was no relationship between EPCs and severity of coronary microvascular disease.	[Chan, Kim H.; Chawantanpipat, Chirapan; Hsu, Chijen; Yu, Young; Keech, Anthony C.; Celermajer, David S.; Ng, Martin K. C.] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Chan, Kim H.; Simpson, Philippa J. L.; Dunn, Louise L.; Hsu, Chijen; Yu, Young; Celermajer, David S.; Ng, Martin K. C.] Heart Res Inst, Sydney, NSW, Australia; [Chan, Kim H.; Hsu, Chijen; Yu, Young; Keech, Anthony C.; Celermajer, David S.; Ng, Martin K. C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Yong, Andy S.] Concord Hosp, Dept Cardiol, Sydney, NSW, Australia; [Keech, Anthony C.] Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW, Australia	University of Sydney; University of Sydney; Heart Research Institute; University of Sydney; Concord Repatriation General Hospital; University of Sydney	Ng, MKC (corresponding author), Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia.	mkcng@med.usyd.edu.au	Yong, Andy S C/B-2196-2008	Yong, Andy/0000-0002-6268-4300; Celermajer, David/0000-0001-7640-0439	National Heart Foundation scholarship [PC 08S 4127]; Royal Australasian College of Physicians scholarship; National Health and Medical Research Council [1013027]	National Heart Foundation scholarship(National Heart Foundation of Australia); Royal Australasian College of Physicians scholarship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Dr. Chan was supported by the National Heart Foundation scholarship (PC 08S 4127) and Royal Australasian College of Physicians scholarship. This study was supported by a grant from the National Health and Medical Research Council to Dr. Ng (No. 1013027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Campioni D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056377; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; George J, 2005, ARTERIOSCL THROM VAS, V25, P2636, DOI 10.1161/01.ATV.0000188554.49745.9e; George J, 2004, EUR HEART J, V25, P1003, DOI 10.1016/j.ehj.2004.03.026; Gibson CM, 2000, CIRCULATION, V101, P125, DOI 10.1161/01.CIR.101.2.125; Guven H, 2006, J AM COLL CARDIOL, V48, P1579, DOI 10.1016/j.jacc.2006.04.101; Haddad F, 2012, CIRC-HEART FAIL, V5, P759, DOI 10.1161/CIRCHEARTFAILURE.111.962787; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Huang PH, 2007, HEART, V93, P1064, DOI 10.1136/hrt.2006.107763; Kong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037266; Kunz GA, 2006, AM HEART J, V152, P190, DOI 10.1016/j.ahj.2006.02.001; Leung DY, 2011, HEART, V97, P587, DOI 10.1136/hrt.2009.183327; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Manginas A, 1999, AM J CARDIOL, V83, P1562, DOI 10.1016/S0002-9149(99)00149-6; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Massa M, 2009, EXP HEMATOL, V37, P8, DOI 10.1016/j.exphem.2008.09.007; Meneveau N, 2011, BASIC RES CARDIOL, V106, P1397, DOI 10.1007/s00395-011-0220-x; Ng MKC, 2006, CIRCULATION, V113, P2054, DOI 10.1161/CIRCULATIONAHA.105.603522; Padfield GJ, 2013, HEART, V99, P791, DOI 10.1136/heartjnl-2012-302949; Pepine CJ, 2010, J AM COLL CARDIOL, V55, P2825, DOI 10.1016/j.jacc.2010.01.054; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; RINGQVIST I, 1983, J CLIN INVEST, V71, P1854, DOI 10.1172/JCI110941; Shantsila E, 2008, J AM COLL CARDIOL, V51, P669, DOI 10.1016/j.jacc.2007.09.057; Shantsila E, 2007, J AM COLL CARDIOL, V49, P741, DOI 10.1016/j.jacc.2006.09.050; Sharpe EE, 2006, AM J PATHOL, V168, P1710, DOI 10.2353/ajpath.2006.050556; Shmilovich H, 2007, HEART, V93, P1071, DOI 10.1136/hrt.2005.077909; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Silvestre JS, 2003, CIRCULATION, V108, P2839, DOI 10.1161/01.CIR.0000106161.43954.DF; Simpson PJL, 2013, INT J CARDIOL, V168, P2042, DOI 10.1016/j.ijcard.2013.01.166; Smadja DM, 2013, ANGIOGENESIS, V16, P147, DOI 10.1007/s10456-012-9306-9; Smadja DM, 2012, CYTOTHERAPY, V14, P232, DOI 10.3109/14653249.2011.627917; Smadja DM, 2011, ANGIOGENESIS, V14, P17, DOI 10.1007/s10456-010-9192-y; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Tokgozoglu L, 2011, ATHEROSCLEROSIS, V219, P851, DOI 10.1016/j.atherosclerosis.2011.08.045; Toshner M, 2009, AM J RESP CRIT CARE, V180, P780, DOI 10.1164/rccm.200810-1662OC; Wang CH, 2011, AM J PHYSIOL-REG I, V300, pR586, DOI 10.1152/ajpregu.00450.2010; Werner GS, 2006, J AM COLL CARDIOL, V48, P51, DOI 10.1016/j.jacc.2005.11.093; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; WHITE CW, 1984, NEW ENGL J MED, V310, P819, DOI 10.1056/NEJM198403293101304; Xiao QZ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000975; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	46	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93980	10.1371/journal.pone.0093980	http://dx.doi.org/10.1371/journal.pone.0093980			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736282	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600039
J	Patterson, KG; Pittaro, JLD; Bastedo, PS; Hess, DA; Haeryfar, SMM; McCormick, JK				Patterson, Kelcey G.; Pittaro, Jennifer L. Dixon; Bastedo, Peter S.; Hess, David A.; Haeryfar, S. M. Mansour; McCormick, John K.			Control of Established Colon Cancer Xenografts Using a Novel Humanized Single Chain Antibody-Streptococcal Superantigen Fusion Protein Targeting the 5T4 Oncofetal Antigen	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; PYROGENIC EXOTOXIN-C; STAPHYLOCOCCAL-ENTEROTOXIN-A; RECEPTOR BETA-CHAIN; CRYSTAL-STRUCTURE; PHASE-I; NAPTUMOMAB ESTAFENATOX; T-CELLS; 3-DIMENSIONAL STRUCTURE; BACTERIAL SUPERANTIGEN	Superantigens (SAgs) are microbial toxins that cross-link T cell receptors with major histocompatibility class II (MHC-II) molecules leading to the activation of large numbers of T cells. Herein, we describe the development and preclinical testing of a novel tumor-targeted SAg (TTS) therapeutic built using the streptococcal pyrogenic exotoxin C (SpeC) SAg and targeting cancer cells expressing the 5T4 tumor-associated antigen (TAA). To inhibit potentially harmful widespread immune cell activation, a SpeC mutation within the high-affinity MHC-II binding interface was generated (SpeC(D203A)) that demonstrated a pronounced reduction in mitogenic activity, yet this mutant could still induce immune cell-mediated cancer cell death in vitro. To target 5T4(+) cancer cells, we engineered a humanized single chain variable fragment (scFv) antibody to recognize 5T4 (scFv5T4). Specific targeting of scFv5T4 was verified. SpeC(D203A) fused to scFv5T4 maintained the ability to activate and induce immune cell-mediated cytotoxicity of colorectal cancer cells. Using a xenograft model of established human colon cancer, we demonstrated that the SpeC-based TTS was able to control the growth and spread of large tumors in vivo. This required both TAA targeting by scFv5T4 and functional SAg activity. These studies lay the foundation for the development of streptococcal SAgs as 'next-generation' TTSs for cancer immunotherapy.	[Patterson, Kelcey G.; Pittaro, Jennifer L. Dixon; Bastedo, Peter S.; Haeryfar, S. M. Mansour; McCormick, John K.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada; [Haeryfar, S. M. Mansour; McCormick, John K.] Univ Western Ontario, Ctr Human Immunol, London, ON, Canada; [Hess, David A.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Hess, David A.] Robarts Res Inst, Vasc Biol Res Grp, London, ON N6A 5C1, Canada; [Haeryfar, S. M. Mansour; McCormick, John K.] Lawson Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	McCormick, JK (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON, Canada.	john.mccormick@uwo.ca	Hess, David A/M-2828-2013; McCormick, John/E-4232-2015	McCormick, John/0000-0003-3742-7289	Canadian Institutes of Health Research (CIHR) [MOP-64176]; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) operating grant to JKM (MOP-64176). SMMH holds a Canada Research Chair in Viral Immunity and Pathogenesis and JKM was the recipient of a New Investigator Award from the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHMSEN L, 1995, EMBO J, V14, P2978, DOI 10.1002/j.1460-2075.1995.tb07300.x; Alpaugh RK, 1998, CLIN CANCER RES, V4, P1903; Ami K, 2002, CLIN EXP IMMUNOL, V128, P453, DOI 10.1046/j.1365-2249.2002.01854.x; Andersen PS, 2002, BIOCHEMISTRY-US, V41, P5177, DOI 10.1021/bi0200209; Arden Bernhard, 1995, Immunogenetics, V42, P455; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Basma H, 1999, INFECT IMMUN, V67, P1871; Borghaei H, 2009, J CLIN ONCOL, V27, P4116, DOI 10.1200/JCO.2008.20.2515; Brouillard JNP, 2007, J MOL BIOL, V367, P925, DOI 10.1016/j.jmb.2007.01.024; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carreno BM, 2009, CLIN CANCER RES, V15, P3277, DOI 10.1158/1078-0432.CCR-08-2502; CHEN TR, 1987, CANCER GENET CYTOGEN, V27, P125, DOI 10.1016/0165-4608(87)90267-6; Cheng JD, 2004, J CLIN ONCOL, V22, P602, DOI 10.1200/JCO.2004.12.034; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; DOHLSTEN M, 1994, P NATL ACAD SCI USA, V91, P8945, DOI 10.1073/pnas.91.19.8945; DOHLSTEN M, 1990, IMMUNOLOGY, V71, P96; Eisen T, 2014, CURR ONCOL REP, V16, DOI 10.1007/s11912-013-0370-0; Erlandsson E, 2003, J MOL BIOL, V333, P893, DOI 10.1016/j.jmb.2003.09.009; Fields BA, 1996, NATURE, V384, P188, DOI 10.1038/384188a0; Fleischer B, 1996, INFECT IMMUN, V64, P987, DOI 10.1128/IAI.64.3.987-994.1996; Forsberg G, 2001, BRIT J CANCER, V85, P129, DOI 10.1054/bjoc.2001.1891; Forsberg G, 2010, J IMMUNOTHER, V33, P492, DOI 10.1097/CJI.0b013e3181d75820; Giantonio BJ, 1997, J CLIN ONCOL, V15, P1994, DOI 10.1200/JCO.1997.15.5.1994; Hayworth JL, 2012, IMMUNOL CELL BIOL, V90, P699, DOI 10.1038/icb.2011.90; Hedlund G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079082; HERRMANN T, 1992, EUR J IMMUNOL, V22, P1935, DOI 10.1002/eji.1830220739; HOLE N, 1988, BRIT J CANCER, V57, P239, DOI 10.1038/bjc.1988.53; Holtfreter S, 2006, J INFECT DIS, V193, P1275, DOI 10.1086/503048; Holtfreter S, 2004, INFECT IMMUN, V72, P4061, DOI 10.1128/IAI.72.7.4061-4071.2004; Hu DL, 2007, CELL MICROBIOL, V9, P2267, DOI 10.1111/j.1462-5822.2007.00957.x; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kalos M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002842; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kasper KJ, 2008, J IMMUNOL, V181, P3384, DOI 10.4049/jimmunol.181.5.3384; KAWABE Y, 1990, J EXP MED, V172, P1065, DOI 10.1084/jem.172.4.1065; KIM JS, 1994, SCIENCE, V266, P1870, DOI 10.1126/science.7997880; Kochenderfer JN, 2012, BLOOD, V119, P2709, DOI 10.1182/blood-2011-10-384388; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li PL, 1997, J EXP MED, V186, P375, DOI 10.1084/jem.186.3.375; Li YL, 2001, IMMUNITY, V14, P93, DOI 10.1016/S1074-7613(01)00092-9; McCormick JK, 2000, J IMMUNOL, V165, P2306, DOI 10.4049/jimmunol.165.4.2306; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; Morita CT, 2001, IMMUNITY, V14, P331, DOI 10.1016/S1074-7613(01)00113-3; Nielsen SE, 2000, J IMMUNOTHER, V23, P146, DOI 10.1097/00002371-200001000-00017; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Petersson K, 2001, EMBO J, V20, P3306, DOI 10.1093/emboj/20.13.3306; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Rahman AKMNU, 2006, J IMMUNOL, V177, P8595, DOI 10.4049/jimmunol.177.12.8595; Rahman AKMNU, 2011, J BIOL CHEM, V286, P4871, DOI 10.1074/jbc.M110.189068; Rosendahl A, 1998, INT J CANCER, V76, P274, DOI 10.1002/(SICI)1097-0215(19980413)76:2<274::AID-IJC16>3.0.CO;2-C; Roussel A, 1997, NAT STRUCT BIOL, V4, P635, DOI 10.1038/nsb0897-635; Sambrook J, 2001, MOL CLONING LAB MANU; Schlievert PM, 2000, INFECT IMMUN, V68, P3630, DOI 10.1128/IAI.68.6.3630-3634.2000; Shaw DM, 2007, BRIT J CANCER, V96, P567, DOI 10.1038/sj.bjc.6603567; Shaw DM, 2000, BBA-GEN SUBJECTS, V1524, P238, DOI 10.1016/S0304-4165(00)00165-3; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SOUTHALL PJ, 1990, BRIT J CANCER, V61, P89, DOI 10.1038/bjc.1990.20; STARZYNSKA T, 1994, BRIT J CANCER, V69, P899, DOI 10.1038/bjc.1994.173; Sundberg EJ, 2002, STRUCTURE, V10, P687, DOI 10.1016/S0969-2126(02)00759-1; SUNDSTEDT A, 1995, J IMMUNOL, V154, P6306; Sundstedt A, 2008, INT IMMUNOPHARMACOL, V8, P442, DOI 10.1016/j.intimp.2007.11.006; Sundstedt A, 2012, J IMMUNOTHER, V35, P344, DOI 10.1097/CJI.0b013e318253ec25; Swann PG, 2008, CURR OPIN IMMUNOL, V20, P493, DOI 10.1016/j.coi.2008.05.013; Terman DS, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00038; Tripp TJ, 2003, INFECT IMMUN, V71, P1548, DOI 10.1128/IAI.71.3.1548-1550.2003; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Vesely MD, 2013, ANN NY ACAD SCI, V1284, P1, DOI 10.1111/nyas.12105; WEI S, 1994, IMMUNOGENETICS, V40, P27, DOI 10.1007/BF00163961; Xu SX, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00052	74	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95200	10.1371/journal.pone.0095200	http://dx.doi.org/10.1371/journal.pone.0095200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736661	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600154
J	Wu, WJ; Ahn, BY				Wu, Wei-Jie; Ahn, Byung-Yong			Statistical Optimization of Ultraviolet Irradiate Conditions for Vitamin D-2 Synthesis in Oyster Mushrooms (Pleurotus ostreatus) Using Response Surface Methodology	PLOS ONE			English	Article							AGARICUS-BISPORUS	Response surface methodology (RSM) was used to determine the optimum vitamin D-2 synthesis conditions in oyster mushrooms (Pleurotus ostreatus). Ultraviolet B (UV-B) was selected as the most efficient irradiation source for the preliminary experiment, in addition to the levels of three independent variables, which included ambient temperature (25-45 degrees C), exposure time (40-120 min), and irradiation intensity (0.6-1.2 W/m(2)). The statistical analysis indicated that, for the range which was studied, irradiation intensity was the most critical factor that affected vitamin D-2 synthesis in oyster mushrooms. Under optimal conditions (ambient temperature of 28.16 degrees C, UV-B intensity of 1.14 W/m(2), and exposure time of 94.28 min), the experimental vitamin D-2 content of 239.67 mu g/g (dry weight) was in very good agreement with the predicted value of 245.49 mu g/g, which verified the practicability of this strategy. Compared to fresh mushrooms, the lyophilized mushroom powder can synthesize remarkably higher level of vitamin D-2 (498.10 mu g/g) within much shorter UV-B exposure time (10 min), and thus should receive attention from the food processing industry.	[Wu, Wei-Jie] Chonbuk Natl Univ, Dept Food Sci & Biotechnol, Iksan, South Korea; [Ahn, Byung-Yong] Chonbuk Natl Univ, Dept Oriental Med Resources, Iksan, South Korea	Jeonbuk National University; Jeonbuk National University	Ahn, BY (corresponding author), Chonbuk Natl Univ, Dept Oriental Med Resources, Iksan, South Korea.	ahn2002@jbnu.ac.kr		Wu, Wei-Jie/0000-0002-4894-5981	Industrial Technology Research Infrastructure Program - Ministry of Trade, Industry and Energy (MTE, Korea) [N0000004]	Industrial Technology Research Infrastructure Program - Ministry of Trade, Industry and Energy (MTE, Korea)	This work was supported by the Industrial Technology Research Infrastructure Program (N0000004) funded by the Ministry of Trade, Industry and Energy (MTE, Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas LAG, 2004, J CLIN ENDOCR METAB, V89, P5387, DOI 10.1210/jc.2004-0360; Bas D, 2007, J FOOD ENG, V78, P836, DOI 10.1016/j.jfoodeng.2005.11.024; Heaney RP, 2011, J CLIN ENDOCR METAB, V96, pE447, DOI 10.1210/jc.2010-2230; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Holick MF, 2008, J CLIN ENDOCR METAB, V93, P677, DOI 10.1210/jc.2007-2308; Holick MF, 2006, J CLIN INVEST, V116, P2062, DOI 10.1172/JCI29449; Jasinghe VJ, 2006, FOOD CHEM, V95, P638, DOI 10.1016/j.foodchem.2005.01.046; Jasinghe VJ, 2005, FOOD CHEM, V92, P541, DOI 10.1016/j.foodchem.2004.08.022; Johnson MA, 2006, NUTR REV, V64, P410, DOI [10.1301/nr.2006.sept.410-421, 10.1111/j.1753-4887.2006.tb00226.x]; Kalaras MD, 2012, J AGR FOOD CHEM, V60, P220, DOI 10.1021/jf203825e; Ko JA, 2008, J AGR FOOD CHEM, V56, P3671, DOI 10.1021/jf073398s; Koyyalamudi SR, 2011, J FOOD COMPOS ANAL, V24, P976, DOI 10.1016/j.jfca.2011.02.007; Koyyalamudi SR, 2009, J AGR FOOD CHEM, V57, P3351, DOI 10.1021/jf803908q; Liyana-Pathirana C, 2005, FOOD CHEM, V93, P47, DOI 10.1016/j.foodchem.2004.08.050; Lu JK, 2007, CHEM ENG TECHNOL, V30, P261, DOI 10.1002/ceat.200600147; Mau JL, 1998, J AGR FOOD CHEM, V46, P5269, DOI 10.1021/jf980602q; Moyad Mark A, 2009, Dermatol Nurs, V21, P25; Roberts JS, 2008, J AGR FOOD CHEM, V56, P4541, DOI 10.1021/jf0732511; Simon RB, 2011, BURLINGTON MAG, V153, P59; Sin HN, 2006, J FOOD ENG, V73, P313, DOI 10.1016/j.jfoodeng.2005.01.031; Teichmann A, 2007, LWT-FOOD SCI TECHNOL, V40, P815, DOI 10.1016/j.lwt.2006.04.003	21	19	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95359	10.1371/journal.pone.0095359	http://dx.doi.org/10.1371/journal.pone.0095359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736742	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600175
J	Ugarte-Berzal, E; Bailon, E; Amigo-Jimenez, I; Albar, JP; Garcia-Marco, JA; Garcia-Pardo, A				Ugarte-Berzal, Estefania; Bailon, Elvira; Amigo-Jimenez, Irene; Pablo Albar, Juan; Garcia-Marco, Jose A.; Garcia-Pardo, Angeles			A Novel CD44-binding Peptide from the Pro-Matrix Metalloproteinase-9 Hemopexin Domain Impairs Adhesion and Migration of Chronic Lymphocytic Leukemia (CLL) Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CD44; Cell Adhesion; Cell Migration; Leukemia; Metalloprotease	ALPHA-4-BETA-1 INTEGRIN; MATRIX-METALLOPROTEINASE-9 MMP-9; B-CELLS; PROMOTES; SURVIVAL; DISEASE; CD44; HYALURONAN; ACTIVATION; MECHANISMS	Background: proMMP-9 binds to CLL cells through the hemopexin domain (PEX9), contributing to disease progression. Results: A 20-residue sequence (P6) within PEX9 inhibits CD44-mediated CLL-proMMP-9 interaction and cell migration. P6 cooperates with the previously identified sequence P3, also located in PEX9. Conclusion: P6 is a CD44-binding site and impairs proMMP-9 effects on CLL. Significance: P6 may be a novel therapeutic target in CLL. (pro)MMP-9 binds to CLL cells through the PEX9 domain and contributes to CLL progression. To biochemically characterize this interaction and identify potential therapeutic targets, we prepared GST-PEX9 forms containing structural blades B1B2 or B3B4. We recently described a sequence in blade B4 (P3 sequence) that bound 41 integrin and partially impaired cell adhesion and migration. We have now studied the possible contribution of the B1B2 region to cell interaction with PEX9. CLL cells bound to GST-B1B2 and CD44 was the primary receptor. GST-B1B2 inhibited CLL cell migration as effectively as GST-B3B4. Overlapping synthetic peptides spanning the B1B2 region identified the sequence FDAIAEIGNQLYLFKDGKYW, present in B1 and contained in peptide P6, as the most effective site. P6 inhibited cell adhesion to PEX9 in a dose-dependent manner and with an IC50 value of 90 m. P6 also inhibited cell adhesion to hyaluronan but had no effect on adhesion to VCAM-1 (41 integrin ligand), confirming its specific interaction with CD44. Spatial localization analyses mapped P6 to the central cavity of PEX9, in close proximity to the previously identified P3 sequence. Both P6 and P3 equally impaired cell adhesion to (pro)MMP-9. Moreover, P6 synergistically cooperated with P3, resulting in complete inhibition of CLL cell binding to PEX9, chemotaxis, and transendothelial migration. Thus, P6 is a novel sequence in PEX9 involved in cell-PEX9/(pro)MMP-9 binding by interacting with CD44. Targeting both sites, P6 and P3, should efficiently prevent (pro)MMP-9 binding to CLL cells and its pathological consequences.	[Ugarte-Berzal, Estefania; Bailon, Elvira; Amigo-Jimenez, Irene; Garcia-Pardo, Angeles] CSIC, Ctr Invest Biol, Dept Cellular & Mol Med, Madrid 28040, Spain; [Pablo Albar, Juan] CSIC, Ctr Nacl Biotecnol, Prote Facil, Madrid 28040, Spain; [Garcia-Marco, Jose A.] Hosp Univ Puerta de Hierro, Serv Hematol, Madrid 28222, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Hospital Puerta de Hierro-Majadahonda	Garcia-Pardo, A (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, Madrid 28040, Spain.	agarciapardo@cib.csic.es	Garcia Marco, Jose/H-2554-2015; Bailón, Elvira/G-5057-2015; Garcia Pardo, Angeles/G-5987-2015	Garcia Marco, Jose/0000-0002-8993-5982; Garcia Pardo, Angeles/0000-0001-5577-2954	Red Tematica de Investigacion Cooperativa en Cancer from Ministry of Economy and Competitivity (Madrid, Spain) [RD12/0036/0061]; Comunidad de Madrid/European Union [S2010/BMD-2314]; Fundacion Puerta de Hierro (Madrid, Spain); Ministry of Economy and Competitivity; Junta de Ampliacion de Estudios program, Consejo Superior de Investigaciones Cientificas/European Union, Spain;  [SAF2012-31613]	Red Tematica de Investigacion Cooperativa en Cancer from Ministry of Economy and Competitivity (Madrid, Spain); Comunidad de Madrid/European Union; Fundacion Puerta de Hierro (Madrid, Spain); Ministry of Economy and Competitivity; Junta de Ampliacion de Estudios program, Consejo Superior de Investigaciones Cientificas/European Union, Spain; 	This work was supported by Grant SAF2012-31613 and by the Red Tematica de Investigacion Cooperativa en Cancer (RD12/0036/0061) (to A. G. P.) from the Ministry of Economy and Competitivity (Madrid, Spain); S2010/BMD-2314 (to A. G. P.) from the Comunidad de Madrid/European Union; and by a grant from the Fundacion Puerta de Hierro (Madrid, Spain) (to J. A. G.-M.).; Supported by a fellowship from the Ministry of Economy and Competitivity.; Supported by the Junta de Ampliacion de Estudios program, Consejo Superior de Investigaciones Cientificas/European Union, Spain.	Bailon E., 2014, J LEUKOC BI IN PRESS, DOI [10.1189/jlb.0913521, DOI 10.1189/JLB.0913521]; Bauvois B, 2002, LEUKEMIA, V16, P791, DOI 10.1038/sj.leu.2402472; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Davids Matthew S, 2012, Open J Hematol, V3; de la Fuente MT, 1999, LEUKEMIA, V13, P266, DOI 10.1038/sj.leu.2401275; de la Fuente MT, 2002, J LEUKOCYTE BIOL, V71, P495; Dufour A, 2011, CANCER RES, V71, P4977, DOI 10.1158/0008-5472.CAN-10-4552; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Fedorchenko O, 2013, BLOOD, V121, P4126, DOI 10.1182/blood-2012-11-466250; Gattei V, 2008, BLOOD, V111, P865, DOI 10.1182/blood-2007-05-092486; Girbl T, 2013, CANCER RES, V73, P561, DOI 10.1158/0008-5472.CAN-12-2749; Herishanu Y, 2011, LEUKEMIA LYMPHOMA, V52, P1758, DOI 10.3109/10428194.2011.569962; Kamiguti AS, 2004, BRIT J HAEMATOL, V125, P128, DOI 10.1111/j.1365-2141.2004.04877.x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; MORODOMI T, 1992, BIOCHEM J, V285, P603, DOI 10.1042/bj2850603; Piccard H, 2007, J LEUKOCYTE BIOL, V81, P870, DOI 10.1189/jlb.1006629; Pleyer L, 2009, NAT REV CLIN ONCOL, V6, P405, DOI 10.1038/nrclinonc.2009.72; Redondo-Munoz J, 2008, BLOOD, V112, P169, DOI 10.1182/blood-2007-08-109249; Redondo-Munoz J, 2006, BLOOD, V108, P3143, DOI 10.1182/blood-2006-03-007294; Redondo-Munoz J, 2010, CANCER CELL, V17, P160, DOI 10.1016/j.ccr.2009.12.044; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Shanafelt TD, 2008, BRIT J HAEMATOL, V140, P537, DOI 10.1111/j.1365-2141.2007.06965.x; Spessotto P, 2002, J CELL BIOL, V158, P1133, DOI 10.1083/jcb.200202120; Till KJ, 1999, CANCER RES, V59, P4419; Ugarte-Berzal E, 2012, J BIOL CHEM, V287, P27601, DOI 10.1074/jbc.M112.354670; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhang SP, 2013, P NATL ACAD SCI USA, V110, P6127, DOI 10.1073/pnas.1221841110	32	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15340	15349		10.1074/jbc.M114.559187	http://dx.doi.org/10.1074/jbc.M114.559187			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24739387	Green Published, hybrid			2022-12-25	WOS:000337465400018
J	Carter, DR; Buckle, AD; Tanaka, K; Perdomo, J; Chong, BH				Carter, Daniel R.; Buckle, Andrew D.; Tanaka, Kumiko; Perdomo, Jose; Chong, Beng H.			Art27 Interacts with GATA4, FOG2 and NKX2.5 and Is a Novel Co-Repressor of Cardiac Genes	PLOS ONE			English	Article							UBIQUITOUSLY EXPRESSED TRANSCRIPT; WNT SIGNALING PATHWAY; CARDIOMYOCYTE DIFFERENTIATION; HEART MORPHOGENESIS; UNFOLDED PROTEINS; CELLS; TBX5; UXT; HYPERTROPHY; COACTIVATOR	Transcription factors play a crucial role in regulation of cardiac biology. FOG-2 is indispensable in this setting, predominantly functioning through a physical interaction with GATA-4. This study aimed to identify novel co-regulators of FOG-2 to further elaborate on its inhibitory activity on GATA-4. The Art27 transcription factor was identified by a yeast-2-hybrid library screen to be a novel FOG-2 protein partner. Characterisation revealed that Art27 is co-expressed with FOG-2 and GATA-4 throughout cardiac myocyte differentiation and in multiple structures of the adult heart. Art27 physically interacts with GATA-4, FOG-2 and other cardiac transcription factors and by this means, down-regulates their activity on cardiac specific promoters a-myosin heavy chain, atrial natriuretic peptide and B-type natriuretic peptide. Regulation of endogenous cardiac genes by Art27 was shown using microarray analysis of P19CL6-Mlc2v-GFP cardiomyocytes. Together these results suggest that Art27 is a novel transcription factor that is involved in downregulation of cardiac specific genes by physically interacting and inhibiting the activity of crucial transcriptions factors involved in cardiac biology.	[Carter, Daniel R.; Buckle, Andrew D.; Tanaka, Kumiko; Perdomo, Jose; Chong, Beng H.] Univ New S Wales, Dept Med, Ctr Vasc Res, St George Clin Sch, Sydney, NSW, Australia; [Chong, Beng H.] Univ New S Wales, Dept Haematol, St George Hosp, Sydney, NSW, Australia; [Chong, Beng H.] Univ New S Wales, Sutherland Hosp, Sydney, NSW, Australia	University of New South Wales Sydney; St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney	Perdomo, J (corresponding author), Univ New S Wales, Dept Med, Ctr Vasc Res, St George Clin Sch, Sydney, NSW, Australia.	j.perdomo@unsw.edu.au	Perdomo, Jose/H-8871-2019; Chong, Beng/AAM-9010-2021; Chong, Beng/AAE-2617-2019	Perdomo, Jose/0000-0002-1554-708X; Carter, Daniel/0000-0002-8464-238X	NHMRC, Australia [APP1012409]; Australian Postgraduate Award	NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government)	This work was supported by a Project Grant from NHMRC, Australia linked to BHC (APP1012409). DRC and ADB were supported by the Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afouda BA, 2008, DEVELOPMENT, V135, P3185, DOI 10.1242/dev.026443; Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Brewer Alison, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000093; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Charron F, 1999, MOL CELL BIOL, V19, P4355; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Crispino JD, 2001, GENE DEV, V15, P839, DOI 10.1101/gad.875201; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; HabaraOhkubo A, 1996, CELL STRUCT FUNCT, V21, P101, DOI 10.1247/csf.21.101; Hirai M, 2004, J BIOL CHEM, V279, P37640, DOI 10.1074/jbc.M401737200; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liang QR, 2001, MOL CELL BIOL, V21, P7460, DOI 10.1128/MCB.21.21.7460-7469.2001; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Luscher TF, 2000, CIRCULATION, V102, P2434, DOI 10.1161/01.CIR.102.19.2434; Markus SM, 2002, MOL BIOL CELL, V13, P670, DOI 10.1091/mbc.01-10-0513; Matsuda N, 2004, J PHARMACOL EXP THER, V309, P786, DOI 10.1124/jpet.103.063065; McGilvray R, 2007, FEBS J, V274, P3960, DOI 10.1111/j.1742-4658.2007.05928.x; Moore JC, 2004, INT J DEV BIOL, V48, P47, DOI 10.1387/ijdb.15005574; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Moss TN, 2007, IN VITRO CELL DEV-AN, V43, P139, DOI 10.1007/s11626-007-9016-6; Mueller I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/380561; Nwachukwu JC, 2009, CANCER RES, V69, P3140, DOI 10.1158/0008-5472.CAN-08-3738; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; ORKIN SH, 1992, BLOOD, V80, P575; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Perdomo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050637; Pizzuti A, 2003, HUM MUTAT, V22, P372, DOI 10.1002/humu.10261; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Schroer A, 1999, GENOMICS, V56, P340, DOI 10.1006/geno.1998.5712; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Silveira HCS, 2004, BRAZ J MED BIOL RES, V37, P785, DOI 10.1590/S0100-879X2004000600002; Snyder M, 2010, J BIOL CHEM, V285, P23639, DOI 10.1074/jbc.M110.101063; Sui SG, 2007, J CELL BIOL, V178, P231, DOI 10.1083/jcb.200611081; Svensson EC, 2000, NAT GENET, V25, P353, DOI 10.1038/77146; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Taneja SS, 2004, J BIOL CHEM, V279, P13944, DOI 10.1074/jbc.M306576200; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Vainberg IE, 1998, CELL, V93, P863, DOI 10.1016/S0092-8674(00)81446-4; Zhao HW, 2005, MOL BIOL CELL, V16, P5857, DOI 10.1091/mbc.E05-08-0705	49	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95253	10.1371/journal.pone.0095253	http://dx.doi.org/10.1371/journal.pone.0095253			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743694	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100097
J	Hernando, G; Bouzat, C				Hernando, Guillermina; Bouzat, Cecilia			Caenorhabditis elegans Neuromuscular Junction: GABA Receptors and Ivermectin Action	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CYS-LOOP RECEPTORS; MACROCYCLIC LACTONE ANTHELMINTICS; GATED CHLORIDE CHANNEL; SOMATIC MUSCLE-CELLS; ASCARIS-SUUM; HAEMONCHUS-CONTORTUS; PHARMACOLOGICAL CHARACTERIZATION; 4-AMINOBUTYRIC ACID; PARASITIC NEMATODE	The prevalence of human and animal helminth infections remains staggeringly high, thus urging the need for concerted efforts towards this area of research. GABA receptors, encoded by the unc-49 gene, mediate body muscle inhibition in Caenorhabditis elegans and parasitic nematodes and are targets of anthelmintic drugs. Thus, the characterization of nematode GABA receptors provides a foundation for rational anti-parasitic drug design. We therefore explored UNC-49 channels from C. elegans muscle cultured cells of the first larval stage at the electrophysiological and behavioral levels. Whole-cell recordings reveal that GABA, muscimol and the anthelmintic piperazine elicit macroscopic currents from UNC-49 receptors that decay in their sustained presence, indicating full desensitization. Single-channel recordings show that all drugs elicit openings of similar to 2.5 pA (+100 mV), which appear either as brief isolated events or in short bursts. The comparison of the lowest concentration required for detectable channel opening, the frequency of openings and the amplitude of macroscopic currents suggest that piperazine is the least efficacious of the three drugs. Macroscopic and single-channel GABA-activated currents are profoundly and apparently irreversibly inhibited by ivermectin. To gain further insight into ivermectin action at C. elegans muscle, we analyzed its effect on single-channel activity of the levamisol-sensitive nicotinic receptor (L-AChR), the excitatory receptor involved in neuromuscular transmission. Ivermectin produces a profound inhibition of the frequency of channel opening without significant changes in channel properties. By revealing that ivermectin inhibits C. elegans muscle GABA and L-AChR receptors, our study adds two receptors to the already known ivermectin targets, thus contributing to the elucidation of its pleiotropic effects. Behavioral assays in worms show that ivermectin potentiates piperazine-induced paralysis, thus suggesting that their combination is a good strategy to overcome the increasing resistance of parasites, an issue of global concern for human and animal health.	[Hernando, Guillermina; Bouzat, Cecilia] Univ Nacl Sur, Inst Invest Bioquim Bahia Blanca, Consejo Nacl Invest Cient & Tecn, RA-8000 Bahia Blanca, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South	Bouzat, C (corresponding author), Univ Nacl Sur, Inst Invest Bioquim Bahia Blanca, Consejo Nacl Invest Cient & Tecn, RA-8000 Bahia Blanca, Buenos Aires, Argentina.	inbouzat@criba.edu.ar		Hernando, Guillermina/0000-0002-8411-5467	Universidad Nacional del Sur (UNS); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina	Universidad Nacional del Sur (UNS); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work has been supported by grants from the Universidad Nacional del Sur (UNS), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT), and Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) from Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi YA, 1995, HDB DRUGS TROPICAL P; Accardi MV, 2012, INVERTEBR NEUROSCI, V12, P3, DOI 10.1007/s10158-012-0129-6; Akk G, 2011, ANESTHESIOLOGY, V115, P1338, DOI 10.1097/ALN.0b013e3182315d93; Almedom RB, 2009, EMBO J, V28, P2636, DOI 10.1038/emboj.2009.204; Andersen N, 2011, J NEUROSCI, V31, P3662, DOI 10.1523/JNEUROSCI.5940-10.2011; Bamber BA, 1999, J NEUROSCI, V19, P5348; Bamber BA, 2005, BRIT J PHARMACOL, V144, P502, DOI 10.1038/sj.bjp.0706052; Bamber BA, 2003, BRIT J PHARMACOL, V138, P883, DOI 10.1038/sj.bjp.0705119; Bartos M, 2009, MOL NEUROBIOL, V40, P236, DOI 10.1007/s12035-009-8084-x; Bouzat C, 2012, J PHYSIOL-PARIS, V106, P23, DOI 10.1016/j.jphysparis.2011.09.012; Brown DDR, 2012, VET PARASITOL, V185, P201, DOI 10.1016/j.vetpar.2011.10.006; Brown KR, 2000, PARASITOLOGY, V121, pS133, DOI 10.1017/S0031182000006570; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Collins T, 2010, MOL PHARMACOL, V78, P198, DOI 10.1124/mol.110.064295; COSTA JL, 1994, LANCET, V343, P739, DOI 10.1016/S0140-6736(94)91625-X; Dadarkar SS, 2007, REGUL TOXICOL PHARM, V47, P257, DOI 10.1016/j.yrtph.2006.10.009; Dent JA, 2000, P NATL ACAD SCI USA, V97, P2674, DOI 10.1073/pnas.97.6.2674; Faghih Ramin, 2007, Recent Pat CNS Drug Discov, V2, P99; Gally C, 2003, J NEUROSCI, V23, P2591; Geary TG, 2005, TRENDS PARASITOL, V21, P530, DOI 10.1016/j.pt.2005.08.014; GEARY TG, 1993, EXP PARASITOL, V77, P88, DOI 10.1006/expr.1993.1064; Geary TG, 2012, CURR PHARM BIOTECHNO, V13, P866; Geary TG, 2012, TRENDS PARASITOL, V28, P176, DOI 10.1016/j.pt.2012.02.006; Glendinning SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022390; Hernando G, 2012, MOL PHARMACOL, V82, P550, DOI 10.1124/mol.112.079962; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Holden-Dye L, 2007, ANTHELMINTIC DRUGS; HOLDENDYE L, 1989, BRIT J PHARMACOL, V98, P841, DOI 10.1111/j.1476-5381.1989.tb14613.x; HOLDENDYE L, 1990, PARASITOLOGY, V101, P265, DOI 10.1017/S0031182000063320; Jones AK, 2011, J BIOL CHEM, V286, P2550, DOI 10.1074/jbc.M110.177238; KASS IS, 1984, MOL BIOCHEM PARASIT, V13, P213, DOI 10.1016/0166-6851(84)90114-2; KASS IS, 1980, P NATL ACAD SCI-BIOL, V77, P6211, DOI 10.1073/pnas.77.10.6211; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Lloberas M, 2012, EXP PARASITOL, V131, P304, DOI 10.1016/j.exppara.2012.04.014; Lynagh T, 2012, TRENDS PHARMACOL SCI, V33, P432, DOI 10.1016/j.tips.2012.05.002; Lynagh T, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00060; Lynagh T, 2011, J BIOL CHEM, V286, P43913, DOI 10.1074/jbc.M111.262634; Martin RJ, 1996, PARASITOLOGY, V112, P247, DOI 10.1017/S0031182000084833; MARTIN RJ, 1985, BRIT J PHARMACOL, V84, P445, DOI 10.1111/j.1476-5381.1985.tb12929.x; MARTIN RJ, 1982, BRIT J PHARMACOL, V77, P255, DOI 10.1111/j.1476-5381.1982.tb09294.x; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Menez C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001883; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Miltsch SM, 2013, PARASITOL INT, V62, P591, DOI 10.1016/j.parint.2013.05.006; Perez R, 2002, VET J, V163, P161, DOI 10.1053/tvjl.2001.0624; Petzold BC, 2011, BIOPHYS J, V100, P1977, DOI 10.1016/j.bpj.2011.02.035; Rayes D, 2005, MOL PHARMACOL, V68, P1475, DOI 10.1124/mol.105.015438; Rayes D, 2007, MOL PHARMACOL, V71, P1407, DOI 10.1124/mol.106.033514; Raymond V, 2000, NEUROSCIENCE, V101, P785, DOI 10.1016/S0306-4522(00)00279-7; Sancar F, 2011, NEUROPHARMACOLOGY, V60, P520, DOI 10.1016/j.neuropharm.2010.11.009; Sattelle DB, 2009, BIOCHEM PHARMACOL, V78, P836, DOI 10.1016/j.bcp.2009.06.020; Schuske K, 2004, TRENDS NEUROSCI, V27, P407, DOI 10.1016/j.tins.2004.05.005; Siddiqui SZ, 2010, J NEUROCHEM, V113, P1113, DOI 10.1111/j.1471-4159.2010.06651.x; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Wang Q, 2012, INT J BIOCHEM CELL B, V44, P335, DOI 10.1016/j.biocel.2011.11.005; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Williamson Sally M., 2007, Invertebrate Neuroscience, V7, P219, DOI 10.1007/s10158-007-0056-0	58	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95072	10.1371/journal.pone.0095072	http://dx.doi.org/10.1371/journal.pone.0095072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743647	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100065
J	Jung, CJ; Hur, YY; Yu, HJ; Noh, JH; Park, KS; Lee, HJ				Jung, Chan Jin; Hur, Youn Young; Yu, Hee-Ju; Noh, Jung-Ho; Park, Kyo-Sun; Lee, Hee Jae			Gibberellin Application at Pre- Bloom in Grapevines Down-Regulates the Expressions of VvIAA9 and VvARF7, Negative Regulators of Fruit Set Initiation, during Parthenocarpic Fruit Development	PLOS ONE			English	Article							AUXIN RESPONSE; SIGNALING PATHWAY; CELL-DIVISION; TOMATO; ARABIDOPSIS; GROWTH; GENES; BIOSYNTHESIS; POLLINATION; SIZE	Fruit set is initiated only after fertilization and is tightly regulated primarily by gibberellins (GAs) and auxins. The application of either of these hormones induces parthenocarpy, fruit set without fertilization, but the molecular mechanism underlying this induction is poorly understood. In the present study, we have shown that the parthenocarpic fruits induced by GA application at pre-bloom result from the interaction of GA with auxin signaling. The transcriptional levels of the putative negative regulators of fruit set initiation, including Vitis auxin/indole-3-acetic acid transcription factor 9 (VvIAA9), Vitis auxin response factor 7 (VvARF7), and VvARF8 were monitored during inflorescence development in seeded diploid 'Tamnara' grapevines with or without GA application. Without GA application, VvIAA9, VvARF7, and VvARF8 were expressed at a relatively high level before full bloom, but decreased thereafter following pollination. After GA application at 14 days before full bloom (DBF); however, the expression levels of VvIAA9 and VvARF7 declined at 5 DBF prior to pollination. The effects of GA application on auxin levels or auxin signaling were also analyzed by monitoring the expression patterns of auxin biosynthesis genes and auxin-responsive genes with or without GA application. Transcription levels of the auxin biosynthesis genes Vitis anthranilate synthase beta subunit (VvASB1-like), Vitis YUCCA2 (VvYUC2), and VvYUC6 were not significantly changed by GA application. However, the expressions of Vitis Gretchen Hagen3.2 (VvGH3.2) and VvGH3.3, auxin-responsive genes, were up-regulated from 2 DBF to full bloom with GA application. Furthermore, the Vitis GA signaling gene, VvDELLA was up-regulated by GA application during 12 DBF to 7 DBF, prior to down-regulation of VvIAA9 and VvARF7. These results suggest that VvIAA9 and VvARF7 are negative regulators of fruit set initiation in grapevines, and GA signaling is integrated with auxin signaling via VvDELLA during parthenocarpic fruit development in grapevines.	[Jung, Chan Jin; Hur, Youn Young; Noh, Jung-Ho; Park, Kyo-Sun] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Fruit Res Div, Suwon, South Korea; [Hur, Youn Young; Lee, Hee Jae] Seoul Natl Univ, Dept Plant Sci, Seoul, South Korea; [Yu, Hee-Ju] Catholic Univ Korea, Dept Life Sci, Puchon, South Korea; [Lee, Hee Jae] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU); Catholic University of Korea; Seoul National University (SNU)	Lee, HJ (corresponding author), Seoul Natl Univ, Dept Plant Sci, Seoul, South Korea.	heejlee@snu.ac.kr	Yu, Hee-Ju/AEX-0574-2022		Next-Generation BioGreen 21 Program [PJ008213]; Rural Development Administration, Suwon, Republic of Korea	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Suwon, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (PJ008213), Rural Development Administration, Suwon, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassel GW, 2004, PLANT PHYSIOL, V136, P2782, DOI 10.1104/pp.103.034876; Bottcher C, 2011, J EXP BOT, V62, P4267, DOI 10.1093/jxb/err134; Boss PK, 2002, NATURE, V416, P847, DOI 10.1038/416847a; Cakir B, 2013, ACTA PHYSIOL PLANT, V35, P365, DOI 10.1007/s11738-012-1079-7; Carrera E, 2012, PLANT PHYSIOL, V160, P1581, DOI 10.1104/pp.112.204552; Casanova L, 2009, SPAN J AGRIC RES, V7, P919, DOI 10.5424/sjar/2009074-1105; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Coombe B. G., 1995, Australian Journal of Grape and Wine Research, V1, P104, DOI 10.1111/j.1755-0238.1995.tb00086.x; COOMBE BG, 1960, PLANT PHYSIOL, V35, P241, DOI 10.1104/pp.35.2.241; Dauelsberg P, 2011, J PLANT PHYSIOL, V168, P1667, DOI 10.1016/j.jplph.2011.03.006; de Jong M, 2009, PLANT J, V57, P160, DOI 10.1111/j.1365-313X.2008.03671.x; de Jong M, 2011, J EXP BOT, V62, P617, DOI 10.1093/jxb/erq293; de Jong M, 2009, J EXP BOT, V60, P1523, DOI 10.1093/jxb/erp094; Dokoozlian NK, 2001, HORTSCIENCE, V36, P706, DOI 10.21273/HORTSCI.36.4.706; Dorcey E, 2009, PLANT J, V58, P318, DOI 10.1111/j.1365-313X.2008.03781.x; Exposito-Rodriguez M, 2011, PLANT PHYSIOL BIOCH, V49, P782, DOI 10.1016/j.plaphy.2011.02.022; Finet C, 2010, PLANT J, V63, P952, DOI 10.1111/j.1365-313X.2010.04292.x; Fos M, 2000, PLANT PHYSIOL, V122, P471, DOI 10.1104/pp.122.2.471; Fos M, 2001, PHYSIOL PLANTARUM, V111, P545, DOI 10.1034/j.1399-3054.2001.1110416.x; Fuentes S, 2012, PLANT CELL, V24, P3982, DOI 10.1105/tpc.112.103192; Fujita K, 2012, MOL BIOL REP, V39, P7823, DOI 10.1007/s11033-012-1625-9; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Goetz M, 2007, PLANT PHYSIOL, V145, P351, DOI 10.1104/pp.107.104174; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Gustafson FG, 1936, P NATL ACAD SCI USA, V22, P628, DOI 10.1073/pnas.22.11.628; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Itoh H, 2002, PLANT CELL, V14, P57, DOI 10.1105/tpc.010319; IWAHORI S, 1968, PLANT PHYSIOL, V43, P333, DOI 10.1104/pp.43.3.333; Jung CJ, 2014, J PLANT RES, V127, P359, DOI 10.1007/s10265-013-0623-x; Kim JI, 2011, J EXP BOT, V62, P3981, DOI 10.1093/jxb/err094; Kuhn N, 2012, PLANT SIGNAL BEHAV, V7, P7, DOI 10.4161/psb.7.1.18353; Kumar R, 2012, MOL GENET GENOMICS, V287, P221, DOI 10.1007/s00438-011-0672-6; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li JS, 2006, PLANT PHYSIOL, V140, P899, DOI 10.1104/pp.105.070987; Lu J, 1997, HORTSCIENCE, V32, P89, DOI 10.21273/HORTSCI.32.1.89; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; Marti C, 2007, PLANT J, V52, P865, DOI 10.1111/j.1365-313X.2007.03282.x; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Nakazawa M, 2001, PLANT J, V25, P213, DOI 10.1046/j.1365-313x.2001.00957.x; Okamoto G, 2005, VITIS, V44, P157; Olimpieri I, 2007, PLANTA, V226, P877, DOI 10.1007/s00425-007-0533-z; Ozga JA, 2003, J PLANT GROWTH REGUL, V22, P73, DOI 10.1007/s00344-003-0024-9; Park KyoSun, 2004, Korean Journal of Horticultural Science & Technology, V22, P458; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Schwabe W. W., 1981, Horticultural Abstracts, V51, P661; Serrani JC, 2008, PLANT J, V56, P922, DOI 10.1111/j.1365-313X.2008.03654.x; Sheerin DJ, 2011, BIOCHEM J, V435, P629, DOI 10.1042/BJ20101941; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Stepanova AN, 2005, PLANT CELL, V17, P2230, DOI 10.1105/tpc.105.033365; Sun Tai-Ping, 2008, Arabidopsis Book, V6, pe0103, DOI 10.1199/tab.0103; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vivian-Smith A, 1999, PLANT PHYSIOL, V121, P437, DOI 10.1104/pp.121.2.437; Wang H, 2005, PLANT CELL, V17, P2676, DOI 10.1105/tpc.105.033415; WANG J, 1993, J JPN SOC HORTIC SCI, V62, P9, DOI 10.2503/jjshs.62.9; WITTWER SH, 1957, PLANT PHYSIOL, V32, P39, DOI 10.1104/pp.32.1.39; Wu J, 2012, MOL GENET GENOMICS, V287, P295, DOI 10.1007/s00438-012-0675-y; Zhong GY, 2012, TRANSGENIC RES, V21, P725, DOI 10.1007/s11248-011-9565-z	63	26	31	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95634	10.1371/journal.pone.0095634	http://dx.doi.org/10.1371/journal.pone.0095634			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743886	gold, Green Submitted, Green Published			2022-12-25	WOS:000335309100149
J	Kaisaki, PJ; Otto, GW; McGouran, JF; Toubal, A; Argoud, K; Waller-Evans, H; Finlay, C; Calderari, S; Bihoreau, MT; Kessler, BM; Gauguier, D; Mott, R				Kaisaki, Pamela J.; Otto, Georg W.; McGouran, Joanna F.; Toubal, Amine; Argoud, Karene; Waller-Evans, Helen; Finlay, Clare; Calderari, Sophie; Bihoreau, Marie-Therese; Kessler, Benedikt M.; Gauguier, Dominique; Mott, Richard			Genetic Control of Differential Acetylation in Diabetic Rats	PLOS ONE			English	Article							LIVER-MITOCHONDRIA; RODENT MODEL; SIRT3; STRESS; DEACETYLASE; ACETYLOME; LONGEVITY; INSIGHTS	Post-translational protein modifications such as acetylation have significant regulatory roles in metabolic processes, but their relationship to both variation in gene expression and DNA sequence is unclear. We address this question in the Goto-Kakizaki (GK) rat inbred strain, a model of polygenic type 2 diabetes. Expression of the NAD-dependent deacetylase Sirtuin-3 is down-regulated in GK rats compared to normoglycemic Brown Norway (BN) rats. We show first that a promoter SNP causes down-regulation of Sirtuin-3 expression in GK rats. We then use mass-spectrometry to identify proteome-wide differential lysine acetylation of putative Sirtuin-3 protein targets in livers of GK and BN rats. These include many proteins in pathways connected to diabetes and metabolic syndrome. We finally sequence GK and BN liver transcriptomes and find that mRNA expression of these targets does not differ significantly between GK and BN rats, in contrast to other components of the same pathways. We conclude that physiological differences between GK and BN rats are mediated by a combination of differential protein acetylation and gene transcription and that genetic variation can modulate acetylation independently of expression.	[Kaisaki, Pamela J.; Otto, Georg W.; Argoud, Karene; Waller-Evans, Helen; Finlay, Clare; Mott, Richard] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [McGouran, Joanna F.; Kessler, Benedikt M.] Univ Oxford, Nuffield Dept Med, Target Discovery Inst, Oxford, England; [Toubal, Amine; Calderari, Sophie; Gauguier, Dominique] INSERM, Cordeliers Res Ctr, U872, Paris, France; [Toubal, Amine; Calderari, Sophie; Gauguier, Dominique] Univ Paris 06, ICAN, Pitie Salpetriere Hosp, Inst Cardiometab & Nutr, Paris, France; [Bihoreau, Marie-Therese] Natl Genotyping Ctr, Evry, France	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Mott, R (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	richard.mott@well.ox.ac.uk	Kessler, Benedikt/AAY-8614-2021; Gauguier, Dominique/G-2190-2016; McGouran, Joanna/A-1545-2019	Kessler, Benedikt/0000-0002-8160-2446; Gauguier, Dominique/0000-0001-6156-9530; McGouran, Joanna/0000-0002-9349-2141; Mott, Richard/0000-0002-1022-9330; Otto, Georg W/0000-0002-3929-948X; Calderari, Sophie/0000-0002-9669-681X; Waller-Evans, Helen/0000-0003-4133-6064	Wellcome Trust [083573/Z/07/Z, 057733, 075491/Z/04, 090532/Z/09/Z]; MRC Hub grant [G0900747 91070]; European Community [HEALTH-F4-2010-241504]; Agence Nationale pour la Recherche [ANR-08-GENOPAT-030]; Fondation pour la Recherche Medicale (FRM) [INE20091217993]; Institute of Cardiometabolism and Nutrition (ICAN) [ANR-10-IAHU-05]; Biomedical Research Centre (NIHR) Oxford; John Fell OUP award	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Hub grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institute of Cardiometabolism and Nutrition (ICAN); Biomedical Research Centre (NIHR) Oxford(National Institute for Health Research (NIHR)); John Fell OUP award	This work was supported by a Wellcome Trust grant to RM (083573/Z/07/Z), a Wellcome Trust Senior Fellowship in Basic Biomedical Science (057733) to DG, a Wellcome Trust Core Award Grant (075491/Z/04), Wellcome Trust grant reference 090532/Z/09/Z, MRC Hub grant G0900747 91070, a grant from the European Community's Seventh Framework Programmes under the grant agreement HEALTH-F4-2010-241504 (EURATRANS), the Agence Nationale pour la Recherche (ANR-08-GENOPAT-030), the Fondation pour la Recherche Medicale (FRM, INE20091217993) and the Institute of Cardiometabolism and Nutrition (ICAN, ANR-10-IAHU-05). BMK is supported by the Biomedical Research Centre (NIHR) Oxford and a John Fell OUP award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Argoud K, 2006, DIABETOLOGIA, V49, P2679, DOI 10.1007/s00125-006-0396-z; Bellizzi D, 2007, GENOMICS, V89, P143, DOI 10.1016/j.ygeno.2006.09.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Braganca J, 2002, J BIOL CHEM, V277, P8559, DOI 10.1074/jbc.M110850200; Chen D, 2011, J BIOL CHEM, V286, P13261, DOI 10.1074/jbc.M110.206771; Cheng ZJ, 2001, HYPERTENSION, V37, P433, DOI 10.1161/01.HYP.37.2.433; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; Collins SC, 2003, MAMM GENOME, V14, P350, DOI 10.1007/s00335-002-3058-6; Deng WJ, 2010, MOL CELL PROTEOMICS, V9, P100, DOI 10.1074/mcp.M900020-MCP200; Ferreira FML, 1999, METABOLISM, V48, P1115, DOI 10.1016/S0026-0495(99)90124-5; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Fischer R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013904; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GILAD GM, 1990, INT J DEV NEUROSCI, V8, P709, DOI 10.1016/0736-5748(90)90064-9; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Jorgensen W, 2012, AM J PHYSIOL-ENDOC M, V303, pE515, DOI 10.1152/ajpendo.00103.2012; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lombard DB, 2011, NATURE, V477, P410, DOI 10.1038/477410a; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Marion E, 2002, DIABETES, V51, P2012, DOI 10.2337/diabetes.51.7.2012; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; ORourke CM, 1997, METABOLISM, V46, P192, DOI 10.1016/S0026-0495(97)90301-2; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Strachan T, 2011, HUMAN MOLECULAR GENETICS 4TH EDITION, P1; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wallis RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002962; Wilder SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-63; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yang L, 2011, J PROTEOME RES, V10, P4134, DOI 10.1021/pr200313x; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	43	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94555	10.1371/journal.pone.0094555	http://dx.doi.org/10.1371/journal.pone.0094555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743600	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000335309100034
J	Kim, HR; Lee, A; Choi, EJ; Kie, JH; Lim, W; Lee, HK; Moon, BI; Seoh, JY				Kim, Hyung-Ran; Lee, Anbok; Choi, Eun-Jeong; Kie, Jeong-Hae; Lim, Woosung; Lee, Hyeon Kook; Moon, Byung-In; Seoh, Ju-Young			Attenuation of Experimental Colitis in Glutathione Peroxidase 1 and Catalase Double Knockout Mice through Enhancing Regulatory T Cell Function	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; OXIDATIVE-STRESS; INDOLEAMINE 2,3-DIOXYGENASE; ARTHRITIS; MACROPHAGES; SUPPRESSION; DEFICIENCY; EXPRESSION; ANTIGEN; INJURY	Reactive oxygen species (ROS) have been implicated in the progression of inflammatory diseases including inflammatory bowel diseases (IBD). Meanwhile, several studies suggested the protective role of ROS in immune-mediated inflammatory diseases, and it was recently reported that dextran sodium sulfate (DSS)-induced colitis was attenuated in mice with an elevated level of ROS due to deficiency of peroxiredoxin II. Regulatory T cells (Tregs) are critical in the prevention of IBD and Treg function was reported to be closely associated with ROS level, but it has been investigated only in lowered levels of ROS so far. In the present study, in order to clarify the relationship between ROS level and Treg function, and their role in the pathogenesis of IBD, we investigated mice with an elevated level of ROS due to deficiency of both glutathione peroxidase (GPx)-1 and catalase (Cat) for the susceptibility of DSS-induced colitis in association with Treg function. The results showed that DSS-induced colitis was attenuated and Tregs were hyperfunctional in GPx1(-/-) x Cat(-/-) mice. In vivo administration of N-acetylcysteine (NAC) aggravated DSS-induced colitis and decreased Treg function to the level comparable to WT mice. Attenuated Th-17 cell differentiation from naive CD4(+) cells as well as impaired production of IL-6 and IL-17A by splenocytes upon stimulation suggested anti-inflammatory tendency of GPx1(-/-) x Cat(-/-) mice. Suppression of Stat3 activation in association with enhancement of indoleamine 2,3-dioxygenase and FoxP3 expression might be involved in the immunosuppressive mechanism of GPx1(-/-) x Cat(-/-) mice. Taken together, it is implied that ROS level is critical in the regulation of Treg function, and IBD may be attenuated in appropriately elevated levels of ROS.	[Kim, Hyung-Ran; Choi, Eun-Jeong; Seoh, Ju-Young] Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea; [Lee, Anbok; Lim, Woosung; Lee, Hyeon Kook; Moon, Byung-In] Natl Hlth Insurance Cooperat Ilsan Hosp, Dept Pathol, Koyang, South Korea; [Kie, Jeong-Hae] Ewha Womans Univ, Grad Sch Med, Dept Surg, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Moon, BI (corresponding author), Natl Hlth Insurance Cooperat Ilsan Hosp, Dept Pathol, Koyang, South Korea.	mbit@ewha.ac.kr; jyseoh@ewha.ac.kr		Kie, Jeong Hae/0000-0003-1782-5650; SEOH, JU-YOUNG/0000-0002-1168-5354	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI12C0050]; RP-Grant of Ewha Womans University	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; RP-Grant of Ewha Womans University	This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI12C0050) (http://www.khidi.or.kr/www/run.do) and RP-Grant 2011 of Ewha Womans University (http://www.ewha.ac.kr/mbs/ewhaen/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrouche-Mekkioui I, 2012, EUR J PHARMACOL, V691, P209, DOI 10.1016/j.ejphar.2012.06.014; Boehm F, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-97; Cale CM, 2007, CLIN EXP IMMUNOL, V148, P79, DOI 10.1111/j.1365-2249.2007.03321.x; Cemerski S, 2003, EUR J IMMUNOL, V33, P2178, DOI 10.1002/eji.200323898; Chen AF, 2012, CLIN SCI, V123, P73, DOI 10.1042/CS20110562; de Haan JB, 2006, J LIPID RES, V47, P1157, DOI 10.1194/jlr.M500377-JLR200; De Ravin SS, 2008, J ALLERGY CLIN IMMUN, V122, P1097, DOI 10.1016/j.jaci.2008.07.050; Efimova O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016013; Esworthy RS, 2001, AM J PHYSIOL-GASTR L, V281, pG848, DOI 10.1152/ajpgi.2001.281.3.G848; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Ho YS, 1997, J BIOL CHEM, V272, P16644, DOI 10.1074/jbc.272.26.16644; Hultqvist M, 2004, P NATL ACAD SCI USA, V101, P12646, DOI 10.1073/pnas.0403831101; Hultqvist M, 2009, TRENDS IMMUNOL, V30, P201, DOI 10.1016/j.it.2009.03.004; Jang MH, 2011, REGULATORY T CELLS, P201; Jung YJ, 2009, IMMUNOBIOLOGY, V214, P291, DOI 10.1016/j.imbio.2008.09.004; Kahles T, 2012, CELL MOL LIFE SCI, V69, P2345, DOI 10.1007/s00018-012-1011-8; Kapp JA, 2007, J IMMUNOL, V179, P2105, DOI 10.4049/jimmunol.179.4.2105; Kim HR, 2013, IMMUNOLOGY, V138, P57, DOI 10.1111/imm.12017; Kim HR, 2012, RHEUMATOLOGY, V51, P1357, DOI 10.1093/rheumatology/kes058; Kim HR, 2012, NEUROIMMUNOMODULAT, V19, P187, DOI 10.1159/000331586; Kim SJ, 2009, J HEPATOL, V50, P1184, DOI 10.1016/j.jhep.2009.01.030; Kraaij MD, 2010, P NATL ACAD SCI USA, V107, P17686, DOI 10.1073/pnas.1012016107; Lee K, 2011, P NATL ACAD SCI USA, V108, P9548, DOI 10.1073/pnas.1012645108; Martin F, 2010, ONCOGENE, V29, P4121, DOI 10.1038/onc.2010.174; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Ogasawara N, 2009, J CELL BIOCHEM, V108, P716, DOI 10.1002/jcb.22308; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Otsuji M, 1996, P NATL ACAD SCI USA, V93, P13119, DOI 10.1073/pnas.93.23.13119; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Si CL, 2013, FOOD CHEM TOXICOL, V59, P145, DOI 10.1016/j.fct.2013.05.051; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Thomas SR, 1999, REDOX REP, V4, P199, DOI 10.1179/135100099101534927; van Horssen J, 2011, BBA-MOL BASIS DIS, V1812, P141, DOI 10.1016/j.bbadis.2010.06.011; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Won HY, 2013, J IMMUNOL, V191, P4029, DOI 10.4049/jimmunol.1203247; Won Hee Yeon, 2011, Immune Netw, V11, P169, DOI 10.4110/in.2011.11.3.169; Won HY, 2010, ANTIOXID REDOX SIGN, V13, P575, DOI 10.1089/ars.2009.2989; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132; Zhu H, 2012, EXP BIOL MED, V237, P474, DOI 10.1258/ebm.2011.011358	40	15	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95332	10.1371/journal.pone.0095332	http://dx.doi.org/10.1371/journal.pone.0095332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743300	gold, Green Submitted, Green Published			2022-12-25	WOS:000335309100105
J	Bartolak-Suki, E; LaPrad, AS; Harvey, BC; Suki, B; Lutchen, KR				Bartolak-Suki, Erzsebet; LaPrad, Adam S.; Harvey, Brian C.; Suki, Bela; Lutchen, Kenneth R.			Tidal Stretches Differently Regulate the Contractile and Cytoskeletal Elements in Intact Airways	PLOS ONE			English	Article							SMOOTH-MUSCLE CONTRACTION; MICROTUBULE DISRUPTION; EXTRACELLULAR-MATRIX; DEEP INSPIRATION; LIGHT-CHAIN; IN-VITRO; ASTHMA; HYPERRESPONSIVENESS; MYOSIN; CELLS	Recent reports suggest that tidal stretches do not cause significant and sustainable dilation of constricted intact airways ex vivo. To better understand the underlying mechanisms, we aimed to map the physiological stretch-induced molecular changes related to cytoskeletal (CSK) structure and contractile force generation through integrin receptors. Using ultrasound, we measured airway constriction in isolated intact airways during 90 minutes of static transmural pressure (Ptm) of 7.5 cmH(2)O or dynamic variations between Ptm of 5 and 10 cmH(2)0 mimicking breathing. Integrin and focal adhesion kinase activity increased during Ptm oscillations which was further amplified during constriction. While Ptm oscillations reduced beta-actin and F-actin formation implying lower CSK stiffness, it did not affect tubulin. However, constriction was amplified when the microtubule structure was disassembled. Without constriction, alpha-smooth muscle actin (ASMA) level was higher and smooth muscle myosin heavy chain 2 was lower during Ptm oscillations. Alternatively, during constriction, overall molecular motor activity was enhanced by Ptm oscillations, but ASMA level became lower. Thus, ASMA and motor protein levels change in opposite directions due to stretch and contraction maintaining similar airway constriction levels during static and dynamic Ptm. We conclude that physiological Ptm variations affect cellular processes in intact airways with constriction determined by the balance among contractile and CSK molecules and structure.	[Bartolak-Suki, Erzsebet; LaPrad, Adam S.; Harvey, Brian C.; Suki, Bela; Lutchen, Kenneth R.] Boston Univ, Boston, MA 02215 USA	Boston University	Bartolak-Suki, E (corresponding author), Boston Univ, Boston, MA 02215 USA.	ebartola22@gmail.com			NIH [HL-096797, HL-098976]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098976, R01HL096797] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants NIH HL-096797 and NIH HL-098976. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; An SS, 2006, AM J RESP CELL MOL, V35, P55, DOI 10.1165/rcmb.2005-0453OC; Ansell TK, 2013, J APPL PHYSIOL, V115, P505, DOI 10.1152/japplphysiol.01286.2012; Bates Jason H. T., 2011, Critical Reviews in Biomedical Engineering, V39, P281, DOI 10.1615/CritRevBiomedEng.v39.i4.30; Brown R, 2001, J APPL PHYSIOL, V91, P1995, DOI 10.1152/jappl.2001.91.5.1995; Busk M, 2013, EUR RESPIR J, V41, P317, DOI 10.1183/09031936.00059712; Chen CM, 2012, J ELECTRON MATER, V41, P1, DOI 10.1007/s11664-011-1777-8; Clarke D, 2009, PULM PHARMACOL THER, V22, P436, DOI 10.1016/j.pupt.2009.04.003; Desai LP, 2011, AM J PHYSIOL-LUNG C, V301, pL275, DOI 10.1152/ajplung.00043.2011; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; Eldib M, 2011, BIOTECHNOL BIOENG, V108, P446, DOI 10.1002/bit.22941; Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016; Fredberg JJ, 1996, J APPL PHYSIOL, V81, P2703, DOI 10.1152/jappl.1996.81.6.2703; Harvey BC, 2013, J APPL PHYSL; Horowitz A, 1996, PHYSIOL REV, V76, P967, DOI 10.1152/physrev.1996.76.4.967; HORSFIEL.K, 1971, J APPL PHYSIOL, V31, P207, DOI 10.1152/jappl.1971.31.2.207; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Khangure SR, 2004, J APPL PHYSIOL, V97, P913, DOI 10.1152/japplphysiol.00262.2004; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; Krishnan R, 2008, RESP PHYSIOL NEUROBI, V163, P17, DOI 10.1016/j.resp.2008.04.006; Laprad AS, 2010, J APPL PHYSL; Latourelle J, 2002, J APPL PHYSIOL, V92, P771, DOI 10.1152/japplphysiol.01090.2000; Lavoie TL, 2012, AM J RESP CRIT CARE, V186, P225, DOI 10.1164/rccm.201202-0368OC; Lei M, 1997, J APPL PHYSIOL, V82, P70, DOI 10.1152/jappl.1997.82.1.70; Meurs H, 2008, EUR RESPIR J, V32, P487, DOI 10.1183/09031936.00023608; Naghshin J, 2003, J APPL PHYSIOL, V95, P448, DOI 10.1152/japplphysiol.01180.2002; Nguyen TTB, 2005, AM J RESP CRIT CARE, V171, P217, DOI 10.1164/rccm.200408-1046OC; Noble PB, 2011, J APPL PHYSIOL, V110, P1510, DOI 10.1152/japplphysiol.01226.2010; Oliver MN, 2007, AM J RESP CELL MOL, V37, P264, DOI 10.1165/rcmb.2006-0418OC; Paul RJ, 2000, AM J PHYSIOL-HEART C, V279, pH2493, DOI 10.1152/ajpheart.2000.279.5.H2493; Pepe C, 2005, J ALLERGY CLIN IMMUN, V116, P544, DOI 10.1016/j.jaci.2005.06.011; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; Shen X, 1997, J APPL PHYSIOL, V83, P1202, DOI 10.1152/jappl.1997.83.4.1202; Sieck GC, 2001, J APPL PHYSIOL, V91, P2266, DOI 10.1152/jappl.2001.91.5.2266; SKLOOT G, 1995, J CLIN INVEST, V96, P2393, DOI 10.1172/JCI118296; Slats AM, 2008, J ALLERGY CLIN IMMUN, V121, P1196, DOI 10.1016/j.jaci.2008.02.017; Stamenovic D, 1999, J THEOR BIOL, V201, P63, DOI 10.1006/jtbi.1999.1014; Stamenovic D, 2008, RESP PHYSIOL NEUROBI, V163, P25, DOI 10.1016/j.resp.2008.02.009; TEPPER RS, 1995, J APPL PHYSIOL, V79, P1190, DOI 10.1152/jappl.1995.79.4.1190; Trepat X, 2007, NATURE, V447, P592, DOI 10.1038/nature05824; Van Citters KM, 2006, BIOPHYS J, V91, P3946, DOI 10.1529/biophysj.106.091264; Wang L, 2000, J APPL PHYSIOL, V88, P2246, DOI 10.1152/jappl.2000.88.6.2246; Yick CY, 2012, ALLERGY, V67, P552, DOI 10.1111/j.1398-9995.2011.02773.x; Zhang Wenwu, 2008, Proc Am Thorac Soc, V5, P32, DOI 10.1513/pats.200704-048VS	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94828	10.1371/journal.pone.0094828	http://dx.doi.org/10.1371/journal.pone.0094828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740101	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900072
J	Belikov, SI; Kondratov, IG; Potapova, UV; Leonova, GN				Belikov, Sergei I.; Kondratov, Ilya G.; Potapova, Ulyana V.; Leonova, Galina N.			The Relationship between the Structure of the Tick-Borne Encephalitis Virus Strains and Their Pathogenic Properties	PLOS ONE			English	Article							WEST-NILE-VIRUS; DEPENDENT RNA-POLYMERASE; NONSTRUCTURAL PROTEIN NS1; INFECTIOUS CDNA-CLONE; DENGUE VIRUS; CYCLIZATION SEQUENCES; FUNCTIONAL-ANALYSIS; 3-NONCODING REGION; NS2B-NS3 PROTEASE; CRYSTAL-STRUCTURE	Tick-borne encephalitis virus (TBEV) is transmitted to vertebrates by taiga or forest ticks through bites, inducing disease of variable severity. The reasons underlying these differences in the severity of the disease are unknown. In order to identify genetic factors affecting the pathogenicity of virus strains, we have sequenced and compared the complete genomes of 34 Far-Eastern subtype (FE) TBEV strains isolated from patients with different disease severity (Primorye, the Russian Far East). We analyzed the complete genomes of 11 human pathogenic strains isolated from the brains of dead patients with the encephalitic form of the disease (Efd), 4 strains from the blood of patients with the febrile form of TBE (Ffd), and 19 strains from patients with the subclinical form of TBE (Sfd). On the phylogenetic tree, pathogenic Efd strains formed two clusters containing the prototype strains, Senzhang and Sofjin, respectively. Sfd strains formed a third separate cluster, including the Oshima strain. The strains that caused the febrile form of the disease did not form a separate cluster. In the viral proteins, we found 198 positions with at least one amino acid residue substitution, of which only 17 amino acid residue substitutions were correlated with the variable pathogenicity of these strains in humans and they authentically differed between the groups. We considered the role of each amino acid substitution and assumed that the deletion of 111 amino acids in the capsid protein in combination with the amino acid substitutions R16K and S45F in the NS3 protease may affect the budding process of viral particles. These changes may be the major reason for the diminished pathogenicity of TBEV strains. We recommend Sfd strains for testing as attenuation vaccine candidates.	[Belikov, Sergei I.; Kondratov, Ilya G.; Potapova, Ulyana V.] Russian Acad Sci, Inst Limnol, Siberian Branch, Irkutsk 664003, Russia; [Leonova, Galina N.] Russian Acad Med Sci, Siberian Branch, Res Inst Epidemiol & Microbiol, Vladivostok, Russia	Irkutsk Science Centre of the Russian Academy of Sciences; Russian Academy of Sciences; Limnological Institute SB RAS; Irkutsk Science Centre of the Russian Academy of Sciences; Scientific Centre for Family Health & Human Reproduction Problems; Russian Academy of Medical Sciences	Belikov, SI (corresponding author), Russian Acad Sci, Inst Limnol, Siberian Branch, Irkutsk 664003, Russia.	sergeibelikov47@gmail.com	Belikov, Sergei I/L-3373-2013; Leonova, Galina/A-5194-2016; Leonova, Galina/J-6196-2018; Kondratov, Ilya/I-5859-2016	Belikov, Sergei I/0000-0001-7206-8299; Leonova, Galina/0000-0001-6387-1127	International Scientific Technical Center Project [4006]; Interdisciplinary Integration Projects of the Siberian Branch of the Russian Academy of Sciences [63, 141];  [P389]	International Scientific Technical Center Project; Interdisciplinary Integration Projects of the Siberian Branch of the Russian Academy of Sciences; 	This work was supported by International Scientific Technical Center Project No. 4006, Interdisciplinary Integration Projects of the Siberian Branch of the Russian Academy of Sciences No. 63 and 141 and State Contract No. P389. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lazikani B, 2001, CURR OPIN CHEM BIOL, V5, P51, DOI 10.1016/S1367-5931(00)00164-2; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994; Ambrose RL, 2011, J VIROL, V85, P11274, DOI 10.1128/JVI.05864-11; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; BAZAN JF, 1989, VIROLOGY, V171, P637, DOI 10.1016/0042-6822(89)90639-9; Belikov SI, 2010, RUSS J GENET+, V46, P315, DOI 10.1134/S1022795410030087; Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Broker Michael, 2003, Travel Med Infect Dis, V1, P181, DOI 10.1016/j.tmaid.2003.07.001; Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.x; CHU PWG, 1987, VIROLOGY, V157, P330, DOI 10.1016/0042-6822(87)90275-3; Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003; Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Durrant DM, 2011, CHEMOKINES VIRAL INF, DOI 10.5772/24720.; Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999; Goto A, 2003, VACCINE, V21, P4043, DOI 10.1016/S0264-410X(03)00269-X; Gritsun TS, 2007, VIROLOGY, V366, P8, DOI 10.1016/j.virol.2007.04.011; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Hayasaka D, 2004, J GEN VIROL, V85, P1007, DOI 10.1099/vir.0.19668-0; Hayasaka D, 2001, J GEN VIROL, V82, P1319, DOI 10.1099/0022-1317-82-6-1319; HEINZ FX, 2000, VIRUS TAXONOMY, P859; Holmes EC, 2003, J VIROL, V77, P11296, DOI 10.1128/JVI.77.20.11296-11298.2003; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KENYON RH, 1992, MICROB PATHOGENESIS, V13, P399, DOI 10.1016/0882-4010(92)90083-Z; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King A. M. Q, 2012, VIRUS TAXONOMY; Kofler RM, 2002, J VIROL, V76, P3534, DOI 10.1128/JVI.76.7.3534-3543.2002; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Labuda M, 1997, ACTA VIROL, V41, P325; Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09; Leonova G. N., 2007, Voprosy Virusologii, V52, P13; Leonova G.N, 2009, TICK BORNE ENCEPHALI; Leonova GN, 2013, VIROLOGY, V443, P89, DOI 10.1016/j.virol.2013.04.029; LEVENBOOK IS, 1987, J BIOL STAND, V15, P305, DOI 10.1016/S0092-1157(87)80003-3; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395; Lindenbach B.D., 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024; Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999; Lindenbach BD, 2007, FIELDS VIROLOGY, V1, P1101, DOI DOI 10.1016/0038-092X(88)90131-4; Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006; Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003; Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003; Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008; Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005; Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156; Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007; Mandl CW, 1998, J VIROL, V72, P2132, DOI 10.1128/JVI.72.3.2132-2140.1998; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; Mandl CW, 2000, J VIROL, V74, P9601, DOI 10.1128/JVI.74.20.9601-9609.2000; Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847; Melik W, 2007, ARCH VIROL, V152, P1027, DOI 10.1007/s00705-006-0922-9; Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200; MONATH TP, 1996, FIELDS VIROLOGY, P961; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676; Novella IS, 2011, J MOL MICROB BIOTECH, V21, P71, DOI 10.1159/000332752; Nuttall PA, 2003, ADV VIRUS RES, V60, P233, DOI 10.1016/S0065-3527(03)60007-2; Onishchenko G. G., 2007, Voprosy Virusologii, V52, P8; Park GS, 2007, J VIROL, V81, P6936, DOI 10.1128/JVI.02830-06; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550; PLETNEV AG, 1990, VIROLOGY, V174, P250, DOI 10.1016/0042-6822(90)90073-Z; Pletnev AG, 2001, VIROLOGY, V282, P288, DOI 10.1006/viro.2001.0846; Potapova UV, 2012, J BIOMOL STRUCT DYN, V30, P638, DOI 10.1080/07391102.2012.689697; Pripuzova NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061094; Randolph SE, 2011, TICKS TICK-BORNE DIS, V2, P179, DOI 10.1016/j.ttbdis.2011.07.004; Rauscher S, 1997, RNA, V3, P779; Robertson SJ, 2009, IMMUNOL RES, V43, P172, DOI 10.1007/s12026-008-8065-6; Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026; Rumyantsev AA, 2006, J VIROL, V80, P1427, DOI 10.1128/JVI.80.3.1427-1439.2006; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stocks CE, 1998, J VIROL, V72, P2141, DOI 10.1128/JVI.72.3.2141-2149.1998; Suss J, 2008, Euro Surveill, V13; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0; Votyakov VI, 2002, EURASIAN TICK BORNE; WALLNER G, 1995, VIROLOGY, V213, P169, DOI 10.1006/viro.1995.1557; WINKLER G, 1988, VIROLOGY, V162, P187, DOI 10.1016/0042-6822(88)90408-4; WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059; YAMSHCHIKOV VF, 1994, J VIROL, V68, P5765, DOI 10.1128/JVI.68.9.5765-5771.1994; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yoshii K, 2014, J VIROL; Zhang Y, 2012, VIRUS RES, V167, P310, DOI 10.1016/j.virusres.2012.05.015; Zilber L. A., 1939, ARCHIV BIOLOGICHESKIKH NATIK [ARCH SCI BIOL] [ LENINGRAD], V56, P9; Zlobin V. I., 2001, Voprosy Virusologii, V46, P12; Zlobin V. I., 2001, Voprosy Virusologii, V46, P17; Zlobin V. I., 2005, Voprosy Virusologii, V50, P26; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	109	37	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94946	10.1371/journal.pone.0094946	http://dx.doi.org/10.1371/journal.pone.0094946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740396	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900084
J	Gholami, M; Erbe, M; Garke, C; Preisinger, R; Weigend, A; Weigend, S; Simianer, H				Gholami, Mahmood; Erbe, Malena; Gaerke, Christian; Preisinger, Rudolf; Weigend, Annett; Weigend, Steffen; Simianer, Henner			Population Genomic Analyses Based on 1 Million SNPs in Commercial Egg Layers	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; PROTEIN 2 GENE; PRODUCTION TRAITS; POU1F1 GENE; IGF-I; CHICKEN; GROWTH; ASSOCIATION; SELECTION; EXPRESSION	Identifying signatures of selection can provide valuable insight about the genes or genomic regions that are or have been under selective pressure, which can lead to a better understanding of genotype-phenotype relationships. A common strategy for selection signature detection is to compare samples from several populations and search for genomic regions with outstanding genetic differentiation. Wright's fixation index, F-ST, is a useful index for evaluation of genetic differentiation between populations. The aim of this study was to detect selective signatures between different chicken groups based on SNP-wise F-ST calculation. A total of 96 individuals of three commercial layer breeds and 14 non-commercial fancy breeds were genotyped with three different 600K SNP-chips. After filtering a total of 1 million SNPs were available for F-ST calculation. Averages of F-ST values were calculated for overlapping windows. Comparisons of these were then conducted between commercial egg layers and non-commercial fancy breeds, as well as between white egg layers and brown egg layers. Comparing non-commercial and commercial breeds resulted in the detection of 630 selective signatures, while 656 selective signatures were detected in the comparison between the commercial egg-layer breeds. Annotation of selection signature regions revealed various genes corresponding to productions traits, for which layer breeds were selected. Among them were NCOA1, SREBF2 and RALGAPA1 associated with reproductive traits, broodiness and egg production. Furthermore, several of the detected genes were associated with growth and carcass traits, including POMC, PRKAB2, SPP1, IGF2, CAPN1, TGFb2 and IGFBP2. Our approach demonstrates that including different populations with a specific breeding history can provide a unique opportunity for a better understanding of farm animal selection.	[Gholami, Mahmood; Erbe, Malena; Gaerke, Christian; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany; [Preisinger, Rudolf] LOHMANN Tierzucht GMBH, Cuxhaven, Germany; [Weigend, Annett; Weigend, Steffen] Friedrich Loeffler Inst FLI, Inst Farm Anim Genet ING, Neustadt, Germany	University of Gottingen; Friedrich Loeffler Institute	Gholami, M (corresponding author), Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany.	mgholam@gwdg.de	Simianer, Henner/A-6574-2015	Simianer, Henner/0000-0002-7551-3797	German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding" [0315528C]	German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding"	This research was funded by the German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding" (Funding ID: 0315528C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Al-Nasser A, 2007, WORLD POULTRY SCI J, V63, P285, DOI 10.1017/S004393390700147X; [Anonymous], 2011, AXIOM GEONTYPING SOL; [Anonymous], 1883, CULDAR112B3BB3F; Arazi H, 2009, POULTRY SCI, V88, P647, DOI 10.3382/ps.2008-00387; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Bennett AK, 2007, POULTRY SCI, V86, P829, DOI 10.1093/ps/86.5.829; Bottje W, 2008, POULTRY SCI, V87, P2073, DOI 10.3382/ps.2008-00060; Brown WRA, 2003, NAT REV GENET, V4, P87, DOI 10.1038/nrg998; Burt DW, 2005, GENOME RES, V15, P1692, DOI 10.1101/gr.4141805; Crawford R.D, 1990, POULTRY BREEDING GEN; Der R, 2011, THEOR POPUL BIOL, V80, P80, DOI 10.1016/j.tpb.2011.06.004; Durinck S, BIOMART INTERFACE BI; Elferink MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032720; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Green M. R., 2012, MOL CLONING LAB MANU, V4th; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HY, 2011, BRIT POULTRY SCI, V52, P328, DOI 10.1080/00071668.2011.577057; Jiang R, 2004, ANIM GENET, V35, P344, DOI 10.1111/j.1365-2052.2004.01164.x; Jiao S, 2013, MOL CELL BIOCHEM, V373, P107, DOI 10.1007/s11010-012-1479-4; Johansson AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001188; Johnson PA, 2009, REPRODUCTION, V137, P857, DOI 10.1530/REP-08-0406; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kang L, 2012, MOL BIOL REP, V39, P3037, DOI 10.1007/s11033-011-1066-x; Kanginakudru S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-174; Kim S, 2009, MOL IMMUNOL, V47, P476, DOI 10.1016/j.molimm.2009.08.027; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Leng L, 2009, POULTRY SCI, V88, P938, DOI 10.3382/ps.2008-00453; Li ZH, 2006, J ANIM SCI, V84, P2902, DOI 10.2527/jas.2006-144; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Muir Wi. M, 2003, POULTRY GENETICS BRE; Myles S, 2008, ANN HUM GENET, V72, P99, DOI 10.1111/j.1469-1809.2007.00390.x; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Nie QH, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-20; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049525; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Seol HS, 2007, COMP BIOCHEM PHYS B, V147, P698, DOI 10.1016/j.cbpb.2007.04.012; Shen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033851; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Tang S, 2011, ANIM GENET, V42, P108, DOI 10.1111/j.1365-2052.2010.02060.x; Tang SQ, 2010, ANIM BIOTECHNOL, V21, P104, DOI 10.1080/10495390903328090; Tao Yong, 2008, Yichuan, V30, P900, DOI 10.3724/SP.J.1005.2008.00900; van Buul-Offers SC, 2000, ENDOCRINOLOGY, V141, P1493, DOI 10.1210/en.141.4.1493; Wang Jin-Lei, 2008, Yichuan, V30, P1033, DOI 10.3724/SP.J.1005.2008.01033; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhang ZR, 2008, J ANIM BREED GENET, V125, P258, DOI 10.1111/j.1439-0388.2008.00723.x; Zhang Z.X., 2007, GEOSPATIAL INFORM, V1, P1; Zhou H, 2011, STAT COMPUT, V21, P261, DOI 10.1007/s11222-009-9166-3	56	23	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94509	10.1371/journal.pone.0094509	http://dx.doi.org/10.1371/journal.pone.0094509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739889	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900049
J	Chaskes, S; Cammer, M; Nieves, E; Casadevall, A				Chaskes, Stuart; Cammer, Michael; Nieves, Edward; Casadevall, Arturo			Pigment Production on L-Tryptophan Medium by Cryptococcus gattii and Cryptococcus neoformans	PLOS ONE			English	Article							YEAST MALASSEZIA-FURFUR; HIGH HIV SEROPREVALENCE; SOUTH-AFRICAN PROVINCE; MELANIN-LIKE PIGMENT; CANDIDA-ALBICANS; RAPID IDENTIFICATION; BRITISH-COLUMBIA; SEROTYPE-B; LACCASE; INFECTION	In recent years strains previously grouped within Cryptococcus neoformans have been divided into two species C. neoformans and C. gattii, with Cryptococcus neoformans comprising serotypes A, D, and AD and C. gattii comprising serotypes B and C. Cryptococcus neoformans have also been subdivided into two varieties C. neoformans var. grubii, serotype A, and C. neoformans var. neoformans, serotype D. We analyzed the growth and pigment production characteristics of 139 strains of Cryptococcus spp. in L-tryptophan containing media. Nearly all strains of Cryptococcus, including each variety and serotype tested produced a pink water-soluble pigment (molecular weight of 535.2 Da) from L-tryptophan. Consequently, the partial separation of the species was based on whether the pink pigment was secreted into the medium (extracellular) or retained as an intracellular pigment. On L-tryptophan medium C. neoformans var. grubii and serotype AD produced a pink extracellular pigment. In contrast, for C. gattii, the pink pigment was localized intracellularly and masked by heavy production of brown pigments. Pigment production by C. neoformans var. neoformans was variable with some strains producing the pink extracellular pigment and others retained the pink pigment intracellularly. The pink intracellular pigment produced by strains of C. neoformans var. neoformans was masked by production of brown pigments. Cryptococcus laccase mutants failed to produce pigments from L-tryptophan. This is the first report that the enzyme laccase is involved in tryptophan metabolism. Prior to this report Cryptococcus laccase produced melanin or melanin like-pigments from heterocyclic compounds that contained ortho or para diphenols, diaminobenzenes and aminophenol compounds. The pigments produced from L-tryptophan were not melanin.	[Chaskes, Stuart] SUNY Agr & Tech Coll Farmingdale, Dept Biol, Farmingdale, NY 11735 USA; [Cammer, Michael] NYU, Microscopy Core, Langone Med Ctr, New York, NY USA; [Nieves, Edward] Albert Einstein Coll Med, Lab Macromol Anal & Prote, Bronx, NY 10467 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	State University of New York (SUNY) System; New York University; NYU Langone Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chaskes, S (corresponding author), SUNY Agr & Tech Coll Farmingdale, Dept Biol, Farmingdale, NY 11735 USA.	chaskesj@farmingdale.edu		Cammer, Michael/0000-0003-4930-1739	National Institutes of Health [AI033774, 5R01HL059842, 2R37AI033142]; NIH Shared Instrumentation Grant [1S10RR019352]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019352] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033774, R37AI033142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by National Institutes of Health Awards AI033774, 5R01HL059842, and 2R37AI033142. The LTQ mass spectrometer was supported through a NIH Shared Instrumentation Grant (1S10RR019352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baro T, 1998, J CLIN MICROBIOL, V36, P458; Baro T, 1999, J CLIN MICROBIOL, V37, P1170; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; CHASKES S, 1981, MYCOPATHOLOGIA, V74, P143, DOI 10.1007/BF00437156; CHASKES S, 1978, MYCOPATHOLOGIA, V64, P105, DOI 10.1007/BF00440970; CHASKES S, 1974, CAN J MICROBIOL, V20, P595, DOI 10.1139/m74-091; CHASKES S, 1978, J CLIN MICROBIOL, V7, P146; Chaskes S, 2008, J CLIN MICROBIOL, V46, P255, DOI 10.1128/JCM.01721-07; Chaturvedi S, 2005, EMERG INFECT DIS, V11, P1686, DOI 10.3201/eid1111.040875; Dannaoui E, 2006, ANTIMICROB AGENTS CH, V50, P2464, DOI 10.1128/AAC.01520-05; Dromer F, 1996, CLIN INFECT DIS, V23, P82, DOI 10.1093/clinids/23.1.82; DUFAIT R, 1987, MYCOSES, V30, P483, DOI 10.1111/j.1439-0507.1987.tb03833.x; EDBERG SC, 1980, J CLIN MICROBIOL, V12, P332, DOI 10.1128/JCM.12.3.332-335.1980; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Franzot SP, 1999, J CLIN MICROBIOL, V37, P838, DOI 10.1128/JCM.37.3.838-840.1999; Frases S, 2006, APPL ENVIRON MICROB, V72, P1542, DOI 10.1128/AEM.72.2.1542-1550.2006; Frases S, 2007, APPL ENVIRON MICROB, V73, P615, DOI 10.1128/AEM.01947-06; Garcia-Rivera J, 2005, FUNGAL GENET BIOL, V42, P989, DOI 10.1016/j.fgb.2005.09.003; Garcia-Rivera J, 2005, INFECT IMMUN, V73, P3124, DOI 10.1128/IAI.73.5.3124-3127.2005; GUNASEKARAN M, 1980, MYCOLOGIA, V72, P578, DOI 10.2307/3759532; Hoang LMN, 2004, J MED MICROBIOL, V53, P935, DOI 10.1099/jmm.0.05427-0; IKEDA R, 1993, MICROBIOL IMMUNOL, V37, P759, DOI 10.1111/j.1348-0421.1993.tb01702.x; Irlinger B, 2004, ANGEW CHEM INT EDIT, V43, P1098, DOI 10.1002/anie.200352549; IROKANULO EAO, 1994, BRIT J BIOMED SCI, V51, P100; Ito-Kuwa S, 2008, MICROBIOL IMMUNOL, V52, P492, DOI 10.1111/j.1348-0421.2008.00063.x; Khan ZU, 2009, INT J ANTIMICROB AG, V33, P559, DOI 10.1016/j.ijantimicag.2008.11.007; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kwon-Chung KJ, 2006, FEMS YEAST RES, V6, P574, DOI 10.1111/j.1567-1364.2006.00088.x; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; KWONCHUNG KJ, 1983, J CLIN MICROBIOL, V18, P1419, DOI 10.1128/JCM.18.6.1419-1421.1983; Litvintseva AP, 2005, J INFECT DIS, V192, P888, DOI 10.1086/432486; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Martinez Machin G, 2004, REV CUBANA MED, V1, P77; Mayser P, 2003, ANTON LEEUW INT J G, V84, P185, DOI 10.1023/A:1026042903354; Mayser P, 2002, ARCH DERMATOL RES, V294, P131, DOI 10.1007/s00403-002-0294-2; Mayser P, 2007, MED MYCOL, V45, P519, DOI 10.1080/13693780701411557; McCarthy KM, 2006, AIDS, V20, P2199, DOI 10.1097/QAD.0b013e3280106d6a; Morgan J, 2006, CLIN INFECT DIS, V43, P1077, DOI 10.1086/507897; Morris-Jones R, 2005, INFECT IMMUN, V73, P6147, DOI 10.1128/IAI.73.9.6147-6150.2005; Mukamurangwa P, 1995, J MED VET MYCOL, V33, P419; NURUDEEN TA, 1979, J CLIN MICROBIOL, V10, P724, DOI 10.1128/JCM.10.5.724-729.1979; Nyhus KJ, 1997, INFECT IMMUN, V65, P434, DOI 10.1128/IAI.65.2.434-438.1997; Phillips P, 2009, CLIN INFECT DIS, V49, P591, DOI 10.1086/603554; POLACHECK I, 1988, J GEN MICROBIOL, V134, P1037; POLACHECK I, 1990, INFECT IMMUN, V58, P2919, DOI 10.1128/IAI.58.9.2919-2922.1990; POLACHECK I, 1982, J BACTERIOL, V150, P1212, DOI 10.1128/JB.150.3.1212-1220.1982; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Saag MS, 2000, CLIN INFECT DIS, V30, P710, DOI 10.1086/313757; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Upton A, 2007, J CLIN MICROBIOL, V45, P3086, DOI 10.1128/JCM.00593-07; Walker CA, 2010, EUKARYOT CELL, V9, P1329, DOI 10.1128/EC.00051-10; WANG HS, 1977, J CLIN MICROBIOL, V6, P445; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; Waterman SR, 2007, INFECT IMMUN, V75, P714, DOI 10.1128/IAI.01351-06; Zhu XD, 2001, INFECT IMMUN, V69, P5589, DOI 10.1128/IAI.69.9.5589-5596.2001	57	6	6	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e91901	10.1371/journal.pone.0091901	http://dx.doi.org/10.1371/journal.pone.0091901			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736553	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600006
J	Duvvari, MR; Paun, CC; Buitendijk, GHS; Saksens, NTM; Volokhina, EB; Ristau, T; Schoenmaker-Koller, FE; van de Ven, JPH; Groenewoud, JMM; van den Heuvel, LPWJ; Hofman, A; Fauser, S; Uitterlinden, AG; Klaver, CCW; Hoyng, CB; de Jong, EK; den Hollander, AI				Duvvari, Maheswara R.; Paun, Codrut C.; Buitendijk, Gabrielle H. S.; Saksens, Nicole T. M.; Volokhina, Elena B.; Ristau, Tina; Schoenmaker-Koller, Frederieke E.; van de Ven, Johannes P. H.; Groenewoud, Joannes M. M.; van den Heuvel, Lambertus P. W. J.; Hofman, Albert; Fauser, Sascha; Uitterlinden, Andre G.; Klaver, Caroline C. W.; Hoyng, Carel B.; de Jong, Eiko K.; den Hollander, Anneke I.			Analysis of Rare Variants in the C3 Gene in Patients with Age-Related Macular Degeneration	PLOS ONE			English	Article							HIGH-RISK; COMPLEMENT ACTIVATION; MUTATION; ALLELES; CONFERS; CELLS; CFH; DNA	Age-related macular degeneration (AMD) is a progressive retinal disorder affecting over 33 million people worldwide. Genome-wide association studies (GWASs) for AMD identified common variants at 19 loci accounting for 15-65% of the heritability and it has been hypothesized that the missing heritability may be attributed to rare variants with large effect sizes. Common variants in the complement component 3 (C3) gene have been associated with AMD and recently a rare C3 variant (Lys155Gln) was identified which exerts a large effect on AMD susceptibility independent of the common variants. To explore whether additional rare variants in the C3 gene are associated with AMD, we sequenced all coding exons in 84 unrelated AMD cases. Subsequently, we genotyped all identified variants in 1474 AMD cases and 2258 controls. Additionally, because of the known genetic overlap between AMD and atypical hemolytic uremic syndrome (aHUS), we genotyped two recurrent aHUS-associated C3 mutations in the entire cohort. Overall, we identified three rare variants (Lys65Gln (P = 0.04), Arg735Trp (OR = 17.4, 95% CI = 2.2-136; P = 0.0003), and Ser1619Arg (OR = 5.2, 95% CI = 1.0-25; P = 0.05) at the C3 locus that are associated with AMD in our EUGENDA cohort. However, the Arg735Trp and Ser1619Arg variants were not found to be associated with AMD in the Rotterdam Study. The Lys65Gln variant was only identified in patients from Nijmegen, the Netherlands, and thus may represent a region-specific AMD risk variant.	[Duvvari, Maheswara R.; Paun, Codrut C.; Saksens, Nicole T. M.; Schoenmaker-Koller, Frederieke E.; van de Ven, Johannes P. H.; Hoyng, Carel B.; de Jong, Eiko K.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Duvvari, Maheswara R.; Paun, Codrut C.; de Jong, Eiko K.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Buitendijk, Gabrielle H. S.; Klaver, Caroline C. W.] Erasmus MC, Dept Ophthalmol, Rotterdam, Netherlands; [Buitendijk, Gabrielle H. S.; Hofman, Albert; Uitterlinden, Andre G.; Klaver, Caroline C. W.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Volokhina, Elena B.; van den Heuvel, Lambertus P. W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Nephrol, NL-6525 ED Nijmegen, Netherlands; [Ristau, Tina; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Dept Vitreoretinal Surg, Cologne, Germany; [Groenewoud, Joannes M. M.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth & Evidence, NL-6525 ED Nijmegen, Netherlands; [Hofman, Albert; Uitterlinden, Andre G.] Netherlands Consortium Hlth Aging, Netherlands Genom Initiat, The Hague, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; University of Cologne; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands.	Anneke.denHollander@radboudumc.nl	Hoyng, C.B./H-8050-2014; Volokhina, Elena/L-4725-2015; Groenewoud, Hans JMM/R-3588-2017; de Jong, Eiko/P-3407-2015; van den Heuvel, L.P.W.J./H-8044-2014; van den Heuvel, Lambertus/AAM-1772-2021; Hollander, Anneke den/N-4911-2014; Klaver, Caroline C.W./A-2013-2016	Volokhina, Elena/0000-0002-4294-8460; Groenewoud, Hans JMM/0000-0002-4974-150X; de Jong, Eiko/0000-0001-6520-0407; van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; Klaver, Caroline/0000-0002-2355-5258	Netherlands Organization for Scientific Research [016.096.309]; Foundation Fighting Blindness USA [C-GE-0811-0548-RAD04]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Foundation Fighting Blindness USA	This study was supported by the Netherlands Organization for Scientific Research (Vidi Innovational Research Award 016.096.309 to AIDH) and the Foundation Fighting Blindness USA (grant C-GE-0811-0548-RAD04 to AIDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bienaime F, 2010, KIDNEY INT, V77, P339, DOI 10.1038/ki.2009.472; de Carvalho JER, 2013, INVEST OPHTH VIS SCI, V54, P6489, DOI 10.1167/iovs.13-12374; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Esparza-Gordillo J, 2005, HUM MOL GENET, V14, P703, DOI 10.1093/hmg/ddi066; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Haynes T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3312; Helgason H, 2013, NAT GENET, V45, P1371, DOI 10.1038/ng.2740; Hofman A, 2011, EUR J EPIDEMIOL, V26, P657, DOI 10.1007/s10654-011-9610-5; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; International Council of Ophthalmology, GLOB EC COST VIS IMP; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller E., 2012, CHARACTERIZATION COM; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Roumenina LT, 2012, BLOOD, V119, P4182, DOI 10.1182/blood-2011-10-383281; Schultz DW, 2003, HUM MOL GENET, V12, P3315, DOI 10.1093/hmg/ddg348; Seddon JM, 2013, FARADAY DISCUSS, V161, P9, DOI 10.1039/c2fd90045a; Smailhodzic D, 2012, OPHTHALMOLOGY, V119, P339, DOI 10.1016/j.ophtha.2011.07.056; Sobrin L, 2010, EUR J HUM GENET, V18, P496, DOI 10.1038/ejhg.2009.185; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; Volokhina E, 2012, PEDIATR NEPHROL, V27, P1519, DOI 10.1007/s00467-012-2183-z; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Zhan XW, 2013, NAT GENET, V45, P1375, DOI 10.1038/ng.2758	31	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94165	10.1371/journal.pone.0094165	http://dx.doi.org/10.1371/journal.pone.0094165			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736606	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600049
J	Faure, E; Thompson, C; Blunck, R				Faure, Elise; Thompson, Christine; Blunck, Rikard			Do Lipids Show State-dependent Affinity to the Voltage-gated Potassium Channel KvAP?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; K+ CHANNEL; S4-S5 LINKER; WILD-TYPE; ACTIVATION; MECHANISM; INTERFACE; BILAYER; WATER; S4	As all integral membrane proteins, voltage-gated ion channels are embedded in a lipid matrix that regulates their channel behavior either by physicochemical properties or by direct binding. Because manipulation of the lipid composition in cells is difficult, we investigated the influence of different lipids on purified KvAP channels reconstituted in planar lipid bilayers of known composition. Lipids developed two distinct and independent effects on the KvAP channels; lipids interacting with the pore lowered the energy barriers for the final transitions, whereas voltage sensor-bound lipids shifted the midpoint of activation dependent on their electrostatic charge. Above all, the midpoint of activation was determined only by those lipids the channels came in contact with first after purification and can seemingly only be exchanged if the channel resides in the open state. The high affinity of the bound lipids to the binding site has implications not only on our understanding of the gating mechanism but also on the general experimental design of any lipid dependence study.	[Thompson, Christine; Blunck, Rikard] Univ Montreal, Dept Phys, Montreal, PQ CH3C 3J7, Canada; [Faure, Elise; Blunck, Rikard] Univ Montreal, Dept Physiol, Montreal, PQ CH3C 3J7, Canada; [Faure, Elise; Thompson, Christine; Blunck, Rikard] Univ Montreal, Grp Etud Prot Membranaires GEPROM, Montreal, PQ CH3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Blunck, R (corresponding author), Univ Montreal, Dept Phys, CP 6128 Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	rikard.blunck@umontreal.ca	Thompson, Christine/GWV-6539-2022; Blunck, Rikard/L-4226-2013; Blunck, Rikard/AAM-3078-2020	Blunck, Rikard/0000-0003-4484-2907; Blunck, Rikard/0000-0003-4484-2907	Canadian Institutes for Health Research [MOP-102689]; Natural Sciences and Engineering Research Council [327201-2012]; Canadian Foundation for Innovation [950-225005]; Fonds de recherche du Quebec-Sante (FRQS); Fonds de recherche du Quebec-Nature et technologie (FRQNT)	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de recherche du Quebec-Sante (FRQS); Fonds de recherche du Quebec-Nature et technologie (FRQNT)	This work was supported in part by Canadian Institutes for Health Research Grant MOP-102689, Natural Sciences and Engineering Research Council Grant 327201-2012, and Canadian Foundation for Innovation Grant 950-225005. GEPROMis a research group supported by the Fonds de recherche du Quebec-Sante (FRQS).; Supported by a fellowship of the Fonds de recherche du Quebec-Nature et technologie (FRQNT).	Abbott GW, 2006, CURR PHARM DESIGN, V12, P3631, DOI 10.2174/138161206778522065; Bahring R, 2011, J PHYSIOL-LONDON, V589, P461, DOI 10.1113/jphysiol.2010.191965; Batulan Z, 2010, J BIOL CHEM, V285, P14005, DOI 10.1074/jbc.M109.097717; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Borjesson SI, 2008, BIOPHYS J, V95, P2242, DOI 10.1529/biophysj.108.130757; Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599; Borjesson SI, 2010, BIOPHYS J, V98, P396, DOI 10.1016/j.bpj.2009.10.026; Combs DJ, 2013, J GEN PHYSIOL, V142, P367, DOI 10.1085/jgp.201310986; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Faure E, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.415497; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; Gaede HC, 2003, BIOPHYS J, V85, P1734, DOI 10.1016/S0006-3495(03)74603-7; Groulx N, 2010, J GEN PHYSIOL, V136, P497, DOI 10.1085/jgp.200910347; Heberle FA, 2013, J AM CHEM SOC, V135, P6853, DOI 10.1021/ja3113615; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Kalstrup T, 2013, P NATL ACAD SCI USA, V110, P8272, DOI 10.1073/pnas.1220398110; Krepkiy D, 2012, J MOL BIOL, V423, P632, DOI 10.1016/j.jmb.2012.07.015; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Salvati A, 2007, J PHYS CHEM B, V111, P10357, DOI 10.1021/jp0731710; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schmidt D, 2009, J MOL BIOL, V390, P902, DOI 10.1016/j.jmb.2009.05.062; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; van der Cruijsen EAW, 2013, P NATL ACAD SCI USA, V110, P13008, DOI 10.1073/pnas.1305563110; Weingarth M, 2013, J AM CHEM SOC, V135, P3983, DOI 10.1021/ja3119114; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279; Zheng H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1254; Zuidam NJ, 1997, BBA-BIOMEMBRANES, V1329, P211, DOI 10.1016/S0005-2736(97)00110-7	40	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16452	16461		10.1074/jbc.M113.537134	http://dx.doi.org/10.1074/jbc.M113.537134			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742679	Green Published, hybrid			2022-12-25	WOS:000337965700047
J	Baek, JH; Rubinstein, M; Scheuer, T; Trimmer, JS				Baek, Je-Hyun; Rubinstein, Moran; Scheuer, Todd; Trimmer, James S.			Reciprocal Changes in Phosphorylation and Methylation of Mammalian Brain Sodium Channels in Response to Seizures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Epilepsy; Ion Channels; Mass Spectrometry (MS); Proteomics	PROTEIN-KINASE-C; STATUS EPILEPTICUS MODEL; TEMPORAL-LOBE EPILEPSY; RAT CA1 NEURONS; ALPHA-SUBUNITS; NA+ CHANNELS; KINDLING EPILEPTOGENESIS; ANTIEPILEPTIC DRUGS; CURRENTS; MECHANISMS	Background: Sodium channels underlie neuronal excitability and are regulated by seizures. Results: Mass spectrometric analysis of brain sodium channels revealed novel phosphorylation and methylation sites that decreased and increased, respectively, after seizures. Inducing methylation increased sodium channel activity. Conclusion: Reciprocal phosphorylation and methylation after seizures will alter sodium channel function. Significance: Such regulation would impact neuronal excitability. Voltage-gated sodium (Nav) channels initiate action potentials in brain neurons and are primary therapeutic targets for anti-epileptic drugs controlling neuronal hyperexcitability in epilepsy. The molecular mechanisms underlying abnormal Nav channel expression, localization, and function during development of epilepsy are poorly understood but can potentially result from altered posttranslational modifications (PTMs). For example, phosphorylation regulates Nav channel gating, and has been proposed to contribute to acquired insensitivity to anti-epileptic drugs exhibited by Nav channels in epileptic neurons. However, whether changes in specific brain Nav channel PTMs occur acutely in response to seizures has not been established. Here, we show changes in PTMs of the major brain Nav channel, Nav1.2, after acute kainate-induced seizures. Mass spectrometry-based proteomic analyses of Nav1.2 purified from the brains of control and seizure animals revealed a significant down-regulation of phosphorylation at nine sites, primarily located in the interdomain I-II linker, the region of Nav1.2 crucial for phosphorylation-dependent regulation of activity. Interestingly, Nav1.2 in the seizure samples contained methylated arginine (MeArg) at three sites. These MeArgs were adjacent to down-regulated sites of phosphorylation, and Nav1.2 methylation increased after seizure. Phosphorylation and MeArg were not found together on the same tryptic peptide, suggesting reciprocal regulation of these two PTMs. Coexpression of Nav1.2 with the primary brain arginine methyltransferase PRMT8 led to a surprising 3-fold increase in Nav1.2 current. Reciprocal regulation of phosphorylation and MeArg of Nav1.2 may underlie changes in neuronal Nav channel function in response to seizures and also contribute to physiological modulation of neuronal excitability.	[Baek, Je-Hyun; Trimmer, James S.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Trimmer, James S.] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [Rubinstein, Moran; Scheuer, Todd] Univ Washington, Dept Pharmacol, Sch Med, Seattle, WA 98195 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Washington; University of Washington Seattle	Trimmer, JS (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, 196 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA.	jtrimmer@ucdavis.edu		Baek, Je-Hyun/0000-0003-4974-8397; Rubinstein, Moran/0000-0003-2617-2276	National Institutes of Health [R21 NS64428, R01 NS25704]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS064428, R01NS025704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21 NS64428 (to J. S. T. and T. S.) and R01 NS25704 (to William A. Catterall).	Agrawal N, 2003, EPILEPSIA, V44, P1601, DOI 10.1111/j.0013-9580.2003.23103.x; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Baek H, 2011, SEMIN CELL DEV BIOL, V22, P153, DOI 10.1016/j.semcdb.2010.09.009; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; Bartolomei F, 1997, J NEUROCYTOL, V26, P667, DOI 10.1023/A:1018549928277; Beacham D, 2007, J NEUROSCI, V27, P11543, DOI 10.1523/JNEUROSCI.1743-07.2007; Beck H, 2007, EPILEPSIA, V48, P14, DOI 10.1111/j.1528-1167.2007.00994.x; Beltran-Alvarez P, 2013, FEBS LETT, V587, P3159, DOI 10.1016/j.febslet.2013.07.043; Beltran-Alvarez P, 2011, J PROTEOME RES, V10, P3712, DOI 10.1021/pr200339n; Ben-Ari Yehezkel, 2006, Critical Reviews in Neurobiology, V18, P135; Berendt FJ, 2010, J PROTEOME RES, V9, P1976, DOI 10.1021/pr901171q; Bosmans F, 2011, P NATL ACAD SCI USA, V108, P20213, DOI 10.1073/pnas.1108497108; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Cantrell AR, 2001, NAT REV NEUROSCI, V2, P397, DOI 10.1038/35077553; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chen YA, 2006, NEURON, V49, P409, DOI 10.1016/j.neuron.2006.01.009; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Curia G, 2007, BRIT J PHARMACOL, V150, P792, DOI 10.1038/sj.bjp.0707144; Curia G, 2004, NEUROSCIENCE, V127, P63, DOI 10.1016/j.neuroscience.2004.04.040; Ellerkmann RK, 2003, NEUROSCIENCE, V119, P323, DOI 10.1016/S0306-4522(03)00168-4; Guo F, 2013, NEUROCHEM INT, V62, P287, DOI 10.1016/j.neuint.2013.01.005; Hargus NJ, 2011, NEUROBIOL DIS, V41, P361, DOI 10.1016/j.nbd.2010.10.004; Isaev D, 2007, J NEUROSCI, V27, P11587, DOI 10.1523/JNEUROSCI.2033-07.2007; Jeub M, 2002, NEUROPHARMACOLOGY, V42, P107, DOI 10.1016/S0028-3908(01)00148-4; Jung S, 2010, J NEUROSCI, V30, P6678, DOI 10.1523/JNEUROSCI.1290-10.2010; Kanade SR, 2012, J BIOL CHEM, V287, P7313, DOI 10.1074/jbc.M111.331660; Ketelaars SOM, 2001, NEUROSCIENCE, V105, P109, DOI 10.1016/S0306-4522(01)00176-2; Kim S, 2010, MOL CELL PROTEOMICS, V9, P2840, DOI 10.1074/mcp.M110.003731; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Minge D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026664; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Qiao X, 2013, EPILEPSY RES, V106, P17, DOI 10.1016/j.eplepsyres.2013.06.006; RACINE R, 1972, ELECTROEN CLIN NEURO, V32, P295, DOI 10.1016/0013-4694(72)90178-2; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Remy S, 2003, EUR J NEUROSCI, V17, P2648, DOI 10.1046/j.1460-9568.2003.02710.x; Schaub C, 2007, EPILEPSIA, V48, P1339, DOI 10.1111/j.1528-1167.2007.01103.x; Scheuer T, 2011, SEMIN CELL DEV BIOL, V22, P160, DOI 10.1016/j.semcdb.2010.10.002; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Trimmer J.S., 2014, HDB ION CHANNELS; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Velisek L, 2006, MODELS OF SEIZURES AND EPILEPSY, P127, DOI 10.1016/B978-012088554-1/50013-X; Vreugdenhil M, 2004, EUR J NEUROSCI, V19, P2769, DOI 10.1111/j.1460-9568.2004.03400.x; Vreugdenhil M, 1998, NEUROSCIENCE, V86, P99, DOI 10.1016/S0306-4522(98)00041-4; Vreugdenhil M, 1999, EPILEPSIA, V40, P1512, DOI 10.1111/j.1528-1157.1999.tb02034.x; WEST JW, 1991, SCIENCE, V254, P866, DOI 10.1126/science.1658937; Whitaker WRJ, 2001, NEUROSCIENCE, V106, P275, DOI 10.1016/S0306-4522(01)00212-3; White HS, 2007, INT REV NEUROBIOL, V81, P85, DOI 10.1016//S0074-7742(06)81006-8; Williams CA, 2013, EXP NEUROL, V244, P51, DOI 10.1016/j.expneurol.2011.12.001	54	43	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15363	15373		10.1074/jbc.M114.562785	http://dx.doi.org/10.1074/jbc.M114.562785			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737319	hybrid, Green Published			2022-12-25	WOS:000337465400020
J	Huyard, F; Yzydorczyk, C; Castro, MM; Cloutier, A; Bertagnolli, M; Sartelet, H; Germain, N; Comte, B; Schulz, R; DeBlois, D; Nuyt, AM				Huyard, Fanny; Yzydorczyk, Catherine; Castro, Michele M.; Cloutier, Anik; Bertagnolli, Mariane; Sartelet, Herve; Germain, Nathalie; Comte, Blandine; Schulz, Richard; DeBlois, Denis; Nuyt, Anne Monique			Remodeling of Aorta Extracellular Matrix as a Result of Transient High Oxygen Exposure in Newborn Rats: Implication for Arterial Rigidity and Hypertension Risk	PLOS ONE			English	Article							COLLAGEN TYPE-I; TISSUE GROWTH-FACTOR; LOW-BIRTH-WEIGHT; CATHEPSIN-K; OXIDATIVE STRESS; REACTIVE OXYGEN; PRETERM BIRTH; MECHANICAL-PROPERTIES; CYSTEINE PROTEASE; ELASTIN CONTENT	Neonatal high-oxygen exposure leads to elevated blood pressure, microvascular rarefaction, vascular dysfunction and arterial (aorta) rigidity in adult rats. Whether structural changes are present in the matrix of aorta wall is unknown. Considering that elastin synthesis peaks in late fetal life in humans, and early postnatal life in rodents, we postulated that transient neonatal high-oxygen exposure can trigger premature vascular remodelling. Sprague Dawley rat pups were exposed from days 3 to 10 after birth to 80% oxygen (vs. room air control) and were studied at 4 weeks. Blood pressure and vasomotor response of the aorta to angiotensin II and to the acetylcholine analogue carbachol were not different between groups. Vascular superoxide anion production was similar between groups. There was no difference between groups in aortic cross sectional area, smooth muscle cell number or media/lumen ratio. In oxygen-exposed rats, aorta elastin/collagen content ratio was significantly decreased, the expression of elastinolytic cathepsin S was increased whereas collagenolytic cathepsin K was decreased. By immunofluorescence we observed an increase in MMP-2 and TIMP-1 staining in aortas of oxygen-exposed rats whereas TIMP-2 staining was reduced, indicating a shift in the balance towards degradation of the extra-cellular matrix and increased deposition of collagen. There was no significant difference in MMP-2 activity between groups as determined by gelatin zymography. Overall, these findings indicate that transient neonatal high oxygen exposure leads to vascular wall alterations (decreased elastin/collagen ratio and a shift in the balance towards increased deposition of collagen) which are associated with increased rigidity. Importantly, these changes are present prior to the elevation of blood pressure and vascular dysfunction in this model, and may therefore be contributory.	[Huyard, Fanny; Yzydorczyk, Catherine; Cloutier, Anik; Bertagnolli, Mariane; Germain, Nathalie; Nuyt, Anne Monique] Univ Montreal, Dept Paediat, St Justine Univ Hosp Res Ctr, Montreal, PQ, Canada; [Castro, Michele M.; Schulz, Richard] Univ Alberta, Dept Pediat, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Castro, Michele M.; Schulz, Richard] Univ Alberta, Dept Pharmacol, Cardiovasc Res Ctr, Edmonton, AB, Canada; [Sartelet, Herve] Univ Montreal, Dept Pathol, St Justine Univ Hosp Res Ctr, Montreal, PQ H3C 3J7, Canada; [Comte, Blandine] Res Ctr Clermont Ferrand Theix, INRA, Unit Human Nutr UMR 1019, St Genes Champanelle, France; [DeBlois, Denis] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; University of Alberta; University of Alberta; Universite de Montreal; INRAE; Universite de Montreal	Nuyt, AM (corresponding author), Univ Montreal, Dept Paediat, St Justine Univ Hosp Res Ctr, Montreal, PQ, Canada.	anne-monique.nuyt@recherche-ste-justine.qc.ca	Schulz, Richard/M-3518-2019; Schulz, Richard/A-8739-2012; Mazzaron de Castro, Michele/C-7412-2013	Schulz, Richard/0000-0002-5045-3193; Schulz, Richard/0000-0002-5045-3193; Mazzaron de Castro, Michele/0000-0002-3424-6573; YZYDORCZYK, Catherine/0000-0002-0617-7558; Bertagnolli, Mariane/0000-0002-1093-1445; Comte, Blandine/0000-0002-4662-6581	Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada; Pfizer Cardiovascular Research-Canadian Hypertension Society Award; National Sciences and Engineering Research Council [403045]; Quebec Training Network in Perinatal Research (Canadian Institutes of Health Research); Fondation des etoiles (Quebec); Fonds de la Recherche en Santedu Quebec; Alberta Innovates - Health Solutions; Heart & Stroke Foundation of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Pfizer Cardiovascular Research-Canadian Hypertension Society Award; National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec Training Network in Perinatal Research (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); Fondation des etoiles (Quebec); Fonds de la Recherche en Santedu Quebec(Fonds de la Recherche en Sante du Quebec); Alberta Innovates - Health Solutions; Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by grants from the Canadian Institutes of Health Research, the Heart and Stroke Foundation of Canada and the Pfizer Cardiovascular Research-Canadian Hypertension Society Award (to AMN) and the National Sciences and Engineering Research Council (403045 to RS). FH and CY were supported by fellowship awards from the Quebec Training Network in Perinatal Research (Canadian Institutes of Health Research) and the Fondation des etoiles (Quebec), respectively. AMN was supported by salary award from the Fonds de la Recherche en Santedu Quebec. MMC was supported by fellowship awards from Alberta Innovates - Health Solutions and the Heart & Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu P, 2010, VASC HEALTH RISK MAN, V6, P215; Bensley JG, 2012, PEDIATR RES, V71, P150, DOI 10.1038/pr.2011.29; BERRY CL, 1975, CARDIOVASC RES, V9, P669, DOI 10.1093/cvr/9.5.669; BERRY CL, 1972, J PATHOL, V108, P265, DOI 10.1002/path.1711080402; BLANCO LN, 1993, PEDIATR RES, V34, P334, DOI 10.1203/00006450-199309000-00019; Bonamy AKE, 2005, PEDIATR RES, V58, P845, DOI 10.1203/01.PDR.0000181373.29290.80; BRUCE MC, 1989, AM REV RESPIR DIS, V140, P1067, DOI 10.1164/ajrccm/140.4.1067; Buhling F, 2004, AM J PATHOL, V164, P2203, DOI 10.1016/S0002-9440(10)63777-7; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Cambonie G, 2007, AM J PHYSIOL-REG I, V292, pR1236, DOI 10.1152/ajpregu.00227.2006; Cena JJ, 2010, AM J PHYSIOL-HEART C, V298, pH45, DOI 10.1152/ajpheart.00273.2009; Ceron CS, 2012, MATRIX BIOL, V31, P261, DOI 10.1016/j.matbio.2012.01.009; Chapman N, 1997, J HYPERTENS, V15, P1449, DOI 10.1097/00004872-199715120-00012; Chen CM, 2007, PEDIATR RES, V62, P128, DOI 10.1203/PDR.0b013e3180987202; Cheng XW, 2006, AM J PATHOL, V168, P685, DOI 10.2353/ajpath.2006.050295; Chintala H, 2012, J BIOL CHEM, V287, P40570, DOI 10.1074/jbc.M112.386565; Chow AK, 2007, BRIT J PHARMACOL, V152, P189, DOI 10.1038/sj.bjp.0707344; de Champlain J, 2004, CLIN EXP HYPERTENS, V26, P593, DOI 10.1081/CEH-200031904; deBlois D, 1997, HYPERTENSION, V29, P340, DOI 10.1161/01.HYP.29.1.340; Ergul A, 2004, AM J HYPERTENS, V17, P775, DOI 10.1016/j.amjhyper.2004.06.025; FISCHER GM, 1966, CIRC RES, V19, P394, DOI 10.1161/01.RES.19.2.394; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Grossman E, 2008, DIABETES CARE, V31, pS185, DOI 10.2337/dc08-s246; Haurani MJ, 2007, CARDIOVASC RES, V75, P679, DOI 10.1016/j.cardiores.2007.06.016; Hayashi A, 1998, ARCH DERMATOL RES, V290, P497, DOI 10.1007/s004030050342; Hirakawa H, 2007, AM J RESP CRIT CARE, V176, P778, DOI 10.1164/rccm.200704-519OC; Hosford GE, 2004, PEDIATR RES, V56, P26, DOI 10.1203/01.PDR.0000130658.45564.1F; Ishikawa J, 2005, HYPERTENS RES, V28, P995, DOI 10.1291/hypres.28.995; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223; Kassab GS, 2006, J R SOC INTERFACE, V3, P719, DOI 10.1098/rsif.2006.0138; Khorram O, 2007, REPROD SCI, V14, P73, DOI 10.1177/1933719106298215; Khorram O, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.020; Knaapi J, 2006, ACTA PAEDIATR, V95, P1298, DOI 10.1080/08035250600586492; Knaapi J, 2011, EXP LUNG RES, V37, P408, DOI 10.3109/01902148.2011.581738; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Laviades C, 1998, CIRCULATION, V98, P535, DOI 10.1161/01.CIR.98.6.535; Libby P, 2000, CIRCULATION, V102, P1874, DOI 10.1161/01.CIR.102.16.1874; Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0; Lopez E, 2006, AM J RESP CELL MOL, V34, P738, DOI 10.1165/rcmb.2005-0254OC; Martinez-Lemus LA, 2011, AM J PHYSIOL-HEART C, V300, pH2005, DOI 10.1152/ajpheart.01066.2010; McEniery CM, 2011, J HYPERTENS, V29, P1367, DOI 10.1097/HJH.0b013e328347e333; McNulty M, 2006, J HUM HYPERTENS, V20, P867, DOI 10.1038/sj.jhh.1002015; Mivelaz Y, 2011, J DEV ORIG HLTH DIS, V52, P889; Morimoto K, 2012, J VASC SURG, V55, P1749, DOI 10.1016/j.jvs.2011.11.059; MULVANY MJ, 1985, CIRC RES, V57, P794, DOI 10.1161/01.RES.57.5.794; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; NISSEN R, 1978, P NATL ACAD SCI USA, V75, P451, DOI 10.1073/pnas.75.1.451; Norman M, 2008, ACTA PAEDIATR, V97, P1165, DOI 10.1111/j.1651-2227.2008.00904.x; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; Ota R, 2009, J CEREBR BLOOD F MET, V29, P1547, DOI 10.1038/jcbfm.2009.77; Pardo A, 1998, AM J PATHOL, V153, P833, DOI 10.1016/S0002-9440(10)65625-8; Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Rossi P, 2011, J ADOLESCENT HEALTH, V48, P520, DOI 10.1016/j.jadohealth.2010.08.004; Safar M E, 1993, Drugs, V46 Suppl 2, P68; SAFAR ME, 1984, HYPERTENSION, V6, P117; Saugstad OD, 2005, BIOL NEONATE, V88, P228, DOI 10.1159/000087586; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; SENIOR RM, 1991, J BIOL CHEM, V266, P7870; Sesso R, 2010, AM J HYPERTENS, V23, P6, DOI 10.1038/ajh.2009.200; SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; SILVER FH, 1989, CRIT REV BIOMED ENG, V17, P323; Skilton MR, 2006, CLIN SCI, V111, P281, DOI 10.1042/CS20060036; Smith ER, 2012, HYPERTENSION, V59, P973, DOI 10.1161/HYPERTENSIONAHA.111.187807; Stegemann JP, 2005, J APPL PHYSIOL, V98, P2321, DOI 10.1152/japplphysiol.01114.2004; Sukhova GK, 1998, J CLIN INVEST, V102, P576, DOI 10.1172/JCI181; Tauzin L, 2005, Pediatr Med Chir, V27, P18; Thibeault DW, 2000, AM J PERINAT, V17, P167, DOI 10.1055/s-2000-9422; TYAGI SC, 1993, J BIOL CHEM, V268, P16513; Van Gorp AW, 2000, AM J PHYSIOL-HEART C, V278, pH1241, DOI 10.1152/ajpheart.2000.278.4.H1241; VANMERODE T, 1988, ULTRASOUND MED BIOL, V14, P563, DOI 10.1016/0301-5629(88)90122-6; Veillard F, 2011, J BIOL CHEM, V286, P37158, DOI 10.1074/jbc.M111.284869; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wang JJ, 2006, HEART, V92, P1583, DOI 10.1136/hrt.2006.090522; Yzydorczyk C, 2006, AM J PHYSIOL-REG I, V291, pR1060, DOI 10.1152/ajpregu.00798.2005; Yzydorczyk C, 2008, HYPERTENSION, V52, P889, DOI 10.1161/HYPERTENSIONAHA.108.116251; Yzydorczyk C, 2013, J CARDIOVASC PHARM, V61, P8, DOI 10.1097/FJC.0b013e318274d1c4	83	19	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e92287	10.1371/journal.pone.0092287	http://dx.doi.org/10.1371/journal.pone.0092287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743169	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100007
J	Khan, HAA; Akram, W				Khan, Hafiz Azhar Ali; Akram, Waseem			The Effect of Temperature on the Toxicity of Insecticides against Musca domestica L.: Implications for the Effective Management of Diarrhea	PLOS ONE			English	Article							DIPTERA MUSCIDAE; SODIUM-CHANNELS; FLY CONTROL; HOUSE-FLY; RESISTANCE; PAKISTAN; LEPIDOPTERA; SHIGELLOSIS; MECHANISM	Background: Diarrhea is an important cause of childhood mortality in developing countries like Pakistan because of unhygienic conditions, lack of awareness, and unwise use of preventive measures. Mechanical transmission of diarrheal pathogens by house flies, Musca domestica, is believed as the most effective route of diarrhea transmission. Although the use of insecticides as a preventive measure is common worldwide for the management of house flies, success of the measure could be compromised by the prevailing environmental temperature since it significantly affects toxicity of insecticides and thus their efficacy. Peaks of the house fly density and diarrheal cases are usually coincided and season specific, yet little is known about the season specific use of insecticides. Methodology/Principal Findings: To determine the temperature-toxicity relationship in house flies, the effect of postbioassays temperature (range, 20-34 degrees C) on the toxicity of seven insecticides from organophosphate (chlorpyrifos, profenofos), pyrethroid (cypermethrin, deltamethrin) and new chemical (emamectin benzoate, fipronil, spinosad) classes was evaluated by using a feeding bioassay method. From 20-34 degrees C, the toxicities of chlorpyrifos, profenofos, emamectin and fipronil increased 2.10, 2.93, 2.40 and 3.82 fold (i.e. positive temperature coefficient), respectively. Whereas, the toxicities of cypermethrin, deltamethrin and spinosad decreased 2.21, 2.42 and 3.16 fold (i.e. negative temperature coefficient), respectively. Conclusion/Significance: These findings suggest that for the reduction in diarrheal cases, house flies should be controlled with insecticides according to the prevailing environmental temperature. Insecticides with a positive temperature coefficient may serve as potential candidates in controlling house flies and diarrhea epidemics in hot season and vice versa.	[Khan, Hafiz Azhar Ali] Univ Punjab, Inst Agr Sci, Lahore, Pakistan; [Akram, Waseem] Univ Agr Faisalabad, Dept Entomol, Faisalabad, Pakistan	University of Punjab; University of Agriculture Faisalabad	Khan, HAA (corresponding author), Univ Punjab, Inst Agr Sci, Lahore, Pakistan.	azhar_naturalist@yahoo.com	Khan, Hafiz Azhar Ali/AAI-7476-2021	Khan, Hafiz Azhar Ali/0000-0002-7209-4750				[Anonymous], 2013, CLIMATE PAKISTAN; Boina DR, 2009, J ECON ENTOMOL, V102, P685, DOI 10.1603/029.102.0229; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Chavasse D, 1996, SOC SCI MED, V43, P1289, DOI 10.1016/0277-9536(95)00409-2; Chavasse DC, 1999, LANCET, V353, P22, DOI 10.1016/S0140-6736(98)03366-2; COHEN D, 1991, LANCET, V337, P993, DOI 10.1016/0140-6736(91)92657-N; Farag TH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002280; Glunt KD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003602; Harwood AD, 2009, ENVIRON TOXICOL CHEM, V28, P1051, DOI 10.1897/08-291.1; Khan HAA, 2014, ACTA TROP, V130, P148, DOI 10.1016/j.actatropica.2013.11.006; Khan HAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077225; Khan HAA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060929; Khan HAA, 2013, PARASITOL RES, V112, P2049, DOI 10.1007/s00436-013-3365-8; Khan HAA, 2013, ECOTOXICOLOGY, V22, P522, DOI 10.1007/s10646-013-1044-2; Khan HAA, 2012, PARASITOL RES, V111, P1165, DOI 10.1007/s00436-012-2947-1; Khan HMR, 2013, JP J BIOSTAT, V9, P1; Kobayashi M, 1999, AM J TROP MED HYG, V61, P625, DOI 10.4269/ajtmh.1999.61.625; Li HP, 2006, PESTIC BIOCHEM PHYS, V86, P151, DOI 10.1016/j.pestbp.2006.03.001; Lindsay SW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001895; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; MONTGOMERY JC, 1990, AM J PHYSIOL, V259, pR191, DOI 10.1152/ajpregu.1990.259.2.R191; Musser FR, 2005, PEST MANAG SCI, V61, P508, DOI 10.1002/ps.998; Muturi EJ, 2011, J MED ENTOMOL, V48, P243, DOI 10.1603/ME10017; Narahashi T, 1995, TOXICOL LETT, V82-3, P239, DOI 10.1016/0378-4274(95)03482-X; Neilsen M, 2001, 25 INT WAT MAN I; NORMENT BR, 1970, J ECON ENTOMOL, V63, P502, DOI 10.1093/jee/63.2.502; Riveron J, 2009, J INSECT PHYSIOL, V55, P943, DOI 10.1016/j.jinsphys.2009.06.009; Saleem MA, 2008, J ECON ENTOMOL, V101, P1667, DOI 10.1603/0022-0493(2008)101[1667:RTSOOC]2.0.CO;2; SALGADO VL, 1989, NEUROTOXICOLOGY, V10, P1; SCOTT JG, 1995, REV PESTICIDE TOXICO, V3, P111; Song JH, 1996, J PHARMACOL EXP THER, V277, P445; United Nations, 2011, MILL DEV GOALS REP 2; Weinzierl R, 1998, MICROBIAL INSECTICID	33	45	47	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95636	10.1371/journal.pone.0095636	http://dx.doi.org/10.1371/journal.pone.0095636			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743188	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100150
J	Matsubara, K; Sarre, SD; Georges, A; Matsuda, Y; Graves, JAM; Ezaz, T				Matsubara, Kazumi; Sarre, Stephen D.; Georges, Arthur; Matsuda, Yoichi; Graves, Jennifer A. Marshall; Ezaz, Tariq			Highly Differentiated ZW Sex Microchromosomes in the Australian Varanus Species Evolved through Rapid Amplification of Repetitive Sequences	PLOS ONE			English	Article							CHROMOSOME EVOLUTION; DETERMINING MECHANISMS; SQUAMATE REPTILES; Y-CHROMOSOME; LIZARDS; DNA; ORIGINS; TRANSITIONS; PHYLOGENY; VARANIDAE	Transitions between sex determination systems have occurred in many lineages of squamates and it follows that novel sex chromosomes will also have arisen multiple times. The formation of sex chromosomes may be reinforced by inhibition of recombination and the accumulation of repetitive DNA sequences. The karyotypes of monitor lizards are known to be highly conserved yet the sex chromosomes in this family have not been fully investigated. Here, we compare male and female karyotypes of three Australian monitor lizards, Varanus acanthurus, V. gouldii and V. rosenbergi, from two different clades. V. acanthurus belongs to the acanthurus clade and the other two belong to the gouldii clade. We applied C-banding and comparative genomic hybridization to reveal that these species have ZZ/ZW sex micro-chromosomes in which the W chromosome is highly differentiated from the Z chromosome. In combination with previous reports, all six Varanus species in which sex chromosomes have been identified have ZZ/ZW sex chromosomes, spanning several clades on the varanid phylogeny, making it likely that the ZZ/ZW sex chromosome is ancestral for this family. However, repetitive sequences of these ZW chromosome pairs differed among species. In particular, an (AAT)n microsatellite repeat motif mapped by fluorescence in situ hybridization on part of W chromosome in V. acanthurus only, whereas a (CGG) n motif mapped onto the W chromosomes of V. gouldii and V. rosenbergi. Furthermore, the W chromosome probe for V. acanthurus produced hybridization signals only on the centromeric regions of W chromosomes of the other two species. These results suggest that the W chromosome sequences were not conserved between gouldii and acanthurus clades and that these repetitive sequences have been amplified rapidly and independently on the W chromosome of the two clades after their divergence.	[Matsubara, Kazumi; Sarre, Stephen D.; Georges, Arthur; Graves, Jennifer A. Marshall; Ezaz, Tariq] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Matsuda, Yoichi] Nagoya Univ, Grad Sch Bioagr Sci, Dept Appl Mol Biosci, Nagoya, Aichi 4648601, Japan	University of Canberra; Nagoya University	Matsubara, K (corresponding author), Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia.	kazumi.matsubara@canberra.edu.au; Tariq.Ezaz@canberra.edu.au	Georges, Arthur/D-2153-2009; Ezaz, Tariq/D-9875-2011	Georges, Arthur/0000-0003-2428-0361; Graves, Jennifer/0000-0001-6480-7856; Ezaz, Tariq/0000-0003-4763-1347; Sarre, Stephen D./0000-0002-7158-2517	Australian Research Council [ARC DP110102262, FT110100733]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council Discovery Grant (ARC DP110102262) awarded to TE, SS, AG, JG and YM. TE was supported by an Australian Research Council Future Fellowship (FT110100733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer SAM, 2008, GENES GENET SYST, V83, P275, DOI 10.1266/ggs.83.275; Ast JC, 2001, CLADISTICS, V17, P211, DOI 10.1111/j.1096-0031.2001.tb00118.x; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Cioffi MB, 2011, CYTOGENET GENOME RES, V132, P188, DOI 10.1159/000321571; COGGER HG, 1992, REPTILES AMPHIBIANS; Ezaz T, 2009, CYTOGENET GENOME RES, V127, P249, DOI 10.1159/000300507; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Ezaz T, 2006, CURR BIOL, V16, pR736, DOI 10.1016/j.cub.2006.08.021; Ezaz T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-899; Ezaz T, 2008, CYTOTECHNOLOGY, V58, P135, DOI 10.1007/s10616-009-9182-3; Fitch AJ, 2006, AUST J ZOOL, V54, P253, DOI 10.1071/ZO05038; Fuller S, 1998, MOL PHYLOGENET EVOL, V9, P294, DOI 10.1006/mpev.1997.0476; Hobza R, 2006, CHROMOSOMA, V115, P376, DOI 10.1007/s00412-006-0065-5; Janzen Fredric J., 2004, P121; Kawai A, 2007, CYTOGENET GENOME RES, V117, P92, DOI 10.1159/000103169; KING M, 1975, AUST J BIOL SCI, V28, P89, DOI 10.1071/BI9750089; KING M, 1982, GENETICA, V58, P39, DOI 10.1007/BF00056001; KRAEMER C, 1993, CHROMOSOMA, V102, P553, DOI 10.1007/BF00368348; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; Matsubara K, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-60; MORITZ C, 1984, CHROMOSOMA, V90, P111, DOI 10.1007/BF00292447; NANDA I, 1990, J MOL EVOL, V30, P456, DOI 10.1007/BF02101117; O'Meally D, 2010, CHROMOSOME RES, V18, P787, DOI 10.1007/s10577-010-9152-9; Organ CL, 2008, INTEGR COMP BIOL, V48, P512, DOI 10.1093/icb/icn041; Pokorna M, 2009, ZOOL J LINN SOC-LOND, V156, P168, DOI 10.1111/j.1096-3642.2008.00481.x; Sarre SD, 2004, BIOESSAYS, V26, P639, DOI 10.1002/bies.20050; Sarre SD, 2011, ANNU REV GENOM HUM G, V12, P391, DOI 10.1146/annurev-genom-082410-101518; Signorino G., 2005, CHROMOREP REPTILE CH; Srikulnath K, 2013, CHROMOSOME RES, V21, P805, DOI 10.1007/s10577-013-9398-0; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Uetz P, 2013, REPTILE DATABASE; Vicoso B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001643; Vidal N, 2012, BIOL LETTERS, V8, P853, DOI 10.1098/rsbl.2012.0460; VIETS BE, 1994, J EXP ZOOL, V270, P45, DOI 10.1002/jez.1402700106	35	37	38	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95226	10.1371/journal.pone.0095226	http://dx.doi.org/10.1371/journal.pone.0095226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743344	Green Published, gold			2022-12-25	WOS:000335309100091
J	Mukhopadhyay, A; Maulik, U				Mukhopadhyay, Anirban; Maulik, Ujjwal			Network-Based Study Reveals Potential Infection Pathways of Hepatitis-C Leading to Various Diseases	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SMALL-MOLECULE INHIBITORS; VIRUS-INFECTION; VIRAL-HEPATITIS; RISK; ASSOCIATION; CANCER	Protein-protein interaction network-based study of viral pathogenesis has been gaining popularity among computational biologists in recent days. In the present study we attempt to investigate the possible pathways of hepatitis-C virus (HCV) infection by integrating the HCV-human interaction network, human protein interactome and human genetic disease association network. We have proposed quasi-biclique and quasi-clique mining algorithms to integrate these three networks to identify infection gateway host proteins and possible pathways of HCV pathogenesis leading to various diseases. Integrated study of three networks, namely HCV-human interaction network, human protein interaction network, and human proteins-disease association network reveals potential pathways of infection by the HCV that lead to various diseases including cancers. The gateway proteins have been found to be biologically coherent and have high degrees in human interactome compared to the other virus-targeted proteins. The analyses done in this study provide possible targets for more effective anti-hepatitis-C therapeutic involvement.	[Mukhopadhyay, Anirban] Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India; [Maulik, Ujjwal] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India	Kalyani University; Jadavpur University	Mukhopadhyay, A (corresponding author), Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India.	anirban@klyuniv.ac.in	Maulik, Ujjwal/AAO-8754-2020; Mukhopadhyay, Anirban/H-3220-2012; Mukhopadhyay, Anirban/ABB-5739-2021	Mukhopadhyay, Anirban/0000-0001-8128-3521; Maulik, Ujjwal/0000-0003-1167-0774				Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Bhattacharyya M, 2012, LNCS; Bhattacharyya M, 2009, MEMET COMPUT, V1, P281, DOI [10.1007/s12293-009-0019-6, DOI 10.1007/S12293-009-0019-6]; Butt AA, 2009, CLIN INFECT DIS, V49, P225, DOI 10.1086/599371; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chen LK, 2005, DIABETIC MED, V22, P340, DOI 10.1111/j.1464-5491.2005.01412.x; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; Andrade LJD, 2009, J GLOB INFECT DIS, V1, P33, DOI 10.4103/0974-777X.52979; El-Serag HB, 2009, HEPATOLOGY, V49, P116, DOI 10.1002/hep.22606; Emilia G, 1997, J MED VIROL, V53, P182, DOI 10.1002/(SICI)1096-9071(19971003)53:2<182::AID-JMV12>3.0.CO;2-L; Ferri C, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3865; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giordanino C, 2012, DIGEST LIVER DIS, V44, P406, DOI 10.1016/j.dld.2011.12.003; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hou JK, 2010, INFLAMM BOWEL DIS, V16, P925, DOI 10.1002/ibd.21284; Huang J, 1997, P NATL ACAD SCI USA, V94, P13396, DOI 10.1073/pnas.94.25.13396; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jain AK., 1988, TECHNOMETRICS; Kim BK, 2011, J KOREAN MED SCI, V26, P1638, DOI 10.3346/jkms.2011.26.12.1638; Klco JM, 2010, AM J HEMATOL, V85, P106, DOI 10.1002/ajh.21600; Kwofie SK, 2011, INFECT GENET EVOL; Lorenz IC, 2010, VIRUSES-BASEL, V2, P1635, DOI 10.3390/v2081635; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; Maulik U, 2011, MOL BIOSYST, V7, P1842, DOI 10.1039/c1mb05026e; Mohamed AA, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-496; Mukhopadhyay A., 2010, 2010 International Conference on Systems in Medicine and Biology (ICSMB), P344, DOI 10.1109/ICSMB.2010.5735401; Mukhopadhyay A., 2007, P 10 INT C INF TECHN, P74, DOI DOI 10.1109/ICIT.2007.13; Mukhopadhyay A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-26; Mukhopadhyay A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032289; Mukhopadhyay A, 2010, CURR BIOINFORM, V5, P204, DOI 10.2174/157489310792006701; Nanda KS, 2009, CLIN GASTROENTEROL H, V7, P894, DOI 10.1016/j.cgh.2009.01.011; Negro F, 2009, PPAR RES, V2009, DOI 10.1155/2009/483485; Omland Lars Haukali, 2010, Clin Epidemiol, V2, P179; Osna NA, 2008, GASTROENTEROLOGY, V134, P2144, DOI 10.1053/j.gastro.2008.02.063; Ouwe-Missi-Oukem-Boyer O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016034; Panchenko A., 2008, PROTEIN PROTEIN INTE, V9; Perlemuter G, 2003, J RHEUMATOL, V30, P1473; Popescu CI, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001278; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Salcedo-Mora X, 2006, DIGESTION, V73, P210, DOI 10.1159/000094787; Schiefke I, 2005, WORLD J GASTROENTERO, V11, P1843, DOI 10.3748/wjg.v11.i12.1843; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Su FH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-495; Suzuki R, 2009, J VIROL, V83, P2389, DOI 10.1128/JVI.01690-08; Tastan O, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P516; Tripathi LP, 2010, MOL BIOSYST, V6, P2539, DOI 10.1039/c0mb00103a; Tsuge M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023856; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Welbourn S, 2009, J GEN VIROL, V90, P1071, DOI 10.1099/vir.0.009944-0; Yamamoto T, 1995, ACTA DERM-VENEREOL, V75, P482; Zhang LL, 2011, J HEPATOL, V55, P289, DOI 10.1016/j.jhep.2010.11.019; Zhang YQ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-1; Zheng SY, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-62	53	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94029	10.1371/journal.pone.0094029	http://dx.doi.org/10.1371/journal.pone.0094029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743187	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100023
J	Smith, SDA; Edgar, RJ				Smith, Stephen D. A.; Edgar, Robert J.			Documenting the Density of Subtidal Marine Debris across Multiple Marine and Coastal Habitats	PLOS ONE			English	Article							NORTHWESTERN HAWAIIAN-ISLANDS; LOST FISHING GEAR; PLASTIC DEBRIS; SEA-TURTLES; NEW-ZEALAND; FUR SEALS; CORAL; LITTER; ACCUMULATION; INGESTION	Marine debris is recognised globally as a key threatening process to marine life, but efforts to address the issue are hampered by the lack of data for many marine habitats. By developing standardised protocols and providing training in their application, we worked with >300 volunteer divers from 11 underwater research groups to document the scale of the subtidal marine debris problem at 120 sites across >1000 km of the coast of NSW, Australia. Sampling consisted of replicated 25x5 m transects in which all debris was identified, counted, and, where appropriate, removed. Sites ranged from estuarine settings adjacent to major population centres, to offshore islands within marine parks. Estuaries and embayments were consistently found to be the most contaminated habitats. Fishing-related items (and especially monofilament and braided fishing line) were most prevalent at the majority of sites, although food and drink items were important contributors at sites adjacent to population centres. The results identified damaging interactions between marine debris and marine biota at some key locations, highlighting the need for management intervention to ensure habitat sustainability. This study reinforces the important contribution that volunteers can make to assessing conservation issues requiring broad-scale data collection. In this case, citizen scientists delivered data that will inform, and help to prioritise, management approaches at both statewide and local scales. These initial data also provide an important baseline for longer-term, volunteer-based monitoring programs.	[Smith, Stephen D. A.; Edgar, Robert J.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia	Southern Cross University	Smith, SDA (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	steve.smith@scu.edu.au	Smith, Stephen D A/I-1945-2012	Smith, Stephen D A/0000-0002-3372-5441	HCRCMA; National Marine Science Centre; Marine Ecology Research Centre, Southern Cross University;  [HCR10_031];  [HCR11_013];  [HCR12_618]	HCRCMA; National Marine Science Centre; Marine Ecology Research Centre, Southern Cross University; ; ; 	The project was funded through Caring for Our Country grants to the NSW Catchment Management Authority (CMA), administered through the Hunter-Central Rivers CMA (HCR10_031, HCR11_013, HCR12_618) (http://www.hcr.cma.nsw.gov.au/). Brian Hughes, Tina Clemens and Hayley Leczkowski (HCRCMA) managed contracts between the HCRCMA and the National Marine Science Centre, and provided support for the project. Publication costs were supported by the Marine Ecology Research Centre, Southern Cross University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hilal A, 2009, J ENVIRON MANAGE, V90, P1043, DOI 10.1016/j.jenvman.2008.03.014; Al-Najjar T., 2011, RED SEA NATURAL SCI, V3, P921, DOI [10.4236/ns.2011.311118, DOI 10.4236/NS.2011.311118]; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2011, UNDERSTANDING TYPES; Asoh K, 2004, CONSERV BIOL, V18, P1645, DOI 10.1111/j.1523-1739.2004.00122.x; Backhurst MK, 2000, J ENVIRON MANAGE, V60, P227, DOI 10.1006/jema.2000.0381; Ballance A, 2000, S AFR J SCI, V96, P210; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bauer LJ, 2008, MAR POLLUT BULL, V56, P402, DOI 10.1016/j.marpolbul.2007.11.001; Beger M, 2014, DIVERS DISTRIB, V20, P245, DOI 10.1111/ddi.12140; BJORNDAL KA, 1994, MAR POLLUT BULL, V28, P154, DOI 10.1016/0025-326X(94)90391-3; Boland RC, 2003, MAR POLLUT BULL, V46, P1385, DOI 10.1016/S0025-326X(03)00291-1; Boren LJ, 2006, MAR POLLUT BULL, V52, P442, DOI 10.1016/j.marpolbul.2005.12.003; Bravo M, 2009, MAR POLLUT BULL, V58, P1718, DOI 10.1016/j.marpolbul.2009.06.017; Campani T, 2013, MAR POLLUT BULL, V74, P225, DOI 10.1016/j.marpolbul.2013.06.053; Cheshire A., 2009, IOC TECHNICAL SERIES; Chiappone M, 2005, BIOL CONSERV, V121, P221, DOI 10.1016/j.biocon.2004.04.023; Codina-Garcia M, 2013, MAR POLLUT BULL, V77, P220, DOI 10.1016/j.marpolbul.2013.10.002; Dameron OJ, 2007, MAR POLLUT BULL, V54, P423, DOI 10.1016/j.marpolbul.2006.11.019; Department of the Environment & Heritage, 2003, KEY THREAT PROC HARM; Derraik JGB, 2002, MAR POLLUT BULL, V44, P842, DOI 10.1016/S0025-326X(02)00220-5; Donohue MJ, 2001, MAR POLLUT BULL, V42, P1301, DOI 10.1016/S0025-326X(01)00139-4; Eriksson C, 2013, MAR POLLUT BULL, V66, P199, DOI 10.1016/j.marpolbul.2012.08.026; Gorley RN, 2006, PRIMER V6; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HARRIOTT VJ, 1994, MAR ECOL PROG SER, V109, P67, DOI 10.3354/meps109067; Harriott VJ, 1999, MAR FRESHWATER RES, V50, P299, DOI 10.1071/MF98042; Jacobsen JK, 2010, MAR POLLUT BULL, V60, P765, DOI 10.1016/j.marpolbul.2010.03.008; Katsanevakis S., 2008, MARINE POLLUTION NEW, P53; LAIST DW, 1987, MAR POLLUT BULL, V18, P319, DOI 10.1016/S0025-326X(87)80019-X; Lavers JL, 2014, ENVIRON POLLUT, V187, P124, DOI 10.1016/j.envpol.2013.12.020; Levy AM, 2009, J WILDLIFE DIS, V45, P834, DOI 10.7589/0090-3558-45.3.834; Malcolm HA, 2010, AQUAT CONSERV, V20, P83, DOI 10.1002/aqc.1055; Martin JM, 2013, MAR POLLUT BULL, V74, P165, DOI 10.1016/j.marpolbul.2013.07.009; Mcllgorm A, 2011, OCEAN COAST MANAGE, V54, P643, DOI 10.1016/j.ocecoaman.2011.05.007; Nagelkerken I, 2001, MAR POLLUT BULL, V42, P786, DOI 10.1016/S0025-326X(01)00091-1; Page B, 2004, MAR POLLUT BULL, V49, P33, DOI 10.1016/j.marpolbul.2004.01.006; Poulos D, 2011, UNIQUE SOFT CORAL HA; Poulos DE, 2013, AQUAT CONSERV, V23, P838, DOI 10.1002/aqc.2362; REES G, 1995, MAR POLLUT BULL, V30, P103, DOI 10.1016/0025-326X(94)00192-C; Richards ZT, 2011, MAR POLLUT BULL, V62, P1693, DOI 10.1016/j.marpolbul.2011.06.003; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Sheavly SB, 2010, NAT MARINE DEBRIS PR; Smith SDA, 2008, CORAL REEFS, V27, P321, DOI 10.1007/s00338-007-0340-9; Smith S.D.A., 2010, MARINE ENV HUNTER CE; Smith SDA, 2008, MAR POLLUT BULL, V56, P525, DOI 10.1016/j.marpolbul.2007.11.016; Smith SDA, 2012, MAR POLLUT BULL, V64, P1880, DOI 10.1016/j.marpolbul.2012.06.013; Smith V. K., 1997, Environmental and Resource Economics, V10, P223, DOI 10.1023/A:1026465413899; Somerville SE, 2003, MAR POLLUT BULL, V46, P1184, DOI 10.1016/S0025-326X(03)00126-7; Storrier KL, 2006, MAR POLICY, V30, P189, DOI 10.1016/j.marpol.2005.01.002; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Szema AM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061449, 10.1371/journal.pone.0074373]; Tomas J, 2002, MAR POLLUT BULL, V44, P211, DOI 10.1016/S0025-326X(01)00236-3; Tourinho PS, 2010, MAR POLLUT BULL, V60, P396, DOI 10.1016/j.marpolbul.2009.10.013; Uneputty P, 1997, MAR ENVIRON RES, V44, P233, DOI 10.1016/S0141-1136(97)00002-0	56	50	53	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94593	10.1371/journal.pone.0094593	http://dx.doi.org/10.1371/journal.pone.0094593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743690	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100035
J	Sun, Y; Wang, LX; Zhou, YF; Mao, XF; Deng, XD				Sun, Yong; Wang, Liangxi; Zhou, Yifang; Mao, Xuefei; Deng, Xiangdong			Cloning and Characterization of the Human Trefoil Factor 3 Gene Promoter	PLOS ONE			English	Article							MOLECULAR-CLONING; ESCHERICHIA-COLI; CANCER-CELLS; TRANSCRIPTION; LUCIFERASE; EXPRESSION; CDNA; IDENTIFICATION; PEPTIDE; FAMILY	Human trefoil factor 3 (hTFF3) is a small-molecule peptide with potential medicinal value. Its main pharmacological function is to alleviate gastrointestinal mucosal injuries caused by various factors and promote the repair of damaged mucosa. However, how its transcription is regulated is not yet known. The aim of this study was to clone the hTFF3 gene promoter region, identify the core promoter and any transcription factors that bind to the promoter, and begin to clarify the regulation of its expression. The 59 flanking sequence of the hTFF3 gene was cloned from human whole blood genomic DNA by PCR. Truncated promoter fragments with different were cloned and inserted into the pGL3-Basic vector to determine the position of the core hTFF3 promoter. Transcription element maintaining basic transcriptional activity was assessed by mutation techniques. Protein-DNA interactions were analyzed by chromatin immunoprecipitation (ChIP). RNA interference and gene over-expression were performed to assay the effect of transcription factor on the hTFF3 expression. The results showed that approximately 1,826 bp of the fragment upstream of hTFF3 was successfully amplified, and its core promoter region was determined to be from -300 bp to -280 bp through analysis of truncated mutants. Mutation analysis confirmed that the sequence required to maintain basic transcriptional activity was accurately positioned from -300 bp to -296 bp. Bioinformatic analysis indicated that this area contained a Sp1 binding site. Sp1 binding to the hTFF3 promoter was confirmed by ChIP experiments. Sp1 over-expression and interference experiments showed that Sp1 enhanced the transcriptional activity of the hTFF3 promoter and increased hTFF3 expression. This study demonstrated that Sp1 plays an important role in maintaining the transcription of hTFF3.	[Sun, Yong; Wang, Liangxi; Zhou, Yifang; Mao, Xuefei; Deng, Xiangdong] Xuzhou Med Coll, Huaihai Hosp, Dept Burn Surg, Xuzhou, Jiangsu, Peoples R China; [Sun, Yong; Wang, Liangxi; Zhou, Yifang; Mao, Xuefei; Deng, Xiangdong] 97 Hosp PLA, Dept Burn Surg, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University	Sun, Y (corresponding author), Xuzhou Med Coll, Huaihai Hosp, Dept Burn Surg, Xuzhou, Jiangsu, Peoples R China.	sunyong_97@sina.com			National Natural Science Foundation of China [81100252]; Scientific Research Funds of Nanjing Military Command [09Z007, 12Z10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Funds of Nanjing Military Command	This work was supported by the National Natural Science Foundation of China (Grant 81100252) and the Scientific Research Funds of Nanjing Military Command (09Z007, 12Z10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-azzeh E, 2002, GUT, V51, P685, DOI 10.1136/gut.51.5.685; Anish R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005103; Choi YS, 2002, COMP BIOCHEM PHYS B, V132, P661, DOI 10.1016/S1096-4959(02)00085-4; DEWET JR, 1985, P NATL ACAD SCI USA, V82, P7870; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Emamzadeh AR, 2006, J BIOCHEM MOL BIOL, V39, P578; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Giraud AS, 2000, AM J PHYSIOL-GASTR L, V278, pG501, DOI 10.1152/ajpgi.2000.278.4.G501; Lee KS, 2001, J BIOTECHNOL, V92, P9, DOI 10.1016/S0168-1656(01)00323-6; Li L, 2008, J CELL BIOCHEM, V105, P365, DOI 10.1002/jcb.21832; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077732; Malecova B, 2007, J BIOL CHEM, V282, P24767, DOI 10.1074/jbc.M702776200; Muenphon K, 2006, WORLD J GASTROENTERO, V12, P4143, DOI 10.3748/wjg.v12.i26.4143; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Sakaguchi T, 2002, J BIOL CHEM, V277, P21361, DOI 10.1074/jbc.M110261200; SUEMORI S, 1991, P NATL ACAD SCI USA, V88, P11017, DOI 10.1073/pnas.88.24.11017; Sun Y, 2008, J TRAUMA, V65, P163, DOI 10.1097/TA.0b013e318076b49f; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062429; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Yamada H, 2012, ENDOCR J, V59, P621, DOI 10.1507/endocrj.EJ12-0077; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Zheng QQ, 2013, BIOCHEM BIOPH RES CO, V438, P6, DOI 10.1016/j.bbrc.2013.06.115	22	7	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95562	10.1371/journal.pone.0095562	http://dx.doi.org/10.1371/journal.pone.0095562			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743382	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100139
J	Wielstra, B; Arntzen, JW				Wielstra, Ben; Arntzen, Jan W.			Exploring the Effect of Asymmetric Mitochondrial DNA Introgression on Estimating Niche Divergence in Morphologically Cryptic Species	PLOS ONE			English	Article							NEWTS TRITURUS-KARELINII; CRESTED NEWTS; NUCLEAR; PHYLOGEOGRAPHY; CONSERVATISM; REPLACEMENT; DIVERSITY; TAXONOMY; LINE	If potential morphologically cryptic species, identified based on differentiated mitochondrial DNA, express ecological divergence, this increases support for their treatment as distinct species. However, mitochondrial DNA introgression hampers the correct estimation of ecological divergence. We test the hypothesis that estimated niche divergence differs when considering nuclear DNA composition or mitochondrial DNA type as representing the true species range. We use empirical data of two crested newt species (Amphibia: Triturus) which possess introgressed mitochondrial DNA from a third species in part of their ranges. We analyze the data in environmental space by determining Fisher distances in a principal component analysis and in geographical space by determining geographical overlap of species distribution models. We find that under mtDNA guidance in one of the two study cases niche divergence is overestimated, whereas in the other it is underestimated. In the light of our results we discuss the role of estimated niche divergence in species delineation.	[Wielstra, Ben; Arntzen, Jan W.] Nat Biodivers Ctr, Leiden, Netherlands; [Wielstra, Ben] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	Naturalis Biodiversity Center; University of Sheffield	Wielstra, B (corresponding author), Nat Biodivers Ctr, Leiden, Netherlands.	ben.wielstra@naturalis.nl	Wielstra, Ben/G-3773-2015; Arntzen, Jan/E-7108-2016	Wielstra, Ben/0000-0002-7112-5965; Arntzen, Jan/0000-0003-3229-5993				Ahmadzadeh F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080563; Arntzen JW, 2007, CONTRIB ZOOL, V76, P261, DOI 10.1163/18759866-07604005; Arntzen JW, 2010, AMPHIBIA-REPTILIA, V31, P311; Arntzen JW, 1999, CONTRIB ZOOL, V68, P181, DOI 10.1163/18759866-06803004; Arntzen JW, 2003, HDB REPTILIEN AMPHIB, VIIA, P421, DOI DOI 10.2307/1565573; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Avise J.C, 2000, PHYLOGEOGRAPHY HIST, DOI DOI 10.2307/J.CTV1NZFGJ7; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Chan KMA, 2005, EVOLUTION, V59, P720; Coyne JA, 2004, SPECIATION; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Irwin DE, 2009, BIOL J LINN SOC, V98, P422, DOI 10.1111/j.1095-8312.2009.01282.x; Ivanovic A, 2013, ZOOL ANZ, V252, P269, DOI 10.1016/j.jcz.2012.08.005; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Raes N, 2007, ECOGRAPHY, V30, P727, DOI 10.1111/j.2007.0906-7590.05041.x; Rodder D, 2011, GLOBAL ECOL BIOGEOGR, V20, P915, DOI 10.1111/j.1466-8238.2011.00659.x; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; WALLIS GP, 1989, EVOLUTION, V43, P88, DOI 10.1111/j.1558-5646.1989.tb04209.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wielstra B, 2014, MOL ECOL RESOUR, V14, P1080, DOI 10.1111/1755-0998.12242; Wielstra B, 2013, ZOOTAXA, V3682, P441, DOI 10.11646/zootaxa.3682.3.5; Wielstra B, 2013, MOL PHYLOGENET EVOL, V67, P167, DOI 10.1016/j.ympev.2013.01.009; Wielstra B, 2010, MOL PHYLOGENET EVOL, V56, P888, DOI 10.1016/j.ympev.2010.04.030; Wielstra B, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-13; Wielstra B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046671; Wielstra B, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-161; Wielstra B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-162; Zielinski P, 2013, MOL ECOL, V22, P1884, DOI 10.1111/mec.12225	40	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95504	10.1371/journal.pone.0095504	http://dx.doi.org/10.1371/journal.pone.0095504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743746	Green Published, gold, Green Accepted			2022-12-25	WOS:000335309100130
J	Zhou, Y; Xu, JC; Liu, YQ; Li, JT; Chang, CF; Xu, CS				Zhou, Yun; Xu, Jiucheng; Liu, Yunqing; Li, Juntao; Chang, Cuifang; Xu, Cunshuan			Rat Hepatocytes Weighted Gene Co-Expression Network Analysis Identifies Specific Modules and Hub Genes Related to Liver Regeneration after Partial Hepatectomy	PLOS ONE			English	Article							EXPRESSION; DISEASE; PROLIFERATION; REVEALS	The recovery of liver mass is mainly mediated by proliferation of hepatocytes after 2/3 partial hepatectomy (PH) in rats. Studying the gene expression profiles of hepatocytes after 2/3 PH will be helpful to investigate the molecular mechanisms of liver regeneration (LR). We report here the first application of weighted gene co-expression network analysis (WGCNA) to analyze the biological implications of gene expression changes associated with LR. WGCNA identifies 12 specific gene modules and some hub genes from hepatocytes genome-scale microarray data in rat LR. The results suggest that upregulated MCM5 may promote hepatocytes proliferation during LR; BCL3 may play an important role by activating or inhibiting NF-kB pathway; MAPK9 may play a permissible role in DNA replication by p38 MAPK inactivation in hepatocytes proliferation stage. Thus, WGCNA can provide novel insight into understanding the molecular mechanisms of LR.	[Zhou, Yun; Liu, Yunqing; Chang, Cuifang; Xu, Cunshuan] Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China; [Zhou, Yun; Liu, Yunqing; Chang, Cuifang; Xu, Cunshuan] Henan Normal Univ, Key Lab Cell Differentiat & Regulat, Xinxiang, Henan, Peoples R China; [Zhou, Yun; Xu, Jiucheng] Henan Normal Univ, Coll Comp & Informat Engn, Xinxiang, Henan, Peoples R China; [Li, Juntao] Henan Normal Univ, Coll Math & Informat Sci, Xinxiang, Henan, Peoples R China	Henan Normal University; Henan Normal University; Henan Normal University; Henan Normal University	Zhou, Y (corresponding author), Henan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China.	zy@htu.cn; cellkeylab@126.com			Natural Science Foundation of Henan Province [122300410355]; Postgraduate Innovative Fund of Henan Normal University [YL201312]; National Science Foundation of China [60873104, 61370169]; National Basic Research 973 Pre-Research Program of China [2012CB722304]	Natural Science Foundation of Henan Province; Postgraduate Innovative Fund of Henan Normal University; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research 973 Pre-Research Program of China(National Basic Research Program of China)	This work was partially supported by the Natural Science Foundation of Henan Province, Grant No. 122300410355, the Postgraduate Innovative Fund of Henan Normal University, Grant No. YL201312, the National Science Foundation of China, Grant Nos. 60873104 and 61370169, and the National Basic Research 973 Pre-Research Program of China, Grant No. 2012CB722304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Campbell JS, 2011, INT J BIOCHEM CELL B, V43, P180, DOI 10.1016/j.biocel.2010.08.002; Chen L, 2009, BIOMOLECULAR NETWORK, V10; Childs KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022196; Dewey FE, 2011, CIRC-CARDIOVASC GENE, V4, P26, DOI 10.1161/CIRCGENETICS.110.941757; Dransfeld O, 2005, LIVER INT, V25, P1243, DOI 10.1111/j.1478-3231.2005.01158.x; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fukuhara Y, 2003, J HEPATOL, V38, P784, DOI 10.1016/S0168-8278(03)00077-1; He DN, 2012, J MOL CELL BIOL, V4, P140, DOI 10.1093/jmcb/mjs011; He DN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-592; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huang XQ, 2006, CANCER RES, V66, P1481, DOI 10.1158/0008-5472.CAN-05-2412; Ilowski M, 2009, CHIRURG FORUM DGAV F, P199; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Liu ZP, 2012, IET SYST BIOL, V6, P22, DOI 10.1049/iet-syb.2010.0052; MacLennan NK, 2009, MOL GENET METAB, V98, P203, DOI 10.1016/j.ymgme.2009.05.004; Maione D, 1998, EMBO J, V17, P5588, DOI 10.1093/emboj/17.19.5588; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Puniya BL, 2013, MOL BIOSYST, V9, P2798, DOI 10.1039/c3mb70278b; Qiu YD, 2012, WORLD J GASTROENTERO, V18, P3288, DOI 10.3748/wjg.v18.i25.3288; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8; Shu RZ, 2009, LAB INVEST, V89, P1043, DOI 10.1038/labinvest.2009.63; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Xu CS, 2005, WORLD J GASTROENTERO, V11, P2932, DOI 10.3748/wjg.v11.i19.2932; Xu CS, 2011, TISSUE CELL, V43, P291, DOI 10.1016/j.tice.2011.06.001; Xu CS, 2010, DEV GENES EVOL, V220, P263, DOI 10.1007/s00427-010-0345-1; Xu Cunshuan, 2004, Genomics Proteomics & Bioinformatics, V2, P109; Yang SB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00427; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22; Zeng A, 2013, J CELL BIOL, V201, P409, DOI 10.1083/jcb.201207172; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang J, 2010, BMC BIOINFORMATICS, V11, DOI [10.1186/1471-2105-11-S9-S5, 10.1186/1471-2105-11-s9-s5]	39	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94868	10.1371/journal.pone.0094868	http://dx.doi.org/10.1371/journal.pone.0094868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743545	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100047
J	Bikker, A; Kruize, AA; van der Wurff-Jacobs, KMG; Peters, RP; Kleinjan, M; Redegeld, F; de Jager, W; Lafeber, FPJG; van Roon, JAG				Bikker, Angela; Kruize, Aike A.; van der Wurff-Jacobs, Kim M. G.; Peters, Rogier P.; Kleinjan, Marije; Redegeld, Frank; de Jager, Wilco; Lafeber, Floris P. J. G.; van Roon, Joel A. G.			Interleukin-7 and Toll-Like Receptor 7 Induce Synergistic B Cell and T Cell Activation	PLOS ONE			English	Article							PRIMARY SJOGRENS-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID SYNOVIAL TISSUE; DENDRITIC CELLS; SALIVARY-GLANDS; CYTOKINE PRODUCTION; MOLECULAR MIMICRY; EPITHELIAL-CELLS; GENE-EXPRESSION; CHRONIC COLITIS	Objectives: To investigate the potential synergy of IL-7-driven T cell-dependent and TLR7-mediated B cell activation and to assess the additive effects of monocyte/macrophages in this respect. Methods: Isolated CD19 B cells and CD4 T cells from healthy donors were co-cultured with TLR7 agonist (TLR7A, Gardiquimod), IL-7, or their combination with or without CD14 monocytes/macrophages (T/B/mono; 1 : 1 : 0,1). Proliferation was measured using H-3-thymidine incorporation and Ki67 expression. Activation marker (CD19, HLA-DR, CD25) expression was measured by FACS analysis. Immunoglobulins were measured by ELISA and release of cytokines was measured by Luminex assay. Results: TLR7-induced B cell activation was not associated with T cell activation. IL-7-induced T cell activation alone and together with TLR7A synergistically increased numbers of both proliferating (Ki67(+)) B cells and T cells, which was further increased in the presence of monocytes/macrophages. This was associated by up regulation of activation markers on B cells and T cells. Additive or synergistic induction of production of immunoglobulins by TLR7 and IL-7 was associated by synergistic induction of T cell cytokines (IFN gamma, IL-17A, IL-22), which was only evident in the presence of monocytes/macrophages. Conclusions: IL-7-induced CD4 T cell activation and TLR7-induced B cell activation synergistically induce T helper cell cytokine and B cell immunoglobulin production, which is critically dependent on monocytes/macrophages. Our results indicate that previously described increased expression of IL-7 and TLR7 together with increased numbers of macrophages at sites of inflammation in autoimmune diseases like RA and pSS significantly contributes to enhanced lymphocyte activation.	[Bikker, Angela; Kruize, Aike A.; van der Wurff-Jacobs, Kim M. G.; Peters, Rogier P.; Lafeber, Floris P. J. G.; van Roon, Joel A. G.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Kleinjan, Marije; Redegeld, Frank] Univ Utrecht, Fac Sci, Dept Pharmaceut Sci, Utrecht, Netherlands; [de Jager, Wilco] Univ Med Ctr Utrecht, Dept Pediat Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center	Bikker, A (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	angela.bikker@gmail.com	Redegeld, Frank A/O-6534-2016	Redegeld, Frank A/0000-0001-8830-7960; de Jager, Wilco/0000-0002-0014-0682	Dutch Arthritis Association ('Nationaal Reumafonds')	Dutch Arthritis Association ('Nationaal Reumafonds')	Financially supported by the 'Dutch Arthritis Association' (het 'Nationaal Reumafonds'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1998, CLIN EXP IMMUNOL, V111, P457; Avalos AM, 2010, AUTOIMMUNITY, V43, P76, DOI 10.3109/08916930903374618; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Bikker A, 2011, ANN RHEUM DIS, V70, pA63, DOI 10.1136/ard.2010.149005.14; Bikker A, 2010, ARTHRITIS RHEUM-US, V62, P969, DOI 10.1002/art.27318; Bikker A, 2012, CURR PHARM DES; Bikker A, 2012, ANN RHEUM DIS; Bikker A, 2012, RHEUMATOLOGY OXFORD; Bonifati C, 1997, CLIN IMMUNOL IMMUNOP, V83, P41, DOI 10.1006/clin.1996.4313; Booth DR, 2005, J MOL MED, V83, P822, DOI 10.1007/s00109-005-0684-y; Brkic Z, 2013, ANN RHEUM DIS, V72, P728, DOI 10.1136/annrheumdis-2012-201381; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christodoulou MI, 2010, J AUTOIMMUN, V34, P400, DOI 10.1016/j.jaut.2009.10.004; de Jager W, 2007, ANN RHEUM DIS, V66, P589, DOI 10.1136/ard.2006.061853; DEBENEDETTI F, 1995, J RHEUMATOL, V22, P1581; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016/S1471-4906(01)02028-2; Giliani S, 2005, IMMUNOL REV, V203, P110, DOI 10.1111/j.0105-2896.2005.00234.x; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; GUERRIER T, 2012, J AUTOIMMUN; Hartgring SAY, 2010, ARTHRITIS RHEUM-US, V62, P2716, DOI 10.1002/art.27578; Hartgring SAY, 2009, ARTHRITIS RHEUM-US, V60, P2595, DOI 10.1002/art.24754; Kattah MG, 2008, ARTHRITIS RHEUM, V58, P1619, DOI 10.1002/art.23497; Kawakami A, 2007, J RHEUMATOL, V34, P1019; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Kormelink TG, 2010, ANN RHEUM DIS, V69, P2137, DOI 10.1136/ard.2009.126441; Krenn V, 1996, RHEUMATOL INT, V15, P239, DOI 10.1007/BF00290377; LALOR PA, 1987, RHEUMATOL INT, V7, P183, DOI 10.1007/BF00541375; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Liu XB, 2010, NAT MED, V16, P191, DOI 10.1038/nm.2077; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Manoussakis MN, 2010, J AUTOIMMUN, V35, P212, DOI 10.1016/j.jaut.2010.06.010; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; Means TK, 2005, ANN NY ACAD SCI, V1062, P242, DOI 10.1196/annals.1358.027; Niess JH, 2008, WORLD J GASTROENTERO, V14, P5138, DOI 10.3748/wjg.14.5138; Poole BD, 2006, AUTOIMMUNITY, V39, P63, DOI 10.1080/08916930500484849; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Rane L, 2010, J NEUROIMMUNOL, V222, P82, DOI 10.1016/j.jneuroim.2010.02.014; Rihl M, 2008, ARTHRITIS RHEUM, V58, P3430, DOI 10.1002/art.23998; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Sammicheli S, 2012, J AUTOIMMUN; Spachidou MP, 2007, CLIN EXP IMMUNOL, V147, P497, DOI 10.1111/j.1365-2249.2006.03311.x; Tsukamoto Y, 2009, MOL IMMUNOL, V46, P1278, DOI 10.1016/j.molimm.2008.11.022; van Bon L, 2011, CURR OPIN RHEUMATOL, V23, P505, DOI 10.1097/BOR.0b013e32834b0dac; van Roon J, 2008, INCREASED IL 7 EXPRE; van Roon JAG, 2005, ARTHRITIS RHEUM, V52, P1700, DOI 10.1002/art.21045; van Roon JAG, 2003, ANN RHEUM DIS, V62, P113, DOI 10.1136/ard.62.2.113; van Roon JAG, 2010, RHEUMATOLOGY, V49, P2084, DOI 10.1093/rheumatology/keq237; Vanden Bush Tony J, 2009, J Immunol, V183, P4833, DOI 10.4049/jimmunol.0900968; Vasir B, 2005, J IMMUNOL, V174, P2376, DOI 10.4049/jimmunol.174.4.2376; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; Watanabe M, 1998, J EXP MED, V187, P389, DOI 10.1084/jem.187.3.389; Watanabe M, 1997, J CLIN IMMUNOL, V17, P282, DOI 10.1023/A:1027322631036; Wildenberg ME, 2009, ANN RHEUM DIS, V68, P420, DOI 10.1136/ard.2008.087874; Yamazaki M, 2003, J IMMUNOL, V171, P1556, DOI 10.4049/jimmunol.171.3.1556; Zheng LY, 2010, ORAL SURG ORAL MED O, V109, P844, DOI 10.1016/j.tripleo.2010.01.006	60	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94756	10.1371/journal.pone.0094756	http://dx.doi.org/10.1371/journal.pone.0094756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740301	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900062
J	Clarke, SM; Henry, HM; Dodds, KG; Jowett, TWD; Manley, TR; Anderson, RM; McEwan, JC				Clarke, Shannon M.; Henry, Hannah M.; Dodds, Ken G.; Jowett, Timothy W. D.; Manley, Tim R.; Anderson, Rayna M.; McEwan, John C.			A High Throughput Single Nucleotide Polymorphism Multiplex Assay for Parentage Assignment in New Zealand Sheep	PLOS ONE			English	Article							PATERNITY ANALYSIS; GENETIC EVALUATION; MARKERS; IDENTIFICATION; SELECTION; ACCURACY; DNA; MISIDENTIFICATION; INFORMATION; GENOTYPES	Accurate pedigree information is critical to animal breeding systems to ensure the highest rate of genetic gain and management of inbreeding. The abundance of available genomic data, together with development of high throughput genotyping platforms, means that single nucleotide polymorphisms (SNPs) are now the DNA marker of choice for genomic selection studies. Furthermore the superior qualities of SNPs compared to microsatellite markers allows for standardization between laboratories; a property that is crucial for developing an international set of markers for traceability studies. The objective of this study was to develop a high throughput SNP assay for use in the New Zealand sheep industry that gives accurate pedigree assignment and will allow a reduction in breeder input over lambing. This required two phases of development- firstly, a method of extracting quality DNA from ear-punch tissue performed in a high throughput cost efficient manner and secondly a SNP assay that has the ability to assign paternity to progeny resulting from mob mating. A likelihood based approach to infer paternity was used where sires with the highest LOD score (log of the ratio of the likelihood given parentage to likelihood given non-parentage) are assigned. An 84 "parentage SNP panel" was developed that assigned, on average, 99% of progeny to a sire in a problem where there were 3,000 progeny from 120 mob mated sires that included numerous half sib sires. In only 6% of those cases was there another sire with at least a 0.02 probability of paternity. Furthermore dam information (either recorded, or by genotyping possible dams) was absent, highlighting the SNP test's suitability for paternity testing. Utilization of this parentage SNP assay will allow implementation of progeny testing into large commercial farms where the improved accuracy of sire assignment and genetic evaluations will increase genetic gain in the sheep industry.	[Clarke, Shannon M.; Henry, Hannah M.; Dodds, Ken G.; Jowett, Timothy W. D.; Manley, Tim R.; Anderson, Rayna M.; McEwan, John C.] Invermay Agr Ctr, AgRes, Mosgiel, New Zealand	AgResearch - New Zealand	Clarke, SM (corresponding author), Invermay Agr Ctr, AgRes, Mosgiel, New Zealand.	Shannon.Clarke@agresearch.co.nz	McEwan, John/A-1143-2008	McEwan, John/0000-0003-4801-6207; Dodds, Ken/0000-0002-9347-6379; Clarke, Shannon/0000-0002-4615-8917; Anderson, Rayna/0000-0003-3970-7209	Ovita Limited; Beef and Lamb New Zealand	Ovita Limited; Beef and Lamb New Zealand	Funding for this research was provided by Ovita Limited and Beef and Lamb New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AUSTR MERINO; Banos G, 2001, J DAIRY SCI, V84, P2523, DOI 10.3168/jds.S0022-0302(01)74703-0; Baruch E, 2008, ANIM GENET, V39, P474, DOI 10.1111/j.1365-2052.2008.01754.x; Bell A. M., 2013, Proceedings of the Twentieth Conference of the Association for the Advancement of Animal Breeding and Genetics, Translating Science into Action, Napier, New Zealand, 20th-23rd October 2013, P278; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cooper TA, 2013, J DAIRY SCI, V96, P3336, DOI 10.3168/jds.2012-6208; Dodds K. G., 2003, 50 years of DNA: Proceedings of the Fifteenth Conference, Association for the Advancement of Animal Breeding and Genetics, Melbourne, Australia, 7-11 July 2003, P39; Dodds KG, 1996, THEOR APPL GENET, V92, P966, DOI 10.1007/BF00224036; Dodds KG, 2005, J ANIM SCI, V83, P2271; Fisher PJ, 2009, J DAIRY SCI, V92, P369, DOI 10.3168/jds.2008-1086; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Gill P, 2001, INT J LEGAL MED, V114, P204, DOI 10.1007/s004149900117; Gudex B, 2014, ANIM GENET, V45, P142, DOI 10.1111/age.12085; Harrison HB, 2013, MOL ECOL, V22, P1158, DOI 10.1111/mec.12138; Hayes B, 2005, AQUACULTURE, V250, P70, DOI 10.1016/j.aquaculture.2005.03.008; Hayes BJ, 2007, GENET RES, V89, P215, DOI 10.1017/S0016672307008865; Heaton MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094851; Heaton MP, 2002, MAMM GENOME, V13, P272, DOI 10.1007/s00335-001-2146-3; Hill WG, 2008, J ANIM SCI, V86, P2508, DOI 10.2527/jas.2007-0276; Israel C, 2000, J DAIRY SCI, V83, P181, DOI 10.3168/jds.S0022-0302(00)74869-7; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Laughlin A. M., 2003, Sheep & Goat Research Journal, V18, P14; Li L, 2006, FORENSIC SCI INT, V162, P74, DOI 10.1016/j.forsciint.2006.06.010; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; MONTGOMERY GW, 1990, NEW ZEAL J AGR RES, V33, P437, DOI 10.1080/00288233.1990.10428440; Norberg E, 2007, J ANIM SCI, V85, P299, DOI 10.2527/jas.2006-257; Parsonson Ian M, 1998, AUSTR ARK HIST DOMES; Pedrosa VB, 2010, SMALL RUMINANT RES, V93, P135, DOI 10.1016/j.smallrumres.2010.05.012; Piper L, 1997, GENETICS SHEEP; Sanders K, 2006, J DAIRY SCI, V89, P315, DOI 10.3168/jds.S0022-0302(06)72096-3; Senneke SL, 2004, J ANIM SCI, V82, P2307; Sise J. A., 2001, Proceedings of the Fourteenth Conference of the Association for the Advancement of Animal Breeding and Genetics, Queenstown, New Zealand, 30 July-2 August 2001, P317; Smith LA, 1998, J DAIRY SCI, V81, P2729, DOI 10.3168/jds.S0022-0302(98)75830-8; Sonesson AK, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-27; SPELMAN RJ, 2002, P 7 WORLD C GEN APPL; Van Eenennaam AL, 2007, J ANIM SCI, V85, P3159, DOI 10.2527/jas.2007-0284; Visscher PM, 2002, J DAIRY SCI, V85, P2368, DOI 10.3168/jds.S0022-0302(02)74317-8; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156	41	44	47	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93392	10.1371/journal.pone.0093392	http://dx.doi.org/10.1371/journal.pone.0093392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740141	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900019
J	Fernandez-Elias, VE; Martinez-Abellan, A; Lopez-Gullon, JM; Moran-Navarro, R; Pallares, JG; De la Cruz-Sanchez, E; Mora-Rodriguez, R				Fernandez-Elias, Valentin E.; Martinez-Abellan, Alberto; Maria Lopez-Gullon, Jose; Moran-Navarro, Ricardo; Pallares, Jesus G.; De la Cruz-Sanchez, Ernesto; Mora-Rodriguez, Ricardo			Validity of Hydration Non-Invasive Indices during the Weightcutting and Official Weigh-In for Olympic Combat Sports	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; PROLONGED EXERCISE; URINARY INDEXES; DEHYDRATION; REHYDRATION; OSMOLALITY; INTENSITY; WRESTLERS; RESPONSES; FATIGUE	Background: In Olympic combat sports, weight cutting is a common practice aimed to take advantage of competing in weight divisions below the athlete's normal weight. Fluid and food restriction in combination with dehydration (sauna and/or exercise induced profuse sweating) are common weight cut methods. However, the resultant hypohydration could adversely affect health and performance outcomes. Purpose: The aim of this study is to determine which of the routinely used non-invasive measures of dehydration best track urine osmolality, the gold standard non-invasive test. Method: Immediately prior to the official weigh-in of three National Championships, the hydration status of 345 athletes of Olympic combat sports (i.e., taekwondo, boxing and wrestling) was determined using five separate techniques: i) urine osmolality (U-OSM), ii) urine specific gravity (U-SG), iii) urine color (U-COL), iv) bioelectrical impedance analysis (BIA), and v) thirst perception scale (TPS). All techniques were correlated with UOSM divided into three groups: euhydrated (G(1); U-OSM 250-700 mOsm.kg H2O-1), dehydrated (G(2); U-OSM 701-1080 mOsm . kg H2O-1), and severely dehydrated (G(3); U-OSM 1081-1500 mOsm . kg H2O-1). Results: We found a positive high correlation between the U-OSM and U-SG (r = 0.89: p = 0.000), although this relationship lost strength as dehydration increased (G(1) r = 0.92; G(2) r = 0.73; and G(3) r = 0.65; p = 0.000). U-COL showed a moderate although significant correlation when considering the whole sample (r = 0.743: p = 0.000) and G(1) (r = 0.702: p = 0.000) but low correlation for the two dehydrated groups (r = 0.498-0.398). TPS and BIA showed very low correlation sizes for all groups assessed. Conclusion: In a wide range of pre-competitive hydration status (U-OSM 250-1500 mOsm . kg H2O-1), U-SG is highly associated with U-OSM while being a more affordable and easy to use technique. U-COL is a suitable tool when U-SG is not available. However, BIA or TPS are not sensitive enough to detect hypohydration at official weight-in before an Olympic combat championship.	[Fernandez-Elias, Valentin E.; Pallares, Jesus G.; Mora-Rodriguez, Ricardo] Univ Castilla La Mancha, Exercise Physiol Lab, Toledo, Spain; [Martinez-Abellan, Alberto; Maria Lopez-Gullon, Jose; Moran-Navarro, Ricardo; Pallares, Jesus G.; De la Cruz-Sanchez, Ernesto] Univ Murcia, Dept Phys Act & Sport, Murcia, Spain	Universidad de Castilla-La Mancha; University of Murcia	Mora-Rodriguez, R (corresponding author), Univ Castilla La Mancha, Exercise Physiol Lab, Toledo, Spain.	Ricardo.Mora@uclm.es	Fernández-Elías, Valentín E./ABD-7398-2021; De la Cruz-Sánchez, Ernesto/F-7406-2010; Pallarés, Jesús G/J-3054-2016; Morán-Navarro, Ricardo/AAB-4361-2020; PALLARES, JESUS G./AAW-3182-2020; Mora-Rodriguez, Ricardo/AAC-9096-2022; López-Gullón, José María/AAW-6701-2020	Fernández-Elías, Valentín E./0000-0002-1459-5442; De la Cruz-Sánchez, Ernesto/0000-0002-4718-7058; Pallarés, Jesús G/0000-0002-6087-1583; PALLARES, JESUS G./0000-0002-6087-1583; Mora-Rodriguez, Ricardo/0000-0001-9252-4933; Moran-Navarro, Ricardo/0000-0002-0991-9203	High-Performance Sports Center Infanta Cristina (General Directorate of Sports, Government of Murcia)	High-Performance Sports Center Infanta Cristina (General Directorate of Sports, Government of Murcia)	This study was supported by grants from the High-Performance Sports Center Infanta Cristina (General Directorate of Sports, Government of Murcia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong LE, 2007, J AM COLL NUTR, V26, p575S, DOI 10.1080/07315724.2007.10719661; Armstrong LE, 2005, NUTR REV, V63, pS40, DOI 10.1111/j.1753-4887.2005.tb00153.x; Armstrong LE, 1998, INT J SPORT NUTR, V8, P345, DOI 10.1123/ijsn.8.4.345; ARMSTRONG LE, 1994, INT J SPORT NUTR, V4, P265, DOI 10.1123/ijsn.4.3.265; Asselin MC, 1998, APPL RADIAT ISOTOPES, V49, P495, DOI 10.1016/S0969-8043(97)00179-6; Baker LB, 2007, MED SCI SPORT EXER, V39, P1114, DOI 10.1249/mss.0b013e3180574b02; Bartok C, 2004, MED SCI SPORT EXER, V36, P160, DOI 10.1249/01.MSS.0000106855.47276.CD; Berneis K, 2000, CLIN NUTR, V19, P361, DOI 10.1054/clnu.2000.0133; Cheuvront Samuel N, 2003, Curr Sports Med Rep, V2, P202, DOI 10.1249/00149619-200308000-00006; Clark RR, 2004, MED SCI SPORT EXER, V36, P639, DOI 10.1249/01.MSS.0000121942.84630.6C; Dougherty KA, 2006, MED SCI SPORT EXER, V38, P1650, DOI 10.1249/01.mss.0000227640.60736.8e; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; ENGELL DB, 1987, PHYSIOL BEHAV, V40, P229, DOI 10.1016/0031-9384(87)90212-5; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; Hamouti N, 2013, EUR J APPL PHYSIOL, V113, P611, DOI 10.1007/s00421-012-2467-9; Hamouti N, 2010, EUR J APPL PHYSIOL, V109, P213, DOI 10.1007/s00421-009-1333-x; HORSWILL CA, 1990, MED SCI SPORT EXER, V22, P470; HORSWILL CA, 1992, SPORTS MED, V14, P114, DOI 10.2165/00007256-199214020-00004; Houston M E, 1981, Phys Sportsmed, V9, P73, DOI 10.1080/00913847.1981.11711208; Howe AS, 2007, AM J SPORT MED, V35, P1384, DOI 10.1177/0363546507305013; Jetton AM, 2013, J STRENGTH COND RES, V27, P1322, DOI 10.1519/JSC.0b013e31828a1e91; Koulmann N, 2000, MED SCI SPORT EXER, V32, P857, DOI 10.1097/00005768-200004000-00020; Maresh CM, 2004, J APPL PHYSIOL, V97, P39, DOI 10.1152/japplphysiol.00956.2003; Maresh CM, 2001, MED SCI SPORT EXER, V33, P1039, DOI 10.1097/00005768-200106000-00025; Murray B, 2007, J AM COLL NUTR, V26, p542S, DOI 10.1080/07315724.2007.10719656; Nybo L, 2001, J APPL PHYSIOL, V91, P1055, DOI 10.1152/jappl.2001.91.3.1055; O'Brien C, 1999, MED SCI SPORT EXER, V31, P1466, DOI 10.1097/00005768-199910000-00017; Oopik V, 2013, APPL PHYSIOL NUTR ME, V38, P621, DOI 10.1139/apnm-2012-0334; Oppliger RA, 2005, INT J SPORT NUTR EXE, V15, P236, DOI 10.1123/ijsnem.15.3.236; Pateyjohns IR, 2006, OBESITY, V14, P2064, DOI 10.1038/oby.2006.241; Pettersson S, 2013, INT J SPORT NUTR EXE; Pettersson S, 2013, J ATHL TRAINING, V48, P99, DOI 10.4085/1062-6050-48.1.04; Popowski LA, 2001, MED SCI SPORT EXER, V33, P747; Quiterio AL, 2009, J STRENGTH COND RES, V23, P1225, DOI 10.1519/JSC.0b013e3181a9ec39; Riebe D, 1997, MED SCI SPORT EXER, V29, P117, DOI 10.1097/00005768-199701000-00017; Saunders MJ, 1998, MED SCI SPORT EXER, V30, P885, DOI 10.1097/00005768-199806000-00017; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Schoffstall JE, 2001, J STRENGTH COND RES, V15, P102; Shirreffs SM, 2003, EUR J CLIN NUTR, V57, pS6, DOI 10.1038/sj.ejcn.1601895; Slater G, 2006, BRIT J SPORT MED, V40, P55, DOI 10.1136/bjsm.2005.019604; Smith MS, 2000, EUR J APPL PHYSIOL, V83, P34, DOI 10.1007/s004210000251; Utter AC, 2012, J STRENGTH COND RES, V26, P9, DOI 10.1519/JSC.0b013e318238ea51; Vincent JW, 2005, STAT KINESIOLOGY; WEBSTER S, 1990, MED SCI SPORT EXER, V22, P229; YOUNG AJ, 1987, J APPL PHYSIOL, V63, P1218, DOI 10.1152/jappl.1987.63.3.1218; ZAMBRASKI EJ, 1974, MED SCI SPORT EXER, V6, P129	46	43	45	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95336	10.1371/journal.pone.0095336	http://dx.doi.org/10.1371/journal.pone.0095336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740242	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900131
J	Forbes, SL; Perrault, KA				Forbes, Shari L.; Perrault, Katelynn A.			Decomposition Odour Profiling in the Air and Soil Surrounding Vertebrate Carrion	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; FLIGHT MASS-SPECTROMETRY; HUMAN REMAINS; WASTE; NONCONTACT; HEADSPACE; CARCASSES; MOISTURE	Chemical profiling of decomposition odour is conducted in the environmental sciences to detect malodourous target sources in air, water or soil. More recently decomposition odour profiling has been employed in the forensic sciences to generate a profile of the volatile organic compounds (VOCs) produced by decomposed remains. The chemical profile of decomposition odour is still being debated with variations in the VOC profile attributed to the sample collection technique, method of chemical analysis, and environment in which decomposition occurred. To date, little consideration has been given to the partitioning of odour between different matrices and the impact this has on developing an accurate VOC profile. The purpose of this research was to investigate the decomposition odour profile surrounding vertebrate carrion to determine how VOCs partition between soil and air. Four pig carcasses (Sus scrofa domesticus L.) were placed on a soil surface to decompose naturally and their odour profile monitored over a period of two months. Corresponding control sites were also monitored to determine the VOC profile of the surrounding environment. Samples were collected from the soil below and the air (headspace) above the decomposed remains using sorbent tubes and analysed using gas chromatography-mass spectrometry. A total of 249 compounds were identified but only 58 compounds were common to both air and soil samples. This study has demonstrated that soil and air samples produce distinct subsets of VOCs that contribute to the overall decomposition odour. Sample collection from only one matrix will reduce the likelihood of detecting the complete spectrum of VOCs, which further confounds the issue of determining a complete and accurate decomposition odour profile. Confirmation of this profile will enhance the performance of cadaver-detection dogs that are tasked with detecting decomposition odour in both soil and air to locate victim remains.	[Forbes, Shari L.; Perrault, Katelynn A.] Univ Technol Sydney, Ctr Forens Sci, Sydney, NSW 2007, Australia	University of Technology Sydney	Forbes, SL (corresponding author), Univ Technol Sydney, Ctr Forens Sci, Sydney, NSW 2007, Australia.	shari.forbes@uts.edu.au	Forbes, Shari L/I-4507-2014; Perrault, Katelynn Amanda/J-4313-2019	Forbes, Shari L/0000-0001-7416-0080; Perrault, Katelynn Amanda/0000-0003-0210-2687	Australian Research Council; University of Technology, Sydney International Research Scholarship	Australian Research Council(Australian Research Council); University of Technology, Sydney International Research Scholarship	This research was funded by an Australian Research Council Future Fellowship (www.arc.gov.au) and the University of Technology, Sydney International Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GS, 1996, J FORENSIC SCI, V41, P617; Asensio D, 2007, PLANT SOIL, V291, P249, DOI 10.1007/s11104-006-9190-4; Brasseur C, 2012, J CHROMATOGR A, V1255, P163, DOI 10.1016/j.chroma.2012.03.048; Cablk ME, 2012, FORENSIC SCI INT, V220, P118, DOI 10.1016/j.forsciint.2012.02.007; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Collick AS, 2007, J ENVIRON QUAL, V36, P1528, DOI 10.2134/jeq2006.0523; DeGreeff LE, 2012, FORENSIC SCI INT, V217, P32, DOI 10.1016/j.forsciint.2011.09.023; DeGreeff LE, 2011, ANAL BIOANAL CHEM, V401, P1295, DOI 10.1007/s00216-011-5167-0; Dekeirsschieter J, 2009, FORENSIC SCI INT, V189, P46, DOI 10.1016/j.forsciint.2009.03.034; Dekeirsschieter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039005; Effmert U, 2012, J CHEM ECOL, V38, P665, DOI 10.1007/s10886-012-0135-5; Font X, 2011, SENSORS-BASEL, V11, P4043, DOI 10.3390/s110404043; Hoffman EM, 2009, FORENSIC SCI INT, V186, P6, DOI 10.1016/j.forsciint.2008.12.022; Kalinova B, 2009, NATURWISSENSCHAFTEN, V96, P889, DOI 10.1007/s00114-009-0545-6; LeBlanc HN, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P205, DOI 10.1007/978-1-4020-9684-6_11; Leditschke J, 2011, FORENSIC SCI INT, V205, P8, DOI 10.1016/j.forsciint.2010.11.002; Liu H, 2012, J HAZARD MATER, V235, P298, DOI 10.1016/j.jhazmat.2012.07.060; Lorenzo N, 2003, ANAL BIOANAL CHEM, V376, P1212, DOI 10.1007/s00216-003-2018-7; Ma ZM, 2013, J ENVIRON SCI, V25, P495, DOI 10.1016/S1001-0742(12)60101-6; Paczkowski S, 2011, APPL MICROBIOL BIOT, V91, P917, DOI 10.1007/s00253-011-3417-x; Paczkowski S, 2011, BIOL INSPIR SYST, V2, P225, DOI 10.1007/978-90-481-9641-8_12; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; PETERSEN LW, 1995, J ENVIRON QUAL, V24, P752, DOI 10.2134/jeq1995.00472425002400040028x; Presley SM, 2006, ENVIRON SCI TECHNOL, V40, P468, DOI 10.1021/es052219p; Scaglia B, 2011, BIORESOURCE TECHNOL, V102, P4638, DOI 10.1016/j.biortech.2011.01.016; Schoenly KG, 2007, J MED ENTOMOL, V44, P881, DOI 10.1603/0022-2585(2007)44[881:CPACOF]2.0.CO;2; Stadler S, 2013, ANAL CHEM, V85, P998, DOI 10.1021/ac302614y; Statheropoulos M, 2007, SCI TOTAL ENVIRON, V385, P221, DOI 10.1016/j.scitotenv.2007.07.003; Statheropoulos M, 2005, FORENSIC SCI INT, V153, P147, DOI 10.1016/j.forsciint.2004.08.015; Statheropoulos M, 2005, J CHROMATOGR B, V822, P112, DOI 10.1016/j.jchromb.2005.05.028; Statheropoulos M, 2011, FORENSIC SCI INT, V210, P154, DOI 10.1016/j.forsciint.2011.02.023; Sundberg C, 2013, WASTE MANAGE, V33, P204, DOI 10.1016/j.wasman.2012.09.017; Swann LM, 2010, ANAL CHIM ACTA, V682, P9, DOI 10.1016/j.aca.2010.09.052; Syrotuck WG., 2000, SCENT SCENTING DOG; Trengrove H, 2011, J Forensic Odontostomatol, V29, P1; Van Durme J, 2013, J AGR FOOD CHEM, V61, P10881, DOI 10.1021/jf403112k; Vass AA, 2002, J FORENSIC SCI, V47, P542; Vass AA, 2004, J FORENSIC SCI, V49, P760; Vass AA, 2008, J FORENSIC SCI, V53, P384, DOI 10.1111/j.1556-4029.2008.00680.x; Vass AA, 2012, FORENSIC SCI INT, V222, P234, DOI 10.1016/j.forsciint.2012.06.006; von Hoermann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058524; von Hoermann C, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-18; Zhang YY, 2012, J ENVIRON MANAGE, V101, P54, DOI 10.1016/j.jenvman.2011.10.018	43	65	66	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95107	10.1371/journal.pone.0095107	http://dx.doi.org/10.1371/journal.pone.0095107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740412	Green Submitted, gold, Green Published			2022-12-25	WOS:000336863900104
J	Graham, JS; McCullough, BR; Kang, HR; Elam, WA; Cao, WX; De La Cruz, EM				Graham, John S.; McCullough, Brannon R.; Kang, Hyeran; Elam, W. Austin; Cao, Wenxiang; De La Cruz, Enrique M.			Multi-Platform Compatible Software for Analysis of Polymer Bending Mechanics	PLOS ONE			English	Article							ACTIN-FILAMENTS; THERMAL FLUCTUATIONS; FLEXIBILITY	Cytoskeletal polymers play a fundamental role in the responses of cells to both external and internal stresses. Quantitative knowledge of the mechanical properties of those polymers is essential for developing predictive models of cell mechanics and mechano-sensing. Linear cytoskeletal polymers, such as actin filaments and microtubules, can grow to cellular length scales at which they behave as semiflexible polymers that undergo thermally-driven shape deformations. Bending deformations are often modeled using the wormlike chain model. A quantitative metric of a polymer's resistance to bending is the persistence length, the fundamental parameter of that model. A polymer's bending persistence length is extracted from its shape as visualized using various imaging techniques. However, the analysis methodologies required for determining the persistence length are often not readily within reach of most biological researchers or educators. Motivated by that limitation, we developed user-friendly, multi-platform compatible software to determine the bending persistence length from images of surface-adsorbed or freely fluctuating polymers. Three different types of analysis are available (cosine correlation, end-to-end and bending-mode analyses), allowing for rigorous cross-checking of analysis results. The software is freely available and we provide sample data of adsorbed and fluctuating filaments and expected analysis results for educational and tutorial purposes.	[Graham, John S.; McCullough, Brannon R.; Kang, Hyeran; Elam, W. Austin; Cao, Wenxiang; De La Cruz, Enrique M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	De La Cruz, EM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	enrique.delacruz@yale.edu		Kang, Ellen/0000-0003-2785-3479	National Institutes of Health [RO1-GM097348]; American Heart Association [0655849T, 09PRE2230014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097348, R25GM096161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant RO1-GM097348 and American Heart Association Established Investigator Award 0655849T awarded to E. M. D. L. C. B. R. M. was partially supported by American Heart Association predoctoral award No. 09PRE2230014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; De La Cruz EM, 2010, BIOPHYS J, V99, P1852, DOI 10.1016/j.bpj.2010.07.009; Doi M., 1986, THEORY POLYM DYNAMIC, V1st ed.; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Gunther K, 2010, NUCLEIC ACIDS RES, V38, P6526, DOI 10.1093/nar/gkq434; Howard J, 2001, MECH MOTOR PROTEINS; Howard J, 2009, ANNU REV BIOPHYS, V38, P217, DOI 10.1146/annurcv.biophys.050708.133732; ISAMBERT H, 1995, J BIOL CHEM, V270, P11437, DOI 10.1074/jbc.270.19.11437; Kang HR, 2012, P NATL ACAD SCI USA, V109, P16923, DOI 10.1073/pnas.1211078109; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Landau L. D., 1980, STAT PHYS 1, V3rd; McCullough BR, 2008, J MOL BIOL, V381, P550, DOI 10.1016/j.jmb.2008.05.055; McCullough BR, 2011, BIOPHYS J, V101, P151, DOI 10.1016/j.bpj.2011.05.049; Pollard T.D., 2017, CELL BIOL, P543	14	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94766	10.1371/journal.pone.0094766	http://dx.doi.org/10.1371/journal.pone.0094766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740323	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900063
J	Minata, M; Gu, CY; Joshi, K; Nakano-Okuno, M; Hong, C; Nguyen, CH; Kornblum, HI; Molla, A; Nakano, I				Minata, Mutsuko; Gu, Chunyu; Joshi, Kaushal; Nakano-Okuno, Mariko; Hong, Christopher; Chi-Hung Nguyen; Kornblum, Harley I.; Molla, Annie; Nakano, Ichiro			Multi-Kinase Inhibitor C1 Triggers Mitotic Catastrophe of Glioma Stem Cells Mainly through MELK Kinase Inhibition	PLOS ONE			English	Article							LEUCINE-ZIPPER KINASE; PROTEIN-KINASE; DNA-REPAIR; GLIOBLASTOMA; GROWTH; RADIOTHERAPY; PEG3; PHOSPHORYLATION; PROLIFERATION; TEMOZOLOMIDE	Glioblastoma multiforme (GBM) is a highly lethal brain tumor. Due to resistance to current therapies, patient prognosis remains poor and development of novel and effective GBM therapy is crucial. Glioma stem cells (GSCs) have gained attention as a therapeutic target in GBM due to their relative resistance to current therapies and potent tumor-initiating ability. Previously, we identified that the mitotic kinase maternal embryonic leucine-zipper kinase (MELK) is highly expressed in GBM tissues, specifically in GSCs, and its expression is inversely correlated with the post-surgical survival period of GBM patients. In addition, patient-derived GSCs depend on MELK for their survival and growth both in vitro and in vivo. Here, we demonstrate evidence that the role of MELK in the GSC survival is specifically dependent on its kinase activity. With in silico structure-based analysis for protein-compound interaction, we identified the small molecule Compound 1 (C1) is predicted to bind to the kinase-active site of MELK protein. Elimination of MELK kinase activity was confirmed by in vitro kinase assay in nano-molar concentrations. When patient-derived GSCs were treated with C1, they underwent mitotic arrest and subsequent cellular apoptosis in vitro, a phenotype identical to that observed with shRNA-mediated MELK knockdown. In addition, C1 treatment strongly induced tumor cell apoptosis in slice cultures of GBM surgical specimens and attenuated growth of mouse intracranial tumors derived from GSCs in a dose-dependent manner. Lastly, C1 treatment sensitizes GSCs to radiation treatment. Collectively, these data indicate that targeting MELK kinase activity is a promising approach to attenuate GBM growth by eliminating GSCs in tumors.	[Minata, Mutsuko; Gu, Chunyu; Joshi, Kaushal; Hong, Christopher; Nakano, Ichiro] Ohio State Univ, Med Ctr, Dept Neurol Surg, Columbus, OH 43210 USA; [Nakano-Okuno, Mariko] Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Nakano, Ichiro] Ohio State Univ, Med Ctr, James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Chi-Hung Nguyen] Inst Curie, CNRS, UMR 176, F-91405 Orsay, France; [Kornblum, Harley I.] Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; [Kornblum, Harley I.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Molla, Annie] Univ Grenoble 1, Inst Albert Bonniot, Grenoble 9, France; [Gu, Chunyu] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Capital Medical University	Nakano, I (corresponding author), Ohio State Univ, Med Ctr, Dept Neurol Surg, Columbus, OH 43210 USA.	Ichiro.Nakano@osumc.edu	Nakano, Ichiro/F-2076-2014; Nguyen, Chi/GZG-5146-2022; Nguyen, Chi/GWR-1592-2022; Nakano, Ichiro/AAR-9562-2020; Molla, Annie/N-1839-2013	Nakano, Ichiro/0000-0002-6734-3468; Nakano, Ichiro/0000-0002-0916-3207; Molla, Annie/0000-0002-9859-8682; Nakano-Okuno, Mariko/0000-0002-2465-3212	American Cancer Society [MRSG-08-108-01]; NIH [NS0525630, R01 NS083767, 1R21CA175875, 1R01NS087913]; NATIONAL CANCER INSTITUTE [R21CA175875, P01CA163205, P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083767, R01NS052563, R01NS087913] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Start-up budget for I. Nakano at the Ohio State University, Department of Neurological Surgery; and the American Cancer Society Grant for I. Nakano (MRSG-08-108-01). HIK is supported by the NIH, NS0525630. IN is also supported by the NIH, R01 NS083767, 1R21CA175875, 1R01NS087913; and Vincent J. Sgro, The American Brain Tumor Association, National Brain Tumor Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Chartrain I, 2006, BIOL CELL, V98, P253, DOI 10.1042/BC20050041; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Delacour-Larose M, 2009, CELL CYCLE, V8, P3608, DOI 10.4161/cc.8.21.9939; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Filiano AN, 2011, RADIAT RES, V176, P49, DOI 10.1667/RR2419.1; Frosina G, 2009, MOL CANCER RES, V7, P989, DOI 10.1158/1541-7786.MCR-09-0030; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Golding SE, 2012, CELL CYCLE, V11, P1167, DOI 10.4161/cc.11.6.19576; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Grunda JM, 2010, CLIN CANCER RES, V16, P2890, DOI 10.1158/1078-0432.CCR-09-3151; Gu CY, 2013, STEM CELLS, V31, P870, DOI 10.1002/stem.1322; Hambardzumyan D, 2008, STEM CELL REV, V4, P203, DOI 10.1007/s12015-008-9021-5; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hoang TMN, 2009, CELL CYCLE, V8, P765, DOI 10.4161/cc.8.5.7879; Hu B, 2008, J BIOL CHEM, V283, P24848, DOI 10.1074/jbc.M801433200; Ianzini F, 1997, INT J RADIAT BIOL, V72, P409, DOI 10.1080/095530097143185; Joshi K, 2011, JOVE-J VIS EXP, DOI 10.3791/2846; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kuner R, 2013, J MOL MED, V91, P237, DOI 10.1007/s00109-012-0949-1; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lin ML, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1650; Lottaz C, 2010, CANCER RES, V70, P2030, DOI 10.1158/0008-5472.CAN-09-1707; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Le LTT, 2013, CHEMMEDCHEM, V8, P289, DOI 10.1002/cmdc.201200479; Mahasenan KV, 2012, J CHEM INF MODEL, V52, P1345, DOI 10.1021/ci300040c; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Mirey G, 2005, CELL CYCLE, V4, P806, DOI 10.4161/cc.4.6.1716; Miyazaki T, 2012, CLIN CANCER RES, V18, P1268, DOI 10.1158/1078-0432.CCR-11-1795; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Nakano I, 2011, NEURO-ONCOLOGY, V13, P622, DOI 10.1093/neuonc/nor023; Raso A, 2012, BRAIN PATHOL, V22, P677, DOI 10.1111/j.1750-3639.2012.00566.x; Ropolo M, 2009, MOL CANCER RES, V7, P383, DOI 10.1158/1541-7786.MCR-08-0409; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sulman Erik, 2008, Curr Probl Cancer, V32, P124, DOI 10.1016/j.currproblcancer.2008.02.004; Tamura K, 2010, J NEUROSURG, V113, P310, DOI 10.3171/2010.2.JNS091607; Visnyei K, 2011, MOL CANCER THER, V10, P1818, DOI 10.1158/1535-7163.MCT-11-0268; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Zhong DS, 2008, CANCER RES, V68, P7270, DOI 10.1158/0008-5472.CAN-08-1484; Ziegler DS, 2008, J CLIN INVEST, V118, P3109, DOI 10.1172/JCI34120	45	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e92546	10.1371/journal.pone.0092546	http://dx.doi.org/10.1371/journal.pone.0092546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739874	Green Published, gold			2022-12-25	WOS:000336863900011
J	Salgado, M; Tarifeno-Saldivia, E; Ordenes, P; Millan, C; Yanez, MJ; Llanos, P; Villagra, M; Elizondo-Vega, R; Martinez, F; Nualart, F; Uribe, E; Garcia-Robles, MD				Salgado, Magdiel; Tarifeno-Saldivia, Estefania; Ordenes, Patricio; Millan, Carola; Jose Yanez, Maria; Llanos, Paula; Villagra, Marcos; Elizondo-Vega, Roberto; Martinez, Fernando; Nualart, Francisco; Uribe, Elena; de los Angeles Garcia-Robles, Maria			Dynamic Localization of Glucokinase and Its Regulatory Protein in Hypothalamic Tanycytes	PLOS ONE			English	Article							HYPOPHYSEAL ADRENOCORTICOTROPIC FUNCTION; PANCREATIC BETA-CELLS; MAMMALIAN GLUCOKINASE; HEPATIC GLUCOKINASE; RAT-BRAIN; MORPHOLOGICAL ASPECTS; ALLOSTERIC REGULATION; GLUCOSENSING NEURONS; LIVER GLUCOKINASE; NUCLEAR EXPORT	Glucokinase (GK), the hexokinase involved in glucose sensing in pancreatic beta cells, is also expressed in hypothalamic tanycytes, which cover the ventricular walls of the basal hypothalamus and are implicated in an indirect control of neuronal activity by glucose. Previously, we demonstrated that GK was preferentially localized in tanycyte nuclei in euglycemic rats, which has been reported in hepatocytes and is suggestive of the presence of the GK regulatory protein, GKRP. In the present study, GK intracellular localization in hypothalamic and hepatic tissues of the same rats under several glycemic conditions was compared using confocal microscopy and Western blot analysis. In the hypothalamus, increased GK nuclear localization was observed in hyperglycemic conditions; however, it was primarily localized in the cytoplasm in hepatic tissue under the same conditions. Both GK and GKRP were next cloned from primary cultures of tanycytes. Expression of GK by Escherichia coli revealed a functional cooperative protein with a S-0.5 of 10 mM. GKRP, expressed in Saccharomyces cerevisiae, inhibited GK activity in vitro with a K-i 0.2 mu M. We also demonstrated increased nuclear reactivity of both GK and GKRP in response to high glucose concentrations in tanycyte cultures. These data were confirmed using Western blot analysis of nuclear extracts. Results indicate that GK undergoes short-term regulation by nuclear compartmentalization. Thus, in tanycytes, GK can act as a molecular switch to arrest cellular responses to increased glucose.	[Salgado, Magdiel; Tarifeno-Saldivia, Estefania; Ordenes, Patricio; Jose Yanez, Maria; Llanos, Paula; Villagra, Marcos; Elizondo-Vega, Roberto; Martinez, Fernando; Nualart, Francisco; de los Angeles Garcia-Robles, Maria] Univ Concepcion, Fac Ciencias Biol, Dept Biol Celular, Concepcion, Chile; [Uribe, Elena] Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile; [Millan, Carola] Univ Adolfo Ibanez, Fac Artes Liberales, Vina Del Mar, Chile	Universidad de Concepcion; Universidad de Concepcion; Universidad Adolfo Ibanez	Garcia-Robles, MD (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Biol Celular, Concepcion, Chile.	mgarcia@udec.cl	Tarifeño-Saldivia, Estefanía/AAD-4649-2019; Nualart, Francisco/AAB-9342-2021; Garcia-Robles, Maria/F-4900-2014; Yañez, Maria/HHM-9251-2022	Garcia-Robles, Maria/0000-0001-8482-0361; Llanos Fuentes, Paula Lorena/0000-0002-4388-4737; Elizondo, Roberto/0000-0001-9790-0002; Yanez, Maria Jose/0000-0002-7990-2079	FONDECYT [1100705]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by FONDECYT grant 1100705(to MAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGIUS L, 1995, BIOCHEM J, V309, P711, DOI 10.1042/bj3090711; AKMAYEV IG, 1977, CELL TISSUE RES, V180, P263; AKMAYEV IG, 1974, CELL TISSUE RES, V152, P403; Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x; Anderka O, 2008, J BIOL CHEM, V283, P31333, DOI 10.1074/jbc.M805434200; Baltrusch S, 2005, DIABETES, V54, P2829, DOI 10.2337/diabetes.54.10.2829; Baltrusch S, 2006, DIABETES, V55, pS55, DOI 10.2337/db06-S008; Brown KS, 1997, DIABETES, V46, P179, DOI 10.2337/diabetes.46.2.179; CHAUVET N, 1995, J NEUROSCI RES, V41, P129, DOI 10.1002/jnr.490410115; Chu CA, 2004, AM J PHYSIOL-GASTR L, V286, pG627, DOI 10.1152/ajpgi.00218.2003; Coppola A, 2007, CELL METAB, V5, P21, DOI 10.1016/j.cmet.2006.12.002; Cortes-Campos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062532; Cortes-Campos C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016411; de la Iglesia N, 2000, J BIOL CHEM, V275, P10597, DOI 10.1074/jbc.275.14.10597; Dunn-Meynell AA, 2002, DIABETES, V51, P2056, DOI 10.2337/diabetes.51.7.2056; FLAMENTDURAND J, 1985, INT REV CYTOL, V96, P121, DOI 10.1016/S0074-7696(08)60596-3; Frayling C, 2011, J PHYSIOL-LONDON, V589, P2275, DOI 10.1113/jphysiol.2010.202051; Garcia MD, 2003, J NEUROCHEM, V86, P709, DOI 10.1046/j.1471-4159.2003.01892.x; Garcia MDA, 2001, J CELL BIOCHEM, V80, P491; Garcia MDL, 2005, GLIA, V50, P32, DOI 10.1002/glia.20133; Goh BH, 2006, HORM METAB RES, V38, P1, DOI 10.1055/s-2006-924964; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; HUGHES SD, 1991, J BIOL CHEM, V266, P4521; Iino T, 2009, BIOORGAN MED CHEM, V17, P3800, DOI 10.1016/j.bmc.2009.04.040; IYNEDJIAN PB, 1993, BIOCHEM J, V293, P1; Jetton T L, 2001, Int J Exp Diabetes Res, V2, P173, DOI 10.1155/EDR.2001.173; JETTON TL, 1994, J BIOL CHEM, V269, P3641; JETTON TL, 1992, P NATL ACAD SCI USA, V89, P2619, DOI 10.1073/pnas.89.7.2619; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kang L, 2008, AM J PHYSIOL-REG I, V294, pR784, DOI 10.1152/ajpregu.00645.2007; Kittner H, 2006, EUR J NEUROSCI, V24, P2049, DOI 10.1111/j.1460-9568.2006.05071.x; Larion M, 2012, ARCH BIOCHEM BIOPHYS, V519, P103, DOI 10.1016/j.abb.2011.11.007; Larion M, 2010, BIOCHEMISTRY-US, V49, P8902, DOI 10.1021/bi1008672; Levin BE, 2008, DIABETES, V57, P1371, DOI 10.2337/db07-1755; LIANG Y, 1991, J BIOL CHEM, V266, P6999; MATSCHIN.FM, 1968, J BIOL CHEM, V243, P2730; MATSCHINSKY F, 1993, J CLIN INVEST, V92, P2092, DOI 10.1172/JCI116809; Matsumoto N, 2004, BRAIN RES, V1009, P234, DOI 10.1016/j.brainres.2004.03.001; Millan C, 2010, ASN NEURO, V2, P135, DOI 10.1042/AN20090059; Mukhtar M, 1999, FEBS LETT, V462, P453, DOI 10.1016/S0014-5793(99)01580-X; Navarro M, 1996, J NEUROCHEM, V67, P1982; Nilaweera K, 2011, GLIA, V59, P1695, DOI 10.1002/glia.21216; Orellana JA, 2012, GLIA, V60, P53, DOI 10.1002/glia.21246; Pautsch A, 2013, BIOCHEMISTRY; PRINTZ RL, 1993, ANNU REV NUTR, V13, P463, DOI 10.1146/annurev.nu.13.070193.002335; Robins SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3049; Rodriguez EM, 2005, INT REV CYTOL, V247, P89, DOI 10.1016/S0074-7696(05)47003-5; Roncero I, 2004, J NEUROCHEM, V88, P1203, DOI 10.1046/j.1471-4159.2003.02269.x; Roncero I, 2009, J NEUROENDOCRINOL, V21, P973, DOI 10.1111/j.1365-2826.2009.01919.x; Roncero I, 2000, J NEUROCHEM, V74, P1848, DOI 10.1046/j.1471-4159.2000.0741848.x; Sanders NM, 2004, DIABETES, V53, P1230, DOI 10.2337/diabetes.53.5.1230; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Segel I, 1994, ENZYME KINETICS BIHA; Shiota C, 1999, J BIOL CHEM, V274, P37125, DOI 10.1074/jbc.274.52.37125; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; Sorimachi M, 2001, NEUROSCIENCE, V105, P393, DOI 10.1016/S0306-4522(01)00192-0; Thorens B., 2012, HDB EXP PHARM, V209, P277, DOI DOI 10.1007/978-3-642-24716-3_12; Tiedge M, 1999, DIABETES, V48, P514, DOI 10.2337/diabetes.48.3.514; Toyoda Y, 1997, ARCH HISTOL CYTOL, V60, P307, DOI 10.1679/aohc.60.307; TOYODA Y, 1995, FEBS LETT, V359, P81, DOI 10.1016/0014-5793(94)01452-7; TOYODA Y, 1995, BIOCHEM BIOPH RES CO, V215, P467, DOI 10.1006/bbrc.1995.2488; VANDERCAMMEN A, 1990, EUR J BIOCHEM, V191, P483, DOI 10.1111/j.1432-1033.1990.tb19147.x; VANDERCAMMEN A, 1991, EUR J BIOCHEM, V200, P545, DOI 10.1111/j.1432-1033.1991.tb16217.x; WEINHOUSE S, 1976, CURR TOP CELL REGUL, V11, P1; Wollmann G, 2005, J NEUROPHYSIOL, V94, P2195, DOI 10.1152/jn.00035.2005; Yang XJ, 1999, DIABETES, V48, P1763, DOI 10.2337/diabetes.48.9.1763; ZAWALICH WS, 1977, ENDOCRINOLOGY, V100, P1; Zhou LG, 2011, BEHAV BRAIN RES, V222, P274, DOI 10.1016/j.bbr.2011.03.043	68	25	25	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94035	10.1371/journal.pone.0094035	http://dx.doi.org/10.1371/journal.pone.0094035			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739934	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900031
J	Zhang, SH; Desrosiers, J; Aponte-Pieras, JR; DaSilva, K; Fast, LD; Terry, F; Martin, WD; De Groot, AS; Moise, L; Moss, SF				Zhang, Songhua; Desrosiers, Joseph; Aponte-Pieras, Jose R.; DaSilva, Kristen; Fast, Loren D.; Terry, Frances; Martin, William D.; De Groot, Anne S.; Moise, Leonard; Moss, Steven F.			Human Immune Responses to H. pylori HLA Class II Epitopes Identified by Immunoinformatic Methods	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; T-CELL RESPONSE; HELICOBACTER-PYLORI; CONFER PROTECTION; DENDRITIC CELLS; VOLUNTEERS; INFECTION; RECEPTOR; DIFFERENTIATION; IMMUNOGENICITY	H. pylori persists in the human stomach over decades and promotes several adverse clinical sequelae including gastritis, peptic ulcers and gastric cancer that are linked to the induction and subsequent evasion of chronic gastric inflammation. Emerging evidence indicates that H. pylori infection may also protect against asthma and some other immune-mediated conditions through regulatory T cell effects outside the stomach. To characterize the complexity of the CD4+ T cell response generated during H. pylori infection, computational methods were previously used to generate a panel of 90 predicted epitopes conserved among H. pylori genomes that broadly cover HLA Class II diversity for maximum population coverage. Here, these sequences were tested individually for their ability to induce in vitro responses in peripheral blood mononuclear cells by interferon-gamma ELISpot assay. The average number of spot-forming cells/million PBMCs was significantly elevated in H. pylori-infected subjects over uninfected persons. Ten of the 90 peptides stimulated IFN-gamma secretion in the H. pylori-infected group only, whereas two out of the 90 peptides elicited a detectable IFN-gamma response in the H. pylori-uninfected subjects but no response in the H. pylori-infected group. Cytokine ELISA measurements performed using in vitro PBMC culture supernatants demonstrated significantly higher levels of TNF-alpha, IL-2, IL-4, IL-6, IL-10, and TGF-beta 1 in the H. pylori-infected subjects, whereas IL-17A expression was not related to the subjects H. pylori-infection status. Our results indicate that the human T cell responses to these 90 peptides are generally increased in actively H. pylori-infected, compared with H. pylorinai naive, subjects. This information will improve understanding of the complex immune response to H. pylori, aiding rational epitope-driven vaccine design as well as helping identify other H. pylori epitopes with potentially immunoregulatory effects.	[Zhang, Songhua; Aponte-Pieras, Jose R.; Moss, Steven F.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Gastroenterol, Providence, RI 02903 USA; [Desrosiers, Joseph; DaSilva, Kristen; Fast, Loren D.; De Groot, Anne S.; Moise, Leonard] Univ Rhode Isl, Inst Immunol & Informat, Providence, RI 02908 USA; [Fast, Loren D.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Hematol & Oncol, Providence, RI 02903 USA; [Terry, Frances; Martin, William D.; De Groot, Anne S.; Moise, Leonard] EpiVax Inc, Providence, RI USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Rhode Island; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Moss, SF (corresponding author), Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Div Gastroenterol, Providence, RI 02903 USA.	steven_moss@brown.edu	Moise, Lenny/AAE-7448-2019; De Groot, Annie/B-6221-2013	Moise, Lenny/0000-0002-4410-865X; De Groot, Annie/0000-0001-5911-1459	United States National Institutes of Health [NIH U19 AI082642]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082642] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the United States National Institutes of Health (grant # NIH U19 AI082642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Aebischer T, 2008, GUT, V57, P1065, DOI 10.1136/gut.2007.145839; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Ardito Matthew, 2011, Immunome Res, V7; Arnold IC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00010; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Arnold IC, 2011, GASTROENTEROLOGY, V140, P199, DOI 10.1053/j.gastro.2010.06.047; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Bogdanos DP, 2004, SCAND J GASTROENTERO, V39, P981, DOI 10.1080/00365520410003236; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cendron L, 2011, FEBS J, V278, P1223, DOI 10.1111/j.1742-4658.2011.08038.x; Chen L, 2013, GASTROENTEROLOGY, V144, P591, DOI 10.1053/j.gastro.2012.12.002; Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821; Cohen T, 2010, J BIOMED BIOTECHNOL, V2010, P2010; Czinn SJ, 2011, NAT REV GASTRO HEPAT, V8, P133, DOI 10.1038/nrgastro.2011.1; Dellon ES, 2011, GASTROENTEROLOGY, V141, P1586, DOI 10.1053/j.gastro.2011.06.081; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Fischer W, 2011, FEBS J, V278, P1203, DOI 10.1111/j.1742-4658.2011.08036.x; Gewirtz AT, 2004, J INFECT DIS, V189, P1914, DOI 10.1086/386289; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Hansen BE, 2007, TISSUE ANTIGENS, V70, P42, DOI 10.1111/j.1399-0039.2007.00849.x; Hare S, 2007, EMBO J, V26, P4926, DOI 10.1038/sj.emboj.7601904; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Islami F, 2008, CANCER PREV RES, V1, P329, DOI 10.1158/1940-6207.CAPR-08-0109; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Khamri W, 2010, INFECT IMMUN, V78, P845, DOI 10.1128/IAI.00524-09; Kotloff KL, 2001, INFECT IMMUN, V69, P3581, DOI 10.1128/IAI.69.6.3581-3590.2001; Liu H, 2008, J IMMUNOL, V180, P7948, DOI 10.4049/jimmunol.180.12.7948; Luther J, 2010, INFLAMM BOWEL DIS, V16, P1077, DOI 10.1002/ibd.21116; Malfertheiner P, 2008, GASTROENTEROLOGY, V135, P787, DOI 10.1053/j.gastro.2008.05.054; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110; Michetti P, 1999, GASTROENTEROLOGY, V116, P804, DOI 10.1016/S0016-5085(99)70063-6; Moran AP, 1997, J BACTERIOL, V179, P6453, DOI 10.1128/jb.179.20.6453-6463.1997; National Institute of Allergy and Infectious Diseases, 2013, EM REEM INF DIS; Oertli M, 2012, GUT MICROBES, V3, P566, DOI 10.4161/gmic.21750; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; Reibman J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004060; Sachs G, 2003, ANNU REV PHYSIOL, V65, P349, DOI 10.1146/annurev.physiol.65.092101.142156; Taylor AW, 2009, J LEUKOCYTE BIOL, V85, P29, DOI 10.1189/jlb.0708415; Tegtmeyer N, 2011, FEBS J, V278, P1190, DOI 10.1111/j.1742-4658.2011.08035.x; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wroblewski LE, 2013, GASTROENTEROL CLIN N, V42, P285, DOI 10.1016/j.gtc.2013.01.006; Wulf M, 2009, METHODS MOL BIOL, V524, P439, DOI 10.1007/978-1-59745-450-6_32; Yang WC, 2013, VACCINE, V31, P1204, DOI 10.1016/j.vaccine.2012.12.058; Zhang SH, 2011, HUM VACCINES, V7, P1153, DOI 10.4161/hv.7.11.17655	50	20	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94974	10.1371/journal.pone.0094974	http://dx.doi.org/10.1371/journal.pone.0094974			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740005	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900089
J	Bang, ML; Gu, YS; Dalton, ND; Peterson, KL; Chien, KR; Chen, J				Bang, Marie-Louise; Gu, Yusu; Dalton, Nancy D.; Peterson, Kirk L.; Chien, Kenneth R.; Chen, Ju			The Muscle Ankyrin Repeat Proteins CARP, Ankrd2, and DARP Are Not Essential for Normal Cardiac Development and Function at Basal Conditions and in Response to Pressure Overload	PLOS ONE			English	Article							SKELETAL-MUSCLE; DILATED CARDIOMYOPATHY; GENE-EXPRESSION; HEART-FAILURE; ECCENTRIC CONTRACTIONS; MUSCULAR-DYSTROPHY; NUCLEAR-PROTEIN; I-BAND; IDENTIFICATION; CELLS	Ankrd1/CARP, Ankrd2/Arpp, and Ankrd23/DARP belong to a family of stress inducible ankyrin repeat proteins expressed in striated muscle (MARPs). The MARPs are homologous in structure and localized in the nucleus where they negatively regulate gene expression as well as in the sarcomeric I-band, where they are thought to be involved in mechanosensing. Together with their strong induction during cardiac disease and the identification of causative Ankrd1 gene mutations in cardiomyopathy patients, this suggests their important roles in cardiac development, function, and disease. To determine the functional role of MARPs in vivo, we studied knockout (KO) mice of each of the three family members. Single KO mice were viable and had no apparent cardiac phenotype. We therefore hypothesized that the three highly homologous MARP proteins may have redundant functions in the heart and studied double and triple MARP KO mice. Unexpectedly, MARP triple KO mice were viable and had normal cardiac function both at basal levels and in response to mechanical pressure overload induced by transverse aortic constriction as assessed by echocardiography and hemodynamic studies. Thus, CARP, Ankrd2, and DARP are not essential for normal cardiac development and function at basal conditions and in response to mechanical pressure overload.	[Bang, Marie-Louise] CNR, UOS Milan, Inst Genet & Biomed Res, Milan, Italy; [Bang, Marie-Louise] Humanitas Clin & Res Ctr, Milan, Italy; [Gu, Yusu; Dalton, Nancy D.; Peterson, Kirk L.; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Chien, Kenneth R.] Karolinska Insititutet, Dept Cell & Mol Biol & Med, Stockholm, Sweden; [Chien, Kenneth R.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); University of California System; University of California San Diego; Karolinska Institutet; Harvard University	Bang, ML (corresponding author), CNR, UOS Milan, Inst Genet & Biomed Res, Milan, Italy.	marie-louise.bang@cnr.it; juchen@ucsd.edu	Bang, Marie-Louise/B-5683-2015; Chen, Ju/E-5579-2011; gu, yu/GSD-4507-2022	Bang, Marie-Louise/0000-0001-8859-5034; 	National Institutes of Health, National Heart, Lung, and Blood Institute [R01-HL66100, R01-HL106968, P01-HL46345]; Telethon Foundation, Italy [S07006TELA]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106968, R01HL066100, P01HL046345] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Telethon Foundation, Italy(Fondazione Telethon); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health, National Heart, Lung, and Blood Institute (R01-HL66100 and R01-HL106968 to J.C.; and P01-HL46345 to K.R.C.); and the Telethon Foundation, Italy (S07006TELA to M. L. B.; http://www.telethon.it/en/funding-research). J.C. is the American Heart Association (AHA) Endowed Chair in Cardiovascular Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2000, HYPERTENSION, V36, P48, DOI 10.1161/01.HYP.36.1.48; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413; Barash IA, 2004, AM J PHYSIOL-CELL PH, V286, pC355, DOI 10.1152/ajpcell.00211.2003; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Baumeister A, 1997, J CELL BIOL, V139, P1231, DOI 10.1083/jcb.139.5.1231; Bean C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.525; Boengler K, 2003, CARDIOVASC RES, V59, P573, DOI 10.1016/S0008-6363(03)00511-X; Chen B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035743; Chen J, 1998, J BIOL CHEM, V273, P1252, DOI 10.1074/jbc.273.2.1252; CHU W, 1995, J BIOL CHEM, V270, P10236, DOI 10.1074/jbc.270.17.10236; de Waard V, 2003, ARTERIOSCL THROM VAS, V23, P64, DOI 10.1161/01.ATV.0000042218.13101.50; Duboscq-Bidot L, 2009, EUR HEART J, V30, P2128, DOI 10.1093/eurheartj/ehp225; Hentzen ER, 2006, J PHYSIOL-LONDON, V570, P157, DOI 10.1113/jphysiol.2005.093005; Ihara Y, 2002, CELL CALCIUM, V32, P21, DOI 10.1016/S0143-4160(02)00096-9; Ikeda K, 2003, J BIOL CHEM, V278, P3514, DOI 10.1074/jbc.M204563200; Ishiguro N, 2002, AM J PATHOL, V160, P1767, DOI 10.1016/S0002-9440(10)61123-6; Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800; Kanai H, 2001, CIRC RES, V88, P30, DOI 10.1161/01.RES.88.1.30; Kemp TJ, 2000, GENOMICS, V66, P229, DOI 10.1006/geno.2000.6213; Kojic S, 2004, J MOL BIOL, V339, P313, DOI 10.1016/j.jmb.2004.03.071; Kojic S, 2010, ARCH BIOCHEM BIOPHYS, V502, P60, DOI 10.1016/j.abb.2010.06.029; Kuo HC, 1999, DEVELOPMENT, V126, P4223; Lehti M, 2009, J APPL PHYSIOL, V106, P1419, DOI 10.1152/japplphysiol.90660.2008; Maeda T, 2002, GENE, V297, P1, DOI 10.1016/S0378-1119(02)00924-1; Mckoy G, 2005, J APPL PHYSIOL, V98, P2337, DOI 10.1152/japplphysiol.01046.2004; Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012; Mohamed JS, J BIOL CHEM, V288, P24560; Moriyama M, 2001, BIOCHEM BIOPH RES CO, V285, P715, DOI 10.1006/bbrc.2001.5216; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Moza M, 2007, MOL CELL BIOL, V27, P244, DOI 10.1128/MCB.00561-06; Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF; Nakada C, 2004, PATHOBIOLOGY, V71, P43, DOI 10.1159/000072961; Nakamura K, 2002, PATHOBIOLOGY, V70, P197, DOI 10.1159/000069329; Pallavicini A, 2001, BIOCHEM BIOPH RES CO, V285, P378, DOI 10.1006/bbrc.2001.5131; Samaras SE, 2006, J INVEST DERM SYMP P, V11, P124, DOI 10.1038/sj.jidsymp.5650014; Shi Y, 2005, AM J PATHOL, V166, P303, DOI 10.1016/S0002-9440(10)62254-7; Song Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050436; Tanaka N, 1996, CIRCULATION, V94, P1109, DOI 10.1161/01.CIR.94.5.1109; Torrado M, 2004, EUR J HEART FAIL, V6, P161, DOI 10.1016/j.ejheart.2003.11.004; Torrado Mario, 2005, J Mol Cell Cardiol, V38, P353, DOI 10.1016/j.yjmcc.2004.11.034; Tsukamoto Y, 2002, LAB INVEST, V82, P645, DOI 10.1038/labinvest.3780459; Tsukamoto Y, 2008, HISTOCHEM CELL BIOL, V129, P55, DOI 10.1007/s00418-007-0348-9; Wei YJ, 2009, EUR J HEART FAIL, V11, P559, DOI 10.1093/eurjhf/hfp049; Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952; Witt SH, 2006, J MUSCLE RES CELL M, P1; Zolk O, 2003, CARDIOVASC RES, V59, P563, DOI 10.1016/S0008-6363(03)00476-0; Zolk O, 2002, BIOCHEM BIOPH RES CO, V293, P1377, DOI 10.1016/S0006-291X(02)00387-X; Zou YM, 1997, DEVELOPMENT, V124, P793	50	41	43	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93638	10.1371/journal.pone.0093638	http://dx.doi.org/10.1371/journal.pone.0093638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736439	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600023
J	Bauermeister, A; Mahnert, A; Auerbach, A; Boker, A; Flier, N; Weber, C; Probst, AJ; Moissl-Eichinger, C; Haberer, K				Bauermeister, Anja; Mahnert, Alexander; Auerbach, Anna; Boeker, Alexander; Flier, Niwin; Weber, Christina; Probst, Alexander J.; Moissl-Eichinger, Christine; Haberer, Klaus			Quantification of Encapsulated Bioburden in Spacecraft Polymer Materials by Cultivation-Dependent and Molecular Methods	PLOS ONE			English	Article							BACTERIA; SPORES; MARS; MICROORGANISMS; INHABITANTS; ENDOSPORES; DIVERSITY; RADIATION; SURVIVAL; GYRB	Bioburden encapsulated in spacecraft polymers (such as adhesives and coatings) poses a potential risk to jeopardize scientific exploration of other celestial bodies. This is particularly critical for spacecraft components intended for hard landing. So far, it remained unclear if polymers are indeed a source of microbial contamination. In addition, data with respect to survival of microbes during the embedding/polymerization process are sparse. In this study we developed testing strategies to quantitatively examine encapsulated bioburden in five different polymers used frequently and in large quantities on spaceflight hardware. As quantitative extraction of the bioburden from polymerized (solid) materials did not prove feasible, contaminants were extracted from uncured precursors. Cultivation-based analyses revealed <0.1-2.5 colony forming units (cfu) per cm(3) polymer, whereas quantitative PCR-based detection of contaminants indicated considerably higher values, despite low DNA extraction efficiency. Results obtained from this approach reflect the most conservative proxy for encapsulated bioburden, as they give the maximum bioburden of the polymers irrespective of any additional physical and chemical stress occurring during polymerization. To address the latter issue, we deployed an embedding model to elucidate and monitor the physiological status of embedded Bacillus safensis spores in a cured polymer. Staining approaches using AlexaFluor succinimidyl ester 488 (AF488), propidium monoazide (PMA), CTC (5-cyano-2,3-diotolyl tetrazolium chloride) demonstrated that embedded spores retained integrity, germination and cultivation ability even after polymerization of the adhesive Scotch-Weld 2216 B/A. Using the methods presented here, we were able to estimate the worst case contribution of encapsulated bioburden in different polymers to the bioburden of spacecraft. We demonstrated that spores were not affected by polymerization processes. Besides Planetary Protection considerations, our results could prove useful for the manufacturing of food packaging, pharmacy industry and implant technology.	[Bauermeister, Anja; Flier, Niwin; Weber, Christina; Haberer, Klaus] Compliance Advice & Serv Microbiol GmbH, Cologne, Germany; [Mahnert, Alexander; Auerbach, Anna; Probst, Alexander J.; Moissl-Eichinger, Christine] Univ Regensburg, Dept Microbiol, D-93053 Regensburg, Germany; [Mahnert, Alexander; Auerbach, Anna; Probst, Alexander J.; Moissl-Eichinger, Christine] Univ Regensburg, Archaea Ctr, D-93053 Regensburg, Germany; [Boeker, Alexander; Weber, Christina] Rhein Westfal TH Aachen, Lehrstuhl Makromol Mat & Oberflachen Macromol Mat, DWI, RWTH Aachen eV, Aachen, Germany	University of Regensburg; University of Regensburg; RWTH Aachen University	Moissl-Eichinger, C (corresponding author), Univ Regensburg, Dept Microbiol, D-93053 Regensburg, Germany.	Christine.Moissl-Eichinger@ur.de	Böker, Alexander/AAA-5106-2022; Probst, Alexander J/K-2813-2016; Moissl-Eichinger, Christine/A-6682-2015	Böker, Alexander/0000-0002-5760-6631; Moissl-Eichinger, Christine/0000-0001-6755-6263; Probst, Alexander/0000-0002-9392-6544	European Space Agency (ESA) [AO/1-6079/09/NL/CP]; German research foundation (DFG)	European Space Agency (ESA)(European Space Agency); German research foundation (DFG)(German Research Foundation (DFG))	This study has been funded by the European Space Agency (ESA) in the context of the project 'Evaluation of Encapsulated Bioburden on Flight Hardware' (contract no. AO/1-6079/09/NL/CP). This publication was supported by the German research foundation (DFG) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarele JO, 2002, TROP J PHARM RES, V1, P23; Allen MJ, 2004, INT J FOOD MICROBIOL, V92, P265, DOI 10.1016/j.ijfoodmicro.2003.08.017; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2011, BIOL IND; [Anonymous], 2008, ECSSQST7055C; [Anonymous], 2013, EV CLEAN ROOMS OTH C; [Anonymous], 2010, HDB MICR EX SPAC HAR; BALTSCHUKAT K, 1991, RADIAT ENVIRON BIOPH, V30, P87, DOI 10.1007/BF01219343; Barer MR, 1999, ADV MICROB PHYSIOL, V41, P93, DOI 10.1016/S0065-2911(08)60166-6; Bernadini JN, 2012, NASA TECH BRIEFS, P13; Bernadini JN, 2013, NASA TECH BRIEFS, P22; BRANNAN DK, 1990, APPL ENVIRON MICROB, V56, P1476, DOI 10.1128/AEM.56.5.1476-1479.1990; BURGGRAF S, 1992, SYST APPL MICROBIOL, V15, P352, DOI 10.1016/S0723-2020(11)80207-9; Cooper M, 2011, APPL ENVIRON MICROB, V77, P5438, DOI 10.1128/AEM.00192-11; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; Cucinotta FA, 1996, ADV SPACE RES-SERIES, V18, P183, DOI 10.1016/0273-1177(96)00039-7; Debus A, 2005, ADV SPACE RES, V35, P1648, DOI 10.1016/j.asr.2005.04.084; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; ESA, 2009, AO1067909NLCP4 ESA D; Ghosh S, 2009, J BACTERIOL, V191, P1787, DOI 10.1128/JB.01668-08; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Horneck G, 2008, ASTROBIOLOGY, V8, P17, DOI 10.1089/ast.2007.0134; Johnson DB, 2003, RES MICROBIOL, V154, P466, DOI 10.1016/S0923-2508(03)00114-1; Keller M, 2004, NAT REV MICROBIOL, V2, P141, DOI 10.1038/nrmicro819; Klappenbach JA, 2001, NUCLEIC ACIDS RES, V29, P181, DOI 10.1093/nar/29.1.181; Kwan K, 2011, APPL ENVIRON MICROB, V77, P2943, DOI 10.1128/AEM.02978-10; La Duc MT, 2004, MICROB ECOL, V47, P150, DOI 10.1007/s00248-003-1012-0; La Duc MT, 2004, J MICROBIOL METH, V56, P383, DOI 10.1016/j.mimet.2003.11.004; La Duc MT, 2009, APPL ENVIRON MICROB, V75, P6559, DOI 10.1128/AEM.01073-09; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lee ZM, 2009, NUCLEIC ACIDS RES, P1; Martinez JE, 2002, PHARM TECHNOL, V26, P58; Mastrapa RME, 2001, EARTH PLANET SC LETT, V189, P1, DOI 10.1016/S0012-821X(01)00342-9; Mileikowsky C, 2000, ICARUS, V145, P391, DOI 10.1006/icar.1999.6317; Mohapatra BR, 2012, MICROBIOL IMMUNOL, V56, P40, DOI 10.1111/j.1348-0421.2011.00404.x; Moissl C, 2007, FEMS MICROBIOL ECOL, V61, P509, DOI 10.1111/j.1574-6941.2007.00360.x; Nellen J, 2006, ADV SPACE RES, V38, P1266, DOI 10.1016/j.asr.2005.10.026; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Nocker A, 2006, J MICROBIOL METH, V67, P310, DOI 10.1016/j.mimet.2006.04.015; PASSEY QR, 1980, ICARUS, V42, P211, DOI 10.1016/0019-1035(80)90072-X; Probst A, 2012, INT J ASTROBIOL, V11, P117, DOI 10.1017/S1473550411000425; Probst A, 2011, APPL ENVIRON MICROB, V77, P1628, DOI 10.1128/AEM.02037-10; Probst A, 2010, APPL ENVIRON MICROB, V76, P5148, DOI 10.1128/AEM.00399-10; Probst AJ, 2013, ISME J, V7, P635, DOI 10.1038/ismej.2012.133; PULEO JR, 1977, APPL ENVIRON MICROB, V33, P379, DOI 10.1128/AEM.33.2.379-384.1977; Rettberg P, 2004, ADV SPACE RES-SERIES, V33, P1294, DOI 10.1016/j.asr.2003.09.050; Rettberg P, 2006, ADV SPACE RES, V38, P1260, DOI 10.1016/j.asr.2006.01.006; Rummel J D, 1989, Adv Space Res, V9, P181, DOI 10.1016/0273-1177(89)90227-5; Rummel JD, 2002, COSPAR IAU WORKSH PL, P2; SARGENT MG, 1980, J GEN MICROBIOL, V116, P511; Satomi M, 2006, INT J SYST EVOL MICR, V56, P1735, DOI 10.1099/ijs.0.64189-0; Shelobolina ES, 2005, CLAY CLAY MINER, V53, P580, DOI 10.1346/CCMN.2005.0530604; Shelobolina ES, 1999, PROCESS MET, V9, P559; Stam CN, 2012, INT J ASTROBIOL, V11, P141, DOI 10.1017/S1473550412000031; Stieglmeier M, 2012, ASTROBIOLOGY, V12, P572, DOI 10.1089/ast.2011.0735; Stoffler D, 2007, ICARUS, V186, P585, DOI 10.1016/j.icarus.2006.11.007; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; Vaishampayan P, 2013, ISME J, V7, P312, DOI 10.1038/ismej.2012.114; VASIN VB, 1994, ADV SPACE RES, V15, P273; Venkateswaran K, 2001, SYST APPL MICROBIOL, V24, P311, DOI 10.1078/0723-2020-00018; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Willis P.B., 1999, SPACE APPL POLYM MAT; YAMAMOTO S, 1995, APPL ENVIRON MICROB, V61, P1104, DOI 10.1128/AEM.61.3.1104-1109.1995; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	66	4	4	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94265	10.1371/journal.pone.0094265	http://dx.doi.org/10.1371/journal.pone.0094265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736730	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600056
J	Chen, JL; Zhang, HB; Zhou, Z; Yang, ZS; Ding, YL; Zhou, ZG; Zhong, E; Arulanandam, B; Baseman, J; Zhong, GM				Chen, Jianlin; Zhang, Hongbo; Zhou, Zhou; Yang, Zhangsheng; Ding, Yiling; Zhou, Zhiguang; Zhong, Edward; Arulanandam, Bernard; Baseman, Joel; Zhong, Guangming			Chlamydial Induction of Hydrosalpinx in 11 Strains of Mice Reveals Multiple Host Mechanisms for Preventing Upper Genital Tract Pathology	PLOS ONE			English	Article							TUBAL FACTOR INFERTILITY; MONOCLONAL-ANTIBODIES; INFECTION; TRACHOMATIS; PROTEIN; IDENTIFICATION; DEFICIENT; MURIDARUM; MEMBRANE; DISEASE	The female lower genital tract is constantly exposed to microbial infection, some of which can ascend to and cause pathology such as hydrosalpinx in the upper genital tract, which can affect fertility. To understand host mechanisms for preventing upper genital tract pathology, we screened 11 inbred strains of mice for hydrosalpinx induction by C. muridarum. When examined on days 60 to 80 after intravaginal infection, the 11 strains fell into 3 groups based on their hydrosalpinx severity: CBA/J and SJL/J mice were highly susceptible with a hydrosalpinx score of 5 or greater; Balb/c, C57BL/6J, C57BL/10J, C3H/HeJ and C3H/HeN were susceptible with a score between 1 and <5; NOD/ShiLtJ, DBA/1J, DBA/2J and A/J were resistant with a score of <1. The diverse range of mouse susceptibility to hydrosalpinx induction may reflect the varied clinical outcomes of C. trachomatis-infected women. When the 11 strains were infected via an intrauterine inoculation to bypass the requirement for ascension, higher incidence and more severe hydrosalpinges were induced in most mice, indicating that the interaction between chlamydial ascension and host control of ascension is critical for determining susceptibility to hydrosalpinx development in many mice. However, a few mouse strains resisted significant exacerbation of hydrosalpinx by intrauterine infection, indicating that these mice have evolved ascension-independent mechanisms for preventing upper genital tract pathology. Together, the above observations have demonstrated that different strains of mice can prevent upper genital tract pathology by using different mechanisms.	[Chen, Jianlin; Zhang, Hongbo; Zhou, Zhou; Yang, Zhangsheng; Baseman, Joel; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Chen, Jianlin; Zhang, Hongbo; Ding, Yiling; Zhou, Zhiguang] Cent S Univ, Xiangya Hosp 2, Dept Obstet & Gynecol, Changsha, Hunan, Peoples R China; [Chen, Jianlin; Zhang, Hongbo; Ding, Yiling; Zhou, Zhiguang] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Chen, Jianlin; Zhang, Hongbo; Ding, Yiling; Zhou, Zhiguang] Cent S Univ, Xiangya Hosp 2, Dept Endocrinol, Changsha, Hunan, Peoples R China; [Zhong, Edward] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Arulanandam, Bernard] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Central South University; Central South University; Central South University; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas at San Antonio (UTSA)	Zhong, GM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	Zhongg@UTHSCSA.EDU	Arulanandam, Bernard P/O-9501-2014	Zhou, Zhiguang/0000-0002-0374-1838	US National Institutes of Health (NIH) [R01AI064537, R01AI047997]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537, R01AI047997] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research is supported by US National Institutes of Health (NIH) grants R01AI064537 and R01AI047997. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budrys NM, 2012, OBSTET GYNECOL, V119, P1009, DOI 10.1097/AOG.0b013e3182519326; Chen CQ, 2006, INFECT IMMUN, V74, P4826, DOI 10.1128/IAI.00081-06; Chen LL, 2010, J IMMUNOL, V184, P2602, DOI 10.4049/jimmunol.0901593; Cheng W, 2008, INFECT IMMUN, V76, P515, DOI 10.1128/IAI.01064-07; Copland DA, 2010, CLIN EXP IMMUNOL, V159, P303, DOI 10.1111/j.1365-2249.2009.04070.x; COTTER TW, 1995, INFECT IMMUN, V63, P4704, DOI 10.1128/IAI.63.12.4704-4714.1995; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Durigutto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058696; Howell GR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-76; Mashruwala MA, 2011, TUBERCULOSIS, V91, pS82, DOI 10.1016/j.tube.2011.10.016; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; Ramsey KH, 2001, INFECT IMMUN, V69, P7374, DOI 10.1128/IAI.69.12.7374-7379.2001; Rodgers AK, 2011, FERTIL STERIL, V96, P715, DOI 10.1016/j.fertnstert.2011.06.021; Shah AA, 2005, SEX TRANSM DIS, V32, P49, DOI 10.1097/01.olq.0000148299.14513.11; SHERMAN KJ, 1990, SEX TRANSM DIS, V17, P115, DOI 10.1097/00007435-199007000-00001; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; SWENSON CE, 1984, SEX TRANSM DIS, V11, P64, DOI 10.1097/00007435-198404000-00002; Tang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071649; Tuite A, 2005, GENES IMMUN, V6, P672, DOI 10.1038/sj.gene.6364254; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	22	53	58	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95076	10.1371/journal.pone.0095076	http://dx.doi.org/10.1371/journal.pone.0095076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736397	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600141
J	Cheng, ZQ; Meng, XX; Wang, HC; Chen, M; Li, MY				Cheng, Zhongqin; Meng, Xiangxun; Wang, Haichao; Chen, Mei; Li, Mengying			Isolation and Characterization of Broad Spectrum Coaggregating Bacteria from Different Water Systems for Potential Use in Bioaugmentation	PLOS ONE			English	Article							FUSOBACTERIUM-NUCLEATUM PK1594; BIOFILM-FORMING BACTERIA; DUAL-SPECIES BIOFILMS; INTERGENERIC COAGGREGATION; PORPHYROMONAS-GINGIVALIS; DRINKING-WATER; STRAINS; IMMOBILIZATION; DEGRADATION; AGGREGATION	The bridging bacteria with broad-spectrum coaggregation ability play an important role during multispecies-biofilm development. In this study, through a visual and semi-quantitative assay, twenty-two bacterial strains with aggregation ability were obtained from 8 different water environments, and these strains were assigned to 7 genera according to their 16S rDNA and they were Aeromonas, Bacillus, Comamonas, Exiguobacterium, Pseudomonas, Shewanella and Comamonas. Furthermore, all possible 231 pairwise combinations among these 22 strains were explored for coaggregation ability by spectrophotometric assay. Among all these strains, it was found that Bacillus cereus G5 and Bacillus megaterium T1 coaggregated with themajority of assayed other strains, 90.5% (19 of 21 strains) and 76.2% respectively (17 of 21 strains) at a higher coaggregation rates (A. I. greater than 50%), indicating they have a broad-spectrum coaggregation property. The images of coaggregates also confirmed the coexistence of G5 and T1 with their partner strains. Biofilm biomass development of G5 cocultured with each of its partner strains were further evaluateded. The results showed that 15 of 21 strains, when paired with G5, developed greater biofilm biomass than the monocultures. Furthermore, the images from both fluorescence microscopy and scanning electron microscopy (SEM) demonstrated that G5 and A3-GFP (a 3,5-dinitrobenzoic acid-degrading strain, staining with gfp), could develop a typical spatial structure of dual-species biofilm when cocultured. These results suggested that bridging-bacteria with a broad spectrum coaggregating ability, such as G5, could mediate the integration of exogenous degrading bacteria into biofilms and contribute to the bioaugmentation treatment.	[Cheng, Zhongqin; Meng, Xiangxun; Wang, Haichao; Chen, Mei; Li, Mengying] Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Peoples R China	Soochow University - China	Li, MY (corresponding author), Soochow Univ, Sch Biol & Basic Med Sci, Suzhou, Peoples R China.	lmysuda@163.com			National Natural Science Foundation of China [51079094]; program for sustainable development of Kunshan Municipal Science and Technology Bureau [KS1245]; Natural Science Foundation of Jiangsu Province [BK2010215]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); program for sustainable development of Kunshan Municipal Science and Technology Bureau; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (no. 51079094), the program for sustainable development of Kunshan Municipal Science and Technology Bureau (no. KS1245), and the Natural Science Foundation of Jiangsu Province (no. BK2010215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2008, APPL MICROBIOL BIOT, V79, P657, DOI 10.1007/s00253-008-1456-8; Bechet M, 2003, J APPL MICROBIOL, V94, P1072, DOI 10.1046/j.1365-2672.2003.01931.x; Buswell CM, 1997, J APPL MICROBIOL, V83, P477, DOI 10.1046/j.1365-2672.1997.00260.x; Di Gioia D, 2004, RES MICROBIOL, V155, P761, DOI 10.1016/j.resmic.2004.05.015; Diaz PI, 2002, MICROBIOL-SGM, V148, P467, DOI 10.1099/00221287-148-2-467; Edwards SJ, 2013, APPL MICROBIOL BIOT, V97, P9909, DOI 10.1007/s00253-013-5216-z; Hou DY, 2013, MAR POLLUT BULL, V67, P146, DOI 10.1016/j.marpolbul.2012.11.021; Jakubovics NS, 2010, ORAL DIS, V16, P729, DOI 10.1111/j.1601-0825.2010.01701.x; Jiang HL, 2006, ENVIRON SCI TECHNOL, V40, P6137, DOI 10.1021/es0609295; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Kwak Y, 2013, BIOREMEDIAT J, V17, P173, DOI 10.1080/10889868.2013.807773; Lertsutthiwong P, 2013, J ENVIRON SCI-CHINA, V25, P262, DOI 10.1016/S1001-0742(12)60059-X; Li CY, 2013, BIORESOURCE TECHNOL, V131, P390, DOI 10.1016/j.biortech.2012.12.140; Li M, 2008, FEMS MICROBIOL LETT, V278, P15, DOI 10.1111/j.1574-6968.2007.00913.x; Liu PF, 2013, CURR MOL MED, V13, P1358, DOI 10.2174/15665240113139990063; [陆健 LU Jian], 2008, [土壤, Soils], V40, P460; Malik A, 2003, J BIOSCI BIOENG, V96, P10, DOI 10.1263/jbb.96.10; Metzger Z, 2009, J ENDODONT, V35, P50, DOI 10.1016/j.joen.2008.09.016; Mollaei M, 2010, J HAZARD MATER, V175, P284, DOI 10.1016/j.jhazmat.2009.10.002; [邱珊莲 Qiu Shanlian], 2004, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V10, P778; Ramalingam B, 2013, WATER SCI TECH-W SUP, V13, P1016, DOI 10.2166/ws.2013.115; Ramli NSK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044104; Rickard AH, 2003, FEMS MICROBIOL LETT, V220, P133, DOI 10.1016/S0378-1097(03)00094-6; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rickard AH, 2002, APPL ENVIRON MICROB, V68, P3644, DOI 10.1128/AEM.68.7.3644-3650.2002; Schneider I, 2013, BIOTECHNOL BIOTEC EQ, V27, P3782, DOI 10.5504/BBEQ.2013.0015; Shen S, 2005, ARCH ORAL BIOL, V50, P23, DOI 10.1016/j.archoralbio.2004.07.002; Simoes LC, 2008, APPL ENVIRON MICROB, V74, P1259, DOI 10.1128/AEM.01747-07; Tait K, 2002, J APPL MICROBIOL, V93, P345, DOI 10.1046/j.1365-2672.2002.01692.x; Tomlin KL, 2004, J MICROBIOL METH, V57, P95, DOI 10.1016/j.mimet.2003.12.007; Weiss EI, 2000, ORAL MICROBIOL IMMUN, V15, P371, DOI 10.1034/j.1399-302x.2000.150606.x; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8	32	10	10	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94220	10.1371/journal.pone.0094220	http://dx.doi.org/10.1371/journal.pone.0094220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736645	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600052
J	Ferdaus, MZ; Xiao, B; Ohara, H; Nemoto, K; Harada, Y; Saar, K; Hubner, N; Isomura, M; Nabika, T				Ferdaus, Mohammed Zubaerul; Xiao, Bing; Ohara, Hiroki; Nemoto, Kiyomitsu; Harada, Yuji; Saar, Kathrin; Huebner, Norbert; Isomura, Minoru; Nabika, Toru			Identification of Stim1 as a Candidate Gene for Exaggerated Sympathetic Response to Stress in the Stroke-Prone Spontaneously Hypertensive Rat	PLOS ONE			English	Article							BLOOD-PRESSURE; CRAC; STORE; ACTIVATION; PROTEINS; EXPRESSION; SHIP2; ORAI1	The stroke-prone spontaneously hypertensive rat (SHRSP) is known to have exaggerated sympathetic nerve activity to various types of stress, which might contribute to the pathogenesis of severe hypertension and stroke observed in this strain. Previously, by using a congenic strain (called SPwch1.72) constructed between SHRSP and the normotensive Wistar-Kyoto rat (WKY), we showed that a 1.8-Mbp fragment on chromosome 1 (Chr1) of SHRSP harbored the responsible gene(s) for the exaggerated sympathetic response to stress. To further narrow down the candidate region, in this study, another congenic strain (SPwch1.71) harboring a smaller fragment on Chr1 including two functional candidate genes, Phox2a and Ship2, was generated. Sympathetic response to cold and restraint stress was compared among SHRSP, SPwch1.71, SPwch1.72 and WKY by three different methods (urinary norepinephrine excretion, blood pressure measurement by the telemetry system and the power spectral analysis on heart rate variability). The results indicated that the response in SPwch1.71 did not significantly differ from that in SHRSP, excluding Phox2a and Ship2 from the candidate genes. As the stress response in SPwch1.72 was significantly less than that in SHRSP, it was concluded that the 1.2-Mbp congenic region covered by SPwch1.72 (and not by SPwch1.71) was responsible for the sympathetic stress response. The sequence analysis of 12 potential candidate genes in this region in WKY/Izm and SHRSP/Izm identified a nonsense mutation in the stromal interaction molecule 1 (Stim1) gene of SHRSP/Izm which was shared among 4 substrains of SHRSP. A western blot analysis confirmed a truncated form of STIM1 in SHRSP/Izm. In addition, the analysis revealed that the protein level of STIM1 in the brainstem of SHRSP/Izm was significantly lower when compared with WKY/Izm. Our results suggested that Stim1 is a strong candidate gene responsible for the exaggerated sympathetic response to stress in SHRSP.	[Ferdaus, Mohammed Zubaerul; Xiao, Bing; Ohara, Hiroki; Isomura, Minoru; Nabika, Toru] Shimane Univ, Sch Med, Dept Funct Pathol, Izumo, Shimane, Japan; [Nemoto, Kiyomitsu] Univ Shizuoka, Sch Pharmaceut Sci, Dept Mol Toxicol, Shizuoka 4228526, Japan; [Harada, Yuji] Shimane Univ Hosp, Dept Surg Pathol, Izumo, Shimane, Japan; [Saar, Kathrin; Huebner, Norbert] Max Delbruck Ctr Mol Med, Dept Expt Genet Cardiovasc Dis, Berlin, Germany	Shimane University; University of Shizuoka; Shimane University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Ohara, H (corresponding author), Shimane Univ, Sch Med, Dept Funct Pathol, Izumo, Shimane, Japan.	oharah@med.shimane-u.ac.jp		Saar, Kathrin/0000-0002-4483-1557; Ferdaus, Mohammed/0000-0002-4860-5506	Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labor, and Welfare, Japan [22590911, 23890115, 24790846]; Japan Research Promotion Society for Cardiovascular Diseases	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Research Promotion Society for Cardiovascular Diseases	This work was partly supported by grants-in-aid for scientific research by the Ministry of Education, Culture, Sports, Science, and Technology, and by the Ministry of Health, Labor, and Welfare, Japan (Grant number 22590911, 23890115 and 24790846) and the Sakakibara Memorial Research Grant from The Japan Research Promotion Society for Cardiovascular Diseases (http://www.sakakibara-heart.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer MC, 2008, BIOCHEMISTRY-US, V47, P6089, DOI 10.1021/bi800496a; Benkirane K, 2006, AM J PHYSIOL-HEART C, V290, pH390, DOI 10.1152/ajpheart.00662.2005; Berna-Erro A, 2012, J CELL MOL MED, V16, P407, DOI 10.1111/j.1582-4934.2011.01395.x; Cai H, 1998, STROKE, V29, P1982, DOI 10.1161/01.STR.29.9.1982; Cui ZH, 2004, J HYPERTENS, V22, P2103, DOI 10.1097/00004872-200411000-00011; Cui ZH, 2003, CLIN EXP PHARMACOL P, V30, P464, DOI 10.1046/j.1440-1681.2003.03860.x; Dyson JM, 2005, INT J BIOCHEM CELL B, V37, P2260, DOI 10.1016/j.biocel.2005.05.003; Gandolgor TA, 2013, HYPERTENSION, V62, P55, DOI 10.1161/HYPERTENSIONAHA.111.00488; Giachini FRC, 2009, HYPERTENSION, V53, P409, DOI 10.1161/HYPERTENSIONAHA.108.124404; Gough SM, 2011, BLOOD, V118, P6247, DOI 10.1182/blood-2011-07-328880; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; Guyton AC, 1996, TXB MED PHYSL, P209; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Keil JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013465; Kumagai H, 2012, HYPERTENS RES, V35, P132, DOI 10.1038/hr.2011.208; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo X, 2012, J MOL CELL CARDIOL, V52, P136, DOI 10.1016/j.yjmcc.2011.11.003; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Marion E, 2002, DIABETES, V51, P2012, DOI 10.2337/diabetes.51.7.2012; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; OKAMOTO K, 1974, CIRC RES, V34, pI143; Oke V, 2012, J AUTOIMMUN, V39, P77, DOI 10.1016/j.jaut.2012.01.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Serikawa T, 2009, EXP ANIM TOKYO, V58, P333, DOI 10.1538/expanim.58.333; Shaw PJ, 2012, J PHYSIOL-LONDON, V590, P4157, DOI 10.1113/jphysiol.2012.233221; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Swanson DJ, 1997, J BIOL CHEM, V272, P27382, DOI 10.1074/jbc.272.43.27382; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Toyokuni S, 2003, PATHOL INT, V53, P259, DOI 10.1046/j.1320-5463.2003.01465.x; Xiao B, 2011, J HYPERTENS, V29, P257, DOI 10.1097/HJH.0b013e32834137cd; Xu L, 2013, PHYSIOL RES, V62, P351, DOI 10.33549/physiolres.932433; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zellmer E, 1995, J NEUROSCI, V15, P8109; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	36	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95091	10.1371/journal.pone.0095091	http://dx.doi.org/10.1371/journal.pone.0095091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736434	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000336922600142
J	Fontanesi, L; Vargiolu, M; Scotti, E; Latorre, R; Pellegrini, MSF; Mazzoni, M; Asti, M; Chiocchetti, R; Romeo, G; Clavenzani, P; De Giorgio, R				Fontanesi, Luca; Vargiolu, Manuela; Scotti, Emilio; Latorre, Rocco; Pellegrini, Maria Simonetta Faussone; Mazzoni, Maurizio; Asti, Martina; Chiocchetti, Roberto; Romeo, Giovanni; Clavenzani, Paolo; De Giorgio, Roberto			The KIT Gene Is Associated with the English Spotting Coat Color Locus and Congenital Megacolon in Checkered Giant Rabbits (Oryctolagus cuniculus)	PLOS ONE			English	Article							HUMAN ENTERIC NEUROPATHIES; SLOW-TRANSIT CONSTIPATION; RECEPTOR MC1R GENE; INTERSTITIAL-CELLS; C-KIT; HIRSCHSPRUNGS-DISEASE; STEM-CELL; MOTILITY DISORDERS; DOMESTIC PIG; W-LOCUS	The English spotting coat color locus in rabbits, also known as Dominant white spotting locus, is determined by an incompletely dominant allele (En). Rabbits homozygous for the recessive wild-type allele (en/en) are self-colored, heterozygous En/en rabbits are normally spotted, and homozygous En/En animals are almost completely white. Compared to vital en/en and En/en rabbits, En/En animals are subvital because of a dilated ("mega") cecum and ascending colon. In this study, we investigated the role of the KIT gene as a candidate for the English spotting locus in Checkered Giant rabbits and characterized the abnormalities affecting enteric neurons and c-kit positive interstitial cells of Cajal (ICC) in the megacolon of En/En rabbits. Twenty-one litters were obtained by crossing three Checkered Giant bucks (En/en) with nine Checkered Giant (En/en) and two en/en does, producing a total of 138 F1 and backcrossed rabbits. Resequencing all coding exons and portions of non-coding regions of the KIT gene in 28 rabbits of different breeds identified 98 polymorphisms. A single nucleotide polymorphism genotyped in all F1 families showed complete cosegregation with the English spotting coat color phenotype (theta = 0.00 LOD = 75.56). KIT gene expression in cecum and colon specimens of En/En (pathological) rabbits was 5-10% of that of en/en (control) rabbits. En/En rabbits showed reduced and altered c-kit immunolabelled ICC compared to en/en controls. Morphometric data on whole mounts of the ascending colon showed a significant decrease of HuC/D (P<0.05) and substance P (P<0.01) immunoreactive neurons in En/En vs. en/en. Electron microscopy analysis showed neuronal and ICC abnormalities in En/En tissues. The En/En rabbit model shows neuro-ICC changes reminiscent of the human non-aganglionic megacolon. This rabbit model may provide a better understanding of the molecular abnormalities underlying conditions associated with non-aganglionic megacolon.	[Fontanesi, Luca; Scotti, Emilio] Univ Bologna, Lab Livestock Genom, Div Anim Sci, Dept Agr & Food Sci, Bologna, Italy; [Fontanesi, Luca] Univ Bologna, Ctr Genome Biol, Bologna, Italy; [Vargiolu, Manuela] Univ Bologna, Hlth Sci & Technol Interdept Ctr Ind Res, Bologna, Italy; [Latorre, Rocco; Mazzoni, Maurizio; Asti, Martina; Chiocchetti, Roberto; Clavenzani, Paolo] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Latorre, Rocco; De Giorgio, Roberto] Univ Bologna, Dept Med & Surg Sci, Ctr Unificato Ric Biomed Applicata CRBA, St Orsola Malpighi Hosp, Bologna, Italy; [Pellegrini, Maria Simonetta Faussone] Univ Florence, Sect Anat & Histol, Dept Expt & Clin Med, Florence, Italy; [Romeo, Giovanni] Univ Bologna, St Orsola Malpighi Hosp, Med Genet Unit, Dept Med & Surg Sci, Bologna, Italy	University of Bologna; University of Bologna; University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Florence; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Fontanesi, L (corresponding author), Univ Bologna, Lab Livestock Genom, Div Anim Sci, Dept Agr & Food Sci, Bologna, Italy.	luca.fontanesi@unibo.it; roberto.degiorgio@unibo.it	Mazzoni, Maurizio/J-1918-2016; Fontanesi, Luca/L-1770-2014	Mazzoni, Maurizio/0000-0002-7384-5990; Fontanesi, Luca/0000-0001-7050-3760; chiocchetti, roberto/0000-0003-4448-6199	University of Bologna FagenomicH; Italian Ministry of Education, University and Research (MIUR); "Fondazione Del Monte di Bologna e Ravenna", Italy; University of Bologna	University of Bologna FagenomicH; Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); "Fondazione Del Monte di Bologna e Ravenna", Italy; University of Bologna	This work was supported by University of Bologna FagenomicH (LF) and the following grants: the Italian Ministry of Education, University and Research (MIUR) (PRIN2009) (RDG), from "Fondazione Del Monte di Bologna e Ravenna", Italy (RDG and PC), and funds from the University of Bologna (RDG and LF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi Y, 2008, J GASTROENTEROL, V43, P626, DOI 10.1007/s00535-008-2207-4; Aigner B, 2000, MAMM GENOME, V11, P700, DOI 10.1007/s003350010120; Andersson L, 2011, GENETICS OF THE PIG, 2ND EDITION, P38, DOI 10.1079/9781845937560.0038; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; BESMER P, 1993, DEVELOPMENT, P125; Bodeker D, 1995, J VET MED A, V42, P549, DOI 10.1111/j.1439-0442.1995.tb00410.x; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Castle WE, 1924, P NATL ACAD SCI USA, V10, P107, DOI 10.1073/pnas.10.3.107; Castle WE, 1930, GENETICS DOMESTIC RA, P31; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; Chantry-Darmon C, 2006, ANIM GENET, V37, P335, DOI 10.1111/j.1365-2052.2006.01462.x; Chiocchetti R, 2004, CELL TISSUE RES, V318, P289, DOI 10.1007/s00441-004-0906-6; Cieslak M, 2011, BIOL REV, V86, P885, DOI 10.1111/j.1469-185X.2011.00177.x; Cooper MP, 2006, ANIM GENET, V37, P163, DOI 10.1111/j.1365-2052.2005.01389.x; De Giorgio R, 2004, NEUROGASTROENT MOTIL, V16, P515, DOI 10.1111/j.1365-2982.2004.00538.x; De Giorgio R, 2004, GUT, V53, P1549, DOI 10.1136/gut.2004.043968; Di Nardo G, 2008, ALIMENT PHARM THER, V28, P25, DOI 10.1111/j.1365-2036.2008.03707.x; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; Farrugia G, 2008, NEUROGASTROENT MOTIL, V20, P54, DOI 10.1111/j.1365-2982.2008.01109.x; Faussone-Pellegrini Maria Simonetta, 2005, Italian Journal of Anatomy and Embryology, V110, P11; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10885, DOI 10.1073/pnas.88.23.10885; Fontanesi L, 2007, WORLD RABBIT SCI, V15, P121; Fontanesi L, 2006, ANIM GENET, V37, P489, DOI 10.1111/j.1365-2052.2006.01494.x; Fontanesi L, 2014, ANIM GENET, V45, P248, DOI 10.1111/age.12104; Fontanesi L, 2010, ANIM GENET, V41, P669, DOI 10.1111/j.1365-2052.2010.02084.x; Fontanesi L, 2010, ANIM GENET, V41, P478, DOI 10.1111/j.1365-2052.2010.02054.x; Fontanesi L, 2010, ANIM GENET, V41, P295, DOI 10.1111/j.1365-2052.2009.02007.x; Fontanesi L, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-59; Fontanesi L, 2010, GENOMICS, V95, P166, DOI 10.1016/j.ygeno.2009.11.003; FOX RR, 1974, BIOL LABORATORY RABB, P1; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GERLITZ S, 1993, DEUT TIERARZTL WOCH, V100, P237; Godornes C, 2007, CYTOKINE, V38, P1, DOI 10.1016/j.cyto.2007.04.002; Haase B, 2007, PLOS GENET, V3, P2101, DOI 10.1371/journal.pgen.0030195; Hagger R, 2000, J AUTONOM NERV SYST, V80, P108, DOI 10.1016/S0165-1838(00)00076-X; He CL, 2000, GASTROENTEROLOGY, V118, P14, DOI 10.1016/S0016-5085(00)70409-4; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Knowles CH, 2013, NAT REV GASTRO HEPAT, V10, P206, DOI 10.1038/nrgastro.2013.18; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Marklund S, 1998, GENOME RES, V8, P826, DOI 10.1101/gr.8.8.826; Marklund S, 1999, MAMM GENOME, V10, P283, DOI 10.1007/s003359900987; Miller I, 2014, CURR PROTEIN PEPT SC, V15, P134, DOI 10.2174/1389203715666140221115135; Mulsant P, 2004, WORLD RABBIT SCI, V12, P1; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Panza E, 2012, PROG NEUROBIOL, V96, P176, DOI 10.1016/j.pneurobio.2012.01.001; Pielberg G, 2002, GENETICS, V160, P305; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Ray P, 2008, CELL CYCLE, V7, P2826, DOI 10.4161/cc.7.18.6752; Robinson R., 1958, Bibliographia Genetica, V17, P229; Rolle U, 2007, PEDIATR SURG INT, V23, P1139, DOI 10.1007/s00383-007-2022-7; Sanders KM, 2010, J PHYSIOL-LONDON, V588, P4621, DOI 10.1113/jphysiol.2010.196030; Searle A.G., 1968, COMP GENETICS COAT C; Shiomi Masashi, 2009, P49, DOI 10.1007/978-90-481-2227-1_7; SPRITZ RA, 1992, AM J HUM GENET, V50, P261; Streutker CJ, 2007, HISTOPATHOLOGY, V50, P176, DOI 10.1111/j.1365-2559.2006.02493.x; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tong WD, 2005, INT J COLORECTAL DIS, V20, P363, DOI 10.1007/s00384-004-0679-0; Utzeri VJ, 2014, ANIMAL GENE IN PRESS; Vanderwinden JM, 1996, GASTROENTEROLOGY, V111, P901, DOI 10.1016/S0016-5085(96)70057-4; Wieberneit D., 1995, World Rabbit Science, V3, P19; Wong AK, 2013, ANIM GENET, V44, P305, DOI 10.1111/age.12006	66	21	22	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93750	10.1371/journal.pone.0093750	http://dx.doi.org/10.1371/journal.pone.0093750			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736498	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600025
J	Kono, M; Nakamura, Y; Enomoto, N; Hashimoto, D; Fujisawa, T; Inui, N; Maekawa, M; Suda, T; Colby, TV; Chida, K				Kono, Masato; Nakamura, Yutaro; Enomoto, Noriyuki; Hashimoto, Dai; Fujisawa, Tomoyuki; Inui, Naoki; Maekawa, Masato; Suda, Takafumi; Colby, Thomas V.; Chida, Kingo			Usual Interstitial Pneumonia Preceding Collagen Vascular Disease: A Retrospective Case Control Study of Patients Initially Diagnosed with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							CONNECTIVE-TISSUE DISEASE; LUNG-DISEASE; RHEUMATOID-ARTHRITIS; SYSTEMIC-SCLEROSIS; SJOGRENS-SYNDROME; REVISED CRITERIA; CLASSIFICATION; DERMATOMYOSITIS; MANIFESTATION; VASCULITIDES	Background: The aim of this study was to evaluate the cumulative incidence and the predictive factors for collagen vascular disease (CVD) in patients initially diagnosed with idiopathic pulmonary fibrosis (IPF), and to examine the features of patients who then developed CVD. Methods: This was a retrospective review of 111 consecutive patients with IPF diagnosed at our institution. None of the patients fulfilled any of the CVD criteria from the American College of Rheumatology (ACR) within 6 months or more after the diagnosis of IPF. Results: Ten patients (9.0%) developed CVD during the follow-up period: four had rheumatoid arthritis (RA); four had microscopic polyangiitis (MPA); one had systemic sclerosis (SSc); and one had SSc and Sjogren's syndrome (SjS). The mean time until CVD diagnosis was 3.9 years. The cumulative incidences of CVD at 1, 5, and 10 years were 0.91%, 9.85%, and 15.5%, respectively. Patients who developed CVD were significantly younger, more likely to be women and had a better prognosis than those with IPF. Cox proportional hazards regression analysis showed that female sex and the presence of lymphoid aggregates with germinal centers were significantly associated with the occurrence of CVD in patients initially diagnosed with IPF. Conclusions: CVD is an important underlying condition in IPF, and shows better prognosis. The possibility of the development of CVD should remain a consideration in the follow-up of IPF.	[Kono, Masato; Nakamura, Yutaro; Enomoto, Noriyuki; Hashimoto, Dai; Fujisawa, Tomoyuki; Inui, Naoki; Suda, Takafumi; Chida, Kingo] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan; [Kono, Masato; Maekawa, Masato] Hamamatsu Univ Sch Med, Dept Lab Med, Hamamatsu, Shizuoka 4313192, Japan; [Colby, Thomas V.] Mayo Clin, Dept Lab Med & Pathol, Scottsdale, AZ USA	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Mayo Clinic; Mayo Clinic Phoenix	Nakamura, Y (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka 4313192, Japan.	nakayuta@hama-med.ac.jp	Enomoto, Noriyuki/GLS-0691-2022	Enomoto, Noriyuki/0000-0003-3187-4264; Maekawa, Masato/0000-0001-9710-5324	Ministry of Health, Labor and Welfare, Japan	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This study was partly supported by a grant to the Diffuse Lung Diseases Research Group from the Ministry of Health, Labor and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamad EH, 2012, RESP MED, V106, P1575, DOI 10.1016/j.rmed.2012.07.009; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Antoniou KM, 2009, EUR RESPIR J, V33, P882, DOI 10.1183/09031936.00152607; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Bouros D, 2002, AM J RESP CRIT CARE, V165, P1581, DOI 10.1164/rccm.2106012; Cipriani NA, 2012, ARCH PATHOL LAB MED, V136, P1253, DOI 10.5858/arpa.2012-0102-OA; Cottin V, 2006, EUR RESPIR J, V28, P893, DOI 10.1183/09031936.00101506; Douglas WW, 2001, AM J RESP CRIT CARE, V164, P1182, DOI 10.1164/ajrccm.164.7.2103110; Fischer A, 2006, CHEST, V130, P976, DOI 10.1378/chest.130.4.976; Fischer A, 2012, LANCET, V380, P689, DOI 10.1016/S0140-6736(12)61079-4; Fischer A, 2010, CHEST, V138, P251, DOI 10.1378/chest.10-0194; Homma S, 2004, RESPIROLOGY, V9, P190, DOI 10.1111/j.1440-1843.2004.00581.x; HOMMA Y, 1995, RESPIRATION, V62, P248, DOI 10.1159/000196457; Ito I, 2005, AM J RESP CRIT CARE, V171, P632, DOI 10.1164/rccm.200403-417OC; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Kim EJ, 2010, EUR RESPIR J, V35, P1322, DOI 10.1183/09031936.00092309; Kim EJ, 2009, CHEST, V136, P1397, DOI 10.1378/chest.09-0444; Kinder BW, 2007, AM J RESP CRIT CARE, V176, P691, DOI 10.1164/rccm.200702-220OC; Lee HK, 2005, CHEST, V127, P2019, DOI 10.1378/chest.127.6.2019; LOMEO RM, 1989, AM J MED, V87, P525; Mittoo S, 2009, RESP MED, V103, P1152, DOI 10.1016/j.rmed.2009.02.009; Nakamura Y, 2003, SARCOIDOSIS VASC DIF, V20, P235; Nakamura Y, 2012, RESP MED, V106, P1164, DOI 10.1016/j.rmed.2012.04.004; Park IN, 2009, EUR RESPIR J, V33, P68, DOI 10.1183/09031936.00158507; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Romagnoli M, 2011, EUR RESPIR J, V38, P384, DOI 10.1183/09031936.00094910; Sato T, 2006, RHEUMATOL INT, V26, P551, DOI 10.1007/s00296-005-0028-9; Song JW, 2009, CHEST, V136, P23, DOI 10.1378/chest.08-2572; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Travis WD, 2008, AM J RESP CRIT CARE, V177, P1338, DOI 10.1164/rccm.200611-1685OC; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tsuchiya Y, 2011, EUR RESPIR J, V37, P1411, DOI 10.1183/09031936.00019210; Tzelepis GE, 2008, EUR RESPIR J, V31, P11, DOI 10.1183/09031936.00060107; Van der Kamp R, 2007, NETH J MED, V65, P390; Vij R, 2011, CHEST, V140, P1292, DOI 10.1378/chest.10-2662; VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309; Yang Y, 2002, INTERNAL MED, V41, P1135, DOI 10.2169/internalmedicine.41.1135	40	48	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94775	10.1371/journal.pone.0094775	http://dx.doi.org/10.1371/journal.pone.0094775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736601	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600089
J	Medrano, C; Igual, R; Plaza, I; Castro, M				Medrano, Carlos; Igual, Raul; Plaza, Inmaculada; Castro, Manuel			Detecting Falls as Novelties in Acceleration Patterns Acquired with Smartphones	PLOS ONE			English	Article								Despite being a major public health problem, falls in the elderly cannot be detected efficiently yet. Many studies have used acceleration as the main input to discriminate between falls and activities of daily living (ADL). In recent years, there has been an increasing interest in using smartphones for fall detection. The most promising results have been obtained by supervised Machine Learning algorithms. However, a drawback of these approaches is that they rely on falls simulated by young or mature people, which might not represent every possible fall situation and might be different from older people's falls. Thus, we propose to tackle the problem of fall detection by applying a kind of novelty detection methods which rely only on true ADL. In this way, a fall is any abnormal movement with respect to ADL. A system based on these methods could easily adapt itself to new situations since new ADL could be recorded continuously and the system could be retrained on the fly. The goal of this work is to explore the use of such novelty detectors by selecting one of them and by comparing it with a state-of-the-art traditional supervised method under different conditions. The data sets we have collected were recorded with smartphones. Ten volunteers simulated eight type of falls, whereas ADL were recorded while they carried the phone in their real life. Even though we have not collected data from the elderly, the data sets were suitable to check the adaptability of novelty detectors. They have been made publicly available to improve the reproducibility of our results. We have studied several novelty detection methods, selecting the nearest neighbour-based technique (NN) as the most suitable. Then, we have compared NN with the Support Vector Machine (SVM). In most situations a generic SVM outperformed an adapted NN.	[Medrano, Carlos] Aragon Inst Engn Res, Comp Vis Lab, Zaragoza, Spain; [Medrano, Carlos; Igual, Raul; Plaza, Inmaculada] Univ Zaragoza, Escuela Univ Politecn, EduQTech Grp, Teruel, Spain; [Castro, Manuel] Spanish Univ Distance Educ UNED, Elect & Comp Engn Dept DIEEC, Madrid, Spain	University of Zaragoza; Universidad Nacional de Educacion a Distancia (UNED)	Medrano, C (corresponding author), Aragon Inst Engn Res, Comp Vis Lab, Zaragoza, Spain.	ctmedra@unizar.es	Castro, Manuel/G-2085-2016	Castro, Manuel/0000-0003-3559-4235; Igual Catalan, Raul/0000-0002-1561-0536; Medrano Sanchez, Carlos Tomas/0000-0001-7671-7540	Fondo Social Europeo; Gobierno de Aragon; CTP project [CTPP 11/12]	Fondo Social Europeo(European Social Fund (ESF)European Commission); Gobierno de Aragon(Gobierno de Aragon); CTP project	This work was funded by the "Fondo Social Europeo", http://ec.europa.eu/esf/home.jsp, the "Gobierno de Aragon", http://www.aragon.es/, and CTP project (CTPP 11/12 sMartxan basic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate S, 2012, PERVASIVE MOB COMPUT, V8, P883, DOI 10.1016/j.pmcj.2012.08.003; Albert MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036556; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P259; Bourke AK, 2007, GAIT POSTURE, V26, P194, DOI 10.1016/j.gaitpost.2006.09.012; Bourke AK, 2010, IEEE ENG MED BIO, P2782, DOI 10.1109/IEMBS.2010.5626364; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Dai JP, 2010, PERS UBIQUIT COMPUT, V14, P633, DOI 10.1007/s00779-010-0292-x; Hsiao ET, 1998, J BIOMECH, V31, P1, DOI 10.1016/S0021-9290(97)00114-0; Igual R, 2013, AMBIENT INTELLIGENCE, V219, P65; Igual R, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-66; Kangas M, 2012, GAIT POSTURE, V35, P500, DOI 10.1016/j.gaitpost.2011.11.016; Kangas M, 2008, GAIT POSTURE, V28, P285, DOI 10.1016/j.gaitpost.2008.01.003; Kangas M, 2009, GAIT POSTURE, V29, P571, DOI 10.1016/j.gaitpost.2008.12.008; Klenk J, 2013, Z GERONTOL GERIATR, V46, P720, DOI 10.1007/s00391-013-0554-0; Klenk J, 2011, MED ENG PHYS, V33, P368, DOI 10.1016/j.medengphy.2010.11.003; Lee RYW, 2011, AGE AGEING, V40, P690, DOI [10.1093/ageing/afr050, 10.1155/2011/653570]; Lindemann U, 2005, MED BIOL ENG COMPUT, V43, P548, DOI 10.1007/BF02351026; Mellone S, 2012, Z GERONTOL GERIATR, V45, P722, DOI 10.1007/s00391-012-0404-5; Mubashir M, 2013, NEUROCOMPUTING, V100, P144, DOI 10.1016/j.neucom.2011.09.037; Noury N, 2007, P ANN INT IEEE EMBS, P1663, DOI 10.1109/IEMBS.2007.4352627; Noury N, 2008, IRBM, V29, P340, DOI 10.1016/j.irbm.2008.08.002; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Plaza I, 2011, J SYST SOFTWARE, V84, P1977, DOI 10.1016/j.jss.2011.05.035; Popescu M, 2009, IEEE ENG MED BIO, P3505, DOI 10.1109/IEMBS.2009.5334521; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Shih-Hau Fang, 2012, 2012 Computing, Communications and Applications Conference (ComComAp 2012), P143, DOI 10.1109/ComComAp.2012.6154019; Sposaro F, 2009, IEEE ENG MED BIO, P6119, DOI 10.1109/IEMBS.2009.5334912; Yuwono M, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-9	29	93	97	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94811	10.1371/journal.pone.0094811	http://dx.doi.org/10.1371/journal.pone.0094811			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736626	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600091
J	Ribeiro, MC; Nakamura, MU; Torloni, MR; Scanavino, MD; Scomparini, FB; Mattar, R				Ribeiro, Meireluci Costa; Nakamura, Mary Uchiyama; Torloni, Maria Regina; Scanavino, Marco de Tubino; Scomparini, Flavia Burin; Mattar, Rosiane			Female Sexual Function of Overweight Women with Gestational Diabetes Mellitus - A Cross-Sectional Study	PLOS ONE			English	Article							PREGNANT-WOMEN; FUNCTION INDEX; OBESE; DYSFUNCTION; PREVALENCE; WEIGHT; ASSOCIATION; VALIDATION; SYMPTOMS; BEHAVIOR	Obesity and gestational diabetes mellitus (GDM) are increasing worldwide and may compromise female sexual function. We hypothesize that among GDM patients in the third trimester of pregnancy, those with excess body fat would have worse female sexual function scores than normal weight women. Our aim was to assess the sexual function of overweight compared to normal weight women with GDM. This was a cross-sectional survey involving 143 Brazilian women with GDM in the third trimester of pregnancy: 76 were overweight (pre-pregnancy body mass index-BMI >= 25.0 Kg/m(2)) and 67 were normal weight (BMI 18.5-24.9 Kg/m(2)). Participants were recruited from March 2010 to April 2013 at the antenatal clinic of a single public tertiary teaching institution. The Female Sexual Function Index (FSFI) questionnaire was used to assess sexual function. Overall, 51.7% of the 143 participants were at risk for sexual dysfunction symptoms (FSFI scores <= 26); this rate was significantly higher among overweight compared to normal weight women (60.5% versus 41.8%, p = 0.038). Mean total FSFI scores were significantly lower in overweight compared to normal weight women (21.7 +/- 9.2 versus 24.9 +/- 8.0, p = 0.029). Compared to normal weight women, overweight participants had lower mean scores in desire (3.4 +/- 1.2 versus 4.0 +/- 1.4, p = 0.007) and lubrication (3.8 +/- 2.0 versus 4.5 +/- 1.6, p = 0.023). According to these results, overweight women with GDM in the third trimester of pregnancy have lower female sexual function scores than normal weight women with the same disorder.	[Ribeiro, Meireluci Costa; Nakamura, Mary Uchiyama; Scomparini, Flavia Burin; Mattar, Rosiane] Sao Paulo Fed Univ UNIFESP, Dept Obstet, Sao Paulo, Brazil; [Torloni, Maria Regina; Scomparini, Flavia Burin] Sao Paulo Fed Univ UNIFESP, Dept Internal Med, Sao Paulo, Brazil; [Scanavino, Marco de Tubino] Sao Paulo State Univ Med Sch FMUSP, Dept & Inst Psychiat, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual Paulista	Ribeiro, MC (corresponding author), Sao Paulo Fed Univ UNIFESP, Dept Obstet, Sao Paulo, Brazil.	ribeiro.meire@hotmail.com	Scanavino, Marco D T/F-5087-2012	Scanavino, Marco D T/0000-0003-3485-3805; Ribeiro, Meireluci Costa/0000-0003-3326-2720	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [09/54509-6, 2012/03670-4, 2012/50225-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was funded by a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Process n. 09/54509-6, 2012/03670-4 and 2012/50225-6; www.fapesp.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar Malihe, 2012, J Caring Sci, V1, P173, DOI 10.5681/jcs.2012.025; Amador N, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.037; Amador-Licona N, 2012, ARCH GYNECOL OBSTET, V285, P105, DOI 10.1007/s00404-011-1879-9; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; American Diabetes Association, 2003, Diabetes Care, V26 Suppl 1, pS103; Aslan G, 2005, INT J IMPOT RES, V17, P154, DOI 10.1038/sj.ijir.3901288; Aversa A, 2013, J SEX MED, V10, P1024, DOI 10.1111/jsm.12069; Basson R, 2000, J SEX MARITAL THER, V26, P51, DOI 10.1080/009262300278641; Bello Folasade Adenike, 2011, ISRN Obstet Gynecol, V2011, P856586, DOI 10.5402/2011/856586; Bodnar LM, 2009, J CLIN PSYCHIAT, V70, P1290, DOI 10.4088/JCP.08m04651; Bogaerts AFL, 2013, OBESITY FACTS, V6, P152, DOI 10.1159/000346315; BOGREN LY, 1991, ARCH SEX BEHAV, V20, P35, DOI 10.1007/BF01543006; Brtnicka H, 2009, BRATISL MED J, V110, P427; Chang SR, 2012, J SEX MED, V9, P2582, DOI 10.1111/j.1743-6109.2012.02874.x; Corbacioglu A, 2012, J SEX MED, V9, P1897, DOI 10.1111/j.1743-6109.2012.02740.x; Eryilmaz G, 2004, GYNECOL OBSTET INVES, V57, P103, DOI 10.1159/000075582; Esposito K, 2007, INT J IMPOT RES, V19, P353, DOI 10.1038/sj.ijir.3901548; Fahs B, 2011, ARCH SEX BEHAV, V40, P903, DOI 10.1007/s10508-010-9681-5; Fanfulla F, 2013, SLEEP MED, V14, P252, DOI 10.1016/j.sleep.2012.11.023; Fok WY, 2005, ACTA OBSTET GYN SCAN, V84, P934, DOI 10.1111/j.0001-6349.2005.00743.x; Gaillard R, 2013, OBESITY, V21, P1046, DOI 10.1002/oby.20088; Hunt KJ, 2007, OBSTET GYN CLIN N AM, V34, P173, DOI 10.1016/j.ogc.2007.03.002; Kennedy CM, 2009, INT J GYNECOL OBSTET, V105, P236, DOI 10.1016/j.ijgo.2009.01.024; Kerdarunsuksri Attapol, 2010, Journal of the Medical Association of Thailand, V93, P265; Khamis Mervat A, 2007, J Egypt Public Health Assoc, V82, P65; Kolotkin RL, 2006, OBESITY, V14, P472, DOI 10.1038/oby.2006.62; Leite APL, 2009, REV ASSOC MED BRAS, V55, P563, DOI 10.1590/S0104-42302009000500020; Leite APL, 2007, REV BRAS GINECOL OBS, V29, P396, DOI 10.1590/S0100-72032007000800003; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Ministerio da Saude, 2006, PNDS 2006, P213; Naldoni LMV, 2011, J SEX MARITAL THER, V37, P116, DOI 10.1080/0092623X.2011.560537; Oruc S, 1999, AUST NZ J OBSTET GYN, V39, P48, DOI 10.1111/j.1479-828X.1999.tb03443.x; Pauleta JR, 2010, J SEX MED, V7, P136, DOI 10.1111/j.1743-6109.2009.01538.x; Pauls RN, 2008, J SEX MED, V5, P1915, DOI 10.1111/j.1743-6109.2008.00884.x; Perkins JM, 2007, CLIN DIABETES, V25, P57; Ribeiro MC, 2012, J SEX MED, V9, P786, DOI 10.1111/j.1743-6109.2011.02577.x; Ribeiro MC, 2011, REV BRAS GINECOL OBS, V33, P219, DOI 10.1590/S0100-72032011000500003; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Serati M, 2010, J SEX MED, V7, P2782, DOI 10.1111/j.1743-6109.2010.01893.x; Shojaa M, 2009, ARCH GYNECOL OBSTET, V279, P353, DOI 10.1007/s00404-008-0735-z; Souza FD, 2013, J SEX MED, V10, P1350, DOI 10.1111/jsm.12106; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; Trutnovsky G, 2006, AUST NZ J OBSTET GYN, V46, P282, DOI 10.1111/j.1479-828X.2006.00592.x; Wiegel M, 2005, J SEX MARITAL THER, V31, P1, DOI 10.1080/00926230590475206; World Health Organization (WHO), 2013, BMI CLASS; Yaylali GF, 2010, INT J IMPOT RES, V22, P220, DOI 10.1038/ijir.2010.7	47	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95094	10.1371/journal.pone.0095094	http://dx.doi.org/10.1371/journal.pone.0095094			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736490	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600144
J	Toschi, L; Finocchiaro, G; Nguyen, TT; Skokan, MC; Giordano, L; Gianoncelli, L; Perrino, M; Siracusano, L; Di Tommaso, L; Infante, M; Alloisio, M; Roncalli, M; Scorsetti, M; Janne, PA; Santoro, A; Varella-Garcia, M				Toschi, Luca; Finocchiaro, Giovanna; Nguyen, Teresa T.; Skokan, Margaret C.; Giordano, Laura; Gianoncelli, Letizia; Perrino, Matteo; Siracusano, Licia; Di Tommaso, Luca; Infante, Maurizio; Alloisio, Marco; Roncalli, Massimo; Scorsetti, Marta; Jaenne, Pasi A.; Santoro, Armando; Varella-Garcia, Marileila			Increased SOX2 Gene Copy Number Is Associated with FGFR1 and PIK3CA Gene Gain in Non-Small Cell Lung Cancer and Predicts Improved Survival in Early Stage Disease	PLOS ONE			English	Article							OPEN-LABEL; AMPLIFICATION; GROWTH; TRANSCRIPTION; SENSITIVITY; ONCOGENE; 1ST-LINE; MUTATION	Background: We aimed to investigate prevalence and prognostic role of SOX2, PIK3CA, FGFR1 and BRF2 gene gain in patients with surgically resected non-small cell lung cancer (NSCLC). Methods: SOX2, PIK3CA, FGFR1 and BRF2 gene copy number was assessed by fluorescence in situ hybridization (FISH) in arrayed tissue cores from 447 resected NSCLCs. Results: Increased gene copy number (FISH+) for SOX2, PIK3CA, FGFR1 and BRF2 was observed in 23.6%, 29.2%, 16.6% and 14.9% of cases, respectively. FISH+ status for each gene was significantly associated with smoking history, squamous cell carcinoma (SCC) histology, and increased copy number of the other studied genes. Multivariate analysis of overall survival indicated increased SOX2 gene copy number (P = 0.008), stage I-II (P<0.001), and adenocarcinoma or SCC histology (P = 0.016) as independent, favorable prognostic factors. A statistically significant interaction was observed between stage and SOX2 gene status (P = 0.021), indicating that the prognostic impact of SOX2 gene gain differs across stages and is limited to patients with stage I-II disease (HR 0.44, 95% CI: 0.25-0.77; P = 0.004, adjusted for histology). Conclusions: Increased SOX2 gene copy number is an independent and favorable prognostic factor in surgically resected, early stage NSCLC, regardless of histology. SOX2, PIK3CA, FGFR1 and BRF2 gene gains are likely to occur concurrently, with potentially relevant implications for the development of new therapeutic strategies.	[Toschi, Luca; Finocchiaro, Giovanna; Gianoncelli, Letizia; Perrino, Matteo; Siracusano, Licia; Santoro, Armando] Humanitas Clin & Res Ctr, Div Hematol & Oncol, Milan, Italy; [Nguyen, Teresa T.; Varella-Garcia, Marileila] Univ Colorado, Sch Med, Aurora, CO USA; [Skokan, Margaret C.] Denver Police Dept Crime Lab, Forens Biol DNA, Denver, CO USA; [Giordano, Laura] Humanitas Clin & Res Ctr, Biostat Unit, Milan, Italy; [Di Tommaso, Luca; Roncalli, Massimo] Humanitas Clin & Res Ctr, Div Pathol, Milan, Italy; [Di Tommaso, Luca; Roncalli, Massimo] Univ Milan, Milan, Italy; [Infante, Maurizio; Alloisio, Marco] Humanitas Clin & Res Ctr, Div Thorac Surg, Milan, Italy; [Scorsetti, Marta] Humanitas Clin & Res Ctr, Dept Radiotherapy, Milan, Italy; [Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Jaenne, Pasi A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Milan; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Toschi, L (corresponding author), Humanitas Clin & Res Ctr, Div Hematol & Oncol, Milan, Italy.	luca.toschi@cancercenter.humanitas.it	Perrino, Matteo/AAC-5580-2019; Santoro, Armando/J-9594-2018; siracusano, licia vanessa/AAB-9927-2020; Perrino, Matteo/AAB-7831-2022; Alloisio, Marco/AAL-5565-2020; Scorsetti, Marta/AAB-7024-2019; Finocchiaro, Giovanna/AAB-7967-2020; INFANTE, Maurizio Valentino/AAC-1834-2019; alloisio, marco/GYV-1110-2022; Toschi, Luca/K-4445-2018	Santoro, Armando/0000-0003-1709-9492; siracusano, licia vanessa/0000-0002-6626-8144; INFANTE, Maurizio Valentino/0000-0002-0920-4443; Finocchiaro, Giovanna/0000-0001-6663-1989; Nguyen, Teresa T./0000-0002-7211-4176; Scorsetti, Marta/0000-0003-0320-559X; alloisio, marco/0000-0002-1415-5439; di tommaso, luca/0000-0002-9013-4728; Perrino, Matteo/0000-0001-9864-8814; Roncalli, Massimo/0000-0002-7901-8910; Giordano, Laura/0000-0002-9587-7870; Toschi, Luca/0000-0002-4023-7542	Colorado Lung Cancer SPORE NCI [P50CA058187]; NCI CCSG [P30CA046934]; NIH/NCATS Colorado CTSI [KL2TR000156]; NATIONAL CANCER INSTITUTE [P50CA058187, P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001080, KL2TR000156, UL1TR001082] Funding Source: NIH RePORTER	Colorado Lung Cancer SPORE NCI; NCI CCSG; NIH/NCATS Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by private donation from Mr. Gerry Scotti, Colorado Lung Cancer SPORE NCI P50CA058187, NCI CCSG P30CA046934 and NIH/NCATS Colorado CTSI KL2TR000156 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaroli JJ, 2012, CLIN CANCER RES, V18, P2704, DOI 10.1158/1078-0432.CCR-11-3167; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Brcic L, 2012, AM J CLIN PATHOL, V138, P712, DOI 10.1309/AJCP05TTWQTWNLTN; Cabarcas S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-47; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Chen YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071140; Craddock KJ, 2013, J THORAC ONCOL, V8, P1371, DOI 10.1097/JTO.0b013e3182a46fe9; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Heist RS, 2012, J THORAC ONCOL, V7, P1775, DOI 10.1097/JTO.0b013e31826aed28; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lockwood WW, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000315; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Rudin CM, 2012, NAT GENET, V44, P1111, DOI 10.1038/ng.2405; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Spoerke JM, 2012, CLIN CANCER RES, V18, P6771, DOI 10.1158/1078-0432.CCR-12-2347; Tran TN, 2013, LUNG CANCER, V81, P462, DOI 10.1016/j.lungcan.2013.05.015; Velcheti V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061427; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wilbertz T, 2011, MODERN PATHOL, V24, P944, DOI 10.1038/modpathol.2011.49; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694	29	43	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95303	10.1371/journal.pone.0095303	http://dx.doi.org/10.1371/journal.pone.0095303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736592	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600167
J	Zhang, ZH; Xu, X; Ni, HY; Deng, HS				Zhang, Zhongheng; Xu, Xiao; Ni, Hongying; Deng, Hongsheng			Predictive Value of Ionized Calcium in Critically III Patients: An Analysis of a Large Clinical Database MIMIC II	PLOS ONE			English	Article							ILL PATIENTS; CRITICAL ILLNESS; TRAUMA PATIENTS; HYPOCALCEMIA; SEPSIS; HYPERCALCEMIA; PREVALENCE; MORTALITY; FAILURE; DISEASE	Background and Objective: ionized calcium (iCa) has been investigated for its association with mortality in intensive care unit (ICU) patients in many studies. However, these studies are small in sample size and the results are conflicting. The present study aimed to establish the association of iCa with mortality by using a large clinical database. Methods: Multiparameter Intelligent Monitoring in Intensive Care II (MIMIC II) database was used for analysis. Patients older than 15 years were eligible, and patients without iCa measured during their ICU stay were excluded. Demographic data and clinical characteristics were extracted and compared between survivors and non-survivors. iCa measure on ICU admission was defined as Ca-0; Ca-max was the maximum iCa during ICU stay; Ca-min was the minimum value of iCa during the ICU stay; Ca-mean was the arithmetic mean iCa during ICU stay. Main results: A total of 15409 ICU admissions satisfied our inclusion criteria and were included in our analysis. The prevalence of hypocalcemia on ICU entry was 62.06%. Ca-0 was significantly lower in non-survivors than in survivors (1.11 +/- 0.14 vs 1.13 +/- 0.10 mmol/l, p<0.001). In multivariate analysis, moderate hypocalcemia in Ca0 was significantly associated with increased risk of death (OR: 1.943; 95% CI: 1.340-2.817), and mild hypercalcemia was associated with lower mortality (OR: 0.553, 95% CI: 0.400-0.767). While moderate and mild hypocalcemia in Ca-mean is associated with increased risk of death (OR: 1.153, 95% CI: 1.006-1.322 and OR: 2.520, 95% CI: 1.485-4.278), hypercalcemia in Ca-mean is not significantly associated with ICU mortality. Conclusion: The relationship between Ca-0 and clinical outcome follows an "U'' shaped curve with the nadir at the normal range, extending slightly to hypercalcemia. Mild hypercalcemia in Ca-0 is protective, whereas moderate and mild hypocalcemia in Ca-mean is associated with increased risk of death.	[Zhang, Zhongheng; Xu, Xiao; Ni, Hongying; Deng, Hongsheng] Zhejiang Univ, Dept Crit Care Med, Jinhua Hosp, Jinhua Municipal Cent Hosp, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhang, ZH (corresponding author), Zhejiang Univ, Dept Crit Care Med, Jinhua Hosp, Jinhua Municipal Cent Hosp, Hangzhou, Zhejiang, Peoples R China.	zh_zhang1984@hotmail.com	zhang, zh/GWV-4677-2022; Zhang, Zhongheng/E-1282-2011	Zhang, Zhongheng/0000-0002-2336-5323	Science and Technology Foundation of Jinhua city [2012-03-31]	Science and Technology Foundation of Jinhua city	This study is partly supported by the Science and Technology Foundation of Jinhua city (2012-03-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert RK, 2013, AM J RESP CRIT CARE, V187, P1173, DOI 10.1164/rccm.201212-2187OE; Catalano A, 2012, AGING CLIN EXP RES, V24, P400; Cherry RA, 2006, J TRAUMA, V61, P774, DOI 10.1097/01.ta.0000239516.49799.63; Choi YC, 2008, J KOREAN MED SCI, V23, P700, DOI 10.3346/jkms.2008.23.4.700; Collage RD, 2013, CRIT CARE MED, V41, pE352, DOI 10.1097/CCM.0b013e31828cf436; Cortese S, 2010, J AM DIET ASSOC, V110, P1098, DOI 10.1016/j.jada.2010.04.001; DESAI TK, 1988, AM J MED, V84, P209, DOI 10.1016/0002-9343(88)90415-9; Egi M, 2011, CRIT CARE MED, V39, P314, DOI 10.1097/CCM.0b013e3181ffe23e; Floud S, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-89; FORSTER J, 1985, ANN SURG, V202, P512, DOI 10.1097/00000658-198510000-00011; Gromadzinski L, 2014, J CARDIOL, V63, P198, DOI 10.1016/j.jjcc.2013.08.003; Hastbacka J, 2003, ACTA ANAESTH SCAND, V47, P1264, DOI 10.1046/j.1399-6576.2003.00236.x; Iqbal M, 2008, ANN THORAC MED, V3, P57, DOI 10.4103/1817-1737.39638; Jacobs TP, 2005, J CLIN ENDOCR METAB, V90, P6316, DOI 10.1210/jc.2005-0675; Jeong Jong Hyeok, 2010, Electrolyte Blood Press, V8, P92, DOI 10.5049/EBP.2010.8.2.92; Kilic A, 2012, ANN THORAC SURG, V93, P699, DOI 10.1016/j.athoracsur.2011.09.037; Kohut B, 2010, BURNS, V36, P360, DOI 10.1016/j.burns.2009.05.001; Laillou A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063979; Lind L, 2000, CRIT CARE MED, V28, P93, DOI 10.1097/00003246-200001000-00015; Lowe Henry J, 2009, AMIA Annu Symp Proc, V2009, P391; Nair P, 2013, INTENS CARE MED, V39, P267, DOI 10.1007/s00134-012-2713-y; Saeed M, 2011, CRIT CARE MED, V39, P952, DOI 10.1097/CCM.0b013e31820a92c6; Scott DJ, 2013, BMC MED INF IN PRESS; Steele T, 2013, CRIT CARE, V17, DOI 10.1186/cc12756; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; TAYLOR B, 1978, CAN J SURG, V21, P429; Tripepi G, 2008, KIDNEY INT, V74, P1512, DOI 10.1038/ki.2008.416; Yusuf J, 2012, PROG CARDIOVASC DIS, V55, P77, DOI 10.1016/j.pcad.2012.02.004; ZALOGA GP, 1985, ANN SURG, V202, P587, DOI 10.1097/00000658-198511000-00009; ZALOGA GP, 1987, ANN INTERN MED, V107, P36, DOI 10.7326/0003-4819-107-1-36; Zivin JR, 2001, AM J KIDNEY DIS, V37, P689, DOI 10.1016/S0272-6386(01)80116-5	31	40	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95204	10.1371/journal.pone.0095204	http://dx.doi.org/10.1371/journal.pone.0095204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736693	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600155
J	Zuo, QF; Cai, CZ; Ding, HL; Wu, Y; Yang, LY; Feng, Q; Yang, HJ; Wei, ZB; Zeng, H; Zou, QM				Zuo, Qian-Fei; Cai, Chang-Zhi; Ding, Hong-Lei; Wu, Yi; Yang, Liu-Yang; Feng, Qiang; Yang, Hui-Jie; Wei, Zhen-Bo; Zeng, Hao; Zou, Quan-Ming			Identification of the Immunodominant Regions of Staphylococcus aureus Fibronectin-Binding Protein A	PLOS ONE			English	Article							CLUMPING FACTOR-A; ANTIBODY-RESPONSES; IMMUNE-RESPONSES; VACCINE; PROTECTION; FIBRINOGEN; INFECTION; MSCRAMM; DOMAIN; MASTITIS	Staphylococcus aureus is an opportunistic bacterial pathogen responsible for a diverse spectrum of human diseases and a leading cause of nosocomial and community-acquired infections. Development of a vaccine against this pathogen is an important goal. The fibronectin binding protein A (FnBPA) of S. aureus is one of multifunctional 'microbial surface components recognizing adhesive matrix molecules' (MSCRAMMs). It is one of the most important adhesin molecules involved in the initial adhesion steps of S. aureus infection. It has been studied as potential vaccine candidates. However, FnBPA is a high-molecular-weight protein of 106 kDa and difficulties in achieving its high-level expression in vitro limit its vaccine application in S. aureus infection diseases control. Therefore, mapping the immunodominant regions of FnBPA is important for developing polyvalent subunit fusion vaccines against S. aureus infections. In the present study, we cloned and expressed the N-terminal and C-terminal of FnBPA. We evaluated the immunogenicity of the two sections of FnBPA and the protective efficacy of the two truncated fragments vaccines in a murine model of systemic S. aureus infection. The results showed recombinant truncated fragment F1(30-500) had a strong immunogenicity property and survival rates significantly increased in the group of mice immunized with F1(30-500) than the control group. We futher identified the immunodominant regions of FnBPA. The mouse antisera reactions suggest that the region covering residues 110 to 263 (F1B(110-263)) is highly immunogenic and is the immunodominant regions of FnBPA. Moreover, vaccination with F1B(110-263) can generate partial protection against lethal challenge with two different S. aureus strains and reduced bacterial burdens against non-lethal challenge as well as that immunization with F1(30-500). This information will be important for further developing anti-S. aureus polyvalent subunit fusion vaccines.	[Zuo, Qian-Fei; Cai, Chang-Zhi; Ding, Hong-Lei; Wu, Yi; Yang, Liu-Yang; Yang, Hui-Jie; Wei, Zhen-Bo; Zeng, Hao; Zou, Quan-Ming] Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing, Peoples R China; [Feng, Qiang] Chongqing Univ Educ, Dept Biol Engn & Chem Engn, Chongqing, Peoples R China	Army Medical University; Chongqing University of Education	Zeng, H (corresponding author), Third Mil Med Univ, Coll Pharm, Dept Microbiol & Biochem Pharm, Natl Engn Res Ctr Immunol Prod, Chongqing, Peoples R China.	zeng1109@163.com; qmzou2007@163.com	yang, liu/GVU-8760-2022; liu, yang/HHY-8583-2022		National Natural Science Foundation of China [81172892]; NSFC-NIH International Cooperation Grant [81261120396]; Natural Science Foundation of Chongqing [CSTC2011jjA10071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC-NIH International Cooperation Grant; Natural Science Foundation of Chongqing(Natural Science Foundation of Chongqing)	This research was supported by National Natural Science Foundation of China (Grant NO: 81172892) and by NSFC-NIH International Cooperation Grant (NO: 81261120396) and by Natural Science Foundation of Chongqing (Grant NO: CSTC2011jjA10071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrecubieta C, 2008, J INFECT DIS, V198, P571, DOI 10.1086/590210; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Broughan J, 2011, EXPERT REV VACCINES, V10, P695, DOI [10.1586/ERV.11.54, 10.1586/erv.11.54]; Casolini F, 1998, INFECT IMMUN, V66, P5433, DOI 10.1128/IAI.66.11.5433-5442.1998; Castagliuolo I, 2006, VACCINE, V24, P4393, DOI 10.1016/j.vaccine.2006.02.055; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Durai Rajaraman, 2010, AORN J, V91, P599, DOI 10.1016/j.aorn.2009.11.065; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fowler VG, 2013, JAMA-J AM MED ASSOC, V309, P1368, DOI 10.1001/jama.2013.3010; Gaudreau MC, 2007, VACCINE, V25, P814, DOI 10.1016/j.vaccine.2006.09.043; Graves SF, 2010, J MOL MED, V88, P109, DOI 10.1007/s00109-009-0573-x; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Jansen KU, 2013, VACCINE, V31, P2723, DOI 10.1016/j.vaccine.2013.04.002; Josefsson E, 2001, J INFECT DIS, V184, P1572, DOI 10.1086/324430; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Krishna S, 2012, SEMIN IMMUNOPATHOL, V34, P261, DOI 10.1007/s00281-011-0292-6; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Loughman A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-74; MAMO W, 1994, VACCINE, V12, P988, DOI 10.1016/0264-410X(94)90333-6; MAMO W, 1994, FEMS IMMUNOL MED MIC, V10, P47, DOI 10.1111/j.1574-695X.1994.tb00010.x; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Narita K, 2010, INFECT IMMUN, V78, P4234, DOI 10.1128/IAI.00447-10; Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Pontes D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044892; Rennermalm A, 2001, VACCINE, V19, P3376, DOI 10.1016/S0264-410X(01)00080-9; Rivas JM, 2004, CURR OPIN DRUG DISC, V7, P223; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Schaffer AC, 2006, INFECT IMMUN, V74, P2145, DOI 10.1128/IAI.74.4.2145-2153.2006; Spellberg B, 2012, SEMIN IMMUNOPATHOL, V34, P335, DOI 10.1007/s00281-011-0293-5; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Taccetti G, 2010, LANCET, V376, P767, DOI 10.1016/S0140-6736(10)61371-2; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Verkaik NJ, 2011, IMMUNOTHERAPY-UK, V3, P1063, DOI [10.2217/imt.11.84, 10.2217/IMT.11.84]; Wang J, 2010, J IMMUNOL, V185, P1670, DOI 10.4049/jimmunol.1001240; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Zeng H, 2012, INFECT IMMUN, V80, P1098, DOI 10.1128/IAI.05894-11	41	10	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95338	10.1371/journal.pone.0095338	http://dx.doi.org/10.1371/journal.pone.0095338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736634	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600170
J	Narayanan, N; Pushpakumar, SB; Givvimani, S; Kundu, S; Metreveli, N; James, D; Bratcher, AP; Tyagi, SC				Narayanan, Nithya; Pushpakumar, Sathnur Basappa; Givvimani, Srikanth; Kundu, Sourav; Metreveli, Naira; James, Dexter; Bratcher, Adrienne P.; Tyagi, Suresh C.			Epigenetic regulation of aortic remodeling in hyperhomocysteinemia	FASEB JOURNAL			English	Article						DNA methylation; extracellular matrix; 5-aza-2 '-deoxycytidine	PLASMA HOMOCYSTEINE; DNA METHYLATION; BLOOD-PRESSURE; NITRIC-OXIDE; DEPENDENT VASORELAXATION; HYPERTENSION; ATHEROSCLEROSIS; DYSFUNCTION; EXPRESSION; DECREASES	Hyperhomocysteinemia (HHcy) is prevalent in patients with hypertension and is an independent risk factor for aortic pathologies. HHcy is known to cause an imbalance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), leading to the accumulation of collagen in the aorta and resulting in stiffness and development of hypertension. Although the exact mechanism of extracellular matrix (ECM) remodeling is unclear, emerging evidence implicates epigenetic regulation involving DNA methylation. Our purpose was to investigate whether 5-aza-2'-deoxycytidine (Aza), a DNA methyltransferase (DNMT1) inhibitor, reduces high blood pressure (BP) by regulating aortic ECM remodeling in HHcy. Wild-type and cystathionine beta-synthase (CBS)(+/-) HHcy mice were treated with Aza (0.5 mg/kg body weight). In HHcy mice, Aza treatment normalized the plasma homocysteine (Hcy) level and BP. Thoracic and abdominal aorta ultrasound revealed a reduction in the resistive index and wall-to-lumen ratio. Vascular response to phenylephrine, acetylcholine, and sodium nitroprusside improved after Aza in HHcy mice. Histology showed a marked reduction in collagen deposition in the aorta. Aza treatment decreased the expression of DNMT1, MMP9, TIMP1, and S-adenosyl homocysteine hydrolase (SAHH) and upregulated methylene tetrahydrofolate reductase (MTHFR). We conclude that reduction of DNA methylation by Aza in HHcy reduces adverse aortic remodeling to mitigate hypertension.	[Narayanan, Nithya; Pushpakumar, Sathnur Basappa; Givvimani, Srikanth; Kundu, Sourav; Metreveli, Naira; Tyagi, Suresh C.] Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40202 USA; [James, Dexter; Bratcher, Adrienne P.] Univ Louisville, Dept Exercise Physiol, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Tyagi, SC (corresponding author), Univ Louisville, Sch Med, Dept Physiol & Biophys, 500 South Preston St, Louisville, KY 40202 USA.	s0tyag01@louisville.edu	Kundu, Sourav/J-1531-2015	Narayanan, Nithya/0000-0001-9110-0311; KUNDU, SOURAV/0000-0001-9027-5734	U.S. National Institutes of Health [R01HL074185-10, NS-084823]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084823] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health grants R01HL074185-10 and NS-084823. The authors declare no conflicts of interest.	Amarnath K, 2003, TALANTA, V60, P1229, DOI 10.1016/S0039-9140(03)00232-7; Basu Poulami, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P266; Bednarek N, 2012, PEDIATR RES, V71, P63, DOI 10.1038/pr.2011.3; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; Chen W, 2012, MOL NUTR FOOD RES, V56, P681, DOI 10.1002/mnfr.201100799; Chicoine E, 2002, BIOCHEM BIOPH RES CO, V297, P765, DOI 10.1016/S0006-291X(02)02283-0; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; Frauchiger B, 2001, STROKE, V32, P836, DOI 10.1161/01.STR.32.4.836; Giusti B, 2004, CELL MOL BIOL, V50, P945; Gupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027598; Guthikonda Sasidhar, 2006, Curr Atheroscler Rep, V8, P100, DOI 10.1007/s11883-006-0046-4; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hucks D, 2004, NEPHROL DIAL TRANSPL, V19, P1999, DOI 10.1093/ndt/gfh270; Jain D, 2011, PATHOL RES PRACT, V207, P60, DOI 10.1016/j.prp.2010.05.010; Juonala M, 2006, HYPERTENSION, V48, P424, DOI 10.1161/01.HYP.0000237666.78217.47; Koullias GJ, 2004, ANN THORAC SURG, V78, P2106, DOI 10.1016/j.athoracsur.2004.05.088; Kraus JP, 1999, HUM MUTAT, V13, P362; Krishna SM, 2010, ATHEROSCLEROSIS, V212, P16, DOI 10.1016/j.atherosclerosis.2010.02.008; Krishna SM, 2013, ATHEROSCLEROSIS, V228, P295, DOI 10.1016/j.atherosclerosis.2013.02.019; Li NJ, 2002, AM J PHYSIOL-HEART C, V283, pH1237, DOI 10.1152/ajpheart.00680.2001; Lim U, 2002, AM J EPIDEMIOL, V156, P1105, DOI 10.1093/aje/kwf157; Mareckova Z, 1999, Vnitr Lek, V45, P232; Mizuno S, 2001, BLOOD, V97, P1172, DOI 10.1182/blood.V97.5.1172; Moroz P, 2007, ANZ J SURG, V77, P329, DOI 10.1111/j.1445-2197.2007.04052.x; Narayanan Nithya, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P32; Nishimura RA, 2002, CIRCULATION, V106, P770, DOI 10.1161/01.CIR.0000027621.26167.5E; Novaro GM, 2004, HEART, V90, P802, DOI 10.1136/hrt.2003.022889; Ovechkin AV, 2006, AM J PHYSIOL-LUNG C, V291, pL905, DOI 10.1152/ajplung.00543.2005; Powers RW, 2004, HYPERTENSION, V44, P327, DOI 10.1161/01.HYP.0000137414.12119.f6; Puranik R, 2005, HEART RHYTHM, V2, P1277, DOI 10.1016/j.hrthm.2005.09.008; Pushpakumar S, 2013, J HYPERTENS, V31, P2270, DOI 10.1097/HJH.0b013e3283649b33; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Reddy HK, 2006, J CARDIOVASC PHARM T, V11, P65, DOI 10.1177/107424840601100106; Sander M, 1999, HYPERTENSION, V33, P937, DOI 10.1161/01.HYP.33.4.937; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Sen U, 2008, AM J PHYSIOL-ENDOC M, V295, pE1205, DOI 10.1152/ajpendo.90534.2008; Sen U, 2007, AM J PHYSIOL-CELL PH, V293, pC1779, DOI 10.1152/ajpcell.00207.2007; Sen U, 2009, AM J PHYSIOL-RENAL, V297, pF410, DOI 10.1152/ajprenal.00145.2009; Sundstrom J, 2003, HYPERTENSION, V42, P1100, DOI 10.1161/01.HYP.0000101690.58391.13; Takagi H, 2005, MED HYPOTHESES, V64, P1007, DOI 10.1016/j.mehy.2004.10.017; Tang BQ, 2010, NUTRITION, V26, P1170, DOI 10.1016/j.nut.2009.10.006; Topal G, 2004, FREE RADICAL BIO MED, V36, P1532, DOI 10.1016/j.freeradbiomed.2004.03.019; Tribouilloy CM, 2000, CHEST, V118, P1685, DOI 10.1378/chest.118.6.1685; Tsai JC, 2005, ATHEROSCLEROSIS, V182, P121, DOI 10.1016/j.atherosclerosis.2005.01.038; Tyagi Neetu, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P210; TYAGI SC, 1993, CLIN BIOCHEM, V26, P191, DOI 10.1016/0009-9120(93)90025-2; Ungvari Z, 2002, AM J PATHOL, V161, P145, DOI 10.1016/S0002-9440(10)64166-1; Vermeulen EGJ, 2000, LANCET, V355, P517, DOI 10.1016/S0140-6736(99)07391-2; Wang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053938, 10.1371/journal.pone.0050627]; Zaina S, 2005, J NUTR, V135, P5, DOI 10.1093/jn/135.1.5; Zhang JG, 2007, CHINESE MED J-PEKING, V120, P2132, DOI 10.1097/00029330-200712010-00013	51	21	26	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3411	3422		10.1096/fj.14-250183	http://dx.doi.org/10.1096/fj.14-250183			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24739303	Green Published			2022-12-25	WOS:000340265400012
J	Cha, ES; Khang, YH; Lee, WJ				Cha, Eun Shil; Khang, Young-Ho; Lee, Won Jin			Mortality from and Incidence of Pesticide Poisoning in South Korea: Findings from National Death and Health Utilization Data between 2006 and 2010	PLOS ONE			English	Article							SUICIDAL IDEATION; RURAL SUICIDE; MALE FARMERS; RISK; SEVERITY; TAIWAN; TRENDS	Pesticide poisoning has been recognized as an important public health issue around the world. The objectives of this study were to report nationally representative figures on mortality from and the incidence of pesticide poisoning in South Korea and to describe their epidemiologic characteristics. We calculated the age-standardized rates of mortality from and the incidence of pesticide poisoning in South Korea by gender and region from 2006 through 2010 using registered death data obtained from Statistics Korea and national healthcare utilization data obtained from the National Health Insurance Review and Assessment Service of South Korea. During the study period of 2006 through 2010, a total of 16,161 deaths and 45,291 patients related to pesticide poisoning were identified, marking respective mortality and incidence rates of 5.35 and 15.37 per 100,000 population. Intentional self-poisoning was identified as the major cause of death due to pesticides (85.9%) and accounted for 20.8% of all recorded suicides. The rates of mortality due to and incidence of pesticide poisoning were higher in rural than in urban areas, and this rural-urban discrepancy was more pronounced for mortality than for incidence. Both the rate of mortality due to pesticide poisoning and its incidence rate increased with age and were higher among men than women. This study provides the magnitude and epidemiologic characteristics for mortality from and the incidence of pesticide poisoning at the national level, and strongly suggests the need for further efforts to prevent pesticide self-poisonings, especially in rural areas in South Korea.	[Cha, Eun Shil; Lee, Won Jin] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea; [Khang, Young-Ho] Univ Ulsan, Dept Prevent Med, Coll Med, Seoul, South Korea; [Khang, Young-Ho] Seoul Natl Univ, Coll Med, Inst Hlth Policy & Management, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Seoul National University (SNU)	Lee, WJ (corresponding author), Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea.	leewj@korea.ac.kr		Lee, Won Jin/0000-0002-0254-7267; Khang, Young-Ho/0000-0002-9585-8266	National Research Foundation of Korea (NRF) - Korean government (MOE), Republic of Korea [2010-0021742]	National Research Foundation of Korea (NRF) - Korean government (MOE), Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean government (MOE) (No. 2010-0021742), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, 31 WHO; Badakhsh R, 2010, PUBLIC HEALTH REP, V125, P457, DOI 10.1177/003335491012500315; Bertolote JM, 2006, BRIT J PSYCHIAT, V189, P201, DOI 10.1192/bjp.bp.105.020834; Chang SS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-260; Chien WC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-703; Conwell Y, 2008, PSYCHIAT CLIN N AM, V31, P333, DOI 10.1016/j.psc.2008.01.004; Freire C, 2013, INT J HYG ENVIR HEAL, V216, P445, DOI 10.1016/j.ijheh.2012.12.003; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; Gunnell D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-357; Hirsch JK, 2006, CRISIS, V27, P189, DOI 10.1027/0227-5910.27.4.189; Institute for Health Metrics and Evaluation, GBD PROF S KOR 2010; Ito T., 2008, J RURAL MED, V3, P5; Judd F, 2006, AUST NZ J PSYCHIAT, V40, P208, DOI 10.1111/j.1440-1614.2006.01776.x; Ki M, 2012, EVALUATION PROJECT I; Kim HJ, 2012, HUM EXP TOXICOL, V31, P751, DOI 10.1177/0960327111431709; Kim J, 2014, ENVIRON RES, V128, P52, DOI 10.1016/j.envres.2013.10.007; Kim J, 2013, OCCUP ENVIRON MED, V70, P303, DOI 10.1136/oemed-2012-101005; Kim JH, 2013, INT J ENV RES PUB HE, V10, P1100, DOI 10.3390/ijerph10031100; Kim MH, 2010, SOC SCI MED, V70, P1254, DOI 10.1016/j.socscimed.2010.01.004; Kim SY, 2011, CRISIS, V32, P5, DOI 10.1027/0227-5910/a000046; Ko Y, 2012, CLIN TOXICOL, V50, P114, DOI 10.3109/15563650.2012.655281; Kong YY, 2010, PSYCHIAT RES, V179, P217, DOI 10.1016/j.psychres.2009.12.005; Langley RL, 2012, J AGROMEDICINE, V17, P300, DOI 10.1080/1059924X.2012.688467; Lee WJ, 2012, AM J IND MED, V55, P799, DOI 10.1002/ajim.22024; Lee WJ, 2009, INT ARCH OCC ENV HEA, V82, P365, DOI 10.1007/s00420-008-0343-z; London L, 2012, NEUROTOXICOLOGY, V33, P887, DOI 10.1016/j.neuro.2012.01.004; Mohamed F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-405; OECD, OECD HLTH DAT 2013; Organization for Economic Co-operation and Development (OECD), 2008, OECD ENV DAT COMP 20; Park BJ, 2003, STRATEGIES IMPROVE V; Phillips MR, 2012, LANCET, V379, P2318, DOI 10.1016/S0140-6736(12)60913-1; Rural Development Administration, 2008, RES ACT STAT PEST PO; Senarathna L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-593; Statistics Korea, 2012, 2011 SURV AGR FISH F; Statistics Korea, 2012, 2011 ANN REP CAUS DE; World Health Organization, 1992, INT STAT CLASS DIS R; Wu KCC, 2012, INT J ENV RES PUB HE, V9, P1135, DOI 10.3390/ijerph9041135; 이원진, 2011, [JOURNAL OF ENVIRONMENTAL HEALTH SCIENCES, 한국환경보건학회지], V37, P81	38	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95299	10.1371/journal.pone.0095299	http://dx.doi.org/10.1371/journal.pone.0095299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3IK	24743877	gold, Green Submitted, Green Published			2022-12-25	WOS:000335309100100
J	Guo, XG; Park, Y; Freedman, ND; Sinha, R; Hollenbeck, AR; Blair, A; Chen, HL				Guo, Xuguang; Park, Yikyung; Freedman, Neal D.; Sinha, Rashmi; Hollenbeck, Albert R.; Blair, Aaron; Chen, Honglei			Sweetened Beverages, Coffee, and Tea and Depression Risk among Older US Adults	PLOS ONE			English	Article							HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; CAFFEINE INTAKE; DECAFFEINATED COFFEE; NATIONAL-INSTITUTES; PARKINSON-DISEASE; MENTAL-HEALTH; WEIGHT-GAIN; SOFT DRINK; CONSUMPTION	Sweetened beverages, coffee, and tea are the most consumed non-alcoholic beverages and may have important health consequences. We prospectively evaluated the consumption of various types of beverages assessed in 1995-1996 in relation to self-reported depression diagnosis after 2000 among 263,923 participants of the NIH-AARP Diet and Health Study. Odds ratios (OR) and 95% confidence intervals (CI) were derived from multivariate logistic regressions. The OR (95% CI) comparing >= 4 cans/cups per day with none were 1.30 (95% CI: 1.17-1.44) for soft drinks, 1.38 (1.15-1.65) for fruit drinks, and 0.91 (0.84-0.98) for coffee (all P for trend < 0.0001). Null associations were observed for iced-tea and hot tea. In stratified analyses by drinkers of primarily diet versus regular beverages, the ORs were 1.31 (1.16-1.47) for diet versus 1.22 (1.03-1.45) for regular soft drinks, 1.51 (1.18-1.92) for diet versus 1.08 (0.79-1.46) for regular fruit drinks, and 1.25 (1.10-1.41) for diet versus 0.94 (0.83-1.08) for regular sweetened iced-tea. Finally, compared to nondrinkers, drinking coffee or tea without any sweetener was associated with a lower risk for depression, adding artificial sweeteners, but not sugar or honey, was associated with higher risks. Frequent consumption of sweetened beverages, especially diet drinks, may increase depression risk among older adults, whereas coffee consumption may lower the risk.	[Guo, Xuguang] Westat Corp, Dept Hlth Studies, Res Triangle Pk, NC USA; [Park, Yikyung; Freedman, Neal D.; Sinha, Rashmi] NCI, Nutr Epidemiol Branch, Rockville, MD USA; [Hollenbeck, Albert R.] AARP, Washington, DC USA; [Blair, Aaron] NCI, Occupat & Environm Epidemiol Branch, Rockville, MD USA; [Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA	Westat; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Chen, HL (corresponding author), NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.	chenh2@niehs.nih.gov	Hollenbeck, Albert/AAG-9461-2020; Sinha, Rashmi/G-7446-2015; Freedman, Neal David/B-9741-2015	Sinha, Rashmi/0000-0002-2466-7462; Freedman, Neal David/0000-0003-0074-1098; Park, Yikyung/0000-0002-6281-489X; Chen, Honglei/0000-0003-3446-7779	National Institute of Environmental Health Sciences; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The work reported in this manuscript was supported by the intramural research funding from the National Institute of Environmental Health Sciences and the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052; Benko CR, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-73; Chen XL, 2010, J CLIN ONCOL, V28, P991, DOI 10.1200/JCO.2009.23.0565; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; GREDEN JF, 1978, AM J PSYCHIAT, V135, P963; Gunter MJ, 2012, INT J CANCER, V131, pE530, DOI 10.1002/ijc.26482; Hintikka J, 2005, EUR J EPIDEMIOL, V20, P359, DOI 10.1007/s10654-005-0148-2; Humphries P, 2008, EUR J CLIN NUTR, V62, P451, DOI 10.1038/sj.ejcn.1602866; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Kawachi I, 1996, ARCH INTERN MED, V156, P521, DOI 10.1001/archinte.156.5.521; Klatsky A L, 1993, Ann Epidemiol, V3, P375, DOI 10.1016/1047-2797(93)90064-B; Lara DR, 2010, J ALZHEIMERS DIS, V20, pS239, DOI 10.3233/JAD-2010-1378; LEIBENLUFT E, 1993, AM J PSYCHIAT, V150, P294; Lien L, 2006, AM J PUBLIC HEALTH, V96, P1815, DOI 10.2105/AJPH.2004.059477; Liu R, 2012, AM J EPIDEMIOL, V175, P1200, DOI 10.1093/aje/kwr451; Lucas M, 2011, ARCH INTERN MED, V171, P1571, DOI 10.1001/archinternmed.2011.393; Luebbe AM, 2009, J SCHOOL HEALTH, V79, P380, DOI 10.1111/j.1746-1561.2009.00424.x; Magnuson BA, 2007, CRIT REV TOXICOL, V37, P629, DOI 10.1080/10408440701516184; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Morelli M, 2010, PROG BRAIN RES, V183, P183, DOI 10.1016/S0079-6123(10)83010-9; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Niu KJ, 2009, AM J CLIN NUTR, V90, P1615, DOI 10.3945/ajcn.2009.28216; Pan XQ, 2011, ACTA PAEDIATR, V100, pE215, DOI 10.1111/j.1651-2227.2011.02369.x; Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; Ruusunen A, 2010, PUBLIC HEALTH NUTR, V13, P1215, DOI 10.1017/S1368980010000509; Santos C, 2010, J ALZHEIMERS DIS, V20, pS187, DOI 10.3233/JAD-2010-091387; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Shi ZM, 2010, PUBLIC HEALTH NUTR, V13, P1073, DOI 10.1017/S1368980009993132; Simons SB, 2012, NAT NEUROSCI, V15, P23, DOI 10.1038/nn.2962; Sinha R, 2012, AM J CLIN NUTR, V96, P374, DOI 10.3945/ajcn.111.031328; Smith AP, 2009, HUM PSYCHOPHARM CLIN, V24, P29, DOI 10.1002/hup.991; Tanskanen A, 2000, EUR J EPIDEMIOL, V16, P789, DOI 10.1023/A:1007614714579; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; Whalen DJ, 2008, J PEDIATR PSYCHOL, V33, P358, DOI 10.1093/jpepsy/jsm086; Whitehouse CR, 2008, AAOHN J, V56, P251, DOI 10.3928/08910162-20080601-02	38	90	95	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94715	10.1371/journal.pone.0094715	http://dx.doi.org/10.1371/journal.pone.0094715			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743309	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100042
J	McDonnell, MD; Ward, LM				McDonnell, Mark D.; Ward, Lawrence M.			Small Modifications to Network Topology Can Induce Stochastic Bistable Spiking Dynamics in a Balanced Cortical Model	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; GAMMA-OSCILLATIONS; NEURONAL NETWORKS; CONNECTIVITY; INFORMATION; INHIBITION; EXCITATION; EXCITATION/INHIBITION; CONNECTOME; MECHANISMS	Directed random graph models frequently are used successfully in modeling the population dynamics of networks of cortical neurons connected by chemical synapses. Experimental results consistently reveal that neuronal network topology is complex, however, in the sense that it differs statistically from a random network, and differs for classes of neurons that are physiologically different. This suggests that complex network models whose subnetworks have distinct topological structure may be a useful, and more biologically realistic, alternative to random networks. Here we demonstrate that the balanced excitation and inhibition frequently observed in small cortical regions can transiently disappear in otherwise standard neuronal-scale models of fluctuation-driven dynamics, solely because the random network topology was replaced by a complex clustered one, whilst not changing the in-degree of any neurons. In this network, a small subset of cells whose inhibition comes only from outside their local cluster are the cause of bistable population dynamics, where different clusters of these cells irregularly switch back and forth from a sparsely firing state to a highly active state. Transitions to the highly active state occur when a cluster of these cells spikes sufficiently often to cause strong unbalanced positive feedback to each other. Transitions back to the sparsely firing state rely on occasional large fluctuations in the amount of non-local inhibition received. Neurons in the model are homogeneous in their intrinsic dynamics and in-degrees, but differ in the abundance of various directed feedback motifs in which they participate. Our findings suggest that (i) models and simulations should take into account complex structure that varies for neuron and synapse classes; (ii) differences in the dynamics of neurons with similar intrinsic properties may be caused by their membership in distinctive local networks; (iii) it is important to identify neurons that share physiological properties and location, but differ in their connectivity.	[McDonnell, Mark D.] Univ S Australia, Computat & Theoret Neurosci Lab, Inst Telecommun Res, Mawson Lakes, SA, Australia; [Ward, Lawrence M.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Ward, Lawrence M.] Univ British Columbia, Brain Res Ctr, Vancouver, BC, Canada	University of South Australia; University of British Columbia; University of British Columbia	McDonnell, MD (corresponding author), Univ S Australia, Computat & Theoret Neurosci Lab, Inst Telecommun Res, Mawson Lakes, SA, Australia.	mark.mcdonnell@unisa.edu.au	McDonnell, Mark/A-8374-2008	McDonnell, Mark/0000-0002-7009-3869; Ward, Lawrence/0000-0003-4431-5015	Australian Research Fellowship from the Australian Research Council [DP1093425]; Australian Government; Natural Sciences and Engineering Research Council (NSERC) of Canada	Australian Research Fellowship from the Australian Research Council(Australian Research Council); Australian Government(Australian GovernmentCGIAR); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Mark D. McDonnell's contribution was by supported by an Australian Research Fellowship from the Australian Research Council (project number DP1093425) (www.arc.gov.au) and an Endeavour Award from the Australian Government (http://www.innovation.gov.au/InternationalEducation/EndeavourAwards/). Lawrence M. Ward's contribution was supported by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Barabasi AL, 2012, NAT PHYS, V8, P14, DOI 10.1038/nphys2188; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bassett DS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000748; Belitski A, 2008, J NEUROSCI, V28, P5696, DOI 10.1523/JNEUROSCI.0009-08.2008; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Brummitt CD, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.045102; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Brunel N, 2008, CHAOS, V18, DOI 10.1063/1.2779858; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Dong CY, 2009, BIOINFORMATICS, V25, P1680, DOI 10.1093/bioinformatics/btp271; Dyhrfjeld-Johnsen J, 2007, J NEUROPHYSIOL, V97, P1566, DOI 10.1152/jn.00950.2006; Economo MN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002354; Fagiolo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026107; Geisler C, 2005, J NEUROPHYSIOL, V94, P4344, DOI 10.1152/jn.00510.2004; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gisiger T, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00001; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Hestrin S, 2005, TRENDS NEUROSCI, V28, P304, DOI 10.1016/j.tins.2005.04.001; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Hu Y, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/03/P03012; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; Kremkow J, 2010, J COMPUT NEUROSCI, V28, P579, DOI 10.1007/s10827-010-0240-9; Lee KM, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033027; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; Luz Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002334; Marx V, 2012, NATURE, V490, P293, DOI 10.1038/490293a; Mazzoni A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000239; McDonnell MD, 2012, BRAIN RES, V1434, P162, DOI 10.1016/j.brainres.2011.08.070; Meffin H, 2004, J COMPUT NEUROSCI, V16, P159, DOI 10.1023/B:JCNS.0000014108.03012.81; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Morrison A, 2007, NEURAL COMPUT, V19, P1437, DOI 10.1162/neco.2007.19.6.1437; Newman M.E.J., 2010, NETWORKS INTRO; Ostojic S, 2009, J NEUROSCI, V29, P10234, DOI 10.1523/JNEUROSCI.1275-09.2009; Perin R, 2011, P NATL ACAD SCI USA, V108, P5419, DOI 10.1073/pnas.1016051108; Pernice V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002059; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Pool RR, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00041; Prettejohn BJ, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00011; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Roxin A, 2011, FRONT COMPUT NEUROSC, V5, P1, DOI 10.3389/fncom.2011.00008; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rubinov M, 2011, J NEUROSCI, V31, P6263, DOI 10.1523/JNEUROSCI.0382-11.2011; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2013, NAT METHODS, V10, P491, DOI 10.1038/nmeth.2485; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Teramae J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00485; Tetzlaff T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002596; Trousdale J, 2005, PLOS COMPUTATIONAL B, V8; TSODYKS MV, 1995, NETWORK-COMP NEURAL, V6, P111, DOI 10.1088/0954-898X/6/2/001; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Vlachos I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002311; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Vogels TP, 2005, ANNU REV NEUROSCI, V28, P357, DOI 10.1146/annurev.neuro.28.061604.135637; Voges N, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00041; Voges N, 2010, J COMPUT NEUROSCI, V28, P137, DOI 10.1007/s10827-009-0193-z; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yagan O, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036103; Yassin L, 2010, NEURON, V68, P1043, DOI 10.1016/j.neuron.2010.11.029; Yger P, 2011, J COMPUT NEUROSCI, V31, P229, DOI 10.1007/s10827-010-0310-z; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zador AM, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001411; Zhao Liqiong, 2011, Front Comput Neurosci, V5, P28, DOI 10.3389/fncom.2011.00028	78	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e88254	10.1371/journal.pone.0088254	http://dx.doi.org/10.1371/journal.pone.0088254			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743633	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000335309100002
J	Ramos-Ibeas, P; Calle, A; Fernandez-Gonzalez, R; Laguna-Barraza, R; Pericuesta, E; Calero, A; Ramirez, MA; Gutierrez-Adan, A				Ramos-Ibeas, Priscila; Calle, Alexandra; Fernandez-Gonzalez, Raul; Laguna-Barraza, Ricardo; Pericuesta, Eva; Calero, Antonia; Angel Ramirez, Miguel; Gutierrez-Adan, Alfonso			Intracytoplasmic Sperm Injection Using DNA-Fragmented Sperm in Mice Negatively Affects Embryo-Derived Embryonic Stem Cells, Reduces the Fertility of Male Offspring and Induces Heritable Changes in Epialleles	PLOS ONE			English	Article							IN-VITRO CULTURE; MATRIX ATTACHMENT REGIONS; BIRTH-DEFECTS; EXPRESSED GENES; MOUSE EMBRYOS; BLASTOCYSTS; INTEGRITY; TRANSCRIPTOME; FERTILIZATION; TECHNOLOGIES	Intracytoplasmic sperm injection (ICSI) in mice using DNA-fragmented sperm (DFS) has been linked to an increased risk of genetic and epigenetic abnormalities both in embryos and offspring. This study examines: whether embryonic stem cells (ESCs) derived from DFS-ICSI embryos reflect the abnormalities observed in the DFS-ICSI progeny; the effect of DFS-ICSI on male fertility; and whether DFS-ICSI induces epigenetic changes that lead to a modified heritable phenotype. DFS-ICSIproduced embryos showed a low potential to generate ESC lines. However, these lines had normal karyotype accompanied by early gene expression alterations, though a normal expression pattern was observed after several passages. The fertility of males in the DFS-ICSI and control groups was compared by mating test. Sperm quantity, vaginal plug and pregnancy rates were significantly lower for the DFS-ICSI-produced males compared to in vivo-produced mice, while the number of females showing resorptions was higher. The epigenetic effects of DFS-ICSI were assessed by analyzing the phenotype rendered by the Axin1(Fu) allele, a locus that is highly sensitive to epigenetic perturbations. Oocytes were injected with spermatozoa from Axin1(Fu/+) mice and the DFS-ICSI-generated embryos were transferred to females. A significantly higher proportion of pups expressed the active kinky-tail epiallele in the DFS-ICSI group than the controls. In conclusion: 1) ESCs cannot be used as a model of DFS-ICSI; 2) DFS-ICSI reduces sperm production and fertility in the male progeny; and 3) DFS-ICSI affects the postnatal expression of a defined epigenetically sensitive allele and this modification may be inherited across generations.	[Ramos-Ibeas, Priscila; Calle, Alexandra; Fernandez-Gonzalez, Raul; Laguna-Barraza, Ricardo; Pericuesta, Eva; Calero, Antonia; Angel Ramirez, Miguel; Gutierrez-Adan, Alfonso] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dpto Reprod Anim & Conservac Recursos Zoogenet, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Ramos-Ibeas, P (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria, Dpto Reprod Anim & Conservac Recursos Zoogenet, Madrid, Spain.	priscilaramosibeas@gmail.com	Gutierrez-Adan, Alfonso/A-1485-2014; de Paz, Miguel Ángel Ramírez/H-3171-2015; Ramos-Ibeas, Priscila/Q-5943-2018	Gutierrez-Adan, Alfonso/0000-0001-9893-9179; de Paz, Miguel Ángel Ramírez/0000-0002-5868-2134; Ramos-Ibeas, Priscila/0000-0003-4578-0189; Calle Arias, Alexandra/0000-0003-3903-5019; Fernandez Gonzalez, Raul/0000-0003-1989-2945	Spanish Ministry of Economy and Competitiveness [AGL2012-39652]; Spanish Ministry of Science and Innovation	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was funded by Grant AGL2012-39652 from the Spanish Ministry of Economy and Competitiveness. P.R.-I. was supported by an FPI grant from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ramirez MA, 2009, BIOL REPROD, V80, P1216, DOI 10.1095/biolreprod.108.075044; Aviles M, 2010, MOL HUM REPROD, V16, P896, DOI 10.1093/molehr/gaq056; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Calle A, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.100743; Ding JJ, 2009, PROTEOMICS, V9, P2711, DOI 10.1002/pmic.200800824; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Fernandez-Gonzalez R, 2008, BIOL REPROD, V78, P761, DOI 10.1095/biolreprod.107.065623; Fernandez-Gonzalez R, 2007, MOL REPROD DEV, V74, P1149, DOI 10.1002/mrd.20746; Fernandez-Gonzalez R, 2009, REPRODUCTION, V137, P271, DOI 10.1530/REP-08-0265; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Gutierrez-Adan A, 2006, REPROD DOMEST ANIM, V41, P54, DOI 10.1111/j.1439-0531.2006.00769.x; Gutierrez-Adan A, 2000, TRANSGENIC RES, V9, P81, DOI 10.1023/A:1008926022370; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hansen M, 2013, HUM REPROD UPDATE, V19, P330, DOI 10.1093/humupd/dmt006; Hollis Roger P, 2003, Reprod Biol Endocrinol, V1, P79, DOI 10.1186/1477-7827-1-79; Hourcade JD, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-9; Irvine DS, 2000, J ANDROL, V21, P33; Katz-Jaffe MG, 2013, FERTIL STERIL, V100, P262, DOI 10.1016/j.fertnstert.2013.03.021; Kohda T, 2011, BIOCHEM BIOPH RES CO, V410, P282, DOI 10.1016/j.bbrc.2011.05.133; Laposa RR, 2004, FASEB J, V18, P896, DOI 10.1096/fj.03-0903fje; Lewis SEM, 2013, REPROD BIOMED ONLINE, V27, P325, DOI 10.1016/j.rbmo.2013.06.014; Moreira PN, 2007, BIOL REPROD, V76, P336, DOI 10.1095/biolreprod.106.056952; Morgan HD, 2008, BIOL REPROD, V79, P618, DOI 10.1095/biolreprod.108.068213; Morita R, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/179594; Peaston AE, 2004, DEV CELL, V7, P597, DOI 10.1016/j.devcel.2004.09.004; Perez-Crespo M, 2008, MOL REPROD DEV, V75, P40, DOI 10.1002/mrd.20759; Petazzi P, 2013, RNA BIOL, V10, P1197, DOI 10.4161/rna.24286; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; REIK W, 1993, DEVELOPMENT, V119, P933; Schultz RM, 2002, SCIENCE, V296, P2188, DOI 10.1126/science.1071741; Scott KA, 2010, BIOL REPROD, V83, P220, DOI 10.1095/biolreprod.109.082826; Sergerie M, 2005, HUM REPROD, V20, P3446, DOI 10.1093/humrep/dei231; van de Lagemaat LN, 2003, TRENDS GENET, V19, P530, DOI 10.1016/j.tig.2003.08.004; Vasicek TJ, 1997, GENETICS, V147, P777; Vermeiden JPW, 2013, FERTIL STERIL, V99, P642, DOI 10.1016/j.fertnstert.2013.01.125; Wang LY, 2013, J ZHEJIANG UNIV-SC B, V14, P372, DOI 10.1631/jzus.B1200321; Wen J, 2012, FERTIL STERIL, V97, P1331, DOI 10.1016/j.fertnstert.2012.02.053; Winkler J, 2009, CURR MED CHEM, V16, P4814, DOI 10.2174/092986709789909657; Yamagata K, 2009, HUM REPROD, V24, P2490, DOI 10.1093/humrep/dep236; Yu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022172; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zini A, 2005, HUM REPROD, V20, P3476, DOI 10.1093/humrep/dei266	44	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95625	10.1371/journal.pone.0095625	http://dx.doi.org/10.1371/journal.pone.0095625			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743851	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100148
J	Ding, HR; Xue, Y; Tang, YM; He, D; Li, ZY; Zhao, Y; Zong, YQ; Wang, Y; Wang, P				Ding, Huairong; Xue, Yuan; Tang, Yanming; He, Dong; Li, Zhiyang; Zhao, Ying; Zong, Yaqi; Wang, Yi; Wang, Pei			Laminoplasty and Laminectomy Hybrid Decompression for the Treatment of Cervical Spondylotic Myelopathy with Hypertrophic Ligamentum Flavum: A Retrospective Study	PLOS ONE			English	Article							OPEN-DOOR LAMINOPLASTY; POSTERIOR LONGITUDINAL LIGAMENT; SUTURE ANCHOR FIXATION; TERM-FOLLOW-UP; COMPRESSIVE MYELOPATHY; SURGICAL TECHNIQUE; STENOTIC MYELOPATHY; TITANIUM MINIPLATE; CANAL EXPANSION; SPINAL-CORD	Objective: To report the outcomes of a posterior hybrid decompression protocol for the treatment of cervical spondylotic myelopathy (CSM) associated with hypertrophic ligamentum flavum (HLF). Background: Laminoplasty is widely used in patients with CSM; however, for CSM patients with HLF, traditional laminoplasty does not include resection of a pathological ligamentum flavum. Methods: This study retrospectively reviewed 116 CSM patients with HLF who underwent hybrid decompression with a minimum of 12 months of follow-up. The procedure consisted of reconstruction of the C4 and C6 laminae using CENTERPIECE plates with spinous process autografts, and resection of the C3, C5, and C7 laminae. Surgical outcomes were assessed using Japanese Orthopedic Association (JOA) score, recovery rate, cervical lordotic angle, cervical range of motion, spinal canal sagittal diameter, bone healing rates on both the hinge and open sides, dural sac expansion at the level of maximum compression, drift-back distance of the spinal cord, and postoperative neck pain assessed by visual analog scale. Results: No hardware failure or restenosis was noted. Postoperative JOA score improved significantly, with a mean recovery rate of 65.3 +/- 15.5%. Mean cervical lordotic angle had decreased 4.9 degrees by 1 year after surgery (P<0.05). Preservation of cervical range of motion was satisfactory postoperatively. Bone healing rates 6 months after surgery were 100% on the hinge side and 92.2% on the open side. Satisfactory decompression was demonstrated by a significantly increased sagittal canal diameter and cross-sectional area of the dural sac together with a significant drift-back distance of the spinal cord. The dural sac was also adequately expanded at the time of the final follow-up visit. Conclusion: Hybrid laminectomy and autograft laminoplasty decompression using Centerpiece plates may facilitate bone healing and produce a comparatively satisfactory prognosis for CSM patients with HLF.	[Ding, Huairong; Xue, Yuan; Tang, Yanming; He, Dong; Li, Zhiyang; Zhao, Ying; Zong, Yaqi; Wang, Yi; Wang, Pei] Tianjin Med Univ, Gen Hosp, Dept Orthoped, Tianjin, Peoples R China	Tianjin Medical University	Xue, Y (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Orthoped, Tianjin, Peoples R China.	xueyuantj@163.com	Xue, Yuan/AFT-1587-2022		National Hightech R&D Program of China (863 Program) [2007AA04Z235]; National Natural Science Foundation of China [81271360, 30973024, 30571876, 30772193]	National Hightech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Hightech R&D Program of China (863 Program) (2007AA04Z235) and National Natural Science Foundation of China [81271360, 30973024, 30571876, 30772193]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen GD, 2012, ORTHOPEDICS, V35, pE543, DOI 10.3928/01477447-20120327-24; Deutsch H, 2004, J SPINAL DISORD TECH, V17, P317, DOI 10.1097/01.bsd.0000091070.73042.23; Fehlings MG, 1998, SPINE, V23, P2730, DOI 10.1097/00007632-199812150-00012; Geck MJ, 2002, ORTHOP CLIN N AM, V33, P329, DOI 10.1016/S0030-5898(02)00002-0; Gok B, 2009, NEUROL RES, V31, P1097, DOI 10.1179/174313209X383277; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; HIRABAYASHI K, 1983, SPINE, V8, P693, DOI 10.1097/00007632-198310000-00003; ITOH T, 1985, SPINE, V10, P729, DOI 10.1097/00007632-198510000-00007; Iwakura M, 1999, NEUROL SURG TOKYO, V27, P525; Jiang JL, 2012, J CLIN NEUROSCI, V19, P804, DOI 10.1016/j.jocn.2011.09.021; Jiang LJ, 2012, ORTHOPEDICS, V35, pE225, DOI 10.3928/01477447-20120123-07; Kawaguchi Y, 2003, CLIN ORTHOP RELAT R, P129, DOI 10.1097/01.blo.0000069889.31220.62; Konya D, 2009, J CLIN NEUROSCI, V16, P404, DOI 10.1016/j.jocn.2008.07.070; Lu JJ, 2007, NEUROSURGERY, V60, P149, DOI 10.1227/01.NEU.0000249219.72956.C7; Machino M, 2011, SPINE, V36, P399, DOI 10.1097/BRS.0b013e3181d2510b; Matsumoto M, 2008, J NEUROSURG-SPINE, V9, P530, DOI 10.3171/SPI.2008.4.08176; Matsunaga S, 1999, SPINAL CORD, V37, P20, DOI 10.1038/sj.sc.3100749; Mummaneni PV, 2009, J NEUROSURG-SPINE, V11, P130, DOI 10.3171/2009.3.SPINE08728; Muthukumar N, 2012, NEUROL INDIA, V60, P201, DOI 10.4103/0028-3886.96402; Naderi S, 1998, NEUROSURGERY, V43, P43, DOI 10.1097/00006123-199807000-00028; OBrien MF, 1996, SPINE, V21, P474, DOI 10.1097/00007632-199602150-00012; Park AE, 2004, J SPINAL DISORD TECH, V17, P265, DOI 10.1097/01.bsd.0000095401.27687.c0; Ratliff JK, 2003, J NEUROSURG, V98, P230, DOI 10.3171/spi.2003.98.3.0230; Rhee JM, 2011, SPINE, V36, P9, DOI 10.1097/BRS.0b013e3181fea49c; Rhee JM, 2008, ASIAN SPINE J, V2, P114, DOI 10.4184/asj.2008.2.2.114; Roberts M P, 1996, Conn Med, V60, P395; Sakaura H, 2003, SPINE, V28, P2447, DOI 10.1097/01.BRS.0000090833.96168.3F; Sathyendra V, 2013, HAND CLIN, V29, P473, DOI 10.1016/j.hcl.2013.08.002; Satomi K, 2001, Spine J, V1, P26, DOI 10.1016/S1529-9430(01)00008-0; SATOMI K, 1994, SPINE, V19, P507, DOI 10.1097/00007632-199403000-00003; Shiraishi Tateru, 2002, Spine J, V2, P108, DOI 10.1016/S1529-9430(01)00118-8; Singhal U, 2009, INDIAN J ORTHOP, V43, P305, DOI 10.4103/0019-5413.49385; Sodeyama T, 1999, SPINE, V24, P1527, DOI 10.1097/00007632-199908010-00005; Steinmetz Michael P, 2006, Spine J, V6, p274S, DOI 10.1016/j.spinee.2006.04.023; Sun Yu, 2010, Evid Based Spine Care J, V1, P27, DOI 10.1055/s-0030-1267065; Tani S, 2002, NEUROSURGERY, V50, P97, DOI 10.1097/00006123-200201000-00017; Toledano M, 2013, NEUROL CLIN, V31, P287, DOI 10.1016/j.ncl.2012.09.003; Tracy JA, 2010, NEUROLOGIST, V16, P176, DOI 10.1097/NRL.0b013e3181da3a29; Tsuji T, 2007, EUR SPINE J, V16, P2072, DOI 10.1007/s00586-007-0428-5; Wang L, 2012, NEUROL INDIA, V60, P210, DOI 10.4103/0028-3886.96403; Wang SJ, 2011, EUR SPINE J, V20, P185, DOI 10.1007/s00586-010-1600-x; Yang SC, 2008, ACTA ORTHOP, V79, P62, DOI 10.1080/17453670710014770; Yang SC, 2007, J SPINAL DISORD TECH, V20, P492, DOI 10.1097/BSD.0b013e318033e844; Yoshida M, 2002, SPINE, V27, P1414, DOI 10.1097/00007632-200207010-00008; Yukawa Y, 2007, SPINE, V32, P1980, DOI 10.1097/BRS.0b013e318133fbce	45	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95482	10.1371/journal.pone.0095482	http://dx.doi.org/10.1371/journal.pone.0095482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740151	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900148
J	Mambetsariev, I; Tian, YF; Wu, TH; Lavoie, T; Solway, J; Birukov, KG; Birukova, AA				Mambetsariev, Isa; Tian, Yufeng; Wu, Tinghuai; Lavoie, Tera; Solway, Julian; Birukov, Konstantin G.; Birukova, Anna A.			Stiffness-Activated GEF-H1 Expression Exacerbates LPS-Induced Lung Inflammation	PLOS ONE			English	Article							VASCULAR-PERMEABILITY; INJURY; MICROTUBULES; INHIBITION	Acute lung injury (ALI) is accompanied by decreased lung compliance. However, a role of tissue mechanics in modulation of inflammation remains unclear. We hypothesized that bacterial lipopolysacharide (LPS) stimulates extracellular matrix (ECM) production and vascular stiffening leading to stiffness-dependent exacerbation of endothelial cell (EC) inflammatory activation and lung barrier dysfunction. Expression of GEF-H1, ICAM-1, VCAM-1, ECM proteins fibronectin and collagen, lysyl oxidase (LOX) activity, interleukin-8 and activation of Rho signaling were analyzed in lung samples and pulmonary EC grown on soft (1.5 or 2.8 kPa) and stiff (40 kPa) substrates. LPS induced EC inflammatory activation accompanied by expression of ECM proteins, increase in LOX activity, and activation of Rho signaling. These effects were augmented in EC grown on stiff substrate. Stiffness-dependent enhancement of inflammation was associated with increased expression of Rho activator, GEF-H1. Inhibition of ECM crosslinking and stiffening by LOX suppression reduced EC inflammatory activation and GEF-H1 expression in response to LPS. In vivo, LOX inhibition attenuated LPS-induced expression of GEF-H1 and lung dysfunction. These findings present a novel mechanism of stiffness-dependent exacerbation of vascular inflammation and escalation of ALI via stimulation of GEF-H1 - Rho pathway. This pathway represents a fundamental mechanism of positive feedback regulation of inflammation.	[Mambetsariev, Isa; Tian, Yufeng; Wu, Tinghuai; Lavoie, Tera; Solway, Julian; Birukov, Konstantin G.; Birukova, Anna A.] Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, Chicago, IL 60637 USA	University of Chicago	Birukova, AA (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	abirukov@medicine.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022		NIH [HL89257, HL107920, HL76259]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107920, R01HL087823, R56HL107920, R01HL076259, R01HL089257] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by NIH HL89257, HL107920, HL76259. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aratyn-Schaus Y, 2011, MOL BIOL CELL, V22, P1330, DOI 10.1091/mbc.E10-11-0891; Aratyn-Schaus Yvonne, 2010, J Vis Exp, DOI 10.3791/2173; Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; Berg JT, 1997, J APPL PHYSIOL, V83, P120, DOI 10.1152/jappl.1997.83.1.120; Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2013, MICROVASC RES, V87, P50, DOI 10.1016/j.mvr.2012.12.006; Birukova AA, 2012, AM J PHYSIOL-LUNG C, V302, pL965, DOI 10.1152/ajplung.00292.2011; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Chandler EM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015008; Deng XL, 2011, BRAIN RES, V1387, P1, DOI 10.1016/j.brainres.2011.02.059; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fu P, 2009, EUR RESPIR J, V33, P612, DOI 10.1183/09031936.00014808; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Guo F, 2012, MOL IMMUNOL, V50, P98, DOI 10.1016/j.molimm.2011.12.009; Guo F, 2012, CYTOKINE, V57, P417, DOI 10.1016/j.cyto.2011.12.009; Heck JN, 2012, MOL BIOL CELL, V23, P2583, DOI 10.1091/mbc.E11-10-0876; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Karsdal MA, 2013, ASSAY DRUG DEV TECHN, V11, P70, DOI 10.1089/adt.2012.474; Kratzer E, 2012, AM J RESP CELL MOL, V47, P688, DOI 10.1165/rcmb.2012-0161OC; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Lavoie TL, 2012, AM J RESP CRIT CARE, V186, P225, DOI 10.1164/rccm.201202-0368OC; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012; Mammoto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2774; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rocco PRM, 2009, MINERVA ANESTESIOL, V75, P730; Rodriguez C, 2008, DRUG NEWS PERSPECT, V21, P218, DOI 10.1358/dnp.2008.21.4.1213351; Schmeck B, 2003, INFLAMMATION, V27, P89, DOI 10.1023/A:1023278600596; Tasaka S, 2005, AM J RESP CELL MOL, V32, P504, DOI 10.1165/rcmb.2004-0009OC; Togbe D, 2007, INT J EXP PATHOL, V88, P387, DOI 10.1111/j.1365-2613.2007.00566.x; Wang Q, 2002, ANTIOXID REDOX SIGN, V4, P39, DOI 10.1089/152308602753625843; Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	37	27	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e92670	10.1371/journal.pone.0092670	http://dx.doi.org/10.1371/journal.pone.0092670			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739883	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900012
J	Thomas, Y; Dumas, F; Andrefouet, S				Thomas, Yoann; Dumas, Franck; Andrefouet, Serge			Larval Dispersal Modeling of Pearl Oyster Pinctada margaritifera following Realistic Environmental and Biological Forcing in Ahe Atoll Lagoon	PLOS ONE			English	Article							MARINE BENTHIC INVERTEBRATES; ARCHIPELAGO FRENCH-POLYNESIA; TUAMOTU ARCHIPELAGO; POPULATION CONNECTIVITY; AQUACULTURE MANAGEMENT; BIVALVE LARVAE; RECRUITMENT; GROWTH; CONSERVATION; CIRCULATION	Studying the larval dispersal of bottom-dwelling species is necessary to understand their population dynamics and optimize their management. The black-lip pearl oyster (Pinctada margaritifera) is cultured extensively to produce black pearls, especially in French Polynesia's atoll lagoons. This aquaculture relies on spat collection, a process that can be optimized by understanding which factors influence larval dispersal. Here, we investigate the sensitivity of P. margaritifera larval dispersal kernel to both physical and biological factors in the lagoon of Ahe atoll. Specifically, using a validated 3D larval dispersal model, the variability of lagoon-scale connectivity is investigated against wind forcing, depth and location of larval release, destination location, vertical swimming behavior and pelagic larval duration (PLD) factors. The potential connectivity was spatially weighted according to both the natural and cultivated broodstock densities to provide a realistic view of connectivity. We found that the mean pattern of potential connectivity was driven by the southwest and northeast main barotropic circulation structures, with high retention levels in both. Destination locations, spawning sites and PLD were the main drivers of potential connectivity, explaining respectively 26%, 59% and 5% of the variance. Differences between potential and realistic connectivity showed the significant contribution of the pearl oyster broodstock location to its own dynamics. Realistic connectivity showed larger larval supply in the western destination locations, which are preferentially used by farmers for spat collection. In addition, larval supply in the same sectors was enhanced during summer wind conditions. These results provide new cues to understanding the dynamics of bottom-dwelling populations in atoll lagoons, and show how to take advantage of numerical models for pearl oyster management.	[Thomas, Yoann; Andrefouet, Serge] Inst Rech Dev, Unite Rech CoReUs, Noumea, New Caledonia; [Dumas, Franck] IFREMER, Ctr Bretagne, DYNECO, F-29280 Plouzane, France	Institut de Recherche pour le Developpement (IRD); Ifremer; Universite de Bretagne Occidentale	Thomas, Y (corresponding author), Inst Rech Dev, Unite Rech CoReUs, Noumea, New Caledonia.	yoann.thomas1@gmail.com	Thomas, Yoann/G-6648-2016	Thomas, Yoann/0000-0001-7980-5239	Agence Nationale de la Recherche (ANR); Direction des Ressources Marines de Polynesie francaise	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Direction des Ressources Marines de Polynesie francaise	This study was funded by the Agence Nationale de la Recherche (ANR, www.agence-nationale-recherche.fr), as part of the POLYPERL project (www.polyperl.org). The authors' research in Ahe atoll has also been supported since several years by the Direction des Ressources Marines de Polynesie francaise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2000, MAR ECOL PROG SER, V196, P25, DOI 10.3354/meps196025; Andrefouet S, 2006, MAR POLLUT BULL, V52, P1138, DOI 10.1016/j.marpolbul.2006.07.014; Andrefouet S, 2013, BIOL CONSERV, V160, P190, DOI 10.1016/j.biocon.2013.01.017; Andrefouet S, 2012, MAR POLLUT BULL, V65, P415, DOI 10.1016/j.marpolbul.2012.05.042; Andrefouet S, 2012, MAR POLLUT BULL, V65, P407, DOI 10.1016/j.marpolbul.2012.06.021; [Anonymous], 2012, CLUSTER CLUSTER ANAL; Botsford LW, 2009, CORAL REEFS, V28, P327, DOI 10.1007/s00338-009-0466-z; Brie C, 1999, MEMOIRE EPHE; Burgess SC, 2012, ECOLOGY, V93, P1378; Charpy L, 2012, MAR POLLUT BULL, V65, P471, DOI 10.1016/j.marpolbul.2011.12.026; Chavez-Villalba J, 2011, J SHELLFISH RES, V30, P231, DOI 10.2983/035.030.0206; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Cowen RK, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.26; Deacon EL, SEA, V1, P43; Dekshenieks MM, 1996, MAR ECOL PROG SER, V136, P97, DOI 10.3354/meps136097; Doroudi Mehdi S., 2003, Molluscan Research, V23, P101, DOI 10.1071/MR02015; Dufour P, 2001, LIMNOL OCEANOGR, V46, P456, DOI 10.4319/lo.2001.46.2.0456; Dumas F, 2012, MAR POLLUT BULL, V65, P425, DOI 10.1016/j.marpolbul.2012.05.041; Eckman JE, 1996, J EXP MAR BIOL ECOL, V200, P207, DOI 10.1016/S0022-0981(96)02644-5; Edwards KP, 2007, MAR ECOL PROG SER, V352, P77, DOI 10.3354/meps07169; Fournier J, 2012, MAR POLLUT BULL, V65, P463, DOI 10.1016/j.marpolbul.2012.03.027; Friedman KJ, 1998, AQUACULTURE, V167, P283, DOI 10.1016/S0044-8486(98)00286-5; Gaymer CF, 2010, MAR FRESHWATER RES, V61, P1185, DOI 10.1071/MF09268; Herbert RJH, 2012, J BIOGEOGR, V39, P585, DOI 10.1111/j.1365-2699.2011.02626.x; Hughes TP, 2000, ECOLOGY, V81, P2241, DOI 10.1890/0012-9658(2000)081[2241:SSEWBW]2.0.CO;2; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; Intes A, 1982, PROGRAMME NACRE ETUD; Intes A, 1985, NOTES DOCUMENTS OCEA; Kim CK, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006115; Lazure P, 2008, ADV WATER RESOUR, V31, P233, DOI 10.1016/j.advwatres.2007.06.010; Lefevre J, 2010, MAR POLLUT BULL, V61, P413, DOI 10.1016/j.marpolbul.2010.06.012; Lett C, 2010, PROG OCEANOGR, V87, P106, DOI 10.1016/j.pocean.2010.09.005; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lopez-Duarte PC, 2012, INTEGR COMP BIOL, V52, P511, DOI 10.1093/icb/ics104; Metaxas A, 2009, BIOL BULL-US, V216, P257, DOI 10.1086/BBLv216n3p257; North EW, 2008, MAR ECOL PROG SER, V359, P99, DOI 10.3354/meps07317; Pante E, 2006, AQUAT LIVING RESOUR, V19, P207, DOI 10.1051/alr:2006021; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Pouvreau S, 2000, AQUAT LIVING RESOUR, V13, P37, DOI 10.1016/S0990-7440(00)00135-2; Pouvreau S, 2001, AQUAT LIVING RESOUR, V14, P155, DOI 10.1016/S0990-7440(01)01120-2; R Development Core Team, 2012, R LANG ENV STAT COMP; Schulte DM, 2009, SCIENCE, V325, P1124, DOI 10.1126/science.1176516; SIMS NA, 1994, AQUACULTURE, V122, P181, DOI 10.1016/0044-8486(94)90509-6; Thielley M, 1993, ETUDE CYTOLOGIQUE GA; Thomas Y, 2012, MAR POLLUT BULL, V65, P441, DOI 10.1016/j.marpolbul.2011.12.027; Thomas Y, 2012, MAR POLLUT BULL, V65, P453, DOI 10.1016/j.marpolbul.2011.12.028; Thomas Y, 2011, J SEA RES, V66, P331, DOI 10.1016/j.seares.2011.04.005; Tranter D, 1958, MAR FRESHWATER RES, V9, P509; Treml EA, 2008, LANDSCAPE ECOL, V23, P19, DOI 10.1007/s10980-007-9138-y; Treml EA, 2012, INTEGR COMP BIOL, V52, P525, DOI 10.1093/icb/ics101; Van Wynsberge S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064641; Watson JR, 2010, MAR ECOL PROG SER, V401, P31, DOI 10.3354/meps08376; Zanini JM, 2000, CORAL REEFS, V19, P83, DOI 10.1007/s003380050231	53	24	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95050	10.1371/journal.pone.0095050	http://dx.doi.org/10.1371/journal.pone.0095050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740288	Green Published, gold			2022-12-25	WOS:000336863900098
J	Allen, PA; Houston, JR; Pollock, JW; Buzzelli, C; Li, X; Harrington, AK; Martin, BA; Loth, F; Lien, MC; Maleki, J; Luciano, MG				Allen, Philip A.; Houston, James R.; Pollock, Joshua W.; Buzzelli, Christopher; Li, Xuan; Harrington, A. Katherine; Martin, Bryn A.; Loth, Francis; Lien, Mei-Ching; Maleki, Jahangir; Luciano, Mark G.			Task-Specific and General Cognitive Effects in Chiari Malformation Type I	PLOS ONE			English	Article							ADULT AGE-DIFFERENCES; INTERFERENCE; CEREBELLUM; CHILDREN; VERSION; MEMORY; PAIN	Objective: Our objective was to use episodic memory and executive function tests to determine whether or not Chiari Malformation Type I (CM) patients experience cognitive dysfunction. Background: CM is a neurological syndrome in which the cerebellum descends into the cervical spine causing neural compression, severe headaches, neck pain, and number of other physical symptoms. While primarily a disorder of the cervico-medullary junction, both clinicians and researchers have suspected deficits in higher-level cognitive function. Design and Methods: We tested 24 CM patients who had undergone decompression neurosurgery and 24 age-and education-matched controls on measures of immediate and delayed episodic memory, as well as three measures of executive function. Results: The CM group showed performance decrements relative to the controls in response inhibition (Stroop interference), working memory computational speed (Ospan), and processing speed (automated digit symbol substitution task), but group differences in recall did not reach statistical significance. After statistical control for depression and anxiety scores, the group effects for working memory and processing speed were eliminated, but not for response inhibition. This response inhibition difference was not due to overall general slowing for the CM group, either, because when controls' data were transformed using the linear function fit to all of the reaction time tasks, the interaction with group remained statistically significant. Furthermore, there was a multivariate group effect for all of the response time measures and immediate and delayed recall after statistical control of depression and anxiety scores. Conclusion: These results suggest that CM patients with decompression surgery exhibit cognitive dysfunction compared to age- and education-matched controls. While some of these results may be related to anxiety and depression (likely proxies for chronic pain), response inhibition effects, in particular, as well as a general cognitive deficit persisted even after control for anxiety and decompression.	[Allen, Philip A.; Houston, James R.; Pollock, Joshua W.; Buzzelli, Christopher; Li, Xuan; Harrington, A. Katherine] Univ Akron, Dept Psychol, Akron, OH 44325 USA; [Allen, Philip A.; Pollock, Joshua W.; Martin, Bryn A.; Loth, Francis] Univ Akron, Conquer Chiari Res Ctr, Akron, OH 44325 USA; [Martin, Bryn A.; Loth, Francis] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA; [Lien, Mei-Ching] Oregon State Univ, Sch Psychol Sci, Corvallis, OR 97331 USA; [Maleki, Jahangir] Cleveland Clin Fdn, Neurol Ctr Pain, Cleveland, OH 44195 USA; [Luciano, Mark G.] Cleveland Clin Fdn, Dept Neurol Surg, Cleveland, OH 44195 USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron; University System of Ohio; University of Akron; Oregon State University; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Allen, PA (corresponding author), Univ Akron, Dept Psychol, Akron, OH 44325 USA.	paallen@uakron.edu	Allen, Philip/R-8191-2019; Martin, Bryn A./N-6640-2016; Houston, James/T-1291-2019; Lien, Mei-Ching/I-3404-2015	Martin, Bryn A./0000-0003-1234-7880; Houston, James/0000-0002-2148-4302; Lien, Mei-Ching/0000-0003-0032-223X; Allen, Philip/0000-0001-8567-2217	Conquer Chiari Foundation	Conquer Chiari Foundation	The Conquer Chiari Foundation supported portions of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PA, 2005, EXP AGING RES, V31, P355, DOI 10.1080/03610730500206642; Allen PA, 2011, J COGN PSYCHOL, V23, P768, DOI 10.1080/20445911.2011.570254; ANDERSON DW, 1992, ANN NEUROL, V31, P333, DOI 10.1002/ana.410310317; Apkarian AV, 2004, J NEUROSCI, V24, P10410, DOI 10.1523/JNEUROSCI.2541-04.2004; Baena E, 2010, NEUROPSYCHOLOGIA, V48, P319, DOI 10.1016/j.neuropsychologia.2009.09.021; Bosma FK, 2002, NEUROPSY NEUROPSY BE, V15, P56; CERELLA J, 1991, J EXP PSYCHOL GEN, V120, P215, DOI 10.1037/0096-3445.120.2.215; Chen Jason A, 2012, Surg Neurol Int, V3, P165, DOI 10.4103/2152-7806.105277; Chung SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064630; Fairbank J C, 1980, Physiotherapy, V66, P271; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Grafman J., 2002, PRINCIPLES FRONTAL L, P292, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0019; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hesselmann G, 2011, NEUROIMAGE, V56, P1608, DOI 10.1016/j.neuroimage.2011.03.017; Karp JF, 2006, PAIN MED, V7, P444, DOI 10.1111/j.1526-4637.2006.00212.x; Krienen FM, 2009, CEREB CORTEX, V19, P2485, DOI 10.1093/cercor/bhp135; Kumar M, 2011, WORLD NEUROSURG, V76, P189, DOI 10.1016/j.wneu.2011.02.022; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Linton SJ, 2011, SCAND J PAIN, V2, P47, DOI 10.1016/j.sjpain.2011.01.005; Luciano MG, 2011, NEUROL RES, V33, P272, DOI 10.1179/016164111X12962202723887; Madden DJ, 2007, CURR DIR PSYCHOL SCI, V16, P70, DOI 10.1111/j.1467-8721.2007.00478.x; MADDEN DJ, 1992, PSYCHOL AGING, V7, P594, DOI 10.1037/0882-7974.7.4.594; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Mueller Diane M, 2004, J Am Acad Nurse Pract, V16, P134; O'Halloran CJ, 2012, J CLIN EXP NEUROPSYC, V34, P35, DOI 10.1080/13803395.2011.614599; Riva D, 2000, BRAIN, V123, P1051, DOI 10.1093/brain/123.5.1051; Riva D, 2011, NEUROL SCI, V32, P307, DOI 10.1007/s10072-011-0779-x; Rogers TD, 2011, SYNAPSE, V65, P1204, DOI 10.1002/syn.20960; Rypma B, 1999, P NATL ACAD SCI USA, V96, P6558, DOI 10.1073/pnas.96.11.6558; Salthouse TA, 1996, NEUROPSYCHOLOGY, V10, P272, DOI 10.1037/0894-4105.10.2.272; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schmidt M., 1996, W PSYCHOL SERVICES; Schroeter ML, 2004, NEUROIMAGE, V23, P1317, DOI 10.1016/j.neuroimage.2004.08.001; SELEMON LD, 1988, J NEUROSCI, V8, P4049; Shaffer N, 2011, NEUROL RES, V33, P247, DOI 10.1179/016164111X12962202723805; Speer Marcy C, 2003, J Genet Couns, V12, P297, DOI 10.1023/A:1023948921381; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Unsworth N, 2005, BEHAV RES METHODS, V37, P498, DOI 10.3758/BF03192720; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Yassari R, 2004, PEDIATR CLIN N AM, V51, P477, DOI 10.1016/S0031-3955(03)00208-6	42	36	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94844	10.1371/journal.pone.0094844	http://dx.doi.org/10.1371/journal.pone.0094844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736676	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600095
J	Eszes, N; Toldi, G; Bohacs, A; Ivancso, I; Muller, V; Rigo, J; Losonczy, G; Vasarhelyi, B; Tamasi, L				Eszes, Noemi; Toldi, Gergely; Bohacs, Aniko; Ivancso, Istvan; Mueller, Veronika; Rigo, Janos, Jr.; Losonczy, Gyoergy; Vasarhelyi, Barna; Tamasi, Lilla			Relationship of Circulating Hyaluronic Acid Levels to Disease Control in Asthma and Asthmatic Pregnancy	PLOS ONE			English	Article							C-REACTIVE PROTEIN; AIRWAY INFLAMMATION; SERUM; SEVERITY; FLUID; PREECLAMPSIA; CHILDREN; OUTCOMES; ALPHA; WOMEN	Uncontrolled asthma is a risk factor for pregnancy-related complications. Hyaluronic acid (HA), a potential peripheral blood marker of tissue fibrosis in various diseases, promotes eosinophil survival and plays a role in asthmatic airway inflammation as well as in physiological processes necessary to maintain normal pregnancy; however the level of circulating HA in asthma and asthmatic pregnancy is unknown. We investigated HA levels in asthmatic patients (N = 52; asthmatic pregnant (AP) N = 16; asthmatic non-pregnant (ANP) N = 36) and tested their relationship to asthma control. Serum HA level was lower in AP than in ANP patients (27 [24.7-31.55] vs. 37.4 [30.1-66.55] ng/mL, p = 0.006); the difference attenuated to a trend after its adjustment for patients' age (p = 0.056). HA levels and airway resistance were positively (r = 0.467, p = 0.004), HA levels and Asthma Control Test (ACT) total score inversely (r = -0.437, p = 0.01) associated in ANP patients; these relationships remained significant even after their adjustments for age. The potential value of HA in the determination of asthma control was analyzed using ROC analysis which revealed that HA values discriminate patients with ACT total score >= 20 (controlled patients) and <20 (uncontrolled patients) with a 0.826 efficacy (AUC, 95% CI: 0.69-0.97, p = 0.001) when 37.4 ng/mL is used as cut-off value in ANP group, and with 0.78 efficacy (AUC, 95% CI: 0.65-0.92, p = 0.0009) in the whole asthmatic cohort. In conclusion circulating HA might be a marker of asthma control, as it correlates with airway resistance and has good sensitivity in the detection of impaired asthma control. Decrease of HA level in pregnancy may be the consequence of pregnancy induced immune tolerance.	[Eszes, Noemi; Bohacs, Aniko; Ivancso, Istvan; Mueller, Veronika; Losonczy, Gyoergy; Tamasi, Lilla] Semmelweis Univ, Dept Pulmonol, H-1085 Budapest, Hungary; [Toldi, Gergely] Semmelweis Univ, Dept Pediat 1, H-1085 Budapest, Hungary; [Rigo, Janos, Jr.] Semmelweis Univ, Dept Obstet & Gynecol 1, H-1085 Budapest, Hungary; [Vasarhelyi, Barna] Semmelweis Univ, Dept Lab Med, H-1085 Budapest, Hungary; [Vasarhelyi, Barna] Hungarian Acad Sci, Res Grp Pediat & Nephrol, Budapest, Hungary	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences	Tamasi, L (corresponding author), Semmelweis Univ, Dept Pulmonol, H-1085 Budapest, Hungary.	tamasi@pulm.sote.hu	Toldi, Gergely/AAI-2620-2020	Toldi, Gergely/0000-0003-0178-1243; Muller, Veronika/0000-0002-1398-3187; Bohacs, Aniko/0000-0002-8229-4254	Hungarian Scientific Research Fund [OTKA] [K109008]; Hungarian Respiratory Society grant; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4. A/2-11-1-2012-0001]	Hungarian Scientific Research Fund [OTKA](Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Respiratory Society grant; European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF))	This work was supported by the Hungarian Scientific Research Fund [OTKA; grant number K109008 to G. L.; Web site: http://www.otka.hu/] and by a Hungarian Respiratory Society grant (to N. E.; Web site: http://www.tudogyogyasz.hu/). The research was also supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4. A/2-11-1-2012-0001 'National Excellence Program' (to G. T.; Web site: http://kih.gov.hu/nemzeti). G. T. is an International Society for the Advancement of Cytometry (ISAC) Scholar (Web site: http://isac-net.org/). The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond A, 2007, CELL MOL LIFE SCI, V64, P1591, DOI 10.1007/s00018-007-7032-z; Berg S, 2001, SCAND J CLIN LAB INV, V61, P131; Blackburn ST, 1992, MATERNAL FETAL NEONA, V171, p[160, 202, 222]; BOULET LP, 1995, AM J RESP CRIT CARE, V152, P865, DOI 10.1164/ajrccm.152.3.7663797; BOUSQUET J, 1991, J ALLERGY CLIN IMMUN, V88, P649, DOI 10.1016/0091-6749(91)90159-L; Breton MC, 2009, THORAX, V64, P101, DOI 10.1136/thx.2008.102970; Cordo-Russo R, 2009, PLACENTA, V30, P88, DOI 10.1016/j.placenta.2008.10.013; DaVeiga SP, 2009, ELEVATION HYALURONAN, V179, pA2852, DOI [10.1164/ajrccm-conference, DOI 10.1164/AJRCCM-CONFERENCE]; Demissie K, 1998, AM J RESP CRIT CARE, V158, P1091, DOI 10.1164/ajrccm.158.4.9802053; ENGSTROMLAURENT A, 1985, SCAND J CLIN LAB INV, V45, P497, DOI 10.3109/00365518509155249; Fuji Y, 2002, OCCUP ENVIRON MED, V59, P124, DOI 10.1136/oem.59.2.124; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; GROOTVELD M, 1991, BIOCHEM J, V273, P459, DOI 10.1042/bj2730459; Ivancso I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060697; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kobayashi H, 1999, OBSTET GYNECOL, V93, P480, DOI 10.1016/S0029-7844(98)00526-2; Kwon HL, 2003, ANN EPIDEMIOL, V13, P317, DOI 10.1016/S1047-2797(03)00008-5; LAURENT TC, 1987, ACTA OTO-LARYNGOL, P7; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; LINDQVIST U, 1992, SCAND J CLIN LAB INV, V52, P613, DOI 10.3109/00365519209115504; Louis R, 2000, AM J RESP CRIT CARE, V161, P9, DOI 10.1164/ajrccm.161.1.9802048; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Murphy VE, 2011, CLIN CHEST MED, V32, P93, DOI 10.1016/j.ccm.2010.10.001; Murphy VE, 2006, THORAX, V61, P169, DOI 10.1136/thx.2005.049718; Ohkawara Y, 2000, AM J RESP CELL MOL, V23, P444, DOI 10.1165/ajrcmb.23.4.3875; Olafsdottir IS, 2005, THORAX, V60, P451, DOI 10.1136/thx.2004.035774; Olczyk P, 2008, POSTEP HIG MED DOSW, V62, P651; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Schatz M, 1999, J ALLERGY CLIN IMMUN, V103, pS330, DOI 10.1016/S0091-6749(99)70258-7; Schatz M, 2010, J ASTHMA, V47, P46, DOI 10.3109/02770900903483758; Silvestri M, 2006, CLIN EXP ALLERGY, V36, P1373, DOI 10.1111/j.1365-2222.2006.02502.x; SODERBERG M, 1989, INT ARCH ALLER A IMM, V88, P373, DOI 10.1159/000234719; Sont JK, 1996, THORAX, V51, P496, DOI 10.1136/thx.51.5.496; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Takemura M, 2006, EUR RESPIR J, V27, P908, DOI 10.1183/09031936.06.00114405; Tamasi L, 2005, CLIN EXP ALLERGY, V35, P1197, DOI 10.1111/j.1365-2222.2005.02322.x; Tamasi L, 2011, RESP MED, V105, P159, DOI 10.1016/j.rmed.2010.11.006; Uzun H, 2010, HYPERTENS PREGNANCY, V29, P153, DOI 10.3109/10641950902968619; Vignola AM, 1998, AM J RESP CRIT CARE, V157, P403, DOI 10.1164/ajrccm.157.2.96-08040; Volbeda F, 2013, THORAX, V68, P19, DOI 10.1136/thoraxjnl-2012-201861; Wood LG, 2012, CHEST, V142, P86, DOI 10.1378/chest.11-1838; YOKOYAMA A, 1995, AM J RESP CRIT CARE, V151, P1354, DOI 10.1164/ajrccm.151.5.7735584	44	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94678	10.1371/journal.pone.0094678	http://dx.doi.org/10.1371/journal.pone.0094678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736408	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000336922600082
J	Lin, MY; Zhao, DJ; Hrabovsky, A; Pedrosa, E; Zheng, DY; Lachman, HM				Lin, Mingyan; Zhao, Dejian; Hrabovsky, Anastasia; Pedrosa, Erika; Zheng, Deyou; Lachman, Herbert M.			Heat Shock Alters the Expression of Schizophrenia and Autism Candidate Genes in an Induced Pluripotent Stem Cell Model of the Human Telencephalon	PLOS ONE			English	Article							MATERNAL IMMUNE ACTIVATION; CARDIO-FACIAL SYNDROME; NERVE GROWTH-FACTOR; GENOME-WIDE ASSOCIATION; COPY NUMBER VARIATIONS; PREFRONTAL CORTEX; NEUROTROPHIC FACTOR; VELOCARDIOFACIAL SYNDROME; DIFFERENTIAL EXPRESSION; SYNAPTIC-TRANSMISSION	Schizophrenia (SZ) and autism spectrum disorders (ASD) are highly heritable neuropsychiatric disorders, although environmental factors, such as maternal immune activation (MIA), play a role as well. Cytokines mediate the effects of MIA on neurogenesis and behavior in animal models. However, MIA stimulators can also induce a febrile reaction, which could have independent effects on neurogenesis through heat shock (HS)-regulated cellular stress pathways. However, this has not been well-studied. To help understand the role of fever in MIA, we used a recently described model of human brain development in which induced pluripotent stem cells (iPSCs) differentiate into 3-dimensional neuronal aggregates that resemble a first trimester telencephalon. RNA-seq was carried out on aggregates that were heat shocked at 39 degrees C for 24 hours, along with their control partners maintained at 37 degrees C. 186 genes showed significant differences in expression following HS (p<0.05), including known HS-inducible genes, as expected, as well as those coding for NGFR and a number of SZ and ASD candidates, including SMARCA2, DPP10, ARNT2, AHI1 and ZNF804A. The degree to which the expression of these genes decrease or increase during HS is similar to that found in copy loss and copy gain copy number variants (CNVs), although the effects of HS are likely to be transient. The dramatic effect on the expression of some SZ and ASD genes places HS, and perhaps other cellular stressors, into a common conceptual framework with disease-causing genetic variants. The findings also suggest that some candidate genes that are assumed to have a relatively limited impact on SZ and ASD pathogenesis based on a small number of positive genetic findings, such as SMARCA2 and ARNT2, may in fact have a much more substantial role in these disorders - as targets of common environmental stressors.	[Lin, Mingyan; Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Zhao, Dejian; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Hrabovsky, Anastasia; Pedrosa, Erika; Lachman, Herbert M.] Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Zheng, Deyou; Lachman, Herbert M.] Albert Einstein Coll Med, Dominick Purpura Dept Neurosci, Bronx, NY 10467 USA; [Lachman, Herbert M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Zheng, DY (corresponding author), Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA.	deyou.zheng@einstein.yu.edu; herb.lachman@einstein.yu.edu	Zhao, Dejian/C-8321-2009; lin, mingyan/HDL-9420-2022	Zhao, Dejian/0000-0002-2105-3799; Zheng, Deyou/0000-0003-4354-5337	National Institute of Mental Health [MH073164, MH097893, MH087840]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH097893, R21MH087840, R01MH073164, R33MH087840] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (MH073164, MH097893 and MH087840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN K, 2013, MOL PSYCHIATR, P18886, DOI DOI 10.1038/MP.2013.59;10.1038/MP.2013.59; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ARNOLD SE, 1995, AM J PSYCHIAT, V152, P738; Arrode-Bruses G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-83; Atladottir HO, 2012, PEDIATRICS, V130, pE1447, DOI 10.1542/peds.2012-1107; Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; BAUMAN MD, 2013, BIOL PSYCHIAT, P18886, DOI DOI 10.1016/J.BIOP-SYCH.2013.06.025; Beck IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069115; Benes FM, 2007, P NATL ACAD SCI USA, V104, P10164, DOI 10.1073/pnas.0703806104; Benes FM, 2011, NEUROPHARMACOLOGY, V60, P1232, DOI 10.1016/j.neuropharm.2010.12.011; Benes FM, 2008, P NATL ACAD SCI USA, V105, P20935, DOI 10.1073/pnas.0810153105; Bobkova NV, 2014, J ALZHEIMERS DIS, V38, P425, DOI 10.3233/JAD-130779; Boulanger LM, 2004, NEURON GLIA BIOL, V1, P283, DOI 10.1017/S1740925X05000128; Brennand KJ, 2012, DIS MODEL MECH, V5, P26, DOI 10.1242/dmm.008268; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Canetta SE, 2012, TRANSL NEUROSCI, V3, P320, DOI 10.2478/s13380-012-0045-6; Chaari A, 2013, INT J BIOL MACROMOL, V60, P196, DOI 10.1016/j.ijbiomac.2013.05.032; Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80; Chinnadurai S, 2012, CURR OPIN OTOLARYNGO, V20, P502, DOI 10.1097/MOO.0b013e328359b476; Corvin A, 2014, BIOL PSYCHIAT, V75, P276, DOI 10.1016/j.biopsych.2013.09.018; Curran LK, 2007, PEDIATRICS, V120, pE1386, DOI 10.1542/peds.2007-0360; Datson NA, 2013, ENDOCRINOLOGY, V154, P3261, DOI 10.1210/en.2012-2233; Deng MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016638; Derks EM, 2013, AM J MED GENET B, V162, P847, DOI 10.1002/ajmg.b.32189; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Dreha-Kulaczewski S, 2014, JIMD REP, V13, P91, DOI 10.1007/8904_2013_261; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; Ducharme G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029754; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El-Ansary A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-265; Evers M, 2002, MOL PSYCHIATR, V7, pS26, DOI 10.1038/sj.mp.4001171; Fan Y, 2011, NEUROSCIENCE, V192, P37, DOI 10.1016/j.neuroscience.2011.07.005; Fatemi SH, 2009, SCHIZOPHRENIA BULL, V35, P528, DOI 10.1093/schbul/sbn187; Fatjo-Vilas M, 2012, BIOL PSYCHIAT, V72, P758, DOI 10.1016/j.biopsych.2012.04.035; Fineberg AM, 2013, BIOL PSYCHIAT, V73, P951, DOI 10.1016/j.biopsych.2013.01.001; Gana S, 2011, CLIN DYSMORPHOL, V20, P38, DOI 10.1097/MCD.0b013e32833edaa9; Garbett KA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.24; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Gejman PV, 2010, PSYCHIAT CLIN N AM, V33, P35, DOI 10.1016/j.psc.2009.12.003; Georgiev D, 2014, AM J PSYCHIAT, V171, P62, DOI 10.1176/appi.ajp.2013.13040468; Ghanizadeh A, 2011, INT J HYPERTHER, V27, P737, DOI 10.3109/02656736.2011.604665; Giusti-Rodriguez P, 2013, J CLIN INVEST, V123, P4557, DOI 10.1172/JCI66031; Glessner JT, 2010, P NATL ACAD SCI USA, V107, P10584, DOI 10.1073/pnas.1000274107; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goshen I, 2009, FRONT NEUROENDOCRIN, V30, P30, DOI 10.1016/j.yfrne.2008.10.001; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Griswold AJ, 2012, HUM MOL GENET, V21, P3513, DOI 10.1093/hmg/dds164; Gruber HE, 2012, BIOTECH HISTOCHEM, V87, P506, DOI 10.3109/10520295.2012.703692; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hattori T, 2010, MOL PSYCHIATR, V15, P798, DOI 10.1038/mp.2010.60; Hirose T, 2014, MOL BIOL CELL, V25, P169, DOI 10.1091/mbc.E13-09-0558; Hotta H, 2009, NEUROSCI RES, V63, P122, DOI 10.1016/j.neures.2008.11.004; Houeland G, 2010, J NEUROSCI, V30, P13089, DOI 10.1523/JNEUROSCI.0457-10.2010; Hsiao EY, 2011, BRAIN BEHAV IMMUN, V25, P604, DOI 10.1016/j.bbi.2010.12.017; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Iderberg H, 2012, NEUROSCIENCE, V211, P13, DOI 10.1016/j.neuroscience.2012.03.023; Ingason A, 2011, AM J PSYCHIAT, V168, P408, DOI 10.1176/appi.ajp.2010.09111660; Ishima T, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.97; Jeffries AR, 2003, MOL PSYCHIATR, V8, P654, DOI 10.1038/sj.mp.4001382; Jodo E, 2013, J PHYSIOL-PARIS, V107, P434, DOI 10.1016/j.jphysparis.2013.06.002; Kahler AK, 2011, BIOL PSYCHIAT, V69, P90, DOI 10.1016/j.biopsych.2010.07.035; Kakiuchi C, 2005, BIOCHEM BIOPH RES CO, V336, P1136, DOI 10.1016/j.bbrc.2005.08.248; Kakiuchi C, 2007, J HUM GENET, V52, P794, DOI 10.1007/s10038-007-0188-4; Kates WR, 2007, AM J MED GENET A, V143A, P2642, DOI 10.1002/ajmg.a.32012; Kato T, 2007, PSYCHIAT CLIN NEUROS, V61, P3, DOI 10.1111/j.1440-1819.2007.01604.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim HG, 2013, BIOL PHARM BULL, V36, P1556, DOI 10.1248/bpb.b13-00268; Koga M, 2009, HUM MOL GENET, V18, P2483, DOI 10.1093/hmg/ddp166; Koizumi S, 2013, GENE, V522, P184, DOI 10.1016/j.gene.2013.03.090; Koo JW, 2009, NEUROSCI LETT, V456, P39, DOI 10.1016/j.neulet.2009.03.068; Kosho T, 2013, AM J MED GENET A, V161A, P1221, DOI 10.1002/ajmg.a.35933; Kowsky S, 2007, P NATL ACAD SCI USA, V104, P20049, DOI 10.1073/pnas.0706177104; Lakhotia SC, 2012, WIRES RNA, V3, P779, DOI 10.1002/wrna.1135; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; Lee YH, 2013, GENE, V525, P107, DOI 10.1016/j.gene.2013.04.014; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Lo-Castro A, 2009, NEUROPEDIATRICS, V40, P137, DOI 10.1055/s-0029-1237724; Loe-Mie Y, 2010, HUM MOL GENET, V19, P2841, DOI 10.1093/hmg/ddq184; Lotan A, 2014, MOL PSYCHIATR, V19, P243, DOI 10.1038/mp.2013.123; Lowe GC, 2008, AM J PHYSIOL-REG I, V295, pR1563, DOI 10.1152/ajpregu.90350.2008; Lu ATH, 2013, MOL PSYCHIATR, V18, P226, DOI 10.1038/mp.2011.155; Madziar B, 2008, J NEUROCHEM, V107, P1284, DOI 10.1111/j.1471-4159.2008.05681.x; Malaspina D, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-71; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martinez-Martinez Pilar, 2013, Frontiers in Genetics, V4, P181, DOI 10.3389/fgene.2013.00181; Martinotti G, 2012, J BIOL REG HOMEOS AG, V26, P347; McAllister AK, 2014, BIOL PSYCHIAT, V75, P262, DOI 10.1016/j.biopsych.2013.10.003; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; Mehler MF, 2009, BRAIN RES REV, V59, P388, DOI 10.1016/j.brainresrev.2008.11.001; Meyer U, 2009, NEUROSCI BIOBEHAV R, V33, P1061, DOI 10.1016/j.neubiorev.2009.05.001; Morcuende S, 2013, NEUROSCIENCE, V250, P31, DOI 10.1016/j.neuroscience.2013.06.050; Muralidharan S, 2013, J LEUKOCYTE BIOL, V94, P1167, DOI 10.1189/jlb.0313153; Murphy KC, 2001, BRIT J PSYCHIAT, V179, P397, DOI 10.1192/bjp.179.5.397; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Nihonmatsu-Kikuchi N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015886; Nilsberth C, 2009, ENDOCRINOLOGY, V150, P1850, DOI 10.1210/en.2008-0806; Numakawa T, 2013, NEUROSCIENCE, V239, P157, DOI 10.1016/j.neuroscience.2012.09.073; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Donovan MC, 2009, HUM GENET, V126, P3, DOI 10.1007/s00439-009-0703-0; Papolos DF, 1998, MOL PSYCHIATR, V3, P346, DOI 10.1038/sj.mp.4000410; Parker-Athill EC, 2010, NEUROSIGNALS, V18, P113, DOI 10.1159/000319828; Perez-Santiago J, 2012, J PSYCHIATR RES, V46, P1464, DOI 10.1016/j.jpsychires.2012.08.005; Pierce A, 2013, J NEUROCHEM, V124, P880, DOI 10.1111/jnc.12080; Pongrac JL, 2004, BIOL PSYCHIAT, V56, P943, DOI 10.1016/j.biopsych.2004.09.005; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Qin XY, 2011, TOXICOL LETT, V206, P152, DOI 10.1016/j.toxlet.2011.07.007; Ratnayake U, 2012, BRAIN BEHAV IMMUN, V26, P1288, DOI 10.1016/j.bbi.2012.08.011; Read DE, 2008, BRAIN RES, V1221, P14, DOI 10.1016/j.brainres.2008.05.028; Richetto J, 2014, SCHIZOPHRENIA BULL, V40, P351, DOI 10.1093/schbul/sbs195; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rivero O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012254; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Roumier A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002595; Sanders AR, 2013, HUM MOL GENET, V22, P5001, DOI 10.1093/hmg/ddt350; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; Schaevitz LR, 2010, PHYSIOL BEHAV, V100, P255, DOI 10.1016/j.physbeh.2009.12.025; Schmunk Galina, 2013, Frontiers in Genetics, V4, P222, DOI 10.3389/fgene.2013.00222; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; SHPRINTZEN RJ, 1978, CLEFT PALATE J, V15, P56; SHPRINTZEN RJ, 1992, AM J MED GENET, V42, P141, DOI 10.1002/ajmg.1320420131; Silverman MN, 2012, ANN NY ACAD SCI, V1261, P55, DOI 10.1111/j.1749-6632.2012.06633.x; Sorensen HJ, 2009, SCHIZOPHRENIA BULL, V35, P631, DOI 10.1093/schbul/sbn121; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; Struber N, 2014, NEUROSCI BIOBEHAV R, V38, P17, DOI 10.1016/j.neubiorev.2013.10.015; Talkowski ME, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.028; Uenishi R, 2006, BIOCHEM BIOPH RES CO, V341, P1072, DOI 10.1016/j.bbrc.2006.01.066; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wei H, 2013, NEUROSCIENCE, V252, P320, DOI 10.1016/j.neuroscience.2013.08.025; Wei HG, 2012, BBA-MOL BASIS DIS, V1822, P831, DOI 10.1016/j.bbadis.2012.01.011; Wolstenholme JT, 2013, HORM BEHAV, V64, P833, DOI 10.1016/j.yhbeh.2013.09.007; Wolstenholme JT, 2012, ENDOCRINOLOGY, V153, P3828, DOI 10.1210/en.2012-1195; Wyrwoll CS, 2012, NEUROENDOCRINOLOGY, V95, P47, DOI 10.1159/000331345; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902; Yao JJ, 2013, AM J PHYSIOL-CELL PH, V305, pC197, DOI 10.1152/ajpcell.00041.2013; Yunoki T, 2013, CANCER LETT, V335, P52, DOI 10.1016/j.canlet.2013.01.049; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; ZERBO O, 2012, J AUTISM DEV DISORD, P18886, DOI DOI 10.1007/S10803-012-1540-X.; Zhao HP, 2012, ADV PHARMACOL, V64, P1, DOI 10.1016/B978-0-12-394816-8.00001-5	145	35	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94968	10.1371/journal.pone.0094968	http://dx.doi.org/10.1371/journal.pone.0094968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736721	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600115
J	Parkhomenko, TA; Doronin, VB; Castellazzi, M; Padroni, M; Pastore, M; Buneva, VN; Granieri, E; Nevinsky, GA				Parkhomenko, Taisiya A.; Doronin, Vasilii B.; Castellazzi, Massimiliano; Padroni, Marina; Pastore, Michela; Buneva, Valentina N.; Granieri, Enrico; Nevinsky, Georgy A.			Comparison of DNA-Hydrolyzing Antibodies from the Cerebrospinal Fluid and Serum of Patients with Multiple Sclerosis	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; ANTIIDIOTYPIC ANTIBODY; CATALYTIC HETEROGENEITY; AUTOIMMUNE; IGGS; AUTOANTIBODIES; DEGRADATION; AFFINITY; IGM	It was found that high-affinity anti-DNA antibodies were one of the major components of the intrathecal IgG response in multiple sclerosis (MS) patients [Williamson et al., PNAS, 2001]. Recently we have shown that IgGs from the sera of MS patients are active in the hydrolysis of DNA. Here we have shown, for the first time, that average concentration of total proteins (132-fold), total IgGs (194-fold) and anti-DNA antibodies (200-fold) in the sera is significantly higher than that in the cerebrospinal fluid (CSF) of fifteen MS patients. The relative activities of total protein from sera and CSFs varied remarkably from patient to patient. It was surprising that the specific DNase activity of the total protein of CSF reparations were 198-fold higher than the serum ones. Electrophoretically and immunologically homogeneous IgGs were obtained by sequential affinity chromatography of the CSF proteins on protein G-Sepharose and FPLC gel filtration. We present first evidence showing that IgGs from CSF not only bind but efficiently hydrolyze DNA and that average specific DNase activity of homogeneous antibodies from CSF is unpredictably similar to 49-fold higher than that from the sera of the same MS patients. Some possible reasons of these findings are discussed. We suggest that DNase IgGs of CSF may promote important neuropathologic mechanisms in this chronic inflammatory disorder and MS pathogenesis development.	[Parkhomenko, Taisiya A.; Buneva, Valentina N.; Nevinsky, Georgy A.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Div, Novosibirsk, Russia; [Doronin, Vasilii B.] Novosibirsk Med Univ, Minist Publ Hlth Russian Federat, Novosibirsk, Russia; [Castellazzi, Massimiliano; Padroni, Marina; Pastore, Michela; Granieri, Enrico] Univ Ferrara, Dept Neurol, Multiple Sclerosis Ctr, I-44100 Ferrara, Italy; [Buneva, Valentina N.; Nevinsky, Georgy A.] Novosibirsk State Univ, Novosibirsk 630090, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; University of Ferrara; Novosibirsk State University	Nevinsky, GA (corresponding author), Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Div, Novosibirsk, Russia.	nevinsky@niboch.nsc.ru	Castellazzi, Massimiliano/K-5083-2016; Buneva, Valentina Nikolaevna/I-6329-2012; Castellazzi, Massimiliano/X-3499-2019; Nevinsky, Georgy/E-6053-2012	Castellazzi, Massimiliano/0000-0001-6555-6075; Buneva, Valentina Nikolaevna/0000-0003-2556-979X; Castellazzi, Massimiliano/0000-0001-6555-6075; Granieri, Enrico/0000-0003-4038-3192; Padroni, Marina/0000-0001-8410-3039; Menzorova, Natalia/0000-0002-2616-7023	Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program, 6.2); Presidium of the Russian Academy of Sciences (Russian Foundation for Basic Research) [13-04-00208, 13-04-00205, 14-04-31281]; Siberian Division of the Russian Academy of Sciences; Regione Emilia Romagna, Italy (Ricerca Sanitaria Finalizzata)	Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program, 6.2); Presidium of the Russian Academy of Sciences (Russian Foundation for Basic Research)(Russian Academy of SciencesRussian Foundation for Basic Research (RFBR)); Siberian Division of the Russian Academy of Sciences(Russian Academy of Sciences); Regione Emilia Romagna, Italy (Ricerca Sanitaria Finalizzata)	This study was supported in part by grants from the Presidium of the Russian Academy of Sciences (Molecular and Cellular Biology Program, 6.2; Russian Foundation for Basic Research (13-04-00208, 13-04-00205, and 14-04-31281), funds from the Siberian Division of the Russian Academy of Sciences and funds from the Regione Emilia Romagna, Italy (Ricerca Sanitaria Finalizzata). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN O, 1993, J NEUROL, V240, P417, DOI 10.1007/BF00867354; Andryushkova AA, 2007, J CELL MOL MED, V11, P531, DOI 10.1111/j.1582-4934.2007.00048.x; Andryushkova AA, 2006, FEBS LETT, V580, P5089, DOI 10.1016/j.febslet.2006.08.036; Avalle B, 1998, APPL BIOCHEM BIOTECH, V75, P3; [Барановский А.Г. Baranovskii A.G.], 2008, [Российский иммунологический журнал, Russian Journal of Immunology, Rossiiskii immunologicheskii zhurnal], V2, P405; Baranovskii AG, 2001, IMMUNOL LETT, V76, P163, DOI 10.1016/S0165-2478(01)00185-7; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Boiko A N, 1995, Mol Biol (Mosk), V29, P727; David B.S., 2005, CATALYTIC ANTIBODIES, P1; Fainardi E, 2004, J NEUROL SCI, V217, P181, DOI 10.1016/j.jns.2003.09.012; FRIBOULET A, 1994, APPL BIOCHEM BIOTECH, V47, P229, DOI 10.1007/BF02787937; Gusev EI, 1997, MULTIPLE SCLEROSIS M, P1; Hu R, 1998, J BIOTECHNOL, V61, P109, DOI 10.1016/S0168-1656(98)00009-1; IKEHARA S, 1990, P NATL ACAD SCI USA, V87, P8341, DOI 10.1073/pnas.87.21.8341; IZADYAR L, 1993, P NATL ACAD SCI USA, V90, P8876, DOI 10.1073/pnas.90.19.8876; Kolesnikov AV, 2000, P NATL ACAD SCI USA, V97, P13526, DOI 10.1073/pnas.200360497; Kozyr AV, 1998, APPL BIOCHEM BIOTECH, V75, P45, DOI 10.1007/BF02787708; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Legostaeva GA, 2010, J CELL MOL MED, V14, P699, DOI 10.1111/j.1582-4934.2009.00738.x; Lerner R A, 1995, EXS, V73, P121; LERNER RA, 1987, TRENDS BIOCHEM SCI, V12, P427, DOI 10.1016/0968-0004(87)90208-8; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Martin AB, 1999, TRENDS BIOCHEM SCI, V24, pM24, DOI 10.1016/S0968-0004(99)01498-X; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Meinl E, 1999, CURR OPIN NEUROL, V12, P303, DOI 10.1097/00019052-199906000-00009; Nevinsky G.A., 2010, AUTOIMMUNE DIS SYMPT, P1; Nevinsky G.A., 2005, CATALYTIC ANTIBODIES, P503; Nevinsky GA, 2003, J CELL MOL MED, V7, P265, DOI 10.1111/j.1582-4934.2003.tb00227.x; Nevinsky GA, 2012, ADV NEUROIMMUNE BIOL, V3, P157, DOI 10.3233/NIB-2012-012042; O'Connor KC, 2001, J CLIN IMMUNOL, V21, P81, DOI 10.1023/A:1011064007686; Parkhomenko TA, 2010, J MOL RECOGNIT, V23, P486, DOI 10.1002/jmr.1016; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Pihlaja H, 2003, GENES IMMUN, V4, P138, DOI 10.1038/sj.gene.6363943; Polosukhina DI, 2006, IMMUNOL LETT, V103, P75, DOI 10.1016/j.imlet.2005.10.018; Polosukhina DI, 2005, MED SCI MONITOR, V11, pBR266; Polosukhina DI, 2004, J CELL MOL MED, V8, P359, DOI 10.1111/j.1582-4934.2004.tb00325.x; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; SALDEN HJM, 1988, CLIN CHEM, V34, P1594; Saveliev AN, 2003, IMMUNOL LETT, V86, P291, DOI 10.1016/S0165-2478(03)00042-7; SCHULTZ PG, 1995, SCIENCE, V269, P1835, DOI 10.1126/science.7569920; SHUSTER AM, 1992, SCIENCE, V256, P665, DOI 10.1126/science.1585181; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Stewart J D, 1993, Int Rev Immunol, V10, P229, DOI 10.3109/08830189309061698; Talbot PJ, 1996, ANN NEUROL, V39, P233, DOI 10.1002/ana.410390213; Williamson RA, 2001, P NATL ACAD SCI USA, V98, P1793, DOI 10.1073/pnas.031567598	45	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93001	10.1371/journal.pone.0093001	http://dx.doi.org/10.1371/journal.pone.0093001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736683	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600013
J	Li, YF; Chen, SJ; Zhang, XJ; Fu, Q; Zhang, ZY; Shi, SH; Zhu, YB; Gu, M; Peng, DX; Liu, XF				Li, Yanfang; Chen, Sujuan; Zhang, Xiaojian; Fu, Qiang; Zhang, Zhiye; Shi, Shaohua; Zhu, Yinbiao; Gu, Min; Peng, Daxin; Liu, Xiufan			A 20-Amino-Acid Deletion in the Neuraminidase Stalk and a Five-Amino-Acid Deletion in the NS1 Protein Both Contribute to the Pathogenicity of H5N1 Avian Influenza Viruses in Mallard Ducks	PLOS ONE			English	Article							ANTIVIRAL CYTOKINE RESPONSES; A VIRUS; INTERSPECIES TRANSMISSION; NONSTRUCTURAL GENE; PANDEMIC INFLUENZA; DOMESTIC POULTRY; WILD BIRDS; RIG-I; HEMAGGLUTININ; VIRULENCE	Since 2003, H5N1-subtype avian influenza viruses (AIVs) with both a deletion of 20 amino acids in the stalk of the neuraminidase (NA) glycoprotein (A-) and a deletion of five amino acids at positions 80 to 84 in the non-structural protein NS1 (S-) have become predominant. To understand the influence of these double deletions in the NA and NS1 proteins on the pathogenicity of H5N1-subtype AIVs, we selected A/mallard/Huadong/S/2005 as a parental strain to generate rescued wild-type A-S- and three variants (A-S+ with a five-amino-acid insertion in the NS1 protein, A+ S- with a 20-amino-acid insertion in the NA stalk, and A+ S+ with insertions in both NA and NS1 proteins) and evaluated their biological characteristics and virulence. The titers of the AIVs with A- and/or S- replicated in DEF cells were higher than that of A+ S+, and the A-S- virus exhibited a replication predominance when co-infected with the other variants in DEF cells. In addition, A-S- induced a more significant increase in the expression of immune-related genes in peripheral blood mononuclear cells of mallard ducks in vitro compared with the other variants. Furthermore, an insertion in the NA and/or NS1 proteins of AIVs resulted in a notable decrease in virulence in ducks, as determined by intravenous pathogenicity index, and the two insertions exerted a synergistic effect on the attenuation of pathogenicity in ducks. In addition, compared with A+ S+ and A+ S- the A-S+ and A-S- viruses that were introduced via the intranasal inoculation route exhibited a faster replication ability in the lungs of ducks. These data indicate that both the deletions in the NA stalk and the NS1 protein contribute to the high pathogenicity of H5N1 AIVs in ducks.	[Li, Yanfang; Chen, Sujuan; Zhang, Xiaojian; Fu, Qiang; Zhang, Zhiye; Shi, Shaohua; Zhu, Yinbiao; Gu, Min; Peng, Daxin; Liu, Xiufan] Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Importan, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Peng, DX (corresponding author), Yangzhou Univ, Jiangsu Coinnovat Ctr Prevent & Control Importan, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China.	daxinpeng@yahoo.com; xfliu@yzu.edu.cn	li, yan/GTI-4638-2022; Peng, Daxin/AAJ-3476-2021		Major National Basic Research Development Program (973 Program) [2011CB505003]; Jiangsu High School Natural Science Foundation [10KJA230055]; Important National Science & Technology Specific Projects [2012ZX10004214001002]; Special Fund for Agro-scientific Research in the Public Interest [20100312]; National High-Tech Research and Development Program of China [2011AA10A209]; Qing Lan Project; Priority Academic Program Development of Jiangsu Higher Education Institutions; Yangzhou University Funding for Scientific Research [2012CXJ081]	Major National Basic Research Development Program (973 Program); Jiangsu High School Natural Science Foundation; Important National Science & Technology Specific Projects; Special Fund for Agro-scientific Research in the Public Interest; National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Qing Lan Project(Jiangsu Polytech Institute); Priority Academic Program Development of Jiangsu Higher Education Institutions; Yangzhou University Funding for Scientific Research	This work was supported by the Major National Basic Research Development Program (973 Program) (grant number 2011CB505003), the Jiangsu High School Natural Science Foundation (10KJA230055), the Important National Science & Technology Specific Projects (2012ZX10004214001002), the Special Fund for Agro-scientific Research in the Public Interest (20100312), the National High-Tech Research and Development Program of China (2011AA10A209), the Qing Lan Project, and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions and the Yangzhou University Funding for Scientific Research (2012CXJ081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SC, 2009, MOL IMMUNOL, V46, P1744, DOI 10.1016/j.molimm.2009.01.025; Baigent SJ, 2001, VIRUS RES, V79, P177, DOI 10.1016/S0168-1702(01)00272-6; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Campitelli L, 2004, VIROLOGY, V323, P24, DOI 10.1016/j.virol.2004.02.015; CASTRUCCI MR, 1993, J VIROL, V67, P759, DOI 10.1128/JVI.67.2.759-764.1993; Chen S, 2013, J IMMUNOL, V191, P2614, DOI 10.4049/jimmunol.1203143; Croville G, 2012, J CLIN MICROBIOL, V50, P2881, DOI 10.1128/JCM.01142-12; Edwards S, 2006, DEV BIOLOGICALS, V124, P159; Egorov A, 1998, J VIROL, V72, P6437, DOI 10.1128/JVI.72.8.6437-6441.1998; ELS MC, 1985, VIROLOGY, V142, P241, DOI 10.1016/0042-6822(85)90332-0; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Giannecchini S, 2006, J GEN VIROL, V87, P171, DOI 10.1099/vir.0.81187-0; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; INGLIS SC, 1979, P NATL ACAD SCI USA, V76, P3790, DOI 10.1073/pnas.76.8.3790; Killian Mary Lea, 2008, V436, P47, DOI 10.1007/978-1-59745-279-3_7; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Lee CW, 2008, J VIROL METHODS, V153, P22, DOI 10.1016/j.jviromet.2008.06.019; Li JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014722; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Liang QL, 2011, MOL IMMUNOL, V48, P924, DOI 10.1016/j.molimm.2010.12.011; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long Jin-xue, 2006, Weishengwu Xuebao, V46, P301; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Luo G, 1993, Virus Res, V29, P321; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Matsuoka Y, 2009, J VIROL, V83, P4704, DOI 10.1128/JVI.01987-08; Munier S, 2010, J VIROL, V84, P940, DOI 10.1128/JVI.01581-09; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; REED L. J., 1938, AMER JOUR HYG, V27, P493; Seo SH, 2004, VIRUS RES, V103, P107, DOI 10.1016/j.virusres.2004.02.022; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Seo SH, 2001, J VIROL, V75, P9517, DOI 10.1128/JVI.75.19.9517-9525.2001; Shi HY, 2007, VACCINE, V25, P7379, DOI 10.1016/j.vaccine.2007.08.011; Sutejo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033732; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Tang Ying-hua, 2008, Chinese Journal of Virology, V24, P340; Yamada S, 2012, J VIROL, V86, P1411, DOI 10.1128/JVI.06100-11; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang WJ, 2011, VACCINE, V29, P8032, DOI 10.1016/j.vaccine.2011.08.054; Zhou HB, 2006, VIRUS GENES, V32, P85, DOI 10.1007/s11262-005-5849-9; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277; Zhou JY, 2009, J VIROL, V83, P8957, DOI 10.1128/JVI.00793-09; Zhu QY, 2008, J VIROL, V82, P220, DOI 10.1128/JVI.00978-07	54	22	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95539	10.1371/journal.pone.0095539	http://dx.doi.org/10.1371/journal.pone.0095539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743258	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100135
J	Liu, SN; Xu, RC; Gerin, I; Cawthorn, WP; MacDougald, OA; Chen, XW; Saltiel, AR; Koenig, RJ; Xu, B				Liu, Shannon; Xu, Ruichuan; Gerin, Isabelle; Cawthorn, William P.; MacDougald, Ormond A.; Chen, Xiao-Wei; Saltiel, Alan R.; Koenig, Ronald J.; Xu, Bin			SRA Regulates Adipogenesis by Modulating p38/JNK Phosphorylation and Stimulating Insulin Receptor Gene Expression and Downstream Signaling	PLOS ONE			English	Article							RNA ACTIVATOR SRA; ADIPOCYTE DIFFERENTIATION; MUSCLE DIFFERENTIATION; PROTEIN SRAP; RESISTANCE; KINASE; GLUCOSE; BINDING; CELLS; MICE	The Steroid Receptor RNA Activator (SRA) enhances adipogenesis and increases both glucose uptake and phosphorylation of Akt and FOXO1 in response to insulin. To assess the mechanism, we differentiated ST2 mesenchymal precursor cells that did or did not overexpress SRA into adipocytes using combinations of methylisobutylxanthine, dexamethasone and insulin. These studies showed that SRA overexpression promotes full adipogenesis in part by stimulation of insulin/insulin-like growth factor-1 (IGF-1) signaling. SRA overexpression inhibited phosphorylation of p38 mitogen activated protein kinase (MAPK) and c-Jun NH2-terminal kinase (JNK) in the early differentiation of ST2 cells. Conversely, knockdown of endogenous SRA in 3T3-L1 cells increased phosphorylation of JNK. Knockdown of SRA in mature 3T3-L1 adipocytes reduced insulin receptor (IR) mRNA and protein levels, which led to decreased autophosphorylation of IR beta and decreased phosphorylation of insulin receptor substrate-1 (IRS-1) and Akt. This likely reflects a stimulatory role of SRA on IR transcription, as transfection studies showed that SRA increased expression of an IR promoter-luciferase reporter construct.	[Liu, Shannon; Xu, Ruichuan; MacDougald, Ormond A.; Koenig, Ronald J.; Xu, Bin] Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Gerin, Isabelle; Cawthorn, William P.; MacDougald, Ormond A.] Univ Michigan, Med Ctr, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Chen, Xiao-Wei; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Saltiel, Alan R.] Univ Michigan, Med Ctr, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, B (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	bxu@umich.edu	Chen, Xiaowei/F-7026-2014; Saltiel, Alan/L-3632-2019; Cawthorn, William P./Y-2115-2019	Cawthorn, William P./0000-0001-7832-5057; Saltiel, Alan/0000-0002-9726-9828; Chen, Xiao-Wei/0000-0001-6466-6248; MacDougald, Ormond/0000-0001-6907-7960	Pilot and Feasibility Grant; Cell and Molecular Biology Core of the Michigan Diabetes Research and Training Center (NIH) [5P60-DK020572]; NIH [DK062876]; Belgian Funds National de la Recherche Scientifique; University of Michigan Training Program in Organogenesis [T32HD007505]; Royal Commission for the Exhibition of 1851 (United Kingdom); Eli Lilly Innovation Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, P60DK020572, R01DK062876, R56DK062876] Funding Source: NIH RePORTER	Pilot and Feasibility Grant; Cell and Molecular Biology Core of the Michigan Diabetes Research and Training Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian Funds National de la Recherche Scientifique; University of Michigan Training Program in Organogenesis(University of Michigan System); Royal Commission for the Exhibition of 1851 (United Kingdom); Eli Lilly Innovation Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by a Pilot and Feasibility Grant and the Cell and Molecular Biology Core of the Michigan Diabetes Research and Training Center (NIH Grant 5P60-DK020572) (B.X.), and NIH grant DK062876 to O.A.M. I.G. was supported by postdoctoral fellowships from the Belgian Funds National de la Recherche Scientifique and the University of Michigan Training Program in Organogenesis (T32HD007505). W.P.C. was supported by a postdoctoral fellowship from the Royal Commission for the Exhibition of 1851 (United Kingdom) and an Eli Lilly Innovation Fellowship Awarded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Aouadi M, 2006, DIABETES, V55, P281, DOI 10.2337/diabetes.55.02.06.db05-0963; Arner P, 2005, DIABETOLOGIA, V48, P2203, DOI 10.1007/s00125-005-1956-3; BENITO M, 1991, SCIENCE, V253, P565, DOI 10.1126/science.1857988; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Choo MK, 2006, MOL CANCER THER, V5, P2970, DOI 10.1158/1535-7163.MCT-06-0379; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; CRETTAZ M, 1980, METABOLISM, V29, P467, DOI 10.1016/0026-0495(80)90172-9; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Ding J, 2003, BIOSCI BIOTECH BIOCH, V67, P314, DOI 10.1271/bbb.67.314; Emberley E, 2003, BIOCHEM BIOPH RES CO, V301, P509, DOI 10.1016/S0006-291X(02)03070-X; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; HARRISON LC, 1976, J CLIN INVEST, V58, P1435, DOI 10.1172/JCI108599; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hube F, 2011, NUCLEIC ACIDS RES, V39, P513, DOI 10.1093/nar/gkq833; KAHN CR, 1980, METABOLISM, V29, P455, DOI 10.1016/0026-0495(80)90171-7; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kawashima H, 2003, BIOCHEM J, V369, P163, DOI 10.1042/BJ20020743; KLETZIEN RF, 1992, MOL PHARMACOL, V41, P393; Lanz RB, 2003, MOL CELL BIOL, V23, P7163, DOI 10.1128/MCB.23.20.7163-7176.2003; Lanz RB, 2002, P NATL ACAD SCI USA, V99, P16081, DOI 10.1073/pnas.192571399; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Li Y, 2002, MOL ENDOCRINOL, V16, P1040, DOI 10.1210/me.16.5.1040; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Singh R, 2013, CELL METAB, V17, P197, DOI 10.1016/j.cmet.2013.01.009; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Wiltshire C, 2002, BIOCHEM J, V367, P577, DOI 10.1042/BJ20020553; Xu B, 2004, J BIOL CHEM, V279, P33051, DOI 10.1074/jbc.M404930200; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Xu B, 2009, MOL CELL BIOL, V29, P1719, DOI 10.1128/MCB.01010-08; Yan Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2359; Youngren JF, 2007, CELL MOL LIFE SCI, V64, P873, DOI 10.1007/s00018-007-6359-9; Zhang HH, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006189, 10.1371/journal.pone.0007826]; Zhao XS, 2004, MOL CELL, V15, P549, DOI 10.1016/j.molcel.2004.06.044	49	38	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95416	10.1371/journal.pone.0095416	http://dx.doi.org/10.1371/journal.pone.0095416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743795	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100117
J	Guidetti, P; Baiata, P; Ballesteros, E; Di Franco, A; Hereu, B; Macpherson, E; Micheli, F; Pais, A; Panzalis, P; Rosenberg, AA; Zabala, M; Sala, E				Guidetti, Paolo; Baiata, Pasquale; Ballesteros, Enric; Di Franco, Antonio; Hereu, Bernat; Macpherson, Enrique; Micheli, Fiorenza; Pais, Antonio; Panzalis, Pieraugusto; Rosenberg, Andrew A.; Zabala, Mikel; Sala, Enric			Large-Scale Assessment of Mediterranean Marine Protected Areas Effects on Fish Assemblages	PLOS ONE			English	Article							SPECIES RICHNESS; TROPHIC CASCADES; RESERVES; SEA; FRAMEWORK; BIOMASS; SIZE; HETEROGENEITY; NORTHWESTERN; TRAJECTORIES	Marine protected areas (MPAs) were acknowledged globally as effective tools to mitigate the threats to oceans caused by fishing. Several studies assessed the effectiveness of individual MPAs in protecting fish assemblages, but regional assessments of multiple MPAs are scarce. Moreover, empirical evidence on the role of MPAs in contrasting the propagation of non-indigenous-species (NIS) and thermophilic species (ThS) is missing. We simultaneously investigated here the role of MPAs in reversing the effects of overfishing and in limiting the spread of NIS and ThS. The Mediterranean Sea was selected as study area as it is a region where 1) MPAs are numerous, 2) fishing has affected species and ecosystems, and 3) the arrival of NIS and the northward expansion of ThS took place. Fish surveys were done in well-enforced no-take MPAs (HP), partially-protected MPAs (IP) and fished areas (F) at 30 locations across the Mediterranean. Significantly higher fish biomass was found in HP compared to IP MPAs and F. Along a recovery trajectory from F to HP MPAs, IP were similar to F, showing that just well enforced MPAs triggers an effective recovery. Within HP MPAs, trophic structure of fish assemblages resembled a top-heavy biomass pyramid. Although the functional structure of fish assemblages was consistent among HP MPAs, species driving the recovery in HP MPAs differed among locations: this suggests that the recovery trajectories in HP MPAs are likely to be functionally similar (i.e., represented by predictable changes in trophic groups, especially fish predators), but the specific composition of the resulting assemblages may depend on local conditions. Our study did not show any effect of MPAs on NIS and ThS. These results may help provide more robust expectations, at proper regional scale, about the effects of new MPAs that may be established in the Mediterranean Sea and other ecoregions worldwide.	[Guidetti, Paolo; Baiata, Pasquale; Di Franco, Antonio] Univ Nice Sophia Antipolis, Fac Sci, EA ECOMERS 4228, F-06189 Nice, France; [Guidetti, Paolo; Di Franco, Antonio] CoNISMa, Rome, Italy; [Ballesteros, Enric; Macpherson, Enrique; Sala, Enric] CEAB CSIC, Ctr Estudis Avancats Blanes, Acces Cala St France, Blanes, Spain; [Hereu, Bernat; Zabala, Mikel] Univ Barcelona, Dept Ecol, E-08028 Barcelona, Spain; [Micheli, Fiorenza] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Pais, Antonio] Univ Sassari, Lab Acquacoltura & Gest Risorse Acquat, Sez Sci Zootecn, Dipartimento Agraria, I-07100 Sassari, Italy; [Panzalis, Pieraugusto] Marine Protected Area Tavolara Punta Coda Cavallo, Olbia, Italy; [Rosenberg, Andrew A.] Union Concerned Scientists, Cambridge, MA USA; [Sala, Enric] Natl Geog Soc, Washington, DC USA	UDICE-French Research Universities; Universite Cote d'Azur; CoNISMa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of Barcelona; Stanford University; University of Sassari; National Geographic Society	Guidetti, P (corresponding author), Univ Nice Sophia Antipolis, Fac Sci, EA ECOMERS 4228, F-06189 Nice, France.	guidetti@unice.fr	Hereu, Bernat/K-9150-2015; Pais, Antonio/D-2209-2012; Zabala, Mikel/AAE-8977-2021; Macpherson, Enrique/J-8982-2012; Di Franco, Antonio/A-8796-2010	Hereu, Bernat/0000-0001-6247-7638; Pais, Antonio/0000-0003-4370-8423; Macpherson, Enrique/0000-0003-4849-4532; Micheli, Fiorenza/0000-0002-6865-1438; Di Franco, Antonio/0000-0003-3411-7015; Guidetti, Paolo/0000-0002-7983-8775	Oak Foundation; Pew Charitable Trusts; Spain's National Council for Scientific Research (CSIC); Lenfest Ocean Program	Oak Foundation; Pew Charitable Trusts; Spain's National Council for Scientific Research (CSIC); Lenfest Ocean Program	This study was funded by the Oak Foundation, the Pew Charitable Trusts, Spain's National Council for Scientific Research (CSIC) and the Lenfest Ocean Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023601; Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Azzurro Ernesto, 2008, CIESM Workshop Monographs, V35, P39; BETHOUX JP, 1990, NATURE, V347, P660, DOI 10.1038/347660a0; Bulleri F, 2008, PLOS BIOL, V6, P1136, DOI 10.1371/journal.pbio.0060162; Burfeind DD, 2013, BIOL INVASIONS, V15, P17, DOI 10.1007/s10530-012-0265-2; Byers JE, 2003, ECOLOGY, V84, P1428, DOI 10.1890/02-3131; Clarke K., 2015, GETTING STARTED PRIM, V91, P192; Claudet J, 2006, BIOL CONSERV, V130, P349, DOI 10.1016/j.biocon.2005.12.030; Claudet J., 2011, ECOLOGY BIODIVERSITY; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Coll J, 2013, ICES J MAR SCI, V70, P578, DOI 10.1093/icesjms/fst025; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Di Franco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052108; Di Franco A, 2009, MAR ECOL PROG SER, V387, P275, DOI 10.3354/meps08051; Diaz-Almela E, 2007, GLOBAL CHANGE BIOL, V13, P224, DOI 10.1111/j.1365-2486.2006.01260.x; Fenberg PB, 2012, MAR POLICY, V36, P1012, DOI 10.1016/j.marpol.2012.02.021; Francour Patrice, 2010, P127; Fridley JD, 2007, ECOLOGY, V88, P3, DOI 10.1890/0012-9658(2007)88[3:TIPRPA]2.0.CO;2; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Galil BS, 2007, MAR POLLUT BULL, V55, P314, DOI 10.1016/j.marpolbul.2006.11.008; Galil B.S., 2000, BIOL INVASIONS, V2, P77; Garcia-Charton JA, 1999, FISH RES, V42, P1; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; GARCIA-RUBIES A, 1990, Scientia Marina, V54, P317; Garcia-Rubies A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073922; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2007, MAR ECOL PROG SER, V335, P43, DOI 10.3354/meps335043; Guidetti P, 2011, FRONT ECOL ENVIRON, V9, P374, DOI 10.1890/11.WB.019; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HARMELIN-VIVIEN M L, 1985, Revue d'Ecologie la Terre et la Vie, V40, P467; Harmelin-Vivien M, 2008, BIOL CONSERV, V141, P1829, DOI 10.1016/j.biocon.2008.04.029; Hiddink JG, 2008, GLOBAL CHANGE BIOL, V14, P453, DOI 10.1111/j.1365-2486.2007.01518.x; Hiddink JG, 2012, GLOBAL CHANGE BIOL, V18, P2161, DOI 10.1111/j.1365-2486.2012.02698.x; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kellner JB, 2010, ECOL APPL, V20, P1979, DOI 10.1890/09-1217.1; Klinger T, 2006, AQUAT CONSERV, V16, P301, DOI 10.1002/aqc.717; Lasram FB, 2010, GLOBAL CHANGE BIOL, V16, P3233, DOI 10.1111/j.1365-2486.2010.02224.x; Lasram FB, 2009, MAR ECOL PROG SER, V376, P253, DOI 10.3354/meps07786; Lasram FB, 2009, BIOL INVASIONS, V11, P697, DOI 10.1007/s10530-008-9284-4; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Maynou F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021818; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Micheli F, 2005, ECOL MONOGR, V75, P81, DOI 10.1890/03-4058; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Morey G, 2003, FISH RES, V62, P89, DOI 10.1016/S0165-7836(02)00250-3; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Occhipinti-Ambrogi A, 2003, MAR POLLUT BULL, V46, P542, DOI 10.1016/S0025-326X(02)00363-6; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Puig P, 2012, NATURE, V489, P286, DOI 10.1038/nature11410; Quignard J.P., 2000, Biologia Marina Mediterranea, V7, P1; Sala E, 1998, OIKOS, V82, P425, DOI 10.2307/3546364; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Sala E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032742; Sala E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017356; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; ter Hofstede R, 2010, MAR ECOL PROG SER, V414, P1, DOI 10.3354/meps08753; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Trebilco R, 2013, TRENDS ECOL EVOL, V28, P423, DOI 10.1016/j.tree.2013.03.008; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zenetos A, 2012, MEDITERR MAR SCI, V13, P328, DOI 10.12681/mms.327; Zenetos A, 2010, MEDITERR MAR SCI, V11, P381, DOI 10.12681/mms.87	68	129	130	3	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e91841	10.1371/journal.pone.0091841	http://dx.doi.org/10.1371/journal.pone.0091841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740479	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900008
J	Lagueux, CJ; Campbell, CL; Strindberg, S				Lagueux, Cynthia J.; Campbell, Cathi L.; Strindberg, Samantha			Artisanal Green Turtle, Chelonia mydas, Fishery of Caribbean Nicaragua: I. Catch Rates and Trends, 1991-2011	PLOS ONE			English	Article							SURVIVAL PROBABILITY; MARINE TURTLES; CONSERVATION; POPULATION; TORTUGUERO; MIGRATION; ECOLOGY; MANAGEMENT; CONFLICT; MATURITY	This is the first assessment of catch rates for the legal, artisanal green turtle, Chelonia mydas, fishery in Caribbean Nicaragua. Data were collected by community members, monitoring up to 14 landing sites from 1991 to 2011. We examined take levels, and temporal and spatial variability in catch rates for the overall fishery, by region, and community using General Additive Mixed Models (GAMMs). More than 171,556 green turtles were killed during the period, with a mean estimated minimum 8,169 +/- 2,182 annually. There was a statistically significant decline in catch rates overall. Catch rates peaked in 1997 and 2002, followed by a downward trend, particularly from mid-2008 to the end of the study period. Similar downward trends were evident in both study regions. Community specific catch rate trends also indicated declines with decreases ranging from 21% to 90%. Decrease in catch rates in Nicaragua is cause for concern even though the principal source rookery at Tortuguero, Costa Rica, shows an increase in nesting activity. Explanations for the apparent discrepancy between the increasing trend at Tortuguero and decreasing catch rate trends in Nicaragua include: i) an increase in reproductive output, ii) insufficient time has passed to observe the impact of the fishery on the rookery due to a time lag, iii) changes in other segments of the population have not been detected since only nesting activity is monitored, iv) the expansive northern Nicaragua foraging ground may provide a refuge for a sufficient portion of the Tortuguero rookery, and/or v) a larger than expected contribution of non-Tortuguero rookeries occurring in Nicaragua turtle fishing areas. Our results highlight the need for close monitoring of rookeries and in-water aggregations in the Caribbean. Where consumptive use still occurs, nations sharing this resource should implement scientifically based limits on exploitation to ensure sustainability and mitigate impacts to regional population diversity.	[Lagueux, Cynthia J.; Campbell, Cathi L.; Strindberg, Samantha] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY USA	Wildlife Conservation Society	Lagueux, CJ (corresponding author), Univ Florida, Dept Biol, Archie Carr Ctr Sea Turtle Res, Gainesville, FL 32611 USA.	cjlagueux@gmail.com			Chelonian Research Institute; Inter-American Foundation; Sea Turtle Conservancy; Sigma Xi; Nature Conservancy, HQ Stew [6-20-93-5]; National Marine Fisheries Service; United States Fish and Wildlife Service	Chelonian Research Institute; Inter-American Foundation; Sea Turtle Conservancy; Sigma Xi; Nature Conservancy, HQ Stew; National Marine Fisheries Service; United States Fish and Wildlife Service(US Fish & Wildlife Service)	Funding was provided to CJL by the Chelonian Research Institute (www.chelonianri.org), Inter-American Foundation (www.iaf.gov), Sea Turtle Conservancy (formerly the Caribbean Conservation Corporation) (www.conserveturtles.org), Sigma Xi (www.sigmaxi.org), and The Nature Conservancy, HQ Stew 6-20-93-5) (www.nature.org). Funding was provided to WCS by the National Marine Fisheries Service (www.nmfs.noaa.gov/pr), United States Fish and Wildlife Service (www.fws.gov/endangered), and by a foundation that wishes to remain anonymous. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu-Grobois FA, 2005, MEMORIAS TALLER RUMB; [Anonymous], DIVERS DISTRIB; Bagley D.A., 2003, THESIS U CENTRAL FLO; Balazs GH, 2004, BIOL CONSERV, V117, P491, DOI 10.1016/j.biocon.2003.08.008; Bass AL, 1998, COPEIA, P1064; Beggs Jennifer A., 2007, Endangered Species Research, V3, P159, DOI 10.3354/esr003159; Bell Catherine D., 2006, Endangered Species Research, V2, P63, DOI 10.3354/esr002063; Bell CDL, 2005, ORYX, V39, P137, DOI 10.1017/S0030605305000372; Bell CN, 1899, TANGWEERA LIFE ADVEN; Bjorndal KA, 1999, CONSERV BIOL, V13, P126, DOI 10.1046/j.1523-1739.1999.97329.x; Bjorndal KA, 2005, ECOL APPL, V15, P304, DOI 10.1890/04-0059; Bjorndal KA, 2000, ECOL APPL, V10, P269, DOI 10.1890/1051-0761(2000)010[0269:GTSGME]2.0.CO;2; Bjorndal KA, 2003, MAR ECOL PROG SER, V252, P273, DOI 10.3354/meps252273; BJORNDAL KA, 1980, MAR BIOL, V56, P147, DOI 10.1007/BF00397131; Blumenthal J.M., 2006, ENDANGER SPECIES RES, V2, P51, DOI [DOI 10.3354/ESR00044, 10.3354/esr002051]; Bowen BW, 2007, MOL ECOL, V16, P49, DOI 10.1111/j.1365-294X.2006.03096.x; Bowen B.W., 1997, BIOL SEA TURTLES, P29; Bowen Brian W., 1996, P190; Brautigam A., 2006, TURNING TIDE EXPLOIT; Bresette Michael J., 2010, Endangered Species Research, V9, P105, DOI 10.3354/esr00245; Broderick AC, 2006, GLOBAL ECOL BIOGEOGR, V15, P21, DOI 10.1111/j.1466-822x.2006.00195.x; Campbell CB, 2003, THESIS U FLORIDA GAI; Campell CL, 2005, HERPETOLOGICA, V61, P91, DOI 10.1655/04-26; Carlson L.A., 1999, NMFSSEFC91 NOAA; Carr A, 1969, P WORK M MAR TURTL S, P13; Carr A, 1978, B AM MUS NAT HIST, V162, P46; Cato JC, 1978, ANAL CAPTURE MARKETI; Ceballos-Fonseca Claudia, 2004, Bol. Invest. Mar. Cost., V33, P79; Chaloupka M, 2005, MAR BIOL, V146, P1251, DOI 10.1007/s00227-004-1512-6; Chaloupka M, 2001, BIOL CONSERV, V101, P263, DOI 10.1016/S0006-3207(00)00199-3; Chaloupka M, 2008, GLOBAL ECOL BIOGEOGR, V17, P297, DOI 10.1111/j.1466-8238.2007.00367.x; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; Crouse DT, 1999, AM FISH S S, V23, P195; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; Dampier William., 1906, DAMPIERS VOYAGES, V1; Exquemelin AlexanderO., 1969, BUCCANEERS AM; Fleming EH, 2001, SWIMMING TIDE RECENT; GODLEY BJ, 2004, ASSESSMENT STATUS EX; Grazette S, 2007, ORYX, V41, P330, DOI 10.1017/S0030605307000613; Helms Mary W., 1971, ASANG ADAPTATIONS CU; Hemley G., 1994, INT WILDLIFE TRADE C; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Heppell SS, 1999, AM FISH S S, V23, P137; IAC Secretariat (compiler), 2010, REG WORKSH HAWKSB TU; INGLE RM, 1949, SEA TURTLES TURTLE I; IUCN, 2002, CITES WID CAR RANG S; IUCN, 2001, 1 CITES WID CAR RANG; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jackson JBC, 1997, CORAL REEFS, V16, pS23, DOI 10.1007/s003380050238; King F. W., 1982, BIOL CONSERVATION SE, P183; Koch V, 2007, MAR BIOL, V153, P35, DOI 10.1007/s00227-007-0782-1; Lagueux C., 2005, MANAGEMENT STRATEGY; Lagueux CJ, 2005, ORYX, V39, P398, DOI 10.1017/S0030605305001067; Lagueux CJ, 1998, THESIS U FLORIDA GAI; Lagueux CJ, 2012, CONSERVATION MONITOR; Lagueux Cynthia J., 2003, Chelonian Conservation and Biology, V4, P588; Lahanas PN, 1998, MAR BIOL, V130, P345, DOI 10.1007/s002270050254; Lewis C. B., 1940, B I JAMAICA SCI SERI, V2, P56; Lima Eduardo H.S.M., 2003, Marine Turtle Newsletter, V101, P27; Lima Eduardo H.S.M., 1999, Marine Turtle Newsletter, V85, P10; Meylan AB., 1982, BIOL CONSERVATION SE, P91; Meylan PA, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/357.1; Moncada F, 2006, J HERPETOL, V40, P22, DOI 10.1670/39-05A.1; Montenegro Jimenez JM, 1992, TORTUGA VERDE UNPUB; MORTIMER JA, 1981, BIOTROPICA, V13, P49, DOI 10.2307/2387870; Musick JA, 1999, AM FISH S S, V23, P1; Musick John A., 1997, P137; National Marine Fisheries Service U.S. Fish and Wildlife Service and SEMARNAT, 2011, BIN REC PLAN KEMPS R; NIETSCHMANN B, 1979, GEOGR REV, V69, P1, DOI 10.2307/214234; NIETSCHMANN B, 1972, HUM ECOL, V1, P41, DOI 10.1007/BF01791280; NIETSCHMANN B, 1990, NAT HIST, P42; Nietschmann B, 1989, UNKNOWN WAR MISKITOS; Nietschmann B., 1995, MESOAMERICA, V29, P1; Nietschmann B, 1979, CARIBBEAN EDGE COMIN; Nietschmann B. Q., 1973, SAGE J, V39, P844; Parsons J, 1962, GREEN TURTLE MAN; Patricio AR, 2011, MAR ECOL PROG SER, V440, P217, DOI 10.3354/meps09337; Pinheiro J, 2001, MIXED EFFECTS MODELS; Piniak Wendy E. Dow, 2011, Endangered Species Research, V15, P129, DOI 10.3354/esr00375; Prieto C. G., 2012, REPORT 2011 GREEN TU; R Development Core Team, 2012, R LANG ENV STAT COMP; Rainey WE, 1972, DISTRIBUTION MANAGEM; Richardson P.B., 2006, Journal of International Wildlife Law and Policy, V9, P223, DOI 10.1080/13880290600764935; Richardson PB, 2009, CHELONIAN CONSERV BI, V8, P192, DOI 10.2744/CCB-0871.1; Rincón-Díaz Martha Patricia, 2004, Bol. Invest. Mar. Cost., V33, P137; Roberts OW, 1965, NARRATIVE VOYAGES EX; Seminoff JA, 2003, J MAR BIOL ASSOC UK, V83, P1355, DOI 10.1017/S0025315403008816; Seminoff JA, 2004, 2004 GLOBAL STATUS A; Sole Genaro, 1994, NOAA Technical Memorandum NMFS-SEFSC, V351, P283; Solow AR, 2002, ECOL LETT, V5, P742, DOI 10.1046/j.1461-0248.2002.00374.x; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Squier EG, 1855, WAIKNA ADVENTURES MO; Stevens K, 2011, BIODIVERS CONSERV, V20, P2597, DOI 10.1007/s10531-011-0093-1; Stringell TB, 2013, OCEAN COAST MANAGE, V82, P34, DOI 10.1016/j.ocecoaman.2013.05.004; Troeng S, 2005, MAR BIOL, V148, P435, DOI 10.1007/s00227-005-0076-4; Troeng S, 2005, BIOL CONSERV, V121, P111, DOI 10.1016/j.biocon.2004.04.014; Troeng S, 2007, MAR BIOL, V151, P1721, DOI 10.1007/s00227-007-0611-6; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Weiss B, 1976, SERIE GEOGRAFIA NATU, V2, P161, DOI Banco de America; Weiss B, 1975, SELLING SUBSISTENCE; Weiss B, 1980, CONT APPROACHES DIET, P147; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Young Thomas, 1842, NARRATIVE RESIDENCE; ZIEMAN JC, 1984, MAR ECOL PROG SER, V15, P151, DOI 10.3354/meps015151; Zuur Alain F., 2009, P1	106	18	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94667	10.1371/journal.pone.0094667	http://dx.doi.org/10.1371/journal.pone.0094667			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740258	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900059
J	Meager, JJ; Limpus, C				Meager, Justin J.; Limpus, Colin			Mortality of Inshore Marine Mammals in Eastern Australia Is Predicted by Freshwater Discharge and Air Temperature	PLOS ONE			English	Article							INDO-PACIFIC HUMPBACK; DUGONGS DUGONG-DUGON; SHARK BAY; EXMOUTH GULF; PENAEUS-MERGUIENSIS; COASTAL FISHERIES; CLIMATE-CHANGE; LOGAN RIVER; HERVEY-BAY; QUEENSLAND	Understanding environmental and climatic drivers of natural mortality of marine mammals is critical for managing populations effectively and for predicting responses to climate change. Here we use a 17-year dataset to demonstrate a clear relationship between environmental forcing and natural mortality of inshore marine mammals across a subtropical-tropical coastline spanning a latitudinal gradient of 13 degrees (>2000 km of coastline). Peak mortality of inshore dolphins and dugongs followed sustained periods of elevated freshwater discharge (9 months) and low air temperature (3 months). At a regional scale, these results translated into a strong relationship between annual mortality and an index of El Nino-Southern Oscillation. The number of cyclones crossing the coastline had a comparatively weak effect on inshore marine mammal mortality, and only in the tropics. Natural mortality of offshore/migratory cetaceans was not predicted by freshwater discharge, but was related to lagged air temperature. These results represent the first quantitative link between environmental forcing and marine mammal mortality in the tropics, and form the basis of a predictive tool for managers to prepare responses to periods of elevated marine mammal mortality.	[Meager, Justin J.; Limpus, Colin] Dept Environm & Heritage Protect, Threatened Species Unit, Dutton Pk, Qld, Australia		Meager, JJ (corresponding author), Dept Environm & Heritage Protect, Threatened Species Unit, Dutton Pk, Qld, Australia.	Justin.Meager@gmail.com		Meager, Justin/0000-0002-3349-1841	Queensland Department of Environment and Heritage Protection	Queensland Department of Environment and Heritage Protection	This study was funded by the Queensland Department of Environment and Heritage Protection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan R, 1996, NINO SO SOCILLATION; Allen S, 2004, P LINN SOC N S W, V125, P211; ANDERSON PK, 1986, NATL GEOGR RES, V2, P473; Beasley I, 2002, RAFFLES B ZOOL, P15; Bowater RO, 2003, AUST VET J, V81, P627, DOI 10.1111/j.1751-0813.2003.tb12509.x; Cagnazzi D, 2013, ENVIRON POLLUT, V182, P490, DOI 10.1016/j.envpol.2013.08.008; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Campbell SJ, 2004, ESTUAR COAST SHELF S, V60, P477, DOI 10.1016/j.ecss.2004.02.007; Carmichael RH, 2012, PLOS ONE, V7; Chilvers BL, 2005, BIOL CONSERV, V122, P559, DOI 10.1016/j.biocon.2004.08.013; Erb J, 2001, OIKOS, V92, P3, DOI 10.1034/j.1600-0706.2001.920101.x; Erskine WD, 1998, AUST GEOGR, V29, P257, DOI 10.1080/00049189808703218; Evans K, 2005, BIOL LETT-UK, V1, P147, DOI 10.1098/rsbl.2005.0313; Gales N, 2004, WILDLIFE RES, V31, P283, DOI 10.1071/WR02073; Gardner TA, 2005, ECOLOGY, V86, P174, DOI 10.1890/04-0141; Gillanders BM, 2002, OCEANOGR MAR BIOL, V40, P233; Gillson J, 2012, FISHERIES MANAG ECOL, V19, P54, DOI 10.1111/j.1365-2400.2011.00816.x; Hagihara R, 2014, MAR MAMMAL SCI, V30, P348, DOI 10.1111/mms.12041; Halvorsen Katherine M., 2008, Aquatic Mammals, V34, P412, DOI 10.1578/AM.34.4.2008.412; Haynes D, 2005, MAR POLLUT BULL, V51, P361, DOI 10.1016/j.marpolbul.2004.10.020; Hermanussen S, 2008, MAR POLLUT BULL, V57, P409, DOI 10.1016/j.marpolbul.2008.01.003; Hobday AJ, 2009, IMPLICATIONS CLIMATE; Holley DK, 2006, WILDLIFE RES, V33, P243, DOI 10.1071/WR05031; Ipsdgc C, 2013, CLIM CHANG 2013 PHYS, P1535, DOI [DOI 10.1017/CBO9781107415324, DOI 10.1017/cbo9781107415324]; Larkum AWD, 1989, BIOL SEGRASSES TREAT; Limpus C, 2000, ATMOS OCEAN SCI LIB, V21, P399; LIMPUS CJ, 1988, AUST WILDLIFE RES, V15, P157; Limpus CJ, 2004, CONSERV TECH DATA RE, V2004, P1; Loneragan NR, 2013, ESTUAR COAST SHELF S, V127, P46, DOI 10.1016/j.ecss.2013.03.024; Loneragan NR, 1999, AUST J ECOL, V24, P431, DOI 10.1046/j.1442-9993.1999.00975.x; Longstaff BJ, 1999, AQUAT BOT, V65, P105, DOI 10.1016/S0304-3770(99)00035-2; MacLeod CD, 2005, BIOL CONSERV, V124, P477, DOI 10.1016/j.biocon.2005.02.004; Marsh H., 2011, ECOLOGY CONSERVATION; Marsh H, 2008, CONT SHELF RES, V28, P2152, DOI 10.1016/j.csr.2008.03.023; Meager JJ, 2003, ESTUAR COAST SHELF S, V57, P569, DOI 10.1016/S0272-7714(02)00375-X; Meager JJ, 2012, CONSERV TECH DATA RE, V2012, P1; MELLORS JE, 1993, AUST J MAR FRESH RES, V44, P33; Mendez M, 2013, MOL ECOL, V22, P5936, DOI 10.1111/mec.12535; Moore JE, 2013, MAR MAMMAL SCI, V29, P446, DOI 10.1111/j.1748-7692.2012.00586.x; Owen HC, 2013, DIS AQUAT ORGAN, V103, P1, DOI 10.3354/dao02568; Parra GJ, 2006, J ANIM ECOL, V75, P862, DOI 10.1111/j.1365-2656.2006.01104.x; Paterson R, 1986, MEMOIRS QUEENSLAND M, V46, P631; Peltier H, 2012, ECOL INDIC, V18, P278, DOI 10.1016/j.ecolind.2011.11.014; Perrin WF, 2002, ENCY MARINE MAMMALS; Pierce GJ, 2007, FISH RES, V87, P219, DOI 10.1016/j.fishres.2007.06.001; Pompa S, 2011, P NATL ACAD SCI USA, V108, P13600, DOI 10.1073/pnas.1101525108; Power S, 1999, CLIM DYNAM, V15, P319, DOI 10.1007/s003820050284; PREEN A, 1995, WILDLIFE RES, V22, P507, DOI 10.1071/WR9950507; PREEN AR, 1995, AQUAT BOT, V52, P3, DOI 10.1016/0304-3770(95)00491-H; Preen AR, 1997, WILDLIFE RES, V24, P185, DOI 10.1071/WR95078; Schaefer AM, 2011, J ENV PUBLIC HLTH, V2011; Schumann N, 2013, AUST J ZOOL, V61, P146, DOI 10.1071/ZO12131; Sheppard JK, 2010, MAR MAMMAL SCI, V26, P855, DOI 10.1111/j.1748-7692.2010.00374.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STAPLES DJ, 1986, MAR ECOL PROG SER, V27, P239, DOI 10.3354/meps027239; Truchon MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059311; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; Vetter W, 2001, ARCH ENVIRON CON TOX, V41, P221; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Wilson B, 1999, P ROY SOC B-BIOL SCI, V266, P1077, DOI 10.1098/rspb.1999.0746; Wood SN, 2006, GEN ADDITIVE MODELS; Yan C, 2013, GLOBAL CHANGE BIOL, V19, P3263, DOI 10.1111/gcb.12321; Zuur Alain F., 2009, P1	63	36	38	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94849	10.1371/journal.pone.0094849	http://dx.doi.org/10.1371/journal.pone.0094849			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740149	Green Published, gold			2022-12-25	WOS:000336863900074
J	Guo, XP; Shi, YL; Sheng, JZ; Wang, FS				Guo, Xueping; Shi, Yanli; Sheng, Juzheng; Wang, Fengshan			A Novel Hyaluronidase Produced by Bacillus sp A50	PLOS ONE			English	Article							STREPTOCOCCUS-AGALACTIAE; TESTICULAR HYALURONIDASE; ALKALINE DEGRADATION; LYASE; PURIFICATION; MECHANISM; OLIGOSACCHARIDES; SUBSTRATE; INSIGHTS; COMPLEX	Hyaluronidases are a family of enzymes that degrade hyaluronic acid (hyaluronan, HA) and widely used in many fields. A hyaluronidase producing bacteria strain was screened from the air. 16S ribosomal DNA (16S rDNA) analysis indicated that the strain belonged to the genus Bacillus, and the strain was named as Bacillus sp. A50. This is the first report of a hyaluronidase from Bacillus, which yields unsaturated oligosaccharides as product like other microbial hyaluronate lyases. Under optimized conditions, the yield of hyaluronidase from Bacillus sp. A50 could reach up to 1.5x10(4) U/mL, suggesting that strain A50 is a good producer of hyaluronidase. The hyaluronidase (HAase-B) was isolated and purified from the bacterial culture, with a specific activity of 1.02x10(6) U/mg protein and a yield of 25.38%. The optimal temperature and pH of HAase-B were 44 degrees C and pH 6.5, respectively. It was stable at pH 5-6 and at a temperature lower than 45 degrees C. The enzymatic activity could be enhanced by Ca2+, Mg2+, or Ni2+, and inhibited by Zn2+, Cu2+, EDTA, ethylene glycol tetraacetic acid (EGTA), deferoxamine mesylate salt (DFO), triton X-100, Tween 80, or SDS at different levels. Kinetic measurements of HAase-B towards HA gave a Michaelis constant (Km) of 0.02 mg/mL, and a maximum velocity (V-max) of 0.27 A(232)/min. HAase-B also showed activity towards chondroitin sulfate A (CSA) with the kinetic parameters, Km and V-max, 12.30 mg/mL and 0.20 A(232)/min respectively. Meanwhile, according to the sequences of genomic DNA and HAase-B's part peptides, a 3,324-bp gene encoding HAase-B was obtained.	[Guo, Xueping; Sheng, Juzheng; Wang, Fengshan] Shandong Univ, Sch Pharmaceut Sci, Inst Biochem & Biotechnol Drug, Key Lab Chem Biol Nat Prod,Minist Educ, Jinan 250100, Peoples R China; [Wang, Fengshan] Shandong Univ, Natl Glycoengn Res Ctr, Jinan 250100, Peoples R China; [Guo, Xueping; Shi, Yanli] Bloomage Freda Biopharm Co Ltd, Jinan, Peoples R China	Shandong University; Shandong University	Wang, FS (corresponding author), Shandong Univ, Sch Pharmaceut Sci, Inst Biochem & Biotechnol Drug, Key Lab Chem Biol Nat Prod,Minist Educ, Jinan 250100, Peoples R China.	fswang@sdu.edu.cn	Sheng, Juzheng/G-2693-2013	Sheng, Juzheng/0000-0003-2856-9162	Natural Science Foundation of Shandong Province [ZR2009CZ010]; Ministry of Science and Technology of China [2012CB822102]; Taishan Scholar Scheme (Special Term Expert for Pharmacy)	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Taishan Scholar Scheme (Special Term Expert for Pharmacy)	This work was financially supported by the Natural Science Foundation of Shandong Province (ZR2009CZ010), the "973" grant from the Ministry of Science and Technology of China (2012CB822102) and the Taishan Scholar Scheme (Special Term Expert for Pharmacy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson C, 1973, Contrib Microbiol Immunol, V1, P376; Albanell J, 2000, SEMIN ONCOL, V27, P347; Bataillon M, 2000, ENZYME MICROB TECH, V26, P187, DOI 10.1016/S0141-0229(99)00143-X; BEMILLER JN, 1962, J ORG CHEM, V27, P1161, DOI 10.1021/jo01051a009; BERTELLI G, 1994, J CANCER RES CLIN, V120, P505, DOI 10.1007/BF01191807; BOCCI V, 1986, GEN PHARMACOL, V17, P93, DOI 10.1016/0306-3623(86)90017-0; Boyer PD, 1970, ENZYMES, V1-22, P29; Hawkins CL, 1998, FREE RADICAL BIO MED, V24, P1396, DOI 10.1016/S0891-5849(98)00009-4; Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1111/j.1574-6968.2000.tb08958.x; Jedrzejas MJ, 1998, PROTEIN EXPRES PURIF, V13, P83, DOI 10.1006/prep.1997.0864; Jedrzejas MJ, 2000, ACTA CRYSTALLOGR D, V56, P460, DOI 10.1107/S0907444900000706; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Kelly SJ, 2001, GLYCOBIOLOGY, V11, P297, DOI 10.1093/glycob/11.4.297; Kiss J., 1974, ADV CARBOHYD CHEM, V29, P229, DOI DOI 10.1016/S0065-2318(08)60251-6; KOSTYUKOVA NN, 1995, FEMS IMMUNOL MED MIC, V10, P133, DOI 10.1111/j.1574-695X.1995.tb00022.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mahesh N, 2012, J MICROBIAL BIOCH TE, V4, P1; MATZKE J, 1960, NATURE, V187, P873, DOI 10.1038/187873a0; Mello LV, 2002, J BIOL CHEM, V277, P36678, DOI 10.1074/jbc.M205140200; Oettl M, 2003, EUR J PHARM SCI, V18, P267, DOI 10.1016/S0928-0987(03)00022-8; PRIMAKOFF P, 1988, NATURE, V335, P543, DOI 10.1038/335543a0; Pritchard DG, 2000, PROTEINS, V40, P126; PRITCHARD DG, 1994, ARCH BIOCHEM BIOPHYS, V315, P431, DOI 10.1006/abbi.1994.1521; Rigden DJ, 2003, J BIOL CHEM, V278, P50596, DOI 10.1074/jbc.M307596200; ROONEY P, 1993, J CELL SCI, V105, P213; SMITH RF, 1968, APPL MICROBIOL, V16, P1434, DOI 10.1128/AEM.16.9.1434-1436.1968; STING R, 1990, ZBL BAKT-INT J MED M, V272, P276; Suzuki K, 2002, J ENZYM INHIB MED CH, V17, P183, DOI 10.1080/14756360290032930; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; TAM YC, 1985, INFECT IMMUN, V47, P508, DOI 10.1128/IAI.47.2.508-513.1985; WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X; WHISTLER RL, 1958, ADV CARBOHYD CHEM, V13, P289; ZAHALKA MA, 1995, J IMMUNOL, V154, P5345	34	32	35	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94156	10.1371/journal.pone.0094156	http://dx.doi.org/10.1371/journal.pone.0094156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736576	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600047
J	Nicolo, A; Bazzucchi, I; Haxhi, J; Felici, F; Sacchetti, M				Nicolo, Andrea; Bazzucchi, Ilenia; Haxhi, Jonida; Felici, Francesco; Sacchetti, Massimo			Comparing Continuous and Intermittent Exercise: An "Isoeffort'' and "Isotime'' Approach	PLOS ONE			English	Article							PERCEIVED EXERTION RESPONSES; OXYGEN-UPTAKE; WORK DURATION; INTENSITY; PERFORMANCE; ADAPTATIONS; PROTOCOLS; TIME	The present study proposes an alternative way of comparing performance and acute physiological responses to continuous exercise with those of intermittent exercise, ensuring similar between-protocol overall effort (isoeffort) and the same total duration of exercise (isotime). This approach was expected to overcome some drawbacks of traditional methods of comparison. Fourteen competitive cyclists (20 +/- 3 yrs) performed a preliminary incremental test and four experimental 30-min self-paced protocols, i.e. one continuous and three passive-recovery intermittent exercise protocols with different work-to-rest ratios (2 = 40: 20s, 1 = 30: 30s and 0.5 = 20: 40s). A "maximal session effort'' prescription was adopted for this experimental design. As expected, a robust perceived exertion template was observed irrespective of exercise protocol. Similar between-protocol pacing strategies further support the use of the proposed approach in competitive cyclists. Total work, oxygen uptake and heart rate mean values were significantly higher (P<0.05) in the continuous compared to intermittent protocols, while lactate values were lower. Manipulating the work-to-rest ratio in intermittent exercise, total work, oxygen uptake and heart rate mean values decreased with the decrease in the work-to-rest ratio, while lactate values increased. Despite this complex physiological picture, all protocols showed similar ventilatory responses and a nearly perfect relationship between respiratory frequency and perceived exertion. In conclusion, our data indicate that overall effort and total duration of exercise are two critical parameters that should both be controlled when comparing continuous with intermittent exercise. On an isoeffort and isotime basis, the work-to-rest ratio manipulation affects physiological responses in a different way from what has been reported in literature with traditional methods of comparison. Finally, our data suggest that during intermittent exercise respiratory frequency reflects physiological strain better than oxygen uptake, heart rate and blood lactate.	[Nicolo, Andrea; Bazzucchi, Ilenia; Haxhi, Jonida; Felici, Francesco; Sacchetti, Massimo] Foro Italico Univ, Dept Human Movement Social & Hlth Sci, Rome, Italy	Foro Italico University of Rome	Sacchetti, M (corresponding author), Foro Italico Univ, Dept Human Movement Social & Hlth Sci, Rome, Italy.	massimo.sacchetti@uniroma4.it	Felici, Francesco/GLR-1531-2022; Felici, Francesco/G-9983-2012; haxhi, jonida/M-4545-2013	Felici, Francesco/0000-0002-7228-9064; haxhi, jonida/0000-0003-2319-869X; Bazzucchi, Ilenia/0000-0002-6017-1683; Sacchetti, Massimo/0000-0002-5365-5161; Nicolo, Andrea/0000-0002-4716-1667	University of Rome "Foro Italico", Italy	University of Rome "Foro Italico", Italy	This study received no external funding. The study was supported by the University of Rome "Foro Italico", Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTRAND I, 1960, ACTA PHYSIOL SCAND, V48, P448, DOI 10.1111/j.1748-1716.1960.tb01879.x; BALLOR DL, 1992, EUR J APPL PHYSIOL, V65, P365, DOI 10.1007/BF00868142; Billat VL, 2001, INT J SPORTS MED, V22, P201, DOI 10.1055/s-2001-16389; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; Burnley M, 2006, MED SCI SPORT EXER, V38, P1995, DOI 10.1249/01.mss.0000232024.06114.a6; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; Davies RC, 2009, EUR J APPL PHYSIOL, V107, P11, DOI 10.1007/s00421-009-1094-6; De Pauw K, 2013, INT J SPORT PHYSIOL, V8, P111, DOI 10.1123/ijspp.8.2.111; EDWARDS RHT, 1972, EUR J CLIN INVEST, V2, P108, DOI 10.1111/j.1365-2362.1972.tb00578.x; EDWARDS RHT, 1973, J PHYSIOL-LONDON, V234, P481, DOI 10.1113/jphysiol.1973.sp010356; Eston R, 2012, INT J SPORT PHYSIOL, V7, P175, DOI 10.1123/ijspp.7.2.175; Foss O, 2005, EUR J APPL PHYSIOL, V93, P453, DOI 10.1007/s00421-004-1226-y; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Gosselin LE, 2012, J STRENGTH COND RES, V26, P2866, DOI 10.1519/JSC.0b013e318241e13d; Hampson DB, 2001, SPORTS MED, V31, P935, DOI 10.2165/00007256-200131130-00004; Hayashi K, 2006, J APPL PHYSIOL, V100, P414, DOI 10.1152/japplphysiol.00541.2005; Hopkins W.G, 2006, SCALE MAGNITUDES EFF; Kim JH, 2013, INT J SPORTS MED, V34, P497, DOI 10.1055/s-0032-1327661; Laursen PB, 2002, SPORTS MED, V32, P53, DOI 10.2165/00007256-200232010-00003; Mann T, 2013, SPORTS MED, V43, P613, DOI 10.1007/s40279-013-0045-x; Marcora SM, 2008, AM J PHYSIOL-REG I, V294, pR874, DOI 10.1152/ajpregu.00678.2007; Midgley AW, 2007, INT J SPORTS MED, V28, P273, DOI 10.1055/s-2006-924336; Nicolo A, 2014, INT J SPORT PHYSIOL, V9, P151, DOI [10.1123/IJSPP.2012-0289, 10.1123/ijspp.2012-0289]; Rozenek R, 2007, J STRENGTH COND RES, V21, P188; Sandbakk O, 2013, J STRENGTH COND RES, V27, P1974, DOI 10.1519/JSC.0b013e3182752f08; Seiler S, 2005, MED SCI SPORT EXER, V37, P1601, DOI 10.1249/01.mss.0000177560.18014.d8; Seiler S, 2004, SCAND J MED SCI SPOR, V14, P318, DOI 10.1046/j.1600-0838.2003.00353.x; Seiler S, 2013, SCAND J MED SCI SPOR, V23, P74, DOI 10.1111/j.1600-0838.2011.01351.x; Seiler S, 2010, INT J SPORT PHYSIOL, V5, P276, DOI 10.1123/ijspp.5.3.276; Thevenet D, 2007, EUR J APPL PHYSIOL, V99, P133, DOI 10.1007/s00421-006-0327-1; Whipp BJ, 2007, EXP PHYSIOL, V92, P347, DOI 10.1113/expphysiol.2006.034363; Zafeiridis A, 2010, EUR J APPL PHYSIOL, V110, P17, DOI 10.1007/s00421-010-1467-x	33	45	45	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94990	10.1371/journal.pone.0094990	http://dx.doi.org/10.1371/journal.pone.0094990			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736313	gold, Green Submitted, Green Published			2022-12-25	WOS:000336922600119
J	Ntshoe, GM; McAnerney, JM; Tempia, S; Blumberg, L; Moyes, J; Buys, A; Naidoo, D; Venter, M; Besselaar, T; Schoub, BD; Harris, BN; Cohen, C				Ntshoe, Genevie M.; McAnerney, Johanna M.; Tempia, Stefano; Blumberg, Lucille; Moyes, Jocelyn; Buys, Amelia; Naidoo, Dhamari; Venter, Marietjie; Besselaar, Terry; Schoub, Barry D.; Harris, Bernice N.; Cohen, Cheryl			Influenza Epidemiology and Vaccine Effectiveness among Patients with Influenza-Like Illness, Viral Watch Sentinel Sites, South Africa, 2005-2009	PLOS ONE			English	Article							SEASONAL INFLUENZA; SURVEILLANCE; VIRUS; EFFICACY; NETWORK; CANADA	Background: There is limited data on the epidemiology of influenza and few published estimates of influenza vaccine effectiveness (VE) from Africa. In April 2009, a new influenza virus strain infecting humans was identified and rapidly spread globally. We compared the characteristics of patients ill with influenza A(H1N1)pdm09 virus to those ill with seasonal influenza and estimated influenza vaccine effectiveness during five influenza seasons (2005-2009) in South Africa. Methods: Epidemiological data and throat and/or nasal swabs were collected from patients with influenza-like illness (ILI) at sentinel sites. Samples were tested for seasonal influenza viruses using culture, haemagglutination inhibition tests and/or polymerase chain reaction (PCR) and for influenza A(H1N1) pdm09 by real-time PCR. For the vaccine effectiveness (VE) analysis we considered patients testing positive for influenza A and/or B as cases and those testing negative for influenza as controls. Age-adjusted VE was calculated as 1-odds ratio for influenza in vaccinated and non-vaccinated individuals. Results: From 2005 through 2009 we identified 3,717 influenza case-patients. The median age was significantly lower among patients infected with influenza A(H1N1) pdm09 virus than those with seasonal influenza, 17 and 27 years respectively (p<0.001). The vaccine coverage during the influenza season ranged from 3.4% in 2009 to 5.1% in 2006 and was higher in the >= 50 years (range 6.9% in 2008 to 13.2% in 2006) than in the,50 years age group (range 2.2% in 2007 to 3.7% in 2006). The age-adjusted VE estimates for seasonal influenza were 48.6% (4.9%, 73.2%); -14.2% (-9.7%, 34.8%); 12.0% (-70.4%, 55.4%); 67.4% (12.4%, 90.3%) and 29.6% (-21.5%, 60.1%) from 2005 to 2009 respectively. For the A(H1N1) pdm09 season, the efficacy of seasonal vaccine was -6.4% (-93.5%, 43.3%). Conclusion: Influenza vaccine demonstrated a significant protective effect in two of the five years evaluated. Low vaccine coverage may have reduced power to estimate vaccine effectiveness.	[Ntshoe, Genevie M.; Blumberg, Lucille] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [McAnerney, Johanna M.; Moyes, Jocelyn; Buys, Amelia; Venter, Marietjie; Cohen, Cheryl] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Tempia, Stefano] Natl Hlth Lab Serv, Natl Inst Communicable Dis, US Ctr Dis Control & Prevent, Influenza Div, Johannesburg, South Africa; [Naidoo, Dhamari; Besselaar, Terry] World Hlth Org, Geneva, Switzerland; [Schoub, Barry D.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Ctr Vaccines & Immunol, Johannesburg, South Africa; [Harris, Bernice N.] Univ Pretoria, Sch Hlth Syst & Publ Hlth, ZA-0002 Pretoria, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; National Institute for Communicable Diseases (NICD); World Health Organization; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria	Ntshoe, GM (corresponding author), Natl Hlth Lab Serv, Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa.	genevien@nicd.ac.za; cherylc@nicd.ac.za	Harris, Bernice N/AAN-6197-2021; Venter, Marietjie/P-9604-2016; Moyes, Jocelyn/AAF-7882-2019	Harris, Bernice N/0000-0002-0924-3178; Venter, Marietjie/0000-0003-2696-824X; Cohen, Cheryl/0000-0003-0376-2302	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Archer BN, 2009, EUROSURVEILLANCE, V14, P11; Carcione D, 2010, EMERG INFECT DIS, V16, P1388, DOI 10.3201/eid1609.100076; CATE TR, 1977, J INFECT DIS, V136, pS518, DOI 10.1093/infdis/136.Supplement_3.S518; *CDCP, 2010, MMWR-MORBID MORTAL W, V58, P521; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; De Serres G, 2013, Euro Surveill, V18; DOLIN R, 1977, J INFECT DIS, V136, pS435, DOI 10.1093/infdis/136.Supplement_3.S435; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Heyman DL, 2004, CONTROL COMMUNICABLE, V18, P281; Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053; Katz MA, 2012, J INFECT DIS, V206, pS1, DOI 10.1093/infdis/jis548; Keeton C, 2010, B WORLD HEALTH ORGAN, V88, P803, DOI 10.2471/BLT.10.021110; Kelly H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005079; Kissling E, 2011, EURO SURVEILL, V16; McAnerney J, 2008, COMMUNICABLE DIS SUR, V6, P7; McAnerney J, 2007, COMMUNICABLE DIS SUR, V5, P5; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Schoub BD, 2009, SAMJ S AFR MED J, V99, P87; Shiley KT, 2010, INFECT CONT HOSP EP, V31, P676, DOI 10.1086/653204; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Statistics South Africa, MORT CAUS DEATH S AF; Theocharis G, 2011, INT J CLIN PRACT, V65, P871, DOI 10.1111/j.1742-1241.2011.02684.x; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Van Kerkhove MD, 2011, INFLUENZA OTHER RESP, V5, pR487, DOI 10.1111/j.1750-2659.2011.00249.x; World Health Organisation, 2009, WKLY EPIDEMIOL REC; World Health Organisation, 2002, WKLY EPIDEMIOL REC, V77, P230; World Health Organisation, WHOHSEGIPDAC20111; World Health Organisation, 2011, WKLY EPIDEMIOL REC, V86, P223; [No title captured]	31	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94681	10.1371/journal.pone.0094681	http://dx.doi.org/10.1371/journal.pone.0094681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736452	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600083
J	Martucci, MEP; De Vos, RCH; Carollo, CA; Gobbo-Neto, L				Poleti Martucci, Maria Elvira; De Vos, Ric C. H.; Carollo, Carlos Alexandre; Gobbo-Neto, Leonardo			Metabolomics as a Potential Chemotaxonomical Tool: Application in the Genus Vernonia Schreb	PLOS ONE			English	Article							MASS-SPECTROMETRY; SESQUITERPENE LACTONES; IDENTIFICATION; FLAVONOIDS; ASTERACEAE; SAPONINS; LEAVES	The taxonomic classification of the genus Vernonia Schreb is complex and, as yet, unclear. We here report the use of untargeted metabolomics approaches, followed by multivariate analyses methods and a phytochemical characterization of ten Vernonia species. Metabolic fingerprints were obtained by accurate mass measurements and used to determine the phytochemical similarities and differences between species through multivariate analyses approaches. Principal component analysis based on the relative levels of 528 metabolites, indicated that the ten species could be clustered into four groups. Thereby, V. polyanthes was the only species with presence of flavones chrysoeriol-7-O-glycuronyl, acacetin-7-O-glycuronyl and sesquiterpenes lactones piptocarphin A and piptocarphin B, while glaucolide A was detected in both V. brasiliana and V. polyanthes, separating these species from the two other species of the Vernonanthura group. Species from the Lessingianthus group were unique in showing a positive response in the foam test, suggesting the presence of saponins, which could be confirmed by metabolite annotation. V. rufogrisea showed a great variety of sesquiterpene lactones, placing this species into a separate group. Species within the Chrysolaena group were unique in accumulating clovamide. Our results of LC-MS-based profiling combined with multivariate analyses suggest that metabolomics approaches, such as untargeted LC-MS, may be potentially used as a large-scale chemotaxonomical tool, in addition to classical morphological and cytotaxonomical approaches, in order to facilitate taxonomical classifications.	[Poleti Martucci, Maria Elvira; Gobbo-Neto, Leonardo] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil; [De Vos, Ric C. H.; Carollo, Carlos Alexandre] BU Biosci, Plant Res Int, Wageningen, Netherlands; [De Vos, Ric C. H.] Ctr Biosyst Genom, Wageningen, Netherlands; [De Vos, Ric C. H.] Netherlands Metab Ctr, Leiden, Netherlands; [Carollo, Carlos Alexandre] Univ Mato Grosso Sul, Lab Pharmacognosy, Campo Grande, MS, Brazil	Universidade de Sao Paulo; Centre for BioSystems Genomics; Universidade Federal de Mato Grosso do Sul	Gobbo-Neto, L (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, BR-14049 Ribeirao Preto, SP, Brazil.	gobbo@fcfrp.usp.br	martucci, maria/V-4922-2019; Gobbo-Neto, Leonardo/AAJ-5547-2020; De Vos, Ric/F-5012-2017; Gobbo Neto, Leonardo/D-2556-2017	Gobbo-Neto, Leonardo/0000-0002-0133-6142; Gobbo Neto, Leonardo/0000-0002-0133-6142; Carollo, Carlos Alexandre/0000-0003-1231-9441; , Maria Elvira Poleti Martucci/0000-0002-0601-8848	Alexander von Humboldt Foundation; FAPESP; Process FAPESP [2012/16646-4]; Centre of Biosystems Genomics part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Netherlands Metabolomics Centre part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Process FAPESP; Centre of Biosystems Genomics part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research; Netherlands Metabolomics Centre part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	The authors thank the Alexander von Humboldt Foundation and FAPESP for financial support and fellowships, mainly by Process FAPESP no 2012/16646-4. RDV acknowledges the Centre of Biosystems Genomics and the Netherlands Metabolomics Centre, which are both part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research, for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J. G., 1873, FLORA BRASILIENSIS, V6, P5; BARDON A, 1988, PHYTOCHEMISTRY, V27, P2691, DOI 10.1016/0031-9422(88)87045-6; BOHLMANN F, 1983, PHYTOCHEMISTRY, V22, P2863, DOI 10.1016/S0031-9422(00)97718-5; Bremer K, 1994, NORD J BOT, V14, P462, DOI DOI 10.1111/J.1756-1051.1994.TB00632.X; Buskuhl H, 2012, PHYTOCHEMISTRY, V71, P1539; Salles-de-Melo MRC, 2010, PLANT SYST EVOL, V285, P189, DOI 10.1007/s00606-010-0277-2; Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q; Cuyckens F, 2004, J MASS SPECTROM, V39, P1, DOI [10.1002/jms.585, 10.1002/jms.622]; De Oliveira VM, 2007, BOT J LINN SOC, V154, P99, DOI 10.1111/j.1095-8339.2007.00633.x; Dematteis M, 2000, CARYOLOGIA, V53, P55, DOI 10.1080/00087114.2000.10589181; Fiseha A, 2010, CHEM NAT COMPD+, V46, P692, DOI 10.1007/s10600-010-9717-z; Frisvad JC, 2008, MYCOL RES, V112, P231, DOI 10.1016/j.mycres.2007.08.018; Gobbo-Neto L, 2008, J AGR FOOD CHEM, V56, P1193, DOI 10.1021/jf072812l; Gobbo-Neto L, 2008, RAPID COMMUN MASS SP, V22, P3802, DOI 10.1002/rcm.3802; Herz Werner, 1996, P229; IGILE G, 1995, J NAT PRODUCTS, V58, P1438, DOI 10.1021/np50123a016; Keeley SC., 1990, PL SYST EVOL S, P45, DOI DOI 10.1007/978-3-7091-6928-5_; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Mabry T. J., 1975, Biochemical Systematics and Ecology, V2, P185, DOI 10.1016/0305-1978(75)90060-5; Betiana AM, 2009, CARYOLOGIA, V62, P81, DOI 10.1080/00087114.2004.10589672; Pereira-Caro G, 2013, J AGR FOOD CHEM, V61, P427, DOI 10.1021/jf304397m; Robinson H., 1999, SMITHSONIAN CONTR BO, V89, P1, DOI DOI 10.5479/SI.0081024X.89; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Schmidt TJ, 1999, CURR ORG CHEM, V96, P545; SCHMITTMANN T, 1994, J PRAK CHEM-CHEM ZTG, V336, P225, DOI 10.1002/prac.19943360307; SEAMAN FC, 1982, BOT REV, V48, P121, DOI 10.1007/BF02919190; Staneva JD, 2008, PHYTOCHEMISTRY, V69, P607, DOI 10.1016/j.phytochem.2007.07.021; STUTTS JG, 1988, RHODORA, V90, P37; Tikunov YM, 2012, METABOLOMICS, V8, P714, DOI 10.1007/s11306-011-0368-2; ZDERO C, 1991, PHYTOCHEMISTRY, V30, P4025, DOI 10.1016/0031-9422(91)83457-V; ZDERO C, 1990, PLANT SYST EVOL, V171, P1, DOI 10.1007/BF00940593	32	101	105	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93149	10.1371/journal.pone.0093149	http://dx.doi.org/10.1371/journal.pone.0093149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736747	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600016
J	Wang, ZL; Liu, M; Liang, XY; Siriwat, S; Li, XL; Chen, XG; Parker, DM; Miao, J; Cui, LW				Wang, Zenglei; Liu, Min; Liang, Xiaoying; Siriwat, Salil; Li, Xiaolian; Chen, Xiaoguang; Parker, Daniel M.; Miao, Jun; Cui, Liwang			A Flow Cytometry-Based Quantitative Drug Sensitivity Assay for All Plasmodium falciparum Gametocyte Stages	PLOS ONE			English	Article							ANTIMALARIAL-DRUGS; SEXUAL DEVELOPMENT; MALARIA PARASITE; ELIMINATING MALARIA; IN-VITRO; TRANSMISSION; PRIMAQUINE; AUTOFLUORESCENCE; IDENTIFICATION; ERYTHROCYTES	Background: Malaria elimination/eradication campaigns emphasize interruption of parasite transmission as a priority strategy. Screening for new drugs and vaccines against gametocytes is therefore urgently needed. However, current methods for sexual stage drug assays, usually performed by counting or via fluorescent markers are either laborious or restricted to a certain stage. Here we describe the use of a transgenic parasite line for assaying drug sensitivity in all gametocyte stages. Methods: A transgenic parasite line expressing green fluorescence protein (GFP) under the control of the gametocyte-specific gene alpha-tubulin II promoter was generated. This parasite line expresses GFP in all gametocyte stages. Using this transgenic line, we developed a flow cytometry-based assay to determine drug sensitivity of all gametocyte stages, and tested the gametocytocidal activities of four antimalarial drugs. Findings: This assay proved to be suitable for determining drug sensitivity of all sexual stages and can be automated. A Z' factor of 0.79 +/- 0.02 indicated that this assay could be further optimized for high-throughput screening. The daily sensitivity of gametocytes to three antimalarial drugs (chloroquine, dihydroartemisinin and pyronaridine) showed a drastic decrease from stage III on, whereas it remained relatively steady for primaquine. Conclusions: A drug assay was developed to use a single transgenic parasite line for determining drug susceptibility of all gametocyte stages. This assay may be further automated into a high-throughput platform for screening compound libraries against P. falciparum gametocytes.	[Wang, Zenglei; Liu, Min; Liang, Xiaoying; Siriwat, Salil; Li, Xiaolian; Parker, Daniel M.; Miao, Jun; Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA; [Liu, Min; Chen, Xiaoguang] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Parasitol, Guangzhou, Guangdong, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Southern Medical University - China	Miao, J (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.	jum23@psu.edu; luc2@psu.edu	Parker, Daniel M./B-5471-2013	Parker, Daniel M./0000-0002-5352-7338; Liang, Xiaoying/0000-0002-6603-3724; Liu, Min/0000-0002-3159-8039; MIAO, JUN/0000-0001-9374-6749	National Institute of Allergy and Infectious Diseases, NIH [U19 AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089672] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants (U19 AI089672) from the National Institute of Allergy and Infectious Diseases, NIH (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; [Anonymous], COCHRANE DATABASE SY; Baird JK, 2010, LANCET, V376, P1883, DOI 10.1016/S0140-6736(10)61494-8; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Baker DA, 2010, MOL BIOCHEM PARASIT, V172, P57, DOI 10.1016/j.molbiopara.2010.03.019; Bellemare MJ, 2009, J PHYS CHEM B, V113, P8391, DOI 10.1021/jp8104375; Buchholz K, 2011, J INFECT DIS, V203, P1445, DOI 10.1093/infdis/jir037; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Carter R., 1988, MALARIA PRINCIPLES P, P253; Chavalitshewinkoon-Petmitr Porntip, 2000, Parasitology International, V48, P275, DOI 10.1016/S1383-5769(99)00028-8; Chevalley S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-49; CHUTMONGKONKUL M, 1992, ANN TROP MED PARASIT, V86, P207, DOI 10.1080/00034983.1992.11812656; Czesny B, 2009, ANTIMICROB AGENTS CH, V53, P4080, DOI 10.1128/AAC.00088-09; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Dixon MWA, 2009, MOL BIOCHEM PARASIT, V163, P123, DOI 10.1016/j.molbiopara.2008.10.004; Eksi S, 2008, MOL BIOCHEM PARASIT, V160, P148, DOI 10.1016/j.molbiopara.2008.04.005; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Ferreira ID, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-1; Fidock DA, 2010, NATURE, V465, P297, DOI 10.1038/465297a; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Hanssen E, 2012, J STRUCT BIOL, V177, P224, DOI 10.1016/j.jsb.2011.09.003; Kariuki MM, 1998, AM J TROP MED HYG, V59, P505, DOI 10.4269/ajtmh.1998.59.505; Khandelwal S, 2007, J BIOSCIENCES, V32, P1139, DOI 10.1007/s12038-007-0115-z; Kim YR, 2004, ARCH PHARM RES, V27, P576, DOI 10.1007/BF02980134; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Krungkrai J, 2000, PARASITE, V7, P19, DOI 10.1051/parasite/2000071019; Krungkrai Jerapan, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P636; Lang-Unnasch N, 1998, ANNU REV MICROBIOL, V52, P561, DOI 10.1146/annurev.micro.52.1.561; Lelievre J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035019; MacRae JI, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-67; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Miao J, 2013, EXP PARASITOL, V135, P541, DOI 10.1016/j.exppara.2013.09.010; MIHALY GW, 1984, BRIT J CLIN PHARMACO, V17, P441, DOI 10.1111/j.1365-2125.1984.tb02369.x; Pasini EM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-190; Peatey CL, 2011, MOL BIOCHEM PARASIT, V180, P127, DOI 10.1016/j.molbiopara.2011.09.002; Peatey CL, 2009, J INFECT DIS, V200, P1518, DOI 10.1086/644645; RAWLINGS DJ, 1992, MOL BIOCHEM PARASIT, V56, P239, DOI 10.1016/0166-6851(92)90173-H; Schwank S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014470; Sinden RE, 2009, PARASITOLOGY, V136, P1427, DOI 10.1017/S0031182009990667; SMALLEY ME, 1977, T ROY SOC TROP MED H, V71, P526, DOI 10.1016/0035-9203(77)90149-3; Tanaka TQ, 2011, MOL BIOCHEM PARASIT, V177, P160, DOI 10.1016/j.molbiopara.2011.02.005; Team R. D. C, 2011, R LANG ENV STAT COMP; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vale N, 2009, EUR J MED CHEM, V44, P937, DOI 10.1016/j.ejmech.2008.08.011; Vigneshwaran N, 2005, SPECTROCHIM ACTA A, V61, P163, DOI 10.1016/j.saa.2004.03.027; White NJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S8; Wilairatana P, 2010, SE ASIAN J TROP MED, V41, P1306; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	50	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93825	10.1371/journal.pone.0093825	http://dx.doi.org/10.1371/journal.pone.0093825			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736563	gold, Green Published			2022-12-25	WOS:000336922600027
J	Zou, HX; Li, N; Wang, LH; Yu, P; Yan, XF				Zou, Hui-Xi; Li, Nan; Wang, Li-Hua; Yu, Ping; Yan, Xiu-Feng			Equilibrium and Kinetic Studies of Cd2+ Biosorption by the Brown Algae Sargassum fusiforme	PLOS ONE			English	Article							HEAVY-METAL BIOSORPTION; ACID DYE ADSORPTION; AQUEOUS-SOLUTION; CADMIUM BIOSORPTION; REMOVAL; GREEN; SPP.	A fundamental investigation of the biosorption of Cd2+ from aqueous solution by the edible seaweed Sargassum fusiforme was performed under batch conditions. The influences of experimental parameters, such as the initial pH, sorption time, temperature, and initial Cd2+ concentration, on Cd2+ uptake by S. fusiforme were evaluated. The results indicated that the biosorption of Cd2+ depended on the initial Cd2+ concentration, as well as the pH. The uptake of Cd2+ could be described by the Langmuir isotherm model, and both the Langmuir biosorption equilibrium constant and the maximum biosorption capacity of the monolayer decreased with increasing temperature, thereby confirming the exothermic character of the sorption process. The biosorption kinetics follows the pseudo-second-order kinetic model, and intraparticle diffusion is the sole rate-limiting step for the entire biosorption period. These fundamental equilibrium and kinetic results can support further studies to the removal of cadmium from S. fusiforme harvested from cadmium-polluted waters.	[Zou, Hui-Xi; Li, Nan; Wang, Li-Hua; Yu, Ping; Yan, Xiu-Feng] Wenzhou Univ, Coll Life & Environm Sci, Zhejiang Prov Key Lab Subtrop Water Environm & Ma, Wenzhou, Peoples R China	Wenzhou University	Yan, XF (corresponding author), Wenzhou Univ, Coll Life & Environm Sci, Zhejiang Prov Key Lab Subtrop Water Environm & Ma, Wenzhou, Peoples R China.	yanxiufeng@wzu.edu.cn	Zou, Hui-Xi/GPS-6496-2022	Yan, Xiufeng/0000-0001-5127-494X; Zou, Hui-Xi/0000-0002-8141-8059	China Natural Science Foundation [31270541]; Zhejiang Provincial Natural Science Foundation of China [LQ13C030005]; Plan for Qianjiang Talent of Zhejiang [QJD1202014]; Program for Wenzhou Science & Technology Innovative Research Team of China [C20120007-08]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Plan for Qianjiang Talent of Zhejiang; Program for Wenzhou Science & Technology Innovative Research Team of China	This material is based upon work funded by China Natural Science Foundation (31270541)(http://www.nsfc.gov.cn/publish/portal0/default.htm), Zhejiang Provincial Natural Science Foundation of China (LQ13C030005)(http://www.zjnsf.gov.cn/), Plan for Qianjiang Talent of Zhejiang (QJD1202014) and Program for Wenzhou Science & Technology Innovative Research Team of China (C20120007-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung WH, 2007, BIORESOURCE TECHNOL, V98, P2897, DOI 10.1016/j.biortech.2006.09.045; Crist RH, 1996, ENVIRON SCI TECHNOL, V30, P2456, DOI 10.1021/es950569d; Cruz CCV, 2004, BIORESOURCE TECHNOL, V91, P249, DOI 10.1016/S0960-8524(03)00194-9; Davis TA, 2004, WATER QUAL RES J CAN, V39, P183, DOI 10.2166/wqrj.2004.027; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Davis TA, 2003, ENVIRON SCI TECHNOL, V37, P261, DOI 10.1021/es025781d; Donmez GC, 1999, PROCESS BIOCHEM, V34, P885; Gin KYH, 2002, WATER RES, V36, P1313, DOI 10.1016/S0043-1354(01)00332-3; Godt J, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-22; Hameed BH, 2009, J HAZARD MATER, V162, P939, DOI 10.1016/j.jhazmat.2008.05.120; Hashim MA, 2004, CHEM ENG J, V97, P249, DOI 10.1016/S1385-8947(03)00216-X; Ho YS, 2004, SCIENTOMETRICS, V59, P171, DOI 10.1023/B:SCIE.0000013305.99473.cf; Ho YS, 2000, SEPAR PURIF METHOD, V29, P189, DOI 10.1081/SPM-100100009; Ho YS, 2006, J HAZARD MATER, V136, P681, DOI 10.1016/j.jhazmat.2005.12.043; Huerta-Diaz MA, 2007, APPL GEOCHEM, V22, P1380, DOI 10.1016/j.apgeochem.2007.03.052; Lazaridis NK, 2003, WATER RES, V37, P2875, DOI 10.1016/S0043-1354(03)00119-2; Lupea M, 2012, ENVIRON ENG MANAG J, V11, P607; Mata YN, 2009, J HAZARD MATER, V163, P555, DOI 10.1016/j.jhazmat.2008.07.015; Naddafi K, 2007, J HAZARD MATER, V147, P785, DOI 10.1016/j.jhazmat.2007.01.122; Nasuha N, 2010, J HAZARD MATER, V175, P126, DOI 10.1016/j.jhazmat.2009.09.138; Pang SJ, 2008, AQUAC RES, V39, P1408, DOI 10.1111/j.1365-2109.2008.02010.x; Patron-Prado M, 2011, WATER AIR SOIL POLL, V221, P137, DOI 10.1007/s11270-011-0776-y; Patron-Prado M, 2010, WATER AIR SOIL POLL, V210, P197, DOI 10.1007/s11270-009-0241-3; Pereira L., 2011, SEAWEED ECOLOGY NUTR, P15, DOI DOI 10.1148/RG.272065101; Rengaraj S, 2002, WATER RES, V36, P1783, DOI 10.1016/S0043-1354(01)00380-3; Sari A, 2008, J HAZARD MATER, V157, P448, DOI 10.1016/j.jhazmat.2008.01.008; Singh R, 2011, INDIAN J PHARMACOL, V43, P246, DOI 10.4103/0253-7613.81505; Suzuki Y, 2005, WATER RES, V39, P1803, DOI 10.1016/j.watres.2005.02.020; Tan IAW, 2008, J HAZARD MATER, V154, P337, DOI 10.1016/j.jhazmat.2007.10.031; Wong YC, 2003, LANGMUIR, V19, P7888, DOI 10.1021/la030064y; Yu JX, 2009, J HAZARD MATER, V168, P1147, DOI 10.1016/j.jhazmat.2009.02.144	31	8	10	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95242	10.1371/journal.pone.0095242	http://dx.doi.org/10.1371/journal.pone.0095242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736449	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600162
J	Kawasaki, Y; Ito, H; Kajimura, H				Kawasaki, Yuuki; Ito, Hiroshi; Kajimura, Hisashi			Equilibrium Frequency of Endosymbionts in Multiple Infections Based on the Balance between Vertical Transmission and Cytoplasmic Incompatibility	PLOS ONE			English	Article							DROSOPHILA-SIMULANS; RAPID SPREAD; WOLBACHIA; POPULATION; DYNAMICS; EVOLUTION; COLEOPTERA; CARDINIUM	Cytoplasmic incompatibility (CI)-inducing endosymbiotic bacteria, such as Wolbachia and Cardinium, have been well studied through field data and validations on the basis of numerical simulations. However, the analytically derived equilibrium frequency of multiple infections has not yet been determined, although the equilibrium for cases of single infection has been reported. In this study, we considered the difference equation for endosymbionts using three parameters: the probability of the failure of vertical transmission (mu), CI strength (z), and the level of host inbreeding (p). To analyze this model, we particularly focused on Q(N), i.e., the frequency of host individuals completely infected with all N-bacterial strains in the population. Q(N)*, Q(N) at the equilibrium state, was analytically calculated in the cases where N = 1,2 and N is any arbitrary value. We found that Q(N)* can be described using two parameters: N and alpha, which is identical to mu/pz. Q(N)* has a larger value in a system with a smaller alpha. In addition, alpha determines the maximum number of strains that infect a single host. Our results revealed the following: i) three parameters can be reduced to a single parameter, i. e., alpha and ii) the threshold of the maximum number of infections is defined by alpha, which prevents additional invasions by endosymbionts.	[Kawasaki, Yuuki; Kajimura, Hisashi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ito, Hiroshi] Kyushu Univ, Fac Design, Fukuoka 812, Japan	Nagoya University; Kyushu University	Ito, H (corresponding author), Kyushu Univ, Fac Design, Fukuoka 812, Japan.	hito@design.kyushu-u.ac.jp		Kawasaki, Yuuki/0000-0002-7725-4768	Japanese Society for Promotion of Science [20405025]	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grants-in-aid from the Japanese Society for Promotion of Science (20405025, http://www.jsps.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bordenstein SR, 2000, HEREDITY, V84, P54, DOI 10.1046/j.1365-2540.2000.00637.x; Branca A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-185; CASPARI E, 1959, EVOLUTION, V13, P568, DOI 10.2307/2406138; Charlat S, 2004, J EVOLUTION BIOL, V17, P322, DOI 10.1046/j.1420-9101.2003.00676.x; Dannowski J, 2009, EVOLUTION, V63, P2525, DOI 10.1111/j.1558-5646.2009.00749.x; De Crespigny FEC, 2006, J EVOLUTION BIOL, V19, P1964, DOI 10.1111/j.1420-9101.2006.01143.x; Dedeine F, 2005, MOL ECOL, V14, P1543, DOI 10.1111/j.1365-294X.2005.02499.x; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Engelstadter J, 2006, GENETICS, V172, P2601, DOI 10.1534/genetics.105.050302; Engelstadter J, 2009, HEREDITY, V103, P196, DOI 10.1038/hdy.2009.53; Farkas JZ, 2010, B MATH BIOL, V72, P2067, DOI 10.1007/s11538-010-9528-1; Flor M, 2007, J EVOLUTION BIOL, V20, P696, DOI 10.1111/j.1420-9101.2006.01252.x; Frank SA, 1998, J THEOR BIOL, V192, P213, DOI 10.1006/jtbi.1998.0652; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Harris LR, 2010, HEREDITY, V104, P239, DOI 10.1038/hdy.2009.130; Hiroki M, 2005, EVOL ECOL RES, V7, P931; James AC, 2000, EVOLUTION, V54, P1661, DOI 10.1111/j.0014-3820.2000.tb00710.x; Jansen VAA, 2008, P ROY SOC B-BIOL SCI, V275, P2769, DOI 10.1098/rspb.2008.0914; Kawasaki Y, 2010, B ENTOMOL RES, V100, P231, DOI 10.1017/S000748530999023X; Kittayapong P, 2002, AM J TROP MED HYG, V66, P103, DOI 10.4269/ajtmh.2002.66.103; Kondo N, 2002, MOL ECOL, V11, P167, DOI 10.1046/j.0962-1083.2001.01432.x; Malloch G, 2005, MOL ECOL, V14, P627, DOI 10.1111/j.1365-294X.2005.02432.x; Mouton L, 2004, GENETICS, V168, P181, DOI 10.1534/genetics.104.026716; Poinsot D, 2000, HEREDITY, V85, P191, DOI 10.1046/j.1365-2540.2000.00736.x; Rasgon JL, 2003, GENETICS, V165, P2029; Shoemaker DD, 1999, EVOLUTION, V53, P1157, DOI [10.2307/2640819, 10.1111/j.1558-5646.1999.tb04529.x]; Shoemaker DD, 2002, P ROY SOC B-BIOL SCI, V269, P2257, DOI 10.1098/rspb.2002.2100; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x; TURELLI M, 1995, GENETICS, V140, P1319; Vavre F, 2001, EVOLUTION, V55, P1710, DOI 10.1111/j.0014-3820.2001.tb00691.x; Watanabe M, 2011, HEREDITY, V106, P642, DOI 10.1038/hdy.2010.100; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Zchori-Fein E, 2004, MOL ECOL, V13, P2009, DOI 10.1111/j.1365-294X.2004.02203.x	35	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94900	10.1371/journal.pone.0094900	http://dx.doi.org/10.1371/journal.pone.0094900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747216	gold, Green Published, Green Submitted			2022-12-25	WOS:000335226500040
J	Bowen, WC; Michalopoulos, AW; Orr, A; Ding, MQ; Stolz, DB; Michalopoulos, GK				Bowen, William C.; Michalopoulos, Amantha W.; Orr, Anne; Ding, Michael Q.; Stolz, Donna B.; Michalopoulos, George K.			Development of a Chemically Defined Medium and Discovery of New Mitogenic Growth Factors for Mouse Hepatocytes: Mitogenic Effects of FGF1/2 and PDGF	PLOS ONE			English	Article							LIVER-REGENERATION; RAT HEPATOCYTES; IN-VITRO; RECEPTOR; ALPHA; CULTURE; INJURY; HOMEOSTASIS; EXPRESSION; REGULATOR	Chemically defined serum-free media for rat hepatocytes have been useful in identifying EGFR ligands and HGF/MET signaling as direct mitogenic factors for rat hepatocytes. The absence of such media for mouse hepatocytes has prevented screening for discovery of such mitogens for mouse hepatocytes. We present results obtained by designing such a chemically defined medium for mouse hepatocytes and demonstrate that in addition to EGFR ligands and HGF, the growth factors FGF1 and FGF2 are also important mitogenic factors for mouse hepatocytes. Smaller mitogenic response was also noticed for PDGF AB. Mouse hepatocytes are more likely to enter into spontaneous proliferation in primary culture due to activation of cell cycle pathways resulting from collagenase perfusion. These results demonstrate unanticipated fundamental differences in growth biology of hepatocytes between the two rodent species.	[Bowen, William C.; Michalopoulos, Amantha W.; Orr, Anne; Ding, Michael Q.; Michalopoulos, George K.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Stolz, Donna B.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Michalopoulos, GK (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	michalopoulosgk@msx.upmc.edu		Ding, Michael/0000-0001-8306-6379	NIH [DK35373, CA103958]; NATIONAL CANCER INSTITUTE [R01CA103958] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by NIH grants DK35373 and CA103958 (GKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awuah PK, 2013, AM J PATHOL, V182, P1648, DOI 10.1016/j.ajpath.2013.01.047; Awuah PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039771; Block GD, 1996, J CELL BIOL, V132, P1133, DOI 10.1083/jcb.132.6.1133; BUCHER NLR, 1990, SEMIN LIVER DIS, V10, P11, DOI 10.1055/s-2008-1040453; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; De Marchis F, 2002, BLOOD, V99, P2045, DOI 10.1182/blood.V99.6.2045; Faraone D, 2006, BLOOD, V107, P1896, DOI 10.1182/blood-2005-04-1524; Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998; KAN M, 1989, P NATL ACAD SCI USA, V86, P7432, DOI 10.1073/pnas.86.19.7432; KOST DP, 1990, J CELL PHYSIOL, V144, P122, DOI 10.1002/jcp.1041440116; KOST DP, 1991, J CELL PHYSIOL, V147, P274, DOI 10.1002/jcp.1041470212; LIU ML, 1994, HEPATOLOGY, V19, P1521; Luo YD, 2010, J BIOL CHEM, V285, P30069, DOI 10.1074/jbc.M110.148288; Michalopoulos GK, 2013, COMPR PHYSIOL, V3, P485, DOI 10.1002/cphy.c120014; Michalopoulos GK, 2011, INT J BIOCHEM CELL B, V43, P173, DOI 10.1016/j.biocel.2009.09.014; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Michalopoulos GK, 2007, J CELL PHYSL; MUSAT AI, 1993, HEPATOLOGY, V18, P198, DOI 10.1002/hep.1840180129; NOVICKI DL, 1985, CANCER RES, V45, P337; Russo K, 2002, J BIOL CHEM, V277, P1284, DOI 10.1074/jbc.M108858200; Steiling H, 2003, ONCOGENE, V22, P4380, DOI 10.1038/sj.onc.1206499; Uriarte I, 2013, GUT, V62, P899, DOI 10.1136/gutjnl-2012-302945; Wagner JP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003994; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Yu CD, 2002, AM J PATHOL, V161, P2003, DOI 10.1016/S0002-9440(10)64478-1	25	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95487	10.1371/journal.pone.0095487	http://dx.doi.org/10.1371/journal.pone.0095487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743506	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000335309100125
J	Carnevali, L; Graiani, G; Rossi, S; Al Banchaabouchi, M; Macchi, E; Quaini, F; Rosenthal, N; Sgoifo, A				Carnevali, Luca; Graiani, Gallia; Rossi, Stefano; Al Banchaabouchi, Mumna; Macchi, Emilio; Quaini, Federico; Rosenthal, Nadia; Sgoifo, Andrea			Signs of Cardiac Autonomic Imbalance and Proarrhythmic Remodeling in FTO Deficient Mice	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; QT INTERVAL PROLONGATION; NERVOUS-SYSTEM; OBESITY; GENE; STIMULATION; ARRHYTHMIAS; DISPERSION; DURATION; BALANCE	In humans, variants of the fat mass and obesity associated (FTO) gene have recently been associated with obesity. However, the physiological function of FTO is not well defined. Previous investigations in mice have linked FTO deficiency to growth retardation, loss of white adipose tissue, increased energy metabolism and enhanced systemic sympathetic activation. In this study we investigated for the first time the effects of global knockout of the mouse FTO gene on cardiac function and its autonomic neural regulation. ECG recordings were acquired via radiotelemetry in homozygous knockout (n = 12) and wild-type (n = 8) mice during resting and stress conditions, and analyzed by means of time-and frequency-domain indexes of heart rate variability. In the same animals, cardiac electrophysiological properties (assessed by epicardial mapping) and structural characteristics were investigated. Our data indicate that FTO knockout mice were characterized by (i) higher heart rate values during resting and stress conditions, (ii) heart rate variability changes (increased LF to HF ratio), (iii) larger vulnerability to stress-induced tachyarrhythmias, (iv) altered ventricular repolarization, and (v) cardiac hypertrophy compared to wild-type counterparts. We conclude that FTO deficiency in mice leads to an imbalance of the autonomic neural modulation of cardiac function in the sympathetic direction and to a potentially proarrhythmic remodeling of electrical and structural properties of the heart.	[Carnevali, Luca; Sgoifo, Andrea] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Graiani, Gallia; Quaini, Federico] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Rossi, Stefano; Macchi, Emilio] Univ Parma, Dept Life Sci, I-43100 Parma, Italy; [Al Banchaabouchi, Mumna] CSF Campus Sci Support Facil GmbH, Preclin Phenotyping Facil, Vienna, Austria; [Rosenthal, Nadia] Monash Univ, Australian Regenerat Med Inst, EMBL Australia, Melbourne, Vic 3004, Australia; [Al Banchaabouchi, Mumna; Rosenthal, Nadia] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy	University of Parma; University of Parma; University Hospital of Parma; University of Parma; Australian Regenerative Medicine Institute; European Molecular Biology Laboratory (EMBL); Monash University; European Molecular Biology Laboratory (EMBL)	Sgoifo, A (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	andrea.sgoifo@unipr.it	Carnevali, Luca/P-9508-2019; Carnevali, Luca/E-5322-2017; Rossi, Stefano/L-2556-2016; Sgoifo, Andrea/AAC-6278-2022	Carnevali, Luca/0000-0001-9053-7976; Carnevali, Luca/0000-0001-9053-7976; Rossi, Stefano/0000-0003-0346-8410; Sgoifo, Andrea/0000-0002-9428-6198; Rosenthal, Nadia/0000-0002-7599-7365; Quaini, Federico/0000-0003-2377-4810; Graiani, Gallia/0000-0003-1926-7568	University of Parma; EU [HEALTH-F4-2009-223487, FP7-214539]; National Health and Medical Research Council Australia; ARC Stem Cells Australia	University of Parma; EU(European Commission); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); ARC Stem Cells Australia(Australian Research Council)	This work was funded by a grant from the University of Parma (FIL Project 2012) to AS and by the EU Grant EUCOMMTOOLS (HEALTH-F4-2009-223487) to MAB and NR. FQ and GG are supported by the EU grant BIOSCENT (FP7-214539), and NR is supported by a National Health and Medical Research Council Australia Fellowship and ARC Stem Cells Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABILDSKOV JA, 1976, AM HEART J, V92, P210, DOI 10.1016/S0002-8703(76)80256-6; Arnar DO, 1997, AM HEART J, V134, P395, DOI 10.1016/S0002-8703(97)70072-3; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BROWNE KF, 1982, AM J CARDIOL, V50, P1099, DOI 10.1016/0002-9149(82)90425-8; Burton FL, 2001, CARDIOVASC RES, V50, P10, DOI 10.1016/S0008-6363(01)00197-3; Camm AJ, 1996, CIRCULATION, V93, P1043; Carnevali L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041184; CHEEMA AN, 1995, J AM COLL CARDIOL, V26, P497, DOI 10.1016/0735-1097(95)80028-F; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Colussi C, 2010, CARDIOVASC RES, V87, P73, DOI 10.1093/cvr/cvq035; Costoli T, 2005, NEUROSCI BIOBEHAV R, V29, P113, DOI 10.1016/j.neubiorev.2004.09.016; Curtis MJ, 2013, PHARMACOL THERAPEUT, V139, P213, DOI 10.1016/j.pharmthera.2013.04.008; DAMPNEY RAL, 1994, PHYSIOL REV, V74, P323, DOI 10.1152/physrev.1994.74.2.323; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; FOZZARD HA, 1972, J PHYSIOL-LONDON, V226, P593, DOI 10.1113/jphysiol.1972.sp009999; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mancia G, 1999, J HYPERTENS, V17, pS55; McMurray F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003166; Nunn N, 2011, CURR NEUROPHARMACOL, V9, P262, DOI 10.2174/157015911795596531; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Oikarinen L, 2001, J HYPERTENS, V19, P1883, DOI 10.1097/00004872-200110000-00025; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; PRIORI SG, 1990, AM J PHYSIOL, V258, pH1796, DOI 10.1152/ajpheart.1990.258.6.H1796; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; SCHWARTZ PJ, 1978, CIRCULATION, V57, P1074, DOI 10.1161/01.CIR.57.6.1074; Sgoifo A, 1997, AM J PHYSIOL-HEART C, V273, pH1754, DOI 10.1152/ajpheart.1997.273.4.H1754; Sgoifo A, 1996, PHYSIOL BEHAV, V60, P1397, DOI 10.1016/S0031-9384(96)00228-4; STEIN PK, 1994, AM HEART J, V127, P1376, DOI 10.1016/0002-8703(94)90059-0; Tan TP, 2003, J CARDIOVASC PHARM, V42, P182, DOI 10.1097/00005344-200308000-00005; Tews D, 2013, ENDOCRINOLOGY, V154, P3141, DOI 10.1210/en.2012-1873; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; TODA N, 1968, J PHARMACOL EXP THER, V159, P298; Trombini M, 2012, STRESS, V15, P457, DOI 10.3109/10253890.2011.639414; VALENZUELA F, 1983, CARDIOVASC RES, V17, P608, DOI 10.1093/cvr/17.10.608; Wang HW, 2009, ACTA PHARMACOL SIN, V30, P1115, DOI 10.1038/aps.2009.96; ZIPES DP, 1983, PACE, V6, P1210, DOI 10.1111/j.1540-8159.1983.tb04459.x	42	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95499	10.1371/journal.pone.0095499	http://dx.doi.org/10.1371/journal.pone.0095499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743632	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100128
J	Fischer, S; Ronellenfitsch, MW; Thiepold, AL; Harter, PN; Reichert, S; Kogel, D; Paschke, R; Mittelbronn, M; Weller, M; Steinbach, JP; Fulda, S; Bahr, O				Fischer, Sebastian; Ronellenfitsch, Michael W.; Thiepold, Anna-Luisa; Harter, Patrick N.; Reichert, Sebastian; Koegel, Donat; Paschke, Reinhard; Mittelbronn, Michel; Weller, Michael; Steinbach, Joachim P.; Fulda, Simone; Baehr, Oliver			Hypoxia Enhances the Antiglioma Cytotoxicity of B10, a Glycosylated Derivative of Betulinic Acid	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; AUTOPHAGY; DEATH; INHIBITION	B10 is a glycosylated derivative of betulinic acid with promising activity against glioma cells. Lysosomal cell death pathways appear to be essential for its cytotoxicity. We investigated the influence of hypoxia, nutrient deprivation and current standard therapies on B10 cytotoxicity. The human glioma cell lines LN-308 and LNT-229 were exposed to B10 alone or together with irradiation, temozolomide, nutrient deprivation or hypoxia. Cell growth and viability were evaluated by crystal violet staining, clonogenicity assays, propidium iodide uptake and LDH release assays. Cell death was examined using an inhibitor of lysosomal acidification (bafilomycin A1), a cathepsin inhibitor (CA074-Me) and a short-hairpin RNA targeting cathepsin B. Hypoxia substantially enhanced B10-induced cell death. This effect was sensitive to bafilomycin A1 and thus dependent on hypoxia-induced lysosomal acidification. Cathepsin B appeared to mediate cell death because either the inhibitor CA074-Me or cathepsin B gene silencing rescued glioma cells from B10 toxicity under hypoxia. B10 is a novel antitumor agent with substantially enhanced cytotoxicity under hypoxia conferred by increased lysosomal cell death pathway activation. Given the importance of hypoxia for therapy resistance, malignant progression, and as a result of antiangiogenic therapies, B10 might be a promising strategy for hypoxic tumors like malignant glioma.	[Fischer, Sebastian; Ronellenfitsch, Michael W.; Thiepold, Anna-Luisa; Steinbach, Joachim P.; Baehr, Oliver] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dr Senckenberg Inst Neurooncol, D-60054 Frankfurt, Germany; [Harter, Patrick N.; Mittelbronn, Michel] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Inst Neurol, Edinger Inst, D-60054 Frankfurt, Germany; [Reichert, Sebastian] Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dept Radiat Therapy & Oncol, D-60054 Frankfurt, Germany; [Koegel, Donat] Goethe Univ Frankfurt, Univ Hosp Frankfurt, D-60054 Frankfurt, Germany; [Paschke, Reinhard] Univ Halle Wittenberg, Bioctr, D-06108 Halle, Germany; [Weller, Michael] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Fulda, Simone] Goethe Univ Frankfurt, Inst Expt Canc Res Pediat, D-60054 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Martin Luther University Halle Wittenberg; University of Zurich; University Zurich Hospital; Goethe University Frankfurt	Bahr, O (corresponding author), Goethe Univ Frankfurt, Univ Hosp Frankfurt, Dr Senckenberg Inst Neurooncol, D-60054 Frankfurt, Germany.	oliver.baehr@med.uni-frankfurt.de	Ronellenfitsch, Michael/AAW-8201-2020; Thiepold, Anna-Luisa/AAW-8310-2021	Ronellenfitsch, Michael/0000-0002-1402-6290; Weller, Michael/0000-0002-1748-174X; Kogel, Donat/0000-0003-1209-0210; Mittelbronn, Michel/0000-0002-2998-052X; Fulda, Simone/0000-0002-0459-6417; Harter, Patrick N./0000-0001-5530-6910	Bundesministerium fur Bildung und Forschung [01GU0610]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work has been partially supported by a Grant from the Bundesministerium fur Bildung und Forschung (01GU0610, www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alakurtti S, 2006, EUR J PHARM SCI, V29, P1, DOI 10.1016/j.ejps.2006.04.006; Azad MB, 2008, AUTOPHAGY, V4, P195, DOI 10.4161/auto.5278; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Colin C, 2009, ACTA NEUROPATHOL, V118, P745, DOI 10.1007/s00401-009-0592-2; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Fulda S, 2009, DRUG DISCOV TODAY, V14, P885, DOI 10.1016/j.drudis.2009.05.015; Gonzalez P, 2012, CELL DEATH DIFFER, V19, P1337, DOI 10.1038/cdd.2012.10; GRADY JE, 1960, CANCER RES, V20, P1114; Kommera H, 2010, CHEM-BIOL INTERACT, V185, P128, DOI 10.1016/j.cbi.2010.02.038; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Reichert S, 2011, RADIOTHER ONCOL, V101, P51, DOI 10.1016/j.radonc.2011.06.037; Ronellenfitsch MW, 2009, BRAIN, V132, P1509, DOI 10.1093/brain/awp093; Roth W, 1997, CANCER IMMUNOL IMMUN, V44, P55, DOI 10.1007/s002620050355; Rozen S, 2000, Methods Mol Biol, V132, P365; Steinbach JP, 2004, CANCER RES, V64, P1575, DOI 10.1158/0008-5472.CAN-03-3775; Steinbach JP, 2003, CELL DEATH DIFFER, V10, P823, DOI 10.1038/sj.cdd.4401252; STUDER A, 1985, ACTA NEUROPATHOL, V66, P208, DOI 10.1007/BF00688585; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wanka C, 2012, ONCOGENE, V31, P3764, DOI 10.1038/onc.2011.530; Wickramasinghe NS, 2005, ANTICANCER RES, V25, P2841; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707	26	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94921	10.1371/journal.pone.0094921	http://dx.doi.org/10.1371/journal.pone.0094921			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743710	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100051
J	Limbri, H; Gunawan, C; Thomas, T; Smith, A; Scott, J; Rosche, B				Limbri, Hendy; Gunawan, Cindy; Thomas, Torsten; Smith, Andrew; Scott, Jason; Rosche, Bettina			Coal-Packed Methane Biofilter for Mitigation of Green House Gas Emissions from Coal Mine Ventilation Air	PLOS ONE			English	Article							METHANOTROPHIC BACTERIA; SP NOV.; BIOTRICKLING FILTERS; BIOFILTRATION; FRACTIONATION; OXIDATION; REMOVAL; WATER	Methane emitted by coal mine ventilation air (MVA) is a significant greenhouse gas. A mitigation strategy is the oxidation of methane to carbon dioxide, which is approximately twenty-one times less effective at global warming than methane on a mass-basis. The low non-combustible methane concentrations at high MVA flow rates call for a catalytic strategy of oxidation. A laboratory-scale coal-packed biofilter was designed and partially removed methane from humidified air at flow rates between 0.2 and 2.4 L min(-1) at 30 degrees C with nutrient solution added every three days. Methane oxidation was catalysed by a complex community of naturally-occurring microorganisms, with the most abundant member being identified by 16S rRNA gene sequence as belonging to the methanotrophic genus Methylocystis. Additional inoculation with a laboratory-grown culture of Methylosinus sporium, as investigated in a parallel run, only enhanced methane consumption during the initial 12 weeks. The greatest level of methane removal of 27.2 +/- 0.66 g methane m(-3) empty bed h(-1) was attained for the non-inoculated system, which was equivalent to removing 19.7 +/- 2.9% methane from an inlet concentration of 1% v/v at an inlet gas flow rate of 1.6 L min(-1) (2.4 min empty bed residence time). These results show that low-cost coal packing holds promising potential as a suitable growth surface and contains methanotrophic microorganisms for the catalytic oxidative removal of methane.	[Limbri, Hendy; Gunawan, Cindy; Smith, Andrew; Scott, Jason] Univ New S Wales, Sch Chem Engn, Sydney, NSW, Australia; [Thomas, Torsten; Rosche, Bettina] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Thomas, Torsten] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Rosche, B (corresponding author), Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	b.rosche@unsw.edu.au		Gunawan, Cindy/0000-0002-2957-1347; Thomas, Torsten/0000-0001-9557-3001; Scott, Jason/0000-0003-2395-2058	Australian Coal Association Research Program (ACARP) [C16048]	Australian Coal Association Research Program (ACARP)	This study was supported by the Australian Coal Association Research Program (ACARP, Project C16048, www.acarp.com.au). The funders had no role in study design, data collection and analysis, or preparation of the manuscript, and have approved publication of the study.	APEL WA, 1991, FUEL, V70, P1001, DOI 10.1016/0016-2361(91)90058-I; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BJORNSEN PK, 1986, APPL ENVIRON MICROB, V51, P1199; Chakravorty RN, 1985, 2 US MIN VENT S REN, P699; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cork D, 2012, AUSTRALIAN MINE VENTILATION CONFERENCE 2011, P117; Cox HHJ, 1998, CURR OPIN BIOTECH, V9, P256, DOI 10.1016/S0958-1669(98)80056-6; Dedysh SN, 2007, INT J SYST EVOL MICR, V57, P472, DOI 10.1099/ijs.0.64623-0; Dever SA, 2007, WASTE MANAGE, V27, P277, DOI 10.1016/j.wasman.2006.01.014; du Plessis CA, 2003, FUEL, V82, P1359, DOI 10.1016/S0016-2361(03)00040-1; EPA US, 2010, COAL MIN METH COUNTR; Gebert J, 2006, WASTE MANAGE, V26, P399, DOI 10.1016/j.wasman.2005.11.007; Girard M, 2011, CHEM ENG J, V168, P151, DOI 10.1016/j.cej.2010.12.054; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Jahnke LL, 1999, GEOCHIM COSMOCHIM AC, V63, P79, DOI 10.1016/S0016-7037(98)00270-1; Josiane N, 2009, CAN J CHEM ENG, V87, P136, DOI 10.1002/cjce.20131; Karakurt I, 2011, RENEW SUST ENERG REV, V15, P1042, DOI 10.1016/j.rser.2010.11.030; Kim JM, 2008, APPL ENVIRON MICROB, V74, P7313, DOI 10.1128/AEM.01695-08; Kim S, 2008, CHEM ENG SCI, V63, P841, DOI 10.1016/j.ces.2007.10.011; Knief C, 2005, ENVIRON MICROBIOL, V7, P1307, DOI 10.1111/j.1462-2920.2005.00814.x; Le Cloirec P, 2001, WATER SCI TECHNOL, V44, P219, DOI 10.2166/wst.2001.0544; Limbri H, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1566-5; Lontoh S, 1998, APPL ENVIRON MICROB, V64, P1106; Lopez JC, 2013, APPL MICROBIOL BIOT, V97, P2277, DOI 10.1007/s00253-013-4734-z; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Nealson KH, 1997, REV MINERAL, V35, P5; Nikiema J, 2005, CHEM ENG J, V113, P111, DOI 10.1016/j.cej.2005.04.005; Popat SC, 2010, PROCESS BIOCHEM, V45, P549, DOI 10.1016/j.procbio.2009.11.017; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramirez AA, 2012, J CHEM TECHNOL BIOT, V87, P848, DOI 10.1002/jctb.3811; Rocha-Rios J, 2009, CHEM ENG J, V152, P289, DOI 10.1016/j.cej.2009.04.028; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SEBACHER DI, 1983, TELLUS B, V35, P103, DOI 10.1111/j.1600-0889.1983.tb00014.x; Serra MCC, 2006, J CHEM THERMODYN, V38, P1629, DOI 10.1016/j.jct.2006.03.019; Sloss L., 2005, COALBED METHANE EMIS; SLY LI, 1993, APPL MICROBIOL BIOT, V39, P400, DOI 10.1007/BF00192101; Su S, 2005, PROG ENERG COMBUST, V31, P123, DOI 10.1016/j.pecs.2004.11.001; Su S, 2008, J ENVIRON MANAGE, V86, P44, DOI 10.1016/j.jenvman.2006.11.025; U. S. Environmental Protection Agency, 2013, INV US GREENH GAS EM; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu G, 2013, INT J SYST EVOL MICR, V63, P3352, DOI 10.1099/ijs.0.049718-0; Wu XL, 2009, INT J SYST EVOL MICR, V59, P300, DOI 10.1099/ijs.0.65758-0; Xie CH, 2005, INT J SYST EVOL MICR, V55, P2419, DOI 10.1099/ijs.0.63733-0; Yoon S, 2009, APPL MICROBIOL BIOT, V83, P949, DOI 10.1007/s00253-009-1977-9	45	30	31	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94641	10.1371/journal.pone.0094641	http://dx.doi.org/10.1371/journal.pone.0094641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743729	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100036
J	Misimi, E; Martinsen, S; Mathiassen, JR; Erikson, U				Misimi, Ekrem; Martinsen, Svein; Mathiassen, John Reidar; Erikson, Ulf			Discrimination between Weaned and Unweaned Atlantic Cod (Gadus morhua) in Capture-Based Aquaculture (CBA) by X-Ray Imaging and Radio-Frequency Metal Detector	PLOS ONE			English	Article							FEED-INTAKE; GROWTH; SALMON	The aim of this study was to investigate the feasibility of two detection methods for use in discrimination and sorting of adult Atlantic cod (about 2 kg) in the small scale capture-based aquaculture (CBA). Presently, there is no established method for discrimination of weaned and unweaned cod in CBA. Generally, 60-70% of the wild-caught cod in the CBA are weaned into commercial dry feed. To increase profitability for the fish farmers, unweaned cod must be separated from the stock, meaning the fish must be sorted into two groups - unweaned and weaned from moist feed. The challenges with handling of large numbers of fish in cages, defined the limits of the applied technology. As a result, a working model was established, focusing on implementing different marking materials added to the fish feed, and different technology for detecting the feed presence in the fish gut. X-ray imaging in two modes (planar and dual energy band) and sensitive radio-frequency metal detection were the detection methods that were chosen for the investigations. Both methods were tested in laboratory conditions using dead fish with marked feed inserted into the gut cavity. In particular, the sensitive radio-frequency metal detection method with carbonyl powder showed very promising results in detection of marked feed. Results show also that Dual energy band X-ray imaging may have potential for prediction of fat content in the feed. Based on the investigations it can be concluded that both X-ray imaging and sensitive radio-frequency metal detector technology have the potential for detecting cod having consumed marked feed. These are all technologies that may be adapted to large scale handling of fish from fish cages. Thus, it may be possible to discriminate between unweaned and weaned cod in a large scale grading situation. Based on the results of this study, a suggestion for evaluation of concept for in-situ sorting system is presented.	[Misimi, Ekrem; Martinsen, Svein; Mathiassen, John Reidar; Erikson, Ulf] SINTEF Fisheries & Aquaculture, Trondheim, Norway	SINTEF	Misimi, E (corresponding author), SINTEF Fisheries & Aquaculture, Trondheim, Norway.	ekrem.misimi@sintef.no		Misimi, Ekrem/0000-0003-2489-7759	Fisheries and Aquaculture Research Fund - FHF through the project "Capture-based Aquaculture"	Fisheries and Aquaculture Research Fund - FHF through the project "Capture-based Aquaculture"	This work was funded by Fisheries and Aquaculture Research Fund - FHF through the project "Capture-based Aquaculture". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAATEN B, 1984, PROPAGATION COD GADU, P677; Dreyer B.M., 2008, CAPTURE BASED AQUACU, P183; GORDEUK VR, 1986, BLOOD, V67, P745; Hermansen O, 2012, MAR POLICY, V36, P206, DOI 10.1016/j.marpol.2011.05.005; Jobling M, 1995, AQUACULT NUTR, V1, P131, DOI 10.1111/j.1365-2095.1995.tb00037.x; Jobling M., 2001, FOOD INTAKE FISH; Jobling Malcolm, 1993, Reviews in Fisheries Science, V1, P223; Martinsen S, 2009, SFH80F094027 SINTEF; Pirhonen J, 2003, AQUACULTURE, V216, P31, DOI 10.1016/S0044-8486(02)00435-0; Refstie S, 2006, AQUACULTURE, V255, P279, DOI 10.1016/j.aquaculture.2006.01.002; Saether BS, 2009, 42009 NOFIMA; Saether BS, 2012, 142012 NOFIMA; Santos JD, 1991, J FISH BIOL, V38, P697; Segtnan VH, 2009, J AGR FOOD CHEM, V57, P1705, DOI 10.1021/jf802080s; TALBOT C, 1983, J FISH BIOL, V23, P211, DOI 10.1111/j.1095-8649.1983.tb02896.x; Toften H, 2003, AQUACULTURE, V217, P647, DOI 10.1016/S0044-8486(02)00404-0; Veliyulin E, 2011, J FOOD SCI, V76, pE328, DOI 10.1111/j.1750-3841.2011.02093.x	17	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95363	10.1371/journal.pone.0095363	http://dx.doi.org/10.1371/journal.pone.0095363			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743448	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100110
J	Singer, BB; Opp, L; Heinrich, A; Schreiber, F; Binding-Liermann, R; Berrocal-Almanza, LC; Heyl, KA; Muller, MM; Weimann, A; Zweigner, J; Slevogt, H				Singer, Bernhard B.; Opp, Lena; Heinrich, Annina; Schreiber, Frauke; Binding-Liermann, Ramona; Berrocal-Almanza, Luis Carlos; Heyl, Kerstin A.; Mueller, Mario M.; Weimann, Andreas; Zweigner, Janine; Slevogt, Hortense			Soluble CEACAM8 Interacts with CEACAM1 Inhibiting TLR2-Triggered Immune Responses	PLOS ONE			English	Article							B-CELL RECEPTOR; EPITHELIAL-CELLS; MORAXELLA-CATARRHALIS; HUMAN NEUTROPHILS; BRONCHOALVEOLAR LAVAGE; INFLAMMATORY RESPONSE; ACTIVATION; ADHESION; EXPRESSION	Lower respiratory tract bacterial infections are characterized by neutrophilic inflammation in the airways. The carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 8 is expressed in and released by human granulocytes. Our study demonstrates that human granulocytes release CEACAM8 in response to bacterial DNA in a TLR9-dependent manner. Individuals with a high percentage of bronchial lavage fluid (BALF) granulocytes were more likely to have detectable levels of released CEACAM8 in the BALF than those with a normal granulocyte count. Soluble, recombinant CEACAM8-Fc binds to CEACAM1 expressed on human airway epithelium. Application of CEACAM8-Fc to CEACAM1-positive human pulmonary epithelial cells resulted in reduced TLR2-dependent inflammatory responses. These inhibitory effects were accompanied by tyrosine phosphorylation of the immunoreceptor tyrosine-based inhibitory motif (ITIM) of CEACAM1 and by recruitment of the phosphatase SHP-1, which could negatively regulate Toll-like receptor 2-dependent activation of the phosphatidylinositol 3-OH kinase-Akt kinase pathway. Our results suggest a new mechanism by which granulocytes reduce pro-inflammatory immune responses in human airways via secretion of CEACAM8 in neutrophil-driven bacterial infections.	[Singer, Bernhard B.] Univ Duisburg Essen, Univ Hosp, Inst Anat, Essen, Germany; [Opp, Lena; Heinrich, Annina; Schreiber, Frauke; Binding-Liermann, Ramona; Berrocal-Almanza, Luis Carlos] Charite, Inst Microbiol & Hyg, Campus Benjamin Franklin, D-13353 Berlin, Germany; [Heyl, Kerstin A.; Mueller, Mario M.; Slevogt, Hortense] Univ Hosp Jena, ZIK Sept, Jena, Germany; [Weimann, Andreas] Lab Berlin Charite Vivantes Serv GmbH, Berlin, Germany; [Weimann, Andreas] Charite, Inst Lab Med Clin Chem & Pathobiochem, D-13353 Berlin, Germany; [Zweigner, Janine] Charite, Inst Hyg & Environm Med, Campus Benjamin Franklin, D-13353 Berlin, Germany	University of Duisburg Essen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena; Labor Berlin - Charite Vivantes GmbH; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Slevogt, H (corresponding author), Univ Hosp Jena, ZIK Sept, Jena, Germany.	hortense.slevogt@med.uni-jena.de	Singer, Bernhard B./AAP-9999-2020	Heyl, Kerstin/0000-0001-9659-2300; Muller, Mario/0000-0002-1898-5691	Deutsche Forschungsgemeinschaft [SL 153/1-2]; International Graduate School (IRTG) [GRK1673]; Federal Ministry for Education and Science [BMBF 03Z2JN22]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Graduate School (IRTG); Federal Ministry for Education and Science	Supported by the Deutsche Forschungsgemeinschaft (SL 153/1-2), by the International Graduate School (IRTG) GRK1673 and by the Federal Ministry for Education and Science (grant BMBF 03Z2JN22) all to HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; El Kebir D, 2009, J IMMUNOL, V182, P4386, DOI 10.4049/jimmunol.0803044; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Greicius G, 2003, J LEUKOCYTE BIOL, V74, P126, DOI 10.1189/jlb.1202594; Hart D, 2008, J IMMUNOL, V181, P8053, DOI 10.4049/jimmunol.181.11.8053; Jiang L, 2010, IMMUNOLOGY, V129, P55, DOI 10.1111/j.1365-2567.2009.03153.x; Jog NR, 2007, AM J PHYSIOL-CELL PH, V292, pC1690, DOI 10.1152/ajpcell.00384.2006; Kammerer R, 1998, EUR J IMMUNOL, V28, P3664, DOI 10.1002/(SICI)1521-4141(199811)28:11<3664::AID-IMMU3664>3.0.CO;2-D; Kammerer R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-196; KUROKI M, 1995, IMMUNOL INVEST, V24, P829, DOI 10.3109/08820139509060710; KUROKI M, 1992, J LEUKOCYTE BIOL, V52, P551, DOI 10.1002/jlb.52.5.551; Lobo EO, 2009, J LEUKOCYTE BIOL, V86, P205, DOI 10.1189/jlb.0109037; Lu RZ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002597; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Meyer KC, 2007, SEMIN RESP CRIT CARE, V28, P546, DOI 10.1055/s-2007-991527; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Pan H, 2010, IMMUNITY, V33, P620, DOI 10.1016/j.immuni.2010.10.009; Parker D, 2011, AM J RESP CELL MOL, V45, P189, DOI 10.1165/rcmb.2011-0011RT; Radsak MP, 2004, J IMMUNOL, V172, P4956, DOI 10.4049/jimmunol.172.8.4956; Schaar V, 2011, CELL MICROBIOL, V13, P432, DOI 10.1111/j.1462-5822.2010.01546.x; Schmidt T, 2012, J LEUKOCYTE BIOL, V91, P791, DOI 10.1189/jlb.0911483; Schwartz DA, 1997, J CLIN INVEST, V100, P68, DOI 10.1172/JCI119523; Shields AM, 2011, CLIN EXP IMMUNOL, V165, P292, DOI 10.1111/j.1365-2249.2011.04433.x; Singer BB, 2002, J IMMUNOL, V168, P5139, DOI 10.4049/jimmunol.168.10.5139; Singer BB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008747; Slevogt H, 2006, AM J PHYSIOL-LUNG C, V290, pL818, DOI 10.1152/ajplung.00428.2005; Slevogt H, 2008, NAT IMMUNOL, V9, P1270, DOI 10.1038/ni.1661; Slevogt H, 2007, CELL MICROBIOL, V9, P694, DOI 10.1111/j.1462-5822.2006.00821.x; Yoon J, 2007, J IMMUNOL, V179, P8454, DOI 10.4049/jimmunol.179.12.8454; Zhao LS, 2004, BRIT J HAEMATOL, V125, P666, DOI 10.1111/j.1365-2141.2004.04963.x	30	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94106	10.1371/journal.pone.0094106	http://dx.doi.org/10.1371/journal.pone.0094106			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743304	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100026
J	Su, YS; Pan, LQ				Su, Yansen; Pan, Linqiang			Identification of Logic Relationships between Genes and Subtypes of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; CARCINOMA; OVEREXPRESSION; ADENOCARCINOMA; AMPLIFICATION; MICROARRAYS; METAGENES; DISCOVERY; PATTERNS; SURVIVAL	Non-small cell lung cancer (NSCLC) has two major subtypes: adenocarcinoma (AC) and squamous cell carcinoma (SCC). The diagnosis and treatment of NSCLC are hindered by the limited knowledge about the pathogenesis mechanisms of subtypes of NSCLC. It is necessary to research the molecular mechanisms related with AC and SCC. In this work, we improved the logic analysis algorithm to mine the sufficient and necessary conditions for the presence states (presence or absence) of phenotypes. We applied our method to AC and SCC specimens, and identified 217 lower and 162 higher logic relationships between genes and two subtypes of NSCLC. The discovered relationships were independent of specimens selected, and their significance was validated by statistic test. Compared with the two earlier methods (the non-negative matrix factorization method and the relevance analysis method), the current method outperformed these methods in the recall rate and classification accuracy on NSCLC and normal specimens. We obtained 19 biomarkers. Among 19 biomarkers, 13 genes have been used to distinguish AC from SCC in practice, and other six genes were newly discovered biomarkers for distinguishing subtypes. Furthermore, NKX2-1 has been considered as a molecular target for the targeted therapy of AC, and 18 other genes may be novel molecular targets. By gene ontology analysis, we found that two biological processes ('epidermis development' and 'cell adhesion') were closely related with the tumorigenesis of subtypes of NSCLC. More generally, the current method could be extended to other complex diseases for distinguishing subtypes and detecting the molecular targets for targeted therapy.	[Su, Yansen; Pan, Linqiang] Huazhong Univ Sci & Technol, Sch Automat, Key Lab Image Informat Proc & Intelligent Control, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Su, YS (corresponding author), Huazhong Univ Sci & Technol, Sch Automat, Key Lab Image Informat Proc & Intelligent Control, Wuhan 430074, Hubei, Peoples R China.	suyansen1985@163.com; lqpan@mail.hust.edu.cn	Pan, Linqiang/E-4714-2011	Pan, Linqiang/0000-0002-4554-455X	National Natural Science Foundation of China [61100145, 61033003, 91130034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors' work is supported by the National Natural Science Foundation of China (Grant Nos. 61100145, 61033003 and 91130034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1993, SIGMOD Record, V22, P207, DOI 10.1145/170036.170072; Angulo B, 2008, J PATHOL, V214, P347, DOI 10.1002/path.2267; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boelens MC, 2007, J CLIN PATHOL, V60, P608, DOI 10.1136/jcp.2005.031443; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chang HH, 2011, CANCER-AM CANCER SOC, V117, P353, DOI 10.1002/cncr.25592; Coate LE, 2009, LANCET ONCOL, V10, P1001, DOI 10.1016/S1470-2045(09)70155-X; Cui TT, 2012, CARCINOGENESIS, V33, P2326, DOI 10.1093/carcin/bgs273; Dempke WCM, 2010, LUNG CANCER, V67, P257, DOI 10.1016/j.lungcan.2009.10.012; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Goh CS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-257; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Hayes DC, 2006, ANTICANCER RES, V26, P1567; Hipp J., 2000, SIGKDD EXPLOR NEWSL, P1, DOI DOI 10.1145/360402.360421; Huang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043441; Hugh J, 2009, J CLIN ONCOL, V27, P1168, DOI 10.1200/JCO.2008.18.1024; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Khayyata S, 2009, DIAGN CYTOPATHOL, V37, P178, DOI 10.1002/dc.20975; Kimchi ET, 2005, CANCER RES, V65, P3146, DOI 10.1158/0008-5472.CAN-04-2490; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Larsson O, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-129; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Massion PP, 2003, CANCER RES, V63, P7113; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Puglisi F, 1999, MODERN PATHOL, V12, P318; Ruan XG, 2008, J BIOMED INFORM, V41, P530, DOI 10.1016/j.jbi.2007.11.006; Sanchez-Cespedes M, 2008, ARCH PATHOL LAB MED, V132, P1562, DOI 10.1043/1543-2165(2008)132[1562:TIOGEM]2.0.CO;2; Schreiber G, 2003, CHEST, V123, p115S, DOI 10.1378/chest.123.1_suppl.115S; Slonim N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100047; Sprinzak E, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-115; Tamura M, 2008, BIOINFORMATICS, V24, P1523, DOI 10.1093/bioinformatics/btn210; Urgard E, 2011, CANCER INFORM, V10, P175, DOI 10.4137/CIN.S7135; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Young GD, 2002, LUNG CANCER-J IASLC, V36, P133, DOI 10.1016/S0169-5002(01)00486-X; Zhang H, 2004, P 14 WORKSH INF TECH, P140; Zhou ZY, 2012, J CHIN MED ASSOC, V75, P269, DOI 10.1016/j.jcma.2012.04.015	45	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94644	10.1371/journal.pone.0094644	http://dx.doi.org/10.1371/journal.pone.0094644			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743794	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100037
J	Syed, K; Mashele, SS				Syed, Khajamohiddin; Mashele, Samson Sitheni			Comparative Analysis of P450 Signature Motifs EXXR and CXG in the Large and Diverse Kingdom of Fungi: Identification of Evolutionarily Conserved Amino Acid Patterns Characteristic of P450 Family	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; COMPARATIVE GENOMICS; CYTOCHROME-P450; GENE; SEQUENCE; DOMAIN; CHRYSOSPORIUM; BIOSYNTHESIS; SUPERFAMILY; ANNOTATION	Cytochrome P450 monooxygenases (P450s) are heme-thiolate proteins distributed across the biological kingdoms. P450s are catalytically versatile and play key roles in organisms primary and secondary metabolism. Identification of P450s across the biological kingdoms depends largely on the identification of two P450 signature motifs, EXXR and CXG, in the protein sequence. Once a putative protein has been identified as P450, it will be assigned to a family and subfamily based on the criteria that P450s within a family share more than 40% homology and members of subfamilies share more than 55% homology. However, to date, no evidence has been presented that can distinguish members of a P450 family. Here, for the first time we report the identification of EXXR- and CXG-motifs-based amino acid patterns that are characteristic of the P450 family. Analysis of P450 signature motifs in the under-explored fungal P450s from four different phyla, ascomycota, basidiomycota, zygomycota and chytridiomycota, indicated that the EXXR motif is highly variable and the CXG motif is somewhat variable. The amino acids threonine and leucine are preferred as second and third amino acids in the EXXR motif and proline and glycine are preferred as second and third amino acids in the CXG motif in fungal P450s. Analysis of 67 P450 families from biological kingdoms such as plants, animals, bacteria and fungi showed conservation of a set of amino acid patterns characteristic of a particular P450 family in EXXR and CXG motifs. This suggests that during the divergence of P450 families from a common ancestor these amino acids patterns evolve and are retained in each P450 family as a signature of that family. The role of amino acid patterns characteristic of a P450 family in the structural and/or functional aspects of members of the P450 family is a topic for future research.	[Syed, Khajamohiddin; Mashele, Samson Sitheni] Cent Univ Technol, Fac Hlth & Environm Sci, Dept Hlth Sci, Bloemfontein, Free State, South Africa	Central University of Technology	Syed, K (corresponding author), Cent Univ Technol, Fac Hlth & Environm Sci, Dept Hlth Sci, Bloemfontein, Free State, South Africa.	khajamohiddinsyed@gmail.com	Syed, Khajamohiddin/L-8774-2013; Mashele, Samson Sitheni/AAC-4015-2020	Syed, Khajamohiddin/0000-0002-1497-3570; Mashele, Samson Sitheni/0000-0002-6339-4807	Central University of Technology (CUT) from the University Research and Innovation fund	Central University of Technology (CUT) from the University Research and Innovation fund	Syed thanks the Central University of Technology (CUT) for a grant from the University Research and Innovation fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; Butchko RAE, 2006, J AGR FOOD CHEM, V54, P9398, DOI 10.1021/jf0617869; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Montellano PR Ortiz, 1995, CYTOCHROME P450 STRU; Eschenfeldt WH, 2003, APPL ENVIRON MICROB, V69, P5992, DOI 10.1128/AEM.69.10.5992-5999.2003; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Fischer M, 2007, BIOINFORMATICS, V23, P2015, DOI 10.1093/bioinformatics/btm268; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; GOTOH O, 1992, J BIOL CHEM, V267, P83; Graham SE, 1999, ARCH BIOCHEM BIOPHYS, V369, P24, DOI 10.1006/abbi.1999.1350; Gricman L, 2014, PROTEINS, V82, P491, DOI 10.1002/prot.24415; Grigoriev I. V., 2011, Mycology - An International Journal on Fungal Biology, V2, P192; HASEMANN CA, 1995, STRUCTURE, V3, P41, DOI 10.1016/S0969-2126(01)00134-4; Hatae T, 1996, FEBS LETT, V389, P268, DOI 10.1016/0014-5793(96)00600-X; Hirosue S, 2011, BIOCHEM BIOPH RES CO, V407, P118, DOI 10.1016/j.bbrc.2011.02.121; Ide M, 2012, ARCH MICROBIOL, V194, P243, DOI 10.1007/s00203-011-0753-2; Kelly SL, 1997, J BIOL CHEM, V272, P9986, DOI 10.1074/jbc.272.15.9986; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Lamb DC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0434; Lepesheva GI, 2007, BBA-GEN SUBJECTS, V1770, P467, DOI 10.1016/j.bbagen.2006.07.018; Lepesheva GI, 2004, MOL CELL ENDOCRINOL, V215, P165, DOI 10.1016/j.mce.2003.11.016; Li ZZ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-130; Lida T, 2000, YEAST, V16, P1077, DOI 10.1002/1097-0061(20000915)16:12<1077::AID-YEA601>3.0.CO;2-K; Lisitsa AV, 2001, SAR QSAR ENVIRON RES, V12, P359, DOI 10.1080/10629360108033244; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Melo NR, 2008, ANTIMICROB AGENTS CH, V52, P3718, DOI 10.1128/AAC.00446-08; Moktali V, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-525; Nakayama N, 1996, J BIOCHEM-TOKYO, V119, P435; NEBERT DW, 1987, DNA-J MOLEC CELL BIO, V6, P1, DOI 10.1089/dna.1987.6.1; NEBERT DW, 1987, ANNU REV BIOCHEM, V56, P945, DOI 10.1146/annurev.biochem.56.1.945; NEBERT DW, 1989, XENOBIOTICA, V19, P1149, DOI 10.3109/00498258909043167; Nelson D R, 1998, Methods Mol Biol, V107, P15; Nelson David R, 2006, Methods Mol Biol, V320, P1; Nelson DR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0430; Nelson DR, 2011, BBA-PROTEINS PROTEOM, V1814, P14, DOI 10.1016/j.bbapap.2010.08.008; Nelson David R., 2009, Human Genomics, V4, P59; NELSON DR, 1993, DNA CELL BIOL, V12, P1, DOI 10.1089/dna.1993.12.1; NELSON DR, 1987, MOL BIOL EVOL, V4, P572; Park J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-402; Rigden DJ, 2003, FEMS MICROBIOL LETT, V221, P103, DOI 10.1016/S0378-1097(03)00160-5; Rojas MC, 2001, P NATL ACAD SCI USA, V98, P5838, DOI 10.1073/pnas.091096298; Rupasinghe S, 2006, FEBS LETT, V580, P6338, DOI 10.1016/j.febslet.2006.10.043; SANGLARD D, 1989, GENE, V76, P121, DOI 10.1016/0378-1119(89)90014-0; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sezutsu H, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0428; Shaner M. C., 1993, Proceeding of the Twenty-Sixth Hawaii International Conference on System Sciences (Cat. No.93TH0501-7), P813, DOI 10.1109/HICSS.1993.270609; SHIMIZU T, 1991, J BIOL CHEM, V266, P3372; Sirim D, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-34; Suzuki H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-444; Syed K, 2014, GENES GENOM, V36, P321, DOI 10.1007/s13258-013-0170-9; Syed K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086683; Syed K, 2013, MYCOLOGIA, V105, P1445, DOI 10.3852/13-002; Syed K, 2013, APPL ENVIRON MICROB, V79, P2692, DOI 10.1128/AEM.03767-12; Syed K, 2012, CRIT REV MICROBIOL, V38, P339, DOI 10.3109/1040841X.2012.682050; Syed K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028286; Syed K, 2010, BIOCHEM BIOPH RES CO, V399, P492, DOI 10.1016/j.bbrc.2010.07.094; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wen Y, 2005, APPL ENVIRON MICROB, V71, P3192, DOI 10.1128/AEM.71.6.3192-3198.2005	62	45	46	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95616	10.1371/journal.pone.0095616	http://dx.doi.org/10.1371/journal.pone.0095616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743800	gold, Green Submitted, Green Published			2022-12-25	WOS:000335309100147
J	Carmichael, SL; Cullen, MR; Mayo, JA; Gould, JB; Loftus, P; Stevenson, DK; Wise, PH; Shaw, GM				Carmichael, Suzan L.; Cullen, Mark R.; Mayo, Jonathan A.; Gould, Jeffrey B.; Loftus, Pooja; Stevenson, David K.; Wise, Paul H.; Shaw, Gary M.			Population-Level Correlates of Preterm Delivery among Black and White Women in the US	PLOS ONE			English	Article							BIRTH; HEALTH	Objective: This study examined the ability of social, demographic, environmental and health-related factors to explain geographic variability in preterm delivery among black and white women in the US and whether these factors explain black-white disparities in preterm delivery. Methods: We examined county-level prevalence of preterm delivery (20-31 or 32-36 weeks gestation) among singletons born 1998-2002. We conducted multivariable linear regression analysis to estimate the association of selected variables with preterm delivery separately for each preterm/race-ethnicity group. Results: The prevalence of preterm delivery varied two-to three-fold across U. S. counties, and the distributions were strikingly distinct for blacks and whites. Among births to blacks, regression models explained 46% of the variability in county-level risk of delivery at 20-31 weeks and 55% for delivery at 32-36 weeks (based on R-squared values). Respective percentages for whites were 67% and 71%. Models included socio-environmental/demographic and health-related variables and explained similar amounts of variability overall. Conclusions: Much of the geographic variability in preterm delivery in the US can be explained by socioeconomic, demographic and health-related characteristics of the population, but less so for blacks than whites.	[Carmichael, Suzan L.; Mayo, Jonathan A.; Gould, Jeffrey B.; Stevenson, David K.; Wise, Paul H.; Shaw, Gary M.] Stanford Univ, Dept Pediat, Sch Med, Div Neonatol & Dev Med, Stanford, CA 94305 USA; [Cullen, Mark R.; Loftus, Pooja] Stanford Univ, Sch Med, Gen Med Disciplines, Stanford, CA 94305 USA	Stanford University; Stanford University	Carmichael, SL (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Neonatol & Dev Med, Stanford, CA 94305 USA.	scarmichael@stanford.edu		cullen, mark/0000-0001-7996-1864; Shaw, Gary/0000-0001-7438-4914	March of Dimes	March of Dimes(March of Dimes)	This work was supported in part by a grant from the March of Dimes to the March of Dimes Prematurity Research Center at the Stanford University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BORN TOO SOON GLOB A; Carolan-Olah M, 2013, HIGH ENV TEMPERATURE; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Cullen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032930; Ferguson KK, 2013, J TOXICOL ENV HEAL B, V16, P69, DOI 10.1080/10937404.2013.775048; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Kramer MR, 2008, PUBLIC HEALTH REP, V123, P576, DOI 10.1177/003335490812300507; Kramer MR, 2011, ACTA OBSTET GYN SCAN, V90, P1307, DOI 10.1111/j.1600-0412.2011.01136.x; Nyarko KA, 2012, MATERN CHILD HLTH J, V16, P1491, DOI 10.1007/s10995-011-0915-5; Raisanen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060660; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Smedley BD, 2012, AM J PUBLIC HEALTH, V102, P933, DOI 10.2105/AJPH.2011.300643; United States Department of Justice. Federal Bureau of Investigation, 2006, ICPSR03721V2 US DEP	13	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94153	10.1371/journal.pone.0094153	http://dx.doi.org/10.1371/journal.pone.0094153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740117	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900035
J	Festuccia, WT; Pouliot, P; Bakan, I; Sabatini, DM; Laplante, M				Festuccia, William T.; Pouliot, Philippe; Bakan, Inan; Sabatini, David M.; Laplante, Mathieu			Myeloid-Specific Rictor Deletion Induces M1 Macrophage Polarization and Potentiates In Vivo Pro-Inflammatory Response to Lipopolysaccharide	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; KAPPA-B ACTIVATION; ADIPOSE-TISSUE; PHOSPHOINOSITIDE 3-KINASE; PI3K-AKT PATHWAY; INNATE IMMUNITY; PROTEIN-KINASE; CELL ADAPTER; OBESITY; MTOR	The phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt) axis plays a central role in attenuating inflammation upon macrophage stimulation with toll-like receptor (TLR) ligands. The mechanistic target of rapamycin complex 2 (mTORC2) relays signal from PI3K to Akt but its role in modulating inflammation in vivo has never been investigated. To evaluate the role of mTORC2 in the regulation of inflammation in vivo, we have generated a mouse model lacking Rictor, an essential mTORC2 component, in myeloid cells. Primary macrophages isolated from myeloid-specific Rictor null mice exhibited an exaggerated response to TLRs ligands, and expressed high levels of M1 genes and lower levels of M2 markers. To determine whether the loss of Rictor similarly affected inflammation in vivo, mice were either fed a high fat diet, a situation promoting chronic but low-grade inflammation, or were injected with lipopolysaccharide (LPS), which mimics an acute, severe septic inflammatory condition. Although high fat feeding contributed to promote obesity, inflammation, macrophage infiltration in adipose tissue and systemic insulin resistance, we did not observe a significant impact of Rictor loss on these parameters. However, mice lacking Rictor exhibited a higher sensitivity to sceptic shock when injected with LPS. Altogether, these results indicate that mTORC2 is a key negative regulator of macrophages TLR signalling and that its role in modulating inflammation is particularly important in the context of severe inflammatory challenges. These observations suggest that approaches aimed at modulating mTORC2 activity may represent a possible therapeutic approach for diseases linked to excessive inflammation.	[Festuccia, William T.] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil; [Sabatini, David M.] MIT, Whitehead Inst Biomed Res, Cambridge, MA USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA USA; [Sabatini, David M.] MIT, Koch Ctr Integrat Canc Res, Cambridge, MA USA; [Pouliot, Philippe; Bakan, Inan; Laplante, Mathieu] Univ Laval, CRIUCPQ, Quebec City, PQ, Canada	Universidade de Sao Paulo; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Laval University	Laplante, M (corresponding author), Univ Laval, CRIUCPQ, Quebec City, PQ, Canada.	mathieu.laplante@criucpq.ulaval.ca	Festuccia, William/C-7618-2012	Festuccia, William/0000-0003-4769-0806; /0000-0002-1446-7256	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Les Fonds de la Recherche Sante Quebec (FRQS); NIH [CA103866, CA129105, AI47389]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Les Fonds de la Recherche Sante Quebec (FRQS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by grants from the Canadian Institutes of Health Research (CIHR), the Natural Sciences and Engineering Research Council of Canada (NSERC) and Les Fonds de la Recherche Sante Quebec (FRQS) to M. L. NIH grants CA103866, CA129105, and AI47389 to D. M. S. D. M. S. is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Arranz A, 2012, P NATL ACAD SCI USA, V109, P9517, DOI 10.1073/pnas.1119038109; BAUSS F, 1987, INFECT IMMUN, V55, P1622, DOI 10.1128/IAI.55.7.1622-1625.1987; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Brown J, 2011, J BIOL CHEM, V286, P44295, DOI 10.1074/jbc.M111.258053; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chaurasia B, 2010, MOL CELL BIOL, V30, P4354, DOI 10.1128/MCB.00069-10; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; HABICHT GS, 1981, MECH AGEING DEV, V16, P97, DOI 10.1016/0047-6374(81)90037-3; Hazeki K, 2007, BIOL PHARM BULL, V30, P1617, DOI 10.1248/bpb.30.1617; Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jeschke MG, 2004, ENDOCRINOLOGY, V145, P4084, DOI 10.1210/en.2004-0592; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawano Y, 2012, DIABETES, V61, P1935, DOI 10.2337/db11-0770; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Luyendyk JP, 2008, J IMMUNOL, V180, P4218, DOI 10.4049/jimmunol.180.6.4218; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; McGuire VA, 2013, MOL CELL BIOL, V33, P4152, DOI 10.1128/MCB.01691-12; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Ni MJ, 2012, P NATL ACAD SCI USA, V109, P267, DOI 10.1073/pnas.1111957108; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rhee SH, 2006, J BIOL CHEM, V281, P18560, DOI 10.1074/jbc.M513861200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, P1963, DOI 10.1161/01.ATV.0000143096.15099.ce; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Siqueira MF, 2010, DIABETOLOGIA, V53, P378, DOI 10.1007/s00125-009-1529-y; Su DM, 2009, DIABETES, V58, P2624, DOI 10.2337/db09-0232; Troutman TD, 2012, CELL CYCLE, V11, P3559, DOI 10.4161/cc.21572; Troutman TD, 2012, P NATL ACAD SCI USA, V109, P273, DOI 10.1073/pnas.1118579109; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025; Zou B, 2012, INFLAMMATION, V35, P723, DOI 10.1007/s10753-011-9367-8	58	79	80	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95432	10.1371/journal.pone.0095432	http://dx.doi.org/10.1371/journal.pone.0095432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740015	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900144
J	Ma, YL; Zhang, HH; Zhang, Q; Ding, XD				Ma, Yunlong; Zhang, Haihan; Zhang, Qin; Ding, Xiangdong			Identification of Selection Footprints on the X Chromosome in Pig	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; GENOME; SIGNATURES; ASSOCIATION; EXPRESSION; MUTATION; SCAN; DNA	Identifying footprints of selection can provide a straightforward insight into the mechanism of artificial selection and further dig out the causal genes related to important traits. In this study, three between-population and two within-population approaches, the Cross Population Extend Haplotype Homozygosity Test (XPEHH), the Cross Population Composite Likelihood Ratio (XPCLR), the F-statistics (Fst), the Integrated Haplotype Score (iHS) and the Tajima's D, were implemented to detect the selection footprints on the X chromosome in three pig breeds using Illumina Porcine60K SNP chip. In the detection of selection footprints using between-population methods, 11, 11 and 7 potential selection regions with length of 15.62 Mb, 12.32 Mb and 9.38 Mb were identified in Landrace, Chinese Songliao and Yorkshire by XPEHH, respectively, and 16, 13 and 17 potential selection regions with length of 15.20 Mb, 13.00 Mb and 19.21 Mb by XPCLR, 4, 2 and 4 potential selection regions with length of 3.20 Mb, 1.60 Mb and 3.20 Mb by Fst. For within-population methods, 7, 10 and 9 potential selection regions with length of 8.12 Mb, 8.40 Mb and 9.99 Mb were identified in Landrace, Chinese Songliao and Yorkshire by iHS, and 4, 3 and 2 potential selection regions with length of 3.20 Mb, 2.40 Mb and 1.60 Mb by Tajima's D. Moreover, the selection regions from different methods were partly overlapped, especially the regions around 22 similar to 25 Mb were detected under selection in Landrace and Yorkshire while no selection in Chinese Songliao by all three between-population methods. Only quite few overlap of selection regions identified by between-population and within-population methods were found. Bioinformatics analysis showed that the genes relevant with meat quality, reproduction and immune were found in potential selection regions. In addition, three out of five significant SNPs associated with hematological traits reported in our genome-wide association study were harbored in potential selection regions.	[Ma, Yunlong; Zhang, Haihan; Zhang, Qin; Ding, Xiangdong] China Agr Univ, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Natl Engn Lab Anim Breeding,Coll Anim Sci & Techn, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Ding, XD (corresponding author), China Agr Univ, Key Lab Anim Genet Breeding & Reprod, Minist Agr, Natl Engn Lab Anim Breeding,Coll Anim Sci & Techn, Beijing 100094, Peoples R China.	xding@cau.edu.cn			National Natural Science Foundation of China [31272418]; earmarked fund for CARS-36; Ministry of Education of China; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]; Key Laboratory of Pig, Ministry of Agriculture [13405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for CARS-36; Ministry of Education of China(Ministry of Education, China); Program for Changjiang Scholar and Innovation Research Team in University; Key Laboratory of Pig, Ministry of Agriculture	This work was supported by National Natural Science Foundation of China (31272418), the earmarked fund for CARS-36, Ministry of Education of China, Program for Changjiang Scholar and Innovation Research Team in University (Grant No. IRT1191), and the open project of Key Laboratory of Pig, Ministry of Agriculture (13405), which will pay the publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056001, 10.1371/journal.pone.0069836, 10.1371/journal.pone.0063641]; Amaral AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014782; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; Choi Y, 2009, BIOL REPROD, V81, P1122, DOI 10.1095/biolreprod.109.076703; CHURCHILL GA, 1994, GENETICS, V138, P963; Cutler DJ, 2010, GENETICS, V186, P41, DOI 10.1534/genetics.110.121012; Gianola D, 2010, GENET RES, V92, P141, DOI 10.1017/S0016672310000121; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Gu JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005767; Heyer E, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-203; Hu GQ, 2009, MOL ENDOCRINOL, V23, P689, DOI 10.1210/me.2008-0350; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Maak S, 2010, MOL CELL PROBE, V24, P32, DOI 10.1016/j.mcp.2009.09.001; Mamone G, 2008, PROTEIN PEPTIDE LETT, V15, P895, DOI 10.2174/092986608785849344; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pestov NB, 2011, BIOCHEM BIOPH RES CO, V412, P543, DOI 10.1016/j.bbrc.2011.07.112; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Qanbari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049525; Quilter CR, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-37; Riebler A, 2008, GENETICS, V178, P1817, DOI 10.1534/genetics.107.081281; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Rusc A, 2011, MEAT SCI, V89, P440, DOI 10.1016/j.meatsci.2011.05.008; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Skinner BM, 2013, BMC GENET, V14, P1, DOI 10.1186/1471-2156-14-3; Steiner-Champliaud MF, 2006, MOL VIS, V12, P892; Suzuki T, 2011, MOL CELL ENDOCRINOL, V340, P148, DOI 10.1016/j.mce.2010.11.001; Suzuki Y, 2010, GENES GENET SYST, V85, P359, DOI 10.1266/ggs.85.359; TAJIMA F, 1989, GENETICS, V123, P585; Tseng YW, 2010, J ANIM SCI, V88, P3563, DOI 10.2527/jas.2010-2905; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang JY, 2013, ANIM GENET, V44, P34, DOI 10.1111/j.1365-2052.2012.02366.x; Wilkinson S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003453; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zhou A, 2013, PLACENTA, V34, P75, DOI 10.1016/j.placenta.2012.10.007	44	24	27	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94911	10.1371/journal.pone.0094911	http://dx.doi.org/10.1371/journal.pone.0094911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740293	Green Submitted, gold, Green Published			2022-12-25	WOS:000336863900080
J	Rowson, B; Anderson, R; Turner, JA; Symondson, WOC				Rowson, Ben; Anderson, Roy; Turner, James A.; Symondson, William O. C.			The Slugs of Britain and Ireland: Undetected and Undescribed Species Increase a Well-Studied, Economically Important Fauna by More Than 20%	PLOS ONE			English	Article							LAND SNAILS; GASTROPODA PULMONATA; TERRESTRIAL SLUGS; DNA TAXONOMY; MOLLUSCA; DIVERSITY; ARIONIDAE; DELIMITATION; LIMACIDAE; MABILLE	The slugs of Britain and Ireland form a well-studied fauna of economic importance. They include many widespread European species that are introduced elsewhere (at least half of the 36 currently recorded British species are established in North America, for example). To test the contention that the British and Irish fauna consists of 36 species, and to verify the identity of each, a species delimitation study was conducted based on a geographically wide survey. Comparisons between mitochondrial DNA (COI, 16S), nuclear DNA (ITS-1) and morphology were investigated with reference to interspecific hybridisation. Species delimitation of the fauna produced a primary species hypothesis of 47 putative species. This was refined to a secondary species hypothesis of 44 species by integration with morphological and other data. Thirty six of these correspond to the known fauna (two species in Arion subgenus Carinarion were scarcely distinct and Arion (Mesarion) subfuscus consisted of two near-cryptic species). However, by the same criteria a further eight previously undetected species (22% of the fauna) are established in Britain and/or Ireland. Although overlooked, none are strictly morphologically cryptic, and some appear previously undescribed. Most of the additional species are probably accidentally introduced, and several are already widespread in Britain and Ireland (and thus perhaps elsewhere). At least three may be plant pests. Some evidence was found for interspecific hybridisation among the large Arion species (although not involving A. flagellus) and more unexpectedly in species pairs in Deroceras (Agriolimacidae) and Limacus (Limacidae). In the latter groups, introgression appears to have occurred in one direction only, with recently-invading lineages becoming common at the expense of long-established or native ones. The results show how even a well-studied, macroscopic fauna can be vulnerable to cryptic and undetected invasions and changes.	[Rowson, Ben; Turner, James A.] Natl Museum Wales, Cardiff CF1 3NP, S Glam, Wales; [Anderson, Roy] Conchol Soc Great Britain & Ireland, Belfast, Antrim, North Ireland; [Symondson, William O. C.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Rowson, B (corresponding author), Natl Museum Wales, Cardiff CF1 3NP, S Glam, Wales.	ben.rowson@museumwales.ac.uk		Symondson, William/0000-0002-3343-4679	Leverhulme Trust [RPG-068]	Leverhulme Trust(Leverhulme Trust)	This study was funded by a Research Grant from the Leverhulme Trust to the authors (RPG-068). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTENA C. O. van REGTEREN, 1963, BASTERIA, V27, P1; Anderson R, 2008, ANNOTATED LIST NONMA; Anderson R, 2004, J CONCHOL, V38, P13; Barker G. M., 2002, MOLLUSCS CROP PESTS; Barker GM, 1999, FAUNA NZ, V38; Barr NB, 2009, J MOLLUS STUD, V75, P187, DOI 10.1093/mollus/eyn047; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Blaxter M, 2004, P ROY SOC B-BIOL SCI, V271, pS189, DOI 10.1098/rsbl.2003.0130; BURNET B, 1972, GENET RES, V20, P161, DOI 10.1017/S0016672300013689; Cain A. J., 1958, Proceedings of the Malacological Society of London, V33, P72; CAMERON R A D, 1983, Field Studies, V5, P807; DAVIES SM, 1979, J CONCHOL, V30, P123; DAVIES SM, 1987, J CONCHOL, V32, P339; Davison A, 2009, MOL ECOL RESOUR, V9, P1092, DOI 10.1111/j.1755-0998.2009.02559.x; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; de Winter A.J., 1986, Zoologische Mededelingen (Leiden), V60, P135; de Winter A. J. (Ton), 2011, Basteria, V75, P11; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Dreijers E, 2013, J MOLLUS STUD, V79, P51, DOI 10.1093/mollus/eys033; EVANS NJ, 1986, ZOOL SCR, V15, P313, DOI 10.1111/j.1463-6409.1986.tb00232.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FOLTZ DW, 1984, MALACOLOGIA, V25, P593; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Garrido Carlos, 1995, Archiv fuer Molluskenkunde, V124, P103; Geenen S, 2006, BIOL J LINN SOC, V89, P589, DOI 10.1111/j.1095-8312.2006.00693.x; Grimm, 2009, IDENTIFYING LAND SNA; Grindon AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065792; Habitas, 2010, MOLLUSCIRELAND; Hagnell J, 2003, BCPC SYMP SER, P221; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hatteland BA, 2010, THESIS U BERGEN NORW; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Herbert DG, 2010, S AFRICAN NATL BIODI, V15; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jordaens K., 2011, IOBC/WPRS Bulletin, V64, P23; Jordaens K, 2010, ZOOL SCR, V39, P343, DOI 10.1111/j.1463-6409.2010.00425.x; Kerney M.P., 1979, P1; Kerney Michael, 1999, P1; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Liberto Fabio, 2012, Biodiversity Journal, V3, P201; Liberto Fabio, 2011, Biodiversity Journal, V2, P27; Likharev IM, 1980, FAUNA SSSR MOLLYUSKI; Lim GS, 2012, SYST BIOL, V61, P165, DOI 10.1093/sysbio/syr030; Linnaeus C., 1758, SYSTEMA NATURAE REGN, V1, DOI 10.5962/bhl.title.542; Lister M, 1685, HIST CONCHYLIORUM; Magnacca KN, 2012, MOL ECOL RESOUR, V12, P990, DOI 10.1111/1755-0998.12001; Mc Donnell RJ, 2011, BIOL INVASIONS, V13, P61, DOI 10.1007/s10530-010-9789-5; McDonnell RJ, 2009, U CALIFORNIA PUBLICA, V8336; Nardi G, 2011, B MALACOL, V48, P150; Nitz B, 2010, EVOLUTION IN ACTION: CASE STUDIES IN ADAPTIVE RADIATION, SPECIATION AND THE ORIGIN OF BIODIVERSITY, P405, DOI 10.1007/978-3-642-12425-9_19; Nitz B, 2009, J MOLLUS STUD, V75, P279, DOI 10.1093/mollus/eyp030; Noble LR, 1996, SYST ASSOC, P93; NOBLE LR, 1992, ZOOL SCR, V21, P255, DOI 10.1111/j.1463-6409.1992.tb00330.x; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; PHILP EG, 1987, J CONCHOL, V32, P302; Pinceel J, 2005, J EVOLUTION BIOL, V18, P1264, DOI 10.1111/j.1420-9101.2005.00932.x; Pinceel J, 2004, BIOL J LINN SOC, V83, P23, DOI 10.1111/j.1095-8312.2004.00368.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Prevot V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060736; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; QUICK H. E., 1960, BULL BRIT MUS [NAT HKST] ZOOL, V6, P103; Reise Heike, 2011, Folia Malacologica, V19, P201, DOI 10.2478/v10125-011-0028-1; Roth S, 2012, J CONCHOL, V41, P249; Rowson B, 2008, J CONCHOL, V39, P537; Scharff RF, 1891, SCI T ROYAL DUBLIN 2, V4, P4513; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Slotsbo S, 2012, COMP BIOCHEM PHYS A, V161, P443, DOI 10.1016/j.cbpa.2012.01.002; SOUTH A, 1992, TERRESTRIAL SLUGS BI; Spelda J, 2011, ZOOKEYS, P123, DOI 10.3897/zookeys.156.2176; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor J. W., 1888, Journal of Conchology, Vv, P337; Taylor JW, 1902, MONOGRAPH LAND FRESH; Valtuena FJ, 2012, MOL ECOL, V21, P1423, DOI 10.1111/j.1365-294X.2012.05473.x; Wade CM, 2006, BIOL J LINN SOC, V87, P593, DOI 10.1111/j.1095-8312.2006.00596.x; WIKTOR A, 1987, Annales Zoologici (Warsaw), V41, P153; Wiktor A, 2001, FAUNA GRAECIAE; Wiktor Andrzej, 2000, Annales Zoologici (Warsaw), V49, P347	79	40	51	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e91907	10.1371/journal.pone.0091907	http://dx.doi.org/10.1371/journal.pone.0091907			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740519	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900009
J	Christie, MP; Simerska, P; Jen, FEC; Hussein, WM; Rawi, MFM; Hartley-Tassell, LE; Day, CJ; Jennings, MP; Toth, I				Christie, Michelle P.; Simerska, Pavla; Jen, Freda E. -C.; Hussein, Waleed M.; Rawi, Mohamad F. M.; Hartley-Tassell, Lauren E.; Day, Christopher J.; Jennings, Michael P.; Toth, Istvan			A Drug Delivery Strategy: Binding Enkephalin to Asialoglycoprotein Receptor by Enzymatic Galactosylation	PLOS ONE			English	Article							IN-VITRO EVALUATION; GUINEA-PIG ILEUM; ANALGESIC ACTIVITY; GLUCOSE-UPTAKE; GLYCOSYLATION; PEPTIDES; AMINOPEPTIDASE; ABSORPTION; BARRIER; ALPHA	Glycosylation of biopharmaceuticals can mediate cell specific delivery by targeting carbohydrate receptors. Additionally, glycosylation can improve the physico-chemical (drug-like) properties of peptide based drug candidates. The main purpose of this study was to examine if glycosylation of the peptide enkephalin could facilitate its binding to the carbohydrate receptor, asialoglycoprotein. Firstly, we described the one-pot enzymatic galactosylation of lactose modified enkephalin in the presence of uridine-5'-diphosphogalactose 4-epimerase and lipopolysaccharyl alpha-1,4-galactosyltransferase. Stability experiments using human plasma and Caco-2 cell homogenates showed that glycosylation considerably improved the stability of enkephalin (at least 60% remained stable after a 2 hr incubation at 37 degrees C). In vitro permeability experiments using Caco-2 cells revealed that the permeability of mono-and trisaccharide conjugated enkephalins was 14 and 28 times higher, respectively, than that of enkephalin alone (Papp 3.1x10(-8) cm/s). By the methods of surface plasmon resonance and molecular modeling, we demonstrated that the enzymatic glycosylation of enkephalin enabled binding the asialoglycoprotein receptor. The addition of a trisaccharide moiety to enkephalin improved the binding of enkephalin to the asialoglycoprotein receptor two fold (K-D=91 mu M). The docking scores from molecular modeling showed that the binding modes and affinities of the glycosylated enkephalin derivatives to the asialoglycoprotein receptor complemented the results from the surface plasmon resonance experiments.	[Christie, Michelle P.; Simerska, Pavla; Hussein, Waleed M.; Rawi, Mohamad F. M.; Toth, Istvan] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Jen, Freda E. -C.; Hartley-Tassell, Lauren E.; Day, Christopher J.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Southport, Qld 4215, Australia; [Toth, Istvan] Univ Queensland, Sch Pharm, Pharm Australia Ctr Excellence, Woolloongabba, Qld, Australia	University of Queensland; Griffith University; University of Queensland	Toth, I (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	i.toth@uq.edu.au	Toth, Istvan/C-1965-2013; Day, Christopher/Z-3305-2019; Jennings, Michael P/G-4822-2013; Hussein, Waleed/AAK-7916-2021	Toth, Istvan/0000-0002-4572-397X; Jennings, Michael P/0000-0002-1027-4684; Hussein, Waleed/0000-0001-5392-1880; Christie, Michelle/0000-0002-7001-3400; Day, Christopher/0000-0001-7953-4408	Australian Research Council [DP1092829]; Australian Postdoctoral Fellowship [DP1092829]; NHMRC [565526, DP103130141];  [DP110100212]	Australian Research Council(Australian Research Council); Australian Postdoctoral Fellowship; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); 	This work was supported by an Australian Research Council Discovery Project Grant (DP1092829). P. S. was supported by an Australian Postdoctoral Fellowship (DP1092829), M.P.J. was supported by a (NHMRC program grant 565526 and DP103130141) and I. T. was supported by a Professorial Research Fellowship (DP110100212), http://www.arc.gov.au, http://www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT R, 1993, LIFE SCI, V53, P517, DOI 10.1016/0024-3205(93)90703-6; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Bergeon JA, 2008, BIOPOLYMERS, V90, P633, DOI 10.1002/bip.21003; Christie MP, 2013, CHEMPLUSCHEM, V78, P793, DOI 10.1002/cplu.201300115; COHEN ML, 1983, J PHARMACOL EXP THER, V224, P379; Cros CD, 2011, BIOORGAN MED CHEM, V19, P1528, DOI 10.1016/j.bmc.2010.12.042; Dangoor D, 2008, J PEPT SCI, V14, P321, DOI 10.1002/psc.932; Di L, 2005, INT J PHARMACEUT, V297, P110, DOI 10.1016/j.ijpharm.2005.03.022; Drozdowski LA, 2006, WORLD J GASTROENTERO, V12, P1657, DOI 10.3748/wjg.v12.i11.1657; DuMont AL, 2013, P NATL ACAD SCI USA, V110, P10794, DOI 10.1073/pnas.1305121110; Egleton RD, 2001, J PHARMACOL EXP THER, V299, P967; Egleton Richard D, 2005, NeuroRx, V2, P44, DOI 10.1007/BF03206641; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; ELLING L, 1993, GLYCOBIOLOGY, V3, P349, DOI 10.1093/glycob/3.4.349; Engel A, 2003, PHARM RES-DORDR, V20, P51, DOI 10.1023/A:1022294624256; Fang JW, 1998, J AM CHEM SOC, V120, P6635, DOI 10.1021/ja9808898; GEARY LE, 1982, J PHARMACOL EXP THER, V221, P104; Gentilucci L, 2006, CURR MED CHEM, V13, P2449, DOI 10.2174/092986706777935041; Goodwin D, 2012, CURR MED CHEM, V19, P4451, DOI 10.2174/092986712803251548; Gunther C, 2001, FASEB J, V15, P1646, DOI 10.1096/fj.00-0645fje; HANSEN DW, 1992, J MED CHEM, V35, P684, DOI 10.1021/jm00082a008; Harvey HA, 2001, MOL MICROBIOL, V42, P659, DOI 10.1046/j.1365-2958.2001.02666.x; Harvey HA, 2000, MOL MICROBIOL, V36, P1059, DOI 10.1046/j.1365-2958.2000.01938.x; Hokke CH, 1996, GLYCOCONJUGATE J, V13, P687, DOI 10.1007/BF00731458; Johnston K, 2005, FEBS LETT, V579, P1653, DOI 10.1016/j.febslet.2004.12.099; Johnstone Ken D., 2005, Current Drug Delivery, V2, P215, DOI 10.2174/1567201054367977; Kellam B, 1998, INT J PHARM, V161, P55, DOI 10.1016/S0378-5173(97)00328-1; Koda Y, 2008, BIOORGAN MED CHEM, V16, P6286, DOI 10.1016/j.bmc.2008.04.020; Lomino JV, 2013, BIOORGAN MED CHEM, V21, P2262, DOI 10.1016/j.bmc.2013.02.007; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Michael S, 2000, EUR J PHARM SCI, V10, P133, DOI 10.1016/S0928-0987(99)00093-7; MolDock Scores, 2011, MOL VIRT DOCK US MAN; Moradi SV, 2013, BIOORGAN MED CHEM, V21, P4259, DOI 10.1016/j.bmc.2013.04.068; Morimoto K, 2003, MOL THER, V7, P254, DOI 10.1016/S1525-0016(02)00053-9; Negri L, 1998, BRIT J PHARMACOL, V124, P1516, DOI 10.1038/sj.bjp.0701971; Nomoto M, 1998, J PHARM SCI, V87, P326, DOI 10.1021/js970269p; PACIFICO F, 1995, BIOCHEM BIOPH RES CO, V210, P138, DOI 10.1006/bbrc.1995.1638; POLT R, 1992, J AM CHEM SOC, V114, P10249, DOI 10.1021/ja00052a022; POLT R, 1994, P NATL ACAD SCI USA, V91, P7114, DOI 10.1073/pnas.91.15.7114; RASMUSSEN GJ, 1991, INT J PHARM, V76, P113, DOI 10.1016/0378-5173(91)90349-S; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Simerska P, 2013, J MOL CATAL B-ENZYM, V97, P196, DOI 10.1016/j.molcatb.2013.08.018; Simerska P, 2011, MED RES REV, V31, P520, DOI 10.1002/med.20191; SPIESS M, 1990, BIOCHEMISTRY-US, V29, P1009, DOI 10.1021/bi00495a001; Susaki H, 1999, BIOL PHARM BULL, V22, P1094; Suzuki K, 1999, J PHARMACOL EXP THER, V288, P888; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Varamini P, 2012, J MED CHEM, V55, P5859, DOI 10.1021/jm300418d; Wang J, 2006, J DRUG TARGET, V14, P127, DOI 10.1080/10611860600648221; Wong AK, 2002, EUR J PHARM SCI, V16, P113, DOI 10.1016/S0928-0987(02)00078-7; Yang JM, 2004, PROTEINS, V55, P288, DOI 10.1002/prot.20035; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x; Zheng Y, 2012, SURGERY, V151, P13, DOI 10.1016/j.surg.2011.07.010	53	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95024	10.1371/journal.pone.0095024	http://dx.doi.org/10.1371/journal.pone.0095024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736570	Green Published, gold			2022-12-25	WOS:000336922600128
J	Kuzin, BA; Nikitina, EA; Cherezov, RO; Vorontsova, JE; Slezinger, MS; Zatsepina, OG; Simonova, OB; Enikolopov, GN; Savvateeva-Popova, EV				Kuzin, Boris A.; Nikitina, Ekaterina A.; Cherezov, Roman O.; Vorontsova, Julia E.; Slezinger, Mikhail S.; Zatsepina, Olga G.; Simonova, Olga B.; Enikolopov, Grigori N.; Savvateeva-Popova, Elena V.			Combination of Hypomorphic Mutations of the Drosophila Homologues of Aryl Hydrocarbon Receptor and Nucleosome Assembly Protein Family Genes Disrupts Morphogenesis, Memory and Detoxification	PLOS ONE			English	Article							SPINELESS-ARISTAPEDIA; TARSAL DEVELOPMENT; BINDING; DIVERSITY; COURTSHIP; RADIATION; INSIGHTS; BEHAVIOR	Aryl hydrocarbon receptor is essential for biological responses to endogenous and exogenous toxins in mammals. Its Drosophila homolog spineless plays an important role in fly morphogenesis. We have previously shown that during morphogenesis spineless genetically interacts with CG5017 gene, which encodes a nucleosome assembly factor and may affect cognitive function of the fly. We now demonstrate synergistic interactions of spineless and CG5017 in pathways controlling oxidative stress response and long-term memory formation in Drosophila melanogaster. Oxidative stress was induced by low doses of X-ray irradiation of flies carrying hypomorphic mutation of spineless, mutation of CG5017, and their combination. To determine the sensitivity of these mutants to pharmacological modifiers of the irradiation effect, we irradiated flies growing on standard medium supplemented by radiosensitizer furazidin and radioprotector serotonin. The effects of irradiation were investigated by analyzing leg and antenna morphological structures and by using real-time PCR to measure mRNA expression levels for spineless, Cyp6g1 and Gst-theta genes. We also examined long-term memory in these mutants using conditioned courtship suppression paradigm. Our results show that the interaction of spineless and CG5017 is important for regulation of morphogenesis, long-term memory formation, and detoxification during oxidative stress. Since spineless and CG5017 are evolutionary conserved, these results must be considered when evaluating the risk of combining similar mutations in other organisms, including humans.	[Kuzin, Boris A.; Cherezov, Roman O.; Vorontsova, Julia E.; Slezinger, Mikhail S.; Simonova, Olga B.] Russian Acad Sci, Koltsov Inst Dev Biol, Moscow, Russia; [Kuzin, Boris A.; Zatsepina, Olga G.; Enikolopov, Grigori N.] Moscow Inst Phys & Technol, NBIC, Moscow, Russia; [Nikitina, Ekaterina A.; Savvateeva-Popova, Elena V.] Russian Acad Sci, Pavlov Inst Physiol, St Petersburg 196140, Russia; [Zatsepina, Olga G.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Enikolopov, Grigori N.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Russian Academy of Sciences; Koltzov Institute of Developmental Biology of the Russian Academy of Sciences; Moscow Institute of Physics & Technology; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Pavlov Institute of Physiology Russian Academy of Sciences; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Cold Spring Harbor Laboratory	Kuzin, BA (corresponding author), Russian Acad Sci, Koltsov Inst Dev Biol, Moscow, Russia.	KuzinB@yandex.ru	Simonova, Olga B/K-8890-2014; Tcherezov, Roman O/K-9082-2014; Enikolopov, Grigori/P-5731-2019; Nikitina, Ekaterina A/L-5761-2014; Vorontsova, Julia E/J-8274-2015	Enikolopov, Grigori/0000-0001-8178-8917; Nikitina, Ekaterina A/0000-0003-1897-8392; Vorontsova, Julia E/0000-0002-3378-1515; Simonova, Olga/0000-0001-9439-524X; Kuzin, Boris/0000-0001-9951-1553	Russian Foundation for Basic Research [12-04-00839-a, 12-04-01737-a, 13-04-0074-a]; Program of the Presidium of the Russian Academy of Sciences [30]; Russian Ministry of Education and Science [11.G34.31.0071]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work was supported by the Russian Foundation for Basic Research (projects nos. 12-04-00839-a, 12-04-01737-a and 13-04-0074-a) and the Program of the Presidium of the Russian Academy of Sciences (nos. 7, 30) to BK and by grant the Russian Ministry of Education and Science (11.G34.31.0071) to GE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 2001, BEHAV GENET, V31, P17, DOI 10.1023/A:1010201723966; Butler RA, 2001, GENE, V278, P223, DOI 10.1016/S0378-1119(01)00724-7; Cespedes MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015382; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2; Duncan DM, 1998, GENE DEV, V12, P1290, DOI 10.1101/gad.12.9.1290; Emmons RB, 1999, DEVELOPMENT, V126, P3937; Hahn ME, 2006, J EXP ZOOL PART A, V305A, P693, DOI 10.1002/jez.a.323; Hahn ME, 2002, CHEM-BIOL INTERACT, V141, P131, DOI 10.1016/S0009-2797(02)00070-4; Jux B, 2011, J INVEST DERMATOL, V131, P203, DOI 10.1038/jid.2010.269; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Kamyshev NG, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-9; Kimura S, 2013, FEBS LETT, V587, P922, DOI 10.1016/j.febslet.2013.02.019; Kuzin B A, 2010, Ontogenez, V41, P364; KUZIN B A, 1991, Ontogenez, V22, P212; Maksymchuk O V, 2008, Ukr Biokhim Zh (1999), V80, P59; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Powell-Coffman JA, 1998, P NATL ACAD SCI USA, V95, P2844, DOI 10.1073/pnas.95.6.2844; Qin HT, 2004, DEV BIOL, V270, P64, DOI 10.1016/j.ydbio.2004.02.004; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Rendic S, 2012, CURR DRUG METAB, V13, P787, DOI 10.2174/138920012800840356; REUVERS AP, 1972, NATURE, V237, P402, DOI 10.1038/237402a0; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rodriguez P, 1997, GENOMICS, V44, P253, DOI 10.1006/geno.1997.4868; Sartor MA, 2009, ENVIRON HEALTH PERSP, V117, P1139, DOI 10.1289/ehp.0800485; Savvateeva E, 2000, J NEURAL TRANSM, V107, P581, DOI 10.1007/s007020070080; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; SMIRNOVA I B, 1984, Radiobiologiya, V24, P236; Sokal R. R., 2012, BIOMETRY; SWANSON HI, 1995, J BIOL CHEM, V270, P26292, DOI 10.1074/jbc.270.44.26292; Zhang Nan, 2011, J Cardiovasc Dis Res, V2, P91, DOI 10.4103/0975-3583.83033; Zhuravlev AV, 2012, J MOL MODEL, V18, P1755, DOI 10.1007/s00894-011-1206-1	33	14	15	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94975	10.1371/journal.pone.0094975	http://dx.doi.org/10.1371/journal.pone.0094975			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736732	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600116
J	Lin, WY				Lin, Wan-Yu			Association Testing of Clustered Rare Causal Variants in Case-Control Studies	PLOS ONE			English	Article							SEQUENCING DATA; DISEASE; COMMON; HAPLOTYPE; TRIGLYCERIDE; T266M; E40K	Biological evidence suggests that multiple causal variants in a gene may cluster physically. Variants within the same protein functional domain or gene regulatory element would locate in close proximity on the DNA sequence. However, spatial information of variants is usually not used in current rare variant association analyses. We here propose a clustering method (abbreviated as "CLUSTER"), which is extended from the adaptive combination of P-values. Our method combines the association signals of variants that are more likely to be causal. Furthermore, the statistic incorporates the spatial information of variants. With extensive simulations, we show that our method outperforms several commonly-used methods in many scenarios. To demonstrate its use in real data analyses, we also apply this CLUSTER test to the Dallas Heart Study data. CLUSTER is among the best methods when the effects of causal variants are all in the same direction. As variants located in close proximity are more likely to have similar impact on disease risk, CLUSTER is recommended for association testing of clustered rare causal variants in case-control studies.	Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	National Taiwan University	Lin, WY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	linwy@ntu.edu.tw		LIN, WAN-YU/0000-0002-3385-4702	Ministry of Science and Technology of Taiwan [102-2628-B-002-039-MY3, 102-2314-B-002-001-MY2]; National Taiwan University [NTU-CESRP-101R7622-8, NTU-CESRP-102R7622-8, NTU-CESRP-103R7622-8, NTU-CDP-102R7769]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was supported by grants 102-2628-B-002-039-MY3 and 102-2314-B-002-001-MY2 from the Ministry of Science and Technology of Taiwan, and NTU-CESRP-101R7622-8, NTU-CESRP-102R7622-8, NTU-CESRP-103R7622-8, and NTU-CDP-102R7769 from National Taiwan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Cheung YH, 2012, GENET EPIDEMIOL, V36, P675, DOI 10.1002/gepi.21662; Davies RB, 1980, J ROYAL STAT SOC C, V29, P323, DOI DOI 10.2307/2346911; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Ionita-Laza I, 2012, AM J HUM GENET, V90, P1002, DOI 10.1016/j.ajhg.2012.04.010; Krebs JE, 2011, LEWINS GENES 10; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lee S, 2013, PACKAGE SKAT; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li Y, 2010, AM J HUM GENET, V87, P728, DOI 10.1016/j.ajhg.2010.10.014; Lin WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085728; Lin WY, 2013, GENET EPIDEMIOL, V37, P560, DOI 10.1002/gepi.21740; Lin WY, 2012, GENET EPIDEMIOL, V36, P572, DOI 10.1002/gepi.21650; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Raab JR, 2010, NAT REV GENET, V11, P439, DOI 10.1038/nrg2765; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schaid DJ, 2013, HUM GENET, V132, P1301, DOI 10.1007/s00439-013-1335-y; Smart-Halajko MC, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-89; Talmud PJ, 2008, ARTERIOSCL THROM VAS, V28, P2319, DOI 10.1161/ATVBAHA.108.176917; Tango T, 2000, STAT MED, V19, P191, DOI 10.1002/(SICI)1097-0258(20000130)19:2<191::AID-SIM281>3.0.CO;2-Q; TANGO T, 1984, BIOMETRICS, V40, P15, DOI 10.2307/2530740; Tango T, 2010, STAT METHODS DIS CLU; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yi NJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002382; Yi NJ, 2011, GENET EPIDEMIOL, V35, P57, DOI 10.1002/gepi.20554; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422	40	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94337	10.1371/journal.pone.0094337	http://dx.doi.org/10.1371/journal.pone.0094337			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736372	gold, Green Published			2022-12-25	WOS:000336922600061
J	Renga, B; Francisci, D; Schiaroli, E; Carino, A; Cipriani, S; D'Amore, C; Sidoni, A; Del Sordo, R; Ferri, I; Lucattelli, M; Lunghi, B; Baldelli, F; Fiorucci, S				Renga, Barbara; Francisci, Daniela; Schiaroli, Elisabetta; Carino, Adriana; Cipriani, Sabrina; D'Amore, Claudio; Sidoni, Angelo; Del Sordo, Rachele; Ferri, Ivana; Lucattelli, Monica; Lunghi, Benedetta; Baldelli, Franco; Fiorucci, Stefano			The HIV Matrix Protein p17 Promotes the Activation of Human Hepatic Stellate Cells through Interactions with CXCR2 and Syndecan-2	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPARAN-SULFATE; PORTAL PRESSURE; LIVER; GP120; EXPRESSION; RECEPTOR; FIBROSIS; PROTEOGLYCANS; CONTRACTILITY	Background: The human immunodeficiency virus type 1 (HIV-1) p17 is a matrix protein involved in virus life's cycle. CXCR2 and Syndecan-2, the two major coreceptors for the p17 protein, are expressed in hepatic stellate cells (HSCs), a key cell type involved in matrix deposition in liver fibrotic disorders. Aim: In this report we have investigated the in vitro impact of p17 on HSCs transdifferentiation and function and underlying signaling pathways involved in these processes. Methods: LX-2 cells, a human HSC line, and primary HSC were challenged with p17 and expressions of fibrogenic markers and of p17 receptors were assessed by qRT-PCR and Western blot. Downstream intracellular signaling pathways were evaluated with qRT-PCR and Western blot as well as after pre-treatment with specific pathway inhibitors. Results: Exposure of LX2 cells to p17 increases their contractile force, reshapes the cytoskeleton fibers and upregulates the expression of transdifferentiation markers including alpha SMA, COL1 alpha 1 and endothelin-1 through the activation of Jak/STAT and Rho signaling pathways. These effects are lost in HSCs pre-incubated with a serum from HIV positive person who underwent a vaccination with a p17 peptide. Confocal laser microscopy studies demonstrates that CXCR2 and syndecan-2 co-associate at the plasma membrane after exposure to p17. Immunostaining of HIV/HCV liver biopsies from co-infected patients reveals that the progression of liver fibrosis correlates with a reduced expression of CXCR2. Conclusions: The HIV matrix protein p17 is pro-fibrogenic through its interactions both with CXCR2 and syndecan-2 on activated HSCs.	[Renga, Barbara; Carino, Adriana; D'Amore, Claudio; Fiorucci, Stefano] Univ Perugia, Dept Expt & Clin Med, I-06100 Perugia, Italy; [Francisci, Daniela; Schiaroli, Elisabetta; Cipriani, Sabrina; Baldelli, Franco] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Sidoni, Angelo; Del Sordo, Rachele; Ferri, Ivana] Univ Perugia, Dept Expt Med & Biochem Sci, Sect Anat Pathol & Histol, I-06100 Perugia, Italy; [Lucattelli, Monica; Lunghi, Benedetta] Univ Siena, Dept Life Sci, I-53100 Siena, Italy	University of Perugia; University of Perugia; University of Perugia; University of Siena	Renga, B (corresponding author), Univ Perugia, Dept Expt & Clin Med, I-06100 Perugia, Italy.	barbara.renga@unipg.it	schiaroli, elisabetta/N-9098-2015; SIDONI, Angelo/K-8171-2016	schiaroli, elisabetta/0000-0002-3216-4144; SIDONI, Angelo/0000-0002-8458-5901; DEL SORDO, RACHELE/0000-0003-3930-2957; Sordo, Rosanna/0000-0003-4979-0659; D'Amore, Claudio/0000-0001-9217-9404; Carino, Adriana/0000-0003-2341-9528				Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Babu CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004623; Bhatia AK, 2007, VIROLOGY, V369, P47, DOI 10.1016/j.virol.2007.06.046; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BLOMHOFF R, 1991, FASEB J, V5, P271, DOI 10.1096/fasebj.5.3.2001786; Bobardt MD, 2004, J VIROL, V78, P6567, DOI 10.1128/JVI.78.12.6567-6584.2004; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bongiovanni M, 2007, CURR HIV RES, V5, P490, DOI 10.2174/157016207781662407; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Caccuri F, 2012, P NATL ACAD SCI USA, V109, P14580, DOI 10.1073/pnas.1206605109; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Dalton AK, 2007, J VIROL, V81, P6434, DOI 10.1128/JVI.02757-06; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; De Francesco MA, 2011, J BIOL CHEM, V286, P19541, DOI 10.1074/jbc.M110.191270; de Parseval A, 2005, J BIOL CHEM, V280, P39493, DOI 10.1074/jbc.M504233200; de Witte L, 2007, P NATL ACAD SCI USA, V104, P19464, DOI 10.1073/pnas.0703747104; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Giagulli C, 2012, BLOOD, V119, P2274, DOI 10.1182/blood-2011-06-364083; Hong F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033659; Iaria ML, 2014, VACCINE, V32, P1072, DOI 10.1016/j.vaccine.2013.12.051; Ibrahim SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085737; KAWADA N, 1992, BIOCHEM J, V285, P367, DOI 10.1042/bj2850367; Kawada N, 1999, BIOCHEM BIOPH RES CO, V266, P296, DOI 10.1006/bbrc.1999.1823; Lakner AM, 2010, WORLD J GASTROENTERO, V16, P5047, DOI 10.3748/wjg.v16.i40.5047; Li JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013955; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Manea SA, 2010, CELL TISSUE RES, V340, P71, DOI 10.1007/s00441-010-0936-1; Mezaki Y, 2013, ACTA HISTOCHEM CYTOC, V46, P137, DOI 10.1267/ahc.13007; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Renga B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035924; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Rockey DC, 1996, HEPATOLOGY, V24, P233; Sulkowski MS, 2008, J INFECT DIS, V197, pS279, DOI 10.1086/533414; Svegliati-Baroni G, 2010, GUT, V59, P428, DOI 10.1136/gut.2009.195024; Uyama N, 2006, GUT, V55, P1276, DOI 10.1136/gut.2005.078865; van Beuge MM, 2011, J PHARMACOL EXP THER, V337, P628, DOI 10.1124/jpet.111.179143; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Woods M, 2003, MOL PHARMACOL, V64, P923, DOI 10.1124/mol.64.4.923	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94798	10.1371/journal.pone.0094798	http://dx.doi.org/10.1371/journal.pone.0094798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736615	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600090
J	Yao, YL; Xue, YX; Ma, J; Shang, C; Wang, P; Liu, LB; Liu, WJ; Li, Z; Qu, ST; Li, ZQ; Liu, YH				Yao, Yilong; Xue, Yixue; Ma, Jun; Shang, Chao; Wang, Ping; Liu, Libo; Liu, Wenjing; Li, Zhen; Qu, Shengtao; Li, Zhiqing; Liu, Yunhui			MiR-330-Mediated Regulation of SH3GL2 Expression Enhances Malignant Behaviors of Glioblastoma Stem Cells by Activating ERK and PI3K/AKT Signaling Pathways	PLOS ONE			English	Article							INDUCED APOPTOSIS; JNK ACTIVATION; CANCER CELLS; EGFR; MICRORNAS; GROWTH; MECHANISMS; RESISTANCE; GENES; PROLIFERATION	MicroRNAs are currently considered as an active and rapidly evolving area for the treatment of tumors. In this study, we elucidated the biological significance of miR-330 in glioblastoma stem cells (GSCs) as well as the possible molecular mechanisms. SH3GL2 is mainly distributed in the central nervous system and considered to be a tumor suppressor in many tumors. In the present study, we identified miR-330 as a potential regulator of SH3GL2 and we found that it was to be inversely correlated with SH3GL2 expression in GSCs which were isolated from U87 cell lines. The expression of miR-330 enhanced cellular proliferation, promoted cell migration and invasion, and dampened cell apoptosis. When the GSCs were co-transfected with the plasmid containing short hairpin RNA directed against human SH3GL2 gene and miR-330 mimic, we found that miR-330 promoted the malignant behavior of GSCs by down-regulating the expression of SH3GL2. Meanwhile, the ERK and PI3K/AKT signaling pathways were significantly activated, leading to the decreased expression of apoptotic protein and increased expression of anti-apoptotic protein. Furthermore, in orthotopic mouse xenografts, the mice given stable over-expressed SH3GL2 cells co-transfected with miR-330 knockdown plasmid had the smallest tumor sizes and longest survival. In conclusion, these results suggested that miR-330 negatively regulated the expression of SH3GL2 in GSCs, which promoted the oncogenic progression of GSCs through activating ERK and PI3K/AKT signaling pathways. The elucidation of these mechanisms will provide potential therapeutic approaches for human glioblastoma.	[Yao, Yilong; Li, Zhen; Qu, Shengtao; Liu, Yunhui] China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Liaoning Provin, Peoples R China; [Xue, Yixue; Ma, Jun; Shang, Chao; Wang, Ping; Liu, Libo; Li, Zhiqing] China Med Univ, Coll Basic Med, Dept Neurobiol, Shenyang, Liaoning Provin, Peoples R China; [Xue, Yixue; Ma, Jun; Shang, Chao; Wang, Ping; Liu, Libo] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Liaoning Provin, Peoples R China; [Liu, Wenjing] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Liu, YH (corresponding author), China Med Univ, Shengjing Hosp, Dept Neurosurg, Shenyang, Liaoning Provin, Peoples R China.	liuyh@sj-hospital.org			Natural Science Foundation of China [81172197, 81072056, 81171131, 81272564, 81272795, 81372484]; special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities [20102104110009]; Natural Science Foundation of Liaoning Province in China [201102300]; Liaoning Science and Technology Plan Projects [2011225020]; Shenyang Science and Technology Plan Projects [F11-264-1-15, F12-277-1-05, F13-318-1-16, F13-220-9-15]; Outstanding Scientific Fund of Shengjing Hospital	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities; Natural Science Foundation of Liaoning Province in China(Natural Science Foundation of Liaoning Province); Liaoning Science and Technology Plan Projects; Shenyang Science and Technology Plan Projects; Outstanding Scientific Fund of Shengjing Hospital	This work is supported by grants from the Natural Science Foundation of China (81172197, 81072056, 81171131, 81272564, 81272795 and 81372484), the special fund for Scientific Research of Doctor-degree Subjects in Colleges and Universities, (20102104110009), the Natural Science Foundation of Liaoning Province in China (No. 201102300), Liaoning Science and Technology Plan Projects (No. 2011225020), Shenyang Science and Technology Plan Projects (nos. F11-264-1-15, F12-277-1-05, F13-318-1-16 and F13-220-9-15), and Outstanding Scientific Fund of Shengjing Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksamitiene E, 2012, BIOCHEM SOC T, V40, P139, DOI 10.1042/BST20110609; Brand TM, 2011, CANCER BIOL THER, V11, P777, DOI 10.4161/cbt.11.9.15050; Callegari Elisa, 2013, Onco Targets Ther, V6, P1167, DOI 10.2147/OTT.S36161; Chandarlapaty S, 2012, CANCER DISCOV, V2, P311, DOI 10.1158/2159-8290.CD-12-0018; Chen J., 2012, BIOMED RES INT, V2012, P1; Dasgupta S, 2013, J MOL MED, V91, P381, DOI 10.1007/s00109-012-0955-3; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dudu V, 2012, CELL MOL BIOENG, V5, P402, DOI 10.1007/s12195-012-0253-8; Fukaya R, 2010, CANCER LETT, V291, P150, DOI 10.1016/j.canlet.2009.10.010; Fulda S, 2009, APOPTOSIS, V14, P409, DOI 10.1007/s10495-008-0306-6; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Giachino C, 1997, GENOMICS, V41, P427, DOI 10.1006/geno.1997.4645; Gibson EM, 2002, CANCER RES, V62, P488; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Henson ES, 2003, J CELL BIOCHEM, V89, P1177, DOI 10.1002/jcb.10597; Hodzic J, 2011, NUCLEOS NUCLEOT NUCL, V30, P1214, DOI 10.1080/15257770.2011.629271; Hong Y, 2012, NEUROSCI LETT, V518, P138, DOI 10.1016/j.neulet.2012.04.071; Ji JF, 2010, NEUROSURG CLIN N AM, V21, P159, DOI 10.1016/j.nec.2009.08.006; Johnson H, 2012, MOL CELL PROTEOMICS, V11, P1724, DOI 10.1074/mcp.M112.019984; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Jun T., 1999, SCI STKE, V13, P1; Kirisits A, 2007, INT J BIOCHEM CELL B, V39, P2173, DOI 10.1016/j.biocel.2007.07.012; Koshkin PA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P325, DOI 10.1134/S0006297913040019; Lee KH, 2009, ONCOGENE, V28, P3360, DOI 10.1038/onc.2009.192; Li YF, 2013, BIOCHEM BIOPH RES CO, V431, P560, DOI 10.1016/j.bbrc.2013.01.016; Lin AN, 2002, AGING CELL, V1, P112, DOI 10.1046/j.1474-9728.2002.00014.x; Lin H, 2002, EXP CELL RES, V272, P192, DOI 10.1006/excr.2001.5417; Maiti GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063440; Majumdar S, 2013, NEOPLASIA, V15, P749, DOI 10.1593/neo.121956; Mangelberger D, 2012, FRONT BIOSCI-LANDMRK, V17, P90, DOI 10.2741/3917; Mao YQ, 2013, ONCOL REP, V30, P327, DOI 10.3892/or.2013.2452; Nesterov A, 2001, J BIOL CHEM, V276, P10767, DOI 10.1074/jbc.M005196200; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Palumbo S, 2013, J CELL PHYSL; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Potter N, 2008, NEOPLASIA, V10, P757, DOI 10.1593/neo.07914; Qu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046010; Ramjaun AR, 2001, J BIOL CHEM, V276, P28913, DOI 10.1074/jbc.M103198200; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Robins H, 2005, P NATL ACAD SCI USA, V102, P15557, DOI 10.1073/pnas.0507443102; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Shang C, 2010, MED SCI MONITOR, V16, pBR168; Sinha S, 2008, ANN SURG ONCOL, V15, P1070, DOI 10.1245/s10434-007-9790-0; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor TE, 2012, CURR CANCER DRUG TAR, V12, P197; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wang SC, 2009, CLIN CANCER RES, V15, P6484, DOI 10.1158/1078-0432.CCR-08-2813; Weber MJ, 2005, FEBS J, V272, P59, DOI 10.1111/j.1432-1033.2004.04389.x; Yu X, 2013, GENE; Zhang FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081815; Zheng ZM, 2011, BBA-GENE REGUL MECH, V1809, P668, DOI 10.1016/j.bbagrm.2011.05.005	55	34	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95060	10.1371/journal.pone.0095060	http://dx.doi.org/10.1371/journal.pone.0095060			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736727	gold, Green Submitted, Green Published			2022-12-25	WOS:000336922600137
J	Abad, MG; Long, YC; Kinchen, RD; Schindel, ET; Gray, MW; Jackman, JE				Abad, Maria G.; Long, Yicheng; Kinchen, R. Dimitri; Schindel, Elinor T.; Gray, Michael W.; Jackman, Jane E.			Mitochondrial tRNA 5'-Editing in Dictyostelium discoideum and Polysphondylium pallidum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dictyostelium; Enzyme; Mitochondria; RNA Editing; Transfer RNA (tRNA); 3-5 Polymerase; tRNA Repair	ACANTHAMOEBA-CASTELLANII MITOCHONDRIA; 3'-5' NUCLEOTIDE ADDITION; TRNA(HIS) GUANYLYLTRANSFERASE; SPIZELLOMYCES-PUNCTATUS; ANTICODON; THG1; MATURATION; MECHANISM; CATALYZES; PROTEINS	Background: Secondary structure modeling predicts 5-editing of mitochondrial tRNAs in amoebozoans Dictyostelium discoideum and Polysphondylium pallidum. Results: Experimental verification reveals unexpected instances of editing and species-specific variations. Conclusion: Mitochondrial tRNA 5-editing is a complex process in which 3-5 RNA polymerases play a key role. Significance: Further biochemical characterization of mitochondrial tRNA 5-editing reactions and enzymes is indicated. Mitochondrial tRNA (mt-tRNA) 5-editing was first described more than 20 years ago; however, the first candidates for 5-editing enzymes were only recently identified in a eukaryotic microbe (protist), the slime mold Dictyostelium discoideum. In this organism, eight of 18 mt-tRNAs are predicted to be edited based on the presence of genomically encoded mismatched nucleotides in their aminoacyl-acceptor stem sequences. Here, we demonstrate that mt-tRNA 5-editing occurs at all predicted sites in D. discoideum as evidenced by changes in the sequences of isolated mt-tRNAs compared with the expected sequences encoded by the mitochondrial genome. We also identify two previously unpredicted editing events in which G-U base pairs are edited in the absence of any other genomically encoded mismatches. A comparison of 5-editing in D. discoideum with 5-editing in another slime mold, Polysphondylium pallidum, suggests organism-specific idiosyncrasies in the treatment of U-G/G-U pairs. In vitro activities of putative D. discoideum editing enzymes are consistent with the observed editing reactions and suggest an overall lack of tRNA substrate specificity exhibited by the repair component of the editing enzyme. Although the presence of terminal mismatches in mt-tRNA sequences is highly predictive of the occurrence of mt-tRNA 5-editing, the variability in treatment of U-G/G-U base pairs observed here indicates that direct experimental evidence of 5-editing must be obtained to understand the complete spectrum of mt-tRNA editing events in any species.	[Abad, Maria G.; Long, Yicheng; Kinchen, R. Dimitri; Jackman, Jane E.] Ohio State Univ, Dept Chem & Biochem, Ctr RNA Biol, Columbus, OH 43210 USA; [Long, Yicheng; Jackman, Jane E.] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Schindel, Elinor T.; Gray, Michael W.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Dalhousie University	Jackman, JE (corresponding author), Ohio State Univ, Dept Chem & Biochem, 484 West 12th Ave, Columbus, OH 43210 USA.	jackman.14@osu.edu	jackman, jane/AAE-1854-2022	jackman, jane/0000-0001-9291-8852; Gray, Michael/0000-0001-7125-2625; Long, Yicheng/0000-0003-3578-5197; Long, Yicheng/0000-0002-0714-2322	National Institutes of Health [R01 GM087543]; Canadian Institutes of Health Research [MOP-4124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM087543 (to J. E. J.) and Canadian Institutes of Health Research Grant MOP-4124 (to M. W. G.).	Abad MG, 2011, RNA, V17, P613, DOI 10.1261/rna.2517111; Abad MG, 2010, P NATL ACAD SCI USA, V107, P674, DOI 10.1073/pnas.0910961107; Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Antes T, 1998, MOL CELL BIOL, V18, P7521, DOI 10.1128/MCB.18.12.7521; Bullerwell CE, 2005, J BIOL CHEM, V280, P2463, DOI 10.1074/jbc.M411273200; Chen WY, 2012, NUCLEIC ACIDS RES, V40, P4666, DOI 10.1093/nar/gks013; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Gott JM, 2000, ANNU REV GENET, V34, P499, DOI 10.1146/annurev.genet.34.1.499; Gott JM, 2010, RNA, V16, P482, DOI 10.1261/rna.1958810; Grosjean H., 1998, MODIFICATION EDITING, DOI [10.1128/9781555818296, DOI 10.1128/9781555818296]; Gu WF, 2003, GENE DEV, V17, P2889, DOI 10.1101/gad.1148603; Heinemann IU, 2010, FEBS LETT, V584, P3567, DOI 10.1016/j.febslet.2010.07.023; Hyde SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067465; Hyde SJ, 2010, P NATL ACAD SCI USA, V107, P20305, DOI 10.1073/pnas.1010436107; Jackman JE, 2006, P NATL ACAD SCI USA, V103, P8640, DOI 10.1073/pnas.0603068103; Jackman JE, 2006, RNA, V12, P1007, DOI 10.1261/rna.54706; Jackman JE, 2012, RNA, V18, P886, DOI 10.1261/rna.032300.112; Laforest MJ, 2004, RNA, V10, P1191, DOI 10.1261/rna.7330504; Laforest MJ, 1997, NUCLEIC ACIDS RES, V25, P626, DOI 10.1093/nar/25.3.626; Leigh J, 2004, RNA, V10, P615, DOI 10.1261/rna.5195504; LONERGAN KM, 1993, SCIENCE, V259, P812, DOI 10.1126/science.8430334; LONERGAN KM, 1993, NUCLEIC ACIDS RES, V21, P4402, DOI 10.1093/nar/21.18.4402; Morl M., 2005, HDB RNA BIOCH, P22; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Price DH, 1999, CURR GENET, V35, P23, DOI 10.1007/s002940050428; Randau L, 2009, SCIENCE, V324, P657, DOI 10.1126/science.1170123; Rao BS, 2013, NUCLEIC ACIDS RES, V41, P1885, DOI 10.1093/nar/gks1242; Rao BS, 2011, NUCLEIC ACIDS RES, V39, P1833, DOI 10.1093/nar/gkq976; Rubio MAT, 2006, J BIOL CHEM, V281, P115, DOI 10.1074/jbc.M510136200; Schindel E. T., 2004, THESIS DALHOUSIE U; Schurer H, 2001, BIOL CHEM, V382, P1147, DOI 10.1515/BC.2001.144; Smith BA, 2014, BIOCHEMISTRY-US, V53, P1380, DOI 10.1021/bi4014648; Smith BA, 2012, BIOCHEMISTRY-US, V51, P453, DOI 10.1021/bi201397f; YOKOBORI S, 1995, NATURE, V377, P490, DOI 10.1038/377490a0; YOKOBORI S, 1995, P NATL ACAD SCI USA, V92, P10432, DOI 10.1073/pnas.92.22.10432	36	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15155	15165		10.1074/jbc.M114.561514	http://dx.doi.org/10.1074/jbc.M114.561514			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737330	Green Published, hybrid			2022-12-25	WOS:000337465400003
J	Du Roure, C; Versavel, A; Doll, T; Cao, C; Pillonel, V; Matthias, G; Kaller, M; Spetz, JF; Kopp, P; Kohler, H; Muller, M; Matthias, P				Du Roure, Camille; Versavel, Aude; Doll, Thierry; Cao, Chun; Pillonel, Vincent; Matthias, Gabriele; Kaller, Markus; Spetz, Jean-Francois; Kopp, Patrick; Kohler, Hubertus; Mueller, Matthias; Matthias, Patrick			Hematopoietic Overexpression of FOG1 Does Not Affect B-Cells but Reduces the Number of Circulating Eosinophils	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SITE-SPECIFIC INTEGRATION; FLP-RECOMBINASE; TRANSGENIC MICE; GENE KNOCKDOWN; ES CELLS; EXPRESSION; GATA-1; COACTIVATOR; MOUSE	We have identified expression of the gene encoding the transcriptional coactivator FOG-1 (Friend of GATA-1; Zfpm1, Zinc finger protein multitype 1) in B lymphocytes. We found that FOG-1 expression is directly or indirectly dependent on the B cell-specific coactivator OBF-1 and that it is modulated during B cell development: expression is observed in early but not in late stages of B cell development. To directly test in vivo the role of FOG-1 in B lymphocytes, we developed a novel embryonic stem cell recombination system. For this, we combined homologous recombination with the FLP recombinase activity to rapidly generate embryonic stem cell lines carrying a Cre-inducible transgene at the Rosa26 locus. Using this system, we successfully generated transgenic mice where FOG-1 is conditionally overexpressed in mature B-cells or in the entire hematopoietic system. While overexpression of FOG-1 in B cells did not significantly affect B cell development or function, we found that enforced expression of FOG-1 throughout all hematopoietic lineages led to a reduction in the number of circulating eosinophils, confirming and extending to mammals the known function of FOG-1 in this lineage.	[Du Roure, Camille; Versavel, Aude; Cao, Chun; Pillonel, Vincent; Matthias, Gabriele; Kaller, Markus; Spetz, Jean-Francois; Kopp, Patrick; Kohler, Hubertus; Matthias, Patrick] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Doll, Thierry; Mueller, Matthias] Novartis Inst Biomed Res, Basel, Switzerland; [Versavel, Aude; Pillonel, Vincent; Matthias, Patrick] Univ Basel, Fac Sci, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Novartis; University of Basel	Matthias, P (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	matthias@fmi.ch	Kaller, Markus/AAZ-4994-2020	Kaller, Markus/0000-0003-4514-5767; Pillonel, Vincent/0000-0002-3633-6716	Novartis Research Foundation	Novartis Research Foundation	This work was funded by the Novartis Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholdy B, 2006, P NATL ACAD SCI USA, V103, P11665, DOI 10.1073/pnas.0509430103; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bordon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004007; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Cantor AB, 2005, SEMIN CELL DEV BIOL, V16, P117, DOI 10.1016/j.semcdb.2004.10.006; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Du Roure C, 2006, BRIT J HAEMATOL, V132, P608, DOI 10.1111/j.1365-2141.2005.05905.x; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Fox AH, 1999, EMBO J, V18, P2812, DOI 10.1093/emboj/18.10.2812; Harju-Baker S, 2008, MOL CELL BIOL, V28, P3101, DOI 10.1128/MCB.01858-07; Hitz C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm475; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hohenstein Peter, 2008, Pathogenetics, V1, P3, DOI 10.1186/1755-8417-1-3; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Katz SG, 2002, MOL CELL BIOL, V22, P3121, DOI 10.1128/MCB.22.9.3121-3128.2002; Kurata H, 2002, J IMMUNOL, V168, P4538, DOI 10.4049/jimmunol.168.9.4538; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Matthias P, 2005, NAT REV IMMUNOL, V5, P497, DOI 10.1038/nri1633; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pal S, 2004, P NATL ACAD SCI USA, V101, P980, DOI 10.1073/pnas.0307612100; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Rapino F, 2013, CELL REP, V3, P1153, DOI 10.1016/j.celrep.2013.03.003; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sakurai K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1234; Sandhu U, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq868; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; SAUER B, 1990, New Biologist, V2, P441; Schebelle L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq044; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schnutgen F, 2006, METHOD ENZYMOL, V420, P100, DOI 10.1016/S0076-6879(06)20007-7; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Seibler J, 1997, BIOCHEMISTRY-US, V36, P1740, DOI 10.1021/bi962443e; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Seibler J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm122; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Soukharev S, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e21; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Tanaka M, 2004, GENES CELLS, V9, P1213, DOI 10.1111/j.1365-2443.2004.00796.x; Tchorz JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030011; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Tsang AP, 1998, GENE DEV, V12, P1176, DOI 10.1101/gad.12.8.1176; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhou MX, 2001, J EXP MED, V194, P1461, DOI 10.1084/jem.194.10.1461	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e92836	10.1371/journal.pone.0092836	http://dx.doi.org/10.1371/journal.pone.0092836			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747299	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500002
J	Gaia, M; Benamar, S; Boughalmi, M; Pagnier, I; Croce, O; Colson, P; Raoult, D; La Scola, B				Gaia, Morgan; Benamar, Samia; Boughalmi, Mondher; Pagnier, Isabelle; Croce, Olivier; Colson, Philippe; Raoult, Didier; La Scola, Bernard			Zamilon, a Novel Virophage with Mimiviridae Host Specificity	PLOS ONE			English	Article							GIANT VIRUSES; DNA VIRUSES; GENOMES; PHYLOGENIES; HIGHLIGHTS; EVOLUTION; FAMILIES; SPUTNIK; ORIGIN	Virophages, which are potentially important ecological regulators, have been discovered in association with members of the order Megavirales. Sputnik virophages target the Mimiviridae, Mavirus was identified with the Cafeteria roenbergensis virus, and virophage genomes reconstructed by metagenomic analyses may be associated with the Phycodnaviridae. Despite the fact that the Sputnik virophages were isolated with viruses belonging to group A of the Mimiviridae, they can grow in amoebae infected by Mimiviridae from groups A, B or C. In this study we describe Zamilon, the first virophage isolated with a member of group C of the Mimiviridae family. By co-culturing amoebae with purified Zamilon, we found that the virophage is able to multiply with members of groups B and C of the Mimiviridae family but not with viruses from group A. Zamilon has a 17,276 bp DNA genome that potentially encodes 20 genes. Most of these genes are closely related to genes from the Sputnik virophage, yet two are more related to Megavirus chiliensis genes, a group B Mimiviridae, and one to Moumouvirus monve transpoviron.	[Gaia, Morgan; Benamar, Samia; Boughalmi, Mondher; Pagnier, Isabelle; Croce, Olivier; Colson, Philippe; Raoult, Didier; La Scola, Bernard] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS IRD 7278, IFR48,Fac Med, Marseille, France; [Colson, Philippe; Raoult, Didier; La Scola, Bernard] Assistance Publ Hop Marseille, Pole Malad Infect, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	La Scola, B (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, UMR CNRS IRD 7278, IFR48,Fac Med, Marseille, France.	Bernard.lascola@univ-amu.fr	RAOULT, Didier/A-8434-2008; LA SCOLA, Bernard/P-6477-2016; Colson, Philippe/P-6355-2014	RAOULT, Didier/0000-0002-0633-5974; LA SCOLA, Bernard/0000-0001-8006-7704; Colson, Philippe/0000-0001-6285-0308; Pagnier, Isabelle/0000-0002-1724-3450	laboratory (URMITE)	laboratory (URMITE)	The work has been supported by the laboratory (URMITE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan D, 2011, P NATL ACAD SCI USA, V108, P17486, DOI 10.1073/pnas.1110889108; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Boughalmi M, 2013, ENVIRON MICROBIOL, V15, P2000, DOI 10.1111/1462-2920.12068; Boyer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015530; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Claverie JM, 2009, ANNU REV GENET, V43, P49, DOI 10.1146/annurev-genet-102108-134255; Colson P, 2013, ARCH VIROL, V158, P2517, DOI 10.1007/s00705-013-1768-6; Colson P, 2012, INTERVIROLOGY, V55, P321, DOI 10.1159/000336562; Desnues C, 2012, P NATL ACAD SCI USA, V109, P18078, DOI 10.1073/pnas.1208835109; Desnues C, 2012, ADV VIRUS RES, V82, P63, DOI 10.1016/B978-0-12-394621-8.00013-3; Duffy S, 2007, EVOLUTION, V61, P2614, DOI 10.1111/j.1558-5646.2007.00226.x; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fischer MG, 2011, SCIENCE, V332, P231, DOI 10.1126/science.1199412; Fischer MG, 2010, P NATL ACAD SCI USA, V107, P19508, DOI 10.1073/pnas.1007615107; Gaia M, 2013, VIROPHAGE CONCEPT, DOI [10.1002/9780470015902.a0024410, DOI 10.1002/9780470015902.A0024410]; Gaia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061912; Ghigo E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000087; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Hyman P, 2010, ADV APPL MICROBIOL, V70, P217, DOI 10.1016/S0065-2164(10)70007-1; Iyer LM, 2001, J VIROL, V75, P11720, DOI 10.1128/JVI.75.23.11720-11734.2001; Jassim SAA, 2013, WORLD J MICROB BIOT, V29, P1751, DOI 10.1007/s11274-013-1358-5; Koskella B, 2013, VIRUSES-BASEL, V5, P806, DOI 10.3390/v5030806; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919; Legendre Matthieu, 2012, Commun Integr Biol, V5, P102; Pagnier I, 2013, INTERVIROLO IN PRESS, V56; Philippe N, 2013, SCIENCE, V341, P281, DOI 10.1126/science.1239181; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; RIEDE I, 1985, EMBO J, V4, P2343, DOI 10.1002/j.1460-2075.1985.tb03936.x; Santini S, 2013, P NATL ACAD SCI USA, V110, P10800, DOI 10.1073/pnas.1303251110; Scanlan PD, 2011, MOL ECOL, V20, P981, DOI 10.1111/j.1365-294X.2010.04903.x; Sun SY, 2010, J VIROL, V84, P894, DOI 10.1128/JVI.01957-09; Suzan-Monti M, 2006, VIRUS RES, V117, P145, DOI 10.1016/j.virusres.2005.07.011; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Van Etten JL, 2010, ANNU REV MICROBIOL, V64, P83, DOI 10.1146/annurev.micro.112408.134338; Wodarz D, 2013, ECOL EVOL, V3, P2103, DOI 10.1002/ece3.600; Yau S, 2011, P NATL ACAD SCI USA, V108, P6163, DOI 10.1073/pnas.1018221108; Yoosuf N, 2012, GENOME BIOL EVOL, V4, P1324, DOI 10.1093/gbe/evs109; Yutin N, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-158; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223; Zhang XZ, 2012, P NATL ACAD SCI USA, V109, P18431, DOI 10.1073/pnas.1211702109; Zhou JL, 2013, J VIROL, V87, P4225, DOI 10.1128/JVI.03398-12	48	66	70	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94923	10.1371/journal.pone.0094923	http://dx.doi.org/10.1371/journal.pone.0094923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747414	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500043
J	Hafner, F; Kieninger, A; Meinitzer, A; Gary, T; Froehlich, H; Haas, E; Hackl, G; Eller, P; Brodmann, M; Seinost, G				Hafner, Franz; Kieninger, Andrea; Meinitzer, Andreas; Gary, Thomas; Froehlich, Harald; Haas, Elke; Hackl, Gerald; Eller, Philipp; Brodmann, Marianne; Seinost, Gerald			Endothelial Dysfunction and Brachial Intima-Media Thickness: Long Term Cardiovascular Risk with Claudication Related to Peripheral Arterial Disease: A Prospective Analysis	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE; SYMMETRIC DIMETHYLARGININE; MYOCARDIAL-INFARCTION; CAROTID-ARTERY; MORTALITY; CORONARY; INDEX; VASODILATATION; HOMOARGININE; DILATATION	Objective: Endothelial dysfunction plays a key role in the development, progression, and clinical manifestation of atherosclerosis, and in symptomatic peripheral arterial disease, endothelial dysfunction and enlarged intima-media thickness might be associated with increased cardiovascular risk. Flow-mediated dilatation and serologic parameters are used to evaluate individual endothelial function. Brachial intima-media thickness, a less recognized parameter of cardiovascular risk, is independently associated with coronary artery disease. The aim of this study was to evaluate the prognostic value of ultrasound and serologic parameters of endothelial function in relation to cardiovascular mortality in peripheral arterial disease. Design: monocentric, prospective cohort study. Methods: Flow mediated dilatation and brachial intima-media thickness were assessed in 184 (124 male) patients with peripheral arterial disease (Rutherford stages 2-3). Serologic parameters of endothelial function included asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), and L-homoarginine. Cardiovascular events were recorded during a follow-up of 99.1 +/- 11.1 months. Subjects who died of noncardiovascular causes were excluded from further analysis. Results: Eighty-two patients (44.6%) died during follow-up after a mean duration of 49.7 +/- 28.3 months. There were 49 cardiovascular deaths (59.8%) and 33 other deaths (40.2%). Flow mediated dilatation was associated with cardiovascular death [1.17% (0.0, 4.3) vs. 4.1% (1.2, 6.4), p < 0.001]. Intima-media thickness was greater in patients who succumbed to cardiovascular disease [0.37 mm (0.30, 0.41)] than in survivors [0.21 mm (0.15, 0.38), p < 0.001]. Brachial intima-media thickness above 0.345 mm was most predictive of cardiovascular death, with sensitivity and specificity values of 0.714 and 0.657, respectively (p < 0.001). Furthermore, ADMA levels above 0.745 mu mol/l and SDMA levels above 0.825 mu mol/l were significantly associated with cardiovascular death (p < 0.001 and 0.030). Conclusion: In symptomatic peripheral arterial disease, decreased flow mediated dilatation, enlarged intima-media thickness, and elevated levels of ADMA and SDMA were associated with increased cardiovascular risk.	[Hafner, Franz; Kieninger, Andrea; Gary, Thomas; Froehlich, Harald; Haas, Elke; Hackl, Gerald; Eller, Philipp; Brodmann, Marianne; Seinost, Gerald] Med Univ Graz, Div Angiol, Dept Internal Med, Graz, Austria; [Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	Medical University of Graz; Medical University of Graz	Brodmann, M (corresponding author), Med Univ Graz, Div Angiol, Dept Internal Med, Graz, Austria.	marianne.brodmann@medunigraz.at	Kieninger-GrÃfitsch, Andrea/ABD-8983-2021	Kieninger-GrÃfitsch, Andrea/0000-0002-9387-3294; Froehlich, Harald/0000-0003-4415-9809				Agewall S, 2005, J HYPERTENS, V23, P119, DOI 10.1097/00004872-200501000-00021; Allan RB, 2013, EUR J VASC ENDOVASC, V45, P263, DOI 10.1016/j.ejvs.2012.12.002; ANDERSON TJ, 1995, J AM COLL CARDIOL, V26, P1235, DOI 10.1016/0735-1097(95)00327-4; Bauersachs J, 2008, PHARMACOL REP, V60, P119; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Black MA, 2008, HYPERTENSION, V51, P203, DOI 10.1161/HYPERTENSIONAHA.107.101014; Boger RH, 2011, J INTERN MED, V269, P349, DOI 10.1111/j.1365-2796.2010.02322.x; Boger RH, 1998, CIRCULATION, V98, P1842, DOI 10.1161/01.CIR.98.18.1842; Brevetti G, 2003, CIRCULATION, V108, P2093, DOI 10.1161/01.CIR.0000095273.92468.D9; Canga A, 2013, ANGIOLOGY, V64, P356, DOI 10.1177/0003319712445373; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; Corretti MC, 2002, J AM COLL CARDIOL, V39, P257, DOI 10.1016/S0735-1097(01)01746-6; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; Ducharme A, 1999, AM J CARDIOL, V84, P952, DOI 10.1016/S0002-9149(99)00478-6; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442; Hafner F, 2010, EUR RADIOL, V20, P2533, DOI 10.1007/s00330-010-1801-z; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Hustad S, 2012, CLIN CHEM, V58, P402, DOI 10.1373/clinchem.2011.174490; Kervancioglu S, 2004, ACTA RADIOL, V45, P815, DOI 10.1080/02841850410009701; Koyoshi R, 2012, CIRC J, V76, P1469, DOI 10.1253/circj.CJ-11-1283; Lind L, 2008, LIPIDS, V43, P133, DOI 10.1007/s11745-007-3125-6; Marz W, 2010, CIRCULATION, V122, P967, DOI 10.1161/CIRCULATIONAHA.109.908988; Meinitzer A, 2007, CLIN CHIM ACTA, V384, P141, DOI 10.1016/j.cca.2007.07.006; Meinitzer A, 2011, CLIN CHEM, V57, P112, DOI 10.1373/clinchem.2010.150854; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Siegerink B, 2013, CLIN RES CARDIOL, V102, P193, DOI 10.1007/s00392-012-0515-4; Stoner L, 2012, J ATHEROSCLER THROMB, V19, P589, DOI 10.5551/jat.11973; Teerlink T, 2002, ANAL BIOCHEM, V303, P131, DOI 10.1006/abio.2001.5575; Valtonen P, 2008, CIRC J, V72, P1879, DOI 10.1253/circj.CJ-08-0240; Vita JA, 2002, CIRCULATION, V106, P640, DOI 10.1161/01.CIR.0000028581.07992.56; White CJ, 2007, CIRCULATION, V116, P2203, DOI 10.1161/CIRCULATIONAHA.106.621391	35	31	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93357	10.1371/journal.pone.0093357	http://dx.doi.org/10.1371/journal.pone.0093357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740106	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900018
J	Takahashi, A; Nagayasu, K; Nishitani, N; Kaneko, S; Koide, T				Takahashi, Aki; Nagayasu, Kazuki; Nishitani, Naoya; Kaneko, Shuji; Koide, Tsuyoshi			Control of Intermale Aggression by Medial Prefrontal Cortex Activation in the Mouse	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; CORTICAL PROJECTIONS; 5-HT1B RECEPTORS; MALE-MICE; ELECTRICAL-STIMULATION; ATTACK BEHAVIOR; SOCIAL DEFEAT; NEURONS; RAT; HYPOTHALAMUS	Aggressive behavior is widely observed throughout the animal kingdom because of its adaptiveness for social animals. However, when aggressive behavior exceeds the species-typical level, it is no longer adaptive, so there should be a mechanism to control excessive aggression to keep it within the adaptive range. Using optogenetics, we demonstrate that activation of excitatory neurons in the medial prefrontal cortex (mPFC), but not the orbitofrontal cortex (OFC), inhibits inter-male aggression in mice. At the same time, optogenetic silencing of mPFC neurons causes an escalation of aggressive behavior both quantitatively and qualitatively. Activation of the mPFC suppresses aggressive bursts and reduces the intensity of aggressive behavior, but does not change the duration of the aggressive bursts. Our findings suggest that mPFC activity has an inhibitory role in the initiation and execution, but not the termination, of aggressive behavior, and maintains such behavior within the adaptive range.	[Takahashi, Aki; Koide, Tsuyoshi] NIG, Mouse Genom Resource Lab, Mishima, Shizuoka, Japan; [Takahashi, Aki; Koide, Tsuyoshi] Grad Univ Adv Studies SOKENDAI, Dept Genet, Mishima, Shizuoka, Japan; [Nagayasu, Kazuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka, Japan; [Nagayasu, Kazuki; Nishitani, Naoya; Kaneko, Shuji] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol Pharmacol, Kyoto, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Osaka University; Kyoto University	Takahashi, A (corresponding author), NIG, Mouse Genom Resource Lab, Mishima, Shizuoka, Japan.	aktakaha@nig.ac.jp	Kaneko, Shuji/AAR-1005-2021; Takahashi, Aki/AAC-9290-2021	Takahashi, Aki/0000-0001-8325-9744; Kaneko, Shuji/0000-0001-5152-5809	KAKENHI [23683021]; Research Foundation for Opto-Science and Technology; Takeda Science Foundation; Grants-in-Aid for Scientific Research [23650243, 25116527] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research Foundation for Opto-Science and Technology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded in part by KAKENHI (23683021), Research Foundation for Opto-Science and Technology (http://www.refost-hq.jp/), Takeda Science Foundation (http://www.takeda-sci.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 1998, J COMP NEUROL, V401, P455; Andrade R, 2011, NEUROPHARMACOLOGY, V61, P382, DOI 10.1016/j.neuropharm.2011.01.015; Brower MC, 2001, J NEUROL NEUROSUR PS, V71, P720, DOI 10.1136/jnnp.71.6.720; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Celada P, 2001, J NEUROSCI, V21, P9917, DOI 10.1523/JNEUROSCI.21-24-09917.2001; Centenaro L, 2008, PSYCHOPHARMACOLOGY, V201, P237, DOI 10.1007/s00213-008-1269-6; Challis C, 2013, J NEUROSCI, V33, P13978, DOI 10.1523/JNEUROSCI.2383-13.2013; Davidson RJ, 2000, SCIENCE, V289, P591, DOI 10.1126/science.289.5479.591; De Almeida RM, 2006, PSYCHOPHARMACOLOGY, V185, P441, DOI 10.1007/s00213-006-0333-3; DEBRUIN JPC, 1983, BEHAV BRAIN RES, V10, P209, DOI 10.1016/0166-4328(83)90032-3; Faccidomo S, 2008, NEUROPSYCHOPHARMACOL, V33, P2888, DOI 10.1038/npp.2008.7; Ferris CF, 1997, J NEUROSCI, V17, P4331; Floyd NS, 2001, J COMP NEUROL, V432, P307, DOI 10.1002/cne.1105; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Fuxjager MJ, 2010, P NATL ACAD SCI USA, V107, P12393, DOI 10.1073/pnas.1001394107; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gobrogge KL, 2009, P NATL ACAD SCI USA, V106, P19144, DOI 10.1073/pnas.0908620106; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; GRANT E. C, 1963, BEHAVIOUR, V21, P246, DOI 10.1163/156853963X00185; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hajos M, 1998, NEUROSCIENCE, V87, P95, DOI 10.1016/S0306-4522(98)00157-2; Halasz J, 2006, BEHAV BRAIN RES, V175, P166, DOI 10.1016/j.bbr.2006.08.019; Haller J, 2006, NEUROSCI BIOBEHAV R, V30, P292, DOI 10.1016/j.neubiorev.2005.01.005; Haller J, 2006, PHYSIOL BEHAV, V88, P173, DOI 10.1016/j.physbeh.2006.03.030; Hewinson James, 2013, Methods Mol Biol, V998, P65, DOI 10.1007/978-1-62703-351-0_5; Hoover WB, 2011, J COMP NEUROL, V519, P3766, DOI 10.1002/cne.22733; Jankowski MP, 2004, J COMP NEUROL, V468, P518, DOI 10.1002/cne.10976; KOLB B, 1974, PHYSIOL BEHAV, V13, P637, DOI 10.1016/0031-9384(74)90234-0; KOOLHAAS JM, 1990, AGGRESSIVE BEHAV, V16, P223; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Mattis J, 2012, NAT METHODS, V9, P159, DOI [10.1038/nmeth.1808, 10.1038/NMETH.1808]; MICZEK KA, 1992, PSYCHOPHARMACOLOGY, V107, P551, DOI 10.1007/BF02245270; MICZEK KA, 1978, PSYCHOPHARMACOLOGY, V57, P47, DOI 10.1007/BF00426957; Miczek KA, 2013, PSYCHOPHARMACOLOGY, V226, P445, DOI 10.1007/s00213-013-3008-x; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Peyron C, 1998, NEUROSCIENCE, V82, P443; Raine A, 1997, BIOL PSYCHIAT, V42, P495, DOI 10.1016/S0006-3223(96)00362-9; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Sano K, 2013, EUR J NEUROSCI, V37, P1308, DOI 10.1111/ejn.12131; SIEGEL A, 1975, BRAIN RES, V93, P473, DOI 10.1016/0006-8993(75)90185-7; SIEGEL A, 1974, BRAIN RES, V66, P467, DOI 10.1016/0006-8993(74)90061-4; Takahashi A, 2010, J NEUROSCI, V30, P11771, DOI 10.1523/JNEUROSCI.1814-10.2010; Tsunematsu T, 2013, BEHAV BRAIN RES, V255, P64, DOI 10.1016/j.bbr.2013.05.021; Varga V, 2003, EUR J NEUROSCI, V17, P280, DOI 10.1046/j.1460-9568.2003.02465.x; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wall VL, 2012, PHYSIOL BEHAV, V107, P440, DOI 10.1016/j.physbeh.2012.09.002; Wang F, 2011, SCIENCE, V334, P693, DOI 10.1126/science.1209951; Yang CF, 2013, CELL, V153, P896, DOI 10.1016/j.cell.2013.04.017; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	49	61	62	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94657	10.1371/journal.pone.0094657	http://dx.doi.org/10.1371/journal.pone.0094657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740241	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900058
J	Arias-Carrion, O; Murillo-Rodriguez, E				Arias-Carrion, Oscar; Murillo-Rodriguez, Eric			Effects of Hypocretin/Orexin Cell Transplantation on Narcoleptic-Like Sleep Behavior in Rats	PLOS ONE			English	Article							PARKINSONS-DISEASE; INTRANASAL OREXIN; GENE-TRANSFER; WAKE CYCLE; CATAPLEXY; NEURONS; MICE; PEPTIDES; THERAPY; HYPOCRETIN-2-SAPORIN	The sleep disorder narcolepsy is now considered a neurodegenerative disease because there is a massive loss of neurons containing the neuropeptide hypocretin/orexin (HCRT). In consequence, narcoleptic patients have very low cerebrospinal fluid (CSF) levels of HCRT. Studies in animal models of narcolepsy have shown the neurophysiological role of the HCRT system in the development of this disease. For example, the injection of the neurotoxin named hypocretin-2-saporin (HCRT2/SAP) into the lateral hypothalamus (LH) destroys the HCRT neurons, therefore diminishes the contents of HCRT in the CSF and induces narcoleptic-like behavior in rats. Transplants of various cell types have been used to induce recovery in a variety of neurodegenerative animal models. In models such as Parkinson's disease, cell survival has been shown to be small but satisfactory. Similarly, cell transplantation could be employed to implant grafts of HCRT cells into the LH or even other brain regions to treat narcolepsy. Here, we report for the first time that transplantation of HCRT neurons into the LH of HCRT2/SAP-lesioned rats diminishes narcoleptic-like sleep behavior. Therefore, cell transplantation may provide an effective method to treat narcolepsy.	[Arias-Carrion, Oscar] Hosp Gen Dr Manuel Gea Gonzalez, Unidad Trastornos Movimiento & Sueno TMS, Mexico City, DF, Mexico; [Arias-Carrion, Oscar] Hosp Gen Ajusco Medio, Unidad Trastornos Movimiento & Sueno TMS, Mexico City, DF, Mexico; [Murillo-Rodriguez, Eric] Univ Anahuac Mayab, Lab Neurociencias Mol & Integrat, Escuela Med, Div Ciencias Salud, Merida, Yucatan, Mexico		Arias-Carrion, O (corresponding author), Hosp Gen Dr Manuel Gea Gonzalez, Unidad Trastornos Movimiento & Sueno TMS, Mexico City, DF, Mexico.	arias@ciencias.unam.mx; eric.murillo@anahuac.mx	Arias-Carrion, Oscar/A-4248-2018	Arias-Carrion, Oscar/0000-0002-9982-7571	CONACYT [79009]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grant CONACYT (79009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Carrion O, 2004, SLEEP, V27, P1465, DOI 10.1093/sleep/27.8.1465; Arias-Carrion O, 2004, J NEUROSCI RES, V78, P16, DOI 10.1002/jnr.20235; Arias-Carrion O, 2006, J NEUROSCI RES, V84, P1425, DOI 10.1002/jnr.21068; Arias-Carrion O, 2006, NEUROSCI LETT, V404, P93, DOI 10.1016/j.neulet.2006.05.017; Arias-Carrion O, 2011, J NEUROSCI RES, V89, P1143, DOI 10.1002/jnr.22666; Arias-Carrion O, 2009, CNS NEUROL DISORD-DR, V8, P309, DOI 10.2174/187152709788921681; Arias-Carrion O, 2009, REV MED CHILE, V137, P1209, DOI /S0034-98872009000900012; Baier PC, 2011, SLEEP MED, V12, P941, DOI 10.1016/j.sleep.2011.06.015; Baier PC, 2008, BRAIN, V131, P2734, DOI 10.1093/brain/awn193; Burgess CR, 2012, J NEUROSCI, V32, P12305, DOI 10.1523/JNEUROSCI.2630-12.2012; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Crocker A, 2005, NEUROLOGY, V65, P1184, DOI 10.1212/01.WNL.0000168173.71940.ab; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DHURIA SV, 2008, J PHARM SCI; Fujiki N, 2003, SLEEP, V26, P953, DOI 10.1093/sleep/26.8.953; Gerashchenko D, 2003, EXP NEUROL, V184, P1010, DOI 10.1016/S0014-4886(03)00388-1; Gerashchenko D, 2003, NEUROSCIENCE, V116, P223, DOI 10.1016/S0306-4522(02)00575-4; Gerashchenko D, 2001, J NEUROSCI, V21, P7273, DOI 10.1523/JNEUROSCI.21-18-07273.2001; Hallschmid M, 2004, PHYSIOL BEHAV, V83, P55, DOI 10.1016/j.physbeh.2004.07.023; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Huang YS, 2006, SLEEP MED, V7, P454, DOI 10.1016/j.sleep.2006.05.009; John J, 2000, Sleep Res Online, V3, P23; Keam S, 2007, CURR OPIN NEUROL, V20, P699, DOI 10.1097/WCO.0b013e3282f22ad9; Kordower JH, 1997, EXP NEUROL, V144, P41, DOI 10.1006/exnr.1996.6386; Lindvall O, 2003, PHARMACOL RES, V47, P279, DOI 10.1016/S1043-6618(03)00037-9; Liu M, 2008, EUR J NEUROSCI, V28, P1382, DOI 10.1111/j.1460-9568.2008.06446.x; Liu M, 2011, J NEUROSCI, V31, P6028, DOI 10.1523/JNEUROSCI.6069-10.2011; Mieda M, 2004, P NATL ACAD SCI USA, V101, P4649, DOI 10.1073/pnas.0400590101; Mignot E, 2005, SLEEP, V28, P754, DOI 10.1093/sleep/28.6.754; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Murillo-Rodriguez E, 2003, SLEEP, V26, P943, DOI 10.1093/sleep/26.8.943; Murillo-Rodriguez E, 2007, EUR J PHARMACOL, V562, P82, DOI 10.1016/j.ejphar.2007.01.076; Nishino S, 2007, EXPERT OPIN INV DRUG, V16, P1785, DOI 10.1517/13543784.16.11.1785; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Siegel JM, 2004, ANNU REV PSYCHOL, V55, P125, DOI 10.1146/annurev.psych.55.090902.141545; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Weinhold SL, 2014, BEHAV BRAIN RES, V262, P8, DOI 10.1016/j.bbr.2013.12.045; Yuan Ti-Fei, 2008, Int Arch Med, V1, P17, DOI 10.1186/1755-7682-1-17	39	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95342	10.1371/journal.pone.0095342	http://dx.doi.org/10.1371/journal.pone.0095342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736646	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600171
J	Braden, BP; Taketa, DA; Pierce, JD; Kassmer, S; Lewis, DD; De Tomaso, AW				Braden, Brian P.; Taketa, Daryl A.; Pierce, James D.; Kassmer, Susannah; Lewis, Daniel D.; De Tomaso, Anthony W.			Vascular Regeneration in a Basal Chordate Is Due to the Presence of Immobile, Bi-Functional Cells	PLOS ONE			English	Article							ZEBRAFISH HEART REGENERATION; COLONIAL UROCHORDATE; BOTRYLLUS-SCHLOSSERI; STEM; ANGIOGENESIS; BIOLOGY; GERM; ALLORECOGNITION; ENDOTHELIUM; EVOLUTION	The source of tissue turnover during homeostasis or following injury is usually due to proliferation of a small number of resident, lineage-restricted stem cells that have the ability to amplify and differentiate into mature cell types. We are studying vascular regeneration in a chordate model organism, Botryllus schlosseri, and have previously found that following surgical ablation of the extracorporeal vasculature, new tissue will regenerate in a VEGF-dependent process within 48 hrs. Here we use a novel vascular cell lineage tracing methodology to assess regeneration in parabiosed individuals and demonstrate that the source of regenerated vasculature is due to the proliferation of pre-existing vascular resident cells and not a mobile progenitor. We also show that these cells are bi-potential, and can reversibly adopt two fates, that of the newly forming vessels or the differentiated vascular tissue at the terminus of the vasculature, known as ampullae. In addition, we show that pre-existing vascular resident cells differentially express progenitor and differentiated cell markers including the Botryllus homologs of CD133, VEGFR-2, and Cadherin during the regenerative process.	[Braden, Brian P.; Taketa, Daryl A.; Pierce, James D.; Kassmer, Susannah; Lewis, Daniel D.; De Tomaso, Anthony W.] Univ Calif Santa Barbara, Dept Mol Cellular Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	De Tomaso, AW (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular Dev Biol, Santa Barbara, CA 93106 USA.	anthony.detomaso@lifesci.ucsb.edu			NIH [AI041588, AG037966]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037966] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH grants AI041588 and AG037966 supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini A, 2013, ANGIOGENESIS, V16, P405, DOI 10.1007/s10456-012-9323-8; Anderson LH, 2011, DEV DYNAM, V240, P674, DOI 10.1002/dvdy.22539; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; Birnbaum KD, 2008, CELL, V132, P697, DOI 10.1016/j.cell.2008.01.040; BOYD HC, 1986, BIOL BULL, V170, P91, DOI 10.2307/1541383; BURIGHEL P, 1971, Bollettino di Zoologia, V38, P273; Cima F, 2010, DEV COMP IMMUNOL, V34, P272, DOI 10.1016/j.dci.2009.10.005; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Gasparini F, 2008, EVOL DEV, V10, P591, DOI 10.1111/j.1525-142X.2008.00274.x; Gasparini F, 2007, DEV DYNAM, V236, P719, DOI 10.1002/dvdy.21073; Gurtner GC, 2007, ANNU REV MED, V58, P299, DOI 10.1146/annurev.med.58.082405.095329; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; Karbanova J, 2008, J HISTOCHEM CYTOCHEM, V56, P977, DOI 10.1369/jhc.2008.951897; Khakoo AY, 2005, ANNU REV MED, V56, P79, DOI 10.1146/annurev.med.56.090203.104149; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; King RS, 2012, J CELL BIOL, V196, P553, DOI 10.1083/jcb.201105099; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Lauzon RJ, 2002, DEV BIOL, V249, P333, DOI 10.1006/dbio.2002.0772; Lauzon RJ, 2013, DEV BIOL, V374, P357, DOI 10.1016/j.ydbio.2012.11.006; Lin CS, 2013, STEM CELLS DEV, V22, P1018, DOI 10.1089/scd.2012.0504; Manni L, 2007, DEV DYNAM, V236, P335, DOI 10.1002/dvdy.21037; McKitrick TR, 2011, IMMUNITY, V34, P616, DOI 10.1016/j.immuni.2011.01.019; MILKMAN R, 1967, BIOL BULL, V132, P229, DOI 10.2307/1539891; MILLAR RH, 1971, ADV MAR BIOL, V9, P1, DOI 10.1016/S0065-2881(08)60341-7; Mimeault M, 2008, STEM CELL REV, V4, P27, DOI 10.1007/s12015-008-9008-2; Mochii M, 2007, DEV GROWTH DIFFER, V49, P155, DOI 10.1111/j.1440-169X.2007.00912.x; MUKAI H, 1978, J MORPHOL, V157, P49, DOI 10.1002/jmor.1051570105; Munoz-Chapuli R, 2011, INT J DEV BIOL, V55, P345, DOI 10.1387/ijdb.103212rm; Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465; Nydam ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065980; Nydam ML, 2013, DEV COMP IMMUNOL, V41, P128, DOI 10.1016/j.dci.2013.03.004; Nyholm SV, 2006, IMMUNITY, V25, P163, DOI 10.1016/j.immuni.2006.04.011; OKA H, 1957, BIOL BULL, V112, P225, DOI 10.2307/1539200; Pascual-Anaya J, 2013, DEV BIOL, V375, P182, DOI 10.1016/j.ydbio.2012.11.015; Pearson JD, 2010, MICROVASC RES, V79, P162, DOI 10.1016/j.mvr.2009.12.004; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Riehle KJ, 2011, J GASTROEN HEPATOL, V26, P203, DOI 10.1111/j.1440-1746.2010.06539.x; Rinkevich Y, 2011, NATURE, V476, P409, DOI 10.1038/nature10346; Rosner A, 2007, DEV BIOL, V304, P687, DOI 10.1016/j.ydbio.2007.01.018; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; SMITH AR, 1975, NATURE, V257, P224, DOI 10.1038/257224a0; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Strilic B, 2010, CELL MOL LIFE SCI, V67, P3209, DOI 10.1007/s00018-010-0400-0; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Tiozzo S, 2008, DEV BIOL, V315, P243, DOI 10.1016/j.ydbio.2007.12.035; Torsney E, 2011, J MOL CELL CARDIOL, V50, P304, DOI 10.1016/j.yjmcc.2010.09.006; Voskoboynik A, 2013, SCIENCE, V341, P384, DOI 10.1126/science.1238036; Wallez Y, 2006, TRENDS CARDIOVAS MED, V16, P55, DOI 10.1016/j.tcm.2005.11.008	61	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95460	10.1371/journal.pone.0095460	http://dx.doi.org/10.1371/journal.pone.0095460			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736432	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600181
J	Hanaoka, Y; Yasuda, O; Soejima, H; Miyata, K; Yamamoto, E; Izumiya, Y; Maeda, N; Ohishi, M; Rakugi, H; Oike, Y; Kim-Mitsuyama, S; Ogawa, H				Hanaoka, Yohsuke; Yasuda, Osamu; Soejima, Hirofumi; Miyata, Keishi; Yamamoto, Eiichiro; Izumiya, Yasuhiro; Maeda, Nobuyo; Ohishi, Mitsuru; Rakugi, Hiromi; Oike, Yuichi; Kim-Mitsuyama, Shokei; Ogawa, Hisao			Tissue Inhibitor of Metalloproteinase-3 Knockout Mice Exhibit Enhanced Energy Expenditure through Thermogenesis	PLOS ONE			English	Article							ADIPOSE-TISSUE; MATRIX METALLOPROTEINASES; INDUCED OBESITY; EXPRESSION; TIMP-3; GENE; BINDING; PROTEIN; DEFICIENCY	Tissue inhibitors of metalloproteinases (TIMPs) regulate matrix metalloproteinase activity and maintain extracellular matrix homeostasis. Although TIMP-3 has multiple functions (e. g., apoptosis, inhibition of VEGF binding to VEGF receptor, and inhibition of TNF alpha converting enzyme), its roles in thermogenesis and metabolism, which influence energy expenditure and can lead to the development of metabolic disorders when dysregulated, are poorly understood. This study aimed to determine whether TIMP-3 is implicated in metabolism by analyzing TIMP-3 knockout (KO) mice. TIMP-3 KO mice had higher body temperature, oxygen consumption, and carbon dioxide production than wild-type (WT) mice, although there were no differences in food intake and locomotor activity. These results suggest that metabolism is enhanced in TIMP-3 KO mice. Real-time PCR analysis showed that the expression of PPAR-delta, UCP-2, NRF-1 and NRF-2 in soleus muscle, and PGC-1 alpha and UCP-2 in gastrocnemius muscle, was higher in TIMP-3 KO mice than in WT mice, suggesting that TIMP-3 deficiency may increase mitochondrial activity. When exposed to cold for 8 hours to induce thermogenesis, TIMP-3 KO mice had a higher body temperature than WT mice. In the treadmill test, oxygen consumption and carbon dioxide production were higher in TIMP-3 KO mice both before and after starting exercise, and the difference was more pronounced after starting exercise. Our findings suggest that TIMP-3 KO mice exhibit enhanced metabolism, as reflected by a higher body temperature than WT mice, possibly due to increased mitochondrial activity. Given that TIMP-3 deficiency increases energy expenditure, TIMP-3 may present a novel therapeutic target for preventing metabolic disorders.	[Hanaoka, Yohsuke; Soejima, Hirofumi; Yamamoto, Eiichiro; Izumiya, Yasuhiro; Ogawa, Hisao] Kumamoto Univ, Dept Cardiovasc Med, Grad Sch Med Sci, Kumamoto, Japan; [Yasuda, Osamu] Kumamoto Univ, Dept Cardiovasc Clin & Translat Res, Kumamoto Univ Hosp, Kumamoto, Japan; [Miyata, Keishi; Oike, Yuichi] Kumamoto Univ, Dept Mol Genet, Grad Sch Med Sci, Kumamoto, Japan; [Maeda, Nobuyo] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA; [Ohishi, Mitsuru] Kagoshima Univ, Dept Cardiovasc Med & Hypertens, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Rakugi, Hiromi] Osaka Univ, Dept Geriatr Med & Nephrol, Grad Sch Med, Suita, Osaka, Japan; [Kim-Mitsuyama, Shokei] Kumamoto Univ, Dept Pharmacol & Mol Therapeut, Grad Sch Med Sci, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Kagoshima University; Osaka University; Kumamoto University	Yasuda, O (corresponding author), Kumamoto Univ, Dept Cardiovasc Clin & Translat Res, Kumamoto Univ Hosp, Kumamoto, Japan.	o-yasuda@kumamoto-u.ac.jp	Miyata, Keishi/HGF-1876-2022	Miyata, Keishi/0000-0003-0336-1859; Rakugi, Hiromi/0000-0001-6508-4338	Japanese Society for the Promotion of Science [23590886]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042630] Funding Source: NIH RePORTER	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Japanese Society for the Promotion of Science (No. 23590886) (http://www.jsps.go.jp/j-grantsinaid/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Basu R, 2013, CARDIOVASC RES, V98, P360, DOI 10.1093/cvr/cvt067; Bernot D, 2010, J BIOL CHEM, V285, P6508, DOI 10.1074/jbc.M109.078444; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Croissandeau G, 2002, BIOCHEM J, V364, P739, DOI 10.1042/BJ20011158; Curcic D, 1997, J CELL BIOCHEM, V65, P287; Elias I, 2013, ADIPOCYTE, V2, P109, DOI 10.4161/adip.22880; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Federici M, 2005, J CLIN INVEST, V115, P3494, DOI 10.1172/JCI26052; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gan ZJ, 2011, GENE DEV, V25, P2619, DOI 10.1101/gad.178434.111; Gastaldi G, 2008, Rev Med Suisse, V4, P1387; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Jacobsen J, 2008, BIOCHEMISTRY-US, V47, P537, DOI 10.1021/bi701629c; Janssen A, 2008, INVEST OPHTH VIS SCI, V49, P2812, DOI 10.1167/iovs.07-1444; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Kawamoto H, 2006, HYPERTENS RES, V29, P285, DOI 10.1291/hypres.29.285; Lijnen HR, 2003, THROMB HAEMOSTASIS, V89, P249; Lijnen HR, 2001, THROMB HAEMOSTASIS, V85, P1111; Lilla J, 2002, AM J PATHOL, V160, P1551, DOI 10.1016/S0002-9440(10)61100-5; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Lu XD, 2012, ENDOCRINOLOGY, V153, P3123, DOI 10.1210/en.2012-1151; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rial E, 1999, EMBO J, V18, P5827, DOI 10.1093/emboj/18.21.5827; Smith MR, 1997, CYTOKINE, V9, P770, DOI 10.1006/cyto.1997.0233; Sowa Y, 1997, CANCER RES, V57, P3145; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; Villena JA, 1998, BIOCHEM J, V331, P121, DOI 10.1042/bj3310121; Wang WM, 2006, BIOCHEM J, V398, P515, DOI 10.1042/BJ20060630; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Warner A, 2013, P NATL ACAD SCI USA, V110, P16241, DOI 10.1073/pnas.1310300110; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94930	10.1371/journal.pone.0094930	http://dx.doi.org/10.1371/journal.pone.0094930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736588	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600107
J	Mu, L; Liang, YL; Han, RL				Mu, Lan; Liang, Yinli; Han, Ruilian			Assessment of the Soil Organic Carbon Sink in a Project for the Conversion of Farmland to Forestland: A Case Study in Zichang County, Shaanxi, China	PLOS ONE			English	Article							LAND-USE CHANGE; LOESS PLATEAU; SEQUESTRATION; STOCKS; AFFORESTATION; AGRICULTURE; NITROGEN; STORAGE; MATTER	The conversion of farmland to forestland not only changes the ecological environment but also enriches the soil with organic matter and affects the global carbon cycle. This paper reviews the influence of land use changes on the soil organic carbon sink to determine whether the Chinese "Grain-for-Green'' (conversion of farmland to forestland) project increased the rate of SOC content during its implementation between 1999 and 2010 in the hilly and gully areas of the Loess Plateau in north-central China. The carbon sink was quantified, and the effects of the main species were assessed. The carbon sink increased from 2.26x10(6) kg in 1999 to 8.32610(6) kg in 2010 with the sustainable growth of the converted areas. The black locust (Robinia pseudoacacia L.) and alfalfa (Medicago sativa L.) soil increased SOC content in the top soil (0-100 cm) in the initial 7-yr period, while the sequestration occurred later (>7 yr) in the 100-120 cm layer after the "Grain-for-Green" project was implemented. The carbon sink function measured for the afforested land provides evidence that the Grain-for-Green project has successfully excavated the carbon sink potential of the Shaanxi province and served as an important milestone for establishing an effective organic carbon management program.	[Mu, Lan; Liang, Yinli; Han, Ruilian] Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Mu, Lan; Liang, Yinli; Han, Ruilian] Chinese Acad Sci, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China; [Mu, Lan; Liang, Yinli; Han, Ruilian] Minist Water Resources, Yangling, Shaanxi Provinc, Peoples R China	Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Northwest A&F University - China; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS; Ministry of Water Resources	Liang, YL (corresponding author), Northwest A&F Univ, Inst Soil & Water Conservat, Yangling, Shaanxi Provinc, Peoples R China.	liangyl@ms.iswc.ac.cn			National Science and Technology Support Program [2011BAD31B05, 2014BAD14B006]	National Science and Technology Support Program	This work was financially supported by the National Science and Technology Support Program (2011BAD31B05) and by the National Science and Technology Support Program (2014BAD14B006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balesdent J, 2000, SOIL TILL RES, V53, P215, DOI 10.1016/S0167-1987(99)00107-5; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Binkley D, 2005, NATO SCI S SS IV EAR, V55, P155; Bolin B., 2000, SPECIAL REPORT LAND; Chang RY, 2012, CATENA, V95, P145, DOI 10.1016/j.catena.2012.02.012; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; Chinese Editorial Committee of Soil Analysis, 1996, SOIL PHYS CHEM AN DE; Dawson JJC, 2007, SCI TOTAL ENVIRON, V382, P165, DOI 10.1016/j.scitotenv.2007.03.023; DeGryze S, 2004, GLOBAL CHANGE BIOL, V10, P1120, DOI 10.1111/j.1529-8817.2003.00786.x; Entry JA, 2002, SOIL SCI SOC AM J, V66, P1957, DOI 10.2136/sssaj2002.1957; Fearnside Philip M., 1998, Forest Ecology and Management, V108, P147, DOI 10.1016/S0378-1127(98)00222-9; Fu BJ, 2009, PROG PHYS GEOG, V33, P793, DOI 10.1177/0309133309350264; Girmay G, 2008, LAND DEGRAD DEV, V19, P351, DOI 10.1002/ldr.844; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; GUPTA RK, 1994, CURR SCI INDIA, V66, P378; *ISS, 1978, PHYS CHEM AN METH SO, P7; [贾松伟 Jia Songwei], 2004, [水土保持学报, Journal of Soil and Water Conservation], V18, P78; Jin TT, 2011, HYDROL EARTH SYST SC, V15, P2519, DOI 10.5194/hess-15-2519-2011; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Lal R, 2010, FOOD SECUR, V4, P1035; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Liski J, 1999, AMBIO, V28, P171; Liu ZP, 2011, AGR ECOSYST ENVIRON, V142, P184, DOI 10.1016/j.agee.2011.05.002; Lubowski RN, 2005, BELFER CENTERPROGRAM, V5, P135; Ostle NJ, 2009, LAND USE POLICY, V26, pS274, DOI 10.1016/j.landusepol.2009.08.006; Pan GX, 2008, ADV CLIM CHANG RES, V4, P282; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Post WM, 2000, GLOBAL CHANGE BIOL, V6, P317, DOI 10.1046/j.1365-2486.2000.00308.x; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Reay DS, 2007, NATURE GEOSCIENCE, V1, P430; Schlesinger WH, 1999, SCIENCE, V284, P2095, DOI 10.1126/science.284.5423.2095; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Smith P, 2004, SOIL USE MANAGE, V20, P212, DOI 10.1079/SUM2004233; Smith P, 1996, EVALUATION SOIL ORGA, P429; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Turner DP, 2003, TELLUS B, V55, P657, DOI 10.1034/j.1600-0889.2003.01416.x; Watson R. T., 2000, LAND USE LAND USE CH, P377; Xi T.T., 2006, ISSUES EC, V6, P519, DOI 10.16832/j.cnki.1005-9709.2006.06.008; [许明祥 Xu Mingxiang], 2012, [生态学报, Acta Ecologica Sinica], V32, P5405; [徐香兰 Xu Xianglan], 2003, [水土保持学报, Journal of Soil and Water Conservation], V17, P13; [徐永荣 Xu Yongrong], 2003, [华中农业大学学报, Journal of Huazhong Agricultural University], V22, P603; Yu DS, 2007, J ENVIRON MANAGE, V85, P680, DOI 10.1016/j.jenvman.2006.09.020	46	5	6	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94770	10.1371/journal.pone.0094770	http://dx.doi.org/10.1371/journal.pone.0094770			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736591	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600088
J	Taylor, AF; Rylott, EL; Anderson, CWN; Bruce, NC				Taylor, Andrew F.; Rylott, Elizabeth L.; Anderson, Christopher W. N.; Bruce, Neil C.			Investigating the Toxicity, Uptake, Nanoparticle Formation and Genetic Response of Plants to Gold	PLOS ONE			English	Article							P-TYPE ATPASE; ARABIDOPSIS-THALIANA; CHLOROPLAST ENVELOPE; METAL NANOPARTICLES; CHILOPSIS-LINEARIS; AU NANOPARTICLES; CELL-WALLS; GROWTH; TRANSPORTER; SILVER	We have studied the physiological and genetic responses of Arabidopsis thaliana L. (Arabidopsis) to gold. The root lengths of Arabidopsis seedlings grown on nutrient agar plates containing 100 mg/L gold were reduced by 75%. Oxidized gold was subsequently found in roots and shoots of these plants, but gold nanoparticles (reduced gold) were only observed in the root tissues. We used a microarray-based study to monitor the expression of candidate genes involved in metal uptake and transport in Arabidopsis upon gold exposure. There was up-regulation of genes involved in plant stress response such as glutathione transferases, cytochromes P450, glucosyl transferases and peroxidases. In parallel, our data show the significant down-regulation of a discreet number of genes encoding proteins involved in the transport of copper, cadmium, iron and nickel ions, along with aquaporins, which bind to gold. We used Medicago sativa L. (alfalfa) to study nanoparticle uptake from hydroponic culture using ionic gold as a non-nanoparticle control and concluded that nanoparticles between 5 and 100 nm in diameter are not directly accumulated by plants. Gold nanoparticles were only observed in plants exposed to ionic gold in solution. Together, we believe our results imply that gold is taken up by the plant predominantly as an ionic form, and that plants respond to gold exposure by up-regulating genes for plant stress and down-regulating specific metal transporters to reduce gold uptake.	[Taylor, Andrew F.; Rylott, Elizabeth L.; Bruce, Neil C.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England; [Anderson, Christopher W. N.] Massey Univ, Inst Agr & Environm, Palmerston North, New Zealand	University of York - UK; Massey University	Bruce, NC (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.	neil.bruce@york.ac.uk	Rylott, Elizabeth L/A-6059-2012	Rylott, Elizabeth L/0000-0002-1609-414X; Bruce, Neil Charles/0000-0003-0398-2997; Taylor, Andrew/0000-0003-1689-5737	Burgess Foundation; EPSRC as part of G8 Research Councils Initiative on Multilateral Research Funding [EP/K022482/1]; Engineering and Physical Sciences Research Council [EP/K022482/1] Funding Source: researchfish; EPSRC [EP/K022482/1] Funding Source: UKRI	Burgess Foundation; EPSRC as part of G8 Research Councils Initiative on Multilateral Research Funding(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by funding from the Burgess Foundation, and from the EPSRC (www.epsrc.ac.uk), grant number EP/K022482/1, as part of the G8 Research Councils Initiative on Multilateral Research Funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Anderson C, 2005, MICROCHEM J, V81, P81, DOI 10.1016/j.microc.2005.01.004; Anderson CWN, 2013, RSC GREEN CHEM SER, V22, P114, DOI 10.1039/9781849737340-00114; Andres-Colas N, 2006, PLANT J, V45, P225, DOI 10.1111/j.1365-313X.2005.02601.x; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bali R, 2010, IND ENG CHEM RES, V49, P12762, DOI 10.1021/ie101600m; Bali R, 2010, CHEM ENG J, V156, P286, DOI 10.1016/j.cej.2009.10.019; Best S.L., 1996, GOLD BULL, V29, P87, DOI [10.1007/BF03214741, DOI 10.1007/BF03214741]; Binder BM, 2007, FEBS LETT, V581, P5105, DOI 10.1016/j.febslet.2007.09.057; CARPITA N, 1979, SCIENCE, V205, P1144, DOI 10.1126/science.205.4411.1144; Catty P, 2011, J BIOL CHEM, V286, P36188, DOI 10.1074/jbc.M111.241034; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Cortie MB, 2004, GOLD BULL, V37, P8; Dietz KJ, 2011, TRENDS PLANT SCI, V16, P582, DOI 10.1016/j.tplants.2011.08.003; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Gardea-Torresdey J, 2005, ANAL BIOANAL CHEM, V382, P347, DOI 10.1007/s00216-004-2966-6; Gardea-Torresdey JL, 2002, NANO LETT, V2, P397, DOI 10.1021/nl015673+; GIRLING CA, 1980, GOLD BULL, V13, P151, DOI DOI 10.1007/BF03215461; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Harris AT, 2008, J NANOPART RES, V10, P691, DOI 10.1007/s11051-007-9288-5; Haverkamp RG, 2007, J NANOPART RES, V9, P697, DOI 10.1007/s11051-006-9198-y; Hunt AJ, 2014, GREEN PROCESS SYNTH, V3, P3, DOI 10.1515/gps-2013-0103; Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Judy JD, 2012, ENVIRON SCI TECHNOL, V46, P8467, DOI 10.1021/es3019397; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Kumari M, 2008, MOL GENET GENOMICS, V279, P339, DOI 10.1007/s00438-007-0316-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XM, 2010, SCI TOTAL ENVIRON, V408, P3053, DOI 10.1016/j.scitotenv.2010.03.031; Marshall AT, 2007, INT J PHYTOREMEDIAT, V9, P197, DOI 10.1080/15226510701376026; Maser P, 2001, PLANT PHYSIOL, V126, P1646, DOI 10.1104/pp.126.4.1646; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Niemietz CM, 2002, FEBS LETT, V531, P443, DOI 10.1016/S0014-5793(02)03581-0; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Reith F, 2009, P NATL ACAD SCI USA, V106, P17757, DOI 10.1073/pnas.0904583106; Rico CM, 2011, J AGR FOOD CHEM, V59, P3485, DOI 10.1021/jf104517j; Rodriguez E, 2007, INT J PHYTOREMEDIAT, V9, P133, DOI 10.1080/15226510701232807; Rogers EE, 2000, P NATL ACAD SCI USA, V97, P12356, DOI 10.1073/pnas.210214197; Sabo-Attwood T, 2012, NANOTOXICOLOGY, V6, P353, DOI 10.3109/17435390.2011.579631; Sarry JE, 2006, PROTEOMICS, V6, P2180, DOI 10.1002/pmic.200500543; Schuler MA, 2003, ANNU REV PLANT BIOL, V54, P629, DOI 10.1146/annurev.arplant.54.031902.134840; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Shah V, 2009, WATER AIR SOIL POLL, V197, P143, DOI 10.1007/s11270-008-9797-6; Sharma NC, 2007, ENVIRON SCI TECHNOL, V41, P5137, DOI 10.1021/es062929a; Sheoran V, 2009, MINER ENG, V22, P1007, DOI 10.1016/j.mineng.2009.04.001; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Starnes DL, 2010, ENVIRON SCI TECHNOL, V44, P7110, DOI 10.1021/es101136q; Tan YF, 2010, PLANT PHYSIOL, V152, P747, DOI 10.1104/pp.109.147942; TEPFER M, 1981, SCIENCE, V213, P761, DOI 10.1126/science.213.4509.761; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wang ZY, 2012, ENVIRON SCI TECHNOL, V46, P4434, DOI 10.1021/es204212z; Wilson-Corral V, 2012, J ENVIRON MANAGE, V111, P249, DOI 10.1016/j.jenvman.2012.07.037	55	143	146	4	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93793	10.1371/journal.pone.0093793	http://dx.doi.org/10.1371/journal.pone.0093793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736522	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600026
J	Wildenschild, C; Riis, AH; Ehrenstein, V; Heitmann, BL; Hatch, EE; Wise, LA; Rothman, KJ; Sorensen, HT; Mikkelsen, EM				Wildenschild, Cathrine; Riis, Anders H.; Ehrenstein, Vera; Heitmann, Berit L.; Hatch, Elizabeth E.; Wise, Lauren A.; Rothman, Kenneth J.; Sorensen, Henrik T.; Mikkelsen, Ellen M.			Weight at Birth and Subsequent Fecundability: A Prospective Cohort Study	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; POPULATION-BASED REGISTRY; PRETERM DELIVERY; DEVELOPMENTAL ORIGINS; RECURRENT MISCARRIAGE; SPONTANEOUS-ABORTION; CIGARETTE-SMOKING; REDUCED UTERINE; FETAL ORIGINS; FINAL HEIGHT	Objective: To examine the association between a woman's birth weight and her subsequent fecundability. Method: In this prospective cohort study, we included 2,773 Danish pregnancy planners enrolled in the internet-based cohort study "Snart-Gravid'', conducted during 2007-2012. Participants were 18-40 years old at study entry, attempting to conceive, and were not receiving fertility treatment. Data on weight at birth were obtained from the Danish Medical Birth Registry and categorized as <2,500 grams, 2,500-2,999 grams, 3,000-3,999 grams, and >= 4,000 grams. In additional analyses, birth weight was categorized according to z-scores for each gestational week at birth. Time-to-pregnancy measured in cycles was used to compute fecundability ratios (FR) and 95% confidence intervals (CI), using a proportional probabilities regression model. esults: Relative to women with a birth weight of 3,000-3,999 grams, FRs adjusted for gestational age, year of birth, and maternal socio-demographic and medical factors were 0.99 (95% CI: 0.73; 1.34), 0.99 (95% CI: 0.87; 1.12), and 1.08 (95% CI: 0.94; 1.24) for birth weight <2,500 grams, 2,500-2,999 grams, and >= 4,000 grams, respectively. Estimates remained unchanged after further adjustment for markers of the participant's mother's fecundability. We obtained similar results when we restricted to women who were born at term, and to women who had attempted to conceive for a maximum of 6 cycles before study entry. Results remained similar when we estimated FRs according to z-scores of birth weight. Conclusion: Our results indicate that birth weight appears not to be an important determinant of fecundability.	[Wildenschild, Cathrine; Riis, Anders H.; Ehrenstein, Vera; Sorensen, Henrik T.; Mikkelsen, Ellen M.] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Heitmann, Berit L.] Univ Copenhagen, Inst Prevent Med, Bispebjerg & Frederiksberg Hosp, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Hatch, Elizabeth E.; Wise, Lauren A.; Rothman, Kenneth J.; Sorensen, Henrik T.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Wise, Lauren A.] Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA; [Rothman, Kenneth J.] RTI Hlth Solut, Res Triangle Pk, NC USA	Aarhus University; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Sydney; Boston University; Boston University; Research Triangle Institute	Wildenschild, C (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.	cwni@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Mikkelsen, Ellen Margrethe/0000-0003-0158-7950; Ehrenstein, Vera/0000-0002-3415-3254; Wise, Lauren/0000-0003-2138-3752; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Riis, Anders Hammerich/0000-0002-6684-4068	National Institute of Child Health and Human Development [R21-050264]; Danish Medical Research Council [271-07-0338]; Health Research Fund of Central Denmark Region [1-01-72-84-10]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Research Fund of Central Denmark Region	The study was supported by the National Institute of Child Health and Human Development (R21-050264)(http://www.nichd.nih.gov), the Danish Medical Research Council (271-07-0338)(http://fivu.dk), and the Health Research Fund of Central Denmark Region (1-01-72-84-10)(http://www.rm.dk/sundhed/faginfo/forskning/region+midtjyllands+sundhedsvidenskabelige+forskningsfond). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2005, HORM RES, V64, P2, DOI 10.1159/000089311; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Basso O, 2003, HUM REPROD, V18, P2478, DOI 10.1093/humrep/deg444; Bergvall N, 2008, J INTERN MED, V264, P205, DOI 10.1111/j.1365-2796.2008.01974.x; Bhattacharya S, 2008, BJOG-INT J OBSTET GY, V115, P1623, DOI 10.1111/j.1471-0528.2008.01943.x; Bhattacharya S, 2010, OBSTET GYNECOL, V115, P1125, DOI 10.1097/AOG.0b013e3181dffcdb; Boyd HA, 2009, AM J EPIDEMIOL, V170, P1358, DOI 10.1093/aje/kwp324; Brown JS, 2008, J EPIDEMIOL COMMUN H, V62, P16, DOI 10.1136/jech.2006.050369; deKeyser N, 2012, HUM REPROD, V27, P1170, DOI 10.1093/humrep/der478; Drake AJ, 2004, J ENDOCRINOL, V180, P1, DOI 10.1677/joe.0.1800001; Ekholm K, 2005, AM J EPIDEMIOL, V161, P725, DOI 10.1093/aje/kwi096; Ghirri P, 2001, GYNECOL ENDOCRINOL, V15, P91, DOI 10.1080/713602799; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Goodman A, 2009, EVOL HUM BEHAV, V30, P329, DOI 10.1016/j.evolhumbehav.2009.03.007; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hauth JC, 2000, OBSTET GYNECOL, V95, P24, DOI 10.1016/S0029-7844(99)00462-7; Ibanez L, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.5.e72; Ibanez L, 2002, J CLIN ENDOCR METAB, V87, P3391, DOI 10.1210/jc.87.7.3391; Ibanez L, 2003, HUM REPROD, V18, P1565, DOI 10.1093/humrep/deg351; Ibanez L, 2000, PEDIATR RES, V47, P575, DOI 10.1203/00006450-200005000-00003; Ibanez L, 2000, J CLIN ENDOCR METAB, V85, P2624, DOI 10.1210/jc.85.7.2624; Kallen K, 2001, EUR J PUBLIC HEALTH, V11, P329, DOI 10.1093/eurpub/11.3.329; Knudsen L B, 1993, Ugeskr Laeger, V155, P2525; Kolte AM, 2011, MOL HUM REPROD, V17, P379, DOI 10.1093/molehr/gar003; Kristensen J, 1996, J CLIN EPIDEMIOL, V49, P893, DOI 10.1016/0895-4356(96)00018-2; Meas T, 2010, HUM REPROD, V25, P2354, DOI 10.1093/humrep/deq184; Messerlian C, 2013, HUM REPROD, V28, P125, DOI 10.1093/humrep/des347; Mikkelsen EM, 2009, INT J EPIDEMIOL, V38, P938, DOI 10.1093/ije/dyn191; Miskovic S, 2012, EUR J OBSTET GYN R B, V161, P182, DOI 10.1016/j.ejogrb.2011.12.027; Murphy M, 2002, POP STUD-J DEMOG, V56, P235, DOI 10.1080/00324720215937; Nohr EA, 2009, HUM REPROD, V24, P226, DOI 10.1093/humrep/den357; OLSEN J, 1992, INT J EPIDEMIOL, V21, P279, DOI 10.1093/ije/21.2.279; Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Pedersen CB, 2006, DAN MED BULL, V53, P441; Persson I, 1999, AM J EPIDEMIOL, V150, P747; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; Pouta A, 2005, EUR J PUBLIC HEALTH, V15, P195, DOI 10.1093/eurpub/cki078; Rogvi RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016668; Schack-Nielsen L, 2006, OBESITY, V14, P1257, DOI 10.1038/oby.2006.143; Shah PS, 2009, ACTA OBSTET GYN SCAN, V88, P1307, DOI 10.3109/00016340903358820; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Sloboda DM, 2007, J CLIN ENDOCR METAB, V92, P46, DOI 10.1210/jc.2006-1378; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; WEINBERG CR, 1989, AM J EPIDEMIOL, V129, P1072, DOI 10.1093/oxfordjournals.aje.a115211; WEINBERG CR, 2008, MODERN EPIDEMIOLOGY; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Wilcox AJ, 2008, AM J EPIDEMIOL, V167, P474, DOI 10.1093/aje/kwm319; WILLIAMS MA, 1991, FERTIL STERIL, V56, P668; Wise LA, 2012, FERTIL STERIL, V97, P1136, DOI 10.1016/j.fertnstert.2012.02.025; Wise LA, 2010, HUM REPROD, V25, P253, DOI 10.1093/humrep/dep360; Ye XB, 2010, HUM REPROD, V25, P2901, DOI 10.1093/humrep/deq235; Zhang BY, 2010, INT J GYNECOL OBSTET, V108, P135, DOI 10.1016/j.ijgo.2009.09.019; ZIELHUIS GA, 1992, INT J EPIDEMIOL, V21, P1151, DOI 10.1093/ije/21.6.1151	57	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95257	10.1371/journal.pone.0095257	http://dx.doi.org/10.1371/journal.pone.0095257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736472	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600163
J	Wopken, K; Bijl, HP; van der Schaaf, A; Christianen, ME; Chouvalova, O; Oosting, SF; van der Laan, BFAM; Roodenburg, JLN; Leemans, CR; Slotman, BJ; Doornaert, P; Steenbakkers, RJHM; Verdonck-de Leeuw, IM; Langendijk, JA				Wopken, Kim; Bijl, Hendrik P.; van der Schaaf, Arjen; Christianen, Miranda E.; Chouvalova, Olga; Oosting, Sjoukje F.; van der Laan, Bernard F. A. M.; Roodenburg, Jan L. N.; Leemans, C. Rene; Slotman, Ben J.; Doornaert, Patricia; Steenbakkers, Roel J. H. M.; Verdonck-de Leeuw, Irma M.; Langendijk, Johannes A.			Development and Validation of a Prediction Model for Tube Feeding Dependence after Curative (Chemo-) Radiation in Head and Neck Cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; ACCELERATED RADIOTHERAPY; SWALLOWING DYSFUNCTION; RANDOMIZED-TRIAL; CHEMOTHERAPY; CARCINOMA; DYSPHAGIA; IMPACT; CHEMORADIOTHERAPY; CHEMORADIATION	Background: Curative radiotherapy or chemoradiation for head and neck cancer (HNC) may result in severe acute and late side effects, including tube feeding dependence. The purpose of this prospective cohort study was to develop a prediction model for tube feeding dependence 6 months (TUBEM6) after curative (chemo-) radiotherapy in HNC patients. Patients and Methods: Tube feeding dependence was scored prospectively. To develop the multivariable model, a group LASSO analysis was carried out, with TUBEM6 as the primary endpoint (n = 427). The model was then validated in a test cohort (n = 183). The training cohort was divided into three groups based on the risk of TUBEM6 to test whether the model could be extrapolated to later time points (12, 18 and 24 months). Results: Most important predictors for TUBEM6 were weight loss prior to treatment, advanced T-stage, positive N-stage, bilateral neck irradiation, accelerated radiotherapy and chemoradiation. Model performance was good, with an Area under the Curve of 0.86 in the training cohort and 0.82 in the test cohort. The TUBEM6-based risk groups were significantly associated with tube feeding dependence at later time points (p<0.001). Conclusion: We established an externally validated predictive model for tube feeding dependence after curative radiotherapy or chemoradiation, which can be used to predict TUBEM6.	[Wopken, Kim; Bijl, Hendrik P.; van der Schaaf, Arjen; Christianen, Miranda E.; Chouvalova, Olga; Steenbakkers, Roel J. H. M.; Langendijk, Johannes A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands; [Slotman, Ben J.; Doornaert, Patricia] Vrije Univ Amsterdam Med Ctr, Dept Radiat Oncol, Amsterdam, Netherlands; [Oosting, Sjoukje F.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [van der Laan, Bernard F. A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Otolaryngol Head & Neck Surg, Groningen, Netherlands; [Roodenburg, Jan L. N.] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands; [Leemans, C. Rene; Verdonck-de Leeuw, Irma M.] Vrije Univ Amsterdam Med Ctr, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands	University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Groningen; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Wopken, K (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Radiat Oncol, Groningen, Netherlands.	k.wopken@umcg.nl	van der Laan, Bernard/H-2420-2011; Van+Der+Schaaf, Arjen/AEX-0530-2022; van der Laan, Bernard/O-7723-2019	van der Laan, Bernard/0000-0002-5016-2871; Van+Der+Schaaf, Arjen/0000-0003-4067-7975; van der Laan, Bernard/0000-0002-5016-2871; Leemans, C. Rene/0000-0001-7887-083X; Langendijk, Johannes A./0000-0003-1083-372X; Verdonck-de Leeuw, Irma/0000-0002-4507-4607	Dutch Cancer Society [RUG 2008-3983]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Dutch Cancer Society (grant no. RUG 2008-3983). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang KK, 2005, J CLIN ONCOL, V23, P3008, DOI 10.1200/JCO.2005.12.060; Bhide SA, 2009, RADIOTHER ONCOL, V93, P539, DOI 10.1016/j.radonc.2009.09.017; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Caglar HB, 2008, INT J RADIAT ONCOL, V72, P1110, DOI 10.1016/j.ijrobp.2008.02.048; Carroll WR, 2008, LARYNGOSCOPE, V118, P39, DOI 10.1097/MLG.0b013e31815659b0; Christianen ME, 2011, RADIOTHER ONCOL; Dirix P, 2009, INT J RADIAT ONCOL, V75, P385, DOI 10.1016/j.ijrobp.2008.11.041; Eisbruch A, 2004, INT J RADIAT ONCOL, V60, P1425, DOI 10.1016/j.ijrobp.2004.05.050; Eisbruch A, 2002, INT J RADIAT ONCOL, V53, P23, DOI 10.1016/S0360-3016(02)02712-8; Feng FY, 2010, J CLIN ONCOL, V28, P2732, DOI 10.1200/JCO.2009.24.6199; Kotz T, 2012, ARCH OTOLARYNGOL, V138, P376, DOI 10.1001/archoto.2012.187; Langendijk JA, 2004, J CLIN ONCOL, V22, P4604, DOI 10.1200/JCO.2004.10.074; Langendijk JA, 2008, J CLIN ONCOL, V26, P3770, DOI 10.1200/JCO.2007.14.6647; Langendijk JA, 2009, RADIOTHER ONCOL, V90, P189, DOI 10.1016/j.radonc.2008.12.017; Levendag PC, 2007, RADIOTHER ONCOL, V85, P64, DOI 10.1016/j.radonc.2007.07.009; Mekhail TM, 2001, CANCER-AM CANCER SOC, V91, P1785, DOI 10.1002/1097-0142(20010501)91:9<1785::AID-CNCR1197>3.3.CO;2-T; MILLER ME, 1993, MED DECIS MAKING, V13, P49, DOI 10.1177/0272989X9301300107; Mortensen HR, 2012, RADIOTHER ONCOL, V103, P69, DOI 10.1016/j.radonc.2012.01.002; Morton RP, 2009, ANZ J SURG, V79, P713, DOI 10.1111/j.1445-2197.2009.05056.x; Nguyen NP, 2005, INT J RADIAT ONCOL, V61, P772, DOI 10.1016/j.ijrobp.2004.06.017; Overgaard J, 2003, LANCET, V362, P933, DOI 10.1016/S0140-6736(03)14361-9; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Salas S, 2008, RADIOTHER ONCOL, V87, P195, DOI 10.1016/j.radonc.2008.02.011; Staar S, 2001, INT J RADIAT ONCOL, V50, P1161, DOI 10.1016/S0360-3016(01)01544-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Terrell JE, 2004, ARCH OTOLARYNGOL, V130, P401, DOI 10.1001/archotol.130.4.401; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Trotti A, 2003, RADIOTHER ONCOL, V66, P253, DOI 10.1016/S0167-8140(02)00404-8; Verdonck-de Leeuw IM, 2007, LARYNGOSCOPE, V117, P238, DOI 10.1097/01.mlg.0000250169.10241.58; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Xu CJ, 2012, INT J RADIAT ONCOL, V82, pE677, DOI 10.1016/j.ijrobp.2011.09.036	31	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94879	10.1371/journal.pone.0094879	http://dx.doi.org/10.1371/journal.pone.0094879			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736318	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600099
J	Arevalo, MT; Navarro, A; Arico, CD; Li, JW; Alkhatib, O; Chen, S; Diaz-Arevalo, D; Zeng, MT				Arevalo, Maria T. l; Navarro, Ashley; Arico, Chenoa D.; Li, Junwei; Alkhatib, Omar; Chen, Shan; Diaz-Arevalo, Diana; Zeng, Mingtao			Targeted Silencing of Anthrax Toxin Receptors Protects against Anthrax Toxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anthrax Toxin; Bacterial Toxin; Macrophage; Receptor; RNA Interference (RNAi); RNA Silencing	CAPILLARY MORPHOGENESIS PROTEIN-2; LETHAL TOXIN; BACILLUS-ANTHRACIS; INHALATIONAL ANTHRAX; CELL-LINES; MICE; SUSCEPTIBILITY; IMMUNIZATION; MACROPHAGES; APOPTOSIS	Anthrax spores can be aerosolized and dispersed as a bioweapon. Current postexposure treatments are inadequate at later stages of infection, when high levels of anthrax toxins are present. Anthrax toxins enter cells via two identified anthrax toxin receptors: tumor endothelial marker 8 (TEM8) and capillary morphogenesis protein 2 (CMG2). We hypothesized that host cells would be protected from anthrax toxins if anthrax toxin receptor expression was effectively silenced using RNA interference (RNAi) technology. Thus, anthrax toxin receptors in mouse and human macrophages were silenced using targeted siRNAs or blocked with specific antibody prior to challenge with anthrax lethal toxin. Viability assays were used to assess protection in macrophages treated with specific siRNA or antibody as compared with untreated cells. Silencing CMG2 using targeted siRNAs provided almost complete protection against anthrax lethal toxin-induced cytotoxicity and death in murine and human macrophages. The same results were obtained by prebinding cells with specific antibody prior to treatment with anthrax lethal toxin. In addition, TEM8-targeted siRNAs also offered significant protection against lethal toxin in human macrophage-like cells. Furthermore, silencing CMG2, TEM8, or both receptors in combination was also protective against MEK2 cleavage by lethal toxin or adenylyl cyclase activity by edema toxin in human kidney cells. Thus, anthrax toxin receptor-targeted RNAi has the potential to be developed as a life-saving, postexposure therapy against anthrax.	[Arevalo, Maria T. l; Navarro, Ashley; Arico, Chenoa D.; Li, Junwei; Alkhatib, Omar; Chen, Shan; Diaz-Arevalo, Diana; Zeng, Mingtao] Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Infect Dis, Paul L Foster Sch Med, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University	Zeng, MT (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Infect Dis, Dept Biomed Sci,Paul L Foster Sch Med, 5001 El Paso Dr, El Paso, TX 79905 USA.	mt.zeng@ttuhsc.edu	Zeng, Ming/GXF-3628-2022	Zeng, Ming/0000-0003-2836-9240; Chen, Shan/0000-0002-1364-4265; Diaz-Arevalo, Diana/0000-0003-3766-5500	Paul L. Foster School of Medicine at Texas Tech University Health Sciences Center, El Paso	Paul L. Foster School of Medicine at Texas Tech University Health Sciences Center, El Paso	This work was supported by a grant (to M.Z.) from the Paul L. Foster School of Medicine at Texas Tech University Health Sciences Center, El Paso.	Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; Bouzianas DG, 2009, TRENDS MICROBIOL, V17, P522, DOI 10.1016/j.tim.2009.08.006; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bradley KA, 2003, BIOCHEM PHARMACOL, V65, P309, DOI 10.1016/S0006-2952(02)01455-7; Chaudhary A, 2012, CANCER CELL, V21, P212, DOI 10.1016/j.ccr.2012.01.004; Choi B, 2008, J DERMATOL SCI, V52, P87, DOI 10.1016/j.jdermsci.2008.05.001; Comer JE, 2012, CLIN VACCINE IMMUNOL, V19, P1517, DOI 10.1128/CVI.00292-12; Cullen M, 2009, CANCER RES, V69, P6021, DOI 10.1158/0008-5472.CAN-09-1086; Emergent BioSolutions, 2013, VACCINE PRODUCT SHEE; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Franz DR, 2009, MOL ASPECTS MED, V30, P503, DOI 10.1016/j.mam.2009.07.002; Grabenstein JD, 2008, CLIN INFECT DIS, V46, P129, DOI 10.1086/523578; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Hudson MJ, 2008, INT J MED MICROBIOL, V298, P345, DOI 10.1016/j.ijmm.2007.09.007; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; Lawrence WS, 2009, COMPARATIVE MED, V59, P257; Liu SH, 2013, NATURE, V501, P63, DOI 10.1038/nature12510; Liu SH, 2013, TOXINS, V5, P1, DOI 10.3390/toxins5010001; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Lui SH, 2010, CELL HOST MICROBE, V8, P455, DOI 10.1016/j.chom.2010.10.004; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Ngundi MM, 2010, CLIN VACCINE IMMUNOL, V17, P895, DOI 10.1128/CVI.00513-09; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Pellizzari R, 2000, INT J MED MICROBIOL, V290, P421; Pluvinet R, 2004, BLOOD, V104, P3642, DOI 10.1182/blood-2004-03-0817; Reeves C, 2013, TOXINS, V5, P315, DOI 10.3390/toxins5020315; Reeves CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034862; Rolando M, 2010, CELL MICROBIOL, V12, P891, DOI 10.1111/j.1462-5822.2010.01438.x; Sastalla I, 2012, INFECT IMMUN, V80, P529, DOI 10.1128/IAI.05947-11; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sherer K, 2007, AM J RESP CRIT CARE, V175, P211, DOI 10.1164/rccm.200608-1239CP; Sweeney DA, 2011, AM J RESP CRIT CARE, V184, P1333, DOI 10.1164/rccm.201102-0209CI; Tournier JN, 2009, MOL ASPECTS MED, V30, P456, DOI 10.1016/j.mam.2009.06.002; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Wu WX, 2009, J IMMUNOL, V183, P5799, DOI 10.4049/jimmunol.0803406; Xie T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066943; Xu QF, 2008, CLIN VACCINE IMMUNOL, V15, P612, DOI 10.1128/CVI.00402-07; Young JJ, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030027; Zeng MT, 2007, VACCINE, V25, P3588, DOI 10.1016/j.vaccine.2007.01.075; Zeng MT, 2006, VACCINE, V24, P662, DOI 10.1016/j.vaccine.2005.08.056; Zhang JY, 2006, ACTA BIOCHIM POL, V53, P525	45	12	13	4	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15730	15738		10.1074/jbc.M113.538587	http://dx.doi.org/10.1074/jbc.M113.538587			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742682	Green Published, hybrid			2022-12-25	WOS:000337465400053
J	de Ghellinck, A; Schaller, H; Laux, V; Haertlein, M; Sferrazza, M; Marechal, E; Wacklin, H; Jouhet, J; Fragneto, G				de Ghellinck, Alexis; Schaller, Hubert; Laux, Valerie; Haertlein, Michael; Sferrazza, Michele; Marechal, Eric; Wacklin, Hanna; Jouhet, Juliette; Fragneto, Giovanna			Production and Analysis of Perdeuterated Lipids from Pichia pastoris Cells	PLOS ONE			English	Article							ANGLE NEUTRON-SCATTERING; FATTY-ACID DESATURATION; SACCHAROMYCES-CEREVISIAE; METHYLOTROPHIC YEAST; PROTEIN-PRODUCTION; MODEL MEMBRANES; DIFFRACTION; PHOSPHATIDYLCHOLINE; EXPRESSION; PHOSPHOLIPIDS	Probing molecules using perdeuteration (i.e deuteration in which all hydrogen atoms are replaced by deuterium) is extremely useful in a wide range of biophysical techniques. In the case of lipids, the synthesis of the biologically relevant unsaturated perdeuterated lipids is challenging and not usually pursued. In this work, perdeuterated phospholipids and sterols from the yeast Pichia pastoris grown in deuterated medium are extracted and analyzed as derivatives by gas chromatography and mass spectrometry respectively. When yeast cells are grown in a deuterated environment, the phospholipid homeostasis is maintained but the fatty acid unsaturation level is modified while the ergosterol synthesis is not affected by the deuterated culture medium. Our results confirm that the production of well defined natural unsaturated perdeuterated lipids is possible and gives also new insights about the process of desaturase enzymes.	[de Ghellinck, Alexis; Laux, Valerie; Haertlein, Michael; Fragneto, Giovanna] Inst Laue Langevin, Grenoble, France; [de Ghellinck, Alexis; Sferrazza, Michele] Univ Libre Brussels, Serv Polymeres, Brussels, Belgium; [Schaller, Hubert] CNRS, Inst Biol Mol Plantes, Strasbourg, France; [Marechal, Eric; Jouhet, Juliette] Univ Grenoble Alpes, INRA, CNRS CEA, Lab physiol Cellulaire & Vegetale, Grenoble, France; [Wacklin, Hanna] European Spallat Source ESS AB, Lund, Sweden; [Wacklin, Hanna] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark	Institut Laue-Langevin (ILL); Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Spallation Source (ESS); University of Copenhagen	Jouhet, J (corresponding author), Univ Grenoble Alpes, INRA, CNRS CEA, Lab physiol Cellulaire & Vegetale, Grenoble, France.	juliette.jouhet@cea.fr		Schaller, Hubert/0000-0002-4099-4447	Engineering and Physical Science Research Council; EU [RII3-CT-2003-505925]; Blue Sky grant from Agence Nationale de la Recherche (ANR ReGal) [ANR-10-BLAN-1524]; European Commission [283883]; Keele University [EP/C015452/1]	Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); Blue Sky grant from Agence Nationale de la Recherche (ANR ReGal)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Keele University	VL and MH acknowledge Engineering and Physical Science Research Council support for the Dlab to V. T. Forsyth, Keele University, under grant EP/C015452/1 and from the EU under contract RII3-CT-2003-505925. JJ and EM were supported by a Blue Sky grant from Agence Nationale de la Recherche (ANR ReGal, ANR-10-BLAN-1524). This research project has been supported by the European Commission under the 7th Framework Programme through the "Research Infrastructures'' action of the "Capacities'' Programme, NMI3-II Grant number 283883. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOSSIE MA, 1989, J BACTERIOL, V171, P6409, DOI 10.1128/jb.171.12.6409-6413.1989; Boumann HA, 2003, BIOCHEMISTRY-US, V42, P3054, DOI 10.1021/bi026801r; Buist PH, 1996, J AM CHEM SOC, V118, P6295, DOI 10.1021/ja953262n; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; CUSACK S, 1985, J MOL BIOL, V186, P565, DOI 10.1016/0022-2836(85)90131-7; Daillant J, 2005, P NATL ACAD SCI USA, V102, P11639, DOI 10.1073/pnas.0504588102; Damasceno LM, 2012, APPL MICROBIOL BIOT, V93, P31, DOI 10.1007/s00253-011-3654-z; De Smet CH, 2012, MOL BIOL CELL, V23, P1146, DOI 10.1091/mbc.E11-07-0624; Fagone P, 2013, BBA-MOL CELL BIOL L, V1831, P523, DOI 10.1016/j.bbalip.2012.09.009; Fitter J, 2006, YEAST, V18, P679; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gawrisch K, 2007, EUR BIOPHYS J BIOPHY, V36, P281, DOI 10.1007/s00249-007-0142-6; Goad LJ., 1997, ANAL STEROLS; Gordeliy VI, 1997, ACTA CRYSTALLOGR D, V53, P377, DOI 10.1107/S0907444997000826; Hammermann M, 1998, BIOPHYS J, V75, P3057, DOI 10.1016/S0006-3495(98)77746-X; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Husselstein-Muller T, 2001, PLANT MOL BIOL, V45, P75, DOI 10.1023/A:1006476123930; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; Kajikawa M, 2006, PLANT CELL PHYSIOL, V47, P64, DOI 10.1093/pcp/pci224; Kajikawa M, 2004, PLANT MOL BIOL, V54, P335, DOI 10.1023/B:PLAN.0000036366.57794.ee; KENNEDY EP, 1953, J AM CHEM SOC, V75, P249, DOI 10.1021/ja01097a522; Krueger S, 2001, CURR OPIN COLLOID IN, V6, P111, DOI 10.1016/S1359-0294(01)00073-5; LEDERER H, 1986, EUR J BIOCHEM, V161, P191, DOI 10.1111/j.1432-1033.1986.tb10141.x; Leonard A, 2001, LANGMUIR, V17, P2019, DOI 10.1021/la001382p; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Martin CE, 2002, BIOCHEM SOC T, V30, P1080, DOI 10.1042/bst0301080; MARTIN CE, 1981, BIOCHIM BIOPHYS ACTA, V665, P399, DOI 10.1016/0005-2760(81)90252-6; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Massou S, 1999, J BIOMOL NMR, V14, P231, DOI 10.1023/A:1008371118772; Massou S, 1998, J CHIM PHYS PCB, V95, P406, DOI 10.1051/jcp:1998152; Morgan WD, 2000, J BIOMOL NMR, V17, P337, DOI 10.1023/A:1008313530207; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; PARFAIT R, 1978, TRENDS BIOCHEM SCI, V3, P41, DOI 10.1016/S0968-0004(78)93434-5; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; PUGH EL, 1975, BIOCHIM BIOPHYS ACTA, V380, P442, DOI 10.1016/0005-2760(75)90112-5; Rahier A, 1989, MASS SPECTRAL IDENTI, P223; Sakaki T, 2001, YEAST, V18, P679, DOI 10.1002/yea.720; SATRE M, 1979, FEBS LETT, V102, P244, DOI 10.1016/0014-5793(79)80010-1; Silvestro D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056429; Smyth TJ, 2010, APPL MICROBIOL BIOT, V87, P1347, DOI 10.1007/s00253-010-2592-5; Wriessnegger T, 2009, BBA-MOL CELL BIOL L, V1791, P166, DOI 10.1016/j.bbalip.2008.12.017; Wriessnegger T, 2007, BBA-MOL CELL BIOL L, V1771, P455, DOI 10.1016/j.bbalip.2007.01.004; Zaccai G, 2000, BIOPHYS CHEM, V86, P249, DOI 10.1016/S0301-4622(00)00172-1; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; ZACCAI G, 1979, J MOL BIOL, V134, P693, DOI 10.1016/0022-2836(79)90480-7; ZACCAI G, 1975, P NATL ACAD SCI USA, V72, P376, DOI 10.1073/pnas.72.1.376	47	34	34	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e92999	10.1371/journal.pone.0092999	http://dx.doi.org/10.1371/journal.pone.0092999			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747350	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500003
J	Maia, JP; Harris, DJ; Carranza, S; Gomez-Diaz, E				Maia, Joao P.; James Harris, D.; Carranza, Salvador; Gomez-Diaz, Elena			A Comparison of Multiple Methods for Estimating Parasitemia of Hemogregarine Hemoparasites (Apicomplexa: Adeleorina) and Its Application for Studying Infection in Natural Populations	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; REAL-TIME PCR; BLOOD PARASITES; QUANTITATIVE PCR; MALARIA PARASITE; MOLECULAR SURVEY; IMMUNE-RESPONSE; AVIAN MALARIA; PLASMODIUM-MEXICANUM; IBERIAN PENINSULA	Identifying factors influencing infection patterns among hosts is critical for our understanding of the evolution and impact of parasitism in natural populations. However, the correct estimation of infection parameters depends on the performance of detection and quantification methods. In this study, we designed a quantitative PCR (qPCR) assay targeting the 18 S rRNA gene to estimate prevalence and intensity of Hepatozoon infection and compared its performance with microscopy and PCR. Using qPCR, we also compared various protocols that differ in the biological source and the extraction methods. Our results show that the qPCR approach on DNA extracted from blood samples, regardless of the extraction protocol, provided the most sensitive estimates of Hepatozoon infection parameters; while allowed us to differentiate between mixed infections of Adeleorinid (Hepatozoon) and Eimeriorinid (Schellackia and Lankesterella), based on the analysis of melting curves. We also show that tissue and saline methods can be used as low-cost alternatives in parasitological studies. The next step was to test our qPCR assay in a biological context, and for this purpose we investigated infection patterns between two sympatric lacertid species, which are naturally infected with apicomplexan hemoparasites, such as the genera Schellackia (Eimeriorina) and Hepatozoon (Adeleorina). From a biological standpoint, we found a positive correlation between Hepatozoon intensity of infection and host body size within each host species, being significantly higher in males, and higher in the smaller sized host species. These variations can be associated with a number of host intrinsic factors, like hormonal and immunological traits, that require further investigation. Our findings are relevant as they pinpoint the importance of accounting for methodological issues to better estimate infection in parasitological studies, and illustrate how between-host factors can influence parasite distributions in sympatric natural populations.	[Maia, Joao P.; James Harris, D.] Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Vairao, Vila Do Conde, Portugal; [Maia, Joao P.] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Maia, Joao P.; Carranza, Salvador; Gomez-Diaz, Elena] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona, Spain	Universidade do Porto; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Maia, JP (corresponding author), Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, Campus Agr Vairao, Vairao, Vila Do Conde, Portugal.	jpmaiapt@gmail.com; elegomezdiaz@gmail.com	Carranza, Salvador/A-2126-2012; Maia, João/I-5748-2014; Gómez-Díaz, Elena/AAA-9141-2019; Gómez-Díaz, Elena/G-2503-2011	Carranza, Salvador/0000-0002-5378-3008; Maia, João/0000-0002-0235-1651; Gómez-Díaz, Elena/0000-0002-4146-9003; Gómez-Díaz, Elena/0000-0002-4146-9003	Fundacao para a Ciencia e a Tecnologia (FCT) under the Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional funds (POPH-QREN) from the European Social Fund (ESF); Portuguese Ministerio da Educacao e Ciencia; Juan de la Cierva from the Ministerio de Educacion y Ciencia, Spain; European Commission [ERG-PARIS-276838]; FEDER - North Portugal Regional Operational Program under NSRF through the European Regional Development Fund [ON.2]	Fundacao para a Ciencia e a Tecnologia (FCT) under the Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional funds (POPH-QREN) from the European Social Fund (ESF); Portuguese Ministerio da Educacao e Ciencia(Portuguese Foundation for Science and Technology); Juan de la Cierva from the Ministerio de Educacion y Ciencia, Spain(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); FEDER - North Portugal Regional Operational Program under NSRF through the European Regional Development Fund	JPM was funded through a PhD grant (SFRH/BD/74305/2010) supported by a Fundacao para a Ciencia e a Tecnologia (FCT) doctoral fellowship under the Programa Operacional Potencial Humano - Quadro de Referencia Estrategico Nacional funds (POPH-QREN) from the European Social Fund (ESF) and Portuguese Ministerio da Educacao e Ciencia. EG-D was supported by a Juan de la Cierva contract from the Ministerio de Educacion y Ciencia, Spain. Financial support was provided by project ERG-PARIS-276838 from the European Commission. DJH is supported by FEDER through the compete program, the project "Genomics and Evolutionary Biology" cofinanced by North Portugal Regional Operational Program (ON.2) under NSRF through the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Agnew P, 1999, EVOL ECOL, V13, P67, DOI 10.1023/A:1006586131235; Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen KE, 2008, VET PARASITOL, V154, P220, DOI 10.1016/j.vetpar.2008.03.027; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; ALTWEGG M, 1995, J MICROBIOL METH, V23, P21, DOI 10.1016/0167-7012(95)92715-X; Alvarez WA, 2013, VET PARASITOL, V193, P66, DOI 10.1016/j.vetpar.2012.11.029; Amo L, 2005, PARASITOL RES, V96, P378, DOI 10.1007/s00436-005-1354-2; Amo L, 2005, PARASITOL RES, V96, P413, DOI 10.1007/s00436-005-1355-1; Amo L, 2004, PARASITOL RES, V94, P290, DOI 10.1007/s00436-004-1212-7; Baneth G, 2011, VET PARASITOL, V181, P3, DOI 10.1016/j.vetpar.2011.04.015; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Beldomenico PM, 2010, TRENDS ECOL EVOL, V25, P21, DOI 10.1016/j.tree.2009.06.015; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonneaud C, 2012, MOL ECOL, V21, P2628, DOI 10.1111/j.1365-294X.2012.05551.x; Brown GP, 2006, CAN J ZOOL, V84, P668, DOI 10.1139/Z06-044; BRUNHAM RC, 1993, INFECT IMMUN, V61, P2273, DOI 10.1128/IAI.61.6.2273-2276.1993; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Camargo A, 2010, MOL ECOL, V19, P3250, DOI 10.1111/j.1365-294X.2010.04722.x; Cogswell FB, 1996, J CLIN MICROBIOL, V34, P980, DOI 10.1128/JCM.34.4.980-982.1996; Combes C, 1996, BIODIVERS CONSERV, V5, P953, DOI 10.1007/BF00054413; Criado-Fornelio A, 2007, VET PARASITOL, V150, P352, DOI 10.1016/j.vetpar.2007.09.025; da Silva FM, 2010, INFECT GENET EVOL, V10, P522, DOI 10.1016/j.meegid.2010.02.005; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen RJ, 2001, PARASITOLOGY, V122, P507, DOI 10.1017/S0031182001007636; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P595, DOI 10.1128/CMR.00022-06; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenner AL, 2011, J ANIM ECOL, V80, P835, DOI 10.1111/j.1365-2656.2011.01825.x; Ferraguti M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066237; Figuerola J, 1999, FUNCT ECOL, V13, P594, DOI 10.1046/j.1365-2435.1999.00354.x; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Friedl TWP, 2012, J ORNITHOL, V153, P239, DOI 10.1007/s10336-011-0735-9; Garcia-Ramirez A, 2005, J NAT HIST, V39, P1299, DOI 10.1080/00222930400015590; Garrido M, 2013, ZOOL ANZ, V252, P588, DOI 10.1016/j.jcz.2012.11.003; Garrido M, 2013, ZOOLOGY, V116, P106, DOI 10.1016/j.zool.2012.09.003; Godfrey SS, 2011, J WILDLIFE DIS, V47, P126, DOI 10.7589/0090-3558-47.1.126; Gomez-Diaz E, 2010, EVOL APPL, V3, P391, DOI 10.1111/j.1752-4571.2010.00127.x; Grodio JL, 2008, AVIAN PATHOL, V37, P385, DOI 10.1080/03079450802216629; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALLIDAY TR, 1988, J HERPETOL, V22, P253, DOI 10.2307/1564148; Harris DJ, 2012, J PARASITOL, V98, P592, DOI 10.1645/JP-GE-2908.1; Harris DJ, 2001, HERPETOL J, V11, P129; Hatcher MJ, 2006, ECOL LETT, V9, P1253, DOI 10.1111/j.1461-0248.2006.00964.x; Hawley DM, 2011, FUNCT ECOL, V25, P48, DOI 10.1111/j.1365-2435.2010.01753.x; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; Huyghe K, 2010, OECOLOGIA, V163, P867, DOI 10.1007/s00442-010-1646-9; Ishtiaq F, 2008, MOL ECOL, V17, P4545, DOI 10.1111/j.1365-294X.2008.03935.x; Jacquin L, 2011, J AVIAN BIOL, V42, P11, DOI 10.1111/j.1600-048X.2010.05120.x; Jirku M, 2009, J EUKARYOT MICROBIOL, V56, P39, DOI 10.1111/j.1550-7408.2008.00362.x; Kaliontzopoulou A, 2008, BIOL J LINN SOC, V93, P111; Kaliontzopoulou A, 2012, ZOOL J LINN SOC-LOND, V164, P173, DOI 10.1111/j.1096-3642.2011.00760.x; Kelly PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053450; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Knowles SCL, 2011, MOL ECOL, V20, P1062, DOI 10.1111/j.1365-294X.2010.04909.x; Lachish S, 2013, ECOGRAPHY, V36, P587, DOI 10.1111/j.1600-0587.2012.07801.x; Lee KA, 2006, INTEGR COMP BIOL, V46, P1000, DOI 10.1093/icb/icl049; Li YH, 2008, VET PARASITOL, V157, P50, DOI 10.1016/j.vetpar.2008.06.027; Lindstrom KM, 2004, P ROY SOC B-BIOL SCI, V271, P1513, DOI 10.1098/rspb.2004.2752; Madsen T, 2006, J EVOLUTION BIOL, V19, P1973, DOI 10.1111/j.1420-9101.2006.01158.x; Madsen T, 2005, OECOLOGIA, V142, P407, DOI 10.1007/s00442-004-1742-9; Maia JPMC, 2012, FOLIA PARASIT, V59, P241, DOI 10.14411/fp.2012.033; Maia JPMC, 2011, J PARASITOL, V97, P513, DOI 10.1645/GE-2666.1; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; MARGOLIS L, 1982, J PARASITOL, V68, P131, DOI 10.2307/3281335; Martinez-de la Puente J, 2011, MOL ECOL, V20, P3275, DOI 10.1111/j.1365-294X.2011.05136.x; Megia-Palma R, 2013, PARASITOLOGY, V140, P1149, DOI 10.1017/S0031182013000553; Moller AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082886; Moller AP, 2003, AM NAT, V161, P657, DOI 10.1086/367879; Molnar O, 2013, NATURWISSENSCHAFTEN, V100, P551, DOI 10.1007/s00114-013-1051-4; Morand S, 2003, ADV PARASIT, V54, P281, DOI 10.1016/S0065-308X(03)54006-4; Morrison DA, 2009, TRENDS PARASITOL, V25, P375, DOI 10.1016/j.pt.2009.05.010; Njabo KY, 2011, MOL ECOL, V20, P1049, DOI 10.1111/j.1365-294X.2010.04904.x; Palacios MG, 2011, ECOLOGY, V92, P952, DOI 10.1890/10-0662.1; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Perera A, 2013, J HELMINTHOL, V87, P189, DOI 10.1017/S0022149X12000181; Perez-Tris J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000235; Perkins SL, 2001, J PARASITOL, V87, P870, DOI 10.1645/0022-3395(2001)087[0870:PONSSR]2.0.CO;2; Pinho C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-63; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pough FH, 2004, HERPETOLOGY; Poulin R, 1999, INT J PARASITOL, V29, P903, DOI 10.1016/S0020-7519(99)00045-4; Poulin R, 2005, PARASITOLOGY, V130, P109, DOI 10.1017/S0031182004006304; POULIN R, 1995, ECOL MONOGR, V65, P283, DOI 10.2307/2937061; POULIN R, 1994, ANIM BEHAV, V48, P137, DOI 10.1006/anbe.1994.1220; Poulin R, 2006, INT J PARASITOL, V36, P877, DOI 10.1016/j.ijpara.2006.02.021; Poulin R, 2011, ADV PARASIT, V74, P1, DOI 10.1016/B978-0-12-385897-9.00001-X; Reardon JT, 2004, J PARASITOL, V90, P1274, DOI 10.1645/GE-3326; Restif O, 2010, P ROY SOC B-BIOL SCI, V277, P2247, DOI 10.1098/rspb.2010.0188; Roca V, 2010, SYST PARASITOL, V75, P75, DOI 10.1007/s11230-009-9206-6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sa-Sousa P, 2002, AMPHIBIA-REPTILIA, V23, P459, DOI 10.1163/15685380260462365; Sa-Sousa P, 2002, AMPHIBIA-REPTILIA, V23, P55, DOI 10.1163/156853802320877627; Sacchi R, 2011, ITAL J ZOOL, V78, P418, DOI 10.1080/11250003.2011.568014; Salkeld DJ, 2005, INT J PARASITOL, V35, P11, DOI 10.1016/j.ijpara.2004.09.005; Salvador A, 1996, BEHAV ECOL, V7, P145, DOI 10.1093/beheco/7.2.145; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schmid-Hempel P, 2003, P ROY SOC B-BIOL SCI, V270, P357, DOI 10.1098/rspb.2002.2265; Simberloff D, 2010, BIOGEOGRAPHY HOST PA; Smith TG, 1996, J PARASITOL, V82, P565, DOI 10.2307/3283781; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Telford SR., 2009, HEMOPARASITES REPTIL; THOMAS F, 1995, P ROY SOC B-BIOL SCI, V260, P349, DOI 10.1098/rspb.1995.0103; Thomas F, 2000, INT J PARASITOL, V30, P669, DOI 10.1016/S0020-7519(00)00040-0; Tome B, 2013, J PARASITOL, V99, P883, DOI 10.1645/12-95.1; Tompkins DM, 2011, J ANIM ECOL, V80, P19, DOI 10.1111/j.1365-2656.2010.01742.x; Tsangaras K, 2012, ANN ANAT, V194, P58, DOI 10.1016/j.aanat.2011.04.003; Turner AK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002343; Uchii K, 2011, ISME J, V5, P244, DOI 10.1038/ismej.2010.123; Ujvari B, 2006, BEHAV ECOL, V17, P20, DOI 10.1093/beheco/ari091; Ujvari B, 2004, J PARASITOL, V90, P670, DOI 10.1645/GE-204R; Vardo AM, 2007, MOL ECOL, V16, P2712, DOI 10.1111/j.1365-294X.2007.03355.x; Whiteman NK, 2006, P ROY SOC B-BIOL SCI, V273, P797, DOI 10.1098/rspb.2005.3396; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Wozniak EJ, 1996, INT J PARASITOL, V26, P141, DOI 10.1016/0020-7519(95)00110-7; WOZNIAK EJ, 1994, J ZOO WILDLIFE MED, V25, P538	120	39	39	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95010	10.1371/journal.pone.0095010	http://dx.doi.org/10.1371/journal.pone.0095010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743340	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100059
J	Nayek, A; Sen Gupta, PS; Banerjee, S; Mondal, B; Bandyopadhyay, AK				Nayek, Arnab; Sen Gupta, Parth Sarthi; Banerjee, Shyamashree; Mondal, Buddhadev; Bandyopadhyay, Amal K.			Salt-Bridge Energetics in Halophilic Proteins	PLOS ONE			English	Article							HALOBACTERIUM-SALINARUM; 2FE-2S FERREDOXIN; CRYSTAL-STRUCTURE; ELECTROSTATIC CONTRIBUTIONS; HALOFERAX-MEDITERRANEI; GLUCOSE-DEHYDROGENASE; MALATE-DEHYDROGENASE; STRUCTURAL FEATURES; T4 LYSOZYME; DEAD-SEA	Halophilic proteins have greater abundance of acidic over basic and very low bulky hydrophobic residues. Classical electrostatic stabilization was suggested as the key determinant for halophilic adaptation of protein. However, contribution of specific electrostatic interactions (i.e. salt-bridges) to overall stability of halophilic proteins is yet to be understood. To understand this, we use Adaptive-Poison-Boltzmann-Solver Methods along with our home-built automation to workout net as well as associated component energy terms such as desolvation energy, bridge energy and background energy for 275 salt-bridges from 20 extremely halophilic proteins. We then perform extensive statistical analysis on general and energetic attributes on these salt-bridges. On average, 8 salt-bridges per 150 residues protein were observed which is almost twice than earlier report. Overall contributions of salt-bridges are -3.0 kcal mol(-1). Majority (78%) of salt-bridges in our dataset are stable and conserved in nature. Although, average contributions of component energy terms are equal, their individual details vary greatly from one another indicating their sensitivity to local micro-environment. Notably, 35% of salt-bridges in our database are buried and stable. Greater desolvation penalty of these buried salt-bridges are counteracted by stable network salt-bridges apart from favorable equal contributions of bridge and background terms. Recruitment of extensive network salt-bridges (46%) with a net contribution of -5.0 kcal mol(-1) per salt-bridge, seems to be a halophilic design wherein favorable average contribution of background term (-10 kcal mol(-1)) exceeds than that of bridge term (-7 kcal mol(-1)). Interiors of proteins from halophiles are seen to possess relatively higher abundance of charge and polar side chains than that of mesophiles which seems to be satisfied by cooperative network salt-bridges. Overall, our theoretical analyses provide insight into halophilic signature in its specific electrostatic interactions which we hope would help in protein engineering and bioinformatics studies.	[Nayek, Arnab; Sen Gupta, Parth Sarthi; Banerjee, Shyamashree; Bandyopadhyay, Amal K.] Univ Burdwan, Dept Biotechnol, Burdwan 713104, W Bengal, India; [Mondal, Buddhadev] Univ Burdwan, Burdwan Raj Coll, Dept Zool, Burdwan 713104, W Bengal, India	University of Burdwan; University of Burdwan	Bandyopadhyay, AK (corresponding author), Univ Burdwan, Dept Biotechnol, Burdwan 713104, W Bengal, India.	akbanerjee@biotech.buruniv.ac.in	Sen Gupta, Parth Sarthi/AAW-4206-2021	Sen Gupta, Parth Sarthi/0000-0002-3083-3957; Bandyopadhyay, Amal kumar/0000-0003-3499-5491				Albeck S, 2000, J MOL BIOL, V298, P503, DOI 10.1006/jmbi.2000.3656; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P77, DOI 10.1016/S0968-0004(98)01345-0; Bandyopadhyay AK, 2000, BIOPHYS J, V79, P501, DOI 10.1016/S0006-3495(00)76312-0; Bandyopadhyay AK, 2001, BIOCHEMISTRY-US, V40, P1284, DOI 10.1021/bi001614j; Bandyopadhyay AK, 2007, EXTREMOPHILES, V11, P615, DOI 10.1007/s00792-007-0075-0; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Barril X, 1998, PROTEINS, V32, P67, DOI 10.1002/(SICI)1097-0134(19980701)32:1<67::AID-PROT8>3.0.CO;2-B; Bolhuis AKD, 2008, HALOPHILIC ADAPTATIO, P71; Bonete MJ, 1996, FEBS LETT, V383, P227, DOI 10.1016/0014-5793(96)00235-9; Britton KL, 2006, P NATL ACAD SCI USA, V103, P4846, DOI 10.1073/pnas.0508854103; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P11521, DOI 10.1021/bi00113a006; DAOPIN S, 1991, BIOCHEMISTRY-US, V30, P7142, DOI 10.1021/bi00243a015; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dong F, 2002, BIOPHYS J, V83, P1341, DOI 10.1016/S0006-3495(02)73904-0; DYM O, 1995, SCIENCE, V267, P1344, DOI 10.1126/science.267.5202.1344; EISENBERG H, 1995, ARCH BIOCHEM BIOPHYS, V318, P1, DOI 10.1006/abbi.1995.1196; Elcock AH, 1998, J MOL BIOL, V280, P731, DOI 10.1006/jmbi.1998.1904; Fleming PJ, 2006, PROTEIN SCI, V15, P1829, DOI 10.1110/ps.062305106; Frolow F, 1996, NAT STRUCT BIOL, V3, P452, DOI 10.1038/nsb0596-452; GINZBURG M, 1970, Journal of General Physiology, V55, P187, DOI 10.1085/jgp.55.2.187; Guest WC, 2010, BIOCHEM CELL BIOL, V88, P371, DOI [10.1139/o09-180, 10.1139/O09-180]; HECHT K, 1990, BIOL CHEM H-S, V371, P515, DOI 10.1515/bchm3.1990.371.1.515; Hendsch ZS, 1998, J PHYS CHEM B, V102, P4404, DOI 10.1021/jp9728666; HENDSCH ZS, 1994, PROTEIN SCI, V3, P211; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; Karan Ram, 2012, Aquat Biosyst, V8, P4, DOI 10.1186/2046-9063-8-4; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; LANYI JK, 1974, BACTERIOL REV, V38, P272, DOI 10.1128/MMBR.38.3.272-290.1974; Lebbink JHG, 2002, BIOCHEMISTRY-US, V41, P15524, DOI 10.1021/bi020461s; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Lounnas V, 1997, BIOCHEMISTRY-US, V36, P5402, DOI 10.1021/bi9622940; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Madigan D, 2013, AM J EPIDEMIOL, V178, P645, DOI 10.1093/aje/kwt010; MARQUSEE S, 1994, PROTEIN SCI, V3, P2217, DOI 10.1002/pro.5560031207; Marti DN, 2003, J MOL BIOL, V330, P621, DOI 10.1016/S0022-2836(03)00623-5; MEVARECH M, 1977, BIOCHEMISTRY-US, V16, P3781, DOI 10.1021/bi00636a009; Mevarech M, 2000, BIOPHYS CHEM, V86, P155, DOI 10.1016/S0301-4622(00)00126-5; Missimer JH, 2007, PROTEIN SCI, V16, P1349, DOI 10.1110/ps.062542907; PACE CN, 1990, TRENDS BIOCHEM SCI, V15, P14, DOI 10.1016/0968-0004(90)90124-T; Paul S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r70; Pieper U, 1998, STRUCTURE, V6, P75, DOI 10.1016/S0969-2126(98)00009-4; RAO JKM, 1981, BIOCHEMISTRY-US, V20, P6536, DOI 10.1021/bi00526a004; Sen Gupta PS, 2014, BIOINFORMATION, V10, P164, DOI 10.6026/97320630010164; Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257; Tsai CJ, 1997, PROTEIN SCI, V6, P24; Tsai CJ, 1997, PROTEIN SCI, V6, P53; WALDBURGER CD, 1995, NAT STRUCT BIOL, V2, P122, DOI 10.1038/nsb0295-122; Winter JA, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-55	53	25	26	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e93862	10.1371/journal.pone.0093862	http://dx.doi.org/10.1371/journal.pone.0093862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743799	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100021
J	Zhang, YG; Cong, J; Lu, H; Yang, CY; Yang, YF; Zhou, JH; Li, DQ				Zhang, Yuguang; Cong, Jing; Lu, Hui; Yang, Caiyun; Yang, Yunfeng; Zhou, Jizhong; Li, Diqiang			An Integrated Study to Analyze Soil Microbial Community Structure and Metabolic Potential in Two Forest Types	PLOS ONE			English	Article							FUNCTIONAL GENE DIVERSITY; 16S RIBOSOMAL-RNA; PLANT-COMMUNITIES; CENTRAL CHINA; PATTERNS; CHRONOSEQUENCE; BIOGEOGRAPHY; RESTORATION; SUCCESSION; MOUNTAINS	Soil microbial metabolic potential and ecosystem function have received little attention owing to difficulties in methodology. In this study, we selected natural mature forest and natural secondary forest and analyzed the soil microbial community and metabolic potential combing the high-throughput sequencing and GeoChip technologies. Phylogenetic analysis based on 16S rRNA sequencing showed that one known archaeal phylum and 15 known bacterial phyla as well as unclassified phylotypes were presented in these forest soils, and Acidobacteria, Protecobacteria, and Actinobacteria were three of most abundant phyla. The detected microbial functional gene groups were related to different biogeochemical processes, including carbon degradation, carbon fixation, methane metabolism, nitrogen cycling, phosphorus utilization, sulfur cycling, etc. The Shannon index for detected functional gene probes was significantly higher (P<0.05) at natural secondary forest site. The regression analysis showed that a strong positive (P<0.05) correlation was existed between the soil microbial functional gene diversity and phylogenetic diversity. Mantel test showed that soil oxidizable organic carbon, soil total nitrogen and cellulose, glucanase, and amylase activities were significantly linked (P<0.05) to the relative abundance of corresponded functional gene groups. Variance partitioning analysis showed that a total of 81.58% of the variation in community structure was explained by soil chemical factors, soil temperature, and plant diversity. Therefore, the positive link of soil microbial structure and composition to functional activity related to ecosystem functioning was existed, and the natural secondary forest soil may occur the high microbial metabolic potential. Although the results can't directly reflect the actual microbial populations and functional activities, this study provides insight into the potential activity of the microbial community and associated feedback responses of the terrestrial ecosystem to environmental changes.	[Zhang, Yuguang; Cong, Jing; Lu, Hui; Li, Diqiang] Chinese Acad Forestry, Inst Forestry Ecol Environm & Protect, Beijing, Peoples R China; [Zhang, Yuguang; Cong, Jing; Lu, Hui; Li, Diqiang] Chinese Acad Forestry, Key Lab Forest Ecol & Environm, State Forestry Adm, Beijing, Peoples R China; [Cong, Jing] Cent S Univ, Sch Mineral Proc & Bioengn, Changsha, Hunan, Peoples R China; [Yang, Caiyun; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [Yang, Caiyun; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA; [Yang, Yunfeng; Zhou, Jizhong] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China; [Zhou, Jizhong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA	Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; Central South University; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman; Tsinghua University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Zhang, YG (corresponding author), Chinese Acad Forestry, Inst Forestry Ecol Environm & Protect, Beijing, Peoples R China.	yuguang@sina.com.cn; lidq@caf.ac.cn	Yang, Yunfeng/H-9853-2013	Yang, Yunfeng/0000-0001-8274-6196	national scientific research institution, China [CAFRIFEEP201101]; National Biological Specimens and Resources Sharing Platform in Nature Reserve [2005DKA21404]	national scientific research institution, China; National Biological Specimens and Resources Sharing Platform in Nature Reserve	This research was supported by the public welfare project of the national scientific research institution (CAFRIFEEP201101), China, and National Biological Specimens and Resources Sharing Platform in Nature Reserve (2005DKA21404). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts Raf, 2011, BMC Ecology, V11, P29, DOI 10.1186/1472-6785-11-29; Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Banning NC, 2011, APPL ENVIRON MICROB, V77, P6158, DOI 10.1128/AEM.00764-11; Bao S, 2013, SOIL AGR CHEM ANAL; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carney KM, 2005, ECOSYSTEMS, V8, P928, DOI 10.1007/s10021-005-0047-0; Chen CR, 2004, SOIL SCI SOC AM J, V68, P282, DOI 10.2136/sssaj2004.2820; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Ding GC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059497; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Fierer N, 2010, RES MICROBIOL, V161, P635, DOI [10.1016/J.resmic.2010.06.002, 10.1016/j.resmic.2010.06.002]; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2011, FRONT ENVIRON SCI EN, V5, P1, DOI 10.1007/s11783-011-0301-y; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kelly JJ, 2003, SOIL SCI, V168, P597, DOI 10.1097/01.ss.0000090800.06903.2e; Kielak A, 2009, ISME J, V3, P378, DOI 10.1038/ismej.2008.113; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Kuramae EE, 2010, ISME J, V4, P711, DOI 10.1038/ismej.2010.11; Liang YT, 2011, ISME J, V5, P403, DOI 10.1038/ismej.2010.142; Little AEF, 2008, ANNU REV MICROBIOL, V62, P375, DOI 10.1146/annurev.micro.030608.101423; Lopez-Lozano NE, 2013, PEERJ, V1, DOI 10.7717/peerj.47; LU Z, 2011, ISME J, V5, P1; Ma CM, 2008, CHINESE SCI BULL, V53, P28, DOI 10.1007/s11434-008-5007-6; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Myers RT, 2001, SOIL SCI SOC AM J, V65, P359, DOI 10.2136/sssaj2001.652359x; Reeve JR, 2010, ISME J, V4, P1099, DOI 10.1038/ismej.2010.42; Waldrop MP, 2004, OECOLOGIA, V138, P275, DOI 10.1007/s00442-003-1419-9; Wang CK, 2007, GLOBAL CHANGE BIOL, V13, P123, DOI 10.1111/j.1365-2486.2006.01291.x; Xie JP, 2011, APPL ENVIRON MICROB, V77, P991, DOI 10.1128/AEM.01798-10; Yergeau E, 2007, ISME J, V1, P163, DOI 10.1038/ismej.2007.24; Zhang YG, 2013, BMC MICROBIOL, V13, DOI [10.1186/1471-2180-13-72, 10.1186/1471-2180-13-720]; Zhao CM, 2005, J INTEGR PLANT BIOL, V47, P1431, DOI 10.1111/j.1744-7909.2005.00164.x; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996; Zhu WZ, 2010, J MT SCI-ENGL, V7, P327, DOI 10.1007/s11629-010-1098-z	43	26	44	7	137	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e93773	10.1371/journal.pone.0093773	http://dx.doi.org/10.1371/journal.pone.0093773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743581	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100018
J	Boender, AJ; de Jong, JW; Boekhoudt, L; Luijendijk, MCM; van der Plasse, G; Adan, RAH				Boender, Arjen J.; de Jong, Johannes W.; Boekhoudt, Linde; Luijendijk, Mieneke C. M.; van der Plasse, Geoffrey; Adan, Roger A. H.			Combined Use of the Canine Adenovirus-2 and DREADD-Technology to Activate Specific Neural Pathways In Vivo	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; DOPAMINE; MICE; EXPRESSION; DEFICIENT; RESPONSES; NEURONS; GENE	We here describe a technique to transiently activate specific neural pathways in vivo. It comprises the combined use of a CRE-recombinase expressing canine adenovirus-2 (CAV-2) and an adeno-associated virus (AAV-hSyn-DIO-hM(3)D(G(q))-mCherry) that contains the floxed inverted sequence of the designer receptor exclusively activated by designer drugs (DREADD) hM(3)D(G(q))-mCherry. CAV-2 retrogradely infects projection neurons, which allowed us to specifically express hM(3)D(G(q))-mCherry in neurons that project from the ventral tegmental area (VTA) to the nucleus accumbens (Acb), the majority of which were dopaminergic. Activation of hM(3)D(G(q))-mCherry by intraperitoneal (i.p.) injections of clozapine-N-oxide (CNO) leads to increases in neuronal activity, which enabled us to specifically activate VTA to Acb projection neurons. The VTA to Acb pathway is part of the mesolimbic dopamine system and has been implicated in behavioral activation and the exertion of effort. Injections of all doses of CNO led to increases in progressive ratio (PR) performance. The effect of the lowest dose of CNO was suppressed by administration of a DRD1-antagonist, suggesting that CNO-induced increases in PR-performance are at least in part mediated by DRD1-signaling. We hereby validate the combined use of CAV-2 and DREADD-technology to activate specific neural pathways and determine consequent changes in behaviorally relevant paradigms.	[Boender, Arjen J.; de Jong, Johannes W.; Boekhoudt, Linde; Luijendijk, Mieneke C. M.; van der Plasse, Geoffrey; Adan, Roger A. H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Adan, RAH (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands.	r.a.h.adan@umcutrecht.nl	Core, Vector/CAF-4832-2022; de Jong, Johannes/AAM-4842-2020	de Jong, Johannes/0000-0002-0788-9282; van der Plasse, Geoffrey/0000-0003-2374-0194; Boender, Arjen/0000-0002-6018-3588	European Community [FP7-KBBE-2009-3-245009, FP7-KBBE-2010-4-266408]	European Community(European Commission)	The work leading to this manuscript was funded by the European Community's Seventh Framework Programme (FP7-KBBE-2009-3-245009 [Neurofast] and FP7-KBBE-2010-4-266408 [Full4Health]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Farrell MS, 2013, NEUROPSYCHOPHARMACOL, V38, P854, DOI 10.1038/npp.2012.251; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Gore BB, 2013, J NEUROSCI, V33, P8640, DOI 10.1523/JNEUROSCI.5532-12.2013; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Jennings JH, 2013, NATURE, V496, P224, DOI 10.1038/nature12041; Krashes MJ, 2011, J CLIN INVEST, V121, P1424, DOI 10.1172/JCI46229; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Nair SG, 2013, BRAIN RES, V1511, P93, DOI 10.1016/j.brainres.2012.10.011; Soden ME, 2013, GENES BRAIN BEHAV; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; White MD, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00008; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	14	81	81	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95392	10.1371/journal.pone.0095392	http://dx.doi.org/10.1371/journal.pone.0095392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736748	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600177
J	Clarkson, JP; Fawcett, L; Anthony, SG; Young, C				Clarkson, John P.; Fawcett, Laura; Anthony, Steven G.; Young, Caroline			A Model for Sclerotinia sclerotiorum Infection and Disease Development in Lettuce, Based on the Effects of Temperature, Relative Humidity and Ascospore Density	PLOS ONE			English	Article							WHITE MOLD; STEM ROT; CARPOGENIC GERMINATION; SPATIAL PATTERN; LEAVES; EPIDEMIOLOGY; APOTHECIA; EQUATION; RELEASE	The plant pathogen Sclerotinia sclerotiorum can cause serious losses on lettuce crops worldwide and as for most other susceptible crops, control relies on the application of fungicides, which target airborne ascospores. However, the efficacy of this approach depends on accurate timing of these sprays, which could be improved by an understanding of the environmental conditions that are conducive to infection. A mathematical model for S. sclerotiorum infection and disease development on lettuce is presented here for the first time, based on quantifying the effects of temperature, relative humidity (RH) and ascospore density in multiple controlled environment experiments. It was observed that disease can develop on lettuce plants inoculated with dry ascospores in the absence of apparent leaf wetness (required for spore germination). To explain this, the model conceptualises an infection court area containing microsites (in leaf axils and close to the stem base) where conditions are conducive to infection, the size of which is modified by ambient RH. The model indicated that minimum, maximum and optimum temperatures for ascospore germination were 0.0, 29.9 and 21.7 degrees C respectively and that maximum rates of disease development occurred at spore densities >87 spores cm(-2). Disease development was much more rapid at 80-100% RH at 20 degrees C, compared to 50-70% RH and resulted in a greater proportion of lettuce plants infected. Disease development was also more rapid at 15-27 degrees C compared to 5-10 degrees C (85% RH). The model was validated by a further series of independent controlled environment experiments where both RH and temperature were varied and generally simulated the pattern of disease development well. The implications of the results in terms of Sclerotinia disease forecasting are discussed.	[Clarkson, John P.] Univ Warwick, Sch Life Sci, Warwick Crop Ctr, Wellesbourne, Warwick, England; [Fawcett, Laura; Anthony, Steven G.] ADAS UK Ltd, Wolverhampton, W Midlands, England; [Young, Caroline] ADAS UK Ltd, ADAS Drayton, Defra Drayton, Stratford Upon, England	University of Warwick	Clarkson, JP (corresponding author), Univ Warwick, Sch Life Sci, Warwick Crop Ctr, Wellesbourne, Warwick, England.	john.clarkson@warwick.ac.uk		Clarkson, John/0000-0001-5931-933X	Department for Environment, Food and Rural Affairs (Defra), UK [HH3215TFV]	Department for Environment, Food and Rural Affairs (Defra), UK(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by Department for Environment, Food and Rural Affairs (Defra), UK. http://www.defra.gov.uk/. Project: HH3215TFV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAWI GS, 1975, PHYTOPATHOLOGY, V65, P673, DOI 10.1094/Phyto-65-673; ABAWI GS, 1979, PHYTOPATHOLOGY, V69, P899, DOI 10.1094/Phyto-69-899; Atallah ZK, 2004, PLANT DIS, V88, P419, DOI 10.1094/PDIS.2004.88.4.419; BOLAND GJ, 1987, CAN J PLANT PATHOL, V9, P218, DOI 10.1080/07060668709501877; BOLAND GJ, 1988, PLANT PATHOL, V37, P329, DOI 10.1111/j.1365-3059.1988.tb02082.x; BOLAND GJ, 1988, CAN J BOT, V66, P247, DOI 10.1139/b88-042; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P2298, DOI 10.1128/AEM.02459-07; Clarkson JP, 2007, PHYTOPATHOLOGY, V97, P621, DOI 10.1094/PHYTO-97-5-0621; Clarkson JP, 2004, PHYTOPATHOLOGY, V94, P268, DOI 10.1094/PHYTO.2004.94.3.268; Clarkson JP, 2003, MYCOL RES, V107, P213, DOI 10.1017/S0953756203007159; CLINE MN, 1983, PLANT DIS, V67, P784, DOI 10.1094/PD-67-784; DILLARD HR, 1985, PHYTOPATHOLOGY, V75, P90, DOI 10.1094/Phyto-75-90; Foster AJ, 2011, CAN J PLANT PATHOL, V33, P187, DOI 10.1080/07060661.2011.563753; GALEA VJ, 1988, T BRIT MYCOL SOC, V91, P419, DOI 10.1016/S0007-1536(88)80117-7; GREGORY PH, 1948, ANN APPL BIOL, V35, P412, DOI 10.1111/j.1744-7348.1948.tb07385.x; Hannusch DJ, 1996, PHYTOPATHOLOGY, V86, P156, DOI 10.1094/Phyto-86-156; Harikrishnan R, 2006, PLANT DIS, V90, P946, DOI 10.1094/PD-90-0946; Heran A., 1999, P 10 INT RAP C NEW H; HUANG HC, 1992, PLANT DIS, V76, P597, DOI 10.1094/PD-76-0597; JAMAUX I, 1995, PLANT PATHOL, V44, P22, DOI 10.1111/j.1365-3059.1995.tb02712.x; Koch S, 2007, PHYTOPATHOLOGY, V97, P1186, DOI 10.1094/PHYTO-97-9-1186; Lopez S, 2000, J ANIM SCI, V78, P1816; MCCARTNEY HA, 1991, GRANA, V30, P486, DOI 10.1080/00173139109432015; McCartney HA, 1999, P 10 INT RAP C NEW H; McDonald MR, 2004, CAN J PLANT PATHOL, V26, P480; McLaren DL, 2004, CAN J PLANT PATHOL, V26, P489; MCLEAN D. M., 1958, PLANT DIS REPORTER, V42, P663; NEWTON HC, 1972, PLANT DIS REP, V56, P798; PHILLIPS AJL, 1994, ANN APPL BIOL, V124, P413, DOI 10.1111/j.1744-7348.1994.tb04147.x; PURDY LAURENCE H., 1953, PLANT DIS REPORTER, V37, P361; PURDY LH, 1958, PHYTOPATHOLOGY, V48, P605; Rogers SL, 2009, PLANT PATHOL, V58, P324, DOI 10.1111/j.1365-3059.2008.01945.x; SEDUN FS, 1987, ANN APPL BIOL, V110, P275, DOI 10.1111/j.1744-7348.1987.tb03257.x; TORES JA, 1991, J PHYTOPATHOL, V132, P65, DOI 10.1111/j.1439-0434.1991.tb00094.x; TU JC, 1989, MICROBIOS, V57, P85; Twengstrom E, 1998, CROP PROT, V17, P405, DOI 10.1016/S0261-2194(98)00035-0; Yan WK, 1999, ANN BOT-LONDON, V84, P607, DOI 10.1006/anbo.1999.0955; Young CS, 2004, PLANT PATHOL, V53, P387, DOI 10.1111/j.1365-3059.2004.01018.x; Young CS, 2001, XITH INTERNATIONAL SCLEROTINIA WORKSHOP, PROGRAMME PAPERS & DELEGATE LIST, P181	39	48	49	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94049	10.1371/journal.pone.0094049	http://dx.doi.org/10.1371/journal.pone.0094049			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736409	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600042
J	El Kaffas, A; Nofiele, J; Giles, A; Cho, S; Liu, SK; Czarnota, GJ				El Kaffas, Ahmed; Nofiele, Joris; Giles, Anoja; Cho, Song; Liu, Stanley K.; Czarnota, Gregory J.			Dll4-Notch Signalling Blockade Synergizes Combined Ultrasound-Stimulated Microbubble and Radiation Therapy in Human Colon Cancer Xenografts	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; UP-REGULATION; ENHANCEMENT; ANGIOGENESIS; VASCULATURE; EXPRESSION; STRATEGIES; RESISTANCE	Tumour vasculature acts as an essential lifeline for tumour progression and facilitates metastatic spread. Novel vascular targeting strategies aiming to sustain vascular shutdown could potentially induce substantial damage, resulting in a significant tumour growth delay. We investigated the combination of two novel complementary vascular targeting agents with radiation therapy in a strategy aiming to sustain vascular disruption. Experiments were carried out with delta-like ligand 4 (Dll4) blockade (angiogenesis deregulator) treatment administered in combination with a radiation-based vascular destruction treatment in a highly aggressive well-perfused colon cancer tumour line implanted in female athymic nude mice. Tumours were treated with permutations of radiation, ultrasound-stimulated microbubbles (USMB) and Dll4 monoclonal antibody (mAb). Tumour vascular response was assessed with three-dimensional power Doppler ultrasound to measure active flow and immunohistochemistry. Tumour response was assessed with histochemical assays and longitudinal measurements of tumour volume. Our results suggest a significant tumour response in animals treated with USMB combined with radiation, and Dll4 mAb, leading to a synergistic tumour growth delay of up to 24 days. This is likely linked to rapid cell death within the tumour and a sustained tumour vascular shutdown. We conclude that the triple combination treatments cause a vascular shutdown followed by a sustained inhibition of angiogenesis and tumour cell death, leading to a rapid tumour vascular-based 'collapse' and a significant tumour growth delay.	[El Kaffas, Ahmed; Giles, Anoja; Liu, Stanley K.; Czarnota, Gregory J.] Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol, Toronto, ON M4N 3M5, Canada; [El Kaffas, Ahmed; Giles, Anoja; Liu, Stanley K.; Czarnota, Gregory J.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [El Kaffas, Ahmed; Nofiele, Joris; Giles, Anoja; Liu, Stanley K.; Czarnota, Gregory J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Cho, Song] MedImmune, Dept Oncol Res, Gaithersburg, MD USA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; AstraZeneca; Medimmune	Czarnota, GJ (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Radiat Oncol, Toronto, ON M4N 3M5, Canada.	gregory.czarnota@sunnybrook.ca		Liu, Stanley/0000-0001-6851-0857	Terry Fox Foundation; CCO Research Chair in Experimental Therapeutics and Imaging; OICR (Ontario Institute of Cancer Research); PCC (Prostate Cancer Canada)	Terry Fox Foundation; CCO Research Chair in Experimental Therapeutics and Imaging; OICR (Ontario Institute of Cancer Research); PCC (Prostate Cancer Canada)	This work was supported by the Terry Fox Foundation through a program project grant "Ultrasound for Cancer Therapy". Dr. Gregory Czarnota is a clinician-scientist and is supported by a CCO Research Chair in Experimental Therapeutics and Imaging. Dr. Stanley Liu is a clinician-scientist and is supported by an OICR (Ontario Institute of Cancer Research) early stage investigator award and acknowledges the support of PCC (Prostate Cancer Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahrouki AA, 2012, ULTRASOUND MED BIOL, V38, P1958, DOI 10.1016/j.ultrasmedbio.2012.07.009; Berbeco RI, 2011, INT J RADIAT ONCOL, V81, P270, DOI 10.1016/j.ijrobp.2010.10.022; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Czarnota GJ, 2012, P NATL ACAD SCI USA, V109, pE2033, DOI 10.1073/pnas.1200053109; El Kaffas A, 2013, ANGIOGENESIS, V16, P443, DOI 10.1007/s10456-012-9329-2; El Kaffas A, 2012, TECHNOL CANCER RES T, V11, P421, DOI 10.7785/tcrt.2012.500265; Foster FS, 2000, ULTRASOUND MED BIOL, V26, P1, DOI 10.1016/S0301-5629(99)00096-4; Franses JW, 2011, CANCER RES, V71, P7339, DOI 10.1158/0008-5472.CAN-11-1718; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Garcia-Barros M, 2010, CANCER RES, V70, P8179, DOI 10.1158/0008-5472.CAN-10-1871; Goel S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006486; Goertz DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052307; Goertz DE, 2002, CANCER RES, V62, P6371; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hida K, 2013, J BIOCHEM, V153, P243, DOI 10.1093/jb/mvs152; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Kim HC, 2013, ULTRASOUND MED BIOL, V39, P1376, DOI 10.1016/j.ultrasmedbio.2013.01.012; Kleibeuker EA, 2012, DRUG RESIST UPDATE, V15, P173, DOI 10.1016/j.drup.2012.04.002; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Kwok SJJ, 2013, ULTRASOUND IN PRESS; Liu SK, 2011, JNCI-J NATL CANCER I, V103, P1778, DOI 10.1093/jnci/djr419; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Mriouah J, 2012, TRENDS BIOTECHNOL, V30, P649, DOI 10.1016/j.tibtech.2012.08.006; Ngwa W, 2012, MED PHYS, V39, P392, DOI 10.1118/1.3671905; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Sainson RCA, 2007, TRENDS MOL MED, V13, P389, DOI 10.1016/j.molmed.2007.07.002; Senan S, 2007, ONCOLOGIST, V12, P465, DOI 10.1634/theoncologist.12-4-465; Thanik VD, 2010, J VASC RES, V47, P472, DOI 10.1159/000313875; Tran WT, 2012, BRIT J CANCER, V107, P469, DOI 10.1038/bjc.2012.279; Vala IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011222	33	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93888	10.1371/journal.pone.0093888	http://dx.doi.org/10.1371/journal.pone.0093888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736631	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600031
J	Saga, H; Ohhata, A; Hayashi, A; Katoh, M; Maeda, T; Mizuno, H; Takada, Y; Komichi, Y; Ota, H; Matsumura, N; Shibaya, M; Sugiyama, T; Nakade, S; Kishikawa, K				Saga, Hiroshi; Ohhata, Akira; Hayashi, Akio; Katoh, Makoto; Maeda, Tatsuo; Mizuno, Hirotaka; Takada, Yuka; Komichi, Yuka; Ota, Hiroto; Matsumura, Naoya; Shibaya, Masami; Sugiyama, Tetsuya; Nakade, Shinji; Kishikawa, Katsuya			A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation In Vivo and Regulates Urethral Tension	PLOS ONE			English	Article							MOTILITY-STIMULATING PROTEIN; LYSOPHOSPHOLIPASE-D; LPA RECEPTORS; EDG FAMILY; CANCER; EXPRESSION; IDENTIFICATION; PATHOGENESIS; INFLAMMATION; RELEVANCE	Autotaxin, also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), is a secreted enzyme that has lysophospholipase D activity, which converts lysophosphatidylcholine to bioactive lysophosphatidic acid. Lysophosphatidic acid activates at least six G-protein coupled recpetors, which promote cell proliferation, survival, migration and muscle contraction. These physiological effects become dysfunctional in the pathology of cancer, fibrosis, and pain. To date, several autotaxin/ENPP2 inhibitors have been reported; however, none were able to completely and continuously inhibit autotaxin/ENPP2 in vivo. In this study, we report the discovery of a highly potent autotaxin/ENPP2 inhibitor, ONO-8430506, which decreased plasma lysophosphatidic acid formation. The IC50 values of ONO-8540506 for lysophospholipase D activity were 6.4-19 nM for recombinant autotaxin/ENPP2 proteins and 4.7-11.6 nM for plasma from various animal species. Plasma lysophosphatidic acid formation during 1-h incubation was almost completely inhibited by the addition of >300 nM of the compound to human plasma. In addition, when administered orally to rats at a dose of 30 mg/kg, the compound demonstrated good pharmacokinetics in rats and persistently inhibited plasma lysophosphatidic acid formation even at 24 h after administration. Smooth muscle contraction is a known to be promoted by lysophosphatidic acid. In this study, we showed that dosing rats with ONO-8430506 decreased intraurethral pressure accompanied by urethral relaxation. These findings demonstrate the potential of this autotaxin/ENPP2 inhibitor for the treatment of various diseases caused by lysophosphatidic acid, including urethral obstructive disease such as benign prostatic hyperplasia.	[Saga, Hiroshi; Hayashi, Akio; Katoh, Makoto; Maeda, Tatsuo; Mizuno, Hirotaka; Takada, Yuka; Komichi, Yuka; Ota, Hiroto; Sugiyama, Tetsuya; Nakade, Shinji; Kishikawa, Katsuya] ONO Pharmaceut Co Ltd, Exploratory Res Labs, Tsukuba, Ibaraki, Japan; [Ohhata, Akira] ONO Pharmaceut Co Ltd, Med Chem Res Labs, Mishima, Osaka, Japan; [Matsumura, Naoya] ONO Pharmaceut Co Ltd, Discovery Technol Labs, Mishima, Osaka, Japan; [Shibaya, Masami] ONO Phamaceut Co Ltd, Safety Res Labs, Sakai, Osaka, Japan	Ono Pharmaceutical Co Ltd; Ono Pharmaceutical Co Ltd; Ono Pharmaceutical Co Ltd; Ono Pharmaceutical Co Ltd	Saga, H (corresponding author), ONO Pharmaceut Co Ltd, Exploratory Res Labs, Tsukuba, Ibaraki, Japan.	saga@ono.co.jp			Ono Pharmaceutical Co. Ltd	Ono Pharmaceutical Co. Ltd(Ono Pharmaceutical Co Ltd)	This study was funded by Ono Pharmaceutical Co. Ltd. The funders had role in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Akiyama K, 1999, J PHARMACOL EXP THER, V291, P81; Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; Brindley DN, 2013, BBA-MOL CELL BIOL L, V1831, P74, DOI 10.1016/j.bbalip.2012.08.015; Dohi T, 2013, ATHEROSCLEROSIS, V229, P192, DOI 10.1016/j.atherosclerosis.2013.03.038; Ferry G, 2008, J PHARMACOL EXP THER, V327, P809, DOI 10.1124/jpet.108.141911; Gierse J, 2010, J PHARMACOL EXP THER, V334, P310, DOI 10.1124/jpet.110.165845; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Masuda A, 2008, BRIT J HAEMATOL, V143, P60, DOI 10.1111/j.1365-2141.2008.07325.x; Miyabe Y, 2013, ARTHRITIS RHEUM-US, V65, P2037, DOI 10.1002/art.37991; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; MURATA J, 1994, J BIOL CHEM, V269, P30479; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Nagai J, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-78; Nakade S, 2002, Remedies for urinary diseases comprising lysophosphatidic acid receptor controlling agents, Patent No. [WO2002062389A1, 2002062389]; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Ohata A, 2011, Interna-tional Publication, Patent No. [WO/2012/005227, 2012005227]; Oikonomou N, 2012, AM J RESP CELL MOL, V47, P566, DOI 10.1165/rcmb.2012-0004OC; ONO Pharmaceutical Co, 2012, WO2012127885A1, Patent No. [2012127885, WO/2012/127885]; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Pyne NJ, 2013, BBA-MOL CELL BIOL L, V1831, P228, DOI 10.1016/j.bbalip.2012.07.003; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; TOKUMURA A, 1991, J PHARM PHARMACOL, V43, P774, DOI 10.1111/j.2042-7158.1991.tb03480.x; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; TOKUMURA A, 1978, LIPIDS, V13, P572, DOI 10.1007/BF02533598; TOKUMURA A, 1982, J PHARM PHARMACOL, V34, P514, DOI 10.1111/j.2042-7158.1982.tb04776.x; Ueda H, 2013, BBA-MOL CELL BIOL L, V1831, P61, DOI 10.1016/j.bbalip.2012.08.014; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; Yanagida K, 2011, J BIOCHEM, V150, P223, DOI 10.1093/jb/mvr087; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879; Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302	36	40	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93230	10.1371/journal.pone.0093230	http://dx.doi.org/10.1371/journal.pone.0093230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747415	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500004
J	Baumer, N; Krause, A; Kohler, G; Lettermann, S; Evers, G; Hascher, A; Baumer, S; Berdel, WE; Muller-Tidow, C; Tickenbrock, L				Baeumer, Nicole; Krause, Annika; Koehler, Gabriele; Lettermann, Stephanie; Evers, Georg; Hascher, Antje; Baeumer, Sebastian; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Tickenbrock, Lara			Proteinase-Activated Receptor 1 (PAR1) Regulates Leukemic Stem Cell Functions	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; THROMBIN RECEPTOR; HEMATOPOIETIC STEM; TUMOR-SUPPRESSOR; NOTCH PATHWAY; CANCER; IDENTIFICATION; EZH2; PROLIFERATION; PROGRESSION	External signals that are mediated by specific receptors determine stem cell fate. The thrombin receptor PAR1 plays an important role in haemostasis, thrombosis and vascular biology, but also in tumor biology and angiogenesis. Its expression and function in hematopoietic stem cells is largely unknown. Here, we analyzed expression and function of PAR1 in primary hematopoietic cells and their leukemic counterparts. AML patients' blast cells expressed much lower levels of PAR1 mRNA and protein than CD34(+) progenitor cells. Constitutive Par1-deficiency in adult mice did not affect engraftment or stem cell potential of hematopoietic cells. To model an AML with Par1-deficiency, we retrovirally introduced the oncogene MLL-AF9 in wild type and Par1(-/-) hematopoietic progenitor cells. Par1-deficiency did not alter initial leukemia development. However, the loss of Par1 enhanced leukemic stem cell function in vitro and in vivo. Re-expression of PAR1 in Par1(-/-) leukemic stem cells delayed leukemogenesis in vivo. These data indicate that Par1 contributes to leukemic stem cell maintenance.	[Baeumer, Nicole; Krause, Annika; Lettermann, Stephanie; Evers, Georg; Baeumer, Sebastian; Berdel, Wolfgang E.; Mueller-Tidow, Carsten; Tickenbrock, Lara] Univ Munster, Dept Med, D-48149 Munster, Germany; [Koehler, Gabriele] Univ Munster, Gerhard Domagk Inst Pathol, D-48149 Munster, Germany; [Mueller-Tidow, Carsten] Univ Munster, Interdisciplinary Ctr Clin Res IZKF, D-48149 Munster, Germany; [Mueller-Tidow, Carsten] Univ Halle, Dept Med Hematol & Oncol 4, Halle, Germany; [Hascher, Antje; Tickenbrock, Lara] Univ Appl Sci, Hsch Hamm Lippstadt, Hamm, Germany	University of Munster; University of Munster; University of Munster; Martin Luther University Halle Wittenberg	Muller-Tidow, C (corresponding author), Univ Munster, Dept Med, D-48149 Munster, Germany.	Carsten.Mueller-Tidow@UK-Halle.de; lara.tickenbrock@hshl.de	Baeumer, Sebastian/GYU-0544-2022; Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232	Deutsche Forschungsgemeinschaft [GZ TI 693/2-1, SFB1009 A07]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft GZ TI 693/2-1 and SFB1009 A07 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2008, LEUKEMIA, V22, P78, DOI 10.1038/sj.leu.2404988; Arora P, 2008, ONCOGENE, V27, P4434, DOI 10.1038/onc.2008.84; Austin KM, 2013, BLOOD, V121, P431, DOI 10.1182/blood-2012-09-355958; Baumer N, 2011, J BIOL CHEM, V286, P28210, DOI 10.1074/jbc.M110.203471; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Connolly AJ, 1996, NATURE, V381, P516, DOI 10.1038/381516a0; Corral J, 1996, CELL, V85, P853, DOI 10.1016/S0092-8674(00)81269-6; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Darmoul D, 2004, J BIOL CHEM, V279, P20927, DOI 10.1074/jbc.M401430200; Darrow AL, 1996, THROMB HAEMOSTASIS, V76, P860; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Even-Ram S, 1998, NAT MED, V4, P909, DOI 10.1038/nm0898-909; Fonseca AV, 2010, J BIOL CHEM, V285, P31661, DOI 10.1074/jbc.M110.145037; Garwicz D, 2006, STEM CELLS, V24, P2158, DOI 10.1634/stemcells.2005-0584; Griffin CT, 2001, SCIENCE, V293, P1666, DOI 10.1126/science.1061259; Hebestreit K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039148; Hernandez NA, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-47; HOXIE JA, 1993, J BIOL CHEM, V268, P13756; Ibrahim S, 2000, AM J CLIN PATHOL, V114, P793, DOI 10.1309/XY44-L8TE-PWU5-62MP; Isken F, 2008, BRIT J HAEMATOL, V140, P153, DOI 10.1111/j.1365-2141.2007.06915.x; Jiao B, 2009, LEUKEMIA, V23, P1598, DOI 10.1038/leu.2009.104; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kaufmann R, 2007, J CELL PHYSIOL, V211, P699, DOI 10.1002/jcp.21027; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Leung AYH, 2013, LEUKEMIA, V27, P260, DOI 10.1038/leu.2012.195; Lobry C, 2013, J EXP MED, V210, P301, DOI 10.1084/jem.20121484; Lopez-Pedrera C, 2006, LEUKEMIA, V20, P1331, DOI 10.1038/sj.leu.2404264; Massi D, 2005, HUM PATHOL, V36, P676, DOI 10.1016/j.humpath.2005.04.008; Misaghian N, 2009, LEUKEMIA, V23, P25, DOI 10.1038/leu.2008.246; Moorman AV, 1998, LEUKEMIA, V12, P805, DOI 10.1038/sj.leu.2401016; Nierodzik ML, 1998, BLOOD, V92, P3694, DOI 10.1182/blood.V92.10.3694.422k40_3694_3700; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Preacher KJ, 2001, CALCULATION CHI SQUA; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Rattenholl A, 2007, J INVEST DERMATOL, V127, P2245, DOI 10.1038/sj.jid.5700847; Schemionek M, 2012, LEUKEMIA, V26, P1030, DOI 10.1038/leu.2011.366; Seeley S, 2003, CHEM BIOL, V10, P1033, DOI 10.1016/j.chembiol.2003.10.014; Shi XL, 2004, MOL CANCER RES, V2, P395; Shpacovitch V, 2008, J LEUKOCYTE BIOL, V83, P1309, DOI 10.1189/jlb.0108001; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Swansbury GJ, 1998, LEUKEMIA, V12, P792, DOI 10.1038/sj.leu.2401014; Trivedi V, 2009, CELL, V137, P332, DOI 10.1016/j.cell.2009.02.018; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vouret-Craviari V, 2002, J CELL SCI, V115, P2475; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Worch J, 2004, ONCOGENE, V23, P9162, DOI 10.1038/sj.onc.1208164; Yue R, 2012, DEV CELL, V22, P1092, DOI 10.1016/j.devcel.2012.01.025	59	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94993	10.1371/journal.pone.0094993	http://dx.doi.org/10.1371/journal.pone.0094993			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740120	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900091
J	Onozuka, D; Chaves, LF				Onozuka, Daisuke; Fernando Chaves, Luis			Climate Variability and Nonstationary Dynamics of Mycoplasma pneumoniae Pneumonia in Japan	PLOS ONE			English	Article							INDIAN-OCEAN DIPOLE; EL-NINO; EPIDEMICS; CHOLERA; DIAGNOSIS; INDEXES; PCR	Background: A stationary association between climate factors and epidemics of Mycoplasma pneumoniae (M. pneumoniae) pneumonia has been widely assumed. However, it is unclear whether elements of the local climate that are relevant to M. pneumoniae pneumonia transmission have stationary signatures of climate factors on their dynamics over different time scales. Methods: We performed a cross-wavelet coherency analysis to assess the patterns of association between monthly M. pneumoniae cases in Fukuoka, Japan, from 2000 to 2012 and indices for the Indian Ocean Dipole (IOD) and El Nino Southern Oscillation (ENSO). Results: Monthly M. pneumoniae cases were strongly associated with the dynamics of both the IOD and ENSO for the 1-2-year periodic mode in 2005-2007 and 2010-2011. This association was non-stationary and appeared to have a major influence on the synchrony of M. pneumoniae epidemics. Conclusions: Our results call for the consideration of non-stationary, possibly non-linear, patterns of association between M. pneumoniae cases and climatic factors in early warning systems.	[Onozuka, Daisuke] Fukuoka Inst Hlth & Environm Sci, Dept Planning Informat & Adm, Fukuoka, Japan; [Fernando Chaves, Luis] Univ Nacl, Escuela Med Vet, Programa Invest Enfermedades Tropicales, Heredia, Costa Rica; [Fernando Chaves, Luis] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 852, Japan	Universidad Nacional Costa Rica; Nagasaki University	Onozuka, D (corresponding author), Fukuoka Inst Hlth & Environm Sci, Dept Planning Informat & Adm, Fukuoka, Japan.	onozuka@fihes.pref.fukuoka.jp	Chaves, Luis Fernando/F-3448-2010; Onozuka, Daisuke/F-5067-2014	Chaves, Luis Fernando/0000-0002-5301-2764; Onozuka, Daisuke/0000-0001-9596-9188	Ministry of Health, Labour and Welfare, Japan; Department of Public Health and Medical Affairs, Fukuoka Prefectural Government	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Department of Public Health and Medical Affairs, Fukuoka Prefectural Government	The study was supported by grants from the Ministry of Health, Labour and Welfare, Japan and budgets for research of the Department of Public Health and Medical Affairs, Fukuoka Prefectural Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein AS, 2013, CHEST, V143, P1455, DOI 10.1378/chest.12-2384; Bradley JS, 2011, CLIN INFECT DIS, V53, pE25, DOI [10.1093/cid/cir531, 10.1093/cid/cir625]; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; Chaves LF, 2006, PLOS MED, V3, P1320, DOI 10.1371/journal.pmed.0030295; Choi KM, 2006, PUBLIC HEALTH, V120, P505, DOI 10.1016/j.puhe.2006.01.011; Dorigo-Zetsma JW, 1999, J CLIN MICROBIOL, V37, P14, DOI 10.1128/JCM.37.1.14-17.1999; Feikin DR, 1999, CLIN INFECT DIS, V29, P1545, DOI 10.1086/313500; FOY HM, 1971, AM J EPIDEMIOL, V93, P55, DOI 10.1093/oxfordjournals.aje.a121228; Fukuoka Prefectural Government, 2013, FUK PREF MIGR SURV; Hallett TB, 2004, NATURE, V430, P71, DOI 10.1038/nature02708; Hashizume M, 2009, P NATL ACAD SCI USA, V106, P1857, DOI 10.1073/pnas.0806544106; Hashizume M, 2011, ENVIRON HEALTH PERSP, V119, P239, DOI 10.1289/ehp.1002302; Johansson MA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000168; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; Kosaka Y, 2013, P NATL ACAD SCI USA, V110, P7574, DOI 10.1073/pnas.1215582110; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Luo JJ, 2012, P NATL ACAD SCI USA, V109, P18701, DOI 10.1073/pnas.1210239109; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P505, DOI 10.5194/npg-11-505-2004; Meyers LA, 2003, EMERG INFECT DIS, V9, P204, DOI 10.3201/eid0902.020188; Newell Leann, 2012, Morbidity and Mortality Weekly Report, V61, P834; Onozuka D, 2009, THORAX, V64, P507, DOI 10.1136/thx.2008.111237; Patz JA, 2002, NATURE, V420, P627, DOI 10.1038/420627a; Paynter S, 2010, LANCET, V376, P1804, DOI 10.1016/S0140-6736(10)62141-1; Reiner RC, 2012, P NATL ACAD SCI USA, V109, P2033, DOI 10.1073/pnas.1108438109; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Shuman EK, 2010, NEW ENGL J MED, V362, P1061, DOI 10.1056/NEJMp0912931; Spuesens EBM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001444; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Templeton KE, 2003, J CLIN MICROBIOL, V41, P4366, DOI 10.1128/JCM.41.9.4366-4371.2003; Tobin-D'Angelo M, 2013, MMWR-MORBID MORTAL W, V62, P603; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Tsiodras S, 2005, J INFECTION, V51, P343, DOI 10.1016/j.jinf.2005.07.005; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Wolter K, 2011, INT J CLIMATOL, V31, P1074, DOI 10.1002/joc.2336; World Health Organization, 2008, The global burden of disease: 2004 update; WRIGHT DN, 1969, J BACTERIOL, V99, P491, DOI 10.1128/JB.99.2.491-495.1969; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	37	9	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95447	10.1371/journal.pone.0095447	http://dx.doi.org/10.1371/journal.pone.0095447			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740102	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900145
J	Tran, DH; Meissner, GW; French, RL; Baker, BS				Tran, David H.; Meissner, Geoffrey W.; French, Rachael L.; Baker, Bruce S.			A Small Subset of Fruitless Subesophageal Neurons Modulate Early Courtship in Drosophila	PLOS ONE			English	Article							SENSORY INTEGRATION; BEHAVIOR; GENE; COORDINATE; DISSECTION; EXPRESSION; DOUBLESEX; ROLES; SEX	We show that a small subset of two to six subesophageal neurons, expressing the male products of the male courtship master regulator gene products fruitless(Male) (fru(M)), are required in the early stages of the Drosophila melanogaster male courtship behavioral program. Loss of fru(M) expression or inhibition of synaptic transmission in these fru(M)(+) neurons results in delayed courtship initiation and a failure to progress to copulation primarily under visually-deficient conditions. We identify a fru(M)-dependent sexually dimorphic arborization in the tritocerebrum made by two of these neurons. Furthermore, these SOG neurons extend descending projections to the thorax and abdominal ganglia. These anatomical and functional characteristics place these neurons in the position to integrate gustatory and higher-order signals in order to properly initiate and progress through early courtship.	[Tran, David H.; French, Rachael L.] San Jose State Univ, Dept Biol Sci, San Jose, CA 95192 USA; [Meissner, Geoffrey W.; Baker, Bruce S.] HHMI, Ashburn, VA 20147 USA	California State University System; San Jose State University; Howard Hughes Medical Institute	Baker, BS (corresponding author), HHMI, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	bakerb@janelia.hhmi.org	French, Rachael/AAI-2427-2020	French, Rachael/0000-0001-9974-4293; Meissner, Geoffrey/0000-0003-0369-9788	NIH NRSA; Div Of Biological Infrastructure [1229817] Funding Source: National Science Foundation	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	NIH NRSA http://grants.nih.gov/training/nrsa.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Belgacem YH, 2002, P NATL ACAD SCI USA, V99, P15154, DOI 10.1073/pnas.232244199; Boll W, 2002, DEVELOPMENT, V129, P5667, DOI 10.1242/dev.00157; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Certel SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013248; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; Dauwalder B, 2011, INT REV NEUROBIOL, V99, P87, DOI 10.1016/B978-0-12-387003-2.00004-5; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Griffith LC, 2009, ANN NY ACAD SCI, V1170, P394, DOI 10.1111/j.1749-6632.2009.04367.x; Kimura K, 2008, NEURON, V59, P759, DOI 10.1016/j.neuron.2008.06.007; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Meissner GW, 2011, GENETICS, V189, P195, DOI 10.1534/genetics.111.129940; Pan Y, 2012, P NATL ACAD SCI USA, V109, P1; Pavlou HJ, 2013, CURR OPIN NEUROBIOL, V23, P76, DOI 10.1016/j.conb.2012.09.002; RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Suster ML, 2004, GENESIS, V39, P240, DOI 10.1002/gene.20051; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Villella A, 1997, GENETICS, V147, P1107; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; WU JR, 2006, NAT PROTOC, P1; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	33	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95472	10.1371/journal.pone.0095472	http://dx.doi.org/10.1371/journal.pone.0095472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740138	Green Published, gold			2022-12-25	WOS:000336863900147
J	Arnoldi, F; De Lorenzo, G; Mano, M; Schraner, EM; Wild, P; Eichwald, C; Burrone, OR				Arnoldi, Francesca; De Lorenzo, Giuditta; Mano, Miguel; Schraner, Elisabeth M.; Wild, Peter; Eichwald, Catherine; Burrone, Oscar R.			Rotavirus Increases Levels of Lipidated LC3 Supporting Accumulation of Infectious Progeny Virus without Inducing Autophagosome Formation	PLOS ONE			English	Article							REPLICATIVE CYCLE; IN-VIVO; NSP5; CELLS; PHOSPHORYLATION; IDENTIFICATION; VACCINATION; PROTEINS; VESICLES; MARKER	Replication of many RNA viruses benefits from subversion of the autophagic pathway through many different mechanisms. Rotavirus, the main etiologic agent of pediatric gastroenteritis worldwide, has been recently described to induce accumulation of autophagosomes as a mean for targeting viral proteins to the sites of viral replication. Here we show that the viral-induced increase of the lipidated form of LC3 does not correlate with an augmented formation of autophagosomes, as detected by immunofluorescence and electron microscopy. The LC3-II accumulation was found to be dependent on active rotavirus replication through the use of antigenically intact inactivated viral particles and of siRNAs targeting viral genes that are essential for viral replication. Silencing expression of LC3 or of Atg7, a protein involved in LC3 lipidation, resulted in a significant impairment of viral titers, indicating that these elements of the autophagic pathway are required at late stages of the viral cycle.	[Arnoldi, Francesca] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Arnoldi, Francesca; De Lorenzo, Giuditta; Mano, Miguel; Burrone, Oscar R.] Int Ctr Genet Engn & Biotechnol ICGEB, Trieste, Italy; [Schraner, Elisabeth M.; Wild, Peter] Univ Zurich, Inst Vet Anat, Zurich, Switzerland; [Schraner, Elisabeth M.; Wild, Peter; Eichwald, Catherine] Univ Zurich, Inst Virol, Zurich, Switzerland	University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB); University of Zurich; University of Zurich	Arnoldi, F (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	farnoldi@units.it; Oscar.Burrone@icgeb.org	Mano, Miguel/A-4462-2013; De Lorenzo, Giuditta/AAZ-9142-2021; Arnoldi, Francesca/AAQ-6859-2021; ARNOLDI, Francesca/K-5020-2016	Mano, Miguel/0000-0003-1922-4824; De Lorenzo, Giuditta/0000-0002-2736-8740; Eichwald, Catherine/0000-0003-0001-4843; ARNOLDI, Francesca/0000-0003-0651-5526; Wild, Peter Johannes/0000-0002-1017-3744	FIRB-Futuro in Ricerca grant - Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy [RBFR08HSWG]; ICGEB pre-doctoral fellowship; Canton Zurich	FIRB-Futuro in Ricerca grant - Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy; ICGEB pre-doctoral fellowship; Canton Zurich	FA was supported by a FIRB-Futuro in Ricerca grant (RBFR08HSWG, http://futuroinricerca.miur.it) funded by the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy. GDL was supported by an ICGEB pre-doctoral fellowship. CE and EMS were supported by Canton Zurich to the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova I, 1998, J GEN VIROL, V79, P2679, DOI 10.1099/0022-1317-79-11-2679; Afrikanova I, 1996, J GEN VIROL, V77, P2059, DOI 10.1099/0022-1317-77-9-2059; Arnoldi F, 2007, J VIROL, V81, P2128, DOI 10.1128/JVI.01494-06; AU KS, 1989, J VIROL, V63, P4553, DOI 10.1128/JVI.63.11.4553-4562.1989; Babji S, 2012, CURR OPIN VIROL, V2, P443, DOI 10.1016/j.coviro.2012.05.005; Berkova Z, 2006, J VIROL, V80, P6061, DOI 10.1128/JVI.02167-05; Campagna M, 2005, J GEN VIROL, V86, P1481, DOI 10.1099/vir.0.80598-0; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Chung YH, 2012, INT J BIOCHEM CELL B, V44, P989, DOI 10.1016/j.biocel.2012.03.007; Cieehomska IA, 2007, AUTOPHAGY, V3, P586, DOI 10.4161/auto.4843; Contin R, 2011, J VIROL, V85, P2781, DOI 10.1128/JVI.01631-10; Crawford SE, 2012, P NATL ACAD SCI USA, V109, pE3405, DOI 10.1073/pnas.1216539109; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Eichwald C, 2002, J VIROL, V76, P3461, DOI 10.1128/JVI.76.7.3461-3470.2002; Eichwald C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047947; ESTES MK, 1979, J VIROL, V31, P810, DOI 10.1128/JVI.31.3.810-815.1979; Estes MK, 2007, FIELDS VIROLOGY, P1917; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; GONZALEZ SA, 1991, VIROLOGY, V182, P8, DOI 10.1016/0042-6822(91)90642-O; GRAHAM A, 1987, J GEN VIROL, V68, P115, DOI 10.1099/0022-1317-68-1-115; GROENE WS, 1992, J VIROL METHODS, V38, P93, DOI 10.1016/0166-0934(92)90172-A; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Huang SC, 2009, J MED VIROL, V81, P1241, DOI 10.1002/jmv.21502; Jordan TX, 2012, MICROBES INFECT, V14, P126, DOI 10.1016/j.micinf.2011.09.007; Jourdan N, 1997, J VIROL, V71, P8268, DOI 10.1128/JVI.71.11.8268-8278.1997; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kemball CC, 2010, J VIROL, V84, P12110, DOI 10.1128/JVI.01417-10; Kim HJ, 2010, SEMIN IMMUNOPATHOL, V32, P323, DOI 10.1007/s00281-010-0226-8; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Lopez T, 2005, J GEN VIROL, V86, P1609, DOI 10.1099/vir.0.80827-0; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Monastyrska I, 2013, AUTOPHAGY, V9, P164, DOI 10.4161/auto.22743; MUSALEM C, 1985, J GEN VIROL, V66, P2715, DOI 10.1099/0022-1317-66-12-2715; O'Donnell V, 2011, VIROLOGY, V410, P142, DOI 10.1016/j.virol.2010.10.042; Patton JT, 2000, METH MOLEC MED, V34, P33, DOI 10.1385/1-59259-078-0:33; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; Sun M, 1997, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V19, P48; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Vascotto F, 2004, J GEN VIROL, V85, P3285, DOI 10.1099/vir.0.80075-0; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08	52	23	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95197	10.1371/journal.pone.0095197	http://dx.doi.org/10.1371/journal.pone.0095197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736649	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600153
J	Poels, EM; Bitsch, N; Slenter, JM; Kooi, ME; de Theije, CC; de Windt, LJ; van Empel, VPM; Martins, PAD				Poels, Ella M.; Bitsch, Nicole; Slenter, Jos M.; Kooi, M. Eline; de Theije, Chiel C.; de Windt, Leon J.; van Empel, Vanessa P. M.; Martins, Paula A. da Costa			Supplementing Exposure to Hypoxia with a Copper Depleted Diet Does Not Exacerbate Right Ventricular Remodeling in Mice	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; HEART-FAILURE; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; NULL MICE; DEFICIENT; RATS; RESPONSES; CARDIOMYOPATHY; TRANSITION	Background: Pulmonary hypertension and subsequent right ventricular (RV) failure are associated with high morbidity and mortality. Prognosis is determined by occurrence of RV failure. Currently, adequate treatment for RV failure is lacking. Further research into the molecular basis for the development of RV failure as well as the development of better murine models of RV failure are therefore imperative. We hypothesize that adding a low-copper diet to chronic hypoxia in mice reinforces their individual effect and that the combination of mild pulmonary vascular remodeling and capillary rarefaction, induces RV failure. Methods: Six week old mice were subjected to normoxia (N; 21% O-2) or hypoxia (H; 10% O-2) during a period of 8 weeks and received either a normal diet (Cu+) or a copper depleted diet (Cu-). Cardiac function was assessed by echocardiography and MRI analysis. Results and Conclusion: Here, we characterized a mouse model of chronic hypoxia combined with a copper depleted diet and demonstrate that eight weeks of chronic hypoxia (10%) is sufficient to induce RV hypertrophy and subsequent RV failure. Addition of a low copper diet to hypoxia did not have any further deleterious effects on right ventricular remodeling.	[Poels, Ella M.; Bitsch, Nicole; de Windt, Leon J.; Martins, Paula A. da Costa] Maastricht Univ, Dept Cardiol, CARIM Sch Cardiovasc Dis, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [Slenter, Jos M.; Kooi, M. Eline] Maastricht Univ, Dept Radiol, CARIM Sch Cardiovasc Dis, Med Ctr, Maastricht, Netherlands; [de Theije, Chiel C.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr Toxicol & Metab, Dept Resp Med, Maastricht, Netherlands; [van Empel, Vanessa P. M.] Maastricht Univ, Med Ctr, Dept Cardiol, Heart Vessel Ctr, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Martins, PAD (corresponding author), Maastricht Univ, Dept Cardiol, CARIM Sch Cardiovasc Dis, Fac Hlth Med & Life Sci, Maastricht, Netherlands.	p.dacostamartins@maastrichtuniversity.nl	Kooi, M. Eline/D-3848-2016; de Windt, Leon/AAO-6395-2020	Kooi, M. Eline/0000-0001-7562-5724; de Windt, Leon/0000-0002-7793-2856	Stichting Sint Annadal; Leducq Career Development Award; Dutch Heart Foundation [NHS2010B261]	Stichting Sint Annadal; Leducq Career Development Award; Dutch Heart Foundation(Netherlands Heart Foundation)	EP was supported by a grant from Stichting Sint Annadal and PCM was supported by a Leducq Career Development Award and the Dutch Heart Foundation grant NHS2010B261. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bartelds B, 2011, EUR J HEART FAIL, V13, P1275, DOI 10.1093/eurjhf/hfr134; Bauer EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028578; Bogaard HJ, 2012, AM J RESP CELL MOL, V46, P582, DOI 10.1165/rcmb.2011-0296OC; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Brown L, 1998, J CARDIOVASC PHARM, V31, P108, DOI 10.1097/00005344-199801000-00016; Brown RD, 2013, AM J PHYSIOL-HEART C, V304, pH269, DOI 10.1152/ajpheart.00158.2012; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Calmettes G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009306; Caruso P, 2012, CIRC RES, V111, P290, DOI 10.1161/CIRCRESAHA.112.267591; Chin KM, 2008, J AM COLL CARDIOL, V51, P1527, DOI 10.1016/j.jacc.2008.01.024; Chin KM, 2005, CORONARY ARTERY DIS, V16, P13, DOI 10.1097/00019501-200502000-00003; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; CLARK DR, 1978, CARDIOVASC RES, V12, P578, DOI 10.1093/cvr/12.10.578; Cruz JA, 2012, AM J PHYSIOL-HEART C, V302, pH2518, DOI 10.1152/ajpheart.01140.2011; Dempsey EC, 2009, AM J PATHOL, V174, P782, DOI 10.2353/ajpath.2009.080345; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Howard LS, 2011, EUR RESPIR REV, V20, P236, DOI 10.1183/09059180.00006711; Hughes WM, 2008, CARDIOVASC TOXICOL, V8, P137, DOI 10.1007/s12012-008-9021-3; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Jiang YC, 2007, J EXP MED, V204, P657, DOI 10.1084/jem.20061943; Klevay LM, 2000, J NUTR, V130, p489S, DOI 10.1093/jn/130.2.489S; KLEVAY LM, 1981, AM J PHYSIOL, V240, pH185, DOI 10.1152/ajpheart.1981.240.2.H185; Martins PADC, 2008, CIRCULATION, V118, P1567, DOI 10.1161/CIRCULATIONAHA.108.769984; Moraes DL, 2000, CIRCULATION, V102, P1718, DOI 10.1161/01.CIR.102.14.1718; Okada K, 1997, AM J PATHOL, V151, P1019; Paddenberg R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-15; Pelouch V, 1997, CARDIOVASC DRUG THER, V11, P177, DOI 10.1023/A:1007788915732; RABINOVITCH M, 1981, AM J PHYSIOL, V240, pH62, DOI 10.1152/ajpheart.1981.240.1.H62; Ramiro-Diaz JM, 2013, AM J PHYSIOL-LUNG C, V304, pL613, DOI 10.1152/ajplung.00408.2012; Rubin LJ, 1997, NEW ENGL J MED, V336, P111, DOI 10.1056/NEJM199701093360207; Sakao S, 2005, FASEB J, V19, P1178, DOI 10.1096/fj.04-3261fje; Scherrer-Crosbie M, 1998, CIRCULATION, V98, P1015, DOI 10.1161/01.CIR.98.10.1015; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Steudel W, 1998, J CLIN INVEST, V101, P2468, DOI 10.1172/JCI2356; van Suylen RJ, 2001, AM J RESP CRIT CARE, V163, P1241, DOI 10.1164/ajrccm.163.5.2003144; Vanderpool RR, 2013, BIOMECH MODEL MECHAN, V12, P33, DOI 10.1007/s10237-012-0379-6; Walker LA, 2009, CURR CARDIOL REV, V5, P22, DOI 10.2174/157340309787048077; Wildman REC, 1996, BIOL TRACE ELEM RES, V55, P55, DOI 10.1007/BF02784168; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yoshikawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052522; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhang YZ, 2012, MOL MED, V18, P215, DOI 10.2119/molmed.2011.00094; Zhou Y, 2009, CARDIOVASC RES, V84, P54, DOI 10.1093/cvr/cvp178	47	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e92983	10.1371/journal.pone.0092983	http://dx.doi.org/10.1371/journal.pone.0092983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736644	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600011
J	Postaire, B; Bruggemann, JH; Magalon, H; Faure, B				Postaire, Bautisse; Bruggemann, J. Henrich; Magalon, Helene; Faure, Baptiste			Evolutionary Dynamics in the Southwest Indian Ocean Marine Biodiversity Hotspot: A Perspective from the Rocky Shore Gastropod Genus Nerita	PLOS ONE			English	Article							DETECTING TEMPORAL SHIFTS; HISTORICAL BIOGEOGRAPHY; WEST PACIFIC; CORAL-REEFS; DIVERSIFICATION; DISPERSAL; SPECIATION; PATTERNS; CONSERVATION; PHYLOGENIES	The Southwest Indian Ocean (SWIO) is a striking marine biodiversity hotspot. Coral reefs in this region host a high proportion of endemics compared to total species richness and they are particularly threatened by human activities. The island archipelagos with their diverse marine habitats constitute a natural laboratory for studying diversification processes. Rocky shores in the SWIO region have remained understudied. This habitat presents a high diversity of molluscs, in particular gastropods. To explore the role of climatic and geological factors in lineage diversification within the genus Nerita, we constructed a new phylogeny with an associated chronogram from two mitochondrial genes [cytochrome oxidase subunit 1 and 16S rRNA], combining previously published and new data from eight species sampled throughout the region. All species from the SWIO originated less than 20 Ma ago, their closest extant relatives living in the Indo-Australian Archipelago (IAA). Furthermore, the SWIO clades within species with Indo-Pacific distribution ranges are quite recent, less than 5 Ma. These results suggest that the regional diversification of Nerita is closely linked to tectonic events in the SWIO region. The Reunion mantle plume head reached Earth's surface 67 Ma and has been stable and active since then, generating island archipelagos, some of which are partly below sea level today. Since the Miocene, sea-level fluctuations have intermittently created new rocky shore habitats. These represent ephemeral stepping-stones, which have likely facilitated repeated colonization by intertidal gastropods, like Nerita populations from the IAA, leading to allopatric speciation. This highlights the importance of taking into account past climatic and geological factors when studying diversification of highly dispersive tropical marine species. It also underlines the unique history of the marine biodiversity of the SWIO region.	[Postaire, Bautisse; Bruggemann, J. Henrich; Magalon, Helene; Faure, Baptiste] Univ Reunion, Lab ECOl MARine, CNRS, FRE3560,INEE, St Denis, Reunion, France; [Postaire, Bautisse; Bruggemann, J. Henrich; Magalon, Helene] Labex CORAIL, Perpignan, France; [Faure, Baptiste] Biotope, Serv Rech & Dev, Meze, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); University of La Reunion	Postaire, B (corresponding author), Univ Reunion, Lab ECOl MARine, CNRS, FRE3560,INEE, St Denis, Reunion, France.	bautisse.postaire@univ-reunion.fr	Postaire, Bautisse Didier/AAW-5096-2021; Magalon, Helene/ABH-1252-2020	Postaire, Bautisse Didier/0000-0001-8566-1040; Magalon, Helene/0000-0002-7061-955X	French Agence Nationale de Recherche (programme BIOTAS) [ANR-06-BDIV-002]; EU	French Agence Nationale de Recherche (programme BIOTAS)(French National Research Agency (ANR)); EU(European Commission)	Funding was provided by the French Agence Nationale de Recherche (programme BIOTAS, no. ANR-06-BDIV-002) and the EU-funded program RUN-EMERGE. We acknowledge the les Territoires Australes et Antarctiques Francaises for logistic support during our fieldwork. We further thank the Affaires Maritimes and the Reserve Naturelle Marine de La Reunion for sampling permits. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2012, CURRENT TOPICS IN PHYLOGENETICS AND PHYLOGEOGRAPHY OF TERRESTRIAL AND AQUATIC SYSTEMS, P33; Aktipis SW, 2010, INVERTEBR BIOL, V129, P220, DOI 10.1111/j.1744-7410.2010.00198.x; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; Antonelli A, 2011, TAXON, V60, P403, DOI 10.1002/tax.602010; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barker PF, 2004, EARTH-SCI REV, V66, P143, DOI 10.1016/j.earscirev.2003.10.003; Barnes R. S. K., 2010, Marine Biodiversity, V40, P95, DOI 10.1007/s12526-010-0036-1; Bellard C, 2014, GLOBAL ECOL BIOGEOGR, V23, P203, DOI 10.1111/geb.12093; Benzie JAH, 1997, EVOLUTION, V51, P768, DOI 10.1111/j.1558-5646.1997.tb03660.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Bouchet P, 2005, MALACOLOGIA, V47, P1; Briggs JC, 1999, EVOLUTION, V53, P326, DOI 10.1111/j.1558-5646.1999.tb03769.x; Briggs JC, 2013, J BIOGEOGR, V40, P1023, DOI 10.1111/jbi.12082; Cabezas P, 2012, EVOLUTION, V66, P1878, DOI 10.1111/j.1558-5646.2011.01560.x; Castro LR, 2010, MOL PHYLOGENET EVOL, V57, P918, DOI 10.1016/j.ympev.2010.08.030; Claremont M, 2011, J BIOGEOGR, V38, P1016, DOI 10.1111/j.1365-2699.2011.02482.x; Condamine FL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-82; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Cowman PF, 2013, J BIOGEOGR, V40, P209, DOI 10.1111/jbi.12003; DiBattista JD, 2013, J BIOGEOGR, V40, P1170, DOI 10.1111/jbi.12068; Drivas J., 1988, COQUILLAGES REUNION; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Duncan R.A., 1990, P ODP SCI RESULTS, V115, P43, DOI DOI 10.2973/ODP.PROC.SR.115.141.1990; Duncan RA, 1992, SYNTHESIS RESULTS SC, V70, P91, DOI DOI 10.1029/GM070P0091; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frey MA, 2008, MOL PHYLOGENET EVOL, V48, P1067, DOI 10.1016/j.ympev.2008.05.009; Frey MA, 2010, J BIOGEOGR, V37, P1515, DOI 10.1111/j.1365-2699.2010.02283.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hoareau TB, 2013, J BIOGEOGR, V40, P2167, DOI 10.1111/jbi.12155; Hoeksema Bert W., 2007, V29, P117; Huber M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001014; Hubert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028987; Hubert N, 2011, ECOL EVOL, V1, P229, DOI 10.1002/ece3.19; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Ivany LC, 2000, NATURE, V407, P887, DOI 10.1038/35038044; Jay M., 2014, MOLLUSQUES ILE REUNI; Kennett JP, 1975, DSDP, V29, P1155; Kirkendale LA, 2004, MOL ECOL, V13, P2749, DOI 10.1111/j.1365-294X.2004.02284.x; Krug PJ, 2011, AM MALACOL BULL, V29, P169, DOI 10.4003/006.029.0210; Lawver LA, 2003, PALAEOGEOGR PALAEOCL, V198, P11, DOI 10.1016/S0031-0182(03)00392-4; LEWIS JOHN B., 1960, CANADIAN JOUR ZOOL, V38, P391, DOI 10.1139/z60-043; Lohman DJ, 2011, ANNU REV ECOL EVOL S, V42, P205, DOI 10.1146/annurev-ecolsys-102710-145001; LUBCHENCO J, 1980, ECOLOGY, V61, P333, DOI 10.2307/1935192; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; Masters JC, 2006, FOLIA PRIMATOL, V77, P399, DOI 10.1159/000095388; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Mittermeier RA., 2005, INT J WILDERNESS, V11, P42; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nagalingum NS, 2011, SCIENCE, V334, P796, DOI 10.1126/science.1209926; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Obura DO, 2012, P 12 INT COR REEF S; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Palumbi Stephen R., 1996, P205; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paulay G, 2002, INTEGR COMP BIOL, V42, P922, DOI 10.1093/icb/42.5.922; Paulay G, 2006, INTEGR COMP BIOL, V46, P269, DOI 10.1093/icb/icj027; PENG ZX, 1995, EARTH PLANET SC LETT, V134, P169, DOI 10.1016/0012-821X(95)00110-X; Pinceel J, 2004, BIOL J LINN SOC, V83, P23, DOI 10.1111/j.1095-8312.2004.00368.x; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Potter PE, 2009, EARTH-SCI REV, V96, P279, DOI 10.1016/j.earscirev.2009.07.003; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; R Core Team, 2021, R LANG ENV STAT COMP; Rabosky Daniel L., 2006, Evolutionary Bioinformatics Online, V2, P257; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2009, P ROY SOC B-BIOL SCI, V276, P995, DOI 10.1098/rspb.2008.1584; Rambaut A, 2012, FIGTREE V1 4 3; Rambaut A, 2007, TREEANNOTATOR V1 7 5; Rambaut A., 2007, TRACER 1 5; Ridgway T, 2008, MAR ECOL PROG SER, V354, P161, DOI 10.3354/meps07245; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Santini F, 2002, J BIOGEOGR, V29, P189, DOI 10.1046/j.1365-2699.2002.00669.x; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; UNDERWOOD AJ, 1975, J EXP MAR BIOL ECOL, V18, P153, DOI 10.1016/0022-0981(75)90071-4; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Wafar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014613; Warren BH, 2010, CLADISTICS, V26, P526, DOI 10.1111/j.1096-0031.2009.00300.x; Waters JM, 2005, MOL ECOL, V14, P2789, DOI 10.1111/j.1365-294X.2005.02635.x; Weersing K, 2009, MAR ECOL PROG SER, V393, P1, DOI 10.3354/meps08287; Wilford G.E., 1994, HIST AUSTR VEGETATIO, P5; Williams ST, 2004, EVOLUTION, V58, P2227; Williams ST, 2008, EVOLUTION, V62, P1618, DOI 10.1111/j.1558-5646.2008.00399.x; WOODS AJC, 1986, J PALEONTOL, V60, P636, DOI 10.1017/S0022336000022162; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239	91	15	16	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95040	10.1371/journal.pone.0095040	http://dx.doi.org/10.1371/journal.pone.0095040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736639	gold, Green Published			2022-12-25	WOS:000336922600133
J	Schuler, BA; Schreiber, MT; Li, LY; Mokry, M; Kingdon, ML; Raugi, DN; Smith, C; Hameister, C; Racaniello, VR; Hall, DJ				Schuler, Bryce A.; Schreiber, Michael T.; Li, LuYuan; Mokry, Michal; Kingdon, Megan L.; Raugi, Dana N.; Smith, Cosonya; Hameister, Chelsea; Racaniello, Vincent R.; Hall, David J.			Major and Minor Group Rhinoviruses Elicit Differential Signaling and Cytokine Responses as a Function of Receptor-Mediated Signal Transduction	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; I INTERFERON; ALVEOLAR MACROPHAGES; C/EBP-ALPHA; RESPIRATORY VIRUSES; VIRAL-INFECTIONS; IL-10 PRODUCTION; KINASE PATHWAYS; MONOCYTIC CELLS; LINEAGE CELLS	Major- and minor-group human rhinoviruses (HRV) enter their host by binding to the cell surface molecules ICAM-1 and LDL-R, respectively, which are present on both macrophages and epithelial cells. Although epithelial cells are the primary site of productive HRV infection, previous studies have implicated macrophages in establishing the cytokine dysregulation that occurs during rhinovirus-induced asthma exacerbations. Analysis of the transcriptome of primary human macrophages exposed to major- and minor-group HRV demonstrated differential gene expression. Alterations in gene expression were traced to differential mitochondrial activity and signaling pathway activation between two rhinovirus serotypes, HRV16 (major-group) and HRV1A (minor-group), upon initial HRV binding. Variances in phosphorylation of kinases (p38, JNK, ERK5) and transcription factors (ATF-2, CREB, CEBP-alpha) were observed between the major-and minor-group HRV treatments. Differential activation of signaling pathways led to changes in the production of the asthma-relevant cytokines CCL20, CCL2, and IL-10. This is the first report of genetically similar viruses eliciting dissimilar cytokine release, transcription factor phosphorylation, and MAPK activation from macrophages, suggesting that receptor use is a mechanism for establishing the inflammatory microenvironment in the human airway upon exposure to rhinovirus.	[Schuler, Bryce A.; Schreiber, Michael T.; Li, LuYuan; Kingdon, Megan L.; Raugi, Dana N.; Smith, Cosonya; Hameister, Chelsea; Hall, David J.] Lawrence Univ, Dept Chem, Appleton, WI 54912 USA; [Schreiber, Michael T.; Racaniello, Vincent R.] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Mokry, Michal] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat, Utrecht, Netherlands	Lawrence University; Columbia University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Hall, DJ (corresponding author), Lawrence Univ, Dept Chem, Appleton, WI 54912 USA.	halld@lawrence.edu	Mokry, Michal/AAN-3809-2021	Mokry, Michal/0000-0002-5298-4852	Lawrence Excellence in Science Fund; NSF [0521112]; Henry Merritt Wriston Scholarship; NIH [R15 AI065505-01A1, 5T32DK007328-33, 1R01AI102597-01, 5R21AI096088-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI065505, R21AI096088, R01AI102597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328] Funding Source: NIH RePORTER	Lawrence Excellence in Science Fund; NSF(National Science Foundation (NSF)); Henry Merritt Wriston Scholarship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Lawrence Excellence in Science Fund, NIH R15 AI065505-01A1, 5T32DK007328-33, 1R01AI102597-01, and 5R21AI096088-02 and NSF 0521112. B. A. S and M. T. S. are Ronald E. McNair Scholars. M. T. S was supported by the Henry Merritt Wriston Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett NW, 2012, EMBO MOL MED, V4, P1244, DOI 10.1002/emmm.201201650; Bentley JK, 2013, J ALLERGY CLIN IMMUN, V132, P758, DOI 10.1016/j.jaci.2013.04.020; Bizzintino J, 2011, EUR RESPIR J, V37, P1037, DOI 10.1183/09031936.00092410; Bochkov YA, 2010, MUCOSAL IMMUNOL, V3, P69, DOI 10.1038/mi.2009.109; Bochkov YA, 2012, MICROBES INFECT, V14, P485, DOI 10.1016/j.micinf.2011.12.011; Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Denlinger LC, 2011, AM J RESP CRIT CARE, V184, P1007, DOI 10.1164/rccm.201103-0585OC; Di Tullio A, 2012, CELL CYCLE, V11, P2739, DOI 10.4161/cc.21119; Fu HY, 2012, MOL BIOL CELL, V23, P1628, DOI 10.1091/mbc.E11-05-0412; Gavala ML, 2011, IMMUNOL REV, V242, P69, DOI 10.1111/j.1600-065X.2011.01031.x; Gern JE, 1996, J IMMUNOL, V156, P621; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Hall DJ, 2005, J IMMUNOL, V174, P8056, DOI 10.4049/jimmunol.174.12.8056; Haugen TS, 1999, EUR RESPIR J, V14, P1100, DOI 10.1183/09031936.99.14511009; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Hogg JC, 2001, AM J RESP CRIT CARE, V164, pS71, DOI 10.1164/ajrccm.164.supplement_2.2106063; HORSNELL C, 1995, J GEN VIROL, V76, P2549, DOI 10.1099/0022-1317-76-10-2549; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; Incrocci R, 2013, J GEN VIROL, V94, P1127, DOI 10.1099/vir.0.049221-0; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kalliolias GD, 2008, J IMMUNOL, V180, P6325, DOI 10.4049/jimmunol.180.9.6325; Karta MR, 2014, J ALLERGY CLIN IMMUN; Karta MR, 2014, AM J RESP CELL MOL B; Katsarou K, 2011, BBA-MOL CELL RES, V1813, P1854, DOI 10.1016/j.bbamcr.2011.06.015; Khaitov M. R., 2006, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P63; Koetzler R, 2009, J ALLERGY CLIN IMMUN, V123, P201, DOI 10.1016/j.jaci.2008.09.041; Konno S, 2002, AM J RESP CELL MOL, V26, P594, DOI 10.1165/ajrcmb.26.5.4438; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Korpi-Steiner NL, 2006, J LEUKOCYTE BIOL, V80, P1364, DOI 10.1189/jlb.0606412; Koshiba Takumi, 2011, Int J Biochem Mol Biol, V2, P257; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Laza-Stanca V, 2006, J VIROL, V80, P8248, DOI 10.1128/JVI.00162-06; Laza-Stanca V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002114; Lee WM, 2012, AM J RESP CRIT CARE, V186, P886, DOI 10.1164/rccm.201202-0330OC; Lewis TC, 2012, CLIN EXP ALLERGY, V42, P1734, DOI 10.1111/cea.12005; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; Nagarkar DR, 2010, J IMMUNOL, V185, P2525, DOI 10.4049/jimmunol.1000286; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Oliver BGG, 2008, THORAX, V63, P519, DOI 10.1136/thx.2007.081752; Palmenberg AC, 2010, J ALLERGY CLIN IMMUN, V125, P1190, DOI 10.1016/j.jaci.2010.04.010; Palmenberg AC, 2009, SCIENCE, V324, P55, DOI 10.1126/science.1165557; Papadopoulos NG, 2002, CLIN EXP ALLERGY, V32, P537, DOI 10.1046/j.0954-7894.2002.01313.x; Papi A, 2013, J ALLERGY CLIN IMMUN, V132, P1075, DOI 10.1016/j.jaci.2013.05.028; Patel JA, 2010, J INTERF CYTOK RES, V30, P917, DOI 10.1089/jir.2010.0033; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Piralla A, 2012, DIAGN MICR INFEC DIS, V73, P162, DOI 10.1016/j.diagmicrobio.2012.02.019; Rajan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066600; Reibman J, 2003, AM J RESP CELL MOL, V28, P648, DOI 10.1165/rcmb.2002-0095OC; Rose CE, 2003, MICROCIRCULATION, V10, P273, DOI 10.1038/sj.mn.7800193; Rovida E, 2008, CANCER BIOL THER, V7, P1241, DOI 10.4161/cbt.7.8.6636; Royal W, 2012, J NEUROIMMUNOL, V247, P16, DOI 10.1016/j.jneuroim.2012.03.015; Sasaki O, 2013, BBA-MOL CELL RES, V1833, P1017, DOI 10.1016/j.bbamcr.2013.01.010; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Schreiber MT, 2013, INNATE IMMUN-LONDON, V19, P278, DOI 10.1177/1753425912460709; Schroth MK, 1999, AM J RESP CELL MOL, V20, P1220, DOI 10.1165/ajrcmb.20.6.3261; Stockl J, 1999, J CLIN INVEST, V104, P957, DOI 10.1172/JCI7255; Sun L, 2013, CLIN EXP IMMUNOL, V172, P263, DOI 10.1111/cei.12059; Suzuki T, 2001, AM J PHYSIOL-LUNG C, V280, pL409, DOI 10.1152/ajplung.2001.280.3.L409; Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044; Tapparel C, 2013, VIROLOGY, V446, P1, DOI 10.1016/j.virol.2013.06.031; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Tsai TT, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-40; Varga ZT, 2012, J VIROL, V86, P8359, DOI 10.1128/JVI.01122-12; Wang J, 2007, AM J PHYSIOL-LUNG C, V292, pL1495, DOI 10.1152/ajplung.00452.2006; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Wark PAB, 2009, RESPIROLOGY, V14, P180, DOI 10.1111/j.1440-1843.2009.01480.x; Wickert LE, 2014, J LEUKOC BIOL, V14; Xiang ZC, 2010, J INFECTION, V61, P289, DOI 10.1016/j.jinf.2010.07.001; Yoshida H, 2012, LEUKEMIA RES, V36, P735, DOI 10.1016/j.leukres.2012.01.009; Zhu W, 2000, J IMMUNOL, V164, P6349, DOI 10.4049/jimmunol.164.12.6349	76	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93897	10.1371/journal.pone.0093897	http://dx.doi.org/10.1371/journal.pone.0093897			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736642	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600032
J	Susarla, R; Liu, L; Walker, EA; Bujalska, IJ; Alsalem, J; Williams, GP; Sreekantam, S; Taylor, AE; Tallouzi, M; Southworth, HS; Murray, PI; Wallace, GR; Rauz, S				Susarla, Radhika; Liu, Lei; Walker, Elizabeth A.; Bujalska, Iwona J.; Alsalem, Jawaher; Williams, Geraint P.; Sreekantam, Sreekanth; Taylor, Angela E.; Tallouzi, Mohammad; Southworth, H. Susan; Murray, Philip I.; Wallace, Graham R.; Rauz, Saaeha			Cortisol Biosynthesis in the Human Ocular Surface Innate Immune Response	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; GLUCOCORTICOID-RECEPTOR; SJOGRENS-SYNDROME; EPITHELIAL-CELLS; DRY EYE; EXPRESSION; CORNEA; DIFFERENTIATION	Innate immune responses have a critical role in regulating sight-threatening ocular surface (OcS) inflammation. While glucocorticoids (GCs) are frequently used to limit tissue damage, the role of intracrine GC (cortisol) bioavailability via 11-beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) in OcS defense, remains unresolved. We found that primary human corneal epithelial cells (PHCEC), fibroblasts (PHKF) and allogeneic macrophages (M1, GM-CSF; M2, M-CSF) were capable of generating cortisol (M1>PHKF>M2>PHCEC) but in corneal cells, this was independent of Toll-like receptor (TLR) activation. While Poly1:C induced maximal cytokine and chemokine production from both PHCEC (IFN gamma, CCL2, CCL3, and (CCL4), IL6, CXCL10, CCL5, TNF alpha) and PHKF (CCL2, IL-6, CXCL10, CCL5), only PHKF cytokines were inhibited by GCs. Both Poly I:C and LPS challenged-corneal cells induced M1 chemotaxis (greatest LPS-PHKF (250%), but down-regulated M1 11 beta-HSD1 activity (30 and 40% respectively). These data were supported by clinical studies demonstrating reduced human tear film cortisol: cortisone ratios (a biomarker of local 11 beta-HSD1 activity) in pseudomonas keratitis (1:2.9) versus healthy controls (1:1.3; p<0.05). This contrasted with putative TLR3-mediated OcS disease (Stevens-Johnson Syndrome, Mucous membrane pemphigoid) where an increase in cortisol: cortisone ratio was observed (113.8: 1; p<0.05). In summary, cortisol biosynthesis in human corneal cells is independent of TLR activation and is likely to afford immunoprotection under physiological conditions. Contribution to ocular mucosal innate responses is dependent on the aetiology of immunological challenge.	[Susarla, Radhika; Liu, Lei; Alsalem, Jawaher; Williams, Geraint P.; Sreekantam, Sreekanth; Tallouzi, Mohammad; Southworth, H. Susan; Murray, Philip I.; Wallace, Graham R.; Rauz, Saaeha] Univ Birmingham, Acad Unit Ophthalmol, Ctr Translat Inflammat Res, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Walker, Elizabeth A.; Bujalska, Iwona J.; Taylor, Angela E.] Univ Birmingham, Ctr Endocrinol Diabet & Metab, Coll Med & Dent Sci, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Rauz, S (corresponding author), Univ Birmingham, Acad Unit Ophthalmol, Ctr Translat Inflammat Res, Coll Med & Dent Sci, Birmingham, W Midlands, England.	s.rauz@bham.ac.uk	Rauz, Saaeha/ABF-2202-2021	Williams, Geraint/0000-0002-2328-5905; Wallace, Graham/0000-0003-2054-0509; Southworth, Sue/0000-0002-6946-8993; Taylor, Angela, E/0000-0002-5835-5643; Rauz, Saaeha/0000-0003-4627-3496; Murray, Philip/0000-0001-8491-3795	Guide Dogs for the Blind (UK registered Charity in England and Wales) [209617]; Guide Dogs for the Blind (UK registered Charity in Scotland) [SC038979, 2006-01b]; Action Medical Research (UK Registered Charity in England Wales) [208701]; Action Medical Research (UK Registered Charity in Scotland) [SC039284, SP4215]; Henry Smith Charity (UK Registered Charity) [230102]; Wellcome Trust (UK); Academy of Medical Sciences (AMS) [AMS-SGCL10-Liu] Funding Source: researchfish; National Institute for Health Research [CL-2012-25-002] Funding Source: researchfish	Guide Dogs for the Blind (UK registered Charity in England and Wales); Guide Dogs for the Blind (UK registered Charity in Scotland); Action Medical Research (UK Registered Charity in England Wales); Action Medical Research (UK Registered Charity in Scotland); Henry Smith Charity (UK Registered Charity); Wellcome Trust (UK)(Wellcome Trust); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding: Guide Dogs for the Blind (UK registered Charity in England and Wales (209617) and Scotland (SC038979)) ref 2006-01b; Action Medical Research (UK Registered Charity in England & Wales (208701) and in Scotland (SC039284)) ref SP4215; Henry Smith Charity (UK Registered Charity 230102); Wellcome Trust (UK): GPW, SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabino S, 2012, PROGR RETINAL EYE RE; Carpenter S, 2009, BIOCHEM J, V422, P1, DOI 10.1042/BJ20090616; Cascallana JL, 2003, INT J DEV BIOL, V47, P59; Chapman KE, 2006, MOL CELL ENDOCRINOL, V248, P3, DOI 10.1016/j.mce.2005.11.036; Cohen J, 2009, CRIT CARE, V13, DOI 10.1186/cc8184; Cruzat A, 2011, INVEST OPHTH VIS SCI, V52, P5136, DOI 10.1167/iovs.10-7048; Curnow SJ, 2005, INVEST OPHTH VIS SCI, V46, P4251, DOI 10.1167/iovs.05-0444; Denniston AK, 2012, INVEST OPHTH VIS SCI, V53, P888, DOI 10.1167/iovs.11-8802; Denniston AK, 2011, J IMMUNOL, V186, P305, DOI 10.4049/jimmunol.1001450; Draper N, 2003, NAT GENET, V34, P434, DOI 10.1038/ng1214; Flammer JR, 2011, MOL ENDOCRINOL, V25, P1075, DOI 10.1210/me.2011-0068; Forsblad-d'Elia H, 2009, J CLIN ENDOCR METAB, V94, P2044, DOI 10.1210/jc.2009-0106; Frank GM, 2012, J IMMUNOL, V188, P1350, DOI 10.4049/jimmunol.1101968; Freeman L, 2005, BLOOD, V106, P2042, DOI 10.1182/blood-2005-01-0186; Fujishima S, 2009, CLIN IMMUNOL, V133, P208, DOI 10.1016/j.clim.2009.07.006; Gilmour JS, 2006, J IMMUNOL, V176, P7605, DOI 10.4049/jimmunol.176.12.7605; Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x; Gross KL, 2011, MOL ENDOCRINOL, V25, P1087, DOI 10.1210/me.2010-0051; Hardy RS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1993; Hintermann E, 2010, J AUTOIMMUN, V35, P424, DOI 10.1016/j.jaut.2010.09.003; Hori J, 2010, OCUL IMMUNOL INFLAMM, V18, P325, DOI 10.3109/09273948.2010.512696; Hori Junko, 2008, J Ocul Biol Dis Infor, V1, P94, DOI 10.1007/s12177-008-9010-6; Ishii T, 2007, FEBS LETT, V581, P349, DOI 10.1016/j.febslet.2006.11.032; Krone N, 2010, J STEROID BIOCHEM, V121, P496, DOI 10.1016/j.jsbmb.2010.04.010; Li J, 2007, MOL VIS, V13, P813; Li X, 2010, J RHEUMATOL, V37, P316, DOI 10.3899/jrheum.090191; Liu L, 2011, INVEST OPHTH VIS SCI, V52, P7282, DOI 10.1167/iovs.11-7463; Mantelli F, 2007, GRAEF ARCH CLIN EXP, V245, P899, DOI 10.1007/s00417-006-0452-x; Mostafa S, 2012, EXP EYE RES, V96, P88, DOI 10.1016/j.exer.2011.12.016; Nichols KK, 2011, INVEST OPHTH VIS SCI, V52, P1922, DOI 10.1167/iovs.10-6997a; Niederkorn JY, 2010, OCUL IMMUNOL INFLAMM, V18, P162, DOI 10.3109/09273948.2010.486100; Onyimba CU, 2006, J ENDOCRINOL, V190, P483, DOI 10.1677/joe.1.06840; Pan JP, 2001, IMMUNOL LETT, V76, P153, DOI 10.1016/S0165-2478(01)00183-3; Perogamvros I, 2009, J CHROMATOGR B, V877, P3771, DOI 10.1016/j.jchromb.2009.09.014; Piemonti L, 1999, J IMMUNOL, V162, P6473; Rauz S, 2003, QJM-INT J MED, V96, P481, DOI 10.1093/qjmed/hcg085; Rauz S, 2003, EXP EYE RES, V77, P101, DOI 10.1016/S0014-4835(03)00088-5; Rauz S, 2001, INVEST OPHTH VIS SCI, V42, P2037; Redfern RL, 2013, INVEST OPHTH VIS SCI, V54, P1554, DOI 10.1167/iovs.12-10739; Sinclair AJ, 2010, J CLIN ENDOCR METAB, V95, P5348, DOI 10.1210/jc.2010-0729; Song PI, 2001, INVEST OPHTH VIS SCI, V42, P2867; Stewart PM, 1996, CLIN ENDOCRINOL, V44, P493, DOI 10.1046/j.1365-2265.1996.716535.x; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Thieringer R, 2001, J IMMUNOL, V167, P30, DOI 10.4049/jimmunol.167.1.30; Tomlinson JW, 2010, J CLIN ENDOCR METAB, V95, P398, DOI 10.1210/jc.2009-0873; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Tomlinson JW, 2000, ENDOCR RES, V26, P711, DOI 10.3109/07435800009048591; Ueta M, 2005, BIOCHEM BIOPH RES CO, V331, P285, DOI 10.1016/j.bbrc.2005.02.196; Ueta M, 2007, BRIT J OPHTHALMOL, V91, P962, DOI 10.1136/bjo.2006.113449; Ueta M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043650; Ueta M, 2010, BRIT J OPHTHALMOL, V94, P1528, DOI 10.1136/bjo.2010.180554; Ueta M, 2010, BRAIN RES BULL, V81, P219, DOI 10.1016/j.brainresbull.2009.10.001; White PC, 1997, ENDOCR REV, V18, P135, DOI 10.1210/er.18.1.135; Wllliams GP, 2013, INVEST OPHTHALMOL, DOI [10.1167/iovs.1113-11859, DOI 10.1167/IOVS.1113-11859]; Xia CQ, 2005, SCAND J IMMUNOL, V62, P45, DOI 10.1111/j.1365-3083.2005.01640.x; Yakirevich E, 2011, HUMAN PATHO IN PRESS; Zhang J, 2003, INVEST OPHTH VIS SCI, V44, P4247, DOI 10.1167/iovs.03-0219; Zizzo G, 2013, J IMMUNOL, V190, P5237, DOI 10.4049/jimmunol.1203017	58	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94913	10.1371/journal.pone.0094913	http://dx.doi.org/10.1371/journal.pone.0094913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736562	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600106
J	Vanstreels, RET; Kolesnikovas, CKM; Sandri, S; Silveira, P; Belo, NO; Ferreira, FC; Epiphanio, S; Steindel, M; Braga, EM; Catao-Dias, JL				Thijl Vanstreels, Ralph Eric; Kolesnikovas, Cristiane K. M.; Sandri, Sandro; Silveira, Patricia; Belo, Nayara O.; Ferreira Junior, Francisco C.; Epiphanio, Sabrina; Steindel, Mario; Braga, Erika M.; Catao-Dias, Jose Luiz			Outbreak of Avian Malaria Associated to Multiple Species of Plasmodium in Magellanic Penguins Undergoing Rehabilitation in Southern Brazil	PLOS ONE			English	Article							SPHENISCUS-HUMBOLDTI; HEALTH EVALUATION; BLOOD PARASITES; MOLECULAR CHARACTERIZATION; STRIX-ALUCO; HAEMOPROTEUS; MORTALITY; WILD; IDENTIFICATION; INFECTIONS	Avian malaria is a mosquito-borne disease caused by Plasmodium spp. Avian plasmodia are recognized conservation-threatening pathogens due to their potential to cause severe epizootics when introduced to bird populations with which they did not co-evolve. Penguins are considered particularly susceptible, as outbreaks in captive populations will often lead to high morbidity and rapid mortality. We used a multidisciplinary approach to investigate an outbreak of avian malaria in 28 Magellanic penguins (Spheniscus magellanicus) at a rehabilitation center during summer 2009 in Florianopolis, Brazil. Hemosporidian infections were identified by microscopic and molecular characterization in 64% (18/28) of the penguins, including Plasmodium (Haemamoeba) tejerai, Plasmodium (Huffia) elongatum, a Plasmodium (Haemamoeba) sp. lineage closely related to Plasmodium cathemerium, and a Haemoproteus (Parahaemoproteus) sp. lineage closely related to Haemoproteus syrnii. P. tejerai played a predominant role in the studied outbreak and was identified in 72% (13/18) of the hemosporidian-infected penguins, and in 89% (8/9) of the penguins that died, suggesting that this is a highly pathogenic parasite for penguins; a detailed description of tissue meronts and lesions is provided. Mixed infections were identified in three penguins, and involved P. elongatum and either P. tejerai or P. (Haemamoeba) sp. that were compatible with P. tejerai but could not be confirmed. In total, 32% (9/28) penguins died over the course of 16 days despite oral treatment with chloroquine followed by sulfadiazine-trimethoprim. Hemosporidian infections were considered likely to have occurred during rehabilitation, probably from mosquitoes infected while feeding on local native birds, whereas penguin-mosquito-penguin transmission may have played a role in later stages of the outbreak. Considering the seasonality of the infection, rehabilitation centers would benefit from narrowing their efforts to prevent avian malaria outbreaks to the penguins that are maintained throughout summer.	[Thijl Vanstreels, Ralph Eric; Catao-Dias, Jose Luiz] Univ Sao Paulo, Lab Patol Comparada Anim Selvagen, Dept Patol, Fac Med Vet & Zootecnia, Sao Paulo, Brazil; [Kolesnikovas, Cristiane K. M.; Sandri, Sandro] Assoc R3 Anim, Florianopolis, SC, Brazil; [Silveira, Patricia; Belo, Nayara O.; Ferreira Junior, Francisco C.; Braga, Erika M.] Univ Fed Minas Gerais, Dept Parasitol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Epiphanio, Sabrina] Univ Sao Paulo, Dept Anal Clin & Toxicol, Fac Ciencias Farmaceut, Sao Paulo, Brazil; [Steindel, Mario] Univ Fed Santa Catarina, Lab Protozool, Dept Microbiol & Parasitol, Ctr Ciencias Biol, Florianopolis, SC, Brazil	Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Universidade de Sao Paulo; Universidade Federal de Santa Catarina (UFSC)	Vanstreels, RET (corresponding author), Univ Sao Paulo, Lab Patol Comparada Anim Selvagen, Dept Patol, Fac Med Vet & Zootecnia, Sao Paulo, Brazil.	ralph_vanstreels@yahoo.com.br	Belo, Nayara/ABE-3106-2021; Steindel, Mario/N-2040-2018; Vanstreels, Ralph/H-8029-2015; Steindel, Mario/H-2945-2015; CATÃO-DIAS, JOSE LUIZ/C-4897-2012; Ferreira, Francisco C./G-4013-2017; Braga, Erika Martins/A-6776-2008; Epiphanio, Sabrina/C-7572-2012; Belo, nayara Oliveira/H-1657-2012	Steindel, Mario/0000-0002-2768-7469; Steindel, Mario/0000-0002-2768-7469; CATÃO-DIAS, JOSE LUIZ/0000-0003-2999-3395; Ferreira, Francisco C./0000-0002-2034-4121; Braga, Erika Martins/0000-0001-5550-7157; Epiphanio, Sabrina/0000-0001-6094-9750; , nayara/0000-0003-1719-7404	Sao Paulo Research Foundation [FAPESP 2009/53956-9, 2010/51801-5]; Minas Gerais Research Foundation (FAPEMIG); Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES); National Counsel of Technological and Scientific Development (CNPq)	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Minas Gerais Research Foundation (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Sao Paulo Research Foundation (FAPESP 2009/53956-9, 2010/51801-5), Minas Gerais Research Foundation (FAPEMIG), Brazilian Federal Agency for the Support and Evaluation of Graduate Education (CAPES) and National Counsel of Technological and Scientific Development (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CT, 2009, J AVIAN MED SURG, V23, P53, DOI 10.1647/2008-059.1; Atkinson CT, 2001, J WILDLIFE DIS, V37, P20, DOI 10.7589/0090-3558-37.1.20; Atkinson CT, 1991, BIRD PARASITE INTERA, P19; BAK U-B, 1984, Korean Journal of Parasitology, V22, P267, DOI 10.3347/kjp.1984.22.2.267; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bueno MG, 2010, VET PARASITOL, V173, P123, DOI 10.1016/j.vetpar.2010.06.026; Cannell BL, 2013, VET PARASITOL, V197, P74, DOI 10.1016/j.vetpar.2013.04.025; Carbo R. L., 1965, Revista Veterinaria Venezolana, V18, P185; COMITE BRASILEIRO DE REGISTROS ORNITOLOGICOS, 2011, LIST AV BRAS; CRANFIELD MR, 1994, J WILDLIFE DIS, V30, P372, DOI 10.7589/0090-3558-30.3.372; Fantham HB, 1944, P ZOOL SOC LOND, V114, P279; Fernandes Chagas Carolina Romeiro, 2013, International Journal for Parasitology Parasites and Wildlife, V2, P286, DOI 10.1016/j.ijppaw.2013.09.008; FIX AS, 1988, J WILDLIFE DIS, V24, P610, DOI 10.7589/0090-3558-24.4.610; FLEISCHMAN RW, 1968, J AM VET MED ASSOC, V153, P928; Galbadon A, 1977, B DIR MALARIOL SAN A, V17, P255; Garcia-Borboroglu P, 2006, MAR POLLUT BULL, V52, P193, DOI 10.1016/j.marpolbul.2005.11.004; Garcia-Borboroglu P, 2010, MAR POLLUT BULL, V60, P1652, DOI 10.1016/j.marpolbul.2010.07.006; Gardiner CH, 1998, ATLAS PROTOZOAN PARA; Gering E, 2004, J PARASITOL, V90, P879, DOI 10.1645/GE-222R; GODFREY RD, 1987, J WILDLIFE DIS, V23, P558, DOI 10.7589/0090-3558-23.4.558; GRACZYK TK, 1994, PARASITOL RES, V80, P634, DOI 10.1007/BF00932944; Grim KC, 2003, J ZOO WILDLIFE MED, V34, P250, DOI 10.1638/02-070; Griner LA, 1967, AM J VET CLIN PATHOL, V1, P7; GRUNBERG W, 1963, ZBL BAKT PARASIT, V189, P511; HAWKEY CM, 1989, AVIAN PATHOL, V18, P495, DOI 10.1080/03079458908418621; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; HERMAN C M, 1968, Bulletin of the Wildlife Disease Association, V4, P132; Huff CG, 1942, J INFECT DIS, V71, P18, DOI 10.1093/infdis/71.1.18; HUFF CG, 1962, J PARASITOL, V48, P495, DOI 10.2307/3275227; International Union for Conservation of Nature, 2013, IUCN RED LIST THREAT; Ishak HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002304; Jones H. I., 1999, Marine Ornithology, V27, P181; Jones HI, 1999, POLAR BIOL, V21, P5, DOI 10.1007/s003000050327; Jovani R, 2001, WATERBIRDS, V24, P430, DOI 10.2307/1522076; Karadjian G, 2013, PARASITE, V20, DOI 10.1051/parasite/2013031; Karesh WB, 1999, J ZOO WILDLIFE MED, V30, P25; Keymer IF, 2001, DIS AQUAT ORGAN, V45, P159, DOI 10.3354/dao045159; Ko Kyeong-Nam, 2008, [Korean J. of Veterinary Research, 대한수의학회지], V48, P197; Laird M., 1981, Parasitological topics -- a presentation volume to P.C.C. Garnham, F.R.S. on the occasion of his 80th birthday, 1981., P159; Levin II, 2013, CONSERV BIOL, V27, P1366, DOI 10.1111/cobi.12127; Levin II, 2009, BIOL CONSERV, V142, P3191, DOI 10.1016/j.biocon.2009.06.017; Miller G. D., 2001, Marine Ornithology, V29, P43; Outlaw DC, 2011, P NATL ACAD SCI USA, V108, P13183, DOI 10.1073/pnas.1109153108; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quillfeldt P, 2010, NATURWISSENSCHAFTEN, V97, P809, DOI 10.1007/s00114-010-0698-3; Raethel H. S., 1960, Kleintier-Praxis, V5, P64; Ramos A.M., 2009, NORMAIS CLIMATOLOGIC; Remple JD, 2004, J AVIAN MED SURG, V18, P75, DOI 10.1647/2003-008; Ribeiro SF, 2005, PARASITOLOGY, V130, P261, DOI 10.1017/S0031182004006596; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; RODHAIN J., 1939, ANN PARASITOL HUMAINE ET COMP, V17, P139; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Silva-Filho RP, 2007, TRATADO ANIMAIS SELV, P309; Silveira P, 2013, PARASITOL INT, V62, P165, DOI 10.1016/j.parint.2012.12.004; Sladen W.J.L., 1979, International Zoo Yearbook, V19, P202, DOI 10.1111/j.1748-1090.1979.tb00565.x; Smith KM, 2008, AVIAN DIS, V52, P130, DOI 10.1637/8265-071007-Reg; STOSKOPF MK, 1979, J AM VET MED ASSOC, V175, P944; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valkiunas G, 2005, AVIAN MALARIA PARASI; Valkiunas G, 2008, PARASITOL RES, V102, P1185, DOI 10.1007/s00436-008-0892-9; Valkiunas G, 2009, J PARASITOL, V95, P1512, DOI 10.1645/GE-2105.1; Valkiunas G, 2008, TRENDS PARASITOL, V24, P247, DOI 10.1016/j.pt.2008.03.004; WALLACE RS, 1995, ZOO BIOL, V14, P311, DOI 10.1002/zoo.1430140403; Williams RB, 2005, AVIAN PATHOL, V34, P29, DOI 10.1080/03079450400025430; Yildirim A, 2013, ANKARA UNIV VET FAK, V60, P179, DOI 10.1501/Vetfak_0000002575; Garamszegi LZ, 2010, J PARASITOL, V96, P1197, DOI 10.1645/GE-2531.1	68	44	44	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94994	10.1371/journal.pone.0094994	http://dx.doi.org/10.1371/journal.pone.0094994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736326	gold, Green Published			2022-12-25	WOS:000336922600120
J	Trewby, ID; Young, R; McDonald, RA; Wilson, GJ; Davison, J; Walker, N; Robertson, A; Doncaster, CP; Delahay, RJ				Trewby, Iain D.; Young, Richard; McDonald, Robbie A.; Wilson, Gavin J.; Davison, John; Walker, Neil; Robertson, Andrew; Doncaster, C. Patrick; Delahay, Richard J.			Impacts of Removing Badgers on Localised Counts of Hedgehogs	PLOS ONE			English	Article							ERINACEUS-EUROPAEUS; INTRAGUILD PREDATION; MESOPREDATOR RELEASE; MELES-MELES; CONSERVATION; ABUNDANCE; TUBERCULOSIS; POPULATIONS; CARNIVORES; EFFICACY	Experimental evidence of the interactions among mammalian predators that eat or compete with one another is rare, due to the ethical and logistical challenges of managing wild populations in a controlled and replicated way. Here, we report on the opportunistic use of a replicated and controlled culling experiment (the Randomised Badger Culling Trial) to investigate the relationship between two sympatric predators: European badgers Meles meles and western European hedgehogs Erinaceus europaeus. In areas of preferred habitat (amenity grassland), counts of hedgehogs more than doubled over a 5-year period from the start of badger culling (from 0.9 ha(-1) pre-cull to 2.4 ha(-1) post-cull), whereas hedgehog counts did not change where there was no badger culling (0.3-0.3 hedgehogs ha(-1)). This trial provides experimental evidence for mesopredator release as an outcome of management of a top predator.	[Trewby, Iain D.; Wilson, Gavin J.; Walker, Neil; Delahay, Richard J.] Anim Hlth & Vet Labs Agcy, Natl Wildlife Management Ctr, Addlestone, Surrey, England; [Young, Richard] Durrell Wildlife Conservat Trust, Jersey, Channel Islands, England; [McDonald, Robbie A.; Robertson, Andrew] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Davison, John] Univ Tartu, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia; [Doncaster, C. Patrick] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England	Veterinary Laboratories Agency; University of Exeter; University of Tartu; Tartu University Institute of Ecology & Earth Sciences; University of Southampton	Trewby, ID (corresponding author), Anim Hlth & Vet Labs Agcy, Natl Wildlife Management Ctr, Addlestone, Surrey, England.	iaintrewby@yahoo.co.uk	McDonald, Robbie A/A-2931-2012; Delahay, Richard/J-2261-2014; Delahay, Richard/GSI-4663-2022; Wilson, Gavin/J-5409-2014; Robertson, Andrew/A-4944-2016; Doncaster, C. Patrick/AAT-7621-2020; McDonald, Robbie/AAK-2718-2020	McDonald, Robbie A/0000-0002-6922-3195; Robertson, Andrew/0000-0003-3720-6670; Doncaster, C. Patrick/0000-0001-9406-0693; McDonald, Robbie/0000-0002-6922-3195; Young, Richard/0000-0002-6515-6343	United Kingdom Government's Department for Environment, Food and Rural Affairs	United Kingdom Government's Department for Environment, Food and Rural Affairs	The study was funded by the United Kingdom Government's Department for Environment, Food and Rural Affairs (http://www.defra.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne J., 2007, BOVINE TB SCI EVIDEN; Chakarov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015229; Crooks KR, 1999, NATURE, V400, P563, DOI 10.1038/23028; DONCASTER CP, 1992, P ROY SOC B-BIOL SCI, V249, P113, DOI 10.1098/rspb.1992.0092; DONCASTER CP, 1994, OIKOS, V69, P182, DOI 10.2307/3546136; Donnelly CA, 2006, NATURE, V439, P843, DOI 10.1038/nature04454; Dowding CV, 2010, ANIM BEHAV, V80, P13, DOI 10.1016/j.anbehav.2010.04.007; Haigh AJ, 2011, ECOLOGY EUROPEAN HED; Hof AR, 2010, ANIM CONSERV, V13, P467, DOI 10.1111/j.1469-1795.2010.00359.x; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; Jackson DB, 2000, BIOL CONSERV, V93, P333, DOI 10.1016/S0006-3207(99)00135-4; Jones C, 2005, NEW ZEAL J ECOL, V29, P29; Letnic M, 2011, ECOGRAPHY, V34, P827, DOI 10.1111/j.1600-0587.2010.06516.x; Levi T, 2012, ECOLOGY, V93, P921, DOI 10.1890/11-0165.1; MICOL T, 1994, J ANIM ECOL, V63, P851, DOI 10.2307/5262; Morris DW, 2005, ECOLOGY, V86, P2568, DOI 10.1890/04-0909; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Prugh LR, 2009, BIOSCIENCE, V59, P779, DOI 10.1525/bio.2009.59.9.9; Reeve N., 1994, HEDGEHOGS T AD POYSE; Ripple WJ, 2013, BIOL CONSERV, V160, P70, DOI 10.1016/j.biocon.2012.12.033; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Salo P, 2008, J ANIM ECOL, V77, P1092, DOI 10.1111/j.1365-2656.2008.01430.x; Salo P, 2010, ECOL MONOGR, V80, P531, DOI 10.1890/09-1260.1; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; Smith GC, 2007, VET REC, V160, P723, DOI 10.1136/vr.160.21.723; SOULE M E, 1988, Conservation Biology, V2, P75, DOI 10.1111/j.1523-1739.1988.tb00337.x; Trewby ID, 2008, BIOL LETTERS, V4, P170, DOI 10.1098/rsbl.2007.0516; Wallach AD, 2010, ECOL LETT, V13, P1008, DOI 10.1111/j.1461-0248.2010.01492.x; Woodroffe R, 2006, J APPL ECOL, V43, P1, DOI 10.1111/j.1365-2664.2005.01144.x; Young RP, 2006, J ZOOL, V269, P349, DOI 10.1111/j.1469-7998.2006.00078.x; Young RP, 2005, THESIS U SOUTHAMPTON	31	29	29	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95477	10.1371/journal.pone.0095477	http://dx.doi.org/10.1371/journal.pone.0095477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736454	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600182
J	Zhang, MA; Mao, WH; Zhang, GP; Wu, FB				Zhang, Mian; Mao, Weihua; Zhang, Guoping; Wu, Feibo			Development and Characterization of Polymorphic EST-SSR and Genomic SSR Markers for Tibetan Annual Wild Barley	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; TRANSFERABILITY; DIVERSITY; DIFFERENCE; STRESS; RICE	Tibetan annual wild barley is rich in genetic variation. This study was aimed at the exploitation of new SSRs for the genetic diversity and phylogenetic analysis of wild barley by data mining. We developed 49 novel EST-SSRs and confirmed 20 genomic SSRs for 80 Tibetan annual wild barley and 16 cultivated barley accessions. A total of 213 alleles were generated from 69 loci with an average of 3.14 alleles per locus. The trimeric repeats were the most abundant motifs (40.82%) among the EST-SSRs, while the majority of the genomic SSRs were di-nuleotide repeats. The polymorphic information content (PIC) ranged from 0.08 to 0.75 with a mean of 0.46. Besides this, the expected heterozygosity (He) ranged from 0.0854 to 0.7842 with an average of 0.5279. Overall, the polymorphism of genomic SSRs was higher than that of EST-SSRs. Furthermore, the number of alleles and the PIC of wild barley were both higher than that of cultivated barley, being 3.12 vs 2.59 and 0.44 vs 0.37. Indicating more polymorphism existed in the Tibetan wild barley than in cultivated barley. The 96 accessions were divided into eight subpopulations based on 69 SSR markers, and the cultivated genotypes can be clearly separated from wild barleys. A total of 47 SSR-containing EST unigenes showed significant similarities to the known genes. These EST-SSR markers have potential for application in germplasm appraisal, genetic diversity and population structure analysis, facilitating marker-assisted breeding and crop improvement in barley.	[Zhang, Mian; Zhang, Guoping; Wu, Feibo] Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Mao, Weihua] Zhejiang Univ, Ctr Anal & Measurement, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wu, FB (corresponding author), Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.	wufeibo@zju.edu.cn		Wu, Feibo/0000-0001-8797-3398	National Natural Science Foundation of China [31171488]; National 863 Program [2012AA101105]; Key Research Foundation of Science and Technology Department of Zhejiang Province of China [2012C12902-2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program(National High Technology Research and Development Program of China); Key Research Foundation of Science and Technology Department of Zhejiang Province of China	The project was supported by National Natural Science Foundation of China (31171488), the National 863 Program (2012AA101105), and the Key Research Foundation of Science and Technology Department of Zhejiang Province of China (2012C12902-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Castillo A, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-97; Dai F, 2012, P NATL ACAD SCI USA, V109, P16969, DOI 10.1073/pnas.1215265109; Dai HX, 2011, J PLANT NUTR SOIL SC, V174, P952, DOI 10.1002/jpln.201100148; Ellis RP, 2000, J EXP BOT, V51, P9, DOI 10.1093/jexbot/51.342.9; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gupta P. K., 2004, Functional & Integrative Genomics, V4, P139, DOI 10.1007/s10142-004-0107-0; Jaikishan I, 2010, PLANT BREEDING, V129, P108, DOI 10.1111/j.1439-0523.2009.01633.x; Jin XL, 2011, J CEREAL SCI, V53, P59, DOI 10.1016/j.jcs.2010.09.006; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Li L, 2008, PROG NAT SCI-MATER, V18, P1485, DOI 10.1016/j.pnsc.2008.05.012; Li M, 2012, MOLECULES, V17, P10716, DOI 10.3390/molecules170910716; Mian MAR, 2005, GENOME, V48, P637, DOI [10.1139/g05-029, 10.1139/G05-029]; Michalek W, 2002, THEOR APPL GENET, V104, P97, DOI 10.1007/s001220200011; Mohan A, 2007, CROP SCI, V47, pS3, DOI [10.2135/cropsci2006.05.0322, 10.2135/cropsci2006-06-0376tpg]; Nevo E, 1997, HEREDITY, V78, P373, DOI 10.1038/hdy.1997.60; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Pritchard JK, 2000, GENETICS, V155, P945; Ren XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062700; Russell J, 2004, GENOME, V47, P389, DOI [10.1139/G03-125, 10.1139/g03-125]; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Sun DF, 2011, EUPHYTICA, V178, P31, DOI 10.1007/s10681-010-0260-6; Tang JF, 2006, EUPHYTICA, V151, P87, DOI 10.1007/s10681-006-9131-6; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Willsmore KL, 2006, AUST J AGR RES, V57, P953, DOI 10.1071/AR05384; Wu DZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022938; Xie WG, 2010, BIOCHEM SYST ECOL, V38, P740, DOI 10.1016/j.bse.2010.06.009; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94; Zhang Qifa, 1992, Acta Genetica Sinica, V19, P236; Zhao J, 2010, EUPHYTICA, V172, P395, DOI 10.1007/s10681-009-0064-8	32	40	42	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94881	10.1371/journal.pone.0094881	http://dx.doi.org/10.1371/journal.pone.0094881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736399	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600101
J	Conroy, PJ; Law, RHP; Gilgunn, S; Hearty, S; Caradoc-Davies, TT; Lloyd, G; O'Kennedy, RJ; Whisstock, JC				Conroy, Paul J.; Law, Ruby H. P.; Gilgunn, Sarah; Hearty, Stephen; Caradoc-Davies, Tom T.; Lloyd, Gordon; O'Kennedy, Richard J.; Whisstock, James C.			Reconciling the Structural Attributes of Avian Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; Cardiovascular Disease; Prostate Cancer; Recombinant Protein Expression; Surface Plasmon Resonance (SPR); X-ray Crystallography; Chicken; Prostate-specific Antigen; Recombinant Antibody; Cardiac Troponin I	RECOMBINANT ANTIBODIES; CHICKEN; PROTEIN; GENE; REPERTOIRE; GENERATION; FRAGMENTS; REVEALS; REGIONS; DISEASE	Background: Antibodies from alternative immune hosts provide insights into novel mechanisms of antibody diversity in restricted germ-line repertoires. Results: The high-resolution crystal structures of the first two chicken single chain antibodies (scFv) with prototypical binding sites are described. Conclusion: Chickens exhibit unique canonical classes in the CDRL1. Significance: Aves employ distinct mechanisms to generate diversity resulting in unique binding-site topologies. Antibodies are high value therapeutic, diagnostic, biotechnological, and research tools. Combinatorial approaches to antibody discovery have facilitated access to unique antibodies by surpassing the diversity limitations of the natural repertoire, exploitation of immune repertoires from multiple species, and tailoring selections to isolate antibodies with desirable biophysical attributes. The V-gene repertoire of the chicken does not utilize highly diverse sequence and structures, which is in stark contrast to the mechanism employed by humans, mice, and primates. Recent exploitation of the avian immune system has generated high quality, high affinity antibodies to a wide range of antigens for a number of therapeutic, diagnostic and biotechnological applications. Furthermore, extensive examination of the amino acid characteristics of the chicken repertoire has provided significant insight into mechanisms employed by the avian immune system. A paucity of avian antibody crystal structures has limited our understanding of the structural consequences of these uniquely chicken features. This paper presents the crystal structure of two chicken single chain fragment variable (scFv) antibodies generated from large libraries by phage display against important human antigen targets, which capture two unique CDRL1 canonical classes in the presence and absence of a non-canonical disulfide constrained CDRH3. These structures cast light on the unique structural features of chicken antibodies and contribute further to our collective understanding of the unique mechanisms of diversity and biochemical attributes that render the chicken repertoire of particular value for antibody generation.	[Conroy, Paul J.; Law, Ruby H. P.; Lloyd, Gordon; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Fac Med Nursing & Hlth Sci, Melbourne, Vic 3800, Australia; [Gilgunn, Sarah; O'Kennedy, Richard J.] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland; [Hearty, Stephen; O'Kennedy, Richard J.] Dublin City Univ, Biomed Diagnost Inst, Natl Ctr Sensor Res, Dublin 9, Ireland; [Caradoc-Davies, Tom T.] Australian Synchrotron, Melbourne, Vic 3168, Australia	Monash University; Dublin City University; Dublin City University	O'Kennedy, RJ (corresponding author), Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland.	richard.okennedy@dcu.ie; james.whisstock@monash.edu	Conroy, Paul/L-1320-2019	Conroy, Paul/0000-0002-9748-4704; Gilgunn, Sarah/0000-0003-3547-5228; Whisstock, James/0000-0003-4200-5611; law, ruby/0000-0001-5432-5781	Science Foundation Ireland (SFI) under Centres for Science Engineering and Technology (CSET) [10/CE/B1821]; SFI Short-term Travel Fellowship; Australian Research Council; National Health and Medical Research Council; Irish Cancer Society program Grant, as part of Prostate Cancer Research Consortium, Dublin, Ireland [PCI11WAT]	Science Foundation Ireland (SFI) under Centres for Science Engineering and Technology (CSET)(Science Foundation Ireland); SFI Short-term Travel Fellowship(Science Foundation Ireland); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Irish Cancer Society program Grant, as part of Prostate Cancer Research Consortium, Dublin, Ireland	This work was supported by the Science Foundation Ireland (SFI) under Centres for Science Engineering and Technology (CSET) Grant 10/CE/B1821 (to P. J. C., S. H., and R. O. K.) and a SFI Short-term Travel Fellowship (to P. J. C.).; Supported by Australian Research Council and National Health and Medical Research Council grants.; Supported by the Irish Cancer Society program Grant PCI11WAT, as part of the Prostate Cancer Research Consortium, Dublin, Ireland.	Abhinandan KR, 2008, MOL IMMUNOL, V45, P3832, DOI 10.1016/j.molimm.2008.05.022; Abhinandan KR, 2010, PROTEIN ENG DES SEL, V23, P689, DOI 10.1093/protein/gzq043; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Almagro JC, 2012, J MOL RECOGNIT, V25, P125, DOI 10.1002/jmr.1168; Andris-Widhopf J, 2000, J IMMUNOL METHODS, V242, P159, DOI 10.1016/S0022-1759(00)00221-0; Ayyar BV, 2010, ANAL BIOCHEM, V407, P165, DOI 10.1016/j.ab.2010.07.033; Bowes T, 2011, J BIOMOL SCREEN, V16, P744, DOI 10.1177/1087057111407067; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Chailyan A, 2011, PROTEINS, V79, P1513, DOI 10.1002/prot.22979; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Colwill K, 2011, NAT METHODS, V8, P551, DOI [10.1038/NMETH.1607, 10.1038/nmeth.1607]; Conroy PJ, 2012, PROTEIN ENG DES SEL, V25, P295, DOI 10.1093/protein/gzs018; Conroy PJ, 2009, SEMIN CELL DEV BIOL, V20, P10, DOI 10.1016/j.semcdb.2009.01.010; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Finlay WJJ, 2006, APPL ENVIRON MICROB, V72, P3343, DOI 10.1128/AEM.72.5.3343-3349.2006; Finlay WJJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00342; Fitzgerald J, 2011, ANAL BIOCHEM, V410, P27, DOI 10.1016/j.ab.2010.11.009; Foord AJ, 2007, J IMMUNOL METHODS, V321, P142, DOI 10.1016/j.jim.2007.01.014; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; Govaert J, 2012, J BIOL CHEM, V287, P1970, DOI 10.1074/jbc.M111.242818; Hearty Stephen, 2011, Bioeng Bugs, V2, P182; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hu ZQ, 2013, ANAL CHIM ACTA, V764, P84, DOI 10.1016/j.aca.2012.12.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lerner RA, 2006, ANGEW CHEM INT EDIT, V45, P8106, DOI 10.1002/anie.200603381; McDonnell B, 2011, ANAL BIOCHEM, V410, P1, DOI 10.1016/j.ab.2010.09.039; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Morea V, 1998, J MOL BIOL, V275, P269, DOI 10.1006/jmbi.1997.1442; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Olsson N, 2012, PROTEIN SCI, V21, P1897, DOI 10.1002/pro.2173; Raghunathan G, 2012, J MOL RECOGNIT, V25, P103, DOI 10.1002/jmr.2158; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Reichert JM, 2013, MABS-AUSTIN, V5, P1, DOI 10.4161/mabs.22976; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1994, ADV IMMUNOL, V57, P353, DOI 10.1016/S0065-2776(08)60676-8; Safdari Y, 2013, BIOTECHNOL GENET ENG, V29, P175, DOI 10.1080/02648725.2013.801235; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Shih HH, 2012, J BIOL CHEM, V287, P44425, DOI 10.1074/jbc.M112.415935; Shirai H, 1996, FEBS LETT, V399, P1, DOI 10.1016/S0014-5793(96)01252-5; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong SE, 2011, PROTEINS, V79, P821, DOI 10.1002/prot.22920; Wu LY, 2012, J IMMUNOL, V188, P322, DOI 10.4049/jimmunol.1102466; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211	51	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15384	15392		10.1074/jbc.M114.562470	http://dx.doi.org/10.1074/jbc.M114.562470			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737329	hybrid, Green Published			2022-12-25	WOS:000337465400022
J	Jenkins, RJ; Heslip, KA; Meagher, JL; Stuckey, JA; Dotson, GD				Jenkins, Ronald J.; Heslip, Kyle A.; Meagher, Jennifer L.; Stuckey, Jeanne A.; Dotson, Garry D.			Structural Basis for the Recognition of Peptide RJPXD33 by Acyltransferases in Lipid A Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acyl Carrier Protein (ACP); Antimicrobial Peptide (AMP); Enzyme Inhibitor; Lipopolysaccharide (LPS); Peptides; X-ray Crystallography; Acyltransferase; Lipid A; LpxA	N-ACETYLGLUCOSAMINE ACYLTRANSFERASE; PROTEIN-PROTEIN INTERACTIONS; ACYL-CHAIN SELECTIVITY; ESCHERICHIA-COLI; STRUCTURE VALIDATION; 1ST STEP; IDENTIFICATION; MOLPROBITY; NUCLEOTIDE; ASSAY	UDP-N-acetylglucosamine acyltransferase (LpxA) and UDP-3-O-(acyl)-glucosamine acyltransferase (LpxD) constitute the essential, early acyltransferases of lipid A biosynthesis. Recently, an antimicrobial peptide inhibitor, RJPXD33, was identified with dual affinity for LpxA and LpxD. To gain a fundamental understanding of the molecular basis of inhibitor binding, we determined the crystal structure of LpxA from Escherichia coli in complex with RJPXD33 at 1.9 resolutions. Our results suggest that the peptide binds in a unique modality that mimics (R)--hydroxyacyl pantetheine binding to LpxA and displays how the peptide binds exclusive of the native substrate, acyl-acyl carrier protein. Acyltransferase binding studies with photo-labile RJPXD33 probes and truncations of RJPXD33 validated the structure and provided fundamental insights for future design of small molecule inhibitors. Overlay of the LpxA-RJPXD33 structure with E. coli LpxD identified a complementary peptide binding pocket within LpxD and serves as a model for further biochemical characterization of RJPXD33 binding to LpxD.	[Jenkins, Ronald J.; Heslip, Kyle A.; Dotson, Garry D.] Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA; [Meagher, Jennifer L.; Stuckey, Jeanne A.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Dotson, GD (corresponding author), Univ Michigan, Coll Pharm, Dept Med Chem, Ann Arbor, MI 48109 USA.	gdotson@umich.edu			United States Department of Energy [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008597] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817). We thank Dr. David Smith of LS-CAT for help with remote data collection.	ANDERSON MS, 1993, J BIOL CHEM, V268, P19858; Bartling CM, 2009, BIOCHEMISTRY-US, V48, P8672, DOI 10.1021/bi901025v; Benson RE, 2003, ANTIMICROB AGENTS CH, V47, P2875, DOI 10.1128/AAC.47.9.2875-2881.2003; Bricogne G., 2011, BUSTER; Buetow L, 2007, P NATL ACAD SCI USA, V104, P4321, DOI 10.1073/pnas.0606356104; Chan WC, 2000, FMOC SOLID PHASE PEP; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hughes RM, 2006, J AM CHEM SOC, V128, P13586, DOI 10.1021/ja0648460; Janz JM, 2011, J AM CHEM SOC, V133, P15878, DOI 10.1021/ja206661w; Jenkins RJ, 2012, ACS CHEM BIOL, V7, P1170, DOI 10.1021/cb300094a; Jenkins RJ, 2012, ANAL BIOCHEM, V425, P21, DOI 10.1016/j.ab.2012.02.027; KELLY TM, 1993, J BIOL CHEM, V268, P19866; MAJERUS PW, 1965, P NATL ACAD SCI USA, V53, P410, DOI 10.1073/pnas.53.2.410; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Onishi HR, 1996, SCIENCE, V274, P980, DOI 10.1126/science.274.5289.980; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Robins LI, 2009, BIOCHEMISTRY-US, V48, P6191, DOI 10.1021/bi900629e; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Ulaganathan V, 2007, J MOL BIOL, V369, P305, DOI 10.1016/j.jmb.2007.03.039; VAARA M, 1993, ANTIMICROB AGENTS CH, V37, P354, DOI 10.1128/AAC.37.2.354; Vaara M, 1996, SCIENCE, V274, P939, DOI 10.1126/science.274.5289.939; VUORIO R, 1992, ANTIMICROB AGENTS CH, V36, P826, DOI 10.1128/AAC.36.4.826; Williams AH, 2007, P NATL ACAD SCI USA, V104, P13543, DOI 10.1073/pnas.0705833104; Williams AH, 2006, P NATL ACAD SCI USA, V103, P10877, DOI 10.1073/pnas.0604465103; Wyckoff TJO, 1999, J BIOL CHEM, V274, P27047, DOI 10.1074/jbc.274.38.27047; Yin H, 2005, ANGEW CHEM INT EDIT, V44, P4130, DOI 10.1002/anie.200461786; Zucker F, 2010, ACTA CRYSTALLOGR D, V66, P889, DOI 10.1107/S0907444910020421	35	21	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15527	15535		10.1074/jbc.M114.564278	http://dx.doi.org/10.1074/jbc.M114.564278			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742680	hybrid, Green Published			2022-12-25	WOS:000337465400035
J	Sun, YR; Yin, SH; Feng, YT; Li, J; Zhou, JH; Liu, CD; Zhu, G; Guo, ZH				Sun, Yueru; Yin, Shuhui; Feng, Yitao; Li, Jie; Zhou, Jiahai; Liu, Changdong; Zhu, Guang; Guo, Zhihong			Molecular Basis of the General Base Catalysis of an alpha/beta-Hydrolase Catalytic Triad	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Mechanisms; Hydrolases; Protein Conformation; Vitamin K; Open-Closed Conformational Change	STRONG HYDROGEN-BOND; HYDROXYNITRILE LYASE; ACTIVE-SITE; CONFORMATIONAL SELECTION; MENAQUINONE BIOSYNTHESIS; CRYSTAL-STRUCTURE; HUMAN GLUCOKINASE; ESCHERICHIA-COLI; FOLD ENZYMES; INDUCED FIT	The serine-histidine-aspartate triad is well known for its covalent, nucleophilic catalysis in a diverse array of enzymatic transformations. Here we show that its nucleophilicity is shielded and its catalytic role is limited to being a specific general base by an open-closed conformational change in the catalysis of (1R,6R)-2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase (or MenH), a typical /-hydrolase fold enzyme in the vitamin K biosynthetic pathway. This enzyme is found to adopt an open conformation without a functional triad in its ligand-free form and a closed conformation with a fully functional catalytic triad in the presence of its reaction product. The open-to-closed conformational transition involves movement of half of the -helical cap domain, which causes extensive structural changes in the /-domain and forces the side chain of the triad histidine to adopt an energetically disfavored gauche conformation to form the functional triad. NMR analysis shows that the inactive open conformation without a triad prevails in ligand-free solution and is converted to the closed conformation with a properly formed triad by the reaction product. Mutation of the residues crucial to this open-closed transition either greatly decreases or completely eliminates the enzyme activity, supporting an important catalytic role for the structural change. These findings suggest that the open-closed conformational change tightly couples formation of the catalytic triad to substrate binding to enhance the substrate specificities and simultaneously shield the nucleophilicity of the triad, thus allowing it to expand its catalytic power beyond the nucleophilic catalysis.	[Sun, Yueru; Yin, Shuhui; Feng, Yitao; Guo, Zhihong] Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China; [Liu, Changdong; Zhu, Guang] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Sun, Yueru; Yin, Shuhui; Feng, Yitao; Liu, Changdong; Zhu, Guang; Guo, Zhihong] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Li, Jie; Zhou, Jiahai] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS	Guo, ZH (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem, Kowloon, Hong Kong, Peoples R China.	chguo@ust.hk	Yin, Shuhui/AAA-4360-2020	Yin, Shuhui/0000-0003-1542-3340; Sun, Yueru/0000-0002-8203-3740	Research Grants Council of the Hong Kong Special Administrative Region government [GRF601413, GRF601209, RPC11SC16]; National Natural Science Foundation of China [NSFC 11079051]	Research Grants Council of the Hong Kong Special Administrative Region government(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by Grants GRF601413, GRF601209, and RPC11SC16 from the Research Grants Council of the Hong Kong Special Administrative Region government (to Z.G.) and by National Natural Science Foundation of China Grant NSFC 11079051 (to J.Z.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antoine M, 2009, BIOCHEMISTRY-US, V48, P5466, DOI 10.1021/bi900374c; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; BRZOZOWSKI AM, 1991, NATURE, V351, P491, DOI 10.1038/351491a0; Cassidy CS, 1997, BIOCHEMISTRY-US, V36, P4576, DOI 10.1021/bi962013o; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dawson A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-19; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleming SM, 2000, BIOCHEMISTRY-US, V39, P1522, DOI 10.1021/bi9923095; Forneris F, 2010, SCIENCE, V330, P1816, DOI 10.1126/science.1195821; Grisostomi C, 1997, BIOORG CHEM, V25, P297, DOI 10.1006/bioo.1997.1073; Guo ZF, 2008, ORG LETT, V10, P649, DOI 10.1021/ol7030153; Hare S, 2009, ACTA CRYSTALLOGR D, V65, P966, DOI 10.1107/S0907444909023695; Harris TK, 1999, PROTEINS, V35, P275, DOI 10.1002/(SICI)1097-0134(19990515)35:3<275::AID-PROT1>3.0.CO;2-V; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Jiang M, 2008, BIOCHEMISTRY-US, V47, P3426, DOI 10.1021/bi7023755; Jiang M, 2007, ORG LETT, V9, P4765, DOI 10.1021/ol702126m; Jiang M, 2007, J AM CHEM SOC, V129, P730, DOI 10.1021/ja065064+; Jiang M, 2007, BIOCHEMISTRY-US, V46, P10979, DOI 10.1021/bi700810x; Jiang M, 2009, BIOCHEMISTRY-US, V48, P6921, DOI 10.1021/bi900897h; Johnson KA, 2008, J BIOL CHEM, V283, P26297, DOI 10.1074/jbc.R800034200; Johnston JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061325; Kim YB, 2007, BIOCHEMISTRY-US, V46, P1423, DOI 10.1021/bi0617308; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li JJ, 2007, ORG BIOMOL CHEM, V5, P507, DOI 10.1039/b615605c; Li JJ, 2006, BIOCHEMISTRY-US, V45, P12461, DOI 10.1021/bi0612519; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDermott A., 1996, ENCY NMR, P3820; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; NARAYANA SVL, 1994, J MOL BIOL, V235, P695, DOI 10.1006/jmbi.1994.1021; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Pletnev S, 2009, ACTA CRYSTALLOGR D, V65, P906, DOI 10.1107/S0907444909020927; Pozzi N, 2012, CURR OPIN STRUC BIOL, V22, P421, DOI 10.1016/j.sbi.2012.05.006; Roussel A, 1999, J BIOL CHEM, V274, P16995, DOI 10.1074/jbc.274.24.16995; Ruzzini AC, 2012, BIOCHEMISTRY-US, V51, P5831, DOI 10.1021/bi300663r; Ruzzini AC, 2012, J AM CHEM SOC, V134, P4615, DOI 10.1021/ja208544g; Schrag JD, 1997, STRUCTURE, V5, P187, DOI 10.1016/S0969-2126(97)00178-0; Speare DM, 2004, ORG BIOMOL CHEM, V2, P2942, DOI 10.1039/b410322j; Stranzl GR, 2004, J BIOL CHEM, V279, P3699, DOI 10.1074/jbc.M306814200; Tummino PJ, 2008, BIOCHEMISTRY-US, V47, P5481, DOI 10.1021/bi8002023; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Viragh C, 2000, BIOCHEMISTRY-US, V39, P16200, DOI 10.1021/bi0022644; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Wagner UG, 1996, STRUCTURE, V4, P811, DOI 10.1016/S0969-2126(96)00088-3; Wajant H, 1996, J BIOL CHEM, V271, P25830, DOI 10.1074/jbc.271.42.25830; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wei Y., 1999, MODEL NMR CHEM SHIFT, P177, DOI [10.1021/bk-1999-0732.ch013, DOI 10.1021/BK-1999-0732.CH013]; Zhang T., 2010, CHINESE PHYS B, V19; Zuegg J, 1999, PROTEIN SCI, V8, P1990, DOI 10.1110/ps.8.10.1990	65	19	19	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15867	15879		10.1074/jbc.M113.535641	http://dx.doi.org/10.1074/jbc.M113.535641			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737327	Green Published, hybrid			2022-12-25	WOS:000337465400065
J	He, Y; Hao, Q; Li, WQ; Yan, CY; Yan, N; Yin, P				He, Yuan; Hao, Qi; Li, Wenqi; Yan, Chuangye; Yan, Nieng; Yin, Ping			Identification and Characterization of ABA Receptors in Oryza sativa	PLOS ONE			English	Article							INDEPENDENT INHIBITION; MOLECULAR-BASIS; RICE; MECHANISM; FAMILY; START; 2C	Abscisic acid (ABA) is an essential phytohormone that regulates plant stress responses. ABA receptors in Arabidopsis thaliana (AtPYLs) have been extensively investigated by structural, biochemical, and in vivo studies. In contrast, relatively little is known about the ABA signal transduction cascade in rice. Besides, the diversities of AtPYLs manifest that the information accumulated in Arabidopsis cannot be simply adapted to rice. Thus, studies on rice ABA receptors are compulsory. By taking a bioinformatic approach, we identified twelve ABA receptor orthologs in Oryza sativa (japonica cultivar-group) (OsPYLs), named OsPYL1-12. We have successfully expressed and purified OsPYL1-3, 6 and 10-12 to homogeneity, tested the inhibitory effects on PP2C in Oryza sativa (OsPP2C), and measured their oligomerization states. OsPYL1-3 mainly exhibit as dimers and require ABA to inhibit PP2C's activity. On the contrary, OsPYL6 retains in the monomer-dimer equilibrium state and OsPYL10-11 largely exist as monomers, and they all display an ABA-independent phosphatase inhibition manner. Interestingly, although OsPYL12 seems to be a dimer, it abrogates the phosphatase activity of PP2Cs in the absence of ABA. Toward a further understanding of OsPYLs on the ABA binding and PP2C inhibition, we determined the crystal structure of ABA-OsPYL2-OsPP2C06 complex. The bioinformatic, biochemical and structural analysis of ABA receptors in rice provide important foundations for designing rational ABA-analogues and breeding the stress-resistant rice for commercial agriculture.	[He, Yuan; Hao, Qi; Li, Wenqi; Yan, Chuangye; Yan, Nieng] State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [He, Yuan; Hao, Qi; Li, Wenqi; Yan, Nieng] Sch Med, Struct Biol Ctr, Beijing, Peoples R China; [Yan, Chuangye] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Yin, Ping] Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Yin, Ping] Natl Ctr Plant Gene Res, Wuhan, Peoples R China; [Yin, Ping] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Peoples R China	Tsinghua University; Huazhong Agricultural University	Yan, N (corresponding author), State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China.	nyan@tsinghua.edu.cn; yinping@mail.hzau.edu.cn	Yan, Chuangye/AAJ-5832-2021	Yan, Chuangye/0000-0001-9338-8048	Ministry of Science and Technology [2011CB910501]; National Natural Science Foundation of China [31125009, 91017011]; Tsinghua University; International Early Career Scientist grant from the Howard Hughes Medical Institute; Huazhong Agricultural University	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University; International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Huazhong Agricultural University	This work was supported by funds from the Ministry of Science and Technology (grant number 2011CB910501), Projects 31125009 and 91017011 of the National Natural Science Foundation of China, and funds from Tsinghua University. The research of Nieng Yan was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute (http://www.hhmi.org/). The research of Ping Yin was supported by the fund from Huazhong Agricultural University (http://www.hzau.edu.cn/en/home/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ben-Ari G, 2012, PLANT CELL REP, V31, P1357, DOI 10.1007/s00299-012-1292-2; Collaborative Computational Project, 1994, CCP4 SUIT PROGR PROT, P760; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedoroff NV, 2002, SCI STKE, V2002, pe10; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Hao Q, 2011, MOL CELL, V42, P662, DOI 10.1016/j.molcel.2011.05.011; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kim H, 2014, J EXP BOT, V65, P453, DOI 10.1093/jxb/ert397; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Klingler JP, 2010, J EXP BOT, V61, P3199, DOI 10.1093/jxb/erq151; Li WQ, 2013, CELL RES, V23, P1369, DOI 10.1038/cr.2013.143; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melcher K, 2010, NAT STRUCT MOL BIOL, V17, P1102, DOI 10.1038/nsmb.1887; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peterson FC, 2010, NAT STRUCT MOL BIOL, V17, P1109, DOI 10.1038/nsmb.1898; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sakai H, 2013, PLANT CELL PHYSIOL, V54, pE6, DOI 10.1093/pcp/pcs183; Santiago J, 2012, PLANT SCI, V182, P3, DOI 10.1016/j.plantsci.2010.11.014; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Yuan XQ, 2010, J BIOL CHEM, V285, P28953, DOI 10.1074/jbc.M110.160192; Zhao Y, 2013, CELL RES, V23, P1380, DOI 10.1038/cr.2013.149	29	76	87	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95246	10.1371/journal.pone.0095246	http://dx.doi.org/10.1371/journal.pone.0095246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743650	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100096
J	Koch, V; Nissen, I; Schmitt, BD; Beye, M				Koch, Vasco; Nissen, Inga; Schmitt, Bjoern D.; Beye, Martin			Independent Evolutionary Origin of fem Paralogous Genes and Complementary Sex Determination in Hymenopteran Insects	PLOS ONE			English	Article							OLFACTORY RECEPTOR GENES; DEATH EVOLUTION; CHEMORECEPTOR SUPERFAMILY; DETERMINATION PATHWAY; MOLECULAR EVOLUTION; PURIFYING SELECTION; MOSAIC STRUCTURE; RECOMBINATION; DUPLICATION; MECHANISMS	The primary signal of sex determination in the honeybee, the complementary sex determiner (csd) gene, evolved from a gene duplication event from an ancestral copy of the fem gene. Recently, other paralogs of the fem gene have been identified in several ant and bumblebee genomes. This discovery and the close phylogenetic relationship of the paralogous gene sequences led to the hypothesis of a single ancestry of the csd genetic system of complementary sex determination in the Hymenopteran insects, in which the fem and csd gene copies evolved as a unit in concert with the mutual transfers of sequences (concerted evolution). Here, we show that the paralogous gene copies evolved repeatedly through independent gene duplication events in the honeybee, bumblebee, and ant lineage. We detected no sequence tracts that would indicate a DNA transfer between the fem and the fem1/csd genes between different ant and bee species. Instead, we found tracts of duplication events in other genomic locations, suggesting that gene duplication was a frequent event in the evolution of these genes. These and other evidences suggest that the fem1/csd gene originated repeatedly through gene duplications in the bumblebee, honeybee, and ant lineages in the last 100 million years. Signatures of concerted evolution were not detectable, implicating that the gene tree based on neutral synonymous sites represents the phylogenetic relationships and origins of the fem and fem1/csd genes. Our results further imply that the fem1 and csd gene in bumblebees, honeybees, and ants are not orthologs, because they originated independently from the fem gene. Hence, the widely shared and conserved complementary sex determination mechanism in Hymenopteran insects is controlled by different genes and molecular processes. These findings highlight the limits of comparative genomics and emphasize the requirement to study gene functions in different species and major hymenopteran lineages.	[Koch, Vasco; Nissen, Inga; Schmitt, Bjoern D.; Beye, Martin] Univ Dusseldorf, Inst Evolutionary Genet, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Beye, M (corresponding author), Univ Dusseldorf, Inst Evolutionary Genet, Dusseldorf, Germany.	martin.beye@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft, DFG	Deutsche Forschungsgemeinschaft, DFG(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft, DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Beye M, 2013, CURR BIOL, V23, P2559, DOI 10.1016/j.cub.2013.10.070; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Bull J. J., 1983, EVOLUTION SEX DETERM; CHARLESWORTH B, 1978, AM NAT, V112, P975, DOI 10.1086/283342; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; Craves JAM, 2008, ANNU REV GENET, V42, P565, DOI 10.1146/annurev.genet.42.110807.091714; Eirin-Lopez JM, 2004, MOL BIOL EVOL, V21, P1992, DOI 10.1093/molbev/msh213; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; Gempe T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000222; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Grimaldi David, 2005, pi; Hasselmann M, 2004, P NATL ACAD SCI USA, V101, P4888, DOI 10.1073/pnas.0307147101; Hasselmann M, 2008, NATURE, V454, P519, DOI 10.1038/nature07052; Hasselmann M, 2008, MOL BIOL EVOL, V25, P696, DOI 10.1093/molbev/msn011; Hasselmann M, 2006, GENETICS, V174, P1469, DOI 10.1534/genetics.106.062018; Hasselmann M, 2010, P NATL ACAD SCI USA, V107, P13378, DOI 10.1073/pnas.1005617107; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Lipinski KJ, 2011, CURR BIOL, V21, P306, DOI 10.1016/j.cub.2011.01.026; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mank JE, 2009, SEX DEV, V3, P60, DOI 10.1159/000223071; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nei M., 2000, MOL EVOLUTION PHYLOG; Niimura Y, 2005, GENE, V346, P23, DOI 10.1016/j.gene.2004.09.027; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; OTA T, 1994, MOL BIOL EVOL, V11, P469; OTA T, 1995, MOL BIOL EVOL, V12, P94, DOI 10.1093/oxfordjournals.molbev.a040194; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pane A, 2002, DEVELOPMENT, V129, P3715; Piontkivska H, 2002, MOL BIOL EVOL, V19, P689, DOI 10.1093/oxfordjournals.molbev.a004127; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Privman E, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2968; Ramirez SR, 2010, MOL PHYLOGENET EVOL, V56, P519, DOI 10.1016/j.ympev.2010.04.026; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rooney AP, 2002, MOL BIOL EVOL, V19, P68, DOI 10.1093/oxfordjournals.molbev.a003983; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Schmieder S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1898; Schutt C, 2000, DEVELOPMENT, V127, P667; Semple C, 1999, J MOL EVOL, V48, P555, DOI 10.1007/PL00006498; SMITH JM, 1992, J MOL EVOL, V34, P126; Su C, 2001, MOL BIOL EVOL, V18, P503, DOI 10.1093/oxfordjournals.molbev.a003829; TAJIMA F, 1993, GENETICS, V135, P599; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Verhulst EC, 2010, SCIENCE, V328, P620, DOI 10.1126/science.1185805; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102	55	15	17	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e91883	10.1371/journal.pone.0091883	http://dx.doi.org/10.1371/journal.pone.0091883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743790	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100005
J	Motherway, MO; Watson, D; Bottacini, F; Clark, TA; Roberts, RJ; Korlach, J; Garault, P; Chervaux, C; Vlieg, JETV; Smokvina, T; van Sinderen, D				Motherway, Mary O'Connell; Watson, Debbie; Bottacini, Francesca; Clark, Tyson A.; Roberts, Richard J.; Korlach, Jonas; Garault, Peggy; Chervaux, Christian; Vlieg, Johan E. T. van Hylckama; Smokvina, Tamara; van Sinderen, Douwe			Identification of Restriction-Modification Systems of Bifidobacterium animalis subsp lactis CNCM I-2494 by SMRT Sequencing and Associated Methylome Analysis	PLOS ONE			English	Article							FERMENTED MILK PRODUCT; IMPROVED CLONING VECTORS; BREVE UCC2003; LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; ANABAENA-VARIABILIS; FUNCTIONAL-ANALYSIS; GENE-EXPRESSION; DN-173 010; GENOME	Bifidobacterium animalis subsp. lactis CNCM I-2494 is a component of a commercialized fermented dairy product for which beneficial effects on health has been studied by clinical and preclinical trials. To date little is known about the molecular mechanisms that could explain the beneficial effects that bifidobacteria impart to the host. Restriction-modification (R-M) systems have been identified as key obstacles in the genetic accessibility of bifidobacteria, and circumventing these is a prerequisite to attaining a fundamental understanding of bifidobacterial attributes, including the genes that are responsible for health-promoting properties of this clinically and industrially important group of bacteria. The complete genome sequence of B. animalis subsp. lactis CNCM I-2494 is predicted to harbour the genetic determinants for two type II R-M systems, designated BanLI and BanLII. In order to investigate the functionality and specificity of these two putative R-M systems in B. animalis subsp. lactis CNCM I-2494, we employed PacBio SMRT sequencing with associated methylome analysis. In addition, the contribution of the identified R-M systems to the genetic accessibility of this strain was assessed.	[Motherway, Mary O'Connell; Watson, Debbie; Bottacini, Francesca; van Sinderen, Douwe] Natl Univ Ireland, Alimentary Pharmabiot Ctr, Cork, Ireland; [Motherway, Mary O'Connell; Watson, Debbie; Bottacini, Francesca; van Sinderen, Douwe] Natl Univ Ireland, Sch Microbiol, Cork, Ireland; [Clark, Tyson A.; Korlach, Jonas] Pacific Biosci, Menlo Pk, CA USA; [Roberts, Richard J.] New England Biolabs Inc, Ipswich, MA USA; [Garault, Peggy; Chervaux, Christian; Vlieg, Johan E. T. van Hylckama; Smokvina, Tamara] Danone Nutricia Res, Palaiseau, France	University College Cork; University College Cork; New England Biolabs; Danone Nutricia	van Sinderen, D (corresponding author), Natl Univ Ireland, Alimentary Pharmabiot Ctr, Cork, Ireland.	d.vansinderen@ucc.ie	Chervaux, Christian/N-1972-2014; van Hylckama Vlieg, Johan/F-7887-2014; Van Sinderen, Douwe/A-6778-2015; Bottacini, Francesca/AAO-2431-2021	Chervaux, Christian/0000-0001-6812-0912; van Hylckama Vlieg, Johan/0000-0001-6656-8668; Van Sinderen, Douwe/0000-0003-1823-7957; Bottacini, Francesca/0000-0002-0142-2956; Garault, Peggy/0000-0001-9105-2831; Roberts, Richard/0000-0002-4348-0169; Clark, Tyson/0000-0002-7779-3227	Danone, a HRB [PDTM/20011/9]; Science Foundation Ireland (SFI) through the Irish Government's National Development Plan [07/CE/B1368, SFI/12/RC/2273]; Danone	Danone, a HRB(Danone Nutricia); Science Foundation Ireland (SFI) through the Irish Government's National Development Plan(Science Foundation Ireland); Danone(Danone Nutricia)	This work was financially supported by Danone, a HRB postdoctoral fellow-Grant no. PDTM/20011/9 and by Science Foundation Ireland (SFI), through the Irish Government's National Development Plan (grant nos. 07/CE/B1368 and SFI/12/RC/2273). The funder, Danone, funded the research and provided support in the form of salaries for authors PG, CC, JvHV and TS. The specific roles of these authors are articulated in the 'author contributions' section.	Agostini S, 2012, NEUROGASTROENT MOTIL, P376; Agrawal A, 2009, ALIMENT PHARM THER, V29, P104, DOI 10.1111/j.1365-2036.2008.03853.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Martin P, 2007, APPL MICROBIOL BIOT, V76, P1395, DOI 10.1007/s00253-007-1115-5; Alvarez-Martin P, 2012, APPL ENVIRON MICROB, V78, P7032, DOI 10.1128/AEM.01776-12; Alvarez-Martin P, 2012, APPL ENVIRON MICROB, V78, P5258, DOI 10.1128/AEM.00804-12; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Bermudez-Brito M, 2012, ANN NUTR METAB, V61, P160, DOI 10.1159/000342079; Bottacini F, 2014, BMC GENOMIC IN PRESS; Brancaccio VF, 2013, BIOENGINEERED, V4, P197, DOI 10.4161/bioe.23381; Chervaux C, 2011, J BACTERIOL, V193, P5560, DOI 10.1128/JB.05716-11; Clark TA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-4; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Fang G, 2012, NAT BIOTECHNOL, V30, P1232, DOI 10.1038/nbt.2432; Fanning S, 2012, P NATL ACAD SCI USA, V109, P2108, DOI 10.1073/pnas.1115621109; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Furmanek-Blaszk B, 2009, MICROBIOL-SGM, V155, P1111, DOI 10.1099/mic.0.025023-0; Guglielmetti S, 2013, BENEF MICROBES, V4, P143, DOI 10.3920/BM2012.0031; Guyonnet D, 2009, BRIT J NUTR, V102, P1654, DOI 10.1017/S0007114509990882; HILL C, 1991, J BACTERIOL, V173, P4363, DOI 10.1128/JB.173.14.4363-4370.1991; Hirayama Y, 2012, APPL ENVIRON MICROB, V78, P4984, DOI 10.1128/AEM.00588-12; HUGHES SG, 1980, BIOCHEM J, V185, P65, DOI 10.1042/bj1850065; Kaczorowski T, 1999, MOL BIOTECHNOL, V13, P1, DOI 10.1385/MB:13:1:1; Kim JY, 2010, J MICROBIOL BIOTECHN, V20, P1022, DOI 10.4014/jmb.1003.03014; Kozdon JB, 2013, P NATL ACAD SCI USA, V110, pE4658, DOI 10.1073/pnas.1319315110; LAW J, 1995, J BACTERIOL, V177, P7011, DOI 10.1128/jb.177.24.7011-7018.1995; McGrath S, 2001, APPL ENVIRON MICROB, V67, P608, DOI 10.1128/AEM.67.2.608-616.2001; Motherway MO, 2008, APPL ENVIRON MICROB, V74, P6271, DOI 10.1128/AEM.01169-08; Motherway MO, 2013, MICROB BIOTECHNOL, V6, P67, DOI 10.1111/1751-7915.12011; Motherway MO, 2011, P NATL ACAD SCI USA, V108, P11217, DOI 10.1073/pnas.1105380108; Motherway MO, 2011, MICROB BIOTECHNOL, V4, P403, DOI 10.1111/j.1751-7915.2010.00218.x; Motherway MO, 2009, MICROB BIOTECHNOL, V2, P321, DOI 10.1111/j.1751-7915.2008.00071.x; Murray IA, 2012, NUCLEIC ACIDS RES, V40, P11450, DOI 10.1093/nar/gks891; MURRAY K, 1976, BIOCHEM J, V159, P317, DOI 10.1042/bj1590317; O'Connell KJ, 2013, APPL ENVIRON MICROB, V79, P6280, DOI 10.1128/AEM.01775-13; O'Connell KJ, 2013, BIOENGINEERED, V4, P313, DOI 10.4161/bioe.24159; O'Driscoll J, 2005, MOL MICROBIOL, V57, P1532, DOI 10.1111/j.1365-2958.2005.04769.x; O'Driscoll J, 2004, APPL ENVIRON MICROB, V70, P5546, DOI 10.1128/AEM.70.9.5546-5556.2004; O'Driscoll J, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-40; ORiordan K, 1998, STUDIES ANTIMICROBIA; OSULLIVAN DJ, 1995, J BACTERIOL, V177, P134, DOI 10.1128/jb.177.1.134-143.1995; Pokusaeva K, 2011, APPL ENVIRON MICROB, V77, P1681, DOI 10.1128/AEM.01786-10; Pokusaeva K, 2010, MICROB BIOTECHNOL, V3, P311, DOI 10.1111/j.1751-7915.2009.00152.x; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; Rossi M, 1998, LETT APPL MICROBIOL, V26, P101; Ruiz L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064699; Ruiz L, 2012, MICROB BIOTECHNOL, V5, P523, DOI 10.1111/j.1751-7915.2011.00329.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sakaguchi K, 2012, APPL MICROBIOL BIOT, V95, P499, DOI 10.1007/s00253-012-4090-4; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SUGISAKI H, 1991, J BIOL CHEM, V266, P13952; Sun ZK, 2012, APPL ENVIRON MICROB, V78, P5035, DOI 10.1128/AEM.00551-12; Tillisch K, 2013, GASTROENTEROLOGY, V144, P1394, DOI 10.1053/j.gastro.2013.02.043; TIMINSKAS A, 1995, GENE, V157, P3, DOI 10.1016/0378-1119(94)00783-O; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Veiga P, 2010, P NATL ACAD SCI USA, V107, P18132, DOI 10.1073/pnas.1011737107; Ventura M, 2014, J SCI FOOD AGR, V94, P163, DOI 10.1002/jsfa.6356; Ventura M, 2012, TRENDS MICROBIOL, V20, P467, DOI 10.1016/j.tim.2012.07.002; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; WELLS JM, 1993, J APPL BACTERIOL, V74, P629, DOI 10.1111/j.1365-2672.1993.tb05195.x; Yasui K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn884	63	20	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94875	10.1371/journal.pone.0094875	http://dx.doi.org/10.1371/journal.pone.0094875			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743599	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100049
J	Wang, H; Tie, S; Yu, D; Guo, YH; Yang, CF				Wang, Hui; Tie, Shuang; Yu, Dan; Guo, You-Hao; Yang, Chun-Feng			Change of Floral Orientation within an Inflorescence Affects Pollinator Behavior and Pollination Efficiency in a Bee-Pollinated Plant, Corydalis sheareri	PLOS ONE			English	Article							POLLEN TRANSFER; SEX ALLOCATION; DISPLAY SIZE; FLOWERS; ARCHITECTURE; BUMBLEBEES; SYMMETRY; DENSITY; SUCCESS; SYSTEMS	Vertical raceme or spike inflorescences that are bee-pollinated tend to present their flowers horizontally. Horizontal presentation of flowers is hypothesized to enhance pollinator recognition and pollination precision, and it may also ensure greater consistency of pollinator movement on inflorescences. We tested the hypotheses using bee-pollinated Corydalis sheareri which has erect inflorescences consisting of flowers with horizontal orientation. We altered the orientation of individual flowers and prepared three types of inflorescences: (i) unmanipulated inflorescences with horizontal-facing flowers, (ii) inflorescences with flowers turned upward, and (iii) inflorescences with flowers turned downward. We compared number of inflorescences approached and visited, number of successive probes within an inflorescence, the direction percentage of vertical movement on inflorescences, efficiency of pollen removal and seed production per inflorescence. Deviation from horizontal orientation decreased both approaches and visits by leafcutter bees and bumble bees to inflorescences. Changes in floral orientation increased the proportion of downward movements by leafcutter bees and decreased the consistency of pollinator movement on inflorescences. In addition, pollen removal per visit and seed production per inflorescence also declined with changes of floral orientation. In conclusion, floral orientation seems more or less optimal as regards bee behavior and pollen transfer for Corydalis sheareri. A horizontal orientation may be under selection of pollinators and co-adapt with other aspects of the inflorescence and floral traits.	[Wang, Hui; Tie, Shuang; Yu, Dan; Guo, You-Hao] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Yang, Chun-Feng] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Guo, YH (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	yhguo@whu.edu.cn; cfyang@wbgcas.cn			National Natural Science Foundation of China [31170214, 31070206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31170214 to YHG and 31070206 to CFY). This work was supported by the National Natural Science Foundation of China (31170214 to YHG and 31070206 to CFY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1793, ENTDECKTE GEHEIMNIS, DOI [10.5962/bhl.title.50179, DOI 10.5962/BHL.TITLE.50179]; Castellanos MC, 2004, J EVOLUTION BIOL, V17, P876, DOI 10.1111/j.1420-9101.2004.00729.x; CORBET SA, 1981, OECOLOGIA, V51, P79, DOI 10.1007/BF00344656; CRUDEN RW, 1977, EVOLUTION, V31, P32, DOI 10.1111/j.1558-5646.1977.tb00979.x; Faegri K, 1979, PRINCIPLES POLLINATI, P288; Fenster CB, 2009, NEW PHYTOL, V183, P502, DOI 10.1111/j.1469-8137.2009.02852.x; Giurfa M, 1999, INT J PLANT SCI, V160, pS41, DOI 10.1086/314214; Glaettli M, 2008, NEW PHYTOL, V179, P1193, DOI 10.1111/j.1469-8137.2008.02532.x; Gong YB, 2011, OECOLOGIA, V166, P671, DOI 10.1007/s00442-011-1910-7; GORI DF, 1989, EVOLUTION, V43, P870, DOI [10.2307/2409314, 10.1111/j.1558-5646.1989.tb05184.x]; Harder LD, 2004, PLANT SPEC BIOL, V19, P137, DOI 10.1111/j.1442-1984.2004.00110.x; Harder LD, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P297, DOI 10.1017/CBO9780511542268.016; Harder LD, 1996, FLORAL BIOL STUDIES, P140, DOI DOI 10.1007/978-1-4613-1165-2_6; HAYNES J, 1984, OECOLOGIA, V61, P249, DOI 10.1007/BF00396768; HOWLETT BJ, 1975, PROC R SOC SER B-BIO, V188, P167, DOI 10.1098/rspb.1975.0010; Huang SQ, 2002, AM J BOT, V89, P1599, DOI 10.3732/ajb.89.10.1599; Ishii HS, 2008, OECOLOGIA, V156, P341, DOI 10.1007/s00442-008-0991-4; Iwata T, 2012, NEW PHYTOL, V193, P196, DOI 10.1111/j.1469-8137.2011.03892.x; Jordan CY, 2006, AM NAT, V167, P496, DOI 10.1086/501142; KEVAN PG, 1975, SCIENCE, V189, P723, DOI 10.1126/science.189.4204.723; KLINKHAMER PGL, 1990, OIKOS, V57, P399, DOI 10.2307/3565970; Kobayashi S, 1997, OECOLOGIA, V111, P535, DOI 10.1007/s004420050268; Kudo G, 2004, ECOSCIENCE, V11, P218, DOI 10.1080/11956860.2004.11682827; KUDO G, 1995, OIKOS, V72, P14, DOI 10.2307/3546032; Kudo G, 2001, J ECOL, V89, P48, DOI 10.1046/j.1365-2745.2001.00512.x; LLOYD DG, 1986, NEW ZEAL J BOT, V24, P135, DOI 10.1080/0028825X.1986.10409725; Mahoro S, 2003, PLANT ECOL, V166, P37, DOI 10.1023/A:1023203325501; Makino TT, 2007, FUNCT ECOL, V21, P87, DOI 10.1111/j.1365-2435.2006.01211.x; Maloof Joan E., 2000, Plant Species Biology, V15, P281, DOI 10.1046/j.1442-1984.2000.00047.x; Neal PR, 1998, ANNU REV ECOL SYST, V29, P345, DOI 10.1146/annurev.ecolsys.29.1.345; OHARA M, 1994, OECOLOGIA, V98, P25, DOI 10.1007/BF00326086; Patino S, 2002, OECOLOGIA, V130, P373, DOI 10.1007/s00442-001-0824-1; PYKE GH, 1978, OECOLOGIA, V36, P281, DOI 10.1007/BF00348054; Sapir N, 2013, FUNCT ECOL, V27, P227, DOI 10.1111/1365-2435.12024; Stolle J, 2004, FLORA, V199, P204, DOI 10.1078/0367-2530-00148; Tadey M, 2001, FUNCT ECOL, V15, P782, DOI 10.1046/j.0269-8463.2001.00580.x; Ushimaru A, 2006, FUNCT ECOL, V20, P585, DOI 10.1111/j.1365-2435.2006.01153.x; Ushimaru A, 2005, EVOL ECOL RES, V7, P151; Ushimaru A, 2009, OECOLOGIA, V160, P667, DOI 10.1007/s00442-009-1334-9; Valtuena FJ, 2013, PLANT BIOLOGY, V15, P328, DOI 10.1111/j.1438-8677.2012.00644.x; WADDINGTON KD, 1979, J COMP PHYSIOL, V134, P113, DOI 10.1007/BF00610469; Wyatt R., 1983, P51; Zhang YW, 2009, ANN BOT-LONDON, V104, P33, DOI 10.1093/aob/mcp104	43	21	25	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95381	10.1371/journal.pone.0095381	http://dx.doi.org/10.1371/journal.pone.0095381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743567	Green Submitted, gold, Green Published			2022-12-25	WOS:000335309100113
J	Zhou, H; Li, YY; Zhang, WQ; Lin, D; Zhang, WM; Dong, WD				Zhou, Han; Li, Ying-Ying; Zhang, Wei-Qiang; Lin, Dan; Zhang, Wei-Ming; Dong, Wei-Da			Expression of Stanniocalcin-1 and Stanniocalcin-2 in Laryngeal Squamous Cell Carcinoma and Correlations with Clinical and Pathological Parameters	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; CANCER-CELLS; GASTRIC-CANCER; COLORECTAL-CANCER; PROGNOSTIC MARKER; PERIPHERAL-BLOOD; BREAST-CANCER; UP-REGULATION; LUNG-CANCER; METASTASIS	Background: Stanniocalcin-1 (STC1) and stanniocalcin-2 (STC2) are secreted glycoprotein hormones involved in various types of human malignancies. The roles of STC1 and STC2 in laryngeal squamous cell carcinoma (LSCC) remain unknown. We investigated correlations between STC1 and STC2 expression and clinicopathological or prognostic factors in LSCC. Methods: Pre-surgical peripheral blood samples were collected between 2012 and 2013 from 62 patients with LSCC. Quantitative RT-PCR analysis was performed to examine mRNA levels of STC1 and STC2. Immunohistochemistry was performed to retrospectively analyze 90 paraffin-embedded LSCC tissue samples, which were obtained from patients who received surgery between 2006 and 2009. These patients did not have histories of treatment or malignancies. Univariate analysis of patient survival was performed by the Kaplan-Meier method. Multivariate analyses were performed with the Cox proportional hazards model. Results: The relative mRNA levels of STC1 and STC2 in peripheral blood were significantly greater in LSCC patients than those of healthy volunteers (both P<0.05). STC2 protein expression in tumor tissues was associated with invasion into the thyroid cartilage, T-Stage, lymphatic metastasis, clinical stage, and pathological differentiation (all P<0.05). In addition, STC2 protein expression was an independent prognostic factor for overall survival in patients with LSCC (P = 0.025). In contrast, STC1 expression only correlated with clinical stage (P = 0.026) and was not an independent or significant prognostic factor. Conclusions: Circulating STC1 and STC2 mRNA are potentially useful blood markers for LSCC. Our results strongly suggest that the STC2 protein, but not STC1, may be a valuable biomarker for LSCC malignancies and a prognostic marker for poor outcome following surgery. Future studies should examine STC2 as a novel molecular target for the treatment of LSCC.	[Zhou, Han; Li, Ying-Ying; Zhang, Wei-Qiang; Lin, Dan; Dong, Wei-Da] Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China; [Zhang, Wei-Ming] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Dong, WD (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Jiangsu, Peoples R China.	weidadong2649@126.com	Zhou, Han/AAV-2874-2021		Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Health Administration of China [Z201202]; Jiangsu Province Hospital [JSDH-XJS-2012-27]	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Health Administration of China; Jiangsu Province Hospital	This study was supported by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD 2010-2013), the grant from Jiangsu Health Administration of China (Z201202), and the new technology project of Jiangsu Province Hospital (JSDH-XJS-2012-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadori G, 2005, EUR J CANCER, V41, P683, DOI 10.1016/j.ejca.2004.10.031; Arigami T, 2012, ONCOLOGY-BASEL, V83, P158, DOI 10.1159/000341390; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Chang ACM, 2003, ENDOCR-RELAT CANCER, V10, P359, DOI 10.1677/erc.0.0100359; CHANG ACM, 1995, MOL CELL ENDOCRINOL, V112, P241, DOI 10.1016/0303-7207(95)03601-3; Chu EA, 2008, OTOLARYNG CLIN N AM, V41, P673, DOI 10.1016/j.otc.2008.01.016; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Du YZ, 2011, J SURG ONCOL, V104, P836, DOI 10.1002/jso.21948; Gertler R, 2011, ANN SURG, V253, P689, DOI 10.1097/SLA.0b013e31821111b5; Gourin CG, 2009, LARYNGOSCOPE, V119, P1312, DOI 10.1002/lary.20477; Guo FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053989; He LF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-39; Higginson IJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046327, 10.1371/journal.pone.0050710]; Ieta K, 2009, INT J CANCER, V125, P926, DOI 10.1002/ijc.24453; Ito D, 2004, MOL CELL BIOL, V24, P9456, DOI 10.1128/MCB.24.21.9456-9469.2004; Joensuu K, 2008, CANCER LETT, V265, P76, DOI 10.1016/j.canlet.2008.02.022; Kita Y, 2011, ANN SURG ONCOL, V18, P261, DOI 10.1245/s10434-010-1271-1; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Lai KP, 2007, BIOCHEM BIOPH RES CO, V356, P968, DOI 10.1016/j.bbrc.2007.03.074; Law AYS, 2008, EXP CELL RES, V314, P1823, DOI 10.1016/j.yexcr.2008.03.001; Law AYS, 2013, MOL CELL ENDOCRINOL, V374, P73, DOI 10.1016/j.mce.2013.04.024; Law AYS, 2011, J CELL BIOCHEM, V112, P2089, DOI 10.1002/jcb.23127; Law AYS, 2010, EXP CELL RES, V316, P3425, DOI 10.1016/j.yexcr.2010.06.026; LIANG P, 1992, CANCER RES, V52, P6966; Lin H, 2011, CRIT REV ONCOL HEMAT, V77, P2, DOI 10.1016/j.critrevonc.2010.04.008; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Loges S, 2009, J THROMB HAEMOST, V7, P21, DOI 10.1111/j.1538-7836.2008.03203.x; Lohynska R, 2005, NEOPLASMA, V52, P483; Low AYS, 2010, EXP CELL RES, V316, P466, DOI 10.1016/j.yexcr.2009.09.018; Meyer HA, 2009, EUR UROL, V55, P669, DOI 10.1016/j.eururo.2008.04.001; Pena C, 2013, CANCER RES, V73, P1287, DOI 10.1158/0008-5472.CAN-12-1875; Shirakawa M, 2012, ONCOL REP, V27, P940, DOI 10.3892/or.2011.1607; Song HZ, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-35; Volland S, 2009, INT J CANCER, V125, P2049, DOI 10.1002/ijc.24564; Wang YY, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-81; Yeung BHY, 2012, MOL CELL ENDOCRINOL, V349, P272, DOI 10.1016/j.mce.2011.11.007; Yokobori T, 2010, ANN SURG ONCOL, V17, P2601, DOI 10.1245/s10434-010-1086-0; Zeiger W, 2011, MOL CELL BIOL, V31, P3710, DOI 10.1128/MCB.05140-11; Zhang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060157	39	18	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95466	10.1371/journal.pone.0095466	http://dx.doi.org/10.1371/journal.pone.0095466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743310	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100121
J	Calabrese, B; Saffin, JM; Halpain, S				Calabrese, Barbara; Saffin, Jean-Michel; Halpain, Shelley			Activity-Dependent Dendritic Spine Shrinkage and Growth Involve Downregulation of Cofilin via Distinct Mechanisms	PLOS ONE			English	Article							POSTSYNAPTIC DENSITY FRACTION; AMPA RECEPTOR TRAFFICKING; PHOSPHOLIPASE-D ACTIVITY; LONG-TERM DEPRESSION; ACTIN POLYMERIZATION; LIM-KINASE; PROTEOMIC ANALYSIS; CATHEPSIN-B; ADF/COFILIN; PLASTICITY	A current model posits that cofilin-dependent actin severing negatively impacts dendritic spine volume. Studies suggested that increased cofilin activity underlies activity-dependent spine shrinkage, and that reduced cofilin activity induces activity-dependent spine growth. We suggest instead that both types of structural plasticity correlate with decreased cofilin activity. However, the mechanism of inhibition determines the outcome for spine morphology. RNAi in rat hippocampal cultures demonstrates that cofilin is essential for normal spine maintenance. Cofilin-F-actin binding and filament barbed-end production decrease during the early phase of activity-dependent spine shrinkage; cofilin concentration also decreases. Inhibition of the cathepsin B/L family of proteases prevents both cofilin loss and spine shrinkage. Conversely, during activity-dependent spine growth, LIM kinase stimulates cofilin phosphorylation, which activates phospholipase D-1 to promote actin polymerization. These results implicate novel molecular mechanisms and prompt a revision of the current model for how cofilin functions in activity-dependent structural plasticity.	[Halpain, Shelley] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sanford Consortium Regenerat Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Halpain, S (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	shalpain@ucsd.edu			National Institute of Health [NS37311, MH087823]; American Health Assistant Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037311] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistant Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by grants of the National Institute of Health to Shelley Halpain (NS37311; MH087823) and by The American Health Assistant Foundation to Barbara Calabrese. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bosch M, 2012, CURR OPIN NEUROBIOL, V22, P383, DOI 10.1016/j.conb.2011.09.002; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Chen LY, 2007, J NEUROSCI, V27, P5363, DOI 10.1523/JNEUROSCI.0164-07.2007; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Fortin DA, 2012, NEUROSCIENTIST, V18, P326, DOI 10.1177/1073858411407206; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Graber S, 2004, NEUROPHARMACOLOGY, V47, P706, DOI 10.1016/j.neuropharm.2004.08.004; Gu JP, 2010, NAT NEUROSCI, V13, P1208, DOI 10.1038/nn.2634; HA KS, 1993, J CELL BIOL, V123, P1789, DOI 10.1083/jcb.123.6.1789; Han L, 2007, EMBO J, V26, P4189, DOI 10.1038/sj.emboj.7601852; Han XL, 2011, MOL MICROBIOL, V81, P860, DOI 10.1111/j.1365-2958.2011.07726.x; Hanley JG, 2008, CELL ADHES MIGR, V2, P276, DOI 10.4161/cam.2.4.6510; Hook VYH, 2006, BIOL CHEM, V387, P1429, DOI 10.1515/BC.2006.179; Hotulainen P, 2009, J CELL BIOL, V185, P323, DOI 10.1083/jcb.200809046; Ishikawa-Ankerhold HC, 2012, MOLECULES, V17, P4047, DOI 10.3390/molecules17044047; Itach SBS, 2012, DEV BIOL, V362, P154, DOI 10.1016/j.ydbio.2011.12.002; Izeddin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015611; Jordan BA, 2004, MOL CELL PROTEOMICS, V3, P857, DOI 10.1074/mcp.M400045-MCP200; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kohrmann M, 1999, J NEUROSCI RES, V58, P831; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LENA JY, 1991, J NEUROSCI RES, V30, P18, DOI 10.1002/jnr.490300104; Lin B, 2005, J NEUROSCI, V25, P2062, DOI 10.1523/JNEUROSCI.4283-04.2005; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Minamide LS, 2000, NAT CELL BIOL, V2, P628, DOI 10.1038/35023579; Munsie LN, 2012, J CELL SCI; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; Pontrello CG, 2012, P NATL ACAD SCI USA, V109, pE442, DOI 10.1073/pnas.1118803109; Racz B, 2006, NEUROSCIENCE, V138, P447, DOI 10.1016/j.neuroscience.2005.11.025; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Rust MB, 2010, EMBO J, V29, P1889, DOI 10.1038/emboj.2010.72; Sarmiere PD, 2004, J NEUROBIOL, V58, P103, DOI 10.1002/neu.10267; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Song XY, 2006, J CELL SCI, V119, P2871, DOI 10.1242/jcs.03017; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Thymiakou E, 2011, JOVE-J VIS EXP, DOI 10.3791/2631; Van Rheenen J, 2007, J CELL BIOL, V179, P1247, DOI 10.1083/jcb.200706206; van Rheenen J, 2009, J CELL SCI, V122, P305, DOI 10.1242/jcs.031146; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang XB, 2010, MOL NEUROBIOL, V41, P29, DOI 10.1007/s12035-009-8093-9; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yoshimura Y, 2004, J NEUROCHEM, V88, P759, DOI 10.1046/j.1471-4159.2003.02136.x; Zhang L, 2010, CHINESE J PHYSIOL, V53, P328, DOI 10.4077/CJP.2010.AMK054; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zouwail S, 2005, BIOCHEM J, V389, P207, DOI 10.1042/BJ20050085	68	50	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94787	10.1371/journal.pone.0094787	http://dx.doi.org/10.1371/journal.pone.0094787			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740405	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900065
J	Carne, C; Semple, S; Morrogh-Bernard, H; Zuberbuhler, K; Lehmann, J				Carne, Charlotte; Semple, Stuart; Morrogh-Bernard, Helen; Zuberbuehler, Klaus; Lehmann, Julia			The Risk of Disease to Great Apes: Simulating Disease Spread in Orang-Utan (Pongo pygmaeus wurmbii) and Chimpanzee (Pan troglodytes schweinfurthii) Association Networks	PLOS ONE			English	Article							GOMBE NATIONAL-PARK; MAHALE; TRANSMISSION; SOCIALITY; OUTBREAKS; DYNAMICS; BEHAVIOR; CULTURES	All great ape species are endangered, and infectious diseases are thought to pose a particular threat to their survival. As great ape species vary substantially in social organisation and gregariousness, there are likely to be differences in susceptibility to disease types and spread. Understanding the relation between social variables and disease is therefore crucial for implementing effective conservation measures. Here, we simulate the transmission of a range of diseases in a population of orang-utans in Sabangau Forest (Central Kalimantan) and a community of chimpanzees in Budongo Forest (Uganda), by systematically varying transmission likelihood and probability of subsequent recovery. Both species have fission-fusion social systems, but differ considerably in their level of gregariousness. We used long-term behavioural data to create networks of association patterns on which the spread of different diseases was simulated. We found that chimpanzees were generally far more susceptible to the spread of diseases than orang-utans. When simulating different diseases that varied widely in their probability of transmission and recovery, it was found that the chimpanzee community was widely and strongly affected, while in orang-utans even highly infectious diseases had limited spread. Furthermore, when comparing the observed association network with a mean-field network (equal contact probability between group members), we found no major difference in simulated disease spread, suggesting that patterns of social bonding in orangutans are not an important determinant of susceptibility to disease. In chimpanzees, the predicted size of the epidemic was smaller on the actual association network than on the mean-field network, indicating that patterns of social bonding have important effects on susceptibility to disease. We conclude that social networks are a potentially powerful tool to model the risk of disease transmission in great apes, and that chimpanzees are particularly threatened by infectious disease outbreaks as a result of their social structure.	[Carne, Charlotte; Semple, Stuart; Lehmann, Julia] Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England; [Morrogh-Bernard, Helen] Univ Palangka Raya, Orang Utan Trop Peatland Project, Ctr Int Cooperat Sustainable Management Trop Peat, Palangka Raya, Central Kaliman, Indonesia; [Morrogh-Bernard, Helen] Univ Exeter, Coll Life & Environm Sci, Ctr Res Anim Behav, Exeter, Devon, England; [Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Zuberbuehler, Klaus] Univ Neuchatel, Ctr Cognit Sci, CH-2000 Neuchatel, Switzerland	Roehampton University; Universitas Palangka Raya (UPR); University of Exeter; University of St Andrews; University of Neuchatel	Carne, C (corresponding author), Univ Roehampton, Ctr Res Evolutionary & Environm Anthropol, London, England.	charlotte.carne@roehampton.ac.uk	Zuberbühler, Klaus/A-9053-2011	Zuberbühler, Klaus/0000-0001-8378-088X; Semple, Stuart/0000-0003-0452-8104; Lehmann, Julia/0000-0001-7278-1705	University of Roehampton; Royal Zoological Society of Scotland; Wildlife Conservation Society (WCS); US Fish and Wildlife Service Great Ape Conservation Fund; Orang-utan Tropical Peatland Project; Primate Conservation Inc.; L.S.B. Leakey Foundation	University of Roehampton; Royal Zoological Society of Scotland; Wildlife Conservation Society (WCS); US Fish and Wildlife Service Great Ape Conservation Fund(US Fish & Wildlife Service); Orang-utan Tropical Peatland Project; Primate Conservation Inc.; L.S.B. Leakey Foundation	Charlotte Carne was funded by a scholarship from the University of Roehampton (http://www.roehampton.ac.uk/home/). The Royal Zoological Society of Scotland (http://www.rzss.org.uk/) provided core funding for the Budongo Conservation Field Station. The orang-utan field research was funded by the Wildlife Conservation Society (WCS: http://www.wcs.org/), the US Fish and Wildlife Service Great Ape Conservation Fund (http://www.fws.gov/international/wildlife-without-borders/great-ape-conservationfund.html), Orang-utan Tropical Peatland Project (OuTrop: http://www.outrop.com/), Primate Conservation Inc. (http://www.primate.org/), and the L.S.B. Leakey Foundation (http://leakeyfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; BAXTER T, 1993, LANCET, V342, P371, DOI 10.1016/0140-6736(93)91516-O; Bermejo M, 2006, SCIENCE, V314, P1564, DOI 10.1126/science.1133105; Craft ME, 2011, INTERDISCIPLINARY PE, V2011; Cranfield MR, 2008, AM J PRIMATOL, V70, P751, DOI 10.1002/ajp.20564; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Cross Paul C., 2009, P9, DOI 10.1007/978-4-431-77134-0_2; Cross PC, 2004, ANN ZOOL FENN, V41, P879; Crowcroft NS, 2006, LANCET, V367, P1926, DOI 10.1016/S0140-6736(06)68848-X; Danon L., 2011, Interdisciplinary Perspectives on Infectious Diseases, V2011, P284909, DOI 10.1155/2011/284909; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Dowell SF, 1999, J INFECT DIS, V179, pS87, DOI 10.1086/514284; Duncan AJ, 2012, EPIDEMICS-NETH, V4, P117, DOI 10.1016/j.epidem.2012.04.003; GALDIKAS BMF, 1985, AM J PRIMATOL, V9, P101, DOI 10.1002/ajp.1350090204; Griffin RH, 2012, EVOL ECOL, V26, P779, DOI 10.1007/s10682-011-9526-2; Guimaraes PR, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.042901; Homsy J., 1999, APE TOURISM HUMAN DI; Kaur T, 2008, AM J PRIMATOL, V70, P755, DOI 10.1002/ajp.20565; Kaur T, 2008, AM J PRIMATOL, V70, P729, DOI 10.1002/ajp.20569; Kilbourn AM, 2003, J WILDLIFE DIS, V39, P73, DOI 10.7589/0090-3558-39.1.73; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Krutzen M, 2011, CURR BIOL, V21, P1808, DOI 10.1016/j.cub.2011.09.017; Leendertz Fabian H., 2006, PLoS Pathogens, V2, P1; Lukasik-Braum M, 2008, AM J PRIMATOL, V70, P734, DOI 10.1002/ajp.20568; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Mitani JC, 2002, EVOL ANTHROPOL, V11, P9, DOI 10.1002/evan.10008; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Muehlenbein MP, 2010, TRAVEL MED INFECT DI, V8, P169, DOI 10.1016/j.tmaid.2010.03.004; Nunn CL, 2006, INFECT DIS PRIMATES; Opsahl T, 2009, STRUCTURE EVOLUTION; Porphyre T, 2008, VET RES, V39, DOI 10.1051/vetres:2008007; Pusey AE, 2008, AM J PRIMATOL, V70, P738, DOI 10.1002/ajp.20567; Reynolds V., 2005, CHIMPANZEES BUDONGO; Rijksen HD, 1978, MEDEDELINGEN LANDBOU; Russon Anne E., 2009, P327; Team R. D. C, 2011, R LANG ENV STAT COMP; van Schaik Carel P., 2009, P299; van Schaik CP, 1999, PRIMATES, V40, P69, DOI 10.1007/BF02557703; Voelkl B, 2008, J THEOR BIOL, V252, P77, DOI 10.1016/j.jtbi.2008.02.002; Wallis J, 1999, INT J PRIMATOL, V20, P803, DOI 10.1023/A:1020879700286; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2007, PHILOS T R SOC B, V362, P603, DOI 10.1098/rstb.2006.1998; Williams JM, 2008, AM J PRIMATOL, V70, P766, DOI 10.1002/ajp.20573; Wolfe ND, 2002, VECTOR-BORNE ZOONOT, V2, P97, DOI 10.1089/153036602321131896; Wrangham R W, 1980, J Reprod Fertil Suppl, VSuppl 28, P13	45	20	20	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95039	10.1371/journal.pone.0095039	http://dx.doi.org/10.1371/journal.pone.0095039			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740263	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900096
J	Chen, XP; Chen, WF; Wang, DW				Chen, Xiao-Ping; Chen, Wei-Feng; Wang, Da-Wei			Prenatal Organophosphates Exposure Alternates the Cleavage Plane Orientation of Apical Neural Progenitor in Developing Neocortex	PLOS ONE			English	Article							CHLORPYRIFOS-OXON; DEVELOPMENTAL NEUROTOXICITY; BEHAVIORAL ALTERATIONS; SPINDLE ORIENTATION; TARGETS; BRAIN; RATS; INSECTICIDES; MECHANISMS; APOPTOSIS	Prenatal organophosphate exposure elicits long-term brain cytoarchitecture and cognitive function impairments, but the mechanism underlying the onset and development of neural progenitors remain largely unclear. Using precise positioned brain slices, we observed an alternated cleavage plane bias that emerged in the mitotic neural progenitors of embryonal neocortex with diazinion (DZN) and chlorpyrifos (CPF) pretreatment. In comparison with the control, DZN and CPF treatment induced decrease of vertical orientation, increase of oblique orientation, and increase of horizontal orientation. That is, the cleavage plane orientation bias had been rotated from vertical to horizontal after DZN and CPF treatment. Meanwhile, general morphology and mitotic index of the progenitors were unchanged. Acephate (ACP), another common organophosphate, had no significant effects on the cleavage plane orientation, cell morphology and mitotic index. These results represent direct evidence for the toxicity mechanism in onset multiplication of neural progenitors.	[Chen, Xiao-Ping; Chen, Wei-Feng; Wang, Da-Wei] Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China	Zhejiang University of Technology	Chen, XP (corresponding author), Zhejiang Univ Technol, Coll Biol & Environm Engn, Hangzhou, Zhejiang, Peoples R China.	chxp@zjut.edu.cn	Chen, Wei/GZK-7348-2022		National Natural Science Foundation of China (NSFC) [81241097, 30972446]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC, 81241097,30972446). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JE, 2005, ENVIRON HEALTH PERSP, V113, P527, DOI 10.1289/ehp.7867; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Caughlan A, 2004, TOXICOL SCI, V78, P125, DOI 10.1093/toxsci/kfh038; Chen XP, 2012, BRAIN RES, V1474, P19, DOI 10.1016/j.brainres.2012.07.036; Chen XP, 2011, J APPL TOXICOL, V31, P355, DOI 10.1002/jat.1598; Colborn T, 2006, ENVIRON HEALTH PERSP, V114, P10, DOI 10.1289/ehp.7940; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Garcia SJ, 2002, DEV BRAIN RES, V133, P151, DOI 10.1016/S0165-3806(02)00283-3; Garcia SJ, 2001, BRAIN RES, V891, P54, DOI 10.1016/S0006-8993(00)03189-9; Gearhart DA, 2007, TOXICOL APPL PHARM, V218, P20, DOI 10.1016/j.taap.2006.10.008; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Grigoryan H, 2009, TOXICOL APPL PHARM, V240, P143, DOI 10.1016/j.taap.2009.07.015; Haydar TF, 2003, P NATL ACAD SCI USA, V100, P2890, DOI 10.1073/pnas.0437969100; Howard AS, 2005, TOXICOL APPL PHARM, V207, P112, DOI 10.1016/j.taap.2004.12.008; Icenogle LM, 2004, NEUROTOXICOL TERATOL, V26, P95, DOI 10.1016/j.ntt.2003.09.001; Jameson RR, 2006, ENVIRON HEALTH PERSP, V114, P667, DOI 10.1289/ehp.8750; Jiang W, 2010, TOXICOL SCI, V115, P183, DOI 10.1093/toxsci/kfq032; Karanth S, 2006, TOXICOL APPL PHARM, V216, P150, DOI 10.1016/j.taap.2006.04.006; Lancaster MA, 2012, CURR OPIN NEUROBIOL, V22, P737, DOI 10.1016/j.conb.2012.04.003; Levin ED, 2002, NEUROTOXICOL TERATOL, V24, P733, DOI 10.1016/S0892-0362(02)00272-6; Mense SM, 2006, TOXICOL SCI, V93, P125, DOI 10.1093/toxsci/kfl046; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Prendergast MA, 2007, NEUROSCIENCE, V146, P330, DOI 10.1016/j.neuroscience.2007.01.023; Rauh VA, 2012, P NATL ACAD SCI USA, V109, P7871, DOI 10.1073/pnas.1203396109; Roy TS, 1998, TERATOLOGY, V58, P62, DOI 10.1002/(SICI)1096-9926(199808)58:2<62::AID-TERA7>3.0.CO;2-2; Roya TS, 2004, DEV BRAIN RES, V148, P197, DOI 10.1016/j.devbrainres.2003.12.004; Rush T, 2010, NEUROSCIENCE, V166, P899, DOI 10.1016/j.neuroscience.2010.01.025; Saulsbury MD, 2009, TOXICOLOGY, V259, P1, DOI 10.1016/j.tox.2008.12.026; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Slotkin TA, 2006, ENVIRON HEALTH PERSP, V114, P746, DOI 10.1289/ehp.8828; Slotkin TA, 2007, REPROD TOXICOL, V23, P421, DOI 10.1016/j.reprotox.2006.07.010; Slotkin TA, 2010, NEUROTOXICOL TERATOL, V32, P124, DOI 10.1016/j.ntt.2009.12.001; SMART IHM, 1973, J ANAT, V116, P67; Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026; Zurich MG, 2004, TOXICOL APPL PHARM, V201, P97, DOI 10.1016/j.taap.2004.05.003	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95343	10.1371/journal.pone.0095343	http://dx.doi.org/10.1371/journal.pone.0095343			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740262	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900132
J	Lu, HP; Li, Z; Fu, SL; Mendez, A; Gasco, G; Paz-Ferreiro, J				Lu, Huanping; Li, Zhian; Fu, Shenglei; Mendez, Ana; Gasco, Gabriel; Paz-Ferreiro, Jorge			Can Biochar and Phytoextractors Be Jointly Used for Cadmium Remediation?	PLOS ONE			English	Article							HEAVY-METALS; CONTAMINATED SOILS; ORGANIC-MATTER; SEWAGE-SLUDGE; PHYTOREMEDIATION; PYROLYSIS; PLANTS; BIOAVAILABILITY; AVAILABILITY; ACCUMULATION	Phytoremediation of soils contaminated with cadmium was tested after liming (CaO) or biochar addition, using red amaranth (Amaranthus tricolor L.) as test plant species. Two biochars with contrasting characteristics were prepared from two feedstocks and added to the soil at a rate of 3% (w:w): Eucalyptus pyrolysed at 600 degrees C (EB) and poultry litter at 400 degrees C (PLB). Liming was carried out in two treatments (CaO1) and (CaO2) to the same pH as the treatments EB and PLB respectively. Total plant mass increased in soils amended with PLB and with a mixture of PLB and EB; however this was not sufficient to increase the efficiency of phytoextraction. Bioavailable and mobile fractions of Cd diminished after liming or biochar addition. Our study infers that, both the amount of Cd immobilized and the main mechanism responsible for this immobilization varies according to biochar properties.	[Lu, Huanping; Li, Zhian; Fu, Shenglei; Paz-Ferreiro, Jorge] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Lu, Huanping] Univ Chinese Acad Sci, Beijing, Peoples R China; [Mendez, Ana] Univ Politecn Madrid, Dept Ingn Mat, Madrid, Spain; [Gasco, Gabriel; Paz-Ferreiro, Jorge] Univ Politecn Madrid, Dept Edafol, Madrid, Spain	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Li, Z (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China.	lizan@scbg.ac.cn	Fu, Shenglei/B-2729-2012; Paz-Ferreiro, Jorge/H-6297-2011; Méndez, Ana María/L-5946-2014	Paz-Ferreiro, Jorge/0000-0001-8169-4099; Méndez, Ana María/0000-0001-9642-0875	Chinese Academy of Sciences [2012Y1SA0002]; National Natural Science Foundation of China [40871221, 41301571]; Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology [2013K0008]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology	J. Paz-Ferreiro was sponsored by the Chinese Academy of Sciences (fellowship for young international scientists number 2012Y1SA0002). The authors acknowledge support from the National Natural Science Foundation of China (No. 40871221 and No. 41301571), and the Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology (2013K0008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano DC, 2004, GEODERMA, V122, P121, DOI 10.1016/j.geoderma.2004.01.003; Ali H, 2013, CHEMOSPHERE, V91, P869, DOI 10.1016/j.chemosphere.2013.01.075; Bian RJ, 2013, ECOL ENG, V58, P378, DOI 10.1016/j.ecoleng.2013.07.031; Chan KY, 2008, AUST J SOIL RES, V46, P437, DOI 10.1071/SR08036; de Abreu CA, 2012, J GEOCHEM EXPLOR, V123, P3, DOI 10.1016/j.gexplo.2012.04.013; Downie A., 2009, BIOCHAR ENV MANAGEME; Fellet G, 2014, SCI TOTAL ENVIRON, V468, P598, DOI 10.1016/j.scitotenv.2013.08.072; Gabos MB, 2011, REV BRAS ENG AGR AMB, V15, P1298, DOI 10.1590/S1415-43662011001200012; Gasco G, 2012, J THERM ANAL CALORIM, V108, P769, DOI 10.1007/s10973-011-2116-2; Houben D, 2013, BIOMASS BIOENERG, V57, P196, DOI 10.1016/j.biombioe.2013.07.019; Houben D, 2013, CHEMOSPHERE, V92, P1450, DOI 10.1016/j.chemosphere.2013.03.055; Ji PH, 2011, ENVIRON POLLUT, V159, P762, DOI 10.1016/j.envpol.2010.11.029; Joseph S, 2013, CARBON MANAG, V4, P323, DOI [10.4155/CMT.13.23, 10.4155/cmt.13.23]; Kabata-Pendias A., 2007, TRACE ELEMEN SOIL HU, DOI [10.1007/978-3-540-32714-1, DOI 10.1007/978-3-540-32714-1, 10.1007/978-3-540-32714-1_20]; Kameyama K, 2012, J ENVIRON QUAL, V41, P1131, DOI 10.2134/jeq2010.0453; Komarek M, 2013, ENVIRON POLLUT, V172, P9, DOI 10.1016/j.envpol.2012.07.045; Kookana RS, 2011, ADV AGRON, V112, P103, DOI 10.1016/B978-0-12-385538-1.00003-2; Lindsey WL, 1969, AGR ABSTR, V61, P84; Liu XY, 2013, PLANT SOIL, V373, P583, DOI 10.1007/s11104-013-1806-x; McGrath SP, 2003, CURR OPIN BIOTECH, V14, P277, DOI 10.1016/S0958-1669(03)00060-0; Mendez A, 2005, CHEM ENG J, V108, P169, DOI 10.1016/j.cej.2005.01.015; Mendez A, 2012, CHEMOSPHERE, V89, P1354, DOI 10.1016/j.chemosphere.2012.05.092; Mohan D, 2007, J COLLOID INTERF SCI, V310, P57, DOI 10.1016/j.jcis.2007.01.020; Namgay T, 2010, AUST J SOIL RES, V48, P638, DOI 10.1071/SR10049; Park JH, 2011, PLANT SOIL, V348, P439, DOI 10.1007/s11104-011-0948-y; Paz-Ferreiro J, 2014, SOLID EARTH, V5, P65, DOI 10.5194/se-5-65-2014; Paz-Ferreiro J, 2014, J SOIL SEDIMENT, V14, P483, DOI 10.1007/s11368-013-0806-z; Rouquerol F., 1999, ADSORPTION POWDERS P; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Uchimiya M, 2011, J HAZARD MATER, V190, P432, DOI 10.1016/j.jhazmat.2011.03.063; Uchimiya M, 2010, CHEMOSPHERE, V80, P935, DOI 10.1016/j.chemosphere.2010.05.020; Ure A.M., 1995, TEC INSTR A, P505; Watanabe T, 2009, COMMUN SOIL SCI PLAN, V40, P3158, DOI 10.1080/00103620903261676; Yoon J, 2006, SCI TOTAL ENVIRON, V368, P456, DOI 10.1016/j.scitotenv.2006.01.016; Yu XY, 2009, CHEMOSPHERE, V76, P665, DOI 10.1016/j.chemosphere.2009.04.001; Zacchini M, 2009, WATER AIR SOIL POLL, V197, P23, DOI 10.1007/s11270-008-9788-7; Zhuang P, 2007, WATER AIR SOIL POLL, V184, P235, DOI 10.1007/s11270-007-9412-2	37	49	50	2	134	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95218	10.1371/journal.pone.0095218	http://dx.doi.org/10.1371/journal.pone.0095218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740346	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900119
J	Bayo, J; Fiore, E; Aquino, JB; Malvicini, M; Rizzo, M; Peixoto, E; Andriani, O; Alaniz, L; Piccioni, F; Bolontrade, M; Podhajcer, O; Garcia, MG; Mazzolini, G				Bayo, Juan; Fiore, Esteban; Aquino, Jorge B.; Malvicini, Mariana; Rizzo, Manglio; Peixoto, Estanislao; Andriani, Oscar; Alaniz, Laura; Piccioni, Flavia; Bolontrade, Marcela; Podhajcer, Osvaldo; Garcia, Mariana G.; Mazzolini, Guillermo			Increased Migration of Human Mesenchymal Stromal Cells by Autocrine Motility Factor (AMF) Resulted in Enhanced Recruitment towards Hepatocellular Carcinoma	PLOS ONE			English	Article							STEM-CELLS; GENE-EXPRESSION; IN-VITRO; MATRIX METALLOPROTEINASE-3; INFLAMMATORY CYTOKINES; UP-REGULATION; TISSUE; ACTIVATION; RECEPTOR; GROWTH	Background and Aims: Several reports described the migration of human mesenchymal stromal cells (MSCs) towards tumor-released factors. Autocrine motility factor (AMF) is produced by several tumors including hepatocellular carcinoma (HCC). The aim of this study was to analyze AMF involvement on MSC migration towards human HCC. Methods: Production of AMF by HCC tumors was evaluated by western analysis. The effects of AMF on MSCs from different sources (bone marrow, adipose tissue and perivascular cells from umbilical cord) were analyzed using in vitro migration assay; metalloproteinase 2 (MMP2) activity and expression of critical genes were studied by zymography and qRT-PCR, respectively. To assess AMF involvement on the in vivo MSC migration, noninvasive fluorescence imaging was performed. To test the effect of AMF-primed MSCs on tumor development, in vitro proliferation and spheroids growth and in vivo tumor volume were evaluated. Results: AMF produced by HCC was found to induce migration of different MSCs in vitro and to enhance their MMP2 activity. Stimulation of MSCs with recombinant AMF (rAMF) also induced the in vitro adhesion to endothelial cells in coincidence with changes in the expression levels of MMP3, AMF receptor, caveolin-1, and -2 and GDI-2. Importantly, stimulation of MSCs with rAMF increased the in vivo migration of MSCs towards experimental HCC tumors. AMF-priming of MSCs did not induce a pro-tumorigenic effect on HCC cells neither in vivo nor in vitro. Conclusion: AMF plays a role in MSC recruitment towards HCC. However, its ability to increase MSC migration to HCC for therapeutic purposes merits further evaluation.	[Bayo, Juan; Fiore, Esteban; Aquino, Jorge B.; Malvicini, Mariana; Rizzo, Manglio; Peixoto, Estanislao; Alaniz, Laura; Piccioni, Flavia; Garcia, Mariana G.; Mazzolini, Guillermo] Univ Austral, Fac Ciencias Biomed, Gene Therapy Lab, Buenos Aires, DF, Argentina; [Aquino, Jorge B.; Alaniz, Laura; Bolontrade, Marcela; Podhajcer, Osvaldo; Garcia, Mariana G.; Mazzolini, Guillermo] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Andriani, Oscar; Mazzolini, Guillermo] Univ Austral, Hosp Univ Austral, Liver Unit, Derqui Pilar, Argentina; [Bolontrade, Marcela; Podhajcer, Osvaldo] Fdn Inst Leloir, Mol & Cellular Therapy Lab, Buenos Aires, DF, Argentina	Austral University; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Austral University; Hospital Universitario Austral; Leloir Institute	Mazzolini, G (corresponding author), Univ Austral, Fac Ciencias Biomed, Gene Therapy Lab, Buenos Aires, DF, Argentina.	gmazzoli@cas.austral.edu.ar	, Ph.D/K-4540-2019; Alaniz, Laura/AAM-2676-2020	Alaniz, Laura/0000-0002-6070-6078; Fiore, Esteban/0000-0003-1059-1695; Aquino, Jorge B/0000-0002-3818-5181; Bolontrade, Marcela/0000-0002-8664-5541; Bayo Fina, Juan Miguel/0000-0003-3999-0841; podhajcer, osvaldo/0000-0002-6512-8553	Austral University [I04-12, T13-12, T13-11]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) [PICT-2007/00082, PICTO 2008/00115, PICT 2008/00123, PICTO 2008/00122, PICT 2010/2818]	Austral University; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT)	This work was supported by grants from Austral University (for JB I04-12; for MGG T13-12 and for GM T13-11) and from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT) grants PICT-2007/00082 (MGG and GM); PICTO 2008/00115 (MGG); PICT 2008/00123 (JA); PICTO 2008/00122 (JA); PICT 2010/2818 (MGG and GM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMANN M, 1990, CANCER INVEST, V8, P351, DOI 10.3109/07357909009012053; Bayo J., 2013, LIVER INT; Bernardo ME, 2009, ANN NY ACAD SCI, V1176, P101, DOI 10.1111/j.1749-6632.2009.04607.x; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; Dobashi Y, 2006, J PATHOL, V210, P431, DOI 10.1002/path.2069; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ferenci P, 2010, J GASTROINTEST LIVER, V19, P311; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Gao Y, 2010, ONCOGENE, V29, P2784, DOI 10.1038/onc.2010.38; Garcia MG, 2011, MOL PHARMACEUT, V8, P1538, DOI 10.1021/mp200137c; Haga A, 2008, FEBS LETT, V582, P1877, DOI 10.1016/j.febslet.2008.05.005; Hu J, 2009, CANCER RES, V69, P6951, DOI 10.1158/0008-5472.CAN-09-0541; Kalwitz G, 2009, INT J BIOCHEM CELL B, V41, P649, DOI 10.1016/j.biocel.2008.07.011; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; LIOTTA LA, 1986, P NATL ACAD SCI USA, V83, P3302, DOI 10.1073/pnas.83.10.3302; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Niess H, 2011, ANN SURG, V254, P767, DOI 10.1097/SLA.0b013e3182368c4f; Ogata R, 1999, HUM PATHOL, V30, P443, DOI 10.1016/S0046-8177(99)90121-1; Prockop DJ, 2012, J CELL BIOCHEM, V113, P1460, DOI 10.1002/jcb.24046; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; de Lope CR, 2012, J HEPATOL, V56, pS75, DOI 10.1016/S0168-8278(12)60009-9; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; SILLETTI S, 1991, CANCER RES, V51, P3507; Tapper J, 2001, CANCER GENET CYTOGEN, V128, P1, DOI 10.1016/S0165-4608(01)00386-7; Tondreau T, 2009, CYTOTHERAPY, V11, P559, DOI 10.1080/14653240903051541; Torimura T, 2001, HEPATOLOGY, V34, P62, DOI 10.1053/jhep.2001.25546; Tsutsumi S, 2003, CANCER RES, V63, P242; Tsutsumi S, 2002, CANCER RES, V62, P4484; Watanabe H, 1996, CANCER RES, V56, P2960; WATANABE H, 1991, J BIOL CHEM, V266, P13442; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yanagawa T, 2004, LAB INVEST, V84, P513, DOI 10.1038/labinvest.3700057; Yu FL, 2004, BIOCHEM BIOPH RES CO, V314, P76, DOI 10.1016/j.bbrc.2003.12.056; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	37	34	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95171	10.1371/journal.pone.0095171	http://dx.doi.org/10.1371/journal.pone.0095171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736611	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600150
J	Deng, ZD; Southall, BL; Carlson, TJ; Xu, JS; Martinez, JJ; Weiland, MA; Ingraham, JM				Deng, Z. Daniel; Southall, Brandon L.; Carlson, Thomas J.; Xu, Jinshan; Martinez, Jayson J.; Weiland, Mark A.; Ingraham, John M.			200 kHz Commercial Sonar Systems Generate Lower Frequency Side Lobes Audible to Some Marine Mammals	PLOS ONE			English	Article							DESIGN	The spectral properties of pulses transmitted by three commercially available 200 kHz echo sounders were measured to assess the possibility that marine mammals might hear sound energy below the center (carrier) frequency that may be generated by transmitting short rectangular pulses. All three sounders were found to generate sound at frequencies below the center frequency and within the hearing range of some marine mammals, e. g. killer whales, false killer whales, beluga whales, Atlantic bottlenose dolphins, harbor porpoises, and others. The frequencies of these sub-harmonic sounds ranged from 90 to 130 kHz. These sounds were likely detectable by the animals over distances up to several hundred meters but were well below potentially harmful levels. The sounds generated by the sounders could potentially affect the behavior of marine mammals within fairly close proximity to the sources and therefore the exclusion of echo sounders from environmental impact analysis based solely on the center frequency output in relation to the range of marine mammal hearing should be reconsidered.	[Deng, Z. Daniel; Carlson, Thomas J.; Xu, Jinshan; Martinez, Jayson J.; Weiland, Mark A.; Ingraham, John M.] Pacific NW Natl Lab, Energy & Environm Directorate, Richland, WA 99352 USA; [Southall, Brandon L.] Southall Environm Associates, Aptos, CA USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Deng, ZD (corresponding author), Pacific NW Natl Lab, Energy & Environm Directorate, Richland, WA 99352 USA.	Zhiqun.deng@pnnl.gov	Deng, Zhiqun Daniel/A-9536-2011	Deng, Zhiqun Daniel/0000-0002-8300-8766	U.S. Department of Energy Office of Energy Efficiency and Renewable Energy (EERE) Wind and Water Power Program	U.S. Department of Energy Office of Energy Efficiency and Renewable Energy (EERE) Wind and Water Power Program	This study was funded by the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy (EERE) Wind and Water Power Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainslie MA, 1998, J ACOUST SOC AM, V103, P1671, DOI 10.1121/1.421258; Au W.L.W., 2008, PRINCIPLES MARINE BI, P337, DOI [10.1007/978-0-387-78365-9_9, DOI 10.1007/978-0-387-78365-9_9, DOI 10.1007/978-0-387-78365-9]; Deng ZD, 2013, MAR TECHNOL SOC J, V47, P113; DENG ZD, 2011, OC 2011 KON HAW 19 2; Deng ZQ, 2010, SENSORS-BASEL, V10, P3090, DOI 10.3390/s100403090; Ellison WT, 2012, CONSERV BIOL, V26, P21, DOI 10.1111/j.1523-1739.2011.01803.x; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; JOHNSON CS, 1968, J ACOUST SOC AM, V43, P757, DOI 10.1121/1.1910893; Li SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029793; Melcon ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032681; Miller PJO, 2014, J ACOUST SOC AM, V135, P975, DOI 10.1121/1.4861346; NRC, 2003, OC NOIS MAR MAMM; Pirotta E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042535; Popper AN, 2009, INTEGR ZOOL, V4, P43, DOI 10.1111/j.1749-4877.2008.00134.x; Sole M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078825; Southall B. L., 2008, AQUAT MAMM, V17, P273, DOI [DOI 10.1578/AM.33.4.2007.411, 10.1578/AM, DOI 10.1578/AM]; Szymanski MD, 1999, J ACOUST SOC AM, V106, P1134, DOI 10.1121/1.427121; Tyack PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017009	18	13	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95315	10.1371/journal.pone.0095315	http://dx.doi.org/10.1371/journal.pone.0095315			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736608	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600168
J	Knudson, SE; Awasthi, D; Kumar, K; Carreau, A; Goullieux, L; Lagrange, S; Vermet, H; Ojima, I; Slayden, RA				Knudson, Susan E.; Awasthi, Divya; Kumar, Kunal; Carreau, Alexandra; Goullieux, Laurent; Lagrange, Sophie; Vermet, Helen; Ojima, Iwao; Slayden, Richard A.			A Trisubstituted Benzimidazole Cell Division Inhibitor with Efficacy against Mycobacterium tuberculosis	PLOS ONE			English	Article							DRUG DISCOVERY; GENOME SEQUENCE; FTSZ; AGENTS; SYSTEM; TARGET	Trisubstituted benzimidazoles have demonstrated potency against Gram-positive and Gram-negative bacterial pathogens. Previously, a library of novel trisubstituted benzimidazoles was constructed for high throughput screening, and compounds were identified that exhibited potency against M. tuberculosis H37Rv and clinical isolates, and were not toxic to Vero cells. A new series of 2-cyclohexyl-5-acylamino-6-N, N-dimethylaminobenzimidazoles derivatives has been developed based on SAR studies. Screening identified compounds with potency against M. tuberculosis. A lead compound from this series, SB-P17G-A20, was discovered to have an MIC of 0.16 mg/mL and demonstrated efficacy in the TB murine acute model of infection based on the reduction of bacterial load in the lungs and spleen by 1.73 +/- 0.24 Log(10) CFU and 2.68 +/- Log(10) CFU, respectively, when delivered at 50 mg/kg by intraperitoneal injection (IP) twice daily (bid). The activity of SB-P17G-A20 was determined to be concentration dependent and to have excellent stability in mouse and human plasma, and liver microsomes. Together, these studies demonstrate that SB-P17G-A20 has potency against M. tuberculosis clinical strains with varying susceptibility and efficacy in animal models of infection, and that trisubstituted benzimidazoles continue to be a platform for the development of novel inhibitors with efficacy.	[Knudson, Susan E.; Slayden, Richard A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Awasthi, Divya; Ojima, Iwao] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Kumar, Kunal; Ojima, Iwao] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Carreau, Alexandra; Goullieux, Laurent; Lagrange, Sophie] Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, Toulouse, France; [Vermet, Helen] Sanofi Aventis R&D, Infect Dis Therapeut Strateg Unit, Montpellier, France	Colorado State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Sanofi-Aventis; Sanofi France; Sanofi-Aventis; Sanofi France	Slayden, RA (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	richard.slayden@ColoState.edu	Slayden, Richard/O-8626-2016; Slayden, Richard/AAV-2582-2021	Slayden, Richard/0000-0001-6857-7277; Slayden, Richard/0000-0001-6857-7277; Ojima, Iwao/0000-0002-3628-1161	National Institute of Health [AIO78251, AI082164]; Sanofi; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082164] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi(Sanofi-Aventis); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institute of Health (AIO78251 and AI082164). Sanofi funded its contribution. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi D, 2013, J MED CHEM, V56, P9756, DOI 10.1021/jm401468w; Boyne ME, 2007, ANTIMICROB AGENTS CH, V51, P3562, DOI 10.1128/AAC.00383-07; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; Huang Q, 2006, J MED CHEM, V49, P463, DOI 10.1021/jm050920y; Huang Q, 2007, CURR TOP MED CHEM, V7, P527, DOI 10.2174/156802607780059790; Kumar K, 2013, BIOORGAN MED CHEM, V21, P3318, DOI 10.1016/j.bmc.2013.02.059; Kumar K, 2011, J MED CHEM, V54, P374, DOI 10.1021/jm1012006; Kumar K, 2010, FUTURE MED CHEM, V2, P1305, DOI [10.4155/fmc.10.220, 10.4155/FMC.10.220]; Lenaerts AJM, 2003, ANTIMICROB AGENTS CH, V47, P783, DOI 10.1128/AAC.47.2.783-785.2003; Mathew B, 2013, TUBERCULOSIS, V93, P398, DOI 10.1016/j.tube.2013.04.002; Mathew B, 2011, BIOORGAN MED CHEM, V19, P7120, DOI 10.1016/j.bmc.2011.09.062; Migliori GB, 2007, EUROSURVEILLANCE, V12; Miyoshi-Akiyama T, 2012, J BACTERIOL, V194, P2770, DOI 10.1128/JB.00353-12; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Reddy VM, 2010, ANTIMICROB AGENTS CH, V54, P2840, DOI 10.1128/AAC.01601-09; Respicio L, 2008, TUBERCULOSIS, V88, P420, DOI 10.1016/j.tube.2008.03.001; Slayden RA, 2000, MOL MICROBIOL, V38, P514, DOI 10.1046/j.1365-2958.2000.02145.x; Slayden RA, 2006, MICROBIOL-SGM, V152, P1789, DOI 10.1099/mic.0.28762-0	19	19	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93953	10.1371/journal.pone.0093953	http://dx.doi.org/10.1371/journal.pone.0093953			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736743	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600037
J	Kurakula, K; Vos, M; Rubio, IO; Marinkovic, G; Buettner, R; Heukamp, LC; Stap, J; de Waard, V; van Tiel, CM; de Vries, CJM				Kurakula, Kondababu; Vos, Mariska; Rubio, Iker Otermin; Marinkovic, Goran; Buettner, Reinhard; Heukamp, Lukas C.; Stap, Jan; de Waard, Vivian; van Tiel, Claudia M.; de Vries, Carlie J. M.			The LIM-Only Protein FHL2 Reduces Vascular Lesion Formation Involving Inhibition of Proliferation and Migration of Smooth Muscle Cells	PLOS ONE			English	Article							NUCLEAR RECEPTOR NUR77; DOMAIN PROTEIN-2; STENT RESTENOSIS; BLOOD-FLOW; CYCLIN D1; ATHEROSCLEROSIS; ACTIVATION; DISEASE; TARGET; ARTERY	The LIM-only protein FHL2, also known as DRAL or SLIM3, has a function in fine-tuning multiple physiological processes. FHL2 is expressed in the vessel wall in smooth muscle cells (SMCs) and endothelial cells and conflicting data have been reported on the regulatory function of FHL2 in SMC phenotype transition. At present the function of FHL2 in SMCs in vascular injury is unknown. Therefore, we studied the role of FHL2 in SMC-rich lesion formation. In response to carotid artery ligation FHL2-deficient (FHL2-KO) mice showed accelerated lesion formation with enhanced Ki67 expression compared with wild-type (WT)-mice. Consistent with these findings, cultured SMCs from FHL2-KO mice showed increased proliferation through enhanced phosphorylation of extracellular-regulated kinase-1/2 (ERK1/2) and induction of CyclinD1 expression. Overexpression of FHL2 in SMCs inhibited CyclinD1 expression and CyclinD1-knockdown blocked the enhanced proliferation of FHL2-KO SMCs. We also observed increased CyclinD1 promoter activity in FHL2-KO SMCs, which was reduced upon ERK1/2 inhibition. Furthermore, FHL2-KO SMCs showed enhanced migration compared with WT SMCs. In conclusion, FHL2 deficiency in mice results in exacerbated SMC-rich lesion formation involving increased proliferation and migration of SMCs via enhanced activation of the ERK1/2-CyclinD1 signaling pathway.	[Kurakula, Kondababu; Vos, Mariska; Rubio, Iker Otermin; Marinkovic, Goran; de Waard, Vivian; van Tiel, Claudia M.; de Vries, Carlie J. M.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Buettner, Reinhard; Heukamp, Lukas C.] Univ Cologne, Inst Pathol, Cologne, Germany; [Stap, Jan] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Cologne; University of Amsterdam; Academic Medical Center Amsterdam	de Vries, CJM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.j.devries@amc.uva.nl	Marinkovic, Goran/ABC-6786-2020; Heukamp, Lukas/G-9967-2012	Heukamp, Lukas/0000-0002-3388-3482; Kurakula, Konda Babu/0000-0002-9830-6344; Marinkovic, Goran/0000-0002-3581-9900	BioMedical Materials institute; Dutch Ministry of Economic Affairs [P1.02 NEXTREAM]; Dutch Heart Foundation [2008B037]	BioMedical Materials institute; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Dutch Heart Foundation(Netherlands Heart Foundation)	This work was supported by the research program of the BioMedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs as a part of Project P1.02 NEXTREAM. This work was also supported by the Dutch Heart Foundation (grant No. 2008B037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann T, 2010, ONCOL REP, V23, P1669, DOI 10.3892/or_00000810; Bonta PI, 2010, CARDIOVASC RES, V87, P561, DOI 10.1093/cvr/cvq064; Braun-Dullaeus RC, 1998, CIRCULATION, V98, P82, DOI 10.1161/01.CIR.98.1.82; Chandrasekar B, 2000, J AM COLL CARDIOL, V35, P555, DOI 10.1016/S0735-1097(99)00596-3; Chu PH, 2010, LIFE SCI, V86, P365, DOI 10.1016/j.lfs.2010.01.007; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; GEISTERFER AAT, 1988, CIRC RES, V62, P749, DOI 10.1161/01.RES.62.4.749; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Goncharova EA, 2006, NAT PROTOC, V1, P2933, DOI 10.1038/nprot.2006.434; Hayashi H, 2009, ARTERIOSCL THROM VAS, V29, P909, DOI 10.1161/ATVBAHA.108.178541; Hinson JS, 2008, AM J PHYSIOL-HEART C, V295, pH1067, DOI 10.1152/ajpheart.91421.2007; Huang PH, 2013, ARTERIOSCL THROM VAS, V33, P709, DOI 10.1161/ATVBAHA.112.300318; Izumi Y, 2001, CIRC RES, V88, P1120, DOI 10.1161/hh1101.091267; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Kearney M, 1997, CIRCULATION, V95, P1998, DOI 10.1161/01.CIR.95.8.1998; Konig K, 2010, J IMMUNOL, V185, P1466, DOI 10.4049/jimmunol.0903449; Kong YF, 2001, CIRCULATION, V103, P2731; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Kurakula K, 2011, J BIOL CHEM, V286, P44336, DOI 10.1074/jbc.M111.308999; Labalette C, 2008, J BIOL CHEM, V283, P15201, DOI 10.1074/jbc.M800708200; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Molenaar JJ, 2010, ONCOGENE, V29, P2739, DOI 10.1038/onc.2010.21; Nelson PR, 1998, J VASC SURG, V27, P117, DOI 10.1016/S0741-5214(98)70298-8; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Ng CF, 2011, CANCER LETT, V304, P97, DOI 10.1016/j.canlet.2011.02.001; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Paul C, 2006, ONCOGENE, V25, P5475, DOI 10.1038/sj.onc.1209567; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; PICKERING JG, 1993, J CLIN INVEST, V91, P1469, DOI 10.1172/JCI116352; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Weintraub WS, 2007, AM J CARDIOL, V100, p3K, DOI 10.1016/j.amjcard.2007.06.002; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	35	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94931	10.1371/journal.pone.0094931	http://dx.doi.org/10.1371/journal.pone.0094931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736599	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600108
J	Li, JF; Qu, F; Zheng, SJ; Ren, JY; Wu, HL; Liu, M; Liu, H; Ren, F; Chen, Y; Zhang, JL; Duan, ZP				Li, Jun-Feng; Qu, Feng; Zheng, Su-Jun; Ren, Jin-Yu; Wu, Hui-Li; Liu, Mei; Liu, Hui; Ren, Feng; Chen, Yu; Zhang, Jin-Lan; Duan, Zhong-Ping			Plasma Sphingolipids as Potential Indicators of Hepatic Necroinflammation in Patients with Chronic Hepatitis C and Normal Alanine Aminotransferase Level	PLOS ONE			English	Article							ALPHA-GALACTOSYLCERAMIDE; PROGRESSION; MEMBRANE; FIBROSIS; THERAPY; TARGET; NEED	Accurate estimation of hepatic necroinflammation caused by chronic hepatitis C (CHC) is crucial for prediction of prognosis and design of therapeutic strategy, which is particularly true for CHC patients with normal alanine aminotransferase (ALT) level. Recent studies have shown that sphingolipids have a close relationship with hepatitis C virus infection. The present study aimed to identify plasma sphingolipids related to hepatic necroinflammation. We included 120 treatment-naive CHC patients and 64/120 had normal ALT levels (<40 U/L). CHC patients who underwent liver biopsies were subjected to Scheuer scoring analysis for scope of hepatic inflammation. Plasma sphingolipids were detected by high-performance liquid chromatography tandem mass spectrometry. Our results showed 44 plasma sphingolipids were detected altogether. Of all detected sphingolipids, hexosylceramide (HexCer) (d18:1/22:0) and HexCer (d18:1/24:0) showed a significant difference among G0/G1, G2, and G3/G4 (P<0.05). For identifying hepatic necroinflammation (G >= 2), after adjusting other factors, the odds ratio (OR) of HexCer (d18:1/22:0) reached 1.01 (95% confidence interval [CI]:1.00-1.02). Furthermore, the area under the curve (AUC) of HexCer (d18:1/22:0) was 0.7 (P = 0.01) and approached that of ALT (AUC = 0.78). However, in CHC patients with normal ALT, HexCer (d18:1/22:0) was an independent factor (OR:1.02, 95% CI:1.01-1.03) to identify the hepatic necroinflammation (G >= 2). HexCer (d18:1/22:0) not only showed the largest AUC (0.78, P = 0.001), but also exhibited the highest specificity of all indicators. These results indicate that plasma HexCer (d18:1/22:0) is a potential indicator to distinguish hepatic necroinflammation in CHC patients. For CHC with normal ALT, the ability of HexCer (d18:1/22:0) to distinguish hepatic necroinflammation might be superior to conventional serum indicators.	[Li, Jun-Feng] Lanzhou Univ, Clin Med Sch 1, Lanzhou 730000, Peoples R China; [Li, Jun-Feng; Zheng, Su-Jun; Wu, Hui-Li; Liu, Mei; Ren, Feng; Chen, Yu; Duan, Zhong-Ping] Capital Med Univ, Beijing YouAn Hosp, Artificial Liver Ctr, Beijing, Peoples R China; [Qu, Feng; Zhang, Jin-Lan] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China; [Qu, Feng; Zhang, Jin-Lan] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ren, Jin-Yu] Kansas Coll Chinese Med, Evergreen Wellness Ctr, Wichita, KS USA; [Liu, Hui] Capital Med Univ, Beijing YouAn Hosp, Dept Pathol, Beijing, Peoples R China	Lanzhou University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University	Zhang, JL (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100730, Peoples R China.	zhjl@imm.ac.cn; duan2517@163.com	Qu, Feng/L-6355-2013	Qu, Feng/0000-0002-3812-0732	National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment" [2012ZX10002004-006, 2012ZX10004904-003-001, 2013ZX10002002-006]; Ministry of Science and Technology of People's Republic of China [2012ZX09301002-006]; High Technical Personnel Training Item in Beijing Health System [2011-3-083]; Beijing Municipal Science & Technology Commission [Z131107002213019]; Special Scientific Research Fund for Beijing Health Development [2011-2018-04]; YouAn Scientific Research Fund for Liver Disease and HIV/AIDS [BJYAH-2011-045]	National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment"; Ministry of Science and Technology of People's Republic of China(Ministry of Science and Technology, China); High Technical Personnel Training Item in Beijing Health System; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Special Scientific Research Fund for Beijing Health Development; YouAn Scientific Research Fund for Liver Disease and HIV/AIDS	This study is supported by the National Science and Technology Key Project on "Major Infectious Diseases such as HIV/AIDS, Viral Hepatitis Prevention and Treatment" (2012ZX10002004-006, 2012ZX10004904-003-001, 2013ZX10002002-006); Ministry of Science and Technology of People's Republic of China (2012ZX09301002-006); the High Technical Personnel Training Item in Beijing Health System (2011-3-083); the Beijing Municipal Science & Technology Commission (No. Z131107002213019); the Special Scientific Research Fund for Beijing Health Development (2011-2018-04); and YouAn Scientific Research Fund for Liver Disease and HIV/AIDS (BJYAH-2011-045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Ascione Antonio, 2007, Dig Liver Dis, V39 Suppl 1, pS4, DOI 10.1016/S1590-8658(07)80003-X; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Fontaine H, 2001, HUM PATHOL, V32, P904, DOI 10.1053/hupa.2001.28228; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Ghany MG, 2003, GASTROENTEROLOGY, V124, P97, DOI 10.1053/gast.2003.50018; Hawkes DJ, 2006, CURR DRUG TARGETS, V7, P1615, DOI 10.2174/138945006779025455; Hepatotogy Branch Infectious and Parasitology branch Chinese Medical Association, 2004, Zhonghua Yu Fang Yi Xue Za Zhi, V38, P210; Ikeda H, 2010, CLIN CHIM ACTA, V411, P765, DOI 10.1016/j.cca.2010.02.063; Inui T, 2005, J HEPATOL, V43, P670, DOI 10.1016/j.jhep.2005.02.027; Jones BE, 1999, HEPATOLOGY, V30, P215, DOI 10.1002/hep.510300146; Lagging LM, 2002, LIVER, V22, P136, DOI 10.1034/j.1600-0676.2002.01623.x; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Marcellin P, 1997, HEPATOLOGY, V26, pS133, DOI 10.1002/hep.510260723; Mari M, 2007, LIVER INT, V27, P440, DOI 10.1111/j.1478-3231.2007.01475.x; Okanoue T, 2005, J HEPATOL, V43, P599, DOI 10.1016/j.jhep.2005.04.008; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Qu F, 2014, ANAL BIOANAL CHEM, V406, P555, DOI 10.1007/s00216-013-7479-8; Qu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052454; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Sanai FM, 2008, LIVER INT, V28, P1011, DOI 10.1111/j.1478-3231.2008.01733.x; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Tassopoulos NC, 1999, J HEPATOL, V31, P193, DOI 10.1016/S0168-8278(99)80400-0; Umehara T, 2006, BIOCHEM BIOPH RES CO, V346, P67, DOI 10.1016/j.bbrc.2006.05.085	28	8	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95095	10.1371/journal.pone.0095095	http://dx.doi.org/10.1371/journal.pone.0095095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736528	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600145
J	Paulus, P; Rupprecht, K; Baer, P; Obermuller, N; Penzkofer, D; Reissig, C; Scheller, B; Holfeld, J; Zacharowski, K; Dimmeler, S; Schlammes, J; Urbschat, A				Paulus, Patrick; Rupprecht, Katrin; Baer, Patrick; Obermueller, Nicholas; Penzkofer, Daniela; Reissig, Christin; Scheller, Bertram; Holfeld, Johannes; Zacharowski, Kai; Dimmeler, Stefanie; Schlammes, Joelle; Urbschat, Anja			The Early Activation of Toll-Like Receptor (TLR)-3 Initiates Kidney Injury after Ischemia and Reperfusion	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; GELATINASE-ASSOCIATED LIPOCALIN; EXPRESSION; MECHANISMS; TLR2; RECOGNITION; HYPOXIA; DISEASE; DANGER; ROLES	Acute kidney injury (AKI) is one of the most important complications in hospitalized patients and its pathomechanisms are not completely elucidated. We hypothesize that signaling via toll-like receptor (TLR)-3, a receptor that is activated upon binding of double-stranded nucleotides, might play a crucial role in the pathogenesis of AKI following ischemia and reperfusion (IR). Male adult C57Bl6 wild-type (wt) mice and TLR-3 knock-out (-/-) mice were subjected to 30 minutes bilateral selective clamping of the renal artery followed by reperfusion for 30 min 2.5h and 23.5 hours or subjected to sham procedures. TLR-3 down-stream signaling was activated already within 3 h of ischemia and reperfusion in post-ischemic kidneys of wt mice lead to impaired blood perfusion followed by a strong pro-inflammatory response with significant neutrophil invasion. In contrast, this effect was absent in TLR-3-/-mice. Moreover, the quick TLR-3 activation resulted in kidney damage that was histomorphologically associated with significantly increased apoptosis and necrosis rates in renal tubules of wt mice. This finding was confirmed by increased kidney injury marker NGAL in wt mice and a better preserved renal perfusion after IR in TLR-3-/-mice than wt mice. Overall, the absence of TLR-3 is associated with lower cumulative kidney damage and maintained renal blood perfusion within the first 24 hours of reperfusion. Thus, we conclude that TLR-3 seems to participate in the pathogenesis of early acute kidney injury.	[Paulus, Patrick; Rupprecht, Katrin; Reissig, Christin; Scheller, Bertram; Zacharowski, Kai; Schlammes, Joelle] Goethe Univ Hosp Frankfurt, Dept Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany; [Baer, Patrick; Obermueller, Nicholas] Goethe Univ Hosp, Div Nephrol, Dept Internal Med 3, Frankfurt, Germany; [Penzkofer, Daniela; Dimmeler, Stefanie] Goethe Univ Frankfurt, Inst Cardiovasc Regenerat, D-60054 Frankfurt, Germany; [Holfeld, Johannes] Med Univ Innsbruck, Dept Cardiac Surg, A-6020 Innsbruck, Austria; [Urbschat, Anja] Univ Marburg, Fac Med, Marburg, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Medical University of Innsbruck; Philipps University Marburg	Paulus, P (corresponding author), Goethe Univ Hosp Frankfurt, Dept Anesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany.	patrick.paulus@kgu.de		Dimmeler, Stefanie/0000-0002-1045-2436; Holfeld, Johannes/0000-0001-6623-0595; Baer, Patrick/0000-0001-8113-3312	4 targets initiative from Bayer AG	4 targets initiative from Bayer AG	The work has emanated from an unrestricted research grant from the grants 4 targets initiative from Bayer AG to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Anders HJ, 2010, J AM SOC NEPHROL, V21, P1270, DOI 10.1681/ASN.2010030233; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Bellomo R, 2012, LANCET, V380, P756, DOI 10.1016/S0140-6736(11)61454-2; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Chen JL, 2011, KIDNEY INT, V79, P288, DOI 10.1038/ki.2010.381; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Gluba A, 2010, NAT REV NEPHROL, V6, P224, DOI 10.1038/nrneph.2010.16; Gonzalez-Villalobos R.A., 2013, J MOL MED; Hause L, 2007, ANTIVIR RES, V76, P159, DOI 10.1016/j.antiviral.2007.06.013; Hou L, 2000, INFECT IMMUN, V68, P4681, DOI 10.1128/IAI.68.8.4681-4687.2000; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Kusagaya H, 2013, AM J RESP CELL MOL B; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lote CJ, 1996, BRIT J ANAESTH, V77, P82, DOI 10.1093/bja/77.1.82; McKay DB, 2011, CRIT REV IMMUNOL, V31, P297, DOI 10.1615/CritRevImmunol.v31.i4.20; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Nguyen MT, 2008, PEDIATR NEPHROL, V23, P2151, DOI 10.1007/s00467-007-0470-x; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Obermuller N, 2013, INT UROLOGY NEPHROLO; Paulus P, 2006, CANCER RES, V66, P4349, DOI 10.1158/0008-5472.CAN-05-3523; Paulus P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073298; Paulus P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039265; Sabbatucci M, 2011, IMMUNOBIOLOGY, V216, P1135, DOI 10.1016/j.imbio.2011.04.005; Schafer R, 2003, CIRCULATION, V108, P1585, DOI 10.1161/01.CIR.0000091085.12422.19; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Shirali AC, 2008, J AM SOC NEPHROL, V19, P1444, DOI 10.1681/ASN.2008010123; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Toda N, 2013, BRIT J PHARMACOL, V168, P519, DOI 10.1111/j.1476-5381.2012.02194.x; Tsuboi N, 2002, J IMMUNOL, V169, P2026, DOI 10.4049/jimmunol.169.4.2026; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Urbschat A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084432; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Vanhoutte F, 2008, IMMUNOL LETT, V116, P86, DOI 10.1016/j.imlet.2007.11.014; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yang X, 2006, AM J PHYSIOL-HEART C, V291, pH2334, DOI 10.1152/ajpheart.00252.2006; Ympa YP, 2005, AM J MED, V118, P827, DOI 10.1016/j.amjmed.2005.01.069; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	45	29	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94366	10.1371/journal.pone.0094366	http://dx.doi.org/10.1371/journal.pone.0094366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736450	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600063
J	Ruggeri, P; Farina, AR; Di Ianni, N; Cappabianca, L; Ragone, M; Ianni, G; Gulino, A; Mackay, AR				Ruggeri, Pierdomenico; Farina, Antonietta R.; Di Ianni, Natalia; Cappabianca, Lucia; Ragone, Marzia; Ianni, Giulia; Gulino, Alberto; Mackay, Andrew R.			The TrkAIII Oncoprotein Inhibits Mitochondrial Free Radical ROS-Induced Death of SH-SY5Y Neuroblastoma Cells by Augmenting SOD2 Expression and Activity at the Mitochondria, within the Context of a Tumour Stem Cell-like Phenotype	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; NERVE GROWTH-FACTOR; NF-KAPPA-B; INDUCED APOPTOSIS; CANCER-CELLS; PC12 CELLS; TYROSINE PHOSPHORYLATION; TRANSCRIPTION FACTOR; ANTITUMOR-ACTIVITY; OXIDATIVE DAMAGE	The developmental and stress-regulated alternative TrkAIII splice variant of the NGF receptor TrkA is expressed by advanced stage human neuroblastomas (NBs), correlates with worse outcome in high TrkA expressing unfavourable tumours and exhibits oncogenic activity in NB models. In the present study, we report that constitutive TrkAIII expression in human SHSY5Y NB cells inhibits Rotenone, Paraquat and LY83583-induced mitochondrial free radical reactive oxygen species (ROS)mediated death by stimulating SOD2 expression, increasing mitochondrial SOD2 activity and attenuating mitochondrial free radical ROS production, in association with increased mitochondrial capacity to produce H2O2, within the context of a more tumour stem cell-like phenotype. This effect can be reversed by the specific TrkA tyrosine kinase inhibitor GW441756, by the multi-kinase TrkA inhibitors K252a, CEP-701 and Go6976, which inhibit SOD2 expression, and by siRNA knockdown of SOD2 expression, which restores the sensitivity of TrkAIII expressing SH-SY5Y cells to Rotenone, Paraquat and LY83583-induced mitochondrial free radical ROS production and ROS-mediated death. The data implicate the novel TrkAIII/SOD2 axis in promoting NB resistance to mitochondrial free radical-mediated death and staminality, and suggest that the combined use of TrkAIII and/or SOD2 inhibitors together with agents that induce mitochondrial free radical ROS-mediated death could provide a therapeutic advantage that may also target the stem cell niche in high TrkA expressing unfavourable NB.	[Ruggeri, Pierdomenico; Farina, Antonietta R.; Di Ianni, Natalia; Cappabianca, Lucia; Ragone, Marzia; Ianni, Giulia; Mackay, Andrew R.] Univ Aquila, Dept Appl Clin & Biotechnol Sci, I-67100 Laquila, Italy; [Di Ianni, Natalia] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, Latina, Italy; [Gulino, Alberto] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy	University of L'Aquila; Sapienza University Rome; Sapienza University Rome	Mackay, AR (corresponding author), Univ Aquila, Dept Appl Clin & Biotechnol Sci, I-67100 Laquila, Italy.	andrewreay.mackay@univaq.it	Di Ianni, Natalia/AAO-1506-2021	Di Ianni, Natalia/0000-0003-0820-0720; Mackay, Andrew Reay/0000-0001-7096-3759; FARINA, Antonietta Rosella/0000-0003-0962-6088; cappabianca, lucia/0000-0002-9112-1750	AIRC; Italian Ministery for University and Research "Progetti di ricerca di interesse natzionali" (PRIN); Maugeri Foundation; INAIL [PMS45/07]	AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Ministery for University and Research "Progetti di ricerca di interesse natzionali" (PRIN)(Ministry of Education, Universities and Research (MIUR)); Maugeri Foundation; INAIL	This work was supported by grants from: AIRC; the Italian Ministery for University and Research "Progetti di ricerca di interesse natzionali" (PRIN); and the Maugeri Foundation. Dr. Natalia Di Ianni is a recipient of an INAIL research grant (PMS45/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Obeidi FA, 2000, ONCOGENE, V19, P5690, DOI 10.1038/sj.onc.1203926; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Arevalo JC, 2000, MOL CELL BIOL, V20, P5908, DOI 10.1128/MCB.20.16.5908-5916.2000; BARKER PA, 1993, J BIOL CHEM, V268, P15150; Baskic D, 2006, CELL BIOL INT, V30, P924, DOI 10.1016/j.cellbi.2006.06.016; Bedogni B, 2003, J BIOL CHEM, V278, P16510, DOI 10.1074/jbc.M301089200; Behrens MM, 1999, J NEUROCHEM, V72, P919, DOI 10.1046/j.1471-4159.1999.0720919.x; BERG MM, 1992, J BIOL CHEM, V267, P13; Bertuzzi A, 2010, B MATH BIOL, V72, P1069, DOI 10.1007/s11538-009-9482-y; Camoratto AM, 1997, INT J CANCER, V72, P673, DOI 10.1002/(SICI)1097-0215(19970807)72:4<673::AID-IJC20>3.0.CO;2-B; Cassano S, 2010, J BIOL CHEM, V285, P24141, DOI 10.1074/jbc.M109.098525; Cecere F, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/801726; Chang YT, 2002, CHEMBIOCHEM, V3, P897, DOI 10.1002/1439-7633(20020902)3:9<897::AID-CBIC897>3.0.CO;2-B; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Chaudhuri L, 2012, ONCOGENE, V31, P1207, DOI 10.1038/onc.2011.325; Connor KM, 2007, CANCER RES, V67, P10260, DOI 10.1158/0008-5472.CAN-07-1204; Cozzi R, 1997, CARCINOGENESIS, V18, P223, DOI 10.1093/carcin/18.1.223; Dayem Ahmed Abdal, 2010, Cancers (Basel), V2, P859, DOI 10.3390/cancers2020859; Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489; Dhar SK, 2012, FREE RADICAL BIO MED, V52, P2209, DOI 10.1016/j.freeradbiomed.2012.03.009; DRUBIN DG, 1985, J CELL BIOL, V101, P1799, DOI 10.1083/jcb.101.5.1799; Eggert A, 2002, CANCER RES, V62, P1802; Epperly M.W., 2003, GENE THER MOL BIOL, V7, P61; Farina AR, 2009, ONCOGENE, V28, P4075, DOI 10.1038/onc.2009.256; Farina AR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/740187; Farina AR, 2009, MOL CELL BIOL, V29, P4812, DOI 10.1128/MCB.00352-09; Farina AR, 2012, NEUROBLASTOMA PRESEN, P111; Fisher CJ, 2008, CANCER BIOL THER, V7, P1271, DOI 10.4161/cbt.7.8.6300; Hasegawa T, 2004, BBA-GEN SUBJECTS, V1670, P19, DOI 10.1016/j.bbagen.2003.10.008; Hempel N, 2009, FREE RADICAL BIO MED, V46, P42, DOI 10.1016/j.freeradbiomed.2008.09.020; Holley AK, 2012, AMINO ACIDS, V42, P139, DOI 10.1007/s00726-010-0600-9; Hosoki A, 2012, J RADIAT RES, V53, P58, DOI 10.1269/jrr.11034; Jung JE, 2009, J NEUROSCI, V29, P7003, DOI 10.1523/JNEUROSCI.1110-09.2009; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Keller JN, 1998, J NEUROSCI, V18, P687; Kim JW, 2008, BIOCHEM PHARMACOL, V76, P1577, DOI 10.1016/j.bcp.2008.08.007; Kiningham KK, 2008, FREE RADICAL BIO MED, V44, P1610, DOI 10.1016/j.freeradbiomed.2008.01.015; Kirkland RA, 2007, J NEUROSCI, V27, P11315, DOI 10.1523/JNEUROSCI.3590-07.2007; Knirsch L, 2001, BIOCHEMISTRY-US, V40, P7890, DOI 10.1021/bi010197n; Kuijpers M, 2011, MOL CELL NEUROSCI, V48, P349, DOI 10.1016/j.mcn.2011.05.004; LAVENIUS E, 1995, CELL GROWTH DIFFER, V6, P727; Lebovitz RM, 1996, P NATL ACAD SCI USA, V93, P9782, DOI 10.1073/pnas.93.18.9782; Lee JH, 2001, BBA-GEN SUBJECTS, V1526, P191, DOI 10.1016/S0304-4165(01)00126-X; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liu SF, 1999, CIRCULATION, V100, P1330, DOI 10.1161/01.CIR.100.12.1330; Lucarelli E, 1997, EUR J CANCER, V33, P2068, DOI 10.1016/S0959-8049(97)00266-9; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; Madhavan L, 2008, STEM CELLS, V26, P254, DOI 10.1634/stemcells.2007-0221; Madhavan L, 2006, STEM CELLS, V24, P2110, DOI 10.1634/stemcells.2006-0018; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Meco D, 2005, CANCER LETT, V228, P211, DOI 10.1016/j.canlet.2005.02.054; Melone MAB, 2009, CANCER BIOL THER, V8, P1300, DOI 10.4161/cbt.8.13.8890; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Miriyala S, 2011, ANTI-CANCER AGENT ME, V11, P181, DOI 10.2174/187152011795255920; Mohr A, 2008, ONCOGENE, V27, P763, DOI 10.1038/sj.onc.1210673; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; Nelson KK, 2003, CLIN CANCER RES, V9, P424; NICOTERA TM, 1989, CANCER RES, V49, P5239; OBERLEY LW, 1979, CANCER RES, V39, P1141; Pelicano H, 2003, J BIOL CHEM, V278, P37832, DOI 10.1074/jbc.M301546200; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Santillo M, 2001, CURR BIOL, V11, P614, DOI 10.1016/S0960-9822(01)00159-2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schramm A, 2012, BRIT J CANCER, V107, P1409, DOI 10.1038/bjc.2012.391; Simpson AM, 2012, P ADV NEUR RES, P164; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Starkov AA, 2010, METHODS MOL BIOL, V648, P245, DOI 10.1007/978-1-60761-756-3_16; Stuart JJ, 2000, BIOCHEM BIOPH RES CO, V274, P641, DOI 10.1006/bbrc.2000.3189; Tacconelli A, 2004, CANCER CELL, V6, P347, DOI 10.1016/j.ccr.2004.09.011; Tacconelli A, 2007, J NEUROIMMUNOL, V183, P151, DOI 10.1016/j.jneuroim.2006.12.005; Takada Y, 2002, MOL CANCER RES, V1, P137; Tanaka T, 2002, EMBO J, V21, P1695, DOI 10.1093/emboj/21.7.1695; Wang ML, 2013, ONCOTARGETS THER, V6, P1207, DOI 10.2147/OTT.S38114; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Wood ER, 2004, BIOORG MED CHEM LETT, V14, P953, DOI 10.1016/j.bmcl.2003.12.002; Yeung BHY, 2008, BRIT J CANCER, V99, P283, DOI 10.1038/sj.bjc.6604477; Zhong C, 2013, EUR J MED CHEM, V62, P187, DOI 10.1016/j.ejmech.2012.12.037	80	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94568	10.1371/journal.pone.0094568	http://dx.doi.org/10.1371/journal.pone.0094568			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736663	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600073
J	Deme, B; Cataye, C; Block, MA; Marechal, E; Jouhet, J				Deme, Bruno; Cataye, Celine; Block, Maryse A.; Marechal, Eric; Jouhet, Juliette			Contribution of galactoglycerolipids to the 3-dimensional architecture of thylakoids	FASEB JOURNAL			English	Article						glycolipid; neutron diffraction; hexagonal II phase; lamellar phase; membrane stacking	LIGHT-HARVESTING COMPLEX; CEREBROSIDE SULFATE; PHOTOSYSTEM-II; NEUTRON-DIFFRACTION; INDUCED AGGREGATION; PROLAMELLAR BODIES; INNER ENVELOPE; PHASE-BEHAVIOR; POLAR LIPIDS; MEMBRANES	Thylakoid membranes, the universal structure where photosynthesis takes place in all oxygenic photosynthetic organisms from cyanobacteria to higher plants, have a unique lipid composition. They contain a high fraction of 2 uncharged glycolipids, the galactoglycerolipids mono- and digalactosyldiacylglycerol (MGDG and DGDG, respectively), and an anionic sulfolipid, sulfoquinovosediacylglycerol (SQDG). A remarkable feature of the evolution from cyanobacteria to higher plants is the conservation of MGDG, DGDG, SQDG, and phosphatidylglycerol (PG), the major phospholipid of thylakoids. Using neutron diffraction on reconstituted thylakoid lipid extracts, we observed that the thylakoid lipid mixture self-organizes as a regular stack of bilayers. This natural lipid mixture was shown to switch from hexagonal II toward lamellar phase on hydration. This transition and the observed phase coexistence are modulated by the fine-tuning of the lipid profile, in particular the MGDG/DGDG ratio, and by the hydration. Our analysis highlights the critical role of DGDG as a contributing component to the membrane stacking via hydrogen bonds between polar heads of adjacent bilayers. DGDG interactions balance the repulsive electrostatic contribution of the charged lipids PG and SQDG and allow the persistence of regularly stacked membranes at high hydration. In developmental contexts or in response to environmental variations, these properties can contribute to the highly dynamic flexibility of plastid structure.	[Deme, Bruno] Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France; [Cataye, Celine; Block, Maryse A.; Marechal, Eric; Jouhet, Juliette] CNRS, UMR 5168, Grenoble, France; [Cataye, Celine; Block, Maryse A.; Marechal, Eric; Jouhet, Juliette] Univ Grenoble Alpes, Grenoble, France; [Cataye, Celine; Block, Maryse A.; Marechal, Eric; Jouhet, Juliette] Commissariat Energie Atom & Energies Alternat C, DSV, IRTSV, Grenoble, France; [Cataye, Celine; Block, Maryse A.; Marechal, Eric; Jouhet, Juliette] INRA, LPCV, USC 1359, Grenoble, France	Institut Laue-Langevin (ILL); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Jouhet, J (corresponding author), Lab Physiol Cellulaire & Vegetale, 17 Rue Martyrs, F-38054 Grenoble 9, France.	juliette.jouhet@cea.fr	Demé, Bruno/AAG-1620-2021	Demé, Bruno/0000-0002-9523-7662	Agence Nationale de la Recherche [ANR-10-BLAN-1524, ANR-12-BIME-0005, ANR-12-JSV2-0001]; Labex Grenoble Alliance for Integrated Structural Cell Biology (GRAL)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Labex Grenoble Alliance for Integrated Structural Cell Biology (GRAL)	The authors are grateful to the Institut Laue-Langevin for the allocation of beam time. C. C., M. A. B., E. M., and J.J. were supported by grants from Agence Nationale de la Recherche (ANR-10-BLAN-1524, ReGal; ANR-12-BIME-0005, DiaDom Oil, ANR-12-JSV2-0001, ChloroMitoLipid) and by the Labex Grenoble Alliance for Integrated Structural Cell Biology (GRAL).	ALLEN KD, 1988, J CELL BIOL, V107, P907, DOI 10.1083/jcb.107.3.907; [Anonymous], METHODS CHLOROPLAST; Armbruster U, 2013, PLANT CELL, V25, P2661, DOI 10.1105/tpc.113.113118; Aronsson H, 2008, PLANT PHYSIOL, V148, P580, DOI 10.1104/pp.108.123372; Austin JR, 2011, PLANT PHYSIOL, V155, P1601, DOI 10.1104/pp.110.170647; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BLOCK MA, 1983, J BIOL CHEM, V258, P3273; Boggs JM, 2000, BIOPHYS J, V78, P874, DOI 10.1016/S0006-3495(00)76645-8; Botte CY, 2011, NAT CHEM BIOL, V7, P834, DOI 10.1038/nchembio.658; Bottier C, 2007, BBA-BIOMEMBRANES, V1768, P1526, DOI 10.1016/j.bbamem.2007.02.021; Boudiere L, 2014, BBA-BIOENERGETICS, V1837, P470, DOI 10.1016/j.bbabio.2013.09.007; Browse J, 2010, SCIENCE, V330, P185, DOI 10.1126/science.1196737; Chow WS, 2005, PHOTOCH PHOTOBIO SCI, V4, P1081, DOI 10.1039/b507310n; Collins AM, 2012, PLANT PHYSIOL, V158, P1600, DOI 10.1104/pp.111.192849; Cui YL, 2011, PLANT PHYSIOL, V155, P130, DOI 10.1104/pp.110.165589; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; deKruijff B, 1997, NATURE, V386, P129, DOI 10.1038/386129a0; Deme B, 2002, LANGMUIR, V18, P997, DOI 10.1021/la010723b; Deme B, 2002, BIOPHYS J, V82, P215, DOI 10.1016/S0006-3495(02)75388-5; Ding L, 2005, LANGMUIR, V21, P203, DOI 10.1021/la047876u; Dobrikova AG, 2013, PHYSIOL PLANTARUM, V147, P248, DOI 10.1111/j.1399-3054.2012.01648.x; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; Douce R, 1984, Subcell Biochem, V10, P1; DOUCE R, 1973, J BIOL CHEM, V248, P7215; Dubois M, 2001, NATURE, V411, P672, DOI 10.1038/35079541; Endow JK, 2010, PLANT SIGNAL BEHAV, V5, P721, DOI 10.4161/psb.5.6.11662; Garab G, 2000, TRENDS PLANT SCI, V5, P489, DOI 10.1016/S1360-1385(00)01767-2; GOUNARIS K, 1983, FEBS LETT, V156, P170, DOI 10.1016/0014-5793(83)80271-3; GOUNARIS K, 1986, BIOCHEM J, V237, P313, DOI 10.1042/bj2370313; GOUNARIS K, 1983, TRENDS BIOCHEM SCI, V8, P378, DOI 10.1016/0968-0004(83)90366-3; GOUNARIS K, 1983, BIOCHIM BIOPHYS ACTA, V728, P129, DOI 10.1016/0005-2736(83)90445-5; Groen D, 2011, BIOPHYS J, V100, P1481, DOI 10.1016/j.bpj.2011.02.001; Gruszecki WI, 2005, BBA-MOL BASIS DIS, V1740, P108, DOI 10.1016/j.bbadis.2004.11.015; Gunning BES, 2001, PROTOPLASMA, V215, P4, DOI 10.1007/BF01280299; Harauz G, 2009, BIOCHEMISTRY-US, V48, P8094, DOI 10.1021/bi901005f; Hartel H, 2000, BIOCHEM SOC T, V28, P729, DOI 10.1042/BST0280729; Hincha DK, 2003, BBA-BIOMEMBRANES, V1611, P180, DOI 10.1016/S0005-2736(03)00053-1; Holzl G, 2009, PLANT PHYSIOL, V150, P1147, DOI 10.1104/pp.109.139758; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; Jahns P, 2009, BBA-BIOENERGETICS, V1787, P3, DOI 10.1016/j.bbabio.2008.09.013; Jouhet J, 2003, FEBS LETT, V544, P63, DOI 10.1016/S0014-5793(03)00477-0; Jouhet J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00494; Kobayashi K, 2007, P NATL ACAD SCI USA, V104, P17216, DOI 10.1073/pnas.0704680104; Koshy KM, 1999, BIOPHYS J, V77, P306, DOI 10.1016/S0006-3495(99)76891-8; Koshy KM, 1996, J BIOL CHEM, V271, P3496; Krumova SB, 2008, BBA-BIOMEMBRANES, V1778, P997, DOI 10.1016/j.bbamem.2008.01.004; Krumova SB, 2010, PHOTOSYNTH RES, V105, P229, DOI 10.1007/s11120-010-9581-5; Ladygin VG, 2005, RUSS J PLANT PHYSL+, V52, P596, DOI 10.1007/s11183-005-0089-3; Latowski D, 2004, BIOCHEMISTRY-US, V43, P4417, DOI 10.1021/bi049652g; Liberton M, 2013, J BIOL CHEM, V288, P3632, DOI 10.1074/jbc.M112.416933; Lindblom G, 2002, BIOCHEMISTRY-US, V41, P11512, DOI 10.1021/bi0263098; MCDANIEL RV, 1988, BIOCHIM BIOPHYS ACTA, V940, P158, DOI 10.1016/0005-2736(88)90020-X; MCDONNEL A, 1980, J CELL BIOL, V84, P40, DOI 10.1083/jcb.84.1.40; MCINTOSH TJ, 1994, ANNU REV BIOPH BIOM, V23, P27, DOI 10.1146/annurev.bb.23.060194.000331; MENIKH A, 1993, EUR BIOPHYS J BIOPHY, V22, P249, DOI 10.1007/BF00180259; Miller W.H., 1839, TREATISE CRYSTALLOGR; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; MURPHY DJ, 1982, FEBS LETT, V150, P19, DOI 10.1016/0014-5793(82)81297-0; Mustardy L, 2003, TRENDS PLANT SCI, V8, P117, DOI 10.1016/S1360-1385(03)00015-3; Nakanishi H, 2005, PLANT CELL PHYSIOL, V46, P467, DOI 10.1093/pcp/pci053; Nevo R, 2012, PLANT J, V70, P157, DOI 10.1111/j.1365-313X.2011.04876.x; Richard D., 1996, J NEUTRON RES, V4, P33, DOI [DOI 10.1080/10238169608200065, 10.1080/10238169608200065]; RIVAS E, 1969, J MOL BIOL, V41, P261, DOI 10.1016/0022-2836(69)90391-X; RYRIE IJ, 1980, EUR J BIOCHEM, V107, P345; Schaller S, 2011, BBA-BIOENERGETICS, V1807, P326, DOI 10.1016/j.bbabio.2010.12.017; Schaller S, 2010, BBA-BIOENERGETICS, V1797, P414, DOI 10.1016/j.bbabio.2009.12.011; Schneck E, 2011, BIOPHYS J, V100, P2151, DOI 10.1016/j.bpj.2011.03.011; Schneck E, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041929; Schneck E, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061924; SELSTAM E, 1984, PLANT PHYSIOL, V76, P1036, DOI 10.1104/pp.76.4.1036; SEN A, 1981, NATURE, V293, P488, DOI 10.1038/293488a0; SEN A, 1982, BIOCHIM BIOPHYS ACTA, V686, P215, DOI 10.1016/0005-2736(82)90115-8; SHIPLEY GG, 1973, BIOCHIM BIOPHYS ACTA, V311, P531; Siegel DP, 1999, BIOPHYS J, V76, P291, DOI 10.1016/S0006-3495(99)77197-3; STEWART RJ, 1993, BIOCHEMISTRY-US, V32, P10666, DOI 10.1021/bi00091a017; Tikkanen M, 2012, BBA-BIOENERGETICS, V1817, P232, DOI 10.1016/j.bbabio.2011.05.005; Torres-Franklin ML, 2007, PHYSIOL PLANTARUM, V131, P201, DOI 10.1111/j.1399-3054.2007.00943.x; WEBB MS, 1988, BIOCHIM BIOPHYS ACTA, V938, P323, DOI 10.1016/0005-2736(88)90130-7; WEBB MS, 1990, BIOCHIM BIOPHYS ACTA, V1030, P231, DOI 10.1016/0005-2736(90)90299-4; Williams WP, 1998, FEBS LETT, V422, P252, DOI 10.1016/S0014-5793(98)00019-2; Zemb T, 1999, SCIENCE, V283, P816, DOI 10.1126/science.283.5403.816	82	105	107	1	66	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3373	3383		10.1096/fj.13-247395	http://dx.doi.org/10.1096/fj.13-247395			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24736411				2022-12-25	WOS:000340265400009
J	Zhu, GX; Fan, ZY; Ding, M; Mu, LB; Liang, J; Ding, YJ; Fu, Y; Huang, BL; Wu, W				Zhu, Guixin; Fan, Zhongyun; Ding, Miao; Mu, Libing; Liang, Juan; Ding, Yajie; Fu, Yu; Huang, Binlu; Wu, Wei			DNA Damage Induces the Accumulation of Tiam1 by Blocking beta-TrCP-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; DNA Damage; E3 Ubiquitin Ligase; c-Jun N-terminal Kinase (JNK); Rac1; Tiam1; Chemotherapy	EXCHANGE FACTOR TIAM1; E3 UBIQUITIN LIGASES; RAC ACTIVATOR TIAM1; DESTRUCTION MOTIF; JNK ACTIVATION; RHO-GTPASES; PHOSPHORYLATION; APOPTOSIS; PROTEIN; INVASION	The Rac1/JNK cascade plays important roles in DNA damage-induced apoptosis. However, how this cascade is activated upon DNA damage remains to be fully understood. We show here that, in untreated cells, Tiam1, a Rac1-specific guanine nucleotide exchange factor, is phosphorylated by casein kinase 1 (CK1) at its C terminus, leading to Skp, Cullin, F-box-containing(-TrCP) recognition, ubiquitination, and proteasome-mediated degradation. Upon DNA-damaging anticancer drug treatment, CK1/-TrCP-mediated Tiam1 degradation is abolished, and the accumulated Tiam1 contributes to downstream activation of Rac1/JNK. Consistently, tumor cells overexpressing Tiam1 are hypersensitive to DNA-damaging drug treatment. In xenograft mice, Tiam1-high cells are more susceptible to doxorubicin treatment. Thus, our results uncover that inhibition of proteasome-mediated Tiam1 degradation is an upstream event leading to Rac1/JNK activation and cell apoptosis in response to DNA-damaging drug treatment.	[Zhu, Guixin; Fan, Zhongyun; Mu, Libing; Liang, Juan; Ding, Yajie; Fu, Yu; Huang, Binlu; Wu, Wei] Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China; [Zhu, Guixin] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Ding, Miao] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China	Tsinghua University; Tsinghua University; Peking University	Wu, W (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Prot Sci, Beijing 100084, Peoples R China.	wwu@mail.tsinghua.edu.cn			National Natural Science Foundation of China [31221064, 81272235]; Tsinghua-Peking Center for Life Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences	This work was supported by National Natural Science Foundation of China Grants 31221064 and 81272235 (to W.W).; Postdoctoral fellow supported by the Tsinghua-Peking Center for Life Sciences.	Alsheich-Bartok O, 2008, ONCOGENE, V27, P3653, DOI 10.1038/sj.onc.1211036; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Habas R, 2006, METHOD ENZYMOL, V406, P500, DOI 10.1016/S0076-6879(06)06038-1; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; HERTZBERG RP, 1989, BIOCHEMISTRY-US, V28, P4629, DOI 10.1021/bi00437a018; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Inuzuka H, 2010, CANCER CELL, V18, P147, DOI 10.1016/j.ccr.2010.06.015; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kadara H, 2008, CANCER RES, V68, P4416, DOI 10.1158/0008-5472.CAN-08-0031; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kawazoe N, 1999, ONCOGENE, V18, P2413, DOI 10.1038/sj.onc.1202555; Lau AW, 2012, FRONT BIOSCI-LANDMRK, V17, P2197, DOI 10.2741/4045; Liang J, 2011, MOL CELL BIOL, V31, P2577, DOI 10.1128/MCB.05103-11; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Malliri A, 2002, NATURE, V417, P867, DOI 10.1038/nature00848; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Marin O, 2003, P NATL ACAD SCI USA, V100, P10193, DOI 10.1073/pnas.1733909100; Mayr M, 2002, FASEB J, V16, P1423, DOI 10.1096/fj.02-0042fje; Mertens AE, 2003, FEBS LETT, V546, P11, DOI 10.1016/S0014-5793(03)00435-6; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Minard ME, 2004, BREAST CANCER RES TR, V84, P21, DOI 10.1023/B:BREA.0000018421.31632.e6; Minard ME, 2006, CLIN EXP METASTAS, V23, P301, DOI 10.1007/s10585-006-9040-z; Nethe M, 2010, J CELL SCI, V123, P4011, DOI 10.1242/jcs.078360; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Oberoi-Khanuja Tripat Kaur, 2012, Small GTPases, V3, P131, DOI 10.4161/sgtp.19988; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Rygiel TP, 2008, J CELL SCI, V121, P1183, DOI 10.1242/jcs.017194; Santos JA, 1996, J CELL SCI, V109, P1847; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Seki A, 2008, J CELL BIOL, V181, P65, DOI 10.1083/jcb.200712027; Shibayama-Imazu CHT, 2007, ANTICANCER RES, V27, P245; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Shirokawa JM, 2000, MOL ENDOCRINOL, V14, P1725, DOI 10.1210/me.14.11.1725; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Suarez Y, 2006, MOL PHARMACOL, V70, P1654, DOI 10.1124/mol.106.025569; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; vanLeeuwen FN, 1995, ONCOGENE, V11, P2215; Wang ZW, 2012, ONCOTARGET, V3, P1026; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xu ZH, 2003, EMBO J, V22, P252, DOI 10.1093/emboj/cdg021; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhu G, 2012, ONCOGENE, V31, P1001, DOI 10.1038/onc.2011.294	59	14	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15482	15494		10.1074/jbc.M114.553388	http://dx.doi.org/10.1074/jbc.M114.553388			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737324	hybrid, Green Published			2022-12-25	WOS:000337465400031
J	Iakoubova, OA; Tong, CH; Rowland, CM; Luke, MM; Garcia, VE; Catanese, JJ; Moomiaie, RM; Sotonyi, P; Ascady, G; Nikas, D; Dedelias, P; Tranquilli, M; Elefteriades, JA				Iakoubova, Olga A.; Tong, Carmen H.; Rowland, Charles M.; Luke, May M.; Garcia, Veronica E.; Catanese, Joseph J.; Moomiaie, Remo M.; Sotonyi, Peter; Ascady, Gyorgy; Nikas, Demitrios; Dedelias, Panagiotis; Tranquilli, Maryann; Elefteriades, John A.			Genetic Variants in FBN-1 and Risk for Thoracic Aortic Aneurysm and Dissection	PLOS ONE			English	Article							MUTATIONS; PREVENTION; REGISTRY; DISEASE; SURGERY	Objectives: A recent genome wide association study (GWAS) by LeMaire et al. found that two single nucleotide polymorphisms (SNPs), rs2118181 and rs10519177 in the FBN-1 gene (encoding Fibrillin-1), were associated with thoracic aortic dissection (TAD), non-dissecting thoracic aortic aneurysm (TAA), and thoracic aortic aneurysm or dissection (TAAD); the largest effect was observed for the association of rs2118181 with TAD. We investigated whether rs2118181 and rs10519177 were associated with TAD, TAA, and TAAD in the Yale study. Methods: The genotypes of rs2118181 and rs10519177 were determined for participants in the Yale study: 637 TAAD cases (140 TAD, 497 TAA) and 275 controls from the United States, Hungary, and Greece. The association of the genotypes with TAD, TAA and TAAD were assessed using logistic regression models adjusted for sex, age, study center and hypertension. Results and Conclusions: In the Yale study, rs2118181 was associated with TAD: compared with non-carriers, carriers of the risk allele had an unadjusted odds ratio for TAD of 1.80 (95% CI 1.15-2.80) and they had odds ratio for TAD of 1.87 (95% CI 1.09-3.20) after adjusting for sex, age, study center and hypertension. We did not find significant differences in aortic size, a potential confounder for TAD, between rs2118181 risk variant carriers and non-carriers: mean aortic size was 5.56 (95% CI: 5.37-5.73) for risk variant carriers (CC+CT) and was 5.48 (95% CI: 5.36-5.61) for noncarriers (TT) (p = 0.56). rs2118181 was not associated with TAA or TAAD. rs10519177 was not associated with TAD, TAA, or TAAD in the Yale study. Thus, the Yale study provided further support for the association of the FBN-1 rs2118181SNP with TAD.	[Iakoubova, Olga A.; Tong, Carmen H.; Rowland, Charles M.; Luke, May M.; Garcia, Veronica E.; Catanese, Joseph J.] Celera A Div Quest Diagnost, Alameda, CA 94502 USA; [Moomiaie, Remo M.; Tranquilli, Maryann; Elefteriades, John A.] Yale Univ, New Haven, CT USA; [Sotonyi, Peter; Ascady, Gyorgy] Semmelweis Univ, H-1085 Budapest, Hungary; [Nikas, Demitrios] Athens Med Ctr, Athens, Greece; [Dedelias, Panagiotis] Evangelismos Med Ctr, Athens, Greece	Yale University; Semmelweis University; Evangelismos Hospital	Iakoubova, OA (corresponding author), Celera A Div Quest Diagnost, Alameda, CA 94502 USA.	olga.iakoubova@celera.com; john.elefteriades@yale.edu		Morelli, Maria Paula/0000-0001-7157-486X; Dedeilias, Panagiotis/0000-0002-7333-8921	Quest Diagnostics	Quest Diagnostics	Quest Diagnostics provided funding for genotyping, data analysis and preparation of the manuscript. OI, CT, CR, ML, VG, and JC, who are employed by the funder, were involved in genetic study design, data collection and analysis and preparation of the manuscript. Decision to publish was made by JE (Yale University). The funders had no role in study design, data collection or decision to publish; they contributed to genotyping, data analysis and manuscript preparation.	Barrett PM, 2013, HEART, V99, P83, DOI 10.1136/heartjnl-2012-301840; Coady MA, 1997, J THORAC CARDIOV SUR, V113, P476, DOI 10.1016/S0022-5223(97)70360-X; Detaint D, 2010, EUR HEART J, V31, P2223, DOI 10.1093/eurheartj/ehq258; Elefteriades JA, 2010, J THORAC CARDIOV SUR, V140, pS5, DOI 10.1016/j.jtcvs.2010.10.001; Elefteriades JA, 2010, J AM COLL CARDIOL, V55, P841, DOI 10.1016/j.jacc.2009.08.084; Goldstein LJ, 2001, J THORAC CARDIOV SUR, V122, P935, DOI 10.1067/mtc.2001.117276; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; LeMaire SA, 2011, NAT GENET, V43, P996, DOI 10.1038/ng.934; LeMaire SA, 2011, NAT REV CARDIOL, V8, P103, DOI 10.1038/nrcardio.2010.187; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Milewicz DM, 2011, CIRCULATION, V124, P1902, DOI 10.1161/CIRCULATIONAHA.111.059337; Morrison AC, 2007, AM J EPIDEMIOL; Olin JW, 2003, ARTERIOSCL THROM VAS, V23, P1721, DOI 10.1161/01.ATV.0000093222.33222.D2; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; Pape LA, 2007, CIRCULATION, V116, P1120, DOI 10.1161/CIRCULATIONAHA.107.702720; Song HK, 2012, J THORAC CARDIOV SUR, V143, P282, DOI 10.1016/j.jtcvs.2011.10.024; Trimarchi S, 2010, ANN THORAC SURG, V90, P1735, DOI 10.1016/j.athoracsur.2010.04.111; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Williams P, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-42; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	20	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e91437	10.1371/journal.pone.0091437	http://dx.doi.org/10.1371/journal.pone.0091437			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743685	Green Submitted, gold, Green Published			2022-12-25	WOS:000335309100003
J	Li, X; Gao, YY; Yang, M; Zhao, Q; Wang, GY; Yang, YM; Yang, Y; Liu, H; Zhang, YQ				Li, Xin; Gao, Yuyan; Yang, Ming; Zhao, Qi; Wang, Guangyu; Yang, Yan Mei; Yang, Yue; Liu, Hui; Zhang, Yanqiao			Identification of Gene Expression Changes from Colitis to CRC in the Mouse CAC Model	PLOS ONE			English	Article							COLORECTAL-CANCER; INFLAMMATION; DATABASE; PHARMACOLOGY; SYNCOLLIN; PATHWAYS; DISEASE	A connection between colorectal carcinogenesis and inflammation is well known, but the underlying molecular mechanisms have not been elucidated. Chemically induced colitis-associated cancer (CAC) is an outstanding mouse model for studying the link between inflammation and cancer. Additionally, the CAC model is used for examining novel diagnostic, prognostic, and predictive markers for use in clinical practice. Here, a CAC model was established in less than 100 days using azoxymethane (AOM) with dextran sulfate sodium salt (DSS) in BALB/c mice. We examined the mRNA expression profiles of three groups: control untreated mice (K), DSS-induced chronic colitis mice (D), and AOM/DSS-induced CAC (AD) mice. We identified 6301 differentially expressed genes (DEGs) among the three groups, including 93 persistently upregulated genes and 139 persistently downregulated genes. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses revealed that the most persistent DEGs were significantly enriched in metabolic or inflammatory components in the tumor microenvironment. Furthermore, several associated DEGs were identified as potential DEGs by protein-protein interaction (PPI) network analysis. We selected 14 key genes from the DEGs and potential DEGs for further quantitative real-time PCR (qPCR) verification. Six persistently upregulated, 3 persistently downregulated DEGs, and the other 3 genes showed results consistent with the microarray data. We demonstrated the regulation of 12 key genes specifically involved in Wnt signaling, cytokine and cytokine receptor interactions, homeostasis, and tumor-associated metabolism during colitis-associated CRC. Our results suggest that a close relationship between metabolic and inflammatory mediators of the tumor microenvironment is present in CAC.	[Li, Xin; Yang, Ming; Zhao, Qi; Wang, Guangyu; Zhang, Yanqiao] Harbin Med Univ, Affiliated Hosp 3, Dept Gastrointestinal Med Oncol, Harbin, Heilongjiang, Peoples R China; [Li, Xin] Harbin Med Univ, Affiliated Hosp 3, Dept Resp Med Oncol, Harbin, Heilongjiang, Peoples R China; [Gao, Yuyan] Harbin Med Univ, Affiliated Hosp 3, Dept Radiat Oncol, Harbin, Heilongjiang, Peoples R China; [Yang, Yan Mei; Yang, Yue] Harbin Med Univ, Canc Res Inst, Harbin, Heilongjiang, Peoples R China; [Liu, Hui] Harbin Inst Technol, Sch Life Sci & Technol, State Key Lab Urban Water Resource & Environm, Harbin 150006, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Institute of Technology	Zhang, YQ (corresponding author), Harbin Med Univ, Affiliated Hosp 3, Dept Gastrointestinal Med Oncol, Harbin, Heilongjiang, Peoples R China.	yanqiaozhang@ems.hrbmu.edu.cn			Ministry of Public Health, China; Nature Science Foundation of China [81172265]	Ministry of Public Health, China; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the Ministry of Public Health, China, a grant from the Nature Science Foundation of China(81172265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; APPLEYARD CB, 1995, AM J PHYSIOL-GASTR L, V269, pG119, DOI 10.1152/ajpgi.1995.269.1.G119; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P915, DOI 10.1001/jama.277.11.915; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Herder WW, 2012, ENDOCR-RELAT CANCER, V19, pE5, DOI 10.1530/ERC-12-0264; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Edwardson JM, 1997, CELL, V90, P325, DOI 10.1016/S0092-8674(00)80340-2; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Gao YY, 2013, CARCINOGENESIS, V34, P1861, DOI 10.1093/carcin/bgt135; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gronborg M, 2004, J PROTEOME RES, V3, P1042, DOI 10.1021/pr0499085; Hildenbrand M, 2010, J INVEST DERMATOL, V130, P1922, DOI 10.1038/jid.2010.54; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishikawa TO, 2010, CARCINOGENESIS, V31, P729, DOI 10.1093/carcin/bgq002; Kanneganti M, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/342637; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Li X, 2010, AMINO ACIDS, V38, P1237, DOI 10.1007/s00726-009-0335-7; Licata L, 2012, NUCLEIC ACIDS RES, V40, pD857, DOI 10.1093/nar/gkr930; Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027; Lutgens MWMD, 2008, GUT, V57, P1246, DOI 10.1136/gut.2007.143453; Makawita S, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008599; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; Rivera E, 2006, INFLAMM BOWEL DIS, V12, P950, DOI 10.1097/01.mib.0000231575.11678.8c; Roach W, 2007, BIOCHEM BIOPH RES CO, V355, P745, DOI 10.1016/j.bbrc.2007.02.025; Rubie C, 2007, WORLD J GASTROENTERO, V13, P4996, DOI 10.3748/wjg.v13.i37.4996; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schottelius AJ, 2006, CANC TREAT, V130, P67; Sharp JA, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-1; Tan S, 2000, AM J PHYSIOL-GASTR L, V278, pG308, DOI 10.1152/ajpgi.2000.278.2.G308; Tang AL, 2012, CARCINOGENESIS, V33, P1375, DOI 10.1093/carcin/bgs183; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484	42	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95347	10.1371/journal.pone.0095347	http://dx.doi.org/10.1371/journal.pone.0095347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743346	Green Submitted, gold, Green Published			2022-12-25	WOS:000335309100108
J	O'Sullivan, MJ; Hirota, N; Martin, JG				O'Sullivan, Michael J.; Hirota, Nobuaki; Martin, James G.			Sphingosine 1-Phosphate (S1P) Induced Interleukin-8 (IL8) Release Is Mediated by S1P Receptor 2 and Nuclear Factor kappa B in BEAS-2B Cells	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; KINASE ACTIVATION; OXIDATIVE STRESS; SECRETION; PROLIFERATION; INFLAMMATION; INVOLVEMENT; MIGRATION; REQUIRES	The airway epithelium may release pro-inflammatory cytokines and chemokines in the asthmatic airway. Sphingosine 1-phosphate (S1P) is a bioactive lipid, increased in the airways of asthmatics, that may trigger the release of the potent neutrophil chemoattractant Interleukin-8 (IL-8) by epithelial cells. S1P is a ligand for 5 G protein-coupled receptors, S1PR1-5. We wished to explore the mechanisms of S1P induced IL-8 secretion with regard to the receptor(s) and downstream signaling events involved. Our results indicate that S1P induced IL-8 release is mediated by S1PR2 and the transcription factor NF-kappa B. Since the Epidermal Growth Factor Receptor (EGFR) and reactive oxygen species (ROS) have been implicated in IL-8 release in response to activation of other G protein-coupled receptors, we examined their importance in S1P induced IL-8 release and established that they are not involved. This study reveals S1PR2 and NF-kB as potential therapeutic targets in neutrophilic airway diseases such as severe asthma.	[Martin, James G.] McGill Univ, Dept Med, Meakins Christie Labs, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	McGill University; McGill University	Martin, JG (corresponding author), McGill Univ, Dept Med, Meakins Christie Labs, Montreal, PQ, Canada.	james.martin@mcgill.ca		Martin, James/0000-0001-7574-5363	Canadian Institutes for Health Research (CIHR)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This project was funded by the Canadian Institutes for Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; BAGGIOLINI M, 1989, J CLIN INVEST, V84, P1045, DOI 10.1172/JCI114265; Blom T, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-45; Calise S, 2012, BBA-MOL CELL RES, V1823, P439, DOI 10.1016/j.bbamcr.2011.11.016; Chiba Y, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-4; Chiba Y, 2010, PHARMACOL RES, V62, P357, DOI 10.1016/j.phrs.2010.05.005; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Cummings RJ, 2002, J BIOL CHEM, V277, P30227, DOI 10.1074/jbc.M111078200; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Douglas MR, 2009, BRAIN, V132, P3102, DOI 10.1093/brain/awp240; Golan K, 2012, BLOOD, V119, P2478, DOI 10.1182/blood-2011-06-358614; Gu YP, 2011, J CELL BIOL, V193, P667, DOI 10.1083/jcb.201010075; Hawkins BJ, 2007, MOL CELL BIOL, V27, P7582, DOI 10.1128/MCB.00493-07; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Jatakanon A, 1999, AM J RESP CRIT CARE, V160, P1532, DOI 10.1164/ajrccm.160.5.9806170; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Maeda Y, 2007, J IMMUNOL, V178, P3437, DOI 10.4049/jimmunol.178.6.3437; McElroy SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038373; McGovern T, 2010, AM J PHYSIOL-LUNG C, V299, pL808, DOI 10.1152/ajplung.00438.2009; Milara J, 2009, EUR J PHARMACOL, V609, P132, DOI 10.1016/j.ejphar.2009.03.012; Olivera A, 2006, J BIOL CHEM, V281, P2515, DOI 10.1074/jbc.M508931200; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Rahman I, 1996, AM J RESP CRIT CARE, V154, P1055, DOI 10.1164/ajrccm.154.4.8887607; Ravasi S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-42; Risse PA, 2011, AM J PHYSIOL-LUNG C, V300, pL958, DOI 10.1152/ajplung.00247.2010; Rosenfeldt HM, 2003, FASEB J, V17, P1789, DOI 10.1096/fj.02-0836com; Roviezzo F, 2010, AM J RESP CELL MOL, V42, P572, DOI 10.1165/rcmb.2009-0108OC; Sadikot RT, 2004, J IMMUNOL, V172, P1801, DOI 10.4049/jimmunol.172.3.1801; Sanchez T, 2007, ARTERIOSCL THROM VAS, V27, P1312, DOI 10.1161/ATVBAHA.107.143735; Shimizu S, 2007, MOL HUM REPROD, V13, P181, DOI 10.1093/molehr/gal113; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Szczepaniak WS, 2010, AM J PHYSIOL-LUNG C, V299, pL137, DOI 10.1152/ajplung.00233.2009; Takuwa N, 2010, CARDIOVASC RES, V85, P484, DOI 10.1093/cvr/cvp312; Tani M, 2005, J LIPID RES, V46, P2458, DOI 10.1194/jlr.M500268-JLR200; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Wright LN, 2012, CLIN CANCER RES, V18, P170, DOI 10.1158/1078-0432.CCR-11-1349; Zhang GQ, 2013, BLOOD, V122, P443, DOI 10.1182/blood-2012-11-467191; Zhao YT, 2006, J BIOL CHEM, V281, P19501, DOI 10.1074/jbc.M511224200	41	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95566	10.1371/journal.pone.0095566	http://dx.doi.org/10.1371/journal.pone.0095566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743449	gold, Green Submitted, Green Published			2022-12-25	WOS:000335309100140
J	Qi, YJ; Wang, M; Liu, RM; Wei, H; Chao, WX; Zhang, T; Lou, Q; Li, XM; Ma, J; Zhu, H; Yang, ZH; Liu, HQ; Ma, YF				Qi, Yi-Jun; Wang, Ming; Liu, Rui-Min; Wei, Hua; Chao, Wei-Xia; Zhang, Tian; Lou, Qiang; Li, Xiu-Min; Ma, Jin; Zhu, Han; Yang, Zhen-Hua; Liu, Hai-Qing; Ma, Yuan-Fang			Downregulation of 14-3-3 sigma Correlates with Multistage Carcinogenesis and Poor Prognosis of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							PROSTATE-CANCER; BREAST-CANCER; MALIGNANT PROGRESSION; PROMOTER METHYLATION; LUNG ADENOCARCINOMA; MICROARRAY ANALYSIS; PANCREATIC-CANCER; OVARIAN-CANCER; SIGMA GENE; EXPRESSION	Aims: The asymptomatic nature of early-stage esophageal squamous cell carcinoma (ESCC) results in late presentation and consequent dismal prognosis This study characterized 14-3-3 sigma protein expression in the multi-stage development of ESCC and determined its correlation with clinical features and prognosis. Materials and Methods: Western blot was used to examine 14-3-3 sigma protein expression in normal esophageal epithelium (NEE), low grade intraepithelial neoplasia (LGIN), high grade intraepithelial neoplasia (HGIN), ESCC of TNM I to IV stage and various esophageal epithelial cell lines with different biological behavior. Immunohistochemistry was used to estimate 14-3-3 sigma protein in 110 biopsy samples of NEE, LGIN or HGIN and in 168 ESCC samples all of whom had follow-up data. Support vector machine (SVM) was used to develop a classifier for prognosis. Results: 14-3-3 sigma decreased progressively from NEE to LGIN, to HGIN, and to ESCC. Chemoresistant sub-lines of EC9706/PTX and EC9706/CDDP showed high expression of 14-3-3 sigma protein compared with non-chemoresistant ESCC cell lines and immortalized NEC. Furthermore, the downregulation of 14-3-3 sigma correlated significantly with histological grade (P = 0.000) and worse prognosis (P = 0.004). Multivariate Cox regression analysis indicated that 14-3-3 sigma protein (P = 0.016) and T stage (P = 0.000) were independent prognostic factors for ESCC. The SVM ESCC classifier comprising sex, age, T stage, histological grade, lymph node metastasis, clinical stage and 14-3-3 sigma, distinguished significantly lower-and higher-risk ESCC patients (91.67% vs. 3.62%, P = 0.000). Conclusions: Downregulation of 14-3-3 sigma arises early in the development of ESCC and predicts poor survival, suggesting that 14-3-3 sigma may be a biomarker for early detection of high-risk subjects and diagnosis of ESCC. Our seven-feature SVM classifier for ESCC prognosis may help to inform clinical decisions and tailor individual therapy.	[Qi, Yi-Jun; Wang, Ming; Liu, Rui-Min; Chao, Wei-Xia; Zhang, Tian; Lou, Qiang; Ma, Jin; Zhu, Han; Ma, Yuan-Fang] Henan Univ, Coll Med, Key Lab Cellular & Mol Immunol, Kaifeng, Henan, Peoples R China; [Wei, Hua] Henan Univ, Huaihe Hosp, Kaifeng, Henan, Peoples R China; [Li, Xiu-Min] Xinxiang Med Univ, Xinxiang, Henan, Peoples R China; [Yang, Zhen-Hua; Liu, Hai-Qing] Linzhou Canc Hosp, Linzhou, Henan, Peoples R China	Henan University; Henan University; Xinxiang Medical University	Qi, YJ (corresponding author), Henan Univ, Coll Med, Key Lab Cellular & Mol Immunol, Kaifeng, Henan, Peoples R China.	qiqiyijun@gmail.com; mayf@henu.edu.cn	li, xiu/GXV-1745-2022	Qi, Yi-Jun/0000-0003-0239-5862	National Natural Science Foundation of China [30700366, 81072039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 30700366 & 81072039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahira J, 2004, CLIN CANCER RES, V10, P2687, DOI 10.1158/1078-0432.CCR-03-0510; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Cheng L, 2004, CLIN CANCER RES, V10, P3064, DOI 10.1158/1078-0432.CCR-03-0652; Dellambra E, 2000, J CELL BIOL, V149, P1117, DOI 10.1083/jcb.149.5.1117; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Feng W, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1762; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Friess H, 2003, CELL MOL LIFE SCI, V60, P1180, DOI 10.1007/s00018-003-3036-5; Gasco M, 2002, CANCER RES, V62, P2072; Han BG, 2006, MOL CANCER THER, V5, P903, DOI 10.1158/1535-7163.MCT-05-0393; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Iacobuzio-Donahue CA, 2003, CANCER RES, V63, P8614; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; Kaneuchi M, 2004, BIOCHEM BIOPH RES CO, V316, P1156, DOI 10.1016/j.bbrc.2004.02.171; Law Simon, 2007, Adv Surg, V41, P93, DOI 10.1016/j.yasu.2007.05.007; Li LW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-52; Li ZM, 2009, AM J TRANSL RES, V1, P326; Ling C, 2010, GENE DEV, V24, P947, DOI 10.1101/gad.1896810; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; Lodygin D, 2004, ONCOGENE, V23, P9034, DOI 10.1038/sj.onc.1208004; Logsdon CD, 2003, CANCER RES, V63, P2649; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Mhawech P, 2005, MODERN PATHOL, V18, P340, DOI 10.1038/modpathol.3800240; Moreira JMA, 2005, MOL CELL PROTEOMICS, V4, P555, DOI 10.1074/mcp.M400205-MCP200; Nabeya K, 1997, Dis Esophagus, V10, P159; Nakayama H, 2005, PATHOL INT, V55, P707, DOI 10.1111/j.1440-1827.2005.01900.x; Okada T, 2006, ANTICANCER RES, V26, P3105; Okumura H, 2010, ANTICANCER RES, V30, P5175; Osada H, 2002, ONCOGENE, V21, P2418, DOI 10.1038/sj.onc.1205303; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Perathoner A, 2005, CLIN CANCER RES, V11, P3274, DOI 10.1158/1078-0432.CCR-04-2207; Pulukuri SM, 2006, ONCOGENE, V25, P4559, DOI 10.1038/sj.onc.1209462; Ravi D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015864; Ren HZ, 2010, DIGEST DIS SCI, V55, P2552, DOI 10.1007/s10620-009-1065-0; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; Shiba-Ishii A, 2012, AM J PATHOL, V180, P1653, DOI 10.1016/j.ajpath.2011.12.014; Shiba-Ishii A, 2011, INT J CANCER, V129, P2445, DOI 10.1002/ijc.25907; Shirakawa Y, 2000, CLIN CANCER RES, V6, P541; Simooka H, 2004, PATHOL INT, V54, P595, DOI 10.1111/j.1440-1827.2004.01668.x; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Suzuki H, 2000, CANCER RES, V60, P4353; Tanaka K, 2004, INT J ONCOL, V25, P1591; Uchida D, 2004, BRIT J CANCER, V91, P1131, DOI 10.1038/sj.bjc.6602004; Umbricht CB, 2001, ONCOGENE, V20, P3348, DOI 10.1038/sj.onc.1204438; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; Villaret DB, 2000, LARYNGOSCOPE, V110, P374, DOI 10.1097/00005537-200003000-00008; Wang GQ, 2005, GUT, V54, P187, DOI 10.1136/gut.2004.046631; Wang WF, 1996, J MOL EVOL, V43, P384; Wilker EW, 2007, NATURE, V446, P329, DOI 10.1038/nature05584; Wong VCL, 2011, BRIT J CANCER, V104, P841, DOI 10.1038/bjc.2011.25; Xue L, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-296; Yi B, 2009, J CELL BIOCHEM, V106, P858, DOI 10.1002/jcb.22051; Zhu YH, 2013, CANCER RES, V73, P2298, DOI 10.1158/0008-5472.CAN-12-2663; Zurita M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-217	59	13	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95386	10.1371/journal.pone.0095386	http://dx.doi.org/10.1371/journal.pone.0095386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743601	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100114
J	Sohn, KC; Li, ZJ; Choi, DK; Zhang, TJ; Lim, JW; Chang, IK; Hur, GM; Im, M; Lee, Y; Seo, YJ; Lee, JH; Kim, CD				Sohn, Kyung-Cheol; Li, Zheng Jun; Choi, Dae-Kyoung; Zhang, Tiejun; Lim, Jae Woo; Chang, In-Kyu; Hur, Gang Min; Im, Myung; Lee, Young; Seo, Young-Joon; Lee, Jeung-Hoon; Kim, Chang Deok			Imiquimod Induces Apoptosis of Squamous Cell Carcinoma (SCC) Cells via Regulation of A20	PLOS ONE			English	Article							NF-KAPPA-B; IMMUNE-RESPONSE MODIFIER; CANCER; KERATINOCYTES; TRANSCRIPTION; EXPRESSION; MECHANISM; GROWTH; SKIN	Imiquimod, a nucleoside analogue of the imidazoquinoline family, is being used to treat various cutaneous cancers including squamous cell carcinoma (SCC). Imiquimod activates anti-tumor immunity via Toll-like receptor 7 (TLR7) in macrophage and other immune cells. Imiquimod can also affect tumor cells directly, regardless of its impact on immune system. In this study, we demonstrated that imiquimod induced apoptosis of SCC cells (SCC12) and A20 was involved in this process. When A20 was overexpressed, imiquimod-induced apoptosis was markedly inhibited. Conversely, knockdown of A20 potentiated imiquimod-induced apoptosis. Interestingly, A20 counteracted activation of c-Jun N-terminal kinase (JNK), suggesting that A20-regulated JNK activity was possible mechanism underlying imiquimod-induced apoptosis of SCC12 cells. Finally, imiquimod-induced apoptosis of SCC12 cells was taken place in a TLR7-independent manner. Our data provide new insight into the mechanism underlying imiquimod effect in cutaneous cancer treatment.	[Sohn, Kyung-Cheol; Li, Zheng Jun; Choi, Dae-Kyoung; Lim, Jae Woo; Chang, In-Kyu; Im, Myung; Lee, Young; Seo, Young-Joon; Lee, Jeung-Hoon; Kim, Chang Deok] Chungnam Natl Univ, Dept Dermatol, Sch Med, Taejon, South Korea; [Sohn, Kyung-Cheol; Li, Zheng Jun; Choi, Dae-Kyoung; Lim, Jae Woo; Chang, In-Kyu; Im, Myung; Lee, Young; Seo, Young-Joon; Lee, Jeung-Hoon; Kim, Chang Deok] Chungnam Natl Univ, Sch Med, Res Inst Med Sci, Taejon, South Korea; [Zhang, Tiejun; Hur, Gang Min] Chungnam Natl Univ, Sch Med, Dept Pharmacol, Taejon, South Korea	Chungnam National University; Chungnam National University; Chungnam National University	Kim, CD (corresponding author), Chungnam Natl Univ, Dept Dermatol, Sch Med, Taejon, South Korea.	cdkimd@cnu.ac.kr	Hur, Gang-min/ABF-9263-2021; Zhang, Tiejun/HDM-7091-2022	Hur, Gang-min/0000-0003-4870-6574; Seo, Young-Joon/0000-0002-4955-590X; Kim, Chang Deok/0000-0001-9341-6491; Lee, Young/0000-0001-9205-1785	National Research Foundation of Korea [NRF-2010-0023545]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from the National Research Foundation of Korea (NRF-2010-0023545). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Balkwill F, 2004, NATURE, V431, P405, DOI 10.1038/431405a; Bong AB, 2002, DERMATOLOGY, V205, P135, DOI 10.1159/000063904; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Garg A, 2002, LEUKEMIA, V16, P1053, DOI 10.1038/sj.leu.2402482; Geisse JK, 2002, J AM ACAD DERMATOL, V47, P390, DOI 10.1067/mjd.2002.126215; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Huang SJ, 2009, J INVEST DERMATOL, V129, P2676, DOI 10.1038/jid.2009.151; Kobielak A, 2006, P NATL ACAD SCI USA, V103, P2322, DOI 10.1073/pnas.0510422103; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee JS, 2013, ANN DERMATOL, V25, P36, DOI 10.5021/ad.2013.25.1.36; Li W, 2010, INT J CLIN EXP PATHO, V3, P238; Li ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077159; Liptay S, 2003, INT J CANCER, V105, P735, DOI 10.1002/ijc.11081; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Schiller M, 2006, EXP DERMATOL, V15, P331, DOI 10.1111/j.0906-6705.2006.00414.x; Schon MP, 2006, J INVEST DERMATOL, V126, P1338, DOI 10.1038/sj.jid.5700286; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054355; Stanley MA, 2002, CLIN EXP DERMATOL, V27, P571, DOI 10.1046/j.1365-2230.2002.01151.x; Stary G, 2007, J EXP MED, V204, P1441, DOI 10.1084/jem.20070021; van Hogerlinden M, 1999, CANCER RES, V59, P3299; Won M, 2010, CELL DEATH DIFFER, V17, P1830, DOI 10.1038/cdd.2010.47; Yokogawa M, 2013, MOL CARCINOGEN, V52, P760, DOI 10.1002/mc.21901; Yu HG, 2003, ONCOLOGY-BASEL, V65, P37, DOI 10.1159/000071203; Zhao L, 2009, CANCER RES, V69, P9439, DOI 10.1158/0008-5472.CAN-09-2976	31	21	21	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95337	10.1371/journal.pone.0095337	http://dx.doi.org/10.1371/journal.pone.0095337			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743316	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100106
J	Bao, J; Yu, KD; Jiang, YZ; Shao, ZM; Di, GH				Bao, Jing; Yu, Ke-Da; Jiang, Yi-Zhou; Shao, Zhi-Ming; Di, Gen-Hong			The Effect of Laterality and Primary Tumor Site on Cancer-Specific Mortality in Breast Cancer: A SEER Population-Based Study	PLOS ONE			English	Article							LYMPHATIC DRAINAGE PATTERNS; HEART-DISEASE; LUNG-CANCER; SURVIVAL; LOCATION; RADIOTHERAPY; QUADRANT; THERAPY; INNER; WOMEN	Background: Reduced overall survival has been observed in patients with left-sided versus right-sided breast cancer due to cardiac toxicity after radiotherapy. However, the effect of laterality and primary tumor site on breast cancer-specific mortality (BCSM) remains unclear. Patients and Methods: We analyzed data from 305,443 women ages 20- to 79-years-old diagnosed with breast cancer between 1990 and 2009. The data were obtained from the population-based Surveillance, Epidemiology, and End Results (SEER) program of the U. S. National Cancer Institute. The survival outcomes with regard to laterality and primary tumor site were compared using univariate and multivariate (Cox proportional hazards regression model) methods. Results: In the multivariate analysis, BCSM was affected by the primary tumor site (P<0.0001) but not laterality (P = 0.331). The combined effect was piecewise: using the left upper-outer quadrant as the reference, the BCSM hazard ratio (HR) was not significant in the right upper quadrant (P = 0.755) and the right central portion (P = 0.329). The BCSM HR was slightly increased in the left central portion as well as the left and right lower-outer quadrants (HRs from 1.136 to 1.145; P<0.0001). The BCSM HR was significantly increased in the upper-inner and lower-inner quadrants (HRs from 1.242 to 1.372; P<0.0001) on both sides. Laterality only impacted BCSM in patients with breast cancer located in the central portion (HR, 1.100; P = 0.013, using the right side as the reference). Conclusion: Patients with tumors in the upper-outer quadrant of both sides and the right central portion have a better prognosis than patients with tumors at other locations. Laterality is not regarded as a prognostic factor in breast cancer.	[Yu, Ke-Da] Fudan Univ, Shanghai Med Coll, Ctr Canc, Dept Breast Surg, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yu, KD (corresponding author), Fudan Univ, Shanghai Med Coll, Ctr Canc, Dept Breast Surg, Shanghai 200433, Peoples R China.	yukd@shca.org.cn; dgh20031126@gmail.com		Di, Genhong/0000-0003-1171-7907	National Natural Science Foundation of China [81370075, 81001169]; Training Plan of Excellent Talents in Shanghai Municipality Health System; Research and Innovation Project of Shanghai Municipal Education Commission; Shanghai International Science and Technique Cooperation Foundation [12410707700]; International S&T Cooperation Program of China (ISTCP) [09]; Shanghai Key Laboratory of Breast Cancer [12DZ2260100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Training Plan of Excellent Talents in Shanghai Municipality Health System; Research and Innovation Project of Shanghai Municipal Education Commission; Shanghai International Science and Technique Cooperation Foundation; International S&T Cooperation Program of China (ISTCP); Shanghai Key Laboratory of Breast Cancer	This work was supported by National Natural Science Foundation of China (81370075, 81001169); Training Plan of Excellent Talents in Shanghai Municipality Health System (for Dr. KDY); Research and Innovation Project of Shanghai Municipal Education Commission (2014, for KDY); Shanghai International Science and Technique Cooperation Foundation (12410707700); International S&T Cooperation Program of China (ISTCP No. 09), and the Shanghai Key Laboratory of Breast Cancer (12DZ2260100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumgart EI, 2011, BREAST CANCER RES TR, V130, P699, DOI 10.1007/s10549-011-1737-2; Colzani E, 2011, J CLIN ONCOL, V29, P4014, DOI 10.1200/JCO.2010.32.6462; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Doyle JJ, 2007, INT J RADIAT ONCOL, V68, P82, DOI 10.1016/j.ijrobp.2006.12.019; EKBOM A, 1994, CANCER CAUSE CONTROL, V5, P510, DOI 10.1007/BF01831378; Estourgie SH, 2004, ANN SURG, V239, P232, DOI 10.1097/01.sla.0000109156.26378.90; Gaffney DK, 2003, J CLIN ONCOL, V21, P467, DOI 10.1200/JCO.2003.12.047; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117; Henson KE, 2013, BRIT J CANCER, V108, P179, DOI 10.1038/bjc.2012.575; Kong AL, 2012, CANCER-AM CANCER SOC, V118, P6287, DOI 10.1002/cncr.27564; MELNIK Y, 1979, J CANCER RES CLIN, V95, P291, DOI 10.1007/BF00410651; Sarp S, 2007, ANN SURG ONCOL, V14, P1031, DOI 10.1245/s10434-006-9231-5; Sohn VY, 2008, AM J SURG, V195, P641, DOI 10.1016/j.amjsurg.2007.12.039; Weiss HA, 1996, CANCER CAUSE CONTROL, V7, P539, DOI 10.1007/BF00051887; Wilting J, 2011, CURR MED CHEM, V18, P5519, DOI 10.2174/092986711798347252; Wo JY, 2011, J CLIN ONCOL, V29, P2619, DOI 10.1200/JCO.2010.29.5907	17	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94815	10.1371/journal.pone.0094815	http://dx.doi.org/10.1371/journal.pone.0094815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740002	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900070
J	Hao, LH; Gong, LL; Guo, YP; Song, Y; Qi, XY; Guan, ZZ; Yang, XH; Zhou, X; Xue, LY; Shao, SJ				Hao Lihong; Gong Linlin; Guo Yiping; Song Yang; Qi Xiaoyu; Guan Zhuzhu; Yang Xiaohan; Zhou Xin; Xue Liyan; Shao Shujuan			Proteomics Approaches for Identification of Tumor Relevant Protein Targets in Pulmonary Squamous Cell Carcinoma by 2D-DIGE-MS	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; DIFFERENCE GEL-ELECTROPHORESIS; CANCER; SERUM; LUNG; ANGIOGENESIS; CHOLESTEROL; HEPATOMA; BINDING; MARKERS	Potential markers for progression of pulmonary squamous cell carcinoma (SCC) were identified by examining samples of lung SCC and adjacent normal tissues using a combination of fluorescence two-dimensional difference gel electrophoresis (2D-DIGE), matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS), and electrospray ionization quadrupole-time of flight mass spectrometry (ESI-Q-TOF). The PANTHER System was used for gel image based quantification and statistical analysis. An analysis of proteomic data revealed that 323 protein spots showed significantly different levels of expression (P <= 0.05) in lung SCC tissue compared to expression in normal lung tissue. A further analysis of these protein spots by MALDI-TOF-MS identified 81 different proteins. A systems biology approach was used to map these proteins to major pathways involved in numerous cellular processes, including localization, transport, cellular component organization, apoptosis, and reproduction. Additionally, the expression of several proteins in lung SCC and normal tissues was examined using immunohistochemistry and western blot. The functions of individual proteins are being further investigated and validated, and the results might provide new insights into the mechanism of lung SCC progression, potentially leading to the design of novel diagnostic and therapeutic strategies.	[Hao Lihong; Gong Linlin; Guo Yiping; Song Yang; Qi Xiaoyu; Guan Zhuzhu; Yang Xiaohan; Zhou Xin; Shao Shujuan] Dalian Med Univ, Key Lab Prote, Dalian, Liaoning Provin, Peoples R China; [Xue Liyan] Chinese Acad Med Sci, Dept Pathol, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Xue Liyan] Peking Union Med Coll, Beijing 100021, Peoples R China	Dalian Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Shao, SJ (corresponding author), Dalian Med Univ, Key Lab Prote, Dalian, Liaoning Provin, Peoples R China.	shaoshujuan2006@126.com			National Basic Research Program of China (973 Program) [2012CB967003]; Projects of Higher Education Department of Liaoning Province of China [LS2010058, LT2010028]; Dalian City Science and technology project [2011E12SF036, 2010E15SF179]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Projects of Higher Education Department of Liaoning Province of China; Dalian City Science and technology project	This work is supported by funding from the National Basic Research Program of China (973 Program grant 2012CB967003), the Projects of Higher Education Department of Liaoning Province of China (grant LS2010058, LT2010028) and Dalian City Science and technology project (grant 2011E12SF036, 2010E15SF179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Auguste P, 2005, CRIT REV ONCOL HEMAT, V54, P53, DOI 10.1016/j.critrevonc.2004.11.006; Chatterji B, 2009, PROTEOMICS, V9, P1044, DOI 10.1002/pmic.200701135; DESSI S, 1994, CANCER, V73, P253, DOI 10.1002/1097-0142(19940115)73:2<253::AID-CNCR2820730204>3.0.CO;2-F; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gao YH, 2010, LABELED IMMUNOASSAYS, V17, P277; Grundy SM, 1990, ARCH INTERN MED, V8, P1579; Hoorn EJ, 2006, NEPHRON PHYSIOL, V104, P61, DOI 10.1159/000093288; Jang JS, 2004, ONCOL RES, V14, P491, DOI 10.3727/0965040042380441; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Maurya P, 2007, ANTICANCER RES, V27, P1247; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; ORAM JF, 1987, J BIOL CHEM, V262, P2405; Park SY, 2010, ARCH PHARM RES, V33, P247, DOI 10.1007/s12272-010-0210-9; Patel Prabhudas S, 2005, Asian Pac J Cancer Prev, V6, P113; Poschmann G, 2009, MOL CELL PROTEOMICS, V8, P1105, DOI 10.1074/mcp.M800422-MCP200; Rho JH, 2009, PROTEIN J, V28, P148, DOI 10.1007/s10930-009-9177-0; Rong JX, 2001, CIRCULATION, V104, P2447, DOI 10.1161/hc4501.098952; Shen L, 2008, BIOL CHEM, V389, P135, DOI 10.1515/BC.2008.016; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wittekind C, 2002, CANCER-AM CANCER SOC, V94, P2511, DOI 10.1002/cncr.10492; Yao HX, 2009, LUNG CANCER, V65, P41, DOI 10.1016/j.lungcan.2008.10.024; Yi ZF, 2009, INT J CANCER, V124, P843, DOI 10.1002/ijc.24027; Yu LR, 2000, ELECTROPHORESIS, V21, P3058, DOI 10.1002/1522-2683(20000801)21:14<3058::AID-ELPS3058>3.0.CO;2-U; Zahedi K, 1997, J BIOL CHEM, V272, P2143; Zhang XZ, 2009, CANCER SCI, V100, P2396, DOI 10.1111/j.1349-7006.2009.01314.x	27	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95121	10.1371/journal.pone.0095121	http://dx.doi.org/10.1371/journal.pone.0095121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740010	Green Submitted, gold, Green Published			2022-12-25	WOS:000336863900106
J	Lange, EM; Johnson, AM; Wang, YF; Zuhlke, KA; Lu, YR; Ribado, JV; Keele, GR; Li, J; Duan, Q; Li, G; Gao, ZR; Li, Y; Xu, JF; Isaacs, WB; Zheng, SQ; Cooney, KA				Lange, Ethan M.; Johnson, Anna M.; Wang, Yunfei; Zuhlke, Kimberly A.; Lu, Yurong; Ribado, Jessica V.; Keele, Gregory R.; Li, Jin; Duan, Qing; Li, Ge; Gao, Zhengrong; Li, Yun; Xu, Jianfeng; Isaacs, William B.; Zheng, Siqun; Cooney, Kathleen A.			Genome-Wide Association Scan for Variants Associated with Early-Onset Prostate Cancer	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; GENETIC ASSOCIATION; GENOTYPE DATA; MULTIPLE LOCI; RISK LOCUS; LINKAGE; 8Q24; MEN; PREDISPOSITION; IDENTIFICATION	Prostate cancer is the most common non-skin cancer and the second leading cause of cancer related mortality for men in the United States. There is strong empirical and epidemiological evidence supporting a stronger role of genetics in early-onset prostate cancer. We performed a genome-wide association scan for early-onset prostate cancer. Novel aspects of this study include the focus on early-onset disease (defined as men with prostate cancer diagnosed before age 56 years) and use of publically available control genotype data from previous genome-wide association studies. We found genome-wide significant (p < 5 x 10(-8)) evidence for variants at 8q24 and 11p15 and strong supportive evidence for a number of previously reported loci. We found little evidence for individual or systematic inflated association findings resulting from using public controls, demonstrating the utility of using public control data in large-scale genetic association studies of common variants. Taken together, these results demonstrate the importance of established common genetic variants for early-onset prostate cancer and the power of including early-onset prostate cancer cases in genetic association studies.	[Lange, Ethan M.; Wang, Yunfei; Lu, Yurong; Ribado, Jessica V.; Keele, Gregory R.; Li, Jin; Duan, Qing; Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA; [Lange, Ethan M.; Wang, Yunfei; Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Johnson, Anna M.; Zuhlke, Kimberly A.; Cooney, Kathleen A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Cooney, Kathleen A.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Li, Ge; Gao, Zhengrong; Xu, Jianfeng; Zheng, Siqun] Wake Forest Univ, Ctr Genom & Personalized Med Res, Winston Salem, NC 27109 USA; [Isaacs, William B.] Johns Hopkins Univ, Dept Urol, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wake Forest University; Johns Hopkins University	Lange, EM (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27514 USA.	elange@med.unc.edu		Cooney, Kathleen/0000-0003-3831-6943; Keele, Gregory/0000-0002-1843-7900; Zuhlke, Kimberly/0000-0001-6941-5376	NIH [R01-CA136621, R01-F023000]; NCI SPORE [P50-CA69568]; NATIONAL CANCER INSTITUTE [R01CA136621, P50CA069568] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by NIH Research Project Grants: R01-CA136621, R01-F023000 and NCI SPORE P50-CA69568. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Olama AA, 2009, NAT GENET, V41, P1058, DOI 10.1038/ng.452; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Bratt O, 2002, J UROLOGY, V167, P2423, DOI 10.1016/S0022-5347(05)64997-X; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duggan D, 2007, JNCI-J NATL CANCER I, V99, P1836, DOI 10.1093/jnci/djm250; Edwards BJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-18; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Eeles RA, 2009, NAT GENET, V41, P1116, DOI 10.1038/ng.450; Ewing CM, 2012, NEW ENGL J MED, V366, P141, DOI 10.1056/NEJMoa1110000; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Goh CL, 2012, J INTERN MED, V271, P353, DOI 10.1111/j.1365-2796.2012.02511.x; Gudmundsson J, 2008, NAT GENET, V40, P281, DOI 10.1038/ng.89; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gudmundsson J, 2009, NAT GENET, V41, P1122, DOI 10.1038/ng.448; Haiman CA, 2011, NAT GENET, V43, P570, DOI 10.1038/ng.839; Ho LA, 2010, HUM GENET, V128, P597, DOI 10.1007/s00439-010-0880-x; Howlader N, 2013, SEER CANC STAT REV 1; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jin GF, 2012, HUM GENET, V131, P1095, DOI 10.1007/s00439-011-1136-0; Karlsson R, 2014, EUR UROL, V65, P169, DOI 10.1016/j.eururo.2012.07.027; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Kote-Jarai Z, 2011, NAT GENET, V43, P785, DOI 10.1038/ng.882; Kraft P, 2008, EPIDEMIOLOGY, V19, P649, DOI 10.1097/EDE.0b013e318181b865; Lange EM, 2003, PROSTATE, V57, P326, DOI 10.1002/pros.10307; Lange EM, 2012, PROSTATE, V72, P147, DOI 10.1002/pros.21414; Lange EM, 2009, PROSTATE, V69, P385, DOI 10.1002/pros.20891; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin DW, 2009, CANCER-AM CANCER SOC, V115, P2863, DOI 10.1002/cncr.24324; Moskvina V, 2005, ANN HUM GENET, V69, P566, DOI 10.1111/j.1529-8817.2005.00175.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schumacher FR, 2011, HUM MOL GENET, V20, P3867, DOI 10.1093/hmg/ddr295; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zeegers MPA, 2003, CANCER-AM CANCER SOC, V97, P1894, DOI 10.1002/cncr.11262; Zheng G, 2005, STAT MED, V24, P869, DOI 10.1002/sim.1976	42	19	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93436	10.1371/journal.pone.0093436	http://dx.doi.org/10.1371/journal.pone.0093436			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740154	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900020
J	Tzanoulinou, S; Garcia-Mompo, C; Castillo-Gomez, E; Veenit, V; Nacher, J; Sandi, C				Tzanoulinou, Stamatina; Garcia-Mompo, Clara; Castillo-Gomez, Esther; Veenit, Vandana; Nacher, Juan; Sandi, Carmen			Long-Term Behavioral Programming Induced by Peripuberty Stress in Rats Is Accompanied by GABAergic-Related Alterations in the Amygdala	PLOS ONE			English	Article							BENZODIAZEPINE-RECEPTOR-BINDING; ELEVATED PLUS-MAZE; MESSENGER-RNA EXPRESSION; ACID DECARBOXYLASE 65; EARLY-LIFE STRESS; GABA(A) RECEPTORS; CHILDHOOD TRAUMA; SOCIAL ANXIETY; CONTRASTING PATTERNS; BASOLATERAL AMYGDALA	Stress during childhood and adolescence is a risk factor for psychopathology. Alterations in gamma-aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain, have been found following stress exposure and fear experiences and are often implicated in anxiety and mood disorders. Abnormal amygdala functioning has also been detected following stress exposure and is also implicated in anxiety and social disorders. However, the amygdala is not a unitary structure; it includes several nuclei with different functions and little is known on the potential differences the impact of early life stress may have on this system within different amygdaloid nuclei. We aimed here to evaluate potential regional differences in the expression of GABAergic-related markers across several amygdaloid nuclei in adult rats subjected to a peripuberty stress protocol that leads to enhanced basal amygdala activity and psychopathological behaviors. More specifically, we investigated the protein expression levels of glutamic acid decarboxylase (GAD; the principal synthesizing enzyme of GABA) and of GABA-A receptor subunits alpha 2 and alpha 3. We found reduced GAD and GABA-A alpha 3, but not alpha 2, subunit protein levels throughout all the amygdala nuclei examined (lateral, basolateral, basomedial, medial and central) and increased anxiety-like behaviors and reduced sociability in peripubertally stressed animals. Our results identify an enduring inhibition of the GABAergic system across the amygdala following exposure to early adversity. They also highlight the suitability of the peripuberty stress model to investigate the link between treatments targeting the dysfunctional GABAergic system in specific amygdala nuclei and recovery of specific stress-induced behavioral dysfunctions.	[Tzanoulinou, Stamatina; Veenit, Vandana; Sandi, Carmen] Ecole Polytech Fed Lausanne, Lab Behav Genet, Brain Mind Inst, Sch Life Sci, Lausanne, Switzerland; [Garcia-Mompo, Clara; Castillo-Gomez, Esther; Nacher, Juan] Univ Valencia, Neurobiol Unit, Valencia, Spain; [Garcia-Mompo, Clara; Castillo-Gomez, Esther; Nacher, Juan] Univ Valencia, Program Basic & Appl Neurosci, Dept Cell Biol, Valencia, Spain; [Nacher, Juan] CIBERSAM Spanish Natl Network Res Mental Hlth, Madrid, Spain; [Nacher, Juan] Fdn Invest Hosp Clin Valencia, INCLIVA, Valencia, Spain	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Valencia; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Sandi, C (corresponding author), Ecole Polytech Fed Lausanne, Lab Behav Genet, Brain Mind Inst, Sch Life Sci, Lausanne, Switzerland.	carmen.sandi@epfl.ch	Nacher, Juan/AAA-4714-2020; MOMPÓ, CLARA GARCÍA/AAB-6794-2019; Nacher, Juan/ABE-5734-2020; CASTILLO-GÓMEZ, ESTHER/ABG-2340-2020; Tzanoulinou, Stamatina/ABH-9318-2020	MOMPÓ, CLARA GARCÍA/0000-0002-1043-8415; CASTILLO-GÓMEZ, ESTHER/0000-0002-7566-0340; Sandi, Carmen/0000-0001-7713-8321; Tzanoulinou, Stamatina/0000-0002-6066-2810; Nacher, Juan/0000-0001-7599-3957	Swiss National Science Foundation [31003AB-135710]; Swiss National Science Foundation (NCCR Synapsy); Oak Foundation; EPFL; Spanish Ministry of Economy and Competitiveness in the frame of ERA-NET NEURON [BFU2012-32512, MICINN-PIM2010ERN 00577/NEUCONNECT]; Generalitat Valenciana [ACOMP/2012/229]; Prometeo Excellence Program [PROMETEO2013/069]; Fundacion Alicia Koplowitz	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation (NCCR Synapsy)(Swiss National Science Foundation (SNSF)); Oak Foundation; EPFL; Spanish Ministry of Economy and Competitiveness in the frame of ERA-NET NEURON; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Prometeo Excellence Program; Fundacion Alicia Koplowitz	This work was supported by grants from the Swiss National Science Foundation (31003AB-135710 and the NCCR Synapsy), Oak Foundation, and intramural funding from the EPFL, as well as by the Spanish Ministry of Economy and Competitiveness BFU2012-32512, MICINN-PIM2010ERN 00577/NEUCONNECT in the frame of ERA-NET NEURON, Generalitat Valenciana ACOMP/2012/229 and Prometeo Excellence Program PROMETEO2013/069 and the Fundacion Alicia Koplowitz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN RF, 1984, J NEUROSCI, V4, P251; Albrechet-Souza L, 2009, NEUROSCIENCE, V164, P387, DOI 10.1016/j.neuroscience.2009.08.038; Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Anderson NJ, 2007, ALCOHOL CLIN EXP RES, V31, P1061, DOI 10.1111/j.1530-0277.2007.00394.x; Atack JR, 2005, BRIT J PHARMACOL, V144, P357, DOI 10.1038/sj.bjp.0706056; Avital A, 2006, BRAIN RES BULL, V68, P419, DOI 10.1016/j.brainresbull.2005.09.015; Barad M, 2006, BIOL PSYCHIAT, V60, P322, DOI 10.1016/j.biopsych.2006.05.029; Barbalho CA, 2009, BRAIN RES, V1267, P65, DOI 10.1016/j.brainres.2009.02.042; Bazak N, 2009, PSYCHONEUROENDOCRINO, V34, P844, DOI 10.1016/j.psyneuen.2008.12.018; Bennur S, 2007, NEUROSCIENCE, V144, P8, DOI 10.1016/j.neuroscience.2006.08.075; Bisaz R, 2011, HIPPOCAMPUS, V21, P56, DOI 10.1002/hipo.20723; Bremner JD, 2000, AM J PSYCHIAT, V157, P1120, DOI 10.1176/appi.ajp.157.7.1120; Bryant RA, 2005, BIOL PSYCHIAT, V58, P111, DOI 10.1016/j.biopsych.2005.03.021; Caldji C, 2000, NEUROPSYCHOPHARMACOL, V22, P219, DOI 10.1016/S0893-133X(99)00110-4; Chung YA, 2006, CLIN NEUROPHYSIOL, V117, P637, DOI 10.1016/j.clinph.2005.10.020; COLE BJ, 1995, PSYCHOPHARMACOLOGY, V121, P118, DOI 10.1007/BF02245598; Conti G, 2012, P NATL ACAD SCI USA, V109, P8866, DOI 10.1073/pnas.1205340109; Corcoran CA, 2012, DEV PSYCHOBIOL, V54, P546, DOI 10.1002/dev.20613; Cordero MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.32; Cullinan WE, 2008, BRAIN STRUCT FUNCT, V213, P63, DOI 10.1007/s00429-008-0192-2; Darnaudery M, 2008, BRAIN RES REV, V57, P571, DOI 10.1016/j.brainresrev.2007.11.004; de Kloet ER, 2008, EUR J PHARMACOL, V585, P473, DOI 10.1016/j.ejphar.2008.03.011; Dias R, 2005, J NEUROSCI, V25, P10682, DOI 10.1523/JNEUROSCI.1166-05.2005; Driessen M, 2004, BIOL PSYCHIAT, V55, P603, DOI 10.1016/j.biopsych.2003.08.018; Duvarci S, 2007, J NEUROSCI, V27, P4482, DOI 10.1523/JNEUROSCI.0680-07.2007; Engin E, 2012, PHARMACOL THERAPEUT, V136, P142, DOI 10.1016/j.pharmthera.2012.08.006; ERLANDER MG, 1991, NEURON, V7, P91, DOI 10.1016/0896-6273(91)90077-D; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fatemi SH, 2005, SCHIZOPHR RES, V72, P109, DOI 10.1016/j.schres.2004.02.017; Fatemi SH, 2002, BIOL PSYCHIAT, V52, P805, DOI 10.1016/S0006-3223(02)01430-0; Fischer BD, 2011, PSYCHOPHARMACOLOGY, V215, P311, DOI 10.1007/s00213-010-2142-y; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; Gafford GM, 2012, P NATL ACAD SCI USA, V109, P16330, DOI 10.1073/pnas.1119261109; Geuze E, 2008, MOL PSYCHIATR, V13, P74, DOI 10.1038/sj.mp.4002054; Gilabert-Juan J, 2011, EXP NEUROL, V232, P33, DOI 10.1016/j.expneurol.2011.07.009; Haller J, 2005, EUR J PHARMACOL, V526, P89, DOI 10.1016/j.ejphar.2005.09.064; Hariri Ahmad R, 2011, F1000 Biol Rep, V3, P2, DOI 10.3410/B3-2; Hasler G, 2008, ARCH GEN PSYCHIAT, V65, P1166, DOI 10.1001/archpsyc.65.10.1166; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Herman JP, 1997, TRENDS NEUROSCI, V20, P78, DOI 10.1016/S0166-2236(96)10069-2; Hettema JM, 2006, MOL PSYCHIATR, V11, P752, DOI 10.1038/sj.mp.4001845; Hettema JM, 2012, DEPRESS ANXIETY, V29, P202, DOI 10.1002/da.20901; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Ilin Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004329; Ito H, 2010, NEUROPHARMACOLOGY, V58, P746, DOI 10.1016/j.neuropharm.2009.12.011; Jacobson-Pick S, 2008, INT J NEUROPSYCHOPH, V11, P891, DOI 10.1017/S1461145708008559; Jacobson-Pick S, 2012, STRESS, V15, P416, DOI 10.3109/10253890.2011.634036; Jacobson-Pick S, 2010, BEHAV BRAIN RES, V214, P268, DOI 10.1016/j.bbr.2010.05.036; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Kim MJ, 2011, BEHAV BRAIN RES, V223, P403, DOI 10.1016/j.bbr.2011.04.025; Kohl C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056871; KRAHN DD, 1990, BIOL PSYCHIAT, V27, P1094, DOI 10.1016/0006-3223(90)90046-5; Li G, 2009, J NEUROPHYSIOL, V101, P1629, DOI 10.1152/jn.90765.2008; Liberzon I, 1999, NEUROPSYCHOPHARMACOL, V21, P40, DOI 10.1016/S0893-133X(98)00128-6; Lin HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055248; LINDEFORS N, 1993, PROG NEURO-PSYCHOPH, V17, P887, DOI 10.1016/0278-5846(93)90018-N; Liu M, 2000, BRAIN RES, V887, P23, DOI 10.1016/S0006-8993(00)02962-0; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; Malizia AL, 1998, ARCH GEN PSYCHIAT, V55, P715, DOI 10.1001/archpsyc.55.8.715; Marowsky A, 2004, EUR J NEUROSCI, V20, P1281, DOI 10.1111/j.1460-9568.2004.03574.x; Marowsky A, 2012, J NEUROSCI, V32, P8611, DOI 10.1523/JNEUROSCI.4404-11.2012; Marquez C, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.144; MARTI O, 1994, PHYSIOL BEHAV, V55, P747, DOI 10.1016/0031-9384(94)90055-8; Martijena ID, 2002, SYNAPSE, V45, P86, DOI 10.1002/syn.10085; McCormick CM, 2008, BEHAV BRAIN RES, V187, P228, DOI 10.1016/j.bbr.2007.09.005; Miskovic V, 2012, NEUROSCI BIOBEHAV R, V36, P459, DOI 10.1016/j.neubiorev.2011.08.002; Mohler H, 2012, NEUROPHARMACOLOGY, V62, P42, DOI 10.1016/j.neuropharm.2011.08.040; MOHLER H, 1995, ADV BIOCHEM PSYCHOPH, V48, P41; MOHLER H, 1995, NEUROCHEM RES, V20, P631, DOI 10.1007/BF01694546; MOODY TW, 1988, ANN NY ACAD SCI, V525, P281, DOI 10.1111/j.1749-6632.1988.tb38613.x; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Nelson EC, 2009, MOL PSYCHIATR, V14, P234, DOI 10.1038/mp.2008.81; Nemeroff Charles B, 2003, Psychopharmacol Bull, V37, P133; NUDO RJ, 1986, J COMP NEUROL, V245, P553, DOI 10.1002/cne.902450410; Nutt DJ, 2004, J CLIN PSYCHIAT, V65, P11; Paulus MP, 2005, ARCH GEN PSYCHIAT, V62, P282, DOI 10.1001/archpsyc.62.3.282; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; PELLOW S, 1986, PHARMACOL BIOCHEM BE, V24, P525, DOI 10.1016/0091-3057(86)90552-6; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Rainnie DG, 2004, J NEUROSCI, V24, P3471, DOI 10.1523/JNEUROSCI.5740-03.2004; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Rudolph U, 2001, TRENDS PHARMACOL SCI, V22, P188, DOI 10.1016/S0165-6147(00)01646-1; SANDERS SK, 1995, PHARMACOL BIOCHEM BE, V52, P701, DOI 10.1016/0091-3057(95)00153-N; SANDERS SK, 1991, BRAIN RES, V567, P101, DOI 10.1016/0006-8993(91)91441-3; Sandi C, 2009, TRENDS NEUROSCI, V32, P312, DOI 10.1016/j.tins.2009.02.004; Shiah IS, 1998, LIFE SCI, V63, P1289, DOI 10.1016/S0024-3205(98)00241-0; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Shin LM, 2004, HIPPOCAMPUS, V14, P292, DOI 10.1002/hipo.10183; Sibille E, 2011, INT J NEUROPSYCHOPH, V14, P721, DOI 10.1017/S1461145710001616; Skolnick P, 2012, TRENDS PHARMACOL SCI, V33, P611, DOI 10.1016/j.tips.2012.08.003; Smith KS, 2012, NEUROPHARMACOLOGY, V63, P250, DOI 10.1016/j.neuropharm.2012.03.001; Smith KS, 2011, PSYCHOPHARMACOLOGY, V213, P697, DOI 10.1007/s00213-010-2026-1; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; Toledo-Rodriguez M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00017; Toledo-Rodriguez M, 2012, NEUROBIOL LEARN MEM, V98, P93, DOI 10.1016/j.nlm.2012.05.006; Toledo-Rodriguez Maria, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/71203; Trezza V, 2009, J NEUROSCI, V29, P1, DOI 10.1523/JNEUROSCI.5193-08.2009; van der Kolk BA, 2003, CHILD ADOL PSYCH CL, V12, P293, DOI 10.1016/S1056-4993(03)00003-8; VANERP AMM, 1994, BEHAV BRAIN RES, V65, P47, DOI 10.1016/0166-4328(94)90072-8; Varea E, 2007, EUR NEUROPSYCHOPHARM, V17, P546, DOI 10.1016/j.euroneuro.2007.01.001; Veenit V, 2014, J PSYCHIATR RES, V53, P1, DOI 10.1016/j.jpsychires.2014.02.015; Veenit V, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00026; Vermetten E, 2007, PSYCHOPHARMACOL BULL, V40, P8; Vidal J, 2007, PHYSIOL BEHAV, V92, P824, DOI 10.1016/j.physbeh.2007.06.004; Vyas A, 2002, J NEUROSCI, V22, P6810; Young E A, 1997, Depress Anxiety, V5, P66, DOI 10.1002/(SICI)1520-6394(1997)5:2<66::AID-DA2>3.3.CO;2-X	113	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94666	10.1371/journal.pone.0094666	http://dx.doi.org/10.1371/journal.pone.0094666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736324	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600080
J	Vuong, TV; Master, ER				Vuong, Thu V.; Master, Emma R.			Fusion of a Xylan-Binding Module to Gluco-Oligosaccharide Oxidase Increases Activity and Promotes Stable Immobilization	PLOS ONE			English	Article							GLUCOOLIGOSACCHARIDE OXIDASE; ACREMONIUM-STRICTUM; CATALYTIC-ACTIVITY; PROTEIN; POLYSACCHARIDES; BIOSENSORS; OXIDATION; CELLULOSE; SEQUENCE	The xylan-binding module Clostridium thermocellum CBM22A was successfully fused to a gluco-oligosaccharide oxidase, GOOX-VN, from Sarocladium strictum via a short TP linker, allowing the fused protein to effectively bind different xylans. The presence of the CtCBM22A at the N-terminal of GOOX-VN increased catalytic activity on mono-and oligo-saccharides by 2-3 fold while not affecting binding affinity to these substrates. Notably, both GOOX-VN and its CBM fusion also showed oxidation of xylo-oligosaccharides with degrees of polymerization greater than six. Whereas fusion to CtCBM22A did not alter the thermostability of GOOX-VN or reduce substrate inhibition, CtCBM22A_GOOX-VN could be immobilized to insoluble oat spelt xylan while retaining wild-type activity. QCM-D analysis showed that the fused enzyme remained bound during oxidation. These features could be harnessed to generate hemicellulose-based biosensors that detect and quantify the presence of different oligosaccharides.	[Vuong, Thu V.; Master, Emma R.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada	University of Toronto	Vuong, TV (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	thu.vuong@utoronto.ca	Master, Emma/O-3554-2014	Master, Emma/0000-0002-6837-9817	Government of Ontario [ORF-RE-05-005]; Natural Sciences and Engineering Research Council	Government of Ontario; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Government of Ontario (ORF-RE-05-005) and the Natural Sciences and Engineering Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boraston AB, 2003, J MOL MICROB BIOTECH, V5, P29, DOI 10.1159/000068721; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Chen C, 2013, RSC ADV, V3, P4473, DOI 10.1039/c2ra22351a; Cruys-Bagger N, 2012, BIOTECHNOL BIOENG, V109, P3199, DOI 10.1002/bit.24593; De Schutter K, 2009, NAT BIOTECHNOL, V27, P561, DOI 10.1038/nbt.1544; Eronen P, 2011, CARBOHYD POLYM, V86, P1281, DOI 10.1016/j.carbpol.2011.06.031; Fan ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031693; Foumani M, 2011, BIOTECHNOL BIOENG, V108, P2261, DOI 10.1002/bit.23149; Freelove ACJ, 2001, J BIOL CHEM, V276, P43010, DOI 10.1074/jbc.M107143200; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; Hao ZY, 2014, CRIT REV BIOCHEM MOL, V49, P212, DOI 10.3109/10409238.2014.889651; Heinze T, 2005, HEMICELLULOSE POLYSA, P1; Huang CH, 2005, J BIOL CHEM, V280, P38831, DOI 10.1074/jbc.M506078200; IRWIN D, 1994, APPL ENVIRON MICROB, V60, P763, DOI 10.1128/AEM.60.3.763-770.1994; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Kittur FS, 2003, FEBS LETT, V549, P147, DOI 10.1016/S0014-5793(03)00803-2; KORMELINK FJM, 1993, APPL MICROBIOL BIOT, V38, P688, DOI 10.1007/BF00182811; Kwan EM, 2005, PROTEIN ENG DES SEL, V18, P497, DOI 10.1093/protein/gzi055; Lee MH, 2005, APPL ENVIRON MICROB, V71, P8881, DOI 10.1128/AEM.71.12.8881-8887.2005; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; LIN SF, 1991, BIOCHIM BIOPHYS ACTA, V1118, P41, DOI 10.1016/0167-4838(91)90439-7; Lin SF, 1996, BIOTECHNOL TECH, V10, P63, DOI 10.1007/BF00161086; Mikkonen KS, 2009, J APPL POLYM SCI, V114, P457, DOI 10.1002/app.30513; Parikka K, 2010, J AGR FOOD CHEM, V58, P262, DOI 10.1021/jf902930t; Pricelius S, 2009, APPL MICROBIOL BIOT, V85, P75, DOI 10.1007/s00253-009-2062-0; Suginta W, 2013, CHEM REV, V113, P5458, DOI 10.1021/cr300325r; Susanto H, 2013, ENZYME MICROB TECH, V52, P386, DOI 10.1016/j.enzmictec.2013.02.005; Teleman A, 2002, CARBOHYD RES, V337, P373, DOI 10.1016/S0008-6215(01)00327-5; Telke AA, 2012, BIORESOURCE TECHNOL, V112, P10, DOI 10.1016/j.biortech.2012.02.066; Velikodvorskaya GA, 2010, APPL ENVIRON MICROB, V76, P8071, DOI 10.1128/AEM.01517-10; Voutilainen S.P., 2013, APPL MICROBIOL BIOT, P1; Vuong TV, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-148; Wang J, 2001, ELECTROANAL, V13, P983, DOI 10.1002/1521-4109(200108)13:12<983::AID-ELAN983>3.0.CO;2-#; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Xu F, 2001, EUR J BIOCHEM, V268, P1136, DOI 10.1046/j.1432-1327.2001.01982.x	36	12	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95170	10.1371/journal.pone.0095170	http://dx.doi.org/10.1371/journal.pone.0095170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736604	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600149
J	Tohme, M; Prud'homme, SM; Boulahtouf, A; Samarut, E; Brunet, F; Bernard, L; Bourguet, W; Gibert, Y; Balaguer, P; Laudet, V				Tohme, Marie; Prud'homme, Sophie M.; Boulahtouf, Abdel; Samarut, Eric; Brunet, Frederic; Bernard, Laure; Bourguet, William; Gibert, Yann; Balaguer, Patrick; Laudet, Vincent			Estrogen-related receptor gamma is an in vivo receptor of bisphenol A	FASEB JOURNAL			English	Article						endocrine disrupters; zebrafish; otolith	ZEBRAFISH DANIO-RERIO; ENVIRONMENTAL ENDOCRINE DISRUPTORS; GENE-EXPRESSION ANALYSIS; ERR-GAMMA; SMALL EXPOSURES; CDNA MICROARRAY; CELL-LINE; CHEMICALS; ACTIVATION; MECHANISMS	Bisphenol A (BPA) is an endocrine disruptor that displays estrogenic activity. Several reports suggest that BPA may have estrogen receptor-independent effects. In zebrafish, 50 mu M BPA exposure induces otic vesicle abnormalities, including otolith aggregation. The purpose of this study was to test if BPA action was mediated in vivo during zebrafish development by the orphan nuclear estrogen related receptor (ERR) gamma. Combining pharmacological and functional approaches, we demonstrate that the zebrafish ERR gamma mediates BPA-induced malformations in otoliths. Using different bisphenol derivatives, we show that different compounds can induce a similar otolith phenotype than BPA and that the binding affinity of these derivatives to the zebrafish ERR gamma correlates with their ability to induce otolith malformations. Morpholino knockdown of ERR gamma function suppresses the BPA effect on otoliths whereas overexpression of ERR gamma led to a BPA-like otolith phenotype. Moreover, a subphenotypical dose of BPA (1 mu M) combined with ERR gamma overexpression led to a full-dose (50 mu M) BPA otolith phenotype. We therefore conclude that ERR gamma mediates the otic vesicle phenotype generated by BPA. Our results suggest that the range of pathways perturbed by this compound and its potential harmful effect are larger than expected.	[Tohme, Marie; Prud'homme, Sophie M.; Samarut, Eric; Brunet, Frederic; Bernard, Laure; Laudet, Vincent] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS,UMR 5242, F-69364 Lyon 07, France; [Boulahtouf, Abdel; Balaguer, Patrick] Ctr Reg Lutte Canc Val dAurelle Paul Lamarque, Inst Rech Cancerol Montpellier, INSERM, U896, Montpellier, France; [Bourguet, William] Univ Montpellier I, Ctr Biochim Struct, CNRS, INSERM,U1054,UMR5048, Montpellier, France; [Bourguet, William] Univ Montpellier 2, Ctr Biochim Struct, CNRS, INSERM,U1054,UMR5048, Montpellier, France; [Gibert, Yann] Deakin Sch Med, Metab Genet Dis Lab, Metab Res Unit, Waurn Ponds, Vic, Australia	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Laudet, V (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, CNRS,UMR 5242, 46 Allee Italie, F-69364 Lyon 07, France.	vincent.laudet@ens-lyon.fr	Bourguet, William/Y-6600-2019; Bourguet, William/I-5569-2013; Balaguer, Patrick/I-2973-2016	Bourguet, William/0000-0002-0643-7719; Bourguet, William/0000-0002-0643-7719; Brunet, Frederic/0000-0001-5145-8925; SAMARUT, ERIC/0000-0001-7818-2009; Prud'homme, Sophie/0000-0002-7199-1839	Agence Nationale de la Recherche [ANR-01-CESA-008]; Centre National de la Recherche Scientifique; Ecole Normale Superieure de Lyon; Conventions Industrielles de Formation par la Recherche fellowship; Watchfrog Co. (Evry, France)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); Conventions Industrielles de Formation par la Recherche fellowship; Watchfrog Co. (Evry, France)	This work was supported by Agence Nationale de la Recherche (Kismet Program ANR-01-CESA-008), the Centre National de la Recherche Scientifique, and the Ecole Normale Superieure de Lyon. M. T. was funded via a Conventions Industrielles de Formation par la Recherche fellowship together with the Watchfrog Co. (Evry, France). Y.G. is supported from the Molecular and Medical Research Strategic Center at Deakin University. The authors thank Joanne Burden and Jean-Marc Vanacker for critical reading of the manuscript and Guillaume Holzer for help with the mutated ERR gamma plasmid.	Abad MC, 2008, J STEROID BIOCHEM, V108, P44, DOI 10.1016/j.jsbmb.2007.06.006; Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Bardet PL, 2005, EVOL DEV, V7, P223, DOI 10.1111/j.1525-142X.2005.05025.x; Bertrand S, 2007, PLOS GENET, V3, P2085, DOI 10.1371/journal.pgen.0030188; Bertrand W, 2004, MOL BIOL EVOL, V21, P1923, DOI 10.1093/molbev/msh200; Bianco S, 2012, J STEROID BIOCHEM, V130, P180, DOI 10.1016/j.jsbmb.2011.03.014; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bondesson M, 2009, REPROD TOXICOL, V28, P563, DOI 10.1016/j.reprotox.2009.06.014; Bouskine A, 2009, ENVIRON HEALTH PERSP, V117, P1053, DOI 10.1289/ehp.0800367; Buterin T, 2006, CARCINOGENESIS, V27, P1567, DOI [10.1093/carcin/bci339, 10.1093/carcin/bgi339]; Chow WS, 2013, J APPL TOXICOL, V33, P670, DOI 10.1002/jat.2723; Cosnefroy A, 2012, TOXICOL SCI, V125, P439, DOI 10.1093/toxsci/kfr297; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Crain DA, 2007, REPROD TOXICOL, V24, P225, DOI 10.1016/j.reprotox.2007.05.008; Duan ZH, 2008, ECOTOX ENVIRON SAFE, V71, P774, DOI 10.1016/j.ecoenv.2008.01.021; Gibert Y, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-4; Gould JC, 1998, MOL CELL ENDOCRINOL, V142, P203, DOI 10.1016/S0303-7207(98)00084-7; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Kang JH, 2007, CRIT REV TOXICOL, V37, P607, DOI 10.1080/10408440701493103; Kausch U, 2008, ENVIRON TOXICOL, V23, P15, DOI 10.1002/tox.20306; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lam SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028273; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; Li DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065399; Lopez-Casas PP, 2012, REPROD TOXICOL, V33, P106, DOI 10.1016/j.reprotox.2011.12.012; Marmugi A, 2012, HEPATOLOGY, V55, P395, DOI 10.1002/hep.24685; Matsushima A, 2007, J BIOCHEM, V142, P517, DOI 10.1093/jb/mvm158; McCollum CW, 2011, BIRTH DEFECTS RES C, V93, P67, DOI 10.1002/bdrc.20210; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Moens LN, 2006, TOXICOL SCI, V93, P298, DOI 10.1093/toxsci/kfl057; Muncke J, 2007, ENVIRON TOXICOL, V22, P185, DOI 10.1002/tox.20255; Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P309, DOI 10.1289/ehp.0800173; N'Tumba-Byn T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051579; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Pastva SD, 2001, CHEMOSPHERE, V45, P535, DOI 10.1016/S0045-6535(01)00018-2; Routledge EJ, 2000, J BIOL CHEM, V275, P35986, DOI 10.1074/jbc.M006777200; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327; Solomon KS, 2004, DEV DYNAM, V230, P419, DOI 10.1002/dvdy.20067; Takayanagi S, 2006, TOXICOL LETT, V167, P95, DOI 10.1016/j.toxlet.2006.08.012; Takeda Y, 2009, J BIOCHEM, V146, P113, DOI 10.1093/jb/mvp049; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; vom Saal FS, 2006, ENVIRON RES, V100, P50, DOI 10.1016/j.envres.2005.09.001; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Whitfield TT, 2002, DEV DYNAM, V223, P427, DOI 10.1002/dvdy.10073; Zoeller RT, 2005, MOL CELL ENDOCRINOL, V242, P10, DOI 10.1016/j.mce.2005.07.006	53	94	95	3	57	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3124	3133		10.1096/fj.13-240465	http://dx.doi.org/10.1096/fj.13-240465			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24744145				2022-12-25	WOS:000337949400033
J	Radhakrishnan, A; Kumar, N; Wright, CC; Chou, TH; Tringides, ML; Bolla, JR; Lei, HT; Rajashankar, KR; Su, CC; Purdy, GE; Yu, EW				Radhakrishnan, Abhijith; Kumar, Nitin; Wright, Catherine C.; Chou, Tsung-Han; Tringides, Marios L.; Bolla, Jani Reddy; Lei, Hsiang-Ting; Rajashankar, Kanagalaghatta R.; Su, Chih-Chia; Purdy, Georgiana E.; Yu, Edward W.			Crystal Structure of the Transcriptional Regulator Rv0678 of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG-RESISTANT TUBERCULOSIS; DNA-BINDING MECHANISM; COMPLEX; VIRULENCE; SOFTWARE; REVEALS; MARR; BIOSYNTHESIS; EVOLUTION; FAMILY	Recent work demonstrates that the MmpL(mycobacterial membrane protein large) transporters are dedicated to the export of mycobacterial lipids for cell wall biosynthesis. An MmpL transporter frequently works with an accessory protein, belonging to the MmpS (mycobacterial membrane protein small) family, to transport these key virulence factors. One such efflux system in Mycobacterium tuberculosis is the MmpS5-MmpL5 transporter. The expression of MmpS5-MmpL5 is controlled by the MarR-like transcriptional regulator Rv0678, whose open reading frame is located downstream of the mmpS5-mmpL5 operon. To elucidate the structural basis of Rv0678 regulation, we have determined the crystal structure of this regulator, to 1.64 angstrom resolution, revealing a dimeric two-domain molecule with an architecture similar to members of the MarR family of transcriptional regulators. Rv0678 is distinct from other MarR regulators in that its DNA-binding and dimerization domains are clustered together. These two domains seemingly cooperate to bind an inducing ligand that we identified as 2-stearoylglycerol, which is a fatty acid glycerol ester. The structure also suggests that the conformational change leading to substrate-mediated derepression is primarily caused by a rigid body rotational motion of the entire DNA-binding domain of the regulator toward the dimerization domain. This movement results in a conformational state that is incompatible with DNA binding. We demonstrate using electrophoretic mobility shift assays that Rv0678 binds to the mmpS5-mmpL5, mmpS4-mmpL4, and the mmpS2-mmpL2 promoters. Binding by Rv0678 was reversed upon the addition of the ligand. These findings provide new insight into the mechanisms of gene regulation in the MarR family of regulators.	[Radhakrishnan, Abhijith; Kumar, Nitin; Tringides, Marios L.; Bolla, Jani Reddy; Lei, Hsiang-Ting; Yu, Edward W.] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Chou, Tsung-Han; Su, Chih-Chia; Yu, Edward W.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Wright, Catherine C.; Purdy, Georgiana E.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Iowa State University; Iowa State University; Oregon Health & Science University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Yu, EW (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	ewyu@iastate.edu	Radhakrishnan, Abhijith/V-6182-2019; Bolla, Jani Reddy/AAT-1370-2020; , Nitin/J-8078-2019	Radhakrishnan, Abhijith/0000-0001-8107-3487; Bolla, Jani Reddy/0000-0003-4346-182X; Tringides, Marios/0000-0002-3800-2365	NIGMS, National Institutes of Health [GM103403]; United States Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086431, P41GM103403] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines of the Advanced Photon Source, supported by NIGMS, National Institutes of Health, Grant GM103403. Use of the Advanced Photon Source is supported by the United States Department of Energy, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. We are grateful to Louis Messerle (University of Iowa) for providing the (NH<INF>4</INF>)<INF>2</INF>W<INF>6</INF>(mu-O)<INF>6</INF>(mu-Cl)<INF>6</INF>Cl<INF>6</INF> complex used in this study.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alekshun MN, 2001, NAT STRUCT BIOL, V8, P710, DOI 10.1038/90429; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; De Silva RS, 2005, J BIOL CHEM, V280, P13779, DOI 10.1074/jbc.M413781200; Deshayes C, 2010, MOL MICROBIOL, V78, P989, DOI 10.1111/j.1365-2958.2010.07385.x; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Ellison DW, 2006, CURR OPIN MICROBIOL, V9, P153, DOI 10.1016/j.mib.2006.02.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; Goldman Robert C., 2007, Infectious Disorders - Drug Targets, V7, P73; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kumarevel T, 2009, NUCLEIC ACIDS RES, V37, P4723, DOI 10.1093/nar/gkp496; Lim D, 2002, J BIOL CHEM, V277, P29253, DOI 10.1074/jbc.M111381200; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Milano A, 2009, TUBERCULOSIS, V89, P84, DOI 10.1016/j.tube.2008.08.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ML PHARE CCP4 PROC 8; Pacheco SA, 2013, J BIOL CHEM, V288, P24213, DOI 10.1074/jbc.M113.473371; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Reddy TBK, 2009, NUCLEIC ACIDS RES, V37, pD499, DOI 10.1093/nar/gkn652; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Udwadia ZF, 2012, CLIN INFECT DIS, V54, P579, DOI 10.1093/cid/cir889; Wilke MS, 2008, P NATL ACAD SCI USA, V105, P14832, DOI 10.1073/pnas.0805489105; Zianni Michael, 2006, J Biomol Tech, V17, P103	40	45	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16526	16540		10.1074/jbc.M113.538959	http://dx.doi.org/10.1074/jbc.M113.538959			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24737322	hybrid, Green Published			2022-12-25	WOS:000337965700054
J	Schiebel, J; Chang, A; Shah, S; Lu, Y; Liu, L; Pan, P; Hirschbeck, MW; Tareilus, M; Eltschkner, S; Yu, WX; Cummings, JE; Knudson, SE; Bommineni, GR; Walker, SG; Slayden, RA; Sotriffer, CA; Tonge, PJ; Kisker, C				Schiebel, Johannes; Chang, Andrew; Shah, Sonam; Lu, Yang; Liu, Li; Pan, Pan; Hirschbeck, Maria W.; Tareilus, Mona; Eltschkner, Sandra; Yu, Weixuan; Cummings, Jason E.; Knudson, Susan E.; Bommineni, Gopal R.; Walker, Stephen G.; Slayden, Richard A.; Sotriffer, Christoph A.; Tonge, Peter J.; Kisker, Caroline			Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SLOW-ONSET INHIBITION; FATTY-ACID SYNTHESIS; CRYSTAL-STRUCTURE; SCORING FUNCTION; 4-PYRIDONE DERIVATIVES; TRICLOSAN RESISTANCE; RESIDENCE TIME; DRUG-TARGET; FABI	Determining the molecular basis for target selectivity is of particular importance in drug discovery. The ideal antibiotic should be active against a broad spectrum of pathogenic organisms with a minimal effect on human targets. CG400549, a Staphylococcus-specific 2-pyridone compound that inhibits the enoyl-acyl carrier protein reductase (FabI), has recently been shown to possess human efficacy for the treatment of methicillin-resistant Staphylococcus aureus infections, which constitute a serious threat to human health. In this study, we solved the structures of three different FabI homologues in complex with several pyridone inhibitors, including CG400549. Based on these structures, we rationalize the 65-fold reduced affinity of CG400549 toward Escherichia coli versus S. aureus FabI and implement concepts to improve the spectrum of antibacterial activity. The identification of different conformational states along the reaction coordinate of the enzymatic hydride transfer provides an elegant visual depiction of the relationship between catalysis and inhibition, which facilitates rational inhibitor design. Ultimately, we developed the novel 4-pyridone-based FabI inhibitor PT166 that retained favorable pharmacokinetics and efficacy in a mouse model of S. aureus infection with extended activity against Gram-negative and mycobacterial organisms.	[Schiebel, Johannes; Hirschbeck, Maria W.; Tareilus, Mona; Eltschkner, Sandra; Kisker, Caroline] Univ Wurzburg, Inst Biol Struct, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Schiebel, Johannes; Sotriffer, Christoph A.] Univ Wurzburg, Inst Pharm & Food Chem, D-97074 Wurzburg, Germany; [Chang, Andrew; Shah, Sonam; Lu, Yang; Liu, Li; Pan, Pan; Yu, Weixuan; Bommineni, Gopal R.; Tonge, Peter J.] SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Chang, Andrew; Lu, Yang; Walker, Stephen G.] SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, Stony Brook, NY 11794 USA; [Cummings, Jason E.; Knudson, Susan E.; Slayden, Richard A.] Colorado State Univ, Rocky Mt Reg Ctr Excellence, Ft Collins, CO 80523 USA; [Cummings, Jason E.; Knudson, Susan E.; Slayden, Richard A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	University of Wurzburg; University of Wurzburg; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Colorado State University; Colorado State University	Tonge, PJ (corresponding author), SUNY Stony Brook, Dept Chem, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA.	peter.tonge@stonybrook.edu; caroline.kisker@virchow.uni-wuerzburg.de	Kisker, Caroline/T-1724-2019; Tonge, Peter J/A-7443-2009; Slayden, Richard/O-8626-2016; Slayden, Richard/AAV-2582-2021	Tonge, Peter J/0000-0003-1606-3471; Slayden, Richard/0000-0001-6857-7277; Slayden, Richard/0000-0001-6857-7277; Eltschkner, Sandra/0000-0002-9854-0800; Chang, Andrew/0000-0002-8416-359X; Lu, Yang/0000-0003-2717-9656; Kisker, Caroline/0000-0002-0216-6026	National Institutes of Health [GM102864, AI044639, AI070383]; Deutsche Forschungsgemeinschaft [SFB630, FZ82]; German Excellence Initiative; Chemical Biology Training Program (National Institutes of Health) [T32GM092714]; Medical Scientist Training Program (National Institutes of Health) [T32GM008444]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044639, U01AI070383, R01AI044639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM092714, T32GM008444, R01GM102864] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Excellence Initiative; Chemical Biology Training Program (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM102864, AI044639, and AI070383 (to P. J. T.) This work was also supported by Deutsche Forschungsgemeinschaft Grants SFB630 (to C. A. S. and C. K.) and Forschungszentrum Grant FZ82 (to C. K.).; Supported by a grant from the German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg. Present address: Dept. of Pharmaceutical Chemistry, University of Marburg, Marbacher Weg 6, D-35032 Marburg, Germany.; Supported by the Chemical Biology Training Program (National Institutes of Health Grant T32GM092714) and by the Medical Scientist Training Program (National Institutes of Health Grant T32GM008444).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balemans W, 2010, NATURE, V463, pE3, DOI 10.1038/nature08667; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Bissantz C, 2010, J MED CHEM, V53, P5061, DOI 10.1021/jm100112j; Brameld KA, 2008, J CHEM INF MODEL, V48, P1, DOI 10.1021/ci7002494; Brenwald NP, 2003, J HOSP INFECT, V55, P141, DOI 10.1016/S0195-6701(03)00222-6; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Bruno IJ, 2004, J CHEM INF COMP SCI, V44, P2133, DOI 10.1021/ci049780b; Chang A, 2013, BIOCHEMISTRY-US, V52, P4217, DOI 10.1021/bi400413c; Chemical Computing Group, 2010, MOL OP ENV VERS 2010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clinical and Laboratory Standards Institute, 2006, M7A5 CLIN LAB STAND; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escaich S, 2011, ANTIMICROB AGENTS CH, V55, P4692, DOI 10.1128/AAC.01248-10; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fan F, 2002, ANTIMICROB AGENTS CH, V46, P3343, DOI 10.1128/AAC.46.11.3343-3347.2002; GERBER AU, 1982, J INFECT DIS, V146, P691, DOI 10.1093/infdis/146.5.691; Gerusz V, 2012, J MED CHEM, V55, P9914, DOI 10.1021/jm301113w; Gerusz V, 2010, ANNU REP MED CHEM, V45, P295, DOI 10.1016/S0065-7743(10)45018-6; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Kitagawa H, 2007, BIOORGAN MED CHEM, V15, P1106, DOI 10.1016/j.bmc.2006.10.012; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Li HJ, 2014, ACS CHEM BIOL, V9, P986, DOI 10.1021/cb400896g; Liu NN, 2011, J ANTIMICROB CHEMOTH, V66, P564, DOI 10.1093/jac/dkq509; Lu H, 2008, ACCOUNTS CHEM RES, V41, P11, DOI 10.1021/ar700156e; Lu H, 2010, BIOCHEMISTRY-US, V49, P1281, DOI 10.1021/bi902001a; Lu H, 2009, ACS CHEM BIOL, V4, P221, DOI 10.1021/cb800306y; Luckner SR, 2010, J BIOL CHEM, V285, P14330, DOI 10.1074/jbc.M109.090373; Marrakchi H, 2000, MICROBIOL-UK, V146, P289, DOI 10.1099/00221287-146-2-289; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Neudert G, 2011, J CHEM INF MODEL, V51, P2731, DOI 10.1021/ci200274q; Neudert G, 2011, BIOINFORMATICS, V27, P1021, DOI 10.1093/bioinformatics/btr055; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pantosti A, 2009, EUR RESPIR J, V34, P1190, DOI 10.1183/09031936.00007709; Park HS, 2007, J ANTIMICROB CHEMOTH, V60, P568, DOI 10.1093/jac/dkm236; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Payne DJ, 2002, ANTIMICROB AGENTS CH, V46, P3118, DOI 10.1128/AAC.46.10.3118-3124.2002; Priyadarshi A, 2010, PROTEINS, V78, P480, DOI 10.1002/prot.22581; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; Ro S., 2009, INT C ANT AG CHEM SA; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Seefeld MA, 2003, J MED CHEM, V46, P1627, DOI 10.1021/jm0204035; Shin K. J., 2011, Korea Patent, Patent No. [WO/2011/014008 A2, 2011014008]; Sievert DM, 2008, CLIN INFECT DIS, V46, P668, DOI 10.1086/527392; Silver LL, 2011, CLIN MICROBIOL REV, V24, P71, DOI 10.1128/CMR.00030-10; Sivaraman S, 2003, BIOCHEMISTRY-US, V42, P4406, DOI 10.1021/bi0300229; Smart O.S., 2011, GRADE; Stewart MJ, 1999, J MOL BIOL, V290, P859, DOI 10.1006/jmbi.1999.2907; Takahata S, 2007, J ANTIBIOT, V60, P123, DOI 10.1038/ja.2007.11; Theobald DL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040043; Tipparaju SK, 2008, BIOORG MED CHEM LETT, V18, P3565, DOI 10.1016/j.bmcl.2008.05.004; Tripos, 2009, SYBYL X VERS 1 0; Velec HFG, 2005, J MED CHEM, V48, P6296, DOI 10.1021/jm050436v; Wang LQ, 2004, DRUG METAB DISPOS, V32, P1162, DOI 10.1124/dmd.104.000273; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; Westley AM, 1996, J BIOL CHEM, V271, P5347, DOI 10.1074/jbc.271.10.5347; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Xu H, 2008, BIOCHEMISTRY-US, V47, P4228, DOI 10.1021/bi800023a; Yao JW, 2013, J BIOL CHEM, V288, P36261, DOI 10.1074/jbc.M113.512905; Yum JH, 2007, ANTIMICROB AGENTS CH, V51, P2591, DOI 10.1128/AAC.01562-06; Zhang YM, 2006, J BIOL CHEM, V281, P17541, DOI 10.1074/jbc.R600004200	82	48	48	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15987	16005		10.1074/jbc.M113.532804	http://dx.doi.org/10.1074/jbc.M113.532804			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24739388	hybrid, Green Published			2022-12-25	WOS:000337965700010
J	Chao, YH; Kang, JM; Zhang, TJ; Yang, QC; Gruber, MY; Sun, Y				Chao, Yuehui; Kang, Junmei; Zhang, Tiejun; Yang, Qingchuan; Gruber, Margaret Yvonne; Sun, Yan			Disruption of the Homogentisate Solanesyltransferase Gene Results in Albino and Dwarf Phenotypes and Root, Trichome and Stomata Defects in Arabidopsis thaliana	PLOS ONE			English	Article							GIBBERELLIN BIOSYNTHESIS; FUNCTIONAL-ANALYSIS; FLORAL-TRANSITION; ABA1 GENE; PLASTOQUINONE; EXPRESSION; PATHWAY; INVOLVEMENT; CHLOROPHYLL; SYNTHASE	Homogentisate solanesyltransferase (HST) plays an important role in plastoquinone (PQ) biosynthesis and acts as the electron acceptor in the carotenoids and abscisic acid (ABA) biosynthesis pathways. We isolated and identified a T-DNA insertion mutant of the HST gene that displayed the albino and dwarf phenotypes. PCR analyses and functional complementation also confirmed that the mutant phenotypes were caused by disruption of the HST gene. The mutants also had some developmental defects, including trichome development and stomata closure defects. Chloroplast development was also arrested and chlorophyll (Chl) was almost absent. Developmental defects in the chloroplasts were consistent with the SDS-PAGE result and the RNAi transgenic phenotype. Exogenous gibberellin (GA) could partially rescue the dwarf phenotype and the root development defects and exogenous ABA could rescue the stomata closure defects. Further analysis showed that ABA and GA levels were both very low in the pds2-1 mutants, which suggested that biosynthesis inhibition by GAs and ABA contributed to the pds2-1 mutants' phenotypes. An early flowering phenotype was found in pds2-1 mutants, which showed that disruption of the HST gene promoted flowering by partially regulating plant hormones. RNA-sequencing showed that disruption of the HST gene resulted in expression changes to many of the genes involved in flowering time regulation and in the biosynthesis of PQ, Chl, GAs, ABA and carotenoids. These results suggest that HST is essential for chloroplast development, hormone biosynthesis, pigment accumulation and plant development.	[Chao, Yuehui; Kang, Junmei; Zhang, Tiejun; Yang, Qingchuan] Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China; [Gruber, Margaret Yvonne] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Sun, Yan] China Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Agriculture & Agri Food Canada; China Agricultural University	Yang, QC (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Beijing 100193, Peoples R China.	qchyang66@163.com	Zhang, Tiejun/HDM-7091-2022		National Science and Technology Supporting Project of China [2011BAD17B01-01-3]; China Agriculture Research System [CARS-35-04]	National Science and Technology Supporting Project of China; China Agriculture Research System	This program was supported by a National Science and Technology Supporting Project of China (No. 2011BAD17B01-01-3) and a grant from The China Agriculture Research System (CARS-35-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, PLANT HORMONES PHYSL, DOI DOI 10.1007/978-94-011-0473-9; BARBER J, 1994, NATURE, V370, P31, DOI 10.1038/370031a0; Barrero JM, 2005, J EXP BOT, V56, P2071, DOI 10.1093/jxb/eri206; Barrero JM, 2008, PLANT CELL ENVIRON, V31, P227, DOI 10.1111/j.1365-3040.2007.01759.x; Cervera M, 2005, METH MOL B, V286, P203; Chao YH, 2009, MOL BIOL REP, V36, P2315, DOI 10.1007/s11033-009-9450-5; Chien JC, 1996, PLANT PHYSIOL, V111, P1321, DOI 10.1104/pp.111.4.1321; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crane FL, 2010, PHOTOSYNTH RES, V103, P195, DOI 10.1007/s11120-010-9537-9; Cunningham FX, 1996, PLANT CELL, V8, P1613, DOI 10.2307/3870254; Davis SJ, 2009, PLANT CELL ENVIRON, V32, P1201, DOI 10.1111/j.1365-3040.2009.01968.x; Domagalska MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014012; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Estevez JM, 2000, PLANT PHYSIOL, V124, P95, DOI 10.1104/pp.124.1.95; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Gordon A, 2010, FASTX TOOLKIT UNPUB; GRAEBE JE, 1987, ANNU REV PLANT PHYS, V38, P419, DOI 10.1146/annurev.pp.38.060187.002223; Hedden P, 1997, ANNU REV PLANT PHYS, V48, P431, DOI 10.1146/annurev.arplant.48.1.431; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; Hsieh MH, 2005, PLANT PHYSIOL, V138, P641, DOI 10.1104/pp.104.058735; Huang XZ, 2009, CELL RES, V19, P1205, DOI 10.1038/cr.2009.84; Inada S, 2000, PLANT CELL PHYSIOL, V41, P657, DOI 10.1093/pcp/41.6.657; Keller Y, 1998, EUR J BIOCHEM, V251, P413, DOI 10.1046/j.1432-1327.1998.2510413.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; LICHTENTHALER HK, 1987, J PLANT PHYSIOL, V131, P101, DOI 10.1016/S0176-1617(87)80271-7; Lin CC, 2011, PLANT CELL PHYSIOL, V52, P421, DOI 10.1093/pcp/pcq206; Lindgren LO, 2003, PLANT PHYSIOL, V132, P779, DOI 10.1104/pp.102.017053; LIVERMAN JL, 1956, PLANT PHYSIOL, V31, P147, DOI 10.1104/pp.31.2.147; Micheals SD, 1999, DEV GENET, V25, P194, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;194::AID-DVG2&gt;3.0.CO;2-2; NIEVELSTEIN V, 1995, EUR J BIOCHEM, V233, P864, DOI 10.1111/j.1432-1033.1995.864_3.x; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Norris SR, 1998, PLANT PHYSIOL, V117, P1317, DOI 10.1104/pp.117.4.1317; Olszewski N, 2002, PLANT CELL, V14, pS61, DOI 10.1105/tpc.010476; Perazza D, 1998, PLANT PHYSIOL, V117, P375, DOI 10.1104/pp.117.2.375; Qin GJ, 2007, CELL RES, V17, P471, DOI 10.1038/cr.2007.40; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROCK CD, 1991, P NATL ACAD SCI USA, V88, P7496, DOI 10.1073/pnas.88.17.7496; Sadre R, 2006, FEBS LETT, V580, P5357, DOI 10.1016/j.febslet.2006.09.002; Sadre R, 2010, J BIOL CHEM, V285, P18191, DOI 10.1074/jbc.M110.117929; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Singh DP, 2002, PLANT CELL, V14, P3133, DOI 10.1105/tpc.003046; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; SOLL J, 1980, ARCH BIOCHEM BIOPHYS, V204, P544, DOI 10.1016/0003-9861(80)90066-1; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Suo HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045568; SWIEZEWSKA E, 1993, J BIOL CHEM, V268, P1494; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Tholl D, 2004, PLANT CELL, V16, P977, DOI 10.1105/tpc.020156; Thomas SG, 1999, P NATL ACAD SCI USA, V96, P4698, DOI 10.1073/pnas.96.8.4698; Tian L, 2007, PLANTA, V226, P1067, DOI 10.1007/s00425-007-0564-5; Venkatesh TV, 2006, PLANTA, V223, P1134, DOI 10.1007/s00425-005-0180-1; Wang SC, 2010, NEW PHYTOL, V185, P387, DOI 10.1111/j.1469-8137.2009.03067.x; Wang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-529; Wang XW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-458; Wang YP, 2013, J EXP BOT, V64, P675, DOI 10.1093/jxb/ers361; WITTWER SH, 1957, SCIENCE, V126, P30, DOI 10.1126/science.126.3262.30; WITTWER SH, 1957, PLANT PHYSIOL, V32, P39, DOI 10.1104/pp.32.1.39; Xing SF, 2010, CELL RES, V20, P688, DOI 10.1038/cr.2010.54; YADEGARI R, 1994, PLANT CELL, V6, P1713, DOI 10.1105/tpc.6.12.1713; Yamaguchi S, 2000, PLANT CELL PHYSIOL, V41, P251, DOI 10.1093/pcp/41.3.251; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; Yang WY, 2011, PLANT J, V65, P206, DOI 10.1111/j.1365-313X.2010.04417.x; Yaxley JR, 2001, PLANT PHYSIOL, V125, P627, DOI 10.1104/pp.125.2.627; Ye NH, 2012, PLANT SIGNAL BEHAV, V7, P563, DOI 10.4161/psb.19919	66	9	11	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94031	10.1371/journal.pone.0094031	http://dx.doi.org/10.1371/journal.pone.0094031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743244	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100024
J	Liu, YJ; Wang, RW; Sun, B; Mi, T; Zhang, JQ; Mu, YX; Chen, J; Bround, MJ; Johnson, JD; Gillis, AM; Chen, SRW				Liu, Yingjie; Wang, Ruiwu; Sun, Bo; Mi, Tao; Zhang, Jingqun; Mu, Yongxin; Chen, Ju; Bround, Michael J.; Johnson, James D.; Gillis, Anne M.; Chen, S. R. Wayne			Generation and Characterization of a Mouse Model Harboring the Exon-3 Deletion in the Cardiac Ryanodine Receptor	PLOS ONE			English	Article							POLYMORPHIC VENTRICULAR-TACHYCARDIA; SUDDEN UNEXPLAINED DEATH; CA2+ RELEASE; MUTATIONAL ANALYSIS; BETA-STRAND; RYR2 GENE; ARRHYTHMIAS; MICE; CARDIOMYOPATHY; DISEASE	A large genomic deletion in human cardiac ryanodine receptor (RYR2) gene has been detected in a number of unrelated families with various clinical phenotypes, including catecholaminergic polymorphic ventricular tachycardia (CPVT). This genomic deletion results in an in-frame deletion of exon-3 (Ex3-del). To understand the underlying disease mechanism of the RyR2 Ex3-del mutation, we generated a mouse model in which the RyR2 exon-3 sequence plus 15-bp intron sequences flanking exon-3 were deleted. Heterozygous Ex3-del mice (Ex3-del(+)/(-)) survived, but no homozygous Ex3-del mice were born. Unexpectedly, the Ex3-del(+)/(-) mice are not susceptible to CPVT. Ex3-del(+)/(-) cardiomyocytes exhibited similar amplitude but altered dynamics of depolarization-induced Ca2+ transients compared to wild type (WT) cells. Immunoblotting analysis revealed markedly reduced expression of RyR2 protein in the Ex3-del(+)/(-) mutant heart, indicating that Ex3-del has a major impact on RyR2 protein expression in mice. Cardiac specific, conditional knockout of the WT RyR2 allele in Ex3-del(+)/(-) mice led to bradycardia and death. Thus, the absence of CPVT and other phenotypes in Ex3-del(+)/(-) mice may be attributable to the predominant expression of the WT RyR2 allele as a result of the markedly reduced expression of the Ex3-del mutant allele. The effect of Ex3-del on RyR2 protein expression is discussed in relation to the phenotypic variability in individuals with the RyR2 exon-3 deletion.	[Liu, Yingjie; Wang, Ruiwu; Sun, Bo; Mi, Tao; Gillis, Anne M.; Chen, S. R. Wayne] Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Liu, Yingjie; Wang, Ruiwu; Sun, Bo; Mi, Tao; Gillis, Anne M.; Chen, S. R. Wayne] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Zhang, Jingqun] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Mu, Yongxin; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bround, Michael J.; Johnson, James D.] Univ British Columbia, Inst Life Sci, Cardiovasc Res Grp, Vancouver, BC V5Z 1M9, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary; Rush University; University of California System; University of California San Diego; University of British Columbia	Chen, SRW (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada.	swchen@ucalgary.ca	Chen, Ju/E-5579-2011		National Institutes of Health [R01HL75210]; Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Alberta; Nunavut; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075210] Funding Source: NIH RePORTER; Alberta Innovates [201400104, 201300501] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Nunavut; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Alberta Innovates	This work was supported by research grants from the National Institutes of Health (R01HL75210), Canadian Institutes of Health Research (CIHR), and the Heart and Stroke Foundation of Alberta, N.W.T. and Nunavut to S. R. W. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador FJ, 2013, J MOL BIOL, V425, P4034, DOI 10.1016/j.jmb.2013.08.015; Bai YL, 2013, CIRC RES, V113, P517, DOI 10.1161/CIRCRESAHA.113.301678; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bhuiyan ZA, 2007, CIRCULATION, V116, P1569, DOI 10.1161/CIRCULATIONAHA.107.711606; Bround MJ, 2013, J BIOL CHEM, V288, P18975, DOI 10.1074/jbc.M112.427062; Bround MJ, 2012, CARDIOVASC RES, V96, P372, DOI 10.1093/cvr/cvs260; Cerrone M, 2005, CIRC RES, V96, pE77, DOI 10.1161/01.RES.0000169067.51055.72; d'Amati G, 2005, HUM PATHOL, V36, P761, DOI 10.1016/j.humpath.2005.04.019; Dulhunty AF, 2012, J GEN PHYSIOL, V140, P87, DOI 10.1085/jgp.201210862; George CH, 2007, J MOL CELL CARDIOL, V42, P34, DOI 10.1016/j.yjmcc.2006.08.115; Goddard CA, 2008, ACTA PHYSIOL, V194, P123, DOI 10.1111/j.1748-1716.2008.01865.x; Hunt DJ, 2007, BIOCHEM J, V404, P431, DOI 10.1042/BJ20070135; Kannankeril PJ, 2006, P NATL ACAD SCI USA, V103, P12179, DOI 10.1073/pnas.0600268103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Loaiza R, 2013, CIRC RES, V112, P298, DOI 10.1161/CIRCRESAHA.112.274803; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Marjamaa A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-12; Medeiros-Domingo A, 2009, J AM COLL CARDIOL, V54, P2065, DOI 10.1016/j.jacc.2009.08.022; Nishio H, 2006, CIRC J, V70, P1402, DOI 10.1253/circj.70.1402; Ohno S, 2014, EUROPACE; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Shan J, 2012, CIRC RES, V111, P708, DOI 10.1161/CIRCRESAHA.112.273342; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Uchinoumi H, 2010, CIRC RES, V106, DOI 10.1161/CIRCRESAHA.109.209312; Venetucci L, 2012, NAT REV CARDIOL, V9, P561, DOI 10.1038/nrcardio.2012.93; Xiao BL, 2005, CIRC RES, V96, P847, DOI 10.1161/01.RES.0000163276.26083.e8; Yang HT, 2002, P NATL ACAD SCI USA, V99, P9225, DOI 10.1073/pnas.142651999; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	36	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95615	10.1371/journal.pone.0095615	http://dx.doi.org/10.1371/journal.pone.0095615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743769	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100146
J	Seo, BR; Min, KJ; Cho, IJ; Kim, SC; Kwon, TK				Seo, Bo Ram; Min, Kyoung-Jin; Cho, Il Je; Kim, Sang Chan; Kwon, Taeg Kyu			Curcumin Significantly Enhances Dual PI3K/Akt and mTOR Inhibitor NVP-BEZ235-Induced Apoptosis in Human Renal Carcinoma Caki Cells through Down-Regulation of p53-Dependent Bcl-2 Expression and Inhibition of Mcl-1 Protein Stability	PLOS ONE			English	Article							FACTOR-KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; T(14/18) LYMPHOMA-CELLS; BREAST-CANCER CELLS; PI3K/MTOR INHIBITOR; PROSTATE-CANCER; ANTITUMOR-ACTIVITY; COLORECTAL-CANCER; LUNG-CANCER; IN-VIVO	The PI3K/Akt and mTOR signaling pathways are important for cell survival and growth, and they are highly activated in cancer cells compared with normal cells. Therefore, these signaling pathways are targets for inducing cancer cell death. The dual PI3K/Akt and mTOR inhibitor NVP-BEZ235 completely inhibited both signaling pathways. However, NVP-BEZ235 had no effect on cell death in human renal carcinoma Caki cells. We tested whether combined treatment with natural compounds and NVP-BEZ235 could induce cell death. Among several chemopreventive agents, curcumin, a natural biologically active compound that is extracted from the rhizomes of Curcuma species, markedly induced apoptosis in NVPBEZ235- treated cells. Co-treatment with curcumin and NVP-BEZ235 led to the down-regulation of Mcl-1 protein expression but not mRNA expression. Ectopic expression of Mcl-1 completely inhibited curcumin plus NVP-NEZ235-induced apoptosis. Furthermore, the down-regulation of Bcl-2 was involved in curcumin plus NVP-BEZ235-induced apoptosis. Curcumin or NVP-BEZ235 alone did not change Bcl-2 mRNA or protein expression, but co-treatment reduced Bcl-2 mRNA and protein expression. Combined treatment with NVP-BEZ235 and curcumin reduced Bcl-2 expression in wild-type p53 HCT116 human colon carcinoma cells but not p53-null HCT116 cells. Moreover, Bcl-2 expression was completely reversed by treatment with pifithrin-a, a p53-specific inhibitor. Ectopic expression of Bcl-2 also inhibited apoptosis in NVP-BE235 plus curcumin-treated cells. In contrast, NVP-BEZ235 combined with curcumin did not have a synergistic effect on normal human skin fibroblasts and normal human mesangial cells. Taken together, combined treatment with NVP-BEZ235 and curcumin induces apoptosis through p53-dependent Bcl-2 mRNA down-regulation at the transcriptional level and Mcl-1 protein down-regulation at the post-transcriptional level.	[Seo, Bo Ram; Min, Kyoung-Jin; Kwon, Taeg Kyu] Keimyung Univ, Sch Med, Dept Immunol, Taegu, South Korea; [Cho, Il Je; Kim, Sang Chan] Daegu Haany Univ, Coll Oriental Med, Gyongsan, South Korea; [Cho, Il Je; Kim, Sang Chan] Daegu Haany Univ, Med Res Ctr Globalizat Herbal Formulat, Gyongsan, South Korea	Keimyung University; Daegu Haany University; Daegu Haany University	Kim, SC (corresponding author), Daegu Haany Univ, Coll Oriental Med, Gyongsan, South Korea.	sckim@dhu.ac.kr; kwontk@dsmc.or.kr			Mid-Career Researcher Program through an NRF; MEST [2011-0016239]; Korea Government(MSIP) [2012-0009400]	Mid-Career Researcher Program through an NRF(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Government(MSIP)	This work was supported by the Mid-Career Researcher Program through an NRF grant funded by the MEST (No. 2011-0016239), NRF grant funded by the Korea Government(MSIP) (2012-0009400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Bondar VM, 2002, MOL CANCER THER, V1, P989; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Bush JA, 2001, EXP CELL RES, V271, P305, DOI 10.1006/excr.2001.5381; Chen H, 1999, ANTICANCER RES, V19, P3675; CHEN HM, 1995, MOL CELL BIOL, V15, P3840; Chiarini F, 2010, CANCER RES, V70, P8097, DOI 10.1158/0008-5472.CAN-10-1814; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Deeb D, 2003, MOL CANCER THER, V2, P95; Doghman M, 2012, MOL CELL ENDOCRINOL, V364, P101, DOI 10.1016/j.mce.2012.08.014; Elfiky AA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-133; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Esatbeyoglu T, 2012, ANGEW CHEM INT EDIT, V51, P5308, DOI 10.1002/anie.201107724; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Gao XH, 2005, J EXP THER ONCOL, V5, P39; Gescher A, 2004, J CHEMOTHERAPY, V16, P3, DOI 10.1179/joc.2004.16.Supplement-1.3; Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gupta AK, 2003, INT J RADIAT ONCOL, V56, P846, DOI 10.1016/S0360-3016(03)00214-1; Han SS, 1999, CLIN IMMUNOL, V93, P152, DOI 10.1006/clim.1999.4769; Heckman C, 1997, J BIOL CHEM, V272, P19609, DOI 10.1074/jbc.272.31.19609; Heckman CA, 2003, ONCOGENE, V22, P7891, DOI 10.1038/sj.onc.1206639; Heckman CA, 2002, ONCOGENE, V21, P3898, DOI 10.1038/sj.onc.1205483; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167; Kunnumakkara AB, 2008, CLIN CANCER RES, V14, P2128, DOI 10.1158/1078-0432.CCR-07-4722; Kunnumakkara AB, 2007, CANCER RES, V67, P3853, DOI 10.1158/0008-5472.CAN-06-4257; Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Loeb S, 2007, J UROLOGY, V177, P899, DOI 10.1016/j.juro.2006.10.028; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Martin J, 2008, BIOCHEM BIOPH RES CO, V372, P578, DOI 10.1016/j.bbrc.2008.05.086; Masuda M, 2011, ONCOL REP, V26, P1273, DOI 10.3892/or.2011.1370; Meng Q, 2006, CELL SIGNAL, V18, P2262, DOI 10.1016/j.cellsig.2006.05.019; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; MIYASHITA T, 1994, CANCER RES, V54, P3131; Moragoda L, 2001, ANTICANCER RES, V21, P873; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Ng SSW, 2001, CLIN CANCER RES, V7, P3269; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pal S, 2001, BIOCHEM BIOPH RES CO, V288, P658, DOI 10.1006/bbrc.2001.5823; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Perkins S, 2002, CANCER EPIDEM BIOMAR, V11, P535; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Roccaro AM, 2010, BLOOD, V115, P559, DOI 10.1182/blood-2009-07-235747; Roulin D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-90; Sandur SK, 2009, INT J RADIAT ONCOL, V75, P534, DOI 10.1016/j.ijrobp.2009.06.034; Santoni M, 2014, BBA-REV CANCER, V1845, P221, DOI 10.1016/j.bbcan.2014.01.007; Schiborr C, 2014, MOL NUTR FOOD RES, V58, P516, DOI 10.1002/mnfr.201300724; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Sourbier C, 2006, CANCER RES, V66, P5130, DOI 10.1158/0008-5472.CAN-05-1469; Stein RC, 2001, ENDOCR-RELAT CANCER, V8, P237, DOI 10.1677/erc.0.0080237; Sun XJ, 2009, ANTICANCER RES, V29, P1739; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Vinod BS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.26; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Woo JH, 2003, CARCINOGENESIS, V24, P1199, DOI 10.1093/carcin/bgg082; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu CX, 2011, CANCER BIOL THER, V12, P549, DOI 10.4161/cbt.12.6.16397; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	67	58	63	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95588	10.1371/journal.pone.0095588	http://dx.doi.org/10.1371/journal.pone.0095588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743574	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100143
J	Venu, RC; Ma, JB; Jia, YL; Liu, GJ; Jia, MH; Nobuta, K; Sreerekha, MV; Moldenhauer, K; McClung, AM; Meyers, BC; Wang, GL				Venu, R. C.; Ma, Jianbing; Jia, Yulin; Liu, Guangjie; Jia, Melissa H.; Nobuta, Kan; Sreerekha, M. V.; Moldenhauer, Karen; McClung, Anna M.; Meyers, Blake C.; Wang, Guo-Liang			Identification of Candidate Genes Associated with Positive and Negative Heterosis in Rice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; ORYZA-SATIVA L.; CONTROLLING HEADING DATE; TRANSCRIPTOME ANALYSIS; GRAIN WIDTH; NATURAL VARIATION; GREEN-REVOLUTION; FLOWERING TIME; DRAFT SEQUENCE; MAJOR QTL	To identify the genes responsible for yield related traits, and heterosis, massively parallel signature sequencing (MPSS) libraries were constructed from leaves, roots and meristem tissues from the two parents, 'Nipponbare' and '93-11', and their F-1 hybrid. From the MPSS libraries, 1-3 million signatures were obtained. Using cluster analysis, commonly and specifically expressed genes in the parents and their F-1 hybrid were identified. To understand heterosis in the F-1 hybrid, the differentially expressed genes in the F-1 hybrid were mapped to yield related quantitative trait loci (QTL) regions using a linkage map constructed from 131 polymorphic simple sequence repeat markers with 266 recombinant inbred lines derived from a cross between Nipponbare and 93-11. QTLs were identified for yield related traits including days to heading, plant height, plant type, number of tillers, main panicle length, number of primary branches per main panicle, number of kernels per main panicle, total kernel weight per main panicle, 1000 grain weight and total grain yield per plant. Seventy one QTLs for these traits were mapped, of which 3 QTLs were novel. Many highly expressed chromatin-related genes in the F-1 hybrid encoding histone demethylases, histone deacetylases, argonaute-like proteins and polycomb proteins were located in these yield QTL regions. A total of 336 highly expressed transcription factor (TF) genes belonging to 50 TF families were identified in the yield QTL intervals. These findings provide the starting genomic materials to elucidate the molecular basis of yield related traits and heterosis in rice.	[Venu, R. C.; Ma, Jianbing; Jia, Yulin; Liu, Guangjie; Jia, Melissa H.; McClung, Anna M.] USDA ARS, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR 72160 USA; [Venu, R. C.; Ma, Jianbing; Liu, Guangjie; Moldenhauer, Karen] Univ Arkansas, Div Agr, Rice Res & Extens Ctr, Stuttgart, AR USA; [Venu, R. C.; Sreerekha, M. V.; Wang, Guo-Liang] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA; [Nobuta, Kan; Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DC USA	United States Department of Agriculture (USDA); University of Arkansas System; University of Arkansas Fayetteville; University System of Ohio; Ohio State University; University of Delaware	Jia, YL (corresponding author), USDA ARS, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR 72160 USA.	yulin.jia@ars.usda.gov	Jia, Yulin/T-8235-2019; jia, yu/HHR-9047-2022; Meyers, Blake/B-6535-2012	Meyers, Blake/0000-0003-3436-6097; Wang, Guo-Liang/0000-0001-8877-3064	Plant Genome Research Program of the National Science Foundation [0701745, 0321437]; ARS [ARS-0425080] Funding Source: Federal RePORTER	Plant Genome Research Program of the National Science Foundation(National Science Foundation (NSF)NSF - Office of the Director (OD)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported in part by the Plant Genome Research Program of the National Science Foundation [Award numbers: 0701745 and 0321437]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Bruce A. B., 1910, Science New York N S, V32, DOI 10.1126/science.32.827.627-a; Cai HY, 2012, EUPHYTICA, V184, P109, DOI 10.1007/s10681-011-0581-0; Chodavarapu RK, 2012, P NATL ACAD SCI USA, V109, P12040, DOI 10.1073/pnas.1209297109; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; East EM, 1936, GENETICS, V21, P375; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Garcia AAF, 2008, GENETICS, V180, P1707, DOI 10.1534/genetics.107.082867; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Gowda M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-310; He GM, 2010, PLANT CELL, V22, P17, DOI 10.1105/tpc.109.072041; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Huang Y, 2006, PLANT MOL BIOL, V62, P579, DOI 10.1007/s11103-006-9040-z; Ishimaru K, 2004, PLANTA, V218, P388, DOI 10.1007/s00425-003-1119-z; Ishimaru K, 2003, PLANT PHYSIOL, V133, P1083, DOI 10.1104/pp.103.027607; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Li XB, 2010, GENETICA, V138, P1221, DOI 10.1007/s10709-010-9521-5; Lin HX, 2002, BREEDING SCI, V52, P35, DOI 10.1270/jsbbs.52.35; Lin SY, 1998, THEOR APPL GENET, V96, P997, DOI 10.1007/s001220050831; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Liu GJ, 2008, EUPHYTICA, V159, P73, DOI 10.1007/s10681-007-9459-6; Liu TM, 2010, THEOR APPL GENET, V120, P933, DOI 10.1007/s00122-009-1222-z; Liu TM, 2009, THEOR APPL GENET, V118, P1509, DOI 10.1007/s00122-009-0999-0; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; McGouch S, 1988, THEOR APPL GENET, V76, P815; Meyer RC, 2010, THEOR APPL GENET, V120, P227, DOI 10.1007/s00122-009-1074-6; Meyers BC, 2004, NAT BIOTECHNOL, V22, P1006, DOI 10.1038/nbt992; Meyers BC, 2004, GENOME RES, V14, P1641, DOI 10.1101/gr.2275604; Moncada P, 2001, THEOR APPL GENET, V102, P41, DOI 10.1007/s001220051616; Ni ZF, 2009, NATURE, V457, P327, DOI 10.1038/nature07523; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Nuruzzaman M., 2002, PAK J BIOL SCI, V5, P1006; Oikawa T, 2009, PLANT CELL, V21, P1095, DOI 10.1105/tpc.108.065425; Rahimi M, 2010, J AGR SCI TECH-IRAN, V12, P223; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Sasaki T., 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; Shindo C, 2006, GENE DEV, V20, P3079, DOI 10.1101/gad.405306; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Simon SA, 2011, CURR OPIN PLANT BIOL, V14, P148, DOI 10.1016/j.pbi.2010.11.007; Simon SA, 2009, ANNU REV PLANT BIOL, V60, P305, DOI 10.1146/annurev.arplant.043008.092032; Song GS, 2010, MOL PLANT, V3, P1012, DOI 10.1093/mp/ssq046; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Swanson-Wagner RA, 2006, P NATL ACAD SCI USA, V103, P6805, DOI 10.1073/pnas.0510430103; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Tian F, 2006, THEOR APPL GENET, V113, P619, DOI 10.1007/s00122-006-0326-y; Vega-Sanchez ME, 2007, PLANT SCI, V173, P371, DOI 10.1016/j.plantsci.2007.07.005; Venu RC, 2011, METHODS MOL BIOL, V722, P167, DOI 10.1007/978-1-61779-040-9_12; Venu RC, 2010, RICE, V3, P22, DOI 10.1007/s12284-010-9037-8; Virmani S.S, 2003, 2 LINE HYBRID RICE B; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang JL, 2006, GENETICS, V172, P507, DOI 10.1534/genetics.105.047894; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ware DH, 2002, PLANT PHYSIOL, V130, P1606, DOI 10.1104/pp.015248; Wei G, 2009, P NATL ACAD SCI USA, V106, P7695, DOI 10.1073/pnas.0902340106; Weng JF, 2008, CELL RES, V18, P1199, DOI 10.1038/cr.2008.307; Xie XB, 2008, THEOR APPL GENET, V116, P613, DOI 10.1007/s00122-007-0695-x; Xie XB, 2006, THEOR APPL GENET, V113, P885, DOI 10.1007/s00122-006-0348-5; Xing YZ, 2010, ANNU REV PLANT BIOL, V61, P421, DOI 10.1146/annurev-arplant-042809-112209; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yamamoto T, 2000, GENETICS, V154, P885; Yan WH, 2011, MOL PLANT, V4, P319, DOI 10.1093/mp/ssq070; Yano M, 1997, THEOR APPL GENET, V95, P1025, DOI 10.1007/s001220050658; Yano M, 2001, PLANT PHYSIOL, V127, P1425, DOI 10.1104/pp.010710; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yao YY, 2005, PLANT MOL BIOL, V58, P367, DOI 10.1007/s11103-005-5102-x; Yonemaru J, 2010, RICE, V3, P194, DOI 10.1007/s12284-010-9041-z; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226; Zhai RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-19; Zhang HY, 2008, MOL PLANT, V1, P720, DOI 10.1093/mp/ssn022; Zhao K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1467; Zhou G, 2012, P NATL ACAD SCI USA, V109, P15847, DOI 10.1073/pnas.1214141109	86	8	11	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95178	10.1371/journal.pone.0095178	http://dx.doi.org/10.1371/journal.pone.0095178			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743656	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100081
J	Zhou, CG; Liu, LK; Li, CH				Zhou, Chenguang; Liu, Likun; Li, Chenghao			Microarray Analysis of Siberian Ginseng Cyclic Somatic Embryogenesis Culture Systems Provides Insight into Molecular Mechanisms of Embryogenic Cell Cluster Generation	PLOS ONE			English	Article							ELEUTHEROCOCCUS-SENTICOSUS; HIGH-FREQUENCY; PLANT-CELLS; ARABIDOPSIS; GENES; XYLOGLUCAN; COTTON; TRANSITION; EXPRESSION; CONVERSION	Four systems of cyclic somatic embryogenesis of Siberian ginseng (Eleutherococcus senticosus Maxim) were used to study the mechanism of embryonic cell cluster generation. The first, direct somatic embryo induction (DSEI), generates secondary embryos directly from the primary somatic embryos; the second, direct embryogenic cell cluster induction (DEC)), induces embryogenic cell clusters directly from somatic embryos in agar medium. Subsequently, we found that when DEC-derived somatic embryos are transferred to suspension culture or a bioreactor culture, only somatic embryos are induced, and embryogenic cell clusters cannot form. Therefore, these new lines were named DEC cultured by liquid medium (ECS) and DEC cultured by bioreactor (ECB), respectively. Transmission electron microscopy showed that DEC epidermal cells contained a variety of inclusions, distinct from other lines. A cDNA library of DEC was constructed, and 1,948 gene clusters were obtained and used as probes. RNA was prepared from somatic embryos from each of the four lines and hybridized to a microarray. In DEC, 7 genes were specifically upregulated compared with the other three lines, and 4 genes were downregulated. EsXTH1 and EsPLT1, which were among the genes upregulated in DEC, were cloned using the rapid amplification of cDNA ends (RACE). Real-time quantitative PCR showed EsXTH1 was more highly expressed in DEC than in other lines throughout the culture cycle, and EsPLT1 expression in DEC increased as culture duration increased, but remained at a low expression level in other lines. These results suggest that EsXTH1 and EsPLT1 may be the essential genes that play important roles during the induction of embryogenic cell clusters.	[Zhou, Chenguang; Li, Chenghao] Northeast Forestry Univ, State Key Lab Forest Genet & Tree Breeding, Harbin, Peoples R China; [Liu, Likun] Kangwon Natl Univ, Coll Biomed Sci, Dept Med Biotechnol, Chunchon, South Korea	Northeast Forestry University - China; Kangwon National University	Li, CH (corresponding author), Northeast Forestry Univ, State Key Lab Forest Genet & Tree Breeding, Harbin, Peoples R China.	chli0@163.com			National Natural Science Foundation of China [30671701]; Fundamental Research Funds for the Central Universities [URL: DL11EA02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (No. 30671701) (URL: http://www.nsfc.gov.cn/publish/portal1/) and Fundamental Research Funds for the Central Universities (URL: DL11EA02) (http://www.nefu.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Blehova A., 2010, Acta Botanica Hungarica, V52, P23, DOI 10.1556/ABot.52.2010.1-2.3; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Canhoto JM, 1996, ANN BOT-LONDON, V78, P513, DOI 10.1006/anbo.1996.0149; Choi YE, 1999, ANN BOT-LONDON, V83, P309, DOI 10.1006/anbo.1998.0827; Choi YE, 1999, PLANT CELL TISS ORG, V58, P93, DOI 10.1023/A:1006318928684; Choi YE, 2002, PLANT CELL REP, V20, P1112, DOI 10.1007/s00299-002-0455-y; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; DEJONG AJ, 1993, PLANT MOL BIOL, V22, P367, DOI 10.1007/BF00014943; Dodeman VL, 1997, J EXP BOT, V48, P1493, DOI 10.1093/jexbot/48.313.1493; Ehlers K, 1999, PROTOPLASMA, V209, P181, DOI 10.1007/BF01453447; Feher A, 2003, PLANT CELL TISS ORG, V74, P201, DOI 10.1023/A:1024033216561; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Gaj MD, 2005, PLANTA, V222, P977, DOI 10.1007/s00425-005-0041-y; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Gliwicka M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069261; Jenik PD, 2007, ANNU REV CELL DEV BI, V23, P207, DOI 10.1146/annurev.cellbio.22.011105.102609; Lin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060337; Malinowski R, 2004, PHYSIOL PLANTARUM, V120, P678, DOI 10.1111/j.0031-9317.2004.0289.x; Monja-Mio KM, 2013, IN VITRO CELL DEV-PL, V49, P541, DOI 10.1007/s11627-013-9535-7; Nole-Wilson S, 2005, PLANT MOL BIOL, V57, P613, DOI 10.1007/s11103-005-0955-6; NOMURA K, 1985, PLANT PHYSIOL, V79, P988, DOI 10.1104/pp.79.4.988; Pinto G, 2010, TREES-STRUCT FUNCT, V24, P763, DOI 10.1007/s00468-010-0446-5; Rocha DI, 2012, PROTOPLASMA, V249, P747, DOI 10.1007/s00709-011-0318-x; San-Jose MC, 2010, PLANT CELL REP, V29, P661, DOI 10.1007/s00299-010-0852-6; Thompson JE, 2001, PLANT J, V26, P23, DOI 10.1046/j.1365-313x.2001.01005.x; Xu ZZ, 2013, J INTEGR PLANT BIOL, V55, P631, DOI 10.1111/jipb.12073; Yang JL, 2012, PLANT CELL TISS ORG, V110, P289, DOI 10.1007/s11240-012-0150-9; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Yang XY, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-110; Yang XY, 2010, CRIT REV PLANT SCI, V29, P36, DOI 10.1080/07352680903436291; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zheng QL, 2013, PLANT PHYSIOL, V161, P2113, DOI 10.1104/pp.113.216275; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	34	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94959	10.1371/journal.pone.0094959	http://dx.doi.org/10.1371/journal.pone.0094959			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743225	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100055
J	de Moura, VCN; Gibbs, S; Jackson, M				de Moura, Vinicius Calado Nogueira; Gibbs, Sara; Jackson, Mary			Gene Replacement in Mycobacterium chelonae: Application to the Construction of Porin Knock-Out Mutants	PLOS ONE			English	Article							RAPIDLY GROWING MYCOBACTERIA; CELL-WALL; SP-NOV; TRANSPOSON DELIVERY; CYSTIC-FIBROSIS; SMEGMATIS; ABSCESSUS; TUBERCULOSIS; MASSILIENSE; RESISTANCE	Mycobacterium chelonae is a rapidly growing mycobacterial opportunistic pathogen closely related to Mycobacterium abscessus that causes cornea, skin and soft tissue infections in humans. Although M. chelonae and the emerging mycobacterial pathogen M. abscessus have long been considered to belong to the same species, these two microorganisms considerably differ in terms of optimum growth temperature, drug susceptibility, pathogenicity and the types of infection they cause. The whole genome sequencing of clinical isolates of M. chelonae and M. abscessus is opening the way to comparative studies aimed at understanding the biology of these pathogens and elucidating the molecular bases of their pathogenicity and biocide resistance. Key to the validation of the numerous hypotheses that this approach will raise, however, is the availability of genetic tools allowing for the expression and targeted mutagenesis of genes in these species. While homologous recombination systems have recently been described for M. abscessus, genetic tools are lacking for M. chelonae. We here show that two different allelic replacement methods, one based on mycobacteriophage-encoded recombinases and the other on a temperature-sensitive plasmid harboring the counterselectable marker sacB, can be used to efficiently disrupt genes in this species. Knock-out mutants for each of the three porin genes of M. chelonae ATCC 35752 were constructed using both methodologies, one of which displays a significantly reduced glucose uptake rate consistent with decreased porin expression.	[de Moura, Vinicius Calado Nogueira; Gibbs, Sara; Jackson, Mary] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA	Colorado State University	Jackson, M (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	Mary.Jackson@colostate.edu	Jackson, Mary/D-5345-2017	Jackson, Mary/0000-0002-9212-0258	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI089718]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089718] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases grant AI089718. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouak W, 2001, FEMS MICROBIOL LETT, V199, P1; Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Aitken ML, 2012, AM J RESP CRIT CARE, V185, P231, DOI 10.1164/ajrccm.185.2.231; Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Cortes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029306; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08; De Groote MA, 2006, CLIN INFECT DIS, V42, P1756, DOI 10.1086/504381; Duarte RS, 2009, J CLIN MICROBIOL, V47, P2149, DOI 10.1128/JCM.00027-09; Fabrino DL, 2009, MICROBES INFECT, V11, P868, DOI 10.1016/j.micinf.2009.05.007; Frenzel E, 2011, APPL ENVIRON MICROB, V77, P3068, DOI 10.1128/AEM.02492-10; GRIFFITH DE, 1993, AM REV RESPIR DIS, V147, P1271, DOI 10.1164/ajrccm/147.5.1271; Heinz Christian, 2003, Methods Mol Biol, V228, P139, DOI 10.1385/1-59259-400-X:139; Hillmann D, 2007, J BACTERIOL, V189, P958, DOI 10.1128/JB.01474-06; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Jackson M, 2001, Methods Mol Med, V54, P59, DOI 10.1385/1-59259-147-7:059; Jackson M, 1996, MICROBIOL-SGM, V142, P2439, DOI 10.1099/00221287-142-9-2439; JARLIER V, 1994, FEMS MICROBIOL LETT, V123, P11, DOI 10.1111/j.1574-6968.1994.tb07194.x; KUSUNOKI S, 1992, INT J SYST BACTERIOL, V42, P240, DOI 10.1099/00207713-42-2-240; Leao SC, 2011, INT J SYST EVOL MICR, V61, P2311, DOI 10.1099/ijs.0.023770-0; Medjahed H, 2009, APPL ENVIRON MICROB, V75, P1331, DOI 10.1128/AEM.01914-08; Niederweis M, 2003, MOL MICROBIOL, V49, P1167, DOI 10.1046/j.1365-2958.2003.03662.x; Pelicic V, 1996, J BACTERIOL, V178, P1197, DOI 10.1128/jb.178.4.1197-1199.1996; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; Petrini B, 2006, APMIS, V114, P319, DOI 10.1111/j.1600-0463.2006.apm_390.x; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Ripoll F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005660; Rodrigues L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-35; Rybniker J, 2006, J MED MICROBIOL, V55, P37, DOI 10.1099/jmm.0.46238-0; Sharbati S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-31; Sharbati-Tehrani S, 2005, MICROBIOL-SGM, V151, P2403, DOI 10.1099/mic.0.27969-0; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Stephan J, 2004, ANTIMICROB AGENTS CH, V48, P4163, DOI 10.1128/AAC.48.11.4163-4170.2004; Svetlikova Z, 2009, ANTIMICROB AGENTS CH, V53, P4015, DOI 10.1128/AAC.00590-09; Talati NJ, 2008, LANCET INFECT DIS, V8, P390, DOI 10.1016/S1473-3099(08)70127-0; Tortoli E, 2008, EMERG INFECT DIS, V14, P984, DOI 10.3201/eid1406.080194; TRIAS J, 1992, SCIENCE, V258, P1479, DOI 10.1126/science.1279810; TRIAS JQ, 1993, J BIOL CHEM, V268, P6234; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	44	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94951	10.1371/journal.pone.0094951	http://dx.doi.org/10.1371/journal.pone.0094951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739882	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900086
J	Li, Y; Wu, SQ; Xiang, Y; Liang, XH				Li, Ying; Wu, Siqi; Xiang, Yun; Liang, Xiaohui			An Investigation of Outpatient Children's Blood Lead Level in Wuhan China	PLOS ONE			English	Article							EXPOSURE	Objective: Blood lead levels (BLLs) and possible influencing factors in children in Wuhan China were investigated in order to understand current lead pollution exposure and provide a scientific basis for prevention and policy making. Materials and Methods: BLL data were collected from 15,536 out-patients in Wuhan Children Hospital in 2012 full year. All of them were under 18 years of age (Mean +/- SD: 4.32 +/- 3.2, 64.4% boys). The BLLs were measured by an atomic absorption spectrometry (BH2100). Results: The geometric mean of BLLs for all the subjects was 44.75 mu g/L (95%CI: 44.46 mu g/L - 45.05 mu g/L), much lower than that reported in previous studies. The prevalence of the elevated BLLs (>= 100 mu g/L) in the children tested was 2% in 2012 and the prevalence of BLLs (>= 50 mu g/L) was 44%. Age and sex could be possible influencing factors for BLLs in the children (p<0.001). In addition, the BLLs in different seasons were different (p<0.001). Conclusions: These results demonstrate that BLLs have significantly decreased in children in Wuhan during recent years. However, we should continuously pay attention to lead pollution and emphasize that prevention is much more important than treatment for controlling children's BLLs.	[Wu, Siqi; Liang, Xiaohui] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China; [Li, Ying; Xiang, Yun] Wuhan Childrens Hosp, Wuhan, Peoples R China	Wuhan University	Liang, XH (corresponding author), Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Peoples R China.	xhliang@whu.edu.cn						*AG TOX SUBST DIS, 2005, TOX PROF LEAD; Bellinger DC, 2004, PEDIATRICS, V113, P1016; Centers for Disease Control and Prevention, 1991, PREV LEAD POIS YOUNG; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1133; Chen GX, 2004, J CLIN PEDIAT, V22, P104; DONG YH, 2001, GUANGDONG TRACE ELEM, V8, P26; He KM, 2009, SCI TOTAL ENVIRON, V407, P3986, DOI 10.1016/j.scitotenv.2009.03.018; Health Canada, 2013, 2 HLTH CAN; Lin GZ, 2010, J CLIN PEDIAT, V25, P416; Liu JH, 2012, PAEDIATR PERINAT EP, V26, P61, DOI 10.1111/j.1365-3016.2011.01234.x; Meyer PA, 2008, MUTAT RES-REV MUTAT, V659, P166, DOI 10.1016/j.mrrev.2008.03.003; Mitra AK, 2012, J HEALTH POPUL NUTR, V30, P404; Qi Qiping, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P162; Schnaas L, 2006, ENVIRON HEALTH PERSP, V114, P791, DOI 10.1289/ehp.8552; Wang HJ, 2011, BIOL TRACE ELEM RES, V12, P9413; Wang SQ, 2006, ENVIRON RES, V101, P412, DOI 10.1016/j.envres.2005.11.007; Wheeler W, 2013, MMWR-MORBID MORTAL W, V62, P245; Woolf AD, 2007, PEDIATR CLIN N AM, V54, P271, DOI 10.1016/j.pcl.2007.01.008; Xu SM, 2003, CHIN J DIS CONTROL P, V7, P414; Ye T, 2003, CHIN J PUBLIC HLTH, V19, P68; Yoshinaga Jun, 2012, Environmental Health and Preventive Medicine, V17, P27, DOI 10.1007/s12199-011-0216-z; Zhang D, 2005, CHINESE J CHILD HLTH, V13, P347; Zheng MG, 2003, STUD TRACE ELEMENTS, V20, P18	23	11	11	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95284	10.1371/journal.pone.0095284	http://dx.doi.org/10.1371/journal.pone.0095284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740029	gold, Green Submitted, Green Published			2022-12-25	WOS:000336863900125
J	Plantinga, TS; van de Vosse, E; Huijbers, A; Netea, MG; Joosten, LAB; Smit, JWA; Netea-Maier, RT				Plantinga, Theo S.; van de Vosse, Esther; Huijbers, Angelique; Netea, Mihai G.; Joosten, Leo A. B.; Smit, Jan W. A.; Netea-Maier, Romana T.			Role of Genetic Variants of Autophagy Genes in Susceptibility for Non-Medullary Thyroid Cancer and Patients Outcome	PLOS ONE			English	Article							CROHNS-DISEASE; MECHANISMS; THERAPY; LOCI; ATG5; POLYMORPHISM; INHIBITION; STATISTICS; BIOGENESIS; INDUCTION	Autophagy is a central process in regulation of cell survival, cell death and proliferation and plays an important role in carcinogenesis, including thyroid carcinoma. Genetic variation in autophagy components has been demonstrated to influence the capacity to execute autophagy and is associated with disease susceptibility, progression and outcome. In the present study, we assessed whether genetic variation in autophagy genes contributes to susceptibility to develop thyroid carcinoma, disease progression and/or patient outcome. The results indicate that patients carrying the ATG5 single nucleotide polymorphisms rs2245214 have a higher probability to develop thyroid carcinoma (OR 1.85 (95% CI 1.04-3.23), P = 0.042). In contrast, no significant differences could be observed for the other genetic variants studied in terms of thyroid carcinoma susceptibility. Furthermore, none of the selected genetic variants were associated with clinical parameters of disease progression and outcome. In conclusion, genetic variation in ATG5, a central player in the autophagy process, is found to be associated with increased susceptibility for thyroid carcinoma, indicating a role for autophagy in thyroid carcinogenesis.	[Plantinga, Theo S.; Huijbers, Angelique; Netea, Mihai G.; Joosten, Leo A. B.; Smit, Jan W. A.; Netea-Maier, Romana T.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Plantinga, Theo S.; Huijbers, Angelique; Smit, Jan W. A.; Netea-Maier, Romana T.] Radboud Univ Nijmegen, Med Ctr, Div Endocrinol, NL-6525 ED Nijmegen, Netherlands; [van de Vosse, Esther] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Netea-Maier, RT (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands.	Romana.Netea-Maier@radboudumc.nl	Joosten, Leo AB/H-3138-2015; Huijbers, Angelique/H-6323-2016; Netea-Maier, R.T./L-4543-2015; van de Vosse, Esther/B-7285-2009; Smit, J.W.A./H-8091-2014; Plantinga, Theo S./A-6895-2015; Netea, Mihai/N-5155-2014; van de Vosse, Esther/HDO-0723-2022	Joosten, Leo AB/0000-0001-6166-9830; Huijbers, Angelique/0000-0002-7194-4602; van de Vosse, Esther/0000-0001-5199-3426; Smit, J.W.A./0000-0003-1052-9314; Plantinga, Theo S./0000-0003-4990-6084; 	Veni grant of the Netherlands Organization for Scientific Research (NWO); Vici grant of the Netherlands Organization for Scientific Research (NWO)	Veni grant of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Vici grant of the Netherlands Organization for Scientific Research (NWO)	TSP was supported by a Veni grant of the Netherlands Organization for Scientific Research (NWO). MGN was supported by a Vici grant of the Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Castino R, 2008, J NEUROENDOCRINOL, V20, P1165, DOI 10.1111/j.1365-2826.2008.01769.x; Chen DF, 2013, NEUROSCI LETT, V538, P49, DOI 10.1016/j.neulet.2013.01.044; Dikic I, 2010, CANCER RES, V70, P3431, DOI 10.1158/0008-5472.CAN-09-4027; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Henckaerts L, 2011, INFLAMM BOWEL DIS, V17, P1392, DOI 10.1002/ibd.21486; Huijbers A, 2012, ENDOCR-RELAT CANCER, V19, pL15, DOI 10.1530/ERC-11-0302; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kim MJ, 2011, J BIOL CHEM, V286, P12924, DOI 10.1074/jbc.M110.138958; Kondo T, 2006, NAT REV CANCER, V6, P292, DOI 10.1038/nrc1836; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Lin CI, 2012, SURGERY, V152, P1142, DOI 10.1016/j.surg.2012.08.016; Lin CI, 2010, MOL CANCER RES, V8, P1217, DOI 10.1158/1541-7786.MCR-10-0162; Lin CI, 2009, SURGERY, V146, P1208, DOI 10.1016/j.surg.2009.09.019; Maddodi N, 2010, J INVEST DERMATOL, V130, P1657, DOI 10.1038/jid.2010.26; Martin LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033454; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morani F, 2014, ENDOCR-RELAT CANCER, V21, pR13, DOI 10.1530/ERC-13-0271; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nose V, 2011, MODERN PATHOL, V24, pS19, DOI 10.1038/modpathol.2010.147; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Peng JY, 2014, SCI CHINA LIFE SCI, V57, P59, DOI 10.1007/s11427-013-4588-8; Plantinga TS, 2012, CURR OPIN PHARMACOL, V12, P497, DOI 10.1016/j.coph.2012.01.017; Raju D, 2012, AUTOPHAGY, V8, P1387, DOI 10.4161/auto.21007; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sobin L., 1997, UICC TNM CLASSIFICAT, P184; Taylor KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001311; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Zeybek ND, 2011, J ENDOCRINOL, V210, P105, DOI 10.1530/JOE-10-0411; Zhao ZJ, 2008, CELL HOST MICROBE, V4, P458, DOI 10.1016/j.chom.2008.10.003	38	28	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94086	10.1371/journal.pone.0094086	http://dx.doi.org/10.1371/journal.pone.0094086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739953	Green Submitted, gold, Green Published			2022-12-25	WOS:000336863900032
J	Tang, QB; Zhan, H; Cao, H; Berg, BG; Yan, FM; Zhao, XC				Tang, Qing-Bo; Zhan, Huan; Cao, Huan; Berg, Bente G.; Yan, Feng-Ming; Zhao, Xin-Cheng			Central Projections of Gustatory Receptor Neurons in the Medial and the Lateral Sensilla Styloconica of Helicoverpa armigera Larvae	PLOS ONE			English	Article							CONFIGURATA WALKER LEPIDOPTERA; DROSOPHILA-MELANOGASTER; BOMBYX-MORI; SUBESOPHAGEAL GANGLION; FINE-STRUCTURE; CHORISTONEURA-FUMIFERANA; SENSORY PROJECTIONS; MOUTHPART SENSILLA; MAXILLARY SENSILLA; SPRUCE BUDWORM	Food selection behavior of lepidopteran larvae is predominantly governed by the activation of taste neurons present in two sensilla styloconica located on the galea of the maxilla. In this study, we present the ultrastructure of the sensilla styloconica and the central projection pattern of their associated receptor neurons in larvae of the heliothine moth, Helicoverpa armigera. By means of light microscopy and scanning electron microscopy, the previous findings of two morphologically fairly similar sensilla comprising a socketed conic tip inserted into a large peg were confirmed. However, the peg size of the medial sensillum was found to be significantly bigger than that of the lateral sensillum. The sensory neurons derived from each sensillum styloconicum were mapped separately using anterograde staining experiments combined with confocal laser-scanning microscopy. For determining the afferents' target regions relative to each other, we reconstructed the labeled axons and placed them into a common reference framework. The sensory axons from both sensilla projected via the ipsilateral maxillary nerve to the suboesophageal ganglion and further through the ipsilateral circumoesophageal connective to the brain. In the suboesophageal ganglion, the sensory projections targeted two areas of the ipsilateral maxillary neuropil, one located in the ventrolateral neuromere and the other adjacent to the neuromere midline. In the brain, the axon terminals targeted the dorso-anterior area of the ipsilateral tritocerebrum. As confirmed by the three-dimensional reconstructions, the target regions of the neural projections originating from each of the two sensilla styloconica were identical.	[Tang, Qing-Bo; Zhan, Huan; Cao, Huan; Yan, Feng-Ming; Zhao, Xin-Cheng] Henan Agr Univ, Coll Plant Protect, Dept Entomol, Zhengzhou, Henan, Peoples R China; [Berg, Bente G.] Norwegian Univ Sci & Technol, Dept Psychol, Neurosci Unit, N-7034 Trondheim, Norway	Henan Agricultural University; Norwegian University of Science & Technology (NTNU)	Zhao, XC (corresponding author), Henan Agr Univ, Coll Plant Protect, Dept Entomol, Zhengzhou, Henan, Peoples R China.	xincheng@henau.edu.cn		Tang, Qingbo/0000-0002-7995-504X; Berg, Bente Gunnveig/0000-0003-4035-9125	National Science Foundation of China [31272373, 31230062, 30800109]; Special Fund for Agro-scientific Researches of the Public Interests [201203036]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Researches of the Public Interests	The work was supported by National Science Foundation of China (No. 31272373, 31230062, 30800109) and Special Fund for Agro-scientific Researches of the Public Interests (No. 201203036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT PJ, 1988, PHYSIOL ENTOMOL, V13, P243, DOI 10.1111/j.1365-3032.1988.tb00473.x; ALBERT PJ, 1981, CAN J ZOOL, V59, P2217, DOI 10.1139/z81-300; ALBERT PJ, 1980, CAN J ZOOL, V58, P842, DOI 10.1139/z80-116; Asaoka K, 2000, J COMP PHYSIOL A, V186, P1011, DOI 10.1007/s003590000154; Asaoka Kiyoshi, 2003, Journal of Insect Biotechnology and Sericology, V72, P117; Asaoka Kiyoshi, 2002, International Journal of Wild Silkmoth & Silk, V7, P43; AUBELE E, 1977, CELL TISSUE RES, V178, P199; Bernays EA, 2001, J INSECT PHYSIOL, V47, P1029, DOI 10.1016/S0022-1910(01)00079-8; BLANEY WM, 1987, PHYSIOL ENTOMOL, V12, P281, DOI 10.1111/j.1365-3032.1987.tb00752.x; BLANEY WM, 1988, ENTOMOL EXP APPL, V46, P267, DOI 10.1007/BF00364198; Cao H, 2013, J HENAN AGR U, V47, P78; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; de Brito Sanchez MG, 2011, CHEM SENSES, V36, P675, DOI 10.1093/chemse/bjr040; DENOTTER CJ, 1992, ENTOMOL EXP APPL, V63, P27, DOI 10.1007/BF00350343; DETHIER VG, 1973, J COMP PHYSIOL, V82, P103, DOI 10.1007/BF00696148; DEVITT BD, 1982, INT J INSECT MORPHOL, V11, P255, DOI 10.1016/0020-7322(82)90015-0; Distler PG, 1997, J EXP BIOL, V200, P1873; EDGECOMB RS, 1992, J COMP NEUROL, V315, P431, DOI 10.1002/cne.903150406; FAUCHEUX MJ, 1995, INT J INSECT MORPHOL, V24, P391, DOI 10.1016/0020-7322(95)00011-R; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; GAFFAL KP, 1979, ZOOMORPHOLOGIE, V92, P273, DOI 10.1007/BF00994088; GRIMES LR, 1986, ANN ENTOMOL SOC AM, V79, P510, DOI 10.1093/aesa/79.3.510; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Ignell R, 2005, J COMP NEUROL, V492, P214, DOI 10.1002/cne.20691; ISHIKAWA S, 1963, J CELL COMPAR PHYSL, V61, P99, DOI 10.1002/jcp.1030610111; ISHIKAWA S, 1966, J CELL PHYSIOL, V67, P1, DOI 10.1002/jcp.1040670102; Jorgensen K, 2006, J COMP NEUROL, V496, P121, DOI 10.1002/cne.20908; Kent K.S., 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V315, P1, DOI 10.1098/rstb.1987.0001; Kvello P, 2006, ARTHROPOD STRUCT DEV, V35, P35, DOI 10.1016/j.asd.2005.10.003; Kwon JY, 2011, J NEUROSCI, V31, P15300, DOI 10.1523/JNEUROSCI.3363-11.2011; Liu Z, 2011, MICRON, V42, P478, DOI 10.1016/j.micron.2011.01.006; Ma W.-C., 1972, DYNAMICS FEEDING RES; Martin TL, 2012, ARTHROPOD-PLANT INTE, V6, P519, DOI 10.1007/s11829-012-9209-0; Mishra D, 2013, CURR BIOL, V23, P1466, DOI 10.1016/j.cub.2013.06.028; Mitchell BK, 1999, MICROSC RES TECHNIQ, V47, P401, DOI 10.1002/(SICI)1097-0029(19991215)47:6<401::AID-JEMT4>3.0.CO;2-7; MITTER C, 1993, ANNU REV ENTOMOL, V38, P207, DOI 10.1146/annurev.en.38.010193.001231; NAYAK SV, 1985, INT J INSECT MORPHOL, V14, P115, DOI 10.1016/0020-7322(85)90051-0; Python F, 2002, J COMP NEUROL, V445, P374, DOI 10.1002/cne.10188; REHDER V, 1988, PROC R SOC SER B-BIO, V235, P179, DOI 10.1098/rspb.1988.0071; REHDER V, 1989, J COMP NEUROL, V279, P499, DOI 10.1002/cne.902790313; SCHOONHOVEN L. M., 1966, ARCH NEER ZOOL, V16, P497; Schoonhoven L. M., 2005, Insect-plant biology; SHIELDS VDC, 1995, PHILOS T R SOC B, V347, P447, DOI 10.1098/rstb.1995.0036; SHIELDS VDC, 1994, CAN J ZOOL, V72, P2032, DOI 10.1139/z94-274; Shields VDC, 1996, J MORPHOL, V228, P89, DOI 10.1002/(SICI)1097-4687(199604)228:1<89::AID-JMOR7>3.0.CO;2-K; Shields VDC, 2009, ANN ENTOMOL SOC AM, V102, P1116, DOI 10.1603/008.102.0621; SIMMONDS MSJ, 1991, SYMP BIOL HUNG, V39, P17; SINGH RN, 1984, INT J INSECT MORPHOL, V13, P255, DOI 10.1016/0020-7322(84)90001-1; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; Tang DL, 2000, SCI CHINA SER C, V43, P606, DOI 10.1007/BF02882281; Tang QB, 2006, ENTOMOL EXP APPL, V118, P221, DOI 10.1111/j.1570-7458.2006.00387.x; WIECZOREK H, 1976, J COMP PHYSIOL, V106, P153, DOI 10.1007/BF00620496; Wu K. J., 1997, INSECT SCI, V14, P277, DOI [10.1111/j.1744-7917.1997.tb00101.x, DOI 10.1111/J.1744-7917.1997.TB00101.X]; ZALUCKI MP, 1986, AUST J ZOOL, V34, P779, DOI 10.1071/ZO9860779; Zhang HJ, 2013, J CHEM ECOL, V39, P1070, DOI 10.1007/s10886-013-0303-2; [张雪凝 Zhang Xuening], 2011, [河南农业大学学报, Journal of Henan Agricultural University], V45, P79; Zhou DS, 2009, J INSECT PHYSIOL, V55, P788, DOI 10.1016/j.jinsphys.2009.04.011; Zhou DS, 2010, J COMP PHYSIOL A, V196, P791, DOI 10.1007/s00359-010-0558-9	59	13	21	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95401	10.1371/journal.pone.0095401	http://dx.doi.org/10.1371/journal.pone.0095401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740428	Green Submitted, gold, Green Published			2022-12-25	WOS:000336863900141
J	Veleirinho, B; Coelho, DS; Dias, PF; Maraschin, M; Pinto, R; Cargnin-Ferreira, E; Peixoto, A; Souza, JA; Ribeiro-do-Valle, RM; Lopes-da-Silva, JA				Veleirinho, Beatriz; Coelho, Daniela S.; Dias, Paulo F.; Maraschin, Marcelo; Pinto, Rubia; Cargnin-Ferreira, Eduardo; Peixoto, Ana; Souza, Jose A.; Ribeiro-do-Valle, Rosa M.; Lopes-da-Silva, Jose A.			Foreign Body Reaction Associated with PET and PET/Chitosan Electrospun Nanofibrous Abdominal Meshes	PLOS ONE			English	Article							HERNIA REPAIR; FIBROUS SCAFFOLDS; BIODEGRADABLE POLYURETHANE; INFLAMMATORY RESPONSE; ADHESION FORMATION; INCISIONAL HERNIA; IN-VIVO; RECURRENCE; ATTACHMENT; SURGERY	Electrospun materials have been widely explored for biomedical applications because of their advantageous characteristics, i.e., tridimensional nanofibrous structure with high surface-to-volume ratio, high porosity, and pore interconnectivity. Furthermore, considering the similarities between the nanofiber networks and the extracellular matrix (ECM), as well as the accepted role of changes in ECM for hernia repair, electrospun polymer fiber assemblies have emerged as potential materials for incisional hernia repair. In this work, we describe the application of electrospun non-absorbable mats based on poly(ethylene terephthalate) (PET) in the repair of abdominal defects, comparing the performance of these meshes with that of a commercial polypropylene mesh and a multifilament PET mesh. PET and PET/chitosan electrospun meshes revealed good performance during incisional hernia surgery, post-operative period, and no evidence of intestinal adhesion was found. The electrospun meshes were flexible with high suture retention, showing tensile strengths of 3 MPa and breaking strains of 8-33%. Nevertheless, a significant foreign body reaction (FBR) was observed in animals treated with the nanofibrous materials. Animals implanted with PET and PET/chitosan electrospun meshes (fiber diameter of 0.71 +/- 0.28 mm and 3.01 +/- 0.72 mu m, respectively) showed, respectively, foreign body granuloma formation, averaging 4.2-fold and 7.4-fold greater than the control commercial mesh group (Marlex). Many foreign body giant cells (FBGC) involving nanofiber pieces were also found in the PET and PET/chitosan groups (11.9 and 19.3 times more FBGC than control, respectively). In contrast, no important FBR was observed for PET microfibers (fiber diameter = 18.9 +/- 0.21 mu m). Therefore, we suggest that the reduced dimension and the high surface-to-volume ratio of the electrospun fibers caused the FBR reaction, pointing out the need for further studies to elucidate the mechanisms underlying interactions between cells/tissues and nanofibrous materials in order to gain a better understanding of the implantation risks associated with nanostructured biomaterials.	[Veleirinho, Beatriz; Lopes-da-Silva, Jose A.] Univ Aveiro, Dept Chem, QOPNA Res Unit, P-3800 Aveiro, Portugal; [Veleirinho, Beatriz; Ribeiro-do-Valle, Rosa M.] Univ Fed Santa Catarina, Biotechnol & Biosci Postgrad Program, Florianopolis, SC, Brazil; [Coelho, Daniela S.; Dias, Paulo F.] Univ Fed Santa Catarina, Dept Cell Biol Embryol & Genet, Florianopolis, SC, Brazil; [Maraschin, Marcelo] Univ Fed Santa Catarina, Plant Morphogenesis & Biochem Lab, Florianopolis, SC, Brazil; [Pinto, Rubia] Epagri, Florianopolis, SC, Brazil; [Cargnin-Ferreira, Eduardo] Fed Inst Educ Sci & Technol Santa Catarina, Garopaba, Brazil; [Peixoto, Ana; Souza, Jose A.] Univ Fed Santa Catarina, Dept Pediat, Florianopolis, SC, Brazil	Universidade de Aveiro; Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Santa Catarina (UFSC)	Veleirinho, B (corresponding author), Univ Aveiro, Dept Chem, QOPNA Res Unit, P-3800 Aveiro, Portugal.	bveleirinho@ua.pt	Ferreira, Eduardo Cargnin/AAQ-2597-2021; Ferreira, Eduardo/AAP-6291-2021; da Silva, José Lopes/A-4240-2013; Maraschin, Marcelo/M-7176-2019	da Silva, José Lopes/0000-0002-2863-1790; Romeu Pinto Muller, Mara Rubia/0000-0003-0869-4628; Sousa Coelho, Daniela/0000-0001-5239-1291	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PEst-C/QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296, SFRH/BD/38881/2007]; European Union [PEst-C/QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296, SFRH/BD/38881/2007]; QREN [PEst-C/QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296, SFRH/BD/38881/2007]; FEDER [PEst-C/QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296, SFRH/BD/38881/2007]; COMPETE [PEst-C/QUI/UI0062/2013, FCOMP-01-0124-FEDER-037296, SFRH/BD/38881/2007]; CNPq (Brazil) [375205/2012-8]; FAPESC (Brazil) [PRONEX 17420/2011/3]	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); European Union(European Commission); QREN; FEDER(European Commission); COMPETE; CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESC (Brazil)	Authors acknowledge Fundacao para a Ciencia e a Tecnologia (FCT, Portugal), the European Union, QREN, FEDER, COMPETE, for funding the Organic Chemistry Research Unit (QOPNA) (project PEst-C/QUI/UI0062/2013; FCOMP-01-0124-FEDER-037296) and for the PhD grant (SFRH/BD/38881/2007). Authors also acknowledge CNPq (Brazil) for a young talent researcher grant (375205/2012-8) and the financial support from FAPESC (Brazil) (PRONEX 17420/2011/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony T, 2000, WORLD J SURG, V24, P95, DOI 10.1007/s002689910018; Barbosa JN, 2010, J BIOMED MATER RES A, V93A, P20, DOI 10.1002/jbm.a.32499; Bartsch H, 2006, LANGENBECK ARCH SURG, V391, P499, DOI 10.1007/s00423-006-0073-1; Bergmeister H, 2012, ARTIF ORGANS, V36, P54, DOI 10.1111/j.1525-1594.2011.01297.x; Bingener Juliane, 2004, JSLS, V8, P127; Binnebosel M, 2011, SEMIN IMMUNOPATHOL, V33, P235, DOI 10.1007/s00281-010-0237-5; Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296; Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609; Carbajo MA, 1999, SURG ENDOSC-ULTRAS, V13, P250, DOI 10.1007/s004649900956; Conze J, 2004, Hernia, V8, P365, DOI 10.1007/s10029-004-0268-8; Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108; Ebersole GC, 2012, SURG ENDOSC, V26, P2717, DOI 10.1007/s00464-012-2258-8; GARVEY W, 1984, STAIN TECHNOL, V59, P213, DOI 10.3109/10520298409113858; Gecim IE, 1996, SURG TODAY, V26, P607, DOI 10.1007/BF00311665; Halm JA, 2009, HERNIA, V13, P275, DOI 10.1007/s10029-008-0469-7; Hashizume R, 2010, BIOMATERIALS, V31, P3253, DOI 10.1016/j.biomaterials.2010.01.051; Hong Y, 2008, BIOMACROMOLECULES, V9, P1200, DOI 10.1021/bm701201w; Hong Y, 2012, TISSUE ENG PART C-ME, V18, P122, DOI [10.1089/ten.TEC.2011.0295, 10.1089/ten.tec.2011.0295]; Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231; Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649; Karabulut B, 2006, SURG ENDOSC, V20, P978, DOI 10.1007/s00464-005-0473-2; Kingsnorth A, 2003, LANCET, V362, P1561, DOI 10.1016/S0140-6736(03)14746-0; Klosterhalfen B, 2000, J MATER SCI, V35, P4769, DOI 10.1023/A:1004812410141; Leong MF, 2009, J BIOMED MATER RES A, V89A, P1040, DOI 10.1002/jbm.a.32061; Lopes-Da-Silva JA, 2009, J NANOSCI NANOTECHNO, V9, P3798, DOI 10.1166/jnn.2009.NS70; Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603; Manabe I, 2011, CIRC J, V75, P2739, DOI 10.1253/circj.CJ-11-1184; Matthews BD, 2003, J SURG RES, V114, P126, DOI 10.1016/S0022-4804(03)00158-6; McGinty JJ, 2005, SURG ENDOSC, V19, P786, DOI 10.1007/s00464-004-8174-9; MENZIES D, 1990, ANN ROY COLL SURG, V72, P60; Ni PY, 2011, INT J NANOMED, V6, P3065, DOI 10.2147/IJN.S25297; Nisbet DR, 2009, BIOMATERIALS, V30, P4573, DOI 10.1016/j.biomaterials.2009.05.011; Pan H, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/6/065002; Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y; Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h; Sanchez VC, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-17; Schofer MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025462; Shalumon KT, 2011, J MACROMOL SCI A, V48, P21, DOI 10.1080/10601325.2011.528288; Soto K, 2007, ACTA BIOMATER, V3, P351, DOI 10.1016/j.actbio.2006.11.004; Stern ST, 2008, TOXICOL SCI, V101, P4, DOI 10.1093/toxsci/kfm169; Tommeraas K, 2001, CARBOHYD RES, V333, P137, DOI 10.1016/S0008-6215(01)00130-6; Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2; VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270; Vasconcelos DP, 2013, BIOMATERIALS, V34, P9952, DOI 10.1016/j.biomaterials.2013.09.012; Vasita R, 2006, INT J NANOMED, V1, P15, DOI 10.2147/nano.2006.1.1.15; Veleirinho B, 2008, J POLYM SCI POL PHYS, V46, P460, DOI 10.1002/polb.21380; Veleirinho B, 2013, MAT SCI ENG C-MATER, V33, P37, DOI 10.1016/j.msec.2012.07.047; Veleirinho B, 2012, INT J BIOL MACROMOL, V51, P343, DOI 10.1016/j.ijbiomac.2012.05.023; Voskerician G, 2006, J BIOMED MATER RES A, V76A, P234, DOI 10.1002/jbm.a.30481; Voskerician G, 2010, J MATER SCI-MATER M, V21, P1989, DOI 10.1007/s10856-010-4037-1; Welty G, 2001, Hernia, V5, P142	51	42	46	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95293	10.1371/journal.pone.0095293	http://dx.doi.org/10.1371/journal.pone.0095293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740104	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900127
J	Bonetti, M; Rodriguez-Martinez, V; Overman, JP; Overvoorde, J; van Eekelen, M; Jopling, C; den Hertog, J				Bonetti, Monica; Rodriguez-Martinez, Virginia; Overman, Jeroen Paardekooper; Overvoorde, John; van Eekelen, Mark; Jopling, Chris; den Hertog, Jeroen			Distinct and Overlapping Functions of ptpn11 Genes in Zebrafish Development	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE SHP-2; ACTIVATED PROTEIN-KINASE; LEOPARD-SYNDROME; NOONAN-SYNDROME; HUMAN-DISEASE; NEURAL CREST; STEM-CELLS; MUTATIONS; DELETION; PATHWAY	The PTPN11 (protein-tyrosine phosphatase, non-receptor type 11) gene encodes SHP2, a cytoplasmic PTP that is essential for vertebrate development. Mutations in PTPN11 are associated with Noonan and LEOPARD syndrome. Human patients with these autosomal dominant disorders display various symptoms, including short stature, craniofacial defects and heart abnormalities. We have used the zebrafish as a model to investigate the role of Shp2 in embryonic development. The zebrafish genome encodes two ptpn11 genes, ptpn11a and ptpn11b. Here, we report that ptpn11a is expressed constitutively and ptpn11b expression is strongly upregulated during development. In addition, the products of both ptpn11 genes, Shp2a and Shp2b, are functional. Target-selected inactivation of ptpn11a and ptpn11b revealed that double homozygous mutants are embryonic lethal at 5-6 days post fertilization (dpf). Ptpn11a-/-ptpn11b-/- embryos showed pleiotropic defects from 4 dpf onwards, including reduced body axis extension and craniofacial defects, which was accompanied by low levels of phosphorylated Erk at 5 dpf. Interestingly, defects in homozygous ptpn11a-/- mutants overlapped with defects in the double mutants albeit they were milder, whereas ptpn11b-/- single mutants did not show detectable developmental defects and were viable and fertile. Ptpn11a-/-ptpn11b-/- mutants were rescued by expression of exogenous ptpn11a and ptpn11b alike, indicating functional redundance of Shp2a and Shp2b. The ptpn11 mutants provide a good basis for further unravelling of the function of Shp2 in vertebrate development.	[Bonetti, Monica; Rodriguez-Martinez, Virginia; Overman, Jeroen Paardekooper; Overvoorde, John; van Eekelen, Mark; Jopling, Chris; den Hertog, Jeroen] Hubrecht Inst Koninklijke Nederlandse Akad Wetens, Utrecht, Netherlands; [Bonetti, Monica; Rodriguez-Martinez, Virginia; Overman, Jeroen Paardekooper; Overvoorde, John; van Eekelen, Mark; Jopling, Chris; den Hertog, Jeroen] Univ Med Ctr Utrecht, Utrecht, Netherlands; [den Hertog, Jeroen] Inst Biol, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	den Hertog, J (corresponding author), Hubrecht Inst Koninklijke Nederlandse Akad Wetens, Utrecht, Netherlands.	j.denhertog@hubrecht.eu	Jopling, Chris/D-1728-2019	jopling, chris/0000-0003-0950-0063	Research Council for Earth and Life Sciences [ALW 819.02.021]; Netherlands Organisation for Scientific Research (NWO)	Research Council for Earth and Life Sciences(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded, in part, by a grant from the Research Council for Earth and Life Sciences (ALW 819.02.021) with financial aid from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bauler TJ, 2011, DIS MODEL MECH, V4, P228, DOI 10.1242/dmm.006130; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Edouard T, 2010, MOL CELL BIOL, V30, P2498, DOI 10.1128/MCB.00646-09; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; GORLIN RJ, 1969, AM J DIS CHILD, V117, P652, DOI 10.1001/archpedi.1969.02100030654006; Hanna N, 2006, FEBS LETT, V580, P2477, DOI 10.1016/j.febslet.2006.03.088; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Ke YH, 2007, MOL CELL BIOL, V27, P6706, DOI 10.1128/MCB.01225-07; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kontaridis MI, 2008, CIRCULATION, V117, P1423, DOI 10.1161/CIRCULATIONAHA.107.728865; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lapinski PE, 2013, DIS MODEL MECH, V6, P1448, DOI 10.1242/dmm.012849; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Martinez-Quintana E, 2013, REV ESP CARDIOL; Nadler MJS, 1997, J BIOL CHEM, V272, P20038, DOI 10.1074/jbc.272.32.20038; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P15436, DOI 10.1073/pnas.0903302106; Nakamura T, 2009, P NATL ACAD SCI USA, V106, P11270, DOI 10.1073/pnas.0902230106; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Noonan JA, 2003, AM J MED GENET A, V123A, P68, DOI 10.1002/ajmg.a.20502; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Oishi K, 2006, HUM MOL GENET, V15, P543, DOI 10.1093/hmg/ddi471; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352; Serra-Nedelec AD, 2012, P NATL ACAD SCI USA, V109, P4257, DOI 10.1073/pnas.1119803109; Stewart RA, 2010, DEV CELL, V18, P750, DOI [10.1016/j.devcel.2010.03.009, 10.1016/j.devce1.2010.03.009]; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2010, MOL SYNDROMOL, V1, P2, DOI 10.1159/000276766; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; THISSE C, 1993, DEVELOPMENT, V119, P1203; van Eekelen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012573; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Yang WT, 2006, DEV CELL, V10, P317, DOI 10.1016/j.devcel.2006.01.002; Yu ZH, 2013, J BIOL CHEM, V288, P10472, DOI 10.1074/jbc.M113.450023; Zenker M, 2009, NOONAN SYNDROME RELA	47	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94884	10.1371/journal.pone.0094884	http://dx.doi.org/10.1371/journal.pone.0094884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736444	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600102
J	Cheon, IS; Shim, BS; Park, SM; Choi, Y; Jang, JE; Jung, DI; Kim, JO; Chang, J; Yun, CH; Song, MK				Cheon, In Su; Shim, Byoung-Shik; Park, Sung-Moo; Choi, Youngjoo; Jang, Ji Eun; Jung, Dae Im; Kim, Jae-Ouk; Chang, Jun; Yun, Cheol-Heui; Song, Man Ki			Development of Safe and Effective RSV Vaccine by Modified CD4 Epitope in G Protein Core Fragment (Gcf)	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; G-GLYCOPROTEIN; T-CELLS; PULMONARY EOSINOPHILIA; PROTECTIVE IMMUNITY; FUSION PROTEIN; SUBGROUP-A; INFECTION; RESPONSES; CHALLENGE	Respiratory syncytial virus (RSV) is a major cause of respiratory tract infection in infants and young children worldwide, but currently no safe and effective vaccine is available. The RSV G glycoprotein (RSVG), a major attachment protein, is an important target for the induction of protective immune responses during RSV infection. However, it has been thought that a CD4(+)T cell epitope (a. a. 183-195) within RSVG is associated with pathogenic pulmonary eosinophilia. To develop safe and effective RSV vaccine using RSV G protein core fragment (Gcf), several Gcf variants resulting from modification to CD4(+)T cell epitope were constructed. Mice were immunized with each variant Gcf, and the levels of RSV-specific serum IgG were measured. At day 4 post-challenge with RSV subtype A or B, lung viral titers and pulmonary eosinophilia were determined and changes in body weight were monitored. With wild type Gcf derived from RSV A2 (wtAGcf), although RSV A subtype-specific immune responses were induced, vaccine-enhanced disease characterized by excessive pulmonary eosinophil recruitment and body weight loss were evident, whereas wtGcf from RSV B1 (wtBGcf) induced RSV B subtype-specific immune responses without the signs of vaccine-enhanced disease. Mice immunized with Th-mGcf, a fusion protein consisting CD4(+)T cell epitope from RSV F (F51-66) conjugated to mGcf that contains alanine substitutions at a. a. position 185 and 188, showed higher levels of RSV-specific IgG response than mice immunized with mGcf. Both wtAGcf and Th-mGcf provided complete protection against RSV A2 and partial protection against RSV B. Importantly, mice immunized with Th-mGcf did not develop vaccine-enhanced disease following RSV challenge. Immunization of Th-mGcf provided protection against RSV infection without the symptom of vaccine-enhanced disease. Our study provides a novel strategy to develop a safe and effective mucosal RSV vaccine by manipulating the CD4(+)T cell epitope within RSV G protein.	[Cheon, In Su; Shim, Byoung-Shik; Choi, Youngjoo; Jang, Ji Eun; Jung, Dae Im; Kim, Jae-Ouk; Song, Man Ki] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea; [Cheon, In Su; Park, Sung-Moo; Yun, Cheol-Heui] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Cheon, In Su; Park, Sung-Moo; Yun, Cheol-Heui] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Cheon, In Su; Park, Sung-Moo; Yun, Cheol-Heui] Seoul Natl Univ, World Class Univ Biomodulat Major, Seoul, South Korea; [Cheon, In Su; Park, Sung-Moo; Yun, Cheol-Heui] Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul, South Korea; [Choi, Youngjoo; Chang, Jun] Ewha Womans Univ, Grad Sch Pharmaceut Sci, Seoul, South Korea	International Vaccine Institute; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Ewha Womans University	Yun, CH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	cyun@snu.ac.kr; mksong@ivi.int	YUN, Cheol-Heui/AAR-2775-2020	YUN, Cheol-Heui/0000-0002-0041-2887; CHANG, JUN/0000-0002-8423-5987	Korea Research Council of Fundamental Science and Technology; KRIBB Initiative program [KGM0821113]; National Research Foundation of Korea - Korean Government [2013K1A2A1058638]	Korea Research Council of Fundamental Science and Technology; KRIBB Initiative program; National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by Top Brand Project grant from Korea Research Council of Fundamental Science and Technology and KRIBB Initiative program (KGM0821113) and the National Research Foundation of Korea Grant funded by the Korean Government (2013K1A2A1058638). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWAN WH, 1993, VACCINE, V11, P431, DOI 10.1016/0264-410X(93)90284-5; ALWAN WH, 1994, J EXP MED, V179, P81, DOI 10.1084/jem.179.1.81; Beck A, 2000, Dev Biol (Basel), V103, P231; Brandt C, 1997, J INFECT DIS, V176, P884, DOI 10.1086/516503; Cane PA, 2001, REV MED VIROL, V11, P103, DOI 10.1002/rmv.305; CHERBY J, 1969, CR ACAD SCI D NAT, V268, P2628; Choi JH, 2012, MOL PHARMACEUT, V9, P156, DOI 10.1021/mp200392g; Choi Y, 2012, VIRAL IMMUNOL, V25, P193, DOI 10.1089/vim.2011.0094; CONNORS M, 1991, J VIROL, V65, P1634, DOI 10.1128/JVI.65.3.1634-1637.1991; de Waal L, 2004, VACCINE, V22, P915, DOI 10.1016/j.vaccine.2003.10.008; Delgado MF, 2009, NAT MED, V15, P34, DOI 10.1038/nm.1894; Jang JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023797; JOHNSON PR, 1987, J VIROL, V61, P3163, DOI 10.1128/JVI.61.10.3163-3166.1987; JOHNSON PR, 1987, P NATL ACAD SCI USA, V84, P5625, DOI 10.1073/pnas.84.16.5625; Johnson TR, 2004, J VIROL, V78, P8753, DOI 10.1128/JVI.78.16.8753-8760.2004; KAPIKIAN AZ, 1969, AM J EPIDEMIOL, V89, P405, DOI 10.1093/oxfordjournals.aje.a120954; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032226; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; Murata Y, 2010, VACCINE, V28, P6242, DOI 10.1016/j.vaccine.2010.07.011; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P197, DOI 10.1128/JCM.24.2.197-202.1986; Nguyen TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034331; Olson MR, 2008, J IMMUNOL, V181, P7958, DOI 10.4049/jimmunol.181.11.7958; OPENSHAW PJM, 1992, INT IMMUNOL, V4, P493, DOI 10.1093/intimm/4.4.493; Park HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039921; Power UF, 1997, VIROLOGY, V230, P155, DOI 10.1006/viro.1997.8465; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; Srikiatkhachorn A, 1997, HEADACHE, V37, P277, DOI 10.1046/j.1526-4610.1997.3705277.x; Srikiatkhachorn A, 1997, J VIROL, V71, P678, DOI 10.1128/JVI.71.1.678-685.1997; Srikiatkhachorn A, 1997, J EXP MED, V186, P421, DOI 10.1084/jem.186.3.421; STOTT EJ, 1987, J VIROL, V61, P3855, DOI 10.1128/JVI.61.12.3855-3861.1987; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Tripp RA, 2004, VIRAL IMMUNOL, V17, P165, DOI 10.1089/0882824041310513; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Varga SM, 2000, J IMMUNOL, V165, P6487, DOI 10.4049/jimmunol.165.11.6487; Varga SM, 2001, IMMUNITY, V15, P637, DOI 10.1016/S1074-7613(01)00209-6; WARIS M, 1991, J INFECT DIS, V163, P464, DOI 10.1093/infdis/163.3.464; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09	37	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94269	10.1371/journal.pone.0094269	http://dx.doi.org/10.1371/journal.pone.0094269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736750	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600057
J	Hurtado, LA; Lee, EJ; Mateos, M; Taiti, S				Hurtado, Luis A.; Lee, Eun J.; Mateos, Mariana; Taiti, Stefano			Global Diversification at the Harsh Sea-Land Interface: Mitochondrial Phylogeny of the Supralittoral Isopod Genus Tylos (Tylidae, Oniscidea)	PLOS ONE			English	Article							BAYESIAN-INFERENCE; MRBAYES; MODEL; CRUSTACEA; SELECTION; PRIORS; LEVEL	The supralittoral environment, at the transition between sea and land, is characterized by harsh conditions for life. Nonetheless, evolution of terrestrial isopods (Oniscidea), the only group of Crustacea fully adapted to live on land, appears to have involved a transitional step within the supralittoral. The two most basal oniscidean lineages (Ligiidae and Tylidae) have representatives that successfully colonized the supralittoral. One of them is the genus Tylos, which is found exclusively in supralittoral sandy beaches from tropical and subtropical coasts around the world. Comprehensive phylogenetic hypotheses for this genus are lacking, which are necessary for understanding the evolution and biogeography of a lineage that successfully diversified in the harsh sea-land interface. Herein, we studied the phylogenetic relationships among 17 of the 21 currently recognized species of the genus Tylos, based on sequences from four mitochondrial genes (Cytochrome Oxidase I, Cytochrome b, 16S rDNA, and 12S rDNA). Maximum Likelihood and Bayesian phylogenetic analyses identified several lineages with deep divergences and discrete geographic distributions. Phylogenetic and distributional patterns of Tylos provide important clues on the biogeography and evolution of this group. Large divergences among the most basal clades are consistent with ancient splits. Due to the biological characteristics of Tylos, which likely prevent dispersal of these isopods across vast oceanic scales, we argue that tectonic events rather than trans-oceanic dispersal explain the distribution of Tylos in different continents. Overwater dispersal, however, likely enabled range expansions within some basins, and explains the colonization of volcanic oceanic islands. Present-day distributions were also likely influenced by sea level and climate changes. High levels of allopatric cryptic genetic differentiation are observed in different regions of the world, implying that the dispersal abilities of Tylos isopods are more limited than previously thought. Our results indicate that a taxonomic revision of this group is necessary.	[Hurtado, Luis A.; Lee, Eun J.; Mateos, Mariana] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Taiti, Stefano] CNR, Ist Studio Ecosistemi, Florence, Italy	Texas A&M University System; Texas A&M University College Station; Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio degli Ecosistemi (ISE-CNR)	Hurtado, LA (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	lhurtado@tamu.edu	Mateos, Mariana/B-5235-2008; Hurtado, Luis A/B-5953-2008; Taiti, Stefano/O-2202-2019	Mateos, Mariana/0000-0001-5738-0145; Hurtado, Luis A/0000-0002-9773-4996; 	NSF [DEB 0743782]; TAMU-CONACyT; Texas A&M Libraries Open Access to Knowledge (OAK) Fund; Division Of Environmental Biology [0743782] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); TAMU-CONACyT; Texas A&M Libraries Open Access to Knowledge (OAK) Fund; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by NSF grant DEB 0743782 to LAH and MM, and by TAMU-CONACyT grants to LAH. The authors would also like to acknowledge the Texas A&M Libraries Open Access to Knowledge (OAK) Fund for covering the publication fee of this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, EVOLUTIONARY BIOL LA; Audouin V., 1826, DESCRIPTION EGYPTE H, P77; Broly P, 2013, EVOL ECOL, V27, P461, DOI 10.1007/s10682-012-9625-8; BROWN AC, 1994, ADV MAR BIOL, V30, P89, DOI 10.1016/S0065-2881(08)60062-0; Carefoot Thomas H., 1995, Crustacean Issues, V9, P47; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Eberl R, 2013, J BIOGEOGR, V40, P2361, DOI 10.1111/jbi.12168; Erhard F, 1998, ISR J ZOOL, V44, P303; Escalona-Alcazar F.J., 2001, REV MEX CIENC GEOL, V18, P111; Garcia-Castellanos D, 2009, NATURE, V462, P778, DOI 10.1038/nature08555; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HARMON RS, 1978, QUATERNARY RES, V9, P205, DOI 10.1016/0033-5894(78)90068-6; HARMON RS, 1981, NATURE, V289, P481, DOI 10.1038/289481a0; Helenes J, 2009, MAR MICROPALEONTOL, V72, P10, DOI 10.1016/j.marmicro.2009.02.003; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurtado LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067827; Hurtado LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011633; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; KENSLEY B, 1974, Annals of the South African Museum, V65, P401; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lewis PO, 2005, SYST BIOL, V54, P241, DOI 10.1080/10635150590924208; Liu S, 2013, THESIS TEXAS A M U C; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; McLachlan A, 2006, ECOLOGY SANDY SHORES, P91, DOI [10.1016/B978-012372569-1/50006-9, DOI 10.1016/B978-012372569-1/50006-9]; Miller A. G., 1996, FLORA ARABIAN PENINS; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Montesanto G, 2014, J CRUSTACEAN BIOL, V34, P47, DOI 10.1163/1937240X-00002206; MULAIK S. B., 1960, REV SOC MEX HIST NAT, V21, P79; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2009, TRACER V1 5 MCMC TRA; Rannala B, 2012, MOL BIOL EVOL, V29, P325, DOI 10.1093/molbev/msr210; Richardson H., 1905, B US NATN MUS, V54, P583, DOI DOI 10.5479/SI.03629236.54.I; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROSEN DE, 1975, SYST ZOOL, V24, P431, DOI 10.2307/2412905; Santamaria CA, 2013, THESIS TEXAS A M U C; Santamaria CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085199; Schmalfuss Helmut, 2000, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V612, P1; Schmalfuss Helmut, 2003, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V654, P1; Schmidt Christian, 2008, Arthropod Systematics & Phylogeny, V66, P191; SCHULTZ G A, 1972, Crustaceana Supplement (Leiden), V3, P79; SCHULTZ G A, 1970, Crustaceana (Leiden), V19, P297, DOI 10.1163/156854070X00383; Smith Judith Terry, 1991, American Association of Petroleum Geologists Memoir, V47, P637; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Suzuki Y, 2002, P NATL ACAD SCI USA, V99, P16138, DOI 10.1073/pnas.212646199; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Taiti S, 2003, CRUSTACEANA MONOGR, V2, P85; Taiti Stefano, 2004, V20, P211; Taiti Stefano, 1996, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V18, P459; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Van Name W. C., 1924, Zoologica New York, V5, P181; Van Name WG, 1936, B AM MUS NAT HIST, V71, P1; Vandel A, 1952, MEM MUS CIV STOR NAT, V3, P59; VANDEL ALBERT, 1960, FAUNE DE FRANCE, V64, P1; Yang Z, 2005, SYST BIOL, V54, P455, DOI 10.1080/10635150590945313; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Zhang C, 2012, SYST BIOL, V61, P779, DOI 10.1093/sysbio/sys030; Zwickl D., 2006, GARLI GENETIC ALGORI	62	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94081	10.1371/journal.pone.0094081	http://dx.doi.org/10.1371/journal.pone.0094081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736501	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600044
J	Neumann, S; Lovdok, L; Bentele, K; Meisig, J; Ullner, E; Paldy, FS; Sourjik, V; Kollmann, M				Neumann, Silke; Lovdok, Linda; Bentele, Kajetan; Meisig, Johannes; Ullner, Ekkehard; Paldy, Ferencz S.; Sourjik, Victor; Kollmann, Markus			Exponential Signaling Gain at the Receptor Level Enhances Signal-to-Noise Ratio in Bacterial Chemotaxis	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; ESCHERICHIA-COLI; CHEMORECEPTOR CLUSTERS; ROBUSTNESS; ADAPTATION; BINDING; NETWORK; CHEY; COMPONENTS; PROTEINS	Cellular signaling systems show astonishing precision in their response to external stimuli despite strong fluctuations in the molecular components that determine pathway activity. To control the effects of noise on signaling most efficiently, living cells employ compensatory mechanisms that reach from simple negative feedback loops to robustly designed signaling architectures. Here, we report on a novel control mechanism that allows living cells to keep precision in their signaling characteristics - stationary pathway output, response amplitude, and relaxation time - in the presence of strong intracellular perturbations. The concept relies on the surprising fact that for systems showing perfect adaptation an exponential signal amplification at the receptor level suffices to eliminate slowly varying multiplicative noise. To show this mechanism at work in living systems, we quantified the response dynamics of the E. coli chemotaxis network after genetically perturbing the information flux between upstream and downstream signaling components. We give strong evidence that this signaling system results in dynamic invariance of the activated response regulator against multiplicative intracellular noise. We further demonstrate that for environmental conditions, for which precision in chemosensing is crucial, the invariant response behavior results in highest chemotactic efficiency. Our results resolve several puzzling features of the chemotaxis pathway that are widely conserved across prokaryotes but so far could not be attributed any functional role.	[Neumann, Silke; Lovdok, Linda; Paldy, Ferencz S.; Sourjik, Victor] Heidelberg Univ, Zentrum Mol Biol, DKFZ ZMBH Alliance, Heidelberg, Germany; [Bentele, Kajetan; Meisig, Johannes] Humboldt Univ, Inst Theoret Biol, D-10099 Berlin, Germany; [Ullner, Ekkehard] Dept Phys, Aberdeen, Scotland; [Ullner, Ekkehard] ICSMB, Aberdeen, Scotland; [Kollmann, Markus] Univ Dusseldorf, Dept Biol, Dusseldorf, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Humboldt University of Berlin; Heinrich Heine University Dusseldorf	Kollmann, M (corresponding author), Univ Dusseldorf, Dept Biol, Dusseldorf, Germany.	markus.kollmann@uni-duesseldorf.de			DFG [KO 3442/3-1, KO 3442/1-1, SO 421/9-1, SO 421/3-3]	DFG(German Research Foundation (DFG))	This work was supported by the DFG grants KO 3442/3-1 and KO 3442/1-1 (to MK) and SO 421/9-1 and SO 421/3-3 (to VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2010, SCIENCE, V329, P1656, DOI 10.1126/science.1190544; Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barnakov AN, 1999, P NATL ACAD SCI USA, V96, P10667, DOI 10.1073/pnas.96.19.10667; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Endres RG, 2006, P NATL ACAD SCI USA, V103, P13040, DOI 10.1073/pnas.0603101103; Francis NR, 2002, J BIOL CHEM, V277, P36755, DOI 10.1074/jbc.M204324200; Grima R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218103; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P1786, DOI 10.1073/pnas.0507438103; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; LI JY, 1995, BIOCHEMISTRY-US, V34, P14626, DOI 10.1021/bi00045a003; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; Lovdok L, 2007, J BIOTECHNOL, V129, P173, DOI 10.1016/j.jbiotec.2007.01.024; Lovdok L, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000171; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Oleksiuk O, 2011, CELL, V45, P213; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Schulmeister S, 2008, P NATL ACAD SCI USA, V105, P6403, DOI 10.1073/pnas.0710611105; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2000, MOL MICROBIOL, V37, P740, DOI 10.1046/j.1365-2958.2000.02044.x; Steuer R, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002218; Stewart RC, 2000, BIOCHEMISTRY-US, V39, P13157, DOI 10.1021/bi001100k; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Thiem S, 2008, MOL MICROBIOL, V68, P1228, DOI 10.1111/j.1365-2958.2008.06227.x; Vaknin A, 2004, P NATL ACAD SCI USA, V101, P17072, DOI 10.1073/pnas.0407812101; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	37	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e87815	10.1371/journal.pone.0087815	http://dx.doi.org/10.1371/journal.pone.0087815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736435	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600002
J	Purcell, SW				Purcell, Steven W.			Value, Market Preferences and Trade of Beche-De-Mer from Pacific Island Sea Cucumbers	PLOS ONE			English	Article								Market preferences of natural resources contribute to shape their exploitation and production. Beche-de-mer, the product after gutting, cooking, salting and drying sea cucumbers, is exported worldwide to Asian dried seafood markets. A better understanding of the trade, value and market preferences of Pacific island beche-de-mer could identify critical postharvest processing techniques and management strategies for fisheries and aquaculture. Data were collected on export prices and trade of beche-de-mer from Kiribati, Fiji, Tonga and New Caledonia, and the selling prices, respective sizes and organoleptic properties of the products in stores in China. Export prices varied considerably within and among the four countries and low-value species were the most exported by volume. Most of the beche-de-mer from the four Pacific islands is exported to Hong Kong, where quality products are sold and others are distributed to mainland China. Prices of the beche-de-mer in Chinese stores varied up to ten-fold and were mostly influenced by species, body size and, to a lesser extent, physical damage to the products. Market prices across species (averaging US$15-385 kg(-1)) appear to have mostly increased six-to twelve-fold over the past decade. The data allude that fisheries for Holothuria scabra, H. lessoni, H. fuscogilva, H. whitmaei and Thelenota ananas should be most carefully managed because they were the highest-value species and under greatest demand. The relationships between size of beche-de-mer and sale price were species specific and highly varied. This study also highlights the need for better regulations and/or enforcement of minimum size limits in sea cucumber fisheries, which can help to maximise economic benefits of wild stocks.	So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia	Southern Cross University	Purcell, SW (corresponding author), So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia.	steven.w.purcell@gmail.com	Purcell, Steven/I-2554-2013; Purcell, Steven/AAQ-1326-2021	Purcell, Steven/0000-0002-6227-6454; Purcell, Steven/0000-0002-6227-6454	Australian Centre for International Agricultural Research (ACIAR); Pacific Agribusiness Research for Development Initiative (PARDI); ZoNeCo programme of New Caledonia	Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); Pacific Agribusiness Research for Development Initiative (PARDI); ZoNeCo programme of New Caledonia	This study was funded by the Australian Centre for International Agricultural Research (ACIAR), the Pacific Agribusiness Research for Development Initiative (PARDI) and the ZoNeCo programme of New Caledonia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine J., 2001, TROPICS, V10, P591, DOI [10.3759/tropics.10.591, DOI 10.3759/TROPICS.10.591]; Anderson SC, 2011, FISH FISH, V12, P317, DOI 10.1111/j.1467-2979.2010.00397.x; [Anonymous], 2001, SPC BECHE DE MER INF, V15, P31; [Anonymous], 2002, SPC BECHE DE MER INF, V16, P21; Bordbar S, 2011, MAR DRUGS, V9, P1761, DOI 10.3390/md9101761; Branch TA, 2013, TRENDS ECOL EVOL, V28, P409, DOI 10.1016/j.tree.2013.03.003; Brown E.O., 2010, VALUE CHAIN ANAL SEA; Burnham K. P., 1998, MODEL SELECTION INFE; Chen JX., 2004, ADV SEA CUCUMBER AQU, V1, P25; Clarke S, 2004, FISH FISH, V5, P53, DOI 10.1111/j.1467-2960.2004.00137.x; Conand C, 1990, 2722 FAO; Conand C., 1993, US NMFS MAR FISH REV, V55, P1; Eriksson H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035504; Essington TE, 2006, P NATL ACAD SCI USA, V103, P3171, DOI 10.1073/pnas.0510964103; Fabinyi M, 2012, ENVIRON CONSERV, V39, P83, DOI 10.1017/S0376892911000609; Ferdouse F., 2004, ADV SEA CUCUMBER AQU, V463, P425; Ferdouse F., 1999, BECHE INF BULL, V11, P3; Friedman K, 2011, FISH FISH, V12, P75, DOI 10.1111/j.1467-2979.2010.00384.x; Ivy G., 2006, BECHE INF BULL, V24, P28; Johnston B.L., 2012, ACIAR P, V136, P205; Kinch J., 2008, FAO Fisheries and Aquaculture Technical Paper, P7; Leopold M, 2013, ENVIRON CONSERV, V40, P367, DOI 10.1017/S037689291300009X; Lo T. H., 2005, SPC BECHE DE MER INF, V20, P34; Perez M.L., 2012, ACIAR P, V136, P177; Purcell SW, 2014, MAR POLICY, V45, P240, DOI 10.1016/j.marpol.2013.11.005; Purcell S.W., 2012, FAO SPECIES CATALOGU; Purcell S.W., 2009, WORLDFISH CTR STUDIE; Purcell S.W., 2010, FAO FISHERIES AQUACU; Purcell SW, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3296; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; Purcell SW, 2012, AQUACULTURE, V368, P68, DOI 10.1016/j.aquaculture.2012.08.053; Ram R., 2008, IMPACTS HARVEST POST; SPC, 2004, PAC ISL SEA CUC BECH; SPC, 1994, HANDBOOK, V18; To Allen W.L., 2012, Traffic Bulletin, V24, P65; Tveteras S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036731; Vannuccini S., 1999, SHARK UTILIZATION MA; Wen J, 2010, J SCI FOOD AGR, V90, P2469, DOI 10.1002/jsfa.4108	38	116	122	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95075	10.1371/journal.pone.0095075	http://dx.doi.org/10.1371/journal.pone.0095075			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736374	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600140
J	Silva, DMZD; Pansonato-Alves, JC; Utsunomia, R; Araya-Jaime, C; Ruiz-Ruano, FJ; Daniel, SN; Hashimoto, DT; Oliveira, C; Camacho, JPM; Porto-Foresti, F; Foresti, F				Silva, Duilio M. Z. de A.; Pansonato-Alves, Jose Carlos; Utsunomia, Ricardo; Araya-Jaime, Cristian; Ruiz-Ruano, Francisco J.; Daniel, Sandro Natal; Hashimoto, Diogo Teruo; Oliveira, Claudio; Camacho, Juan Pedro M.; Porto-Foresti, Fabio; Foresti, Fausto			Delimiting the Origin of a B Chromosome by FISH Mapping, Chromosome Painting and DNA Sequence Analysis in Astyanax paranae (Teleostei, Characiformes)	PLOS ONE			English	Article							SCABRIPINNIS PISCES; REPETITIVE DNA; CYTOGENETIC ANALYSIS; MICRODISSECTION; POLYMORPHISM; POPULATION; EVOLUTION; MACRO; GENE; SEX	Supernumerary (B) chromosomes have been shown to contain a wide variety of repetitive sequences. For this reason, fluorescent in situ hybridisation (FISH) is a useful tool for ascertaining the origin of these genomic elements, especially when combined with painting from microdissected B chromosomes. In order to investigate the origin of B chromosomes in the fish species Astyanax paranae, these two approaches were used along with PCR amplification of specific DNA sequences obtained from the B chromosomes and its comparison with those residing in the A chromosomes. Remarkably, chromosome painting with the one-arm metacentric B chromosome probe showed hybridization signals on entire B chromosome, while FISH mapping revealed the presence of H1 histone and 18S rDNA genes symmetrically placed in both arms of the B chromosome. These results support the hypothesis that the B chromosome of A. paranae is an isochromosome. Additionally, the chromosome pairs Nos. 2 or 23 are considered the possible B chromosome ancestors since both contain syntenic H1 and 18S rRNA sequences. The analysis of DNA sequence fragments of the histone and rRNA genes obtained from the microdissected B chromosomes showed high similarity with those obtained from 0B individuals, which supports the intraspecific origin of B chromosomes in A. paranae. Finally, the population hereby analysed showed a female-biased B chromosome presence suggesting that B chromosomes in this species could influence sex determinism.	[Silva, Duilio M. Z. de A.; Pansonato-Alves, Jose Carlos; Utsunomia, Ricardo; Araya-Jaime, Cristian; Oliveira, Claudio; Foresti, Fausto] Univ Estadual Paulista, Dept Morfol, Inst Biociencias, Sao Paulo, Brazil; [Hashimoto, Diogo Teruo] Univ Estadual Paulista, CAUNESP, Sao Paulo, Brazil; [Ruiz-Ruano, Francisco J.; Camacho, Juan Pedro M.] Univ Granada, Dept Genet, Granada, Spain; [Daniel, Sandro Natal; Porto-Foresti, Fabio] Univ Estadual Paulista, Dept Ciencias Biol, Fac Ciencias, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; University of Granada; Universidade Estadual Paulista	Silva, DMZD (corresponding author), Univ Estadual Paulista, Dept Morfol, Inst Biociencias, Sao Paulo, Brazil.	duilio@ibb.unesp.br	Araya, Cristian Andrés/H-7988-2016; Porto-Foresti, Fabio/AAC-4797-2020; Hashimoto, Diogo Teruo/AAP-7423-2020; Daniel, Sandro/N-7218-2016; Camacho, Juan Pedro M/L-6869-2014; Hashimoto, Diogo Teruo/A-4377-2013; Oliveira, Claudio/D-7713-2012; Araya-Jaime, Cristian/J-8903-2016; Araya-Jaime, Cristian/AAB-4234-2020; Pansonato Alves, Jose Carlos/C-3062-2014; Utsunomia, Ricardo/O-8955-2015; Ruiz-Ruano, Francisco J./D-8254-2014	Porto-Foresti, Fabio/0000-0001-8845-3845; Hashimoto, Diogo Teruo/0000-0002-8808-2498; Daniel, Sandro/0000-0002-0235-6831; Camacho, Juan Pedro M/0000-0002-2507-9814; Oliveira, Claudio/0000-0002-7010-8880; Araya-Jaime, Cristian/0000-0003-4639-5207; Pansonato Alves, Jose Carlos/0000-0003-3580-7384; Ruiz-Ruano, Francisco J./0000-0002-5391-301X; Utsunomia, Ricardo/0000-0003-4565-6065	State of Sao Paulo Research Foundation (FAPESP) [2011/16825-3, 2010/17009-2]; National Council for Research and Development (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Research and Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was funded by grants from the State of Sao Paulo Research Foundation (FAPESP) to DMZAS (2011/16825-3) and CO (2010/17009-2), grants from National Council for Research and Development (CNPq) to FF and by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Artoni RF, 2006, GENETICA, V127, P277, DOI 10.1007/s10709-005-4846-1; Banaei-Moghaddam AM, 2013, PLANT CELL, V25, P2536, DOI 10.1105/tpc.113.111856; Bueno D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066532; Bugrov AG, 2003, FOLIA BIOL-KRAKOW, V51, P1; Bugrov AG, 2007, CHROMOSOME RES, V15, P315, DOI 10.1007/s10577-007-1128-z; Cabrero J, 2003, CHROMOSOMA, V112, P207, DOI 10.1007/s00412-003-0264-2; Camacho Juan Pedro M., 2005, P223, DOI 10.1016/B978-012301463-4/50006-1; Carchilan M, 2009, CHROMOSOMA, V118, P607, DOI 10.1007/s00412-009-0222-8; Martins CCC, 2013, APIDOLOGIE, V44, P75, DOI 10.1007/s13592-012-0157-6; Carvalho RA, 2008, J FISH BIOL, V72, P1907, DOI 10.1111/j.1095-8649.2008.01835.x; CHILDS G, 1981, CELL, V23, P651, DOI 10.1016/0092-8674(81)90428-1; Daniel SN, 2012, CARYOLOGIA, V65, P229, DOI 10.1080/00087114.2012.738488; Darlington CD., 1958, EVOLUTION GENETIC SY; Dhar MK, 2002, CHROMOSOMA, V111, P332, DOI 10.1007/s00412-002-0214-4; dos Santos LP, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-48; Eigenmann C. H., 1914, INDIANA U STUD, V20, P44; Fantinatti BEA, 2011, GENETICA, V139, P1273, DOI 10.1007/s10709-012-9629-x; Fernandes CA, 2005, GENETICA, V124, P301, DOI 10.1007/s10709-005-4751-7; Ferro DAD, 2003, GENETICA, V119, P147, DOI 10.1023/A:1026086501252; FORESTI F, 1981, CYTOGENET CELL GENET, V31, P137, DOI 10.1159/000131639; FRIEBE B, 1995, PLANT SYST EVOL, V196, P131, DOI 10.1007/BF00982954; Goodwin SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002070; Gribble S, 2004, CHROMOSOME RES, V12, P143, DOI 10.1023/B:CHRO.0000013167.12527.f0; Grier H, 2000, J MORPHOL, V243, P265, DOI 10.1002/(SICI)1097-4687(200003)243:3<265::AID-JMOR4>3.0.CO;2-I; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hashimoto DT, 2012, COMP CYTOGENET, V6, P141, DOI 10.3897/CompCytogen.v6i2.1769; Hashimoto DT, 2010, NEOTROP ICHTHYOL, V8, P861, DOI 10.1590/S1679-62252010000400016; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Houben A, 2014, CELL MOL LIFE SCI, V71, P467, DOI 10.1007/s00018-013-1437-7; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; JONES RN, 1991, AM NAT, V137, P430, DOI 10.1086/285175; Jones RN, 1985, EVOLUTION GENOME SIZ, P397; Klemme S, 2013, NEW PHYTOL, V199, P550, DOI 10.1111/nph.12289; Kour G, 2014, CYTOGENET GENOME RES, V142, P121, DOI 10.1159/000356472; Kuhn GCS, 2012, MOL BIOL EVOL, V29, P7, DOI 10.1093/molbev/msr173; Leach CR, 2005, GENETICS, V171, P269, DOI 10.1534/genetics.105.043273; LEVAN A, 1964, HEREDITAS-GENETISK A, V52, P201, DOI 10.1111/j.1601-5223.1964.tb01953.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Long H, 2008, J INTEGR PLANT BIOL, V50, P183, DOI 10.1111/j.1744-7909.2007.00588.x; MAISTRO EL, 1992, GENETICA, V87, P101, DOI 10.1007/BF00120999; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Mestriner CA, 2000, HEREDITY, V85, P1, DOI 10.1046/j.1365-2540.2000.00702.x; MIAO VP, 1991, SCIENCE, V254, P1773, DOI 10.1126/science.1763326; Mizoguchi SMHN, 1997, HEREDITAS, V127, P249, DOI 10.1111/j.1601-5223.1997.00249.x; Moreira O, 2004, CYTOGENET GENOME RES, V106, P230, DOI 10.1159/000079292; Moreira-Filho Orlando, 2001, Cytologia (Tokyo), V66, P59; NEI M, 1986, MOL BIOL EVOL, V3, P418; Neo DM, 2000, GENETICA, V108, P211, DOI 10.1023/A:1004157901097; NUR U, 1977, GENETICS, V87, P499; NUR U, 1966, GENETICS, V54, P1225; Oliveira C, 2009, FISH PHYSIOL BIOCHEM, V35, P81, DOI 10.1007/s10695-008-9250-1; Oliveira NL, 2011, MOL CYTOGENET, V4, DOI 10.1186/1755-8166-4-24; OSTERGREN G., 1945, Botaniska Notiser, P157; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PLOWMAN AB, 1994, HEREDITY, V72, P587, DOI 10.1038/hdy.1994.81; Poletto AB, 2010, BMC GENET, V11, DOI [10.1186/1471-2156-11-1, 10.1186/1471-2156-11-50]; PortoForesti F, 1997, BRAZ J GENET, V20, P377, DOI 10.1590/S0100-84551997000300004; Rubtsov NB, 2004, CYTOGENET GENOME RES, V106, P289, DOI 10.1159/000079301; Ruiz-Estevez M, 2013, GENETICA, V141, P337, DOI 10.1007/s10709-013-9733-6; Ruiz-Estevez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036600; SALVADOR LB, 1992, HEREDITY, V69, P50, DOI 10.1038/hdy.1992.93; STANGE EAR, 1993, REV BRAS GENET, V16, P601; Stitou S, 2000, CHROMOSOME RES, V8, P305, DOI 10.1023/A:1009227427575; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teruel M, 2009, CYTOGENET GENOME RES, V125, P286, DOI 10.1159/000235935; Teruel M, 2013, HEREDITY, P1; Teruel M, 2010, CHROMOSOMA, V119, P217, DOI 10.1007/s00412-009-0251-3; Teruel M, 2009, CHROMOSOME RES, V17, P11, DOI 10.1007/s10577-008-9001-2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trifonov VA, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-90; Vicari MR, 2011, GENETICA, V139, P1073, DOI 10.1007/s10709-011-9611-z; Vicente VE, 1996, CYTOGENET CELL GENET, V74, P70, DOI 10.1159/000134385; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WERREN JH, 1987, NATURE, V327, P75, DOI 10.1038/327075a0; Werren JH, 2003, GENETICA, V117, P85, DOI 10.1023/A:1022368700752; WHITE M J D, 1973, P961; Yoshida K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002203; Zhou Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-109; Ziegler CG, 2003, CHROMOSOME RES, V11, P23, DOI 10.1023/A:1022053931308	81	72	75	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94896	10.1371/journal.pone.0094896	http://dx.doi.org/10.1371/journal.pone.0094896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736529	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600105
J	Trilles, L; Wang, B; Firacative, C; Lazera, MD; Wanke, B; Meyer, W				Trilles, Luciana; Wang, Bin; Firacative, Carolina; Lazera, Marcia dos Santos; Wanke, Bodo; Meyer, Wieland			Identification of the Major Molecular Types of Cryptococcus neoformans and C-gattii by Hyperbranched Rolling Circle Amplification	PLOS ONE			English	Article							FUNGAL PATHOGENS; PADLOCK PROBES; POPULATION; GENOTYPE; MUTATION; DISEASE; SAMPLES	The agents of cryptococcosis C. neoformans and C. gattii are important agents of meningoencephalitis in immunocompromised and immunocompetent hosts, respectively. They are grouped into eight major molecular types, VNI-VNIV for C. neoformans and VGI-VGIV for C. gattii. These major molecular types differ in their host range, epidemiology, antifungal susceptibility and geographic distribution. To enable a rapid identification of the major molecular types and potential hybrids within the two species specific probes based on the PLB1 gene in combination with hyperbranched rolling circle amplification (HRCA) were developed. HRCA was applied to 76 cryptococcal strains, 10 strains each representing the 7 haploid major molecular types, 4 VNIII hybrid strains and 2 inter-species hybrid strains. All strains were correctly identified to the major molecular type and or hybrid type using HRCA alone. To increase the sensitivity a semi-nested PCR step was developed, which will enable the identification of the molecular types/hybrids directly from clinical samples, harboring a low copy number of DNA (40 copies). Thus, HRCA based on the PLB1 locus alone and in combination with a semi-nested PCR showed to be a specific and sensitive methodology, with a great potential to be used on clinical specimens for the direct diagnosis of the agents of cryptococcosis, including hybrid strains, enabling a rapid and patient tailored treatment choice of this disease.	[Trilles, Luciana; Firacative, Carolina; Meyer, Wieland] Univ Sydney, Ctr Infect Dis & Microbiol, Mol Mycol Res Lab,Westmead Millennium Inst Infect, Sydney Med Sch,Westmead Hosp,Marie Bashir Inst In, Sydney, NSW 2006, Australia; [Trilles, Luciana; Lazera, Marcia dos Santos; Wanke, Bodo] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, Lab Micol, BR-21045900 Rio De Janeiro, Brazil; [Wang, Bin] Univ Sydney, Westmead Millennium Inst, Retroviral Genet Lab, Ctr Virus Res, Sydney, NSW 2006, Australia	University of Sydney; Fundacao Oswaldo Cruz; University of Sydney; Westmead Institute for Medical Research	Trilles, L (corresponding author), Univ Sydney, Ctr Infect Dis & Microbiol, Mol Mycol Res Lab,Westmead Millennium Inst Infect, Sydney Med Sch,Westmead Hosp,Marie Bashir Inst In, Sydney, NSW 2006, Australia.	luciana.trilles@ipec.fiocruz.br	Firacative, Carolina/ABB-9942-2021; Meyer, Wieland/G-1204-2015	Firacative, Carolina/0000-0001-7547-5172; Meyer, Wieland/0000-0001-9933-8340	NHMRC [APP1031943]; CNPq [201552/2010-8]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding provided by NH&MRC project grant # APP1031943 to WM; CNPq travel grant # 201552/2010-8 to LT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsmadi OA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-21; Aminnejad M, 2012, MYCOPATHOLOGIA, V173, P337, DOI 10.1007/s11046-011-9491-x; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2007, J CLIN MICROBIOL, V45, P1874, DOI 10.1128/JCM.00223-07; Byrnes EJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002205; Feng X, 2013, JCM, DOI 10.11.28/JCM.01455-13; Ferrer C, 2001, J CLIN MICROBIOL, V39, P2873, DOI 10.1128/JCM.39.8.2873-2879.2001; Hanafy A, 2008, MED MYCOL, V46, P685, DOI 10.1080/13693780802027062; Harris J, 2012, MED MYCOL, V50, P113, DOI 10.3109/13693786.2011.607854; Huston SM, 2009, CLIN CHEST MED, V30, P253, DOI 10.1016/j.ccm.2009.02.006; Johnson MD, 2012, CLIN INFECT DIS, V54, P502, DOI 10.1093/cid/cir827; Kaocharoen S, 2008, ELECTROPHORESIS, V29, P3183, DOI 10.1002/elps.200700903; Katsu M, 2004, FEMS YEAST RES, V4, P377, DOI 10.1016/S1567-1356(03)00176-4; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Kurt K, 2009, J CLIN MICROBIOL, V47, P577, DOI 10.1128/JCM.01347-08; Lazera M.S., 2005, DINAMICA DOENCAS INF, VII, P1223; Leaw SN, 2006, J CLIN MICROBIOL, V44, P693, DOI 10.1128/JCM.44.3.693-699.2006; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Lucas S, 2010, CLIN MICROBIOL INFEC, V16, P711, DOI 10.1111/j.1469-0691.2009.02919.x; Magee PT, 2003, INFECT IMMUN, V71, P2299, DOI 10.1128/IAI.71.5.2299-2309.2003; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P327; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Skladny H, 1999, J CLIN MICROBIOL, V37, P3865, DOI 10.1128/JCM.37.12.3865-3871.1999; Sorrell TC, 2001, MED MYCOL, V39, P155, DOI 10.1080/mmy.39.2.155.168; Spiess B, 2007, J CLIN MICROBIOL, V45, P3743, DOI 10.1128/JCM.00942-07; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas LB, 2012, ANN CLIN LAB SCI, V42, P355; Trilles L, 2008, MEM I OSWALDO CRUZ, V103, P455, DOI 10.1590/S0074-02762008000500008; Trilles L, 2012, MED MYCOL, V50, P328, DOI 10.3109/13693786.2011.602126; van der Velden WJFM, 2011, CURR OPIN INFECT DIS, V24, P554, DOI 10.1097/QCO.0b013e32834ab1f4; Wang B, 2009, J VIROL METHODS, V161, P128, DOI 10.1016/j.jviromet.2009.06.004; Wiesner DL, 2012, MBIO, V3, DOI 10.1128/mBio.00196-12	36	32	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94648	10.1371/journal.pone.0094648	http://dx.doi.org/10.1371/journal.pone.0094648			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736745	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600077
J	Poluzzi, C; Casulli, J; Goyal, A; Mercer, TJ; Neill, T; Iozzo, RV				Poluzzi, Chiara; Casulli, Joshua; Goyal, Atul; Mercer, Thomas J.; Neill, Thomas; Iozzo, Renato V.			Endorepellin Evokes Autophagy in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; FIBROBLAST-GROWTH-FACTOR; PERLECAN PROTEIN CORE; BASEMENT-MEMBRANE PROTEOGLYCANS; DENSITY-LIPOPROTEIN-RECEPTOR; COLON CARCINOMA-CELLS; IMPRINTED GENE; CANCER GROWTH; TUMOR-GROWTH; ALPHA(2)BETA(1) INTEGRINS	Endorepellin, the C-terminal fragment of the heparan sulfate proteoglycan perlecan, possesses angiostatic activity via dual receptor antagonism, through concurrent binding to the alpha 2 beta 1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2). Here, we discovered that soluble endorepellin induced autophagy in endothelial cells by modulating the expression of Beclin 1, LC3, and p62, three established autophagic markers. Moreover, endorepellin evoked expression of the imprinted tumor suppressor gene Peg3 and its co-localization with Beclin 1 and LC3 in autophagosomes, suggesting a major role for this gene in endothelial cell autophagy. Mechanistically, endorepellin induced autophagy by down-regulating VEGFR2 via the two LG1/2 domains, whereas the C-terminal LG3 domain, the portion responsible for binding the alpha 2 beta 1 integrin, was ineffective. Endorepellin also induced transcriptional activity of the BECN1 promoter in endothelial cells, and the VEGFR2-specific tyrosine kinase inhibitor, SU5416, blocked this effect. Finally, we found a correlation between endorepellin-evoked inhibition of capillary morphogenesis and enhanced autophagy. Thus, we have identified a new role for this endogenous angiostatic fragment in inducing autophagy through a VEGFR2-dependent but alpha 2 beta 1 integrin-independent pathway. This novel mechanism specifically targets endothelial cells and could represent a promising new strategy to potentiate the angiostatic effect of endorepellin and perhaps other angiostatic matrix proteins.	[Iozzo, Renato V.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Canc Cell Biol & Signaling Program, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Iozzo, RV (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, 1020 Locust St,Ste 336 JAH, Philadelphia, PA 19107 USA.	renato.iozzo@jefferson.edu	Iozzo, Renato/AAS-1980-2020; Poluzzi, Chiara/T-3376-2019	Iozzo, Renato/0000-0002-5908-5112; Casulli, Joshua/0000-0002-3733-7614	National Institutes of Health [RO1 CA3948, RO1 CA47282, RO1 CA164462, T32 AA07463]; NATIONAL CANCER INSTITUTE [R01CA047282, P30CA056036, R01CA039481, R01CA164462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA007463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 CA3948, RO1 CA47282, and RO1 CA164462 (to R. V. I.).; Supported by National Institutes of Health Training Grant T32 AA07463.	Aviezer D, 1997, MOL CELL BIOL, V17, P1938, DOI 10.1128/MCB.17.4.1938; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Bix G, 2005, TRENDS CELL BIOL, V15, P52, DOI 10.1016/j.tcb.2004.11.008; Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150; Bix G, 2006, J NATL CANCER I, V98, P1634, DOI 10.1093/jnci/djj441; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Buraschi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045559; CARSON DD, 1993, DEV BIOL, V155, P97, DOI 10.1006/dbio.1993.1010; Chau YP, 2003, HISTOL HISTOPATHOL, V18, P715, DOI 10.14670/HH-18.715; Chuang CY, 2010, BIOCHEMISTRY-US, V49, P5524, DOI 10.1021/bi1005199; COHEN IR, 1993, P NATL ACAD SCI USA, V90, P10404, DOI 10.1073/pnas.90.21.10404; COHEN IR, 1994, CANCER RES, V54, P5771; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; COUCHMAN JR, 1995, J HISTOCHEM CYTOCHEM, V43, P955, DOI 10.1177/43.9.7543915; Datta S, 2006, INT J BIOCHEM CELL B, V38, P1855, DOI 10.1016/j.biocel.2006.03.022; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Fong TAT, 1999, CANCER RES, V59, P99; Fuki IV, 2000, J BIOL CHEM, V275, P25742, DOI 10.1074/jbc.M909173199; Gonzalez EM, 2005, J BIOL CHEM, V280, P7080, DOI 10.1074/jbc.M409841200; Gonzalez EM, 2003, J BIOL CHEM, V278, P38113, DOI 10.1074/jbc.C300310200; Gonzalez-Iriarte M, 2003, J MOL CELL CARDIOL, V35, P795, DOI 10.1016/S0022-2828(03)00134-2; Goyal A, 2012, J BIOL CHEM, V287, P43543, DOI 10.1074/jbc.M112.401786; Goyal A, 2011, J BIOL CHEM, V286, P25947, DOI 10.1074/jbc.M111.243626; Gustafsson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053715; Handler M, 1997, DEV DYNAM, V210, P130, DOI 10.1002/(SICI)1097-0177(199710)210:2<130::AID-AJA6>3.0.CO;2-H; Howell A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2435; Ida-Yonemochi H, 2011, MATRIX BIOL, V30, P379, DOI 10.1016/j.matbio.2011.08.001; Inomata T, 2012, INVEST OPHTH VIS SCI, V53, P1277, DOI 10.1167/iovs.11-8742; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; IOZZO RV, 1987, J BIOL CHEM, V262, P1888; IOZZO RV, 1993, EXPERIENTIA, V49, P447, DOI 10.1007/BF01923588; Iozzo RV, 1999, P NATL ACAD SCI USA, V96, P3092, DOI 10.1073/pnas.96.6.3092; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; IOZZO RV, 1988, CANCER METAST REV, V7, P39, DOI 10.1007/BF00048277; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; IOZZO RV, 1984, J CELL BIOL, V99, P403, DOI 10.1083/jcb.99.2.403; Ishijima M, 2012, MATRIX BIOL, V31, P234, DOI 10.1016/j.matbio.2012.02.006; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Jung M, 2013, J BIOL CHEM, V288, P3289, DOI 10.1074/jbc.M112.387811; Kaneko H, 2013, MATRIX BIOL, V32, P178, DOI 10.1016/j.matbio.2013.01.004; Komatsu M, 2010, FEBS LETT, V584, P1374, DOI 10.1016/j.febslet.2010.02.017; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Mathiak M, 1997, CANCER RES, V57, P2130; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molinaro P, 2011, J NEUROSCI, V31, P7312, DOI 10.1523/JNEUROSCI.6296-10.2011; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Mongiat M, 2003, J BIOL CHEM, V278, P4238, DOI 10.1074/jbc.M210445200; Mongiat M, 2001, J BIOL CHEM, V276, P10263, DOI 10.1074/jbc.M011493200; Mongiat M, 2000, J BIOL CHEM, V275, P7095, DOI 10.1074/jbc.275.10.7095; MURDOCH AD, 1994, J HISTOCHEM CYTOCHEM, V42, P239, DOI 10.1177/42.2.7507142; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Murphy-Ullrich JE, 2012, MATRIX BIOL, V31, P152, DOI 10.1016/j.matbio.2012.01.002; Nguyen TMB, 2007, BLOOD, V109, P4793, DOI 10.1182/blood-2006-11-059352; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; NOONAN DM, 1991, J BIOL CHEM, V266, P22939; Nugent MA, 2000, P NATL ACAD SCI USA, V97, P6722, DOI 10.1073/pnas.97.12.6722; Nystrom A, 2009, BLOOD, V114, P4897, DOI 10.1182/blood-2009-02-207134; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ramakrishnan S, 2007, AUTOPHAGY, V3, P512; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Roberts DD, 2012, MATRIX BIOL, V31, P162, DOI 10.1016/j.matbio.2012.01.005; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; RUDNICKA L, 1994, J CLIN INVEST, V93, P1709, DOI 10.1172/JCI117154; RYYNANEN M, 1992, J CLIN INVEST, V89, P974, DOI 10.1172/JCI115680; Sai JQ, 2008, J BIOL CHEM, V283, P26538, DOI 10.1074/jbc.M805611200; San Antonio JD, 2009, AM J PATHOL, V175, P1338, DOI 10.2353/ajpath.2009.090234; Sanderson RD, 2012, MATRIX BIOL, V31, P283, DOI 10.1016/j.matbio.2012.05.001; Sanderson RD, 2004, MATRIX BIOL, V23, P341, DOI 10.1016/j.matbio.2004.08.004; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Seppinen L, 2011, MATRIX BIOL, V30, P83, DOI 10.1016/j.matbio.2010.11.001; Sharma B, 1998, J BIOL CHEM, V273, P4642, DOI 10.1074/jbc.273.8.4642; Sharma B, 1998, J CLIN INVEST, V102, P1599, DOI 10.1172/JCI3793; Sher I, 2006, J BIOL CHEM, V281, P5178, DOI 10.1074/jbc.M509500200; Soto-Pantoja DR, 2012, AUTOPHAGY, V8, P1628, DOI 10.4161/auto.21562; Sweeney SM, 2003, J BIOL CHEM, V278, P30516, DOI 10.1074/jbc.M304237200; Thadikkaran L, 2005, CLIN CHIM ACTA, V360, P27, DOI 10.1016/j.cccn.2005.04.018; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Whitelock JM, 1999, MATRIX BIOL, V18, P163, DOI 10.1016/S0945-053X(99)00014-1; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938; Willis CD, 2012, EXTRACELLULAR MATRIX: PATHOBIOLOGY AND SIGNALING, P171; Willis CD, 2013, FEBS J, V280, P2271, DOI 10.1111/febs.12164; Wilusz RE, 2012, MATRIX BIOL, V31, P320, DOI 10.1016/j.matbio.2012.05.002; Woodall BP, 2008, J BIOL CHEM, V283, P2335, DOI 10.1074/jbc.M708364200; Zoeller JJ, 2008, J CELL BIOL, V181, P381, DOI 10.1083/jcb.200708022; Zoeller JJ, 2009, MATRIX BIOL, V28, P284, DOI 10.1016/j.matbio.2009.04.010	101	65	66	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16114	16128		10.1074/jbc.M114.556530	http://dx.doi.org/10.1074/jbc.M114.556530			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24737315	Green Published, hybrid			2022-12-25	WOS:000337965700019
J	Barrios-Garcia, T; Tecalco-Cruz, A; Gomez-Romero, V; Reyes-Carmona, S; Meneses-Morales, I; Leon-Del-Rio, A				Barrios-Garcia, Tonatiuh; Tecalco-Cruz, Angeles; Gomez-Romero, Vania; Reyes-Carmona, Sandra; Meneses-Morales, Ivan; Leon-Del-Rio, Alfonso			Tristetraprolin Represses Estrogen Receptor alpha Transactivation in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Corepressor Transcription; Estrogen Receptor; Gene Regulation; Hormone Receptors; Nuclear Receptors; Tristetraprolin	LIGAND-INDEPENDENT ACTIVATION; HISTONE DEACETYLASES; PROTEIN TRISTETRAPROLIN; MOLECULAR DETERMINANTS; COREPRESSOR COMPLEX; STEROID-HORMONE; N-COR; NUCLEAR; BINDING; RECRUITMENT	Estrogen receptor (ER) mediates the effects of 17-estradiol (E2) in normal mammary gland, and it is a key participant in breast cancer tumor development. ER transactivation activity is mediated by the synergistic interaction of two domains designated AF1 and AF2. The function of AF2 is to recruit coactivator and corepressor proteins that allow ER to oscillate between the roles of transcriptional activator and repressor. In contrast, the mechanism responsible for AF-1 transcriptional activity is not completely understood. In this study, we identified tristetraproline (TTP) as a novel ER-associated protein. TTP expression in MCF7 cells repressed ER transactivation and reduced MCF7 cell proliferation and the ability of the cells to form tumors in a mouse model. We show that TTP transcriptional activity is mediated through its recruitment to the promoter region of ER target genes and its interaction with histone deacetylases, in particular with HDAC1. TTP expression attenuates the coactivating activity of SRC-1, suggesting that exchange between TTP and other coactivators may play an important role in fine-tuning ER transactivation. These results indicate that TTP acts as a bona fide ER corepressor and suggest that this protein may be a contributing factor in the development of E2-dependent tumors in breast cancer.	[Leon-Del-Rio, Alfonso] Univ Nacl Autonoma Mexico, Programa Invest Canc Mama, Inst Invest Biomed, Mexico City 04510, DF, Mexico; Univ Nacl Autonoma Mexico, Programa Invest Canc Mama, Dept Biol Mol & Biotecnol, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Leon-Del-Rio, A (corresponding author), Univ Nacl Autonoma Mexico, Programa Invest Canc Mama, Inst Invest Biomed, Mexico City 04510, DF, Mexico.	leon@biomedicas.unam.mx	Tecalco-Cruz, Angeles C./ABA-7761-2020; Meneses-Morales, Ivan/F-6765-2018; TECALCO-CRUZ, ANGELES C./K-1983-2019; Leon-Del-Rio, Alfonso/L-5932-2019	Meneses-Morales, Ivan/0000-0002-3146-1374; TECALCO-CRUZ, ANGELES C./0000-0001-9199-3834; Reyes, Sandra/0000-0002-1015-5079; Leon-Del-Rio, Alfonso/0000-0001-7683-5109	Programa de Investigacion de Cancer de Mama; Instituto de Investigaciones Biomedicas; Universidad Nacional Autonoma de Mexico (UNAM); Consejo Nacional de Ciencia y Tecnologia [SALUD-CONACYT 14467, 183069]; Fundacion Miguel Aleman (Estimulo a la Investigacion Medica) [2013-1]; Consejo Nacional de Ciencia y Tecnologia; DGAPA, Universidad Nacional Autonoma de Mexico	Programa de Investigacion de Cancer de Mama; Instituto de Investigaciones Biomedicas; Universidad Nacional Autonoma de Mexico (UNAM)(Universidad Nacional Autonoma de Mexico); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Fundacion Miguel Aleman (Estimulo a la Investigacion Medica); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This work was supported by Programa de Investigacion de Cancer de Mama, Instituto de Investigaciones Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and Consejo Nacional de Ciencia y Tecnologia (Grants SALUD-CONACYT 14467 and 183069), and Fundacion Miguel Aleman (Estimulo a la Investigacion Medica 2013-1).; Students of Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico and are recipients of a scholarship from Consejo Nacional de Ciencia y Tecnologia.; Recipient of a Posdoctoral Scholarship from DGAPA, Universidad Nacional Autonoma de Mexico.	Ahn BY, 2010, CANCER RES, V70, P3013, DOI 10.1158/0008-5472.CAN-09-3108; Al-Ahmadi W, 2013, J PATHOL, V230, P28, DOI 10.1002/path.4178; Al-Souhibani N, 2010, ONCOGENE, V29, P4205, DOI 10.1038/onc.2010.168; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Brennan SE, 2009, CANCER RES, V69, P5168, DOI 10.1158/0008-5472.CAN-08-4238; Cenni B, 1999, TRENDS ENDOCRIN MET, V10, P41, DOI 10.1016/S1043-2760(98)00121-0; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Deblois G, 2003, J STEROID BIOCHEM, V85, P123, DOI 10.1016/S0960-0760(03)00225-5; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; DUBOIS RN, 1990, J BIOL CHEM, V265, P19185; Fisher B, 2005, JNCI-J NATL CANCER I, V97, P1652, DOI 10.1093/jnci/dji372; Gburcik V, 2005, MOL CELL BIOL, V25, P3421, DOI 10.1128/MCB.25.9.3421-3430.2005; Gburcik Valentina, 2006, Nucl Recept Signal, V4, pe005; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Glass CK, 2000, GENE DEV, V14, P121; Green CD, 2007, MOL CANCER RES, V5, P1191, DOI 10.1158/1541-7786.MCR-07-0123; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; GRONEMEYER H, 1991, ANNU REV GENET, V25, P89, DOI 10.1146/annurev.ge.25.120191.000513; Guenther MG, 2000, GENE DEV, V14, P1048; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Johnson CA, 1999, SEMIN CELL DEV BIOL, V10, P179, DOI 10.1006/scdb.1999.0299; JORDAN VC, 1995, BREAST CANCER RES TR, V36, P267, DOI 10.1007/BF00713399; Katzenellenbogen BS, 2000, RECENT PROG HORM RES, V55, P163; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Liang J, 2009, J BIOL CHEM, V284, P29383, DOI 10.1074/jbc.M109.024745; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; MA QF, 1991, ONCOGENE, V6, P1277; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Milke L, 2013, CARCINOGENESIS, V34, P850, DOI 10.1093/carcin/bgs387; Nagy L, 1999, GENE DEV, V13, P3209, DOI 10.1101/gad.13.24.3209; Nicholson RI, 1999, ENDOCR-RELAT CANCER, V6, P373, DOI 10.1677/erc.0.0060373; Osborne CK, 2000, J CLIN ONCOL, V18, P3172, DOI 10.1200/JCO.2000.18.17.3172; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Phillips RS, 2002, J BIOL CHEM, V277, P11606, DOI 10.1074/jbc.M111457200; Sandler H, 2011, NUCLEIC ACIDS RES, V39, P4373, DOI 10.1093/nar/gkr011; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Taylor GA, 1996, MOL ENDOCRINOL, V10, P140, DOI 10.1210/me.10.2.140; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Upadhyay R, 2013, INT J CANCER, V132, pE128, DOI 10.1002/ijc.27789; Valadez-Graham V, 2004, NUCLEIC ACIDS RES, V32, P1354, DOI 10.1093/nar/gkh301; VARNUM BC, 1991, MOL CELL BIOL, V11, P1754, DOI 10.1128/MCB.11.3.1754; VARNUM BC, 1989, ONCOGENE, V4, P119; Vermeulen M, 2004, MOL CELL BIOL, V24, P2364, DOI 10.1128/MCB.24.6.2364-2372.2004; Goddio MV, 2012, BREAST CANCER RES TR, V135, P749, DOI 10.1007/s10549-012-2216-0; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; Weigel NL, 1998, J MOL MED, V76, P469, DOI 10.1007/s001090050241; Wu LY, 2003, J BIOL CHEM, V278, P15192, DOI 10.1074/jbc.M212332200; Wu XY, 2001, J BIOL CHEM, V276, P23962, DOI 10.1074/jbc.M101041200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	58	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15554	15565		10.1074/jbc.M114.548552	http://dx.doi.org/10.1074/jbc.M114.548552			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737323	hybrid, Green Published			2022-12-25	WOS:000337465400038
J	Mu, YH; Zhao, WC; Duan, P; Chen, Y; Zhao, WD; Wang, Q; Tu, HY; Zhang, Q				Mu, Yong-hui; Zhao, Wen-chao; Duan, Ping; Chen, Yun; Zhao, Wei-da; Wang, Qian; Tu, Hui-yin; Zhang, Qian			RyR2 Modulates a Ca2+-Activated K+ Current in Mouse Cardiac Myocytes	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; SMALL-CONDUCTANCE; SARCOPLASMIC-RETICULUM; HIPPOCAMPAL-NEURONS; FUNCTIONAL ROLES; CALCIUM-RELEASE; CA2+ CHANNELS; SK2; EXPRESSION; ATRIAL	In cardiomyocytes, Ca2+ entry through voltage-dependent Ca2+ channels (VDCCs) binds to and activates RyR2 channels, resulting in subsequent Ca2+ release from the sarcoplasmic reticulum (SR) and cardiac contraction. Previous research has documented the molecular coupling of small-conductance Ca2+-activated K+ channels (SK channels) to VDCCs in mouse cardiac muscle. Little is known regarding the role of RyRs-sensitive Ca2+ release in the SK channels in cardiac muscle. In this study, using whole-cell patch clamp techniques, we observed that a Ca2+-activated K+ current (I-K,I-Ca) recorded from isolated adult C57B/L mouse atrial myocytes was significantly decreased by ryanodine, an inhibitor of ryanodine receptor type 2 (RyR2), or by the co-application of ryanodine and thapsigargin, an inhibitor of the sarcoplasmic reticulum calcium ATPase (SERCA) (p<0.05, p<0.01, respectively). The activation of RyR2 by caffeine increased the I-K,I-Ca in the cardiac cells (p<0.05, p<0.01, respectively). We further analyzed the effect of RyR2 knockdown on I-K,I-Ca and Ca2+ in isolated adult mouse cardiomyocytes using a whole-cell patch clamp technique and confocal imaging. RyR2 knockdown in mouse atrial cells transduced with lentivirus-mediated small hairpin interference RNA (shRNA) exhibited a significant decrease in I-K,I-Ca (p<0.05) and [Ca2+](i) fluorescence intensity (p<0.01). An immunoprecipitated complex of SK2 and RyR2 was identified in native cardiac tissue by co-immunoprecipitation assays. Our findings indicate that RyR2-mediated Ca2+ release is responsible for the activation and modulation of SK channels in cardiac myocytes.	[Mu, Yong-hui; Zhao, Wen-chao; Duan, Ping; Chen, Yun; Wang, Qian; Zhang, Qian] Zhengzhou Univ, Dept Physiol, Sch Med, Zhengzhou 450052, Henan, Peoples R China; [Mu, Yong-hui] Xinxiang Med Coll, Sch Basic Med Sci, Dept Pathophysiol, Xinxiang, Henan, Peoples R China; [Zhao, Wei-da] Univ Henan, Dept Biol Engn, Kaifeng, Henan, Peoples R China; [Tu, Hui-yin] Univ Nebraska Med Ctr, Dept Emergency Med, Omaha, NE USA	Zhengzhou University; Xinxiang Medical University; Henan University; University of Nebraska System; University of Nebraska Medical Center	Zhang, Q (corresponding author), Zhengzhou Univ, Dept Physiol, Sch Med, Zhengzhou 450052, Henan, Peoples R China.	qianzhang@zzu.edu.cn		, HUIYIN/0000-0002-1662-2088	National Natural Science Foundation of China [30870909, 81270248]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (grant No. 30870909 and 81270248, URL. http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Chen-Izu Y, 2006, BIOPHYS J, V91, P1, DOI 10.1529/biophysj.105.077180; Coulon P, 2009, CELL CALCIUM, V46, P333, DOI 10.1016/j.ceca.2009.09.005; ENDO M, 1985, CURR TOP MEMBR TRANS, V25, P181; Essin K, 2009, J BIOMED BIOTECHNOL, V2009, P1155; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; Hammond RS, 2006, J NEUROSCI, V26, P1844, DOI 10.1523/JNEUROSCI.4106-05.2006; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Lader AS, 2000, AM J PHYSIOL-CELL PH, V278, pC436, DOI 10.1152/ajpcell.2000.278.2.C436; Li N, 2009, J PHYSIOL-LONDON, V587, P1087, DOI 10.1113/jphysiol.2008.167718; Lu L, 2007, CIRC RES, V100, P112, DOI 10.1161/01.RES.0000253095.44186.72; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Moriguchi S, PNAS, V103, P10811; Moriguchi S, 2006, P NATL ACAD SCI USA, V103, P10811, DOI 10.1073/pnas.0509863103; Ozgen N, 2007, CARDIOVASC RES, V75, P758, DOI 10.1016/j.cardiores.2007.05.008; Pedarzani P, 2005, J BIOL CHEM, V280, P41404, DOI 10.1074/jbc.M509610200; Pereira L, 2007, J PHYSIOL-LONDON, V583, P685, DOI 10.1113/jphysiol.2007.133066; Ren YJ, 2006, J BIOL CHEM, V281, P11769, DOI 10.1074/jbc.M513125200; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Takita T, 2000, J GEN PHYSIOL, V116, P697; Tuteja D, 2005, AM J PHYSIOL-HEART C, V289, pH2714, DOI 10.1152/ajpheart.00534.2005; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Vinod SV, 2002, AM J PHYSIOL-HEART C, V282, pH72; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu YF, 2003, J BIOL CHEM, V278, P49085, DOI 10.1074/jbc.M307508200; Zhang Q, 2008, CIRC RES, V102, P465, DOI 10.1161/CIRCRESAHA.107.161778	28	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94905	10.1371/journal.pone.0094905	http://dx.doi.org/10.1371/journal.pone.0094905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747296	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500041
J	Yang, JH; Li, Z; Fan, XH; Cheng, YY				Yang, Jihong; Li, Zheng; Fan, Xiaohui; Cheng, Yiyu			A Three Step Network Based Approach (TSNBA) to Finding Disease Molecular Signature and Key Regulators: A Case Study of IL-1 and TNF-Alpha Stimulated Inflammation	PLOS ONE			English	Article							COEXPRESSED GENE NETWORKS; EXPRESSION DATA; ATTED-II; IDENTIFICATION; PREDICTION; TRANSCRIPTION; INFORMATION; DISCOVERY; WEBGESTALT; COMPENDIUM	A disease molecular signature is a set of biomolecular features that are prognostic of clinical phenotypes and indicative of underlying pathology. It is of great importance to develop computational approaches for finding more relevant molecular signatures. Based upon the hypothesis that various components in a molecular signature are more likely to share similar patterns, we introduced a novel three step network based approach (TSNBA) to identify the molecular signature and key pathological regulators. Protein-protein interaction (PPI) network and ranking algorithm were integrated in the first step to find pathology related proteins with high accuracy. It was followed by the second step to further screen with co-expression patterns for better pathology enrichment. Context likelihood of relatedness (CLR) algorithm was used in the third step to infer gene regulatory networks and identify key transcription regulators. We applied this approach to study IL-1 (interleukin-1) and TNF-alpha (tumor necrosis factor-alpha) stimulated inflammation. TSNBA identified inflammatory signature with high accuracy and outperformed 5 competing methods namely fold change, degree, interconnectivity, neighborhood score and network propagation based approaches. The best molecular signature, with 80% (40/50) confirmed inflammatory genes, was used to predict inflammation related genes. As a result, 8 out of 10 predicted inflammation genes that were not included in the benchmark Entrez Gene database were validated by literature evidence. Furthermore, 23 of the 32 predicted inflammation regulators were validated by literature evidence. The rest 9 were also validated with TF (transcription factor) binding site analysis. In conclusion, we developed an efficient strategy for disease molecular signature finding and key pathological regulator identification.	[Yang, Jihong; Fan, Xiaohui; Cheng, Yiyu] Zhejiang Univ, Pharmaceut Informat Inst, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zheng] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China	Zhejiang University; Tianjin University of Traditional Chinese Medicine	Li, Z (corresponding author), Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China.	lizheng1@gmail.com; fanxh@zju.edu.cn	FAN, Xiaohui/F-6458-2010	FAN, Xiaohui/0000-0002-6336-3007; Yang, Jihong/0000-0002-2753-0939	National ST Major Project [2012ZX09503001]; Natural Science Foundation of China [81373893]	National ST Major Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National S&T Major Project (No. 2012ZX09503001) and the Natural Science Foundation of China (No. 81373893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bovelstad HM, 2007, BIOINFORMATICS, V23, P2080, DOI 10.1093/bioinformatics/btm305; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Bulow L, 2007, NUCLEIC ACIDS RES, V35, pD841, DOI 10.1093/nar/gkl835; Butte A J, 2000, Pac Symp Biocomput, P418; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Cohen AL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.47; Dudley JT, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P27; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emig D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060618; Essaghir A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq149; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Friedman DR, 2009, CLIN CANCER RES, V15, P6947, DOI 10.1158/1078-0432.CCR-09-1132; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gabay C, 2010, NAT REV RHEUMATOL, V6, P232, DOI 10.1038/nrrheum.2010.4; Guo Z, 2007, BIOINFORMATICS, V23, P2121, DOI 10.1093/bioinformatics/btm294; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Henrick J.M., 1973, ANN STAT, V1, P588; Hines A, 2010, TOXICOL SCI, V115, P369, DOI 10.1093/toxsci/kfq004; Hsu CL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S25; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hur J, 2011, BRAIN, V134, P3222, DOI 10.1093/brain/awr228; Jayasuriya CT, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4033; Jung KH, 2012, ENVIRON SCI TECHNOL, V46, P12882, DOI 10.1021/es302480v; Kim WJ, 2011, MOL MED, V17, P478, DOI 10.2119/molmed.2010.00274; Kim Y, 2011, BIOINFORMATICS, V27, P391, DOI 10.1093/bioinformatics/btq670; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Man K, 2010, ANN SURG, V251, P1154, DOI 10.1097/SLA.0b013e3181d96e3d; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mayer H, 2004, ARTERIOSCL THROM VAS, V24, P1192, DOI 10.1161/01.ATV.0000131263.06296.77; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Newaz Mohammad, 2013, Journal of Basic and Clinical Physiology and Pharmacology, V24, P287, DOI 10.1515/jbcpp-2013-0017; Nilsson R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-38; Nitsch D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-460; Nunez V, 2010, P NATL ACAD SCI USA, V107, P10626, DOI 10.1073/pnas.0913545107; Obayashi T, 2008, NUCLEIC ACIDS RES, V36, pD77, DOI 10.1093/nar/gkm840; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; Pittman J, 2004, P NATL ACAD SCI USA, V101, P8431, DOI 10.1073/pnas.0401736101; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Arias CR, 2012, SCI WORLD J, DOI 10.1100/2012/842727; Schwarz E, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.3; Shapira M, 2004, MOL BIOL CELL, V15, P5659, DOI 10.1091/mbc.E04-04-0340; Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P337, DOI 10.1371/journal.pcbi.0030042; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sung JY, 2012, BIOTECHNOL J, V7, P946, DOI 10.1002/biot.201100305; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Xie L, 2013, J INTERF CYTOK RES, V33, P588, DOI 10.1089/jir.2012.0065; Xu YC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-567; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zajac M, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-44; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965	64	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94360	10.1371/journal.pone.0094360	http://dx.doi.org/10.1371/journal.pone.0094360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747419	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500026
J	Chen, ZL; Chen, XY; Zhou, EX; Chen, GL; Qian, K; Wu, X; Miao, XY; Tang, ZH				Chen, Zonglin; Chen, Xianyu; Zhou, Enxiang; Chen, Ganlong; Qian, Ke; Wu, Xia; Miao, Xiongying; Tang, Zhonghua			Intratumoral CD8(+) Cytotoxic Lymphocyte Is a Favorable Prognostic Marker in Node-Negative Breast Cancer	PLOS ONE			English	Article							T-CELLS; IMMUNE CELLS; INFILTRATION; EXPRESSION; CARCINOMA; CD4(+); IMMUNOSURVEILLANCE; INFLAMMATION; RECURRENCE; SURVIVAL	Background: The prognostic effect of tumor infiltrating CD8(+) cytotoxic lymphocytes (CTLs) in breast cancer is controversial. We analyzed the association between CD8(+) CTLs and survival of untreated node-negative breast cancer patients. Material and Methods: CD8(+) CTLs infiltrate was evaluated by immunostaining in a cohort of 332 node-negative breast cancer patients with a median follow-up of 152 months. The prognostic significance of CD8(+) CTLs for disease-free survival (DFS) and breast cancer-specific overall survival (OS) was evaluated with Kaplan-Meier survival analysis as well as univariate analysis and multivariate Cox analysis adjusted for age at diagnosis, pT stage, histological grade, estrogen receptor (ER) status, progesterone receptor (PR) status, Ki-67 expression and human epidermal growth factor receptor 2 (HER-2) status. Results: 285 (85.8%) patients showed strong CD8(+) CTLs infiltrate positive status. Univariate analysis showed that CD8(+) CTLs had statistically significant association with DFS (P = 0.004, hazard ratio [HR] = 0.454, 95% confidence interval [CI] = 0.265-0.777) and OS (P = 0.014, HR = 0.430, 95% CI = 0.220-0.840) in the entire cohort. The significance of CD8(+) CTLs was especially strong in ER negative, HER-2 negative and ER, PR, HER-2 triple-negative breast cancers. In Kaplan-Meier analysis, CD8(+) CTLs had significant effect on prognosis of patients (Log-rank test: P = 0.003 for DFS and P = 0.011 for OS), independent of established clinical factors for DFS (P = 0.002, HR = 0.418, 95% CI = 0.242-0.724) as well as for OS (P = 0.009, HR = 0.401, 95% CI = 0.202-0.797).	[Chen, Zonglin; Chen, Xianyu; Zhou, Enxiang; Chen, Ganlong; Qian, Ke; Miao, Xiongying; Tang, Zhonghua] Cent S Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha, Hunan, Peoples R China; [Wu, Xia] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Chen, ZL (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha, Hunan, Peoples R China.	TZH18773150286@163.com			department of general surgery of the Second Xiangya Hospital of Central South University	department of general surgery of the Second Xiangya Hospital of Central South University	The work was funded by the department of general surgery of the Second Xiangya Hospital of Central South University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexe G, 2007, CANCER RES, V67, P10669, DOI 10.1158/0008-5472.CAN-07-0539; Anz D, 2011, HISTOPATHOLOGY, V59, P965, DOI 10.1111/j.1365-2559.2011.04040.x; Ashida A, 2006, INT J ONCOL, V28, P1345; Baker K, 2011, HISTOPATHOLOGY, V58, P1107, DOI 10.1111/j.1365-2559.2011.03846.x; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Calabro A, 2009, BREAST CANCER RES TR, V116, P69, DOI 10.1007/s10549-008-0105-3; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Chen ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044741; Cho Y, 2003, CANCER RES, V63, P1555; DeNardo DG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1746; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Fukunaga A, 2004, PANCREAS, V28, pE26, DOI 10.1097/00006676-200401000-00023; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Hamanishi J, 2011, CLIN IMMUNOL, V141, P338, DOI 10.1016/j.clim.2011.08.013; Hiraoka K, 2006, BRIT J CANCER, V94, P275, DOI 10.1038/sj.bjc.6602934; Kawai O, 2008, CANCER-AM CANCER SOC, V113, P1387, DOI 10.1002/cncr.23712; Lee AHS, 2006, HISTOPATHOLOGY, V48, P692, DOI 10.1111/j.1365-2559.2006.02410.x; Lee SC, 2011, IMMUNOL RES, V50, P248, DOI 10.1007/s12026-011-8231-0; Liu FF, 2011, BREAST CANCER RES TR, V130, P645, DOI 10.1007/s10549-011-1647-3; Liu SZ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3148; Mahmoud SMA, 2012, BREAST CANCER RES TR, V132, P545, DOI 10.1007/s10549-011-1620-1; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mahmoud SMA, 2011, BREAST CANCER RES TR, V127, P99, DOI 10.1007/s10549-010-0987-8; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Menetrier-Caux C, 2009, CANCER RES, V69, P7895, DOI 10.1158/0008-5472.CAN-09-1642; Nakano O, 2001, CANCER RES, V61, P5132; Oh E, 2012, BREAST CANCER RES TR, V132, P499, DOI 10.1007/s10549-011-1626-8; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Perez SA, 2007, CLIN CANCER RES, V13, P2714, DOI 10.1158/1078-0432.CCR-06-2347; Rody A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2234; Schmidt M, 2012, CLIN CANCER RES, V18, P2695, DOI 10.1158/1078-0432.CCR-11-2210; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Tadmor T, 2011, CANCER IMMUNOL IMMUN, V60, P609, DOI 10.1007/s00262-011-0972-z; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	38	44	47	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95475	10.1371/journal.pone.0095475	http://dx.doi.org/10.1371/journal.pone.0095475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743335	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100122
J	Gautam, US; Mehra, S; Ahsan, MH; Alvarez, X; Niu, T; Kaushal, D				Gautam, Uma S.; Mehra, Smriti; Ahsan, Muhammad H.; Alvarez, Xavier; Niu, Tianhua; Kaushal, Deepak			Role of TNF in the Altered Interaction of Dormant Mycobacterium tuberculosis with Host Macrophages	PLOS ONE			English	Article							NONREPLICATING PERSISTENCE; RESPONSE REGULATOR; HYPOXIC RESPONSE; KAPPA-B; APOPTOSIS; MECHANISMS; EXPRESSION; COMPONENTS; GRANULOMA; INFECTION	Mycobacterium tuberculosis (Mtb) persists within lung granulomas, despite being subjected to diverse stress conditions, including hypoxia. We hypothesized that the response of host phagocytes to Mtb experiencing hypoxia is radically altered and designed in vitro experiment to study this phenomenon. Hypoxia-stressed (Mtb-H) and aerobically grown Mtb (Mtb-A) were used to infect Rhesus Macaque Bone Marrow Derived Macrophages (Rh-BMDMs) and the comparative host response to Mtb infection studied. Mechanistic insights were gained by employing RNAi. Mtb-H accumulated significantly lower bacterial burden during growth in Rh-BMDMs, concomitantly generating a drastically different host transcriptional profile (with only <2% of all genes perturbed by either infection being shared between the two groups). A key component of this signature was significantly higher TNF and apopotosis in Mtb-H-compared to Mtb-A-infected Rh-BMDMs. Silencing of TNF by RNAi reversed the significant control of Mtb replication. These results indicate a potential mechanism for the rapid clearance of hypoxia-conditioned bacilli by phagocytes. In conclusion, hypoxia-conditioned Mtb undergo significantly different interactions with host macrophages compared to Mtb grown in normoxia. These interactions result in the induction of the TNF signaling pathway, activation of apoptosis, and DNA-damage stress response. Our results show that Mtb-H bacilli are particularly susceptible to killing governed by TNF.	[Gautam, Uma S.; Ahsan, Muhammad H.; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA 70433 USA; [Mehra, Smriti] Tulane Natl Primate Res Ctr, Dept Microbiol, Covington, LA USA; [Alvarez, Xavier] Tulane Natl Primate Res Ctr, Dept Comparat Pathol, Covington, LA USA; [Niu, Tianhua] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Biostat & Bioinformat, New Orleans, LA USA; [Kaushal, Deepak] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA	Tulane University; Tulane University; Tulane University; Tulane University; Tulane University	Kaushal, D (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol & Parasitol, Covington, LA 70433 USA.	dkaushal@tulane.edu	Uma S Gautam, MSc/H-3474-2019; GAUTAM, UMA/AAI-1531-2021	Uma S Gautam, MSc/0000-0003-0326-6325; 	NIH [AI089323, HL106790, RR020159, RR000164/OD011104, C06AI058609]; Office of the Director, Tulane National Primate Research Center; Louisiana Vaccine Center, Tulane Center for Infectious Diseases; Tulane Office of Vice-President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164, P20RR020159, T32RR021309] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089323] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011124, P51OD011104, T32OD011064] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director, Tulane National Primate Research Center; Louisiana Vaccine Center, Tulane Center for Infectious Diseases; Tulane Office of Vice-President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants: AI089323 and HL106790 with additional support from NIH grants RR020159, RR000164/OD011104 and C06AI058609, as well as awards from the Office of the Director, Tulane National Primate Research Center, the Louisiana Vaccine Center, Tulane Center for Infectious Diseases and a Bridge Fund from the Tulane Office of Vice-President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2007, J INVEST DERMATOL, V127, P538, DOI 10.1038/sj.jid.5700588; Aggarwal BB, 2000, BIOCHEM PHARMACOL, V60, P1033, DOI 10.1016/S0006-2952(00)00393-2; Basler T, 2010, J LEUKOCYTE BIOL, V87, P173, DOI 10.1189/jlb.0309207; Behar SM, 2011, MUCOSAL IMMUNOL, V4, P279, DOI 10.1038/mi.2011.3; Chauhan S, 2011, NUCLEIC ACIDS RES, V39, P7400, DOI 10.1093/nar/gkr375; Chen MJ, 2006, J IMMUNOL, V176, P3707, DOI 10.4049/jimmunol.176.6.3707; Cho HJ, 2010, J BIOL CHEM, V285, P25500, DOI 10.1074/jbc.M109.091413; Dutta NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028958; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Gautam US, 2014, J BACTERIOL, V196, P790, DOI 10.1128/JB.01270-13; Iona E, 2012, MICROBES INFECT, V14, P959, DOI 10.1016/j.micinf.2012.04.003; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Kaushal Deepak, 2004, Curr Protoc Bioinformatics, VChapter 7, DOI 10.1002/0471250953.bi0709s7; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; Kim JS, 2011, MICROBES INFECT, V13, P1242, DOI 10.1016/j.micinf.2011.07.002; Majumdar SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035847; Mariotti S, 2013, J IMMUNOL, V191, P274, DOI 10.4049/jimmunol.1202900; Martinez AN, 2013, J INFECT DIS, V207, P1253, DOI 10.1093/infdis/jit037; Mehra S, 2013, J INFECT DIS, V207, P1115, DOI 10.1093/infdis/jis778; Mehra S, 2012, J INFECT DIS, V205, P1203, DOI 10.1093/infdis/jis102; Mehra S, 2011, J MED PRIMATOL, V40, P233, DOI 10.1111/j.1600-0684.2011.00485.x; Mehra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012266; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Myers TA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000659; Nickel D, 2012, J IMMUNOL, V188, P4001, DOI 10.4049/jimmunol.1100976; Paige C, 2010, CELL MICROBIOL, V12, P301, DOI 10.1111/j.1462-5822.2009.01424.x; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Saini DK, 2004, FEBS LETT, V565, P75, DOI 10.1016/j.febslet.2004.02.092; Salerno DM, 2012, J CELL PHYSIOL, V227, P3613, DOI 10.1002/jcp.24067; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sestak K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018648; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1967, J BACTERIOL, V93, P1374, DOI 10.1128/JB.93.4.1374-1381.1967; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; ZHANG YH, 1995, J CLIN INVEST, V95, P586, DOI 10.1172/JCI117702; ZHANG YH, 1993, J CLIN INVEST, V91, P2076, DOI 10.1172/JCI116430	43	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95220	10.1371/journal.pone.0095220	http://dx.doi.org/10.1371/journal.pone.0095220			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743303	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100089
J	Riess, K; Oberwinkler, F; Bauer, R; Garnica, S				Riess, Kai; Oberwinkler, Franz; Bauer, Robert; Garnica, Sigisfredo			Communities of Endophytic Sebacinales Associated with Roots of Herbaceous Plants in Agricultural and Grassland Ecosystems Are Dominated by Serendipita herbamans sp nov.	PLOS ONE			English	Article							FUNGUS PIRIFORMOSPORA-INDICA; HAPLOTYPE RECONSTRUCTION; RECOMBINATION EVENTS; DIVERSITY; SOFTWARE; NUMBER; GROWTH; SAMPLE; SNAP; TOOL	Endophytic fungi are known to be commonly associated with herbaceous plants, however, there are few studies focusing on their occurrence and distribution in plant roots from ecosystems with different land uses. To explore the phylogenetic diversity and community structure of Sebacinales endophytes from agricultural and grassland habitats under different land uses, we analysed the roots of herbaceous plants using strain isolation, polymerase chain reaction (PCR), transmission electron microscopy (TEM) and co-cultivation experiments. A new sebacinoid strain named Serendipita herbamans belonging to Sebacinales group B was isolated from the roots of Bistorta vivipara, which is characterized by colourless monilioid cells (chlamydospores) that become yellow with age. This species was very common and widely distributed in association with a broad spectrum of herbaceous plant families in diverse habitats, independent of land use type. Ultrastructurally, the presence of S. herbamans was detected in the cortical cells of Plantago media, Potentilla anserina and Triticum aestivum. In addition, 13 few frequent molecular operational taxonomic units (MOTUs) or species were found across agricultural and grassland habitats, which did not exhibit a distinctive phylogenetic structure. Laboratory-based assays indicate that S. herbamans has the ability to colonize fine roots and stimulate plant growth. Although endophytic Sebacinales are widely distributed across agricultural and grassland habitats, TEM and nested PCR analyses reinforce the observation that these microorganisms are present in low quantity in plant roots, with no evidence of host specificity.	[Riess, Kai; Oberwinkler, Franz; Bauer, Robert; Garnica, Sigisfredo] Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany	Eberhard Karls University of Tubingen	Garnica, S (corresponding author), Univ Tubingen, Inst Evolut & Ecol, Tubingen, Germany.	sigisfredo.garnica@uni-tuebingen.de	Sigisfredo, Garnica/P-6506-2014; Riess, Kai/B-5491-2015	Riess, Kai/0000-0002-8804-0175	German Foundation Research [OB 24/30-1]; Tuebingen University; Doctoral Government Scholarship	German Foundation Research(German Research Foundation (DFG)); Tuebingen University; Doctoral Government Scholarship	This research was funded by the German Foundation Research (OB 24/30-1) and the Open Access Publishing Fund of Tuebingen University. Additional funding was received by a Doctoral Government Scholarship to KR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Achatz B, 2010, PLANT SOIL, V333, P59, DOI 10.1007/s11104-010-0319-0; Arnold AE, 2007, MYCOLOGIA, V99, P185, DOI 10.3852/mycologia.99.2.185; Aylor DL, 2006, BIOINFORMATICS, V22, P1399, DOI 10.1093/bioinformatics/btl136; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bauer R, 2006, MYCOL PROG, V5, P41, DOI 10.1007/s11557-006-0502-0; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Fakhro A, 2010, MYCORRHIZA, V20, P191, DOI 10.1007/s00572-009-0279-5; Garcia E, 2013, FUNGAL DIVERS, V60, P71, DOI 10.1007/s13225-012-0219-0; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Garnica S, 2013, FEMS MICROBIOL ECOL, V83, P265, DOI 10.1111/j.1574-6941.2012.01473.x; Ghimire SR, 2009, BIOENERG RES, V2, P51, DOI 10.1007/s12155-009-9033-2; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; Gotelli NJ, 2002, ECOL LETT, V5, P86, DOI 10.1046/j.1461-0248.2002.00288.x; HUDSON RR, 1985, GENETICS, V111, P147; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kharkwal A. C., 2007, V11, P247; Kottke I, 1987, TREES-STRUCT FUNCT, V1, P191, DOI 10.1007/BF00193562; Lee C, 2002, BIOINFORMATICS, V18, P452, DOI 10.1093/bioinformatics/18.3.452; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luz C, 2007, MYCOPATHOLOGIA, V164, P39, DOI 10.1007/s11046-007-9020-0; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Myers SR, 2003, GENETICS, V163, P375; Oberwinkler F, 2013, MYCOL PROG, V12, P1, DOI 10.1007/s11557-012-0880-4; Pancher M, 2012, APPL ENVIRON MICROB, V78, P4308, DOI 10.1128/AEM.07655-11; Peskan-Berghofer T, 2004, PHYSIOL PLANTARUM, V122, P1399; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; Rambaut A, 2009, FIGTREE DRAW TOOL VE; Redman RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014823; Riess K, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-102; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rodriguez RJ, 2008, ISME J, V2, P404, DOI 10.1038/ismej.2007.106; Saari S, 2012, NEW PHYTOL, V195, P231, DOI 10.1111/j.1469-8137.2012.04140.x; Saunders M, 2009, NEW PHYTOL, V182, P229, DOI 10.1111/j.1469-8137.2008.02746.x; Selosse MA, 2009, MYCOL RES, V113, P1062, DOI 10.1016/j.mycres.2009.07.004; Serfling A, 2007, PHYTOPATHOLOGY, V97, P523, DOI 10.1094/PHYTO-97-4-0523; Setaro Sabrina D, 2011, PLoS Curr, V3, pRRN1227, DOI 10.1371/currents.RRN1227; Setaro SD, 2012, BIODIVERS CONSERV, V21, P2269, DOI 10.1007/s10531-011-0205-y; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Varma A, 1999, APPL ENVIRON MICROB, V65, P2741; Verma S, 1998, MYCOLOGIA, V90, P896, DOI 10.2307/3761331; WARCUP JH, 1988, NEW PHYTOL, V110, P227, DOI 10.1111/j.1469-8137.1988.tb00256.x; Wearn JA, 2012, J ECOL, V100, P1085, DOI 10.1111/j.1365-2745.2012.01997.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Weiss M, 2004, MYCOL RES, V108, P1003, DOI 10.1017/S0953756204000772; Weiss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016793; White T., 1990, PCR PROTOCOLS GUIDE, P315; WORRALL JJ, 1991, MYCOLOGIA, V83, P296, DOI 10.2307/3759989; Yue Q, 2000, J AGR FOOD CHEM, V48, P4687, DOI 10.1021/jf990685q; [No title captured]	56	40	41	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94676	10.1371/journal.pone.0094676	http://dx.doi.org/10.1371/journal.pone.0094676			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743185	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100039
J	Calzolari, A; Saulle, E; De Angelis, ML; Pasquini, L; Boe, A; Pelacchi, F; Ricci-Vitiani, L; Baiocchi, M; Testa, U				Calzolari, Alessia; Saulle, Ernestina; De Angelis, Maria Laura; Pasquini, Luca; Boe, Alessandra; Pelacchi, Federica; Ricci-Vitiani, Lucia; Baiocchi, Marta; Testa, Ugo			Salinomycin Potentiates the Cytotoxic Effects of TRAIL on Glioblastoma Cell Lines	PLOS ONE			English	Article							APOPTOSIS-INDUCING LIGAND; CANCER STEM-CELL; MALIGNANT GLIOMA; UP-REGULATION; IN-VITRO; DEATH; EXPRESSION; MULTIFORME; DOXORUBICIN; RESISTANCE	Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been reported to exhibit therapeutic activity in cancer. However, many tumors remain resistant to treatment with TRAIL. Therefore, small molecules that potentiate the cytotoxic effects of TRAIL could be used for combinatorial therapy. Here we found that the ionophore antibiotic salinomycin acts in synergism with TRAIL, enhancing TRAIL-induced apoptosis in glioma cells. Treatment with low doses of salinomycin in combination with TRAIL augmented the activation of caspase-3 and increased TRAIL-R2 cell surface expression. TRAIL-R2 upmodulation was required for mediating the stimulatory effect of salinomycin on TRAIL-mediated apoptosis, since it was abrogated by siRNA-mediated TRAIL-R2 knockdown. Salinomycin in synergism with TRAIL exerts a marked anti-tumor effect in nude mice xenografted with human glioblastoma cells. Our results suggest that the combination of TRAIL and salinomycin may be a useful tool to overcome TRAIL resistance in glioma cells and may represent a potential drug for treatment of these tumors. Importantly, salinomycin+TRAIL were able to induce cell death of well-defined glioblastoma stem-like lines.	[Calzolari, Alessia; Saulle, Ernestina; De Angelis, Maria Laura; Pasquini, Luca; Boe, Alessandra; Pelacchi, Federica; Ricci-Vitiani, Lucia; Baiocchi, Marta; Testa, Ugo] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS)	Testa, U (corresponding author), Ist Super Sanita, Dept Hematol Oncol & Mol Med, Viale Regina Elena 299, I-00161 Rome, Italy.	ugo.testa@iss.it	Saulle, Ernestina/AAE-4654-2021; De Angelis, Maria Laura/Y-4004-2019; Boe, Alessandra/AAA-2653-2019; pasquini, luca/J-8319-2016; SAULLE, ERNESTINA/J-8834-2016; Testa, Ugo/J-6472-2016; Ricci Vitiani, Lucia/J-8320-2016	De Angelis, Maria Laura/0000-0003-4220-8822; Boe, Alessandra/0000-0002-8888-7501; pasquini, luca/0000-0002-3484-6288; Testa, Ugo/0000-0001-7900-8942; Ricci Vitiani, Lucia/0000-0001-7336-5615; saulle, ernestina/0000-0001-6681-6887; Baiocchi, Marta/0000-0003-0976-0690				Al Dhaheri Y, 2013, BIOCHIM BIOPHYS ACTA, V1830, P312; Ashley DM, 2008, BRIT J CANCER, V99, P294, DOI 10.1038/sj.bjc.6604459; Badr CE, 2011, NEURO-ONCOLOGY, V13, P1213, DOI 10.1093/neuonc/nor067; Bardsley MR, 2010, GASTROENTEROLOGY, V139, P942, DOI 10.1053/j.gastro.2010.05.083; Basu D, 2011, CELL CYCLE, V10, P2008, DOI 10.4161/cc.10.12.15883; Bellail AC, 2010, J CELL MOL MED, V14, P1303, DOI 10.1111/j.1582-4934.2009.00777.x; Boehmerle W, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.46; Booth L, 2014, CANC BIOL T IN PRESS; De Stasio C, 2001, CANCER RES, V61, P4272; Delwar Z. M., 2011, DRUG THERAPY STUDIES, V10, P40; Ding LJ, 2011, CANCER INVEST, V29, P511, DOI 10.3109/07357907.2011.605412; Fuchs D, 2010, BIOCHEM BIOPH RES CO, V394, P1098, DOI 10.1016/j.bbrc.2010.03.138; Fuchs D, 2009, BIOCHEM BIOPH RES CO, V390, P743, DOI 10.1016/j.bbrc.2009.10.042; Georgakis GV, 2005, BRIT J HAEMATOL, V130, P501, DOI 10.1111/j.1365-2141.2005.05656.x; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Huczynski A, 2012, CHEM BIOL D IN PRESS; Joon MJ, 2013, CARCINOGENE IN PRESS; Kim JH, 2011, BRIT J PHARMACOL, V162, P773, DOI 10.1111/j.1476-5381.2010.01089.x; Kim KY, 2011, BIOCHEM BIOPH RES CO, V413, P80, DOI 10.1016/j.bbrc.2011.08.054; Koo KH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.223; Kuijlen JMA, 2010, NEUROPATH APPL NEURO, V36, P168, DOI 10.1111/j.1365-2990.2010.01069.x; Kuijlen JMA, 2006, J NEURO-ONCOL, V78, P161, DOI 10.1007/s11060-005-9081-1; Lu DS, 2011, P NATL ACAD SCI USA, V108, P13253, DOI 10.1073/pnas.1110431108; MIYAZAKI Y, 1974, J ANTIBIOT, V27, P814, DOI 10.7164/antibiotics.27.814; Murphy AC, 2013, APOPTOSIS IN PRESS; Pallini R, 2008, CLIN CANCER RES, V14, P8205, DOI 10.1158/1078-0432.CCR-08-0644; Panner A, 2009, CANCER RES, V69, P7911, DOI 10.1158/0008-5472.CAN-09-1287; Parajuli B, 2013, ANTICANCER RES, V33, P1457; Pukac L, 2005, BRIT J CANCER, V92, P1430, DOI 10.1038/sj.bjc.6602487; Qi L, 2011, APOPTOSIS, V16, P1150, DOI 10.1007/s10495-011-0645-6; Quintavalle C, 2013, ONCOGENE, V32, P4001, DOI 10.1038/onc.2012.410; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Riccioni R, 2010, BLOOD CELL MOL DIS, V45, P86, DOI 10.1016/j.bcmd.2010.03.008; Roth P, 2009, CLIN CANCER RES, V15, P6609, DOI 10.1158/1078-0432.CCR-09-0548; Roth W, 1999, BIOCHEM BIOPH RES CO, V265, P479, DOI 10.1006/bbrc.1999.1693; Story Phillipa, 2004, N Z Med J, V117, pU799; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Tang QL, 2011, CANCER LETT, V311, P113, DOI 10.1016/j.canlet.2011.07.016; Tian XB, 2011, J BIOL CHEM, V286, P29408, DOI 10.1074/jbc.M110.197665; Verbrugge I, 2012, CANCER DISCOV, V2, P112, DOI 10.1158/2159-8290.CD-11-0350; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang Y, 2011, MED CHEM, V7, P106, DOI 10.2174/157340611794859307; Yamamoto K, 2012, J ANTIBIOT IN PRESS; Yan K, 2013, CURR OPIN NEUROL, V26, P701, DOI 10.1097/WCO.0000000000000032; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	45	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94438	10.1371/journal.pone.0094438	http://dx.doi.org/10.1371/journal.pone.0094438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740347	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900045
J	Palacios, RDY; Verhoye, M; Henningsen, K; Wiborg, O; Van der Linden, A				Delgado y Palacios, Rafael; Verhoye, Marleen; Henningsen, Kim; Wiborg, Ove; Van der Linden, Annemie			Diffusion Kurtosis Imaging and High-Resolution MRI Demonstrate Structural Aberrations of Caudate Putamen and Amygdala after Chronic Mild Stress	PLOS ONE			English	Article							RAT MODEL; PREFRONTAL CORTEX; DEPRESSION; RESILIENCE; ESCITALOPRAM; HIPPOCAMPAL; PATTERNS; NEUROBIOLOGY; RESISTANCE; MORPHOLOGY	The pathophysiology of major depressive disorder (MDD) and other stress related disorders has been associated with aberrations in the hippocampus and the frontal brain areas. More recently, other brain regions, such as the caudate nucleus, the putamen and the amygdala have also been suggested to play a role in the development of mood disorders. By exposing rats to a variety of stressors over a period of eight weeks, different phenotypes, i.e. stress susceptible (anhedonic-like) and stress resilient animals, can be discriminated based on the sucrose consumption test. The anhedonic-like animals are a well validated model for MDD. Previously, we reported that in vivo diffusion kurtosis imaging (DKI) of the hippocampus shows altered diffusion properties in chronically stressed rats independent of the hedonic state and that the shape of the right hippocampus is differing among the three groups, including unchallenged controls. In this study we evaluated diffusion properties in the prefrontal cortex, caudate putamen (CPu) and amygdala of anhedonic-like and resilient phenotypes and found that mean kurtosis in the CPu was significantly different between the anhedonic-like and resilient animals. In addition, axial diffusion and radial diffusion were increased in the stressed animal groups in the CPu and the amygdala, respectively. Furthermore, we found that the CPu/brain volume ratio was increased significantly in anhedonic-like animals as compared with control animals. Concurrently, our results indicate that the effects of chronic stress on the brain are not lateralized in these regions. These findings confirm the involvement of the CPu and the amygdala in stress related disorders and MDD. Additionally, we also show that DKI is a potentially important tool to promote the objective assessment of psychiatric disorders.	[Delgado y Palacios, Rafael; Verhoye, Marleen; Van der Linden, Annemie] Univ Antwerp, B-2020 Antwerp, Belgium; [Henningsen, Kim; Wiborg, Ove] Aarhus Univ Hosp, Ctr Psychiat Res, Risskov, Denmark	University of Antwerp; Aarhus University	Palacios, RDY (corresponding author), Univ Antwerp, B-2020 Antwerp, Belgium.	Rafael.Delgadoypalacios@gmail.com	Van der Linden, Annemie/L-7855-2017	Van der Linden, Annemie/0000-0003-2941-6520; Verhoye, Marleen/0000-0002-6267-0611	ECFP6-project Diagnostic Molecular Imaging [LSHB-CT-2005-512146]; Strategisch Basisch Onderzoek Grant from the Flemish Institute [IWT-60838: BRAINSTIM]; Inter University Attraction Poles [IUAP-NIMI-P6/38]	ECFP6-project Diagnostic Molecular Imaging; Strategisch Basisch Onderzoek Grant from the Flemish Institute; Inter University Attraction Poles(Belgian Federal Science Policy Office)	This study was funded, in part, by the ECFP6-project Diagnostic Molecular Imaging, LSHB-CT-2005-512146; the Strategisch Basisch Onderzoek Grant (IWT-60838: BRAINSTIM) from the Flemish Institute supporting scientific-technological research in industry innovatie door wetenschap en Techniek); and the Inter University Attraction Poles (IUAP-NIMI-P6/38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bennur S, 2007, NEUROSCIENCE, V144, P8, DOI 10.1016/j.neuroscience.2006.08.075; Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9; Bergstrom A, 2008, BRAIN RES, V1196, P41, DOI 10.1016/j.brainres.2007.12.025; Bisgaard CF, 2007, J MOL NEUROSCI, V32, P132, DOI 10.1007/s12031-007-0025-4; Blood AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013945; Butters MA, 2009, AM J GERIAT PSYCHIAT, V17, P4, DOI 10.1097/JGP.0b013e31816ff72b; Cerqueira JJ, 2007, J NEUROSCI, V27, P2781, DOI 10.1523/JNEUROSCI.4372-06.2007; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; Palacios RDY, 2011, BIOL PSYCHIAT, V70, P449, DOI 10.1016/j.biopsych.2011.05.014; Dias-Ferreira E, 2009, SCIENCE, V325, P621, DOI 10.1126/science.1171203; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Farooq RK, 2012, BEHAV BRAIN RES, V231, P130, DOI 10.1016/j.bbr.2012.03.020; Feder A, 2009, NAT REV NEUROSCI, V10, P446, DOI 10.1038/nrn2649; Helpern JA, 2011, J MAGN RESON IMAGING, V33, P17, DOI 10.1002/jmri.22397; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Kerbler GM, 2013, NEUROIMAGE, V66, P133, DOI 10.1016/j.neuroimage.2012.10.075; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; McEwen BS, 2003, BIOL PSYCHIAT, V54; Michelsen KA, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-107; Mitra R, 2005, P NATL ACAD SCI USA, V102, P9371, DOI 10.1073/pnas.0504011102; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Paxinos G., 2006, RAT BRAIN STEREOTACT; Perez-Cruz Claudia, 2007, Neural Plasticity, V2007, DOI 10.1155/2007/46276; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sanchez C, 2003, BEHAV PHARMACOL, V14, P465, DOI 10.1097/01.fbp.0000087733.21047.60; Sexton CE, 2009, BIOL PSYCHIAT, V66, P814, DOI 10.1016/j.biopsych.2009.05.024; Sobocki P, 2006, J MENT HEALTH POLICY, V9, P87; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Starkman MN, 2007, J AFFECT DISORDERS, V101, P139, DOI 10.1016/j.jad.2006.11.007; Taneja M, 2011, BEHAV BRAIN RES, V221, P25, DOI 10.1016/j.bbr.2011.02.018; Vyas A, 2003, BRAIN RES, V965, P290, DOI 10.1016/S0006-8993(02)04162-8; Vyas A, 2002, J NEUROSCI, V22, P6810; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zurawek D, 2013, PSYCHOPHARMACOLOGY, V227, P583, DOI 10.1007/s00213-013-2990-3	44	44	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95077	10.1371/journal.pone.0095077	http://dx.doi.org/10.1371/journal.pone.0095077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740310	Green Submitted, gold, Green Published			2022-12-25	WOS:000336863900100
J	Herfindal, L; Krakstad, C; Myhren, L; Hagland, H; Kopperud, R; Teigen, K; Schwede, F; Kleppe, R; Doskeland, SO				Herfindal, Lars; Krakstad, Camilla; Myhren, Lene; Hagland, Hanne; Kopperud, Reidun; Teigen, Knut; Schwede, Frank; Kleppe, Rune; Doskeland, Stein Ove			Introduction of Aromatic Ring-Containing Substituents in Cyclic Nucleotides Is Associated with Inhibition of Toxin Uptake by the Hepatocyte Transporters OATP 1B1 and 1B3	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; MICROCYSTIN-INDUCED APOPTOSIS; RAT HEPATOCYTES; PHOSPHATASE INHIBITORS; CORTISOL SYNTHESIS; DRUG-INTERACTIONS; POLYPEPTIDE 1B3; CGMP ANALOGS; INTACT-CELLS; CAMP	Analogs of the cyclic nucleotides cAMP and cGMP have been extensively used to mimic or modulate cellular events mediated by protein kinase A (PKA), Exchange protein directly activated by cAMP (Epac), or protein kinase G (PKG). We report here that some of the most commonly used cyclic nucleotide analogs inhibit transmembrane transport mediated by the liver specific organic anion transporter peptides OATP1B1 and OATP1B3, unrelated to actions on Epac, PKA or PKG. Several cAMP analogs, particularly with 8-pCPT-substitution, inhibited nodularin (Nod) induced primary rat hepatocyte apoptosis. Inhibition was not mediated by PKA or Epac, since increased endogenous cAMP, and some strong PKA- or Epac-activating analogs failed to protect cells against Nod induced apoptosis. The cAMP analogs inhibiting Nod induced hepatocyte apoptosis also reduced accumulation of radiolabeled Nod or cholic acid in primary rat hepatocytes. They also inhibited Nod induced apoptosis in HEK293 cells with enforced expression of OATP1B1 or 1B3, responsible for Nod transport into cells. Similar results were found with adenosine analogs, disconnecting the inhibitory effect of certain cAMP analogs from PKA or Epac. The most potent inhibitors were 8-pCPT-6-Phe-cAMP and 8-pCPT-2'-O-Me-cAMP, whereas analogs like 6-MB-cAMP or 8-Br-cAMP did not inhibit Nod uptake. This suggests that the addition of aromatic ring-containing substituents like the chloro-phenyl-thio group to the purines of cyclic nucleotides increases their ability to inhibit the OATP-mediated transport. Taken together, our data show that aromatic ring substituents can add unwanted effects to cyclic nucleotides, and that such nucleotide analogs must be used with care, particularly when working with cells expressing OATP1B1/1B3, like hepatocytes, or intact animals where hepatic metabolism can be an issue, as well as certain cancer cells. On the other hand, cAMP analogs with substituents like bromo, monobutyryl were non-inhibitory, and could be considered an alternative when working with cells expressing OATP1 family members.	[Herfindal, Lars; Krakstad, Camilla; Myhren, Lene; Hagland, Hanne; Kopperud, Reidun; Teigen, Knut; Kleppe, Rune; Doskeland, Stein Ove] Univ Bergen, Dept Biomed, Bergen, Norway; [Herfindal, Lars] Haukeland Hosp, Translat Signaling Grp, N-5021 Bergen, Norway; [Schwede, Frank] BIOLOG Life Sci Inst, Bremen, Germany	University of Bergen; University of Bergen; Haukeland University Hospital	Herfindal, L (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	lars.herfindal@biomed.uib.no	Hagland, Hanne R/H-8749-2017; Teigen, Knut/K-3934-2012; Krakstad, Camilla/AAB-5138-2020	Teigen, Knut/0000-0002-7031-9215; Krakstad, Camilla/0000-0002-0174-8139; Doskeland, Stein Ove/0000-0002-4009-4756; Kleppe, Rune/0000-0002-6086-755X; Herfindal, Lars/0000-0003-0353-3614	Norwegian Research Council [157338/187413]; Norwegian Western Regional Health authorities	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Western Regional Health authorities	This work was supported financially by the Norwegian Research Council [Projects 157338/187413] and the Norwegian Western Regional Health authorities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2001, GASTROENTEROLOGY, V120, P1689, DOI 10.1053/gast.2001.24804; Bartsch M, 2003, BIOL CHEM, V384, P1321, DOI 10.1515/BC.2003.148; Borner S, 2011, NAT PROTOC, V6, P427, DOI 10.1038/nprot.2010.198; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Christensen A.E., 2003, HDB CELL SIGNALING, P549; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Cui YH, 2003, LAB INVEST, V83, P527, DOI 10.1097/01.LAB.0000065015.02412.48; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; De Bruyn T, 2013, MOL PHARMACOL, V83, P1257, DOI 10.1124/mol.112.084152; De Bruyn T, 2011, J PHARM SCI-US, V100, P5018, DOI 10.1002/jps.22694; de Figueiredo DR, 2004, ECOTOX ENVIRON SAFE, V59, P151, DOI 10.1016/j.ecoenv.2004.04.006; Ding WX, 2000, HEPATOLOGY, V32, P547, DOI 10.1053/jhep.2000.16183; EKANGER R, 1985, J BIOL CHEM, V260, P3393; Enyeart JA, 2011, AM J PHYSIOL-ENDOC M, V301, pE941, DOI 10.1152/ajpendo.00282.2011; Enyeart JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006088; Fischer A, 2010, TOXICOL APPL PHARM, V245, P9, DOI 10.1016/j.taap.2010.02.006; Fischer WJ, 2005, TOXICOL APPL PHARM, V203, P257, DOI 10.1016/j.taap.2004.08.012; Fladmark KE, 1999, CELL DEATH DIFFER, V6, P1099, DOI 10.1038/sj.cdd.4400590; Fladmark KE, 2002, J BIOL CHEM, V277, P2804, DOI 10.1074/jbc.M109049200; FLOCCO MM, 1994, J MOL BIOL, V235, P709, DOI 10.1006/jmbi.1994.1022; Gambaryan S, 2004, BLOOD, V103, P2593, DOI 10.1182/blood-2003-09-3349; Gausdal G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.39; Glaeser H, 2010, BRIT J PHARMACOL, V159, P698, DOI 10.1111/j.1476-5381.2009.00568.x; Gui C, 2008, BIOCHEMISTRY-US, V47, P9090, DOI 10.1021/bi8008455; Hagenbuch B, 2008, XENOBIOTICA, V38, P778, DOI [10.1080/00498250801986951, 10.1080/00498250801986951 ]; Hamada A, 2008, CLIN CANCER RES, V14, P3312, DOI 10.1158/1078-0432.CCR-07-4118; Herfindal L, 2013, BIOCHEM BIOPH RES CO, V437, P603, DOI 10.1016/j.bbrc.2013.07.007; Herfindal L, 2011, MOL PHARMACEUT, V8, P360, DOI 10.1021/mp1002224; Herfindal L, 2009, J MED CHEM, V52, P5758, DOI 10.1021/jm900502e; Huseby S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.124; Jensen BO, 2011, PLATELETS, V22, P8, DOI 10.3109/09537104.2010.517581; Karlgren M, 2012, J MED CHEM, V55, P4740, DOI 10.1021/jm300212s; Konig J, 2011, HANDB EXP PHARMACOL, V201, P1, DOI 10.1007/978-3-642-14541-4_1; Konig J, 2000, J BIOL CHEM, V275, P23161, DOI 10.1074/jbc.M001448200; Konig J, 2000, AM J PHYSIOL-GASTR L, V278, pG156, DOI 10.1152/ajpgi.2000.278.1.G156; Krakstad C, 2006, CELL DEATH DIFFER, V13, P1191, DOI 10.1038/sj.cdd.4401798; Krakstad C, 2004, J LEUKOCYTE BIOL, V76, P641, DOI 10.1189/jlb.0104005; LANOTTE M, 1991, J CELL PHYSIOL, V146, P73, DOI 10.1002/jcp.1041460110; Lee W, 2008, CANCER RES, V68, P10315, DOI 10.1158/0008-5472.CAN-08-1984; Li N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036647; Lu H, 2008, TOXICOL SCI, V103, P35, DOI 10.1093/toxsci/kfn038; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Meier-Abt F, 2005, J MEMBRANE BIOL, V208, P213, DOI 10.1007/s00232-005-7004-x; MELLGREN G, 1995, J CELL PHYSIOL, V163, P232, DOI 10.1002/jcp.1041630203; Muto M, 2007, CANCER SCI, V98, P1570, DOI 10.1111/j.1349-7006.2007.00570.x; Nicolaou M, 2012, J PATHOL, V226, P300, DOI 10.1002/path.3019; Obaidat A, 2012, ANNU REV PHARMACOL, V52, P135, DOI 10.1146/annurev-pharmtox-010510-100556; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Sand C, 2010, THROMB HAEMOSTASIS, V103, P662, DOI 10.1160/TH09-06-0341; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Spoof L, 2003, TOXICON, V41, P153, DOI 10.1016/S0041-0101(02)00245-3; Tewari AK, 2008, BIOORGAN MED CHEM, V16, P126, DOI 10.1016/j.bmc.2007.09.023; UELAND PM, 1982, MOL PHARMACOL, V21, P108; Ulvestad M, 2011, BIOCHEM PHARMACOL, V82, P1219, DOI 10.1016/j.bcp.2011.07.076; Waidmann O, 2009, J BIOL CHEM, V284, P32256, DOI 10.1074/jbc.M109.056622; Werner K, 2011, N-S ARCH PHARMACOL, V384, P169, DOI 10.1007/s00210-011-0662-6	57	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94926	10.1371/journal.pone.0094926	http://dx.doi.org/10.1371/journal.pone.0094926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740327	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900082
J	Rossnagl, S; von Au, A; Vasel, M; Cecchini, AG; Nakchbandi, IA				Rossnagl, Stephanie; von Au, Anja; Vasel, Matthaeus; Cecchini, Arco G.; Nakchbandi, Inaam A.			Blood Clot Formation Does Not Affect Metastasis Formation or Tumor Growth in a Murine Model of Breast Cancer	PLOS ONE			English	Article							BONE-MARROW; IN-VITRO; TISSUE FACTOR; MOUSE MODEL; CELLS; ANGIOGENESIS; MICROENVIRONMENT; CHEMOTHERAPY; CHEMOKINE; VEGF	Cancer is associated with increased fracture risk, due either to metastasis or associated osteoporosis. After a fracture, blood clots form. Because proteins of the coagulation cascade and activated platelets promote cancer development, a fracture in patients with cancer often raises the question whether it is a pathologic fracture or whether the fracture itself might promote the formation of metastatic lesions. We therefore examined whether blood clot formation results in increased metastasis in a murine model of experimental breast cancer metastasis. For this purpose, a clot was surgically induced in the bone marrow of the left tibia of immundeficient mice. Either one minute prior to or five minutes after clot induction, human cancer cells were introduced in the circulation by intracardiac injection. The number of cancer cells that homed to the intervention site was determined by quantitative real-time PCR and flow cytometry. Metastasis formation and longitudinal growth were evaluated by bioluminescence imaging. The number of cancer cells that homed to the intervention site after 24 hours was similar to the number of cells in the opposite tibia that did not undergo clot induction. This effect was confirmed using two more cancer cell lines. Furthermore, no difference in the number of macroscopic lesions or their growth could be detected. In the control group 72% developed a lesion in the left tibia. In the experimental groups with clot formation 79% and 65% developed lesions in the left tibia (p = ns when comparing each experimental group with the controls). Survival was similar too. In summary, the growth factors accumulating in a clot/hematoma are neither enough to promote cancer cell homing nor support growth in an experimental model of breast cancer bone metastasis. This suggests that blood clot formation, as occurs in traumatic fractures, surgical interventions, and bruises, does not increase the risk of metastasis formation.	[Rossnagl, Stephanie; von Au, Anja; Vasel, Matthaeus; Nakchbandi, Inaam A.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Rossnagl, Stephanie; von Au, Anja; Vasel, Matthaeus; Nakchbandi, Inaam A.] Heidelberg Univ, Inst Immunol, Heidelberg, Germany; [Cecchini, Arco G.] Univ Bern, Dept Urol, Bern, Switzerland	Max Planck Society; Ruprecht Karls University Heidelberg; University of Bern	Nakchbandi, IA (corresponding author), Max Planck Inst Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.	inaam.nakchbandi@immu.uni-heidelberg.de			Max-Planck Society; University of Heidelberg	Max-Planck Society(Max Planck Society); University of Heidelberg	Funding was provided by the Max-Planck Society and the University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron R., 1983, BONE HISTOMORPHOMETR; BATTEGAY EJ, 1994, J CELL BIOL, V125, P917, DOI 10.1083/jcb.125.4.917; Benoy IH, 2006, BRIT J CANCER, V94, P672, DOI 10.1038/sj.bjc.6602985; Bentmann A, 2010, J BONE MINER RES, V25, P706, DOI 10.1359/jbmr.091011; Body JJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-384; Buijs JT, 2011, CANCER MICROENVIRON, V4, P261, DOI 10.1007/s12307-011-0075-6; Bussard KM, 2008, CANCER METAST REV, V27, P41, DOI 10.1007/s10555-007-9109-4; Bussard KM, 2010, J CELL BIOCHEM, V111, P1138, DOI 10.1002/jcb.22799; Coleman RE, 2001, CANCER TREAT REV, V27, P165, DOI 10.1053/ctrv.2000.0210; Cosby CN, 2008, J HISTOTECHNOL, V31, P169; Fradet A, 2011, CANCER RES, V71, P5728, DOI 10.1158/0008-5472.CAN-11-1431; Garnier D, 2010, THROMB RES, V125, pS44, DOI 10.1016/S0049-3848(10)70012-8; Gazitt Y, 2004, LEUKEMIA, V18, P1, DOI 10.1038/sj.leu.2403173; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Green D, 2010, CELL CYCLE, V9, P656, DOI 10.4161/cc.9.4.10729; HANNINK M, 1989, BIOCHIM BIOPHYS ACTA, V989, P1, DOI 10.1016/0304-419X(89)90031-0; Havens A, 2008, NEOPLASIA, V10, P371, DOI 10.1593/neo.08154; HIRSHBERG A, 1993, J ORAL MAXIL SURG, V51, P1334, DOI 10.1016/S0278-2391(10)80138-7; Horwood NJ, 1999, BIOCHEM BIOPH RES CO, V265, P144, DOI 10.1006/bbrc.1999.1623; Kawamoto T, 2003, ARCH HISTOL CYTOL, V66, P123, DOI 10.1679/aohc.66.123; Kawelke N, 2008, J BONE MINER RES, V23, P1278, DOI 10.1359/JBMR.080313; Kowalska MA, 2000, BLOOD, V96, P50, DOI 10.1182/blood.V96.1.50.013k40_50_57; Li X, 2011, J BONE MINER RES, V26, P125, DOI 10.1002/jbmr.204; Lipton A, 2010, AM J CLIN ONCOL-CANC, V33, pS1, DOI 10.1097/COC.0b013e3181deb9e5; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Melton LJ, 2012, J BONE MINER RES; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakchbandi IA, 2001, ENDOCRINOLOGY, V142, P3850, DOI 10.1210/en.142.9.3850; Nakchbandi IA, 2008, NAT CLIN PRACT GASTR, V5, P445, DOI 10.1038/ncpgasthep1184; Nakchbandi W, 2008, J GASTROINTEST LIVER, V17, P285; Nieswandt B, 1999, CANCER RES, V59, P1295; Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4; Nunamaker DM, 1998, CLIN ORTHOP RELAT R, pS56; Obata NH, 1997, ANTICANCER RES, V17, P337; Palumbo JS, 2008, J THROMB HAEMOST, V6, P812, DOI 10.1111/j.1538-7836.2008.02938.x; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PFEILSCHIFTER J, 1989, J BONE MINER RES, V4, P113, DOI 10.1002/jbmr.5650040116; Phadke PA, 2006, CLIN CANCER RES, V12, P1431, DOI 10.1158/1078-0432.CCR-05-1806; Rak J, 2006, SEMIN THROMB HEMOST, V32, P54, DOI 10.1055/s-2006-933341; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Shiozawa Y, 2011, J CLIN INVEST, V121, P1298, DOI 10.1172/JCI43414; SNELL W, 1964, SURG GYNECOL OBSTET, V119, P22; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; SUVA LJ, 1993, J BONE MINER RES, V8, P379; van der Pluijm G, 2005, CANCER RES, V65, P7682, DOI 10.1158/0008-5472.CAN-04-4188; von Au A, 2013, NEOPLASIA IN PRESS, P15; Wartiovaara U, 1998, THROMB HAEMOSTASIS, V80, P171, DOI 10.1055/s-0037-1615158; Wetterwald A, 2002, AM J PATHOL, V160, P1143, DOI 10.1016/S0002-9440(10)64934-6; WOOD DP, 1994, CANCER, V74, P2533, DOI 10.1002/1097-0142(19941101)74:9<2533::AID-CNCR2820740922>3.0.CO;2-D; Xue YB, 2012, AM J PHYSIOL-ENDOC M, V302, pE841, DOI 10.1152/ajpendo.00599.2011	51	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94922	10.1371/journal.pone.0094922	http://dx.doi.org/10.1371/journal.pone.0094922			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740307	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900081
J	Verstrepen, BE; Verschoor, EJ; Fagrouch, ZC; Mooij, P; de Groot, NG; Bontrop, RE; Bogers, WM; Heeney, JL; Koopman, G				Verstrepen, Babs E.; Verschoor, Ernst J.; Fagrouch, Zahra C.; Mooij, Petra; de Groot, Natasja G.; Bontrop, Ronald E.; Bogers, Willy M.; Heeney, Jonathan L.; Koopman, Gerrit			Strong Vaccine-Induced CD8 T-Cell Responses Have Cytolytic Function in a Chimpanzee Clearing HCV Infection	PLOS ONE			English	Article							C VIRUS-INFECTION; CLASS-I ALLELES; HEPATITIS-C; RHESUS MACAQUES; EPITOPES; LIVER; SPECIFICITY; RECHALLENGE; CLEARANCE; MOLECULE	A single correlate of effective vaccine protection against chronic HCV infection has yet to be defined. In this study, we analyzed T-cell responses in four chimpanzees, immunized with core-E1-E2-NS3 and subsequently infected with HCV1b. Viral clearance was observed in one animal, while the other three became chronically infected. In the animal that cleared infection, NS3-specific CD8 T-cell responses were observed to be more potent in terms of frequency and polyfunctionality of cytokine producing cells. Unique to this animal was the presence of killing-competent CD8 T-cells, specific for NS3(1258-1272), being presented by the chimpanzee MHC class I molecule Patr-A*03:01, and a high affinity recognition of this epitope. In the animals that became chronically infected, T-cells were able to produce cytokines against the same peptide but no cytolysis could be detected. In conclusion, in the animal that was able to clear HCV infection not only cytokine production was observed but also cytolytic potential against specific MHC class I/peptide-combinations.	[Verstrepen, Babs E.; Verschoor, Ernst J.; Fagrouch, Zahra C.; Mooij, Petra; Bogers, Willy M.; Koopman, Gerrit] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands; [de Groot, Natasja G.; Bontrop, Ronald E.] Biomed Primate Res Ctr, Dept Comparat Genet & Refinement, Rijswijk, Netherlands; [Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England	University of Cambridge	Koopman, G (corresponding author), Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands.	koopman@bprc.nl	Bontrop, Ronald E/J-3628-2012	Bontrop, Ronald E/0000-0003-0874-6467; Heeney, Jonathan/0000-0003-2702-1621; Verstrepen, Babs E/0000-0002-4666-0798	EC [QLK2-CT-1999-00356]; ZonMw [114024014]	EC(European CommissionEuropean Commission Joint Research Centre); ZonMw(Netherlands Organization for Health Research and Development)	This research was initiated by EC grant number QLK2-CT-1999-00356 and supported by ZonMw number 114024014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2001, J VIROL, V75, P738, DOI 10.1128/JVI.75.2.738-749.2001; Bacchetti P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001628; Balla-Jhagjhoorsingh SS, 1999, J IMMUNOL, V162, P2308; Bell MJ, 2009, MOL IMMUNOL, V46, P1911, DOI 10.1016/j.molimm.2008.12.003; Bettauer RH, 2010, J MED PRIMATOL, V39, P9, DOI 10.1111/j.1600-0684.2009.00390.x; Bukh J, 2012, GASTROENTEROLOGY, V142, P1279, DOI 10.1053/j.gastro.2012.02.016; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; de Groot NG, 2010, P NATL ACAD SCI USA, V107, P15175, DOI 10.1073/pnas.1009136107; de Groot NG, 2000, IMMUNOGENETICS, V51, P398, DOI 10.1007/s002510050638; Diepolder Helmut M, 2003, Hepatology, V37, P1472; Fattori E, 2006, GENE THER, V13, P1088, DOI 10.1038/sj.gt.3302754; Haaijman JJ, 1995, AIDS RES EC LEVEL, P139; Hoffmeister B, 2003, METHODS, V29, P270, DOI 10.1016/S1046-2023(02)00349-3; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Kim AY, 2011, GASTROENTEROLOGY, V140, P686, DOI 10.1053/j.gastro.2010.09.042; Loffredo JT, 2004, J IMMUNOL, V173, P5064, DOI 10.4049/jimmunol.173.8.5064; Nascimbeni M, 2003, J VIROL, V77, P4781, DOI 10.1128/JVI.77.8.4781-4793.2003; Neumann-Haefelin C, 2010, HEPATOLOGY, V51, P54, DOI 10.1002/hep.23275; Osburn WO, 2010, GASTROENTEROLOGY, V138, P315, DOI 10.1053/j.gastro.2009.09.017; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Prince AM, 2005, J INFECT DIS, V192, P1701, DOI 10.1086/496889; Ramalingam RK, 2008, J VIROL, V82, P10487, DOI 10.1128/JVI.00588-08; Rollier CS, 2007, HEPATOLOGY, V45, P602, DOI 10.1002/hep.21573; SETTE A, 1994, J IMMUNOL, V153, P5586; Shin EC, 2008, J VIROL, V82, P9782, DOI 10.1128/JVI.00475-08; Sidney J, 2007, IMMUNOGENETICS, V59, P745, DOI 10.1007/s00251-007-0243-5; Thimme R, 2002, P NATL ACAD SCI USA, V99, P15661, DOI 10.1073/pnas.202608299; Watanabe H, 2010, J VIRAL HEPATITIS, V17, P245, DOI 10.1111/j.1365-2893.2009.01172.x; Zubkova I, 2009, VACCINE, V27, P2594, DOI 10.1016/j.vaccine.2009.02.045	29	8	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95103	10.1371/journal.pone.0095103	http://dx.doi.org/10.1371/journal.pone.0095103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740375	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900102
J	Willems, E; Hu, TT; Vasco, LS; Buyse, J; Decuypere, E; Arckens, L; Everaert, N				Willems, Els; Hu, Tjing-Tjing; Vasco, Laura Soler; Buyse, Johan; Decuypere, Eddy; Arckens, Lutgarde; Everaert, Nadia			Embryonic Protein Undernutrition by Albumen Removal Programs the Hepatic Amino Acid and Glucose Metabolism during the Perinatal Period in an Avian Model	PLOS ONE			English	Article							DIFFERENCE GEL-ELECTROPHORESIS; GENE-EXPRESSION; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; MATERNAL UNDERNUTRITION; GLUCOCORTICOID RECEPTOR; BROILER-CHICKENS; VISUAL-CORTEX; RAT; PERFORMANCE; NUTRITION	Different animal models have been used to study the effects of prenatal protein undernutrition and the mechanisms by which these occur. In mammals, the maternal diet is manipulated, exerting both direct nutritional and indirect hormonal effects. Chicken embryos develop independent from the hen in the egg. Therefore, in the chicken, the direct effects of protein deficiency by albumen removal early during incubation can be examined. Prenatal protein undernutrition was established in layer-type eggs by the partial replacement of albumen by saline at embryonic day 1 (albumen-deprived group), compared to a mock-treated sham and a non-treated control group. At hatch, survival of the albumen-deprived group was lower compared to the control and sham group due to increased early mortality by the manipulation. No treatment differences in yolk-free body weight or yolk weight could be detected. The water content of the yolk was reduced, whereas the water content of the carcass was increased in the albumen-deprived group, compared to the control group, indicating less uptake of nutrients from the yolk. At embryonic day 16, 20 and at hatch, plasma triiodothyronine (T-3), corticosterone, lactate or glucose concentrations and hepatic glycogen content were not affected by treatment. At embryonic day 20, the plasma thyroxine (T-4) concentrations of the albumen-deprived embryos was reduced compared to the control group, indicating a decreased metabolic rate. Screening for differential protein expression in the liver at hatch using two-dimensional difference gel electrophoresis revealed not only changed abundance of proteins important for amino acid metabolism, but also of enzymes related to energy and glucose metabolism. Interestingly, GLUT1, a glucose transporter, and PCK2 and FBP1, two out of three regulatory enzymes of the gluconeogenesis were dysregulated. No parallel differences in gene expressions causing the differences in protein abundance could be detected pointing to post-transcriptional or post-translational regulation of the observed differences.	[Willems, Els; Buyse, Johan; Decuypere, Eddy; Everaert, Nadia] Katholieke Univ Leuven, Dept Biosyst, Lab Livestock Physiol, Louvain, Belgium; [Hu, Tjing-Tjing; Arckens, Lutgarde] Katholieke Univ Leuven, Lab Neuroplast & Neuroprote, Louvain, Belgium; [Vasco, Laura Soler] Katholieke Univ Leuven, Dept Biosyst, Div Livestock Nutr Qual, Louvain, Belgium; [Everaert, Nadia] Univ Liege, Gembloux Agrobio Tech, Anim Sci Unit, Gembloux, Belgium	KU Leuven; KU Leuven; KU Leuven; University of Liege	Buyse, J (corresponding author), Katholieke Univ Leuven, Dept Biosyst, Lab Livestock Physiol, Louvain, Belgium.	Johan.buyse@biw.kuleuven.be	Everaert, Nadia/AAJ-7714-2021; Arckens, Lutgarde/C-3822-2016	Arckens, Lutgarde/0000-0002-2909-8449; Everaert, Nadia/0000-0001-9282-6288	Fund for Scientific Research Flanders (FWO-Vlaanderen) (FWO) [G.0566.08]	Fund for Scientific Research Flanders (FWO-Vlaanderen) (FWO)	This research was supported by the Fund for Scientific Research Flanders (FWO-Vlaanderen, www.fwo.be) (FWO nr. G.0566.08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1995, EUR J CLIN INVEST, V25, P457, DOI 10.1111/j.1365-2362.1995.tb01730.x; Bertram C, 2001, ENDOCRINOLOGY, V142, P2841, DOI 10.1210/en.142.7.2841; Christensen VL, 2001, POULTRY SCI, V80, P1729, DOI 10.1093/ps/80.12.1729; Darras VM, 1996, GEN COMP ENDOCR, V104, P203, DOI 10.1006/gcen.1996.0163; Desai M, 1997, AM J PHYSIOL-GASTR L, V272, pG1083, DOI 10.1152/ajpgi.1997.272.5.G1083; DREILING CE, 1987, MEAT SCI, V20, P167, DOI 10.1016/0309-1740(87)90009-X; Everaert N, 2013, BRIT J NUTR, V110, P265, DOI 10.1017/S000711451200503X; Finkler MS, 1998, J COMP PHYSIOL B, V168, P17, DOI 10.1007/s003600050116; Freeman B.M., 1974, DEV AVIAN EMBRYO BEH; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gould GW, 1997, FACILITATIVE GLUCOSE; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HAMADA T, 1984, COMP BIOCHEM PHYS B, V77, P547, DOI 10.1016/0305-0491(84)90273-6; HILL WL, 1993, DEV PSYCHOBIOL, V26, P237, DOI 10.1002/dev.420260502; HOD Y, 1986, ANN NY ACAD SCI, V478, P31, DOI 10.1111/j.1749-6632.1986.tb15519.x; Kono T, 2005, BRIT POULTRY SCI, V46, P510, DOI 10.1080/00071660500181289; Lane RH, 2002, ENDOCRINOLOGY, V143, P2486, DOI 10.1210/en.143.7.2486; Lesage J, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740037; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matthiesen CF, 2010, ARCH ANIM NUTR, V64, P56, DOI 10.1080/17450390903299141; McNabb F.M. Anne, 2000, P461; Nguyen LT, 2010, PLACENTA, V31, P902, DOI 10.1016/j.placenta.2010.07.014; Rao KQ, 2009, BRIT J NUTR, V102, P848, DOI 10.1017/S0007114509276434; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Ravelli ACJ, 1998, LANCET, V351, P173, DOI 10.1016/S0140-6736(97)07244-9; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Seki Y, 2003, GEN COMP ENDOCR, V133, P80, DOI 10.1016/S0016-6480(03)00145-X; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Van den Bergh G, 2004, CURR OPIN BIOTECH, V15, P38, DOI 10.1016/j.copbio.2003.12.001; Van den Bergh G, 2003, J NEUROCHEM, V85, P193, DOI 10.1046/j.1471-4159.2003.01668.x; Van den Bergh G, 2006, PROTEOMICS, V6, P3821, DOI 10.1002/pmic.200500570; Wang Y, 2014, ANIMAL, V8, P610, DOI 10.1017/S175173111400007X; Whorwood CB, 2001, ENDOCRINOLOGY, V142, P2854, DOI 10.1210/en.142.7.2854; Willems E, 2013, POULTRY SCI, V92, P1905, DOI 10.3382/ps.2012-03003; Willems E, 2014, WPSJ IN PRESS	36	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94902	10.1371/journal.pone.0094902	http://dx.doi.org/10.1371/journal.pone.0094902			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740266	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900078
J	Willfuhr, K; Myrskyla, M				Willfuehr, Kai; Myrskylae, Mikko			Disease Load at Conception Predicts Survival in Later Epidemics in a Historical French-Canadian Cohort, Suggesting Functional Trans-Generational Effects in Humans	PLOS ONE			English	Article							SLOW GROWTH PERIOD; STRESS RESPONSES; MORTALITY; MEASLES; INHERITANCE; PREGNANCY; NUTRITION; CHILDREN; LONGEVITY; DEFENSES	Objective: Functional trans-generational and parental effects are potentially important determinants of health in several mammals. For humans, the existing evidence is weak. We investigate whether disease exposure triggers functional trans-generational response effects among humans by analyzing siblings who were conceived under different disease loads, and comparing their mortality in later epidemics. Under functional trans-generational response mechanisms, we expect that those who were conceived under high pathogenic stress load will have relatively low mortality during a later epidemic. Methods: We use data from the Registre de la Population du Quebec Ancien, which covers the historical population living in St. Lawrence Valley, Quebec, Canada. Children born in 1705-1724 were grouped according to their exposure during conception to the measles 1714-15 epidemic. The 1714-15 epidemic was followed by two mortality crises in 1729-1734. The cause of the first crises in 1729 is not exactly known. The second crisis in 1732 was caused by a smallpox epidemic. Using proportional hazard Cox regression models with multivariate adjustment and with fixed-effects approach that compare siblings, we analyze whether mortality in 1729-1734 is affected by exposure to the 1714-15 epidemic. Results: Children who were conceived during the peak of the measles epidemic of 1714-15 exhibited significantly lower mortality during the 1729-1734 crisis than those who were born before the 1714-15 epidemic (mortality hazard ratio 0.106, p < .05 in multivariate adjusted models; 0.142 p < .1 in sibling comparison models). Conclusions: The results are consistent with a trans-generational mechanism that functionally responds to pathogen stress and suggest that early disease exposure may be protective later in life. Alternative explanations for the mortality patterns are discussed and shown to be problematic.	[Willfuehr, Kai] Max Planck Inst Demog Res, Rostock, Germany; [Myrskylae, Mikko] Univ London London Sch Econ & Polit Sci, London WC2A 2AE, England	Max Planck Society; University of London; London School Economics & Political Science	Willfuhr, K (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	willfuehr@demogr.mpg.de						AABY P, 1988, LANCET, V1, P516; Agrawal AA, 1999, NATURE, V401, P60, DOI 10.1038/43425; Ali EM, 1997, INT J GYNECOL OBSTET, V59, P109; Allison P., 2009, FIXED EFFECTS REGRES, DOI [10.4135/9781412993869, DOI 10.4135/9781412993869]; [Anonymous], 1993, 1 FRENCH CANADIANS P; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Behrman R E, 1996, NELSON TXB PEDIAT, V15th; BONGAARTS J, 1987, POPUL DEV REV, V13, P323, DOI 10.2307/1973197; Bygren LO, 2001, ACTA BIOTHEOR, V49, P53, DOI 10.1023/A:1010241825519; Charbonneau H., 2000, POPULATION HIST N AM, P99; Chiba ME, 2003, J INFECTION, V47, P40, DOI 10.1016/S0163-4453(03)00045-8; COX DR, 1972, J R STAT SOC B, V34, P187; Crews D, 2012, P NATL ACAD SCI USA, V109, P9143, DOI 10.1073/pnas.1118514109; EBERHARTPHILLIPS JE, 1993, OBSTET GYNECOL, V82, P797; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Franklin TB, 2010, BIOL PSYCHIAT, V68, P408, DOI 10.1016/j.biopsych.2010.05.036; Fridlizius G., 1989, SCANDINAVIAN EC HIST, V37, P3, DOI DOI 10.1080/03585522.1989.10408152; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Hammill E, 2008, J EVOLUTION BIOL, V21, P705, DOI 10.1111/j.1420-9101.2008.01520.x; Hayward AD, 2013, EVOLUTION MED PUBLIC; Hayward AD, 2013, P NATL ACAD SCI USA, V110, P13886, DOI 10.1073/pnas.1301817110; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Mazan R, 2007, PSC DISCUSSION PAPER, V21; Mazan RM, 2011, ANAL EPIDEMICS NEW F; Mazan R, 2012, CAN STUD POPUL, V39, P9; Myrskyla M, 2012, DEMOGRAPHY, V49, P1231, DOI 10.1007/s13524-012-0132-x; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; POTTER JE, 1988, POPUL DEV REV, V14, P179, DOI 10.2307/1972507; Rickard IJ, 2007, TRENDS ENDOCRIN MET, V18, P94, DOI 10.1016/j.tem.2007.02.004; Rutstein SO., 1984, INFANT CHILD MORTALI; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Trussel J, 1987, POPUL DEV REV, V1987, P171; Willfuhr KP, 2013, BIODEMOGR SOC BIOL, V59, P191, DOI 10.1080/19485565.2013.833803; Willfuhr KP, 2013, AM J HUM BIOL, V25, P318, DOI 10.1002/ajhb.22362; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; Zhu JL, 2008, EUR J EPIDEMIOL, V23, P443, DOI 10.1007/s10654-008-9253-3	37	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93868	10.1371/journal.pone.0093868	http://dx.doi.org/10.1371/journal.pone.0093868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4VW	24739873	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000336863900029
J	Abreu, TP; Silva, LS; Takiya, CM; Souza, MC; Henriques, MG; Pinheiro, AAS; Caruso-Neves, C				Abreu, Thiago P.; Silva, Leandro S.; Takiya, Christina M.; Souza, Mariana C.; Henriques, Maria G.; Pinheiro, Ana Acacia S.; Caruso-Neves, Celso			Mice Rescued from Severe Malaria Are Protected against Renal Injury during a Second Kidney Insult	PLOS ONE			English	Article							SEPSIS	Malaria is a worldwide disease that leads to 1 million deaths per year. Plasmodium falciparum is the species responsible for the most severe form of malaria leading to different complications. Beyond the development of cerebral malaria, impairment of renal function is a mortality indicator in infected patients. Treatment with antimalarial drugs can increase survival, however the long-term effects of malaria on renal disease, even after treatment with antimalarials, are unknown. The aim of this study was to evaluate the effect of antimalarial drug treatment on renal function in a murine model of severe malaria and then evaluate kidney susceptibility to a second renal insult. Initially, mice infected with Plasmodium berghei ANKA achieved 20% parasitemia on day 5 post infection, which was completely abolished after treatment with 25 mg/kg artesunate and 40 mg/kg mefloquine. The treatment also decreased plasma creatinine levels by 43% and partially reversed the reduction in the glomerular filtration rate induced by infection. The urinary protein/creatinine ratio, collagen deposition, and size of the interstitial space decreased by 75%, 40%, and 20%, respectively, with drugs compared with untreated infected animals. In infected-treated mice that underwent a second renal insult, the plasma creatinine level decreased by 60% and the glomerular filtration rate increased compared with infected animals treated only with antimalarials. The number of glomerular cells, collagen deposition and the size of the interstitial space decreased by 20%, 39.4%, and 41.3%, respectively, in the infected group that underwent a second renal insult compared with the infected-treated groups. These functional and structural data show that renal injury observed in a murine model of severe malaria is partially reversed after antimalarial drug treatment, making the kidney less susceptible to a second renal insult.	[Abreu, Thiago P.; Silva, Leandro S.; Takiya, Christina M.; Pinheiro, Ana Acacia S.; Caruso-Neves, Celso] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil; [Souza, Mariana C.; Henriques, Maria G.] Fundacao Oswaldo Cruz, Inst Tecnol Farmacos, Rio De Janeiro, RJ, Brazil; [Pinheiro, Ana Acacia S.] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Pesquisa Translac Saude & Ambiente Regi, Rio De Janeiro, RJ, Brazil; [Caruso-Neves, Celso] Conselho Nacl Desenvolvimento Cient & Tecnol MCT, Inst Nacl Ciencia & Tecnol Biol & Bioimagem, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz	Caruso-Neves, C (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, RJ, Brazil.	caruso@biof.ufrj.br	Caruso-Neves, Celso/C-4014-2013; Sila, Leandro/B-1381-2018; Souza, Mariana/GQQ-6648-2022; Takiya, Christina/AAU-5959-2021; Henriques, Maria das Graças M O/G-2998-2013; Souza, Mariana/C-1677-2015	Caruso-Neves, Celso/0000-0002-2415-7753; Sila, Leandro/0000-0001-8720-0088; Takiya, Christina/0000-0002-8019-628X; Henriques, Maria das Graças M O/0000-0003-3065-0541; Pinheiro, Ana Acacia/0000-0002-3894-1645; Souza, Mariana/0000-0002-6933-9227	Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INBEB/CNPq/MCT); Brazilian agency: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ	Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT); Brazilian agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INBEB/CNPq/MCT); Brazilian agency: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ	This work was supported by grants from the Brazilian agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (INCT-INPeTAm/CNPq/MCT, INCT-INBEB/CNPq/MCT) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro - FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Campos SB, 2001, KIDNEY INT, V59, P1044, DOI 10.1046/j.1523-1755.2001.0590031044.x; Clemmer L, 2011, ANTIMICROB AGENTS CH, V55, P1383, DOI 10.1128/AAC.01277-10; Dunn SR, 2004, KIDNEY INT, V65, P1959, DOI 10.1111/j.1523-1755.2004.00600.x; EDDY AA, 1989, AM J PATHOL, V135, P719; Eiam-Ong S, 1998, AM J KIDNEY DIS, V32, P361, DOI 10.1053/ajkd.1998.v32.pm9740151; Genton B, 2012, INFECT DIS CLIN N AM, V26, P637, DOI 10.1016/j.idc.2012.05.003; HAINES H, 1991, PARASITOL RES, V77, P411, DOI 10.1007/BF00931636; Kanodia KV, 2010, SAUDI J KIDNEY DIS T, V21, P1088; Landgraf SS, 2011, AM J PHYSIOL-RENAL, V300, pF499, DOI 10.1152/ajprenal.00384.2010; Li RM, 1998, J PATHOL, V185, P219, DOI 10.1002/(SICI)1096-9896(199806)185:2&lt;219::AID-PATH77&gt;3.0.CO;2-Q; Li RM, 1998, KIDNEY INT, V53, P845, DOI 10.1111/j.1523-1755.1998.00848.x; Gorriz JL, 2012, TRANSPLANT REV-ORLAN, V26, P3, DOI 10.1016/j.trre.2011.10.002; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Milner DA, 2010, CURR OPIN INFECT DIS, V23, P456, DOI 10.1097/QCO.0b013e32833c3dbe; Nascimento DC, 2010, CRIT CARE MED, V38, P1718, DOI 10.1097/CCM.0b013e3181e78ad0; Portella VG, 2013, CRIT CARE MED, V41, P1056, DOI 10.1097/CCM.0b013e3182746696; Sinniah R, 1999, INT J EXP PATHOL, V80, P87, DOI 10.1046/j.1365-2613.1999.00101.x; Soniran O T, 2012, Malar Res Treat, V2012, P960758, DOI 10.1155/2012/960758; Wang J, 2006, ANTIMICROB AGENTS CH, V50, P2420, DOI 10.1128/AAC.01066-05; White LE, 2011, J SURG RES, V167, P306, DOI 10.1016/j.jss.2010.11.923	21	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93634	10.1371/journal.pone.0093634	http://dx.doi.org/10.1371/journal.pone.0093634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736406	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600022
J	Chen, JJ; Wang, Y; Xue, JY; Chen, Y; Chen, YL; Xiao, Q; Yang, WT; Shao, ZM; Wu, J				Chen, Jia-jian; Wang, Yan; Xue, Jing-yan; Chen, Ying; Chen, Ya-ling; Xiao, Qin; Yang, Wen-tao; Shao, Zhi-min; Wu, Jiong			A Clinicopathological Study of Early-Stage Synchronous Bilateral Breast Cancer: A Retrospective Evaluation and Prospective Validation of Potential Risk Factors	PLOS ONE			English	Article							CARCINOMA; SURVIVAL; DISEASE; PROGNOSIS; OUTCOMES; PATIENT; IMPACT	Background: The aim of the present study was to investigate potential risk factors for synchronous bilateral breast cancer sBBC). Methods: A retrospective analysis was performed of patients diagnosed and treated with operable bilateral breast cancer (BBC) between June 2007 and December 2011. Risk factors for sBBC were evaluated in this cohort and further validated in a prospective observational validation analysis of patients between January 2012 and December 2012. Patients treated with operable unilateral breast cancer during the same period were used as a control group. Results: A total of 11,247 patients with primary breast cancer underwent operations at the Fudan University Shanghai Cancer Center between June 2007 and December 2012. The incidence of sBBC was 1.6%. The age at diagnosis (HR = 2.4, 95% C.I.: 1.4-4.0, p = 0.001), presence of sclerosing adenosis (HR = 11.8, 95% C.I.: 5.3-26.3, p<0.001), lobular carcinoma component involvement (HR = 5.6, 95% C.I.: 2.6-12.1, p<0.001), and family history of first-degree relatives with breast cancer (HR = 2.0, 95% C.I.: 1.1-3.4, p<0.001) were independent risk factors for sBBC. A subsequent validation study failed to confirm the significance of family history. No significant difference on survival was found between patients with early-stage sBBC and control cases. Conclusions: Patients with the presence of sclerosing in the affected breast, and lobular carcinoma component involvement may be at high risk for developing sBBC. This study supports the hypothesis that the host-carcinoma biological relationship, especially for the tumor microenvironment, played a critical role in the carcinogenesis of sBBC.	[Chen, Jia-jian; Wang, Yan; Xue, Jing-yan; Chen, Ying; Shao, Zhi-min; Wu, Jiong] Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Chen, Jia-jian; Wang, Yan; Xue, Jing-yan; Chen, Ying; Chen, Ya-ling; Xiao, Qin; Yang, Wen-tao; Shao, Zhi-min; Wu, Jiong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Chen, Ya-ling] Fudan Univ, Dept Ultrasound, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Xiao, Qin] Fudan Univ, Dept Diagnost Radiol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China; [Yang, Wen-tao] Fudan Univ, Dept Pathol, Shanghai Canc Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Wu, J (corresponding author), Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Shanghai 200433, Peoples R China.	wujiong1122@vip.sina.com		CHEN, Jiajian/0000-0001-9202-404X	Research Foundation of the Fudan University Shanghai Cancer Center [YJ200908]; Youth Scientific Research Foundation of the Shanghai Municipal Health Bureau [20124Y067]	Research Foundation of the Fudan University Shanghai Cancer Center; Youth Scientific Research Foundation of the Shanghai Municipal Health Bureau	This study was supported in part by grants from the Research Foundation of the Fudan University Shanghai Cancer Center (No. YJ200908) and Youth Scientific Research Foundation of the Shanghai Municipal Health Bureau (No. 20124Y067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla I, 2000, CANCER J, V6, P266; Baykara M, 2012, ASIAN PAC J CANCER P, V13, P4571, DOI 10.7314/APJCP.2012.13.9.4571; Beckmann KR, 2011, BREAST, V20, P158, DOI 10.1016/j.breast.2010.10.004; BLOOM ND, 1980, NEW YORK STATE J MED, V80, P908; Borg A, 2010, HUM MUTAT, V31, pE1200, DOI 10.1002/humu.21202; BURNS PE, 1984, CAN MED ASSOC J, V130, P881; Carmichael AR, 2002, EUR J SURG ONCOL, V28, P388, DOI 10.1053/ejso.2002.1266; CHAUDARY MA, 1984, BRIT J SURG, V71, P711, DOI 10.1002/bjs.1800710924; Diaz R, 2012, MED ONCOL, V29, P16, DOI 10.1007/s12032-010-9785-8; Hartman M, 2005, LANCET ONCOL, V6, P377, DOI 10.1016/S1470-2045(05)70174-1; Heron DE, 2000, CANCER, V88, P2739, DOI 10.1002/1097-0142(20000615)88:12<2739::AID-CNCR12>3.3.CO;2-A; Huo DZ, 2011, CANCER-AM CANCER SOC, V117, P907, DOI 10.1002/cncr.25587; Intra M, 2004, CANCER-AM CANCER SOC, V101, P905, DOI 10.1002/cncr.20452; Kast K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-217; Kheirelseid EAH, 2011, BREAST CANCER RES TR, V126, P131, DOI 10.1007/s10549-010-1057-y; Kilgore AR, 1921, J AMER MED ASSOC, V77, P454; Kollias J, 2001, WORLD J SURG, V25, P1117, DOI 10.1007/BF03215857; Liang XR, 2013, TUMOR BIOL, V34, P995, DOI 10.1007/s13277-012-0636-4; Linan MAL, 2013, CIR ESPAN, V91, P195, DOI 10.1016/j.ciresp.2012.05.025; Marpeau O, 2008, GYNECOL OBSTET FERTI, V36, P35, DOI 10.1016/j.gyobfe.2007.09.021; Newman LA, 2001, CANCER-AM CANCER SOC, V91, P1845, DOI 10.1002/1097-0142(20010515)91:10<1845::AID-CNCR1205>3.0.CO;2-Z; Nichol AM, 2011, J CLIN ONCOL, V29, P4763, DOI 10.1200/JCO.2011.35.0165; Ogura K, 2013, BREAST CANC; Schmid SM, 2011, EJSO-EUR J SURG ONC, V37, P623, DOI 10.1016/j.ejso.2011.05.006; Shi YX, 2012, J CANCER RES CLIN, V138, P705, DOI 10.1007/s00432-011-1141-7; Tate G, 2008, CANCER GENET CYTOGEN, V184, P67, DOI 10.1016/j.cancergencyto.2008.03.013; Tonyali O, 2012, CLIN BREAST CANCER, V12, P145, DOI 10.1016/j.clbc.2011.09.003; Verkooijen HM, 2007, BREAST CANCER RES TR, V105, P347, DOI 10.1007/s10549-006-9455-x; Vuoto HD, 2010, BREAST J, V16, P625, DOI 10.1111/j.1524-4741.2010.00976.x; Yoshida A, 2012, CLIN BREAST CANCER, V12, P398, DOI 10.1016/j.clbc.2012.08.002	30	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95185	10.1371/journal.pone.0095185	http://dx.doi.org/10.1371/journal.pone.0095185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736632	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600152
J	Clark, LP; Millet, DB; Marshall, JD				Clark, Lara P.; Millet, Dylan B.; Marshall, Julian D.			National Patterns in Environmental Injustice and Inequality: Outdoor NO2 Air Pollution in the United States	PLOS ONE			English	Article							NITROGEN-DIOXIDE; CONTROL STRATEGIES; URBAN AREA; EXPOSURE; HEALTH; CALIFORNIA; MORTALITY; HAZARDS; TOXICS; SEGREGATION	We describe spatial patterns in environmental injustice and inequality for residential outdoor nitrogen dioxide (NO2) concentrations in the contiguous United States. Our approach employs Census demographic data and a recently published high-resolution dataset of outdoor NO2 concentrations. Nationally, population-weighted mean NO2 concentrations are 4.6 ppb (38%, p<0.01) higher for nonwhites than for whites. The environmental health implications of that concentration disparity are compelling. For example, we estimate that reducing nonwhites' NO2 concentrations to levels experienced by whites would reduce Ischemic Heart Disease (IHD) mortality by similar to 7,000 deaths per year, which is equivalent to 16 million people increasing their physical activity level from inactive (0 hours/week of physical activity) to sufficiently active (>2.5 hours/week of physical activity). Inequality for NO2 concentration is greater than inequality for income (Atkinson Index: 0.11 versus 0.08). Low-income nonwhite young children and elderly people are disproportionately exposed to residential outdoor NO2. Our findings establish a national context for previous work that has documented air pollution environmental injustice and inequality within individual US metropolitan areas and regions. Results given here can aid policy-makers in identifying locations with high environmental injustice and inequality. For example, states with both high injustice and high inequality (top quintile) for outdoor residential NO2 include New York, Michigan, and Wisconsin.	[Clark, Lara P.; Millet, Dylan B.; Marshall, Julian D.] Univ Minnesota, Dept Civil Engn, Minneapolis, MN 55455 USA; [Millet, Dylan B.] Univ Minnesota, Dept Soil Water & Climate, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Marshall, JD (corresponding author), Univ Minnesota, Dept Civil Engn, Minneapolis, MN 55455 USA.	julian@umn.edu	Marshall, Julian/AAC-1376-2020; Millet, Dylan B/G-5832-2012	Marshall, Julian/0000-0003-4087-1209; 	University of Minnesota; National Science Foundation [0853467]	University of Minnesota(University of Minnesota System); National Science Foundation(National Science Foundation (NSF))	This material is based upon work partially supported by University of Minnesota and by the National Science Foundation under Grant No. 0853467. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON SJ, 1978, ATMOS ENVIRON, V12, P1531, DOI 10.1016/0004-6981(78)90097-5; Beckerman B, 2008, ATMOS ENVIRON, V42, P275, DOI 10.1016/j.atmosenv.2007.09.042; Bell ML, 2012, ENVIRON HEALTH PERSP, V120, P1699, DOI 10.1289/ehp.1205201; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Brauer M, 2008, ENVIRON HEALTH PERSP, V116, P680, DOI 10.1289/ehp.10952; Brooks N, 1997, J ENVIRON ECON MANAG, V32, P233, DOI 10.1006/jeem.1996.0967; BROWN P, 1995, ENVIRON RES, V69, P15, DOI 10.1006/enrs.1995.1021; Chakraborty J, 2011, AM J PUBLIC HEALTH, V101, pS27, DOI 10.2105/AJPH.2010.300109; Chiusolo M, 2011, ENVIRON HEALTH PERSP, V119, P1233, DOI 10.1289/ehp.1002904; Council on Environmental Quality, 1971, 2 COUNC ENV QUAL; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Downey L, 2008, ORGAN ENVIRON, V21, P270, DOI 10.1177/1086026608321327; Fann N, 2011, RISK ANAL, V36, P1; Filleul L, 2005, OCCUP ENVIRON MED, V62, P453, DOI 10.1136/oem.2004.014746; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; General Accounting Office, 1983, GAORCED83168; Grineski S, 2007, SOC SCI QUART, V88, P535, DOI 10.1111/j.1540-6237.2007.00470.x; HEWITT CN, 1991, ATMOS ENVIRON B-URB, V25, P429, DOI 10.1016/0957-1272(91)90014-6; Jerrett M, 2007, J TOXICOL ENV HEAL A, V70, P200, DOI 10.1080/15287390600883018; Jerrett M, 2013, AM J RESP CRIT CARE, V188, P593, DOI 10.1164/rccm.201303-0609OC; Levy Jonathan I, 2006, Int J Equity Health, V5, P2, DOI 10.1186/1475-9276-5-2; Levy JI, 2007, ENVIRON HEALTH PERSP, V115, P743, DOI 10.1289/ehp.9712; Levy JI, 2009, RISK ANAL, V29, P34, DOI 10.1111/j.1539-6924.2008.01119.x; Lopez R, 2002, ENVIRON HEALTH PERSP, V110, P289, DOI 10.1289/ehp.02110s2289; Marshall JD, 2008, ATMOS ENVIRON, V42, P5499, DOI 10.1016/j.atmosenv.2008.02.005; Miranda ML, 2011, INT J ENV RES PUB HE, V8, P1755, DOI 10.3390/ijerph8061755; Mohai P, 2009, ANNU REV ENV RESOUR, V34, P405, DOI 10.1146/annurev.environ.082508-094348; Morello-Frosch R, 2006, ENVIRON HEALTH PERSP, V114, P386, DOI 10.1289/ehp.8500; Novotny EV, 2011, ENVIRON SCI TECHNOL, V45, P4407, DOI 10.1021/es103578x; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Post ES, 2011, INT J ENV RES PUB HE, V8, P1872, DOI 10.3390/ijerph8061872; Schweitzer L, 2004, J PLAN LIT, V18, P383, DOI 10.1177/0885412204262958; Schweitzer L, 2010, J AM PLANN ASSOC, V76, P363, DOI 10.1080/01944363.2010.486623; Stuart AL, 2011, J ENVIRON MANAGE, V92, P1923, DOI 10.1016/j.jenvman.2011.03.003; Su JG, 2012, ENVIRON INT, V40, P79, DOI 10.1016/j.envint.2011.11.003; U. S. Centers for Disease Control, NAT VIT STAT REP DEA; U. S. Central Intelligence Agency, WORLD FACT BOOK 2013; United Church of Christ/Commission on Racial Justice, 1987, TOX WAST RAC US NAT; United States Environmental Protection Agency, OUR NAT AIR STAT TRE; VANARSDOL MD, 1964, J HEALTH HUM BEHAV, V5, P144; VANARSDOL MD, 1966, EKISTIC, V21, P48; World Health Organization, COMP QUANT HLTH RISK; World Health Organization, GLOB HLTH RISKS MORT; Yanosky JD, 2008, J TOXICOL ENV HEAL A, V71, P1593, DOI 10.1080/15287390802414307	44	214	215	5	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94431	10.1371/journal.pone.0094431	http://dx.doi.org/10.1371/journal.pone.0094431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5PW	24736569	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600067
J	Hoffmann, A; Stoffel, MH; Nitzsche, B; Lobsien, D; Seeger, J; Schneider, H; Boltze, J				Hoffmann, Anke; Stoffel, Michael H.; Nitzsche, Bjoern; Lobsien, Donald; Seeger, Johannes; Schneider, Holm; Boltze, Johannes			The Ovine Cerebral Venous System: Comparative Anatomy, Visualization, and Implications for Translational Research	PLOS ONE			English	Article							LARGE ANIMAL-MODEL; ONTOGENIC DEVELOPMENT; CHORDAE WILLISII; CAVERNOUS SINUS; SAGITTAL SINUS; SHEEP; CATHETERIZATION; PATTERN; MIDDLE; BRAIN	Cerebrovascular diseases are significant causes of death and disability in humans. Improvements in diagnostic and therapeutic approaches strongly rely on adequate gyrencephalic, large animal models being demanded for translational research. Ovine stroke models may represent a promising approach but are currently limited by insufficient knowledge regarding the venous system of the cerebral angioarchitecture. The present study was intended to provide a comprehensive anatomical analysis of the intracranial venous system in sheep as a reliable basis for the interpretation of experimental results in such ovine models. We used corrosion casts as well as contrast-enhanced magnetic resonance venography to scrutinize blood drainage from the brain. This combined approach yielded detailed and, to some extent, novel findings. In particular, we provide evidence for chordae Willisii and lateral venous lacunae, and report on connections between the dorsal and ventral sinuses in this species. For the first time, we also describe venous confluences in the deep cerebral venous system and an 'anterior condylar confluent' as seen in humans. This report provides a detailed reference for the interpretation of venous diagnostic imaging findings in sheep, including an assessment of structure detectability by in vivo (imaging) versus ex vivo (corrosion cast) visualization methods. Moreover, it features a comprehensive interspecies-comparison of the venous cerebral angioarchitecture in man, rodents, canines and sheep as a relevant large animal model species, and describes possible implications for translational cerebrovascular research.	[Hoffmann, Anke; Seeger, Johannes] Univ Leipzig, Inst Anat Histol & Embryol, Fac Vet Med, D-04109 Leipzig, Germany; [Stoffel, Michael H.] Univ Bern, Vetsuisse Fac, Div Vet Anat, Bern, Switzerland; [Nitzsche, Bjoern; Boltze, Johannes] Fraunhofer Inst Cell Therapy & Immunol, Dept Cell Therapy, Leipzig, Germany; [Lobsien, Donald] Univ Hosp Leipzig, Dept Neuroradiol, Leipzig, Germany; [Schneider, Holm] Univ Hosp Erlangen, Dept Pediat, Erlangen, Germany; [Boltze, Johannes] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Boltze, Johannes] Massachusetts Gen Hosp, Charlestown, MA USA; [Boltze, Johannes] Harvard Univ, Sch Med, Neurovasc Regulat Lab, Neurosci Ctr, Charlestown, MA USA	Leipzig University; University of Bern; Fraunhofer Gesellschaft; Leipzig University; University of Erlangen Nuremberg; Leipzig University; Harvard University; Massachusetts General Hospital; Harvard University	Boltze, J (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Dept Cell Therapy, Leipzig, Germany.	johannes.boltze@izi.fraunhofer.de	Stoffel, Michael Hubert/I-6939-2015	Stoffel, Michael Hubert/0000-0002-4699-5125; Nitzsche, Bjorn/0000-0002-4759-0760; Boltze, Johannes/0000-0003-3956-4164	University of Leipzig; Fraunhofer-Institute of Cell Therapy and Immunology	University of Leipzig; Fraunhofer-Institute of Cell Therapy and Immunology	This project was financed by intramural funds and resources provided by the University of Leipzig and the Fraunhofer-Institute of Cell Therapy and Immunology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo C, 2002, OPERATIVE NEUROSURGI, P37; Anson BJ, 1966, BLAKISTONDIVISION; ARMSTRONG LD, 1971, AM J ANAT, V132, P479, DOI 10.1002/aja.1001320406; Ashwini C.A., 2008, NEUROANATOMY, V7, P54; Benninghoff A, 1993, MAKROSKOPISCHE ANATO, P361; Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89; Budras K. D., 2007, ANATOMY DOG; Cimsit NC, 2003, NEURORADIOLOGY, V45, P900, DOI 10.1007/s00234-003-1103-0; Erden H, 1993, SELCUK U VET FAK DER, V9, P75; Evans H.E., 1993, MILLERS ANATOMY DOG; Fink JN, 2001, NEUROLOGY, V57, P1739, DOI 10.1212/WNL.57.9.1739; Forschler A, 2007, ROFO-FORTSCHR RONTG, V179, P516, DOI 10.1055/s-2007-962977; Georgescu B, 2010, B UASVM VET MED, V67; GODYNICKI S, 1981, ZBL VET MED C, V10, P227; HALES JRS, 1972, PFLUG ARCH EUR J PHY, V337, P81, DOI 10.1007/BF00587875; Haziroglu R. M., 1994, Veteriner Fakultesi Dergisi, Ankara Universitesi, V41, P533; K?nig, 1979, ANATOMIE ENTWICKLUNG; Kandziora F, 2001, SPINE, V26, P1028, DOI 10.1097/00007632-200105010-00008; KHAMAS WA, 1984, AM J VET RES, V45, P156; Khan M, 2010, STROKE RES TREAT, V2010, DOI 10.4061/2010/956302; Kilic Turker, 2008, Front Neurol Neurosci, V23, P4; Krayenbuahl HA., 1982, CEREBRAL ANGIOGRAPHY; Massoud TF, 2000, AM J NEURORADIOL, V21, P1268; Mehra M, 2012, J NEUROINTERV SURG, V4, P307, DOI 10.1136/neurintsurg-2011-010101; Miller M., 1965, MEDICINA ACAD, V151, P610, DOI [10.1002/ar.1091510412, DOI 10.1002/AR.1091510412]; Nickel R, 1984, LEHRBUCH ANATOMIE HA, P174; Patel N, 2009, SEMIN ULTRASOUND CT, V30, P513, DOI 10.1053/j.sult.2009.08.003; Ruiz DS, 2002, AM J NEURORADIOL, V23, P1500; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; SCHMUTZ HK, 1980, ACTA ANAT, V108, P94; Schnabl J, 2012, OTOL NEUROTOL, V33, P481, DOI 10.1097/MAO.0b013e318248ee3a; Schutze M, 2007, LAB ANIM-UK, V41, P492, DOI 10.1258/002367707782314319; SCHUMACHER M, 1984, NEURORADIOLOGY, V26, P137, DOI 10.1007/BF00339862; Schunke M, 2010, ATLAS ANATOMY, P412; Scott JN, 2003, NEUROIMAG CLIN N AM, V13, P1, DOI 10.1016/S1052-5149(02)00062-X; Scremin OU, 2004, RAT NERVOUS SYSTEM; Sharifi M, 2004, J NEUROSURG, V101, P832, DOI 10.3171/jns.2004.101.5.0832; Sun J, 2011, AJNR Am J Neuroradiol, V32, pE191, DOI 10.3174/ajnr.A2308; SZABO K, 1990, ANAT EMBRYOL, V182, P225; SZABO K, 1995, ANN ANAT, V177, P313, DOI 10.1016/S0940-9602(11)80371-7; Traystman RJ, 2003, ILAR J, V44, P85, DOI 10.1093/ilar.44.2.85; Trolard P, 1868, THESIS FM PARIS PARI; Tsutsumi S, 2013, CHILD NERV SYST, V29, P465, DOI 10.1007/s00381-012-1966-7; Tubbs RS, 2007, CLIN ANAT, V20, P755, DOI 10.1002/ca.20494; Viegas LD, 2014, CEREBROVASC DIS, V37, P43, DOI 10.1159/000356840; Weed LH, 1914, J MED RES, V31, P51; Wells AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042157; WOLF BS, 1955, RADIOLOGY, V64, P161, DOI 10.1148/64.2.161; Xu CH, 2010, J INT MED RES, V38, P1596, DOI 10.1177/147323001003800504	49	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e92990	10.1371/journal.pone.0092990	http://dx.doi.org/10.1371/journal.pone.0092990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736654	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600012
J	Hoffmann, BD; Auina, S; Stanley, MC				Hoffmann, Benjamin D.; Auina, Saronna; Stanley, Margaret C.			Targeted Research to Improve Invasive Species Management: Yellow Crazy Ant Anoplolepis gracilipes in Samoa	PLOS ONE			English	Article							LONGIPES JERDON HYMENOPTERA; BIOLOGICAL-CONTROL AGENT; DIORHABDA-CARINULATA; BIOTIC RESISTANCE; LIFE-HISTORY; BIRD-ISLAND; RAIN-FOREST; IMPACT; ERADICATION; FORMICIDAE	Lack of biological knowledge of invasive species is recognised as a major factor contributing to eradication failure. Management needs to be informed by a site-specific understanding of the invasion system. Here, we describe targeted research designed to inform the potential eradication of the invasive yellow crazy ant Anoplolepis gracilipes on Nu'utele island, Samoa. First, we assessed the ant's impacts on invertebrate biodiversity by comparing invertebrate communities between infested and uninfested sites. Second, we investigated the timing of production of sexuals and seasonal variation of worker abundance and nest density. Third, we investigated whether an association existed between A. gracilipes and carbohydrate sources. Within the infested area there were few other ants larger than A. gracilipes, as well as fewer spiders and crabs, indicating that A. gracilipes is indeed a significant conservation concern. The timing of male reproduction appears to be consistent with places elsewhere in the world, but queen reproduction was outside of the known reproductive period for this species in the region, indicating that the timing of treatment regimes used elsewhere are not appropriate for Samoa. Worker abundance and nest density were among the highest recorded in the world, being greater in May than in October. These abundance and nest density data form baselines for quantifying treatment efficacy and set sampling densities for post-treatment assessments. The number of plants and insects capable of providing a carbohydrate supply to ants were greatest where A. gracilipes was present, but it is not clear if this association is causal. Regardless, indirectly controlling ant abundance by controlling carbohydrate supply appears to be promising avenue for research. The type of targeted, site-specific research such as that described here should be an integral part of any eradication program for invasive species to design knowledge-based treatment protocols and determine assessment benchmarks to achieve eradication.	[Hoffmann, Benjamin D.] CSIRO Ecosyst Sci, Trop Ecosyst Res Ctr, Darwin, NT, Australia; [Auina, Saronna; Stanley, Margaret C.] Univ Auckland, Sch Biol Sci, Ctr Biodivers & Biosecur, Auckland 1, New Zealand	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Auckland	Hoffmann, BD (corresponding author), CSIRO Ecosyst Sci, Trop Ecosyst Res Ctr, Darwin, NT, Australia.	Ben.Hoffmann@csiro.au	Hoffmann, Ben D/A-2746-2011; Stanley, Margaret/F-2580-2011	Hoffmann, Ben D/0000-0002-4010-4723; Stanley, Margaret/0000-0003-0701-8935	University of Auckland; Secretariate of the Pacific Regional Environmental Program	University of Auckland; Secretariate of the Pacific Regional Environmental Program	Financial support was provided by University of Auckland and the Secretariate of the Pacific Regional Environmental Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KL, 2007, BIOL INVASIONS, V9, P453, DOI 10.1007/s10530-006-9052-2; Abbott KL, 2005, INSECT SOC, V52, P266, DOI 10.1007/s00040-005-0800-6; Abbott KL, 2006, DELIMITING SURVEY YE; ABBOTT KL, 2004, THESIS MONASH U MELB; BAKER GL, 1976, INSECT SOC, V23, P253, DOI 10.1007/BF02283900; Bean DW, 2012, EVOL APPL, V5, P511, DOI 10.1111/j.1752-4571.2012.00262.x; Bohn T, 2004, OIKOS, V106, P138, DOI 10.1111/j.0030-1299.2004.13022.x; Bos MM, 2008, BIOL INVASIONS, V10, P1399, DOI 10.1007/s10530-008-9215-4; Donlan CJ, 2003, CONSERV BIOL, V17, P1850, DOI 10.1111/j.1523-1739.2003.00012.x; Drescher J, 2007, MOL ECOL, V16, P1453, DOI 10.1111/j.1365-294X.2007.03260.x; Dudley TL, 2012, PAN-PAC ENTOMOL, V88, P319, DOI 10.3956/2011-10.1; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Gerlach J, 2004, J INSECT CONSERV, V8, P15, DOI 10.1023/B:JICO.0000027454.78591.97; Gillespie Rosemary G., 1993, Pacific Science, V47, P21; GREENSLADE P J M, 1971, Journal of the Australian Entomological Society, V10, P241; Gruber MAM, 2013, INSECT SOC, V60, P135, DOI 10.1007/s00040-012-0277-z; Gruber MAM, 2012, ECOL EVOL, V2, P2091, DOI 10.1002/ece3.313; Gruber MAM, 2012, DIVERS DISTRIB, V18, P323, DOI 10.1111/j.1472-4642.2011.00833.x; HAINES IH, 1978, ECOL ENTOMOL, V3, P109, DOI 10.1111/j.1365-2311.1978.tb00909.x; HAINES IH, 1978, B ENTOMOL RES, V68, P627, DOI 10.1017/S0007485300009603; Helms KR, 2008, ENVIRON ENTOMOL, V37, P487, DOI 10.1603/0046-225X(2008)37[487:PRACGI]2.0.CO;2; Hill M, 2003, BIODIVERS CONSERV, V12, P1969, DOI 10.1023/A:1024151630204; Hoffmann BD, 1999, OECOLOGIA, V120, P595, DOI 10.1007/PL00008824; Hoffmann BD, 2011, STATUS IMPACTS YELLO; Hoffmann Ben, 2011, Aliens (Auckland), V31, P16; Hoffmann BD, 2010, BIOL INVASIONS, V12, P3093, DOI 10.1007/s10530-010-9701-3; Hoffmann BD, 2009, BIOL INVASIONS, V11, P1403, DOI 10.1007/s10530-008-9348-5; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Howald G, 2007, CONSERV BIOL, V21, P1258, DOI 10.1111/j.1523-1739.2007.00755.x; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Kelehear C, 2012, ECOL LETT, V15, P329, DOI 10.1111/j.1461-0248.2012.01742.x; Kumschick S, 2013, DIVERS DISTRIB, V19, P1095, DOI 10.1111/ddi.12110; Lach L, 2010, ANT ECOLOGY, P261; Lambertini M, 2011, SCIENCE, V333, P404, DOI 10.1126/science.333.6041.404-b; Lester Philip J., 2004, Pacific Science, V58, P391, DOI 10.1353/psc.2004.0031; Leung B, 2002, P ROY SOC B-BIOL SCI, V269, P2407, DOI 10.1098/rspb.2002.2179; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Marr R.M., 2003, ASSESSMENT NONTARGET; McNatty A, 2009, OECOLOGIA, V160, P187, DOI 10.1007/s00442-009-1279-z; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; O'Dowd DJ, 2003, ECOL LETT, V6, P812, DOI 10.1046/j.1461-0248.2003.00512.x; RAO NS, 1991, ENTOMON, V16, P261; Ricciardi A, 2004, ECOL LETT, V7, P781, DOI 10.1111/j.1461-0248.2004.00642.x; Rowles AD, 2009, OECOLOGIA, V161, P161, DOI 10.1007/s00442-009-1368-z; Sarty M, 2006, OECOLOGIA, V149, P465, DOI 10.1007/s00442-006-0453-9; Savage AM, 2011, AUSTRAL ECOL, V36, P310, DOI 10.1111/j.1442-9993.2010.02152.x; Savage AM, 2009, DIVERS DISTRIB, V15, P751, DOI 10.1111/j.1472-4642.2009.00579.x; Shik JZ, 2013, BIOL INVASIONS, V15, P829, DOI 10.1007/s10530-012-0330-x; Stanley MC, 2013, ARTHROPOD-PLANT INTE, V7, P59, DOI 10.1007/s11829-012-9215-2; Thomas ML, 2010, BIOL INVASIONS, V12, P677, DOI 10.1007/s10530-009-9473-9; Touyama Y, 2008, INSECT SOC, V55, P144, DOI 10.1007/s00040-008-0983-8; Tschinkel WR., 2006, FIRE ANTS; Vanderwoude C, 2006, ASSESSMENT YELLOW CR; Veitch C. R., 2011, ISLAND INVASIVES ERA; Vonshak M, 2012, BIOL INVASIONS, V14, P851, DOI 10.1007/s10530-011-0122-8; Ward DF, 2010, N Z ENTOMOL, V33, P68, DOI 10.1080/00779962.2010.9722193; Wetterer James K., 2003, Pacific Science, V57, P409, DOI 10.1353/psc.2003.0036; Wetterer JK, 2005, SOCIOBIOLOGY, V45, P77; Wilder SM, 2011, P NATL ACAD SCI USA, V108, P20639, DOI 10.1073/pnas.1115263108; WILLIAMS DF, 1994, WESTV STUD, P282; Young G.R., 1996, Papua New Guinea Journal of Agriculture Forestry and Fisheries, V39, P10	62	6	8	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95301	10.1371/journal.pone.0095301	http://dx.doi.org/10.1371/journal.pone.0095301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736559	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600166
J	Mihaly, SR; Morioka, S; Ninomiya-Tsuji, J; Takaesu, G				Mihaly, September R.; Morioka, Sho; Ninomiya-Tsuji, Jun; Takaesu, Giichi			Activated Macrophage Survival Is Coordinated by TAK1 Binding Proteins	PLOS ONE			English	Article							NF-KAPPA-B; REACTIVE OXYGEN; KINASE TAK1; CELL-DEATH; SIGNALING PATHWAYS; TAB1; APOPTOSIS; NECROSIS; RECEPTOR; IL-1	Macrophages play diverse roles in tissue homeostasis and immunity, and canonically activated macrophages are critically associated with acute inflammatory responses. It is known that activated macrophages undergo cell death after transient activation in some settings, and the viability of macrophages impacts on inflammatory status. Here we report that TGF beta-activated kinase (TAK1) activators, TAK1-binding protein 1 (TAB1) and TAK1-binding protein 2 (TAB2), are critical molecules in the regulation of activated macrophage survival. While deletion of Tak1 induced cell death in bone marrow derived macrophages even without activation, Tab1 or Tab2 deletion alone did not profoundly affect survival of naive macrophages. However, in lipopolysaccharide (LPS)-activated macrophages, even single deletion of Tab1 or Tab2 resulted in macrophage death with both necrotic and apoptotic features. We show that TAB1 and TAB2 were redundantly involved in LPS-induced TAK1 activation in macrophages. These results demonstrate that TAK1 activity is the key to activated macrophage survival. Finally, in an in vivo setting, Tab1 deficiency impaired increase of peritoneal macrophages upon LPS challenge, suggesting that TAK1 complex regulation of macrophages may participate in in vivo macrophage homeostasis. Our results demonstrate that TAB1 and TAB2 are required for activated macrophages, making TAB1 and TAB2 effective targets to control inflammation by modulating macrophage survival.	[Mihaly, September R.; Morioka, Sho; Ninomiya-Tsuji, Jun; Takaesu, Giichi] N Carolina State Univ, Dept Biol Sci Environm & Mol Toxicol, Raleigh, NC 27695 USA; [Takaesu, Giichi] Keio Univ, Sch Med, Dept Microbiol & Immunol, Ctr Integrated Med Res, Tokyo, Japan	University of North Carolina; North Carolina State University; Keio University	Ninomiya-Tsuji, J (corresponding author), N Carolina State Univ, Dept Biol Sci Environm & Mol Toxicol, Raleigh, NC 27695 USA.	Jun_Tsuji@ncsu.edu; takaesug@med.u-ryukyu.ac.jp	Morioka, Sho/I-2074-2019	Morioka, Sho/0000-0002-1153-4919; Ninomiya-Tsuji, Jun/0000-0002-5584-0176; Takaesu, Giichi/0000-0002-1581-1055	"Keio Kanrinmaru Project," the Promotion of Environmental Improvement for Independence of Young Researchers under the Special Coordination Funds for Promoting Science and Technology (JST, Japan); National Institutes of Health [GM068812]; NATIONAL CANCER INSTITUTE [F31CA171675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068812] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25860322] Funding Source: KAKEN	"Keio Kanrinmaru Project," the Promotion of Environmental Improvement for Independence of Young Researchers under the Special Coordination Funds for Promoting Science and Technology (JST, Japan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by "Keio Kanrinmaru Project," the Promotion of Environmental Improvement for Independence of Young Researchers under the Special Coordination Funds for Promoting Science and Technology (JST, Japan) (to G. T.), and National Institutes of Health Grant GM068812 (to J.N-T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajibade A. A., 2012, IMMUNITY, V36, P1; Badea TC, 2003, J NEUROSCI, V23, P2314; Bettermann K, 2010, CANCER CELL, V17, P481, DOI 10.1016/j.ccr.2010.03.021; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Cheung PCF, 2004, BIOCHEM J, V378, P27, DOI 10.1042/BJ20031794; Chorro L, 2010, TRENDS IMMUNOL, V31, P438, DOI 10.1016/j.it.2010.09.003; Eftychi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031550; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Inagaki M, 2008, GENESIS, V46, P431, DOI 10.1002/dvg.20418; Inagaki M, 2008, J BIOL CHEM, V283, P33080, DOI 10.1074/jbc.M807574200; Inokuchi S, 2010, P NATL ACAD SCI USA, V107, P844, DOI 10.1073/pnas.0909781107; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jadrich JL, 2006, DEVELOPMENT, V133, P1529, DOI 10.1242/dev.02333; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Ji K, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/627325; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kajino-Sakamoto R, 2008, J IMMUNOL, V181, P1143, DOI 10.4049/jimmunol.181.2.1143; Kajino-Sakamoto R, 2010, J IMMUNOL, V185, P4729, DOI 10.4049/jimmunol.0903587; Kanayama A, 2004, MOL CELL, V15, P535, DOI 10.1016/j.molcel.2004.08.008; Kishida S, 2005, GENES CELLS, V10, P447, DOI 10.1111/j.1365-2443.2005.00852.x; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Komatsu Y, 2002, MECH DEVELOP, V119, P239, DOI 10.1016/S0925-4773(02)00391-X; Lamothe B, 2013, MOL CELL BIOL, V33, P582, DOI 10.1128/MCB.01225-12; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Omori E, 2008, J BIOL CHEM, V283, P26161, DOI 10.1074/jbc.M804513200; Omori E, 2012, P NATL ACAD SCI USA, V109, P3365, DOI 10.1073/pnas.1116188109; Omori E, 2006, J BIOL CHEM, V281, P19610, DOI 10.1074/jbc.M603384200; Ono K, 2001, J BIOL CHEM, V276, P24396, DOI 10.1074/jbc.M102631200; Ori D, 2013, J IMMUNOL, V190, P4037, DOI 10.4049/jimmunol.1300173; Park JM, 2005, IMMUNITY, V23, P319, DOI 10.1016/j.immuni.2005.08.010; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Sanjo H, 2003, MOL CELL BIOL, V23, P1231, DOI 10.1128/MCB.23.4.1231-1238.2003; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2006, INT IMMUNOL, V18, P1405, DOI 10.1093/intimm/dxl082; Scholz R, 2010, J BIOL CHEM, V285, P25753, DOI 10.1074/jbc.M109.093468; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Singhirunnusorn P, 2005, J BIOL CHEM, V280, P7359, DOI 10.1074/jbc.M407537200; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Takaesu G, 2003, J MOL BIOL, V326, P105, DOI 10.1016/S0022-2836(02)01404-3; Takaesu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051073; Tang MH, 2008, J EXP MED, V205, P1611, DOI 10.1084/jem.20080297; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Weigert A, 2006, BLOOD, V108, P1635, DOI 10.1182/blood-2006-04-014852; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247	53	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94982	10.1371/journal.pone.0094982	http://dx.doi.org/10.1371/journal.pone.0094982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736749	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600117
J	Salimi, V; Abbasi, S; Zahraei, SM; Fatemi-Nasab, G; Adjaminezhad-Fard, F; Shadab, A; Ghavami, N; Zareh-Khoshchehre, R; Soltanshahi, R; Bont, L; Mokhtari-Azad, T				Salimi, Vahid; Abbasi, Simin; Zahraei, Seyed Mohsen; Fatemi-Nasab, Ghazal; Adjaminezhad-Fard, Fatemeh; Shadab, Azadeh; Ghavami, Nastaran; Zareh-Khoshchehre, Raziyeh; Soltanshahi, Rambod; Bont, Louis; Mokhtari-Azad, Talat			Implementation of a National Measles Elimination Program in Iran: Phylogenetic Analysis of Measles Virus Strains Isolated during 2010-2012 Outbreaks	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; DIAGNOSIS; COUNTRIES; GENOTYPES	Measles virus (MV) causes small and large outbreaks in Iran. Molecular assays allow identifying and the sources of measles imported from neighboring countries. We carried out a phylogenetic analysis of measles virus circulating in Iran over the period 2010-2012. Specimens from suspected cases of measles were collected from different regions of Iran. Virus isolation was performed on urine and throat swabs. Partial nucleoprotein gene segments of MV were amplified by RT-PCR. PCR products of 173 samples were sequenced and analyzed. The median age of confirmed cases was 2 years. Among all confirmed cases, 32% had unknown vaccination status, 20% had been vaccinated, and 48% had not been vaccinated. Genotypes B3 and D8 (for the first time), H1 and D4 were detected mainly in unvaccinated toddlers and young children. Genotype B3 became predominant in 2012 and was closely related to African strains. H1 strains were also found in small and large outbreaks during 2012 but were not identical to Iranian H1-2009 strains. A majority of the Iranian D4 strains during 2010-2012 outbreaks were linked to the D4 strain identified in the Pakistan in 2007. We identified a single case in 2010 belonging to D8 genotype with 99.7% identity to Indian isolates. Although the vaccination program is currently good enough to prevent nationwide epidemics and successfully decreased measles incidence in Iran, the fraction of protected individuals in the population was not high enough to prevent continuous introduction of cases from abroad. Due to increasing number of susceptible individuals in some areas, sustained transmission of the newly introduced viral genotype remains possible.	[Salimi, Vahid; Abbasi, Simin; Ghavami, Nastaran; Zareh-Khoshchehre, Raziyeh; Mokhtari-Azad, Talat] Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran; [Salimi, Vahid; Fatemi-Nasab, Ghazal; Adjaminezhad-Fard, Fatemeh; Shadab, Azadeh; Mokhtari-Azad, Talat] Univ Tehran Med Sci, Sch Publ Hlth, Natl Reference Lab Measles & Rubella, Tehran, Iran; [Zahraei, Seyed Mohsen; Soltanshahi, Rambod] Minist Hlth & Med Educ, Ctr Communicable Dis Control, Vaccine Preventable Dis Dept, Tehran, Iran; [Bont, Louis] Univ Med Ctr Utrecht, Dept Pediat, Utrecht, Netherlands; [Bont, Louis] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Mokhtari-Azad, T (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran.	mokhtari@sina.tums.ac.ir	Bont, Louis/J-6370-2014	Salimi, Vahid/0000-0002-8541-7846; Zahraei, Seyed Mohsen/0000-0002-1940-2216	Ministry of Health and Medical Education in Iran	Ministry of Health and Medical Education in Iran	This study received financial support from the Ministry of Health and Medical Education in Iran. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, Wkly Epidemiol Rec, V88, P29; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P229; Bankamp B, 2013, J CLIN VIROL, V58, P176, DOI 10.1016/j.jcv.2013.05.018; Carr MJ, 2009, J MED VIROL, V81, P125, DOI 10.1002/jmv.21365; Cheng WY, 2013, J MED VIROL, V85, P1095, DOI 10.1002/jmv.23563; Demanou M, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-71; Djebbi A, 2005, J CLIN VIROL, V34, P1, DOI 10.1016/j.jcv.2004.11.026; Esteghamati A, 2007, PEDIATR INFECT DIS J, V26, P1137, DOI 10.1097/INF.0b013e3181462090; Griffin DE, 2001, MEASLES VIRUS FIELDS, P1401; Jayamaha J, 2012, J CLIN VIROL, V54, P168, DOI 10.1016/j.jcv.2012.02.025; Naseri M, 2011, IRAN J PUBLIC HEALTH, V40, P41; Ono N, 2001, J VIROL, V75, P4399, DOI 10.1128/JVI.75.9.4399-4401.2001; Rota J, 2006, EMERG INFECT DIS, V12, P1779, DOI 10.3201/eid1211.060635; Rota PA, 2011, J INFECT DIS, V204, pS514, DOI 10.1093/infdis/jir118; Salimi V, 2011, J MED VIROL, V83, P2200, DOI 10.1002/jmv.22220; Shakya AK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-237; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tricou V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-103; Vainio K, 2012, EURO SURVEILL, V17; van Binnendijk RS, 2003, J INFECT DIS, V188, P898, DOI 10.1086/377103; Wairagkar N, 2011, J INFECT DIS, V204, pS403, DOI 10.1093/infdis/jir150; WHO, 2007, MAN DIAGN MEASL RUB; Zahraei SM, 2011, J INFECT DIS, V204, pS305, DOI 10.1093/infdis/jir076	23	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94846	10.1371/journal.pone.0094846	http://dx.doi.org/10.1371/journal.pone.0094846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736720	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600096
J	Tian, YL; Zheng, CY; Chen, J; Chen, CQ; Deng, AX; Song, ZW; Zhang, BM; Zhang, WJ				Tian, Yunlu; Zheng, Chengyan; Chen, Jin; Chen, Changqing; Deng, Aixing; Song, Zhenwei; Zhang, Baoming; Zhang, Weijian			Climatic Warming Increases Winter Wheat Yield but Reduces Grain Nitrogen Concentration in East China	PLOS ONE			English	Article							TEMPERATURE TRENDS; CROP PRODUCTION; DRY-MATTER; REMOBILIZATION; IMPACT; GROWTH; ACCUMULATION; PRODUCTIVITY; PREANTHESIS; SENESCENCE	Climatic warming is often predicted to reduce wheat yield and grain quality in China. However, direct evidence is still lacking. We conducted a three-year experiment with a Free Air Temperature Increase (FATI) facility to examine the responses of winter wheat growth and plant N accumulation to a moderate temperature increase of 1.5 degrees C predicted to prevail by 2050 in East China. Three warming treatments (AW: all-day warming; DW: daytime warming; NW: nighttime warming) were applied for an entire growth period. Consistent warming effects on wheat plant were recorded across the experimental years. An increase of ca. 1.5 degrees C in daily, daytime and nighttime mean temperatures shortened the length of pre-anthesis period averagely by 12.7, 8.3 and 10.7 d (P<0.05), respectively, but had no significant impact on the length of the post-anthesis period. Warming did not significantly alter the aboveground biomass production, but the grain yield was 16.3, 18.1 and 19.6% (P<0.05) higher in the AW, DW and NW plots than the non-warmed plot, respectively. Warming also significantly increased plant N uptake and total biomass N accumulation. However, warming significantly reduced grain N concentrations while increased N concentrations in the leaves and stems. Together, our results demonstrate differential impacts of warming on the depositions of grain starch and protein, highlighting the needs to further understand the mechanisms that underlie warming impacts on plant C and N metabolism in wheat.	[Tian, Yunlu; Chen, Changqing; Zhang, Weijian] Nanjing Agr Univ, Inst Appl Ecol, Nanjing, Jiangsu, Peoples R China; [Zheng, Chengyan; Deng, Aixing; Song, Zhenwei; Zhang, Baoming; Zhang, Weijian] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Crop Physiol & Ecol, Minist Agr, Beijing 100193, Peoples R China; [Chen, Jin] Minist Agr, Soil & Fertilizer & Resources & Environm Inst, Jiangxi Acad Agr Sci, Key Lab Crop Ecophysiol & Farming Syst Middle & L, Nanchang, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Zhang, WJ (corresponding author), Nanjing Agr Univ, Inst Appl Ecol, Nanjing, Jiangsu, Peoples R China.	zwj@njau.edu.cn		Song, Zhenwei/0000-0001-9057-2157	National Basic Research Program of China [2010CB951501]; National Key Technology Support Program of China [2011BAD16B14]; Chinese Nature Science Foundation [30771278]; Chinese Academy of Agricultural Sciences	National Basic Research Program of China(National Basic Research Program of China); National Key Technology Support Program of China(National Key Technology R&D Program); Chinese Nature Science Foundation; Chinese Academy of Agricultural Sciences	This work was supported by the National Basic Research Program of China (2010CB951501), the National Key Technology Support Program of China (2011BAD16B14), the Chinese Nature Science Foundation (30771278) and the innovation program of Chinese Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khatib K, 1999, CROP SCI, V39, P119, DOI 10.2135/cropsci1999.0011183X003900010019x; Aronson EL, 2009, AGR FOREST METEOROL, V149, P1791, DOI 10.1016/j.agrformet.2009.06.007; Barbottin A, 2005, CROP SCI, V45, P1141, DOI 10.2135/cropsci2003.0361; BHULLAR SS, 1985, AUST J PLANT PHYSIOL, V12, P363, DOI 10.1071/PP9850363; Bloom AJ, 2010, SCIENCE, V328, P899, DOI 10.1126/science.1186440; BONNETT GD, 1992, ANN BOT-LONDON, V69, P219, DOI 10.1093/oxfordjournals.aob.a088333; Borghi B, 1997, EUR J AGRON, V6, P145, DOI 10.1016/S1161-0301(96)02040-0; Chavas DR, 2009, AGR FOREST METEOROL, V149, P1118, DOI 10.1016/j.agrformet.2009.02.001; Cheng L, 2012, SCIENCE, V337, P1084, DOI 10.1126/science.1224304; Cui KH, 2002, THEOR APPL GENET, V105, P745, DOI 10.1007/s00122-002-0908-2; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Fang SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067518; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Gebbing T, 1998, PLANT CELL ENVIRON, V21, P301, DOI 10.1046/j.1365-3040.1998.00286.x; Gregersen PL, 2008, PLANT BIOLOGY, V10, P37, DOI 10.1111/j.1438-8677.2008.00114.x; HERZOG H, 1983, EUPHYTICA, V32, P511, DOI 10.1007/BF00021463; Hou RX, 2012, ECOL EVOL, V2, P2999, DOI 10.1002/ece3.403; IPCC, 2007, CONTRIBUTION WORKING; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; Kimball BA, 2009, AGR FOREST METEOROL, V149, P721, DOI 10.1016/j.agrformet.2008.09.015; Larmure A, 2005, FUNCT PLANT BIOL, V32, P1009, DOI 10.1071/FP05154; Liu HJ, 2006, BIOSYST ENG, V95, P349, DOI 10.1016/j.biosystemseng.2006.07.010; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2007, AGR FOREST METEOROL, V145, P229, DOI 10.1016/j.agrformet.2007.05.002; Lobell DB, 2007, AGRON J, V99, P469, DOI 10.2134/agronj2006.0209; Lobell DB, 2012, NAT CLIM CHANGE, V2, P186, DOI [10.1038/nclimate1356, 10.1038/NCLIMATE1356]; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; NELSON DW, 1973, AGRON J, V65, P109, DOI 10.2134/agronj1973.00021962006500010033x; Nicholls N, 1997, NATURE, V387, P484, DOI 10.1038/387484a0; Nijs I, 1996, PLANT CELL ENVIRON, V19, P495, DOI 10.1111/j.1365-3040.1996.tb00343.x; Ortiz R, 2008, AGR ECOSYST ENVIRON, V126, P46, DOI 10.1016/j.agee.2008.01.019; Ottman MJ, 2012, AGRON J, V104, P7, DOI 10.2134/agronj2011.0212; PALTA JA, 1995, AUST J AGR RES, V46, P507, DOI 10.1071/AR9950507; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Porter JR, 2005, PHILOS T R SOC B, V360, P2021, DOI 10.1098/rstb.2005.1752; RANDALL PJ, 1990, AUST J AGR RES, V41, P603, DOI 10.1071/AR9900603; RAWSON HM, 1971, AUST J AGR RES, V22, P851, DOI 10.1071/AR9710851; Sadras VO, 2006, FIELD CROP RES, V99, P136, DOI 10.1016/j.fcr.2006.04.003; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Shah NH, 2003, PLANT SOIL, V257, P219, DOI 10.1023/A:1026237816578; Slafer GA, 1995, AUST J PLANT PHYSIOL, V22, P913, DOI 10.1071/PP9950913; Sommer R, 2013, AGR ECOSYST ENVIRON, V178, P78, DOI 10.1016/j.agee.2013.06.011; Stafford N, 2007, NATURE, V448, P526, DOI 10.1038/448526a; Tahir ISA, 2005, J AGRON CROP SCI, V191, P106, DOI 10.1111/j.1439-037X.2004.00127.x; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tubiello FN, 2007, P NATL ACAD SCI USA, V104, P19686, DOI 10.1073/pnas.0701728104; Turnbull MH, 2002, PLANT CELL ENVIRON, V25, P1729, DOI 10.1046/j.1365-3040.2002.00947.x; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wang HL, 2008, AGR FOREST METEOROL, V148, P1242, DOI 10.1016/j.agrformet.2008.03.003; Welch JR, 2010, P NATL ACAD SCI USA, V107, P14562, DOI 10.1073/pnas.1001222107; Xiao GJ, 2008, AGR ECOSYST ENVIRON, V127, P37, DOI 10.1016/j.agee.2008.02.007; You LZ, 2009, AGR FOREST METEOROL, V149, P1009, DOI 10.1016/j.agrformet.2008.12.004; Zhong X, 2008, J AGRON CROP SCI, V194, P343, DOI 10.1111/j.1439-037X.2008.00320.x	53	28	35	7	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95108	10.1371/journal.pone.0095108	http://dx.doi.org/10.1371/journal.pone.0095108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736557	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600146
J	Wang, ZC; Fan, YT; Xu, J; Li, L; Heng, DH; Han, S; Yin, J; Peng, BW; Liu, WH; He, XH				Wang, Zhongcheng; Fan, Yuanteng; Xu, Jian; Li, Liang; Heng, Duanhe; Han, Song; Yin, Jun; Peng, Biwen; Liu, Wanhong; He, Xiaohua			Transcriptome Analysis of the Hippocampus in Novel Rat Model of Febrile Seizures	PLOS ONE			English	Article							HYPERTHERMIA-INDUCED SEIZURES; INFLAMMATORY CYTOKINES; NEUROPEPTIDE-Y; HISTONE H3; THERMOTOLERANCE ACQUISITION; STATUS EPILEPTICUS; GENE-EXPRESSION; EPILEPSY; SUSCEPTIBILITY; BRAIN	Febrile seizures (FS) are the most common type of convulsive events in infants and young children, but the precise underlying genetic mechanism remains to be explored. To investigate the underlying pathogenic factors in FS and subsequent epilepsy, alterations in gene expression between the two new strains of rats (hyperthermia-prone [HP] vs hyperthermia-resistant [HR]), were investigated by using the Whole Rat Genome Oligo Microarray. This process identified 1,140 differentially expressed genes (DEGs; 602 upregulated and 538 downregulated), which were analyzed to determine significant Gene Ontology (GO) categories, signaling pathways and gene networks. Based on the GO analyses, the modified genes are closely related to various FS pathogenesis factors, including immune and inflammatory responses and ion transport. Certain DEGs identified have not been previously examined in relation to FS pathogenesis. Among these genes is dipeptidyl peptidase 4 (DPP4), a gene closely linked to interleukin 6 (IL-6), which played a key role in the gene network analysis. Furthermore, sitagliptin, a DPP4 inhibitor significantly decreased epileptic discharge in rats, observed via electroencephalogram, suggesting an important role for DPP4 in FS. The effectiveness of sitagliptin in reducing seizure activity may occur through a mechanism that stabilizes cellular Ca2+ homeostasis. In addition, DPP4 expression may be regulated by DNA methylation. The hippocampal gene expression profiles in novel rat models of FS provides a large database of candidate genes and pathways, which will be useful for researchers interested in disorders of neuronal excitability.	[Wang, Zhongcheng; Fan, Yuanteng; Xu, Jian; Li, Liang; Heng, Duanhe; Han, Song; Yin, Jun; He, Xiaohua] Wuhan Univ, Dept Pathophysiol, Sch Basic Med Sci, Wuhan 430072, Peoples R China; [Peng, Biwen] Wuhan Univ, Hubei Prov Key Lab Developmentally Originated Dis, Sch Basic Med Sci, Wuhan 430072, Peoples R China; [Liu, Wanhong] Wuhan Univ, Hubei Prov Key Lab Allergy & Immunol, Sch Basic Med Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Liu, WH (corresponding author), Wuhan Univ, Hubei Prov Key Lab Allergy & Immunol, Sch Basic Med Sci, Wuhan 430072, Peoples R China.	liuwanhong@whu.edu.cn; hexiaohua@whu.edu.cn		Wang, Zhongcheng/0000-0001-8971-7742; /0000-0002-5599-6779	National Natural Sciences Foundation of China [81371422, 81171127, 81100970, 81171577]; National Basic Research Program of China [2010CB529803]; National Science and Technology Major Projects of New Drugs [2012ZX09103301-028]; Translational Medical Research Fund of Wuhan University school of medicine	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Projects of New Drugs; Translational Medical Research Fund of Wuhan University school of medicine	This work was supported by the National Natural Sciences Foundation of China (81371422, 81171127, and 81100970), the National Basic Research Program of China (2010CB529803), the National Science and Technology Major Projects of New Drugs (2012ZX09103301-028), Translational Medical Research Fund of Wuhan University school of medicine, and National Natural Sciences Foundation of China No. 81171577. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; An FM, 2012, APOPTOSIS, V17, P702, DOI 10.1007/s10495-012-0704-7; Audenaert D, 2006, NEUROLOGY, V67, P687, DOI 10.1212/01.wnl.0000230145.73496.a2; Baticic L, 2011, J CELL BIOCHEM, V112, P3322, DOI 10.1002/jcb.23261; CAMFIELD P, 1994, DEV MED CHILD NEUROL, V36, P887; Choi J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-135; Chungath M, 2008, NAT CLIN PRACT NEURO, V4, P610, DOI 10.1038/ncpneuro0922; Cui XK, 2011, NEUROSCI LETT, V503, P27, DOI 10.1016/j.neulet.2011.08.001; D'Amico M, 2010, EXP GERONTOL, V45, P202, DOI 10.1016/j.exger.2009.12.004; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; During MJ, 2003, NAT MED, V9, P1173, DOI 10.1038/nm919; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Fukuda M, 2009, SEIZURE-EUR J EPILEP, V18, P211, DOI 10.1016/j.seizure.2008.10.001; Galic MA, 2008, J NEUROSCI, V28, P6904, DOI 10.1523/JNEUROSCI.1901-08.2008; Gilby KL, 2009, BEHAV NEUROSCI, V123, P337, DOI 10.1037/a0014730; Gilman CP, 2003, J NEUROCHEM, V87, P1137, DOI 10.1046/j.1471-4159.2003.02073.x; Gulec G, 2010, NEUROPEPTIDES, V44, P285, DOI 10.1016/j.npep.2010.02.002; Hamati-Haddad A, 1998, NEUROLOGY, V50, P917, DOI 10.1212/WNL.50.4.917; Huang CC, 1999, EPILEPSIA, V40, P719, DOI 10.1111/j.1528-1157.1999.tb00769.x; Huang YF, 2002, J NEUROSCI, V22, P8422; Keane FM, 2011, FEBS J, V278, P1316, DOI 10.1111/j.1742-4658.2011.08051.x; Kisliouk T, 2011, EUR J NEUROSCI, V33, P224, DOI 10.1111/j.1460-9568.2010.07493.x; Kisliouk T, 2010, DEV NEUROBIOL, V70, P100, DOI 10.1002/dneu.20763; Kisliouk T, 2009, EUR J NEUROSCI, V30, P1909, DOI 10.1111/j.1460-9568.2009.06957.x; Lehtimaki KA, 2003, MOL BRAIN RES, V110, P253, DOI 10.1016/S0169-328X(02)00654-X; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Macdonald RL, 2006, ADV PHARMACOL, V54, P147, DOI 10.1016/S1054-3589(06)54007-4; McGuinness C, 2008, FRONT BIOSCI-LANDMRK, V13, P2435, DOI 10.2741/2856; N'Gouemo P, 2011, EXPERT OPIN THER TAR, V15, P1283, DOI 10.1517/14728222.2011.620607; Nakayama J, 2009, BRAIN DEV-JPN, V31, P359, DOI 10.1016/j.braindev.2008.11.014; Pennell PB, 2009, NEUROL CLIN, V27, P941, DOI 10.1016/j.ncl.2009.08.005; Reddy DS, 2010, PROG BRAIN RES, V186, P113, DOI 10.1016/B978-0-444-53630-3.00008-7; Reinhart CJ, 2006, J COMP PSYCHOL, V120, P19, DOI 10.1037/0735-7036.120.1.19; Richichi C, 2004, J NEUROSCI, V24, P3051, DOI 10.1523/JNEUROSCI.4056-03.2004; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Sheehan JJ, 2009, EPILEPSIA, V50, P711, DOI 10.1111/j.1528-1167.2008.01888.x; Shi YW, 2012, GENES BRAIN BEHAV, V11, P170, DOI 10.1111/j.1601-183X.2011.00756.x; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Srinivasan Jayasri, 2005, Aust Fam Physician, V34, P1021; SUNAMI K, 1988, JPN J PSYCHIAT NEUR, V42, P549; Takasawa W, 2010, BIOCHEM BIOPH RES CO, V401, P7, DOI 10.1016/j.bbrc.2010.08.112; TSUBOI T, 1987, HUM GENET, V75, P7; Turcot V, 2011, OBESITY, V19, P388, DOI 10.1038/oby.2010.198; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; van Gassen KLI, 2008, GENES BRAIN BEHAV, V7, P578, DOI 10.1111/j.1601-183X.2008.00393.x; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2011, BRAIN BEHAV IMMUN, V25, P1281, DOI 10.1016/j.bbi.2011.03.018; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Xu J, 2013, EPILEPSY RES, V106, P311, DOI 10.1016/j.eplepsyres.2013.07.002	53	5	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95237	10.1371/journal.pone.0095237	http://dx.doi.org/10.1371/journal.pone.0095237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736375	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600160
J	Zhao, JL; Kang, FF; Wang, LX; Yu, XW; Zhao, WH; Song, XS; Zhang, YL; Chen, F; Sun, Y; He, TF; Han, HR				Zhao, Jinlong; Kang, Fengfeng; Wang, Luoxin; Yu, Xiaowen; Zhao, Weihong; Song, Xiaoshuai; Zhang, Yanlei; Chen, Feng; Sun, Yu; He, Tengfei; Han, Hairong			Patterns of Biomass and Carbon Distribution across a Chronosequence of Chinese Pine (Pinus tabulaeformis) Forests	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; SOIL ORGANIC-CARBON; AGE-SEQUENCE; ALLOCATION PATTERNS; ECOSYSTEM CARBON; TREE BIOMASS; STAND AGE; STORAGE; NITROGEN; SPRUCE	Patterns of biomass and carbon (C) storage distribution across Chinese pine (Pinus tabulaeformis) natural secondary forests are poorly documented. The objectives of this study were to examine the biomass and C pools of the major ecosystem components in a replicated age sequence of P. tabulaeformis secondary forest stands in Northern China. Within each stand, biomass of above-and belowground tree, understory (shrub and herb), and forest floor were determined from plot-level investigation and destructive sampling. Allometric equations using the diameter at breast height (DBH) were developed to quantify plant biomass. C stocks in the tree and understory biomass, forest floor, and mineral soil (0-100 cm) were estimated by analyzing the C concentration of each component. The results showed that the tree biomass of P. tabulaeformis stands was ranged from 123.8 Mg.ha(-1) for the young stand to 344.8 Mg.ha(-1) for the mature stand. The understory biomass ranged from 1.8 Mg.ha(-1) in the middle-aged stand to 3.5 Mg.ha(-1) in the young stand. Forest floor biomass increased steady with stand age, ranging from 14.9 to 23.0 Mg.ha(-1). The highest mean C concentration across the chronosequence was found in tree branch while the lowest mean C concentration was found in forest floor. The observed C stock of the aboveground tree, shrub, forest floor, and mineral soil increased with increasing stand age, whereas the herb C stock showed a decreasing trend with a sigmoid pattern. The C stock of forest ecosystem in young, middle-aged, immature, and mature stands were 178.1, 236.3, 297.7, and 359.8 Mg C ha(-1), respectively, greater than those under similar aged P. tabulaeformis forests in China. These results are likely to be integrated into further forest management plans and generalized in other contexts to evaluate C stocks at the regional scale.	[Zhao, Jinlong; Kang, Fengfeng; Wang, Luoxin; Yu, Xiaowen; Zhao, Weihong; Song, Xiaoshuai; Zhang, Yanlei; Chen, Feng; Sun, Yu; He, Tengfei; Han, Hairong] Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China	Beijing Forestry University	Han, HR (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing, Peoples R China.	hanhr@bjfu.edu.cn			Special Fund for Forestry Scientific Research in the Public Interest [201204101]; CFERN&GENE Award Funds on Ecological Paper	Special Fund for Forestry Scientific Research in the Public Interest; CFERN&GENE Award Funds on Ecological Paper	This research was jointly supported by the Special Fund for Forestry Scientific Research in the Public Interest (No. 201204101) and CFERN&GENE Award Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baishya R, 2011, ANN FOREST SCI, V68, P727, DOI 10.1007/s13595-011-0089-8; Bradford JB, 2008, GLOBAL CHANGE BIOL, V14, P2882, DOI 10.1111/j.1365-2486.2008.01686.x; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; Cao JX, 2012, ECOL RES, V27, P883, DOI 10.1007/s11284-012-0965-1; Cheng XQ, 2014, J PLANT INTERACT, V9, P521, DOI 10.1080/17429145.2013.862360; Chmura DJ, 2007, FOREST ECOL MANAG, V243, P219, DOI 10.1016/j.foreco.2007.02.027; Choi SD, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001914; COVINGTON WW, 1981, ECOLOGY, V62, P41, DOI 10.2307/1936666; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Farley KA, 2004, ECOSYSTEMS, V7, P729, DOI 10.1007/s10021-004-0047-5; Feldpausch TR, 2004, ECOL APPL, V14, pS164; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Gower S. T., 1994, ECOL BULL, P115; Guo H, 2008, SCI CHINA SER C, V51, P662, DOI 10.1007/s11427-008-0083-z; Hashimoto T., 2004, TROPICS, V14, P123, DOI DOI 10.3759/tropics.14.123; Heath LS, 2003, CARBON TRENDS US FOR, P35; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Hooker TD, 2003, ECOL APPL, V13, P299, DOI 10.1890/1051-0761(2003)013[0299:FECANA]2.0.CO;2; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Houghton RA, 2005, GLOBAL CHANGE BIOL, V11, P945, DOI 10.1111/j.1365-2486.2005.00955.x; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Joosten R, 2004, FOREST ECOL MANAG, V189, P87, DOI 10.1016/j.foreco.2003.07.037; Kenzo T, 2009, J TROP ECOL, V25, P371, DOI 10.1017/S0266467409006129; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Lehtonen A, 2004, FOREST ECOL MANAG, V188, P211, DOI 10.1016/j.foreco.2003.07.008; Lemma B, 2006, GEODERMA, V136, P886, DOI 10.1016/j.geoderma.2006.06.008; Li CY, 2013, FOREST CHRON, V89, P192, DOI 10.5558/tfc2013-037; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Li Y, 2005, GLOBAL CHANGE BIOL, V11, P239, DOI 10.1111/j.1365-2486.2005.00896.x; Litton CM, 2004, ECOL APPL, V14, P460, DOI 10.1890/02-5291; Martin JL, 2005, GLOBAL CHANGE BIOL, V11, P1883, DOI 10.1111/j.1365-2486.2005.01019.x; Noh NJ, 2010, SCI CHINA LIFE SCI, V53, P822, DOI 10.1007/s11427-010-4018-0; Peichl M, 2007, FOREST ECOL MANAG, V253, P68, DOI 10.1016/j.foreco.2007.07.003; Peichl M, 2006, AGR FOREST METEOROL, V140, P51, DOI 10.1016/j.agrformet.2006.08.004; PENG G, 2013, PLOS ONE, V0008; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Schimel DS, 2001, NATURE, V414, P169, DOI 10.1038/35102500; Somogyi Z, 2007, EUR J FOREST RES, V126, P197, DOI 10.1007/s10342-006-0125-7; State Forest Administration, 2003, TECHN REG NAT FOR CO; Tan K, 2007, FOREST ECOL MANAG, V240, P114, DOI 10.1016/j.foreco.2006.12.018; Taylor AR, 2007, CAN J FOREST RES, V37, P2260, DOI 10.1139/X07-080; Uri V, 2012, FOREST ECOL MANAG, V267, P117, DOI 10.1016/j.foreco.2011.11.033; Vesterdal L, 2008, FOREST ECOL MANAG, V255, P35, DOI 10.1016/j.foreco.2007.08.015; Wang B, 2011, OBSERVATION METHODOL, P1; Wang JR, 2000, FOREST ECOL MANAG, V130, P17, DOI 10.1016/S0378-1127(99)00193-0; Waring R.H., 2010, FOREST ECOSYSTEMS AN; Zerva A, 2005, FOREST ECOL MANAG, V205, P227, DOI 10.1016/j.foreco.2004.10.035; Zhao M, 2005, FOREST ECOL MANAG, V207, P295, DOI 10.1016/j.foreco.2004.10.049; Zheng H, 2008, FOREST ECOL MANAG, V255, P1113, DOI 10.1016/j.foreco.2007.10.015; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168	51	41	43	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94966	10.1371/journal.pone.0094966	http://dx.doi.org/10.1371/journal.pone.0094966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736660	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600114
J	Wan, M; Soehnlein, O; Tang, X; van der Does, AM; Smedler, E; Uhlen, P; Lindbom, L; Agerberth, B; Haeggstrom, JZ				Wan, Min; Soehnlein, Oliver; Tang, Xiao; van der Does, Anne M.; Smedler, Erik; Uhlen, Per; Lindbom, Lennart; Agerberth, Birgitta; Haeggstrom, Jesper Z.			Cathelicidin LL-37 induces time-resolved release of LTB4 and TXA(2) by human macrophages and triggers eicosanoid generation in vivo	FASEB JOURNAL			English	Article						inflammation; antimicrobial peptides; thromboxane; leukotriene; P2X(7)R	ANTIMICROBIAL PEPTIDE LL-37; HUMAN NEUTROPHILS; THROMBOXANE A(2); LEUKOTRIENE BIOSYNTHESIS; PROSTANOID BIOSYNTHESIS; HUMAN KERATINOCYTES; ACUTE-INFLAMMATION; P2X(7) RECEPTOR; ATHEROSCLEROSIS; CELLS	In humans, LL-37 and eicosanoids are important mediators of inflammation and immune responses. Here we report that LL-37 promotes leukotriene B-4 (LTB4) and thromboxane A(2) (TXA(2)) generation by human monocyte-derived macrophages (HMDMs). LL-37 evokes calcium mobilization apparently via the P2X(7) receptor (P2X(7)R), activation of ERK1/2 and p38 MAPKs, as well as cytosolic phospholipase A(2) (cPLA(2)) and 5-lipoxygenase in HMDMs, leading to an early (1 h) release of LTB4. Similarly, TXA(2) production at an early time involved the same signaling sequence along an LL-37-P2X(7)R-cPLA(2)-cyclooxygenase-1 (COX-1) axis. However, at later (6-8 h) time points, internalized LL-37 up-regulates COX-2 expression, promoting TXA(2) production. Furthermore, intraperitoneal injection of mice with murine cathelicidin-related antimicrobial peptide (mCRAMP) induces significantly higher levels of LTB4 and TXA(2) in mouse ascites rich in macrophages. Conversely, cathelicidin-deficient (Cnlp(-/-)) mice produce much less LTB4 and TXB2 in vivo in response to TNF-alpha compared with control mice. We conclude that LL-37 elicits a biphasic release of eicosanoids in macrophages with early, Ca2+ -dependent formation of LTB4 and TXA(2) followed by a late peak of TXA(2), generated via induction of COX-2 by internalized LL-37, thus allowing eicosanoid production in a temporally controlled manner. Moreover, our findings provide evidence that LL-37 is an endogenous regulator of eicosanoid-dependent inflammatory responses in vivo.	[Wan, Min; Tang, Xiao; Agerberth, Birgitta; Haeggstrom, Jesper Z.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, S-17177 Stockholm, Sweden; [van der Does, Anne M.; Lindbom, Lennart] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Smedler, Erik; Uhlen, Per] Karolinska Inst, Div Mol Neurobiol, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Soehnlein, Oliver] Univ Munich, Inst Cardiovasc Prevent, Munich, Germany; [Soehnlein, Oliver] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Soehnlein, Oliver] German Ctr Cardiovasc Res DZHK, Munich Heart Alliance, Munich, Germany	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Munich; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; German Centre for Cardiovascular Research; Munich Heart Alliance	Haeggstrom, JZ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, S-17177 Stockholm, Sweden.	jesper.haeggstrom@ki.se	van der Does, Anne M./AAA-2247-2022	van der Does, Anne M./0000-0002-1613-106X; Smedler, Erik/0000-0003-4609-3620; Uhlen, Per/0000-0003-1446-1062	Swedish Research Council [10350, 11217, 20854, 04342]; CIDaT, EC FP7 [201668]; Torsten Soderberg Foundation; Swedish Foundation for Strategic Research [RBd08-0014]; Swedish Cancer Society [CAN 2011/559]; Netherlands Organisation for Scientific Research (NOW; Vidi Project) [91712303]; Deutsche Forschungsgemeinschaft (DFG) [SO876/3-1, SO876/6-1, FOR809, SFB914-B08]; LMU excellence initiative; Knut and Alice Wallenberg Foundation; thematic center of cardiovascular diseases (CVP); Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); CIDaT, EC FP7; Torsten Soderberg Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Cancer Society(Swedish Cancer Society); Netherlands Organisation for Scientific Research (NOW; Vidi Project); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); LMU excellence initiative; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); thematic center of cardiovascular diseases (CVP); Karolinska Institutet(Karolinska Institutet)	The authors are grateful to Dr. Fabio Luiz D'Alexandri and Mats Hamberg for help with LC-MS/MS and GC-MS analyses. This study was supported by the Swedish Research Council (10350, 11217, 20854, 04342, Linneus grant CERIC), CIDaT, EC FP7 funding (201668), the Torsten Soderberg Foundation, the Swedish Foundation for Strategic Research (RBd08-0014), and the Swedish Cancer Society (CAN 2011/559). O.S. is supported by the Netherlands Organisation for Scientific Research (NOW; Vidi Project 91712303), the Deutsche Forschungsgemeinschaft (DFG; SO876/3-1, SO876/6-1, FOR809, SFB914-B08), and the LMU excellence initiative. The Center of Live Imaging of Cells at Karolinska (CLICK) Institutet was funded by the Knut and Alice Wallenberg Foundation. J.Z.H. was supported by the thematic center of cardiovascular diseases (CVP) and a Distinguished Professor Award from Karolinska Institutet. The authors declare no conflicts of interest.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Arulkumaran N, 2011, EXPERT OPIN INV DRUG, V20, P897, DOI 10.1517/13543784.2011.578068; Bandholtz L, 2006, SCAND J IMMUNOL, V63, P410, DOI 10.1111/j.1365-3083.2006.001752.x; Bowdish DME, 2004, J IMMUNOL, V172, P3758, DOI 10.4049/jimmunol.172.6.3758; Chen X, 2013, BIOCHEM BIOPH RES CO, V433, P532, DOI 10.1016/j.bbrc.2013.03.024; Chotjumlong P, 2013, J INNATE IMMUN, V5, P72, DOI 10.1159/000342928; Ciornei Cristina D, 2006, BMC Cardiovasc Disord, V6, P49, DOI 10.1186/1471-2261-6-49; Cyrus T, 2007, BLOOD, V109, P3291, DOI 10.1182/blood-2006-08-044990; Daniel TO, 1999, CANCER RES, V59, P4574; Doring Y, 2012, CIRC RES, V110, P1052, DOI 10.1161/CIRCRESAHA.112.265868; Edfeldt K, 2006, ARTERIOSCL THROM VAS, V26, P1551, DOI 10.1161/01.ATV.0000223901.08459.57; Egan KM, 2005, CIRCULATION, V111, P334, DOI 10.1161/01.CIR.0000153386.95356.78; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Esser J, 2010, J ALLERGY CLIN IMMUN, V126, P1032, DOI 10.1016/j.jaci.2010.06.039; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gabrielsen A, 2010, J MOL MED, V88, P795, DOI 10.1007/s00109-010-0621-6; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Koczulla R, 2003, J CLIN INVEST, V111, P1665, DOI 10.1172/JCI200317545; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Lau YE, 2005, INFECT IMMUN, V73, P583, DOI 10.1128/IAI.73.1.583-591.2005; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; MURAKAMI M, 1994, J BIOL CHEM, V269, P22269; Naraba H, 1998, J IMMUNOL, V160, P2974; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Niyonsaba F, 2001, EUR J IMMUNOL, V31, P1066, DOI 10.1002/1521-4141(200104)31:4<1066::AID-IMMU1066>3.0.CO;2-#; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Perez-Chacon G, 2009, BBA-MOL CELL BIOL L, V1791, P1103, DOI 10.1016/j.bbalip.2009.08.007; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Soehnlein O, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002531; Sorensen O, 1997, BLOOD, V90, P2796; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Syrbu SI, 1999, J IMMUNOL, V162, P2334; Tokumaru S, 2005, J IMMUNOL, V175, P4662, DOI 10.4049/jimmunol.175.7.4662; van der Does AM, 2010, J IMMUNOL, V185, P1442, DOI 10.4049/jimmunol.1000376; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Wan M, 2014, J LEUKOCYTE BIOL, V95, P971, DOI 10.1189/jlb.0513304; Wan M, 2011, FASEB J, V25, P1697, DOI 10.1096/fj.10-175687; Wantha S, 2013, CIRC RES, V112, P792, DOI 10.1161/CIRCRESAHA.112.300666; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496	50	29	29	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3456	3467		10.1096/fj.14-251306	http://dx.doi.org/10.1096/fj.14-251306			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24736410				2022-12-25	WOS:000340265400016
J	Lee, HW; Singh, TD; Lee, SW; Ha, JH; Rehemtulla, A; Ahn, BC; Jeon, YH; Lee, J				Lee, Ho Won; Singh, Thoudam Debraj; Lee, Sang-Woo; Ha, Jeoung-Hee; Rehemtulla, Alnawaz; Ahn, Byeong-Cheol; Jeon, Young Hyun; Lee, Jaetae			Evaluation of therapeutic effects of natural killer (NK) cell-based immunotherapy in mice using in vivo apoptosis bioimaging with a caspase-3 sensor	FASEB JOURNAL			English	Article						glioma; molecular imaging; Renilla luciferase	LEUKEMIA-CELLS; CANCER-CELLS; GENE; LINE; ACTIVATION; EXPRESSION; PROMOTER; VIRUSES; LIGAND; NK-92	Natural killer (NK) cell-based immunotherapy is a promising strategy for cancer treatment, and caspase-3 is an important effector molecule in NK cell-mediated apoptosis in cancers. Here, we evaluated the antitumor effects of NK cell-based immunotherapy by serial noninvasive imaging of apoptosis using a caspase-3 sensor in mice with human glioma xenografts. Human glioma cells expressing both a caspase-3 sensor as a surrogate marker for caspase-3 activation and Renilla luciferase (Rluc) as a surrogate marker for cell viability were established and referred to as D54-CR cells. Human NK92 cells were used as effector cells. Treatment with NK92 cells resulted in a time-and effector number-dependent increase in bioluminescence imaging (BLI) activity of the caspase-3 sensor in D54-CR cells in vitro. Caspase-3 activation by NK92 treatment was blocked by Z-VAD treatment in D54-CR cells. Transfusion of NK92 cells induced an increase of the BLI signal by caspase-3 activation in a dose-and time-dependent manner in D54-CR tumor-bearing mice but not in PBS-treated mice. Accordingly, sequential BLI with the Rluc reporter gene revealed marked retardation of tumor growth in the NK92-treatment group but not in the PBS-treatment group. These data suggest that noninvasive imaging of apoptosis with a caspase-3 sensor can be used as an effective tool for evaluation of therapeutic efficacy as well as for optimization of NK cell-based immunotherapy.	[Lee, Ho Won; Singh, Thoudam Debraj; Lee, Sang-Woo; Ahn, Byeong-Cheol; Jeon, Young Hyun; Lee, Jaetae] Kyungpook Natl Univ, Dept Nucl Med, Taegu, South Korea; [Ha, Jeoung-Hee] Kyungpook Natl Univ, Dept Nucl Med, Taegu, South Korea; [Rehemtulla, Alnawaz] Univ Michigan, Dept Radiat Oncol, Ann Arbor, MI 48109 USA	Kyungpook National University; Kyungpook National University; University of Michigan System; University of Michigan	Jeon, YH (corresponding author), Kyungpook Natl Univ Hosp, Leading Edge Res Ctr Drug Discovery & Dev Diabet, 807 Hogukro, Taegu 702210, South Korea.	jeon9014@gmail.com; jaetae@knu.ac.kr	Lee, Jaetae/ABF-3980-2020; Lee, Jaetae/AAR-3317-2021	SINGH, THOUDAM DEBRAJ/0000-0003-0750-9136	Republic of Korea National Research Foundation (NRF) - Ministry of Education, Science, and Technology (MEST) [2009-0078234]; National Nuclear R&D Program through the NRF (MEST) [2012M2A2A7014020]; Repbulic of Korea Health Technology R&D Project, Ministry of Health and Welfare [A111345]; Regional Technology Innovation Program of the Ministry of Knowledge Economy (MKE) [RTI04-01-01]; Kyungpook National University Research Fund	Republic of Korea National Research Foundation (NRF) - Ministry of Education, Science, and Technology (MEST); National Nuclear R&D Program through the NRF (MEST); Repbulic of Korea Health Technology R&D Project, Ministry of Health and Welfare; Regional Technology Innovation Program of the Ministry of Knowledge Economy (MKE)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Kyungpook National University Research Fund	This work was supported by a Republic of Korea National Research Foundation (NRF) grant funded by the Ministry of Education, Science, and Technology (MEST; 2009-0078234), by the National Nuclear R&D Program through the NRF (MEST grant 2012M2A2A7014020), by the Repbulic of Korea Health Technology R&D Project, Ministry of Health and Welfare (grant A111345), by the Regional Technology Innovation Program of the Ministry of Knowledge Economy (MKE; grant RTI04-01-01), and by the Kyungpook National University Research Fund (2013).	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Coppola JM, 2008, CLIN CANCER RES, V14, P2492, DOI 10.1158/1078-0432.CCR-07-0782; Dai CH, 1999, BLOOD, V93, P3309, DOI 10.1182/blood.V93.10.3309.410k04_3309_3316; Hori T, 2010, J ORTHOP RES, V28, P739, DOI 10.1002/jor.21056; Ishikawa E, 2004, INT J RADIAT ONCOL, V59, P1505, DOI 10.1016/j.ijrobp.2004.04.046; Jacob D, 2004, CLIN CANCER RES, V10, P3535, DOI 10.1158/1078-0432.CCR-03-0512; Jeon YH, 2010, MOL CANCER THER, V9, P126, DOI 10.1158/1535-7163.MCT-09-0540; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lin TY, 2002, ONCOGENE, V21, P8020, DOI 10.1038/sj.onc.1205926; McQueen KL, 2002, CURR OPIN IMMUNOL, V14, P615, DOI 10.1016/S0952-7915(02)00380-1; MELDER RJ, 1993, CANCER RES, V53, P5867; Muller T, 2008, CANCER IMMUNOL IMMUN, V57, P411, DOI 10.1007/s00262-007-0383-3; Nagashima S, 1998, BLOOD, V91, P3850, DOI 10.1182/blood.V91.10.3850.3850_3850_3861; Nowosielska EM, 2011, INT J RADIAT BIOL, V87, P202, DOI 10.3109/09553002.2010.519422; Ramakrishnan R, 2010, J CLIN INVEST, V120, P1111, DOI 10.1172/JCI40269; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Reid GSD, 2002, CLIN EXP IMMUNOL, V129, P265, DOI 10.1046/j.1365-2249.2002.01919.x; Rosen D, 2000, J IMMUNOL, V164, P3229, DOI 10.4049/jimmunol.164.6.3229; Screpanti V, 2005, MOL IMMUNOL, V42, P495, DOI 10.1016/j.molimm.2004.07.033; Shi J, 2008, BLOOD, V111, P1309, DOI 10.1182/blood-2007-03-078535; Tam YK, 2003, CYTOTHERAPY, V5, P259, DOI 10.1080/14653240310001523; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Trapani JA, 2002, NAT REV IMMUNOL, V2, P735, DOI 10.1038/nri911; Uherek C, 2002, BLOOD, V100, P1265, DOI 10.1182/blood.V100.4.1265.h81602001265_1265_1273; Yan Y, 1998, CLIN CANCER RES, V4, P2859; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	28	14	17	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					2932	2941		10.1096/fj.13-243014	http://dx.doi.org/10.1096/fj.13-243014			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24736413	Green Submitted			2022-12-25	WOS:000337949400017
J	Ding, KS; Banerjee, A; Tan, S; Zhao, JS; Zhuang, Q; Li, R; Qian, PX; Liu, SL; Wu, ZS; Lobie, PE; Zhu, T				Ding, Keshuo; Banerjee, Arindam; Tan, Sheng; Zhao, JunSong; Zhuang, Qian; Li, Rui; Qian, Pengxu; Liu, Suling; Wu, Zheng-Sheng; Lobie, Peter E.; Zhu, Tao			Artemin, a Member of the Glial Cell Line-derived Neurotrophic Factor Family of Ligands, Is HER2-regulated and Mediates Acquired Trastuzumab Resistance by Promoting Cancer Stem Cell-like Behavior in Mammary Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-BREAST-CANCER; PROGNOSTIC-SIGNIFICANCE; BCL-2 EXPRESSION; GROWTH; RECEPTOR; ACTIVATION; HERCEPTIN; GDNF; HER2; NEU	Previous studies have demonstrated that Artemin (ARTN) functions as a cancer stem cell (CSC) and metastatic factor in mammary carcinoma. Herein, we report that ARTN mediates acquired resistance to trastuzumab in HER2-positive mammary carcinoma cells. Ligands that increase HER2 activity increased ARTN expression in HER2-positive mammary carcinoma cells, whereas trastuzumab inhibited ARTN expression. Forced expression of ARTN decreased the sensitivity of HER2-positive mammary carcinoma cells to trastuzumab both in vitro and in vivo. Conversely, siRNA-mediated depletion of ARTN enhanced trastuzumab efficacy. Cells with acquired resistance to trastuzumab exhibited increased ARTN expression, the depletion of which restored trastuzumab sensitivity. Trastuzumab resistance produced an increased CSC population concomitant with enhanced mammospheric growth. ARTN mediated the enhancement of the CSC population by increased BCL-2 expression, and the CSC population in trastuzumab-resistant cells was abrogated upon inhibition of BCL-2. Hence, we conclude that ARTN is one mediator of acquired resistance to trastuzumab in HER2-positive mammary carcinoma cells.	[Ding, Keshuo; Tan, Sheng; Zhao, JunSong; Zhuang, Qian; Li, Rui; Qian, Pengxu; Liu, Suling; Wu, Zheng-Sheng; Zhu, Tao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Ding, Keshuo; Tan, Sheng; Zhao, JunSong; Zhuang, Qian; Li, Rui; Qian, Pengxu; Liu, Suling; Wu, Zheng-Sheng; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Wu, Zheng-Sheng] Anhui Med Univ, Dept Pathol, Hefei 230032, Anhui, Peoples R China; [Wu, Zheng-Sheng] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China; [Banerjee, Arindam; Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Banerjee, Arindam; Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117599, Singapore; [Lobie, Peter E.] Natl Univ Hlth Syst, Natl Canc Inst Singapore, Singapore 119074, Singapore	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Fudan University; National University of Singapore; National University of Singapore; National University of Singapore	Lobie, PE (corresponding author), Natl Univ Singapore, Canc Sci Inst Singapore, Ctr Translat Med MD6, 11-01K,14 Med Dr, Singapore 117599, Singapore.	csipel@nus.edu.sg; zhut@ustc.edu.cn	liu, suling/AAF-5249-2019; Zhu, Tao/H-3495-2018; Liu, Suling/N-2796-2013; tan, sheng/GSN-2599-2022; Qian, Pengxu/B-9376-2016	liu, suling/0000-0002-0475-0242; Liu, Suling/0000-0002-0475-0242; Qian, Pengxu/0000-0001-5636-6704	National Key Scientific Programme of China [2012CB934002, 2010CB912804]; National Natural Science Foundation of China [1272925, 31201022]; Chinese Academy of Sciences [XDA01040410]; Cancer Science Institute through Ministry of Education, Singapore; National Research Foundation, Singapore	National Key Scientific Programme of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Cancer Science Institute through Ministry of Education, Singapore(Ministry of Education, Singapore); National Research Foundation, Singapore(National Research Foundation, Singapore)	This work was funded by The National Key Scientific Programme of China Grants 2012CB934002 and 2010CB912804, The National Natural Science Foundation of China Grants 1272925 and 31201022, Chinese Academy of Sciences Grant XDA01040410, and The Cancer Science Institute through grants from The Ministry of Education, Singapore and National Research Foundation, Singapore. P. E. L. is an inventor on PCT/NZ2008/000152 and derivatives thereof and on PCT/NZ2010/000207 and derivatives thereof. Z. T. and P. E. L. previously received consultancies from Saratan Therapeutics Ltd. (a biotech company formed around the potential to use Artemin as a target for breast cancer).	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Banerjee A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050098; Banerjee A, 2012, J BIOL CHEM, V287, P42502, DOI 10.1074/jbc.M112.365163; Banerjee A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3054; Bedard PL, 2009, J MAMMARY GLAND BIOL, V14, P55, DOI 10.1007/s10911-009-9116-x; BENZ CC, 1992, BREAST CANCER RES TR, V24, P85, DOI 10.1007/BF01961241; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Bilak MM, 2001, NEUROREPORT, V12, P2531, DOI 10.1097/00001756-200108080-00048; Chakrabarty A, 2013, CANCER RES, V73, P1190, DOI 10.1158/0008-5472.CAN-12-2440; Crawford Anatasha, 2011, Current Pharmacogenomics & Personalized Medicine, V9, P184; D'Costa AP, 1998, J NEUROBIOL, V36, P379; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Duru N, 2012, CLIN CANCER RES, V18, P6634, DOI 10.1158/1078-0432.CCR-12-1436; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gradishar WJ, 2013, ANN ONCOL, V24, P2492, DOI 10.1093/annonc/mdt217; Huang Y, 2013, CURR DRUG TARGETS, V14, P889, DOI 10.2174/13894501113149990161; Ithimakin S, 2013, CANCER RES, V73, P1635, DOI 10.1158/0008-5472.CAN-12-3349; Kang J, 2010, ONCOGENE, V29, P3228, DOI 10.1038/onc.2010.71; Kang J, 2009, ONCOGENE, V28, P2034, DOI 10.1038/onc.2009.66; Klapper LN, 1999, P NATL ACAD SCI USA, V96, P4995, DOI 10.1073/pnas.96.9.4995; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Kurokawa H, 2000, CANCER RES, V60, P5887; Lang JY, 2011, CANCER CELL, V20, P341, DOI 10.1016/j.ccr.2011.07.017; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Lu YH, 2004, INT J CANCER, V108, P334, DOI 10.1002/ijc.11445; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Milella M, 2004, CLIN CANCER RES, V10, P7747, DOI 10.1158/1078-0432.CCR-04-0908; Minami T, 2012, MOL CANCER THER, V11, P830, DOI 10.1158/1535-7163.MCT-11-0884; Nahta R, 2005, CANCER RES, V65, P11118, DOI 10.1158/0008-5472.CAN-04-3841; Nahta R, 2012, BREAST CANCER-TARGET, V4, P53, DOI 10.2147/BCTT.S24976; Nahta R, 2012, BREAST CANCER RES TR, V135, P39, DOI 10.1007/s10549-012-2067-8; Oliveras-Ferraros C, 2012, CELL CYCLE, V11, P4020, DOI 10.4161/cc.22225; Pandey V, 2008, ENDOCRINOLOGY, V149, P3909, DOI 10.1210/en.2008-0286; Pandey V, 2010, TRANSL ONCOL, V3, P218, DOI 10.1593/tlo.09325; Park BH, 2007, CANCER CELL, V12, P297, DOI 10.1016/j.ccr.2007.10.004; PIETRAS RJ, 1995, ONCOGENE, V10, P2435; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51; Tawfik K, 2012, HUM PATHOL, V43, P23, DOI 10.1016/j.humpath.2011.04.011; Tseng PH, 2006, MOL PHARMACOL, V70, P1534, DOI 10.1124/mol.106.023911; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wong ALA, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/415170; Wu YY, 2012, MOL CANCER RES, V10, P1597, DOI 10.1158/1541-7786.MCR-12-0155-T; Wu ZS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-34; Yang QF, 2009, BREAST CANCER RES TR, V115, P343, DOI 10.1007/s10549-008-0068-4; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	52	24	34	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16057	16071		10.1074/jbc.M113.529552	http://dx.doi.org/10.1074/jbc.M113.529552			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24737320	Green Published, hybrid			2022-12-25	WOS:000337965700015
J	Fjaere, E; Aune, UL; Roen, K; Keenan, AH; Ma, T; Borkowski, K; Kristensen, DM; Novotny, GW; Mandrup-Poulsen, T; Hudson, BD; Milligan, G; Xi, YN; Newman, JW; Haj, FG; Liaset, B; Kristiansen, K; Madsen, L				Fjaere, Even; Aune, Ulrike L.; Roen, Kristin; Keenan, Alison H.; Ma, Tao; Borkowski, Kamil; Kristensen, David M.; Novotny, Guy W.; Mandrup-Poulsen, Thomas; Hudson, Brian D.; Milligan, Graeme; Xi, Yannan; Newman, John W.; Haj, Fawaz G.; Liaset, Bjorn; Kristiansen, Karsten; Madsen, Lise			Indomethacin Treatment Prevents High Fat Diet-induced Obesity and Insulin Resistance but Not Glucose Intolerance in C57BL/6J Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID; CYCLOOXYGENASE-2; HOMEOSTASIS; SECRETION; PROSTAGLANDIN-E2; ACCUMULATION; INFLAMMATION; FFA1/GPR40; METABOLISM; DISCOVERY	Chronic low grade inflammation is closely linked to obesity-associated insulin resistance. To examine how administration of the anti-inflammatory compound indomethacin, a general cyclooxygenase inhibitor, affected obesity development and insulin sensitivity, we fed obesity-prone male C57BL/6J mice a high fat/high sucrose (HF/HS) diet or a regular diet supplemented or not with indomethacin (+/- INDO) for 7 weeks. Development of obesity, insulin resistance, and glucose intolerance was monitored, and the effect of indomethacin on glucose-stimulated insulin secretion (GSIS) was measured in vivo and in vitro using MIN6 beta-cells. We found that supplementation with indomethacin prevented HF/HS-induced obesity and diet-induced changes in systemic insulin sensitivity. Thus, HF/HS+INDO-fed mice remained insulin-sensitive. However, mice fed HF/HS+INDO exhibited pronounced glucose intolerance. Hepatic glucose output was significantly increased. Indomethacin had no effect on adipose tissue mass, glucose tolerance, or GSIS when included in a regular diet. Indomethacin administration to obese mice did not reduce adipose tissue mass, and the compensatory increase in GSIS observed in obese mice was not affected by treatment with indomethacin. We demonstrate that indomethacin did not inhibit GSIS per se, but activation of GPR40 in the presence of indomethacin inhibited glucose-dependent insulin secretion in MIN6 cells. We conclude that constitutive high hepatic glucose output combined with impaired GSIS in response to activation of GPR40-dependent signaling in the HF/HS+INDO-fed mice contributed to the impaired glucose clearance during a glucose challenge and that the resulting lower levels of plasma insulin prevented the obesogenic action of the HF/HS diet.	[Fjaere, Even; Aune, Ulrike L.; Roen, Kristin; Keenan, Alison H.; Ma, Tao; Borkowski, Kamil; Kristiansen, Karsten; Madsen, Lise] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [Fjaere, Even; Aune, Ulrike L.; Milligan, Graeme; Liaset, Bjorn; Madsen, Lise] Natl Inst Nutr & Seafood Res, N-5817 Bergen, Norway; [Keenan, Alison H.; Xi, Yannan; Newman, John W.; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Haj, Fawaz G.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Kristensen, David M.] Univ Rennes 1, INSERM, U1085, IRSET, Rennes, France; [Kristensen, David M.] Univ Copenhagen, Fac Hlth Sci, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Novotny, Guy W.; Mandrup-Poulsen, Thomas] Univ 2200 Copenhagen, Dept Biomed Sci, Sect Endocrinol Res, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Dept Mol Med & Surg, S-17177 Solna, Sweden; [Hudson, Brian D.] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland; [Newman, John W.] ARS, USDA, Western Human Nutr Res Ctr, Davis, CA 95616 USA	University of Copenhagen; University of California System; University of California Davis; University of California System; University of California Davis; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of Copenhagen; Karolinska Institutet; University of Glasgow; United States Department of Agriculture (USDA)	Kristiansen, K (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	kk@bio.ku.dk; lise.madsen@nifes.no	Hudson, B. D./H-4845-2013; Madsen, Lise/C-6246-2012; Kristiansen, Karsten/J-5148-2014	Hudson, B. D./0000-0001-7059-0091; Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Mandrup-Poulsen, Thomas/0000-0002-3215-9273; Kristensen, David Mobjerg/0000-0003-0657-1632; Newman, John/0000-0001-9632-6571; Liaset, Bjorn/0000-0002-8652-7801; Novotny, Guy/0000-0002-1828-1053	National Institutes of Health [RO1DK090492]; European Union FP7 project DIABAT [HEALTH-F2-2011-278373]; Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation; SHARE Cross Faculty Ph.D. Initiative of the University of Copenhagen; NIFES; Danish Council for Strategic Research Grant [2101 06 0005, 11-116196]; Juvenile Diabetes Research Foundation [1-2009-337]; United States Department of Agriculture Agricultural Research Service Grants [5306-51000-016-00D, 5306-51000-019-00D]; National Institute of Food and Agriculture National Needs Fellowship [2008-38420-04759]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090492, R01DK095359, U24DK092993] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union FP7 project DIABAT; Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); SHARE Cross Faculty Ph.D. Initiative of the University of Copenhagen; NIFES; Danish Council for Strategic Research Grant(Danske Strategiske Forskningsrad (DSF)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); United States Department of Agriculture Agricultural Research Service Grants; National Institute of Food and Agriculture National Needs Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1DK090492 (to F. G. H.). This work was also supported by the European Union FP7 project DIABAT (HEALTH-F2-2011-278373), the Danish Natural Science Research Council, the Novo Nordisk Foundation, the Carlsberg Foundation, the SHARE Cross Faculty Ph.D. Initiative of the University of Copenhagen, and NIFES. Part of this work was carried out as a part of the research program of the Danish Obesity Research Centre (DanORC). DanORC is supported by Danish Council for Strategic Research Grant 2101 06 0005. Part of this work was also supported by Danish Council for Strategic Research Grant 11-116196 for the FFARMED project. The laboratory of F. G. H. is supported by Juvenile Diabetes Research Foundation Grant 1-2009-337. This study was supported in part by intramural funds from United States Department of Agriculture Agricultural Research Service Grants 5306-51000-016-00D (to J. W. N.) and 5306-51000-019-00D (to J. W. N.) and National Institute of Food and Agriculture National Needs Fellowship 2008-38420-04759 (to A. H. K.).	Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Arias AMP, 2000, METABOLISM, V49, P839, DOI 10.1053/meta.2000.6748; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; Brons C, 2009, J PHYSIOL-LONDON, V587, P2387, DOI 10.1113/jphysiol.2009.169078; Brown PJ, 1997, CHEM BIOL, V4, P909, DOI 10.1016/S1074-5521(97)90299-4; CHATZIPANTELI K, 1992, DIABETES, V41, P927, DOI 10.2337/diabetes.41.8.927; Christiansen E, 2013, ACS MED CHEM LETT, V4, P441, DOI 10.1021/ml4000673; Christiansen E, 2010, ACS MED CHEM LETT, V1, P345, DOI 10.1021/ml100106c; Dikopoulos N, 2007, EUR J CLIN INVEST, V37, P222, DOI 10.1111/j.1365-2362.2007.01779.x; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Fujita H, 2007, BIOCHEM BIOPH RES CO, V363, P37, DOI 10.1016/j.bbrc.2007.08.090; Ghoshal S, 2011, J BIOL CHEM, V286, P889, DOI 10.1074/jbc.M110.139139; Hao Q, 2012, AM J PHYSIOL-ENDOC M, V302, pE1097, DOI 10.1152/ajpendo.00524.2011; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Jaradat MS, 2001, BIOCHEM PHARMACOL, V62, P1587, DOI 10.1016/S0006-2952(01)00822-X; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Katsuki A, 2001, DIABETES CARE, V24, P362, DOI 10.2337/diacare.24.2.362; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Liaset B, 2003, PROCESS BIOCHEM, V38, P1747, DOI 10.1016/S0032-9592(02)00251-0; Liaset B, 2011, J BIOL CHEM, V286, P28382, DOI 10.1074/jbc.M111.234732; Lillefosse HH, 2013, J NUTR, V143, P1367, DOI 10.3945/jn.112.170415; Luria A, 2011, P NATL ACAD SCI USA, V108, P9038, DOI 10.1073/pnas.1103482108; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Malaisse WJ, 2012, ARCH BIOCHEM BIOPHYS, V517, P138, DOI 10.1016/j.abb.2011.11.014; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Montell E, 2001, AM J PHYSIOL-ENDOC M, V280, pE229, DOI 10.1152/ajpendo.2001.280.2.E229; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Poitout V, 2013, DIABETOLOGIA, V56, P231, DOI 10.1007/s00125-012-2788-6; RICHELSEN B, 1987, ENDOCRINOLOGY, V121, P1221, DOI 10.1210/endo-121-4-1221; Robertson RP, 1998, DIABETES, V47, P1379, DOI 10.2337/diabetes.47.9.1379; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; SEIBERT K, 1994, RECEPTOR, V4, P17; Stephensen CB, 2011, J LIPID RES, V52, P991, DOI 10.1194/jlr.P012864; TOPOL E, 1980, DIABETES, V29, P379, DOI 10.2337/diabetes.29.5.379; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Wan SG, 2011, INT J CANCER, V129, P331, DOI 10.1002/ijc.25688; YAMAMOTO F, 1980, Gastroenterologia Japonica, V15, P433	44	30	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16032	16045		10.1074/jbc.M113.525220	http://dx.doi.org/10.1074/jbc.M113.525220			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742673	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000337965700013
J	Mills, LD; Zhang, LZ; Marler, R; Svingen, P; Fernandez-Barrena, MG; Dave, M; Bamlet, W; McWilliams, RR; Petersen, GM; Faubion, W; Fernandez-Zapico, ME				Mills, Lisa D.; Zhang, Lizhi; Marler, Ronald; Svingen, Phyllis; Fernandez-Barrena, Maite G.; Dave, Maneesh; Bamlet, William; McWilliams, Robert R.; Petersen, Gloria M.; Faubion, William; Fernandez-Zapico, Martin E.			Inactivation of the Transcription Factor GLI1 Accelerates Pancreatic Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNALING PATHWAY; BREAST-CANCER; TUMOR MICROENVIRONMENT; INTRAEPITHELIAL NEOPLASIA; MESENCHYMAL TRANSITION; DUCTAL ADENOCARCINOMA; BLADDER-CANCER; IMMUNE EVASION; SELF-RENEWAL; EXPRESSION	The role of GLI1 in pancreatic tumor initiation promoting the progression of preneoplastic lesions into tumors is well established. However, its function at later stages of pancreatic carcinogenesis remains poorly understood. To address this issue, we crossed the gli1 knock-out (GKO) animal with cre-dependent pancreatic activation of oncogenic kras concomitant with loss of the tumor suppressor tp53 (KPC). Interestingly, in this model, GLI1 played a tumor-protective function, where survival of GKO/KPC mice was reduced compared with KPC littermates. Both cohorts developed pancreatic cancer without significant histopathological differences in survival studies. However, analysis of mice using ultrasound-based imaging at earlier time points showed increased tumor burden in GKO/KPC mice. These animals have larger tumors, decreased body weight, increased lactate dehydrogenase production, and severe leukopenia. In vivo and in vitro expression studies identified FAS and FAS ligand (FASL) as potential mediators of this phenomenon. The FAS/FASL axis, an apoptotic inducer, plays a role in the progression of pancreatic cancer, where its expression is usually lost or significantly reduced in advanced stages of the disease. Chromatin immunoprecipitation and reporter assays identified FAS and FASL as direct targets of GLI1, whereas GKO/KPC mice showed lower levels of this ligand compared with KPC animals. Finally, decreased levels of apoptosis were detected in tumor tissue in the absence of GLI1 by TUNEL staining. Together, these findings define a novel pathway regulated by GLI1 controlling pancreatic tumor progression and provide a new theoretical framework to help with the design and analysis of trials targeting GLI1-related pathways.	[Mills, Lisa D.; Fernandez-Barrena, Maite G.; Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Zhang, Lizhi] Mayo Clin, Lab Med & Pathol, Rochester, MN 55905 USA; [Svingen, Phyllis; Dave, Maneesh; Faubion, William] Mayo Clin, Lab Epigenet & Chromatin Dynam, Rochester, MN 55905 USA; [Bamlet, William] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [McWilliams, Robert R.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Petersen, Gloria M.] Mayo Clin, Div Epidemiol, Rochester, MN 55905 USA; [Marler, Ronald] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu	Fernandez-Barrena, Maite G/J-8040-2014	Fernandez-Barrena, Maite G/0000-0003-0375-6236; Bamlet, William/0000-0003-2903-1284	National Institutes of Health from NCI [CA136526, P50 CA102701, P30 DK84567]; NATIONAL CANCER INSTITUTE [P30CA015083, P50CA102701, R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089714] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136526, Grant P50 CA102701 (Mayo Clinic Pancreatic SPORE), and P30 DK84567 (Mayo Clinic Center for Cell Signaling in Gastroenterology) (to M. E. F.-Z.) from NCI.	Balmanoukian A, 2012, CANCER INVEST, V30, P571, DOI 10.3109/07357907.2012.700987; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bennett MW, 2001, J CLIN PATHOL, V54, P598, DOI 10.1136/jcp.54.8.598; Boldrini L, 2001, ONCOGENE, V20, P6632, DOI 10.1038/sj.onc.1204727; Butt Adeel A., 2002, International Journal of Infectious Diseases, V6, P178, DOI 10.1016/S1201-9712(02)90107-4; Carlsson A, 2008, EUR J CANCER, V44, P472, DOI 10.1016/j.ejca.2007.11.025; Chen MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061901; Ciucci A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060145; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cui DM, 2010, J NEUROL SCI, V288, P156, DOI 10.1016/j.jns.2009.09.006; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dahmane N, 1997, NATURE, V389, P876, DOI 10.1038/39918; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Dijkgraaf GJP, 2011, CANCER RES, V71, P435, DOI 10.1158/0008-5472.CAN-10-2876; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; FERRARIS AM, 1979, BLOOD, V54, P928; Fogar P, 2011, PANCREAS, V40, P1131, DOI 10.1097/MPA.0b013e31822077b8; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Harmsma M, 2013, BBA-REV CANCER, V1836, P255, DOI 10.1016/j.bbcan.2013.06.002; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huang FT, 2012, INT J ONCOL, V41, P1707, DOI 10.3892/ijo.2012.1597; Husain K, 2013, CARCINOGENESIS, V34, P858, DOI 10.1093/carcin/bgt002; Inoue K, 2000, CANCER RES, V60, P2290; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Joost S, 2012, CANCER RES, V72, P88, DOI 10.1158/0008-5472.CAN-10-4621; Katoh Y, 2009, INT J ONCOL, V35, P187, DOI 10.3892/ijo_00000328; Kornmann M, 1999, CANCER RES, V59, P3505; Kwon YJ, 2011, CLIN EXP METASTAS, V28, P437, DOI 10.1007/s10585-011-9382-z; Li Y, 2012, HISTOL HISTOPATHOL, V27, P475, DOI 10.14670/HH-27.475; LoRusso PM, 2011, CLIN CANCER RES, V17, P2502, DOI 10.1158/1078-0432.CCR-10-2745; Lu JT, 2012, ACTA PHARMACOL SIN, V33, P691, DOI 10.1038/aps.2012.24; Maas S, 2004, UROLOGY, V63, P392, DOI 10.1016/j.urology.2003.08.023; Maftouh M, 2014, BRIT J CANCER, V110, P172, DOI 10.1038/bjc.2013.681; Mantovani A, 2008, CANCER LETT, V267, P180, DOI 10.1016/j.canlet.2008.05.003; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Mohamed MM, 2014, INT J BIOCHEM CELL B, V46, P138, DOI 10.1016/j.biocel.2013.11.015; Moutasim KA, 2014, J PATHOL, V233, P196, DOI 10.1002/path.4342; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Orchekowski R, 2005, CANCER RES, V65, P11193, DOI 10.1158/0008-5472.CAN-05-1436; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Rattigan YL, 2012, EXP CELL RES, V318, P326, DOI 10.1016/j.yexcr.2011.11.014; Ravishankaran P, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-18; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; Sastra Stephen A, 2013, Methods Mol Biol, V980, P249, DOI 10.1007/978-1-62703-287-2_13; Sheng WW, 2014, HISTOPATHOLOGY, V64, P523, DOI 10.1111/his.12273; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Steyerberg EW, 2012, EUR J CLIN INVEST, V42, P216, DOI 10.1111/j.1365-2362.2011.02562.x; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Tredan O, 2013, EUR J CANCER, V49, P1673, DOI 10.1016/j.ejca.2012.11.028; Volkmann M, 2001, J MOL MED-JMM, V79, P594, DOI 10.1007/s001090100244; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yang SH, 2013, ONCOLOGY-BASEL, V85, P86, DOI 10.1159/000353452	61	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16516	16525		10.1074/jbc.M113.539031	http://dx.doi.org/10.1074/jbc.M113.539031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24737325	hybrid, Green Published			2022-12-25	WOS:000337965700053
J	Chutake, YK; Costello, WN; Lam, C; Bidichandani, SI				Chutake, Yogesh K.; Costello, Whitney N.; Lam, Christina; Bidichandani, Sanjay I.			Altered Nucleosome Positioning at the Transcription Start Site and Deficient Transcriptional Initiation in Friedreich Ataxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Transcription; Heterochromatin; Neurological Diseases; Nucleotide Repeat Disease; Transcription Promoter; Friedreich Ataxia; Expanded Triplet Repeat; Nucleosome Positioning; Transcription Start Site	DOT-TTC REPEATS; TRIPLET-REPEAT; FRATAXIN GENE; EPIGENETIC CHANGES; CLINICAL-FEATURES; DNA METHYLATION; STICKY DNA; GAA; EXPANSION; PROMOTERS	Background: Friedreich ataxia (FRDA) is caused by an expanded GAA triplet repeat (GAA-TR) mutation that results in FXN transcriptional deficiency. Results: Repressive chromatin spreads from the expanded GAA-TR mutation, switching off the FXN gene promoter. Conclusion: Reduced transcriptional initiation is the major cause of FXN transcriptional deficiency in FRDA. Significance: Reactivation of FXN transcriptional initiation is a potential therapeutic strategy in FRDA. Most individuals with Friedreich ataxia (FRDA) are homozygous for an expanded GAA triplet repeat (GAA-TR) mutation in intron 1 of the FXN gene, which results in deficiency of FXN transcript. Consistent with the expanded GAA-TR sequence as a cause of variegated gene silencing, evidence for heterochromatin has been detected in intron 1 in the immediate vicinity of the expanded GAA-TR mutation in FRDA. Transcriptional deficiency in FRDA is thought to result from deficient elongation through the expanded GAA-TR sequence because of repeat-proximal heterochromatin and abnormal DNA structures adopted by the expanded repeat. There is also evidence for deficient transcriptional initiation in FRDA, but its relationship to the expanded GAA-TR mutation remains unclear. We show that repressive chromatin extends from the expanded GAA-TR in intron 1 to the upstream regions of the FXN gene, involving the FXN transcriptional start site. Using a chromatin accessibility assay and a high-resolution nucleosome occupancy assay, we found that the major FXN transcriptional start site, which is normally in a nucleosome-depleted region, is rendered inaccessible by altered nucleosome positioning in FRDA. Consistent with the altered epigenetic landscape the FXN gene promoter, a typical CpG island promoter, was found to be in a transcriptionally non-permissive state in FRDA. Both metabolic labeling of nascent transcripts and an unbiased whole transcriptome analysis revealed a severe deficiency of transcriptional initiation in FRDA. Deficient transcriptional initiation, and not elongation, is the major cause of FXN transcriptional deficiency in FRDA, and it is related to the spread of repressive chromatin from the expanded GAA-TR mutation.	[Chutake, Yogesh K.; Costello, Whitney N.; Lam, Christina; Bidichandani, Sanjay I.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Oklahoma City, OK 73104 USA; [Bidichandani, Sanjay I.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Bidichandani, SI (corresponding author), 1200 Childrens Ave,Ste 12100, Oklahoma City, OK 73104 USA.	Sanjay-Bidichandani@ouhsc.edu	Costello, Whitney/W-1204-2018	Costello, Whitney/0000-0001-6731-8978; Bidichandani, Sanjay/0000-0001-6191-6475	National Institutes of Health [R01 NS072418]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS072418 (to S. I. B.).	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074956; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castaldo I, 2008, J MED GENET, V45, P808, DOI 10.1136/jmg.2008.058594; Clark RM, 2006, GENOMICS, V87, P57, DOI 10.1016/j.ygeno.2005.09.006; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Evans-Galea MV, 2012, ANN NEUROL, V71, P487, DOI 10.1002/ana.22671; Filla A, 1996, AM J HUM GENET, V59, P554; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Grabczyk E, 2007, NUCLEIC ACIDS RES, V35, P5351, DOI 10.1093/nar/gkm589; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Holwerda SJB, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0369; Kelly TK, 2012, GENOME RES, V22, P2497, DOI 10.1101/gr.143008.112; Kim E, 2011, NUCLEIC ACIDS RES, V39, P8366, DOI 10.1093/nar/gkr542; Kumari D, 2011, J BIOL CHEM, V286, P4209, DOI 10.1074/jbc.M110.194035; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Parkinson MH, 2013, J NEUROCHEM, V126, P103, DOI 10.1111/jnc.12317; Pastore A, 2013, J NEUROCHEM, V126, P43, DOI 10.1111/jnc.12220; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Plasterer HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063958; Punga T, 2010, EMBO MOL MED, V2, P120, DOI 10.1002/emmm.201000064; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Saveliev A, 2003, NATURE, V422, P909, DOI 10.1038/nature01596; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Tolstorukov MY, 2009, GENOME RES, V19, P967, DOI 10.1101/gr.084830.108; Vavouri T, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r110	33	30	31	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15194	15202		10.1074/jbc.M114.566414	http://dx.doi.org/10.1074/jbc.M114.566414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737321	Green Published, hybrid			2022-12-25	WOS:000337465400006
J	Nye, MD; Almada, LL; Fernandez-Barrena, MG; Marks, DL; Elsawa, SF; Vrabel, A; Tolosa, EJ; Ellenrieder, V; Fernandez-Zapico, ME				Nye, Monica D.; Almada, Luciana L.; Fernandez-Barrena, Maite G.; Marks, David L.; Elsawa, Sherine F.; Vrabel, Anne; Tolosa, Ezequiel J.; Ellenrieder, Volker; Fernandez-Zapico, Martin E.			The Transcription Factor GLI1 Interacts with SMAD Proteins to Modulate Transforming Growth Factor beta-Induced Gene Expression in a p300/CREB-binding Protein-associated Factor (PCAF)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Gene Expression; SMAD Transcription Factor; Transcription Factor; Transforming Growth Factor (TGF); GLI1; PCAF	HISTONE ACETYLTRANSFERASE PCAF; HEDGEHOG SIGNALING PATHWAY; PANCREATIC-CANCER; TGF-BETA; TARGET GENES; IN-VITRO; ACTIVATION; MECHANISMS; INHIBITION; APOPTOSIS	The biological role of the transcription factor GLI1 in the regulation of tumor growth is well established; however, the molecular events modulating this phenomenon remain elusive. Here, we demonstrate a novel mechanism underlying the role of GLI1 as an effector of TGF signaling in the regulation of gene expression in cancer cells. TGF stimulates GLI1 activity in cancer cells and requires its transcriptional activity to induce BCL2 expression. Analysis of the mechanism regulating this interplay identified a new transcriptional complex including GLI1 and the TGF-regulated transcription factor, SMAD4. We demonstrate that SMAD4 physically interacts with GLI1 for concerted regulation of gene expression and cellular survival. Activation of the TGF pathway induces GLI1-SMAD4 complex binding to the BCL2 promoter whereas disruption of the complex through SMAD4 RNAi depletion impairs GLI1-mediated transcription of BCL2 and cellular survival. Further characterization demonstrated that SMAD2 and the histone acetyltransferase, PCAF, participate in this regulatory mechanism. Both proteins bind to the BCL2 promoter and are required for TGF- and GLI1-stimulated gene expression. Moreover, SMAD2/4 RNAi experiments showed that these factors are required for the recruitment of GLI1 to the BCL2 promoter. Finally, we determined whether this novel GLI1 transcriptional pathway could regulate other TGF targets. We found that two additional TGF-stimulated genes, INTERLEUKIN-7 and CYCLIN D1, are dependent upon the intact GLI1-SMAD-PCAF complex for transcriptional activation. Collectively, these results define a novel epigenetic mechanism that uses the transcription factor GLI1 and its associated complex as a central effector to regulate gene expression in cancer cells.	[Nye, Monica D.; Almada, Luciana L.; Fernandez-Barrena, Maite G.; Marks, David L.; Vrabel, Anne; Tolosa, Ezequiel J.; Fernandez-Zapico, Martin E.] Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Elsawa, Sherine F.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Ellenrieder, Volker] Univ Marburg, Dept Gastroenterol, Signaling & Transcript Lab, D-35037 Marburg, Germany; [Fernandez-Zapico, Martin E.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic; Northern Illinois University; Philipps University Marburg; Mayo Clinic	Fernandez-Zapico, ME (corresponding author), Mayo Clin, Div Oncol Res, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	fernandezzapico.martin@mayo.edu	Fernandez-Barrena, Maite G/J-8040-2014; Tolosa, Ezequiel J/AAD-9799-2019	Fernandez-Barrena, Maite G/0000-0003-0375-6236; Tolosa, Ezequiel J/0000-0001-5167-0782	National Institutes of Health [GM55252, CA136526]; Mayo Clinic College of Medicine Graduate School, Division of Oncology Research (Mayo Clinic); Mayo Clinic Pancreatic SPORE [CA102701]; Mayo Clinic Center for Cell Signaling in Gastroenterology [P30 DK84567]; Deutsche Forschungsgemeinschaft [KFO210, SFB-TR17]; German Cancer Research Foundation [109423]; NATIONAL CANCER INSTITUTE [R25CA057726, P30CA015083, P20CA102701, P50CA102701, R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic College of Medicine Graduate School, Division of Oncology Research (Mayo Clinic); Mayo Clinic Pancreatic SPORE; Mayo Clinic Center for Cell Signaling in Gastroenterology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55252 and by National Institutes of Health Grant CA136526 (to M. E. F.-Z.). This work was also supported by the Mayo Clinic College of Medicine Graduate School, Division of Oncology Research (Mayo Clinic), and Mayo Clinic Pancreatic SPORE P50 Grant CA102701 (to M. E. F.-Z.), Mayo Clinic Center for Cell Signaling in Gastroenterology Grant P30 DK84567 (to M. E. F.-Z.), Deutsche Forschungsgemeinschaft Grant KFO210 (to V. E.), SFB-TR17, and the German Cancer Research Foundation 109423 "Inflammation and Cancer" (to V. E.).	Bermudez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063226; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Chen M, 2011, EXPERT REV ENDOCRINO, V6, P453, DOI 10.1586/EEM.11.24; Ciucci A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060145; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Duan H, 2007, ONCOGENE, V26, P2635, DOI 10.1038/sj.onc.1210061; Eberl M, 2012, EMBO MOL MED, V4, P218, DOI 10.1002/emmm.201100201; Elsawa SF, 2011, J BIOL CHEM, V286, P21524, DOI 10.1074/jbc.M111.234146; Fiaschi M, 2011, AM J PATHOL, V179, P2569, DOI 10.1016/j.ajpath.2011.07.033; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Goel HL, 2013, EMBO MOL MED, V5, P488, DOI 10.1002/emmm.201202078; Guo JF, 2013, CANCER LETT, V339, P185, DOI 10.1016/j.canlet.2013.06.010; Heldin CH, 2012, CELL TISSUE RES, V347, P21, DOI 10.1007/s00441-011-1190-x; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; Javelaud D, 2011, CANCER RES, V71, P5606, DOI 10.1158/0008-5472.CAN-11-1194; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; Joost S, 2012, CANCER RES, V72, P88, DOI 10.1158/0008-5472.CAN-10-4621; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Keysar SB, 2013, CANCER RES, V73, P3381, DOI 10.1158/0008-5472.CAN-12-4047; KINZLER KW, 1987, SCIENCE, V236, P70, DOI 10.1126/science.3563490; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lim JH, 2005, EMBO J, V24, P3038, DOI 10.1038/sj.emboj.7600768; Lo Re AE, 2012, J BIOL CHEM, V287, P25325, DOI 10.1074/jbc.M112.370809; Love IM, 2012, CELL CYCLE, V11, P2458, DOI 10.4161/cc.20864; Malatesta M, 2013, CANCER RES, V73, P6323, DOI 10.1158/0008-5472.CAN-12-4660; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Mazza D, 2013, CELL DEATH DIFFER, V20, P1688, DOI 10.1038/cdd.2013.120; Mills LD, 2013, J BIOL CHEM, V288, P11786, DOI 10.1074/jbc.M112.438846; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Nakamura I, 2013, J BIOL CHEM, V288, P21389, DOI 10.1074/jbc.M112.443440; Nolan-Stevaux O, 2009, GENE DEV, V23, P24, DOI 10.1101/gad.1753809; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Poux AN, 2003, BIOCHEMISTRY-US, V42, P14366, DOI 10.1021/bi035632n; Rajurkar M, 2012, P NATL ACAD SCI USA, V109, pE1038, DOI 10.1073/pnas.1114168109; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Savani M, 2012, THER ADV MED ONCOL, V4, P225, DOI 10.1177/1758834012450362; Saze Z, 2012, DIGEST SURG, V29, P115, DOI 10.1159/000336949; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Thomas ZI, 2011, BRIT J CANCER, V104, P1575, DOI 10.1038/bjc.2011.133; Wanshura LEC, 2011, CANCER RES, V71, P5336, DOI 10.1158/0008-5472.CAN-10-2633; Warmflash A, 2012, P NATL ACAD SCI USA, V109, pE1947, DOI 10.1073/pnas.1207607109; Wu JY, 2011, HEPATO-GASTROENTEROL, V58, P1511, DOI 10.5754/hge10765; Xenaki G, 2008, ONCOGENE, V27, P5785, DOI 10.1038/onc.2008.192; Xu PL, 2012, FEBS LETT, V586, P1871, DOI 10.1016/j.febslet.2012.05.010; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581	52	36	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15495	15506		10.1074/jbc.M113.545194	http://dx.doi.org/10.1074/jbc.M113.545194			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24739390	Green Published, hybrid			2022-12-25	WOS:000337465400032
J	Arroyo-Berdugo, Y; Alonso, S; Ribas, G; Ibarrola-Villava, M; Pena-Chilet, M; Martinez-Cadenas, C; Gardeazabal, J; Ratoon-Nieto, JA; Sanchez-Diez, A; Careaga, JM; Perez-Yarza, G; Carretero, G; Martin-Gonzalez, M; Gomez-Fernandez, C; Nagore, E; Asumendi, A; Boyano, MD				Arroyo-Berdugo, Yoana; Alonso, Santos; Ribas, Gloria; Ibarrola-Villava, Maider; Pena-Chilet, Maria; Martinez-Cadenas, Conrado; Gardeazabal, Jesus; Antonio Raton-Nieto, Juan; Sanchez-Diez, Ana; Maria Careaga, Jesus; Perez-Yarza, Gorka; Carretero, Gregorio; Martin-Gonzalez, Manuel; Gomez-Fernandez, Cristina; Nagore, Eduardo; Asumendi, Aintzane; Dolores Boyano, Maria			Involvement of ANXA5 and ILKAP in Susceptibility to Malignant Melanoma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTEGRIN-LINKED KINASE; GERMLINE MUTATIONS; MEMBRANE-BINDING; VARIANTS; ANNEXINS; RISK; MC1R; IDENTIFICATION; POLYMORPHISMS	Single nucleotide-polymorphisms (SNPs) are a source of diversity among human population, which may be responsible for the different individual susceptibility to diseases and/or response to drugs, among other phenotypic traits. Several low penetrance susceptibility genes associated with malignant melanoma (MM) have been described, including genes related to pigmentation, DNA damage repair and oxidative stress pathways. In the present work, we conducted a candidate gene association study based on proteins and genes whose expression we had detected altered in melanoma cell lines as compared to normal melanocytes. The result was the selection of 88 loci and 384 SNPs, of which 314 fulfilled our quality criteria for a case-control association study. The SNP rs6854854 in ANXA5 was statistically significant after conservative Bonferroni correction when 464 melanoma patients and 400 controls were analyzed in a discovery Phase I. However, this finding could not be replicated in the validation phase, perhaps because the minor allele frequency of SNP rs6854854 varies depending on the geographical region considered. Additionally, a second SNP (rs6431588) located on ILKAP was found to be associated with melanoma after considering a combined set of 1,883 MM cases and 1,358 disease-free controls. The OR was 1.29 (95% CI 1.12-1.48; p-value= 4x10(-4)). Both SNPs, rs6854854 in ANXA5 and rs6431588 in ILKAP, show population structure, which, assuming that the Spanish population is not significantly structured, suggests a role of these loci on a specific genetic adaptation to different environmental conditions. Furthermore, the biological relevance of these genes in MM is supported by in vitro experiments, which show a decrease in the transcription levels of ANXA5 and ILKAP in melanoma cells compared to normal melanocytes.	[Arroyo-Berdugo, Yoana; Perez-Yarza, Gorka; Asumendi, Aintzane; Dolores Boyano, Maria] Univ Basque Country UPV EHU, Sch Med & Dent, Dept Cell Biol & Histol, Leioa, Bizkaia, Spain; [Alonso, Santos] Univ Basque Country UPV EHU, Fac Sci & Technol, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Bizkaia, Spain; [Ribas, Gloria; Ibarrola-Villava, Maider; Pena-Chilet, Maria] INCLIVA, Inst Invest Sanitaria, Dept Hematol & Med Oncol, Valencia, Spain; [Martinez-Cadenas, Conrado] Univ Castellon Jaume I, Dept Med, Castellon de La Plana, Spain; [Gardeazabal, Jesus; Antonio Raton-Nieto, Juan] Univ Basque Country, BioCruces Hlth Res Inst, Cruces Univ Hosp, Dept Dermatol Ophthalmol & Otorhinolaryngol,Serv, Baracaldo, Bizkaia, Spain; [Sanchez-Diez, Ana; Maria Careaga, Jesus] Univ Basque Country, BioCruces Hlth Res Inst, Basurto Univ Hosp, Dept Dermatol Ophthalmol & Otorhinolaryngol,Serv, Bilbao, Bizkaia, Spain; [Carretero, Gregorio] Doctor Negrin Hosp, Dept Dermatol, Las Palmas Gran Canaria, Spain; [Martin-Gonzalez, Manuel] Hosp Ramon & Cajal, Dept Dermatol, E-28034 Madrid, Spain; [Gomez-Fernandez, Cristina] La Paz Univ Hosp, Dept Dermatol, Madrid, Spain; [Nagore, Eduardo] Inst Valenciano Oncol, Dept Dermatol, Valencia, Spain	University of Basque Country; University of Basque Country; Universitat Jaume I; Hospital Universitario Cruces; University of Basque Country; Basurto Hospital; University of Basque Country; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Instituto Valenciano De Oncologia	Boyano, MD (corresponding author), Univ Basque Country UPV EHU, Sch Med & Dent, Dept Cell Biol & Histol, Leioa, Bizkaia, Spain.	lola.boyano@ehu.es	Martinez-Cadenas, Conrado/AAB-3266-2021; Nagore, Eduardo/Z-2126-2019; Ribas-Despuig, Gloria/M-6190-2017; Alonso, Santos/L-8316-2014; BOYANO LOPEZ, MARIA DOLORES/ABF-6668-2021; Peña-Chilet, Maria/A-8387-2015; Perez-Yarza, Gorka/ABF-7159-2021; Gardeazabal, Jesus/E-1751-2012; Asumendi, Aintzane/ABF-7001-2021; Ribas, Gloria/K-3379-2013	Martinez-Cadenas, Conrado/0000-0002-5252-563X; Nagore, Eduardo/0000-0003-3433-8707; Alonso, Santos/0000-0003-0221-4048; BOYANO LOPEZ, MARIA DOLORES/0000-0001-6051-1054; Peña-Chilet, Maria/0000-0002-6445-9617; Ribas, Gloria/0000-0001-6883-4130; Bowcock, Anne/0000-0001-8691-9090; PEREZYARZA, GORKA/0000-0003-3236-491X; Asumendi, Aintzane/0000-0002-2156-2323; Ibarrola-Villava, Maider/0000-0003-0946-8075	Dpt. Educacion, Universidades e Investigacion of the Basque Government [IT524-10]; Diputacion Foral de Bizkaia [DIPE 08/19]; University of the Basque Country [UFI11/44]; Dept. Educacion, Universidades e Investigacion of the Basque Government [BFI07.282]	Dpt. Educacion, Universidades e Investigacion of the Basque Government; Diputacion Foral de Bizkaia; University of the Basque Country; Dept. Educacion, Universidades e Investigacion of the Basque Government	This work was supported by the Dpt. Educacion, Universidades e Investigacion of the Basque Government, project IT524-10; Diputacion Foral de Bizkaia, project DIPE 08/19, the University of the Basque Country program UFI11/44 and a predoctoral fellowship from the Dept. Educacion, Universidades e Investigacion of the Basque Government to YA-B (BFI07.282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JH, 2011, NAT GENET, V43, P1108, DOI 10.1038/ng.959; Boyano MD, 1997, ONCOLOGY, V54, P400; Cabanes Domenech A, 2009, SITUACION CANC ESPAN; Crocetti E, 2012, ISRN ONCOL, V2012; Dai DL, 2003, CLIN CANCER RES, V9, P4409; Deng SS, 2013, ONCOL LETT, V5, P107, DOI 10.3892/ol.2012.959; Denninghoff V, 2006, MEDICINA-BUENOS AIRE, V66, P144; Di Gaetano C, 2013, EVOL BIOINFORM, V9, P29, DOI 10.4137/EBO.S10211; Dummer R, 2011, SKIN CANCER - A WORLD-WIDE PERSPECTIVE, P1, DOI 10.1007/978-3-642-05072-5; Fardo DW, 2009, EUR J HUM GENET, V17, P1676, DOI 10.1038/ejhg.2009.85; Fernandez L, 2008, HUM MUTAT, V29, P1161, DOI 10.1002/humu.20804; Gayan J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-326; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Ghiorzo P, 2012, EXP DERMATOL, V21, P718, DOI 10.1111/j.1600-0625.2012.01549.x; Gudbjartsson DF, 2008, NAT GENET, V40, P1029, DOI 10.1038/ng0808-1029; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Gunther T, 2013, GENETICS, V195, P205, DOI 10.1534/genetics.113.152462; Hayward N, 2000, Curr Oncol Rep, V2, P300, DOI 10.1007/s11912-000-0022-z; Hsu I, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-62; HUBER R, 1990, FEBS LETT, V275, P15, DOI 10.1016/0014-5793(90)81428-Q; Ibarrola-Villava M, 2011, EUR J CANCER, V47, P2618, DOI 10.1016/j.ejca.2011.05.011; Ibarrola-Villava M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019271; Ibarrola-Villava M, 2010, EXP DERMATOL, V19, P836, DOI 10.1111/j.1600-0625.2010.01115.x; Kim BC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S2; Kumar AS, 2004, ONCOGENE, V23, P3454, DOI 10.1038/sj.onc.1207473; Laohavisit A, 2009, PLANT SCI, V177, P532, DOI 10.1016/j.plantsci.2009.09.008; Leitner R M C, 2006, Rev. argent. dermatol., V87, P86; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Peng BY, 2014, CLIN CHIM ACTA, V427, P42, DOI 10.1016/j.cca.2013.09.048; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raimondi S, 2008, INT J CANCER, V122, P2753, DOI 10.1002/ijc.23396; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Russak JE, 2012, DERMATOL CLIN, V30, P363, DOI 10.1016/j.det.2012.05.002; Soufir N, 1998, HUM MOL GENET, V7, P209, DOI 10.1093/hmg/7.2.209; TAJIMA F, 1989, GENETICS, V123, P585; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Udayakumar D, 2009, HEMATOL ONCOL CLIN N, V23, P415, DOI 10.1016/j.hoc.2009.03.011; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ward KA, 2012, J AM ACAD DERMATOL, V67, P1055, DOI 10.1016/j.jaad.2012.02.042; Wehder L, 2009, CELL CYCLE, V8, P1552, DOI 10.4161/cc.8.10.8404; Zhou W, 2013, J BIOL CHEM, V288, P6259, DOI 10.1074/jbc.M112.432195; Zuo L, 1996, NAT GENET, V12, P97, DOI 10.1038/ng0196-97	43	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95522	10.1371/journal.pone.0095522	http://dx.doi.org/10.1371/journal.pone.0095522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743186	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100134
J	Buot, MLG; Docena, JP; Ratemo, BK; Bittner, MJ; Burlew, JT; Nuritdinov, AR; Robbins, JR				Buot, Max-Louis G.; Docena, Jeffrey P.; Ratemo, Brenda K.; Bittner, Matthew J.; Burlew, Jacob T.; Nuritdinov, Aziz R.; Robbins, Jennifer R.			Beyond Race and Place: Distal Sociological Determinants of HIV Disparities	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASE; SUB-SAHARAN AFRICA; UNITED-STATES; RACIAL DISPARITIES; TRANSACTIONAL SEX; SOUTH-AFRICA; SOCIAL DETERMINANTS; BISEXUAL MEN; SURVIVAL SEX; RISK	Informed behavior change as an HIV prevention tool has yielded unequal successes across populations. Despite decades of HIV education, some individuals remain at high risk. The mainstream media often portrays these risk factors as products of race and national borders; however, a rich body of recent literature proposes a host of complex social factors that influence behavior, including, but not limited to: poverty, income inequality, stigmatizing social institutions and health care access. We examined the relationship between numerous social indicators and HIV incidence across eighty large U. S. cities in 1990 and 2000. During this time, major correlating factors included income inequality, poverty, educational attainment, residential segregation and marriage rates. However, these ecological factors were weighted differentially across risk groups (e. g. heterosexual, intravenous drug use, men who have sex with men (MSM)). Heterosexual risk rose significantly with poor economic indicators, while MSM risk depended more heavily on anti-homosexual stigma (as measured by same-sex marriage laws). HIV incidence among black individuals correlated significantly with numerous economic factors but also with segregation and imbalances in the male: female ratio (often an effect of mass incarceration). Our results support an overall model of HIV ecology where poverty, income inequality and social inequality (in the form of institutionalized racism and anti-homosexual stigma) have over time developed into synergistic drivers of disease transmission in the U. S., inhibiting information-based prevention efforts. The relative weights of these distal factors vary over time and by HIV risk group. Our testable model may be more generally applicable within the U. S. and beyond.	[Buot, Max-Louis G.] Xavier Univ, Dept Math & Comp Sci, Cincinnati, OH 45207 USA; [Docena, Jeffrey P.; Ratemo, Brenda K.; Bittner, Matthew J.; Burlew, Jacob T.; Nuritdinov, Aziz R.; Robbins, Jennifer R.] Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA	Xavier University; Xavier University	Robbins, JR (corresponding author), Xavier Univ, Dept Biol, Cincinnati, OH 45207 USA.	robbins@xavier.edu		Robbins, Jennifer/0000-0002-7414-6702	Jesuit Faculty Fellowship	Jesuit Faculty Fellowship	This work was supported in part by the Jesuit Faculty Fellowship sabbatical award, granted to JRR. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2006, JAIDS-J ACQ IMM DEF, V41, P616, DOI 10.1097/01.qai.0000191382.62070.a5; Adimora AA, 2002, EPIDEMIOLOGY, V13, P707, DOI 10.1097/00001648-200211000-00016; Adimora AA, 2006, SEX TRANSM DIS, V33, pS39, DOI 10.1097/01.olq.0000228298.07826.68; An Q, 2013, AM J PUBLIC HEALTH, V103, P120, DOI 10.2105/AJPH.2012.300853; [Anonymous], 2005, SEXUAL BEHAV SELECTE; Bank TW, 1997, CONFRONTING AIDS PUB, P30; Barnett T., 2006, AIDS 21 CENTURY DIS, Vsecond; Beyrer C, 2007, CLIN INFECT DIS, V44, P981, DOI 10.1086/512371; Biello KB, 2013, SEX TRANSM DIS, V40, P444, DOI 10.1097/01.olq.0000430673.76944.b8; Biello KB, 2012, AM J PUBLIC HEALTH, V102, P1370, DOI 10.2105/AJPH.2011.300516; Brooks RA, 2005, AIDS PATIENT CARE ST, V19, P737, DOI 10.1089/apc.2005.19.737; Brown E. R., 2000, DISPARITIES HLTH INS; Bureau USC, 2000, DEC US CENS; Campbell C, 1997, SOC SCI MED, V45, P273, DOI 10.1016/S0277-9536(96)00343-7; Centers for Disease Control and Prevention, 2011, HIV AIDS SURVEILLANC, V23; Centers for Disease Control (CDC), 1981, MMWR-MORBID MORTAL W, V30, P305; Clark S, 2004, STUD FAMILY PLANN, V35, P149, DOI 10.1111/j.1728-4465.2004.00019.x; Clark SJ, 2007, SCAND J PUBLIC HEALT, V35, P35, DOI 10.1080/14034950701355619; Cote AM, 2004, AIDS, V18, P917, DOI [10.1097/01.aids.0000111475.61782.98, 10.1097/00002030-200404090-00009]; Denning Paul H., 2011, Morbidity and Mortality Weekly Report, V60, P1045; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Fenton L, 2004, LANCET, V364, P1186, DOI 10.1016/S0140-6736(04)17109-2; Ford CL, 2007, ANN EPIDEMIOL, V17, P209, DOI 10.1016/j.annepidem.2006.09.006; Fox AM, 2012, J BIOSOC SCI, V44, P459, DOI 10.1017/S0021932011000745; Gates GJ, 2006, SAME SEX COUPLES GAY; Glaeser EL, 2004, URBAN INEQUALITY; Glynn JR, 2003, JAIDS-J ACQ IMM DEF, V33, P526, DOI 10.1097/00126334-200308010-00015; HAHN RA, 1989, AM J PUBLIC HEALTH, V79, P467, DOI 10.2105/AJPH.79.4.467; Haley N, 2004, SEX TRANSM INFECT, V80, P526, DOI 10.1136/sti.2004.010728; Hallfors DD, 2007, AM J PUBLIC HEALTH, V97, P125, DOI 10.2105/AJPH.2005.075747; Harawa NT, 2003, J ADOLESCENT HEALTH, V32, P187, DOI 10.1016/S1054-139X(02)00458-5; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Hogben M, 2008, SEX TRANSM DIS, V35, pS13, DOI 10.1097/OLQ.0b013e31818d3cad; John C.M., 2004, EOS, V85, P158, DOI DOI 10.1029/2004EO160004; Logan J, 2004, METROPOLITAN RACIAL; Maruschak LM, 2012, HIV PRISONS 2001 201; Meadows SO, 2008, AM SOCIOL REV, V73, P314, DOI 10.1177/000312240807300207; Millett G, 2005, J NATL MED ASSOC, V97, p52S; Mishra V, 2007, AIDS, V21, pS17, DOI 10.1097/01.aids.0000300532.51860.2a; Moskowitz DA, 2011, AIDS BEHAV, V15, P621, DOI 10.1007/s10461-010-9692-1; Nagelkerke NJD, 2009, AIDS, V23, P125, DOI 10.1097/QAD.0b013e3283177f20; Neblett RC, 2011, J URBAN HEALTH, V88, P54, DOI 10.1007/s11524-010-9513-x; Newcomb ME, 2011, ARCH SEX BEHAV, V40, P189, DOI 10.1007/s10508-009-9573-8; Newmann S, 2000, INT J STD AIDS, V11, P250, DOI 10.1258/0956462001915796; Organista KC, 1997, J COMMUN HEALTH, V22, P185, DOI 10.1023/A:1025173008088; Parkhurst JO, 2010, B WORLD HEALTH ORGAN, V88, P519, DOI 10.2471/BLT.09.070185; Peterman TA, 2005, J INFECT DIS, V191, pS123, DOI 10.1086/425284; Piot P, 2007, PLOS MED, V4, P1571, DOI 10.1371/journal.pmed.0040314; Pouget ER, 2010, PUBLIC HEALTH REP, V125, P70, DOI 10.1177/00333549101250S411; R Core Team R, 2022, R LANG ENV STAT COMP; Razani N, 2007, ADDICTION, V102, P1472, DOI 10.1111/j.1360-0443.2007.01914.x; Reports UC, 2000, REP UC FED BUR INV; Riley Elise D, 2007, Curr HIV/AIDS Rep, V4, P181, DOI 10.1007/s11904-007-0026-5; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Santelli J, 2006, J ADOLESCENT HEALTH, V38, P72, DOI 10.1016/j.jadohealth.2005.10.006; Sauve N, 2002, J ACQ IMMUN DEF SYND, V29, P402, DOI 10.1097/00126334-200204010-00012; Schultheis E, 2012, LIVING WAGE CALCULAT; Shelton JD, 2005, LANCET, V366, P1057, DOI 10.1016/S0140-6736(05)67401-6; Shisana O, 2009, HIV/AIDS IN SOUTH AFRICA 25 YEARS ON: PSYCHOSOCIAL PERSPECTIVES, P89, DOI 10.1007/978-1-4419-0306-8_7; Sikkema KJ, 1996, AM J PUBLIC HEALTH, V86, P1123, DOI 10.2105/AJPH.86.8_Pt_1.1123; Smith A., 2010, Morbidity and Mortality Weekly Report, V59, P1201; Stratford D, 2008, PUBLIC HEALTH REP, V123, P9, DOI 10.1177/003335490812300103; Szymanski DM, 2008, COUNS PSYCHOL, V36, P525, DOI 10.1177/0011000007309489; Tamhane Ajit C, 2004, J Biopharm Stat, V14, P843, DOI 10.1081/BIP-200035413; Thomas JC, 2006, AM J PUBLIC HEALTH, V96, P1762, DOI 10.2105/AJPH.2005.081760; Tillerson K, 2008, STAT MED, V27, P4132, DOI 10.1002/sim.3224; Tonry M, 2010, CRIME JUSTICE, V39, P273, DOI 10.1086/653045; Trenholm C, 2008, J POLICY ANAL MANAG, V27, P255, DOI 10.1002/pam.20324; *UNAIDS, 2007, PRACT GUID INT HIV P; US Department of Health and Human Services CfDCaP National Center for HIV STD and TB Prevention, 2005, CDC WONDER ON LIN DA; van Ryn M, 2003, AM J PUBLIC HEALTH, V93, P248, DOI 10.2105/AJPH.93.2.248; Vermund SH, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007195; Watson T, 2011, J HUM RESOUR, V46, P482; White P, 2013, NEW PUBLIC HLTH STD, P33; Wilkinson RG, 2009, ANNU REV SOCIOL, V35, P493, DOI 10.1146/annurev-soc-070308-115926; Zembe YZ, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-28	76	96	96	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e91711	10.1371/journal.pone.0091711	http://dx.doi.org/10.1371/journal.pone.0091711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3IK	24743728	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100004
J	Zhang, JL; Liu, FZ; Cui, GF				Zhang, Jianliang; Liu, Fangzheng; Cui, Guofa			The Efficacy of Landscape-Level Conservation in Changbai Mountain Biosphere Reserve, China	PLOS ONE			English	Article							PROTECTED AREAS; POPULATION-GROWTH; BIODIVERSITY; FRAGMENTATION; DEFORESTATION; DEGRADATION; ENVIRONMENT; IMPACT	Anthropogenic landscape alteration is rather common in many protected areas (PAs), jeopardizing the efficacy of PAs conservation. However, the general consensus is that PAs still remain effective in habitat conservation. To assess the efficacy of landscape-level conservation, we examined landscape alterations in the Changbai Mountain Biosphere Reserve (CMBR), which was established in 1960 as a "flagship'' protected area in China. Based on analyses of high-resolution satellite images and data of forest inventory, field survey and interview, we developed two new indexes to assess the efficacy of landscape conservation, i.e. the quality index of protected landscape and the interference index of anthropogenic landscape. From 1993 to 2012, the quality index increased from 74.48 to 75.50, and the interference index decreased from 0.49 to 0.06, suggesting that the overall quality of protected landscape improved and the degree of anthropogenic interference decreased in CMBR. The increase in landscape quality was mainly due to the progressive vegetation recovery of previous cutover land in the windthrow area, the cease of the use of the cultivated land, and the amelioration of spatial pattern of protected landscape. We conclude that the current landscape conservation methods used in CMBR are effective, and the method we developed has the potential to be used to assess the efficacy of landscape-level conservation in nature reserves worldwide.	[Zhang, Jianliang; Liu, Fangzheng; Cui, Guofa] Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China	Beijing Forestry University	Cui, GF (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Beijing, Peoples R China.	fa6716@163.com			Special Funds of Forestry Research for Public Welfare, China [201104029]	Special Funds of Forestry Research for Public Welfare, China	This study was supported by the Special Funds of Forestry Research for Public Welfare, China (Grant 201104029), the funder's website is as follows: http://www.forestry.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, ECOL SOC, DOI DOI 10.5751/ES-00015-010104; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Fahring L, 1986, ECOLOGY, V67, P61; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Foretry survey and planning institute of Jilin province, 1995, COMPR SURV FOR RES C; He JJ, 1984, RES PAPERS CHANGBAI, P207; HOBBS RJ, 1993, BIOL CONSERV, V64, P193, DOI 10.1016/0006-3207(93)90321-Q; Howard PC, 2000, CONSERV BIOL, V14, P858, DOI 10.1046/j.1523-1739.2000.99180.x; IUCN and UNEP-WCMC, 2012, WORLD DAT PROT AR; Jha S, 2006, CONSERV BIOL, V20, P906, DOI 10.1111/j.1523-1739.2006.00398.x; [蒋明康 Jiang Mingkang], 2004, [农村生态环境, Rural Eco-Environment], V20, P1; Jochen P, 1978, PERCEPT MOTOR SKILL, V46, P831; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; KRUMMEL JR, 1987, OIKOS, V48, P321, DOI 10.2307/3565520; [李宗峰 Li Zongfeng], 2005, [西南师范大学学报. 自然科学版, Journal of Southwest China Normal University. Natural Science], V30, P329; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Liu JG, 2001, SCIENCE, V292, P98, DOI 10.1126/science.1058104; Ma HY, 2009, PUBLIC ADM LAW, V12, P61; McPherson M., 2008, J CONSERV PLANN, V4, P60; Mehring M, 2011, ECOL SOC, V16, DOI 10.5751/ES-04349-160403; Ministry of Environmental Protection of the People's Republic of China [MEPPRC], 2012, NAT RES LISTS CHIN; Ministry of Land and Resources, 2007, GBT210102007; Nianyong Han, 2001, Journal of Sustainable Tourism, V9, P228, DOI 10.1080/09669580108667400; Piao ZJ, 2011, J HYDRO ECOL, V32, P51; Pimm SL, 1998, SCIENCE, V279, P2068, DOI 10.1126/science.279.5359.2068; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Rayn D, 2011, BIODIVERS CONSERV, V20, P1625, DOI 10.1007/s10531-011-0051-y; Sajeev R, 2003, J GEOL SOC INDIA, V61, P573; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Shao GF, 1996, CAN J FOREST RES, V26, P206, DOI 10.1139/x26-024; Southworth J, 2004, APPL GEOGR, V24, P303, DOI 10.1016/j.apgeog.2004.07.003; State Forestry Bureau, 2008, CLASS LAND COV NAT R; State forestry bureau survey planning and design institute, 2011, GBT264242010 STAT FO; Tang LN, 2011, MT RES DEV, V31, P169, DOI 10.1659/MRD-JOURNAL-D-10-00120.1; Tang LN, 2010, BIOL CONSERV, V143, P1295, DOI 10.1016/j.biocon.2010.01.024; Terborgh J, 2002, MAKING PARKS WORK: STRATEGIES FOR PRESERVING TROPICAL NATURE, P3; Vunohelainen AJ, 2011, ENVIRON MANAGE, V50, P645; Wang S. X, 2007, BIOL RESOURCES CHANG; [王智 Wang Zhi], 2004, [农村生态环境, Rural Eco-Environment], V20, P72; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; WRI/IUCN/UNEP, 1992, GLOB BIOD STRAT; WU JG, 1993, ECOL MODEL, V65, P221, DOI 10.1016/0304-3800(93)90081-3; Wu RD, 2011, FRONT ECOL ENVIRON, V9, P383, DOI 10.1890/100093; Xue J., 2009, TERRITORY NATURAL RE, V1, P95; Yang X, 2003, BIODIVERS CONSERV, V12, P883, DOI 10.1023/A:1022841107685; Yuan JQ, 2008, ECOL SOC, V13; Zhao JZ, 2011, ANN FOREST SCI, V68, P935, DOI 10.1007/s13595-011-0099-6; Zhao ZJ, 1984, RES PAPERS CHANGBI M, P30; Zheng YM, 2012, CHINESE SCI BULL, V57, P1116, DOI 10.1007/s11434-011-4942-9; 赵光, 2001, 生态学报, V21, P1393	52	8	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95081	10.1371/journal.pone.0095081	http://dx.doi.org/10.1371/journal.pone.0095081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743693	Green Submitted, gold, Green Published			2022-12-25	WOS:000335309100066
J	Dib, S; Xiao, SX; Miletic, D; Robertson, J				Dib, Samar; Xiao, Shangxi; Miletic, Denise; Robertson, Janice			Gene Targeting of Mouse Tardbp Negatively Affects Masp2 Expression	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; EMBRYONIC STEM-CELLS; FRONTOTEMPORAL LOBAR DEGENERATION; MAMMALIAN-CELLS; TDP-43; INCLUSIONS; UBIQUITIN; EMBRYOGENESIS; SELECTION; DISEASE	Amyotrophic Lateral Sclerosis (ALS) is a devastating adult onset neurodegenerative disease affecting both upper and lower motor neurons. TDP-43, encoded by the TARDBP gene, was identified as a component of motor neuron cytoplasmic inclusions in both familial and sporadic ALS and has become a pathological signature of the disease. TDP-43 is a nuclear protein involved in RNA metabolism, however in ALS, TDP-43 is mislocalized to the cytoplasm of affected motor neurons, suggesting that disease might be caused by TDP-43 loss of function. To investigate this hypothesis, we attempted to generate a mouse conditional knockout of the Tardbp gene using the classical Cre-loxP technology. Even though heterozygote mice for the targeted allele were successfully generated, we were unable to obtain homozygotes. Here we show that although the targeting vector was specifically designed to not overlap with Tardbp adjacent genes, the homologous recombination event affected the expression of a downstream gene, Masp2. This may explain the inability to obtain homozygote mice with targeted Tardbp.	[Dib, Samar; Xiao, Shangxi; Miletic, Denise; Robertson, Janice] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada	University of Toronto	Robertson, J (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.	Jan.Robertson@utoronto.ca			Canadian Institutes of Health Research; ALS Canada (FRN) [116639]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); ALS Canada (FRN)	This work was supported by a grant from the Canadian Institutes of Health Research and ALS Canada (FRN# is 116639). S. D. holds a Tim E. Noel postdoctoral fellowship from ALS Canada and Canadian Institutes of Health Research. J.R. holds a Canada Research Chair in Molecular Mechanisms of ALS. Canadian Institutes of Health Research, http://www.cihr-irsc.gc.ca; ALS Canada, http://www.als.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; BERGMANN M, 1993, PATHOL RES PRACT, V189, P902; BRINSTER RL, 1989, P NATL ACAD SCI USA, V86, P7087, DOI 10.1073/pnas.86.18.7087; Buratti E, 2010, RNA BIOL, V7, P420, DOI 10.4161/rna.7.4.12205; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; Endo Y, 2002, INT IMMUNOL, V14, P1193, DOI 10.1093/intimm/dxf085; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586; Heiman-Patterson TD, 2011, AMYOTROPH LATERAL SC, V12, P79, DOI 10.3109/17482968.2010.550626; Iguchi Y, 2013, BRAIN; JASIN M, 1988, GENE DEV, V2, P1353, DOI 10.1101/gad.2.11.1353; Kiper C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070512; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Park S, 2013, MOL ENDOCRINOL, V27, P2013, DOI 10.1210/me.2013-1161; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; THOMAS KR, 1986, NATURE, V324, P34, DOI 10.1038/324034a0; Unterberger C, 2007, BIOCHEM BIOPH RES CO, V364, P1022, DOI 10.1016/j.bbrc.2007.10.114; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; Wenger AM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003728; Wu LS, 2012, J BIOL CHEM, V287, P27335, DOI 10.1074/jbc.M112.359000; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; ZHENG H, 1991, P NATL ACAD SCI USA, V88, P8067, DOI 10.1073/pnas.88.18.8067	31	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95373	10.1371/journal.pone.0095373	http://dx.doi.org/10.1371/journal.pone.0095373			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740308	gold, Green Submitted, Green Published			2022-12-25	WOS:000336863900135
J	Hanks, AS; Just, DR; Wansink, B				Hanks, Andrew S.; Just, David R.; Wansink, Brian			Chocolate Milk Consequences: A Pilot Study Evaluating the Consequences of Banning Chocolate Milk in School Cafeterias	PLOS ONE			English	Article							CHILDREN; CHOICES; CONSUMPTION; ADOLESCENTS; INCENTIVES; STUDENTS; FOODS	Objectives: Currently, 68.3% of the milk available in schools is flavored, with chocolate being the most popular (61.6% of all milk). If chocolate milk is removed from a school cafeteria, what will happen to overall milk selection and consumption? Methods: In a before-after study in 11 Oregon elementary schools, flavored milk-which will be referred to as chocolate milk-was banned from the cafeteria. Milk sales, school enrollment, and data for daily participation in the National School Lunch Program (NSLP) were compared year to date. Results: Total daily milk sales declined by 9.9% (p < 0.01). Although white milk increased by 161.2 cartons per day (p < 0.001), 29.4% of this milk was thrown away. Eliminating chocolate milk was also associated with 6.8% fewer students eating school lunches, and although other factors were also involved, this is consistent with the notion of psychological reactance. Conclusions: Removing chocolate milk from school cafeterias may reduce calorie and sugar consumption, but it may also lead students to take less milk overall, drink less (waste more) of the white milk they do take, and no longer purchase school lunch. Food service managers need to carefully weigh the costs and benefits of eliminating chocolate milk and should consider alternative options that make white milk more convenient, attractive, and normal to choose.	[Hanks, Andrew S.; Just, David R.] Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY USA; [Hanks, Andrew S.; Just, David R.; Wansink, Brian] Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA	Cornell University; Cornell University	Wansink, B (corresponding author), Cornell Univ, Dyson Sch Appl Econ & Management, Ithaca, NY 14850 USA.	foodandbrandlab@cornell.edu	Hanks, Andrew/B-7807-2015	Hanks, Andrew/0000-0003-0687-4772	USDA ERS/FNS [59-5000-0-0090]; USDA NIFA/Hatch [002254837]	USDA ERS/FNS(United States Department of Agriculture (USDA)); USDA NIFA/Hatch(United States Department of Agriculture (USDA))	There were two grants which were sources of funding for this study, USDA ERS/FNS 59-5000-0-0090, and USDA NIFA/Hatch 002254837. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black RE, 2002, AM J CLIN NUTR, V76, P675, DOI 10.1093/ajcn/76.3.675; Connors P, 2001, J NUTR EDUC, V33, P31, DOI 10.1016/S1499-4046(06)60007-9; Cullen KW, 2006, PUBLIC HEALTH NUTR, V9, P814, DOI 10.1079/PHN2005878; Fisher JO, 1999, AM J CLIN NUTR, V69, P1264; Frary CD, 2004, J ADOLESCENT HEALTH, V34, P56, DOI 10.1016/S1054-139X(03)00248-9; Gordon Anne, 2007, SCH NUTR DIET ASS ST, VI; Goto K, 2013, APPL ECON PERSPECT P, V35, P360, DOI 10.1093/aepp/ppt004; Goulding A, 2004, J AM DIET ASSOC, V104, P250, DOI 10.1016/j.jada.2003.11.008; Hanks A. S., 2012, Agricultural and Resource Economics Review, V41, P114; Hanks AS, 2014, J ACAD NUTR DIET, V114, P470, DOI 10.1016/j.jand.2013.08.013; Hanks AS, 2013, J PEDIATR-US, V162, P867, DOI 10.1016/j.jpeds.2012.12.031; Hanks AS, 2012, J PUBLIC HEALTH-UK, V34, P370, DOI 10.1093/pubmed/fds003; Heaney RP, 2009, J AM COLL NUTR, V28, p82S, DOI 10.1080/07315724.2009.10719808; Hurley KM, 2011, J NUTR, V141, P495, DOI 10.3945/jn.110.130047; Johnson RK, 2002, J AM DIET ASSOC, V102, P853, DOI 10.1016/S0002-8223(02)90192-6; JOHNSON SL, 1994, PEDIATRICS, V94, P653; Just D. R., 2009, Choices. The Magazine of Food, Farm, and Resources Issues, V24, punpaginated; Just D, 2013, PUBLIC HEALTH NUTR, V16, P2281, DOI 10.1017/S1368980013001468; Just DR, 2013, J HUM RESOUR, V48, P855; Kalkwarf HJ., 2007, NUTR ASPECTS OSTEOPO, P39; Kutner M., 2005, APPL LINEAR STAT MOD; Murphy MM, 2008, J AM DIET ASSOC, V108, P631, DOI 10.1016/j.jada.2008.01.004; Patterson J, 2009, J AM DIET ASSOC, V109, pA97, DOI DOI 10.1016/J.JADA.2009.06.330; Prime Consulting Group, 2012, 2011 2012 ANN SCH CH; Wansink B, 2014, OBESITY, V22, P630, DOI 10.1002/oby.20668; Wansink B, 2013, CHILD OBES, V9, P277, DOI 10.1089/chi.2013.9405; Wells A., 2000, Nutrition & Food Science, P76, DOI 10.1108/00346650010314322	27	45	45	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e91022	10.1371/journal.pone.0091022	http://dx.doi.org/10.1371/journal.pone.0091022			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740451	Green Published, gold			2022-12-25	WOS:000336863900006
J	Perez-Bercoff, L; Valentini, D; Gaseitsiwe, S; Mahdavifar, S; Schutkowski, M; Poiret, T; Perez-Bercoff, A; Ljungman, P; Maeurer, MJ				Perez-Bercoff, Lena; Valentini, Davide; Gaseitsiwe, Simani; Mahdavifar, Shahnaz; Schutkowski, Mike; Poiret, Thomas; Perez-Bercoff, Asa; Ljungman, Per; Maeurer, Markus J.			Whole CMV Proteome Pattern Recognition Analysis after HSCT Identifies Unique Epitope Targets Associated with the CMV Status	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; EPSTEIN-BARR-VIRUS; HUMAN CYTOMEGALOVIRUS; ANTIBODY-RESPONSE; SYSTEMS BIOLOGY; INFECTION; PREVENTION; STRAINS; GENE	Cytomegalovirus (CMV) infection represents a vital complication after Hematopoietic Stem Cell Transplantation (HSCT). We screened the entire CMV proteome to visualize the humoral target epitope-focus profile in serum after HSCT. IgG profiling from four patient groups (donor and/or recipient +/- for CMV) was performed at 6, 12 and 24 months after HSCT using microarray slides containing 17174 of 15mer-peptides overlapping by 4 aa covering 214 proteins from CMV. Data were analyzed using maSigPro, PAM and the 'exclusive recognition analysis (ERA)' to identify unique CMV epitope responses for each patient group. The 'exclusive recognition analysis' of serum epitope patterns segregated best 12 months after HSCT for the D+/R+ group (versus D-/R-). Epitopes were derived from UL123 (IE1), UL99 (pp28), UL32 (pp150), this changed at 24 months to 2 strongly recognized peptides provided from UL123 and UL100. Strongly (IgG) recognized CMV targets elicited also robust cytokine production in T-cells from patients after HSCT defined by intracellular cytokine staining (IL-2, TNF, IFN and IL-17). High-content peptide microarrays allow epitope profiling of entire viral proteomes; this approach can be useful to map relevant targets for diagnostics and therapy in patients with well defined clinical endpoints. Peptide microarray analysis visualizes the breadth of B-cell immune reconstitution after HSCT and provides a useful tool to gauge immune reconstitution.	[Perez-Bercoff, Lena; Ljungman, Per] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden; [Perez-Bercoff, Lena; Ljungman, Per] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden; [Perez-Bercoff, Lena; Valentini, Davide; Maeurer, Markus J.] Karolinska Hosp, CAST Ctr Allogene Stem Cell Transplantat, S-10401 Stockholm, Sweden; [Gaseitsiwe, Simani] Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Mahdavifar, Shahnaz] Swedish Inst Infect Dis Control SMI, Stockholm, Sweden; [Schutkowski, Mike] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Dept Enzymol, D-06108 Halle, Germany; [Poiret, Thomas; Maeurer, Markus J.] LabMed Karolinska Inst, Div Therapeut Immunol TIM, Stockholm, Sweden; [Perez-Bercoff, Asa] Australian Natl Univ, John Curtin Sch Med Res, Dept Genome Biol, Canberra, ACT 2601, Australia	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Swedish Institute for Infectious Disease Control; Martin Luther University Halle Wittenberg; Karolinska Institutet; Australian National University; John Curtin School of Medical Research	Maeurer, MJ (corresponding author), Karolinska Hosp, CAST Ctr Allogene Stem Cell Transplantat, S-10401 Stockholm, Sweden.	markus.maeurer@ki.se	Poiret, Thomas/AAZ-5434-2020; Ljungman, Per/M-4946-2019	Poiret, Thomas/0000-0003-1965-3522; Maeurer, Markus/0000-0002-8436-8077; Schutkowski, MIke/0000-0003-0919-7076	ALF (Arbetslivfonden); Karolinska Institutet; Vinnova, Sweden	ALF (Arbetslivfonden); Karolinska Institutet(Karolinska Institutet); Vinnova, Sweden(Vinnova)	The work has been funded by ALF (Arbetslivfonden) to M. M. and P. L. funds from Karolinska Institutet and Vinnova, Sweden to M. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balboni I, 2006, ANNU REV IMMUNOL, V24, P391, DOI 10.1146/annurev.immunol.24.021605.090709; Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; Barrios Y, 2007, MOL IMMUNOL, V44, P680, DOI 10.1016/j.molimm.2006.04.024; Bjorklund A, 2007, BONE MARROW TRANSPL, V40, P1055, DOI 10.1038/sj.bmt.1705856; Boeckh M, 2001, BIOL BLOOD MARROW TR, V7, P343, DOI 10.1016/S1083-8791(01)80005-7; BOWDEN RA, 1991, J INFECT DIS, V164, P483, DOI 10.1093/infdis/164.3.483; BRITT WJ, 1990, J VIROL, V64, P1079, DOI 10.1128/JVI.64.3.1079-1085.1990; Bronzini M, 2012, J VIROL, V86, P6875, DOI 10.1128/JVI.06310-11; Bunde T, 2005, J EXP MED, V201, P1031, DOI 10.1084/jem.20042384; Burkhardt C, 2009, J GEN VIROL, V90, P1951, DOI 10.1099/vir.0.010967-0; Cai JS, 1999, J VET MED SCI, V61, P503, DOI 10.1292/jvms.61.503; CHANDLER SH, 1987, J INFECT DIS, V155, P655, DOI 10.1093/infdis/155.4.655; CHANDLER SH, 1986, J GEN VIROL, V67, P2179, DOI 10.1099/0022-1317-67-10-2179; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; CHOU SW, 1990, J INFECT DIS, V162, P738, DOI 10.1093/infdis/162.3.738; Chuang HY, 2010, ANNU REV CELL DEV BI, V26, P721, DOI 10.1146/annurev-cellbio-100109-104122; Conesa A, 2006, BIOINFORMATICS, V22, P1096, DOI 10.1093/bioinformatics/btl056; Enbom M, 2000, J MED VIROL, V62, P498, DOI 10.1002/1096-9071(200012)62:4&lt;498::AID-JMV15&gt;3.0.CO;2-B; Furebring C, 2002, MOL IMMUNOL, V38, P833, DOI 10.1016/S0161-5890(01)00119-5; Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840; Hecker M, 2012, AUTOIMMUN REV, V11, P180, DOI 10.1016/j.autrev.2011.05.010; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kuzmina Z, 2011, BLOOD, V117, P2265, DOI 10.1182/blood-2010-07-295766; Lang DT, 2001, CLIN DIAGN LAB IMMUN, V8, P747, DOI 10.1128/CDLI.8.4.747-756.2001; Linnebacher M, 2012, ANAL BIOANAL CHEM, V403, P227, DOI 10.1007/s00216-012-5781-5; LJUNGMAN P, 1994, BLOOD, V84, P657; LJUNGMAN P, 1990, J INFECT DIS, V162, P496, DOI 10.1093/infdis/162.2.496; Ljungman P, 2006, HAEMATOLOGICA, V91, P78; Magalhaes I, 2010, IMMUNOLOGY, V131, P128, DOI 10.1111/j.1365-2567.2010.03284.x; Marie-Cardine A, 2008, CLIN IMMUNOL, V127, P14, DOI 10.1016/j.clim.2007.11.013; Mattsson J, 2001, LEUKEMIA, V15, P1976, DOI 10.1038/sj.leu.2402311; Mezzasoma L, 2002, CLIN CHEM, V48, P121; Murphy E, 2003, P NATL ACAD SCI USA, V100, P13585, DOI 10.1073/pnas.1735466100; Nahtman T, 2007, J IMMUNOL METHODS, V328, P1, DOI 10.1016/j.jim.2007.07.015; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Parkman R, 1997, IMMUNOL REV, V157, P73, DOI 10.1111/j.1600-065X.1997.tb00975.x; Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749; Pignatelli S, 2003, J GEN VIROL, V84, P647, DOI 10.1099/vir.0.18704-0; Prechl J, 2010, TRENDS IMMUNOL, V31, P133, DOI 10.1016/j.it.2010.01.004; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; RHODES G, 1990, J CLIN LAB ANAL, V4, P456, DOI 10.1002/jcla.1860040613; RINGDEN O, 1994, BLOOD, V83, P2723, DOI 10.1182/blood.V83.9.2723.2723; Ringden O, 2011, EUR J HAEMATOL, V87, P503, DOI 10.1111/j.1600-0609.2011.01685.x; Robinson WH, 2002, BIOTECHNIQUES, P66; Ruutu T, 1997, BONE MARROW TRANSPL, V19, P233, DOI 10.1038/sj.bmt.1700649; Schoppel K, 1998, J INFECT DIS, V178, P1233, DOI 10.1086/314428; Shimamura M, 2006, J VIROL, V80, P4591, DOI 10.1128/JVI.80.9.4591-4600.2006; SMALL TN, 1990, BLOOD, V76, P1647; Tedeschi R, 2006, J MED VIROL, V78, P372, DOI 10.1002/jmv.20549; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tomaras GD, 2011, J VIROL, V85, P11502, DOI 10.1128/JVI.05363-11; Urban M, 1996, J GEN VIROL, V77, P1537, DOI 10.1099/0022-1317-77-7-1537; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; WAHREN B, 1984, J INFECT DIS, V150, P358, DOI 10.1093/infdis/150.3.358; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Weseslindtner L, 2012, AM J TRANSPLANT, V12, P2172, DOI 10.1111/j.1600-6143.2012.04076.x; Yun ZB, 2000, TRANSPLANTATION, V69, P1733; Yun ZB, 2003, J VIROL METHODS, V110, P73, DOI 10.1016/S0166-0934(03)00103-4	60	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e89648	10.1371/journal.pone.0089648	http://dx.doi.org/10.1371/journal.pone.0089648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740411	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900002
J	Woodard, D; Bell, D; Tipton, D; Durrance, S; Cole, L; Li, B; Xu, SH				Woodard, Daniel; Bell, Dylan; Tipton, David; Durrance, Samuel; Cole, Lisa; Li, Bin; Xu, Shaohua			Gel Formation in Protein Amyloid Aggregation: A Physical Mechanism for Cytotoxicity	PLOS ONE			English	Article							DIFFUSION; CONVECTION; VULNERABILITY; TRANSPORT; DEMENTIA; WATER	Amyloid fibers are associated with disease but have little chemical reactivity. We investigated the formation and structure of amyloids to identify potential mechanisms for their pathogenic effects. We incubated lysozyme 20 mg/ml at 55C and pH 2.5 in a glycine-HCl buffer and prepared slides on mica substrates for examination by atomic force microscopy. Structures observed early in the aggregation process included monomers, small colloidal aggregates, and amyloid fibers. Amyloid fibers were observed to further self-assemble by two mechanisms. Two or more fibers may merge together laterally to form a single fiber bundle, usually in the form of a helix. Alternatively, fibers may become bound at points where they cross, ultimately forming an apparently irreversible macromolecular network. As the fibers assemble into a continuous network, the colloidal suspension undergoes a transition from a Newtonian fluid into a viscoelastic gel. Addition of salt did not affect fiber formation but inhibits transition of fibers from linear to helical conformation, and accelerates gel formation. Based on our observations, we considered the effects of gel formation on biological transport. Analysis of network geometry indicates that amyloid gels will have negligible effects on diffusion of small molecules, but they prevent movement of colloidal-sized structures. Consequently gel formation within neurons could completely block movement of transport vesicles in neuronal processes. Forced convection of extracellular fluid is essential for the transport of nutrients and metabolic wastes in the brain. Amyloid gel in the extracellular space can essentially halt this convection because of its low permeability. These effects may provide a physical mechanism for the cytotoxicity of chemically inactive amyloid fibers in neurodegenerative disease.	[Woodard, Daniel] InnoMed Hlth Applicat Inc, Kennedy Space Ctr, FL 32899 USA; [Bell, Dylan; Durrance, Samuel] Florida Inst Technol, Dept Phys & Space Sci, Melbourne, FL 32901 USA; [Tipton, David] Aerosp Med & Occupat Hlth Branch, Kennedy Space Ctr, FL USA; [Li, Bin; Xu, Shaohua] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Cole, Lisa] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA	Florida Institute of Technology; Florida Institute of Technology; Columbia University	Woodard, D (corresponding author), InnoMed Hlth Applicat Inc, Kennedy Space Ctr, FL 32899 USA.	daniel.woodard-1@nasa.gov		Xu, Shaohua/0000-0003-1221-6354	NASA Kennedy Space Center; Florida Institute of Technology; Community Foundation of Brevard; Space Florida	NASA Kennedy Space Center(National Aeronautics & Space Administration (NASA)); Florida Institute of Technology; Community Foundation of Brevard; Space Florida	This work was supported by grants from: NASA Kennedy Space Center (http://www.ksc.nasa.gov), Florida Institute of Technology (http://www.fit.edu), The Community Foundation of Brevard (http://www.cfbrevard.org/), and Space Florida (http://www.spaceflorida.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalbert R, 2013, NEUROPATH APPL NEURO, V39, P90, DOI 10.1111/j.1365-2990.2012.01308.x; Aggeli A, 2006, MOL GELS MAT SELFASS, P721; Arnsdorf MF, 1996, J CARDIOVASC ELECTR, V7, P639, DOI 10.1111/j.1540-8167.1996.tb00572.x; ASTBURY WT, 1959, BIOCHIM BIOPHYS ACTA, V35, P17, DOI 10.1016/0006-3002(59)90330-0; Bolisetty S, 2012, BIOMACROMOLECULES, V13, P3241, DOI 10.1021/bm301005w; Bostrom M, 2006, J PHYS CHEM B, V110, P7563, DOI 10.1021/jp051025t; Budzinski KL, 2009, BIOPHYS J, V97, P2577, DOI 10.1016/j.bpj.2009.08.032; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Chatterjee AP, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/37/375106; Cole L, 2010, APPL PROTEIN AGGREGA; Conforti L, 2007, TRENDS NEUROSCI, V30, P159, DOI 10.1016/j.tins.2007.02.004; Cserr H F, 1988, Ann N Y Acad Sci, V529, P9, DOI 10.1111/j.1749-6632.1988.tb51415.x; Estroff LA, 2006, MOLECULAR GELS: MATERIALS WITH SELF-ASSEMBLED FIBRILLAR NETWORKS, P721, DOI 10.1007/1-4020-3689-2_21; Fujiwara S, 2003, J MOL BIOL, V331, P21, DOI 10.1016/S0022-2836(03)00722-8; Galvin JE, 2006, ACTA NEUROPATHOL, V112, P115, DOI 10.1007/s00401-006-0096-2; Gosal WS, 2004, BIOMACROMOLECULES, V5, P2408, DOI 10.1021/bm049659d; Hauser CAE, 2011, P NATL ACAD SCI USA, V108, P1361, DOI 10.1073/pnas.1014796108; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Herculano-Houzel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017514; Hill SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018171; Israelachvili JN, 2011, INTERMOLECULAR AND SURFACE FORCES, 3RD EDITION, P1; Johnston ST, 1999, J MEMBRANE SCI, V153, P271, DOI 10.1016/S0376-7388(98)00260-9; LAUFFER MA, 1961, BIOPHYS J, V1, P205, DOI 10.1016/S0006-3495(61)86884-7; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Manno M, 2010, LANGMUIR, V26, P1424, DOI 10.1021/la903340v; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Masaro L, 1999, PROG POLYM SCI, V24, P731, DOI 10.1016/S0079-6700(99)00016-7; MILLERO FJ, 1976, J BIOL CHEM, V251, P4001; Moores B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025954; Nicholson C, 2001, REP PROG PHYS, V64, P815, DOI 10.1088/0034-4885/64/7/202; Nield DA, 2006, CONVECTION POROUS ME; Ow SY, 2013, SOFT MATTER, V9, P9692, DOI 10.1039/c3sm51671g; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Raghavan SR, 2006, MOLECULAR GELS: MATERIALS WITH SELF-ASSEMBLED FIBRILLAR NETWORKS, P241, DOI 10.1007/1-4020-3689-2_9; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Ruben G, 1997, MICROSC MICROANAL, V3, P47; Silverberg GD, 2001, NEUROLOGY, V57, P1763, DOI 10.1212/WNL.57.10.1763; Tamagawa H, 2000, POLYMER, V41, P7201, DOI 10.1016/S0032-3861(00)00047-1; Terech P, 2006, ENCY SURFACE COLLOID, V4, P2678; Terech P, 2012, J PHYS CHEM B, V116, P11344, DOI 10.1021/jp305365m; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Wang F, 1996, ACTA CRYSTALLOGR D, V52, P901, DOI 10.1107/S0907444996005227; Ward SM, 2012, BIOCHEM SOC T, V40, P667, DOI 10.1042/BST20120134; Xu SH, 2007, AMYLOID, V14, P119, DOI 10.1080/13506120701260059; Xu SH, 2009, J PHYS CHEM B, V113, P12447, DOI 10.1021/jp903106x; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	46	26	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94789	10.1371/journal.pone.0094789	http://dx.doi.org/10.1371/journal.pone.0094789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740416	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900066
J	Gerhart, J; Greenbaum, M; Scheinfeld, V; FitzGerald, P; Crawford, M; Bravo-Nuevo, A; Pitts, M; George-Weinstein, M				Gerhart, Jacquelyn; Greenbaum, Marvin; Scheinfeld, Victoria; FitzGerald, Paul; Crawford, Mitchell; Bravo-Nuevo, Arturo; Pitts, Meghan; George-Weinstein, Mindy			Myo/Nog Cells: Targets for Preventing the Accumulation of Skeletal Muscle-Like Cells in the Human Lens	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; POSTERIOR CAPSULE OPACIFICATION; ANTERIOR SUBCAPSULAR CATARACT; MYOSIN HEAVY-CHAIN; MYOD MESSENGER-RNA; EPIBLAST CELLS; CHICK-EMBRYO; RAT LENS; EXPRESSION	Posterior capsule opacification (PCO) is a vision impairing condition that arises in some patients following cataract surgery. The fibrotic form of PCO is caused by myofibroblasts that may emerge in the lens years after surgery. In the chick embryo lens, myofibroblasts are derived from Myo/Nog cells that are identified by their expression of the skeletal muscle specific transcription factor MyoD, the bone morphogenetic protein inhibitor Noggin, and the epitope recognized by the G8 monoclonal antibody. The goal of this study was to test the hypothesis that depletion of Myo/Nog cells will prevent the accumulation of myofibroblasts in human lens tissue. Myo/Nog cells were present in anterior, equatorial and bow regions of the human lens, cornea and ciliary processes. In anterior lens tissue removed by capsulorhexis, Myo/Nog cells had synthesized myofibroblast and skeletal muscle proteins, including vimentin, MyoD and sarcomeric myosin. Alpha smooth muscle actin (alpha-SMA) was detected in a subpopulation of Myo/Nog cells. Areas of the capsule denuded of epithelial cells were surrounded by Myo/Nog cells. Some of these cell free areas contained a wrinkle in the capsule. Depletion of Myo/Nog cells eliminated cells expressing skeletal muscle proteins in 5-day cultures but did not affect cells immunoreactive for beaded filament proteins that accumulate in differentiating lens epithelial cells. Transforming growth factor-betas 1 and 2 that mediate an epithelial-mesenchymal transition, did not induce the expression of skeletal muscle proteins in lens cells following Myo/Nog cell depletion. This study demonstrates that Myo/Nog cells in anterior lens tissue removed from cataract patients have undergone a partial differentiation to skeletal muscle. Myo/Nog cells appear to be the source of skeletal muscle-like cells in explants of human lens tissue. Targeting Myo/Nog cells with the G8 antibody during cataract surgery may reduce the incidence of PCO.	[Gerhart, Jacquelyn; Scheinfeld, Victoria; Crawford, Mitchell; Bravo-Nuevo, Arturo; Pitts, Meghan; George-Weinstein, Mindy] Lankenau Inst Med Res, Wynnewood, PA USA; [Greenbaum, Marvin] Lankenau Med Ctr, Wynnewood, PA USA; [FitzGerald, Paul] Univ Calif Davis, Dept Cell Biol & Human Anat, Sch Med, Davis, CA 95616 USA	Lankenau Medical Center; Lankenau Institute for Medical Research; Lankenau Medical Center; University of California System; University of California Davis	George-Weinstein, M (corresponding author), Rowan Univ, Dept Biomed Sci, Cooper Med Sch, Camden, NJ 08103 USA.	George-weinstein@rowan.edu	Nuevo, Arturo Bravo/AAQ-1900-2020	Nuevo, Arturo Bravo/0000-0001-8237-7802; Gerhart, Jacquelyn/0000-0003-1528-5320	Sharp-Strumia Research Foundation; March of Dimes; National Institutes of Health [EY08747]; NATIONAL EYE INSTITUTE [R01EY008747] Funding Source: NIH RePORTER	Sharp-Strumia Research Foundation; March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was funded by the Sharp-Strumia Research Foundation (http://www.mainlinehealth.org/sharpe-strumia) and March of Dimes (http://www.marchofdimes.com) awarded to Dr. George-Weinstein and the National Institutes of Health (EY08747) awarded to Dr. FitzGerald. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh A, 2003, INVEST OPHTH VIS SCI, V44, P5252, DOI 10.1167/iovs.03-0224; Alizadeh A, 2002, INVEST OPHTH VIS SCI, V43, P3722; Andjelic S, 2011, ACTA OPHTHALMOL, V89, pe645, DOI 10.1111/j.1755-3768.2011.02199.x; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3; Awasthi N, 2009, ARCH OPHTHALMOL-CHIC, V127, P555, DOI 10.1001/archophthalmol.2009.3; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Banh A, 2006, INVEST OPHTH VIS SCI, V47, P3450, DOI 10.1167/iovs.05-1208; Baratz KH, 2001, AM J OPHTHALMOL, V131, P161, DOI 10.1016/S0002-9394(00)00795-9; Barth Peter J, 2007, Curr Stem Cell Res Ther, V2, P221, DOI 10.2174/157488807781696249; Bertelmann E, 2001, CURR OPIN OPHTHALMOL, V12, P35, DOI 10.1097/00055735-200102000-00007; Boureau C, 2009, CLIN OPHTHALMOL, V3, P277; Dawes LJ, 2008, INVEST OPHTH VIS SCI, V49, P650, DOI 10.1167/iovs.07-0586; de Iongh RU, 2005, CELLS TISSUES ORGANS, V179, P43, DOI 10.1159/000084508; de Longh RU, 2001, DEVELOPMENT, V128, P3995; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Findl O, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003738.pub2; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GeorgeWeinstein M, 1996, DEV BIOL, V173, P279, DOI 10.1006/dbio.1996.0023; Gerhart J, 2000, J CELL BIOL, V149, P825, DOI 10.1083/jcb.149.4.825; Gerhart J, 2004, J CELL BIOL, V164, P739, DOI 10.1083/jcb.200309152; Gerhart J, 2001, J CELL BIOL, V155, P381, DOI 10.1083/jcb.200105139; Gerhart J, 2007, J CELL BIOL, V178, P649, DOI 10.1083/jcb.200703060; Gerhart J, 2006, J CELL BIOL, V175, P283, DOI 10.1083/jcb.200605037; Gerhart Jacquelyn, 2004, Biol Proced Online, V6, P149, DOI 10.1251/bpo84; Gerhart J, 2012, EXP DERMATOL, V21, P466, DOI 10.1111/j.1600-0625.2012.01503.x; Gerhart J, 2011, DEV BIOL, V359, P12, DOI 10.1016/j.ydbio.2011.08.007; Gerhart J, 2009, DEV BIOL, V336, P30, DOI 10.1016/j.ydbio.2009.09.022; Gordon-Thomson C, 1998, INVEST OPHTH VIS SCI, V39, P1399; HALES AM, 1995, INVEST OPHTH VIS SCI, V36, P1709; Hay ED, 1995, ACTA ANAT, V154, P8; ISAACS WB, 1989, J BIOL CHEM, V264, P17953; ISHIZAKI Y, 1993, J CELL BIOL, V121, P899, DOI 10.1083/jcb.121.4.899; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; JIN JP, 1990, ANN NY ACAD SCI, V588, P393, DOI 10.1111/j.1749-6632.1990.tb13243.x; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; KUROSAKA D, 1994, INVEST OPHTH VIS SCI, V35, P3408; Lee EH, 1999, INVEST OPHTH VIS SCI, V40, P2025; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; LIU J, 1994, INVEST OPHTH VIS SCI, V35, P388; Lovicu FJ, 2002, BRIT J OPHTHALMOL, V86, P220, DOI 10.1136/bjo.86.2.220; Maddala R, 2004, LAB INVEST, V84, P679, DOI 10.1038/labinvest.3700105; Marcantonio JM, 2000, INVEST OPHTH VIS SCI, V41, P1130; Mayer DCG, 1997, J CELL BIOL, V139, P1477, DOI 10.1083/jcb.139.6.1477; MCDONNELL PJ, 1983, OPHTHALMOLOGY, V90, P1548; Michael R, 2000, INVEST OPHTH VIS SCI, V41, P204; OGATA I, 1993, CELL MOTIL CYTOSKEL, V26, P125, DOI 10.1002/cm.970260204; PINNEY DF, 1988, CELL, V53, P781, DOI 10.1016/0092-8674(88)90095-5; Raj SM, 2007, INT J BIOMED SCI, V3, P13; Richiert DM, 1999, CURR EYE RES, V18, P62, DOI 10.1076/ceyr.18.1.62.5393; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Saika S, 2002, BRIT J OPHTHALMOL, V86, P1428, DOI 10.1136/bjo.86.12.1428; Saika S, 2001, EXP EYE RES, V72, P679, DOI 10.1006/exer.2001.1002; SAPPINO AP, 1990, LAB INVEST, V63, P144; Saxby L, 1998, BRIT J OPHTHALMOL, V82, P945, DOI 10.1136/bjo.82.8.945; SCHAART G, 1991, DIFFERENTIATION, V46, P105, DOI 10.1111/j.1432-0436.1991.tb00871.x; Sharma N, 1999, J CATARACT REFR SURG, V25, P1585, DOI 10.1016/S0886-3350(99)00296-5; Strony R, 2005, GENE EXPR PATTERNS, V5, P387, DOI 10.1016/j.modgep.2004.09.006; Tonegawa A, 1998, DEV BIOL, V202, P172, DOI 10.1006/dbio.1998.8895; VALENZUELA DM, 1995, J NEUROSCI, V15, P6077; Walker JL, 2010, P NATL ACAD SCI USA, V107, P13730, DOI 10.1073/pnas.0910382107; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; WOODCOCKMITCHELL J, 1988, DIFFERENTIATION, V39, P161, DOI 10.1111/j.1432-0436.1988.tb00091.x; Wormstone IM, 2006, EXP EYE RES, V83, P1238, DOI 10.1016/j.exer.2006.06.013; Wormstone IM, 2009, EXP EYE RES, V88, P257, DOI 10.1016/j.exer.2008.10.016; Wormstone IM, 2004, EXP EYE RES, V78, P705, DOI 10.1016/j.exer.2003.08.006; Wormstone IM, 2002, INVEST OPHTH VIS SCI, V43, P2301; Wormstone IM, 1997, INVEST OPHTH VIS SCI, V38, P396; Yoon KH, 2008, INVEST OPHTH VIS SCI, V49, P1030, DOI 10.1167/iovs.07-1149	71	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95262	10.1371/journal.pone.0095262	http://dx.doi.org/10.1371/journal.pone.0095262			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736495	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600164
J	Magee, MJ; Kempker, RR; Kipiani, M; Tukvadze, N; Howards, PP; Narayan, KMV; Blumberg, HM				Magee, Matthew J.; Kempker, Russell R.; Kipiani, Maia; Tukvadze, Nestani; Howards, Penelope P.; Narayan, K. M. Venkat; Blumberg, Henry M.			Diabetes Mellitus, Smoking Status, and Rate of Sputum Culture Conversion in Patients with Multidrug-Resistant Tuberculosis: A Cohort Study from the Country of Georgia	PLOS ONE			English	Article							TREATMENT OUTCOMES; PREDICTORS; ASSOCIATION; IMPACT; RISK	Introduction: Diabetes mellitus (DM) is a risk factor for active tuberculosis (TB) but little is known about the effect of DM on culture conversion among patients with multidrug-resistant (MDR)-TB. The primary aim was to estimate the association between DM and rate of TB sputum culture conversion. A secondary objective was to estimate the association between DM and the risk of poor treatment outcomes among patients with MDR-TB. Materials and Methods: A cohort of all adult patients starting MDR-TB treatment in the country of Georgia between 20092011 was followed during second-line TB therapy. Cox proportional models were used to estimate the adjusted hazard rate of sputum culture conversion. Log-binomial regression models were used to estimate the cumulative risk of poor TB treatment outcome. Results: Among 1,366 patients with sputum culture conversion information, 966 (70.7%) had culture conversion and the median time to conversion was 68 days (interquartile range 50-120). The rate of conversion was similar among patients with MDR-TB and DM (adjusted hazard ratio [aHR] 0.95, 95% CI 0.71-1.28) compared to patients with MDR-TB only. The rate of culture conversion was significantly less in patients that currently smoked (aHR 0.82, 95% CI 0.71-0.95), had low body mass index (aHR 0.71, 95% CI 0.59-0.84), second-line resistance (aHR 0.56, 95% CI 0.43-0.73), lung cavities (aHR 0.70, 95% CI 0.59-0.83) and with disseminated TB (aHR 0.75, 95% CI 0.62-0.90). The cumulative risk of poor treatment outcome was also similar among TB patients with and without DM (adjusted risk ratio [aRR] 1.03, 95% CI 0.93-1.14). Conclusions: In adjusted analyses, DM did not impact culture conversion rates in a clinically meaningful way but smoking did.	[Magee, Matthew J.; Howards, Penelope P.; Narayan, K. M. Venkat; Blumberg, Henry M.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Magee, Matthew J.; Narayan, K. M. Venkat; Blumberg, Henry M.] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Kempker, Russell R.; Blumberg, Henry M.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Kipiani, Maia; Tukvadze, Nestani] Natl Ctr TB & Lung Dis, Tbilisi, Georgia	Emory University; Rollins School Public Health; Emory University; Rollins School Public Health; Emory University	Magee, MJ (corresponding author), Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	mjmagee@emory.edu	Magee, Matthew/W-1169-2019; Blumberg, Henry/W-2156-2019; Narayan, K.M. Venkat/J-9819-2012	Blumberg, Henry/0000-0002-3110-2443; Narayan, K.M. Venkat/0000-0001-8621-5405; Howards, Penelope/0000-0001-7539-8701	National Institute of Health (NIH) Fogarty International Center [D43TW007124, D43TW007124-06S1]; NIH National Institute of Allergy and Infectious Diseases [K23AI1030344]; Atlanta Clinical and Translational Science Institute [NIH/NCATS UL1TR000454]; Emory Laney Graduate School; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER [D43TW007124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI103034] Funding Source: NIH RePORTER	National Institute of Health (NIH) Fogarty International Center; NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Atlanta Clinical and Translational Science Institute; Emory Laney Graduate School; Emory Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the National Institute of Health (NIH) Fogarty International Center [D43TW007124 and D43TW007124-06S1], NIH National Institute of Allergy and Infectious Diseases [K23AI1030344], the Atlanta Clinical and Translational Science Institute [NIH/NCATS UL1TR000454], Emory Laney Graduate School, and the Emory Global Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon J, 2003, PHIL J INTERNAL MED, V41, P7; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Chiang CY, 2013, RESPIROLOGY; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Fisher-Hoch SP, 2008, SCAND J INFECT DIS, V40, P888, DOI 10.1080/00365540802342372; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Garcia F, 2007, REV SOC PERU MED INT, V20, P90; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Harries AD, 2010, TROP MED INT HEALTH, V15, P659, DOI 10.1111/j.1365-3156.2010.02523.x; Holtz TH, 2006, ANN INTERN MED, V144, P650, DOI 10.7326/0003-4819-144-9-200605020-00008; IDF, 2013, DIABETES ATLAS; IUATBLD, 2000, TECHN GUID SPUT EX T; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kapur A, 2013, DIABETES RES CLIN PR; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P1335, DOI 10.5588/ijtld.11.0811; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Maciel EL, 2013, INT J TUBERC LUNG D, V17, P225, DOI 10.5588/ijtld.12.0426; Magee MJ, 2011, INT J EPIDEMIOL, V40, P428, DOI 10.1093/ije/dyq268; Qazi F, 2011, INT J TUBERC LUNG D, V15, P1556, DOI 10.5588/ijtld.10.0679; Restrepo BI, 2008, AM J TROP MED HYG, V79, P541, DOI 10.4269/ajtmh.2008.79.541; Richards DC, 2006, INT J TUBERC LUNG D, V10, P396; ROTHMAN KJ, 2008, MODERN EPIDEMIOLOGY; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Singh R, 2007, LUNG INDIA, V24, P54, DOI 10.4103/0970-2113.44211; Stevenson CR, 2007, CHRONIC ILLN, V3, P228, DOI 10.1177/1742395307081502; Tachfouti N, 2011, INT J TUBERC LUNG D, V15, P838, DOI 10.5588/ijtld.10.0437; Tanrikulu AC, 2008, TROP DOCT, V38, P91, DOI 10.1258/td.2007.070131; Tukvadze N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031563; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	34	28	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94890	10.1371/journal.pone.0094890	http://dx.doi.org/10.1371/journal.pone.0094890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736471	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600103
J	Morioka, K; Fukai, K; Sakamoto, K; Yoshida, K; Kanno, T				Morioka, Kazuki; Fukai, Katsuhiko; Sakamoto, Kenichi; Yoshida, Kazuo; Kanno, Toru			Evaluation of Monoclonal Antibody-Based Sandwich Direct ELISA (MSD-ELISA) for Antigen Detection of Foot-and-Mouth Disease Virus Using Clinical Samples	PLOS ONE			English	Article							DIAGNOSIS	A monoclonal antibody-based sandwich direct ELISA (MSD-ELISA) method was previously developed for foot-and-mouth disease (FMD) viral antigen detection. Here we evaluated the sensitivity and specificity of two FMD viral antigen detection MSD-ELISAs and compared them with conventional indirect sandwich (IS)-ELISA. The MSD-ELISAs were able to detect the antigen in saliva samples of experimentally-infected pigs for a longer term compared to the IS-ELISA. We also used 178 RT-PCR-positive field samples from cattle and pigs affected by the 2010 type-O FMD outbreak in Japan, and we found that the sensitivities of both MSD-ELISAs were about 7 times higher than that of the IS-ELISA against each sample (P<0.01). In terms of the FMD-positive farm detection rate, the sensitivities of the MSD-ELISAs were about 6 times higher than that of the IS-ELISA against each farm (P<0.01). Although it is necessary to conduct further validation study using the other virus strains, MSD-ELISAs could be appropriate as a method to replace IS-ELISA for FMD antigen detection.	[Morioka, Kazuki; Fukai, Katsuhiko; Sakamoto, Kenichi; Yoshida, Kazuo; Kanno, Toru] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Exot Dis Res Stn, Tokyo, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Kanno, T (corresponding author), Natl Agr & Food Res Org, Natl Inst Anim Hlth, Exot Dis Res Stn, Tokyo, Japan.	kannot@affrc.go.jp			Foot-and-Mouth Disease Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan	Foot-and-Mouth Disease Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan	This study was supported by Grants-in-Aid for Scientific Research from the Foot-and-Mouth Disease Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan. URL http://www.s.affrc.go.jp/docs/pdf/2008_project_2_1.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; CHAPMAN WG, 1971, APPL MICROBIOL, V22, P1; Fukai K, 2011, J VET MED SCI, V73, P1207, DOI 10.1292/jvms.11-0063; Mohapatra JK, 2007, J VIROL METHODS, V143, P117, DOI 10.1016/j.jviromet.2007.02.008; Morioka K, 2008, J VET MED SCI, V70, P653, DOI 10.1292/jvms.70.653; Morioka K, 2009, J CLIN MICROBIOL, V47, P3663, DOI 10.1128/JCM.00695-09; Mumford JA, 2007, REV SCI TECH OIE, V26, P69, DOI 10.20506/rst.26.1.1730; Paton DJ, 2005, REV SCI TECH OIE, V24, P981, DOI 10.20506/rst.24.3.1632; Reid SM, 1998, J VIROL METHODS, V70, P213, DOI 10.1016/S0166-0934(97)00181-X; Sakamoto K, 2002, J VET MED SCI, V64, P91, DOI 10.1292/jvms.64.91; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; World Organisation for Animal Health, 2012, MAN DIAGN TESTS VACC	12	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94143	10.1371/journal.pone.0094143	http://dx.doi.org/10.1371/journal.pone.0094143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736560	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600046
J	Tsukiyama, T; Ohinata, Y				Tsukiyama, Tomoyuki; Ohinata, Yasuhide			A Modified EpiSC Culture Condition Containing a GSK3 Inhibitor Can Support Germline-Competent Pluripotency in Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; PIGGYBAC TRANSPOSITION; MOUSE EMBRYOS; GROUND-STATE; WNT; EXPRESSION; GENERATION; VECTORS; PROTEIN	Embryonic stem cells (ESCs) can contribute to the tissues of chimeric animals, including the germline. By contrast, epiblast stem cells (EpiSCs) barely contribute to chimeras. These two types of cells are established and maintained under different culture conditions. Here, we show that a modified EpiSC culture condition containing the GSK3 inhibitor CHIR99021 can support a germline-competent pluripotent state that is intermediate between ESCs and EpiSCs. When ESCs were cultured under a modified condition containing bFGF, Activin A, and CHIR99021, they converted to intermediate pluripotent stem cells (INTPSCs). These INTPSCs were able to form teratomas in vivo and contribute to chimeras by blastocyst injection. We also induced formation of INTPSCs (iINTPSCs) from mouse embryonic fibroblasts by exogenous expression of four reprogramming factors, Oct3/4, Sox2, Klf4, and c-Myc, under the INTPSC culture condition. These iINTPSCs contributed efficiently to chimeras, including the germline, by blastocyst injection. The INTPSCs exhibited several characteristic properties of both ESCs and EpiSCs. Our results suggest that the modified EpiSC culture condition can support growth of cells that meet the most stringent criteria for pluripotency, and that germline-competent pluripotency may depend on the activation state of Wnt signaling.	[Tsukiyama, Tomoyuki; Ohinata, Yasuhide] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan; [Tsukiyama, Tomoyuki; Ohinata, Yasuhide] RIKEN Ctr Dev Biol CDB, Lab Pluripotent Stem Cell Studies, Kobe, Hyogo, Japan; [Ohinata, Yasuhide] Univ Yamanashi, Fac Life & Environm Sci, Life Sci Expt Facil, Dept Biotechnol, Kofu, Yamanashi, Japan	Japan Science & Technology Agency (JST); RIKEN; University of Yamanashi	Ohinata, Y (corresponding author), Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama, Japan.	yasuhideohinata@gmail.com	TSUKIYAMA, Tomoyuki/AAI-3082-2020	TSUKIYAMA, Tomoyuki/0000-0002-2657-7719	Japan Science and Technology Agency PRESTO; Japan Society for the Promotion of Science	Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants from the Japan Science and Technology Agency PRESTO to YO, and the Japan Society for the Promotion of Science (Research Fellowship Program) to YO and TT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Chang KH, 2013, STEM CELLS, V31, P918, DOI 10.1002/stem.1330; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cox WG, 1999, J HISTOCHEM CYTOCHEM, V47, P1443, DOI 10.1177/002215549904701110; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa H, 2011, NAT CELL BIOL, V13, P1024, DOI 10.1038/ncb2333; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Sumi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063378; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tsukiyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092973; Tsukiyama T, 2011, GENES CELLS, V16, P815, DOI 10.1111/j.1365-2443.2011.01528.x; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108	32	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95329	10.1371/journal.pone.0095329	http://dx.doi.org/10.1371/journal.pone.0095329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736627	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600169
J	Vaucher, L; Funaro, MG; Mehta, A; Mielnik, A; Bolyakov, A; Prossnitz, ER; Schlegel, PN; Paduch, DA				Vaucher, Laurent; Funaro, Michael G.; Mehta, Akanksha; Mielnik, Anna; Bolyakov, Alexander; Prossnitz, Eric R.; Schlegel, Peter N.; Paduch, Darius A.			Activation of GPER-1 Estradiol Receptor Downregulates Production of Testosterone in Isolated Rat Leydig Cells and Adult Human Testis	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GROWTH-FACTOR RECEPTOR; ESTROGEN-RECEPTOR; ANDROGEN; GPR30; 17-BETA-ESTRADIOL; ALPHA; LOCALIZATION; EPIDIDYMIS; PROSTATE	Purpose: Estradiol (E2) modulates testicular functions including steroidogenesis, but the mechanisms of E2 signaling in human testis are poorly understood. GPER-1 (GPR30), a G protein-coupled membrane receptor, mediates rapid genomic and non-genomic response to estrogens. The aim of this study was to evaluate GPER-1 expression in the testis, and its role in estradiol dependent regulation of steroidogenesis in isolated rat Leydig cells and human testis. Materials and Methods: Isolated Leydig cells (LC) from adult rats and human testicular tissue were used in this study. Expression and localization studies of GPER-1 were performed with qRT-PCR, immunofluorescence, immunohistochemistry and Western Blot. Luteinizing Hormone (LH) -stimulated, isolated LC were incubated with estradiol, G-1 (GPER-1-selective agonist), and estrogen receptor antagonist ICI 182,780. Testosterone production was measured with radioimmunoassay. LC viability after incubation with G-1 was measured using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay. Results: GPER-1 mRNA is abundantly expressed in rat LC and human testis. Co-localization experiments showed high expression levels of GPER-1 protein in LC. E2-dependent activation of GPER-1 lowers testosterone production in isolated rats LCs and in human testis, with statistically and clinically significant drops in testosterone production by 20-30% as compared to estradiol-naive LC. The exposure to G-1 does not affect viability of isolated LCs. Conclusions: Our results indicate that activation of GPER-1 lowers testosterone levels in the rat and human testis. The expression of GPER-1 in human testis, which lack ER alpha, makes it an exciting target for developing new agents affecting testosterone production in men.	[Vaucher, Laurent; Funaro, Michael G.; Mehta, Akanksha; Mielnik, Anna; Bolyakov, Alexander; Schlegel, Peter N.; Paduch, Darius A.] Weill Cornell Med Coll, Dept Urol & Reprod Med, New York, NY 10021 USA; [Vaucher, Laurent; Bolyakov, Alexander; Schlegel, Peter N.; Paduch, Darius A.] Populat Council, Ctr Biomed Res, New York, NY 10021 USA; [Vaucher, Laurent] CHU Vaudois, Dept Urol, CH-1011 Lausanne, Switzerland; [Prossnitz, Eric R.] Univ New Mexico, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA	Cornell University; Population Council; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of New Mexico	Paduch, DA (corresponding author), Weill Cornell Med Coll, Dept Urol & Reprod Med, New York, NY 10021 USA.	dap2013@med.cornell.edu	Paduch, Darius/AAD-9734-2020; Prossnitz, Eric R./B-4543-2008; Prossnitz, Eric/I-4599-2019	Paduch, Darius/0000-0003-1105-3493; Prossnitz, Eric/0000-0001-9190-8302	Robert Dow foundation; NIH [CA127731]; NATIONAL CANCER INSTITUTE [R01CA127731] Funding Source: NIH RePORTER	Robert Dow foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Partially funded by support through Robert Dow foundation. MF was supported by grant from Eric M. Smith. ERP is supported by NIH grant CA127731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney TO, 1999, STEROIDS, V64, P610, DOI 10.1016/S0039-128X(99)00041-0; Akingbemi BT, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-51; Akingbemi BT, 2003, ENDOCRINOLOGY, V144, P84, DOI 10.1210/en.2002-220292; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Chen HL, 2004, ENDOCRINOLOGY, V145, P4441, DOI 10.1210/en.2004-0639; COCHRAN RC, 1981, INVEST UROL, V19, P142; Ded L, 2013, REPRODUCTION, V145, P255, DOI 10.1530/REP-12-0472; Delbes G, 2005, ENDOCRINOLOGY, V146, P2454, DOI 10.1210/en.2004-1540; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Hess RA, 1997, NATURE, V390, P509, DOI 10.1038/37352; Hess Rex A, 2003, Reprod Biol Endocrinol, V1, P52, DOI 10.1186/1477-7827-1-52; HSUEH AJW, 1978, ENDOCRINOLOGY, V103, P1096, DOI 10.1210/endo-103-4-1096; Laurentino SS, 2013, ANDROLOGIA, V45, P187, DOI 10.1111/j.1439-0272.2012.01333.x; MURPHY JB, 1980, J CLIN ENDOCR METAB, V50, P938, DOI 10.1210/jcem-50-5-938; Otto C, 2008, ENDOCRINOLOGY; Pelletier G, 2000, J ENDOCRINOL, V165, P359, DOI 10.1677/joe.0.1650359; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Revankar CM, 2007, ACS CHEM BIOL, V2, P536, DOI 10.1021/cb700072n; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Salva A, 2001, J ANDROL, V22, P665; Saunders PTK, 2005, TRENDS ENDOCRIN MET, V16, P222, DOI 10.1016/j.tem.2005.05.006; Saunders PTK, 2002, J CLIN ENDOCR METAB, V87, P2706, DOI 10.1210/jc.87.6.2706; Savchuk I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071722; Schellhammer PF, 2013, NEW ENGL J MED, V369, P2456, DOI 10.1056/NEJMc1313169; Sirianni R, 2008, ENDOCRINOLOGY, V149, P5043, DOI 10.1210/en.2007-1593; Thomas P, 2006, STEROIDS, V71, P310, DOI 10.1016/j.steroids.2005.09.015; Valenti S, 1997, EUR J ENDOCRINOL, V136, P633, DOI 10.1530/eje.0.1360633; Wang C, 2008, MOL ENDOCRINOL, V22, P636, DOI 10.1210/me.2007-0359; Wibowo E, 2013, CRIT REV ONCOL HEMAT, V87, P224, DOI 10.1016/j.critrevonc.2013.01.006; Zhou Q, 2002, J ANDROL, V23, P870	32	49	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e92425	10.1371/journal.pone.0092425	http://dx.doi.org/10.1371/journal.pone.0092425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736568	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600007
J	Fortin, J; Boehm, U; Deng, CX; Treier, M; Bernard, DJ				Fortin, Jerome; Boehm, Ulrich; Deng, Chu-Xia; Treier, Mathias; Bernard, Daniel J.			Follicle-stimulating hormone synthesis and fertility depend on SMAD4 and FOXL2	FASEB JOURNAL			English	Article						FSH; activin; pituitary	GONADOTROPIN-RELEASING-HORMONE; BETA-SUBUNIT TRANSCRIPTION; ACTIVIN-A; RECEPTOR GENE; HYPOGONADOTROPIC HYPOGONADISM; FSH SYNTHESIS; PITUITARY; EXPRESSION; MUTATIONS; MOUSE	Follicle-stimulating hormone (FSH) is an essential regulator of gonadal function and fertility. Loss-of-function mutations in the FSHB/Fshb gene cause hypogonadotropic hypogonadism in humans and mice. Both gonadotropin-releasing hormone (GnRH) and activins, members of the transforming growth factor beta (TGF beta) superfamily, stimulate FSH synthesis; yet, their relative roles and mechanisms of action in vivo are unknown. Here, using conditional gene-targeting, we show that the canonical mediator of TGF beta superfamily signaling, SMAD4, is absolutely required for normal FSH synthesis in both male and female mice. Moreover, when the Smad4 gene is ablated in combination with its DNA binding cofactor Foxl2 in gonadotrope cells, mice make essentially no FSH and females are sterile. Indeed, the phenotype of these animals is remarkably similar to that of Fshb-knockout mice. Not only do these results establish SMAD4 and FOXL2 as essential master regulators of Fshb transcription in vivo, they also suggest that activins, or related ligands, could play more important roles in FSH synthesis than GnRH.	[Fortin, Jerome; Bernard, Daniel J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Boehm, Ulrich] Univ Saarland, Sch Med, Dept Pharmacol & Toxicol, Homburg, Germany; [Deng, Chu-Xia] Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD USA; [Treier, Mathias] Max Delbruck Ctr Mol Med, Berlin, Germany	McGill University; Saarland University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Fortin, J (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, 3655 Promenade Sir William Osler,Rm 1315, Montreal, PQ H3G 1Y6, Canada.	jerome.fortin@mail.mcgill.ca; daniel.bernard@mcgill.ca	Treier, Mathias/AAD-6388-2021; deng, chuxia/N-6713-2016	Bernard, Daniel/0000-0001-5365-5586	Doctoral Research Award from the Canadian Institutes of Health Research (CIHR); Samuel Solomon Fellowship in Endocrinology from the Endocrine Division and McGill Faculty of Medicine (McGill University); CIHR [MOP-89991/-123447]; DFG [BO1743/2]; U.S. National Institutes of Health/National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction Research) grant [U54-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER	Doctoral Research Award from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Samuel Solomon Fellowship in Endocrinology from the Endocrine Division and McGill Faculty of Medicine (McGill University); CIHR(Canadian Institutes of Health Research (CIHR)); DFG(German Research Foundation (DFG)); U.S. National Institutes of Health/National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction Research) grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Ken McDonald for assistance with FACS, as well as the Goodman Cancer Research Center Histology Facility (McGill University) and the Center for Bone and Periodontal Research Histology Platform (McGill University) for the preparation of histological sections. The authors also thank Dr. Alfredo Ribeiro-da-Silva for generously providing access to the Zeiss Axioplan 2 microscope and Dr. Derek Boerboom for insightful comments on ovarian histology. J.F. was supported by a Doctoral Research Award from the Canadian Institutes of Health Research (CIHR) and the Samuel Solomon Fellowship in Endocrinology from the Endocrine Division and McGill Faculty of Medicine (McGill University). This work was funded by CIHR operating grants MOP-89991/-123447 (to D.J.B.). D.J.B. was a Senior Research Scholar of the Fonds de la Recherche en Sante de Quebec. U. B. is funded by DFG BO1743/2. The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core (Charlottesville, VA, USA) is supported by the U.S. National Institutes of Health/National Institute of Child Health and Human Development (Specialized Cooperative Centers Program in Reproduction Research) grant U54-HD28934.	AITTOMAKI K, 1995, CELL, V82, P959, DOI 10.1016/0092-8674(95)90275-9; Bernard DJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107797; Bernard DJ, 2010, FERTIL STERIL, V93, P2465, DOI 10.1016/j.fertnstert.2010.03.034; Bernard DJ, 2004, MOL ENDOCRINOL, V18, P606, DOI 10.1210/me.2003-0264; Besecke LM, 1996, ENDOCRINOLOGY, V137, P3667, DOI 10.1210/en.137.9.3667; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Blount AL, 2009, J BIOL CHEM, V284, P7631, DOI 10.1074/jbc.M806676200; Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; BRADEN TD, 1992, ENDOCRINOLOGY, V130, P2101, DOI 10.1210/en.130.4.2101; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Caligioni C. S., 2009, CURR PROTOC NEUROSCI, V41; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; Chan YM, 2009, P NATL ACAD SCI USA, V106, P11703, DOI 10.1073/pnas.0903449106; CLAY CM, 1993, J BIOL CHEM, V268, P13556; Corpuz PS, 2010, MOL ENDOCRINOL, V24, P1037, DOI 10.1210/me.2009-0425; CORRIGAN AZ, 1991, ENDOCRINOLOGY, V128, P1682, DOI 10.1210/endo-128-3-1682; Coss D, 2010, TRENDS ENDOCRIN MET, V21, P562, DOI 10.1016/j.tem.2010.05.006; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; Dalkin AC, 1999, ENDOCRINOLOGY, V140, P903, DOI 10.1210/en.140.2.903; DEJONG FH, 1988, PHYSIOL REV, V68, P555, DOI 10.1152/physrev.1988.68.2.555; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Duval DL, 1999, ENDOCRINOLOGY, V140, P1949, DOI 10.1210/en.140.4.1949; Egashira N, 2011, MODERN PATHOL, V24, P765, DOI 10.1038/modpathol.2010.169; Ellsworth BS, 2006, MOL ENDOCRINOL, V20, P2796, DOI 10.1210/me.2005-0303; FernandezVazquez G, 1996, MOL ENDOCRINOL, V10, P356, DOI 10.1210/me.10.4.356; Fortin J, 2014, FASEB J, V28, P1474, DOI 10.1096/fj.13-237818; Fortin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059058; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; Gregory SJ, 2005, MOL ENDOCRINOL, V19, P237, DOI 10.1210/me.2003-0473; Ho CC, 2009, BIOL REPROD, V81, P133, DOI 10.1095/biolreprod.108.074211; HOAK DC, 1980, P NATL ACAD SCI-BIOL, V77, P4953, DOI 10.1073/pnas.77.8.4953; KERI RA, 1991, MOL ENDOCRINOL, V5, P725, DOI 10.1210/mend-5-5-725; KREMER H, 1995, NAT GENET, V9, P160, DOI 10.1038/ng0295-160; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lamba P, 2006, J MOL ENDOCRINOL, V36, P201, DOI 10.1677/jme.1.01961; Lamba P, 2008, ENDOCRINOLOGY, V149, P3095, DOI 10.1210/en.2007-0425; Lamba P, 2010, ENDOCRINOLOGY, V151, P5456, DOI 10.1210/en.2010-0605; Lamba P, 2009, MOL ENDOCRINOL, V23, P1001, DOI 10.1210/me.2008-0324; Layman LC, 1998, NAT GENET, V18, P14, DOI 10.1038/ng0198-14; LING N, 1986, NATURE, V321, P779, DOI 10.1038/321779a0; MATTHEWS CH, 1993, NAT GENET, V5, P83, DOI 10.1038/ng0993-83; PEDERSEN T, 1968, J REPROD FERTIL, V17, P555, DOI 10.1530/jrf.0.0170555; Rejon CA, 2013, CELL SIGNAL, V25, P1403, DOI 10.1016/j.cellsig.2013.03.002; Ruckle J, 2009, J BONE MINER RES, V24, P744, DOI 10.1359/JBMR.081208; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Singh SP, 2009, BIOL REPROD, V81, P488, DOI 10.1095/biolreprod.108.075259; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suszko MI, 2008, MOL CELL ENDOCRINOL, V281, P27, DOI 10.1016/j.mce.2007.10.003; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; Thackray VG, 2010, MOL CELL ENDOCRINOL, V314, P192, DOI 10.1016/j.mce.2009.09.003; Themmen APN, 2000, ENDOCR REV, V21, P551, DOI 10.1210/er.21.5.551; Tran S, 2013, MOL ENDOCRINOL, V27, P407, DOI 10.1210/me.2012-1286; Tran S, 2011, MOL ENDOCRINOL, V25, P1170, DOI 10.1210/me.2010-0480; Uhlenhaut NH, 2009, CELL, V139, P1130, DOI 10.1016/j.cell.2009.11.021; Wang Y, 2010, J MOL ENDOCRINOL, V44, P349, DOI 10.1677/JME-09-0142; WEISS J, 1992, NEW ENGL J MED, V326, P179, DOI 10.1056/NEJM199201163260306; Welt C, 2002, EXP BIOL MED, V227, P724, DOI 10.1177/153537020222700905; Wen S, 2008, ENDOCRINOLOGY, V149, P2701, DOI 10.1210/en.2007-1502; Wen SP, 2010, P NATL ACAD SCI USA, V107, P16372, DOI 10.1073/pnas.1000423107; WIERMAN ME, 1988, MOL ENDOCRINOL, V2, P492, DOI 10.1210/mend-2-6-492; Yang X, 2002, GENESIS, V32, P80, DOI 10.1002/gene.10029; Zakaria MM, 2002, MOL ENDOCRINOL, V16, P1840, DOI 10.1210/me.2002-0088	64	59	60	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3396	3410		10.1096/fj.14-249532	http://dx.doi.org/10.1096/fj.14-249532			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24739304	Green Published			2022-12-25	WOS:000340265400011
J	Shang, LM; Daubeuf, B; Triantafilou, M; Olden, R; Depis, F; Raby, AC; Herren, S; Dos Santos, A; Malinge, P; Dunn-Siegrist, I; Benmkaddem, S; Geinoz, A; Magistrelli, G; Rousseau, F; Buatois, V; Salgado-Pires, S; Reith, W; Monteiro, R; Pugin, J; Leger, O; Ferlin, W; Kosco-Vilbois, M; Triantafilou, K; Elson, G				Shang, Limin; Daubeuf, Bruno; Triantafilou, Martha; Olden, Robin; Depis, Fabien; Raby, Anne-Catherine; Herren, Suzanne; Dos Santos, Anaelle; Malinge, Pauline; Dunn-Siegrist, Irene; Benmkaddem, Sanae; Geinoz, Antoine; Magistrelli, Giovanni; Rousseau, Francois; Buatois, Vanessa; Salgado-Pires, Susana; Reith, Walter; Monteiro, Renato; Pugin, Jerome; Leger, Olivier; Ferlin, Walter; Kosco-Vilbois, Marie; Triantafilou, Kathy; Elson, Greg			Selective Antibody Intervention of Toll-like Receptor 4 Activation through Fc gamma Receptor Tethering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; Fc gamma Receptor; Inflammation; Lipid Raft; Toll-like Receptor (TLR); Toll-like Receptor 4; Monoclonal Antibody	MONOCLONAL-ANTIBODY; TLR4 ACTIVATION; DENDRITIC CELLS; IMMUNE-SYSTEM; LIPOPOLYSACCHARIDE; RECOGNITION; MECHANISMS; REGULATORS; RESPONSES; DISEASES	Background: Dysregulated leukocyte activation via Toll-like receptor 4 (TLR4) is central to numerous inflammatory disorders. Results: A novel mechanism of action involving Fc receptor tethering allows anti-TLR4 blocking antibodies to achieve increased potency on inflammatory leukocytes. Conclusion: This novel mechanism of action allows selective targeting of TLR4 activation during inflammation. Significance: The data provide a novel mechanism to dampen TLR4-mediated inflammatory disorders. Inflammation is mediated mainly by leukocytes that express both Toll-like receptor 4 (TLR4) and Fc receptors (FcR). Dysregulated activation of leukocytes via exogenous and endogenous ligands of TLR4 results in a large number of inflammatory disorders that underlie a variety of human diseases. Thus, differentially blocking inflammatory cells while sparing structural cells, which are FcR-negative, represents an elegant strategy when targeting the underlying causes of human diseases. Here, we report a novel tethering mechanism of the Fv and Fc portions of anti-TLR4 blocking antibodies that achieves increased potency on inflammatory cells. In the presence of ligand (e.g. lipopolysaccharide (LPS)), TLR4 traffics into glycolipoprotein microdomains, forming concentrated protein platforms that include FcRs. This clustering produces a microenvironment allowing anti-TLR4 antibodies to co-engage TLR4 and FcRs, increasing their avidity and thus substantially increasing their inhibitory potency. Tethering of antibodies to both TLR4 and FcRs proves valuable in ameliorating inflammation in vivo. This novel mechanism of action therefore has the potential to enable selective intervention of relevant cell types in TLR4-driven diseases.	[Shang, Limin; Daubeuf, Bruno; Depis, Fabien; Raby, Anne-Catherine; Herren, Suzanne; Dos Santos, Anaelle; Malinge, Pauline; Magistrelli, Giovanni; Rousseau, Francois; Buatois, Vanessa; Salgado-Pires, Susana; Leger, Olivier; Ferlin, Walter; Kosco-Vilbois, Marie; Elson, Greg] NovImmune SA, CH-1228 Plan Les Ouates, Switzerland; [Triantafilou, Martha; Olden, Robin; Triantafilou, Kathy] Cardiff Univ, Sch Med, Dept Child Hlth, Univ Wales Hosp, Cardiff CF10 3AX, S Glam, Wales; [Dunn-Siegrist, Irene; Pugin, Jerome] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Benmkaddem, Sanae; Monteiro, Renato] Fac Med Paris Diderot, INSERM, UMR 699, F-75018 Paris 18, France; [Geinoz, Antoine; Reith, Walter] Univ Geneva, Dept Pathol & Immunol, Sch Med, CH-1211 Geneva, Switzerland	NovImmune SA; Cardiff University; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Geneva	Shang, LM (corresponding author), NovImmune SA, 14 Chemin Aulx, CH-1228 Plan Les Ouates, Switzerland.	lshang@novimmune.com	Monteiro, Renato C/U-8633-2017	Monteiro, Renato C/0000-0001-5202-5646				Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Chu CL, 2008, EUR J IMMUNOL, V38, P166, DOI 10.1002/eji.200737600; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; Dunn-Siegrist I, 2007, J BIOL CHEM, V282, P34817, DOI 10.1074/jbc.M706440200; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Haegel H, 2013, MABS-AUSTIN, V5, P736, DOI 10.4161/mabs.25743; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Legein B, 2013, CELL MOL LIFE SCI, V70, P3847, DOI 10.1007/s00018-013-1289-1; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Magistrelli G, 2012, J IMMUNOL METHODS, V375, P20, DOI 10.1016/j.jim.2011.09.002; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nemeth T, 2012, IMMUNOL LETT, V143, P9, DOI 10.1016/j.imlet.2012.01.013; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Parihar A, 2010, J INNATE IMMUN, V2, P204, DOI 10.1159/000296507; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pfeiffer A, 2001, EUR J IMMUNOL, V31, P3153, DOI 10.1002/1521-4141(200111)31:11<3153::AID-IMMU3153>3.0.CO;2-0; Pfirsch-Maisonnas S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001309; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rittirsch D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000464; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Shalova IN, 2012, J IMMUNOL, V188, P3584, DOI 10.4049/jimmunol.1100244; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Triantafilou M, 2002, J CELL SCI, V115, P2603; Tsukamoto H, 2012, INT IMMUNOL, V24, P495, DOI 10.1093/intimm/dxs053; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4	34	21	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15309	15318		10.1074/jbc.M113.537936	http://dx.doi.org/10.1074/jbc.M113.537936			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737331	hybrid, Green Published			2022-12-25	WOS:000337465400015
J	Azandeme-Hounmalon, GY; Fellous, S; Kreiter, S; Fiaboe, KKM; Subramanian, S; Kungu, M; Martin, T				Azandeme-Hounmalon, Ginette Y.; Fellous, Simon; Kreiter, Serge; Fiaboe, Komi K. M.; Subramanian, Sevgan; Kungu, Miriam; Martin, Thibaud			Dispersal Behavior of Tetranychus evansi and T. urticae on Tomato at Several Spatial Scales and Densities: Implications for Integrated Pest Management	PLOS ONE			English	Article							SPIDER-MITE ACARI; AERIAL DISPERSAL; POPULATION	Studying distribution is necessary to understand and manage the dynamics of species with spatially structured populations. Here we studied the distribution in Tetranychus evansi and T. urticae, two mite pests of tomato, in the scope of evaluating factors that can influence the effectiveness of Integrated Pest Management strategies. We found greater positive density-dependent distribution with T. evansi than T. urticae when assayed on single, detached tomato leaves. Indeed, T. evansi distribution among leaflets increased with initial population density while it was high even at low T. urticae densities. Intensity and rate of damage to whole plants was higher with T. evansi than T. urticae. We further studied the circadian migration of T. evansi within plant. When T. evansi density was high the distribution behavior peaked between 8 am and 3 pm and between 8 pm and 3 am local time of Kenya. Over 24 h the total number of mites ascending and descending was always similar and close to the total population size. The gregarious behavior of T. evansi combined with its rapid population growth rate, may explain why few tomato plants can be severely damaged by T. evansi and how suddenly all the crop can be highly infested. However the localisation and elimination of the first infested plants damaged by T. evansi could reduce the risk of outbreaks in the entire crop. These findings suggest also that an acaricide treated net placed on the first infested plants could be very effective to control T. evansi. Moreover circadian migration would therefore accentuate the efficiency of an acaricide treated net covering the infested plants.	[Azandeme-Hounmalon, Ginette Y.; Martin, Thibaud] UPR Hortsys, Cirad, Montpellier, France; [Azandeme-Hounmalon, Ginette Y.; Fiaboe, Komi K. M.; Subramanian, Sevgan; Kungu, Miriam; Martin, Thibaud] Icipe Plant Hlth Dept, Nairobi, Kenya; [Fellous, Simon] UMR CBGP, INRA, Montpellier, France; [Kreiter, Serge] Montpellier SupAgro, UMR CBGP, Montpellier, France	CIRAD; International Centre of Insect Physiology & Ecology (ICIPE); INRAE; Institut de Recherche pour le Developpement (IRD); Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Martin, T (corresponding author), UPR Hortsys, Cirad, Montpellier, France.	thibaud.martin@cirad.fr	Kreiter, Serge/AAG-5946-2021; , Subramanian/H-8531-2014	, Subramanian/0000-0003-4447-0744	United States Agency for International Development (USAID) [EPP-A-00-09-00004]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	The study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under Award No. EPP-A-00-09-00004. The contents are the responsibility of Horticulture CRSP project BioNetAgro investigators and do not necessarily reflect the views of USAID or the United States Government. We wish to acknowledge our project partners, Cirad and icipe for all the support they accorded us in planning and implementation of the project. The funding sources had no involvement at any stage in the preparation of this paper and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2002, AM NAT, V159, P553, DOI 10.1086/339463; [Anonymous], 2003, MITES ACARI PEST CON, DOI [10.1002/9780470750995, DOI 10.1002/9780470750995]; Bell JR, 2005, B ENTOMOL RES, V95, P69, DOI 10.1079/BER2004350; Bergman CM, 2000, OECOLOGIA, V123, P364, DOI 10.1007/s004420051023; Bextine B, 2001, PLANT DIS, V85, P875, DOI 10.1094/PDIS.2001.85.8.875; Bonato O, 1999, EXP APPL ACAROL, V23, P11, DOI 10.1023/A:1006144610009; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; BOYKIN LS, 1984, ENVIRON ENTOMOL, V13, P221, DOI 10.1093/ee/13.1.221; Britto EPJ, 2009, BIOCONTROL, V54, P363, DOI 10.1007/s10526-008-9178-5; Clotuche G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018854; DEANGELIS JD, 1982, ENVIRON ENTOMOL, V11, P975, DOI 10.1093/ee/11.4.975; DUNNING JB, 1995, ECOL APPL, V5, P3, DOI 10.2307/1942045; Fellous S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048436; Furtado IP, 2007, BIOL CONTROL, V42, P139, DOI 10.1016/j.biocontrol.2007.04.016; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I., 1999, METAPOPULATION ECOLO; HUSSEY N. W., 1963, ENTOMOL EXP APPL, V6, P207, DOI 10.1007/BF00300527; Hussey NW, 1985, SPIDER MITES THEIR B, V1B, P285; Ims Rolf A., 2001, P203; Le Goff G, 2009, P 5 M EC BEH LYON FR; LI JB, 1993, ENTOMOL EXP APPL, V68, P79, DOI 10.1007/BF02380584; MacGregor EA, 1913, 172 USDA BUR ENT, V172; Maniania NK, 2008, EXP APPL ACAROL, V46, P259, DOI 10.1007/s10493-008-9180-8; Martin T, 2010, CROP PROT, V29, P470, DOI 10.1016/j.cropro.2009.11.004; Nichols J., 2001, DISPERSAL; Osakabe M, 2008, EXP APPL ACAROL, V44, P165, DOI 10.1007/s10493-008-9141-2; Picanco MC, 2007, MANEJO INTEGRADO DOE, P505; PRALAVORIO M, 1989, ENTOMOPHAGA, V34, P129, DOI 10.1007/BF02372596; Sabelis M.W., 1991, P23; Sabelis M.W., 1985, P337; Saunyama I. G. M., 2003, African Crop Science Journal, V11, P269; Sibanda T, 2000, CROP PROT, V19, P807, DOI 10.1016/S0261-2194(00)00108-3; Turchin Peter, 1998; Weeks AR, 2000, J ECON ENTOMOL, V93, P1415, DOI 10.1603/0022-0493-93.5.1415; Wekesa VW, 2005, EXP APPL ACAROL, V36, P41, DOI 10.1007/s10493-005-0508-3; Wertheim B, 2005, OIKOS, V109, P117, DOI 10.1111/j.0030-1299.2005.13340.x; Yano S, 2008, ANN ENTOMOL SOC AM, V101, P247, DOI 10.1603/0013-8746(2008)101[247:CASBOT]2.0.CO;2; Yano S, 2004, EXP APPL ACAROL, V32, P243, DOI 10.1023/B:APPA.0000023241.73640.e4	38	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95071	10.1371/journal.pone.0095071	http://dx.doi.org/10.1371/journal.pone.0095071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743580	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100064
J	Chung, KM; Kolling, FW; Gajdosik, MD; Burger, S; Russell, AC; Nelson, CE				Chung, Kyung-Min; Kolling, Frederick W.; Gajdosik, Matthew D.; Burger, Steven; Russell, Alexander C.; Nelson, Craig E.			Single Cell Analysis Reveals the Stochastic Phase of Reprogramming to Pluripotency Is an Ordered Probabilistic Process	PLOS ONE			English	Article							STEM-CELLS; GENE-EXPRESSION; TRANSCRIPTION FACTORS; EPIGENETIC DYNAMICS; HUMAN FIBROBLASTS; SOMATIC-CELLS; GENERATION; INDUCTION; CYCLE; MECHANISMS	Despite years of research, the reprogramming of human somatic cells to pluripotency remains a slow, inefficient process, and a detailed mechanistic understanding of reprogramming remains elusive. Current models suggest reprogramming to pluripotency occurs in two-phases: a prolonged stochastic phase followed by a rapid deterministic phase. In this paradigm, the early stochastic phase is marked by the random and gradual expression of pluripotency genes and is thought to be a major rate-limiting step in the successful generation of induced Pluripotent Stem Cells (iPSCs). Recent evidence suggests that the epigenetic landscape of the somatic cell is gradually reset during a period known as the stochastic phase, but it is known neither how this occurs nor what rate-limiting steps control progress through the stochastic phase. A precise understanding of gene expression dynamics in the stochastic phase is required in order to answer these questions. Moreover, a precise model of this complex process will enable the measurement and mechanistic dissection of treatments that enhance the rate or efficiency of reprogramming to pluripotency. Here we use single-cell transcript profiling, FACS and mathematical modeling to show that the stochastic phase is an ordered probabilistic process with independent gene-specific dynamics. We also show that partially reprogrammed cells infected with OSKM follow two trajectories: a productive trajectory toward increasingly ESC-like expression profiles or an alternative trajectory leading away from both the fibroblast and ESC state. These two pathways are distinguished by the coordinated expression of a small group of chromatin modifiers in the productive trajectory, supporting the notion that chromatin remodeling is essential for successful reprogramming. These are the first results to show that the stochastic phase of reprogramming in human fibroblasts is an ordered, probabilistic process with gene-specific dynamics and to provide a precise mathematical framework describing the dynamics of pluripotency gene expression during reprogramming by OSKM.	[Chung, Kyung-Min; Kolling, Frederick W.; Gajdosik, Matthew D.; Burger, Steven; Nelson, Craig E.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Russell, Alexander C.] Univ Connecticut, Dept Comp Sci & Engn, Storrs, CT USA	University of Connecticut; University of Connecticut	Nelson, CE (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	craig.nelson@uconn.edu		Russell, Alexander/0000-0002-8228-6238	University of Connecticut	University of Connecticut	Funding was provided by the University of Connecticut www.UCONN.edu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2013, NAT REV GENET, V14, P427, DOI 10.1038/nrg3473; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dowell KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056810; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Flottmann M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00216; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Gibson JD, 2009, INTEGR BIOL-UK, V1, P540, DOI 10.1039/b908276j; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Gurdon JB, 1999, SEMIN CELL DEV BIOL, V10, P239, DOI 10.1006/scdb.1998.0284; Hanna J, 2008, COLD SH Q B, V73, P147, DOI 10.1101/sqb.2008.73.025; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Li WL, 2010, TRENDS PHARMACOL SCI, V31, P36, DOI 10.1016/j.tips.2009.10.002; Li YQ, 2011, CELL RES, V21, P196, DOI 10.1038/cr.2010.142; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Mattout A, 2011, J MOL CELL BIOL, V3, P341, DOI 10.1093/jmcb/mjr028; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Narsinh KH, 2011, J CLIN INVEST, V121, P1217, DOI 10.1172/JCI44635; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Nishino K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002085; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Soufi A, 2012, CELL; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Taapken SM, 2011, NAT BIOTECHNOL, V29, P313, DOI 10.1038/nbt.1835; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanabe K, 2013, P NATL ACAD SCI USA, V110, P12172, DOI 10.1073/pnas.1310291110; Yamanaka S, 2012, CELL STEM CELL, V10, P678, DOI 10.1016/j.stem.2012.05.005; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yang KE, 2011, MOL CELLS, V32, P99, DOI 10.1007/s10059-011-0064-0; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	61	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95304	10.1371/journal.pone.0095304	http://dx.doi.org/10.1371/journal.pone.0095304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743916	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100101
J	Orihuela, G; Terborgh, J; Ceballos, N; Glander, K				Orihuela, Gabriela; Terborgh, John; Ceballos, Natalia; Glander, Kenneth			When Top-Down Becomes Bottom Up: Behaviour of Hyperdense Howler Monkeys (Alouatta seniculus) Trapped on a 0.6 Ha Island	PLOS ONE			English	Article							POPULATION	Predators are a ubiquitous presence in most natural environments. Opportunities to contrast the behaviour of a species in the presence and absence of predators are thus rare. Here we report on the behaviour of howler monkey groups living under radically different conditions on two land-bridge islands in Lago Guri, Venezuela. One group of 6 adults inhabited a 190-ha island (Danto) where they were exposed to multiple potential predators. This group, the control, occupied a home range of 23 ha and contested access to food resources with neighbouring groups in typical fashion. The second group, containing 6 adults, was isolated on a remote, predator-free 0.6 ha islet (Iguana) offering limited food resources. Howlers living on the large island moved, fed and rested in a coherent group, frequently engaged in affiliative activities, rarely displayed agonistic behaviour and maintained intergroup spacing through howling. In contrast, the howlers on Iguana showed repulsion, as individuals spent most of their time spaced widely around the perimeter of the island. Iguana howlers rarely engaged in affiliative behaviour, often chased or fought with one another and were not observed to howl. These behaviors are interpreted as adjustments to the unrelenting deprivation associated with bottom-up limitation in a predator-free environment.	[Orihuela, Gabriela] Fairchild Trop Bot Garden, Coral Gables, FL USA; [Terborgh, John] Duke Univ, Ctr Trop Conservat, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; [Ceballos, Natalia] Univ Cambridge, Sch Anat, Wildlife Res Grp, Cambridge, England; [Glander, Kenneth] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA	Duke University; University of Cambridge; Duke University	Terborgh, J (corresponding author), Duke Univ, Ctr Trop Conservat, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA.	manu@duke.edu		Glander, Kenneth/0000-0001-9563-4660	MacArthur Foundation; National Science Foundation (NSF) [DEB97-09281, DEB01-08107]	MacArthur Foundation; National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the following funding sources: A MacArthur Foundation (www.macfound.org/) fellowship to JT; two National Science Foundation (NSF) (www.nsf.gov/) grants to JT: (DEB97-09281 and DEB01-08107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAZA F, 1983, MAMMALIA, V47, P205, DOI 10.1515/mamm.1983.47.2.205; Crockett C.M., 1984, P173; Crockett Carolyn M., 2000, P75, DOI 10.1017/CBO9780511542312.006; Glander K.E., 1981, P231; Irwin MT, 2007, AM J PRIMATOL, V69, P434, DOI 10.1002/ajp.20360; Kinzey WG, 1998, PRIMATE CONS, V9, P66; LANDEAU L, 1986, ANIM BEHAV, V34, P1372, DOI 10.1016/S0003-3472(86)80208-1; Lopez GO, 2005, J TROP ECOL, V21, P445, DOI 10.1017/S0266467405002415; MORALES LC, 1986, INTERCIENCIA, V11, P272; Nilsen EB, 2009, J ANIM ECOL, V78, P585, DOI 10.1111/j.1365-2656.2009.01523.x; Rudran R, 2003, INT J PRIMATOL, V24, P925, DOI 10.1023/A:1026241625910; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Terborgh J., 2010, TROPHIC CASCADES PRE; Terborgh John, 2008, P308; Terborgh John, 1997, P256; THORINGTON RW, 1979, VERTEBRATE ECOLOGY N, P97; Wang E, 2003, INT J PRIMATOL, V24, P1227, DOI 10.1023/B:IJOP.0000005989.29238.ce	19	8	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e82197	10.1371/journal.pone.0082197	http://dx.doi.org/10.1371/journal.pone.0082197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743575	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100001
J	Rohlmann, A; Zander, T; Graichen, F; Schmidt, H; Bergmann, G				Rohlmann, Antonius; Zander, Thomas; Graichen, Friedmar; Schmidt, Hendrik; Bergmann, Georg			Spinal Loads during Cycling on an Ergometer	PLOS ONE			English	Article							VERTEBRAL BODY REPLACEMENT; IN-VIVO; INTRADISCAL PRESSURE; IMPLANT; WEIGHT	Cycling on an ergometer is an effective exercise for improving fitness. However, people with back problems or previous spinal surgery are often not aware of whether cycling could be harmful for them. To date, little information exists about spinal loads during cycling. A telemeterized vertebral body replacement allows in vivo measurement of implant loads during the activities of daily living. Five patients with a severe compression fracture of a lumbar vertebral body received these implants. During one measurement session, four of the participants exercised on a bicycle ergometer at various power levels. As the power level increased, the maximum resultant force and the difference between the maximum and minimum force (force range) during each pedal revolution increased. The average maximum-force increases between the two power levels 25 and 85 W were 73, 84, 225 and 75 N for the four patients. The corresponding increases in the force range during a pedal revolution were 84, 98, 166 and 101 N. There were large variations in the measured forces between the patients and also within the same patient, especially for high power levels. In two patients, the maximum forces during high-power cycling were higher than the forces during walking measured on the same day. Therefore, the authors conclude that patients with back problems should not cycle at high power levels shortly after surgery as a precaution.	[Rohlmann, Antonius; Zander, Thomas; Graichen, Friedmar; Schmidt, Hendrik; Bergmann, Georg] Charite, Julius Wolff Inst, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohlmann, A (corresponding author), Charite, Julius Wolff Inst, D-13353 Berlin, Germany.	antonius.rohlmann@charite.de	Rohlmann, Antonius/E-4778-2011	Rohlmann, Antonius/0000-0002-0083-2793; Schmidt, Hendrik/0000-0003-3300-8685	Deutsche Forschungsgemeinschaft, Bonn, Germany [Ro 581/18-1]; Deutsche Arthrose-Hilfe, Frankfurt, Germany	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Deutsche Arthrose-Hilfe, Frankfurt, Germany	Funding for this study was obtained from the Deutsche Forschungsgemeinschaft, Bonn, Germany (Ro 581/18-1) and the Deutsche Arthrose-Hilfe, Frankfurt, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dreischarf M, 2010, SPINE, V35, P2015, DOI 10.1097/BRS.0b013e3181d55d52; Graichen F, 2007, IEEE T BIO-MED ENG, V54, P253, DOI 10.1109/TBME.2006.886857; Kutzner I, 2012, J ORTHOP SPORT PHYS, V42, P1032, DOI 10.2519/jospt.2012.4001; Lange U, 2003, ARCH ORTHOP TRAUM SU, V123, P203, DOI 10.1007/s00402-003-0486-z; Magerl F, 1994, Eur Spine J, V3, P184, DOI 10.1007/BF02221591; NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020; Rohlmann A, 2014, ERGONOMICS, V57, P262, DOI 10.1080/00140139.2014.887789; Rohlmann A, 2014, GAIT POSTURE, V39, P750, DOI 10.1016/j.gaitpost.2013.10.010; Rohlmann A, 2013, EUR SPINE J, V22, P2575, DOI 10.1007/s00586-013-3057-1; Rohlmann A, 2000, SPINE, V25, P2981, DOI 10.1097/00007632-200012010-00004; Rohlmann A, 2007, MED ENG PHYS, V29, P580, DOI 10.1016/j.medengphy.2006.06.012; Rohlmann A, 2014, EUR SPINE J, V23, P666, DOI 10.1007/s00586-013-3087-8; Rohlmann A, 2013, CLIN BIOMECH, V28, P490, DOI 10.1016/j.clinbiomech.2013.03.010; Rohlmann A, 2013, J BIOMECH, V46, P511, DOI 10.1016/j.jbiomech.2012.10.022; Rohlmann A, 2011, SPINE J, V11, P870, DOI 10.1016/j.spinee.2011.06.017; Rohlmann A, 2010, EUR SPINE J, V19, P1129, DOI 10.1007/s00586-010-1346-5; Sato K, 1999, SPINE, V24, P2468, DOI 10.1097/00007632-199912010-00008; van Deursen LL, 2005, CLIN BIOMECH, V20, P547, DOI 10.1016/j.clinbiomech.2005.01.005; Weber J, 2009, Z ORTHOP UNFALLCHIR, V147, P588, DOI 10.1055/s-0029-1186019; Wilke HJ, 2001, CLIN BIOMECH, V16, pS111, DOI 10.1016/S0268-0033(00)00103-0	20	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95497	10.1371/journal.pone.0095497	http://dx.doi.org/10.1371/journal.pone.0095497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743577	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100127
J	Verkerke, H; Naylor, C; Zabeau, L; Tavernier, J; Petri, WA; Marie, C				Verkerke, Hans; Naylor, Caitlin; Zabeau, Lennart; Tavernier, Jan; Petri, William A., Jr.; Marie, Chelsea			Kinetics of Leptin Binding to the Q223R Leptin Receptor	PLOS ONE			English	Article							BODY-MASS INDEX; BREAST-CANCER INCIDENCE; POLYMORPHISMS; ASSOCIATION; OBESITY; ACTIVATION; GENES	Studies in human populations and mouse models of disease have linked the common leptin receptor Q223R mutation to obesity, multiple forms of cancer, adverse drug reactions, and susceptibility to enteric and respiratory infections. Contradictory results cast doubt on the phenotypic consequences of this variant. We set out to determine whether the Q223R substitution affects leptin binding kinetics using surface plasmon resonance (SPR), a technique that allows sensitive real-time monitoring of protein-protein interactions. We measured the binding and dissociation rate constants for leptin to the extracellular domain of WT and Q223R murine leptin receptors expressed as Fc-fusion proteins and found that the mutant receptor does not significantly differ in kinetics of leptin binding from the WT leptin receptor. (WT: k(a) 1.76x10(6)+/- 0.193x10(6) M-1 s(-1), k(d) 1.21x10(-4)+/- 0.707x10(-4) s(-1), K-D 6.47x10(-11)+/- 3.30x10(-11) M; Q223R: k(a) 1.75x10(6)+/- 0.0245x10(6) M-1 s(-1), k(d) 1.47x10(-4)+/- 0.0505x10(-4) s(-1), K-D 8.43x10(-11)+/- 0.407x10-(11) M). Our results support earlier findings that differences in affinity and kinetics of leptin binding are unlikely to explain mechanistically the phenotypes that have been linked to this common genetic variant. Future studies will seek to elucidate the mechanism by which this mutation influences susceptibility to metabolic, infectious, and malignant pathologies.	[Verkerke, Hans; Naylor, Caitlin; Petri, William A., Jr.; Marie, Chelsea] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA; [Zabeau, Lennart; Tavernier, Jan] Univ Ghent VIB, Dept Med Prot Res, B-9052 Ghent, Belgium	University of Virginia; Flanders Institute for Biotechnology (VIB); Ghent University	Marie, C (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA 22903 USA.	csm8r@virginia.edu	Tavernier, Jan/AAG-3636-2019; Petri, William A./D-3639-2019; Petri, William/AAL-3642-2020	Petri, William/0000-0002-7268-1218; Naylor, Caitlin/0000-0002-5922-7539	National Institutes of Health [R01 AI-26649]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026649, T32AI055432, F32AI093041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01 AI-26649 to WAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Becer E, 2013, GENE, V529, P16, DOI 10.1016/j.gene.2013.08.003; Bender N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026157; Bracho-Riquelme RL, 2011, CRIT CARE, V15, DOI 10.1186/cc10467; Carpenter B, 2012, STRUCTURE, V20, P487, DOI 10.1016/j.str.2012.01.019; Cleveland RJ, 2010, BREAST CANCER RES TR, V120, P745, DOI 10.1007/s10549-009-0503-1; Day YSN, 2002, PROTEIN SCI, V11, P1017, DOI 10.1110/ps.4330102; Duggal P, 2011, J CLIN INVEST, V121, P1191, DOI 10.1172/JCI45294; Ellingrod VL, 2007, PSYCHOPHARMACOL BULL, V40, P57; Gu FY, 2012, BREAST CANCER RES TR, V131, P17, DOI 10.1007/s10549-011-1778-6; Guo X, 2011, MUCOSAL IMMUNOL, V4, P294, DOI 10.1038/mi.2010.76; Heo M, 2002, INT J OBESITY, V26, P640, DOI 10.1038/sj.ijo.0801990; Kimber W, 2008, ENDOCRINOLOGY, V149, P6043, DOI 10.1210/en.2008-0544; LeGal CS, 1997, FEBS LETT, V404, P185, DOI 10.1016/S0014-5793(97)00125-7; Mackey-Lawrence NM, 2012, MUCOSAL IMMUNOL, V5, P472, DOI 10.1038/mi.2012.40; Madan R, 2014, INFECT IMMUN, V82, P341, DOI 10.1128/IAI.00972-13; Mancour LV, 2012, MOL CELL, V48, P655, DOI 10.1016/j.molcel.2012.09.003; Marie CS, 2012, INFECT IMMUN; Mistrik P, 2004, ANAL BIOCHEM, V327, P271, DOI 10.1016/j.ab.2004.01.022; Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Peelman F, 2006, J BIOL CHEM, V281, P15496, DOI 10.1074/jbc.M512622200; Skibola CF, 2004, CANCER EPIDEM BIOMAR, V13, P779; Stratigopoulos G, 2009, OBESITY, V17, P126, DOI 10.1038/oby.2008.489; Uotani S, 1999, DIABETES, V48, P279, DOI 10.2337/diabetes.48.2.279; Wang BL, 2013, ASIA-PAC J PUBLIC HE, V25, p80S, DOI 10.1177/1010539513497218; Yapijakis C, 2009, J CANCER RES CLIN, V135, P603, DOI 10.1007/s00432-008-0494-z; Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078	29	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94843	10.1371/journal.pone.0094843	http://dx.doi.org/10.1371/journal.pone.0094843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743494	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100046
J	Kikhno, I				Kikhno, Irina			Identification of a Conserved Non-Protein-Coding Genomic Element that Plays an Essential Role in Alphabaculovirus Pathogenesis	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; NON-HR ORIGIN; ENVELOPE FUSION PROTEIN; SEQUENCE-ANALYSIS; DNA-REPLICATION; FUNCTIONAL-ANALYSIS; MULTIPLE NUCLEOPOLYHEDROVIRUS; BACULOVIRUS GENOME; GENE ORGANIZATION; FACTOR-BINDING	Highly homologous sequences 154-157 bp in length grouped under the name of "conserved non-protein-coding element'' (CNE) were revealed in all of the sequenced genomes of baculoviruses belonging to the genus Alphabaculovirus. A CNE alignment led to the detection of a set of highly conserved nucleotide clusters that occupy strictly conserved positions in the CNE sequence. The significant length of the CNE and conservation of both its length and cluster architecture were identified as a combination of characteristics that make this CNE different from known viral non-coding functional sequences. The essential role of the CNE in the Alphabaculovirus life cycle was demonstrated through the use of a CNE-knockout Autographa californica multiple nucleopolyhedrovirus (AcMNPV) bacmid. It was shown that the essential function of the CNE was not mediated by the presumed expression activities of the protein-and non-protein-coding genes that overlap the AcMNPV CNE. On the basis of the presented data, the AcMNPV CNE was categorized as a complex-structured, polyfunctional genomic element involved in an essential DNA transaction that is associated with an undefined function of the baculovirus genome.	Ukrainian Acad Sci, Inst Mol Biol & Genet, UA-252627 Kiev, Ukraine	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Kikhno, I (corresponding author), Ukrainian Acad Sci, Inst Mol Biol & Genet, UA-252627 Kiev, Ukraine.	i.m.kikhno@imbg.org.ua			Ukrainian National Academy of Science [0107V000337]	Ukrainian National Academy of Science	This research was funded by Ukrainian National Academy of Science (http://www.nas.gov.ua Grant number 0107V000337). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens CH, 1997, VIROLOGY, V229, P381, DOI 10.1006/viro.1997.8448; AMBINDER RF, 1990, J VIROL, V64, P2369, DOI 10.1128/JVI.64.5.2369-2379.1990; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; BAUMRUKER T, 1988, GENE DEV, V2, P1400, DOI 10.1101/gad.2.11.1400; Benachenhou F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005179; Bernard HU, 2013, VIROLOGY, V445, P197, DOI 10.1016/j.virol.2013.04.035; BOWATER R, 1991, BIOCHEMISTRY-US, V30, P11495, DOI 10.1021/bi00113a003; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; CARSON DD, 1991, VIROLOGY, V182, P279, DOI 10.1016/0042-6822(91)90671-W; CARSTENS EB, 1979, VIROLOGY, V99, P386, DOI 10.1016/0042-6822(79)90017-5; Catalano C.E., 2005, VIRAL GENOME PACKAGI; Chen SC, 2007, J VIROL, V81, P6771, DOI 10.1128/JVI.02231-06; Chen XW, 2001, J GEN VIROL, V82, P241, DOI 10.1099/0022-1317-82-1-241; Chen YR, 2008, J GEN VIROL, V89, P2315, DOI 10.1099/vir.0.2008/001412-0; Chen YR, 2013, J VIROL, V87, P6391, DOI 10.1128/JVI.00194-13; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Oliveira JVD, 2006, J GEN VIROL, V87, P3233, DOI 10.1099/vir.0.82161-0; de Jong JG, 2005, J GEN VIROL, V86, P929, DOI 10.1099/vir.0.80490-0; DEISS LP, 1986, J VIROL, V59, P605, DOI 10.1128/JVI.59.3.605-618.1986; Garrity DB, 1997, VIROLOGY, V231, P167, DOI 10.1006/viro.1997.8540; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; Goodman D, 2007, LECT N BIOINFORMAT, V4751, P69; GREAVES DR, 1985, J MOL BIOL, V185, P461, DOI 10.1016/0022-2836(85)90064-6; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; Hajos JP, 2000, ARCH VIROL, V145, P159, DOI 10.1007/s007050050012; Harrison RL, 2003, J GEN VIROL, V84, P1827, DOI 10.1099/vir.0.19146-0; Harrison RL, 2008, J GEN VIROL, V89, P775, DOI 10.1099/vir.0.83566-0; Harrison RL, 2007, VIRUS GENES, V35, P857, DOI 10.1007/s11262-007-0136-6; Hayakawa T, 2000, VIROLOGY, V278, P1, DOI 10.1006/viro.2000.0668; Heldens JGM, 1997, J GEN VIROL, V78, P1497, DOI 10.1099/0022-1317-78-6-1497; Herniou EA, 2001, J VIROL, V75, P8117, DOI 10.1128/JVI.75.17.8117-8126.2001; Herniou EA., 2011, VIRUS TAXONOMY, P163; Hilton S, 2008, J GEN VIROL, V89, P2898, DOI 10.1099/vir.0.2008/002881-0; Hilton S, 2007, J GEN VIROL, V88, P1496, DOI 10.1099/vir.0.82760-0; Hindmarsh P, 1999, MICROBIOL MOL BIOL R, V63, P836, DOI 10.1128/MMBR.63.4.836-843.1999; Hou S, 2002, BIOTECHNIQUES, V32, P783, DOI 10.2144/02324st04; Huang JH, 1999, J GEN VIROL, V80, P2263, DOI 10.1099/0022-1317-80-8-2263; Hyink O, 2002, J GEN VIROL, V83, P957, DOI 10.1099/0022-1317-83-4-957; IJkel WFJ, 1999, J GEN VIROL, V80, P3289, DOI 10.1099/0022-1317-80-12-3289; Ikeda M, 2006, J GEN VIROL, V87, P2549, DOI 10.1099/vir.0.81930-0; Jakubowska AK, 2006, J GEN VIROL, V87, P537, DOI 10.1099/vir.0.81461-0; Garavaglia MJ, 2012, J VIROL, V86, P12069, DOI 10.1128/JVI.01873-12; Jehle JA, 2002, J GEN VIROL, V83, P2025, DOI 10.1099/0022-1317-83-8-2025; Kamita SG, 2003, J VIROL, V77, P13053, DOI 10.1128/JVI.77.24.13053-13061.2003; Kaufer BB, 2011, J EXP MED, V208, P605, DOI 10.1084/jem.20101402; Kikhno I. M., 2002, Biopolimery i Kletka, V18, P522; KOOL M, 1994, J GEN VIROL, V75, P3345, DOI 10.1099/0022-1317-75-12-3345; KRAPPA R, 1991, J VIROL, V65, P805, DOI 10.1128/JVI.65.2.805-812.1991; KRAPPA R, 1992, J VIROL, V66, P3494, DOI 10.1128/JVI.66.6.3494-3503.1992; Kuzio J, 1999, VIROLOGY, V253, P17, DOI 10.1006/viro.1998.9469; Lauzon HAM, 2005, J GEN VIROL, V86, P945, DOI 10.1099/vir.0.80489-0; Le TH, 1997, VIRUS RES, V49, P67, DOI 10.1016/S0168-1702(97)01454-8; Leisy DJ, 1997, J VIROL, V71, P5088, DOI 10.1128/JVI.71.7.5088-5094.1997; Li LL, 2002, VIROLOGY, V297, P226, DOI 10.1006/viro.2002.1411; Li QJ, 2002, VIROLOGY, V294, P106, DOI 10.1006/viro.2001.1313; Lin GY, 2002, J VIROL, V76, P2770, DOI 10.1128/JVI.76.6.2770-2779.2002; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Ma XC, 2007, VIROLOGY, V360, P235, DOI 10.1016/j.virol.2006.10.024; MERCHLINSKY M, 1989, J VIROL, V63, P4354, DOI 10.1128/JVI.63.10.4354-4361.1989; Miele Solange Ana Belen, 2011, Int J Evol Biol, V2011, P379424, DOI 10.4061/2011/379424; Milks ML, 2003, VIROLOGY, V310, P224, DOI 10.1016/S0042-6822(03)00143-0; Mirny LA, 2002, NUCLEIC ACIDS RES, V30, P1704, DOI 10.1093/nar/30.7.1704; MIZUUCHI K, 1980, COLD SPRING HARB SYM, V45, P429; Monsma SA, 1996, J VIROL, V70, P4607, DOI 10.1128/JVI.70.7.4607-4616.1996; Nai YS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-116; Nakai M, 2003, VIROLOGY, V316, P171, DOI 10.1016/j.virol.2003.08.002; NASH HA, 1981, ANNU REV GENET, V15, P143, DOI 10.1146/annurev.ge.15.120181.001043; Nie ZM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-248; Ohkawa T, 2002, J VIROL, V76, P12281, DOI 10.1128/JVI.76.23.12281-12289.2002; Okano K, 2006, VIROLOGY, V344, P77, DOI 10.1016/j.virol.2005.09.019; Oppenheimer DI, 1997, ARCH VIROL, V142, P2107, DOI 10.1007/s007050050229; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; PEARSON M, 1992, SCIENCE, V257, P1382, DOI 10.1126/science.1529337; PEARSON MN, 1993, VIROLOGY, V197, P715, DOI 10.1006/viro.1993.1647; Pena CEA, 1997, J MOL BIOL, V266, P76, DOI 10.1006/jmbi.1996.0774; Possee RD., 1992, BACULOVIRUS EXPRESSI; Prikhod'ko EA, 1999, J VIROL, V73, P2460; Prikhodko EA, 1998, J VIROL, V72, P684; PULLEN SS, 1995, J VIROL, V69, P3575, DOI 10.1128/JVI.69.6.3575-3583.1995; Rogozin IB, 2001, BIOINFORMATICS, V17, P890, DOI 10.1093/bioinformatics/17.10.890; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; SMITHMUNGO L, 1994, J BIOL CHEM, V269, P20798; Summers MD, 1987, TEXAS AGR EXPT STATI; Svoboda P, 2006, CELL MOL LIFE SCI, V63, P901, DOI 10.1007/s00018-005-5558-5; Tang XD, 2009, VIRUS GENES, V38, P495, DOI 10.1007/s11262-009-0355-0; THEILMANN DA, 1992, VIROLOGY, V187, P97, DOI 10.1016/0042-6822(92)90298-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; van der Velden GJ, 2012, J VIROL, V86, P12362, DOI 10.1128/JVI.01532-12; van Oers MM, 2005, J GEN VIROL, V86, P2069, DOI 10.1099/vir.0.80964-0; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; Vanarsdall AL, 2004, VIROLOGY, V326, P191, DOI 10.1016/j.virol.2004.06.003; WANG XS, 1995, J MOL BIOL, V250, P573, DOI 10.1006/jmbi.1995.0398; WANG Y, 1989, BIOCHEM BIOPH RES CO, V158, P423, DOI 10.1016/S0006-291X(89)80064-6; Wang YS, 2012, J VIROL, V86, P11948, DOI 10.1128/JVI.02119-12; Willis LG, 2005, VIROLOGY, V338, P209, DOI 10.1016/j.virol.2005.04.041; Xiao H, 2007, VIRUS GENES, V35, P845, DOI 10.1007/s11262-007-0106-z; Xu YP, 2010, J MICROBIOL, V48, P102, DOI 10.1007/s12275-009-0197-4; Zhang CL, 2006, NUCLEIC ACIDS RES, V34, P2238, DOI 10.1093/nar/gkl248; Zhang CX, 2005, VIROLOGY, V333, P190, DOI 10.1016/j.virol.2004.12.028; Zhu SY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-91	103	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95322	10.1371/journal.pone.0095322	http://dx.doi.org/10.1371/journal.pone.0095322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740153	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900129
J	Rebollar, EA; Hughey, MC; Harris, RN; Domangue, RJ; Medina, D; Ibanez, R; Belden, LK				Rebollar, Eria A.; Hughey, Myra C.; Harris, Reid N.; Domangue, Rickie J.; Medina, Daniel; Ibanez, Roberto; Belden, Lisa K.			The Lethal Fungus Batrachochytrium dendrobatidis Is Present in Lowland Tropical Forests of Far Eastern Panama	PLOS ONE			English	Article							POPULATION DECLINES; CHYTRID FUNGUS; AFFECTS PREVALENCE; CHYTRIDIOMYCOSIS; AMPHIBIANS; INFECTION; CONSERVATION; MORTALITY; PATHOGEN; DISEASE	The fungal disease chytridiomycosis, caused by Batrachochytrium dendrobatidis (Bd), is one of the main causes of amphibian population declines and extinctions all over the world. In the Neotropics, this fungal disease has caused catastrophic declines in the highlands as it has spread throughout Central America down to Panama. In this study, we determined the prevalence and intensity of Bd infection in three species of frogs in one highland and four lowland tropical forests, including two lowland regions in eastern Panama in which the pathogen had not been detected previously. Bd was present in all the sites sampled with a prevalence ranging from 15-34%, similar to other Neotropical lowland sites. The intensity of Bd infection on individual frogs was low, ranging from average values of 0.11-24 zoospore equivalents per site. Our work indicates that Bd is present in anuran communities in lowland Panama, including the Darien province, and that the intensity of the infection may vary among species from different habitats and with different life histories. The population-level consequences of Bd infection in amphibian communities from the lowlands remain to be determined. Detailed studies of amphibian species from the lowlands will be essential to determine the reason why these species are persisting despite the presence of the pathogen.	[Rebollar, Eria A.; Harris, Reid N.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Hughey, Myra C.; Medina, Daniel; Belden, Lisa K.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Domangue, Rickie J.] James Madison Univ, Dept Math & Stat, Harrisonburg, VA 22807 USA; [Ibanez, Roberto] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	James Madison University; Virginia Polytechnic Institute & State University; James Madison University; Smithsonian Institution; Smithsonian Tropical Research Institute	Rebollar, EA (corresponding author), James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA.	ea.rebollar@gmail.com	Rebollar, Eria/B-2044-2015; Rebollar Caudillo, Eria/HFZ-8793-2022; Medina, Daniel/AAI-2357-2020	Rebollar, Eria/0000-0001-8827-023X; Belden, Lisa/0000-0002-3514-3920	National Science Foundation [DEB-1136640, DEB-1136602]; Division Of Environmental Biology [1136602, 1136640] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This project was funded by the National Science Foundation Dimensions of Biodiversity program, under grants DEB-1136640 to Lisa K. Belden and DEB-1136602 to Reid N. Harris (http://www.nsf.gov/).	Becker CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048205; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brem FMR, 2008, DIS AQUAT ORGAN, V81, P189, DOI 10.3354/dao01960; Broad Institute Fungal Genome Initiative, 2013, BATR DENDR SEQ PROJ; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Gagliardo R., 2008, International Zoo Yearbook, V42, P125, DOI 10.1111/j.1748-1090.2008.00043.x; Grundler MC, 2012, DIS AQUAT ORGAN, V97, P173, DOI 10.3354/dao02413; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jaramillo C, 2010, CONSERVATION MESOAME; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kilburn VL, 2010, ECOHEALTH, V7, P537, DOI 10.1007/s10393-010-0634-1; Kriger KM, 2007, DIVERS DISTRIB, V13, P781, DOI 10.1111/j.1472-4642.2007.00394.x; Kung D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087101; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 1999, CONSERV BIOL, V13, P117, DOI 10.1046/j.1523-1739.1999.97185.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Lips KR, 2003, CONS BIOL, V17, P1; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059499; Murphy PJ, 2009, ECOHEALTH, V6, P109, DOI 10.1007/s10393-009-0230-4; Murray KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061061; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Rowley JJL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01515; Ruiz A, 2008, ECOHEALTH, V5, P27, DOI 10.1007/s10393-008-0159-z; Savage J.M., 2002, AMPHIBIANS REPTILES; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Urbina Jenny C., 2011, Herpetological Review, V42, P558; Velasquez-E BE, 2008, HERPETOTROPICOS, V4, P65; Velo-Anton G, 2012, BIOL CONSERV, V146, P213, DOI 10.1016/j.biocon.2011.12.003; Flechas SV, 2012, ECOHEALTH, V9, P298, DOI 10.1007/s10393-012-0771-9; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Whitfield SM, 2012, BIOTROPICA, V44, P779, DOI 10.1111/j.1744-7429.2012.00872.x; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2008, ECOHEALTH, V5, P268, DOI 10.1007/s10393-008-0190-0	50	33	34	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95484	10.1371/journal.pone.0095484	http://dx.doi.org/10.1371/journal.pone.0095484			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740162	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900149
J	Reiling, E; Dolle, MET; Youssef, SA; Lee, M; Nagarajah, B; Roodbergen, M; de With, P; de Bruin, A; Hoeijmakers, JH; Vijg, J; van Steeg, H; Hasty, P				Reiling, Erwin; Dolle, Martijn E. T.; Youssef, Sameh A.; Lee, Moonsook; Nagarajah, Bhawani; Roodbergen, Marianne; de With, Piet; de Bruin, Alain; Hoeijmakers, Jan H.; Vijg, Jan; van Steeg, Harry; Hasty, Paul			The Progeroid Phenotype of Ku80 Deficiency Is Dominant over DNA-PKCS Deficiency	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; EMBRYONIC LETHALITY; CATALYTIC SUBUNIT; SCID MUTATION; MICE; DELETION; COMPLEX; PROTEIN; REPAIR; NEUROGENESIS	Ku80 and DNA-PKCS are both involved in the repair of double strand DNA breaks via the nonhomologous end joining (NHEJ) pathway. While ku80(-/-) mice exhibit a severely reduced lifespan and size, this phenotype is less pronounced in dna-pk(cs)(-/-) mice. However, these observations are based on independent studies with varying genetic backgrounds. Here, we generated ku80(-/-), dna-pk(cs)(-/-) and double knock out mice in a C57Bl6/J*FVB F1 hybrid background and compared their lifespan, end of life pathology and mutation frequency in liver and spleen using a lacZ reporter. Our data confirm that inactivation of Ku80 and DNA-PKCS causes reduced lifespan and bodyweights, which is most severe in ku80(-/-) mice. All mutant mice exhibited a strong increase in lymphoma incidence as well as other aging-related pathology (skin epidermal and adnexal atrophy, trabacular bone reduction, kidney tubular anisokaryosis, and cortical and medullar atrophy) and severe lymphoid depletion. LacZ mutation frequency analysis did not show strong differences in mutation frequencies between knock out and wild type mice. The ku80(-/-) mice had the most severe phenotype and the Ku80-mutation was dominant over the DNA-PKCS-mutation. Presumably, the more severe degenerative effect of Ku80 inactivation on lifespan compared to DNA-PKCS inactivation is caused by additional functions of Ku80 or activity of free Ku70 since both Ku80 and DNA-PKCS are essential for NHEJ.	[Reiling, Erwin; Dolle, Martijn E. T.; Nagarajah, Bhawani; Roodbergen, Marianne; de With, Piet; van Steeg, Harry] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Reiling, Erwin; Hoeijmakers, Jan H.] Erasmus MC, Ctr Biomed Genet, Dept Cell Biol & Genet, Rotterdam, Netherlands; [Youssef, Sameh A.; de Bruin, Alain] Univ Utrecht, Fac Vet Med, Dept Pathobiol, Utrecht, Netherlands; [Lee, Moonsook; Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [van Steeg, Harry] Leiden Univ, Med Ctr, Dept Toxicogenet, Leiden, Netherlands; [Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Barshop Inst Longev & Aging Studies, Dept Mol Med, San Antonio, TX 78229 USA; [Hasty, Paul] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Barshop Inst Longev & Aging Studies, Inst Biotechnol, San Antonio, TX 78229 USA	Netherlands National Institute for Public Health & the Environment; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Yeshiva University; Albert Einstein College of Medicine; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Hasty, P (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, Barshop Inst Longev & Aging Studies, Dept Mol Med, San Antonio, TX 78229 USA.	hastye@uthscsa.edu	Hoeijmakers, Jan/AAX-6972-2021; de Bruin, Alain/AAL-9195-2020	Hasty, Paul/0000-0003-3046-0131; youssef, sameh/0000-0002-6402-9975; de Bruin, Alain/0000-0001-8579-2649	National Institutes of Health [P01 AG17242]; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a National Institutes of Health grant (P01 AG17242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Busuttil RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003458; Choi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086358; Dolle M. E., 2011, PATHOBIOL AGING AGE, V1; Dolle MET, 1996, MUTAGENESIS, V11, P111, DOI 10.1093/mutage/11.1.111; Espejel S, 2004, J CELL BIOL, V167, P627, DOI 10.1083/jcb.200407178; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gu YS, 2000, P NATL ACAD SCI USA, V97, P2668, DOI 10.1073/pnas.97.6.2668; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Hasty P, 2008, CELL CYCLE, V7, P1139, DOI 10.4161/cc.7.9.5807; Holcomb VB, 2006, ONCOGENE, V25, P7159, DOI 10.1038/sj.onc.1209704; Holcomb VB, 2008, CANCER RES, V68, P9497, DOI 10.1158/0008-5472.CAN-08-2085; Holcomb VB, 2007, MECH AGEING DEV, V128, P601, DOI 10.1016/j.mad.2007.08.006; Ilina ES, 2008, BBA-PROTEINS PROTEOM, V1784, P1777, DOI 10.1016/j.bbapap.2008.08.001; Karanjawala ZE, 2002, DNA REPAIR, V1, P1017, DOI 10.1016/S1568-7864(02)00151-9; Li H, 2009, ONCOGENE, V28, P1875, DOI 10.1038/onc.2009.57; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; Liang F, 1996, P NATL ACAD SCI USA, V93, P8929, DOI 10.1073/pnas.93.17.8929; Lim DS, 2000, MOL CELL BIOL, V20, P3772, DOI 10.1128/MCB.20.11.3772-3780.2000; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Reliene R, 2006, DNA REPAIR AMST; Sundberg JP, 2011, COMPARATIVE MED, V61, P204; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; TACCIOLI GE, 1994, SCIENCE, V265, P1442, DOI 10.1126/science.8073286; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	34	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93568	10.1371/journal.pone.0093568	http://dx.doi.org/10.1371/journal.pone.0093568			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740260	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900023
J	San Martin-Uriz, P; Mirete, S; Alcolea, PJ; Gomez, MJ; Amils, R; Gonzalez-Pastor, JE				San Martin-Uriz, Patxi; Mirete, Salvador; Alcolea, Pedro J.; Gomez, Manuel J.; Amils, Ricardo; Gonzalez-Pastor, Jose E.			Nickel-Resistance Determinants in Acidiphilium sp PM Identified by Genome-Wide Functional Screening	PLOS ONE			English	Article							ESCHERICHIA-COLI; COBALT RESISTANCE; MICROBIAL ECOLOGY; METAL RESISTANCE; CELL-DIVISION; CNR COBALT; SEQUENCE; GENES; EXPRESSION; PLASMID	Acidiphilium spp. are conspicuous dwellers of acidic, metal-rich environments. Indeed, they are among the most metal-resistant organisms; yet little is known about the mechanisms behind the metal tolerance in this genus. Acidiphilium sp. PM is an environmental isolate from Rio Tinto, an acidic, metal-laden river located in southwestern Spain. The characterization of its metal resistance revealed a remarkable ability to tolerate high Ni concentrations. Here we report the screening of a genomic library of Acidiphilium sp. PM to identify genes involved in Ni resistance. This approach revealed seven different genes conferring Ni resistance to E. coli, two of which form an operon encoding the ATP-dependent protease HslVU (ClpQY). This protease was found to enhance resistance to both Ni and Co in E. coli, a function not previously reported. Other Ni-resistance determinants include genes involved in lipopolysaccharide biosynthesis and the synthesis of branched amino acids. The diversity of molecular functions of the genes recovered in the screening suggests that Ni resistance in Acidiphilium sp. PM probably relies on different molecular mechanisms.	[San Martin-Uriz, Patxi; Mirete, Salvador; Gomez, Manuel J.; Amils, Ricardo; Gonzalez-Pastor, Jose E.] Inst Nacl Tecn Aeroespacial, Ctr Astrobiol INTA CSIC, Madrid, Spain; [Alcolea, Pedro J.] CSIC, Ctr Invest Biol, Madrid, Spain; [Amils, Ricardo] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Gonzalez-Pastor, JE (corresponding author), Inst Nacl Tecn Aeroespacial, Ctr Astrobiol INTA CSIC, Madrid, Spain.	gonzalezpje@cab.inta-csic.es	Amils, Ricardo/X-2706-2019; González-Pastor, José/I-2118-2015; Mirete, Salvador/E-3137-2012; Alcolea Alcolea, Pedro José/O-5654-2016; Gómez, Manuel J/F-8854-2016	González-Pastor, José/0000-0002-7615-7042; Alcolea Alcolea, Pedro José/0000-0002-0729-8941; Gómez, Manuel J/0000-0002-4111-4835	European Research Council [ERC 250350]; Spanish Ministry of Science and Innovation [CGL2009-11059, CGL-2009-10756/BOS, CE-CSD2007-00005]; National Institute for Aerospace Technology (INTA)	European Research Council(European Research Council (ERC)European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institute for Aerospace Technology (INTA)	This work was funded by European Research Council advanced grant ERC 250350 and Spanish Ministry of Science and Innovation grants CGL2009-11059, CGL-2009-10756/BOS and CONSOLIDER Ingenio 2010 ("The Metagenome of the Iberian Peninsula", CE-CSD2007-00005). PSMU is supported by a "Calvo Rodes" fellowship from the National Institute for Aerospace Technology (INTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Cheng ZY, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-18; CHUANG SE, 1993, GENE, V134, P1, DOI 10.1016/0378-1119(93)90167-2; Dew DW, 1999, BIOLEACHING COPPER S; Dopson M, 2003, MICROBIOL-SGM, V149, P1959, DOI 10.1099/mic.0.26296-0; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Forzani C, 2002, GENE, V293, P199, DOI 10.1016/S0378-1119(02)00758-8; Garcia-Moyano A, 2012, FEMS MICROBIOL ECOL, V81, P303, DOI 10.1111/j.1574-6941.2012.01346.x; Geslin C, 2001, RES MICROBIOL, V152, P901, DOI 10.1016/S0923-2508(01)01273-6; Gonzalez-Toril E, 2003, APPL ENVIRON MICROB, V69, P4853, DOI 10.1128/AEM.69.8.4853-4865.2003; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; Grass G, 2000, J BACTERIOL, V182, P1390, DOI 10.1128/JB.182.5.1390-1398.2000; Gray H.B., 2006, BIOL INORGANIC CHEM; Guazzaroni ME, 2013, ENVIRON MICROBIOL, V15, P1088, DOI 10.1111/1462-2920.12021; Guldan H, 2008, BIOCHEMISTRY-US, V47, P7376, DOI 10.1021/bi8005779; Haferburg G, 2007, J BASIC MICROB, V47, P453, DOI 10.1002/jobm.200700275; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Jain R, 2007, BIOCHEM BIOPH RES CO, V359, P486, DOI 10.1016/j.bbrc.2007.05.142; JOHO M, 1995, J IND MICROBIOL, V14, P164, DOI 10.1007/BF01569899; Kanemori M, 1997, J BACTERIOL, V179, P7219, DOI 10.1128/jb.179.23.7219-7225.1997; Khattar MM, 1997, FEBS LETT, V414, P402, DOI 10.1016/S0014-5793(97)01024-7; Lien Hsiang-Yun, 2009, Open Microbiol J, V3, P29, DOI 10.2174/1874285800903010029; LIESEGANG H, 1993, J BACTERIOL, V175, P767, DOI 10.1128/JB.175.3.767-778.1993; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Macomber L, 2011, METALLOMICS, V3, P1153, DOI 10.1039/c1mt00063b; Mahapatra NR, 2002, CURR MICROBIOL, V45, P180, DOI 10.1007/s00284-001-0113-6; Malki M, 2008, APPL ENVIRON MICROB, V74, P4472, DOI 10.1128/AEM.00209-08; Messerschmidt A, 2005, HDB METALLOPROTEINS; Mirete S, 2007, APPL ENVIRON MICROB, V73, P6001, DOI 10.1128/AEM.00048-07; Missiakas D, 1996, EMBO J, V15, P6899, DOI 10.1002/j.1460-2075.1996.tb01082.x; Morgante V, 2014, ENV MICROBI IN PRESS; Mulrooney SB, 2003, FEMS MICROBIOL REV, V27, P239, DOI 10.1016/S0168-6445(03)00042-1; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Park JE, 2004, INT MICROBIOL, V7, P27; PARKER CT, 1992, J BACTERIOL, V174, P2525, DOI 10.1128/jb.174.8.2525-2538.1992; PARKER CT, 1992, J BACTERIOL, V174, P930, DOI 10.1128/jb.174.3.930-934.1992; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruteanu M, 2007, J BACTERIOL, V189, P3017, DOI 10.1128/JB.01531-06; Rawlings DE, 2002, ANNU REV MICROBIOL, V56, P65, DOI 10.1146/annurev.micro.56.012302.161052; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Sambrook J, 2001, MOL CLONING LAB MANU; San Martin-Uriz P, 2011, J BACTERIOL, V193, P5585, DOI 10.1128/JB.05386-11; Sanchez-Roman M, 2014, SCI REP IN PRESS; Santiago B, 2012, J BACTERIOL, V194, P2010, DOI 10.1128/JB.06737-11; Schonknecht G, 2013, SCIENCE, V339, P1207, DOI 10.1126/science.1231707; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Sigel A., 2007, NICKEL ITS SURPRISIN; Sigel R.K.O., 2007, MET IONS LIFE SCI, V2, P109; Stahler FN, 2006, INFECT IMMUN, V74, P3845, DOI 10.1128/IAI.02025-05; Suzuki K, 1997, APPL ENVIRON MICROB, V63, P2089, DOI 10.1128/AEM.63.5.2089-2091.1997; Suzuki K, 1998, APPL ENVIRON MICROB, V64, P411; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian J, 2007, APPL ENVIRON MICROB, V73, P2364, DOI 10.1128/AEM.00207-07; Tibazarwa C, 2000, J BACTERIOL, V182, P1399, DOI 10.1128/JB.182.5.1399-1409.2000; Tremaroli V, 2009, APPL ENVIRON MICROB, V75, P719, DOI 10.1128/AEM.01771-08; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; WOLIN EA, 1963, J BIOL CHEM, V238, P2882; Zhu T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017367	61	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95041	10.1371/journal.pone.0095041	http://dx.doi.org/10.1371/journal.pone.0095041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740277	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900097
J	Schramm, K; Marzi, C; Schurmann, C; Carstensen, M; Reinmaa, E; Biffar, R; Eckstein, G; Gieger, C; Grabe, HJ; Homuth, G; Kastenmuller, G; Magi, R; Metspalu, A; Mihailov, E; Peters, A; Petersmann, A; Roden, M; Strauch, K; Suhre, K; Teumer, A; Volker, U; Volzke, H; Wang-Sattler, R; Waldenberger, M; Meitinger, T; Illig, T; Herder, C; Grallert, H; Prokisch, H				Schramm, Katharina; Marzi, Carola; Schurmann, Claudia; Carstensen, Maren; Reinmaa, Eva; Biffar, Reiner; Eckstein, Gertrud; Gieger, Christian; Grabe, Hans-Joergen; Homuth, Georg; Kastenmueller, Gabriele; Maegi, Reedik; Metspalu, Andres; Mihailov, Evelin; Peters, Annette; Petersmann, Astrid; Roden, Michael; Strauch, Konstantin; Suhre, Karsten; Teumer, Alexander; Voelker, Uwe; Voelzke, Henry; Wang-Sattler, Rui; Waldenberger, Melanie; Meitinger, Thomas; Illig, Thomas; Herder, Christian; Grallert, Harald; Prokisch, Holger			Mapping the Genetic Architecture of Gene Regulation in Whole Blood	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHRONIC KIDNEY-DISEASE; EXPRESSION; POPULATION; VARIANTS; PRESSURE; HEALTH; COHORT; KORA	Background: We aimed to assess whether whole blood expression quantitative trait loci (eQTLs) with effects in cis and trans are robust and can be used to identify regulatory pathways affecting disease susceptibility. Materials and Methods: We performed whole-genome eQTL analyses in 890 participants of the KORA F4 study and in two independent replication samples (SHIP-TREND, N = 976 and EGCUT, N = 842) using linear regression models and Bonferroni correction. Results: In the KORA F4 study, 4,116 cis-eQTLs (defined as SNP-probe pairs where the SNP is located within a 500 kb window around the transcription unit) and 94 trans-eQTLs reached genome-wide significance and overall 91% (92% of cis-, 84% of trans-eQTLs) were confirmed in at least one of the two replication studies. Different study designs including distinct laboratory reagents (PAXgene (TM) vs. Tempus (TM) tubes) did not affect reproducibility (separate overall replication overlap: 78% and 82%). Immune response pathways were enriched in cis- and trans-eQTLs and significant cis-eQTLs were partly coexistent in other tissues (cross-tissue similarity 40-70%). Furthermore, four chromosomal regions displayed simultaneous impact on multiple gene expression levels in trans, and 746 eQTL-SNPs have been previously reported to have clinical relevance. We demonstrated cross-associations between eQTL-SNPs, gene expression levels in trans, and clinical phenotypes as well as a link between eQTLs and human metabolic traits via modification of gene regulation in cis. Conclusions: Our data suggest that whole blood is a robust tissue for eQTL analysis and may be used both for biomarker studies and to enhance our understanding of molecular mechanisms underlying gene-disease associations.	[Schramm, Katharina; Eckstein, Gertrud; Meitinger, Thomas; Prokisch, Holger] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Human Genet, Neuherberg, Germany; [Schramm, Katharina; Peters, Annette; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Marzi, Carola; Wang-Sattler, Rui; Waldenberger, Melanie; Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Mol Epidemiol, Neuherberg, Germany; [Marzi, Carola; Wang-Sattler, Rui; Waldenberger, Melanie; Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol 2, Neuherberg, Germany; [Marzi, Carola; Grallert, Harald] German Ctr Diabet Res DZDeV, Neuherberg, Germany; [Schurmann, Claudia; Homuth, Georg; Teumer, Alexander; Voelker, Uwe] Univ Med Greifswald, Dept Funct Gen, Interfac Inst Genet & Funct Gen, Greifswald, Germany; [Carstensen, Maren; Roden, Michael; Herder, Christian] Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Carstensen, Maren; Roden, Michael; Herder, Christian] Partner Site Dusseldorf, German Ctr Diabet Res DZDeV, Dusseldorf, Germany; [Reinmaa, Eva; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Reinmaa, Eva; Maegi, Reedik; Metspalu, Andres; Mihailov, Evelin] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Biffar, Reiner] Univ Med Greifswald, Dept Prosthet Dent Gerostomatol & Dent Mat, Greifswald, Germany; [Gieger, Christian; Strauch, Konstantin] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Genet Epidemiol, Neuherberg, Germany; [Grabe, Hans-Joergen] Univ Med Greifswald, Helios Hosp Stralsund, Dept Psychiat & Psychotherapy, Greifswald, Germany; [Kastenmueller, Gabriele; Suhre, Karsten] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Mihailov, Evelin] Estonian Bioctr, Tartu, Estonia; [Petersmann, Astrid] Inst Clin Chem, Greifswald, Germany; [Petersmann, Astrid] Lab Med, Greifswald, Germany; [Roden, Michael] Univ Hosp Dusseldorf, Div Endocrinol & Diabetol, Dusseldorf, Germany; [Strauch, Konstantin] Univ Munich, Inst Med Informat Biometry & Epidemiol, Neuherberg, Germany; [Suhre, Karsten] Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha, Qatar; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Meitinger, Thomas] Munich Heart Alliance, Munich, Germany; [Illig, Thomas] Hannover Med Sch, Hannover Unified Biobank, Hannover, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of Tartu; University of Tartu; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Estonian Biocentre; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; University of Munich; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Greifswald Medical School; Munich Heart Alliance; Hannover Medical School	Prokisch, H (corresponding author), German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Human Genet, Neuherberg, Germany.		Wang-Sattler, Rui/B-5354-2014; Teumer, Alexander/S-7438-2019; Suhre, Karsten/AAF-1778-2020; Schurmann, Claudia/L-1204-2016; Meitinger, Thomas/O-1318-2015; Roden, Michael/AAD-3843-2019; Kastenmüller, Gabi/ABF-5987-2020; Waldenberger, Melanie/B-5355-2014; Mägi, Reedik/AAJ-9679-2021; Peters, Annette/A-6117-2011	Wang-Sattler, Rui/0000-0002-8794-8229; Teumer, Alexander/0000-0002-8309-094X; Suhre, Karsten/0000-0001-9638-3912; Schurmann, Claudia/0000-0003-4158-9192; Waldenberger, Melanie/0000-0003-0583-5093; Peters, Annette/0000-0001-6645-0985; Kastenmuller, Gabi/0000-0002-2368-7322; Magi, Reedik/0000-0002-2964-6011; Gieger, Christian/0000-0001-6986-9554; Meitinger, Thomas/0000-0002-8838-8403; Volker, Uwe/0000-0002-5689-3448; Prokisch, Holger/0000-0003-2379-6286	Helmholtz Zentrum Munchen, German Research Center for Environmental Health; State of Bavaria; Munich Center of Health Sciences (MC Health); Ludwig Maximilians-Universitat, as part of the LMUinnovative; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westphalia; Systems Biology of Metabotypes grant (SysMBo) [0315494A]; BMBF (National Genome Research Network NGFNplus Atherogenomics) [01GS0834]; EuropeanEuropean Commission [277984]; 'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar; Qatar Foundation; BMBF (German Ministry of Education and Research); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; 'Greifswald Approach to Individualized Medicine (GANI_MED)' consortium - BMBF [03IS2061A]; BMBF [03ZIK012]; Federal State of Mecklenburg, West Pomerania; University of Tartu (grant "Center of Translational Genomics"); Estonian Goverment [SF0180142s08]; European Commission through the European Regional Development Fund in the frame of grant "Centre of Excellence in Genomics"; Estonian Research Infrastructure's Roadmap [313010]	Helmholtz Zentrum Munchen, German Research Center for Environmental Health(Helmholtz Association); State of Bavaria; Munich Center of Health Sciences (MC Health); Ludwig Maximilians-Universitat, as part of the LMUinnovative; German Federal Ministry of Health; Ministry of School, Science and Research of the State of North-Rhine-Westphalia; Systems Biology of Metabotypes grant (SysMBo); BMBF (National Genome Research Network NGFNplus Atherogenomics)(Federal Ministry of Education & Research (BMBF)); EuropeanEuropean Commission; 'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); BMBF (German Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; 'Greifswald Approach to Individualized Medicine (GANI_MED)' consortium - BMBF(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); Federal State of Mecklenburg, West Pomerania; University of Tartu (grant "Center of Translational Genomics"); Estonian Goverment; European Commission through the European Regional Development Fund in the frame of grant "Centre of Excellence in Genomics"; Estonian Research Infrastructure's Roadmap	The KORA research platform and the KORA Augsburg studies are financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, which is funded by the BMBF and by the State of Bavaria. Furthermore, KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig Maximilians-Universitat, as part of the LMUinnovative and in part by a grant from the BMBF to the German Center for Diabetes Research (DZD). The German Diabetes Center is funded by the German Federal Ministry of Health and the Ministry of School, Science and Research of the State of North-Rhine-Westphalia. This study was supported by the BMBF funded Systems Biology of Metabotypes grant (SysMBo#0315494A). Additional support was obtained from the BMBF (National Genome Research Network NGFNplus Atherogenomics, 01GS0834) and from the European Commission's Seventh Framework Programme (FP7/2007-2013, HEALTH-F2-2011, grant agreement No. 277984, TIRCON). K. Suhre is supported by 'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar, a program funded by the Qatar Foundation. SHIP-TREND is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the BMBF (German Ministry of Education and Research), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Analyses were supported by the 'Greifswald Approach to Individualized Medicine (GANI_MED)' consortium funded by the BMBF (grant 03IS2061A). Genome-wide genotyping and expression data have been supported by the BMBF (grant no. 03ZIK012) and the Federal State of Mecklenburg, West Pomerania. The University of Greifswald is a member of the 'Center of Knowledge Interchange' program of the Siemens AG and the Cache ' Campus program of the InterSystems GmbH. EGCUT studies were financed by University of Tartu (grant "Center of Translational Genomics"), by Estonian Goverment (grant #SF0180142s08) and by European Commission through the European Regional Development Fund in the frame of grant "Centre of Excellence in Genomics" and Estonian Research Infrastructure's Roadmap and through FP7 grant #313010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chambers JC, 2010, NAT GENET, V42, P373, DOI 10.1038/ng.566; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Imboden M, 2012, J ALLERGY CLIN IMMUN, V129, P1218, DOI 10.1016/j.jaci.2012.01.074; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Jones Bryony L, 2011, Hugo J, V5, P13, DOI 10.1007/s11568-011-9155-4; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Mehta D, 2013, EUR J HUM GENET, V21, P48, DOI 10.1038/ejhg.2012.106; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Menke Andreas, 2012, BMC Res Notes, V5, P1, DOI 10.1186/1756-0500-5-1; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Sasayama D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054967; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Schurmann C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050938; Simon-Sanchez J, 2008, HUM MUTAT, V29, P315, DOI 10.1002/humu.20626; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Suhre K, 2012, NAT REV GENET, V13, P759, DOI 10.1038/nrg3314; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Turner ST, 2010, AM J HYPERTENS, V23, P1014, DOI 10.1038/ajh.2010.98; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; Wain LV, 2011, NAT GENET, V43, P1005, DOI 10.1038/ng.922; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693	36	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93844	10.1371/journal.pone.0093844	http://dx.doi.org/10.1371/journal.pone.0093844			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740359	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900028
J	Frisvad, JC; Petersen, LM; Lyhne, EK; Larsen, TO				Frisvad, Jens C.; Petersen, Lene M.; Lyhne, E. Kirstine; Larsen, Thomas O.			Formation of Sclerotia and Production of Indoloterpenes by Aspergillus niger and Other Species in Section Nigri	PLOS ONE			English	Article							SEXUAL REPRODUCTION; ANTIINSECTAN METABOLITE; CRYPTIC SEXUALITY; TUBINGENSIN-A; FUMONISIN B-2; PENICILLIUM; OCHRATOXIN; GROWTH; FUNGI; TOOLS	Several species in Aspergillus section Nigri have been reported to produce sclerotia on well-known growth media, such as Czapek yeast autolysate (CYA) agar, with sclerotia considered to be an important prerequisite for sexual development. However Aspergillus niger sensu stricto has not been reported to produce sclerotia, and is thought to be a purely asexual organism. Here we report, for the first time, the production of sclerotia by certain strains of Aspergillus niger when grown on CYA agar with raisins, or on other fruits or on rice. Up to 11 apolar indoloterpenes of the aflavinine type were detected by liquid chromatography and diode array and mass spectrometric detection where sclerotia were formed, including 10,23dihydro-24,25-dehydroaflavinine. Sclerotium induction can thus be a way of inducing the production of new secondary metabolites from previously silent gene clusters. Cultivation of other species of the black aspergilli showed that raisins induced sclerotium formation by A. brasiliensis, A. floridensis A. ibericus, A. luchuensis, A. neoniger, A. trinidadensis and A. saccharolyticus for the first time.	[Frisvad, Jens C.; Petersen, Lene M.; Lyhne, E. Kirstine; Larsen, Thomas O.] Tech Univ Denmark, Dept Syst Biol, Chemodivers Grp, DK-2800 Lyngby, Denmark	Technical University of Denmark	Frisvad, JC (corresponding author), Tech Univ Denmark, Dept Syst Biol, Chemodivers Grp, DK-2800 Lyngby, Denmark.	jcf@bio.dtu.dk	Frisvad, Jens C/K-2818-2017	Frisvad, Jens C/0000-0002-0573-4340; Larsen, Thomas Ostenfeld/0000-0002-3362-5707	Danish Research Agency for Technology and Production [09-064967]	Danish Research Agency for Technology and Production	Funded by the Danish Research Agency for Technology and Production Grant 09-064967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNIHOTRI VP, 1969, CAN J MICROBIOL, V15, P835, DOI 10.1139/m69-149; AGNIHOTRI VP, 1968, CAN J MICROBIOL, V14, P1253, DOI 10.1139/m68-208; Al-Musallam A., 1980, REVISION BLACK ASPER; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Baker SE, 2006, MED MYCOL, V44, pS17, DOI 10.1080/13693780600921037; Batista AC, 1957, ANAIS SOC BIOL PERNA, V15, P181; Bohm J, 2013, P NATL ACAD SCI USA, V110, P1476, DOI 10.1073/pnas.1217943110; Bradshaw B, 2008, ORG BIOMOL CHEM, V6, P772, DOI 10.1039/b718280e; COATS JOHN HENRY, 1959, DISSERTATION ABSTS, V20, P1544; Darbyshir HL, 2013, FUNG GEN REP S, V60, P290; Dyer PS, 2012, FEMS MICROBIOL REV, V36, P165, DOI 10.1111/j.1574-6976.2011.00308.x; FENNELL DI, 1959, MYCOLOGIA, V51, P409, DOI 10.2307/3756060; Ferracin LM, 2009, BRAZ ARCH BIOL TECHN, V52, P241, DOI 10.1590/S1516-89132009000700031; Frisvad JC, 2007, STUD MYCOL, P31, DOI 10.3114/sim.2007.59.04; Frisvad JC, 2000, STUD MYCOL, P201; Frisvad JC, 2004, STUD MYCOL, P1; FRISVAD JC, 1987, J CHROMATOGR, V404, P195, DOI 10.1016/S0021-9673(01)86850-3; Frisvad JC, 2007, J AGR FOOD CHEM, V55, P9727, DOI 10.1021/jf0718906; Frisvad Jens C, 2012, Methods Mol Biol, V944, P47, DOI 10.1007/978-1-62703-122-6_3; Frisvad JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023496; GLOER JB, 1995, ACCOUNTS CHEM RES, V28, P343, DOI 10.1021/ar00056a004; HOCKING AD, 1980, APPL ENVIRON MICROB, V39, P488, DOI 10.1128/AEM.39.3.488-492.1980; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063769; Horn BW, 2013, MYCOLOGIA, V105, P1153, DOI 10.3852/13-101; Horn BW, 2011, MYCOLOGIA, V103, P174, DOI 10.3852/10-115; Horn BW, 2009, MYCOLOGIA, V101, P423, DOI 10.3852/09-011; Horn BW, 2009, MYCOLOGIA, V101, P275, DOI 10.3852/08-205; Houbraken J, 2012, ANTON LEEUW INT J G, V101, P403, DOI 10.1007/s10482-011-9647-1; Houbraken J, 2011, IMA FUNGUS, V2, P87, DOI 10.5598/imafungus.2011.02.01.12; JARVIS WR, 1985, CAN J BOT, V63, P1567, DOI 10.1139/b85-217; Jorgensen TR, 2011, APPL ENVIRON MICROB, V77, P5270, DOI 10.1128/AEM.00118-11; Jurjevic Z, 2012, IMA FUNGUS, V3, P159, DOI 10.5598/imafungus.2012.03.02.08; Kjer J, 2010, NAT PROTOC, V5, P479, DOI 10.1038/nprot.2009.233; Kuck U, 2013, APPL MICROBIOL BIOT, V97, P9609, DOI 10.1007/s00253-013-5268-0; Mendes JAS, 2013, IND CROP PROD, V43, P25, DOI 10.1016/j.indcrop.2012.06.047; Mogensen JM, 2009, INT J FOOD MICROBIOL, V132, P141, DOI 10.1016/j.ijfoodmicro.2009.04.011; Mogensen JM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-281; Mogensen JM, 2010, J AGR FOOD CHEM, V58, P954, DOI 10.1021/jf903116q; Moore GG, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003574; Myung K, 2013, J AGR FOOD CHEM, V61, P8737, DOI 10.1021/jf402846k; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Nielsen ML, 2011, FEMS MICROBIOL LETT, V321, P157, DOI 10.1111/j.1574-6968.2011.02327.x; Noonim P, 2009, FOOD ADDIT CONTAM A, V26, P94, DOI 10.1080/02652030802366090; Noonim P, 2008, INT J FOOD MICROBIOL, V128, P197, DOI 10.1016/j.ijfoodmicro.2008.08.005; Noonim P, 2008, INT J SYST EVOL MICR, V58, P1727, DOI 10.1099/ijs.0.65694-0; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Perrone G, 2011, FUNGAL BIOL-UK, V115, P1138, DOI 10.1016/j.funbio.2011.07.008; PETERS I, 1949, ARCH MIKROBIOL, V14, P203, DOI 10.1007/BF00446700; PORTER CL, 1957, MYCOLOGIA, V49, P895, DOI 10.2307/3755813; RAI JN, 1967, MYCOPATH MYCOL APPL, V31, P209, DOI 10.1007/BF02053418; RAJENDRAN C, 1980, P INDIAN AS-PLANT SC, V89, P185; Rank C, 2012, METABOLITES, V2, P39, DOI 10.3390/metabo2010039; Raper KB, 1965, GENUS ASPERGILLUS GE; Samson RA, 2007, STUD MYCOL, P129, DOI 10.3114/sim.2007.59.13; Samson RA, 2004, STUD MYCOL, P45; Sings HL, 2001, J NAT PROD, V64, P836, DOI 10.1021/np000613p; Smedsgaard J, 1997, J CHROMATOGR A, V760, P264, DOI 10.1016/S0021-9673(96)00803-5; Sorensen A, 2011, INT J SYST EVOL MICR, V61, P3077, DOI 10.1099/ijs.0.029884-0; Sorensen LM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-255; STAUB GM, 1992, J AM CHEM SOC, V114, P1015, DOI 10.1021/ja00029a033; TEPASKE MR, 1989, TETRAHEDRON, V45, P4961, DOI 10.1016/S0040-4020(01)81077-2; TEPASKE MR, 1989, J ORG CHEM, V54, P4743, DOI 10.1021/jo00281a010; TEPASKE MR, 1989, TETRAHEDRON LETT, V30, P5965, DOI 10.1016/S0040-4039(01)93829-8; UDAGAWA S, 1994, MYCOTAXON, V52, P207; Varga J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.69.01; Wicklow D.T., 1988, P173; Wicklow DT, 1996, CAN J MICROBIOL, V42, P1100, DOI 10.1139/m96-141	67	47	48	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94857	10.1371/journal.pone.0094857	http://dx.doi.org/10.1371/journal.pone.0094857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736731	Green Published, gold			2022-12-25	WOS:000336922600097
J	Totta, P; Pesiri, V; Marino, M; Acconcia, F				Totta, Pierangela; Pesiri, Valeria; Marino, Maria; Acconcia, Filippo			Lysosomal Function Is Involved in 17 beta-Estradiol-Induced Estrogen Receptor alpha Degradation and Cell Proliferation	PLOS ONE			English	Article							ER-ALPHA; BREAST-CANCER; MEMBRANE; PROTEASOME; TURNOVER; INTERNALIZATION; LOCALIZATION; ENDOCYTOSIS; MATRIX; DRUG	The homeostatic control of the cellular proteome steady-state is dependent either on the 26S proteasome activity or on the lysosome function. The sex hormone 17 beta-estradiol (E2) controls a plethora of biological functions by binding to the estrogen receptor alpha (ER alpha), which is both a nuclear ligand-activated transcription factor and also an extrinsic plasma membrane receptor. Regulation of E2-induced physiological functions (e.g., cell proliferation) requires the synergistic activation of both transcription of estrogen responsive element (ERE)-containing genes and rapid extra-nuclear phosphorylation of many different signalling kinases (e.g., ERK/MAPK; PI3K/AKT). Although E2 controls ER alpha intracellular content and activity via the 26S proteasome-mediated degradation, biochemical and microscopy-based evidence suggests a possible cross-talk among lysosomes and ERa activities. Here, we studied the putative localization of endogenous ERa to lysosomes and the role played by lysosomal function in ERa signalling. By using confocal microscopy and biochemical assays, we report that ER alpha localizes to lysosomes and to endosomes in an E2-dependent manner. Moreover, the inhibition of lysosomal function obtained by chloroquine demonstrates that, in addition to 26S proteasome-mediated receptor elimination, lysosome-based degradation also contributes to the E2-dependent ERa breakdown. Remarkably, the lysosome function is further involved in those ERa activities required for E2-dependent cell proliferation while it is dispensable for ER alpha-mediated ERE-containing gene transcription. Our discoveries reveal a novel lysosome-dependent degradation pathway for ER alpha and show a novel biological mechanism by which E2 regulates ER alpha cellular content and, as a consequence, cellular functions.	[Totta, Pierangela; Pesiri, Valeria; Marino, Maria; Acconcia, Filippo] Univ Roma Tre, Sect Biomed Sci & Technol, Dept Sci, Rome, Italy	Italfarmaco; Roma Tre University	Acconcia, F (corresponding author), Univ Roma Tre, Sect Biomed Sci & Technol, Dept Sci, Rome, Italy.	filippo.acconcia@uniroma3.it	Acconcia, Filippo/K-4960-2016; Acconcia, Filippo/AAB-6247-2022; Totta, Pierangela/I-3251-2018	Acconcia, Filippo/0000-0002-4651-2509; Totta, Pierangela/0000-0001-7826-4733	AIRC-Associazione Italiana Ricerca sul Cancro [MFAG12756]; Ateneo Roma Tre	AIRC-Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ateneo Roma Tre	This study was supported by grants from AIRC-Associazione Italiana Ricerca sul Cancro (MFAG12756) and Ateneo Roma Tre to F.A. and to M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2005, J CELL PHYSIOL, V203, P193, DOI 10.1002/jcp.20219; Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; Acconcia F, 2004, BIOCHEM BIOPH RES CO, V316, P878, DOI 10.1016/j.bbrc.2004.02.129; Acconcia F, 2006, CANCER LETT, V238, P1, DOI 10.1016/j.canlet.2005.06.018; Acconcia F, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00030; Adlanmerini M, 2014, P NATL ACAD SCI USA, V111, pE283, DOI 10.1073/pnas.1322057111; Berry NB, 2008, MOL ENDOCRINOL, V22, P1535, DOI 10.1210/me.2007-0449; Burns KA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187773; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Dan P, 2003, AM J PHYSIOL-HEART C, V284, pH1295, DOI 10.1152/ajpheart.00781.2002; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; He Y, 2013, SCI SIGNAL, V4, pra44; Imperi F, 2013, P NATL ACAD SCI USA, V110, P7458, DOI 10.1073/pnas.1222706110; Kisler K, 2013, J STEROIDS HORM SC S, V12; La Rosa P, 2014, PLOS ONE; La Rosa P, 2011, CELL SIGNAL, V23, P1128, DOI 10.1016/j.cellsig.2011.02.006; La Rosa P, 2012, MOL ENDOCRINOL, V26, P762, DOI 10.1210/me.2011-1208; La Rosa P, 2011, J STEROID BIOCHEM, V127, P223, DOI 10.1016/j.jsbmb.2011.07.008; Laios I, 2005, J STEROID BIOCHEM, V94, P347, DOI 10.1016/j.jsbmb.2005.02.005; Leclercq G, 2006, CURR CANCER DRUG TAR, V6, P39, DOI 10.2174/156800906775471716; Marquez DC, 2006, MOL CELL ENDOCRINOL, V246, P91, DOI 10.1016/j.mce.2005.11.020; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Moats RK, 2000, J ENDOCRINOL, V166, P631, DOI 10.1677/joe.0.1660631; Pedram A, 2012, MOL BIOL CELL, V23, P188, DOI 10.1091/mbc.E11-07-0638; PIETRAS RJ, 1984, BIOCHEM BIOPH RES CO, V123, P84, DOI 10.1016/0006-291X(84)90383-8; Powers ET, 2013, NAT REV MOL CELL BIO, V14, P237, DOI 10.1038/nrm3542; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Scita G, 2010, NATURE, V463, P464, DOI 10.1038/nature08910; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; Wang X, 2013, J MOL CELL CARDIOL; Welsh AW, 2012, CLIN CANCER RES, V18, P118, DOI 10.1158/1078-0432.CCR-11-1236	35	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94880	10.1371/journal.pone.0094880	http://dx.doi.org/10.1371/journal.pone.0094880			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736371	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600100
J	Wei, W; Guo, HR; Li, JL; Ren, SS; Wei, ZH; Bao, WG; Hu, XM; Zhao, K; Zhang, WY; Zhou, YL; Sun, F; Markham, R; Yu, XF				Wei, Wei; Guo, Haoran; Li, Jingliang; Ren, Sangsang; Wei, Zhenhong; Bao, Wanguo; Hu, Xiaoming; Zhao, Ke; Zhang, Wenyan; Zhou, Yulai; Sun, Fei; Markham, Richard; Yu, Xiao-Fang			Circulating HFMD-Associated Coxsackievirus A16 Is Genetically and Phenotypically Distinct from the Prototype CV-A16	PLOS ONE			English	Article							MOUTH-DISEASE; ENTEROVIRUS 71; HAND; FOOT; RECOMBINATION; OUTBREAK; EPIDEMIC; EMERGENCE; INFECTION; RECEPTOR	Human enteroviruses (HEV) have been linked to hand, foot, and mouth disease (HFMD) in the Pacific and Southeast Asia for decades. Many cases of HFMD have been attributed to coxsackievirus A16 (CV-A16, CA16), based on only partial viral genome determination. Viral phenotypes are also poorly defined. Herein, we have genetically and phenotypically characterized multiple circulating CV-A16 viruses from HFMD patients and determined multiple full-length sequences of these circulating viruses. We discovered that the circulating CV-A16 viruses from HFMD patients are genetically distinct from the proto-type CV-A16 G10. We have also isolated circulating CV-A16 viruses from hospitalized HFMD patients and compared their virological differences. Interestingly, circulating CV-A16 viruses are more pathogenic in a neonatal mouse model than is CV-A16 G10. Thus, we have found circulating recombinant forms of CV-A16 (CRF CV-A16) that are related to, but different from, the prototype CV-A16 G10 that have distinct biological phenotypes.	[Wei, Wei; Li, Jingliang; Zhao, Ke; Zhang, Wenyan; Yu, Xiao-Fang] Jilin Univ, Hosp 1, Insititute Virol & AIDS Res, Changchun 130023, Jilin Province, Peoples R China; [Guo, Haoran; Yu, Xiao-Fang] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China; [Wei, Zhenhong; Zhou, Yulai; Sun, Fei] Jilin Univ, Coll Pharm, Changchun 130023, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun 130023, Jilin Province, Peoples R China; [Hu, Xiaoming] Hefei Vocat & Tech Coll, Hefei, Anhui, Peoples R China; [Wei, Wei; Ren, Sangsang; Markham, Richard; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Jilin University; Tianjin University; Jilin University; Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yu, XF (corresponding author), Jilin Univ, Hosp 1, Insititute Virol & AIDS Res, Changchun 130023, Jilin Province, Peoples R China.	xfyu@jhsph.edu	Wei, Wei/ABG-9776-2021; R, S/AAY-2885-2021	Wei, Wei/0000-0003-4456-840X; 	Chinese Ministry of Science and Technology [2012CB911100, 2013ZX0001-005]; Chinese Ministry of Education [IRT1016]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China); Key Laboratory of Molecular Virology, Jilin Province, China	This work was supported in part by funding from the Chinese Ministry of Science and Technology (No. 2012CB911100 and No. 2013ZX0001-005), the Chinese Ministry of Education (No IRT1016), and the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 2009, EMERG INFECT DIS, V15, P79, DOI 10.3201/eid1501.080264; Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Bendig J W, 1996, Commun Dis Rep CDR Rev, V6, pR81; Cabrerizo M, 2010, EPIDEMIOL INFECT, V138, P1775, DOI 10.1017/S0950268810002219; Chakraborty R, 2004, AIDS, V18, P1968, DOI 10.1097/00002030-200409240-00018; Chan YF, 2012, TROP BIOMED, V29, P451; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chang Zhao-rui, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P676; Chen XM, 2010, VIROLOGY, V398, P251, DOI 10.1016/j.virol.2009.12.007; Cui Ai-Li, 2009, Zhongguo Yi Miao He Mian Yi, V15, P135; HAGIWARA A, 1978, INTERVIROLOGY, V9, P60, DOI 10.1159/000148922; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Li J, 2014, J GEN VIROL; Li Ren-Qing, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P784; Lin Si-en, 2004, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V18, P227; Liu Jian-Feng, 2009, Zhongguo Yi Miao He Mian Yi, V15, P345; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mao QY, 2012, J VIROL, V86, P11967, DOI 10.1128/JVI.00902-12; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Nishimura Y, 2009, NAT MED, V15, P794, DOI 10.1038/nm.1961; Pan Hao, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P339; Patel KP, 2009, NAT MED, V15, P728, DOI 10.1038/nm0709-728; POYRY T, 1994, VIROLOGY, V202, P982, DOI 10.1006/viro.1994.1423; Reed LJ, 1938, AM J HYG, V27, P493, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A118408; Sarkis PTN, 2006, J IMMUNOL, V177, P4530, DOI 10.4049/jimmunol.177.7.4530; SICKLES GM, 1955, P SOC EXP BIOL MED, V90, P529, DOI 10.3181/00379727-90-22088; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vijayaraghavan PM, 2012, J GLOB INFECT DIS, V4, P153, DOI 10.4103/0974-777X.100572; Wang CY, 2004, PEDIATR INFECT DIS J, V23, P275, DOI 10.1097/01.inf.0000115950.63906.78; Wang XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048069, 10.1371/journal.pone.0051667, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0032405, 10.1371/journal.pone.0036274]; Wu PC, 2010, J MICROBIOL IMMUNOL, V43, P271, DOI 10.1016/S1684-1182(10)60043-6; Yamayoshi S, 2009, NAT MED, V15, P798, DOI 10.1038/nm.1992; Yip CCY, 2010, ARCH VIROL, V155, P1413, DOI 10.1007/s00705-010-0722-0; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Yong, 2009, Chinese Journal of Virology, V25, P159; Zhao K, 2011, EMERG INFECT DIS, V17, P1537, DOI 10.3201/eid1708.101719	37	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94746	10.1371/journal.pone.0094746	http://dx.doi.org/10.1371/journal.pone.0094746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736564	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600087
J	Zhao, Y; Cao, YS; Cui, LH; Ma, B; Mu, XY; Li, YW; Zhang, ZH; Li, D; Wei, W; Gao, MC; Wang, JW				Zhao, Yan; Cao, Yongsheng; Cui, Lihong; Ma, Bo; Mu, Xiaoyu; Li, Yanwei; Zhang, Zhihui; Li, Dan; Wei, Wei; Gao, Mingchun; Wang, Junwei			Duck Enteritis Virus Glycoprotein D and B DNA Vaccines Induce Immune Responses and Immunoprotection in Pekin Ducks	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; MAREKS-DISEASE VIRUS; BOVINE HERPESVIRUS-1; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; T-LYMPHOCYTES; CELL-SURFACE; PROTECTION; INFECTION; IDENTIFICATION	DNA vaccine is a promising strategy for protection against virus infection. However, little is known on the efficacy of vaccination with two plasmids for expressing the glycoprotein D (gD) and glycoprotein B (gB) of duck enteritis virus (DEV) in inducing immune response and immunoprotection against virulent virus infection in Pekin ducks. In this study, two eukaryotic expressing plasmids of pcDNA3.1-gB and pcDNA3.1-gD were constructed. Following transfection, the gB and gD expressions in DF1 cells were detected. Groups of ducks were vaccinated with pcDNA3.1-gB and/or pcDNA3.1-gD, and boosted with the same vaccine on day 14 post primary vaccination. We found that intramuscular vaccinations with pcDNA3.1-gB and/or pcDNA3.1-gD, but not control plasmid, stimulated a high frequency of CD4(+) and CD8(+) T cells in Pekin ducks, particularly with both plasmids. Similarly, vaccination with these plasmids, particularly with both plasmids, promoted higher levels of neutralization antibodies against DEV in Pekin ducks. More importantly, vaccination with both plasmids significantly reduced the virulent DEV-induced mortality in Pekin ducks. Our data indicated that vaccination with plasmids for expressing both gB and gD induced potent cellular and humoral immunity against DEV in Pekin ducks. Therefore, this vaccination strategy may be used for the prevention of DEV infection in Pekin ducks.	[Zhao, Yan] Chinese Acad Agr Sci, Grp Avian Resp Infect Dis, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin, Peoples R China; [Zhao, Yan; Cao, Yongsheng; Cui, Lihong; Ma, Bo; Mu, Xiaoyu; Li, Yanwei; Zhang, Zhihui; Li, Dan; Wei, Wei; Gao, Mingchun; Wang, Junwei] Northeast Agr Univ, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northeast Agricultural University - China	Wang, JW (corresponding author), Northeast Agr Univ, Harbin, Peoples R China.	jwwang@neau.edu.cn	li, yan/GTI-4638-2022; zhang, zh/GWV-4677-2022		National Natural Science Foundation of China [31302092]; Research Fund for the Doctoral Program of Higher Education of China [20102325110004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by National Natural Science Foundation of China(31302092) and the Research Fund for the Doctoral Program of Higher Education of China (20102325110004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABIUK LA, 1987, VIROLOGY, V159, P57, DOI 10.1016/0042-6822(87)90347-3; Baudet AERF, 1923, TIJDSCHR DIERGENEESK, V50, P5; Bourne N, 2003, J INFECT DIS, V187, P542, DOI 10.1086/374002; BURGESS EC, 1979, AVIAN DIS, V23, P940, DOI 10.2307/1589610; BYRNE KM, 1995, VIROLOGY, V209, P230, DOI 10.1006/viro.1995.1248; CANTIN EM, 1987, P NATL ACAD SCI USA, V84, P5908, DOI 10.1073/pnas.84.16.5908; Caselli E, 2001, INTERVIROLOGY, V44, P1, DOI 10.1159/000050023; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; CRANAGE MP, 1986, EMBO J, V5, P3057, DOI 10.1002/j.1460-2075.1986.tb04606.x; DAVISON S, 1993, AVIAN DIS, V37, P1142, DOI 10.2307/1591927; DENIS M, 1993, IMMUNOLOGY, V78, P7; FITZPATRICK DR, 1988, J VIROL, V62, P4239, DOI 10.1128/JVI.62.11.4239-4248.1988; FULLER AO, 1987, P NATL ACAD SCI USA, V84, P5454, DOI 10.1073/pnas.84.15.5454; GUO P, 1990, J VIROL, V64, P2399, DOI 10.1128/JVI.64.5.2399-2406.1990; HIGHLANDER SL, 1987, J VIROL, V61, P3356, DOI 10.1128/JVI.61.11.3356-3364.1987; Huang YX, 1959, S CHINA AGR U J, V1, P12; IKUTA K, 1984, MICROBIOL IMMUNOL, V28, P923, DOI 10.1111/j.1348-0421.1984.tb00748.x; IKUTA K, 1984, J VIROL, V49, P1014, DOI 10.1128/JVI.49.3.1014-1017.1984; ISRAEL BA, 1992, VIROLOGY, V188, P256, DOI 10.1016/0042-6822(92)90755-E; Jin YW, 2005, CLIN DIAGN LAB IMMUN, V12, P1364, DOI 10.1128/CDLI.12.12.1364-1369.2005; KELLER PM, 1984, J VIROL, V52, P293, DOI 10.1128/JVI.52.1.293-297.1984; King A.M.Q., 2012, 9 INT COMM TAX VIR, P1344; KUHN JE, 1990, J VIROL, V64, P2491; LANDOLFI V, 1993, VACCINE, V11, P407, DOI 10.1016/0264-410X(93)90280-B; Lennette EH, 1995, DIAGNOSIS PROCEDURE; Lian B, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-214; LITTELVANDENHURK SV, 1990, VACCINE, V8, P358, DOI 10.1016/0264-410X(90)90095-4; Ll YH, 1997, VIROLOGY, V228, P39, DOI 10.1006/viro.1996.8372; LONG D, 1984, INFECT IMMUN, V43, P761, DOI 10.1128/IAI.43.2.761-764.1984; MANSERVIGI R, 1990, J VIROL, V64, P431, DOI 10.1128/JVI.64.1.431-436.1990; MIETHKE A, 1995, J GEN VIROL, V76, P1623, DOI 10.1099/0022-1317-76-7-1623; Milligan GN, 1998, J IMMUNOL, V160, P6093; MISHKIN EM, 1991, VACCINE, V9, P147, DOI 10.1016/0264-410X(91)90146-W; NIIKURA M, 1992, J VIROL, V66, P2631, DOI 10.1128/JVI.66.5.2631-2638.1992; Oliveira SC, 2000, J IMMUNOL METHODS, V245, P109, DOI 10.1016/S0022-1759(00)00267-2; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; van Drunen Littel-van den Hurk S, 1993, PROTECTION CATTLE BH; Zhou FJ, 2003, DNA CELL BIOL, V22, P475, DOI 10.1089/104454903322247352	38	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95093	10.1371/journal.pone.0095093	http://dx.doi.org/10.1371/journal.pone.0095093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736466	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600143
J	Sany, SBT; Hashim, R; Salleh, A; Rezayi, M; Mehdinia, A; Safari, O				Sany, Seyedeh Belin Tavakoly; Hashim, Rosli; Salleh, Aishah; Rezayi, Majid; Mehdinia, Ali; Safari, Omid			Polycyclic Aromatic Hydrocarbons in Coastal Sediment of Klang Strait, Malaysia: Distribution Pattern, Risk Assessment and Sources	PLOS ONE			English	Article							ORGANIC CONTAMINANTS; SOURCE APPORTIONMENT; IDENTIFYING SOURCES; SURFACE SEDIMENTS; HEAVY-METALS; PAHS; RIVER; WATER; SOIL; IDENTIFICATION	Concentration, source, and ecological risk of polycyclic aromatic hydrocarbons (PAHs) were investigated in 22 stations from surface sediments in the areas of anthropogenic pollution in the Klang Strait (Malaysia). The total PAH level in the Klang Strait sediment was 994.02+/-918.1 mg/kg dw. The highest concentration was observed in stations near the coastline and mouth of the Klang River. These locations were dominated by high molecular weight PAHs. The results showed both pyrogenic and petrogenic sources are main sources of PAHs. Further analyses indicated that PAHs primarily originated from pyrogenic sources (coal combustion and vehicular emissions), with significant contribution from petroleum inputs. Regarding ecological risk estimation, only station 13 was moderately polluted, the rest of the stations suffered rare or slight adverse biological effects with PAH exposure in surface sediment, suggesting that PAHs are not considered as contaminants of concern in the Klang Strait.	[Sany, Seyedeh Belin Tavakoly; Hashim, Rosli; Salleh, Aishah] Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia; [Sany, Seyedeh Belin Tavakoly; Rezayi, Majid] ACECR Mashhad Branch, Food Sci & Technol Res Inst, Mashhad, Iran; [Rezayi, Majid] Univ Malaya, Dept Chem, Fac Sci, Kuala Lumpur 59100, Malaysia; [Mehdinia, Ali] Iranian Natl Inst Oceanog, Dept Marine Sci, Marine Living Grp, Tehran, Iran; [Safari, Omid] Ferdowsi Univ Mashhad, Fac Nat Resources & Environm, Mashhad, Iran	Universiti Malaya; Universiti Malaya; Ferdowsi University Mashhad	Sany, SBT (corresponding author), Univ Malaya, Inst Biol Sci, Kuala Lumpur, Malaysia.	belintavakoli332@gmail.com	rezayi, majid/AAA-8972-2020; Safari, Omid/L-2458-2019; Sany, Seyedeh Belin Tavakoly/B-5876-2019; Safari, Omid/G-1983-2016; Hashim, Rosli/A-8555-2010; Mehdinia, Ali/AFR-0315-2022; Mehdinia, Ali/ABA-1298-2021; Mehdinia, Ali/F-7229-2011	Sany, Seyedeh Belin Tavakoly/0000-0002-7891-4449; Safari, Omid/0000-0001-8378-8291; Mehdinia, Ali/0000-0001-6080-0681	Ministry of Higher Education (Malaysia) [UM.C/625/1/HIR/162]; University Malaya Research Grant [RP004A-SUS]	Ministry of Higher Education (Malaysia)(Ministry of Education, Malaysia); University Malaya Research Grant	This work and survey components were supported by the High Impact Research Grant (UM.C/625/1/HIR/162) from the Ministry of Higher Education (Malaysia) and University Malaya Research Grant (RP004A-SUS). Study designs and data collections were done by the academic staff at the Institute of Biological Science, University Malaya, Kuala Lumpur, Malaysia. Analyses undertaken and the decision to prepare and publish this manuscript were made by Institute staff in conjunction with the Chemistry Department of University Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh S, 2011, MOLECULES, V16, P8130, DOI 10.3390/molecules16098130; Alam L, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-43; Barkhordarian A, 2012, SCI WORLD J, DOI 10.1100/2012/525303; Beyer J, 2010, ENVIRON TOXICOL PHAR, V30, P224, DOI 10.1016/j.etap.2010.08.004; Boonyatumanond R, 2007, SCI TOTAL ENVIRON, V384, P420, DOI 10.1016/j.scitotenv.2007.06.046; Boonyatumanond R, 2006, MAR POLLUT BULL, V52, P942, DOI 10.1016/j.marpolbul.2005.12.015; Budzinski H, 2004, AQUAT LIVING RESOUR, V17, P329, DOI 10.1051/alr:2004040; Chandru K, 2008, MAR POLLUT BULL, V56, P950, DOI 10.1016/j.marpolbul.2008.01.028; Chen HY, 2012, SCI TOTAL ENVIRON, V414, P293, DOI 10.1016/j.scitotenv.2011.10.057; Dsikowitzky L, 2011, MAR POLLUT B, V26, P1330; Dsikowitzky L, 2011, MAR POLLUT BULL, V62, P851, DOI 10.1016/j.marpolbul.2011.02.023; Ekpo BO, 2011, DISTRIBUTIONS SOURCE, P1; Elias MS, 2009, FRESEN ENVIRON BULL, V18, P843; EPA, 1991, SED QUAL GU IN PRESS; de Vallejuelo SFO, 2010, J HAZARD MATER, V181, P565, DOI 10.1016/j.jhazmat.2010.05.050; Guo ZG, 2006, ENVIRON SCI TECHNOL, V40, P5304, DOI 10.1021/es060878b; Hale SE, 2012, ENVIRON SCI TECHNOL, V46, P2830, DOI 10.1021/es203984k; Isobe T, 2007, ENVIRON MONIT ASSESS, V135, P423, DOI 10.1007/s10661-007-9661-y; Khairy MA, 2009, J HAZARD MATER, V170, P389, DOI 10.1016/j.jhazmat.2009.04.084; Larsen RK, 2003, ENVIRON SCI TECHNOL, V37, P1873, DOI 10.1021/es0206184; Liang JT, 2011, INT J ELECTROCHEM SC, V6, P5314; Liu Y, 2009, SCI TOTAL ENVIRON, V407, P2931, DOI 10.1016/j.scitotenv.2008.12.046; LONG ER, 1995, ENVIRON MANAGE, V19, P81, DOI 10.1007/BF02472006; MacDonald DD, 1996, ECOTOXICOLOGY, V5, P253, DOI 10.1007/BF00118995; MADEP, 2007, SED TOX PETR HYDR FR; Mahyar Sakari, 2010, Environment Asia, V3, P131; McCready S, 2006, ENVIRON INT, V32, P455, DOI 10.1016/j.envint.2005.10.006; Mirsadeghi SA, 2011, J ENVIRON SCI-CHINA, V23, P336, DOI 10.1016/S1001-0742(10)60411-1; Montuori P, 2012, MAR POLLUT BULL, V64, P512, DOI 10.1016/j.marpolbul.2012.01.003; Naji A, 2012, AQUAT ECOSYST HEALTH, V15, P287, DOI 10.1080/14634988.2012.706108; Nasher E, 2013, SCI WORLD J, DOI 10.1155/2013/858309; Neff JM, 2005, INTEGR ENVIRON ASSES, V1, P22, DOI 10.1897/IEAM_2004a-016.1; Ogunkunle CO, 2013, POL J ENVIRON STUD, V22, P487; Okere U, 2012, J BIOREMED BIODEGRAD, VS 1, P2; Pan K, 2011, SCI TOTAL ENVIRON, V421-422, P4; Primpas I, 2011, ENVIRON MONIT ASSESS, V178, P257, DOI 10.1007/s10661-010-1687-x; Rauret G, 1998, TALANTA, V46, P449, DOI 10.1016/S0039-9140(97)00406-2; Rezayi M, 2011, INT J ELECTROCHEM SC, V6, P4378; Riccardi C, 2013, SCI TOTAL ENVIRON, V450, P13, DOI 10.1016/j.scitotenv.2013.01.082; Rinawati, 2012, J HAZARD MATER, V217, P208, DOI 10.1016/j.jhazmat.2012.03.023; Saadati N, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-63; Saha M, 2009, MAR POLLUT BULL, V58, P189, DOI 10.1016/j.marpolbul.2008.04.049; Sany B.T., 2012, WORLD ACAD SCI ENG T, V69, P43; Sany SBT, 2012, ENVIRON EARTH SCI, V69, P1; Sany SBT, 2014, ENVIRON SCI POLLUT R, V21, P813, DOI 10.1007/s11356-013-2217-5; Sany SBT, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1476-6; Tavakoly Sany SB, 2013, ENVIRON EARTH SCI, V1-14; Tehrani GM, 2012, ENVIRON PROT ENG, V15, P115; US EPA, 2005, PRED TOX AMPH SED CH; US EPA (The United States Environmental Protection Agency), 2010, CLEAN CONSTR US; Veltman Karin, 2011, Integrated Environmental Assessment and Management, V7, P678, DOI 10.1002/ieam.246; Wagener ADR, 2012, MAR POLLUT BULL, V64, P284, DOI 10.1016/j.marpolbul.2011.11.018; Wang C, 2011, APPL GEOCHEM; Yap, 2005, POLLUTION, P225; Yunker MB, 2002, ORG GEOCHEM, V33, P489, DOI 10.1016/S0146-6380(02)00002-5; Zakaria MP, 2002, ENVIRON SCI TECHNOL, V36, P1907, DOI 10.1021/es011278+; Zakaria MP, 2001, MAR POLLUT BULL, V42, P1357; Zhang Y, 2012, WATER RES, V46, P3065, DOI 10.1016/j.watres.2012.03.006; Zhou Qun-fang, 2002, ScientificWorldJournal, V2, P655	59	48	48	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94907	10.1371/journal.pone.0094907	http://dx.doi.org/10.1371/journal.pone.0094907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747349	Green Published, gold			2022-12-25	WOS:000335226500042
J	Wang, MJ; Li, HM; You, L; Yu, XL; Zhang, M; Zhu, RJ; Hao, CM; Zhang, ZJ; Chen, J				Wang, Mengjing; Li, Haiming; You, Li; Yu, Xiaoling; Zhang, Min; Zhu, Ruijiang; Hao, Chuanming; Zhang, Zhijie; Chen, Jing			Association of Serum Phosphorus Variability with Coronary Artery Calcification among Hemodialysis Patients	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; FIBROBLAST GROWTH FACTOR-23; STAGE RENAL-DISEASE; BEAM COMPUTED-TOMOGRAPHY; SMOOTH-MUSCLE-CELLS; VASCULAR CALCIFICATION; RISK-FACTORS; CARDIOVASCULAR-DISEASE; PARATHYROID-HORMONE; OSTEOBLASTIC DIFFERENTIATION	Coronary artery calcification (CAC) is associated with increased mortality in patients on maintenance hemodialysis (MHD), but the pathogenesis of this condition is not well understood. We evaluated the relationship of CAC score (CACs) and variability in serum phosphorus in MHD patients. Seventy-seven adults on MHD at Huashan Hospital (Shanghai) were enrolled in July, 2010. CAC of all the patients were measured by computed tomography and CACs was calculated by the Agatston method at the entry of enrollment. Patients were divided into three categories according to their CACs (0 similar to 10, 11 similar to 400, and >400). Blood chemistry was recorded every 3 months from January 2008 to July 2010. Phosphorus variation was defined by the standard deviation (SD) or coefficient of variation (CV) and it was calculated from the past records. The ordinal multivariate logistic regression analysis was used to analyze the predictors of CAC. The mean patient age (+/- SD) was 61.7 years (+/- 11.3) and 51% of patients were men. The mean CACs was 609.6 (+/- 1062.9), the median CACs was 168.5, and 78% of patients had CACs more than 0. Multivariate analysis indicated that female gender (OR = 0.20, 95% CI = 0.07-0.55), age (OR = 2.31, 95% CI = 1.32-4.04), serum fibroblast growth factor 23 (OR = 2.25, 95% CI = 1.31-3.85), SD-phosphorus calculated from the most recent 6 measurements (OR = 2.12; 95% CI = 1.23-3.63), and CV-phosphorus calculated from the most recent 6 measurements (OR = 1.90, 95% CI = 1.16-3.11) were significantly and independently associated with CACs. These associations persisted for phosphorus variation calculated from past 7, 8, 9, 10, and 11 follow-up values. Variability of serum phosphorus may contribute significantly to CAC and keeping serum phosphorus stable may decrease coronary calcification and associated morbidity and mortality in MHD patients.	[Wang, Mengjing; Li, Haiming; You, Li; Yu, Xiaoling; Zhang, Min; Hao, Chuanming; Chen, Jing] Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhu, Ruijiang] Fudan Univ, Div Radiol, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhang, Zhijie] Fudan Univ, Dept Epidemiol & Biostatist, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Zhang, Zhijie] Fudan Univ, Biomed Stat Ctr, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Chen, J (corresponding author), Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	chenjing1998@fudan.edu.cn	Chen, Jing/AAM-2184-2021	zhang, zhijie/0000-0002-1276-787X	Major State Basic Research Development Program of China (973 program) [374 2012CB517700]; China Natural Science Foundation [81170684/30971373]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported in part by the Major State Basic Research Development Program of China (973 program, No. 374 2012CB517700), and the China Natural Science Foundation (81170684/30971373) to Jing Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allison MA, 2005, INT J CARDIOL, V98, P325, DOI 10.1016/j.ijcard.2004.03.015; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Atkinson J, 2008, J APPL PHYSIOL, V105, P1643, DOI 10.1152/japplphysiol.90476.2008; Barreto DV, 2008, AM J KIDNEY DIS, V52, P1139, DOI 10.1053/j.ajkd.2008.06.024; Barreto DV, 2005, KIDNEY INT, V67, P1576, DOI 10.1111/j.1523-1755.2005.00239.x; Barreto FC, 2008, KIDNEY INT, V73, P771, DOI 10.1038/sj.ki.5002769; Bas A, 2006, J BONE MINER RES, V21, P484, DOI 10.1359/JBMR.051211; Bhan I, 2009, CLIN J AM SOC NEPHRO, V4, pS102, DOI 10.2215/CJN.04800709; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; Braun J, 1996, AM J KIDNEY DIS, V27, P394, DOI 10.1016/S0272-6386(96)90363-7; Cannata-Andia JB, 2011, NEPHROL DIAL TRANSPL, V26, P3429, DOI 10.1093/ndt/gfr591; Chen NX, 2006, NEPHROL DIAL TRANSPL, V21, P3435, DOI 10.1093/ndt/gfl429; Cheung AK, 2004, KIDNEY INT, V65, P2380, DOI 10.1111/j.1523-1755.2004.00657.x; Civilibal M, 2009, PEDIATR NEPHROL, V24, P555, DOI 10.1007/s00467-008-1038-0; Coen G, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-10; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Dellegrottaglie S, 2006, AM J CARDIOL, V98, P571, DOI 10.1016/j.amjcard.2006.03.030; Desjardins L, 2012, OSTEOPOROSIS INT, V23, P2017, DOI 10.1007/s00198-011-1838-0; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Goodman WG, 2000, NEW ENGL J MED, V342, P1478, DOI 10.1056/NEJM200005183422003; Harris DCH, 1995, J AM SOC NEPHROL, V6, P1607; Haydar AA, 2004, NEPHROL DIAL TRANSPL, V19, P2307, DOI 10.1093/ndt/gfh120; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Hruska KA, 2008, KIDNEY INT, V74, P148, DOI 10.1038/ki.2008.130; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hujairi NMA, 2004, AM J KIDNEY DIS, V43, P234, DOI 10.1053/j.ajkd.2003.10.014; Inaba M, 2006, OSTEOPOROSIS INT, V17, P1506, DOI 10.1007/s00198-006-0154-6; Jean G, 2012, NEPHRON CLIN PRACT, V120, pC132, DOI 10.1159/000334424; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Jung HH, 2006, NEPHROL DIAL TRANSPL, V21, P1915, DOI 10.1093/ndt/gfl118; Kakuta T, 2011, AM J KIDNEY DIS, V57, P422, DOI 10.1053/j.ajkd.2010.10.055; Kendrick J, 2011, AM J KIDNEY DIS, V58, P826, DOI 10.1053/j.ajkd.2011.07.020; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kestenbaum B, 2007, SEMIN DIALYSIS, V20, P286, DOI 10.1111/j.1525-139X.2007.00303.x; Khan AM, 2012, CLIN J AM SOC NEPHRO, V7, P2017, DOI 10.2215/CJN.02160212; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kolovou GD, 2008, ANGIOLOGY, V59, p54S, DOI 10.1177/0003319708319645; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; London GM, 2004, J AM SOC NEPHROL, V15, P1943, DOI 10.1097/01.asn.0000129337.50739.48; Masai H, 2013, ATHEROSCLEROSIS, V226, P228, DOI 10.1016/j.atherosclerosis.2012.10.045; Mathew S, 2008, J AM SOC NEPHROL, V19, P1092, DOI 10.1681/ASN.2007070760; McCullough PA, 2004, J NEPHROL, V17, P205; Mody N, 2001, FREE RADICAL BIO MED, V31, P509, DOI 10.1016/S0891-5849(01)00610-4; Nasrallah MM, 2010, NEPHROL DIAL TRANSPL, V25, P2679, DOI 10.1093/ndt/gfq089; Neves KR, 2007, KIDNEY INT, V71, P1262, DOI 10.1038/sj.ki.5002241; Nitta K, 2004, HYPERTENS RES, V27, P47, DOI 10.1291/hypres.27.47; Nitta K, 2011, THER APHER DIAL, V15, P513, DOI 10.1111/j.1744-9987.2011.00979.x; Noordzij M, 2011, NEPHROL DIAL TRANSPL, V26, P1662, DOI 10.1093/ndt/gfq582; Ohtake T, 2010, HEMODIAL INT, V14, P218, DOI 10.1111/j.1542-4758.2009.00423.x; Olesen P, 2007, AM J PHYSIOL-HEART C, V292, pH1058, DOI 10.1152/ajpheart.00047.2006; Ozkok A, 2012, CLIN J AM SOC NEPHRO, V7, P965, DOI 10.2215/CJN.11191111; Palmer SC, 2011, JAMA-J AM MED ASSOC, V305, P1119, DOI 10.1001/jama.2011.308; Pencak P, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-10; PORTALE AA, 1987, J CLIN INVEST, V80, P1147, DOI 10.1172/JCI113172; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Shantouf R, 2009, CLIN J AM SOC NEPHRO, V4, P1106, DOI 10.2215/CJN.06091108; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Son BK, 2006, CIRC RES, V98, P1024, DOI 10.1161/01.RES.0000218859.90970.8d; Srivaths PR, 2011, PEDIATR NEPHROL, V26, P945, DOI 10.1007/s00467-011-1822-0; Taki K, 2006, KIDNEY INT, V70, P218, DOI 10.1038/sj.ki.5000330; Terauchi Masakazu, 2011, Clin Calcium, V21, P1353, DOI CliCa110913531359; Termorshuizen F, 2004, J AM SOC NEPHROL, V15, P1061, DOI 10.1097/01.ASN.0000117976.29592.93; Tomson C, 2003, NEPHRON CLIN PRACT, V93, pC124, DOI 10.1159/000070231; Vliegenthart R, 2004, ARCH INTERN MED, V164, P2355, DOI 10.1001/archinte.164.21.2355; Wadwa RP, 2006, INT J BIOCHEM CELL B, V38, P996, DOI 10.1016/j.biocel.2005.09.015; Wang MJ, 2013, CLIN J AM SOC NEPHRO, V8, P116, DOI 10.2215/CJN.00230112; WATSON PE, 1980, AM J CLIN NUTR, V33, P27, DOI 10.1093/ajcn/33.1.27; Wexler L, 1996, CIRCULATION, V94, P1175, DOI 10.1161/01.CIR.94.5.1175; Wong ND, 2000, AM J CARDIOL, V86, P495, DOI 10.1016/S0002-9149(00)01000-6; Zarjou A, 2009, J AM SOC NEPHROL, V20, P1254, DOI 10.1681/ASN.2008070788; Zoppellaro G, 2012, AM J KIDNEY DIS, V59, P135, DOI 10.1053/j.ajkd.2011.07.027	80	8	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e93360	10.1371/journal.pone.0093360	http://dx.doi.org/10.1371/journal.pone.0093360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747427	Green Submitted, Green Published, gold			2022-12-25	WOS:000335226500005
J	Channanath, AM; Farran, B; Behbehani, K; Thanaraj, TA				Channanath, Arshad Mohamed; Farran, Bassam; Behbehani, Kazem; Thanaraj, Thangavel Alphonse			Impact of Hypertension on the Association of BMI with Risk and Age at Onset of Type 2 Diabetes Mellitus: Age- and Gender-Mediated Modifications	PLOS ONE			English	Article							BODY-MASS INDEX; GLUCOSE-TOLERANCE; BLOOD-PRESSURE; WEIGHT-GAIN; WOMEN; POPULATION; PREVENTION; PREDICTORS; OBESITY; COHORT	Aims: Given that BMI correlates with risk of Type 2 diabetes mellitus (T2DM), and that hypertension is a common comorbid condition, we hypothesize that hypertension augments significantly the impact of obesity on T2DM onset. Methods: We obtained data on T2DM in Kuwaiti natives from Kuwait Health Network Registry. We considered 1339 comorbid individuals with onset of hypertension preceding that of T2DM, and 3496 non-hypertensive individuals but with T2DM. Multiple linear regressions, ANOVA tests, and Cox proportional hazards models were used to quantify the impact of hypertension on correlation of BMI with age at onset and risk of T2DM. Results: Impact of increasing levels of BMI on age at onset ot T2DM is seen augmented in patients diagnosed with hypertension. We find that the slope of the inverse linear relationship between BMI and onset age of T2DM is much steep in hypertensive patients (-0.69, males and -0.39, females) than in non-hypertensive patients (-0.36, males and -0.17, females). The decline in onset age for an unit increase of BMI is two-fold in males than in females. Upon considering BMI as a categorical variable, we find that while the mean onset age of T2DM in hypertensive patients decreases by as much as 5-12 years in every higher BMI categories, significant decrease in non-hypertensive patients exists only when severely obese. Hazard due to hypertension (against the baseline of non-hypertension and normal weight) increases at least two-fold in every obese category. While males have higher hazard due to hypertension in early adulthood, females have higher hazard in late adulthood. Conclusion: Pre-existing condition of hypertension augments the association of BMI with Type 2 diabetes onset in both males and females. The presented results provide health professionals directives on the extent of weight-loss required to delay onset of Type 2 diabetes in hypertensive versus non-hypertensive patients.	[Channanath, Arshad Mohamed; Farran, Bassam; Behbehani, Kazem; Thanaraj, Thangavel Alphonse] Dasman Diabet Inst, Dasman, Kuwait		Thanaraj, TA (corresponding author), Dasman Diabet Inst, Dasman, Kuwait.	Alphonse.Thangavel@dasmaninstitute.org						Abdul-Ghani MA, 2005, ISR MED ASSOC J, V7, P360; Aksnes TA, 2008, J HUM HYPERTENS, V22, P520, DOI 10.1038/jhh.2008.41; Alhyas L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040948; Burke JP, 2003, DIABETES CARE, V26, P1999, DOI 10.2337/diacare.26.7.1999; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Channanath AM, 2013, DIABETES CARE, V36, pE75, DOI 10.2337/dc12-2451; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; de Lauzon-Guillain B, 2010, DIABETES CARE, V33, P298, DOI 10.2337/dc09-1304; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Farran B, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002457; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Golden SH, 2003, DIABETES CARE, V26, P1110, DOI 10.2337/diacare.26.4.1110; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; Hillier TA, 2001, DIABETES CARE, V24, P1522, DOI 10.2337/diacare.24.9.1522; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Leibson CL, 2001, DIABETES CARE, V24, P1584, DOI 10.2337/diacare.24.9.1584; Logue J, 2011, DIABETOLOGIA, V54, P3003, DOI 10.1007/s00125-011-2313-3; Mullican DR, 2009, DIABETES CARE, V32, P1870, DOI 10.2337/dc09-0328; Naser KA, 2006, INT J CLIN PRACT, V60, P1093, DOI 10.1111/j.1742-1241.2006.01003.x; Penn L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057143; Schienkiewitz A, 2006, AM J CLIN NUTR, V84, P427; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Wareham NJ, 2002, DIABETIC MED, V19, P558, DOI 10.1046/j.1464-5491.2002.00741.x	25	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95308	10.1371/journal.pone.0095308	http://dx.doi.org/10.1371/journal.pone.0095308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743162	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100102
J	Huang, Y; Li, ZP; Xing, H; Jiao, Y; Ouyang, YB; Liao, LJ; Jiang, SB; Armstrong, R; Shao, YM; Ma, LY				Huang, Yang; Li, Zhenpeng; Xing, Hui; Jiao, Yang; Ouyang, Yabo; Liao, Lingjie; Jiang, Shibo; Armstrong, Rebecca; Shao, Yiming; Ma, Liying			Identification of the Critical Sites of NNRTI-Resistance in Reverse Transcriptase of HIV-1 CRF_BC Strains	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; BETA-7-BETA-8 LOOP; P51 SUBUNIT; INFECTION; PREVENTION; MUTATIONS; SELECTION	Background: The polymorphisms involved in drug resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1 CRF_BC, the most prevalent HIV-1 strain in China, have been poorly characterized. Results: To reveal the drug resistance mutations, we compared the gene sequences of pol region of HIV-1 CRF_BC from 631 treatment-naive and 363 treatment-experienced patients using the selection pressure-based method. We calculated an individual Ka/Ks value for each specific amino acid mutation. Result showed that eight polymorphic mutations (W88C, K101Q, I132L, R135L, T139K/R, H221Y and L228R) in RT for treatment-experienced patients were identified, while they, except for R135L, were completely absent in those from treatment-naive patients. The I132L and T139K/R mutants exhibited high-level resistance to DLV and NVP and moderate resistance to TMC-125 and EFV, while the K101Q and H221Y mutants exhibited an increased resistance to all four NNRTIs tested. The W88C, R135L, and L228R may be RTI-induced adaptive mutations. Y181C+K101Q mutant showed a 2.5-, 4.4-, and 4.7-fold higher resistance to TMC-125, NVP and EFV, respectively, than Y181C alone mutant, while Y181C+ H221Y or K103N+H221Y mutants had significantly higher resistance to all four NNRTIs than Y181C or K103N mutants. K103N+T139K and G190A+T139K mutant induce higher resistance (2.0 similar to 14.2-fold and 1.5 similar to 7.2-fold, respectively) to all four NNRTIs than K103N or G190A alone mutation. Conclusions: I132L and T139K/R are rare but critical mutations associated with NNRTI-resistance for some NNRTIs. K101Q, H221Y and T139K can enhance K103N/Y181C/G190A-assocated NNRTI-resistance. Monitoring these mutations will provide useful information for rational design of the NNRTI-based antiretroviral regimen for HIV-1 CRF_BC-infected patients.	[Huang, Yang; Li, Zhenpeng; Xing, Hui; Jiao, Yang; Ouyang, Yabo; Liao, Lingjie; Armstrong, Rebecca; Shao, Yiming; Ma, Liying] Chinese Ctr Dis Control & Prevent China CDC, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Educ, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Hlth, Shanghai 200433, Peoples R China; [Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Fudan University; Fudan University; Fudan University	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Collaborat Innovat Ctr Diag & Treatment Infect Di, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China.	yshao08@gmail.com; mal@chinaaids.cn	Jiang, Shibo/L-4500-2014	Jiang, Shibo/0000-0001-8283-7135	State Key Laboratory for Infectious Disease Prevention and Control [2011SKLID102]; National Nature Science Foundation of China [30872232, 81172733]; Ministry of Science and Technology of China [2005CB523103, 2012ZX10001-002]	State Key Laboratory for Infectious Disease Prevention and Control; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by grants from State Key Laboratory for Infectious Disease Prevention and Control [2011SKLID102], National Nature Science Foundation of China [30872232 and 81172733] and Ministry of Science and Technology of China [2005CB523103 and 2012ZX10001-002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J, 2007, AIDS, V21, P1693, DOI 10.1097/QAD.0b013e32825eabd0; Asahchop EL, 2011, ANTIMICROB AGENTS CH, V55, P600, DOI 10.1128/AAC.01192-10; Auwerx J, 2005, MOL PHARMACOL, V68, P652, DOI 10.1124/mol.105.012351; Azijn H, 2010, ANTIMICROB AGENTS CH, V54, P718, DOI 10.1128/AAC.00986-09; Bacheler LT, 2000, ANTIMICROB AGENTS CH, V44, P2475, DOI 10.1128/AAC.44.9.2475-2484.2000; Brenner BG, 2007, CURR OPIN HIV AIDS, V2, P94, DOI 10.1097/COH.0b013e32801682e2; Ceccherini-Silberstein F, 2007, J VIROL, V81, P11507, DOI 10.1128/JVI.00303-07; Chen L, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-14; Chen LM, 2004, J VIROL, V78, P3722, DOI 10.1128/JVI.78.7.3722-3732.2004; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Coovadia HM, 2012, LANCET, V379, P221, DOI 10.1016/S0140-6736(11)61653-X; Holguin A, 2006, AIDS REV, V8, P98; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Kashuba ADM, 2012, LANCET, V379, P2409, DOI 10.1016/S0140-6736(11)61852-7; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Kulkarni R, 2012, JAIDS-J ACQ IMM DEF, V59, P47, DOI 10.1097/QAI.0b013e31823aca74; Lai MT, 2010, ANTIMICROB AGENTS CH, V54, P4812, DOI 10.1128/AAC.00829-10; Liao LJ, 2012, CLIN INFECT DIS, V54, pS320, DOI 10.1093/cid/cir1016; Liu AY, 2006, JAMA-J AM MED ASSOC, V296, P863, DOI 10.1001/jama.296.7.863; Ma LY, 2010, AIDS RES HUM RETROV, V26, P1007, DOI 10.1089/aid.2009.0252; Ma LY, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-45; Ouyang YB, 2012, CURR HIV RES, V10, P151, DOI 10.2174/157016212799937236; Pan C, 2007, NUCLEIC ACIDS RES, V35, pD371, DOI 10.1093/nar/gkl855; Pandey PK, 2001, BIOCHEMISTRY-US, V40, P9505, DOI 10.1021/bi002872j; Pandey PK, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-18; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Qiu P, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp251; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao Y, 1999, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V13, P109; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Xu HT, 2010, ANTIMICROB AGENTS CH, V54, P2401, DOI 10.1128/AAC.01795-09; Yu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017605; Zhang J, 2010, P NATL ACAD SCI USA, V107, P1321, DOI 10.1073/pnas.0907304107	33	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e93804	10.1371/journal.pone.0093804	http://dx.doi.org/10.1371/journal.pone.0093804			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743727	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100020
J	Swan, BK; Chaffin, MD; Martinez-Garcia, M; Morrison, HG; Field, EK; Poulton, NJ; Masland, EDP; Harris, CC; Sczyrba, A; Chain, PSG; Koren, S; Woyke, T; Stepanauskas, R				Swan, Brandon K.; Chaffin, Mark D.; Martinez-Garcia, Manuel; Morrison, Hilary G.; Field, Erin K.; Poulton, Nicole J.; Masland, E. Dashiell P.; Harris, Christopher C.; Sczyrba, Alexander; Chain, Patrick S. G.; Koren, Sergey; Woyke, Tanja; Stepanauskas, Ramunas			Genomic and Metabolic Diversity of Marine Group I Thaumarchaeota in the Mesopelagic of Two Subtropical Gyres	PLOS ONE			English	Article							AMMONIA OXIDATION; MESOPHILIC CRENARCHAEOTA; PLANKTONIC ARCHAEA; NITRITE REDUCTASE; BACTERIAL; GENES; NITRIFICATION; SEQUENCE; ASSIMILATION; SIGNATURE	Marine Group I (MGI) Thaumarchaeota are one of the most abundant and cosmopolitan chemoautotrophs within the global dark ocean. To date, no representatives of this archaeal group retrieved from the dark ocean have been successfully cultured. We used single cell genomics to investigate the genomic and metabolic diversity of thaumarchaea within the mesopelagic of the subtropical North Pacific and South Atlantic Ocean. Phylogenetic and metagenomic recruitment analysis revealed that MGI single amplified genomes (SAGs) are genetically and biogeographically distinct from existing thaumarchaea cultures obtained from surface waters. Confirming prior studies, we found genes encoding proteins for aerobic ammonia oxidation and the hydrolysis of urea, which may be used for energy production, as well as genes involved in 3-hydroxypropionate/4-hydroxybutyrate and oxidative tricarboxylic acid pathways. A large proportion of protein sequences identified in MGI SAGs were absent in the marine cultures Cenarchaeum symbiosum and Nitrosopumilus maritimus, thus expanding the predicted protein space for this archaeal group. Identifiable genes located on genomic islands with low metagenome recruitment capacity were enriched in cellular defense functions, likely in response to viral infections or grazing. We show that MGI Thaumarchaeota in the dark ocean may have more flexibility in potential energy sources and adaptations to biotic interactions than the existing, surface-ocean cultures.	[Swan, Brandon K.; Chaffin, Mark D.; Field, Erin K.; Poulton, Nicole J.; Masland, E. Dashiell P.; Harris, Christopher C.; Stepanauskas, Ramunas] Single Cell Genom Ctr, Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA; [Chaffin, Mark D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA; [Martinez-Garcia, Manuel] Univ Alicante, Dept Physiol Genet & Microbiol, E-03080 Alicante, Spain; [Morrison, Hilary G.] Josephine Bay Paul Ctr Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA 02543 USA; [Sczyrba, Alexander] Univ Bielefeld, Ctr Biotechnol, D-33615 Bielefeld, Germany; [Chain, Patrick S. G.] Los Alamos Natl Lab, Genome Sci Grp, Los Alamos, NM USA; [Chain, Patrick S. G.; Woyke, Tanja] Joint Genome Inst, Walnut Creek, CA USA; [Koren, Sergey] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA; [Koren, Sergey] Natl Biodef Anal & Countermeasures Ctr, Frederick, MD USA	Bigelow Laboratory for Ocean Sciences; Colby College; Universitat d'Alacant; Marine Biological Laboratory - Woods Hole; University of Bielefeld; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University System of Maryland; University of Maryland College Park	Stepanauskas, R (corresponding author), Single Cell Genom Ctr, Bigelow Lab Ocean Sci, East Boothbay, ME 04544 USA.	rstepanauskas@bigelow.org	Koren, Sergey/AAE-8314-2019; Swan, Brandon K/O-9824-2018; Martínez-García, Manuel/AAT-1935-2021; Chain, Patrick/O-4140-2019	Swan, Brandon K/0000-0003-0465-1444; Martínez-García, Manuel/0000-0001-5056-1525; Chain, Patrick/0000-0003-3949-3634; Morrison, Hilary/0000-0003-0281-326X; Koren, Sergey/0000-0002-1472-8962; Stepanauskas, Ramunas/0000-0003-4458-3108; Sczyrba, Alexander/0000-0002-4405-3847; Poulton, Nicole/0000-0003-3020-4509; Chaffin, Mark/0000-0002-1234-5562	NSF [EF-826924, OCE-821374, OCE-1232982]; DOE JGI Microbes Program grant [CSP77]; National Institutes of Health [1UH2DK083993]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Department of Homeland Security (DHS) [HSHQDC-07-C-00020]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UH2DK083993] Funding Source: NIH RePORTER; Directorate For Geosciences [1232982] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); DOE JGI Microbes Program grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Department of Homeland Security (DHS)(United States Department of Homeland Security (DHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF grants EF-826924 (R.S.), OCE-821374 (R.S.) and OCE-1232982 (R.S. and B.K.S.); the DOE JGI 2010 Microbes Program grant CSP77 (R.S. and M.E.S.); National Institutes of Health grant 1UH2DK083993 (H.G.M.). Work conducted by the U.S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The contributions of S.K. were funded under Agreement No. HSHQDC-07-C-00020 awarded by the Department of Homeland Security (DHS) for the management and operation of the National Biodefense Analysis and Countermeasures Center (NBACC), a Federally Funded Research and Development Center. The views and conclusions contained in this document are those of the authors and should not be interpreted as necessarily representing the official policies, either expressed or implied, of the U.S. Department of Homeland Security. In no event shall the DHS, NBACC, or Battelle National Biodefense Institute (BNBI) have any responsibility or liability for any use, misuse, inability to use, or reliance upon the information contained herein. The Department of Homeland Security does not endorse any products or commercial services mentioned in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Alonso-Saez L, 2012, P NATL ACAD SCI USA, V109, P17989, DOI 10.1073/pnas.1201914109; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Bartossek R, 2010, ENVIRON MICROBIOL, V12, P1075, DOI 10.1111/j.1462-2920.2010.02153.x; Beaumont HJE, 2002, J BACTERIOL, V184, P2557, DOI 10.1128/JB.184.9.2557-2560.2002; Beja O, 2002, APPL ENVIRON MICROB, V68, P335, DOI 10.1128/AEM.68.1.335-345.2002; Beman JM, 2008, ISME J, V2, P429, DOI 10.1038/ismej.2007.118; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; Berg IA, 2010, MICROBIOL-SGM, V156, P256, DOI 10.1099/mic.0.034298-0; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Casciotti KL, 2001, APPL ENVIRON MICROB, V67, P2213, DOI 10.1128/AEM.67.5.2213-2221.2001; Chitsaz H, 2011, NAT BIOTECHNOL, V29, P915, DOI 10.1038/nbt.1966; Church MJ, 2010, ENVIRON MICROBIOL, V12, P679, DOI 10.1111/j.1462-2920.2009.02108.x; Cleland D, 2004, J MICROBIOL METH, V58, P31, DOI 10.1016/j.mimet.2004.02.015; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Drummond A., 2011, GENEIOUS V5 5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fuhrman JA, 1997, MAR ECOL PROG SER, V150, P275, DOI 10.3354/meps150275; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hansman RL, 2009, P NATL ACAD SCI USA, V106, P6513, DOI 10.1073/pnas.0810871106; Hugler M, 2003, ARCH MICROBIOL, V179, P160, DOI 10.1007/s00203-002-0512-5; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Jason J, 2007, ARCH MICROBIOL, V188, P349, DOI 10.1007/s00203-007-0255-4; Jousset A, 2012, ENVIRON MICROBIOL, V14, P1830, DOI 10.1111/j.1462-2920.2011.02627.x; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KONSTANTINIDIS K, 2008, ISME J; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Martinez-Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035314; Massana R, 1997, APPL ENVIRON MICROB, V63, P50, DOI 10.1128/AEM.63.1.50-56.1997; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Schmidt I, 2001, MICROBIOL-SGM, V147, P2247, DOI 10.1099/00221287-147-8-2247; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmieder R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-341; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Teira E, 2006, LIMNOL OCEANOGR, V51, P60, DOI 10.4319/lo.2006.51.1.0060; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Tully BJ, 2012, ENVIRON MICROBIOL, V14, P254, DOI 10.1111/j.1462-2920.2011.02628.x; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Walker CB, 2010, P NATL ACAD SCI USA, V107, P8818, DOI 10.1073/pnas.0913533107; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Yakimov MM, 2011, ISME J, V5, P945, DOI 10.1038/ismej.2010.197	56	53	56	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95380	10.1371/journal.pone.0095380	http://dx.doi.org/10.1371/journal.pone.0095380			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743558	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100112
J	Trettin, J; Seyferth, T; Heinze, J				Trettin, Juergen; Seyferth, Thomas; Heinze, Juergen			Behavioral Plasticity in Ant Queens: Environmental Manipulation Induces Aggression among Normally Peaceful Queens in the Socially Polymorphic Ant Leptothorax acervorum	PLOS ONE			English	Article							REPRODUCTIVE-SKEW MODELS; EGG CANNIBALISM; HYMENOPTERA; DOMINANCE; ECOLOGY; ORGANIZATION; FORMICIDAE; COLONIES; POLYGYNY; COMPETITION	The behavioral traits that shape the structure of animal societies vary considerably among species but appear to be less flexible within species or at least within populations. Populations of the ant Leptothorax acervorum differ in how queens interact with other queens. Nestmate queens from extended, homogeneous habitats tolerate each other and contribute quite equally to the offspring of the colony (polygyny: low reproductive skew). In contrast, nestmate queens from patchy habitats establish social hierarchies by biting and antennal boxing, and eventually only the top-ranking queen of the colony lays eggs (functional monogyny: high reproductive skew). Here we investigate whether queen-queen behavior is fixed within populations or whether aggression and high skew can be elicited by manipulation of socio-environmental factors in colonies from low skew populations. An increase of queen/worker ratio and to a lesser extent food limitation elicited queen-queen antagonism in polygynous colonies from Nurnberger Reichswald similar to that underlying social and reproductive hierarchies in high-skew populations from Spain, Japan, and Alaska. In manipulated colonies, queens differed more in ovarian status than in control colonies. This indicates that queens are in principle capable of adapting the magnitude of reproductive skew to environmental changes in behavioral rather than evolutionary time.	[Trettin, Juergen; Seyferth, Thomas; Heinze, Juergen] Univ Regensburg, D-93053 Regensburg, Germany	University of Regensburg	Trettin, J (corresponding author), Univ Regensburg, D-93053 Regensburg, Germany.	juergen.trettin@ur.de			Deutsche Forschungsgemeinschaft [He1623/25]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (He1623/25) including the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOURKE AFG, 1994, P ROY SOC B-BIOL SCI, V255, P55, DOI 10.1098/rspb.1994.0008; BOURKE AFG, 1991, ANIM BEHAV, V42, P295, DOI 10.1016/S0003-3472(05)80561-5; BOURKE AFG, 1994, PHILOS T R SOC B, V345, P359, DOI 10.1098/rstb.1994.0115; BUSCHINGER A, 1974, INSECT SOC, V21, P381, DOI 10.1007/BF02331567; BUSCHINGER A, 1968, INSECT SOC, V15, P217, DOI 10.1007/BF02225844; BUSCHINGER A, 1978, INSECT SOC, V25, P339, DOI 10.1007/BF02224298; Buschinger A, 1974, SOZIALPOLYMORPHISMUS, P604; Chen YP, 2000, ANN ENTOMOL SOC AM, V93, P295, DOI 10.1603/0013-8746(2000)093[0295:EOQATW]2.0.CO;2; Felke M, 1999, INSECT SOC, V46, P84, DOI 10.1007/s000400050117; FRANKS NR, 1983, NATURE, V304, P724, DOI 10.1038/304724a0; Gill RJ, 2011, P ROY SOC B-BIOL SCI, V278, P1524, DOI 10.1098/rspb.2010.1774; Gill RJ, 2009, P ROY SOC B-BIOL SCI, V276, P4423, DOI 10.1098/rspb.2009.1408; Gotzek D, 2007, Q REV BIOL, V82, P201, DOI 10.1086/519965; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hammond RL, 2006, BEHAV ECOL SOCIOBIOL, V61, P265, DOI 10.1007/s00265-006-0257-2; HEINZE J, 1991, Psyche (Cambridge), V98, P227, DOI 10.1155/1991/21921; Heinze J., 1992, P25; HEINZE J, 1990, BEHAV ECOL SOCIOBIOL, V27, P1; Heinze J, 1995, BEHAV ECOL, V6, P359, DOI 10.1093/beheco/6.4.359; Heinze J., 1995, Zoology (Jena), V98, P127; HEINZE J, 1992, ETHOLOGY, V90, P265; Helms KR, 2013, BEHAV ECOL SOCIOBIOL, V67, P1563, DOI 10.1007/s00265-013-1568-8; HOLM S, 1979, SCAND J STAT, V6, P65; Ito F, 2005, BELG J ZOOL, V135, P3; ITO F, 1990, Psyche (Cambridge), V97, P203, DOI 10.1155/1990/17607; Jamieson IG, 1997, P ROY SOC B-BIOL SCI, V264, P335, DOI 10.1098/rspb.1997.0048; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; KELLER L, 1994, TRENDS ECOL EVOL, V9, P98, DOI 10.1016/0169-5347(94)90204-6; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P265, DOI 10.1098/rspb.2002.2238; Kutsukake N, 2006, BEHAV ECOL SOCIOBIOL, V60, P695, DOI 10.1007/s00265-006-0213-1; Linklater WL, 2000, BIOL REV, V75, P1, DOI 10.1017/S0006323199005411; Magrath RD, 2000, J AVIAN BIOL, V31, P247, DOI 10.1034/j.1600-048X.2000.310217.x; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; Nonacs P, 2011, BIOL REV, V86, P271, DOI 10.1111/j.1469-185X.2010.00144.x; Ortius D, 1999, BEHAV ECOL SOCIOBIOL, V45, P151, DOI 10.1007/s002650050548; OSTFELD RS, 1990, TRENDS ECOL EVOL, V5, P411, DOI 10.1016/0169-5347(90)90026-A; Overson R, 2014, BEHAV ECOL SOCIOBIOL, V68, P21, DOI 10.1007/s00265-013-1618-2; Pardi L., 1946, B I ENT U BOLOGNA, V15, P25; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reeve HK, 2001, ANNU REV ENTOMOL, V46, P347, DOI 10.1146/annurev.ento.46.1.347; Reeve HK, 2000, AM NAT, V155, P365, DOI 10.1086/303322; Reeve Hudson K., 1993, P45; Ruppell O, 2002, J INSECT BEHAV, V15, P447, DOI 10.1023/A:1016277511957; Salomon M, 2008, BEHAV ECOL, V19, P605, DOI 10.1093/beheco/arn008; Sokal R. R., 2012, BIOMETRY; SOMMEIJER MJ, 1990, ENTOMOL EXP APPL, V56, P229, DOI 10.1007/BF00163694; STILLE M, 1991, BEHAV ECOL SOCIOBIOL, V28, P91, DOI 10.1007/BF00180985; Trettin Juergen, 2011, BMC Ecology, V11, P21, DOI 10.1186/1472-6785-11-21; Wilson E.O., 1971, INSECT SOC; Yamauchi K, 2007, INSECT SOC, V54, P268, DOI 10.1007/s00040-007-0941-x	51	4	4	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95153	10.1371/journal.pone.0095153	http://dx.doi.org/10.1371/journal.pone.0095153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743352	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100076
J	Che, X; He, FL; Deng, Y; Xu, SQ; Fan, XQ; Gu, P; Wang, ZL				Che, Xin; He, Fanglin; Deng, Yuan; Xu, Shiqiong; Fan, Xianqun; Gu, Ping; Wang, Zhiliang			HIV-1 Tat-Mediated Apoptosis in Human Blood-Retinal Barrier-Associated Cells	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; NMDA RECEPTORS; RETINOPATHY; INFECTION; GLUTAMATE; PROTEIN; DEATH; QUANTIFICATION; PERMEABILITY; ASTROCYTES	HIV-1-associated ocular complications, such as microvasculopathies, can lead to the loss of vision in HIV-1-infected patients. Even in patients under highly active antiretroviral therapy, ocular lesions are unavoidable. Ocular complications have been demonstrated to be closely related to the breakdown of the blood-retinal-barrier (BRB); however, the underlying mechanism is not clear. The data from this study indicated that the HIV-1 Tat protein induced the apoptosis of human retinal microvascular endothelial cells (HRMECs) and retinal pigmen epithelium (RPE) cells, which compose the inner BRB and the outer BRB, respectively. In addition, this study found that the activation of N-methyl-D-aspartate receptors (NMDARs) was involved in the apoptosis of RPE cells, but it caused no changes in HRMECs. Furthermore, both cell types exhibited enhanced expression of Bak, Bax and Cytochrome c. The inhibition of Tat activity protected against the apoptosis induced by NMDAR activation and prevented the dysregulation of Bak, Bax and Cytochrome c, revealing an important role for the mitochondrial pathway in HIV-1 Tat-induced apoptosis. Together, these findings suggest a possible mechanism and may identify a potential therapeutic strategy for HIV-1-associated ocular complications.	[Che, Xin; He, Fanglin; Deng, Yuan; Xu, Shiqiong; Fan, Xianqun; Gu, Ping; Wang, Zhiliang] Shanghai Jiao Tong Univ, Dept Ophthalmol, Peoples Hosp 9, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Gu, P (corresponding author), Shanghai Jiao Tong Univ, Dept Ophthalmol, Peoples Hosp 9, Shanghai 200030, Peoples R China.	guping2009@hotmail.com; ophwzl@163.com			National Natural Science Foundations of China [81070757, 81070737]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundations of China (81070757, 81070737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bek T, 2013, PROG RETIN EYE RES, V36, P247, DOI 10.1016/j.preteyeres.2013.07.002; Benjamin LA, 2012, LANCET NEUROL, V11, P878, DOI 10.1016/S1474-4422(12)70205-3; BILL A, 1980, T OPHTHAL SOC UK, V100, P332; Capozzi ME, 2013, INVEST OPHTH VIS SCI, V54, P4197, DOI 10.1167/iovs.13-11608; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cunha-Vaz J, 2011, EUR J OPHTHALMOL, V21, pS3, DOI 10.5301/EJO.2010.6049; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Eugenin EA, 2006, J NEUROSCI, V26, P1098, DOI 10.1523/JNEUROSCI.3863-05.2006; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; FABER DW, 1992, INVEST OPHTH VIS SCI, V33, P2345; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Han Y, 2011, AIDS, V25, P1925, DOI 10.1097/QAD.0b013e32834b3578; Haughey NJ, 2001, J NEUROCHEM, V78, P457, DOI 10.1046/j.1471-4159.2001.00396.x; Jaffar S, 1999, TROP MED INT HEALTH, V4, P487, DOI 10.1046/j.1365-3156.1999.00425.x; Kabashima Y, 2009, J BIOCHEM, V146, P845, DOI 10.1093/jb/mvp140; Kim TA, 2003, J IMMUNOL, V170, P2629, DOI 10.4049/jimmunol.170.5.2629; King JE, 2010, AM J PATHOL, V176, P2819, DOI 10.2353/ajpath.2010.090642; KORTE GE, 1984, INVEST OPHTH VIS SCI, V25, P1027; Krishnaswamy G, 2000, Cardiol Rev, V8, P260, DOI 10.1097/00045415-200008050-00005; Liu JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064904; LOPEZCOLOME AM, 1993, J NEUROSCI RES, V34, P454, DOI 10.1002/jnr.490340410; Mascarell L, 2005, J VIROL, V79, P9872, DOI 10.1128/JVI.79.15.9872-9884.2005; Miao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042318; Mishra R, 2013, J NEUROSCI, V33, P5992, DOI 10.1523/JNEUROSCI.4796-12.2013; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Park IW, 2001, J IMMUNOL, V167, P2766, DOI 10.4049/jimmunol.167.5.2766; Pathanapitoon K, 2011, AIDS, V25, P81, DOI 10.1097/QAD.0b013e328340fe91; Penha FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064094; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pugliese A, 2005, CELL BIOCHEM FUNCT, V23, P223, DOI 10.1002/cbf.1147; Shen Y, 2006, MOL NEUROBIOL, V34, P163, DOI 10.1385/MN:34:3:163; Smith FB, 1998, CHEST, V114, P337, DOI 10.1378/chest.114.1.337; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Tejada P., 1997, International Ophthalmology, V21, P319, DOI 10.1023/A:1006027318983; TSO MOM, 1982, OPHTHALMOLOGY, V89, P1132; Tsujimoto Y, 2000, FEBS LETT, V466, P6, DOI 10.1016/S0014-5793(99)01761-5; VALERIANOMARCET J, 1990, J RHEUMATOL, V17, P1091; WAKAI S, 1989, J NEUROL NEUROSUR PS, V52, P595, DOI 10.1136/jnnp.52.5.595; Wang ZL, 2012, AM J OPHTHALMOL, V153, P363, DOI 10.1016/j.ajo.2011.07.018; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; Xu RF, 2012, BRAIN RES, V1436, P13, DOI 10.1016/j.brainres.2011.11.052	44	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95420	10.1371/journal.pone.0095420	http://dx.doi.org/10.1371/journal.pone.0095420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739951	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900143
J	Wang, QQ; Guo, JJ; Jiao, PZ; Liu, HX; Yao, XJ				Wang, Qianqian; Guo, Jingjing; Jiao, Pingzu; Liu, Huanxiang; Yao, Xiaojun			Exploring the Influence of EGCG on the beta-Sheet-Rich Oligomers of Human Islet Amyloid Polypeptide (hIAPP(1-37)) and Identifying Its Possible Binding Sites from Molecular Dynamics Simulation	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALPHA-SYNUCLEIN; HEXAPEPTIDE NFGAIL; FIBRIL FORMATION; PEPTIDE; PROTEIN; IAPP; AGGREGATION; ALZHEIMERS; INHIBITION	EGCG possesses the ability of disaggregating the existing amyloid fibrils which were associated with many age-related degenerative diseases. However, the molecular mechanism of EGCG to disaggregate these fibrils is poorly known. In this work, to study the influence of EGCG on the full-length human islet amyloid polypeptide 1-37 (hIAPP(1-37)) oligomers, molecular dynamics simulations of hIAPP(1-37) pentamer and decamer with EGCG were performed, respectively. The obtained results indicate that EGCG indeed destabilized the hIAPP(1-37) oligomers. The nematic order parameter and secondary structure calculations coupled with the free-energy landscape indicate that EGCG broke the initial ordered pattern of two polymers, greatly reduced their beta-sheet content and enlarged their conformational space. On this basis, three possible target sites were identified with the binding capacity order of S1>S2>S3. After a deeper analysis of each site, we found that S1 was the most possible site on which residues B-Ile26/Ala25, A-Phe23, B/C-Leu27 and E-Tyr37 played an important role for their binding. The proposal of this molecular mechanism can not only provide a prospective interaction figure between EGCG and beta-sheet-rich fibrils of hIAPP(1-37), but also is useful for further discovering other potential inhibitors.	[Wang, Qianqian; Guo, Jingjing; Jiao, Pingzu; Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Guo, Jingjing; Liu, Huanxiang; Yao, Xiaojun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Guo, Jingjing; Liu, Huanxiang; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Taipa, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Macau University of Science & Technology	Liu, HX (corresponding author), Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China.	hxliu@lzu.edu.cn	Guo, Jingjing/GZL-0645-2022	Guo, Jingjing/0000-0002-4632-4364; Wang, Qianqian/0000-0003-2574-0120; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21103075, 21375054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos: 21103075 and 21375054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, AMBER 10; [Anonymous], 2009, DISC STUD VERS 2 5 5; Bae SY, 2010, BIOCHEM BIOPH RES CO, V400, P531, DOI 10.1016/j.bbrc.2010.08.088; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Butterfield SM, 2002, J AM CHEM SOC, V124, P9751, DOI 10.1021/ja026668q; Cecchini M, 2004, J CHEM PHYS, V121, P10748, DOI 10.1063/1.1809588; Chandrashekaran IR, 2011, ARCH BIOCHEM BIOPHYS, V513, P153, DOI 10.1016/j.abb.2011.07.008; Chen Y, 2010, BIOPOLYMERS, V93, P578, DOI 10.1002/bip.21405; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; CLARK A, 1987, LANCET, V2, P231; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Engel MFM, 2012, J AM CHEM SOC, V134, P14781, DOI 10.1021/ja3031664; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; Guo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065579; Hamley IW, 2007, ANGEW CHEM INT EDIT, V46, P8128, DOI 10.1002/anie.200700861; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Hirohata M, 2005, NEUROPHARMACOLOGY, V49, P1088, DOI 10.1016/j.neuropharm.2005.07.004; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang P, 2011, BIOPHYS J, V100, P1550, DOI 10.1016/j.bpj.2011.02.010; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lemkul JA, 2012, BIOCHEMISTRY-US, V51, P5990, DOI 10.1021/bi300113x; Liang GZ, 2013, BIOCHEMISTRY-US, V52, P1089, DOI 10.1021/bi301525e; Liang Y, 2010, J AM CHEM SOC, V132, P6306, DOI 10.1021/ja910964c; Liu FF, 2011, J PHYS CHEM B, V115, P11879, DOI 10.1021/jp202640b; Lockhart C, 2012, J PHYS CHEM B, V116, P12922, DOI 10.1021/jp306208n; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; Viet MH, 2011, J PHYS CHEM B, V115, P7433, DOI 10.1021/jp1116728; Marek P, 2010, J MOL BIOL, V400, P878, DOI 10.1016/j.jmb.2010.05.041; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Mo YX, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3097982; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Ngo ST, 2012, J PHYS CHEM B, V116, P10165, DOI 10.1021/jp302506a; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nieznanski K, 2012, J BIOL CHEM, V287, P33104, DOI 10.1074/jbc.C112.400614; Palhano FL, 2013, J AM CHEM SOC, V135, P7503, DOI 10.1021/ja3115696; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Raman EP, 2009, BIOPHYS J, V97, P2070, DOI 10.1016/j.bpj.2009.07.032; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Sellin D, 2010, BIOPHYS CHEM, V150, P73, DOI 10.1016/j.bpc.2010.01.006; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P451, DOI 10.1021/cn200133x; SIPE JD, 1994, CRIT REV CL LAB SCI, V31, P325, DOI 10.3109/10408369409084679; Thomas T, 2001, NEUROREPORT, V12, P3263, DOI 10.1097/00001756-200110290-00024; TIRADORIVES J, 1991, BIOCHEMISTRY-US, V30, P3864, DOI 10.1021/bi00230a009; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; WESTERMARK P, 1987, P NATL ACAD SCI USA, V84, P3881, DOI 10.1073/pnas.84.11.3881; Wu C, 2005, J AM CHEM SOC, V127, P13530, DOI 10.1021/ja050767x; Wu C, 2004, BIOPHYS J, V87, P3000, DOI 10.1529/biophysj.104.047076; Xu XJ, 2004, COMPUTER AIDED DRUG; Yan LM, 2006, P NATL ACAD SCI USA, V103, P2046, DOI 10.1073/pnas.0507471103; Yang C, 2010, J MOL MODEL, V16, P813, DOI 10.1007/s00894-009-0594-y; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200; Yang ZX, 2011, J PHYS CHEM B, V115, P11137, DOI 10.1021/jp2046454; Ye W, 2013, ACTA BIOCH BIOPH SIN, V45, P503, DOI 10.1093/abbs/gmt026; Zhang T, 2013, J PHYS CHEM B, V117, P3993, DOI 10.1021/jp312573y; Zhang YS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029519, 10.1371/journal.pone.0038191]; Zhao J, 2012, BBA-BIOMEMBRANES, V1818, P3121, DOI 10.1016/j.bbamem.2012.08.012; Zhao J, 2011, BIOMACROMOLECULES, V12, P1781, DOI 10.1021/bm2001507; Zhao J, 2011, BIOMACROMOLECULES, V12, P210, DOI 10.1021/bm101159p; Zhao LN, 2012, J PHYS CHEM B, V116, P7428, DOI 10.1021/jp3034209	74	29	30	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94796	10.1371/journal.pone.0094796	http://dx.doi.org/10.1371/journal.pone.0094796			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739876	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900067
J	Wei, XQ; Ke, BL; Zhao, ZY; Ye, X; Gao, ZG; Ye, JP				Wei, Xiuqing; Ke, Bilun; Zhao, Zhiyun; Ye, Xin; Gao, Zhanguo; Ye, Jianping			Regulation of Insulin Degrading Enzyme Activity by Obesity-Associated Factors and Pioglitazone in Liver of Diet-Induced Obese Mice	PLOS ONE			English	Article							MULTIPLE SERINE KINASES; NF-KAPPA-B; PPAR-GAMMA; CAFETERIA DIET; FATTY-ACIDS; TNF-ALPHA; INHIBITION; CLEARANCE; RESISTANCE; HYPERINSULINEMIA	Insulin degrading enzyme (IDE) is a potential drug target in the treatment of type 2 diabetes (T2D). IDE controls circulating insulin through a degradation-dependent clearance mechanism in multiple tissues. However, there is not sufficient information about IDE regulation in obesity. In this study, we test obesity-associated factors and pioglitazone in the regulation of IDE in diet-induced obese (DIO) C57BL/6 mice. The enzyme activity and protein level of IDE were increased in the liver of DIO mice. Pioglitazone (10 mg/kg/day) administration for 2 months significantly enhanced the enzyme activity (75%), protein (180%) and mRNA (100%) of IDE in DIO mice. The pioglitazone-induced changes were coupled with 50% reduction in fasting insulin and 20% reduction in fasting blood glucose. The mechanism of IDE regulation in liver was investigated in the mouse hepatoma cell line (Hepa 1c1c7 cells), in which pioglitazone (5 mu M) increased IDE protein and mRNA in a time-dependent manner in an 8 h study. Free fatty acid (palmitate 300 mM) induced IDE protein, but reduced the mRNA. Glucagon induced, and TNF-alpha decreased IDE protein. Insulin did not exhibit any activity in the same condition. In summary, pioglitazone, FFA and glucagon directly increased, but TNF-alpha decreased the IDE activity in hepatocytes. The results suggest that IDE activity is regulated in liver by multiple factors in obesity and pioglitazone may induce IDE activity in the control of T2D.	[Wei, Xiuqing; Ke, Bilun] Sun Yet Sen Univ, Affiliated Hosp 3, Dept Digest Dis, Guangzhou, Guangdong, Peoples R China; [Wei, Xiuqing; Ke, Bilun; Zhao, Zhiyun; Ye, Xin; Gao, Zhanguo; Ye, Jianping] Louisiana State Univ Syst, Antioxidant & Gene Regulat Lab, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA	Sun Yat Sen University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Ye, JP (corresponding author), Louisiana State Univ Syst, Antioxidant & Gene Regulat Lab, Pennington Biomed Res Ctr, Baton Rouge, LA 70803 USA.	yej@pbrc.edu	Ye, Jianping/N-1998-2017	Ye, Jianping/0000-0003-3875-365X	National Institutes of Health [DK068036, DK085495]; National Opinion Research Center [NIH 2P30DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068036, P30DK072476, R56DK068036, R01DK085495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Opinion Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant (DK068036 and DK085495) to JY, and National Opinion Research Center (NIH 2P30DK072476) center grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Hay SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020818; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Brandimarti P, 2013, J ENDOCRINOL, V219, P173, DOI 10.1530/JOE-13-0177; Castell-Auvi A, 2012, BRIT J NUTR, V108, P1155, DOI 10.1017/S0007114511006623; Cordes CM, 2009, BIOCHEM PHARMACOL, V77, P1064, DOI 10.1016/j.bcp.2008.12.006; Corkey BE, 2012, DIABETES, V61, P4, DOI 10.2337/db11-1483; Du J, 2009, BIOCHEM BIOPH RES CO, V383, P485, DOI 10.1016/j.bbrc.2009.04.047; DUCKWORTH WC, 1994, J BIOL CHEM, V269, P24575; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Erdmann J, 2009, REGUL PEPTIDES, V152, P1, DOI 10.1016/j.regpep.2008.10.008; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Grasso G, 2008, BBA-PROTEINS PROTEOM, V1784, P1122, DOI 10.1016/j.bbapap.2008.04.011; Grasso G, 2011, CHEM-EUR J, V17, P2752, DOI 10.1002/chem.201002809; Hamel FG, 2003, ENDOCRINOLOGY, V144, P2404, DOI 10.1210/en.2002-0007; Hulse RE, 2009, VITAM HORM, V80, P635, DOI 10.1016/S0083-6729(08)00622-5; Leal MC, 2012, BBA-MOL CELL RES, V1823, P227, DOI 10.1016/j.bbamcr.2011.09.014; Lee YH, 2004, ARCH PHARM RES, V27, P361, DOI 10.1007/BF02980074; Marlowe L, 2006, NEURODEGENER DIS, V3, P320, DOI 10.1159/000097300; Mora MEV, 2003, J AM COLL NUTR, V22, P487, DOI 10.1080/07315724.2003.10719326; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Osei K, 2007, METABOLISM, V56, P24, DOI 10.1016/j.metabol.2006.08.018; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Pivovarova O, 2009, DIABETOLOGIA, V52, P1656, DOI 10.1007/s00125-009-1350-7; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sheng L, 2012, NAT MED, V18, P943, DOI 10.1038/nm.2756; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song ES, 2003, J BIOL CHEM, V278, P49789, DOI 10.1074/jbc.M308983200; SVEDBERG J, 1990, DIABETES, V39, P570, DOI 10.2337/diabetes.39.5.570; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068; Ye Jianping, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P65; Ye JP, 2013, FRONT MED-PRC, V7, P14, DOI 10.1007/s11684-013-0262-6; Ye JP, 2013, AM J PHYSIOL-ENDOC M, V304, pE466, DOI 10.1152/ajpendo.00266.2012; Zhang J, 2008, J BIOL CHEM, V283, P35375, DOI 10.1074/jbc.M806480200; Zhang L, 2012, EVID-BASED COMPL ALT, V2012, P1, DOI 10.1155/2012/678107; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	42	45	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95399	10.1371/journal.pone.0095399	http://dx.doi.org/10.1371/journal.pone.0095399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740421	Green Submitted, gold, Green Published			2022-12-25	WOS:000336863900140
J	Xiang, Y; Zhou, XY; Tan, YR; Tan, ML; Liu, HJ; Liu, C; Qu, XP; Qin, XQ				Xiang, Yang; Zhou, Xiao-Yan; Tan, Yu-Rong; Tan, Mei-Ling; Liu, Hui-Jun; Liu, Chi; Qu, Xiang-Ping; Qin, Xiao-Qun			Analysis on the Relevance of Asthma Susceptibility with the Alteration of Integrin beta 4 Expression	PLOS ONE			English	Article							AIRWAY EPITHELIAL-CELLS; CYTOPLASMIC DOMAIN; ENDOTHELIAL-CELLS; ADHESION; GENE; HYPERRESPONSIVENESS; HEMIDESMOSOMES; MIGRATION; MICE	Accumulated research has suggested the importance of the adhesion molecules modulation as therapeutic approach for bronchial asthma. Adhesion molecules expression alteration contributes to the pathogenesis of asthma. In order to probe the roles of expression imbalance of adhesion molecules in asthma pathogenesis, expression profiling of adhesion molecules was performed using cDNA microarray assay. The results showed that the expression pattern of adhesion molecules was altered in peripheral blood leucocytes of asthma patients. In this study, we focused on one of the abnormally expressed molecule, integrin beta 4, which was down-regulated in all asthma patients, to analyze the relevance of asthma susceptibility with the alteration of integrin beta 4 expressions. Real time PCR was used to verify the down-regulation of integrin beta 4 in additional 38 asthma patients. Next, the 5'flanking region of integrin beta 4 DNA were amplified, sequenced and site-directed mutagenesis technology in correspondent variation sites were carried out. Among 4 variation sites found in 5' flanking region of integrin beta 4, 3 were related to asthma susceptibility: -nt1029 G/A, -nt 1051 G/A, and -nt 1164 G/C. A reduction of human integrin beta 4 promoter activity was observed at mutants of these sites. This study demonstrates that various adhesion molecules in asthma patients are abnormally expressed. Mutations in 59 flanking region result in reduced integrin beta 4 expression, which is related to increased risk of asthma.	[Xiang, Yang; Zhou, Xiao-Yan; Tan, Yu-Rong; Tan, Mei-Ling; Liu, Hui-Jun; Liu, Chi; Qu, Xiang-Ping; Qin, Xiao-Qun] Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha, Hunan, Peoples R China	Central South University	Qin, XQ (corresponding author), Cent S Univ, Xiangya Sch Med, Dept Physiol, Changsha, Hunan, Peoples R China.	qinxiaoqun@mail.csu.edu.cn			National Natural Science Foundation of China [81270065, 81170024, 31100553]; National Basic Research Program of China(973 Program) [2012CB518104]; open fund of Hunan College Innovation Program [12K003]; Hunan Natural Science Foundation [13JJ4030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(973 Program)(National Basic Research Program of China); open fund of Hunan College Innovation Program; Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province)	This work was supported by grants #81270065, #81170024, and #31100553 from National Natural Science Foundation of China, grant #2012CB518104 of National Basic Research Program of China(973 Program), grant #12K003 from the open fund of Hunan College Innovation Program, and grant #13JJ4030 from Hunan Natural Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broide DH, 1998, AM J RESP CELL MOL, V18, P218, DOI 10.1165/ajrcmb.18.2.2829; Chen WG, 2010, J CELL BIOCHEM, V110, P718, DOI 10.1002/jcb.22582; Chinese Society of Respiratory Diseases AG, 2008, CHIN J TUBERC RESP D, V31, P171; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Faiz Alen, 2012, J Allergy (Cairo), V2012, P241314, DOI 10.1155/2012/241314; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Hansel Nadia N, 2007, Proc Am Thorac Soc, V4, P32, DOI 10.1513/pats.200606-132JG; Iacovacci S, 1997, MAMM GENOME, V8, P448, DOI 10.1007/s003359900467; Johansson Mats W, 2013, Front Pharmacol, V4, P33, DOI 10.3389/fphar.2013.00033; Johansson MW, 2013, AM J RESP CELL MOL, V48, P503, DOI 10.1165/rcmb.2012-0150OC; Joly D, 2003, AM J PATHOL, V163, P1791, DOI 10.1016/S0002-9440(10)63539-0; Jones J, 1996, CELL ADHES COMMUN, V4, P307, DOI 10.3109/15419069609010774; Lafferriere J, 2004, CLIN EXP METASTAS, V21, P257, DOI 10.1023/B:CLIN.0000037708.09420.9a; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Liu C., 2012, PLOS ONE, V7, DOI DOI 10.1371/journal.pone.0032060; Liu C, 2010, ACTA BIOCH BIOPH SIN, V42, P538, DOI 10.1093/abbs/gmq058; Liu C, 2010, MOL CELL BIOCHEM, V341, P259, DOI 10.1007/s11010-010-0457-y; Liu C, 2010, BIOCHEM BIOPH RES CO, V397, P290, DOI 10.1016/j.bbrc.2010.05.102; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; Mercurio AM, 2001, CURR OPIN CELL BIOL, V13, P541, DOI 10.1016/S0955-0674(00)00249-0; Miao JY, 1997, BIOCHEM BIOPH RES CO, V233, P182, DOI 10.1006/bbrc.1997.6422; Milner JD, 2005, CURR OPIN ALLERGY CL, V5, P235, DOI 10.1097/01.all.0000168787.59335.8a; Murgia C, 1998, EMBO J, V17, P3940, DOI 10.1093/emboj/17.14.3940; Nikolopoulos SN, 2004, CANCER CELL, V6, P471, DOI 10.1016/j.ccr.2004.09.029; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Qin Xiao-Qun, 2007, Shengli Xuebao, V59, P454; Takaoka AS, 1998, J BIOL CHEM, V273, P33848, DOI 10.1074/jbc.273.50.33848; Wang L, 2012, J CELL PHYSIOL, V227, P474, DOI 10.1002/jcp.22769; Woodruff PG, 2007, P NATL ACAD SCI USA, V104, P15858, DOI 10.1073/pnas.0707413104; Xiang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031158; Ying S, 2006, CELL MOL IMMUNOL, V3, P321	32	9	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95533	10.1371/journal.pone.0095533	http://dx.doi.org/10.1371/journal.pone.0095533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740264	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900152
J	Chang, HW; Chieh, HF; Lin, CJ; Su, FC; Tsai, MJ				Chang, Hsun-Wen; Chieh, Hsiao-Feng; Lin, Chien-Ju; Su, Fong-Chin; Tsai, Ming-June			The Relationships between Foot Arch Volumes and Dynamic Plantar Pressure during Midstance of Walking in Preschool Children	PLOS ONE			English	Article							NONOBESE ADULTS; PATTERNS; POSTURE; SPEED; OBESE	Objectives: The purpose of this study was to examine the correlation between the foot arch volume measured from static positions and the plantar pressure distribution during walking. Methods: A total of 27 children, two to six years of age, were included in this study. Measurements of static foot posture were obtained, including navicular height and foot arch volume in sitting and standing positions. Plantar pressure, force and contact areas under ten different regions of the foot were obtained during walking. Results: The foot arch index was correlated (r = 0.32) with the pressure difference under the midfoot during the foot flat phase. The navicular heights and foot arch volumes in sitting and standing positions were correlated with the mean forces and pressures under the first (r = -0.296 similar to-0.355) and second metatarsals (r = -0.335 similar to-0.504) and midfoot (r = -0.331 similar to-0.496) during the stance phase of walking. The contact areas under the foot were correlated with the foot arch parameters, except for the area under the midfoot. Conclusions: The foot arch index measured in a static position could be a functional index to predict the dynamic foot functions when walking. The foot arch is a factor which will influence the pressure distribution under the foot. Children with a lower foot arch demonstrated higher mean pressure and force under the medial forefoot and midfoot, and lower contact areas under the foot, except for the midfoot region. Therefore, children with flatfoot may shift their body weight to a more medial foot position when walking, and could be at a higher risk of soft tissue injury in this area.	[Chang, Hsun-Wen; Chieh, Hsiao-Feng; Lin, Chien-Ju; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Chang, Hsun-Wen] Fooyin Univ, Dept Phys Therapy, Kaohsiung, Taiwan; [Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan 70101, Taiwan; [Tsai, Ming-June] Natl Cheng Kung Univ, Dept Mech Engn, Tainan 70101, Taiwan	National Cheng Kung University; Fooyin University; National Cheng Kung University; National Cheng Kung University	Su, FC (corresponding author), Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan.	fcsu@mail.ncku.edu.tw	SU, FONG-CHIN/C-8094-2011; Lin, Chien-Ju/AAP-5725-2020; Chieh, Hsiao-Feng/AAP-5236-2020	SU, FONG-CHIN/0000-0002-3870-4842; Lin, Chien-Ju/0000-0001-9571-8610; Chieh, Hsiao-Feng/0000-0001-8844-8026	Fooyin University	Fooyin University	The funding is supported by Fooyin University. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. http://web.fy.edu.tw/bin/home.php	Birtane M, 2004, CLIN BIOMECH, V19, P1055, DOI 10.1016/j.clinbiomech.2004.07.008; Burnfield JM, 2004, CLIN BIOMECH, V19, P78, DOI 10.1016/j.clinbiomech.2003.09.007; Burns J, 2005, CLIN BIOMECH, V20, P877, DOI 10.1016/j.clinbiomech.2005.03.006; Cashmere T, 1999, FOOT ANKLE INT, V20, P112, DOI 10.1177/107110079902000208; Cavanagh PR, 1997, J BIOMECH, V30, P243, DOI 10.1016/S0021-9290(96)00136-4; Chang HW, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-76; Chang YW., 2010, INT J SPORT EXERC SC, V2, P35; Chuckpaiwong B, 2008, GAIT POSTURE, V28, P405, DOI 10.1016/j.gaitpost.2008.01.012; D'Amico J C, 1984, Clin Podiatry, V1, P535; Franettovich MM, 2007, J AM PODIAT MED ASSN, V97, P115, DOI 10.7547/0970115; HENNIG EM, 1994, FOOT ANKLE, V15, P35, DOI 10.1177/107110079401500107; Hills AP, 2001, INT J OBESITY, V25, P1674, DOI 10.1038/sj.ijo.0801785; Jonely H, 2011, CLIN BIOMECH, V26, P873, DOI 10.1016/j.clinbiomech.2011.04.008; Ledoux WR, 2002, GAIT POSTURE, V15, P1, DOI 10.1016/S0966-6362(01)00165-5; Lin CJ, 2001, J PEDIATR ORTHOPED, V21, P378, DOI 10.1097/00004694-200105000-00022; Mentiplay BF, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-14; Menz HB, 2006, GAIT POSTURE, V24, P229, DOI 10.1016/j.gaitpost.2005.09.002; Milton JS, 1996, INTRO STAT, P478; Morag E, 1999, J BIOMECH, V32, P359, DOI 10.1016/S0021-9290(98)00188-2; Pataky TC, 2008, J BIOMECH, V41, P1987, DOI 10.1016/j.jbiomech.2008.03.034; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; Queen RM, 2009, GAIT POSTURE, V29, P582, DOI 10.1016/j.gaitpost.2008.12.010; Razeghi M, 2002, GAIT POSTURE, V15, P282, DOI 10.1016/S0966-6362(01)00151-5; Rosenbaum D., 1994, GAIT POSTURE, V2, P191, DOI DOI 10.1016/0966-6362(94)90007-8); Teyhen DS, 2009, CLIN BIOMECH, V24, P391, DOI 10.1016/j.clinbiomech.2009.01.006; Tsung BYS, 2003, J REHABIL RES DEV, V40, P517, DOI 10.1682/JRRD.2003.11.0517; Williams DS, 2001, CLIN BIOMECH, V16, P341, DOI 10.1016/S0268-0033(01)00005-5; Witana CP, 2006, INT J IND ERGONOM, V36, P789, DOI 10.1016/j.ergon.2006.06.004; [No title captured]	29	16	16	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94535	10.1371/journal.pone.0094535	http://dx.doi.org/10.1371/journal.pone.0094535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736650	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600072
J	Jonathan, WK; Sun, JP; Li, M; Pratico, ED; Fereshteh, MP; Ahrens, DP; Sullenger, BA; Kovacs, JJ				Kotula, Jonathan W.; Sun, Jinpeng; Li, Margie; Pratico, Elizabeth D.; Fereshteh, Mark P.; Ahrens, Douglas P.; Sullenger, Bruce A.; Kovacs, Jeffrey J.			Targeted Disruption of beta-Arrestin 2-Mediated Signaling Pathways by Aptamer Chimeras Leads to Inhibition of Leukemic Cell Growth	PLOS ONE			English	Article							STEM-CELLS; RECEPTOR; BETA-ARRESTIN-2; ENDOCYTOSIS; ACTIVATION; EXPRESSION; DELIVERY	beta-arrestins, ubiquitous cellular scaffolding proteins that act as signaling mediators of numerous critical cellular pathways, are attractive therapeutic targets because they promote tumorigenesis in several tumor models. However, targeting scaffolding proteins with traditional small molecule drugs has been challenging. Inhibition of beta-arrestin 2 with a novel aptamer impedes multiple oncogenic signaling pathways simultaneously. Additionally, delivery of the beta-arrestin 2-targeting aptamer into leukemia cells through coupling to a recently described cancer cell-specific delivery aptamer, inhibits multiple beta-arrestin-mediated signaling pathways known to be required for chronic myelogenous leukemia (CML) disease progression, and impairs tumorigenic growth in CML patient samples. The ability to target scaffolding proteins such as beta-arrestin 2 with RNA aptamers may prove beneficial as a therapeutic strategy. Highlights: An RNA aptamer inhibits beta-arrestin 2 activity. Inhibiting beta-arrestin 2 impedes multiple tumorigenic pathways simultaneously. The therapeutic aptamer is delivered to cancer cells using a cell-specific DNA aptamer. Targeting beta-arrestin 2 inhibits tumor progression in CML models and patient samples.	[Kotula, Jonathan W.; Pratico, Elizabeth D.; Sullenger, Bruce A.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Kotula, Jonathan W.; Pratico, Elizabeth D.; Sullenger, Bruce A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Sun, Jinpeng; Li, Margie; Fereshteh, Mark P.; Kovacs, Jeffrey J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Sun, Jinpeng; Li, Margie; Fereshteh, Mark P.; Kovacs, Jeffrey J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Ahrens, Douglas P.; Kovacs, Jeffrey J.] B3 Bio Inc, Res Triangle Pk, NC USA	Duke University; Duke University; Duke University; Duke University	Kovacs, JJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	jeff.kovacs@duke.edu	sun, Jinpeng/AAR-9196-2020		NIH [4R01-CA129190, HL16037, HL70631]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH grants 4R01-CA129190, HL16037, and HL70631. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Chen W, 2003, SCIENCE, V301, P1394, DOI 10.1126/science.1083195; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chu TC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl388; Chu TC, 2006, CANCER RES, V66, P5989, DOI 10.1158/0008-5472.CAN-05-4583; Dasgupta P, 2011, JNCI-J NATL CANCER I, V103, P317, DOI 10.1093/jnci/djq541; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Fereshteh M, 2012, P NATL ACAD SCI US; Gold L, 1995, Harvey Lect, V91, P47; Grcevic D, 2003, LEUKEMIA RES, V27, P731, DOI 10.1016/S0145-2126(02)00281-3; Handa H, 1997, LEUKEMIA RES, V21, P479, DOI 10.1016/S0145-2126(97)00006-4; Hunton DL, 2005, MOL PHARMACOL, V67, P1229, DOI 10.1124/mol.104.006270; Kanwar JR, 2011, CRIT REV BIOCHEM MOL, V46, P459, DOI 10.3109/10409238.2011.614592; Karasawa M, 1996, LEUKEMIA RES, V20, P85, DOI 10.1016/0145-2126(95)00125-5; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Khan NI, 2007, BRIT J HAEMATOL, V138, P338, DOI 10.1111/j.1365-2141.2007.06667.x; Kotula JW, 2012, NUCLEIC ACID THER, V22, P187, DOI 10.1089/nat.2012.0347; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Long B, 2011, J EXP CLIN CANC RES, V16, P30; Lovgren AK, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001564; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Pastor F, 2011, MOL THER, V19, P1878, DOI 10.1038/mt.2011.145; Que-Gewirth NS, 2007, GENE THER, V14, P283, DOI 10.1038/sj.gt.3302900; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Walker JKL, 2003, J CLIN INVEST, V112, P566, DOI 10.1172/JCI200317265; Xiao KH, 2004, J BIOL CHEM, V279, P55744, DOI 10.1074/jbc.M409785200; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Zhang J, 1997, RECEPTOR CHANNEL, V5, P193; Zhang ZQ, 2013, BIOMATERIALS, V34, P9728, DOI 10.1016/j.biomaterials.2013.08.079; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	41	30	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93441	10.1371/journal.pone.0093441	http://dx.doi.org/10.1371/journal.pone.0093441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736311	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600019
J	Onat, S; Acik, A; Schumann, F; Konig, P				Onat, Selim; Acik, Alper; Schumann, Frank; Koenig, Peter			The Contributions of Image Content and Behavioral Relevancy to Overt Attention	PLOS ONE			English	Article							EYE-MOVEMENTS; LUMINANCE-CONTRAST; VISUAL-ATTENTION; FREE EXPLORATION; SALIENCY MAP; GAZE; FEATURES; OBJECT; GUIDANCE; INFORMATION	During free-viewing of natural scenes, eye movements are guided by bottom-up factors inherent to the stimulus, as well as top-down factors inherent to the observer. The question of how these two different sources of information interact and contribute to fixation behavior has recently received a lot of attention. Here, a battery of 15 visual stimulus features was used to quantify the contribution of stimulus properties during free-viewing of 4 different categories of images (Natural, Urban, Fractal and Pink Noise). Behaviorally relevant information was estimated in the form of topographical interestingness maps by asking an independent set of subjects to click at image regions that they subjectively found most interesting. Using a Bayesian scheme, we computed saliency functions that described the probability of a given feature to be fixated. In the case of stimulus features, the precise shape of the saliency functions was strongly dependent upon image category and overall the saliency associated with these features was generally weak. When testing multiple features jointly, a linear additive integration model of individual saliencies performed satisfactorily. We found that the saliency associated with interesting locations was much higher than any low-level image feature and any pair-wise combination thereof. Furthermore, the low-level image features were found to be maximally salient at those locations that had already high interestingness ratings. Temporal analysis showed that regions with high interestingness ratings were fixated as early as the third fixation following stimulus onset. Paralleling these findings, fixation durations were found to be dependent mainly on interestingness ratings and to a lesser extent on the low-level image features. Our results suggest that both low-and high-level sources of information play a significant role during exploration of complex scenes with behaviorally relevant information being more effective compared to stimulus features.	[Onat, Selim; Acik, Alper; Schumann, Frank; Koenig, Peter] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany	University Osnabruck	Onat, S (corresponding author), Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany.	sonat@uos.de	Açık, Alper/AAH-2965-2020; König, Peter/ABB-2380-2020	König, Peter/0000-0003-3654-5267; Onat, Selim/0000-0002-4782-5603; Schumann, Frank/0000-0001-9262-4539; Acik, Alper/0000-0002-9706-4662	ERC-AdG [269716-MULTISENSE];  [FP7-ICT-270212 eSMCs]	ERC-AdG; 	This work was funded by FP7-ICT-270212 eSMCs and ERC-2010-AdG #269716-MULTISENSE grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acik A, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00207; Acik A, 2009, VISION RES, V49, P1541, DOI 10.1016/j.visres.2009.03.011; Althaus N, 2012, CHILD DEV, V83, P1122, DOI 10.1111/j.1467-8624.2012.01766.x; ANTES JR, 1974, J EXP PSYCHOL, V103, P62, DOI 10.1037/h0036799; Baddeley RJ, 2006, VISION RES, V46, P2824, DOI 10.1016/j.visres.2006.02.024; Berg DJ, 2009, J VISION, V9, DOI 10.1167/9.5.19; Betz T, 2010, J VISION, V10, DOI 10.1167/10.3.15; BIEDERMAN I, 1974, J EXP PSYCHOL, V103, P597, DOI 10.1037/h0037158; Borji A, 2014, IEEE T SYST MAN CY-S, V44, P523, DOI 10.1109/TSMC.2013.2279715; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Cerf M, 2009, J VISION, V9, DOI 10.1167/9.12.10; DERRINGTON AM, 1984, J PHYSIOL-LONDON, V357, P241, DOI 10.1113/jphysiol.1984.sp015499; Dorr M, 2012, VIS COGN, V20, P495, DOI 10.1080/13506285.2012.667456; Dorr M, 2010, J VISION, V10, DOI 10.1167/10.10.28; Driver J, 1998, CURR OPIN NEUROBIOL, V8, P245, DOI 10.1016/S0959-4388(98)80147-5; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Einhauser W, 2003, EUR J NEUROSCI, V17, P1089, DOI 10.1046/j.1460-9568.2003.02508.x; Elazary L, 2008, J VISION, V8, DOI 10.1167/8.3.3; Engmann S, 2009, ATTEN PERCEPT PSYCHO, V71, P1337, DOI 10.3758/APP.71.6.1337; Frey HP, 2007, PERCEPT PSYCHOPHYS, V69, P153, DOI 10.3758/BF03193738; Frey HP, 2008, J VISION, V8, DOI 10.1167/8.14.6; Gautier J, 2012, COGN COMPUT, V4, P141, DOI 10.1007/s12559-012-9138-3; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Itti L., 2007, SCHOLARPEDIA, V2, P3327, DOI [10.4249/scholarpedia.3327, DOI 10.4249/SCHOLARPEDIA.3327, DOI 10.4249/SCH0LARPEDIA.3327]; Jansen L, 2009, J VISION, V9, DOI 10.1167/9.1.29; Joost van de Weijer TG, 2004, TENSOR BASED FEATURE, P100; Jordan MI, 1998, ADV NEURAL INFORM PR; Kaspar K, 2011, J VISION, V11, DOI 10.1167/11.13.26; Kaspar K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021719; Kienzle W, 2009, J VISION, V9, DOI 10.1167/9.5.7; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Kollmorgen S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000791; Kootstra G, 2011, COGN COMPUT, V3, P223, DOI 10.1007/s12559-010-9089-5; Kovesi P., 2003, AUSTR PATT REC SOC C; Kovesi P, 1997, 10 AUST JT C ART INT; Le Meur O, 2006, IEEE T PATTERN ANAL, V28, P802, DOI 10.1109/TPAMI.2006.86; Leek EC, 2012, NEUROPSYCHOLOGIA, V50, P2142, DOI 10.1016/j.neuropsychologia.2012.05.005; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; LOFTUS GR, 1978, J EXP PSYCHOL HUMAN, V4, P565, DOI 10.1037/0096-1523.4.4.565; Mackay M, 2012, J VISION, V12, DOI 10.1167/12.4.9; Marat S, 2012, VIS COGN, V20, P580, DOI 10.1080/13506285.2012.667007; Masciocchi CM, 2009, J VISION, V9, DOI 10.1167/9.11.25; Mota C, 2005, SIGNAL PROCESS-IMAGE, V20, P529, DOI 10.1016/j.image.2005.03.008; Naber M, 2011, J VISION, V11, DOI 10.1167/11.4.8; Nothdurft HC, 2000, VISION RES, V40, P1183, DOI 10.1016/S0042-6989(00)00031-6; Oliva A, 2007, TRENDS COGN SCI, V11, P520, DOI 10.1016/j.tics.2007.09.009; Onat S, 2007, J VISION, V7, DOI 10.1167/7.10.11; Ossandon JP, 2012, NEUROPSYCHOLOGIA, V50, P3478, DOI 10.1016/j.neuropsychologia.2012.09.043; Parikh N, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016006; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Parkhurst DJ, 2004, EUR J NEUROSCI, V19, P783, DOI 10.1111/j.0953-816X.2003.03183.x; Parkhurst DJ, 2003, SPATIAL VISION, V16, P125, DOI 10.1163/15685680360511645; Reinagel P, 1999, NETWORK-COMP NEURAL, V10, P341, DOI 10.1088/0954-898X/10/4/304; Renninger Laura Walker, 2005, Adv Neural Inf Process Syst, V17, P1121; Saal H, 2006, IEEE ADV CYBERN SYST; Schutz AC, 2011, J VISION, V11, DOI 10.1167/11.5.9; Schumann F, 2008, J VISION, V8, DOI 10.1167/8.14.12; Stirk JA, 2007, J VISION, V7, DOI 10.1167/7.10.3; 't Hart BM, 2009, VIS COGN, V17, P1132, DOI 10.1080/13506280902812304; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Theeuwes J, 2012, VISION RES, V74, P80, DOI 10.1016/j.visres.2012.07.024; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe SJ, 2001, EUR J NEUROSCI, V14, P869, DOI 10.1046/j.0953-816x.2001.01717.x; Torralba A, 2003, J OPT SOC AM A, V20, P1407, DOI 10.1364/JOSAA.20.001407; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Underwood G, 2006, Q J EXP PSYCHOL, V59, P1931, DOI 10.1080/17470210500416342; Wang HX, 2012, J VISION, V12, DOI [10.1167/12.1.16, 10.1167/12.6.26]; Wilming N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002871; Wilming N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024038; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Yoshida M, 2012, CURR BIOL, V22, P1429, DOI 10.1016/j.cub.2012.05.046; Zhao Q, 2012, J VISION, V12, DOI 10.1167/12.6.22; Zhao Q, 2011, J VISION, V11, DOI 10.1167/11.3.9; Zhaoping L, 2008, J VISION, V8, DOI 10.1167/8.5.1	79	26	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93254	10.1371/journal.pone.0093254	http://dx.doi.org/10.1371/journal.pone.0093254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5PW	24736751	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600017
J	Li, Z; Gherasim, C; Lesniak, NA; Banerjee, R				Li, Zhu; Gherasim, Carmen; Lesniak, Nicholas A.; Banerjee, Ruma			Glutathione-dependent One-electron Transfer Reactions Catalyzed by a B-12 Trafficking Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN METHIONINE SYNTHASE; REDUCED GLUTATHIONE; VITAMIN-B-12; MUTATIONS; MMACHC; DOMAIN; IDENTIFICATION; CHAPERONE; REDUCTASE; BINDING	CblC is involved in an early step in cytoplasmic cobalamin processing following entry of the cofactor into the cytoplasm. CblC converts the cobalamin cargo arriving from the lysosome to a common cob(II) alamin intermediate, which can be subsequently converted to the biologically active forms. Human CblC exhibits glutathione (GSH)-dependent alkyltransferase activity and flavin-dependent reductive decyanation activity with cyanocobalamin (CNCbl). In this study, we discovered two new GSH-dependent activities associated with the Caenorhabditis elegans CblC for generating cob(II) alamin: decyanation of CNCbl and reduction of aquocobalamin (OH(2)Cbl). We subsequently found that human CblC also catalyzes GSH-dependent decyanation of CNCbl and reduction of OH(2)Cbl, albeit efficiently only under anaerobic conditions. The air sensitivity of the human enzyme suggests interception by oxygen during the single-electron transfer step from GSH to CNCbl. These newly discovered GSH-dependent single-electron transfer reactions expand the repertoire of catalytic activities supported by CblC, a versatile B-12-processing enzyme.	[Li, Zhu; Gherasim, Carmen; Lesniak, Nicholas A.; Banerjee, Ruma] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, 4220C MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu		Li, Zhu/0000-0003-1536-9401; Lesniak, Nicholas/0000-0001-9359-5194	National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045776, R29DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776 (to R. B.).	Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Banerjee R, 2006, ACS CHEM BIOL, V1, P149, DOI 10.1021/cb6001174; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BANERJEE RV, 1990, FASEB J, V4, P1450, DOI 10.1096/fasebj.4.5.2407589; Chen HP, 1997, BIOCHEMISTRY-US, V36, P14939, DOI 10.1021/bi971374g; Coelho D, 2012, NAT GENET, V44, P1152, DOI 10.1038/ng.2386; Deme JC, 2012, MOL GENET METAB, V107, P352, DOI 10.1016/j.ymgme.2012.07.001; Froese DS, 2012, BIOCHEMISTRY-US, V51, P5083, DOI 10.1021/bi300150y; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Gherasim C, 2013, BIOCHIMIE, V95, P1023, DOI 10.1016/j.biochi.2013.02.003; Gherasim CG, 2008, BIOCHEMISTRY-US, V47, P12515, DOI 10.1021/bi8008328; Gulati S, 1996, HUM MOL GENET, V5, P1859, DOI 10.1093/hmg/5.12.1859; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Hannibal L, 2008, CLIN CHEM LAB MED, V46, P1739, DOI 10.1515/CCLM.2008.356; HARMAN LS, 1986, J BIOL CHEM, V261, P1642; HOFFMAN MZ, 1973, J PHYS CHEM-US, V77, P990, DOI 10.1021/j100627a005; Jeong J, 2011, BIOCHEM BIOPH RES CO, V412, P360, DOI 10.1016/j.bbrc.2011.07.103; Jeong J, 2011, BMB REP, V44, P170, DOI 10.5483/BMBRep.2011.44.3.170; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Koutmos M, 2011, J BIOL CHEM, V286, P29780, DOI 10.1074/jbc.M111.261370; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; LEDLEY FD, 1988, AM J HUM GENET, V42, P839; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; LEXA D, 1980, J AM CHEM SOC, V102, P2654, DOI 10.1021/ja00528a023; Mc Guire PJ, 2009, MOL GENET METAB, V98, P173, DOI 10.1016/j.ymgme.2009.06.007; Mosharov E, 2000, BIOCHEMISTRY-US, V39, P13005, DOI 10.1021/bi001088w; NAKAMURA M, 1986, J BIOL CHEM, V261, P13923; Richard E, 2009, HUM MUTAT, V30, P1558, DOI 10.1002/humu.21107; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; Vitvitsky V, 2004, AM J PHYSIOL-REG I, V287, pR39, DOI 10.1152/ajpregu.00036.2004; Yamada K, 2006, P NATL ACAD SCI USA, V103, P9476, DOI 10.1073/pnas.0603694103; Yu HC, 2013, AM J HUM GENET, V93, P506, DOI 10.1016/j.ajhg.2013.07.022; Zheng DH, 1997, J ELECTROANAL CHEM, V429, P61, DOI 10.1016/S0022-0728(96)05021-8	33	27	28	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16487	16497		10.1074/jbc.M114.567339	http://dx.doi.org/10.1074/jbc.M114.567339			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742678	hybrid, Green Published			2022-12-25	WOS:000337965700050
J	Figaj, D; Gieldon, A; Polit, A; Sobiecka-Szkatula, A; Koper, T; Denkiewicz, M; Banecki, B; Lesner, A; Ciarkowski, J; Lipinska, B; Skorko-Glonek, J				Figaj, Donata; Gieldon, Artur; Polit, Agnieszka; Sobiecka-Szkatula, Anna; Koper, Tomasz; Denkiewicz, Milena; Banecki, Bogdan; Lesner, Adam; Ciarkowski, Jerzy; Lipinska, Barbara; Skorko-Glonek, Joanna			The LA Loop as an Important Regulatory Element of the HtrA (DegP) Protease from Escherichia coli STRUCTURAL AND FUNCTIONAL STUDIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mutation; Fluorescence; Molecular Biology; Molecular Modeling; Protein Structure; Serine Protease	LOW-RESOLUTION MODELS; PROTEOLYTIC ACTIVITY; MOLECULAR-DYNAMICS; SUBSTRATE-SPECIFICITY; REPLICA EXCHANGE; SERINE-PROTEASE; E-CADHERIN; CHAPERONE; PROTEINS; SURVIVAL	Bacterial HtrAs are serine proteases engaged in extracytoplasmic protein quality control and are required for the virulence of several pathogenic species. The proteolytic activity of HtrA (DegP) from Escherichia coli, a model prokaryotic HtrA, is stimulated by stressful conditions; the regulation of this process is mediated by the LA, LD, L1, L2, and L3 loops. The precise mechanism of action of the LA loop is not known due to a lack of data concerning its three-dimensional structure as well as its mode of interaction with other regulatory elements. To address these issues we generated a theoretical model of the three-dimensional structure of the LA loop as per the resting state of HtrA and subsequently verified its correctness experimentally. We identified intra- and intersubunit contacts that formed with the LA loops; these played an important role in maintaining HtrA in its inactive conformation. The most significant proved to be the hydrophobic interactions connecting the LA loops of the hexamer and polar contacts between the LA (the LA loop on an opposite subunit) and L1 loops on opposite subunits. Disturbance of these interactions caused the stimulation of HtrA proteolytic activity. We also demonstrated that LA loops contribute to the preservation of the integrity of the HtrA oligomer and to the stability of the monomer. The model presented in this work explains the regulatory role of the LA loop well; it should also be applicable to numerous Enterobacteriaceae pathogenic species as the amino acid sequences of the members of this bacterial family are highly conserved.	[Figaj, Donata; Sobiecka-Szkatula, Anna; Koper, Tomasz; Denkiewicz, Milena; Lipinska, Barbara; Skorko-Glonek, Joanna] Univ Gdansk, Dept Biochem, Fac Biol, PL-80308 Gdansk, Poland; [Gieldon, Artur; Ciarkowski, Jerzy] Univ Gdansk, Dept Theoret Chem, Fac Chem, PL-80952 Gdansk, Poland; [Polit, Agnieszka] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Phys Biochem, PL-30387 Krakow, Poland; [Banecki, Bogdan] Univ Gdansk, Dept Mol & Cellular Biol, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Banecki, Bogdan] Med Univ Gdansk, PL-80822 Gdansk, Poland; [Lesner, Adam] Univ Gdansk, Dept Biochem, Fac Chem, PL-80952 Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk; Jagiellonian University; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; University of Gdansk	Skorko-Glonek, J (corresponding author), Univ Gdansk, Dept Biochem, Fac Biol, Wita Stwosza 59, PL-80308 Gdansk, Poland.	joanna.skorko-glonek@biol.ug.edu.pl	Skorko-Glonek, Joanna/AAF-5516-2020; Lipinska, Barbara/ABA-6124-2020; Lesner, Adam/M-2732-2019	Skorko-Glonek, Joanna/0000-0002-8084-5251; Lipinska, Barbara/0000-0001-9510-4811; Polit, Agnieszka/0000-0001-5811-9838; Figaj, Donata/0000-0002-0625-2968; Lesner, Adam/0000-0001-8335-3431; Denkiewicz-Kruk, Milena/0000-0002-4357-9636; Banecki, Bogdan/0000-0003-3286-2388; Gieldon, Artur/0000-0003-0415-9214	Ministry of Science and Higher Education (Poland) [0393/B/P01/40]	Ministry of Science and Higher Education (Poland)(Ministry of Science and Higher Education, Poland)	This work was supported by Ministry of Science and Higher Education (Poland) Grant 0393/B/P01/40.	CALHOUN D B, 1986, Proteins Structure Function and Genetics, V1, P109, DOI 10.1002/prot.340010202; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; CREED D, 1984, PHOTOCHEM PHOTOBIOL, V39, P537; Creighton T. E, 1992, PROTEINS STRUCTURE M, p[182, 221]; Czaplewski C, 2009, J CHEM THEORY COMPUT, V5, P627, DOI 10.1021/ct800397z; Frees Dorte, 2013, Subcell Biochem, V66, P161, DOI 10.1007/978-94-007-5940-4_7; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Giorgetti A, 2005, BIOINFORMATICS, V21, P72, DOI 10.1093/bioinformatics/bti1112; Graf L., 2004, HDB PROTEOLYTIC ENZY, P1495; Hagen M, 2007, J PHYS CHEM B, V111, P1416, DOI 10.1021/jp064479e; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; Hoy B, 2012, J BIOL CHEM, V287, P10115, DOI 10.1074/jbc.C111.333419; Hoy B, 2010, EMBO REP, V11, P798, DOI 10.1038/embor.2010.114; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Jomaa A, 2007, J BACTERIOL, V189, P706, DOI 10.1128/JB.01334-06; Keskin O, 1998, FOLD DES, V3, P469, DOI 10.1016/S1359-0278(98)00064-9; Kim S, 2012, P NATL ACAD SCI USA, V109, P7263, DOI 10.1073/pnas.1204791109; Kim S, 2011, CELL, V145, P67, DOI 10.1016/j.cell.2011.02.024; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MR, 2001, J MOL BIOL, V313, P417, DOI 10.1006/jmbi.2001.5032; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matyus L, 2006, J PHOTOCH PHOTOBIO B, V83, P223, DOI 10.1016/j.jphotobiol.2005.12.017; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Oberfelder R., 1993, METHODS NONRADIOACTI, P83; Park IH, 2012, J PHYS CHEM B, V116, P2365, DOI 10.1021/jp209657n; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Skorko-Glonek J, 2003, BBA-PROTEINS PROTEOM, V1649, P171, DOI 10.1016/S1570-9639(03)00170-5; Skorko-Glonek J, 2013, CURR PHARM DESIGN, V19, P977, DOI 10.2174/1381612811319060003; SKORKOGLONEK J, 1995, GENE, V163, P47, DOI 10.1016/0378-1119(95)00406-V; Sobiecka-Szkatula A, 2010, ARCH BIOCHEM BIOPHYS, V500, P123, DOI 10.1016/j.abb.2010.05.028; Sobiecka-Szkatula A, 2009, BBA-PROTEINS PROTEOM, V1794, P1573, DOI 10.1016/j.bbapap.2009.07.002; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Takatsuka Y, 2010, METHODS MOL BIOL, V634, P343, DOI 10.1007/978-1-60761-652-8_24; Wysocka M, 2010, ANAL BIOCHEM, V399, P196, DOI 10.1016/j.ab.2010.01.007; Zurawa-Janicka D, 2013, CELL STRESS CHAPERON, V18, P35, DOI 10.1007/s12192-012-0355-1	42	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15880	15893		10.1074/jbc.M113.532895	http://dx.doi.org/10.1074/jbc.M113.532895			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24737328	Green Published, hybrid			2022-12-25	WOS:000337465400066
J	Wang, JJ; Nemeria, NS; Chandrasekhar, K; Kumaran, S; Arjunan, P; Reynolds, S; Calero, G; Brukh, R; Kakalis, L; Furey, W; Jordan, F				Wang, Junjie; Nemeria, Natalia S.; Chandrasekhar, Krishnamoorthy; Kumaran, Sowmini; Arjunan, Palaniappa; Reynolds, Shelley; Calero, Guillermo; Brukh, Roman; Kakalis, Lazaros; Furey, William; Jordan, Frank			Structure and Function of the Catalytic Domain of the Dihydrolipoyl Acetyltransferase Component in Escherichia coli Pyruvate Dehydrogenase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Enzyme Catalysis; Mass Spectrometry (MS); Nuclear Magnetic Resonance (NMR); Pyruvate Dehydrogenase Complex (PDC); X-ray Crystallography; HD Exchange	SITE-DIRECTED MUTAGENESIS; THIAMIN DIPHOSPHATE; MULTIENZYME COMPLEX; AZOTOBACTER-VINELANDII; NUCLEOTIDE-SEQUENCE; 1',4'-IMINOPYRIMIDINE TAUTOMER; TRANSACETYLASE COMPONENT; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; E1 SUBUNIT	Background: The E. coli pyruvate dehydrogenase complex catalyzes conversion of pyruvate to acetyl-CoA and comprises E1p, E2p, and E3 components. Results: The structure of the E2 core domain was solved and shown to efficiently catalyze acetyl transfer between domains. Conclusion: Mass spectrometry revealed hitherto unrecognized domain-induced interactions between E1 and E2 core domain. Significance: A multifaceted approach is required to understand communication between intact multidomain components. The Escherichia coli pyruvate dehydrogenase complex (PDHc) catalyzing conversion of pyruvate to acetyl-CoA comprises three components: E1p, E2p, and E3. The E2p is the five-domain core component, consisting of three tandem lipoyl domains (LDs), a peripheral subunit binding domain (PSBD), and a catalytic domain (E2pCD). Herein are reported the following. 1) The x-ray structure of E2pCD revealed both intra- and intertrimer interactions, similar to those reported for other E2pCDs. 2) Reconstitution of recombinant LD and E2pCD with E1p and E3p into PDHc could maintain at least 6.4% activity (NADH production), confirming the functional competence of the E2pCD and active center coupling among E1p, LD, E2pCD, and E3 even in the absence of PSBD and of a covalent link between domains within E2p. 3) Direct acetyl transfer between LD and coenzyme A catalyzed by E2pCD was observed with a rate constant of 199 s(-1), comparable with the rate of NADH production in the PDHc reaction. Hence, neither reductive acetylation of E2p nor acetyl transfer within E2p is rate-limiting. 4) An unprecedented finding is that although no interaction could be detected between E1p and E2pCD by itself, a domain-induced interaction was identified on E1p active centers upon assembly with E2p and C-terminally truncated E2p proteins by hydrogen/deuterium exchange mass spectrometry. The inclusion of each additional domain of E2p strengthened the interaction with E1p, and the interaction was strongest with intact E2p. E2p domain-induced changes at the E1p active site were also manifested by the appearance of a circular dichroism band characteristic of the canonical 4-aminopyrimidine tautomer of bound thiamin diphosphate (AP).	[Wang, Junjie; Nemeria, Natalia S.; Kumaran, Sowmini; Brukh, Roman; Kakalis, Lazaros; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Chandrasekhar, Krishnamoorthy; Arjunan, Palaniappa; Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Furey, William] Vet Affairs Med Ctr, Pittsburgh, PA 15240 USA; [Reynolds, Shelley; Calero, Guillermo] Univ Pittsburgh, Dept Biol Struct, Sch Med, Pittsburgh, PA 15261 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Furey, W (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	fureyw@pitt.edu; frjordan@rutgers.edu	Wang, Junjie/K-7509-2014	Wang, Junjie/0000-0002-0587-2209	National Institutes of Health [GM061791, GM050380]; Veterans Affairs Merit Review; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061791, R01GM050380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM061791 (to W. F.) and GM050380 (to F. J.). This work was also supported by a Veterans Affairs Merit Review (to W. F.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALI ST, 1990, BIOCHEM J, V271, P139, DOI 10.1042/bj2710139; Allen MD, 1997, FEBS LETT, V413, P339, DOI 10.1016/S0014-5793(97)00932-0; Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; BLEILE DM, 1979, P NATL ACAD SCI USA, V76, P4385, DOI 10.1073/pnas.76.9.4385; BUTTERWORTH PJ, 1975, J BIOL CHEM, V250, P1921; CAJACOB CA, 1985, J BIOL CHEM, V260, P4610; Chandrasekhar K, 2013, J BIOL CHEM, V288, P15402, DOI 10.1074/jbc.M113.466789; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; GREEN JDF, 1992, J BIOL CHEM, V267, P23484; Hamuro Y, 2008, RAPID COMMUN MASS SP, V22, P1041, DOI 10.1002/rcm.3467; HENDLE J, 1995, BIOCHEMISTRY-US, V34, P4287, DOI 10.1021/bi00013a018; HUPE DJ, 1977, J AM CHEM SOC, V99, P451, DOI 10.1021/ja00444a023; Izard T, 1999, P NATL ACAD SCI USA, V96, P1240, DOI 10.1073/pnas.96.4.1240; Jones DD, 2000, BIOCHEMISTRY-US, V39, P8448, DOI 10.1021/bi992978i; Jones DD, 2000, J MOL BIOL, V295, P289, DOI 10.1006/jmbi.1999.3335; Jones DD, 2001, J MOL BIOL, V305, P49, DOI 10.1006/jmbi.2000.4257; Jordan F, 2005, BIOORG CHEM, V33, P190, DOI 10.1016/j.bioorg.2005.02.001; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; Jordan F, 2009, J MOL CATAL B-ENZYM, V61, P14, DOI 10.1016/j.molcatb.2009.04.008; Kato M, 2006, EMBO J, V25, P5983, DOI 10.1038/sj.emboj.7601444; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Keller R., 2004, COMPUTER AIDED RESON, V1; Knapp JE, 1998, J MOL BIOL, V280, P655, DOI 10.1006/jmbi.1998.1924; Knapp JE, 2000, PROTEIN SCI, V9, P37; LESLIE AGW, 1988, P NATL ACAD SCI USA, V85, P4133, DOI 10.1073/pnas.85.12.4133; LIVE DH, 1984, J AM CHEM SOC, V106, P6104, DOI 10.1021/ja00332a071; Marrott NL, 2012, FEBS J, V279, P713, DOI 10.1111/j.1742-4658.2011.08461.x; MATTEVI A, 1993, BIOCHEMISTRY-US, V32, P3887, DOI 10.1021/bi00066a007; MATTEVI A, 1993, J MOL BIOL, V230, P1183, DOI 10.1006/jmbi.1993.1235; Nambi S, 2012, J BIOL CHEM, V287, P18115, DOI 10.1074/jbc.M111.328112; Nemeria N, 2004, BIOCHEMISTRY-US, V43, P6565, DOI 10.1021/bi049549r; Nemeria N, 1998, BIOCHEMISTRY-US, V37, P911, DOI 10.1021/bi9722251; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; NIU XD, 1990, BIOCHEMISTRY-US, V29, P8614, DOI 10.1021/bi00489a017; Park YH, 2004, BIOCHEMISTRY-US, V43, P14037, DOI 10.1021/bi049027b; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Perham RN, 2002, BIOCHEM SOC T, V30, P47, DOI 10.1042/bst0300047; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; REED LJ, 1990, J BIOL CHEM, V265, P8971; REED LJ, 1975, P NATL ACAD SCI USA, V72, P3068, DOI 10.1073/pnas.72.8.3068; RUSSELL GC, 1990, BIOCHEM J, V269, P443, DOI 10.1042/bj2690443; RUSSELL GC, 1991, P ROY SOC B-BIOL SCI, V243, P155, DOI 10.1098/rspb.1991.0025; RUSSELL GC, 1991, BIOCHIM BIOPHYS ACTA, V1076, P225, DOI 10.1016/0167-4838(91)90271-Z; SCHULZE E, 1991, EUR J BIOCHEM, V201, P561, DOI 10.1111/j.1432-1033.1991.tb16315.x; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Song JY, 2012, BIOCHEMISTRY-US, V51, P2795, DOI 10.1021/bi201614n; Song JY, 2010, J BIOL CHEM, V285, P4680, DOI 10.1074/jbc.M109.082842; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P155, DOI 10.1111/j.1432-1033.1983.tb07441.x; STEPHENS PE, 1983, EUR J BIOCHEM, V135, P519, DOI 10.1111/j.1432-1033.1983.tb07683.x; STEPHENS PE, 1983, EUR J BIOCHEM, V133, P481, DOI 10.1111/j.1432-1033.1983.tb07490.x; Stoops JK, 1997, J BIOL CHEM, V272, P5757, DOI 10.1074/jbc.272.9.5757; Tompa P, 2014, CHEM REV, V114, P6715, DOI 10.1021/cr4005082; Vijayakrishnan S, 2010, J MOL BIOL, V399, P71, DOI 10.1016/j.jmb.2010.03.043; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; YANG YS, 1986, BIOCHEMISTRY-US, V25, P8173, DOI 10.1021/bi00373a008; Yu XK, 2008, STRUCTURE, V16, P104, DOI 10.1016/j.str.2007.10.024; Zhou ZH, 2001, J BIOL CHEM, V276, P21704, DOI 10.1074/jbc.M101765200	62	29	31	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15215	15230		10.1074/jbc.M113.544080	http://dx.doi.org/10.1074/jbc.M113.544080			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742683	hybrid, Green Published			2022-12-25	WOS:000337465400008
J	Yoo, DS; Chang, J; Kim, JT; Choi, MJ; Choi, J; Choi, KH; Park, MS; Cho, KH				Yoo, Deok-Sang; Chang, Jane; Kim, Joon-Tae; Choi, Min-Ji; Choi, Jina; Choi, Kang-Ho; Park, Man-Seok; Cho, Ki-Hyun			Various Blood Glucose Parameters that Indicate Hyperglycemia after Intravenous Thrombolysis in Acute Ischemic Stroke Could Predict Worse Outcome	PLOS ONE			English	Article							POSTSTROKE HYPERGLYCEMIA; OXIDATIVE STRESS; CONTROLLED-TRIAL; INFARCT SIZE; MEAN GLUCOSE; ADMISSION; VARIABILITY; PRESSURE; TOPOGRAPHY; MORTALITY	Background: Hyperglycemia is common after stroke, and it is well known to worsen its outcome. However, it is important to consider that blood glucose (BG) levels can undergo dynamic changes during the acute stage of ischemic stroke. We sought to investigate the clinical significance of various glucose parameters within first 24 hours in acute ischemic stroke (AIS). The study focused on hyperacute stage patients who underwent IVT and investigated which parameters of glucose demonstrated to be helpful for predicting outcome. Methods: This was a retrospective study of consecutive patients with AIS at a single stroke center. Patients were consecutively enrolled if they were treated with IV-tPA within 3 hours of symptom onset. BG was measured immediately upon arrival in ER, after IVT and every 6-8 hours during the first 24 hours after IVT. The various parameters of BG were the following: BG before IVT, BG after IVT, mean BG (mBG), maximal BG (max BG), standard deviation of BG (sdBG), and standard deviation of mean BG (sdmBG). Results: 207 patients (127 men and 80 women) were included in this study. Seventy seven of 207 patients had favorable outcomes at 3 months. High BG after IVT, mBG and max BG were independently associated with mRS>2 at 3 months (adjusted by age, NIHSS, and atrial fibrillation). Several parameters of BG were also independently associated with early mortality within 3 months (BG after IVT, mBG, and max BG). BG after IVT and mBG over 180 mg/dL were independently associated with early mortality within 3 months. Conclusion: Serial measurements of BG might be a better predictor of clinical outcome in patients with AIS treated with IVT than single BG measurements before IVT. Therefore, these results suggest that variable parameters of BG could be important for the prediction of clinical outcome in AIS treated with IVT.	[Yoo, Deok-Sang; Chang, Jane; Kim, Joon-Tae; Choi, Min-Ji; Choi, Jina; Choi, Kang-Ho; Park, Man-Seok; Cho, Ki-Hyun] Chonnam Natl Univ Hosp, Dept Neurol, Cerebrovasc Ctr, Kwangju, South Korea	Chonnam National University; Chonnam National University Hospital	Kim, JT (corresponding author), Chonnam Natl Univ Hosp, Dept Neurol, Cerebrovasc Ctr, Kwangju, South Korea.	alldelight2@hanmail.net			Chonnam National University Hospital Biomedical Research Institute [CRI13041-21]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Chonnam National University Hospital Biomedical Research Institute; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant (CRI13041-21) Chonnam National University Hospital Biomedical Research Institute. This study was supported by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Ahmed N, 2010, ARCH NEUROL-CHICAGO, V67, P1123, DOI 10.1001/archneurol.2010.210; Ali NA, 2008, CRIT CARE MED, V36, P2316, DOI 10.1097/CCM.0b013e3181810378; Baird TA, 2003, STROKE, V34, P2208, DOI 10.1161/01.STR.0000085087.41330.FF; Bellolio MF, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005346.pub4; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Bruno A, 2002, NEUROLOGY, V59, P669, DOI 10.1212/WNL.59.5.669; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Christensen H, 2002, EUR J NEUROL, V9, P297, DOI 10.1046/j.1468-1331.2002.00409.x; Darby DG, 1999, STROKE, V30, P2043, DOI 10.1161/01.STR.30.10.2043; Fuentes B, 2009, STROKE, V40, P562, DOI 10.1161/STROKEAHA.108.519926; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HELGASON CM, 1988, STROKE, V19, P1049, DOI 10.1161/01.STR.19.8.1049; Johnston KC, 2009, STROKE, V40, P3804, DOI 10.1161/STROKEAHA.109.561498; Kang J, 2012, NEUROLOGY, V79, P2018, DOI 10.1212/WNL.0b013e3182749eb8; KIERS L, 1992, J NEUROL NEUROSUR PS, V55, P263, DOI 10.1136/jnnp.55.4.263; Kim JT, 2011, EUR J NEUROL, V18, P988, DOI 10.1111/j.1468-1331.2011.03351.x; Kruyt ND, 2010, NAT REV NEUROL, V6, P145, DOI 10.1038/nrneurol.2009.231; Luitse MJA, 2012, LANCET NEUROL, V11, P261, DOI 10.1016/S1474-4422(12)70005-4; MacDougall NJJ, 2011, J CEREBR BLOOD F MET, V31, P807, DOI 10.1038/jcbfm.2010.210; McCormick M, 2010, ANN NEUROL, V67, P570, DOI 10.1002/ana.21983; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Parsons MW, 2002, ANN NEUROL, V52, P20, DOI 10.1002/ana.10241; Pisarchik AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046582; PRADO R, 1988, J CEREBR BLOOD F MET, V8, P186, DOI 10.1038/jcbfm.1988.48; Putaala J, 2011, CEREBROVASC DIS, V31, P83, DOI 10.1159/000321332; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Scott JF, 1999, LANCET, V353, P376, DOI 10.1016/S0140-6736(05)74948-5; Siegelaar SE, 2010, CRIT CARE, V14, DOI 10.1186/cc9369; TONI D, 1994, J NEUROL SCI, V123, P129, DOI 10.1016/0022-510X(94)90214-3	32	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94364	10.1371/journal.pone.0094364	http://dx.doi.org/10.1371/journal.pone.0094364			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747428	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500027
J	Jaramillo, M; Mathew, S; Task, K; Barner, S; Banerjee, I				Jaramillo, Maria; Mathew, Shibin; Task, Keith; Barner, Sierra; Banerjee, Ipsita			Potential for Pancreatic Maturation of Differentiating Human Embryonic Stem Cells Is Sensitive to the Specific Pathway of Definitive Endoderm Commitment	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE; BETA-CELLS; GENERATION; ACTIVIN; MOUSE; GENE; PROGENITORS; COOPERATE; REGULATOR; PAX4	This study provides a detailed experimental and mathematical analysis of the impact of the initial pathway of definitive endoderm (DE) induction on later stages of pancreatic maturation. Human embryonic stem cells (hESCs) were induced to insulin-producing cells following a directed-differentiation approach. DE was induced following four alternative pathway modulations. DE derivatives obtained from these alternate pathways were subjected to pancreatic progenitor (PP) induction and maturation and analyzed at each stage. Results indicate that late stage maturation is influenced by the initial pathway of DE commitment. Detailed quantitative analysis revealed WNT3A and FGF2 induced DE cells showed highest expression of insulin, are closely aligned in gene expression patterning and have a closer resemblance to pancreatic organogenesis. Conversely, BMP4 at DE induction gave most divergent differentiation dynamics with lowest insulin upregulation, but highest glucagon upregulation. Additionally, we have concluded that early analysis of PP markers is indicative of its potential for pancreatic maturation.	[Jaramillo, Maria; Banerjee, Ipsita] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Mathew, Shibin; Task, Keith; Barner, Sierra; Banerjee, Ipsita] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA; [Banerjee, Ipsita] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Banerjee, I (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	ipb1@pitt.edu	Mathew, Shibin/ABH-1727-2020		NIH [DP2 116520, UL1 RR024153, UL1TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006491] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge support from NIH New Innovator Award DP2 116520. hESCs were obtained from the University of Pittsburgh Stem Cell Core supported by the NIH through Grant Numbers UL1 RR024153 and UL1TR000005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameri J, 2010, STEM CELLS, V28, P45, DOI 10.1002/stem.249; Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Becker KA, 2010, J CELL PHYSIOL, V222, P103, DOI 10.1002/jcp.21925; Bone HK, 2011, J CELL SCI, V124, P1992, DOI 10.1242/jcs.081679; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bramswig NC, 2011, DIABETES OBES METAB, V13, P13, DOI 10.1111/j.1463-1326.2011.01440.x; Candiello J, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-9; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Gibson JD, 2009, INTEGR BIOL-UK, V1, P540, DOI 10.1039/b908276j; Gosmain Y, 2012, ENDOCRINOLOGY, V153, P4204, DOI 10.1210/en.2012-1425; Jahansouz C, 2011, DIABETES TECHNOL THE, V13, P395, DOI 10.1089/dia.2010.0133; Jaramillo M, 2012, J TISSUE ENG REGEN M; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Lee DH, 2012, PANCREAS, V41, P65, DOI 10.1097/MPA.0b013e3182223e35; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Mathew S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-154; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Mfopou JK, 2010, GASTROENTEROLOGY, V138, P2233, DOI 10.1053/j.gastro.2010.02.056; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Phillips BW, 2007, STEM CELLS DEV, V16, P561, DOI 10.1089/scd.2007.0029; Ptasznik A, 1997, J CELL BIOL, V137, P1127, DOI 10.1083/jcb.137.5.1127; Sander M, 2000, DEVELOPMENT, V127, P5533; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Servitja JM, 2004, DIABETOLOGIA, V47, P597, DOI 10.1007/s00125-004-1368-9; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Sinner D, 2004, DEVELOPMENT, V131, P3069, DOI 10.1242/dev.01176; Sosa-Pineda B, 2004, MOL CELLS, V18, P289; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Task K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032975; Teo AKK, 2012, STEM CELLS, V30, P631, DOI 10.1002/stem.1022; Tsaniras SC, 2010, J ENDOCRINOL, V206, P13, DOI 10.1677/JOE-10-0073; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; Wen YJ, 2011, EXPERT OPIN BIOL TH, V11, P41, DOI 10.1517/14712598.2011.540235; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Xu XF, 2011, MECH DEVELOP, V128, P412, DOI 10.1016/j.mod.2011.08.001; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhang DH, 2009, SCI CHINA SER C, V52, P615, DOI 10.1007/s11427-009-0095-3; Zorn AM, 2009, ANNU REV CELL DEV BI, V25, P221, DOI 10.1146/annurev.cellbio.042308.113344	47	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94307	10.1371/journal.pone.0094307	http://dx.doi.org/10.1371/journal.pone.0094307			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743345	Green Accepted, Green Published, gold			2022-12-25	WOS:000335309100029
J	Moulton, EA; Becerra, L; Johnson, A; Burstein, R; Borsook, D				Moulton, Eric A.; Becerra, Lino; Johnson, Adriana; Burstein, Rami; Borsook, David			Altered Hypothalamic Functional Connectivity with Autonomic Circuits and the Locus Coeruleus in Migraine	PLOS ONE			English	Article							TEMPORAL POLE; RESPONSES; BRAIN; PAIN; METAANALYSIS; ACTIVATION; SYSTEM; CORTEX; SLEEP; PART	The hypothalamus has been implicated in migraine based on the manifestation of autonomic symptoms with the disease, as well as neuroimaging evidence of hypothalamic activation during attacks. Our objective was to determine functional connectivity (FC) changes between the hypothalamus and the rest of the brain in migraine patients vs. control subjects. This study uses fMRI (functional magnetic resonance imaging) to acquire resting state scans in 12 interictal migraine patients and 12 healthy matched controls. Hypothalamic connectivity seeds were anatomically defined based on high-resolution structural scans, and FC was assessed in the resting state scans. Migraine patients had increased hypothalamic FC with a number of brain regions involved in regulation of autonomic functions, including the locus coeruleus, caudate, parahippocampal gyrus, cerebellum, and the temporal pole. Stronger functional connections between the hypothalamus and brain areas that regulate sympathetic and parasympathetic functions may explain some of the hypothalamic-mediated autonomic symptoms that accompany or precede migraine attacks.	[Moulton, Eric A.; Becerra, Lino; Johnson, Adriana; Borsook, David] Harvard Univ, Sch Med, Ctr Pain & Brain, Dept Anesthesia,Boston Childrens Hosp,Pain Analge, Waltham, MA 02138 USA; [Becerra, Lino; Borsook, David] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Borsook, David] Harvard Univ, McLean Hosp, Sch Med, Ctr Pain & Brain,Dept Psychiat,PAIN Grp, Belmont, MA USA; [Burstein, Rami] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; McLean Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Moulton, EA (corresponding author), Harvard Univ, Sch Med, Ctr Pain & Brain, Dept Anesthesia,Boston Childrens Hosp,Pain Analge, Waltham, MA 02138 USA.	eric.moulton@childrens.harvard.edu	Moulton, Eric/AAF-8225-2019	Moulton, Eric/0000-0002-7959-8441	National Institutes of Health [R01NS073997, K24NS0624050]; L Herlands fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073997, R37NS079678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); L Herlands fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (R01NS073997 to D. B., K24NS0624050 to D. B.); the L Herlands fund to the P.A.I.N. Group (D. B., L. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman S, 2011, NAT REV NEUROSCI, V12, P570, DOI 10.1038/nrn3057; Alstadhaug KB, 2009, CEPHALALGIA, V29, P809, DOI 10.1111/j.1468-2982.2008.01814.x; AstonJones G, 1996, PROG BRAIN RES, V107, P379; Bashir A, 2013, NEUROLOGY, V81, P1260, DOI 10.1212/WNL.0b013e3182a6cb32; Beissner F, 2013, J NEUROSCI, V33, P10503, DOI 10.1523/JNEUROSCI.1103-13.2013; Borsook D, 2014, NEUROBIOL D IN PRESS; Borsook D, 2012, NEURON, V73, P219, DOI 10.1016/j.neuron.2012.01.001; Borsook D, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-27; Buchel C, 2000, NEURAL NETWORKS, V13, P871, DOI 10.1016/S0893-6080(00)00066-6; Burstein R, 2005, J COMP NEUROL, V493, P9, DOI 10.1002/cne.20688; Cochran SD, 2007, AM J PUBLIC HEALTH, V97, P2048, DOI 10.2105/AJPH.2006.087254; Condes-Lara M, 1998, EUR J PAIN, V2, P15, DOI 10.1016/S1090-3801(98)90042-8; Cortelli P, 2007, NEUROL SCI, V28, pS198, DOI 10.1007/s10072-007-0776-2; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Critchley HD, 2000, J NEUROSCI, V20, P3033; Demarquay G, 2008, CEPHALALGIA, V28, P1069, DOI 10.1111/j.1468-2982.2008.01672.x; Demarquay G, 2006, CEPHALALGIA, V26, P1123, DOI 10.1111/j.1468-2982.2006.01174.x; Denuelle M, 2007, HEADACHE, V47, P1418, DOI 10.1111/j.1526-4610.2007.00776.x; Dodick DW, 2003, HEADACHE, V43, P282, DOI 10.1046/j.1526-4610.2003.03055.x; Facchinetti F, 2000, FUNCT NEUROL, V15, P137; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; HAINES DE, 1984, J COMP NEUROL, V229, P559, DOI 10.1002/cne.902290409; Holland P, 2007, HEADACHE, V47, P951, DOI 10.1111/j.1526-4610.2007.00842.x; Jeffery KJ, 2007, CURR OPIN NEUROBIOL, V17, P684, DOI 10.1016/j.conb.2007.11.008; JONES SL, 1991, PROG BRAIN RES, V88, P381; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; KIEVIT J, 1975, SCIENCE, V187, P660, DOI 10.1126/science.1114317; Lai TH, 2009, J NEUROL NEUROSUR PS, V80, P1116, DOI 10.1136/jnnp.2008.157743; Maleki N, 2013, BRAIN STRUCT FUNCT, V218, P903, DOI 10.1007/s00429-012-0437-y; MARKOWITSCH HJ, 1985, J COMP NEUROL, V242, P425, DOI 10.1002/cne.902420310; Mosek A, 1999, HEADACHE, V39, P108, DOI 10.1046/j.1526-4610.1999.3902108.x; Moulton EA, 2011, CEREB CORTEX, V21, P435, DOI 10.1093/cercor/bhq109; Moulton EA, 2011, J NEUROSCI, V31, P3795, DOI 10.1523/JNEUROSCI.6709-10.2011; Nelson LE, 2002, NAT NEUROSCI, V5, P979, DOI 10.1038/nn913; Overeem S, 2002, LANCET NEUROL, V1, P437, DOI 10.1016/S1474-4422(02)00191-6; Pendse G, 2009, NEUROIMAGE, V47, P231, DOI 10.1016/j.neuroimage.2009.02.035; Peterlin BL, 2010, HEADACHE, V50, P631, DOI 10.1111/j.1526-4610.2009.01554.x; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Saleem SN, 2007, RADIOGRAPHICS, V27, P1087, DOI 10.1148/rg.274065123; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P254, DOI 10.2174/157015908785777193; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Saunders RC, 2007, HIPPOCAMPUS, V17, P396, DOI 10.1002/hipo.20276; Seifert F, 2013, HUM BRAIN MAPP, V34, P1768, DOI 10.1002/hbm.22035; ShammahLagnado SJ, 1996, J COMP NEUROL, V376, P489, DOI 10.1002/(SICI)1096-9861(19961216)376:3<489::AID-CNE10>3.0.CO;2-H; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stankewitz A, 2011, J NEUROSCI, V31, P1937, DOI 10.1523/JNEUROSCI.4496-10.2011; STEWART WF, 1994, NEUROLOGY, V44, P17; Stoffers D., 2013, BRAIN; Stone EA, 2007, BIOCHEM PHARMACOL, V73, P1063, DOI 10.1016/j.bcp.2006.10.001; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Vollono C, 2013, J CLIN SLEEP MED, V9, P707, DOI 10.5664/jcsm.2846; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931	52	81	87	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95508	10.1371/journal.pone.0095508	http://dx.doi.org/10.1371/journal.pone.0095508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743801	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100131
J	Qiao, SM; Peng, RY; Yan, HT; Gao, YB; Wang, CZ; Wang, SM; Zou, Y; Xu, XP; Zhao, L; Dong, J; Su, ZT; Feng, XX; Wang, LF; Hu, XJ				Qiao, Simo; Peng, Ruiyun; Yan, Haitao; Gao, Yabing; Wang, Changzhen; Wang, Shuiming; Zou, Yong; Xu, Xinping; Zhao, Li; Dong, Ji; Su, Zhentao; Feng, Xinxin; Wang, Lifeng; Hu, Xiangjun			Reduction of Phosphorylated Synapsin I (Ser-553) Leads to Spatial Memory Impairment by Attenuating GABA Release after Microwave Exposure in Wistar Rats	PLOS ONE			English	Article							SYNAPTIC VESICLES; TERM; HIPPOCAMPUS; PLASTICITY; RECEPTORS; COGNITION	Background: Abnormal release of neurotransmitters after microwave exposure can cause learning and memory deficits. This study investigated the mechanism of this effect by exploring the potential role of phosphorylated synapsin I (p-Syn I). Methods: Wistar rats, rat hippocampal synaptosomes, and differentiated (neuronal) PC12 cells were exposed to microwave radiation for 5 min at a mean power density of 30 mW/cm(2). Sham group rats, synaptosomes, and cells were otherwise identically treated and acted as controls for all of the following post-exposure analyses. Spatial learning and memory in rats was assessed using the Morris Water Maze (MWM) navigation task. The protein expression and presynaptic distribution of p-Syn I and neurotransmitter transporters were examined via western blotting and immunoelectron microscopy, respectively. Levels amino acid neurotransmitter release from rat hippocampal synaptosomes and PC12 cells were measured using high performance liquid chromatograph (HPLC) at 6 hours after exposure, with or without synapsin I silencing via shRNA transfection. Results: In the rat experiments, there was a decrease in spatial memory performance after microwave exposure. The expression of p-Syn I (ser-553) was decreased at 3 days post-exposure and elevated at later time points. Vesicular GABA transporter (VGAT) was significantly elevated after exposure. The GABA release from synaptosomes was attenuated and p-Syn I (ser-553) and VGAT were both enriched in small clear synaptic vesicles, which abnormally assembled in the presynaptic terminal after exposure. In the PC12 cell experiments, the expression of p-Syn I (ser-553) and GABA release were both attenuated at 6 hours after exposure. Both microwave exposure and p-Syn I silencing reduced GABA release and maximal reduction was found for the combination of the two, indicating a synergetic effect. Conclusion: p-Syn I (ser-553) was found to play a key role in the impaired GABA release and cognitive dysfunction that was induced by microwave exposure.	[Qiao, Simo; Peng, Ruiyun; Gao, Yabing; Wang, Changzhen; Wang, Shuiming; Zou, Yong; Xu, Xinping; Zhao, Li; Dong, Ji; Wang, Lifeng; Hu, Xiangjun] Beijing Inst Radiat Med, Dept Expt Pathol, Beijing, Peoples R China; [Su, Zhentao] Beijing Inst Radiat Med, Dept Radiat Protect & Hlth Phys, Beijing, Peoples R China; [Yan, Haitao] Beijing Inst Pharmacol & Toxicol, Dept Biochem Pharmacol, Beijing, Peoples R China; [Feng, Xinxin] Chinese Acad Med Sci, Cardiovasc Inst, Endocrine & Cardiovasc Ctr, Beijing 100730, Peoples R China; [Feng, Xinxin] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS	Feng, XX (corresponding author), Chinese Acad Med Sci, Cardiovasc Inst, Endocrine & Cardiovasc Ctr, Beijing 100730, Peoples R China.	xinxin_feng@hotmail.com; fangchang_14@163.com; xjhu2003@vip.sina.com			National Basic Research Program of China [2011CB503706]; National Natural Science Foundation of China [30900382]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2011CB503706) and National Natural Science Foundation of China (30900382). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldelli P, 2007, J NEUROSCI, V27, P13520, DOI 10.1523/JNEUROSCI.3151-07.2007; Bykhovskaia M, 2011, SEMIN CELL DEV BIOL, V22, P387, DOI 10.1016/j.semcdb.2011.07.003; Chiappalone M, 2009, CEREB CORTEX, V19, P1422, DOI 10.1093/cercor/bhn182; Coleman WL, 2009, MOL CELL NEUROSCI, V41, P286, DOI 10.1016/j.mcn.2009.03.008; Consales C, 2012, INT J CELL BIOL; Cui YJ, 2008, CELL, V135, P549, DOI 10.1016/j.cell.2008.09.060; D'Andrea JA, 2003, BIOELECTROMAGNETICS, pS107, DOI 10.1002/bem.10179; D'Andrea JA, 2003, BIOELECTROMAGNETICS, pS39, DOI 10.1002/bem.10169; DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2; Farisello P, 2013, CEREB CORTEX, V23, P581, DOI 10.1093/cercor/bhs041; Giachello CNG, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/670821; Giachello CNG, 2010, J CELL SCI, V123, P881, DOI 10.1242/jcs.056846; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Hunt RF, 2013, NAT NEUROSCI, V16, P692, DOI 10.1038/nn.3392; Janac B, 2009, GEN PHYSIOL BIOPHYS, V28, P41; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Kleschevnikov AM, 2012, J NEUROSCI, V32, P9217, DOI 10.1523/JNEUROSCI.1673-12.2012; La Vignera S, 2012, J ANDROL, V33, P350, DOI 10.2164/jandrol.111.014373; Lignani G, 2013, HUM MOL GENET, V22, P2186, DOI 10.1093/hmg/ddt071; Mausset-Bonnefont AL, 2004, NEUROBIOL DIS, V17, P445, DOI 10.1016/j.nbd.2004.07.004; Michels B, 2005, LEARN MEMORY, V12, P224, DOI 10.1101/lm.92805; Narayanan SN, 2009, CLINICS, V64; Nittby H, 2008, BIOELECTROMAGNETICS, V29, P219, DOI 10.1002/bem.20386; Schluter OM, 2006, J NEUROSCI, V26, P1239, DOI 10.1523/JNEUROSCI.3553-05.2006; Schuderer J, 2003, BIOELECTROMAGNETICS, V24, P103, DOI 10.1002/bem.10066; Shin EJ, 2007, J PHARMACOL SCI, V105, P367, DOI 10.1254/jphs.SC0070348; SUDHOF T, 2011, COLD SPRING HARB PER, V3; Sung JH, 2003, ARCH PHARM RES, V26, P487, DOI 10.1007/BF02976868; Van Liefferinge J, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00139; Wang BM, 2000, BIOELECTROMAGNETICS, V21, P52, DOI 10.1002/(SICI)1521-186X(200001)21:1<52::AID-BEM8>3.0.CO;2-6; Wang H, 2013, INT J RADIAT BIOL, V89, P1100, DOI 10.3109/09553002.2013.817701; Wang LF, 2009, SYNAPSE, V63, P1010, DOI 10.1002/syn.20684; Witzmann FA, 2005, PROTEOMICS, V5, P2177, DOI 10.1002/pmic.200401102; Zhao L, 2012, BIOMED ENVIRON SCI, V25, P182, DOI 10.3967/0895-3988.2012.02.009	36	24	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95503	10.1371/journal.pone.0095503	http://dx.doi.org/10.1371/journal.pone.0095503			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743689	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100129
J	Kargel, C; Sartory, G; Kariofillis, D; Wiltfang, J; Muller, BW				Kaergel, Christian; Sartory, Gudrun; Kariofillis, Daniela; Wiltfang, Jens; Mueller, Bernhard W.			Mismatch Negativity Latency and Cognitive Function in Schizophrenia	PLOS ONE			English	Article							AUDITORY SENSORY MEMORY; EVENT-RELATED POTENTIALS; TEMPORAL INTEGRATION; ALZHEIMERS-DISEASE; DIFFERENT PATTERNS; STIMULUS DEVIANCE; DURATION; IMPAIRMENT; MMN; DEFICITS	Background: The Mismatch Negativity (MMN) is an event-related potential (ERP) sensitive to early auditory deviance detection and has been shown to be reduced in schizophrenia patients. Moreover, MMN amplitude reduction to duration deviant tones was found to be related to functional outcomes particularly, to neuropsychological (working memory and verbal domains) and psychosocial measures. While MMN amplitude is thought to be correlated with deficits of early sensory processing, the functional significance of MMN latency remains unclear so far. The present study focused on the investigation of MMN in relation to neuropsychological function in schizophrenia. Method: Forty schizophrenia patients and 16 healthy controls underwent a passive oddball paradigm (2400 binaural tones; 88% standards [1 kHz, 80 db, 80 ms], 11% frequency deviants [1.2 kHz], 11% duration deviants [40 ms]) and a neuropsychological test-battery. Patients were assessed with regard to clinical symptoms. Results: Compared to healthy controls schizophrenia patients showed diminished MMN amplitude and shorter MMN latency to both deviants as well as an impaired neuropsychological test performance. Severity of positive symptoms was related to decreased MMN amplitude to duration deviants. Furthermore, enhanced verbal memory performance was associated with prolonged MMN latency to frequency deviants in patients. Conclusion: The present study corroborates previous results of a diminished MMN amplitude and its association with positive symptoms in schizophrenia patients. Both, the findings of a shorter latency to duration and frequency deviants and the relationship of the latter with verbal memory in patients, emphasize the relevance of the temporal aspect of early auditory discrimination processing in schizophrenia.	[Kaergel, Christian; Mueller, Bernhard W.] Univ Duisburg Essen, Clin Psychiat & Psychotherapy, Essen, Germany; [Sartory, Gudrun; Kariofillis, Daniela] Univ Wuppertal, Dept Psychol, Wuppertal, Germany; [Kaergel, Christian] Univ Duisburg Essen, Inst Forens Psychiat, Essen, Germany; [Wiltfang, Jens] Univ Gottingen, Clin Psychiat & Psychotherapy, D-37073 Gottingen, Germany	University of Duisburg Essen; University of Wuppertal; University of Duisburg Essen; University of Gottingen	Kargel, C (corresponding author), Univ Duisburg Essen, Clin Psychiat & Psychotherapy, Essen, Germany.	christian.kaergel@uni-due.de	Müller, Bernhard W./D-9896-2011; Cruz e Silva, Odete/AAH-5595-2020	Müller, Bernhard W./0000-0002-9573-1417; Wiltfang, Jens/0000-0003-1492-5330	Deutsche Forschungsgemeinschaft (DFG) [SA 735/19-1, MU 1623/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding for this study was provided by the Deutsche Forschungsgemeinschaft (DFG; SA 735/19-1; MU 1623/5-1). The DFG had no further role in the study design nor in the collection, analysis and interpretation of the data, in the writing of the report and in the decision to submit the paper for publication.	Ahveninen J, 2006, BIOL PSYCHIAT, V60, P612, DOI 10.1016/j.biopsych.2006.04.015; ALAIN C, 1994, NEUROREPORT, V6, P140, DOI 10.1097/00001756-199412300-00036; Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; American Psychiatric Association Task Force on DSM-IV, 2000, SOC OCC FUNCT ASS SC; American Psychiatric Association Task Force on DSM-IV, 2000, GLOB ASS FUNCT SCAL; Badcock NA, 2013, PEERJ, V1, DOI 10.7717/peerj.38; Baldeweg T, 2006, INT J PSYCHOPHYSIOL, V59, P49, DOI 10.1016/j.ijpsycho.2005.07.014; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Bendixen A, 2012, INT J PSYCHOPHYSIOL, V83, P120, DOI 10.1016/j.ijpsycho.2011.08.003; Benton AL, 1976, MULTILINGUAL APHASIA; CATTS SV, 1995, AM J PSYCHIAT, V152, P213; Cheng CH, 2012, BIOL PSYCHOL, V89, P365, DOI 10.1016/j.biopsycho.2011.11.010; De Pascalis V, 2012, J INDIVID DIFFER, V33, P101, DOI 10.1027/1614-0001/a000078; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Domjan N, 2012, SCHIZOPHR RES, V139, P253, DOI 10.1016/j.schres.2012.06.002; Dulude L, 2010, J CLIN PSYCHOPHARM, V30, P541, DOI 10.1097/JCP.0b013e3181f0c9c6; Duncan CC, 2009, CLIN NEUROPHYSIOL, V120, P1883, DOI 10.1016/j.clinph.2009.07.045; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Engeland C, 2002, BRAIN COGNITION, V49, P232, DOI 10.1006/brcg.2001.1474; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Ferri R, 2003, CLIN NEUROPHYSIOL, V114, P1671, DOI 10.1016/S1388-2457(03)00153-6; Fisher DJ, 2012, SCHIZOPHR RES, V139, P237, DOI 10.1016/j.schres.2012.06.004; Fisher DJ, 2011, INT J PSYCHOPHYSIOL, V81, P245, DOI 10.1016/j.ijpsycho.2011.06.018; Foster SM, 2013, NEUROPSYCHOLOGIA, V51, P211, DOI 10.1016/j.neuropsychologia.2012.09.017; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Grzella I, 2001, J PSYCHIATR NEUROSCI, V26, P235; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; He JF, 1997, J NEUROSCI, V17, P2615; He JF, 1998, HEARING RES, V121, P147, DOI 10.1016/S0378-5955(98)00076-8; He JB, 2013, PSYCHOPHARMACOLOGY, V225, P353, DOI 10.1007/s00213-012-2816-8; Hermens DF, 2010, PROG NEURO-PSYCHOPH, V34, P822, DOI 10.1016/j.pnpbp.2010.03.019; Higuchi Y., 2013, PLOS ONE, V8; Holland PC, 1997, ANIM LEARN BEHAV, V25, P373, DOI 10.3758/BF03209846; Horton J, 2011, SCHIZOPHR RES, V126, P202, DOI 10.1016/j.schres.2010.11.028; Ikeda K, 2009, INT J NEUROSCI, V119, P778, DOI 10.1080/03008200802323842; Inami R, 2005, PHARMACOL BIOCHEM BE, V80, P453, DOI 10.1016/j.pbb.2005.01.001; Inami R, 2007, NEUROPSYCHOBIOLOGY, V56, P64, DOI 10.1159/000111536; Jakoby H, 2011, PSYCHOPHYSIOLOGY, V48, P1516, DOI 10.1111/j.1469-8986.2011.01227.x; Javitt DC, 2009, SCHIZOPHRENIA BULL, V35, P1059, DOI 10.1093/schbul/sbp110; Javitt DC, 2000, CLIN NEUROPHYSIOL, V111, P1733, DOI 10.1016/S1388-2457(00)00377-1; Javitt DC, 1998, EVOKED POTENTIAL, V108, P143, DOI 10.1016/S0168-5597(97)00073-7; Javitt DC, 1997, J ABNORM PSYCHOL, V106, P315, DOI 10.1037/0021-843X.106.2.315; Jessen F, 2001, NEUROSCI LETT, V309, P185, DOI 10.1016/S0304-3940(01)02072-9; KATHMANN N, 1995, BIOL PSYCHIAT, V37, P754, DOI 10.1016/0006-3223(94)00309-Q; Kawakubo Y, 2006, NEUROREPORT, V17, P1043, DOI 10.1097/01.wnr.0000221828.10846.ba; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keselman HJ, 2001, BRIT J MATH STAT PSY, V54, P1, DOI 10.1348/000711001159357; Kiang M, 2007, J INT NEUROPSYCH SOC, V13, P653, DOI 10.1017/S1355617707070816; Kumari V, 2005, NEUROSCI BIOBEHAV R, V29, P1021, DOI 10.1016/j.neubiorev.2005.02.006; Li Z, 2013, ASIA-PAC PSYCHIAT, V5, P69, DOI 10.1111/appy.12030; Lin Y. S., 2012, PLOS ONE, V7; Lopez L, 2003, ANN NY ACAD SCI, V999, P124, DOI 10.1196/annals.1284.013; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; Matuoka T, 2008, NEUROREPORT, V19, P1003, DOI 10.1097/WNR.0b013e328303ba66; Matuoka T, 2006, CLIN EEG NEUROSCI, V37, P223, DOI 10.1177/155005940603700312; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Michie PT, 2002, BIOL PSYCHIAT, V52, P749, DOI 10.1016/S0006-3223(02)01379-3; Miyanishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061152; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Mowszowski L, 2012, J ALZHEIMERS DIS, V30, P209, DOI 10.3233/JAD-2012-111868; Muller BW, 2002, NEUROIMAGE, V17, P231, DOI 10.1006/nimg.2002.1176; Muller BW, 2004, EUR PSYCHOL, V9, P96, DOI 10.1027/1016-9040.9.2.96; Muller BW, 2002, NEUROREPORT, V13, P1317; Murphy JR, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-45; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naismith SL, 2012, J AFFECT DISORDERS, V138, P71, DOI 10.1016/j.jad.2011.12.028; Oades RD, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-7; Picton TW, 2000, AUDIOL NEURO-OTOL, V5, P111, DOI 10.1159/000013875; Rasser PE, 2011, SCHIZOPHRENIA BULL, V37, P131, DOI 10.1093/schbul/sbp060; Rissling AJ, 2013, SCHIZOPHR RES, V146, P326, DOI 10.1016/j.schres.2013.01.035; Roberts TPL, 2012, NEUROREPORT, V23, P463, DOI 10.1097/WNR.0b013e32835202b6; Rosburg T, 2003, COGNITIVE BRAIN RES, V16, P83, DOI 10.1016/S0926-6410(02)00222-7; Sa&beta; H., 2003, DIAGNOSTISCHE KRITER; Salisbury DF, 2002, ARCH GEN PSYCHIAT, V59, P686, DOI 10.1001/archpsyc.59.8.686; Salisbury DF, 2003, ELECTROPHYSIOLOGY SC, P298; SAMS M, 1985, ELECTROEN CLIN NEURO, V62, P437, DOI 10.1016/0168-5597(85)90054-1; Schall U, 1999, INT J NEUROPSYCHOPH, V2, P83, DOI 10.1017/S1461145799001418; Schneider Kim-Fredrik, 2006, COMMUNICATION; SHELLEY AM, 1991, BIOL PSYCHIAT, V30, P1059, DOI 10.1016/0006-3223(91)90126-7; Shin KS, 2009, BIOL PSYCHIAT, V65, P1071, DOI 10.1016/j.biopsych.2008.12.024; Shutara Y, 1996, BRAIN TOPOGR, V8, P285, DOI 10.1007/BF01184786; Spreen O, 1998, COMPENDIUM NEUROPSYC; Sullivan K, 1996, J CLIN EXP NEUROPSYC, V18, P707, DOI 10.1080/01688639608408293; Tervaniemi M, 2000, NEUROSCI LETT, V279, P29, DOI 10.1016/S0304-3940(99)00941-6; Thonnessen H, 2008, BIOL PSYCHOL, V77, P205, DOI 10.1016/j.biopsycho.2007.10.009; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Tiitinen H, 1997, PROG NEURO-PSYCHOPH, V21, P751, DOI 10.1016/S0278-5846(97)00077-8; Todd J, 2003, CLIN NEUROPHYSIOL, V114, P2061, DOI 10.1016/S1388-2457(03)00246-3; Todd J, 2008, BIOL PSYCHIAT, V63, P58, DOI 10.1016/j.biopsych.2007.02.016; Todd J, 2012, INT J PSYCHOPHYSIOL, V83, P222, DOI 10.1016/j.ijpsycho.2011.10.003; Toyomaki A, 2008, PROG NEURO-PSYCHOPH, V32, P95, DOI 10.1016/j.pnpbp.2007.07.020; Umbricht D, 2005, SCHIZOPHR RES, V76, P1, DOI 10.1016/j.schres.2004.12.002; Von Aster M, 2006, DEUTSCHSPRACHIGE BEA; Wechsler D, 1987, MANUAL WESCHLER MEMO; Weickert TW, 2000, ARCH GEN PSYCHIAT, V57, P907, DOI 10.1001/archpsyc.57.9.907; Wittchen H.U., 1997, SKID STRUKTURIERTES; Wynn JK, 2010, BIOL PSYCHIAT, V67, P940, DOI 10.1016/j.biopsych.2009.11.024; Youn T, 2003, SCHIZOPHR RES, V59, P253, DOI 10.1016/S0920-9964(02)00154-8	99	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e84536	10.1371/journal.pone.0084536	http://dx.doi.org/10.1371/journal.pone.0084536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4VW	24740391	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900001
J	Velo-Anton, G; Godinho, R; Campos, JC; Brito, JC				Velo-Anton, Guillermo; Godinho, Raquel; Campos, Joao Carlos; Brito, Jose Carlos			Should I Stay or Should I Go? Dispersal and Population Structure in Small, Isolated Desert Populations of West African Crocodiles	PLOS ONE			English	Article							CROCODYLUS-MORELETII; AMPHIBIAN PERSISTENCE; MITOCHONDRIAL-DNA; GENETIC DIVERSITY; METABOLIC-RATE; WATER; CONSERVATION; EXTINCTION; HYBRIDIZATION; SOFTWARE	The maintenance of both spatial and genetic connectivity is paramount to the long-term persistence of small, isolated populations living in environments with extreme climates. We aim to identify the distribution of genetic diversity and assess population sub-structuring and dispersal across dwarfed desert populations of Crocodylus suchus, which occur in isolated groups, usually less than five individuals, along the mountains of Mauritania (West Africa). We used both invasive and non-invasive sampling methods and a combination of mitochondrial DNA (12 S and ND4) and microsatellite markers (32 loci and a subset of 12 loci). Our results showed high genetic differentiation and geographic structure in Mauritanian populations of C. suchus. We identified a metapopulation system acting within four river sub-basins (high gene flow and absence of genetic structure) and considerable genetic differentiation between sub-basins (F-ST range: 0.12-0.24) with rare dispersal events. Effective population sizes tend to be low within sub-basins while genetic diversity is maintained. Our study suggests that hydrographic networks (temporal connections along seasonal rivers during rainy periods) allow C. suchus to disperse and maintain metapopulation dynamics within sub-basins, which attenuate the loss of genetic diversity and the risk of extinction. We highlight the need of hydrographic conservation to protect vulnerable crocodiles isolated in small water bodies. We propose C. suchus as an umbrella species in Mauritania based on ecological affinities shared with other water-dependent species in desert environments.	[Velo-Anton, Guillermo; Godinho, Raquel; Campos, Joao Carlos; Brito, Jose Carlos] Univ Porto, Inst Ciencias Agr Vairao, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal; [Brito, Jose Carlos] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Velo-Anton, G (corresponding author), Univ Porto, Inst Ciencias Agr Vairao, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal.	guillermo.velo@cibio.up.pt; jcbrito@cibio.up.pt	Brito, José C./A-7831-2010; Antón, Guillermo Velo/I-7694-2013; Godinho, Raquel/L-6804-2013; Campos, João/L-7901-2013	Brito, José C./0000-0001-5444-8132; Antón, Guillermo Velo/0000-0002-9483-5695; Godinho, Raquel/0000-0002-4260-4799; Campos, João/0000-0002-9144-4680	National Geographic Society [8412-08]; Fundacao para a Ciencia e a Tecnologia through EU Programme COMPETE [FCT: PTDC/BIA BEC/099934/2008]; North Portugal Regional Operational Programme (ON.2 - O Novo Norte) under the National Strategic Reference Framework (NSRF) through the European Regional Development Fund (ERDF); FCT [SFRH/BPD/74834/2010, IF/564/2012, SFRH/BD/87885/2012, IF/00459/2013]	National Geographic Society(National Geographic Society); Fundacao para a Ciencia e a Tecnologia through EU Programme COMPETE; North Portugal Regional Operational Programme (ON.2 - O Novo Norte) under the National Strategic Reference Framework (NSRF) through the European Regional Development Fund (ERDF); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was partially supported by National Geographic Society (Grant 8412-08) and by Fundacao para a Ciencia e a Tecnologia (FCT: PTDC/BIA BEC/099934/2008) through EU Programme COMPETE and the project "Biodiversity, Ecology and Global Change" co-financed by North Portugal Regional Operational Programme 2007/2013 (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF). GV-A, RG, JCB, and JCC are supported by FCT (SFRH/BPD/74834/2010, IF/564/2012, SFRH/BD/87885/2012 and IF/00459/2013 respectively). Logistic support for fieldwork was given by Pedro Santos Lda (Trimble GPS), Off Road Power Shop, P.N. Banc d'Arguin (Mauritania), and Ministere Delegue aupres du Premier Ministre Charge de l'Environnement et du Developpement durable of Mauritania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Belkhir K, 2002, MOL ECOL NOTES, V2, P611, DOI 10.1046/j.1471-8286.2002.00273.x; Bilton DT, 2001, ANNU REV ECOL SYST, V32, P159, DOI 10.1146/annurev.ecolsys.32.081501.114016; Bishop JM, 2009, BIOL CONSERV, V142, P2335, DOI 10.1016/j.biocon.2009.05.016; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Brito J., 2011, CROCODILE SPECIALIST, V30, P7; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Brito JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014734; Bromham L, 2002, MOL BIOL EVOL, V19, P302, DOI 10.1093/oxfordjournals.molbev.a004083; Campos JC, 2012, J HYDROL, V464, P438, DOI 10.1016/j.jhydrol.2012.07.042; Chapman BB, 2011, ECOL LETT, V14, P871, DOI 10.1111/j.1461-0248.2011.01648.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper A, 2006, J ARID ENVIRON, V67, P116, DOI 10.1016/j.jaridenv.2006.02.003; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; Crooks K. R., 2006, CONNECTIVITY CONSERV; Davis LM, 2002, J EXP ZOOL, V294, P352, DOI 10.1002/jez.10189; de Thoisy B, 2006, BIOL CONSERV, V133, P474, DOI 10.1016/j.biocon.2006.07.009; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Drake NA, 2011, P NATL ACAD SCI USA, V108, P458, DOI 10.1073/pnas.1012231108; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewi M, 2010, AFR SECUR REV, V19, P64, DOI 10.1080/10246029.2010.539812; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fagan WF, 2006, ECOL LETT, V9, P51, DOI 10.1111/j.1461-0248.2005.00845.x; Fagan WF, 2002, ECOLOGY, V83, P3250, DOI 10.1890/0012-9658(2002)083[3250:RFAERI]2.0.CO;2; Falush D, 2003, GENETICS, V164, P1567; Faubet P, 2008, GENETICS, V178, P1491, DOI 10.1534/genetics.107.082560; Fitzsimmons NN, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P51; Fortuna MA, 2006, P ROY SOC B-BIOL SCI, V273, P1429, DOI 10.1098/rspb.2005.3448; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Galtier N, 2009, BIOL LETTERS, V5, P413, DOI 10.1098/rsbl.2008.0662; Glenn TC, 2002, J EXP ZOOL, V294, P312, DOI 10.1002/jez.10206; Gonzalez-Trujillo R, 2012, CONSERV GENET, V13, P1677, DOI 10.1007/s10592-012-0406-2; Gotelli NJ, 1999, EVOL ECOL RES, V1, P847; Grant EHC, 2010, P NATL ACAD SCI USA, V107, P6936, DOI 10.1073/pnas.1000266107; HASTINGS A, 1993, ECOLOGY, V74, P1362, DOI 10.2307/1940066; Hekkala E, 2011, MOL ECOL, V20, P4199, DOI 10.1111/j.1365-294X.2011.05245.x; Hermoso V, 2013, DIVERS DISTRIB, V19, P1031, DOI 10.1111/ddi.12082; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson PCD, 2007, GENETICS, V175, P827, DOI 10.1534/genetics.106.064618; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; Manel S, 2013, TRENDS ECOL EVOL, V28, P614, DOI 10.1016/j.tree.2013.05.012; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; Massot M, 2008, GLOBAL CHANGE BIOL, V14, P461, DOI 10.1111/j.1365-2486.2007.01514.x; McRae BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052604; Miles LG, 2009, CONSERV GENET, V10, P963, DOI 10.1007/s10592-008-9600-7; Milian-Garcia Y, 2011, J EXP ZOOL PART A, V315A, P358, DOI 10.1002/jez.683; Morrissey MB, 2009, AM NAT, V174, P875, DOI 10.1086/648311; Murphy NP, 2012, J BIOGEOGR, V39, P1573, DOI 10.1111/j.1365-2699.2012.02725.x; Nevado B, 2013, MOL ECOL, V22, P3933, DOI 10.1111/mec.12374; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.1111/j.1558-5646.1989.tb04226.x; Ray DA, 2004, CONSERV GENET, V5, P449, DOI 10.1023/B:COGE.0000041024.96928.fe; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodriguez D, 2011, CONSERV GENET, V12, P449, DOI 10.1007/s10592-010-0153-1; Cedeno-Vazquez JR, 2008, J EXP ZOOL PART A, V309A, P661, DOI 10.1002/jez.473; Ross JP., 1998, CROCODILES STATUS SU; Saccheri I, 1998, NATURE, V392, P491, DOI 10.1038/33136; Schmitz A, 2003, CR PALEVOL, V2, P703, DOI 10.1016/j.crpv.2003.07.002; Shine T, 2001, ORYX, V35, P260, DOI 10.1046/j.1365-3008.2001.00187.x; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; Shirley MH, 2009, ORYX, V43, P136, DOI 10.1017/S0030605309001586; Shkedy Y, 2000, CONSERV BIOL, V14, P200, DOI 10.1046/j.1523-1739.2000.98291.x; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Telleria JL, 2008, ORYX, V42, P292, DOI 10.1017/S0030605308007850; Trape S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004400; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Velo-Anton G, 2013, MOL ECOL, V22, P3261, DOI 10.1111/mec.12310; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	76	23	23	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94626	10.1371/journal.pone.0094626	http://dx.doi.org/10.1371/journal.pone.0094626			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740183	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900057
J	Lin, YC; Richburg, JH				Lin, Yi-Chen; Richburg, John H.			Characterization of the Role of Tumor Necrosis Factor Apoptosis Inducing Ligand (TRAIL) in Spermatogenesis through the Evaluation of Trail Gene-Deficient Mice	PLOS ONE			English	Article							NF-KAPPA-B; THYMOCYTE APOPTOSIS; CELL APOPTOSIS; JNK ACTIVATION; GERM-CELLS; ALPHA; RECEPTOR; DEATH; EXPRESSION; MEMBER	TRAIL (TNFSF10/Apo2L) is a member of the tumor necrosis factor (TNF) superfamily of proteins and is expressed in human and rodent testis. Although the functional role of TRAIL in spermatogenesis is not known, TRAIL is recognized to induce apoptosis via binding to its cognate receptors; DR4 (TRAIL-R1/TNFRSF10A) and DR5 (TRAIL-R2/TNFRSF10B). Here, we utilize Trail gene-deficient (Trail(-/-)) mice to evaluate the role of TRAIL in spermatogenesis by measuring testis weight, germ cell apoptosis, and spermatid head count at postnatal day (PND) 28 (pubertal) and PND 56 (adult). Trail(-/-) mice have significantly reduced testis to body weight ratios as compared to wild-type C57BL/6J at both ages. Also, Trail(-/-) mice (PND 28) show a dramatic increase in basal germ cell apoptotic index (AI, 16.77) as compared to C57BL/6J (3.5). In the testis of adult C57BL/6J mice, the AI was lower than in PND 28 C57BL/6J mice (2.2). However, in adult Trail(-/-) mice, the AI was still higher than that of controls (9.0); indicating a relative high incidence of germ cell apoptosis. Expression of cleaved caspase-8 (CC8) and cleaved caspase-9 (CC9) (markers of the extrinsic and intrinsic apoptotic pathway, respectively) revealed a twofold increase in the activity of both pathways in adult Trail(-/-) mice compared to C57BL/6J. Spermatid head counts in adult Trail(-/-) mice were dramatically reduced by 54% compared to C57BL/6J, indicating these animals suffer a marked decline in the production of mature spermatozoa. Taken together, these findings indicate that TRAIL is an important signaling molecule for maintaining germ cell homeostasis and functional spermatogenesis in the testis.	[Lin, Yi-Chen; Richburg, John H.] Univ Texas Austin, Coll Pharm, Dept Pharmacol & Toxicol, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Richburg, JH (corresponding author), Univ Texas Austin, Coll Pharm, Dept Pharmacol & Toxicol, Ctr Mol & Cellular Toxicol, Austin, TX 78712 USA.	john.richburg@austin.utexas.edu	Richburg, John H/P-4369-2014	Richburg, John H/0000-0001-6334-9777	National Institute of environmental Health Sciences [NIEHS/NIH 5R01ES016591]; National Institutes of Health Training Grant from the National Cancer Institute [T32 CA009480]; NATIONAL CANCER INSTITUTE [T32CA009480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007247, R01ES016591] Funding Source: NIH RePORTER	National Institute of environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health Training Grant from the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research is supported in part by the National Institute of environmental Health Sciences (NIEHS/NIH 5R01ES016591), and the National Institutes of Health Training Grant from the National Cancer Institute (T32 CA009480, Y-C.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chaudhary PM, 1997, IMMUNITY, V7, P821, DOI 10.1016/S1074-7613(00)80400-8; Cleophas T. J., 2006, STAT APPL CLIN TRIAL; Corazza N, 2004, CELL DEATH DIFFER, V11, pS213, DOI 10.1038/sj.cdd.4401525; Corazza N, 2004, CELL DEATH DIFFER, V11, pS122, DOI 10.1038/sj.cdd.4401542; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Dwyer Jessica L, 2012, Spermatogenesis, V2, P104; Grataroli R, 2004, MOL HUM REPROD, V10, P123, DOI 10.1093/molehr/gah016; Grataroli R, 2002, BIOL REPROD, V66, P1707, DOI 10.1095/biolreprod66.6.1707; Ishimura N, 2006, AM J PHYSIOL-GASTR L, V290, pG129, DOI 10.1152/ajpgi.00242.2005; Kavurma MM, 2008, J BIOL CHEM, V283, P7754, DOI 10.1074/jbc.M706927200; Koji T, 2003, ARCH HISTOL CYTOL, V66, P1, DOI 10.1679/aohc.66.1; Krieg A, 2003, BRIT J CANCER, V88, P918, DOI 10.1038/sj.bjc.6600772; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lamhamedi-Cherradi SE, 2003, DIABETES, V52, P2274, DOI 10.2337/diabetes.52.9.2274; Lin YC, 2010, TOXICOL SCI, V114, P335, DOI 10.1093/toxsci/kfq015; Lizama C, 2007, APOPTOSIS, V12, P499, DOI 10.1007/s10495-006-0012-1; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; McKee CM, 2006, APOPTOSIS, V11, P2237, DOI 10.1007/s10495-006-0288-1; Moreno RD, 2006, CELL TISSUE RES, V325, P533, DOI 10.1007/s00441-006-0186-4; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Park H. M., 2008, WORKING PAPER; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Richburg JH, 2000, ENDOCRINOLOGY, V141, P787, DOI 10.1210/en.141.2.787; ROBB GW, 1978, J REPROD FERTIL, V54, P103, DOI 10.1530/jrf.0.0540103; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Russell LD, 2002, BIOL REPROD, V66, P950, DOI 10.1095/biolreprod66.4.950; Russell LD, 2001, BIOL REPROD, V65, P318, DOI 10.1095/biolreprod65.1.318; Sedger LM, 2002, EUR J IMMUNOL, V32, P2246, DOI 10.1002/1521-4141(200208)32:8<2246::AID-IMMU2246>3.0.CO;2-6; Siegmund D, 2007, CELL SIGNAL, V19, P1172, DOI 10.1016/j.cellsig.2006.12.008; Song JH, 2007, CANCER RES, V67, P6946, DOI 10.1158/0008-5472.CAN-06-3896; Wang RA, 1998, BIOL REPROD, V58, P1250, DOI 10.1095/biolreprod58.5.1250; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1999, CANCER RES, V59, P2770; Yao PL, 2007, J BIOL CHEM, V282, P5420, DOI 10.1074/jbc.M609068200; Yokonishi T, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.108613; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	40	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93926	10.1371/journal.pone.0093926	http://dx.doi.org/10.1371/journal.pone.0093926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736722	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600035
J	Dow, LE; Nasr, Z; Saborowski, M; Ebbesen, SH; Manchado, E; Tasdemir, N; Lee, T; Pelletier, J; Lowe, SW				Dow, Lukas E.; Nasr, Zeina; Saborowski, Michael; Ebbesen, Saya H.; Manchado, Eusebio; Tasdemir, Nilgun; Lee, Teresa; Pelletier, Jerry; Lowe, Scott W.			Conditional Reverse Tet-Transactivator Mouse Strains for the Efficient Induction of TRE-Regulated Transgenes in Mice	PLOS ONE			English	Article							GENE-EXPRESSION; PANCREATIC-CANCER; CRE RECOMBINASE; MODELS; SYSTEM; ONCOGENE; TISSUES; CELLS	Tetracycline or doxycycline (dox)-regulated control of genetic elements allows inducible, reversible and tissue specific regulation of gene expression in mice. This approach provides a means to investigate protein function in specific cell lineages and at defined periods of development and disease. Efficient and stable regulation of cDNAs or non-coding elements (e. g. shRNAs) downstream of the tetracycline-regulated element (TRE) requires the robust expression of a tet-transactivator protein, commonly the reverse tet-transactivator, rtTA. Most rtTA strains rely on tissue specific promoters that often do not provide sufficient rtTA levels for optimal inducible expression. Here we describe the generation of two mouse strains that enable Cre-dependent, robust expression of rtTA3, providing tissue-restricted and consistent induction of TRE-controlled transgenes. We show that these transgenic strains can be effectively combined with established mouse models of disease, including both Cre/LoxP-based approaches and non Cre-dependent disease models. The integration of these new tools with established mouse models promises the development of more flexible genetic systems to uncover the mechanisms of development and disease pathogenesis.	[Dow, Lukas E.; Saborowski, Michael; Ebbesen, Saya H.; Manchado, Eusebio; Tasdemir, Nilgun; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Nasr, Zeina; Lee, Teresa; Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Ebbesen, Saya H.; Tasdemir, Nilgun] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; McGill University; Cold Spring Harbor Laboratory; McGill University; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pelletier, J (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.	jerry.pelletier@mcgill.ca; lowes@mskcc.org		Dow, Lukas/0000-0001-7048-1418	Cancer Target Discovery Development (CTDD) Consortium from the National Cancer Institute [NCI - CA168409]; Canadian Institutes of Health Research [CIHR - MOP-106530]; National Health and Medical Research Council (NHMRC) Overseas Biomedical Fellowship; NATIONAL CANCER INSTITUTE [U01CA168409, P30CA008748, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065094] Funding Source: NIH RePORTER	Cancer Target Discovery Development (CTDD) Consortium from the National Cancer Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Health and Medical Research Council (NHMRC) Overseas Biomedical Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Cancer Target Discovery Development (CTDD) Consortium from the National Cancer Institute (NCI - CA168409) and a grant from the Canadian Institutes of Health Research (CIHR - MOP-106530). LED was supported by a National Health and Medical Research Council (NHMRC) Overseas Biomedical Fellowship and SWL is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Das AT, 2004, J BIOL CHEM, V279, P18776, DOI 10.1074/jbc.M313895200; Dow LE, 2012, NATURE PROTOCOLS; Dow LE, 2012, CELL, V148, P1099, DOI 10.1016/j.cell.2012.02.023; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huijbers IJ, 2011, BIOESSAYS, V33, P701, DOI 10.1002/bies.201100018; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Saborowski M, 2014, GENE DEV, V28, P85, DOI 10.1101/gad.232082.113; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Takiguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054009; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wang L, 2008, NEUROBIOL DIS, V29, P400, DOI 10.1016/j.nbd.2007.10.004; Yu HMI, 2005, P NATL ACAD SCI USA, V102, P8615, DOI 10.1073/pnas.0500124102; Zuber J, 2011, GENE DEV, V25, P1628, DOI 10.1101/gad.17269211	22	50	51	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95236	10.1371/journal.pone.0095236	http://dx.doi.org/10.1371/journal.pone.0095236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743474	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000335309100093
J	Guo, LJ; Han, LJ; Yang, LY; Zeng, HC; Fan, DD; Zhu, YB; Feng, Y; Wang, GF; Peng, CF; Jiang, XT; Zhou, DJ; Ni, PX; Liang, CC; Liu, L; Wang, J; Mao, C; Fang, XD; Peng, M; Huang, JS				Guo, Lijia; Han, Lijuan; Yang, Laying; Zeng, Huicai; Fan, Dingding; Zhu, Yabin; Feng, Yue; Wang, Guofen; Peng, Chunfang; Jiang, Xuanting; Zhou, Dajie; Ni, Peixiang; Liang, Changcong; Liu, Lei; Wang, Jun; Mao, Chao; Fang, Xiaodong; Peng, Ming; Huang, Junsheng			Genome and Transcriptome Analysis of the Fungal Pathogen Fusarium oxysporum f. sp cubense Causing Banana Vascular Wilt Disease	PLOS ONE			English	Article							MAJOR FACILITATOR SUPERFAMILY; 2-COMPONENT HISTIDINE KINASE; RICE BLAST FUNGUS; MEDIATES APPRESSORIUM DIFFERENTIATION; MULTIDRUG-RESISTANCE TRANSPORTER; PEPTIDE SYNTHETASE GENE; SKN7 RESPONSE REGULATOR; OSMOTIC-STRESS RESPONSE; VIRULENCE FACTOR; ASPERGILLUS-FUMIGATUS	Background: The asexual fungus Fusarium oxysporum f. sp. cubense (Foc) causing vascular wilt disease is one of the most devastating pathogens of banana (Musa spp.). To understand the molecular underpinning of pathogenicity in Foc, the genomes and transcriptomes of two Foc isolates were sequenced. Methodology/Principal Findings: Genome analysis revealed that the genome structures of race 1 and race 4 isolates were highly syntenic with those of F. oxysporum f. sp. lycopersici strain Fol4287. A large number of putative virulence associated genes were identified in both Foc genomes, including genes putatively involved in root attachment, cell degradation, detoxification of toxin, transport, secondary metabolites biosynthesis and signal transductions. Importantly, relative to the Foc race 1 isolate (Foc1), the Foc race 4 isolate (Foc4) has evolved with some expanded gene families of transporters and transcription factors for transport of toxins and nutrients that may facilitate its ability to adapt to host environments and contribute to pathogenicity to banana. Transcriptome analysis disclosed a significant difference in transcriptional responses between Foc1 and Foc4 at 48 h post inoculation to the banana 'Brazil' in comparison with the vegetative growth stage. Of particular note, more virulence-associated genes were up regulated in Foc4 than in Foc1. Several signaling pathways like the mitogen-activated protein kinase Fmk1 mediated invasion growth pathway, the FGA1-mediated G protein signaling pathway and a pathogenicity associated two-component system were activated in Foc4 rather than in Foc1. Together, these differences in gene content and transcription response between Foc1 and Foc4 might account for variation in their virulence during infection of the banana variety 'Brazil'. Conclusions/Significance: Foc genome sequences will facilitate us to identify pathogenicity mechanism involved in the banana vascular wilt disease development. These will thus advance us develop effective methods for managing the banana vascular wilt disease, including improvement of disease resistance in banana.	[Guo, Lijia; Yang, Laying; Wang, Guofen; Liang, Changcong; Liu, Lei; Wang, Jun; Mao, Chao; Huang, Junsheng] Chinese Acad Trop Agr Sci, Minist Agr, Environm & Plant Protect Inst, Key Lab Monitoring & Control Trop Agr & Forest In, Haikou, Peoples R China; [Zeng, Huicai; Peng, Ming] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Haikou, Peoples R China; [Han, Lijuan; Fan, Dingding; Zhu, Yabin; Feng, Yue; Peng, Chunfang; Jiang, Xuanting; Zhou, Dajie; Ni, Peixiang; Fang, Xiaodong] BGI Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences; Beijing Genomics Institute (BGI)	Guo, LJ (corresponding author), Chinese Acad Trop Agr Sci, Minist Agr, Environm & Plant Protect Inst, Key Lab Monitoring & Control Trop Agr & Forest In, Haikou, Peoples R China.	heartone@126.com	Mao, Chao/AAM-6358-2020; Fang, Xiaodong/K-6743-2018	Fang, Xiaodong/0000-0001-7061-3337; , chao/0000-0002-8685-8539	Commonwealth industry (Agriculture) [200903049]; fundamental research funds for environment and plant protection institute; Chinese academy of tropical agricultural sciences [2008hzs1j001, 2009hzs1j003]	Commonwealth industry (Agriculture); fundamental research funds for environment and plant protection institute; Chinese academy of tropical agricultural sciences	This work was supported by the Commonwealth industry (Agriculture) Specific Fund(200903049) and the fundamental research funds for environment and plant protection institute, Chinese academy of tropical agricultural sciences (2008hzs1j001 and 2009hzs1j003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimanianda V, 2010, VIRULENCE, V1, P185, DOI 10.4161/viru.1.3.11317; Alex LA, 1996, P NATL ACAD SCI USA, V93, P3416, DOI 10.1073/pnas.93.8.3416; Amey RC, 2003, FUNGAL GENET BIOL, V39, P264, DOI 10.1016/S1087-1845(03)00061-6; Garcia-Sanchez MA, 2010, FUNGAL GENET BIOL, V47, P216, DOI 10.1016/j.fgb.2009.11.006; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Beckman C. H., 1987, The nature of wilt diseases of plants.; Bohnert HU, 2004, PLANT CELL, V16, P2499, DOI 10.1105/tpc.104.022715; Brandhorst TT, 1999, J EXP MED, V189, P1207, DOI 10.1084/jem.189.8.1207; Brito N, 2006, MOL PLANT MICROBE IN, V19, P25, DOI 10.1094/MPMI-19-0025; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Calabrese D, 2000, MICROBIOL-UK, V146, P2743, DOI 10.1099/00221287-146-11-2743; Calera JA, 2000, INFECT IMMUN, V68, P518, DOI 10.1128/IAI.68.2.518-525.2000; Callahan TM, 1999, MOL PLANT MICROBE IN, V12, P901, DOI 10.1094/MPMI.1999.12.10.901; Caracuel Z, 2003, MOL MICROBIOL, V48, P765, DOI 10.1046/j.1365-2958.2003.03465.x; Caracuel Z, 2005, MOL PLANT MICROBE IN, V18, P1140, DOI 10.1094/MPMI-18-1140; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Chan K, 2005, INFECT IMMUN, V73, P5438, DOI 10.1128/IAI.73.9.5438-5449.2005; Chen HQ, 2007, MOL MICROBIOL, V64, P755, DOI 10.1111/j.1365-2958.2007.05689.x; Chen LH, 2012, FUNGAL GENET BIOL, V49, P802, DOI 10.1016/j.fgb.2012.07.006; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Clemons KV, 2002, MED MYCOL, V40, P259, DOI 10.1080/mmy.40.3.259.262; Coenjaerts FEJ, 2006, FEMS YEAST RES, V6, P652, DOI 10.1111/j.1567-1364.2006.00065.x; Collemare J, 2008, NEW PHYTOL, V179, P196, DOI 10.1111/j.1469-8137.2008.02459.x; Covert SF, 1996, MOL GEN GENET, V251, P397; Crowhurst RN, 1997, MOL PLANT MICROBE IN, V10, P355, DOI 10.1094/MPMI.1997.10.3.355; DeZwaan TM, 1999, PLANT CELL, V11, P2013, DOI 10.1105/tpc.11.10.2013; Di Pietro A, 2003, MOL PLANT PATHOL, V4, P315, DOI [10.1046/j.1364-3703.2003.00180.x, 10.1046/J.1364-3703.2003.00180.X]; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Dufresne M, 2000, PLANT CELL, V12, P1579, DOI 10.1105/tpc.12.9.1579; Duyvesteijn RGE, 2005, MOL MICROBIOL, V57, P1051, DOI 10.1111/j.1365-2958.2005.04751.x; Fassler JS, 2011, EUKARYOT CELL, V10, P156, DOI 10.1128/EC.00245-10; Fleissner A, 2002, MOL PLANT MICROBE IN, V15, P102, DOI 10.1094/MPMI.2002.15.2.102; Gao QA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001264; Gehrke A, 2010, APPL ENVIRON MICROB, V76, P3989, DOI 10.1128/AEM.00052-10; Grice CM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00026; Han YK, 2004, CURR GENET, V46, P205, DOI 10.1007/s00294-004-0528-2; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Huang K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001335; Huitema E, 2005, MOL PLANT MICROBE IN, V18, P183, DOI 10.1094/MPMI-18-0183; Hung CY, 2002, INFECT IMMUN, V70, P3443, DOI 10.1128/IAI.70.7.3443-3456.2002; Ichinose H, 2012, BIOL PHARM BULL, V35, P833; Imazaki I, 2007, MOL MICROBIOL, V63, P737, DOI 10.1111/j.1365-2958.2006.05554.x; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; Izumitsu K, 2007, EUKARYOT CELL, V6, P171, DOI 10.1128/EC.00326-06; Jain S, 2005, FEMS MICROBIOL LETT, V243, P165, DOI 10.1016/j.femsle.2004.12.009; Jain S, 2003, CURR GENET, V43, P79, DOI 10.1007/s00294-003-0372-9; Jain S, 2002, CURR GENET, V41, P407, DOI 10.1007/s00294-002-0322-y; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; Jeong JS, 2007, FEMS MICROBIOL LETT, V273, P157, DOI 10.1111/j.1574-6968.2007.00796.x; Johnson RD, 2000, MOL PLANT MICROBE IN, V13, P742, DOI 10.1094/MPMI.2000.13.7.742; Joubert DA, 2007, MOL PLANT MICROBE IN, V20, P392, DOI 10.1094/MPMI-20-4-0392; Kang S, 2001, MOL PLANT MICROBE IN, V14, P671, DOI 10.1094/MPMI.2001.14.5.671; Kato N, 2009, CHEMBIOCHEM, V10, P920, DOI 10.1002/cbic.200800787; Kelkar HS, 1997, J BIOL CHEM, V272, P1589, DOI 10.1074/jbc.272.3.1589; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim S, 2005, MOL MICROBIOL, V57, P1224, DOI 10.1111/j.1365-2958.2005.04750.x; Kong CH, 2004, PHYTOCHEMISTRY, V65, P1123, DOI 10.1016/j.phytochem.2004.02.017; Krappmann S, 2004, MOL MICROBIOL, V52, P785, DOI 10.1111/j.1365-2958.2004.04015.x; Kruppa M, 2006, FEMS YEAST RES, V6, P149, DOI 10.1111/j.1567-1364.2006.00024.x; Li C, 2013, PLOS ONE, V8; Li DH, 2003, MOL PLANT MICROBE IN, V16, P545, DOI 10.1094/MPMI.2003.16.6.545; LI DX, 1995, MOL PLANT MICROBE IN, V8, P388, DOI 10.1094/MPMI-8-0388; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Lievens B, 2009, FEMS MICROBIOL LETT, V300, P201, DOI 10.1111/j.1574-6968.2009.01783.x; Liu XG, 2003, CURR GENET, V44, P95, DOI 10.1007/s00294-003-0428-x; Lopez-Berges MS, 2013, MOL MICROBIOL, V87, P49, DOI 10.1111/mmi.12082; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; MALONEY AP, 1994, MOL GEN GENET, V243, P506, DOI 10.1007/BF00284198; Martin-Udiroz M, 2004, MICROBIOL-SGM, V150, P3175, DOI 10.1099/mic.0.27236-0; Meldrum RA, 2012, AUSTRALAS PLANT PATH, V41, P551, DOI 10.1007/s13313-012-0122-x; Molina L, 2007, PLANT CELL, V19, P2293, DOI 10.1105/tpc.107.052332; Motoyama T, 2005, FUNGAL GENET BIOL, V42, P200, DOI 10.1016/j.fgb.2004.11.002; Motoyama T, 2008, CURR GENET, V54, P185, DOI 10.1007/s00294-008-0211-0; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; Nathues E, 2004, MOL PLANT MICROBE IN, V17, P383, DOI 10.1094/MPMI.2004.17.4.383; Nelson PE, 1981, FUSARIUM DIS BIOL TA, P457; Oeser B, 2002, FUNGAL GENET BIOL, V36, P176, DOI 10.1016/S1087-1845(02)00020-8; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Oide S, 2010, EUKARYOT CELL, V9, P1867, DOI 10.1128/EC.00150-10; Ospina-Giraldo MD, 2003, CURR GENET, V44, P49, DOI 10.1007/s00294-003-0419-y; PANACCIONE DG, 1992, P NATL ACAD SCI USA, V89, P6590, DOI 10.1073/pnas.89.14.6590; Patkar RN, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002888; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Podell S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r16; Pott GB, 2000, FUNGAL GENET BIOL, V31, P55, DOI 10.1006/fgbi.2000.1225; Prados-Rosales R, 2009, PROTEOMICS, V9, P4755, DOI 10.1002/pmic.200800950; Qi XZ, 2013, PHYSIOL MOL PLANT P, V84, P76, DOI 10.1016/j.pmpp.2013.07.007; Qutob D, 2002, PLANT J, V32, P361, DOI 10.1046/j.1365-313X.2002.01439.x; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; REIMMANN C, 1994, GENE, V146, P221, DOI 10.1016/0378-1119(94)90296-8; Rep M, 2005, MOL PLANT MICROBE IN, V18, P15, DOI 10.1094/MPMI-18-0015; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Rispail N, 2010, MOL PLANT PATHOL, V11, P395, DOI [10.1111/J.1364-3703.2010.00612.X, 10.1111/j.1364-3703.2010.00612.x]; Rogers LM, 2000, P NATL ACAD SCI USA, V97, P9813, DOI 10.1073/pnas.160271497; ROGERS LM, 1994, PLANT CELL, V6, P935, DOI 10.1105/tpc.6.7.935; Roldan-Arjona T, 1999, MOL PLANT MICROBE IN, V12, P852, DOI 10.1094/MPMI.1999.12.10.852; Roohparvar R, 2007, FUNGAL GENET BIOL, V44, P378, DOI 10.1016/j.fgb.2006.09.007; Rose JKC, 2002, PLANT CELL, V14, P1329, DOI 10.1105/tpc.002253; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Santos J. L., 2001, SCI SIGNAL, V98, P1; Siewers V, 2005, MOL PLANT MICROBE IN, V18, P602, DOI 10.1094/MPMI-18-0602; Singh P, 2004, INFECT IMMUN, V72, P2390, DOI 10.1128/IAI.72.4.2390-2394.2004; Singh S, 2012, MOL PLANT MICROBE IN, V25, P569, DOI 10.1094/MPMI-08-11-0217; Skamnioti P, 2007, PLANT CELL, V19, P2674, DOI 10.1105/tpc.107.051219; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stergiopoulos I, 2003, MOL PLANT MICROBE IN, V16, P689, DOI 10.1094/MPMI.2003.16.8.689; STLEGER RJ, 1992, GENE, V120, P119, DOI 10.1016/0378-1119(92)90019-L; Sun CB, 2006, PLANT CELL, V18, P3686, DOI 10.1105/tpc.105.037861; SWEIGARD JA, 1992, MOL GEN GENET, V232, P183, DOI 10.1007/BF00279995; TAKANO Y, 1995, MOL GEN GENET, V249, P162, DOI 10.1007/BF00290362; Talbot NJ, 1996, PLANT CELL, V8, P985, DOI 10.1105/tpc.8.6.985; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; Thatcher LF, 2012, MOL PLANT MICROBE IN, V25, P180, DOI 10.1094/MPMI-08-11-0212; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai HF, 1998, J BACTERIOL, V180, P3031, DOI 10.1128/JB.180.12.3031-3038.1998; Urban M, 1999, EMBO J, V18, P512, DOI 10.1093/emboj/18.3.512; van der Does HC, 2008, FUNGAL GENET BIOL, V45, P1257, DOI 10.1016/j.fgb.2008.06.002; van der Does HC, 2008, ENVIRON MICROBIOL, V10, P1475, DOI 10.1111/j.1462-2920.2007.01561.x; Viaud M, 2006, MOL PLANT MICROBE IN, V19, P1042, DOI 10.1094/MPMI-19-1042; Voigt CA, 2005, PLANT J, V42, P364, DOI 10.1111/j.1365-313X.2005.02377.x; Wang CF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002460; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; WELTRING KM, 1988, GENE, V68, P335, DOI 10.1016/0378-1119(88)90036-4; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Winnenburg R, 2008, NUCLEIC ACIDS RES, V36, pD572, DOI 10.1093/nar/gkm858; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; WurglerMurphy SM, 1997, TRENDS BIOCHEM SCI, V22, P172, DOI 10.1016/S0968-0004(97)01036-0; Yamada-Okabe T, 1999, J BACTERIOL, V181, P7243, DOI 10.1128/JB.181.23.7243-7247.1999; Yan X, 2011, FUNGAL GENET BIOL, V48, P144, DOI 10.1016/j.fgb.2010.09.005; Zhang HF, 2010, CURR GENET, V56, P517, DOI 10.1007/s00294-010-0319-x	136	95	104	3	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95543	10.1371/journal.pone.0095543	http://dx.doi.org/10.1371/journal.pone.0095543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743270	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100136
J	Resano-Mayor, J; Hernandez-Matias, A; Real, J; Moleon, M; Pares, F; Inger, R; Bearhop, S				Resano-Mayor, Jaime; Hernandez-Matias, Antonio; Real, Joan; Moleon, Marcos; Pares, Francesc; Inger, Richard; Bearhop, Stuart			Multi-Scale Effects of Nestling Diet on Breeding Performance in a Terrestrial Top Predator Inferred from Stable Isotope Analysis	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; BONELLIS EAGLE POPULATION; RESOURCE USE; PREY CHOICE; LARGE-SCALE; INDIVIDUAL SPECIALIZATION; HABITAT HETEROGENEITY; NICHE; SUCCESS; AGE	Inter-individual diet variation within populations is likely to have important ecological and evolutionary implications. The diet-fitness relationships at the individual level and the emerging population processes are, however, poorly understood for most avian predators inhabiting complex terrestrial ecosystems. In this study, we use an isotopic approach to assess the trophic ecology of nestlings in a long-lived raptor, the Bonelli's eagle Aquila fasciata, and investigate whether nestling dietary breath and main prey consumption can affect the species' reproductive performance at two spatial scales: territories within populations and populations over a large geographic area. At the territory level, those breeding pairs whose nestlings consumed similar diets to the overall population (i.e. moderate consumption of preferred prey, but complemented by alternative prey categories) or those disproportionally consuming preferred prey were more likely to fledge two chicks. An increase in the diet diversity, however, related negatively with productivity. The age and replacements of breeding pair members had also an influence on productivity, with more fledglings associated to adult pairs with few replacements, as expected in long-lived species. At the population level, mean productivity was higher in those population-years with lower dietary breadth and higher diet similarity among territories, which was related to an overall higher consumption of preferred prey. Thus, we revealed a correspondence in diet-fitness relationships at two spatial scales: territories and populations. We suggest that stable isotope analyses may be a powerful tool to monitor the diet of terrestrial avian predators on large spatio-temporal scales, which could serve to detect potential changes in the availability of those prey on which predators depend for breeding. We encourage ecologists and evolutionary and conservation biologists concerned with the multi-scale fitness consequences of inter-individual variation in resource use to employ similar stable isotope-based approaches, which can be successfully applied to complex ecosystems such as the Mediterranean.	[Resano-Mayor, Jaime; Hernandez-Matias, Antonio; Real, Joan; Pares, Francesc] Univ Barcelona, Dept Biol Anim, Equip Biol Conservacio, Barcelona, Catalonia, Spain; [Moleon, Marcos] Univ Miguel Hernandez, Dept Biol Aplicada, Alicante, Spain; [Inger, Richard] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Bearhop, Stuart] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn, Cornwall, England	University of Barcelona; Universidad Miguel Hernandez de Elche; University of Exeter; University of Exeter	Resano-Mayor, J (corresponding author), Univ Barcelona, Dept Biol Anim, Equip Biol Conservacio, Barcelona, Catalonia, Spain.	jresano@ub.edu	Bearhop, Stuart/G-3105-2012; Inger, Richard/D-3445-2009; Real, Joan/L-1590-2017; Moleón, Marcos/K-2875-2014; Resano Mayor, Jaime/L-3069-2017	Bearhop, Stuart/0000-0002-5864-0129; Inger, Richard/0000-0003-1660-3706; Moleón, Marcos/0000-0002-3126-619X; HERNANDEZ-MATIAS, ANTONIO/0000-0001-9810-8121; Real, Joan/0000-0003-1355-8938; Resano Mayor, Jaime/0000-0002-0962-6873	Ministerio de Ciencia e Innovacion, Gobierno de Espana [CGL2007-64805, CGL2010-17056]; Area d'Espais Naturals de la Diputacio de Barcelona; Miquel Torres S.A.; Departamento de Educacion, Gobierno de Navarra; Plan de Formacion y de I+D; Ministerio de Educacion, Gobierno de Espana; Plan Nacional de I+D+i	Ministerio de Ciencia e Innovacion, Gobierno de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Area d'Espais Naturals de la Diputacio de Barcelona; Miquel Torres S.A.; Departamento de Educacion, Gobierno de Navarra; Plan de Formacion y de I+D; Ministerio de Educacion, Gobierno de Espana; Plan Nacional de I+D+i	Funding for this work was provided by projects CGL2007-64805 and CGL2010-17056 from the "Ministerio de Ciencia e Innovacion, Gobierno de Espana'', the "Area d'Espais Naturals de la Diputacio de Barcelona", and Miquel Torres S.A. Fieldwork in France was carried out within the framework of the second National Action Plan for Bonelli's eagle from the "Ministere francais de l'Ecologie, de L'Energie, du Developpement Durable et de la Mer'' and coordinated by the DREAL LR "Direction Regionale de l'Environnement, de l'Amenagement et du Logement-Languedoc-Roussillon''. J. Resano-Mayor was supported by a predoctoral grant from the "Departamento de Educacion, Gobierno de Navarra; Plan de Formacion y de I+D 2008-2009", and M. Moleon by a postdoctoral grant from the "Ministerio de Educacion, Gobierno de Espana; Plan Nacional de I+D+i 2008-2011". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MS, 2009, J ANIM ECOL, V78, P848, DOI 10.1111/j.1365-2656.2009.01546.x; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Arroyo BE, 2006, BIRD STUDY, V53, P73, DOI 10.1080/00063650609461418; Bates D, 2012, LME4 LINEAR MIXED EF; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; BirdLife International, 2004, BIRDLIFE CONSERVATIO, V12; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.2307/3072028; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Carrete M, 2006, OIKOS, V112, P680, DOI 10.1111/j.0030-1299.2006.14528.x; Elmhagen B, 2000, J ZOOL, V251, P139, DOI 10.1111/j.1469-7998.2000.tb00599.x; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Forsman D, 1999, RAPTORS EUROPE MIDDL; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gil-Sanchez JM, 2004, BIOL CONSERV, V118, P685, DOI 10.1016/j.biocon.2003.10.017; Gil-Sanchez Jose Maria, 2000, Ardeola, V47, P1; Golet GH, 2000, AUK, V117, P82, DOI 10.1642/0004-8038(2000)117[0082:APCACG]2.0.CO;2; Hernandez-Matias A, 2013, ECOL MONOGR, V83, P239, DOI 10.1890/12-1248.1; Hernandez-Matias A, 2011, IBIS, V153, P846, DOI 10.1111/j.1474-919X.2011.01158.x; Hernandez-Matias A, 2011, J WILDLIFE MANAGE, V75, P856, DOI 10.1002/jwmg.102; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Inger R, 2008, J AVIAN BIOL, V39, P704, DOI 10.1111/j.1600-048X.2008.04332.x; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Inger R, 2010, J ANIM ECOL, V79, P974, DOI 10.1111/j.1365-2656.2010.01712.x; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson AL, 2009, ECOL LETT, V12, pE1, DOI 10.1111/j.1461-0248.2008.01233.x; Jackson MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031757; Katzner TE, 2005, IBIS, V147, P576, DOI 10.1111/j.1474-919X.2005.00443.x; KORPIMAKI E, 1992, CAN J ZOOL, V70, P2373, DOI 10.1139/z92-319; Kruger O, 2012, J ANIM ECOL, V81, P330, DOI 10.1111/j.1365-2656.2011.01904.x; L'Herault V, 2013, ECOL EVOL, V3, P2867, DOI 10.1002/ece3.675; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lefcheck JS, 2013, ECOLOGY, V94, P565, DOI 10.1890/12-0192.1; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Margalida A, 2007, J ORNITHOL, V148, P309, DOI 10.1007/s10336-007-0133-5; Margalida A, 2012, IBIS, V154, P184, DOI 10.1111/j.1474-919X.2011.01189.x; Moleon M, 2007, ARDEOLA, V54, P135; Moleon M, 2012, J ANIM ECOL, V81, P1154, DOI 10.1111/j.1365-2656.2012.02006.x; Moleon M, 2012, OECOLOGIA, V168, P679, DOI 10.1007/s00442-011-2134-6; Moleon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022851; Moleon M, 2009, J BIOGEOGR, V36, P1502, DOI 10.1111/j.1365-2699.2009.02078.x; Moleon M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002307; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Palma L, 2006, J APPL ECOL, V43, P1075, DOI 10.1111/j.1365-2664.2006.01213.x; Parnell A., 2008, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Penteriani V, 2003, IBIS, V145, pE77, DOI 10.1046/j.1474-919X.2003.00159.x; Pires MM, 2011, J ANIM ECOL, V80, P896, DOI 10.1111/j.1365-2656.2011.01818.x; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; Real J, 2000, J WILDLIFE DIS, V36, P64, DOI 10.7589/0090-3558-36.1.64; Real J., 2004, LIBRO ROJO AVES ESPA, P154; Real J., 1991, THESIS U BARCELONA B; Real J, 1987, RAPACI MEDITERRANEI, VXI, P185; Resano J, 2011, J RAPTOR RES, V45, P342, DOI 10.3356/JRR-11-13.1; Resano-Mayor J, 2014, IBIS, V156, P176, DOI 10.1111/ibi.12095; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Schreiber SJ, 2011, ECOLOGY, V92, P1582; Shannon CE, 1997, MATH THEORY COMMUNIC; Sorensen MC, 2009, J ANIM ECOL, V78, P460, DOI 10.1111/j.1365-2656.2008.01492.x; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Suryan RM, 2000, CONDOR, V102, P374, DOI 10.1650/0010-5422(2000)102[0374:PSAVFS]2.0.CO;2; Svanback R, 2005, EVOL ECOL RES, V7, P993; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; THOMPSON ID, 1990, OECOLOGIA, V83, P443, DOI 10.1007/BF00317193; Tinker MT, 2012, ECOL LETT, V15, P475, DOI 10.1111/j.1461-0248.2012.01760.x; Votier SC, 2004, CONDOR, V106, P275, DOI 10.1650/7261; Watson J., 2010, GOLDEN EAGLE, V2; Whitfield DP, 2009, IBIS, V151, P255, DOI 10.1111/j.1474-919X.2009.00924.x; Woo KJ, 2008, J ANIM ECOL, V77, P1082, DOI 10.1111/j.1365-2656.2008.01429.x	75	23	24	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95320	10.1371/journal.pone.0095320	http://dx.doi.org/10.1371/journal.pone.0095320			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743233	Green Published, gold			2022-12-25	WOS:000335309100103
J	Aroca, R; Chamorro, C; Vega, A; Ventura, I; Gomez, E; Perez-Cano, R; Blanca, M; Monteseirin, J				Aroca, Rocio; Chamorro, Cristina; Vega, Antonio; Ventura, Inmaculada; Gomez, Elisa; Perez-Cano, Ramon; Blanca, Miguel; Monteseirin, Javier			Immunotherapy Reduces Allergen-Mediated CD66b Expression and Myeloperoxidase Levels on Human Neutrophils from Allergic Patients	PLOS ONE			English	Article							ACTIVATION; CHILDREN; ANTIGENS; RELEASE	CD66b is a member of the carcinoembryonic antigen family, which mediates the adhesion between neutrophils and to endothelial cells. Allergen-specific immunotherapy is widely used to treat allergic diseases, and the molecular mechanisms underlying this therapy are poorly understood. The present work was undertaken to analyze A) the in vitro effect of allergens and immunotherapy on cell-surface CD66b expression of neutrophils from patients with allergic asthma and rhinitis and B) the in vivo effect of immunotherapy on cell-surface CD66b expression of neutrophils from nasal lavage fluid during the spring season. Myeloperoxidase expression and activity was also analyzed in nasal lavage fluid as a general marker of neutrophil activation. Results: CD66b cell-surface expression is upregulated in vitro in response to allergens, and significantly reduced by immunotherapy (p<0.001). Myeloperoxidase activity in nasal lavage fluid was also significantly reduced by immunotherapy, as were the neutrophil cell-surface expression of CD66b and myeloperoxidase (p<0.001). Interestingly, CD66b expression was higher in neutrophils from nasal lavage fluid than those from peripheral blood, and immunotherapy reduced the number of CD66(+)MPO(+) cells in nasal lavage fluid. Thus, immunotherapy positive effects might, at least in part, be mediated by the negative regulation of the CD66b and myeloperoxidase activity in human neutrophils.	[Aroca, Rocio; Chamorro, Cristina; Vega, Antonio; Ventura, Inmaculada; Gomez, Elisa; Monteseirin, Javier] Hosp Univ Virgen Macarena, Serv Reg Inmunol & Alergia, Seville, Spain; [Perez-Cano, Ramon; Monteseirin, Javier] Univ Seville, Fac Med, Dept Med, Seville, Spain; [Blanca, Miguel] Carlos Haya Hosp Fdn IMABIS, Res Lab, Malaga, Spain	Hospital Universitario Virgen Macarena; University of Sevilla; Hospital Carlos Haya	Monteseirin, J (corresponding author), Hosp Univ Virgen Macarena, Serv Reg Inmunol & Alergia, Seville, Spain.	fmonteseirin@us.es		Vega Rioja, Antonio/0000-0003-4698-9697	Junta de Andalucia (Ayudas Grupos de Investigacion); Fundacion Sanitaria Virgen Macarena; Fundacion Alergol, Spain; FIS-Thematic Networks and Co-Operative Research Centres RIRAAF [RD07-0064]	Junta de Andalucia (Ayudas Grupos de Investigacion)(Junta de Andalucia); Fundacion Sanitaria Virgen Macarena; Fundacion Alergol, Spain; FIS-Thematic Networks and Co-Operative Research Centres RIRAAF	This work was supported by grants from the Junta de Andalucia (Ayudas Grupos de Investigacion), Fundacion Sanitaria Virgen Macarena, and Fundacion Alergol, Spain. Funding also came from the FIS-Thematic Networks and Co-Operative Research Centres RIRAAF (RD07-0064). Javier Monteseirin is under the Programa de Intensificacion de la Actividad Investigadora del Sistema Nacional de Salud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipour A, 2013, EUR J CLIN INVEST, V43, P920, DOI 10.1111/eci.12121; Andersson JA, 2002, ALLERGY, V57, P718, DOI 10.1034/j.1398-9995.2002.23593.x; Beauchemin N, 1999, EXP CELL RES, V252, P243; Brown KA, 2006, LANCET, V368, P157, DOI 10.1016/S0140-6736(06)69005-3; Compalati E, 2014, CURR OPIN PULM MED, V20, P109, DOI 10.1097/MCP.0000000000000016; DUCKER TP, 1992, J LEUKOCYTE BIOL, V52, P11, DOI 10.1002/jlb.52.1.11; Feuk-Lagerstedt E, 1999, J IMMUNOL, V163, P5592; GEORAS SN, 1992, AM J RESP CELL MOL, V7, P261, DOI 10.1165/ajrcmb/7.3.261; GLEICH GJ, 1982, J ALLERGY CLIN IMMUN, V70, P261, DOI 10.1016/0091-6749(82)90062-8; GREIFF L, 1990, CLIN EXP ALLERGY, V20, P253, DOI 10.1111/j.1365-2222.1990.tb02680.x; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Kinhult J, 2003, CLIN EXP ALLERGY, V33, P1141, DOI 10.1046/j.1365-2222.2003.01682.x; KUIJPERS TW, 1992, J CELL BIOL, V118, P457, DOI 10.1083/jcb.118.2.457; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Mallia P, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-72; Mansson A, 2010, J INVEST ALLERG CLIN, V20, P476; Matsuoka T, 2013, ALLERGOL INT, V62, P403, DOI 10.2332/allergolint.13-RAI-0650; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Monteseirin J, 2005, CLIN EXP ALLERGY, V35, P1204, DOI 10.1111/j.1365-2222.2005.02320.x; Monteseirin J, 2004, J ASTHMA, V41, P639, DOI 10.1081/JAS-200026407; Monteseirin J, 2003, INT ARCH ALLERGY IMM, V131, P174, DOI 10.1159/000071483; Monteseirin J, 2009, J INVEST ALLERG CLIN, V19, P340; Monteseirin J, 2001, J ALLERGY CLIN IMMUN, V107, P623, DOI 10.1067/mai.2001.113566; Monteseirin J, 2004, J LEUKOCYTE BIOL, V76, P692, DOI 10.1189/jlb.0903441; Monteseirin J, 2007, J IMMUNOL, V179, P2634, DOI 10.4049/jimmunol.179.4.2634; National Asthma Education and Prevention Program, 2007, NIH PUBLICATION; Pajno GB, 2001, CLIN EXP ALLERGY, V31, P1392, DOI 10.1046/j.1365-2222.2001.01161.x; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; RuchaudSparagano MH, 1997, BRIT J HAEMATOL, V98, P612, DOI 10.1046/j.1365-2141.1997.2523070.x; Schmidt T, 2012, J LEUKOCYTE BIOL, V91, P791, DOI 10.1189/jlb.0911483; Skubitz KM, 1996, J LEUKOCYTE BIOL, V60, P106, DOI 10.1002/jlb.60.1.106; Veen JCCMI, 1998, CLIN EXP ALLERGY, V28, P606; Ventura I, 2014, PEDIAT ALLERG IMM-UK, V25, P129, DOI 10.1111/pai.12145; Zhao LS, 2004, J IMMUNOL METHODS, V293, P207, DOI 10.1016/j.jim.2004.08.009	34	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94558	10.1371/journal.pone.0094558	http://dx.doi.org/10.1371/journal.pone.0094558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740105	gold, Green Submitted, Green Published			2022-12-25	WOS:000336863900054
J	Cardona, PJ; Vilaplana, C				Cardona, Pere-Joan; Vilaplana, Cristina			Multiple Consecutive Infections Might Explain the Lack of Protection by BCG	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; INITIATION; VACCINES; MICE	Although contacts between tuberculosis patients may result in multiple consecutive infections (MCI), no experimental animal models consider this fact when used in basic studies. Moreover, the current TB vaccine (BCG) has demonstrated a limited protection in humans. In this study we evaluate the effect of tuberculosis MCI by way of a simple mathematical analysis using data from the low dose aerosol murine experimental model. The results show that a higher number of, or shorter intervals between, multiple consecutive infections reduce the protective effect of BCG. This is due to both the increase in bacillary load at the stationary level of the infection, and the protective immune response induced by the infection itself. This factor must therefore be taken into account when designing new prophylactic strategies as candidate vaccines for the replacement of BCG.	[Cardona, Pere-Joan; Vilaplana, Cristina] Fundacio Inst Invest Ciencies Salut Germans Trias, Unitat TB Expt, Badalona, Catalonia, Spain; [Cardona, Pere-Joan; Vilaplana, Cristina] UAB, Bellaterra, Catalonia, Spain; [Cardona, Pere-Joan; Vilaplana, Cristina] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Cardona, PJ (corresponding author), Fundacio Inst Invest Ciencies Salut Germans Trias, Unitat TB Expt, Badalona, Catalonia, Spain.	pjcardona@igtp.cat; cvilaplana@gmail.com	Cardona, Pere-Joan/A-5258-2011; Vilaplana, Cristina/K-7216-2012	Cardona, Pere-Joan/0000-0001-5623-7873; Vilaplana, Cristina/0000-0002-2808-7270	Spanish Government [FIS 011/01702, CP13/00174]	Spanish Government(Spanish GovernmentEuropean Commission)	This study was supported by the Spanish Government (project FIS 011/01702 and contract CP13/00174. The funders did not participate in the study design, collection, analysis and interpretation of data, writing of the manuscript, or in the decision to submit the manuscript for publication.	Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; Bru A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012985; Cardona PJ, 2009, INFECTION, V37, P80, DOI 10.1007/s15010-008-8087-y; Cardona PJ, 2004, EUR RESPIR J, V24, P1044, DOI 10.1183/09031936.04.00072604; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Delogu G, 2013, CLIN MICROBIOL INFEC; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Johnson L, 2007, TUBERCULOSIS, V87, P71, DOI 10.1016/j.tube.2006.04.002; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Lewinsohn DA, 2011, IMMUNOL REV, V240, P25, DOI 10.1111/j.1600-065X.2010.00997.x; Mollenkopf HJ, 2004, J INFECT DIS, V190, P588, DOI 10.1086/422394; Orme IM, 2005, TUBERCULOSIS, V85, P13, DOI 10.1016/j.tube.2004.08.001; Pai M, 2007, AM J RESP CRIT CARE, V175, P529, DOI 10.1164/rccm.200701-024ED; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Rieder HL, 2003, INT J TUBERC LUNG D, V7, pS333; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367	18	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94736	10.1371/journal.pone.0094736	http://dx.doi.org/10.1371/journal.pone.0094736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740286	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900061
J	Hache, S; Hobson, KA; Bayne, EM; Van Wilgenburg, SL; Villard, MA				Hache, Samuel; Hobson, Keith A.; Bayne, Erin M.; Van Wilgenburg, Steven L.; Villard, Marc-Andre			Tracking Natal Dispersal in a Coastal Population of a Migratory Songbird Using Feather Stable Isotope (delta H-2, delta S-34) Tracers	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; BREEDING DISPERSAL; HYDROGEN ISOTOPES; SULFUR ISOTOPES; BIRDS; ORIGINS; AGE; OVENBIRDS; PRECIPITATION; DISTRIBUTIONS	Adult birds tend to show high fidelity to their breeding territory or disperse over relatively short distances. Gene flow among avian populations is thus expected to occur primarily through natal dispersal. Although natal dispersal is a critical demographic process reflecting the area over which population dynamics take place, low recapture rates of birds breeding for the first time have limited our ability to reliably estimate dispersal rates and distances. Stable isotope approaches can elucidate origins of unmarked birds and so we generated year-and age-specific delta H-2 and delta S-34 feather isoscapes (ca. 180 000 km(2)) of coastal-breeding Ovenbirds (Seiurus aurocapilla) and used bivariate probability density functions to assign the likely natal areas of 35 males recruited as first-year breeders into a population located in northwestern New Brunswick, Canada. Most individuals (80-94% depending on the magnitude of an age correction factor used; i.e. 28-33 out of 35) were classified as residents (i.e. fledged within our study area) and estimated minimum dispersal distances of immigrants were between 40 and 240 km. Even when considering maximum dispersal distances, the likely origin of most first-year breeders was<200 km from our study area. Our method identified recruitment into our population from large geographic areas with relatively few samples whereas previous mark-recapture based methods have required orders of magnitude more individuals to describe dispersal at such geographic scales. Natal dispersal movements revealed here suggest the spatial scale over which many population processes are taking place and we suggest that conservation plans aiming to maintain populations of Ovenbirds and ecologically-similar species should consider management units within 100 or at most 200 km of target breeding populations.	[Hache, Samuel; Bayne, Erin M.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Hobson, Keith A.; Van Wilgenburg, Steven L.] Environm Canada, Saskatoon, SK, Canada; [Villard, Marc-Andre] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada	University of Alberta; Environment & Climate Change Canada; University of Moncton	Hache, S (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	hach@ualberta.ca	Hobson, Keith/Q-9306-2019	Van Wilgenburg, Steven/0000-0002-6742-4567; Bayne, Erin/0000-0002-0679-4521	Natural Sciences and Engineering Research Council of Canada (NSERC); New Brunswick Wildlife Trust Fund; Environment Canada; NSERC - J.D. Irving Ltd. Industrial Postgraduate Scholarship; NSERC Postgraduate Scholarship; Queen Elizabeth II Graduate Scholarship (University of Alberta); Dissertation Fellowship (University of Alberta)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Brunswick Wildlife Trust Fund; Environment Canada(CGIAR); NSERC - J.D. Irving Ltd. Industrial Postgraduate Scholarship; NSERC Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship (University of Alberta); Dissertation Fellowship (University of Alberta)	This study was supported by research grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to E.M.B., M.-A.V., and K.A.H., the New Brunswick Wildlife Trust Fund to M.-A.V., an operating grant from Environment Canada to K. A. H., and by a NSERC - J.D. Irving Ltd. Industrial Postgraduate Scholarship, NSERC Postgraduate Scholarship, Queen Elizabeth II Graduate Scholarship (University of Alberta), and a Dissertation Fellowship (University of Alberta) to S.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayne EM, 2001, AUK, V118, P380, DOI 10.1642/0004-8038(2001)118[0380:EOHFOP]2.0.CO;2; Bayne EM, 2002, ECOLOGY, V83, P1307, DOI 10.1890/0012-9658(2002)083[1307:ASOMOI]2.0.CO;2; Bullock JM, 2002, DISPERSAL ECOLOGY, P279; CHAMBERS LA, 1979, GEOMICROBIOL J, V1, P249, DOI 10.1080/01490457909377735; Colbert J, 2001, DISPERSAL; Coulton DW, 2010, WATERBIRDS, V33, P10, DOI 10.1675/063.033.0102; Dale S, 2005, BEHAV ECOL, V16, P20, DOI 10.1093/beheco/arh129; DANSGAARD W, 1964, TELLUS, V16, P436; Donovan T, 2006, AUK, V123, P500, DOI 10.1642/0004-8038(2006)123[500:TDIBAT]2.0.CO;2; DONOVAN TM, 1995, J FIELD ORNITHOL, V66, P247; Flockhart DTT, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1087; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; Garrard GE, 2012, J ANIM ECOL, V81, P14, DOI 10.1111/j.1365-2656.2011.01891.x; Gow EA, 2012, CAN J ZOOL, V90, P585, DOI 10.1139/Z2012-024; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Hache S, 2012, CAN J ZOOL, V90, P722, DOI 10.1139/Z2012-039; Hache S, 2013, ECOLOGY, V94, P861, DOI 10.1890/12-1025.1; Hache S, 2010, J ANIM ECOL, V79, P897, DOI 10.1111/j.1365-2656.2010.01694.x; Hallworth MT, 2013, AUK, V130, P273, DOI 10.1525/auk.2013.13037; Henaux V, 2011, METHODS ECOL EVOL, V2, P489, DOI 10.1111/j.2041-210X.2011.00107.x; Hijmans RJ., 2012, RASTER GEOGRAPHIC AN; Hobson KA, 2004, CONDOR, V106, P732, DOI 10.1650/7631; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 2003, OECOLOGIA, V136, P302, DOI 10.1007/s00442-003-1271-y; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; HOLMES RT, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P563; Jamieson RE, 2000, J GEOPHYS RES-ATMOS, V105, P20549, DOI 10.1029/2000JD900249; Kelly JF, 2005, ECOL APPL, V15, P1487, DOI 10.1890/04-1704; Kosciuch KL, 2008, J AVIAN BIOL, V39, P364, DOI 10.1111/j.0908-8857.2008.04170.x; Krouse HR, 1991, SCOPE, V43, P308; Lambrechts MM, 2010, ACTA ORNITHOL, V45, P1, DOI 10.3161/000164510X516047; Langin KM, 2007, OECOLOGIA, V152, P449, DOI 10.1007/s00442-007-0669-3; Lott CA, 2003, OECOLOGIA, V134, P505, DOI 10.1007/s00442-002-1153-8; McKim-Louder MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056059; Miller NG, 2011, BIOL LETTERS, V7, P43, DOI 10.1098/rsbl.2010.0525; Mosseler A., 2003, Environmental Reviews, V11, pS47, DOI 10.1139/a03-015; NASA Land Processes Distributed Active Archive Center, 2012, GDEX ASTER GLOB DEM; Ogden LJE, 2005, AVIAN CONSERV ECOL, V1; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Petit L. J., 1999, BIRDS N AM ONLINE; Poage MA, 2001, AM J SCI, V301, P1, DOI 10.2475/ajs.301.1.1; Poesel A, 2008, BEHAV ECOL SOCIOBIOL, V63, P153, DOI 10.1007/s00265-008-0644-y; Porneluzi P., 2011, BIRDS N AM ONLINE; Porneluzi PA, 2003, CONDOR, V105, P73, DOI 10.1650/0010-5422(2003)105[73:PBSARR]2.0.CO;2; Prochazka P, 2013, J AVIAN BIOL, V44, P541, DOI 10.1111/j.1600-048X.2013.00185.x; Pyle P., 1997, IDENTIFICATION GUI 1; RICH TD, 2004, PARTNERS FLIGHT N AM; Rimmer C. C., 2001, BIRDS N AM ONLINE; Royle JA, 2004, ECOL APPL, V14, P1780; Schaub M, 2013, ECOLOGY, V94, P1828, DOI 10.1890/12-1395.1; Sellick MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004735; Studds CE, 2012, DIVERS DISTRIB, V18, P919, DOI 10.1111/j.1472-4642.2012.00931.x; Sutherland GD, 2000, CONSERV ECOL, V4, DOI 10.5751/es-00184-040116; Szep T, 2009, J ORNITHOL, V150, P621, DOI 10.1007/s10336-009-0382-6; Tittler R, 2006, ECOLOGY, V87, P3029, DOI 10.1890/0012-9658(2006)87[3029:EOLSDA]2.0.CO;2; Tittler R, 2009, ECOGRAPHY, V32, P1051, DOI 10.1111/j.1600-0587.2009.05680.x; Valenzuela LO, 2011, RAPID COMMUN MASS SP, V25, P861, DOI 10.1002/rcm.4934; Villard MA, 2012, BIOL CONSERV, V155, P33, DOI 10.1016/j.biocon.2012.06.007; Ward MP, 2005, CONSERV BIOL, V19, P1528, DOI 10.1111/j.1523-1739.2005.00245.x; Wassenaar LI, 2008, TERR ECOL SER, V2, P21, DOI 10.1016/S1936-7961(07)00002-4; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wesolowski T, 2011, ACTA ORNITHOL, V46, P13, DOI 10.3161/000164511X589866; West JB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P1, DOI 10.1007/978-90-481-3354-3; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x; Winkler DW, 2011, BIRDS N AM; Wunder MB, 2005, OECOLOGIA, V144, P607, DOI 10.1007/s00442-005-0071-y; Zazzo A, 2011, RAPID COMMUN MASS SP, V25, P2371, DOI 10.1002/rcm.5131	69	22	22	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94437	10.1371/journal.pone.0094437	http://dx.doi.org/10.1371/journal.pone.0094437			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740314	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900044
J	Ingawa, K; Aruga, N; Matsumura, Y; Shibata, M; Osakabe, N				Ingawa, Kodai; Aruga, Nozomi; Matsumura, Yusuke; Shibata, Masahiro; Osakabe, Naomi			Alteration of the Systemic and Microcirculation by a Single Oral Dose of Flavan-3-Ols	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL-CELLS; CACAO LIQUOR; CARDIOVASCULAR RISK; SIGNALING PATHWAYS; VASCULAR FUNCTION; THEOBROMA-CACAO; HEALTHY HUMANS; BLOOD-PRESSURE; SHEAR-STRESS	Several systematic reviews have reported that flow mediated dilatation (FMD) was significantly increased in subjects after ingestion of chocolate that contains flavan-3-ols; however, the mechanisms responsible for this effect are not clear. In this study, we evaluated the effects of a single oral dose of flavan-3-ols on the systemic circulation and microcirculation in the cremaster muscle using intravital video microscopy in vivo. The cremaster muscle in rats was spread over a plastic chamber and a gastric tube was placed into the stomach. Blood flow in the cremasteric artery was determined using a laser Doppler flowmeter, while blood pressure and heart rate were measured by the tail-cuff method. Red blood cell velocity in arterioles and blood flow in the artery were significantly increased 5 min after the administration of 10 mg/kg flavan-3-ols compared with distilled water treatment. The number of capillaries recruited in the cremaster muscle was also significantly increased 15 min after treatment. Microscopic observation confirmed that increased shear stress on endothelial cells was maintained during the measurement period. The mean arterial blood pressure and heart rate were also significantly elevated soon after administration and returned to baseline before the end of the observation period. Plasma nitrate and nitrite levels, and NO phosphorylation of aortic tissue were significantly increased at 60 min after administration of flavan-3-ols. According to these results, a single oral dose of flavan-3-ols elevates blood pressure and flow transiently, and these effects induce NO production through increased shear stress on endothelial cells.	[Ingawa, Kodai; Aruga, Nozomi; Matsumura, Yusuke; Shibata, Masahiro; Osakabe, Naomi] Shibaura Inst Technol, Dept Biosci & Engn, Fukasaku, Munumaku Saitam, Japan	Shibaura Institute of Technology	Osakabe, N (corresponding author), Shibaura Inst Technol, Dept Biosci & Engn, Fukasaku, Munumaku Saitam, Japan.	nao-osa@sic.shibaura-it.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22580146]; Grants-in-Aid for Scientific Research [24650269] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (ID 22580146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2002, FREE RADICAL BIO MED, V33, P142, DOI 10.1016/S0891-5849(02)00871-7; Baba S, 2001, J NUTR, V131, P2885, DOI 10.1093/jn/131.11.2885; Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059; Birk GK, 2013, INT J SPORTS MED, V34, P409, DOI 10.1055/s-0032-1323829; Brossette T, 2011, EUR J NUTR, V50, P595, DOI 10.1007/s00394-011-0172-9; Buitrago-Lopez A, 2011, CHOCOLATE CONSUMPTIO; Byun EB, 2012, EUR J PHARMACOL, V692, P52, DOI 10.1016/j.ejphar.2012.07.011; Chen H, 2013, PHYSIOL BEHAV, V118, P152, DOI 10.1016/j.physbeh.2013.05.024; Davis ME, 2001, CIRC RES, V89, P1073, DOI 10.1161/hh2301.100806; Desch S, 2010, AM J HYPERTENS, V23, P97, DOI 10.1038/ajh.2009.213; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Hammerstone JF, 1999, J AGR FOOD CHEM, V47, P490, DOI 10.1021/jf980760h; Hatano T, 2002, PHYTOCHEMISTRY, V59, P749, DOI 10.1016/S0031-9422(02)00051-1; HONIG CR, 1980, AM J PHYSIOL, V238, pH31, DOI 10.1152/ajpheart.1980.238.1.H31; Hooper L, 2008, AM J CLIN NUTR, V88, P38, DOI 10.1093/ajcn/88.1.38; Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457; Katayama K, 2013, EUR J APPL PHYSIOL, V113, P349, DOI 10.1007/s00421-012-2442-5; Larsson SC, 2012, NEUROLOGY, V79, P1223, DOI 10.1212/WNL.0b013e31826aacfa; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Monahan KD, 1985, J APPL PHYSIOL, V111, P1568; Natsume M, 2003, FREE RADICAL BIO MED, V34, P840, DOI 10.1016/S0891-5849(02)01434-X; Natsume M, 2000, BIOSCI BIOTECH BIOCH, V64, P2581, DOI 10.1271/bbb.64.2581; Osakabe N, 1998, J NUTR SCI VITAMINOL, V44, P313, DOI 10.3177/jnsv.44.313; Rakobowchuk M, 2012, EXP PHYSIOL, V97, P375, DOI 10.1113/expphysiol.2011.062836; Ramirez-Sanchez I, 2011, AM J PHYSIOL-CELL PH, V300, pC880, DOI 10.1152/ajpcell.00406.2010; Ramirez-Sanchez I, 2010, HYPERTENSION, V55, P1398, DOI 10.1161/HYPERTENSIONAHA.109.147892; Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39; Sanbongi C, 1998, J AGR FOOD CHEM, V46, P454, DOI 10.1021/jf970575o; Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103; Shrime MG, 2011, J NUTR, V141, P1982, DOI 10.3945/jn.111.145482; Spencer JPE, 2001, ANTIOXID REDOX SIGN, V3, P1023, DOI 10.1089/152308601317203558; Taubert D, 2007, ARCH INTERN MED, V167, P626, DOI 10.1001/archinte.167.7.626; Tokede OA, 2011, EUR J CLIN NUTR, V65, P879, DOI 10.1038/ejcn.2011.64; WEBB RC, 1979, EXPERIENTIA, V35, P1476, DOI 10.1007/BF01962794; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217; Yamamoto K, 2011, J PHARMACOL SCI, V116, P323, DOI 10.1254/jphs.10R29FM	36	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94853	10.1371/journal.pone.0094853	http://dx.doi.org/10.1371/journal.pone.0094853			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740211	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900076
J	Yousif, M; Bell, TG; Mudawi, H; Glebe, D; Kramvis, A				Yousif, Mukhlid; Bell, Trevor G.; Mudawi, Hatim; Glebe, Dieter; Kramvis, Anna			Analysis of Ultra-Deep Pyrosequencing and Cloning Based Sequencing of the Basic Core Promoter/Precore/Core Region of Hepatitis B Virus Using Newly Developed Bioinformatics Tools	PLOS ONE			English	Article							E-ANTIGEN; CLINICAL-SIGNIFICANCE; PRECORE REGION; PROMOTER; MUTATIONS; STRAINS; GENOME; GENE; VARIABILITY; EXPRESSION	Aims: The aims of this study were to develop bioinformatics tools to explore ultra-deep pyrosequencing (UDPS) data, to test these tools, and to use them to determine the optimum error threshold, and to compare results from UDPS and cloning based sequencing (CBS). Methods: Four serum samples, infected with either genotype D or E, from HBeAg-positive and HBeAg-negative patients were randomly selected. UDPS and CBS were used to sequence the basic core promoter/precore region of HBV. Two online bioinformatics tools, the "Deep Threshold Tool" and the "Rosetta Tool'' (http://hvdr.bioinf.wits.ac.za/tools/), were built to test and analyze the generated data. Results: A total of 10952 reads were generated by UDPS on the 454 GS Junior platform. In the four samples, substitutions, detected at 0.5% threshold or above, were identified at 39 unique positions, 25 of which were non-synonymous mutations. Sample #2 (HBeAg-negative, genotype D) had substitutions in 26 positions, followed by sample #1 (HBeAg-negative, genotype E) in 12 positions, sample #3 (HBeAg-positive, genotype D) in 7 positions and sample #4 (HBeAg-positive, genotype E) in only four positions. The ratio of nucleotide substitutions between isolates from HBeAg-negative and HBeAg-positive patients was 3.5:1. Compared to genotype E isolates, genotype D isolates showed greater variation in the X, basic core promoter/precore and core regions. Only 18 of the 39 positions identified by UDPS were detected by CBS, which detected 14 of the 25 non-synonymous mutations detected by UDPS. Conclusion: UDPS data should be approached with caution. Appropriate curation of read data is required prior to analysis, in order to clean the data and eliminate artefacts. CBS detected fewer than 50% of the substitutions detected by UDPS. Furthermore it is important that the appropriate consensus (reference) sequence is used in order to identify variants correctly.	[Yousif, Mukhlid; Bell, Trevor G.; Kramvis, Anna] Univ Witwatersrand, Dept Internal Med, Hepatitis Virus Divers Res Programme, Johannesburg, Gauteng, South Africa; [Mudawi, Hatim] Univ Khartoum, Fac Med, Dept Med, Khartoum, Sudan; [Glebe, Dieter] Univ Giessen, Inst Med Virol, Natl Reference Ctr Hepatitis B&D, D-35390 Giessen, Hesse, Germany	University of Witwatersrand; University of Khartoum; Justus Liebig University Giessen	Kramvis, A (corresponding author), Univ Witwatersrand, Dept Internal Med, Hepatitis Virus Divers Res Programme, Johannesburg, Gauteng, South Africa.	Anna.Kramvis@wits.ac.za	Yousif, Mukhlid/AAD-6755-2019; Bell, Trevor Graham/B-7388-2016	Yousif, Mukhlid/0000-0002-8707-2255; Bell, Trevor Graham/0000-0003-2630-7513; Kramvis, Anna/0000-0001-6006-3765	Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) of the special African-German collaborative programme, "Africa Initiative" [GL595/3-1]; Faculty of Health Sciences, University of the Witwatersrand; University of the Witwatersrand (SPARC); National Research Foundation of South Africa (GUN) [86215]	Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) of the special African-German collaborative programme, "Africa Initiative"; Faculty of Health Sciences, University of the Witwatersrand; University of the Witwatersrand (SPARC); National Research Foundation of South Africa (GUN)	The authors acknowledge financial support from the Deutsche Forschungsgemeinschaft (DFG; German Research Foundation) of the special African-German collaborative programme, "Africa Initiative", (Grant GL595/3-1 to AK, HM and DG), Faculty of Health Sciences, University of the Witwatersrand. TB received post-doctoral funding from the University of the Witwatersrand (SPARC) and the National Research Foundation of South Africa (GUN #86215). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell TG, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-62; Brodin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070388; CARMAN WF, 1989, LANCET, V2, P588; Desmond CP, 2012, J VIROL, V86, P1181, DOI 10.1128/JVI.05308-11; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Homs M, 2011, NUCLEIC ACIDS RES, V39, P8457, DOI 10.1093/nar/gkr451; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ijaz S, 2008, J MED VIROL, V80, P1160, DOI 10.1002/jmv.21206; JEANJEAN O, 1989, VIROLOGY, V170, P99, DOI 10.1016/0042-6822(89)90356-5; Kramvis A, 1999, J VIRAL HEPATITIS, V6, P415, DOI 10.1046/j.1365-2893.1999.00189.x; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Mizokami M, 1997, J MOL EVOL, V44, pS83, DOI 10.1007/PL00000061; Ni YH, 2004, PEDIATR RES, V56, P396, DOI 10.1203/01.PDR.0000136282.20470.87; OKAMOTO H, 1994, J VIROL, V68, P8102, DOI 10.1128/JVI.68.12.8102-8110.1994; Ouneissa R, 2012, J MED VIROL, V84, P1719, DOI 10.1002/jmv.23394; R Development Core Team, 2005, R LANG ENV STAT COMP; Radecke K, 2000, J MED VIROL, V62, P479, DOI 10.1002/1096-9071(200012)62:4<479::AID-JMV13>3.0.CO;2-M; Ramirez C, 2013, ANTIVIRAL RES; Revill P, 2010, J MED VIROL, V82, P104, DOI 10.1002/jmv.21645; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Sendi H, 2005, J GEN VIROL, V86, P2451, DOI 10.1099/vir.0.81023-0; Settles M, 2011, RSFFREADER RSFFREADE; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; TAKAHASHI K, 1995, J GEN VIROL, V76, P3159, DOI 10.1099/0022-1317-76-12-3159; Veazjalali M, 2009, J VIRAL HEPATITIS, V16, P259, DOI 10.1111/j.1365-2893.2009.01069.x; Wu J-F, 2013, J INFECT DIS; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Yousif M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-328; Zhu R, 2008, PATHOL RES PRACT, V204, P731, DOI 10.1016/j.prp.2008.05.001	37	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95377	10.1371/journal.pone.0095377	http://dx.doi.org/10.1371/journal.pone.0095377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740330	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900136
J	Courtois, A; Berthou, C; Guezennec, J; Boisset, C; Bordron, A				Courtois, Anthony; Berthou, Christian; Guezennec, Jean; Boisset, Claire; Bordron, Anne			Exopolysaccharides Isolated from Hydrothermal Vent Bacteria Can Modulate the Complement System	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; POLYSACCHARIDES; PATHWAY; C1Q; ACTIVATION; EXPRESSION; ANTITUMOR; CLEAVAGE; BINDING; C3B	The complement system is involved in the defence against bacterial infection, or in the elimination of tumour cells. However, disturbances in this system contributes to the pathogenesis of various inflammatory diseases. The efficiency of therapeutic anti-tumour antibodies is enhanced when the complement system is stimulated. In contrast, cancer cells are able to inhibit the complement system and thus proliferate. Some marine molecules are currently being developed as new drugs for use in humans. Among them, known exopolyssacharides (EPSs) generally originate from fungi, but few studies have been performed on bacterial EPSs and even fewer on EPSs extracted from deep-sea hydrothermal vent microbes. For use in humans, these high molecular weight EPSs must be depolymerised. Furthermore, the over-sulphation of EPSs can modify their biological activity. The aim of this study was to investigate the immunodulation of the complement system by either native or over-sulphated low molecular weight EPSs isolated from vent bacteria in order to find pro or anti-activators of complement.	[Courtois, Anthony; Guezennec, Jean; Boisset, Claire] IFREMER, Biotechnol & Marine Mol Lab, Brest, France; [Courtois, Anthony; Berthou, Christian; Bordron, Anne] Univ Hosp Brest, Cellular Therapy & Immunobiol Canc Lab, Brest, France	Ifremer; CHU Brest; Universite de Bretagne Occidentale	Bordron, A (corresponding author), Univ Hosp Brest, Cellular Therapy & Immunobiol Canc Lab, Brest, France.	anne.bordron@univ-brest.fr	Bordron, Anne/Y-1615-2019	Bordron, Anne/0000-0002-7886-2546	Brest Metropole Oceane; "Celine et Stephane" association; Canceropole Grand Ouest	Brest Metropole Oceane(Region Bretagne); "Celine et Stephane" association; Canceropole Grand Ouest	This work was supported by Brest Metropole Oceane, the "Celine et Stephane" association and Canceropole Grand Ouest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto MF, 2008, THROMB RES, V122, P109, DOI 10.1016/j.thromres.2007.09.001; Arena A, 2006, INT IMMUNOPHARMACOL, V6, P8, DOI 10.1016/j.intimp.2005.07.004; Blondin C, 1996, BIOMATERIALS, V17, P597, DOI 10.1016/0142-9612(96)88710-2; Caldwell EEO, 1999, ARCH BIOCHEM BIOPHYS, V361, P215, DOI 10.1006/abbi.1998.0996; Cheng SC, 2012, EUR J IMMUNOL, V42, P993, DOI 10.1002/eji.201142057; Courtois A, 2008, MAR DRUGS, V6, P407, DOI [10.3390/md20080019, 10.3390/md6030407]; Courtois A, 2012, ELECTRON J BIOTECHN, V15, DOI 10.2225/vol15-issue5-fulltext-3; Gadjeva M, 2001, CURR OPIN IMMUNOL, V13, P74, DOI 10.1016/S0952-7915(00)00185-0; Galili U, 2001, BIOCHIMIE, V83, P557, DOI 10.1016/S0300-9084(01)01294-9; GOOD AH, 1992, TRANSPL P, V24, P559; Hodoniczky J, 2005, BIOTECHNOL PROGR, V21, P1644, DOI 10.1021/bp050228w; Hosszu KK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00038; Hu WG, 2011, CANCER RES, V71, P2298, DOI 10.1158/0008-5472.CAN-10-3016; Jokiranta TS, 2001, INT IMMUNOPHARMACOL, V1, P495, DOI 10.1016/S1567-5769(00)00042-4; Jouault SC, 2001, BBA-GEN SUBJECTS, V1528, P141, DOI 10.1016/S0304-4165(01)00185-4; Kazatchkine M, 1985, DOSAGES HEMOLYTIQUES, P15; Khalikova T. A., 2006, Experimental Oncology, V28, P308; Kirschfink M, 1997, J IMMUNOL, V158, P1324; Kwang-Soon S, 2007, FOOD TECHNOL BIOTECH, V45, P319; LIJOUR Y, 1994, ANAL BIOCHEM, V220, P244, DOI 10.1006/abio.1994.1334; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lutz HU, 1996, BLOOD, V88, P184; MaigaRevel O, 1997, CARBOHYD POLYM, V32, P89, DOI 10.1016/S0144-8617(96)00171-3; Makino S, 2006, J DAIRY SCI, V89, P2873, DOI 10.3168/jds.S0022-0302(06)72560-7; Makrides SC, 1998, PHARMACOL REV, V50, P59; Markiewski MM, 2007, AM J PATHOL, V171, P715, DOI 10.2353/ajpath.2007.070166; McDonnell JM, 2001, CURR OPIN CHEM BIOL, V5, P572, DOI 10.1016/S1367-5931(00)00251-9; MULLEREB.HJ, 1969, ANNU REV BIOCHEM, V38, P389, DOI 10.1146/annurev.bi.38.070169.002133; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Mulloy B, 2000, J BIOTECHNOL, V77, P123, DOI 10.1016/S0168-1656(99)00211-4; Nardella A, CARBOHYDR RES, V289, P201; Nwodo UU, 2012, INT J MOL SCI, V13, P14002, DOI 10.3390/ijms131114002; OKUTANI K, 1984, B JPN SOC SCI FISH, V50, P1035; Raguenes G, 1997, INT J SYST BACTERIOL, V47, P989, DOI 10.1099/00207713-47-4-989; Raguenes GHC, 1997, J APPL MICROBIOL, V82, P422, DOI 10.1046/j.1365-2672.1997.00125.x; Rougeaux H, 1999, CARBOHYD RES, V322, P40, DOI 10.1016/S0008-6215(99)00214-1; Roumenina LT, 2011, J IMMUNOL, V187, P4369, DOI 10.4049/jimmunol.1101749; Rudd PM, 2004, TRENDS BIOTECHNOL, V22, P524, DOI 10.1016/j.tibtech.2004.07.012; TALMONT F, 1991, FEBS LETT, V281, P55, DOI 10.1016/0014-5793(91)80357-9; Tissot B, 2005, BIOCHEMISTRY-US, V44, P2602, DOI 10.1021/bi047802h; Tissot B, 2003, GLYCOBIOLOGY, V13, p29G, DOI 10.1093/glycob/cwg126; Triolo G, 2003, CLIN EXP RHEUMATOL, V21, P225; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; VUKAJLOVICH SW, 1986, INFECT IMMUN, V53, P480, DOI 10.1128/IAI.53.3.480-485.1986; Yamamoto F, 2004, Immunohematology, V20, P3; Zanchetta P, 2003, CALCIFIED TISSUE INT, V73, P232, DOI 10.1007/s00223-002-2081-7; Zanchetta P, 2003, CALCIFIED TISSUE INT, V72, P74, DOI 10.1007/s00223-001-2091-x	47	13	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94965	10.1371/journal.pone.0094965	http://dx.doi.org/10.1371/journal.pone.0094965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736648	gold, Green Published			2022-12-25	WOS:000336922600113
J	Dutta, S; Teresinski, HJ; Smith, MD				Dutta, Siddhartha; Teresinski, Howard J.; Smith, Matthew D.			A Split-Ubiquitin Yeast Two-Hybrid Screen to Examine the Substrate Specificity of atToc159 and atToc132, Two Arabidopsis Chloroplast Preprotein Import Receptors	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; PLASTID TRANSIT PEPTIDES; OUTER ENVELOPE MEMBRANE; N-TERMINAL DOMAIN; PRECURSOR PROTEINS; IN-VIVO; MOLECULAR CHAPERONE; TARGETING PEPTIDES; DISTINCT PATHWAYS; COUPLED RECEPTOR	Post-translational import of nucleus-encoded chloroplast pre-proteins is critical for chloroplast biogenesis, and the Toc159 family of proteins serve as receptors for the process. Toc159 shares with other members of the family (e. g. Toc132), homologous GTPase (G-) and Membrane (M-) domains, but a highly dissimilar N-terminal acidic (A-) domain. Although there is good evidence that atToc159 and atToc132 from Arabidopsis mediate the initial sorting step, preferentially recognizing photosynthetic and non-photosynthetic preproteins, respectively, relatively few chloroplast preproteins have been assigned as substrates for particular members of the Toc159 family, which has limited the proof for the hypothesis. The current study expands the number of known preprotein substrates for members of the Arabidopsis Toc159 receptor family using a split-ubiquitin membrane-based yeast two-hybrid system using the atToc159 G-domain (Toc159G), atToc132 G-domain (Toc132G) and atToc132 A-plus G-domains (Toc132AG) as baits. cDNA library screening with all three baits followed by pairwise interaction assays involving the 81 chloroplast preproteins identified show that although G-domains of the Toc159 family are sufficient for preprotein recognition, they alone do not confer specificity for preprotein subclasses. The presence of the A-domain fused to atToc132G (Toc132AG) not only positively influences its specificity for non-photosynthetic preproteins, but also negatively regulates the ability of this receptor to interact with a subset of photosynthetic preproteins. Our study not only substantiates the fact that atToc132 can serve as a receptor by directly binding to chloroplast preproteins but also proposes the existence of subsets of preproteins with different but overlapping affinities for more than one member of the Toc159 receptor family.	[Dutta, Siddhartha; Teresinski, Howard J.; Smith, Matthew D.] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada	Wilfrid Laurier University	Smith, MD (corresponding author), Wilfrid Laurier Univ, Dept Biol, Waterloo, ON N2L 3C5, Canada.	msmith@wlu.ca	DUTTA, SIDDHARTHA/ABG-6036-2020; Smith, Matthew/M-4726-2014	DUTTA, SIDDHARTHA/0000-0002-8040-1853; Smith, Matthew/0000-0002-2855-5126	Natural Sciences and Engineering Research Council of Canada [312143-10]; Ontario Early Researcher Award [ER07-03-166]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario)	Funding to MDS (Discovery Grant #312143-10 from the Natural Sciences and Engineering Research Council of Canada and Ontario Early Researcher Award #ER07-03-166) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson H, 2010, PLANT J, V63, P297, DOI 10.1111/j.1365-313X.2010.04242.x; Auerbach D, 2002, PROTEOMICS, V2, P611, DOI 10.1002/1615-9861(200206)2:6<611::AID-PROT611>3.0.CO;2-Y; Bauer J, 2000, NATURE, V403, P203, DOI 10.1038/35003214; Bauer J, 2002, J CELL BIOL, V159, P845, DOI 10.1083/jcb.200208018; Becker T, 2004, EMBO J, V23, P520, DOI 10.1038/sj.emboj.7600089; Bedard J, 2007, J BIOL CHEM, V282, P21404, DOI 10.1074/jbc.M611545200; Benz JP, 2009, PLANT CELL, V21, P3965, DOI 10.1105/tpc.109.069815; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Bhushan S, 2006, FEBS LETT, V580, P3966, DOI 10.1016/j.febslet.2006.06.018; Bilgin DD, 2010, PLANT CELL ENVIRON, V33, P1597, DOI 10.1111/j.1365-3040.2010.02167.x; Bionda T, 2010, J MOL BIOL, V402, P510, DOI 10.1016/j.jmb.2010.07.052; Bischof S, 2011, PLANT CELL, V23, P3911, DOI 10.1105/tpc.111.092882; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Bruce BD, 2000, TRENDS CELL BIOL, V10, P440, DOI 10.1016/S0962-8924(00)01833-X; Bruce BD, 2001, BBA-MOL CELL RES, V1541, P2, DOI 10.1016/S0167-4889(01)00149-5; Burke D., 2000, METHODS YEAST GENETI; Caliebe A, 1997, EMBO J, V16, P7342, DOI 10.1093/emboj/16.24.7342; Chotewutmontri P, 2012, PLANT CELL, V24, P3040, DOI 10.1105/tpc.112.098327; Constan D, 2004, PLANT J, V38, P93, DOI 10.1111/j.1365-313X.2004.02024.x; Dutta S, 2009, PLANT PHYSIOL, V150, P1050, DOI 10.1104/pp.109.137265; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ehlert A, 2006, PLANT J, V46, P890, DOI 10.1111/j.1365-313X.2006.02731.x; Fashena SJ, 2000, GENE, V250, P1, DOI 10.1016/S0378-1119(00)00182-7; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Fetchko M, 2004, METHODS, V32, P349, DOI 10.1016/j.ymeth.2003.10.010; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; FRIEDMAN AL, 1989, PLANT PHYSIOL, V89, P993, DOI 10.1104/pp.89.3.993; GALILI G, 1995, PLANT CELL, V7, P899, DOI 10.2307/3870045; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gutensohn M, 2000, PLANT J, V23, P771, DOI 10.1046/j.1365-313x.2000.00849.x; Hiltbrunner A, 2004, PLANT MOL BIOL, V54, P427, DOI 10.1023/B:PLAN.0000036374.92546.51; HIRSCH S, 1994, SCIENCE, V266, P1989, DOI 10.1126/science.7801125; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HURT EC, 1986, EMBO J, V5, P1343, DOI 10.1002/j.1460-2075.1986.tb04365.x; Infanger S, 2011, MOL PLANT, V4, P252, DOI 10.1093/mp/ssq071; Inoue H, 2010, PLANT CELL, V22, P1947, DOI 10.1105/tpc.110.074328; Inoue K, 2011, TRENDS PLANT SCI, V16, P550, DOI 10.1016/j.tplants.2011.06.005; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Ivanova Y, 2004, MOL BIOL CELL, V15, P3379, DOI 10.1091/mbc.E03-12-0923; Iyer Kavitha, 2005, Sci STKE, V2005, ppl3, DOI 10.1126/stke.2752005pl3; Jackson-Constan D, 2001, PLANT PHYSIOL, V125, P1567, DOI 10.1104/pp.125.4.1567; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kamal AHM, 2012, MOL BIOL REP, V39, P9059, DOI 10.1007/s11033-012-1777-7; Kessler F, 2006, TRAFFIC, V7, P248, DOI 10.1111/j.1600-0854.2005.00382.x; Kessler F, 2004, TRENDS CELL BIOL, V14, P334, DOI 10.1016/j.tcb.2004.05.004; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kouranov A, 1997, J CELL BIOL, V139, P1677, DOI 10.1083/jcb.139.7.1677; Kovacs-Bogdan E, BMC PLANT BIOL, V11, P133; Kubis S, 2004, PLANT CELL, V16, P2059, DOI 10.1105/tpc.104.023309; Kuchler M, 2002, EMBO J, V21, P6136, DOI 10.1093/emboj/cdf621; Lee DW, 2008, PLANT CELL, V20, P1603, DOI 10.1105/tpc.108.060541; Lee DW, 2009, PLANT PHYSIOL, V151, P129, DOI 10.1104/pp.109.140673; Lentze N, 2008, CURR PROT PROTEIN SC; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Ma YK, 1996, J CELL BIOL, V134, P315, DOI 10.1083/jcb.134.2.315; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Pandey S, 2004, PLANT CELL, V16, P1616, DOI 10.1105/tpc.020321; PERRY SE, 1994, PLANT CELL, V6, P93, DOI 10.1105/tpc.6.1.93; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Richardson LGL, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-35; Richly E, 2004, GENE, V329, P11, DOI 10.1016/j.gene.2004.01.008; Serebriiskii IG, 2000, BIOTECHNIQUES, V29, P278, DOI 10.2144/00292st03; Smith MD, 2006, CAN J BOT, V84, P531, DOI 10.1139/B06-050; Smith MD, 2004, J CELL BIOL, V165, P323, DOI 10.1083/jcb.200311074; Smith MD, 2002, J CELL BIOL, V159, P833, DOI 10.1083/jcb.200208017; Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83; Stengel A, 2007, BIOL CHEM, V388, P765, DOI 10.1515/BC.2007.099; Stoevesandt O, 2009, EXPERT REV PROTEOMIC, V6, P145, DOI 10.1586/EPR.09.2; Sun Q, 2004, PLANT PHYSIOL, V135, P723, DOI 10.1104/pp.104.040717; Sveshnikova N, 2000, P NATL ACAD SCI USA, V97, P4973, DOI 10.1073/pnas.080491597; Taylor NL, 2009, J PROTEOMICS, V72, P367, DOI 10.1016/j.jprot.2008.11.006; Teng YS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001416; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Ueda M, 2008, MOL BIOL EVOL, V25, P1566, DOI 10.1093/molbev/msn102; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ulrich T, 2012, J BIOL CHEM, V287, P27467, DOI 10.1074/jbc.M112.382093; VONHEIJNE G, 1989, EUR J BIOCHEM, V180, P535; Wallas TR, 2003, J BIOL CHEM, V278, P44289, DOI 10.1074/jbc.M307873200; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	87	28	30	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95026	10.1371/journal.pone.0095026	http://dx.doi.org/10.1371/journal.pone.0095026			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736607	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600130
J	Nair, J; Ghatge, M; Kakkar, VV; Shanker, J				Nair, Jiny; Ghatge, Madankumar; Kakkar, Vijay V.; Shanker, Jayashree			Network Analysis of Inflammatory Genes and Their Transcriptional Regulators in Coronary Artery Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TOLL-LIKE RECEPTORS; CELL-CYCLE PROGRESSION; FACTOR-KAPPA-B; C-JUN; SIGNAL TRANSDUCER; ATHEROSCLEROSIS; ACTIVATION; EXPRESSION; CYTOKINE	Network analysis is a novel method to understand the complex pathogenesis of inflammation-driven atherosclerosis. Using this approach, we attempted to identify key inflammatory genes and their core transcriptional regulators in coronary artery disease (CAD). Initially, we obtained 124 candidate genes associated with inflammation and CAD using Polysearch and CADgene database for which protein-protein interaction network was generated using STRING 9.0 (Search Tool for the Retrieval of Interacting Genes) and visualized using Cytoscape v 2.8.3. Based on betweenness centrality (BC) and node degree as key topological parameters, we identified interleukin-6 (IL-6), vascular endothelial growth factor A (VEGFA), interleukin-1 beta (IL-1B), tumor necrosis factor (TNF) and prostaglandin-endoperoxide synthase 2 (PTGS2) as hub nodes. The backbone network constructed with these five hub genes showed 111 nodes connected via 348 edges, with IL-6 having the largest degree and highest BC. Nuclear factor kappa B1 (NFKB1), signal transducer and activator of transcription 3 (STAT3) and JUN were identified as the three core transcription factors from the regulatory network derived using MatInspector. For the purpose of validation of the hub genes, 97 test networks were constructed, which revealed the accuracy of the backbone network to be 0.7763 while the frequency of the hub nodes remained largely unaltered. Pathway enrichment analysis with ClueGO, KEGG and REACTOME showed significant enrichment of six validated CAD pathways smooth muscle cell proliferation, acute-phase response, calcidiol 1-monooxygenase activity, toll-like receptor signaling, NOD-like receptor signaling and adipocytokine signaling pathways. Experimental verification of the above findings in 64 cases and 64 controls showed increased expression of the five candidate genes and the three transcription factors in the cases relative to the controls (p<0.05). Thus, analysis of complex networks aid in the prioritization of genes and their transcriptional regulators in complex diseases.	[Nair, Jiny; Shanker, Jayashree] Thrombosis Res Inst, Mary & Garry Weston Funct Genom Unit, Bengaluru, Karnataka, India; [Ghatge, Madankumar] Thrombosis Res Unit, Tata Prote & Coagulat Unit, Bengaluru, Karnataka, India; [Kakkar, Vijay V.] Thrombosis Res Inst, Bengaluru, Karnataka, India; [Kakkar, Vijay V.] Thrombosis Res Inst, London SW3 6LR, England	Thrombosis Research Institute	Shanker, J (corresponding author), Thrombosis Res Inst, Mary & Garry Weston Funct Genom Unit, Bengaluru, Karnataka, India.	Jayashreeshanker@triindia.org.in	Ghatge, Madankumar/CAG-8432-2022	Ghatge, Madankumar/0000-0002-6606-0108	Thrombosis Research Institute, London; Thrombosis Research Institute, Bangalore; Weston Foundation, UK; Foundation Bey, Switzerland; Tata Social Welfare Trust, India [TSWT/IG/SNB/JP/Sdm]; Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/01/CDE/08/07]	Thrombosis Research Institute, London; Thrombosis Research Institute, Bangalore; Weston Foundation, UK; Foundation Bey, Switzerland; Tata Social Welfare Trust, India; Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	The authors gratefully acknowledge the support extended by the trustees of Thrombosis Research Institute, London and Bangalore, Weston Foundation, UK, Foundation Bey, Switzerland, the Tata Social Welfare Trust, India (TSWT/IG/SNB/JP/Sdm) and Department of Biotechnology, Ministry of Science and Technology, Government of India (BT/01/CDE/08/07). The sponsors did not participate in the design, conduct, sample collection analysis and interpretation of the data or in the preparation, review or approval of the manuscript.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Anfossi G, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/174341; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARATH P, 1990, AM J CARDIOL, V65, P297, DOI 10.1016/0002-9149(90)90291-8; Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bjorkegren JLM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004201; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen BS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-46; Chen F, 2005, INT J MOL MED, V15, P57; Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296; Chin BSP, 2002, AM J CARDIOL, V90, P1258, DOI 10.1016/S0002-9149(02)02848-5; Cho DY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002820; Cipollone F, 2001, CIRCULATION, V104, P921, DOI 10.1161/hc3401.093152; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/circ.105.10.1158; Fang Y, 2011, MED SCI MONITOR, V17, pRA100, DOI 10.12659/MSM.881709; Feldmann R, 2013, NUCLEIC ACIDS RES, V41, P3518, DOI 10.1093/nar/gkt034; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fukata M, 2009, SEMIN IMMUNOL, V21, P242, DOI 10.1016/j.smim.2009.06.005; Galea J, 1996, ARTERIOSCL THROM VAS, V16, P1000, DOI 10.1161/01.ATV.16.8.1000; Galhardo M, 2014, NUCLEIC ACIDS RES, V42, P1474, DOI 10.1093/nar/gkt989; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; Hojo Y, 2000, J AM COLL CARDIOL, V35, P968, DOI 10.1016/S0735-1097(99)00632-4; Hong IS, 2004, HUM REPROD, V19, P2192, DOI 10.1093/humrep/deh424; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Jacoby JJ, 2003, P NATL ACAD SCI USA, V100, P12929, DOI 10.1073/pnas.2134694100; Jawien J, 2005, J PHYSIOL PHARMACOL, V56, P483; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jones W Keith, 2003, Cardiovasc Toxicol, V3, P229, DOI 10.1385/CT:3:3:229; Kaimal V, 2011, METHODS MOL BIOL, V700, P241, DOI 10.1007/978-1-61737-954-3_16; Kanjilal S, 2008, VASC HEALTH RISK MAN, V4, P189, DOI 10.2147/vhrm.2008.04.01.189; Khachigian LM, 2002, J BIOL CHEM, V277, P22985, DOI 10.1074/jbc.M200977200; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Kumar Nandini K., 2006, Eastern Mediterranean Health Journal, V12, pS56; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lim CP, 2012, PROG MOL BIOL TRANSL, V106, P63, DOI 10.1016/B978-0-12-396456-4.00010-9; Liu H, 2011, NUCLEIC ACIDS RES, V39, pD991, DOI 10.1093/nar/gkq1106; Maitra A, 2008, THROMB HAEMOSTASIS, V99, P944, DOI 10.1160/TH07-11-0686; Maitra A, 2011, ARCH MED SCI, V7, P781, DOI 10.5114/aoms.2011.25552; McPherson R, 2012, CAN J CARDIOL, V28, P662, DOI 10.1016/j.cjca.2012.05.014; Meijer CA, 2012, CLIN SCI, V122, P421, DOI 10.1042/CS20110234; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Negoro S, 2000, CARDIOVASC RES, V47, P797, DOI 10.1016/S0008-6363(00)00138-3; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Osugi T, 2002, J BIOL CHEM, V277, P6676, DOI 10.1074/jbc.M108246200; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Rivard A, 2000, HISTOL HISTOPATHOL, V15, P557, DOI 10.14670/HH-15.557; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarajlic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071537; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shanker Jayashree, 2010, Open Cardiovasc Med J, V4, P30, DOI 10.2174/1874192401004020030; Shanker J, 2011, CORONARY ARTERY DIS, V22, P324, DOI 10.1097/MCA.0b013e3283472a57; Shanker Jayashree, 2010, Indian Heart J, V62, P286; Simon AD, 2000, J THROMB THROMBOLYS, V9, P217, DOI 10.1023/A:1018758409934; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Taube A, 2012, AM J PHYSIOL-HEART C, V302, pH2148, DOI 10.1152/ajpheart.00907.2011; Valcarcel B, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0908; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Vangala RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057193; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Young JL, 2002, THROMB HAEMOSTASIS, V88, P554, DOI 10.1055/s-0037-1613256; Yu HG, 2003, CANCER LETT, V195, P43, DOI 10.1016/S0304-3835(03)00153-8; Zhang LC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039542; Zhang SSM, 2005, EXP EYE RES, V81, P103, DOI 10.1016/j.exer.2005.01.016; Zhang YP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03426	79	46	52	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94328	10.1371/journal.pone.0094328	http://dx.doi.org/10.1371/journal.pone.0094328			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736319	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600060
J	Rice, EA; Khandelwal, A; Creelman, RA; Griffith, C; Ahrens, JE; Taylor, JP; Murphy, LR; Manjunath, S; Thompson, RL; Lingard, MJ; Back, SL; Larue, H; Brayton, BR; Burek, AJ; Tiwari, S; Adam, L; Morrell, JA; Caldo, RA; Huai, Q; Kouadio, JLK; Kuehn, R; Sant, AM; Wingbermuehle, WJ; Sala, R; Foster, M; Kinser, JD; Mohanty, R; Jiang, DM; Ziegler, TE; Huang, MYG; Kuriakose, SV; Skottke, K; Repetti, PP; Reuber, TL; Ruff, TG; Petracek, ME; Loida, PJ				Rice, Elena A.; Khandelwal, Abha; Creelman, Robert A.; Griffith, Cara; Ahrens, Jeffrey E.; Taylor, J. Philip; Murphy, Lesley R.; Manjunath, Siva; Thompson, Rebecca L.; Lingard, Matthew J.; Back, Stephanie L.; Larue, Huachun; Brayton, Bonnie R.; Burek, Amanda J.; Tiwari, Shiv; Adam, Luc; Morrell, James A.; Caldo, Rico A.; Huai, Qing; Kouadio, Jean-Louis K.; Kuehn, Rosemarie; Sant, Anagha M.; Wingbermuehle, William J.; Sala, Rodrigo; Foster, Matt; Kinser, Josh D.; Mohanty, Radha; Jiang, Dongming; Ziegler, Todd E.; Huang, Mingya G.; Kuriakose, Saritha V.; Skottke, Kyle; Repetti, Peter P.; Reuber, T. Lynne; Ruff, Thomas G.; Petracek, Marie E.; Loida, Paul J.			Expression of a Truncated ATHB17 Protein in Maize Increases Ear Weight at Silking	PLOS ONE			English	Article							RETICULUM STRESS-RESPONSE; II TRANSCRIPTION FACTORS; KERNEL SINK CAPACITY; ZIPPER GENE FAMILY; HOMEOBOX GENES; SHADE AVOIDANCE; PLANT-GROWTH; ARABIDOPSIS; HOMEODOMAIN; PROTOPLASTS	ATHB17 (AT2G01430) is an Arabidopsis gene encoding a member of the a-subclass of the homeodomain leucine zipper class II (HD-Zip II) family of transcription factors. The ATHB17 monomer contains four domains common to all class II HD-Zip proteins: a putative repression domain adjacent to a homeodomain, leucine zipper, and carboxy terminal domain. However, it also possesses a unique N-terminus not present in other members of the family. In this study we demonstrate that the unique 73 amino acid N-terminus is involved in regulation of cellular localization of ATHB17. The ATHB17 protein is shown to function as a transcriptional repressor and an EAR-like motif is identified within the putative repression domain of ATHB17. Transformation of maize with an ATHB17 expression construct leads to the expression of ATHB17 Delta 113, a truncated protein lacking the first 113 amino acids which encodes a significant portion of the repression domain. Because ATHB17 Delta 113 lacks the repression domain, the protein cannot directly affect the transcription of its target genes. ATHB17 Delta 113 can homodimerize, form heterodimers with maize endogenous HD-Zip II proteins, and bind to target DNA sequences; thus, ATHB17 Delta 113 may interfere with HD-Zip II mediated transcriptional activity via a dominant negative mechanism. We provide evidence that maize HD-Zip II proteins function as transcriptional repressors and that ATHB17 Delta 113 relieves this HD-Zip II mediated transcriptional repression activity. Expression of ATHB17 Delta 113 in maize leads to increased ear size at silking and, therefore, may enhance sink potential. We hypothesize that this phenotype could be a result of modulation of endogenous HD-Zip II pathways in maize.	[Rice, Elena A.; Khandelwal, Abha; Griffith, Cara; Ahrens, Jeffrey E.; Taylor, J. Philip; Murphy, Lesley R.; Manjunath, Siva; Thompson, Rebecca L.; Lingard, Matthew J.; Back, Stephanie L.; Larue, Huachun; Morrell, James A.; Caldo, Rico A.; Kouadio, Jean-Louis K.; Kuehn, Rosemarie; Sant, Anagha M.; Wingbermuehle, William J.; Sala, Rodrigo; Foster, Matt; Kinser, Josh D.; Mohanty, Radha; Jiang, Dongming; Ziegler, Todd E.; Huang, Mingya G.; Skottke, Kyle; Ruff, Thomas G.; Petracek, Marie E.; Loida, Paul J.] Monsanto Co, St Louis, MO 63167 USA; [Creelman, Robert A.; Burek, Amanda J.; Repetti, Peter P.; Reuber, T. Lynne] Mendel Biotechnol Inc, Hayward, CA USA; [Brayton, Bonnie R.] Dupont Pioneer Hibred Int, Waipahu, HI USA; [Tiwari, Shiv] Dupont Pioneer Hibred Int, Hayward, CA USA; [Adam, Luc] ABCAM, Burlingame, CA USA; [Huai, Qing] Monsanto Co, Cambridge, MA USA; [Kuriakose, Saritha V.] Monsanto Co, Bangalore, Karnataka, India	Monsanto; Monsanto; Monsanto	Loida, PJ (corresponding author), Monsanto Co, St Louis, MO 63167 USA.	paul.j.loida@monsanto.com		Khandelwal, Abha/0000-0002-5190-3467; Murphy, Lesley/0000-0002-5268-1122; Ziegler, Todd/0000-0001-8947-5763; Reuber, Lynne/0000-0001-7806-2437	Monsanto Company; BASF; Mendel Biotechnology	Monsanto Company; BASF(BASF); Mendel Biotechnology	"This work was supported by Monsanto Company and BASF and was conducted in collaboration with Mendel Biotechnology. The funders Monsanto Company and Mendel Biotechnology provided support in the form of salaries for all authors, as well as logistical, scientific and regulatory support. The funders also played a role in the design, data analysis and the decision to publish. The specific roles of the authors are articulated in the 'author contributions' section.	ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Agalou A, 2008, PLANT MOL BIOL, V66, P87, DOI 10.1007/s11103-007-9255-7; Ariel FD, 2007, TRENDS PLANT SCI, V12, P419, DOI 10.1016/j.tplants.2007.08.003; Borras L, 2006, FIELD CROP RES, V95, P223, DOI 10.1016/j.fcr.2005.03.001; Borras L, 2010, FIELD CROP RES, V118, P1, DOI 10.1016/j.fcr.2010.04.010; Bou-Torrent J, 2012, PLANT SIGNAL BEHAV, V7, P1382, DOI 10.4161/psb.21824; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Ciarbelli AR, 2008, PLANT MOL BIOL, V68, P465, DOI 10.1007/s11103-008-9383-8; Deng X, 2002, PLANT MOL BIOL, V49, P601, DOI 10.1023/A:1015501205303; Du LQ, 2004, PLANT MOL BIOL, V54, P549, DOI 10.1023/B:PLAN.0000038269.98972.bb; Echarte L, 2006, FIELD CROP RES, V96, P307, DOI 10.1016/j.fcr.2005.07.013; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elmore R, 2010, REDUCED 2010 CORN YI; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Frank W, 1998, PLANT J, V15, P413, DOI 10.1046/j.1365-313X.1998.00222.x; Gambin BL, 2010, ANN APPL BIOL, V156, P91, DOI 10.1111/j.1744-7348.2009.00367.x; GOODALL GJ, 1991, EMBO J, V10, P2635, DOI 10.1002/j.1460-2075.1991.tb07806.x; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Harris JC, 2011, NEW PHYTOL, V190, P823, DOI 10.1111/j.1469-8137.2011.03733.x; HARTER K, 1994, PLANT CELL, V6, P545, DOI 10.1105/tpc.6.4.545; Hayashi S, 2008, PLANT CELL PHYSIOL, V49, P1522, DOI 10.1093/pcp/pcn120; Henriksson E, 2005, PLANT PHYSIOL, V139, P509, DOI 10.1104/pp.105.063461; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; Hymus GJ, 2013, J EXP BOT, V64, P4479, DOI 10.1093/jxb/ert261; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Ito M, 2002, INT REV CYTOL, V218, P1; Iven T, 2010, PLANT J, V63, P155, DOI 10.1111/j.1365-313X.2010.04230.x; Iwata Y, 2005, P NATL ACAD SCI USA, V102, P5280, DOI 10.1073/pnas.0408941102; Jones RJ, 1996, CROP SCI, V36, P301, DOI 10.2135/cropsci1996.0011183X003600020015x; Kabbage M, 2008, CELL MOL LIFE SCI, V65, P1390, DOI 10.1007/s00018-008-7535-2; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Khanna R, 2006, PLANT CELL, V18, P2157, DOI 10.1105/tpc.106.042200; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee EA, 2007, CROP SCI, V47, pS202, DOI 10.2135/cropsci2007.04.0010IPBS; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049836; Liu ZC, 2008, TRENDS PLANT SCI, V13, P137, DOI 10.1016/j.tplants.2007.12.005; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Lu PZ, 1996, PLANT CELL, V8, P2155, DOI 10.1105/tpc.8.12.2155; Lund AA, 1998, PLANT PHYSIOL, V116, P1097, DOI 10.1104/pp.116.3.1097; Maddonni GA, 1998, FIELD CROP RES, V56, P257, DOI 10.1016/S0378-4290(97)00094-4; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Meijer AH, 1997, PLANT J, V11, P263, DOI 10.1046/j.1365-313X.1997.11020263.x; Meijer AH, 2000, MOL GEN GENET, V263, P12, DOI 10.1007/PL00008671; Mukherjee K, 2009, MOL BIOL EVOL, V26, P2775, DOI 10.1093/molbev/msp201; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nakamura M, 2006, PLANT PHYSIOL, V141, P1363, DOI 10.1104/pp.106.077388; Nawy T, 2005, PLANT CELL, V17, P1908, DOI 10.1105/tpc.105.031724; Ohashi-Ito K, 2005, PLANT CELL PHYSIOL, V46, P1646, DOI 10.1093/pcp/pci180; Ohashi-Ito K, 2003, PLANT CELL PHYSIOL, V44, P1350, DOI 10.1093/pcp/pcg164; Ohashi-Ito K, 2002, PLANT CELL PHYSIOL, V43, P1146, DOI 10.1093/pcp/pcf135; Ohgishi M, 2001, PLANT J, V25, P389, DOI 10.1046/j.1365-313x.2001.00966.x; Park MY, 2013, MOL CELLS, V35, P125, DOI 10.1007/s10059-013-2245-5; Qi QG, 2012, J BIOL CHEM, V287, P31482, DOI 10.1074/jbc.M112.346940; Qin YF, 2010, PLANT CELL REP, V29, P1147, DOI 10.1007/s00299-010-0901-1; RERIE WG, 1994, GENE DEV, V8, P1388, DOI 10.1101/gad.8.12.1388; Ritchie SW, 1997, CORN PLANT DEV; RUBERTI I, 1991, EMBO J, V10, P1787, DOI 10.1002/j.1460-2075.1991.tb07703.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sawa S, 2002, PLANT J, V32, P1011, DOI 10.1046/j.1365-313X.2002.01488.x; Seo PJ, 2011, TRENDS PLANT SCI, V16, P541, DOI 10.1016/j.tplants.2011.06.001; SESSA G, 1993, EMBO J, V12, P3507, DOI 10.1002/j.1460-2075.1993.tb06025.x; SHEEN JY, 1985, PLANT PHYSIOL, V79, P1072, DOI 10.1104/pp.79.4.1072; Sidorov V, 2009, METHODS MOL BIOL, V526, P47, DOI 10.1007/978-1-59745-494-0_4; SKUZESKI JM, 1990, PLANT MOL BIOL, V15, P65, DOI 10.1007/BF00017725; Sorin C, 2009, PLANT J, V59, P266, DOI 10.1111/j.1365-313X.2009.03866.x; Staudt AC, 2011, EMBO REP, V12, P35, DOI 10.1038/embor.2010.196; Steindler C, 1999, DEVELOPMENT, V126, P4235; Tiwari SB, 2004, PLANT CELL, V16, P533, DOI 10.1105/tpc.017384; Tiwari Shiv, 2006, V323, P237; Turchi L, 2013, DEVELOPMENT, V140, P2118, DOI 10.1242/dev.092833; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488; Zuniga-Mayo VM, 2012, PLANT J, V71, P314, DOI 10.1111/j.1365-313X.2012.04990.x	78	20	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94238	10.1371/journal.pone.0094238	http://dx.doi.org/10.1371/journal.pone.0094238			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736658	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600053
J	Vrech, DE; Olivero, PA; Mattoni, CI; Peretti, AV				Vrech, David E.; Olivero, Paola A.; Mattoni, Camilo I.; Peretti, Alfredo V.			Testes Mass, but Not Sperm Length, Increases with Higher Levels of Polyandry in an Ancient Sex Model	PLOS ONE			English	Article							INTRASPECIFIC VARIATION; COMPETITION GAMES; FINE-STRUCTURE; MATING PLUG; SIZE; EVOLUTION; MORPHOLOGY; SCORPIONS; INVESTMENT; BOTHRIURIDAE	There is strong evidence that polyandrous taxa have evolved relatively larger testes than monogamous relatives. Sperm size may either increase or decrease across species with the risk or intensity of sperm competition. Scorpions represent an ancient direct mode with spermatophore-mediated sperm transfer and are particularly well suited for studies in sperm competition. This work aims to analyze for the first time the variables affecting testes mass, ejaculate volume and sperm length, according with their levels of polyandry, in species belonging to the Neotropical family Bothriuridae. Variables influencing testes mass and sperm length were obtained by model selection analysis using corrected Akaike Information Criterion. Testes mass varied greatly among the seven species analyzed, ranging from 1.6 +/- 1.1 mg in Timogenes dorbignyi to 16.3 +/- 4.5 mg in Brachistosternus pentheri with an average of 8.4 +/- 5.0 mg in all the species. The relationship between testes mass and body mass was not significant. Body allocation in testes mass, taken as Gonadosomatic Index, was high in Bothriurus cordubensis and Brachistosternus ferrugineus and low in Timogenes species. The best-fitting model for testes mass considered only polyandry as predictor with a positive influence. Model selection showed that body mass influenced sperm length negatively but after correcting for body mass, none of the variables analyzed explained sperm length. Both body mass and testes mass influenced spermatophore volume positively. There was a strong phylogenetic effect on the model containing testes mass. As predicted by the sperm competition theory and according to what happens in other arthropods, testes mass increased in species with higher levels of sperm competition, and influenced positively spermatophore volume, but data was not conclusive for sperm length.	[Vrech, David E.; Olivero, Paola A.; Mattoni, Camilo I.; Peretti, Alfredo V.] Natl Univ Cordoba, CONICET, Lab Reprod Biol & Evolut, Inst Anim Div & Ecol IDEA, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Peretti, AV (corresponding author), Natl Univ Cordoba, CONICET, Lab Reprod Biol & Evolut, Inst Anim Div & Ecol IDEA, Cordoba, Argentina.	aperetti@com.uncor.edu		Mattoni, Camilo/0000-0001-8570-8814	FONCYT PICT, Argentina [2010-096]; CONICET PIP	FONCYT PICT, Argentina(ANPCyTFONCyT); CONICET PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Funding was provided by FONCYT PICT 2010-096, Argentina, CONICET PIP 2009-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTI G, 1983, J MORPHOL, V177, P205, DOI 10.1002/jmor.1051770207; Althaus S, 2010, J MORPHOL, V271, P383, DOI 10.1002/jmor.10804; [Anonymous], [No title captured]; Armas LF, 2004, ESPECIAL MONOGRAFICO, V2, P3; AUSTAD SN, 1984, AM ZOOL, V24, P309; Baer B, 2004, BEHAV ECOL, V15, P426, DOI 10.1093/beheco/arh025; Balshine S, 2001, BEHAV ECOL, V12, P726, DOI 10.1093/beheco/12.6.726; Birkhead TR, 1998, SPERM COMPETITION SE; Breed WG, 2000, J MAMMAL, V81, P758, DOI 10.1644/1545-1542(2000)081&lt;0758:BMTMAS&gt;2.3.CO;2; Briskie JV, 1997, EVOLUTION, V51, P937, DOI 10.1111/j.1558-5646.1997.tb03674.x; BRISKIE JV, 1992, P ROY SOC B-BIOL SCI, V247, P89, DOI 10.1098/rspb.1992.0013; Brody S., 1945, BIOENERGETICS GROWTH; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Byrne PG, 2002, J EVOLUTION BIOL, V15, P347, DOI 10.1046/j.1420-9101.2002.00409.x; Calder WAI., 1996, SIZE FUNCTION LIFE H; Chapman R.F., 2012, INSECTS STRUCTURE FU; Coddington JA, 2004, ASSEMBLING THE TREE OF LIFE, P296; Contreras-Garduno J, 2006, ETHOLOGY, V112, P152, DOI 10.1111/j.1439-0310.2006.01149.x; CUMMINS JM, 1985, J REPROD FERTIL, V75, P153, DOI 10.1530/jrf.0.0750153; Davey K. G., 1960, Proceedings of the Royal Entomological Society of London (A), V35, P107; Demary KC, 2007, INVERTEBR BIOL, V126, P74, DOI 10.1111/j.1744-7410.2007.00078.x; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Eberhard WG, 1998, EVOLUTION, V52, P415, DOI 10.1111/j.1558-5646.1998.tb01642.x; Elgar Mark A., 1998, P307, DOI 10.1016/B978-012100543-6/50034-9; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; FRANCKE OF, 1979, J ARACHNOL, V7, P19; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; GAGE MJG, 1994, P ROY SOC B-BIOL SCI, V258, P247, DOI 10.1098/rspb.1994.0169; Gage MJG, 2002, P ROY SOC B-BIOL SCI, V269, P2309, DOI 10.1098/rspb.2002.2154; Gage MJG, 1998, BEHAV ECOL, V9, P592, DOI 10.1093/beheco/9.6.592; Gay L, 2009, J EVOLUTION BIOL, V22, P1143, DOI 10.1111/j.1420-9101.2009.01724.x; GINSBERG JR, 1989, TRENDS ECOL EVOL, V4, P74, DOI 10.1016/0169-5347(89)90152-3; GOMENDIO M, 1991, P ROY SOC B-BIOL SCI, V243, P181, DOI 10.1098/rspb.1991.0029; HARCOURT AH, 1995, FUNCT ECOL, V9, P468, DOI 10.2307/2390011; HARCOURT AH, 1991, EVOLUTION, V45, P314, DOI [10.2307/2409666, 10.1111/j.1558-5646.1991.tb04406.x]; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Herberstein ME, 2011, BEHAV ECOL, V22, P692, DOI 10.1093/beheco/arr053; Hjelle J.T., 1990, P9; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Hosken DJ, 2001, ECOL LETT, V4, P10, DOI 10.1046/j.1461-0248.2001.00198.x; Hosken DJ, 1998, P ROY SOC LOND B BIO, V264, P385; Iossa G, 2008, FUNCT ECOL, V22, P655, DOI 10.1111/j.1365-2435.2008.01409.x; JESPERSEN A, 1973, J ULTRA MOL STRUCT R, V45, P366, DOI 10.1016/S0022-5320(73)80068-1; Johnson DDP, 1999, CONDOR, V101, P848, DOI 10.2307/1370074; Katvala M, 2008, J EVOLUTION BIOL, V21, P471, DOI 10.1111/j.1420-9101.2007.01494.x; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Lautie N, 2008, INVERTEBR REPROD DEV, V51, P77, DOI 10.1080/07924259.2008.9652258; Mattoni CI, 2004, ZOOL ANZ, V243, P75, DOI 10.1016/j.jcz.2004.07.002; Mattoni CI, 2007, DARWINIANA S, V45, P96; Michalik P, 2010, J ZOOL SYST EVOL RES, V48, P89, DOI 10.1111/j.1439-0469.2009.00540.x; Michelena P, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016014, 10.1371/journal.pone.0018631]; Minder AM, 2005, J EVOLUTION BIOL, V18, P60, DOI 10.1111/j.1420-9101.2004.00799.x; Morrow EH, 2000, P ROY SOC B-BIOL SCI, V267, P307, DOI 10.1098/rspb.2000.1001; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Olsson M., 1998, P503, DOI 10.1016/B978-012100543-6/50038-6; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PARKER GA, 1978, ANNU REV ENTOMOL, V23, P173, DOI 10.1146/annurev.en.23.010178.001133; PARKER GA, 1982, J THEOR BIOL, V96, P281, DOI 10.1016/0022-5193(82)90225-9; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P245, DOI 10.1098/rspb.1993.0110; Parker GA, 2005, BIOL LETTERS, V1, P235, DOI 10.1098/rsbl.2004.0273; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Parker GA, 2010, BIOL REV, V85, P897, DOI 10.1111/j.1469-185X.2010.00140.x; Peretti Alfredo V., 1996, Revista de la Sociedad Entomologica Argentina, V55, P7; Peretti Alfredo V., 2010, P218; Peretti AV, 2003, J ZOOL, V261, P135, DOI 10.1017/S095283690300400X; Peretti AV, 2003, ZOOL ANZ, V242, P21, DOI 10.1078/0044-5231-00085; PERETTI AV, 2001, REV ETOLOGIA, P25; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Pitnick S, 1996, AM NAT, V148, P57, DOI 10.1086/285911; PITNICK S, 1995, P NATL ACAD SCI USA, V92, P10614, DOI 10.1073/pnas.92.23.10614; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Polis G.A., 1990, P161; Prendini L, 2005, CLADISTICS, V21, P446, DOI 10.1111/j.1096-0031.2005.00073.x; Presgraves DC, 1999, P ROY SOC B-BIOL SCI, V266, P1041, DOI 10.1098/rspb.1999.0741; Proctor HC, 1998, ANNU REV ENTOMOL, V43, P153, DOI 10.1146/annurev.ento.43.1.153; Pyron M, 2000, BEHAV ECOL SOCIOBIOL, V48, P132, DOI 10.1007/s002650000191; R Core Team, 2012, R LANG ENV STAT COMP; Reiss M.J., 1991, ALLOMETRY GROWTH REP; SCHALLER F, 1971, ANNU REV ENTOMOL, V16, P407, DOI 10.1146/annurev.en.16.010171.002203; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider Jutta, 2011, P215; Schulte-Hostedde AI, 2004, BEHAV ECOL SOCIOBIOL, V55, P272, DOI 10.1007/s00265-003-0707-z; Short R.V., 1981, P319; Short R. V., 1977, P3; SHORT RV, 1979, BRIT MED BULL, V35, P121, DOI 10.1093/oxfordjournals.bmb.a071558; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2008, EVOLUTION, V62, P2580, DOI 10.1111/j.1558-5646.2008.00479.x; Simmons LW, 2007, EVOLUTION, V61, P2684, DOI 10.1111/j.1558-5646.2007.00243.x; SIMMONS LW, 1993, P ROY SOC B-BIOL SCI, V251, P183, DOI 10.1098/rspb.1993.0027; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; Stockley P, 1997, AM NAT, V149, P933, DOI 10.1086/286031; Thomas R.H., 1984, P179; Tomkins JL, 2002, ANIM BEHAV, V63, P1009, DOI 10.1006/anbe.2001.1994; Toscano-Gadea CA, 2010, J ARACHNOL, V38, P360, DOI 10.1636/Hi09-31.1; Tourmente M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021244; Tourmente M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-12; Tourmente M, 2009, EVOLUTION, V63, P2513, DOI 10.1111/j.1558-5646.2009.00739.x; Vahed K, 2012, ETHOLOGY, V118, P107, DOI 10.1111/j.1439-0310.2011.01991.x; Vahed K, 2011, BIOL LETTERS, V7, P261, DOI 10.1098/rsbl.2010.0840; Vignoli V, 2008, TISSUE CELL, V40, P411, DOI 10.1016/j.tice.2008.04.002; Vrech DE, 2011, ZOOL J LINN SOC-LOND, V161, P463, DOI 10.1111/j.1096-3642.2010.00647.x; Wang RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053904; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wedell Nina, 2010, P307; WEYGOLDT P, 1979, Z ZOOL SYST EVOL, V17, P85; ZHANG DY, 1994, AM NAT, V144, P65, DOI 10.1086/285661	107	14	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94135	10.1371/journal.pone.0094135	http://dx.doi.org/10.1371/journal.pone.0094135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736525	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600045
J	Yoshimura, S; Isobe, N; Matsushita, T; Masaki, K; Sato, S; Kawano, Y; Ochi, H; Kira, J				Yoshimura, Satoshi; Isobe, Noriko; Matsushita, Takuya; Masaki, Katsuhisa; Sato, Shinya; Kawano, Yuji; Ochi, Hirofumi; Kira, Jun-ichi			Genetic and Infectious Profiles Influence Cerebrospinal Fluid IgG Abnormality in Japanese Multiple Sclerosis Patients	PLOS ONE			English	Article							CHLAMYDIA-PNEUMONIAE INFECTION; OLIGOCLONAL BANDS; NEUROMYELITIS-OPTICA; ENVIRONMENTAL-FACTORS; DIAGNOSTIC-CRITERIA; IMMUNE-RESPONSE; ANTIBODY; DISTINCT; RISK; HETEROGENEITY	Background: Abnormal intrathecal synthesis of IgG, reflected by cerebrospinal fluid (CSF) oligoclonal IgG bands (OBs) and increased IgG index, is much less frequently observed in Japanese multiple sclerosis (MS) cohorts compared with Western cohorts. We aimed to clarify whether genetic and common infectious backgrounds influence CSF IgG abnormality in Japanese MS patients. Methodology: We analyzed HLA-DRB1 alleles, and IgG antibodies against Chlamydia pneumoniae, Helicobacter pylori, Epstein-Barr virus nuclear antigen (EBNA), and varicella zoster virus (VZV) in 94 patients with MS and 367 unrelated healthy controls (HCs). We defined CSF IgG abnormality as the presence of CSF OBs and/or increased IgG index (>0.658). Principal Findings: CSF IgG abnormality was found in 59 of 94 (62.8%) MS patients. CSF IgG abnormality-positive patients had a significantly higher frequency of brain MRI lesions meeting the Barkhof criteria compared with abnormality-negative patients. Compared with HCs, CSF IgG abnormality-positive MS patients showed a significantly higher frequency of DRB1*1501, whereas CSF IgG abnormality-negative patients had a significantly higher frequency of DRB1*0405. CSF IgG abnormality-positive MS patients had a significantly higher frequency of anti-C. pneumoniae IgG antibodies compared with CSF IgG abnormality-negative MS patients, although there was no difference in the frequency of anti-C. pneumoniae IgG antibodies between HCs and total MS patients. Compared with HCs, anti-H. pylori IgG antibodies were detected significantly less frequently in the total MS patients, especially in CSF IgG abnormality-negative MS patients. The frequencies of antibodies against EBNA and VZV did not differ significantly among the groups. Conclusions: CSF IgG abnormality is associated with Western MS-like brain MRI features. DRB1*1501 and C. pneumoniae infection confer CSF IgG abnormality, while DRB1*0405 and H. pylori infection are positively and negatively associated with CSF IgG abnormality-negative MS, respectively, suggesting that genetic and environmental factors differentially contribute to MS susceptibility according to the CSF IgG abnormality status.	[Yoshimura, Satoshi; Isobe, Noriko; Matsushita, Takuya; Masaki, Katsuhisa; Sato, Shinya; Kawano, Yuji; Kira, Jun-ichi] Kyushu Univ, Neurol Inst, Dept Neurol, Grad Sch Med Sci, Fukuoka 812, Japan; [Ochi, Hirofumi] Ehime Univ, Grad Sch Med, Dept Mol & Genet Med, Matsuyama, Ehime 790, Japan	Kyushu University; Ehime University	Kira, J (corresponding author), Kyushu Univ, Neurol Inst, Dept Neurol, Grad Sch Med Sci, Fukuoka 812, Japan.	kira@neuro.med.kyushu-u.ac.jp	Isobe, Noriko/AAJ-3043-2020	Isobe, Noriko/0000-0001-9525-4254	Health and Labour Sciences Research Grant on Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan [H20-Nanchi-Ippan-016]; Ministry of Education, Culture, Sports, Science and Technology, Japan [22390178]; Grants-in-Aid for Scientific Research [25117012, 25670423] Funding Source: KAKEN	Health and Labour Sciences Research Grant on Intractable Diseases from the Ministry of Health, Labour and Welfare, Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Health and Labour Sciences Research Grant on Intractable Diseases (H20-Nanchi-Ippan-016) from the Ministry of Health, Labour and Welfare, Japan, and a Grant-in-Aid (B; No. 22390178) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagos PG, 2006, MULT SCLER J, V12, P397, DOI 10.1191/1352458506ms1291oa; Barkhof F, 1997, BRAIN, V120, P2059, DOI 10.1093/brain/120.11.2059; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Derfuss T, 2001, BRAIN, V124, P1325, DOI 10.1093/brain/124.7.1325; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Fukazawa T, 1998, J NEUROL SCI, V158, P209, DOI 10.1016/S0022-510X(98)00127-0; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; Hermann C, 2002, J CLIN MICROBIOL, V40, P1603, DOI 10.1128/JCM.40.5.1603-1609.2002; Imrell K, 2006, NEUROLOGY, V67, P1062, DOI 10.1212/01.wnl.0000237343.93389.35; Ishizu T, 2009, J NEUROL SCI, V280, P22, DOI 10.1016/j.jns.2009.01.008; Isobe N, 2012, MULT SCLER J, V18, P1541, DOI 10.1177/1352458512443917; Kamradt T, 2005, TRENDS IMMUNOL, V26, P260, DOI 10.1016/j.it.2005.03.009; Kikuchi S, 2003, NEUROLOGY, V60, P647, DOI 10.1212/01.WNL.0000048202.09147.9E; Kira J, 2003, LANCET NEUROL, V2, P117, DOI 10.1016/S1474-4422(03)00308-9; Kira J, 1996, ANN NEUROL, V40, P569; Koch M, 2007, EUR J NEUROL, V14, P797, DOI 10.1111/j.1468-1331.2007.01859.x; Kuenz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002559; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Laheij RJF, 1998, J CLIN MICROBIOL, V36, P2803, DOI 10.1128/JCM.36.10.2803-2809.1998; Layh-Schmitt G, 2000, ANN NEUROL, V47, P652, DOI 10.1002/1531-8249(200005)47:5<652::AID-ANA15>3.0.CO;2-5; Lechner-Scott J, 2012, MULT SCLER J, V18, P974, DOI 10.1177/1352458511431729; Levin LI, 2010, ANN NEUROL, V67, P824, DOI 10.1002/ana.21978; Li W, 2007, J NEUROIMMUNOL, V184, P227, DOI 10.1016/j.jneuroim.2006.12.010; Li W, 2009, MULT SCLER J, V15, P1411, DOI 10.1177/1352458509348961; Link H, 2006, J NEUROIMMUNOL, V180, P17, DOI 10.1016/j.jneuroim.2006.07.006; Lourenco P, 2013, MULT SCLER J, V19, P577, DOI 10.1177/1352458512459684; Masterman T, 2000, ANN NEUROL, V48, P211, DOI 10.1002/1531-8249(200008)48:2<211::AID-ANA11>3.3.CO;2-I; Matsuoka T, 2008, J NEUROL SCI, V266, P115, DOI 10.1016/j.jns.2007.09.010; Nakashima I, 2002, MULT SCLER, V8, P459, DOI 10.1191/1352458502ms831oa; Nakashima I, 2005, J NEUROIMMUNOL, V159, P133, DOI 10.1016/j.jneuroim.2004.09.011; Okuda DT, 2009, BRAIN, V132, P250, DOI 10.1093/brain/awn301; Ono T, 1998, TISSUE ANTIGENS, V52, P539, DOI 10.1111/j.1399-0039.1998.tb03084.x; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER S, 1981, J NEUROL, V225, P219, DOI 10.1007/BF00313751; Romero-Pinel L, 2011, EUR J NEUROL, V18, P1258, DOI 10.1111/j.1468-1331.2011.03379.x; Saiz A, 2001, J NEUROL, V248, P617, DOI 10.1007/s004150170141; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sellebjerg F, 2000, TISSUE ANTIGENS, V55, P312, DOI 10.1034/j.1399-0039.2000.550404.x; Siritho S, 2007, CAN J NEUROL SCI, V34, P99, DOI 10.1017/S0317167100005874; Siritho S, 2009, J NEUROL SCI, V279, P21, DOI 10.1016/j.jns.2008.12.029; Sotgiu S, 2001, MULT SCLER, V7, P371, DOI 10.1177/135245850100700605; Sriram S, 1999, ANN NEUROL, V46, P6, DOI 10.1002/1531-8249(199907)46:1<6::AID-ANA4>3.3.CO;2-D; STENDAHLBRODIN L, 1980, J NEUROL NEUROSUR PS, V43, P102, DOI 10.1136/jnnp.43.2.102; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wu JS, 2010, J NEUROL SCI, V288, P63, DOI 10.1016/j.jns.2009.10.005; Yamasaki K, 1999, BRAIN, V122, P1689, DOI 10.1093/brain/122.9.1689; Yoshimura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048592; Yoshimura S, 2013, J NEUROL NEUROSUR PS, V84, P29, DOI 10.1136/jnnp-2012-302925; Zeman AZJ, 1996, J NEUROL NEUROSUR PS, V60, P27, DOI 10.1136/jnnp.60.1.27	49	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95367	10.1371/journal.pone.0095367	http://dx.doi.org/10.1371/journal.pone.0095367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736746	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600176
J	Conley, SM; Al-Ubaidi, MR; Han, ZC; Naash, MI				Conley, Shannon M.; Al-Ubaidi, Muayyad R.; Han, Zongchao; Naash, Muna I.			Rim formation is not a prerequisite for distribution of cone photoreceptor outer segment proteins	FASEB JOURNAL			English	Article						RDS; degeneration; morphogenesis; retina	NUCLEOTIDE-GATED CHANNEL; NA/CA-K EXCHANGER; DISK MORPHOGENESIS; MEMBRANE-PROTEIN; ROD; PERIPHERIN/RDS; BINDING; MODEL; NRL; OLIGOMERIZATION	Retinal degeneration slow (RDS/PRPH2) is critical for the formation of the disc/lamella rim in photoreceptor outer segments (OSs), but plays a different role in rods vs. cones. Without RDS, rods fail to form OSs, however, cones lacking RDS (in the rds(-/-) / Nrl (-/-)) exhibit balloon-like OSs devoid of lamellae. We show that distribution of most proteins in the lamella and PM domains is preserved even in the absence of RDS, rim, and lamella structures. However, the rim protein prominin-1 exhibits altered trafficking and OS localization, suggesting that proper targeting and distribution of rim proteins may require RDS. Our ultrastructural studies show that in cones, OS formation is initiated by the growth of opsin-containing membrane with RDS-mediated rim formation as a secondary step. This is directly opposite to rods and significantly advances our understanding of the role of the rim in cone OS morphogenesis. Furthermore, our results suggest that the unique folded lamella architecture of the cone OS may maximize density or proximity of phototransduction proteins, but is not required for OS function or for protein distribution and retention in different membrane domains.	[Conley, Shannon M.; Al-Ubaidi, Muayyad R.; Han, Zongchao; Naash, Muna I.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Naash, MI (corresponding author), OUHSC, Dept Cell Biol, 940 Stanton L Young Blvd BMSB 781, Oklahoma City, OK 73104 USA.	muna-naash@ouhsc.edu		Han, Zongchao/0000-0002-2019-395X	U.S. National Eye Institute [EY10609, EY018512]; Foundation Fighting Blindness; Knights Templar Eye Foundation; Oklahoma Center for the Advancement of Science and Technology; NATIONAL EYE INSTITUTE [R55EY010609, R01EY010609, F32EY018512, R56EY010609] Funding Source: NIH RePORTER	U.S. National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness(European Commission); Knights Templar Eye Foundation; Oklahoma Center for the Advancement of Science and Technology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the U.S. National Eye Institute (EY10609, M.I.N.; EY018512, S. M. C.); the Foundation Fighting Blindness (M.I.N. and M. R. A.); the Knights Templar Eye Foundation (Z.H.), and the Oklahoma Center for the Advancement of Science and Technology (S. M. C., Z.H., and M.I.N.). The authors thank Mr. Justin Burnett, Ms. Barb Nagel, and Ms. Reem Alomer for their technical assistance. The compacted DNA NPs were generated in collaboration with Dr. Mark Cooper at Copernicus Therapeutics, Inc. (Cleveland, OH, USA). Antibodies (as detailed in Materials and Methods) were generously shared by Dr. Cheryl Craft (University of Southern California, Los Angeles, CA, USA), Dr. Jonathan Lytton (University of Calgary Health Sciences Center, Calgary, AB, Canada), Dr. Xi-Qin Ding (University of Oklahoma Health Sciences Center), Dr. Eric Pierce (Massachusetts Eye and Ear Infirmary, Boston, MA, USA), and Dr. David Garbers (University of Texas Southwestern Medical Center, Dallas, TX, USA). Mice were generously shared by Dr. Anand Swaroop, (Nrl<SUP>-/-</SUP>, National Eye Institute, Bethesda, MD, USA), and Dr. Neeraj Agarwal (rds<SUP>-/-</SUP>, U.S. National Institutes of Health, Bethesda, MD, USA). The authors declare no conflicts of interest.	ANDERSON DH, 1978, INVEST OPHTH VIS SCI, V17, P117; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Bauer PJ, 2002, ANN NY ACAD SCI, V976, P325; BIGAY J, 1994, BIOCHEMISTRY-US, V33, P14081, DOI 10.1021/bi00251a017; Boesze-Battaglia K, 2000, METHOD ENZYMOL, V316, P65; Cai X, 2010, FASEB J, V24, P1178, DOI 10.1096/fj.09-139147; Cai X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005290; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2010, HUM MOL GENET, V19, P4799, DOI 10.1093/hmg/ddq410; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; Conley SM, 2008, CURR OPIN MOL THER, V10, P456; Craig SEL, 2010, INVEST OPHTH VIS SCI, V51, P3244, DOI 10.1167/iovs.09-4879; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427; ECKMILLER MS, 1987, J CELL BIOL, V105, P2267, DOI 10.1083/jcb.105.5.2267; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; Fitzgerald JB, 2008, ADV EXP MED BIOL, V613, P327, DOI 10.1007/978-0-387-74904-4_38; Han Z, 2012, INVEST OPHTH VIS SCI, V53, P361, DOI 10.1167/iovs.11-8635; Han ZC, 2012, J CLIN INVEST, V122, P3221, DOI 10.1172/JCI64833; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kim TSY, 1998, J BIOL CHEM, V273, P16561, DOI 10.1074/jbc.273.26.16561; Kizhatil K, 2009, SCIENCE, V323, P1614, DOI 10.1126/science.1169789; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li XF, 2006, J BIOL CHEM, V281, P6273, DOI 10.1074/jbc.M512137200; Liu Q, 2004, J NEUROSCI, V24, P6427, DOI 10.1523/JNEUROSCI.1335-04.2004; Matveev AV, 2008, J NEUROCHEM, V106, P2042, DOI 10.1111/j.1471-4159.2008.05548.x; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Nour M, 2004, INVEST OPHTH VIS SCI, V45, P2514, DOI 10.1167/iovs.04-0065; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Schwarzer A, 1997, BIOCHEMISTRY-US, V36, P13667, DOI 10.1021/bi9710232; Schwarzer A, 2000, J BIOL CHEM, V275, P13448, DOI 10.1074/jbc.275.18.13448; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; VAUGHAN DK, 1989, INVEST OPHTH VIS SCI, V30, P339; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wrigley JDJ, 2000, J BIOL CHEM, V275, P13191, DOI 10.1074/jbc.C900853199; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zhu XM, 2003, J NEUROSCI, V23, P6152, DOI 10.1523/JNEUROSCI.23-14-06152.2003	47	14	14	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3468	3479		10.1096/fj.14-251397	http://dx.doi.org/10.1096/fj.14-251397			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24736412	Green Published			2022-12-25	WOS:000340265400017
J	Juan, WC; Roca, X; Ong, ST				Juan, Wen Chun; Roca, Xavier; Ong, S. Tiong			Identification of cis-Acting Elements and Splicing Factors Involved in the Regulation of BIM Pre-mRNA Splicing	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; DISEASE-CAUSING MUTATIONS; HNRNP-H; CELL-DEATH; PREMESSENGER RNA; BCL-2 FAMILY; COMPARATIVE GENOMICS; EXON DEFINITION; LEUKEMIC-CELLS; SR PROTEINS	Aberrant changes in the expression of the pro-apoptotic protein, BCL-2-like 11 (BIM), can result in either impaired or excessive apoptosis, which can contribute to tumorigenesis and degenerative disorders, respectively. Altering BIM pre-mRNA splicing is an attractive approach to modulate apoptosis because BIM activity is partly determined by the alternative splicing of exons 3 or 4, whereby exon 3-containing transcripts are not apoptotic. Here we identified several cis-acting elements and splicing factors involved in BIM alternative splicing, as a step to better understand the regulation of BIM expression. We analyzed a recently discovered 2,903-bp deletion polymorphism within BIM intron 2 that biased splicing towards exon 3, and which also impaired BIM-dependent apoptosis. We found that this region harbors multiple redundant cis-acting elements that repress exon 3 inclusion. Furthermore, we have isolated a 23-nt intronic splicing silencer at the 39 end of the deletion that is important for excluding exon 3. We also show that PTBP1 and hnRNP C repress exon 3 inclusion, and that downregulation of PTBP1 inhibited BIM-mediated apoptosis. Collectively, these findings start building our understanding of the cis-acting elements and splicing factors that regulate BIM alternative splicing, and also suggest potential approaches to alter BIM splicing for therapeutic purposes.	[Juan, Wen Chun; Ong, S. Tiong] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Signature Res Programme, Singapore, Singapore; [Roca, Xavier] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Ong, S. Tiong] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore; [Ong, S. Tiong] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore; [Ong, S. Tiong] Duke Univ, Med Ctr, Dept Med, Div Med Oncol, Chapel Hill, NC USA	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore General Hospital; National Cancer Centre Singapore (NCCS); Duke University	Roca, X (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	xroca@ntu.edu.sg; sintiong.ong@duke-nus.edu.sg	Roca, Xavier/C-5838-2011	Roca, Xavier/0000-0003-3853-5273; Ong, S. Tiong/0000-0001-9460-3483	National Medical Research Council of Singapore [CIRG11NOV084]; Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), Singapore	National Medical Research Council of Singapore(National Medical Research Council, Singapore); Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This study was supported by grants from the National Medical Research Council of Singapore CIRG11NOV084, and Biomedical Research Council of the Agency for Science, Technology and Research (A*STAR), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichberger KJ, 2005, CANCER RES, V65, P9436, DOI 10.1158/0008-5472.CAN-05-0972; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Caputi M, 2002, EMBO J, V21, P845, DOI 10.1093/emboj/21.4.845; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Chang KC, 2007, FASEB J, V21, P708, DOI 10.1096/fj.06-6805com; Chen CD, 1999, GENE DEV, V13, P593, DOI 10.1101/gad.13.5.593; Chou MY, 1999, MOL CELL BIOL, V19, P69; Cornelis S, 2005, NUCLEIC ACIDS RES, V33, P3095, DOI 10.1093/nar/gki611; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Costa DB, 2007, PLOS MED, V4, P1669, DOI 10.1371/journal.pmed.0040315; Coutinho-Mansfield GC, 2007, GENE DEV, V21, P1573, DOI 10.1101/gad.1575607; Cragg MS, 2007, PLOS MED, V4, P1681, DOI 10.1371/journal.pmed.0040316; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Crawford JB, 2006, MOL CELL BIOL, V26, P8791, DOI 10.1128/MCB.01677-06; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Gagne V, 2013, CLIN CANCER RES, V19, P5240, DOI 10.1158/1078-0432.CCR-13-1215; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; GOGUEL V, 1993, MOL CELL BIOL, V13, P6841, DOI 10.1128/MCB.13.11.6841; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Ke SD, 2011, RNA BIOL, V8, P384, DOI 10.4161/rna.8.3.14458; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lauer C, 2012, J IMMUNOL, V188, P916, DOI 10.4049/jimmunol.1101864; LeFave CV, 2011, EMBO J, V30, P4084, DOI 10.1038/emboj.2011.259; Lu ZX, 2012, WIRES RNA, V3, P581, DOI 10.1002/wrna.120; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Masuda A, 2008, HUM MOL GENET, V17, P4022, DOI 10.1093/hmg/ddn305; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mitchell SA, 2001, MOL CELL BIOL, V21, P3364, DOI 10.1128/MCB.21.10.3364-3374.2001; MULLIGAN GJ, 1992, J BIOL CHEM, V267, P25480; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Ness JM, 2006, BRAIN RES, V1099, P150, DOI 10.1016/j.brainres.2006.04.132; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Pagani F, 2003, HUM MOL GENET, V12, P1111, DOI 10.1093/hmg/ddg131; Paz I, 2010, NUCLEIC ACIDS RES, V38, pW281, DOI 10.1093/nar/gkq444; Piva F, 2009, BIOINFORMATICS, V25, P1211, DOI 10.1093/bioinformatics/btp124; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Roca X, 2008, GENOME RES, V18, P77, DOI 10.1101/gr.6859308; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wang EM, 2007, NUCLEIC ACIDS RES, V35, P4164, DOI 10.1093/nar/gkm387; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Wentz MP, 1997, J VIROL, V71, P8542, DOI 10.1128/JVI.71.11.8542-8551.1997; Wiggins CM, 2010, CELL SIGNAL, V22, P801, DOI 10.1016/j.cellsig.2010.01.004; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang XHF, 2004, GENE DEV, V18, P1241, DOI 10.1101/gad.1195304; Zheng ZM, 1996, J VIROL, V70, P4691, DOI 10.1128/JVI.70.7.4691-4699.1996; Zhou ZH, 2013, CHROMOSOMA, V122, P191, DOI 10.1007/s00412-013-0407-z; Zhu J, 2001, MOL CELL, V8, P1351, DOI 10.1016/S1097-2765(01)00409-9	62	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95210	10.1371/journal.pone.0095210	http://dx.doi.org/10.1371/journal.pone.0095210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743263	gold, Green Published			2022-12-25	WOS:000335309100088
J	Li, YJ; Zeng, MT; Chen, WQ; Liu, CL; Wang, F; Han, X; Zuo, ZY; Peng, SL				Li, Yujuan; Zeng, Minting; Chen, Weiqiang; Liu, Chuiliang; Wang, Fei; Han, Xue; Zuo, Zhiyi; Peng, Shuling			Dexmedetomidine Reduces Isoflurane-Induced Neuroapoptosis Partly by Preserving PI3K/Akt Pathway in the Hippocampus of Neonatal Rats	PLOS ONE			English	Article							INCOMPLETE CEREBRAL-ISCHEMIA; BRAIN-INJURY; ALPHA(2A)-ADRENOCEPTOR SUBTYPE; POSTNATAL MEMORY; EARLY EXPOSURE; IN-VITRO; ANESTHESIA; SEVOFLURANE; APOPTOSIS; SURVIVAL	Prolonged exposure to volatile anesthetics, such as isoflurane and sevoflurane, causes neurodegeneration in the developing animal brains. Recent studies showed that dexmedetomidine, a selective alpha 2-adrenergic agonist, reduced isoflurane-induced cognitive impairment and neuroapoptosis. However, the mechanisms for the effect are not completely clear. Thus, we investigated whether exposure to isoflurane or sevoflurane at an equivalent dose for anesthesia during brain development causes different degrees of neuroapoptosis and whether this neuroapoptosis is reduced by dexmedetomidine via effects on PI3K/Akt pathway that can regulate cell survival. Seven-day-old (P7) neonatal Sprague-Dawley rats were randomly exposed to 0.75% isoflurane, 1.2% sevoflurane or air for 6 h. Activated caspase-3 was detected by immunohistochemistry and Western blotting. Phospho-Akt, phospho-Bad, Akt, Bad and Bcl-xL proteins were detected by Western blotting in the hippocampus at the end of exposure. Also, P7 rats were pretreated with various concentrations of dexmedetomidine alone or together with PI3K inhibitor LY294002, and then exposed to 0.75% isoflurane. Terminal deoxyribonucleotide transferase-mediated dUTP nick end labeling (TUNEL) and activated caspase-3 were used to detect neuronal apoptosis in their hippocampus. Isoflurane, not sevoflurane at the equivalent dose, induced significant neuroapoptosis, decreased the levels of phospho-Akt and phospho-Bad proteins, increased the expression of Bad protein and reduced the ratio of Bcl-xL/Bad in the hippocampus. Dexmedetomidine pretreatment dose-dependently inhibited isoflurane-induced neuroapoptosis and restored protein expression of phospho-Akt and Bad as well as the Bcl-xL/Bad ratio induced by isoflurane. Pretreatment with single dose of 75 mu g/kg dexmedetomidine provided a protective effect similar to that with three doses of 25 mu g/kg dexmedetomidine. Moreover, LY294002, partly inhibited neuroprotection of dexmedetomidine. Our results suggest that dexmedetomidine pretreatment provides neuroprotection against isoflurane-induced neuroapoptosis in the hippocampus of neonatal rats by preserving PI3K/Akt pathway activity.	[Li, Yujuan; Zeng, Minting; Chen, Weiqiang; Wang, Fei; Han, Xue; Zuo, Zhiyi; Peng, Shuling] Sun Yat Sen Univ, Dept Anesthesiol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Weiqiang] Sun Yat Sen Univ, Affiliated Shantou Hosp, Dept Anesthesiol, Shantou, Guangdong, Peoples R China; [Liu, Chuiliang] ChanCheng Ctr Hosp, Dept Anesthesiol, Foshan, Guangdong, Peoples R China; [Zuo, Zhiyi] Univ Virginia Hlth Syst, Dept Anesthesiol, Charlottesville, VA USA	Sun Yat Sen University; Sun Yat Sen University; University of Virginia	Li, YJ (corresponding author), Sun Yat Sen Univ, Dept Anesthesiol, Sun Yat Sen Mem Hosp, Guangzhou 510275, Guangdong, Peoples R China.	yujuan_04@hotmail.com; pslmzk@aliyun.com	li, yu/HGL-9518-2022; Zuo, Zhiyi/F-3950-2010; Li, yu/HHZ-5236-2022	Zuo, Zhiyi/0000-0002-3542-5047; 	National Natural Science Foundation of China [81371259, 30772091]; Guangdong Natural Science Foundation [S2013010016207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Natural Science Foundation of China (grant 81371259 to YL and grant 30772091 to SP) and the Guangdong Natural Science Foundation (S2013010016207 to YL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boscolo A, 2012, NEUROBIOL DIS, V45, P1031, DOI 10.1016/j.nbd.2011.12.022; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Cheng Y, 1997, ANN NEUROL, V41, P521, DOI 10.1002/ana.410410416; Chong ZZ, 2005, PROG NEUROBIOL, V75, P207, DOI 10.1016/j.pneurobio.2005.02.004; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Dahmani S, 2005, ANESTHESIOLOGY, V103, P969, DOI 10.1097/00000542-200511000-00011; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Daniel W. W., 1990, APPL NONPARAMETRIC S, P240; Engelhard K, 2003, ANESTH ANALG, V96, P524, DOI 10.1097/00000539-200302000-00041; Hou JL, 2011, CURR NEUROVASC RES, V8, P220, DOI 10.2174/156720211796558069; Hsu SY, 1997, MOL ENDOCRINOL, V11, P1858, DOI 10.1210/me.11.12.1858; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Istaphanous GK, 2009, CURR OPIN ANESTHESIO, V22, P368, DOI 10.1097/ACO.0b013e3283294c9e; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kalkman CJ, 2009, ANESTHESIOLOGY, V110, P805, DOI 10.1097/ALN.0b013e31819c7124; Koh PO, 2011, NEUROSCI LETT, V498, P105, DOI 10.1016/j.neulet.2011.05.003; Kong FJ, 2011, EUR J PHARMACOL, V670, P168, DOI 10.1016/j.ejphar.2011.08.050; Li Y, 2013, ACTA ANAESTH SCAND, V57, P380, DOI 10.1111/aas.12018; Li YJ, 2007, NEUROPHARMACOLOGY, V53, P942, DOI 10.1016/j.neuropharm.2007.09.005; Li YJ, 2013, NEUROSCI LETT, V545, P17, DOI 10.1016/j.neulet.2013.04.008; Liang G, 2008, ANESTH ANALG, V106, P492, DOI 10.1213/ane.0b013e3181605b71; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Loepke AW, 2006, ANESTH ANALG, V102, P75, DOI 10.1213/01.ANE.0000181102.92729.B8; Ma DQ, 2004, EUR J PHARMACOL, V502, P87, DOI 10.1016/j.ejphar.2004.08.044; Orliaguet G, 2001, ANESTHESIOLOGY, V95, P734, DOI 10.1097/00000542-200109000-00028; Paris A, 2006, ANESTH ANALG, V102, P456, DOI 10.1213/01.ane.0000194301.79118.e9; Paxinos G, 1990, ATLAS DEV RAT BRAIN; Rajakumaraswamy N, 2006, NEUROSCI LETT, V409, P128, DOI 10.1016/j.neulet.2006.09.020; Rizzi S, 2008, BRAIN PATHOL, V18, P198, DOI 10.1111/j.1750-3639.2007.00116.x; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Sanders RD, 2009, ANESTHESIOLOGY, V110, P1077, DOI 10.1097/ALN.0b013e31819daedd; Sato K, 2010, ACTA ANAESTH SCAND, V54, P377, DOI 10.1111/j.1399-6576.2009.02139.x; Satomoto M, 2009, ANESTHESIOLOGY, V110, P628, DOI 10.1097/ALN.0b013e3181974fa2; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Wei HF, 2005, BRAIN RES, V1037, P139, DOI 10.1016/j.brainres.2005.01.009; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Yang H, 2008, ANESTHESIOLOGY, V109, P243, DOI 10.1097/ALN.0b013e31817f5c47; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Yon JH, 2005, NEUROSCIENCE, V135, P815, DOI 10.1016/j.neuroscience.2005.03.064; Zhao H, 2003, J NEUROCHEM, V85, P1026, DOI 10.1046/j.1471-4159.2003.01756.x; Zhao XL, 2013, ANESTHESIOLOGY, V118, P537, DOI 10.1097/ALN.0b013e3182833fae; Zhao YF, 2010, J PHARMACOL EXP THER, V333, P14, DOI 10.1124/jpet.109.161562; Zhua YM, 2013, BRAIN RES, V1494, P1, DOI 10.1016/j.brainres.2012.11.047	43	62	77	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e93639	10.1371/journal.pone.0093639	http://dx.doi.org/10.1371/journal.pone.0093639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743508	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100016
J	Peng, HY; Lin, CC; Wang, HY; Shih, Y; Chou, ST				Peng, Hsin-Yi; Lin, Chih-Chien; Wang, Hsun-Yen; Shih, Ying; Chou, Su-Tze			The Melanogenesis Alteration Effects of Achillea millefolium L. Essential Oil and Linalyl Acetate: Involvement of Oxidative Stress and the JNK and ERK Signaling Pathways in Melanoma Cells	PLOS ONE			English	Article							ANTIOXIDANT; STIMULATION; TYROSINASE; INHIBITORS; EXTRACT	The mitogen-activated protein kinase (MAPK) family, including extracellular signal-regulated kinase (ERK) 1/2, c-Jun N-terminal kinase (JNK) 1/2 and p38 MAPK, is known to be activated by ultraviolet (UV) radiation in melanocytes to regulate melanin production. Reactive oxygen species (ROS) play important roles in the pathway of ERK and JNK activation. It has been established that the essential oil of Achillea millefolium L. (AM-EO) has activities that suppress the oxidative stress and inflammatory responses. Thus, we analyzed the effects of AM-EO on melanogenesis in melanocyte stimulating hormone (alpha-MSH) treated melanoma cells. The results demonstrated that AM-EO suppresses melanin production by decreasing tyrosinase activity through the regulation of the JNK and ERK signaling pathways. This effect might be associated with the AM-EO activity leading to the suppression of ROS, and linalyl acetate is its major functional component. Therefore, we propose that AM-EO has the potential to treat hyperpigmentation in the future.	[Peng, Hsin-Yi; Chou, Su-Tze] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Lin, Chih-Chien; Shih, Ying] Providence Univ, Dept Cosmet Sci, Taichung, Taiwan; [Wang, Hsun-Yen] Triserv Gen Hosp, Taipei, Taiwan	Providence University - Taiwan; Providence University - Taiwan; Tri-Service General Hospital	Shih, Y (corresponding author), Providence Univ, Dept Cosmet Sci, Taichung, Taiwan.	yingshih@pu.edu.tw; stchou@pu.edu.tw	Chou, Su-Tze/AAR-7175-2021	Chou, Su-Tze/0000-0002-6588-0358; Lin, Chih-Chien/0000-0002-4664-2995	National Science Council of the Republic of China [NSC 102-2313-B-126-004-MY3, NSC 102-2113-M-126-003, NSC102-2313-B-126-001-MY3]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	The authors are grateful for financial support from the National Science Council of the Republic of China (NSC 102-2313-B-126-004-MY3, NSC 102-2113-M-126-003and NSC102-2313-B-126-001-MY3). The URL of NSC's website is http://web1.nsc.gov.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak MJ, 2012, INT J MOL SCI, V13, P2314, DOI 10.3390/ijms13022314; Benedek B, 2007, WIEN MED WOCHENSCHR, V157, P312, DOI 10.1007/s10354-007-0431-9; Chang TS, 2012, MATERIALS, V5, P1661, DOI 10.3390/ma5091661; Chen YS, 2013, J BIOSCI BIOENG, V115, P242, DOI 10.1016/j.jbiosc.2012.09.013; Chou ST, 2013, INT J MOL SCI, V14, P12978, DOI 10.3390/ijms140712978; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Videira IFD, 2013, AN BRAS DERMATOL, V88, P76, DOI 10.1590/S0365-05962013000100009; Ellouze I, 2012, J FOOD SCI, V77, pT173, DOI 10.1111/j.1750-3841.2012.02846.x; Feizpour A, 2013, INDIAN J PHARMACOL, V45, P13, DOI 10.4103/0253-7613.106428; Freire ACG, 2003, LEUKEMIA RES, V27, P823, DOI 10.1016/S0145-2126(03)00013-4; Furneri PM, 2012, EUR J MED CHEM, V52, P66, DOI 10.1016/j.ejmech.2012.03.005; Hirata N, 2007, BIOORGAN MED CHEM, V15, P4897, DOI 10.1016/j.bmc.2007.04.046; Huang CS, 2013, J BIOSCI BIOENG, V115, P418, DOI 10.1016/j.jbiosc.2012.11.003; Jeong YM, 2013, BIOSCI BIOTECH BIOCH, V77, P119, DOI 10.1271/bbb.120602; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Khan AU, 2011, PHYTOTHER RES, V25, P577, DOI 10.1002/ptr.3303; Kim KN, 2013, FOOD CHEM TOXICOL, V59, P521, DOI 10.1016/j.fct.2013.06.031; Lee BJ, 2012, SCI WORLD J, DOI 10.1100/2012/792756; Maresca V, 2010, PIGM CELL MELANOMA R, V23, P263, DOI 10.1111/j.1755-148X.2010.00673.x; Muthusamy V, 2010, ARCH DERMATOL RES, V302, P5, DOI 10.1007/s00403-009-0994-y; Park CM, 2011, J ETHNOPHARMACOL, V133, P834, DOI 10.1016/j.jep.2010.11.015; Seo WD, 2010, EUR J MED CHEM, V45, P2010, DOI 10.1016/j.ejmech.2010.01.049; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Tundis R, 2012, J FOOD SCI, V77, pH40, DOI 10.1111/j.1750-3841.2011.02511.x; Yao XC, 2013, FOOD CHEM, V139, P59, DOI 10.1016/j.foodchem.2012.12.045; Yen FL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/867494; Yin H, 2012, J FOOD SCI, V77, pC278, DOI 10.1111/j.1750-3841.2011.02577.x; Zhao LM, 2012, ASIAN PAC J CANCER P, V13, P3795, DOI 10.7314/APJCP.2012.13.8.3795	29	64	68	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95186	10.1371/journal.pone.0095186	http://dx.doi.org/10.1371/journal.pone.0095186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743745	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100083
J	Runckel, C; DeRisi, J; Flenniken, ML				Runckel, Charles; DeRisi, Joseph; Flenniken, Michelle L.			A Draft Genome of the Honey Bee Trypanosomatid Parasite Crithidia mellificae	PLOS ONE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; PICORNA-LIKE VIRUS; PROTOZOAN PARASITES; BOMBUS-TERRESTRIS; PARALYSIS VIRUS; NUCLEOTIDE-SEQUENCE; GUT MICROBIOTA; COLONY; INFECTIONS; EVOLUTION	Since 2006, honey bee colonies in North America and Europe have experienced increased annual mortality. These losses correlate with increased pathogen incidence and abundance, though no single etiologic agent has been identified. Crithidia mellificae is a unicellular eukaryotic honey bee parasite that has been associated with colony losses in the USA and Belgium. C. mellificae is a member of the family Trypanosomatidae, which primarily includes other insect-infecting species (e. g., the bumble bee pathogen Crithidia bombi), as well as species that infect both invertebrate and vertebrate hosts including human pathogens (e. g., Trypanosoma cruzi, T. brucei, and Leishmania spp.). To better characterize C. mellificae, we sequenced the genome and transcriptome of strain SF, which was isolated and cultured in 2010. The 32 megabase draft genome, presented herein, shares a high degree of conservation with the related species Leishmania major. We estimate that C. mellificae encodes over 8,300 genes, the majority of which are orthologs of genes encoded by L. major and other Leishmania or Trypanosoma species. Genes unique to C. mellificae, including those of possible bacterial origin, were annotated based on function and include genes putatively involved in carbohydrate metabolism. This draft genome will facilitate additional investigations of the impact of C. mellificae infection on honey bee health and provide insight into the evolution of this unique family.	[Runckel, Charles; DeRisi, Joseph] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Runckel, Charles; DeRisi, Joseph] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Flenniken, Michelle L.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Montana State University System; Montana State University Bozeman	DeRisi, J (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	joe@derisilab.ucsf.edu; michelle.flenniken@montana.edu			Project Apis m.; Howard Hughes Medical Institute; A.P. Giannini Foundation; Honey Bee Biology Postdoctoral Fellowship - UC-Davis; Haagen Dazs; National Science Foundation EPSCoR [EPS-110134]; National Institutes of Health [GM103500]; Montana State University Agricultural Experimental Station; Montana Department of Agriculture; Office of Integrative Activities [1443108] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103500] Funding Source: NIH RePORTER	Project Apis m.; Howard Hughes Medical Institute(Howard Hughes Medical Institute); A.P. Giannini Foundation; Honey Bee Biology Postdoctoral Fellowship - UC-Davis; Haagen Dazs; National Science Foundation EPSCoR(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana State University Agricultural Experimental Station; Montana Department of Agriculture; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a research grant from Project Apis m.(www.projectapism.org) awarded to Joseph DeRisi for support of Charles Runckel. Joseph DeRisi is supported by the Howard Hughes Medical Institute. Michelle L. Flenniken was supported by postdoctoral fellowships awarded by the A.P. Giannini Foundation and by a Honey Bee Biology Postdoctoral Fellowship co-sponsored by UC-Davis and Haagen Dazs. Michelle L. Flenniken is currently supported by the National Science Foundation EPSCoR Cooperative Agreement (EPS-110134), the National Institutes of Health (grant GM103500), the Montana State University Agricultural Experimental Station, the Montana Department of Agriculture, and Project Apis m.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves JMP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-190; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Baer B, 2003, ECOL LETT, V6, P106, DOI 10.1046/j.1461-0248.2003.00411.x; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Brown M, 2000, OIKOS; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Cornman SR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-602; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; de Miranda JR, 2004, J GEN VIROL, V85, P2263, DOI 10.1099/vir.0.79990-0; Dimon MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013875; Drummond A, 2011, DRUMMOND GENEIOUS V5; Durbin R., 1998, BIOL SEQUENCE ANAL P; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; ENGEL JC, 1985, J BIOL CHEM, V260, P105; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Figueiredo EN, 2007, J PROTOZOOL, V25, P546, DOI [10.1111/j.1550-7408.1978.tb04184.x, DOI 10.1111/J.1550-7408.1978.TB04184.X]; Fujiyuki T, 2006, J VIROL, V80, P11528, DOI 10.1128/JVI.00754-06; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; Govan VA, 2000, VIROLOGY, V277, P457, DOI 10.1006/viro.2000.0616; HOARE CA, 1966, NATURE, V212, P1385, DOI 10.1038/2121385a0; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Hughes AL, 2003, MOL BIOL EVOL, V20, P644, DOI 10.1093/molbev/msg062; Imhoof B, 1999, INSECT SOC, V46, P233, DOI 10.1007/s000400050139; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Koch H, 2012, ECOL LETT, V15, P1095, DOI 10.1111/j.1461-0248.2012.01831.x; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Langridge D. F., 1967, Journal of Protozoology, V14, P485; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Leat N, 2000, J GEN VIROL, V81, P2111, DOI 10.1099/0022-1317-81-8-2111; Lewis PO, 2001, TRENDS ECOL EVOL, V16, P30, DOI 10.1016/S0169-5347(00)02025-5; Lukes J, 2002, EUKARYOT CELL, V1, P495, DOI 10.1128/EC.1.4.495-502.2002; Lye LF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001161; Motta MCM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060209; Motta MCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012415; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; Morimoto T, 2013, ENV MICROBIOL REP, V5, P74, DOI 10.1111/j.1758-2229.2012.00385.x; Novy FG, 1907, J INFECT DIS, V4, P223, DOI 10.1093/infdis/4.2.223; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P470, DOI 10.1016/j.pt.2007.08.002; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Schluns H, 2010, DEV COMP IMMUNOL, V34, P705, DOI 10.1016/j.dci.2010.02.002; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; Schwarz RS, 2013, DEV COMP IMMUNOL, V40, P300, DOI 10.1016/j.dci.2013.03.010; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Simpson L, TRITRYPDB FUNCTIONAL; Stevens JR, 2008, PARASITE, V15, P226, DOI 10.1051/parasite/2008153226; Teixeira MMG, 2011, PROTIST, V162, P503, DOI 10.1016/j.protis.2011.01.001; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Yang B, 2013, ECOL EVOL, V3, P298, DOI 10.1002/ece3.464; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811; Yourth CP, 2008, INSECT SOC, V55, P86, DOI 10.1007/s00040-007-0974-1; Yourth CP, 2006, P ROY SOC B-BIOL SCI, V273, P655, DOI 10.1098/rspb.2005.3371; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	70	44	47	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95057	10.1371/journal.pone.0095057	http://dx.doi.org/10.1371/journal.pone.0095057			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743507	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100062
J	Zhao, N; He, NP; Wang, QF; Zhang, XY; Wang, RL; Xu, ZW; Yu, GR				Zhao, Ning; He, Nianpeng; Wang, Qiufeng; Zhang, Xinyu; Wang, Ruili; Xu, Zhiwei; Yu, Guirui			The Altitudinal Patterns of Leaf C:N:P Stoichiometry Are Regulated by Plant Growth Form, Climate and Soil on Changbai Mountain, China	PLOS ONE			English	Article							PHOSPHORUS STOICHIOMETRY; NITROGEN; CARBON; FOREST; LIMITATION; WORLDWIDE; ELEVATION; GRADIENT; FOLIAR; TREE	Understanding the geographic patterns and potential drivers of leaf stoichiometry is critical for modelling the nutrient fluxes of ecosystems and to predict the responses of ecosystems to global changes. This study aimed to explore the altitudinal patterns and potential drivers of leaf C:N:P stoichiometry. We measured the concentrations of leaf C, N and P in 175 plant species as well as soil nutrient concentrations along an altitudinal transect (500-2300 m) on the northern slope of Changbai Mountain, China to explore the response of leaf C: N: P stoichiometry to plant growth form (PGF), climate and soil. Leaf C, N, P and C: N: P ratios showed significant altitudinal trends. In general, leaf C and C: N: P ratios increased while leaf N and P decreased with elevation. Woody and herbaceous species showed different responses to altitudinal gradients. Trees had the largest variation in leaf C, C:N and C:P ratios, while herbs showed the largest variation in leaf N, P and N: P ratio. PGF, climate and soil jointly regulated leaf stoichiometry, explaining 17.6% to 52.1% of the variation in the six leaf stoichiometric traits. PGF was more important in explaining leaf stoichiometry variation than soil and climate. Our findings will help to elucidate the altitudinal patterns of leaf stoichiometry and to model ecosystem nutrient cycling.	[Zhao, Ning; He, Nianpeng; Wang, Qiufeng; Zhang, Xinyu; Wang, Ruili; Xu, Zhiwei; Yu, Guirui] Chinese Acad Sci, Inst Geog & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Synth Res Ctr Chinese Ecosyst Res Network, Beijing, Peoples R China; [Zhao, Ning; Wang, Ruili; Xu, Zhiwei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, GR (corresponding author), Chinese Acad Sci, Inst Geog & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Synth Res Ctr Chinese Ecosyst Res Network, Beijing, Peoples R China.	yugr@igsnrr.ac.cn	wang, qiufeng/C-1654-2013; 于, 贵瑞/C-1768-2014	于, 贵瑞/0000-0002-1859-8966; he, nianpeng/0000-0002-0458-5953	Major Program of the National Natural Science Foundation of China [31290220]	Major Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study supported by the Major Program of the National Natural Science Foundation of China (Grant No. 31290220) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Barry R. G., 1981, MOUNTAIN WEATHER CLI; Baumann F, 2009, GLOBAL CHANGE BIOL, V15, P3001, DOI 10.1111/j.1365-2486.2009.01953.x; BOWMAN RA, 1988, SOIL SCI SOC AM J, V52, P1301, DOI 10.2136/sssaj1988.03615995005200050016x; Chen YH, 2013, ECOGRAPHY, V36, P178, DOI 10.1111/j.1600-0587.2011.06833.x; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Fisher JB, 2013, OECOLOGIA, V172, P889, DOI 10.1007/s00442-012-2522-6; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Gusewell S, 2004, NEW PHYTOL, V164, P243, DOI 10.1111/j.1469-8137.2004.01192.x; Gusewell S, 2002, PERSPECT PLANT ECOL, V5, P37, DOI 10.1078/1433-8319-0000022; Han WX, 2011, ECOL LETT, V14, P788, DOI 10.1111/j.1461-0248.2011.01641.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; He JS, 2008, OECOLOGIA, V155, P301, DOI 10.1007/s00442-007-0912-y; He JS, 2006, OECOLOGIA, V149, P115, DOI 10.1007/s00442-006-0425-0; Hedin LO, 2003, ECOLOGY, V84, P2231, DOI 10.1890/02-4066; Heikkinen RK, 2005, P ROY SOC B-BIOL SCI, V272, P2203, DOI 10.1098/rspb.2005.3212; Hobbie SE, 2002, OECOLOGIA, V131, P453, DOI 10.1007/s00442-002-0892-x; Hoch G, 2002, OIKOS, V98, P361, DOI 10.1034/j.1600-0706.2002.980301.x; Hoch G, 2012, GLOBAL ECOL BIOGEOGR, V21, P861, DOI 10.1111/j.1466-8238.2011.00731.x; HOU HY, 1982, VEGETATION GEOGRAPHY; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Kohler L, 2006, FLORA, V201, P202, DOI 10.1016/j.flora.2005.07.003; Korner C, 2012, AMBIO, V41, P197, DOI 10.1007/s13280-012-0313-2; KORNER C, 1989, OECOLOGIA, V81, P379, DOI 10.1007/BF00377088; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; Liu C, 2013, J PLANT ECOL, V6, P220, DOI 10.1093/jpe/rts028; Liu JX, 2013, GLOBAL CHANGE BIOL, V19, P208, DOI 10.1111/gcb.12022; Macek P, 2012, ARCT ANTARCT ALP RES, V44, P62, DOI 10.1657/1938-4246-44.1.62; Macek P, 2009, ACTA OECOL, V35, P778, DOI 10.1016/j.actao.2009.08.013; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Millard P, 2007, NEW PHYTOL, V175, P11, DOI 10.1111/j.1469-8137.2007.02079.x; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; R Core Team, 2021, R LANG ENV STAT COMP; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Sardans J, 2011, FOREST ECOL MANAG, V262, P2024, DOI 10.1016/j.foreco.2011.08.019; Shao GF, 1996, CAN J FOREST RES, V26, P206, DOI 10.1139/x26-024; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Shi WQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044628; Soethe N, 2008, J TROP ECOL, V24, P397, DOI 10.1017/S026646740800504X; Sterner R.W., 2002, ECOLOGICAL STOICHIOM; Sundqvist MK, 2011, WITHIN AND ACROSS SP; van de Weg MJ, 2009, PLANT ECOL DIVERS, V2, P243, DOI 10.1080/17550870903518045; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wu TG, 2012, BIOCHEM SYST ECOL, V44, P255, DOI 10.1016/j.bse.2012.06.002; Yang YH, 2007, PEDOSPHERE, V17, P776, DOI 10.1016/S1002-0160(07)60093-9; Zhang M, 2011, PEDOSPHERE, V21, P615, DOI 10.1016/S1002-0160(11)60163-X; Zhang SB, 2012, GLOBAL ECOL BIOGEOGR, V21, P809, DOI 10.1111/j.1466-8238.2011.00729.x; Zhu BA, 2010, J PLANT RES, V123, P439, DOI 10.1007/s10265-009-0301-1	49	68	89	22	187	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95196	10.1371/journal.pone.0095196	http://dx.doi.org/10.1371/journal.pone.0095196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743878	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100085
J	Zhou, BY; Yan, SY; Shi, WL; Qu, Z; Zhao, X; Liu, ZM; Pu, XP				Zhou, Bing-Ying; Yan, Shi-Yan; Shi, Wan-Lu; Qu, Zhi; Zhao, Xin; Liu, Zhi-Min; Pu, Xiao-Ping			Serum Proteomic Analysis Reveals High Frequency of Haptoglobin Deficiency and Elevated Thyroxine Level in Heroin Addicts	PLOS ONE			English	Article							PROTEIN EXPRESSION; ASSOCIATION; POLYMORPHISMS; GENE; METHADONE; ALBUMIN; SYSTEM	Heroin addiction is a chronic, complex disease, often accompanied by other concomitant disorders, which may encumber effective prevention and treatment. To explore the differences in expression profiles of serum proteins in control and heroin addicts, we used two-dimensional electrophoresis coupled to MALDI-TOF/TOF, and identified 4 proteins of interest. Following validation of the increase in serum transthyretin, we assessed serum levels of thyroid stimulating hormone (TSH), triiodothyronine (T3), and thyroxine (T4), and observed a robust increase in T4 in heroin addicts compared to controls. In addition, we performed haptoglobin (Hp) phenotyping, and showed that the frequency of Hp0 (serum devoid of haptoglobin) was significantly higher in heroin addicts. Altogether, these findings indicated that: (1) thyroid hormone imbalance is present in heroin addicts; (2) anhaptoglobinemia (Hp0) might a risk factor or a deleterious effect of heroin abuse.	[Zhou, Bing-Ying; Shi, Wan-Lu; Zhao, Xin; Pu, Xiao-Ping] Peking Univ, Natl Key Res Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Zhou, Bing-Ying; Shi, Wan-Lu; Zhao, Xin; Pu, Xiao-Ping] Peking Univ, Sch Pharmaceut Sci, Dept Mol & Cellular Pharmacol, Beijing 100871, Peoples R China; [Yan, Shi-Yan; Qu, Zhi; Liu, Zhi-Min] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Pu, XP (corresponding author), Peking Univ, Natl Key Res Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	pxp123@bjmu.edu.cn			National Key Research Laboratory of Natural and Biomimetic Drugs Project, Peking University; National "Twelfth FiveYear" Plan for Science & Technology Support [2012 BAI01B07]	National Key Research Laboratory of Natural and Biomimetic Drugs Project, Peking University; National "Twelfth FiveYear" Plan for Science & Technology Support	This work was supported by National Key Research Laboratory of Natural and Biomimetic Drugs Project, Peking University and National "Twelfth FiveYear" Plan for Science & Technology Support (2012 BAI01B07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIAFRASIABI M, 1979, PSYCHONEUROENDOCRINO, V4, P145, DOI 10.1016/0306-4530(79)90028-3; ASCH E, 1990, J CLIN INVEST, V85, P1372, DOI 10.1172/JCI114581; AZIZI F, 1974, ANN INTERN MED, V80, P194, DOI 10.7326/0003-4819-80-2-194; Bessa SS, 2007, EUR J INTERN MED, V18, P489, DOI 10.1016/j.ejim.2007.02.033; Bierczynska-Krzysik A, 2006, NEUROCHEM INT, V49, P401, DOI 10.1016/j.neuint.2006.01.024; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; Bodzon-Kulakowska A, 2005, AMINO ACIDS, V28, P13, DOI 10.1007/s00726-004-0144-y; Bodzon-Kulakowska A, 2009, J SEP SCI, V32, P1200, DOI 10.1002/jssc.200800464; BRAMBILLA F, 1980, J ENDOCRINOL INVEST, V3, P251, DOI 10.1007/BF03348271; Cami J, 2003, NEW ENGL J MED, V349, P975, DOI 10.1056/NEJMra023160; CHAN V, 1979, CLIN ENDOCRINOL, V10, P557, DOI 10.1111/j.1365-2265.1979.tb02115.x; Chen YY, 2005, ELECTROPHORESIS, V26, P2117, DOI 10.1002/elps.200410381; Chevalier Francois, 2007, V355, P145; Clarke TK, 2012, GENES BRAIN BEHAV, V11, P415, DOI 10.1111/j.1601-183X.2012.00785.x; Delanghe J, 1998, BLOOD, V91, P3524, DOI 10.1182/blood.V91.9.3524.3524_3524_3524; Ferri M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003410.pub4; Fleming CE, 2009, PROG NEUROBIOL, V89, P266, DOI 10.1016/j.pneurobio.2009.07.007; Frankel PS, 2008, NEUROPHARMACOLOGY, V55, P41, DOI 10.1016/j.neuropharm.2008.04.019; Gao WM, 2007, J NEUROTRAUM, V24, P43, DOI 10.1089/neu.2006.0061; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Hemby SE, 2010, J NEUROIMMUNE PHARM, V5, P70, DOI 10.1007/s11481-009-9189-8; Hochberg I, 2002, ATHEROSCLEROSIS, V161, P441, DOI 10.1016/S0021-9150(01)00657-8; Lai JH, 2010, BRAIN RES, V1359, P227, DOI 10.1016/j.brainres.2010.08.064; Levran O, 2008, GENES BRAIN BEHAV, V7, P720, DOI 10.1111/j.1601-183X.2008.00410.x; Li N, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt22; Longauerova A, 2006, Bratisl Lek Listy, V107, P448; Malinin AI, 2001, THROMB RES, V104, P297, DOI 10.1016/S0049-3848(01)00376-0; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Miike K, 2010, PROTEOMICS, V10, P2678, DOI 10.1002/pmic.200900496; Nelson EC, 2014, ADDICT BIOL, V19, P111, DOI 10.1111/j.1369-1600.2012.00445.x; Nielsen DA, 2010, PSYCHIAT GENET, V20, P207, DOI 10.1097/YPG.0b013e32833a2106; Omenn GS, 2005, PROTEOMICS, V5, P3223, DOI 10.1002/pmic.200590056; PARKER CJ, 1989, BRIT J HAEMATOL, V71, P245, DOI 10.1111/j.1365-2141.1989.tb04262.x; Proudnikov D, 2008, NEUROSCI LETT, V435, P234, DOI 10.1016/j.neulet.2008.02.042; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Reynolds JL, 2006, AM J INFECT DIS, V2, P49, DOI 10.3844/ajidsp.2006.49.57; Sadrzadeh S.M., 2004, AM J CLIN PATHOL, V121, P97; SAOJI AM, 1980, INT J LEPROSY, V48, P422; Sekijima Y, 2001, AMYLOID, V8, P257, DOI 10.3109/13506120108993822; Serrano A, 2011, PHARMACOL THERAPEUT, V132, P215, DOI 10.1016/j.pharmthera.2011.06.005; Sher L, 2007, EUR NEUROPSYCHOPHARM, V17, P12, DOI 10.1016/j.euroneuro.2006.04.011; Shippenberg TS, 2009, NEUROPSYCHOPHARMACOL, V34, P247, DOI 10.1038/npp.2008.165; Shui HA, 2007, PROTEOMICS, V7, P796, DOI 10.1002/pmic.200600699; Suder P, 2009, J PROTEOME RES, V8, P4633, DOI 10.1021/pr900443r; Urban NBL, 2012, PSYCHIAT CLIN N AM, V35, P521, DOI 10.1016/j.psc.2012.03.011; Vitalis Z, 2011, HUM IMMUNOL, V72, P348, DOI 10.1016/j.humimm.2011.01.008; WETLI CV, 1974, SOUTHERN MED J, V67, P193, DOI 10.1097/00007611-197402000-00017; WISE RA, 1987, PHARMACOL THERAPEUT, V35, P227, DOI 10.1016/0163-7258(87)90108-2; Yang M, 2012, PROG NEURO-PSYCHOPH, V36, P282, DOI 10.1016/j.pnpbp.2011.11.009; Zhao X, 2010, NEUROSCI LETT, V479, P175, DOI 10.1016/j.neulet.2010.05.063; Zill P, 2011, EUR ARCH PSY CLIN N, V261, P121, DOI 10.1007/s00406-010-0129-7	52	4	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95345	10.1371/journal.pone.0095345	http://dx.doi.org/10.1371/journal.pone.0095345			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743330	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100107
J	Gowan, TA; Ortega-Ortiz, JG				Gowan, Timothy A.; Ortega-Ortiz, Joel G.			Wintering Habitat Model for the North Atlantic Right Whale (Eubalaena glacialis) in the Southeastern United States	PLOS ONE			English	Article							SOUTHERN RIGHT WHALES; SPECIES DISTRIBUTION MODELS; SEA-SURFACE TEMPERATURE; MEGAPTERA-NOVAEANGLIAE; NICHE; ENERGETICS; AUSTRALIS; ABUNDANCE; STRIKING; FEMALE	The coastal waters off the southeastern United States (SEUS) are a primary wintering ground for the endangered North Atlantic right whale (Eubalaena glacialis), used by calving females along with other adult and juvenile whales. Management actions implemented in this area for the recovery of the right whale population rely on accurate habitat characterization and the ability to predict whale distribution over time. We developed a temporally dynamic habitat model to predict wintering right whale distribution in the SEUS using a generalized additive model framework and aerial survey data from 2003/2004 through 2012/2013. We built upon previous habitat models for right whales in the SEUS and include data from new aerial surveys that extend the spatial coverage of the analysis, particularly in the northern portion of this wintering ground. We summarized whale sightings, survey effort corrected for probability of whale detection, and environmental data at a semimonthly resolution. Consistent with previous studies, sea surface temperature (SST), water depth, and survey year were significant predictors of right whale relative abundance. Additionally, distance to shore, distance to the 22uC SST isotherm, and an interaction between time of year and latitude (to account for the latitudinal migration of whales) were also selected in the analysis presented here. Predictions from the model revealed that the location of preferred habitat differs within and between years in correspondence with variation in environmental conditions. Although cow-calf pairs were rarely sighted in the company of other whales, there was minimal evidence that the preferred habitat of cow-calf pairs was different than that of whale groups without calves at the scale of this study. The results of this updated habitat model can be used to inform management decisions for a migratory species in a dynamic oceanic environment.	[Gowan, Timothy A.; Ortega-Ortiz, Joel G.] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL 33701 USA	Florida Fish & Wildlife Conservation Commission	Gowan, TA (corresponding author), Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, St Petersburg, FL 33701 USA.	tim.gowan@myfwc.com		Gowan, Timothy/0000-0002-0082-1621	National Marine Fisheries Service (NMFS) [6WCA90016]; Save the Manatee Trust Fund	National Marine Fisheries Service (NMFS); Save the Manatee Trust Fund	This research was funded by the National Marine Fisheries Service (NMFS) [grant P.O. Number 6WCA90016; http://www.nmfs.noaa.gov/] and the Save the Manatee Trust Fund [http://myfwc.com/research/manatee/trust-fund/]. Other than a contribution from NMFS to original survey protocols and survey lines design for the right whale early warning system, the funders had no role in the analysis, decision to publish, or preparation of the manuscript.	Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; BANE JM, 1979, GEOPHYS RES LETT, V6, P280, DOI 10.1029/GL006i004p00280; Best Benjamin D., 2012, Endangered Species Research, V18, P1, DOI 10.3354/esr00430; BIVAND R, 2007, SPDEP SPATIAL DEPEND; BRODIE PF, 1975, ECOLOGY, V56, P152, DOI 10.2307/1935307; Buckland S.T., 2001, pi; Bull JW, 2013, FRONT ECOL ENVIRON, V11, P203, DOI 10.1890/120020; Burnell SR, 1997, J ZOOL, V241, P613, DOI 10.1111/j.1469-7998.1997.tb05736.x; Cartwright R, 2009, BEHAVIOUR, V146, P1573, DOI 10.1163/156853909X458377; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dormann CF, 2008, ECOLOGY, V89, P3371, DOI 10.1890/07-1772.1; Elwen SH, 2004, MAR MAMMAL SCI, V20, P567, DOI 10.1111/j.1748-7692.2004.tb01180.x; Elwen SH, 2004, MAR ECOL PROG SER, V269, P289, DOI 10.3354/meps269289; Ersts PJ, 2003, J ZOOL, V260, P337, DOI 10.1017/S0952836903003807; Fauchald P, 2011, ECOLOGY, V92, P228, DOI 10.1890/10-0818.1; Felix Fernando, 2005, Journal of Cetacean Research and Management, V7, P21; Fonnesbeck Christopher J., 2008, Endangered Species Research, V6, P87, DOI 10.3354/esr00134; Forney Karin A., 2012, Endangered Species Research, V16, P113, DOI 10.3354/esr00393; Good CP, 2008, THESIS DUKE U DURHAM; Greene C., 2003, OCEANOGRAPHY, V16, P98; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hain JHW, 1999, MARINE MAMMAL SURVEY AND ASSESSMENT METHODS, P191; Hamazaki T, 2002, MAR MAMMAL SCI, V18, P920, DOI 10.1111/j.1748-7692.2002.tb01082.x; HASTIE T. J., 1990, MONOGRAPHS STAT APPL, V43; Hedley SL, 2004, J AGR BIOL ENVIR ST, V9, P181, DOI 10.1198/1085711043578; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Keller CA, 2006, MAR MAMMAL SCI, V22, P426, DOI 10.1111/j.1748-7692.2006.00033.x; Keller Cherie A., 2012, Endangered Species Research, V18, P73, DOI 10.3354/esr00413; Kenney Robert D., 2007, P436; Knowlton A.R., 2002, RIGHT WHALE SIGHTING; Knowlton Amy R., 2001, Journal of Cetacean Research and Management Special Issue, V2, P193; Kraus Scott D., 2007, P1; KSHATRIYA M, 1988, J THEOR BIOL, V133, P479, DOI 10.1016/S0022-5193(88)80336-9; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; Montgomery D. C., 1992, INTRO LINEAR REGRESS; NationalMarine Fisheries Service, 2005, REC PLAN N ATL RIGHT; North Atlantic Right Whale Consortium, 2012, N ATL RIGHT WHAL CON; Pendleton Daniel E., 2012, Endangered Species Research, V18, P147, DOI 10.3354/esr00433; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Pulliam HR, 2000, ECOL LETT, V3, P349, DOI 10.1046/j.1461-0248.2000.00143.x; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Redfern JV, 2013, CONSERV BIOL, V27, P292, DOI 10.1111/cobi.12029; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Schick RS, 2009, CAN J FISH AQUAT SCI, V66, P1399, DOI 10.1139/F09-115; Stegmann PM, 1996, CONT SHELF RES, V16, P843, DOI 10.1016/0278-4343(95)00029-1; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Waring G. T., 2013, NMFSNE223 NOAA; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood S.N., 2001, R R NEWS, V1, P20; Wood SN, 2003, J ROY STAT SOC B, V65, P95, DOI 10.1111/1467-9868.00374; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	53	24	24	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95126	10.1371/journal.pone.0095126	http://dx.doi.org/10.1371/journal.pone.0095126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740091	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900107
J	Voss, JD; Allison, DB; Webber, BJ; Otto, JL; Clark, LL				Voss, Jameson D.; Allison, David B.; Webber, Bryant J.; Otto, Jean L.; Clark, Leslie L.			Lower Obesity Rate during Residence at High Altitude among a Military Population with Frequent Migration: A Quasi Experimental Model for Investigating Spatial Causation	PLOS ONE			English	Article							BODY-WEIGHT; OPERATION EVEREST; ACUTE EXPOSURE; HYPOBARIC HYPOXIA; SIMULATED ASCENT; LEPTIN LEVELS; ERYTHROPOIETIN; ADIPONECTIN; CONSUMPTION; OVERWEIGHT	We sought to evaluate whether residence at high altitude is associated with the development of obesity among those at increased risk of becoming obese. Obesity, a leading global health priority, is often refractory to care. A potentially novel intervention is hypoxia, which has demonstrated positive long-term metabolic effects in rats. Whether or not high altitude residence confers benefit in humans, however, remains unknown. Using a quasi-experimental, retrospective study design, we observed all outpatient medical encounters for overweight active component enlisted service members in the U.S. Army or Air Force from January 2006 to December 2012 who were stationed in the United States. We compared high altitude (>1.96 kilometers above sea level) duty assignment with low altitude (<0.98 kilometers). The outcome of interest was obesity related ICD-9 codes (278.00-01, V85.3x-V85.54) by Cox regression. We found service members had a lower hazard ratio (HR) of incident obesity diagnosis if stationed at high altitude as compared to low altitude (HR 0.59, 95% confidence interval [CI] 0.54-0.65; p < 0.001). Using geographic distribution of obesity prevalence among civilians throughout the U.S. as a covariate (as measured by the Centers for Disease Control and Prevention and the REGARDS study) also predicted obesity onset among service members. In conclusion, high altitude residence predicts lower rates of new obesity diagnoses among overweight service members in the U.S. Army and Air Force. Future studies should assign exposure using randomization, clarify the mechanism(s) of this relationship, and assess the net balance of harms and benefits of high altitude on obesity prevention.	[Voss, Jameson D.] US Air Force Sch Aerosp Med, Epidemiol Consult Div, Wright Patterson AFB, OH 45433 USA; [Voss, Jameson D.; Webber, Bryant J.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med, Bethesda, MD 20814 USA; [Allison, David B.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Allison, David B.] Univ Alabama Birmingham, Nutr & Obes Res Ctr, Birmingham, AL USA; [Webber, Bryant J.] Joint Base San Antonio Lackland, Trainee Hlth Surveillance, Lackland AFB, TX USA; [Otto, Jean L.; Clark, Leslie L.] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA; [Otto, Jean L.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Clark, Leslie L.] Gen Dynam Informat Technol, Fairfax, VA USA	Uniformed Services University of the Health Sciences - USA; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Voss, JD (corresponding author), US Air Force Sch Aerosp Med, Epidemiol Consult Div, Wright Patterson AFB, OH 45433 USA.	jameson.voss@us.af.mil	Voss, Jameson D/P-8392-2017; Webber, Bryant/ABI-7744-2020	Voss, Jameson D/0000-0002-4104-1744; Webber, Bryant/0000-0002-2099-2671	Armed Forces Health Surveillance Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	Armed Forces Health Surveillance Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors' fees were paid by Armed Forces Health Surveillance Center. Those affiliated with the funding organization contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aeberli I, 2012, EUR J NUTR; Armed Forces Health Surveillance Center (AFHSC), 2011, MSMR, V18, P2; [Anonymous], LIST ZIP COD PREF; [Anonymous], L002 3 DIG ZIP COD P; [Anonymous], 2012, ACCELERATING PROGR O; [Anonymous], 2013, 2011 HLTH RELATED BE; Bailey D M, 2000, High Alt Med Biol, V1, P9, DOI 10.1089/152702900320649; Barnholt KE, 2006, AM J PHYSIOL-ENDOC M, V290, pE1078, DOI 10.1152/ajpendo.00449.2005; Baze MM, 2010, PHYSL GENOMICS; Bozzini CE, 2005, GROWTH DEVELOP AGING, V69, P81; Brenner B, 2011, HIGH ALT MED BIOL, V12, P31, DOI 10.1089/ham.2010.1058; Brookhart MA, 2008, J AM SOC NEPHROL, V19, P1389, DOI 10.1681/ASN.2007111181; Budweiser S, 2006, RESP CARE, V51, P126; Cawley J, 2012, HEALTH ECON, V21, P1348, DOI 10.1002/hec.1794; *CDCP, DIAB DAT TRENDS; Centers for Disease Control and Prevention, 2011, OV OB; Centers for Disease Control and Prevention, 2013, STAT TOB ACT TRACK E; Chia M, 2013, CHINESE J PHYSL, P2; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Clair C, 2013, JAMA-J AM MED ASSOC, V309, P1014, DOI 10.1001/jama.2013.1644; Csongradi E, 2012, INT J OBESITY, V36, P244, DOI 10.1038/ijo.2011.78; Dall TM, 2007, AM J HEALTH PROMOT, V22, P120, DOI 10.4278/0890-1171-22.2.120; Defense Travel Management Office, 2009, BROWS ALL TABL REG F; ELIA R, 1985, ACTA PHYSIOL PHARM L, V35, P311; Fiedler KK, 2012, J ADDICT MED, V6, P166, DOI 10.1097/ADM.0b013e31824b6c62; Floyd ZE, 2012, BBA-MOL BASIS DIS, V1822, P1090, DOI 10.1016/j.bbadis.2012.03.014; Gabrielsen JS, 2012, J CLIN INVEST, V122, P3529, DOI 10.1172/JCI44421; Ge Ri-Li, 2010, Shengli Xuebao, V62, P541; Grosfeld A, 2002, J BIOL CHEM, V277, P42953, DOI 10.1074/jbc.M206775200; Hamad N, 2006, EUR J GASTROEN HEPAT, V18, P5, DOI 10.1097/00042737-200601000-00002; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosick P, 2013, INT J OBESITY; Kayser B, 2013, OBESITY REV; Kessler R, 2011, AM J PREV MED, V40, P637, DOI 10.1016/j.amepre.2011.02.023; Kong Z, 2013, SLEEP BREATH; Le A, 2013, OBESITY SILVER SPRIN; Leal T. L., 1995, Acta Physiologica Pharmacologica et Therapeutica Latinoamericana, V45, P9; Lippl FJ, 2010, OBESITY, V18, P675, DOI 10.1038/oby.2009.509; Loshbaugh JE, 2006, HIGH ALT MED BIOL, V7, P47, DOI 10.1089/ham.2006.7.47; Matthews LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055234; Meyer E, 2013, ARCH ARGENT PEDIATR, P111; Minamiyama Y, 2010, AM J PHYSIOL-ENDOC M, V298, pE1140, DOI 10.1152/ajpendo.00620.2009; Netzer NC, 2008, SLEEP BREATH, V12, P129, DOI 10.1007/s11325-007-0149-3; Norese MF, 2002, HIGH ALT MED BIOL, V3, P49, DOI 10.1089/152702902753639540; OBACH R, 1986, EUR J PHARMACOL, V127, P225, DOI 10.1016/0014-2999(86)90368-7; Packnett ER, 2011, AM J CLIN NUTR, V93, P608, DOI 10.3945/ajcn.110.007070; Palmer BF, 2013, OBESITY SILVER SPRIN; Popkin BM, 2011, CURR OPIN ENDOCRINOL; Quintero P, 2010, MED HYPOTHESES, V74, P901, DOI 10.1016/j.mehy.2009.10.022; Reiter CEN, 2012, FEBS OPEN BIO, V2, P113, DOI 10.1016/j.fob.2012.05.003; Ri-Li G, 2003, ANN INTERN MED, V139, P253, DOI 10.7326/0003-4819-139-4-200308190-00007; Ryter SW, 2013, KOREAN J INTERN MED, V28, P123, DOI 10.3904/kjim.2013.28.2.123; SCHERER G, 1990, INT ARCH OCC ENV HEA, V62, P459, DOI 10.1007/BF00379064; SCHNAKENBERG DD, 1971, J NUTR, V101, P787, DOI 10.1093/jn/101.6.787; Shadish WR, 2009, ANNU REV PSYCHOL, V60, P607, DOI 10.1146/annurev.psych.60.110707.163544; Sherpa LY, 2010, INT J ENV RES PUB HE, V7, P1670, DOI 10.3390/ijerph7041670; Shukla V, 2005, NUTR NEUROSCI, V8, P161, DOI 10.1080/10284150500132823; Sierra-Johnson J, 2008, J APPL PHYSIOL, V105, P1684, DOI 10.1152/japplphysiol.01284.2007; Smith TJ, 2012, OBESITY, V20, P1534, DOI 10.1038/oby.2012.25; SURKS MI, 1966, J APPL PHYSIOL, V21, P1741, DOI 10.1152/jappl.1966.21.6.1741; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Tschop M, 1998, LANCET, V352, P1119, DOI 10.1016/S0140-6736(05)79760-9; Tyagi R, 2008, ANTHROPOL ANZ, V66, P419, DOI 10.1127/aa/66/2008/419; Vats P, 2013, HIGH ALT MED BIOL, V14, P45, DOI 10.1089/ham.2012.1071; Voss J, 2013, OBESITY PANACEA PLOS; Voss JD, 2013, INT J OBES LOND; Wagner PD, 2010, HIGH ALT MED BIOL, V11, P111, DOI 10.1089/ham.2009.1084; Wasse LK, 2012, J APPL PHYSIOL, V112, P552, DOI 10.1152/japplphysiol.00090.2011; Westerterp-Plantenga MS, 1999, J APPL PHYSIOL, V87, P391, DOI 10.1152/jappl.1999.87.1.391; Wilson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011565; Wlazlo N, 2013, DIABETES CARE, V36, P309, DOI 10.2337/dc12-0505; YOUNG PM, 1989, J APPL PHYSIOL, V66, P1430, DOI 10.1152/jappl.1989.66.3.1430	73	46	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93493	10.1371/journal.pone.0093493	http://dx.doi.org/10.1371/journal.pone.0093493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740173	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900021
J	Xu, LJ; Jiang, T; Zhao, W; Han, JF; Liu, J; Deng, YQ; Zhu, SY; Li, YX; Nian, QG; Zhang, Y; Wu, XY; Qin, ED; Qin, CF				Xu, Li-Juan; Jiang, Tao; Zhao, Wei; Han, Jian-Feng; Liu, Juan; Deng, Yong-Qiang; Zhu, Shun-Ya; Li, Yue-Xiang; Nian, Qing-Gong; Zhang, Yu; Wu, Xiao-Yan; Qin, E-De; Qin, Cheng-Feng			Parallel mRNA and MicroRNA Profiling of HEV71-Infected Human Neuroblastoma Cells Reveal the Up-Regulation of miR-1246 in Association with DLG3 Repression	PLOS ONE			English	Article							ENTEROVIRUS TYPE-71 INFECTIONS; POLIOMYELITIS-LIKE DISEASE; NMDA RECEPTOR; IN-VITRO; ENCEPHALITIS; EXPRESSION; EPIDEMIC; PROTEIN; IDENTIFICATION; EVOLUTION	Human enterovirus 71 (HEV71) has emerged as the leading cause of viral encephalitis in children in most Asian countries. The roles of host miRNAs in the neurological pathogenesis of HEV71 infection remain unknown. In the present study, comprehensive miRNA expression profiling in HEV71-infected human neuroblastoma SH-SY5Y cells was performed using the Affymetrix Gene Chip microarray assay and was validated using real-time RT-PCR. Among the 69 differentially expressed miRNAs, miR-1246 was specifically induced by HEV71 infection in human neuroblastoma cells, but inhibition of miR-1246 failed to affect HEV71 replication. Parallel mRNA and microRNA profiling based on the 35 K Human Genome Array identified 182 differentially regulated genes. Target prediction of miR-1246 and network modeling revealed 14 potential target genes involved in cell death and cell signaling. Finally, a combined analysis of the results from mRNA profiling and miR-1246 target predication led to the identification of disc-large homolog 3 (DLG3), which is associated with neurological disorders, for further validation. Sequence alignment and luciferase reporter assay showed that miR-1246 directly bound with the 3'-UTR of DLG3 gene. Down-regulation of miR-1246 induced significant changes in DLG3 expression levels in HEV71-infected SHSY5Y cells. Together, these results suggested that miR-1246 might play a role in neurological pathogenesis of HEV71 by regulating DLG3 gene in infected cells. These findings provide new information on the miRNA and mRNA profiles of HEV71-infected neuroblastoma cells. The biological significance of miR-1246 and DLG3 during the course of HEV71 infection deserves further investigation.	[Xu, Li-Juan; Jiang, Tao; Han, Jian-Feng; Liu, Juan; Deng, Yong-Qiang; Zhu, Shun-Ya; Li, Yue-Xiang; Nian, Qing-Gong; Zhang, Yu; Wu, Xiao-Yan; Qin, E-De; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China; [Xu, Li-Juan] PLA 404 Hosp, Weihai, Shandong, Peoples R China; [Zhao, Wei] Southern Med Univ, Sch Publ Hlth & Trop Med, Guangzhou, Guangdong, Peoples R China; [Li, Yue-Xiang; Qin, Cheng-Feng] Anhui Med Univ, Grad Sch, Hefei, Anhui, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Southern Medical University - China; Anhui Medical University	Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Dept Virol, Beijing, Peoples R China.	qincf@bmi.ac.cn	Qin, Cheng-Feng/I-6839-2019; Tao, Jiang/AAE-6623-2019; LI, Yue/GRS-8071-2022	Qin, Cheng-Feng/0000-0002-0632-2807; Tao, Jiang/0000-0003-1908-2926; 	Beijing Natural Science Foundation [7122129, 7112108]; National Natural Science Foundation of China [81000721, 31270195]; Beijing Nova Program of Science and Technology [2010B041]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program of Science and Technology	This work was supported by the Beijing Natural Science Foundation (No. 7122129 and No. 7112108) and the National Natural Science Foundation of China (No. 81000721 and No. 31270195). CFQ was supported by the Beijing Nova Program of Science and Technology (No. 2010B041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Barnes D, 2008, CELL HOST MICROBE, V4, P239, DOI 10.1016/j.chom.2008.08.003; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Cao RY, 2011, J CLIN VIROL, V51, P242, DOI 10.1016/j.jcv.2011.05.002; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Cordey S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002826; Cui FM, 2013, J TOXICOL ENV HEAL A, V76, P107, DOI 10.1080/15287394.2013.738176; Cui LB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/425939; Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071; Cuthbert PC, 2007, J NEUROSCI, V27, P2673, DOI 10.1523/JNEUROSCI.4457-06.2007; Fujita A, 2000, BIOCHEM BIOPH RES CO, V269, P1, DOI 10.1006/bbrc.1999.1893; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Gillen AE, 2011, BIOCHEM J, V438, P25, DOI 10.1042/BJ20110672; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; HAGIWARA A, 1984, ARCH VIROL, V79, P273, DOI 10.1007/BF01310816; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Han JF, 2012, EMERG INFECT DIS, V18, P351, DOI 10.3201/eid1802.111524; Han JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-106; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Ho BC, 2011, CELL HOST MICROBE, V9, P58, DOI 10.1016/j.chom.2010.12.001; Hsueh C, 2000, MODERN PATHOL, V13, P1200, DOI 10.1038/modpathol.3880222; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang SC, 2009, J MED VIROL, V81, P1241, DOI 10.1002/jmv.21502; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Jones CI, 2012, BRIT J CANCER, V107, P1987, DOI 10.1038/bjc.2012.525; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Katoh M, 2006, CANCER BIOL THER, V5, P1059, DOI 10.4161/cbt.5.9.3151; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Kelly EJ, 2008, NAT MED, V14, P1278, DOI 10.1038/nm.1776; Kelly EJ, 2010, J VIROL, V84, P1550, DOI 10.1128/JVI.01788-09; Kuwahara H, 1999, J BIOL CHEM, V274, P32204, DOI 10.1074/jbc.274.45.32204; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lang UE, 2007, CELL PHYSIOL BIOCHEM, V20, P687, DOI 10.1159/000110430; Lauring AS, 2010, NAT BIOTECHNOL, V28, P573, DOI 10.1038/nbt.1635; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lickert Heiko, 2012, Commun Integr Biol, V5, P287, DOI 10.4161/cib.19792; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; MELNICK JL, 1984, REV INFECT DIS, V6, pS387; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nagata N, 2004, J GEN VIROL, V85, P2981, DOI 10.1099/vir.0.79883-0; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Nishikawa T, 2011, J CHROMATOGR B, V879, P3169, DOI 10.1016/j.jchromb.2011.08.030; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pigati L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013515; ROSS RA, 1983, J NATL CANCER I, V71, P741; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Tsai WC, 2009, HEPATOLOGY, V49, P1571, DOI 10.1002/hep.22806; Tung WH, 2010, CELL SIGNAL, V22, P234, DOI 10.1016/j.cellsig.2009.09.018; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Van Campenhout CA, 2011, DEV CELL, V21, P479, DOI 10.1016/j.devcel.2011.08.003; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang YF, 2004, J VIROL, V78, P7916, DOI 10.1128/JVI.78.15.7916-7924.2004; Wen BP, 2013, INTERVIROLOGY, V56, P195, DOI 10.1159/000348504; Wong KT, 2000, NEUROPATH APPL NEURO, V26, P313, DOI 10.1046/j.1365-2990.2000.00256.x; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065948; Ye Q, 2012, J GEN VIROL, V93, P1959, DOI 10.1099/vir.0.043844-0; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98; Zheng Z, 2013, J VIROL	77	28	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95272	10.1371/journal.pone.0095272	http://dx.doi.org/10.1371/journal.pone.0095272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739954	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900124
J	Yuan, GR; Shi, WZ; Yang, WJ; Jiang, XZ; Dou, W; Wang, JJ				Yuan, Guo-Rui; Shi, Wen-Zhi; Yang, Wen-Jia; Jiang, Xuan-Zhao; Dou, Wei; Wang, Jin-Jun			Molecular Characteristics, mRNA Expression, and Alternative Splicing of a Ryanodine Receptor Gene in the Oriental Fruit Fly, Bactrocera dorsalis (Hendel)	PLOS ONE			English	Article							CA2+ RELEASE CHANNELS; SKELETAL-MUSCLE; DIAMONDBACK MOTH; LEPIDOPTERA PLUTELLIDAE; ANTHRANILIC DIAMIDES; FIELD POPULATIONS; MOUSE-BRAIN; CALCIUM; IDENTIFICATION; RESISTANCE	Ryanodine receptors (RyRs) are a distinct class of ligand-gated channels controlling the release of calcium from intracellular stores. The emergence of diamide insecticides, which selectively target insect RyRs, has promoted the study of insect RyRs. In the present study, the full-length RyR cDNA (BdRyR) was cloned and characterized from the oriental fruit fly, Bactrocera dorsalis (Hendel), a serious pest of fruits and vegetables throughout East Asia and the Pacific Rim. The cDNA of BdRyR contains a 15,420-bp open reading frame encoding 5,140 amino acids with a predicted molecular weight of 582.4 kDa and an isoelectric point of 5.38. BdRyR shows a high level of amino acid sequence identity (78 to 97%) to other insect RyR isoforms. All common structural features of the RyRs are present in the BdRyR, including a well-conserved C-terminal domain containing consensus calcium-binding EF-hands and six transmembrane domains, and a large N-terminal domain. Quantitative real-time PCR analyses revealed that BdRyR was expressed at the lowest and highest levels in egg and adult, respectively, and that the BdRyR expression levels in the third instar larva, pupa and adult were 166.99-, 157.56- and 808.56-fold higher, respectively, than that in the egg. Among different adult body parts, the highest expression level was observed in the thorax compared with the head and abdomen. In addition, four alternative splice sites were identified in the BdRyR gene, with the first, ASI, being located in the central part of the predicted second spore lysis A/RyR domain. Diagnostic PCR analyses revealed that alternative splice variants were generated not only in a tissue-specific manner but also in a developmentally regulated manner. These results lay the foundation for further understanding the structural and functional properties of BdRyR, and the molecular mechanisms for target site resistance in B. dorsalis.	[Yuan, Guo-Rui; Shi, Wen-Zhi; Yang, Wen-Jia; Jiang, Xuan-Zhao; Dou, Wei; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Southwest University - China	Dou, W (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	wangjinjun@swu.edu.cn; jjwang7008@yahoo.com	jiang, xuanzhao/AAR-3786-2020	jiang, xuanzhao/0000-0002-1608-3846	Fundamental Research Funds for Central Universities, China [XDJK2012C076]; Doctor Foundation Project of Southwest University [SWU112002]; China Postdoctoral Science Foundation [2013M540693]; Fundamental and Advanced Research Program of Chongqing (CSTC) [2013jcyjA80020]	Fundamental Research Funds for Central Universities, China; Doctor Foundation Project of Southwest University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental and Advanced Research Program of Chongqing (CSTC)	This research was supported in part by the Fundamental Research Funds for Central Universities, China (XDJK2012C076), the Doctor Foundation Project of Southwest University (SWU112002), China Postdoctoral Science Foundation (2013M540693) and Fundamental and Advanced Research Program of Chongqing (CSTC, 2013jcyjA80020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bhat MB, 1997, BIOPHYS J, V73, P1329, DOI 10.1016/S0006-3495(97)78166-9; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; Cordova D, 2006, PESTIC BIOCHEM PHYS, V84, P196, DOI 10.1016/j.pestbp.2005.07.005; Cui L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075825; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; Ebbinghaus-Kintscher U, 2006, CELL CALCIUM, V39, P21, DOI 10.1016/j.ceca.2005.09.002; FLETCHER BS, 1987, ANNU REV ENTOMOL, V32, P115, DOI 10.1146/annurev.en.32.010187.000555; FURUICHI T, 1994, J NEUROSCI, V14, P4794; FUTATSUGI A, 1995, BIOCHEM J, V305, P373, DOI 10.1042/bj3050373; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; George CH, 2006, CIRC RES, V98, P88, DOI 10.1161/01.RES.0000199296.70534.7c; George CH, 2004, MOL BIOL CELL, V15, P2627, DOI 10.1091/mbc.E03-09-0688; George CH, 2007, CIRC RES, V100, P874, DOI 10.1161/01.RES.0000260804.77807.cf; GIANNINI G, 1995, J CELL BIOL, V128, P893, DOI 10.1083/jcb.128.5.893; Guo L, 2014, PEST MANAG SCI, V70, P1083, DOI 10.1002/ps.3651; Hsu JC, 2004, J ECON ENTOMOL, V97, P1682, DOI 10.1603/0022-0493-97.5.1682; Isaacs AK, 2012, CHEM RES TOXICOL, V25, P1571, DOI 10.1021/tx300326m; Jin T, 2011, PEST MANAG SCI, V67, P370, DOI 10.1002/ps.2076; Kato K, 2009, BIOCHEMISTRY-US, V48, P10342, DOI 10.1021/bi900866s; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; KUWAJIMA G, 1992, NEURON, V9, P1133, DOI 10.1016/0896-6273(92)90071-K; Lahm GP, 2005, BIOORG MED CHEM LETT, V15, P4898, DOI 10.1016/j.bmcl.2005.08.034; LEDBETTER MW, 1994, J BIOL CHEM, V269, P31544; Marziah G, 1996, FEBS LETT, V394, P76, DOI 10.1016/0014-5793(96)00944-1; Miyatake R, 1996, FEBS LETT, V395, P123, DOI 10.1016/0014-5793(96)01022-8; Murayama T, 1996, J BIOL CHEM, V271, P5079; Nauen R., 2007, Pflanzenschutz-Nachrichten Bayer, V60, P247; Ogawa Y, 1999, MOL CELL BIOCHEM, V190, P191, DOI 10.1023/A:1006903401123; Ottini L, 1996, BIOCHEM J, V315, P207, DOI 10.1042/bj3150207; OYAMADA H, 1994, J BIOL CHEM, V269, P17206; PEPPER BP, 1945, J ECON ENTOMOL, V38, P59, DOI 10.1093/jee/38.1.59; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponting C, 1997, TRENDS BIOCHEM SCI, V22, P193, DOI 10.1016/S0968-0004(97)01049-9; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P48; Roderick HL, 1997, FEBS LETT, V405, P181, DOI 10.1016/S0014-5793(97)00183-X; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Shen GM, 2012, PEST MANAG SCI, V68, P1553, DOI 10.1002/ps.3340; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Sorrentino V, 2000, CURR OPIN GENET DEV, V10, P662, DOI 10.1016/S0959-437X(00)00139-8; SORRENTINO V, 1993, TRENDS PHARMACOL SCI, V14, P98, DOI 10.1016/0165-6147(93)90072-R; Tae H, 2011, CHANNELS, V5, P148, DOI 10.4161/chan.5.2.14407; TAKESHIMA H, 1993, ANN NY ACAD SCI, V707, P165, DOI 10.1111/j.1749-6632.1993.tb38051.x; TAKESHIMA H, 1994, FEBS LETT, V337, P81, DOI 10.1016/0014-5793(94)80634-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao Y, 2013, INSECT BIOCHEM MOLEC, V43, P820, DOI 10.1016/j.ibmb.2013.06.006; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tohnishi M, 2005, J PESTIC SCI, V30, P354, DOI 10.1584/jpestics.30.354; Troczka B, 2012, INSECT BIOCHEM MOLEC, V42, P873, DOI 10.1016/j.ibmb.2012.09.001; Wang J, 2014, PEST MANAG SCI, V70, P790, DOI 10.1002/ps.3616; Wang J, 2013, PESTIC BIOCHEM PHYS, V107, P327, DOI 10.1016/j.pestbp.2013.09.006; Wang JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036623; Wang XL, 2013, PEST MANAG SCI, V69, P661, DOI 10.1002/ps.3422; Wang XL, 2012, J ECON ENTOMOL, V105, P1019, DOI 10.1603/EC12059; Wang XL, 2012, PESTIC BIOCHEM PHYS, V102, P204, DOI 10.1016/j.pestbp.2012.01.009; Wang XL, 2010, J ECON ENTOMOL, V103, P843, DOI 10.1603/EC09367; Wu SF, 2013, DEV COMP IMMUNOL, V41, P1, DOI 10.1016/j.dci.2013.04.006; Xiong H, 1998, BIOCHEMISTRY-US, V37, P4804, DOI 10.1021/bi971198b; Xu XH, 2000, BIOPHYS J, V78, P1270, DOI 10.1016/S0006-3495(00)76683-5; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971	62	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95199	10.1371/journal.pone.0095199	http://dx.doi.org/10.1371/journal.pone.0095199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740254	gold, Green Submitted, Green Published			2022-12-25	WOS:000336863900114
J	Galicia-Connolly, E; Adams, D; Bateman, J; Dagenais, S; Clifford, T; Baydala, L; King, WJ; Vohra, S				Galicia-Connolly, Elaine; Adams, Denise; Bateman, Justin; Dagenais, Simon; Clifford, Tammy; Baydala, Lola; King, W. James; Vohra, Sunita			CAM Use in Pediatric Neurology: An Exploration of Concurrent Use with Conventional Medicine	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; ALTERNATIVE MEDICINE; SPECTRUM DISORDER; THERAPY USE; COMPLEMENTARY; CHILDREN; EPILEPSY; CANCER; ILLNESS; AUTISM	Background: Previous studies have found that up to 60% of children with neurologic conditions have tried complementary and alternative medicine (CAM). Objective: To assess the use of CAM among patients presenting to neurology clinics at two academic centers in Canada. Methods: A survey instrument was developed to inquire about use of CAM products and therapies, including reasons for use, perceived helpfulness, and concurrent use with conventional medicine, and administered to patients or their parents/guardians at the Stollery Children's Hospital in Edmonton and the Children's Hospital of Eastern Ontario (CHEO) in Ottawa. Results: Overall CAM use at the Stollery was 78%, compared to 48% at CHEO. The most common CAM products used were multi-vitamins (84%), vitamin C (37%), homeopathic remedies (24%), and fish oil/omega 3 s (22%). The most common CAM practices used were massage (47%), chiropractic (37%), faith healing (18%), aromatherapy (16%), homeopathy (16%), and relaxation (16%). Many patients used CAM products at the same time as conventional medicine but just over half (57%) discussed this concurrent use with their physician. Conclusion: CAM use is common in pediatric neurology patients and most respondents felt that it was helpful, with few or no harms associated. However, this use is often undisclosed, increasing possibility of interactions with conventional drugs. We urge clinicians to inquire about CAM use during routine history taking at every patient visit. Parents would clearly like more information about CAM from their specialty clinics; such information would be easier to share if more primary data were available about the safety and effectiveness of commonly used therapies.	[Galicia-Connolly, Elaine; Adams, Denise] Univ Alberta, Dept Pediat, CARE Program, Edmonton, AB, Canada; [Bateman, Justin] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Dagenais, Simon] Palladian Hlth, West Seneca, NY USA; [Clifford, Tammy] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Clifford, Tammy] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Clifford, Tammy] Canadian Agcy Drugs & Technol Hlth, Ottawa, ON, Canada; [Clifford, Tammy; Baydala, Lola] Univ Alberta, Dept Pediat, Fac Med & Dent, Edmonton, AB, Canada; [King, W. James] Univ Ottawa, Dept Pediat, Div Pediat Med, Ottawa, ON K1N 6N5, Canada; [King, W. James] Childrens Hosp Eastern Ontario, Ottawa, ON K1H 8L1, Canada; [Vohra, Sunita] Univ Alberta, Dept Pediat, PedCAM Network, Fac Med & Dent,CARE Program, Edmonton, AB, Canada; [Vohra, Sunita] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Ottawa; University of Ottawa; University of Alberta; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario; University of Alberta; University of Alberta	Vohra, S (corresponding author), Univ Alberta, Dept Pediat, PedCAM Network, Fac Med & Dent,CARE Program, Edmonton, AB, Canada.	svohra@ualberta.ca	; Vohra, Sunita/F-5755-2016	Dagenais, Simon/0000-0003-3062-9312; Vohra, Sunita/0000-0002-6210-7933	SickKids Foundation; Alberta Innovates-Health Solutions	SickKids Foundation; Alberta Innovates-Health Solutions	This project was supported by a grant from the SickKids Foundation. Sunita Vohra receives salary support from Alberta Innovates-Health Solutions (formerly Alberta Heritage Foundation for Medical Research), which is a government agency that supports research in Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2013, PEDIATRICS, V131, P225, DOI 10.1542/peds.2012-1220; Armishaw J, 1999, ARCH DIS CHILD, V81, P133, DOI 10.1136/adc.81.2.133; Ball SD, 2005, J AM DIET ASSOC, V105, P78, DOI 10.1016/j.jada.2004.10.008; Barnes PM, 2008, NATL HLTH STAT REPOR, V12, P1, DOI DOI 10.1037/E623942009-001; Birdee GS, 2010, PEDIATRICS, V125, P249, DOI 10.1542/peds.2009-1406; Cheuk DKL, 2008, COCHRANE DB SYST REV, V4; Christon LM, 2010, RES AUTISM SPECT DIS, V4, P249, DOI 10.1016/j.rasd.2009.09.013; Cvijovic K, 2009, CAN PHARM J, V142, P224, DOI 10.3821/1913-701X-142.5.224; Devinsky O, 2005, COMPLEMENTARY ALTERN, pe129; Fernandez CV, 1998, J CLIN ONCOL, V16, P1279, DOI 10.1200/JCO.1998.16.4.1279; Friedman T, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.6.e1; Golomb MR, 2003, J CHILD NEUROL, V18, P714, DOI 10.1177/08830738030180100201; Gross-Tsur V, 2003, PEDIATR NEUROL, V29, P53, DOI 10.1016/s0887-8994(03)00027-4; Hagen LEM, 2003, ARTHRIT RHEUM-ARTHR, V49, P3, DOI 10.1002/art.10931; Hanson E, 2007, J AUTISM DEV DISORD, V37, P628, DOI 10.1007/s10803-006-0192-0; Harrington JW, 2006, J DEV BEHAV PEDIATR, V27, pS156, DOI 10.1097/00004703-200604002-00014; Hurvitz EA, 2003, DEV MED CHILD NEUROL, V45, P364, DOI 10.1017/S0012162203000707; Johnston GA, 2004, BRIT J DERMATOL, V150, P1186, DOI 10.1111/j.1365-2133.2004.05888.x; Kemper KJ, 2010, PEDIATR REV, V31, pE17, DOI 10.1542/pir.31-2-e17; Kemper KJ, 2008, PEDIATRICS, V122, P1374, DOI 10.1542/peds.2008-2173; Levy R, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001903; Levy SE, 2003, J DEV BEHAV PEDIATR, V24, P418, DOI 10.1097/00004703-200312000-00003; Lim J Y F, 2004, Ann Acad Med Singap, V33, pS76; Maha Nita, 2007, BMC Complement Altern Med, V7, P17, DOI 10.1186/1472-6882-7-17; Mazur L J, 2001, Tex Med, V97, P64; Murphy SP, 2002, AM J EPIDEMIOL, V156, P669, DOI 10.1093/aje/kwf097; Neuhouser ML, 2001, PREV MED, V33, P347, DOI 10.1006/pmed.2001.0911; PENDERGRASS TW, 1981, AM J PEDIAT HEMATOL, V3, P339; Ramaratnam S, 2009, COCHRANE DB SYST REV, V3; Ranganathan LN, 2005, COCHRANE DB SYST REV, V2; Ricotti V, 2006, CURR NEUROL NEUROSCI, V6, P347, DOI 10.1007/s11910-006-0029-4; Rogovik AL, 2010, ANN PHARMACOTHER, V44, P311, DOI 10.1345/aph.1M238; Samuels N, 2008, EPILEPSIA, V49, P373, DOI 10.1111/j.1528-1167.2007.01379.x; Sinha D, 2005, J PAEDIATR CHILD H, V41, P23, DOI 10.1111/j.1440-1754.2005.00530.x; Sirven JI, 2007, SEMIN NEUROL, V27, P325, DOI 10.1055/s-2007-985334; Soo I, 2005, CAN J NEUROL SCI, V32, P524, DOI 10.1017/S0317167100004558; Weber W, 2007, PEDIATR CLIN N AM, V54, P983, DOI 10.1016/j.pcl.2007.09.006	37	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94078	10.1371/journal.pone.0094078	http://dx.doi.org/10.1371/journal.pone.0094078			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736474	gold, Green Submitted, Green Published			2022-12-25	WOS:000336922600043
J	Grans, A; Sandblom, E; Kiessling, A; Axelsson, M				Grans, Albin; Sandblom, Erik; Kiessling, Anders; Axelsson, Michael			Post-Surgical Analgesia in Rainbow Trout: Is Reduced Cardioventilatory Activity a Sign of Improved Animal Welfare or the Adverse Effects of an Opioid Drug?	PLOS ONE			English	Article							GASTROINTESTINAL BLOOD-FLOW; HEART-RATE-VARIABILITY; ONCORHYNCHUS-MYKISS; POSTOPERATIVE PAIN; FISH; BUPRENORPHINE; MORPHINE; RESPONSES; EXERCISE	The use of fish models in biomedical research is increasing. Since behavioural and physiological consequences of surgical procedures may affect experimental results, these effects should be defined and, if possible, ameliorated. Thus, the use of post-surgical analgesia should be considered after invasive procedures also in fish, but presently, little information exists on the effects of analgesics in fish. This study assessed the effects of an opioid drug, buprenorphine (0.05 mg/kg IM), on resting ventilation and heart rates during 7 days of postsurgical recovery in rainbow trout (Oncorhynchus mykiss) at 10 degrees C by non-invasively recording bioelectric potentials from the fish via electrodes in the water. Baseline ventilation and heart rates were considerably lower compared to previously reported values for rainbow trout at 10 degrees C, possibly due to the non-invasive recording technique. Buprenorphine significantly decreased both ventilation and heart rates further, and the effects were most pronounced at 4-7 days after anaesthesia, surgical procedures and administration of the drug. Somewhat surprisingly, the same effects of buprenorphine were seen in the two control groups that had not been subject to surgery. These results indicate that the reductions in ventilation and heart rates are not caused by an analgesic effect of the drug, but may instead reflect a general sedative effect acting on both behaviour as well as e. g. central control of ventilation in fishes. This resembles what has previously been demonstrated in mammals, although the duration of the drug effect is considerably longer in this ectothermic animal. Thus, before using buprenorphine for postoperative analgesic treatment in fish, these potentially adverse effects need further characterisation.	[Grans, Albin; Sandblom, Erik; Axelsson, Michael] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Kiessling, Anders] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden	University of Gothenburg; Swedish University of Agricultural Sciences	Grans, A (corresponding author), Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden.	albin.grans@bioenv.gu.se	Axelsson, Michael/D-1412-2009	Axelsson, Michael/0000-0002-7839-3233; Grans, Albin/0000-0003-0268-1199	Swedish Research Council FORMAS; Swedish Research Council VR; Swedish board of agriculture; Helge Ax:son Johnsson foundation; Royal Society of Arts and Sciences in Goteborg; Wilhelm and Martina Lundgrens foundation	Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council VR(Swedish Research Council); Swedish board of agriculture; Helge Ax:son Johnsson foundation; Royal Society of Arts and Sciences in Goteborg; Wilhelm and Martina Lundgrens foundation	This research was supported by the Swedish Research Councils FORMAS and VR, the Swedish board of agriculture, the Helge Ax:son Johnsson foundation, the Royal Society of Arts and Sciences in Goteborg and Wilhelm and Martina Lundgrens foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya UR, 2006, MED BIOL ENG COMPUT, V44, P1031, DOI 10.1007/s11517-006-0119-0; Altimiras J, 2000, J FISH BIOL, V57, P197, DOI 10.1111/j.1095-8649.2000.tb00786.x; Altimiras J, 1999, COMP BIOCHEM PHYS A, V124, P447, DOI 10.1016/S1095-6433(99)00137-3; Bennett A.F., 1987, P147; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Brown SM, 2011, ANESTHESIOLOGY, V115, P1251, DOI 10.1097/ALN.0b013e318238fea0; Campbell HA, 2004, J EXP BIOL, V207, P1969, DOI 10.1242/jeb.00972; COWAN A, 1977, BRIT J PHARMACOL, V60, P547, DOI 10.1111/j.1476-5381.1977.tb07533.x; Curtin LI, 2009, COMPARATIVE MED, V59, P60; Dahan A, 2006, PALLIATIVE MED, V20, pS3, DOI 10.1191/0269216306pm1126oa; DEVERA L, 1991, J EXP BIOL, V156, P611; Eliason EJ, 2008, COMP BIOCHEM PHYS A, V149, P380, DOI 10.1016/j.cbpa.2008.01.033; Fish RE, 2008, AM COLL LAB, P1; GOODMAN DA, 1971, BEHAV RES METH INSTR, V3, P281, DOI 10.3758/BF03209946; Grans A, 2009, J EXP BIOL, V212, P2550, DOI 10.1242/jeb.030593; Harms CA, 2005, LAB ANIMAL, V34, P28, DOI 10.1038/laban0105-28; Hojesjo J, 1999, J FISH BIOL, V55, P1009, DOI 10.1111/j.1095-8649.1999.tb00736.x; Huntingford FA, 2006, J FISH BIOL, V68, P332, DOI 10.1111/j.0022-1112.2006.001046.x; Jeanne M, 2009, AUTON NEUROSCI-BASIC, V147, P91, DOI 10.1016/j.autneu.2009.01.005; Johansen R, 2006, LAB ANIM-UK, V40, P323, DOI 10.1258/002367706778476451; LAITINEN M, 1995, AQUAT TOXICOL, V31, P99, DOI 10.1016/0166-445X(94)00060-4; MAUNUKSELA EL, 1988, BRIT J ANAESTH, V60, P48, DOI 10.1093/bja/60.1.48; Mettam JJ, 2011, APPL ANIM BEHAV SCI, V133, P265, DOI 10.1016/j.applanim.2011.06.009; Newby NC, 2006, COMP BIOCHEM PHYS C, V143, P275, DOI 10.1016/j.cbpc.2006.03.003; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Rose JD, 2012, FISH FISH, P1; Sandblom E, 2006, COMP BIOCHEM PHYS A, V144, P401, DOI 10.1016/j.cbpa.2006.03.003; Seth H, 2010, AM J PHYSIOL-REG I, V298, pR1240, DOI 10.1152/ajpregu.00781.2009; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2003, P ROY SOC B-BIOL SCI, V270, P1115, DOI 10.1098/rspb.2003.2349; Sneddon LU, 2009, ILAR J, V50, P338, DOI 10.1093/ilar.50.4.338; Stanway GW, 2002, VET ANAESTH ANALG, V29, P29, DOI 10.1046/j.1467-2987.2001.00062.x; STEVENS ED, 1967, J EXP BIOL, V46, P307; Taylor SE, 1996, J EXP BIOL, V199, P835; Yu G, 2006, J PHARMACOL EXP THER, V318, P282, DOI 10.1124/jpet.105.099937	35	18	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95283	10.1371/journal.pone.0095283	http://dx.doi.org/10.1371/journal.pone.0095283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736526	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600165
J	Ryu, YS; Biswas, RK; Shin, K; Parisutham, V; Kim, SM; Lee, SK				Ryu, Young Shin; Biswas, Rajesh Kumar; Shin, Kwangsu; Parisutham, Vinuselvi; Kim, Suk Min; Lee, Sung Kuk			A Simple and Effective Method for Construction of Escherichia coli Strains Proficient for Genome Engineering	PLOS ONE			English	Article							GRAM-NEGATIVE BACTERIA; ALLELIC REPLACEMENT; SYNTHETIC BIOLOGY; MISMATCH REPAIR; CLONING; LAMBDA; SYSTEM; CHROMOSOME; PLASMIDS; SEQUENCE	Multiplex genome engineering is a standalone recombineering tool for large-scale programming and accelerated evolution of cells. However, this advanced genome engineering technique has been limited to use in selected bacterial strains. We developed a simple and effective strain-independent method for effective genome engineering in Escherichia coli. The method involves introducing a suicide plasmid carrying the l Red recombination system into the mutS gene. The suicide plasmid can be excised from the chromosome via selection in the absence of antibiotics, thus allowing transient inactivation of the mismatch repair system during genome engineering. In addition, we developed another suicide plasmid that enables integration of large DNA fragments into the lacZ genomic locus. These features enable this system to be applied in the exploitation of the benefits of genome engineering in synthetic biology, as well as the metabolic engineering of different strains of E. coli.	[Ryu, Young Shin; Biswas, Rajesh Kumar; Kim, Suk Min; Lee, Sung Kuk] UNIST, Sch Energy & Chem Engn, Ulsan, South Korea; [Shin, Kwangsu; Parisutham, Vinuselvi; Lee, Sung Kuk] UNIST, Sch Biol Sci, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST); Ulsan National Institute of Science & Technology (UNIST)	Lee, SK (corresponding author), UNIST, Sch Energy & Chem Engn, Ulsan, South Korea.	sklee@unist.ac.kr	Parisutham, Vinuselvi/AAA-4030-2019; Lee, Sung K/E-6525-2010; Biswas, Rajesh Kumar/H-1776-2013; Lee, Sung K/HGC-6832-2022; Kim, Suk Min/F-1794-2014; Kim, S. Min/ABB-4868-2020	Parisutham, Vinuselvi/0000-0002-0349-4072; Biswas, Rajesh Kumar/0000-0003-1686-229X; Kim, Suk Min/0000-0003-1264-7250; Kim, S. Min/0000-0003-1264-7250	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [NRF-2009-C1AAA001-2009-0093491]; Intelligent Synthetic Biology Center of Global Frontier Project - MSIP [2011-0031948]; Next-Generation Bio Green 21 Program (SSAC), Rural Development Administration, Republic of Korea [PJ0099058]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP); Intelligent Synthetic Biology Center of Global Frontier Project - MSIP; Next-Generation Bio Green 21 Program (SSAC), Rural Development Administration, Republic of Korea	This work was supported by the National Research Foundation of Korea (NRF) through grants funded by the Ministry of Science, ICT & Future Planning (MSIP) (NRF-2009-C1AAA001-2009-0093491), by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the MSIP (2011-0031948), and by a grant from the Next-Generation Bio Green 21 Program (SSAC, PJ0099058), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Court DL, 2003, GENE, V315, P63, DOI 10.1016/S0378-1119(03)00728-5; Datta S, 2006, GENE, V379, P109, DOI 10.1016/j.gene.2006.04.018; Durfee T, 2008, J BACTERIOL, V190, P2597, DOI 10.1128/JB.01695-07; Esvelt KM, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2012.66; Fu CL, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn167; Ham TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002815; Hirayama Y, 2012, APPL ENVIRON MICROB, V78, P4984, DOI 10.1128/AEM.00588-12; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Kang MJ, 2005, BIOTECHNOL BIOENG, V91, P636, DOI 10.1002/bit.20539; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Marinus MG, 2010, MUTAT RES-REV MUTAT, V705, P71, DOI 10.1016/j.mrrev.2010.05.001; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mosberg JA, 2010, GENETICS, V186, P791, DOI 10.1534/genetics.110.120782; Mosberg JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044638; Sadowski PD, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-9; Sandoval NR, 2012, P NATL ACAD SCI USA, V109, P10540, DOI 10.1073/pnas.1206299109; Sergueev K, 2002, J MOL BIOL, V324, P297, DOI 10.1016/S0022-2836(02)01037-9; Sergueev K, 2001, GENE, V272, P227, DOI 10.1016/S0378-1119(01)00535-2; Swingle Bryan, 2010, Bioeng Bugs, V1, P263, DOI 10.4161/bbug.1.4.12098; Wang HH, 2012, ACS SYNTH BIOL, V1, P43, DOI 10.1021/sb3000029; Wang HH, 2012, NAT METHODS, V9, P591, DOI [10.1038/NMETH.1971, 10.1038/nmeth.1971]; Wang HH, 2011, NUCLEIC ACIDS RES, V39, P7336, DOI 10.1093/nar/gkr183; Wang HH, 2011, METHOD ENZYMOL, V498, P409, DOI 10.1016/B978-0-12-385120-8.00018-8; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Yu C, 2011, APPL MICROBIOL BIOT, V89, P573, DOI 10.1007/s00253-010-2970-z; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	30	10	10	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94266	10.1371/journal.pone.0094266	http://dx.doi.org/10.1371/journal.pone.0094266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747264	Green Published, gold, Green Submitted			2022-12-25	WOS:000335226500021
J	Bao, AL; Zhao, ZQ; Ding, GD; Shi, L; Xu, FS; Cai, HM				Bao, Aili; Zhao, Zhuqing; Ding, Guangda; Shi, Lei; Xu, Fangsen; Cai, Hongmei			Accumulated Expression Level of Cytosolic Glutamine Synthetase 1 Gene (OsGS1; 1 or OsGS1; 2) Alter Plant Development and the Carbon-Nitrogen Metabolic Status in Rice	PLOS ONE			English	Article							GLUTAMINE-SYNTHETASE GENE; AMINO-ACID-METABOLISM; AMMONIUM ASSIMILATION; TRANSGENIC POPLAR; USE EFFICIENCY; GROWTH; OVEREXPRESSION; ARABIDOPSIS; IDENTIFICATION; NUTRIENT	Maintaining an appropriate balance of carbon to nitrogen metabolism is essential for rice growth and yield. Glutamine synthetase is a key enzyme for ammonium assimilation. In this study, we systematically analyzed the growth phenotype, carbon-nitrogen metabolic status and gene expression profiles in GS1; 1-, GS1; 2-overexpressing rice and wildtype plants. Our results revealed that the GS1; 1-, GS1; 2-overexpressing plants exhibited a poor plant growth phenotype and yield and decreased carbon/nitrogen ratio in the stem caused by the accumulation of nitrogen in the stem. In addition, the leaf SPAD value and photosynthetic parameters, soluble proteins and carbohydrates varied greatly in the GS1; 1-, GS1; 2-overexpressing plants. Furthermore, metabolite profile and gene expression analysis demonstrated significant changes in individual sugars, organic acids and free amino acids, and gene expression patterns in GS1; 1-, GS1; 2-overexpressing plants, which also indicated the distinct roles that these two GS1 genes played in rice nitrogen metabolism, particularly when sufficient nitrogen was applied in the environment. Thus, the unbalanced carbon-nitrogen metabolic status and poor ability of nitrogen transportation from stem to leaf in GS1; 1-, GS1; 2-overexpressing plants may explain the poor growth and yield.	[Bao, Aili; Zhao, Zhuqing; Ding, Guangda; Shi, Lei; Xu, Fangsen; Cai, Hongmei] Huazhong Agr Univ, Microelement Res Ctr, Wuhan, Peoples R China; [Bao, Aili; Zhao, Zhuqing; Ding, Guangda; Shi, Lei; Xu, Fangsen; Cai, Hongmei] Huazhong Agr Univ, Minist Agr, Key Lab Arable Land Conservat Middle & Lower Reac, Wuhan, Peoples R China; [Shi, Lei; Xu, Fangsen] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Cai, HM (corresponding author), Huazhong Agr Univ, Microelement Res Ctr, Wuhan, Peoples R China.	caihongmei@mail.hzau.edu.cn	Ding, Guangda/AAH-5026-2021; Ding, Guangda/ABG-3651-2020	Ding, Guangda/0000-0003-3702-5087	National Natural Science Foundation of China [31000932]; Specialized Research Fund for the Doctoral Program of Higher Education; Ministry of Education of China [20100146120017]; Special Fund for Agro-scientific Research in the Public Interest [201003016]; Fundamental Research Funds for the Central Universities [2013PY041]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Education of China(Ministry of Education, China); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported in part by grants from the National Natural Science Foundation of China (31000932); the Specialized Research Fund for the Doctoral Program of Higher Education, the Ministry of Education of China (20100146120017); the Special Fund for Agro-scientific Research in the Public Interest (201003016) and the Fundamental Research Funds for the Central Universities (2013PY041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard SM, 2008, PLANT MOL BIOL, V67, P89, DOI 10.1007/s11103-008-9303-y; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cai HM, 2010, CHINESE SCI BULL, V55, P823, DOI 10.1007/s11434-010-0075-9; Cai HM, 2009, PLANT CELL REP, V28, P527, DOI 10.1007/s00299-008-0665-z; Canas RA, 2010, PLANT BIOTECHNOL J, V8, P966, DOI 10.1111/j.1467-7652.2010.00524.x; Canovas FM, 2007, J EXP BOT, V58, P2307, DOI 10.1093/jxb/erm051; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; CRAWFORD NM, 2002, ARABIDOPSIS BOOK; Deng YW, 2010, MOL BIOTECHNOL, V44, P51, DOI 10.1007/s12033-009-9203-7; Fei HM, 2003, PLANTA, V216, P467, DOI 10.1007/s00425-002-0873-7; Frink CR, 1999, P NATL ACAD SCI USA, V96, P1175, DOI 10.1073/pnas.96.4.1175; Fuentes SI, 2001, J EXP BOT, V52, P1071, DOI 10.1093/jexbot/52.358.1071; Gadaleta A, 2011, FUNCT INTEGR GENOMIC, V11, P665, DOI 10.1007/s10142-011-0235-2; Gallais A, 2004, J EXP BOT, V55, P295, DOI 10.1093/jxb/erh006; Gallardo F, 1999, PLANTA, V210, P19, DOI 10.1007/s004250050649; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Habash DZ, 2001, ANN APPL BIOL, V138, P83, DOI 10.1111/j.1744-7348.2001.tb00087.x; HAYAKAWA T, 1990, PLANT CELL PHYSIOL, V31, P1071; Hirel B, 2001, PLANT NITROGEN, P79; HIREL B, 1980, PLANT PHYSIOL, V66, P619, DOI 10.1104/pp.66.4.619; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Ireland RJ, 1999, BOOK SOIL P, P49; Ishiyama K, 2004, PLANT CELL PHYSIOL, V45, P1640, DOI 10.1093/pcp/pch190; Jing ZP, 2004, NEW PHYTOL, V164, P137, DOI 10.1111/j.1469-8137.2004.01173.x; KAMACHI K, 1991, PLANT PHYSIOL, V96, P411, DOI 10.1104/pp.96.2.411; Krapp A, 2002, ADV PHOTOSYNTHESIS; Krapp A, 2006, J CROP IMPROV, V15, P127, DOI 10.1300/J411v15n02_05; Kusano M, 2007, J CHROMATOGR B, V855, P71, DOI 10.1016/j.jchromb.2007.05.002; Kusano M, 2011, PLANT J, V66, P456, DOI 10.1111/j.1365-313X.2011.04506.x; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; LI MG, 1993, PLANT MOL BIOL, V23, P401, DOI 10.1007/BF00029015; Limami A, 1999, PLANTA, V209, P495, DOI 10.1007/s004250050753; Lothier J, 2011, J EXP BOT, V62, P1375, DOI 10.1093/jxb/erq299; Man HM, 2005, NEW PHYTOL, V167, P31, DOI 10.1111/j.1469-8137.2005.01461.x; Maness N, 2010, METHODS MOL BIOL, V639, P341, DOI 10.1007/978-1-60761-702-0_22; MANN AF, 1979, BIOCHEM BIOPH RES CO, V88, P515, DOI 10.1016/0006-291X(79)92078-3; Martin A, 2006, PLANT CELL, V18, P3252, DOI 10.1105/tpc.106.042689; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Melo PM, 2003, PLANT PHYSIOL, V132, P390, DOI 10.1104/pp.102.016675; Miflin B. J., 1980, The biochemistry of plants. A comprehensive treatise. Volume 5. Amino acids and derivatives., P169; Migge A, 2000, PLANTA, V210, P252, DOI 10.1007/PL00008132; MORRIS DL, 1948, SCIENCE, V107, P254, DOI 10.1126/science.107.2775.254; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Obara M, 2004, THEOR APPL GENET, V110, P1, DOI 10.1007/s00122-004-1828-0; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; Oliveira IC, 2002, PLANT PHYSIOL, V129, P1170, DOI 10.1104/pp.020013; Ortega JL, 2004, PLANTA, V219, P807, DOI 10.1007/s00425-004-1292-8; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Pascual MB, 2008, PHYTOCHEMISTRY, V69, P382, DOI 10.1016/j.phytochem.2007.07.031; Redestig H, 2009, ANAL CHEM, V81, P7974, DOI 10.1021/ac901143w; Schluter U, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-442; Socolow RH, 1999, P NATL ACAD SCI USA, V96, P6001, DOI 10.1073/pnas.96.11.6001; Tabuchi M, 2005, PLANT J, V42, P641, DOI 10.1111/j.1365-313X.2005.02406.x; Tabuchi M, 2007, J EXP BOT, V58, P2319, DOI 10.1093/jxb/erm016; TINGEY SV, 1987, PLANT PHYSIOL, V84, P366, DOI 10.1104/pp.84.2.366; Tobin AK, 2001, J EXP BOT, V52, P591, DOI 10.1093/jexbot/52.356.591; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Vincent R, 1997, PLANTA, V201, P424, DOI 10.1007/s004250050085; Yamaya T, 2002, J EXP BOT, V53, P917, DOI 10.1093/jexbot/53.370.917; Yamaya T, 2004, PLANT ECOPH, V3, P35; Yoshida S., 1976, LAB MANUAL PHYSL STU; Zheng ZL, 2009, PLANT SIGNAL BEHAV, V4, P584, DOI 10.4161/psb.4.7.8540; Zozaya-Garza M., 1999, Plant Physiology, V119, P1568	65	58	71	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95581	10.1371/journal.pone.0095581	http://dx.doi.org/10.1371/journal.pone.0095581			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743556	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100142
J	Martins, SCV; Galmes, J; Cavatte, PC; Pereira, LF; Ventrella, MC; DaMatta, FM				Martins, Samuel C. V.; Galmes, Jeroni; Cavatte, Paulo C.; Pereira, Lucas F.; Ventrella, Marilia C.; DaMatta, Fabio M.			Understanding the Low Photosynthetic Rates of Sun and Shade Coffee Leaves: Bridging the Gap on the Relative Roles of Hydraulic, Diffusive and Biochemical Constraints to Photosynthesis	PLOS ONE			English	Article							MESOPHYLL CONDUCTANCE; INTERNAL CONDUCTANCE; LEAF PHOTOSYNTHESIS; RESPIRATORY METABOLISM; ELECTRON-TRANSPORT; CO2 ASSIMILATION; SEASONAL-CHANGES; WATER; ARABICA; GROWTH	It has long been held that the low photosynthetic rates (A) of coffee leaves are largely associated with diffusive constraints to photosynthesis. However, the relative limitations of the stomata and mesophyll to the overall diffusional constraints to photosynthesis, as well as the coordination of leaf hydraulics with photosynthetic limitations, remain to be fully elucidated in coffee. Whether the low actual A under ambient CO2 concentrations is associated with the kinetic properties of Rubisco and high (photo) respiration rates also remains elusive. Here, we provide a holistic analysis to understand the causes associated with low A by measuring a variety of key anatomical/hydraulic and photosynthetic traits in sun- and shade-grown coffee plants. We demonstrate that leaf hydraulic architecture imposes a major constraint on the maximisation of the photosynthetic gas exchange of coffee leaves. Regardless of the light treatments, A was mainly limited by stomatal factors followed by similar limitations associated with the mesophyll and biochemical constraints. No evidence of an inefficient Rubisco was found; rather, we propose that coffee Rubisco is well tuned for operating at low chloroplastic CO2 concentrations. Finally, we contend that large diffusive resistance should lead to large CO2 drawdown from the intercellular airspaces to the sites of carboxylation, thus favouring the occurrence of relatively high photorespiration rates, which ultimately leads to further limitations to A.	[Martins, Samuel C. V.; Cavatte, Paulo C.; Pereira, Lucas F.; Ventrella, Marilia C.; DaMatta, Fabio M.] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil; [Galmes, Jeroni] Univ Illes Balears, Dept Biol, Res Grp Plant Biol Mediterranean Condit, Palma De Mallorca, Balearic Island, Spain	Universidade Federal de Vicosa; Universitat de les Illes Balears	DaMatta, FM (corresponding author), Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil.	fdamatta@ufv.br	DaMatta, Fabio/AAZ-1515-2020; Rodrigues, Fabricio/AAH-7572-2020; Cavatte, Paulo Cezar/AAD-9303-2020; PEREIRA, LUCAS/HHZ-5877-2022; Galmés, Jeroni/J-6749-2017	DaMatta, Fabio/0000-0002-9637-8475; Galmés, Jeroni/0000-0002-7299-9349	Foundation for Research Assistance of the Minas Gerais State, Brazil (Fapemig) [APQ-01138-12]; National Council for Scientific and Technological Development (CNPq) [302605/2010-0, 475780/2012-4]; Plan Nacional (Spain) [AGL2009-07999]; CNPq	Foundation for Research Assistance of the Minas Gerais State, Brazil (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Plan Nacional (Spain); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by the Foundation for Research Assistance of the Minas Gerais State, Brazil (Fapemig, Grant APQ-01138-12), by the National Council for Scientific and Technological Development (CNPq) (Grants 302605/2010-0 and 475780/2012-4) to FMD, and by Plan Nacional (Spain) (GrantAGL2009-07999) to JG. A PhD scholarship granted by CNPq to SCVM is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes WC, 2008, ANN APPL BIOL, V153, P33, DOI 10.1111/j.1744-7348.2008.00235.x; Araujo WL, 2008, PLANT PHYSIOL BIOCH, V46, P884, DOI 10.1016/j.plaphy.2008.05.005; Batista KD, 2012, TREES-STRUCT FUNCT, V26, P459, DOI 10.1007/s00468-011-0606-2; Boyce CK, 2010, ANN MO BOT GARD, V97, P527, DOI 10.3417/2009143; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; Brodribb TJ, 2009, PLANT SCI, V177, P245, DOI 10.1016/j.plantsci.2009.06.001; Brodribb TJ, 2005, NEW PHYTOL, V165, P839, DOI 10.1111/j.1469-8137.2004.01259.x; Brodribb TJ, 2003, PLANT PHYSIOL, V132, P2166, DOI 10.1104/pp.103.023879; Carins Murphy MR, 2014, PLANT CELL ENVIRON, V37, P124, DOI 10.1111/pce.12136; Carins Murphy MR, 2012, PLANT CELL ENVIRON, V35, P1407, DOI 10.1111/j.1365-3040.2012.02498.x; Casson SA, 2009, CURR BIOL, V19, P229, DOI 10.1016/j.cub.2008.12.046; Cavatte PC, 2012, PHYSIOL PLANTARUM, V144, P111, DOI 10.1111/j.1399-3054.2011.01525.x; Ceulemans R, 1993, PHYSL TREES, P21; Chaturvedi RK, 2011, J VEG SCI, V22, P917, DOI 10.1111/j.1654-1103.2011.01299.x; Chaves ARM, 2008, TREES-STRUCT FUNCT, V22, P351, DOI 10.1007/s00468-007-0190-7; Chaves ARM, 2012, ENVIRON EXP BOT, V77, P207, DOI 10.1016/j.envexpbot.2011.11.011; Da Matta FM, 1997, PHOTOSYNTHETICA, V34, P257, DOI 10.1023/A:1006848825581; DaMatta FM, 2008, NEW PHYTOL, V178, P348, DOI 10.1111/j.1469-8137.2008.02367.x; DaMatta FM, 2010, AGR ISSUES POLICIES, P181; DaMatta FM, 2010, AGR ISSUES POLICIES, P1; DaMatta FM, 2004, FIELD CROP RES, V86, P99, DOI 10.1016/j.fcr.2003.09.001; Eensalu E, 2008, FUNCT PLANT BIOL, V35, P103, DOI 10.1071/FP07258; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; Farquhar G. D., 1982, Encyclopedia of plant physiology. New series. Volume 12B. Physiological plant ecology. II. Water relations and carbon assimilation. [Lange, O.L.; Nobel, P.S.; Osmond, C.B.; Ziegler, H. (Editors)], P549; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Ferrio JP, 2012, PLANT CELL ENVIRON, V35, P611, DOI 10.1111/j.1365-3040.2011.02440.x; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2013, PHOTOSYNTH RES, V117, P45, DOI 10.1007/s11120-013-9844-z; Flexas J, 2012, PLANT SCI, V193, P70, DOI 10.1016/j.plantsci.2012.05.009; Franck N, 2006, TREE PHYSIOL, V26, P517, DOI 10.1093/treephys/26.4.517; Franks PJ, 2009, PLANT CELL ENVIRON, V32, P1737, DOI [10.1111/j.1365-3040.2009.02031.x, 10.1111/j.1365-3040.2009.002031.x]; Franks PJ, 2001, PLANT PHYSIOL, V125, P935, DOI 10.1104/pp.125.2.935; Galmes J, 2005, PLANT CELL ENVIRON, V28, P571, DOI 10.1111/j.1365-3040.2005.01300.x; Galmes J, 2007, NEW PHYTOL, V175, P81, DOI 10.1111/j.1469-8137.2007.02087.x; Galmes J, 2013, PLANT CELL ENVIRON, V36, P920, DOI 10.1111/pce.12022; Galmes J, 2011, PLANT CELL ENVIRON, V34, P245, DOI 10.1111/j.1365-3040.2010.02239.x; Gasco A, 2004, FUNCT PLANT BIOL, V31, P1161, DOI 10.1071/FP04032; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Grassi G, 2005, PLANT CELL ENVIRON, V28, P834, DOI 10.1111/j.1365-3040.2005.01333.x; Gu LH, 2010, PLANT CELL ENVIRON, V33, P1852, DOI 10.1111/j.1365-3040.2010.02192.x; Hanba YT, 2003, ISOT ENVIRON HEALT S, V39, P5, DOI 10.1080/1025601031000102233; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Laisk A.K., 1977, KINETICS PHOTOSYNTHE; LEWIS AM, 1995, AM J BOT, V82, P1112, DOI 10.2307/2446063; Manter DK, 2004, J EXP BOT, V55, P2581, DOI 10.1093/jxb/erh260; Martins SCV, 2013, J EXP BOT, V64, P3285, DOI 10.1093/jxb/ert168; Monti A, 2009, J EXP BOT, V60, P2341, DOI 10.1093/jxb/erp032; Niinemets U, 1998, TREE PHYSIOL, V18, P681; Niinemets U, 2009, J EXP BOT, V60, P2249, DOI 10.1093/jxb/erp036; Nogueira A, 2004, PHOTOSYNTHETICA, V42, P351, DOI 10.1023/B:PHOT.0000046152.05364.77; Rodeghiero M, 2007, PLANT CELL ENVIRON, V30, P1006, DOI 10.1111/j.1365-3040.2007.001689.x; Ronquim JC, 2006, EXP AGR, V42, P147, DOI 10.1017/S0014479705003121; Russo SE, 2010, AM J BOT, V97, P1109, DOI 10.3732/ajb.0900344; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Sack L, 2005, NEW PHYTOL, V167, P403, DOI 10.1111/j.1469-8137.2005.01432.x; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Sage RF, 2002, PHOTOSYNTH RES, V71, P241, DOI 10.1023/A:1015510005536; Salisbury EJ, 1928, PHILOS T R SOC LON B, V216, P1, DOI 10.1098/rstb.1928.0001; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; Scoffoni C, 2011, PLANT PHYSIOL, V156, P832, DOI 10.1104/pp.111.173856; Silva EA, 2004, FIELD CROP RES, V89, P349, DOI 10.1016/j.fcr.2004.02.010; Tcherkez G, 2005, PLANT PHYSIOL, V138, P1596, DOI 10.1104/pp.105.062141; Tcherkez G, 2008, P NATL ACAD SCI USA, V105, P797, DOI 10.1073/pnas.0708947105; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; VALENTINI R, 1995, PLANT CELL ENVIRON, V18, P631, DOI 10.1111/j.1365-3040.1995.tb00564.x; von Caemmerer S, 2000, BIOCH MODELS LEAF PH; Warren CR, 2007, ENVIRON EXP BOT, V59, P130, DOI 10.1016/j.envexpbot.2005.11.004; Warren CR, 2008, J EXP BOT, V59, P1475, DOI 10.1093/jxb/erm245; Warren CR, 2006, PLANT CELL ENVIRON, V29, P192, DOI 10.1111/j.1365-3040.2005.01412.x	72	58	60	3	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95571	10.1371/journal.pone.0095571	http://dx.doi.org/10.1371/journal.pone.0095571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743509	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100141
J	Rybarsch, M; Bornholdt, S				Rybarsch, Matthias; Bornholdt, Stefan			Avalanches in Self-Organized Critical Neural Networks: A Minimal Model for the Neural SOC Universality Class	PLOS ONE			English	Article							NEURONAL AVALANCHES; CORTICAL NETWORKS; OSCILLATIONS; RANGE	The brain keeps its overall dynamics in a corridor of intermediate activity and it has been a long standing question what possible mechanism could achieve this task. Mechanisms from the field of statistical physics have long been suggesting that this homeostasis of brain activity could occur even without a central regulator, via self-organization on the level of neurons and their interactions, alone. Such physical mechanisms from the class of self-organized criticality exhibit characteristic dynamical signatures, similar to seismic activity related to earthquakes. Measurements of cortex rest activity showed first signs of dynamical signatures potentially pointing to self-organized critical dynamics in the brain. Indeed, recent more accurate measurements allowed for a detailed comparison with scaling theory of non-equilibrium critical phenomena, proving the existence of criticality in cortex dynamics. We here compare this new evaluation of cortex activity data to the predictions of the earliest physics spin model of self-organized critical neural networks. We find that the model matches with the recent experimental data and its interpretation in terms of dynamical signatures for criticality in the brain. The combination of signatures for criticality, power law distributions of avalanche sizes and durations, as well as a specific scaling relationship between anomalous exponents, defines a universality class characteristic of the particular critical phenomenon observed in the neural experiments. Thus the model is a candidate for a minimal model of a self-organized critical adaptive network for the universality class of neural criticality. As a prototype model, it provides the background for models that may include more biological details, yet share the same universality class characteristic of the homeostasis of activity in the brain.	[Rybarsch, Matthias; Bornholdt, Stefan] Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany	University of Bremen	Bornholdt, S (corresponding author), Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany.	bornholdt@itp.uni-bremen.de						BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; Bak P, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031912; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Bornholdt S, 2000, PHYS REV LETT, V84, P6114, DOI 10.1103/PhysRevLett.84.6114; Bornholdt S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.066118; Bornholdt S, 2001, ARXIVCONDMAT0109256V; de Arcangelis L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028107; de Arcangelis L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00062; de Arcangelis L, 2010, P NATL ACAD SCI USA, V107, P3977, DOI 10.1073/pnas.0912289107; Droste F, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0558; Eurich CW, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.066137; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Gireesh ED, 2008, P NATL ACAD SCI USA, V105, P7576, DOI 10.1073/pnas.0800537105; HERZ AVM, 1995, PHYS REV LETT, V75, P1222, DOI 10.1103/PhysRevLett.75.1222; Kauffman S.A., 1993, ORIGINS ORDER; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; LANGTON CG, 1990, PHYSICA D, V42, P12, DOI 10.1016/0167-2789(90)90064-V; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Levina A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118110; Lombardi F, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.228703; Magnasco MO, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258102; Mazzoni A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000439; Meisel C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.061917; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Pellegrini GL, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.016107; Peng JY, 2013, PHYSICA A, V392, P1611, DOI 10.1016/j.physa.2012.11.013; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Priesemann V, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002985; Rybarsch M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026114; Scarpetta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064162; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Stewart CV, 2008, J NEUROSCI METH, V169, P405, DOI 10.1016/j.jneumeth.2007.10.021; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012	36	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e93090	10.1371/journal.pone.0093090	http://dx.doi.org/10.1371/journal.pone.0093090			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743324	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100012
J	Corby-Harris, V; Maes, P; Anderson, KE				Corby-Harris, Vanessa; Maes, Patrick; Anderson, Kirk E.			The Bacterial Communities Associated with Honey Bee (Apis mellifera) Foragers	PLOS ONE			English	Article							RIBOSOMAL-RNA; GUT BACTERIA; POLLEN; MICROBIOLOGY; MICROFLORA; SENSITIVITY; DIVERSITY; NUTRITION; COLONIES; HEALTH	The honey bee is a key pollinator species in decline worldwide. As part of a commercial operation, bee colonies are exposed to a variety of agricultural ecosystems throughout the year and a multitude of environmental variables that may affect the microbial balance of individuals and the hive. While many recent studies support the idea of a core microbiota in guts of younger in-hive bees, it is unknown whether this core is present in forager bees or the pollen they carry back to the hive. Additionally, several studies hypothesize that the foregut (crop), a key interface between the pollination environment and hive food stores, contains a set of 13 lactic acid bacteria (LAB) that inoculate collected pollen and act in synergy to preserve pollen stores. Here, we used a combination of 454 based 16S rRNA gene sequencing of the microbial communities of forager guts, crops, and corbicular pollen and crop plate counts to show that (1) despite a very different diet, forager guts contain a core microbiota similar to that found in younger bees, (2) corbicular pollen contains a diverse community dominated by hive-specific, environmental or phyllosphere bacteria that are not prevalent in the gut or crop, and (3) the 13 LAB found in culture-based studies are not specific to the crop but are a small subset of midgut or hindgut specific bacteria identified in many recent 454 amplicon-based studies. The crop is dominated by Lactobacillus kunkeei, and Alpha 2.2 (Acetobacteraceae), highly osmotolerant and acid resistant bacteria found in stored pollen and honey. Crop taxa at low abundance include core hindgut bacteria in transit to their primary niche, and potential pathogens or food spoilage organisms seemingly vectored from the pollination environment. We conclude that the crop microbial environment is influenced by worker task, and may function in both decontamination and inoculation.	[Corby-Harris, Vanessa; Anderson, Kirk E.] USDA, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA; [Maes, Patrick; Anderson, Kirk E.] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA	United States Department of Agriculture (USDA); University of Arizona	Anderson, KE (corresponding author), USDA, Carl Hayden Bee Res Ctr, Tucson, AZ 85719 USA.	kirk.anderson@ars.usda.gov		Corby-Harris, Vanessa/0000-0001-7680-0328	USA tax-payer supported operating budget of the ARS-USDA Carl Hayden Bee Research Center, Tucson AZ	USA tax-payer supported operating budget of the ARS-USDA Carl Hayden Bee Research Center, Tucson AZ	Funding was provided entirely by the USA tax-payer supported operating budget of the ARS-USDA Carl Hayden Bee Research Center, Tucson AZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no current external funding sources for this study.	Ahn JH, 2012, J MICROBIOL, V50, P735, DOI 10.1007/s12275-012-2188-0; Aizenberg-Gershtein Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067556; Alvarez-Perez S, 2013, INT J SYST EVOL MICR, V63, P1532, DOI 10.1099/ijs.0.043489-0; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Anderson KE, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083125, 10.1371/journal.pone.0058425]; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; BATRA LR, 1973, MYCOPATH MYCOL APPL, V49, P13, DOI 10.1007/BF02057445; Blatt J, 2002, J INSECT PHYSIOL, V48, P643, DOI 10.1016/S0022-1910(02)00090-2; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Butler E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-235; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; CRAILSHEIM K, 1992, J COMP PHYSIOL B, V162, P681, DOI 10.1007/BF00301617; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Dainat B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032151; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Disayathanoowat T, 2012, FEMS MICROBIOL ECOL, V79, P273, DOI 10.1111/j.1574-6941.2011.01216.x; Dreller C, 1999, BEHAV ECOL SOCIOBIOL, V45, P227, DOI 10.1007/s002650050557; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Endo A, 2012, INT J SYST EVOL MICR, V62, P500, DOI 10.1099/ijs.0.031054-0; Endo A, 2009, SYST APPL MICROBIOL, V32, P593, DOI 10.1016/j.syapm.2009.08.002; Engel P, 2013, INT J SYST EVOL MICR, V63, P3646, DOI 10.1099/ijs.0.049569-0; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Feng M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-645; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Gardner T, 2012, J ENVIRON QUAL, V41, P744, DOI 10.2134/jeq2011.0347; GILLIAM M, 1989, APIDOLOGIE, V20, P53, DOI 10.1051/apido:19890106; GILLIAM M, 1990, APIDOLOGIE, V21, P89, DOI 10.1051/apido:19900201; GILLIAM M, 1974, J INVERTEBR PATHOL, V23, P38, DOI 10.1016/0022-2011(74)90069-X; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gruter C, 2011, J EXP BIOL, V214, P1397, DOI 10.1242/jeb.050583; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamdi C, 2011, J APPL ENTOMOL, V135, P524, DOI 10.1111/j.1439-0418.2010.01609.x; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Holldobler B, 2008, SUPERORGANISM BEAUTY; INGLIS GD, 1993, MICROBIAL ECOL, V26, P125, DOI 10.1007/BF00177048; Jackson CR, 2011, MICROB ECOL, V61, P113, DOI 10.1007/s00248-010-9742-2; Judd Timothy M., 2011, P1; Junker RR, 2011, PLANT BIOLOGY, V13, P918, DOI 10.1111/j.1438-8677.2011.00454.x; Kacaniova M, 2004, FOLIA MICROBIOL, V49, P169, DOI 10.1007/BF02931394; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, 2010, EVOL ECOL, V24, P463, DOI 10.1007/s10682-009-9319-z; Kaltenpoth M, 2009, TRENDS MICROBIOL, V17, P529, DOI 10.1016/j.tim.2009.09.006; Koch H, 2013, MOL ECOL, V22, P2028, DOI 10.1111/mec.12209; Kwong WK, 2012, INT J SYST EVOL MICR; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Loncaric I, 2009, APIDOLOGIE, V40, P40, DOI 10.1051/apido/2008062; LOPER GM, 1980, APIDOLOGIE, V11, P63, DOI 10.1051/apido:19800108; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; McFrederick QS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2653; McFrederick QS, 2013, APPL ENVIRON MICROB, V79, P1803, DOI 10.1128/AEM.03681-12; McFrederick QS, 2012, MOL ECOL, V21, P1754, DOI 10.1111/j.1365-294X.2012.05496.x; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neveling DP, 2012, CURR MICROBIOL; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Olofsson TC, 2008, DETECTION IDENTIFICA; Olofsson TC, 2011, APIDOLOGIE, V42, P696, DOI 10.1007/s13592-011-0064-2; Olofsson TC, 2009, J APICULT RES, V48, P233, DOI 10.3896/IBRA.1.48.4.02; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P209, DOI 10.1051/apido:19660302; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Piccini C, 2004, J APICULT RES, V43, P101, DOI 10.1080/00218839.2004.11101118; Promnuan Y, 2009, WORLD J MICROB BIOT, V25, P1685, DOI 10.1007/s11274-009-0051-1; Rada V, 1997, APIDOLOGIE, V28, P357, DOI 10.1051/apido:19970603; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; RUIZARGUESO T, 1975, APPL MICROBIOL, V30, P893, DOI 10.1128/AEM.30.6.893-896.1975; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sabree ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041250; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Seipke RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022028; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036978; Toth AL, 2005, J EXP BIOL, V208, P4641, DOI 10.1242/jeb.01956; Toth AL, 2005, ANIM BEHAV, V69, P427, DOI 10.1016/j.anbehav.2004.03.017; Vanengelsdorp D, 2009, J INVERTEBR PATHOL, V101, P147, DOI 10.1016/j.jip.2009.03.008; Vasquez A, 2011, MICROBIOLOGY TODAY, V38, P226; Vasquez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033188; Vasquez A, 2009, J APICULT RES, V48, P189, DOI 10.3896/IBRA.1.48.3.07; Vojvodic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072106; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yashiro E, 2011, J APPL MICROBIOL, V110, P1284, DOI 10.1111/j.1365-2672.2011.04975.x	87	164	170	1	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95056	10.1371/journal.pone.0095056	http://dx.doi.org/10.1371/journal.pone.0095056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740297	Green Submitted, gold, Green Published			2022-12-25	WOS:000336863900099
J	Ghezali, L; Liagre, B; Limami, Y; Beneytout, JL; Leger, DY				Ghezali, Lamia; Liagre, Bertrand; Limami, Youness; Beneytout, Jean-Louis; Leger, David Yannick			Sonic Hedgehog Activation Is Implicated in Diosgenin-Induced Megakaryocytic Differentiation of Human Erythroleukemia Cells	PLOS ONE			English	Article							HUMAN CANCER; CYCLOPAMINE; APOPTOSIS; LEUKEMIA; INHIBITION; PATHWAY; EXPRESSION; THERAPY; WNT	Differentiation therapy is a means to treat cancer and is induced by different agents with low toxicity and more specificity than traditional ones. Diosgenin, a plant steroid, is able to induce megakaryocytic differentiation or apoptosis in human HEL erythroleukemia cells in a dose-dependent manner. However, the exact mechanism by which diosgenin induces megakaryocytic differentiation has not been elucidated. In this study, we studied the involvement of Sonic Hedgehog in megakaryocytic differentiation induced by diosgenin in HEL cells. First, we showed that different elements of the Hedgehog pathway are expressed in our model by qRT-PCR. Then, we focused our interest on key elements in the Sonic Hedgehog pathway: Smoothened receptor, GLI transcription factor and the ligand Sonic Hedgehog. We showed that Smoothened and Sonic Hedgehog were overexpressed in disogenin-treated cells and that GLI transcription factors were activated. Then, we showed that SMO inhibition using siSMO or the GLI antagonist GANT-61, blocked megakaryocytic differentiation induced by diosgenin in HEL cells. Furthermore, we demonstrated that Sonic Hedgehog pathway inhibition led to inhibition of ERK1/2 activation, a major physiological pathway involved in megakaryocytic differentiation. In conclusion, our study reports, for the first time, a crucial role for the Sonic Hedgehog pathway in diosgenin-induced megakaryocytic differentiation in HEL cells.	[Ghezali, Lamia; Liagre, Bertrand; Limami, Youness; Beneytout, Jean-Louis; Leger, David Yannick] Univ Limoges, Fac Pharm, FR GEIST 3503, EA Lab Chim Subst Nat 1069,GDR CNRS 3049,Lab Bioc, Limoges, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Limoges	Leger, DY (corresponding author), Univ Limoges, Fac Pharm, FR GEIST 3503, EA Lab Chim Subst Nat 1069,GDR CNRS 3049,Lab Bioc, Limoges, France.	david.leger@unilim.fr	Limami, Youness/AAE-9695-2021	Limami, Youness/0000-0002-8816-3001; Liagre, Bertrand/0000-0003-4148-2598	French Ministry of Education and Research; Conseil Regional du Limousin	French Ministry of Education and Research; Conseil Regional du Limousin(Region Nouvelle-Aquitaine)	This research was supported by grants from the French Ministry of Education and Research and from the Conseil Regional du Limousin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LY, 2012, LEUKEMIA LYMPHOMA, V53, P1196, DOI 10.3109/10428194.2011.639877; Beloti MM, 2005, CELL BIOL INT, V29, P537, DOI 10.1016/j.cellbi.2005.02.007; BENEYTOUT JL, 1995, BIOCHEM BIOPH RES CO, V207, P398, DOI 10.1006/bbrc.1995.1201; BRYDEN MM, 1971, J ANAT, V110, P507; Cai JQ, 2012, CELL BIOL INT, V36, P349, DOI 10.1042/CBI20110284; Cailleteau C, 2010, ANAL BIOANAL CHEM, V398, P1273, DOI 10.1007/s00216-010-4062-4; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020164; Corbiere C, 2004, CELL RES, V14, P188, DOI 10.1038/sj.cr.7290219; Corbiere C, 2003, INT J ONCOL, V22, P899; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; Das S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046641; Detmer K, 2000, BLOOD CELL MOL DIS, V26, P360, DOI 10.1006/bcmd.2000.0318; Dyer MA, 2001, DEVELOPMENT, V128, P1717; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Gao MY, 2012, INT IMMUNOPHARMACOL, V14, P233, DOI 10.1016/j.intimp.2012.06.021; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Ghezali L, 2013, EXP CELL RES, V319, P1043, DOI 10.1016/j.yexcr.2013.01.014; Gonnissen A, 2013, INT J MOL SCI, V14, P13979, DOI 10.3390/ijms140713979; Gritli-Linde A, 2007, DEV CELL, V12, P99, DOI 10.1016/j.devcel.2006.12.006; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hwang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068271; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Irvine DA, 2012, BLOOD, V119, P2196, DOI 10.1182/blood-2011-10-383752; Katagiri S, 2013, CLIN CANCER RES, V19, P1422, DOI 10.1158/1078-0432.CCR-12-1777; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Leger DY, 2006, ANAL BIOCHEM, V355, P19, DOI 10.1016/j.ab.2006.05.033; Leger DY, 2006, INT J ONCOL, V28, P201; Leszczyniecka M, 2001, PHARMACOL THERAPEUT, V90, P105, DOI 10.1016/S0163-7258(01)00132-2; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Lin TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015262; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAEDA S, 1978, J CELL PHYSIOL, V94, P181, DOI 10.1002/jcp.1040940207; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Mar BG, 2011, LEUKEMIA, V25, P1665, DOI 10.1038/leu.2011.143; Outram SV, 2009, BLOOD, V113, P2217, DOI 10.1182/blood-2008-03-144840; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; Pinon A, 2011, EXP CELL RES, V317, P1669, DOI 10.1016/j.yexcr.2011.04.014; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sell S, 2005, STEM CELL REV, V1, P197, DOI 10.1385/SCR:1:3:197; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Stanton BZ, 2010, MOL BIOSYST, V6, P44, DOI 10.1039/b910196a; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takahashi T, 2011, LEUKEMIA RES, V35, P638, DOI 10.1016/j.leukres.2010.09.022; Tsiftsoglou AS, 2003, PHARMACOL THERAPEUT, V100, P257, DOI 10.1016/j.pharmthera.2003.09.002; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Whisenant TC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000908; Wu X, 2004, CHEM BIOL, V11, P1229, DOI 10.1016/j.chembiol.2004.06.010; Zacharias WJ, 2011, DEV BIOL, V355, P152, DOI 10.1016/j.ydbio.2011.04.025	54	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95016	10.1371/journal.pone.0095016	http://dx.doi.org/10.1371/journal.pone.0095016			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740159	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900093
J	Michaels, CJ; Antwis, RE; Preziosi, RF				Michaels, Christopher J.; Antwis, Rachael E.; Preziosi, Richard F.			Impact of Plant Cover on Fitness and Behavioural Traits of Captive Red-Eyed Tree Frogs (Agalychnis callidryas)	PLOS ONE			English	Article							CORTICOSTERONE METABOLITE RESPONSES; BODY CONDITION; URINARY CORTICOSTERONE; AMPHIBIAN DECLINES; 4-TOED SALAMANDERS; PREDATOR IDENTITY; GROWTH; IDENTIFICATION; METAMORPHOSIS; CONSERVATION	Despite the importance of ex situ conservation programmes as highlighted in the Amphibian Conservation Action Plan, there are few empirical studies that examine the influence of captive conditions on the fitness of amphibians, even for basic components of enclosure design such as cover provision. Maintaining the fitness of captive amphibian populations is essential to the success of ex situ conservation projects. Here we examined the impact of plant cover on measures of fitness and behaviour in captive red-eyed tree frogs (Agalychnis callidryas). We found significant effects of plant provision on body size, growth rates and cutaneous bacterial communities that together demonstrate a compelling fitness benefit from cover provision. We also demonstrate a strong behavioural preference for planted rather than non-planted areas. We also assessed the impact of plant provision on the abiotic environment in the enclosure as a potential driver of these behavioural and fitness effects. Together this data provides valuable information regarding enclosure design for a non-model amphibian species and has implications for amphibian populations maintained in captivity for conservation breeding programmes and research.	[Michaels, Christopher J.; Antwis, Rachael E.; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Michaels, CJ (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	c.j.michaels44@gmail.com	Preziosi, Richard F/A-8626-2010	Preziosi, Richard F/0000-0003-0468-6655; Antwis, Rachael/0000-0002-8849-8194	Natural Environment Research Council; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [961801] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The research was supported by a Natural Environment Research Council studentship to CJM and a Biotechnology and Biological Sciences Research Council studentship to REA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allran JW, 2001, ENVIRON TOXICOL CHEM, V20, P769, DOI [10.1897/1551-5028(2001)020&lt;0769:EOAOEL&gt;2.0.CO;2, 10.1002/etc.5620200411]; Altwegg R, 2003, EVOLUTION, V57, P872; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Antwis RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085563; Archard GA, 2013, APPL ANIM BEHAV SCI, V145, P123, DOI 10.1016/j.applanim.2013.02.006; Archard GA, 2012, APPL ANIM BEHAV SCI, V139, P264, DOI 10.1016/j.applanim.2012.04.003; Babbitt KJ, 1998, OECOLOGIA, V114, P258, DOI 10.1007/s004420050444; Babbitt KJ, 1997, J HERPETOL, V31, P128, DOI 10.2307/1565342; Banning JL, 2008, OECOLOGIA, V156, P423, DOI 10.1007/s00442-008-1002-5; Bardsley L, 1998, ECOLOGY, V79, P1751, DOI 10.2307/176793; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Bland Adam, 2013, Herpetological Bulletin, P9; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Briggs VS, 2013, HERPETOL J, V23, P131; Brizzi R, 2002, J MORPHOL, V254, P328, DOI 10.1002/jmor.10039; Brown M. J., 2004, Animal Technology and Welfare, V3, P87; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Carr JA, 2002, COMP BIOCHEM PHYS B, V132, P151, DOI 10.1016/S1096-4959(01)00545-0; Chum H, 2013, APPL ANIM BEHAV SCI, V143, P150, DOI 10.1016/j.applanim.2012.10.013; Crespi EJ, 2005, COMP BIOCHEM PHYS A, V141, P381, DOI 10.1016/j.cbpb.2004.12.007; Daskin JH, 2012, P ROY SOC B-BIOL SCI, V279, P1457, DOI 10.1098/rspb.2011.2276; Davis Andrew K., 2007, APPLIED HERPETOLOGY, V4, P195, DOI 10.1163/157075407781268282; Drogemuller C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011258; Eisenhauer N, 2013, FUNCT ECOL, V27, P282, DOI 10.1111/j.1365-2435.2012.02060.x; Gagliardo R., 2008, International Zoo Yearbook, V42, P125, DOI 10.1111/j.1748-1090.2008.00043.x; GASCON C, 2007, AMPHIBIAN CONSERVATI; Gouchie GM, 2008, LAB ANIMAL, V37, P165, DOI 10.1038/laban0408-165; Griffiths RA, 2008, CONSERV BIOL, V22, P852, DOI 10.1111/j.1523-1739.2008.00967.x; Harris RN, 2004, ECOLOGY, V85, P1585, DOI 10.1890/03-0492; HILKEN G, 1995, LAB ANIM, V29, P152, DOI 10.1258/002367795780740276; Inceli MS, 2010, BIOLOGIA, V65, P157, DOI 10.2478/s11756-009-0230-4; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; JORGENSEN CB, 1986, J ZOOL, V210, P211; Lamoureux VS, 2002, J HERPETOL, V36, P245, DOI 10.2307/1565997; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Loudon AH, 2014, ISME J, V8, P830, DOI 10.1038/ismej.2013.200; MacCracken JG, 2012, J HERPETOL, V46, P346, DOI 10.1670/10-292; Matos A, 2005, MICROB ECOL, V49, P257, DOI 10.1007/s00248-004-0179-3; Michaels Christopher J., 2013, Herpetological Bulletin, P1; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Narayan E, 2010, AUST J ZOOL, V58, P189, DOI 10.1071/ZO10010; Narayan EJ, 2011, GEN COMP ENDOCR, V173, P371, DOI 10.1016/j.ygcen.2011.06.015; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; Ogilvy V, 2012, ZOO BIOL, V31, P470, DOI 10.1002/zoo.20416; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Reading CJ, 2007, OECOLOGIA, V151, P125, DOI 10.1007/s00442-006-0558-1; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Seebacher F, 2002, J HERPETOL, V36, P69, DOI 10.1670/0022-1511(2002)036[0069:SMDBTA]2.0.CO;2; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tarr TL, 2002, AMPHIBIA-REPTILIA, V23, P13, DOI 10.1163/156853802320877591; Torreilles SL, 2007, J AM ASSOC LAB ANIM, V46, P33; TRAVIS J, 1985, EVOLUTION, V39, P1087, DOI 10.1111/j.1558-5646.1985.tb00449.x; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Walsh PT, 2005, HERPETOL J, V15, P245; Webster G, 2003, J MICROBIOL METH, V55, P155, DOI 10.1016/S0167-7012(03)00140-4; Yeager CR, 2013, J HERPETOL, V47, P459, DOI 10.1670/12-073	60	24	27	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95207	10.1371/journal.pone.0095207	http://dx.doi.org/10.1371/journal.pone.0095207			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740289	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000336863900116
J	Spulber, S; Kilian, P; Ibrahim, WNW; Onishchenko, N; Ulhaq, M; Norrgren, L; Negri, S; Di Tuccio, M; Ceccatelli, S				Spulber, Stefan; Kilian, Pascal; Ibrahim, Wan Norhamidah Wan; Onishchenko, Natalia; Ulhaq, Mazhar; Norrgren, Leif; Negri, Sara; Di Tuccio, Marcello; Ceccatelli, Sandra			PFOS Induces Behavioral Alterations, Including Spontaneous Hyperactivity That Is Corrected by Dexamfetamine in Zebrafish Larvae	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; PERFLUOROOCTANE SULFONATE PFOS; LOCOMOTOR-ACTIVITY; DEVELOPMENTAL TOXICITY; PERFLUOROALKYL ACIDS; PERFLUORINATED CHEMICALS; PRENATAL EXPOSURE; MOTOR PATTERNS; GENE; PERFLUOROHEXANESULFONATE	Perfluorooctane sulfonate (PFOS) is a widely spread environmental contaminant. It accumulates in the brain and has potential neurotoxic effects. The exposure to PFOS has been associated with higher impulsivity and increased ADHD prevalence. We investigated the effects of developmental exposure to PFOS in zebrafish larvae, focusing on the modulation of activity by the dopaminergic system. We exposed zebrafish embryos to 0.1 or 1 mg/L PFOS (0.186 or 1.858 mu M, respectively) and assessed swimming activity at 6 dpf. We analyzed the structure of spontaneous activity, the hyperactivity and the habituation during a brief dark period (visual motor response), and the vibrational startle response. The findings in zebrafish larvae were compared with historical data from 3 months old male mice exposed to 0.3 or 3 mg/kg/day PFOS throughout gestation. Finally, we investigated the effects of dexamfetamine on the alterations in spontaneous activity and startle response in zebrafish larvae. We found that zebrafish larvae exposed to 0.1 mg/L PFOS habituate faster than controls during a dark pulse, while the larvae exposed to 1 mg/L PFOS display a disorganized pattern of spontaneous activity and persistent hyperactivity. Similarly, mice exposed to 0.3 mg/kg/day PFOS habituated faster than controls to a new environment, while mice exposed to 3 mg/kg/day PFOS displayed more intense and disorganized spontaneous activity. Dexamfetamine partly corrected the hyperactive phenotype in zebrafish larvae. In conclusion, developmental exposure to PFOS in zebrafish induces spontaneous hyperactivity mediated by a dopaminergic deficit, which can be partially reversed by dexamfetamine in zebrafish larvae.	[Spulber, Stefan; Kilian, Pascal; Ibrahim, Wan Norhamidah Wan; Onishchenko, Natalia; Ceccatelli, Sandra] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Ibrahim, Wan Norhamidah Wan] Univ Putra Malaysia, Fac Sci, Dept Biol, Serdang 43400, Selangor, Malaysia; [Ulhaq, Mazhar; Norrgren, Leif] Swedish Univ Agr Sci, Dept Biomed & Vet Publ Hlth, Uppsala, Sweden; [Negri, Sara; Di Tuccio, Marcello] Salvatore Maugeri Fdn IRCCS, Environm Res Ctr, Pavia, Italy	Karolinska Institutet; Universiti Putra Malaysia; Swedish University of Agricultural Sciences; Istituti Clinici Scientifici Maugeri IRCCS	Spulber, S (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	stefan.spulber@ki.se	Negri, Sara/AAB-8042-2020	Negri, Sara/0000-0001-6687-741X; Spulber, Stefan/0000-0001-8122-6738; Ceccatelli, Sandra/0000-0002-9367-8480; Di Tuccio, Marcello/0000-0002-6775-1453	Swedish Research Council; Karolinska Institutet; Swedish Society for Medical Research (SSMF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Swedish Society for Medical Research (SSMF)	This work was funded by the Swedish Research Council (VR and Formas grants), Karolinska Institutet research grants, and by the Swedish Society for Medical Research (SSMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2008, EFSA J, V6; Ali S, 2012, BEHAV BRAIN RES, V228, P272, DOI 10.1016/j.bbr.2011.11.020; Anichtchik OV, 2004, J NEUROCHEM, V88, P443, DOI 10.1046/j.1471-4159.2003.02190.x; Apelberg BJ, 2007, ENVIRON SCI TECHNOL, V41, P3891, DOI 10.1021/es0700911; Arcos-Burgos M, 2010, MOL PSYCHIATR, V15, P1053, DOI 10.1038/mp.2010.6; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Best JD, 2008, NEUROPSYCHOPHARMACOL, V33, P1206, DOI 10.1038/sj.npp.1301489; Borg D, 2010, REPROD TOXICOL, V30, P558, DOI 10.1016/j.reprotox.2010.07.004; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Chang SC, 2012, REPROD TOXICOL, V33, P428, DOI 10.1016/j.reprotox.2011.07.002; Chen MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042474; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; Costa RM, 2006, NEURON, V52, P359, DOI 10.1016/j.neuron.2006.07.030; Costa RM, 2011, CURR OPIN NEUROBIOL, V21, P579, DOI 10.1016/j.conb.2011.05.004; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Ellis LD, 2012, BRAIN RES, V1449, P46, DOI 10.1016/j.brainres.2012.02.022; Emran Farida, 2008, J Vis Exp, DOI 10.3791/923; Fei CY, 2008, ENVIRON HEALTH PERSP, V116, P1391, DOI 10.1289/ehp.11277; Fei CY, 2011, ENVIRON HEALTH PERSP, V119, P573, DOI 10.1289/ehp.1002026; Fromme H, 2009, INT J HYG ENVIR HEAL, V212, P239, DOI 10.1016/j.ijheh.2008.04.007; FRY W, 1960, J EXP ANAL BEHAV, V3, P193, DOI 10.1901/jeab.1960.3-193; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Gump BB, 2011, ENVIRON SCI TECHNOL, V45, P8151, DOI 10.1021/es103712g; Hagenaars A, 2011, CHEMOSPHERE, V82, P764, DOI 10.1016/j.chemosphere.2010.10.076; Harada KH, 2007, ENVIRON TOXICOL PHAR, V24, P134, DOI 10.1016/j.etap.2007.04.003; Haug LS, 2009, ENVIRON SCI TECHNOL, V43, P2131, DOI 10.1021/es802827u; Hoffman K, 2010, ENVIRON HEALTH PERSP, V118, P1762, DOI 10.1289/ehp.1001898; Howard AL, 2011, J ATTEN DISORD, V15, P403, DOI 10.1177/1087054710365990; Huang HH, 2010, AQUAT TOXICOL, V98, P139, DOI 10.1016/j.aquatox.2010.02.003; Ibrahim WNW, 2013, TOXICOL APPL PHARM, V269, P51, DOI 10.1016/j.taap.2013.03.003; Ingebretson JJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00109; Irons TD, 2013, PHARMACOL BIOCHEM BE, V103, P792, DOI 10.1016/j.pbb.2012.12.010; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; Johansson N, 2008, NEUROTOXICOLOGY, V29, P160, DOI 10.1016/j.neuro.2007.10.008; Lambert AM, 2012, J NEUROSCI, V32, P13488, DOI 10.1523/JNEUROSCI.1638-12.2012; Lange M, 2012, MOL PSYCHIATR, V17, P946, DOI 10.1038/mp.2012.29; Lau C, 2004, TOXICOL APPL PHARM, V198, P231, DOI 10.1016/j.taap.2003.11.031; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Liu YC, 2012, J COMP PHYSIOL A, V198, P11, DOI 10.1007/s00359-011-0682-1; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Maestri L, 2006, RAPID COMMUN MASS SP, V20, P2728, DOI 10.1002/rcm.2661; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; Maximino C, 2010, ZEBRAFISH, V7, P359, DOI 10.1089/zeb.2010.0669; Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009; Olsen GW, 2005, ENVIRON HEALTH PERSP, V113, P539, DOI 10.1289/ehp.7544; Onishchenko N, 2011, NEUROTOX RES, V19, P452, DOI 10.1007/s12640-010-9200-4; Organisation for Economic Co-operation and Development OECD, 2013, TEST NO 236 FISH EMB, DOI [DOI 10.1787/9789264203709-EN, 10.1787/9789264203709-en]; Padilla S, 2011, NEUROTOXICOL TERATOL, V33, P624, DOI 10.1016/j.ntt.2011.08.005; Panula P, 2006, ZEBRAFISH, V3, P235, DOI 10.1089/zeb.2006.3.235; Quinete N, 2009, CHEMOSPHERE, V77, P863, DOI 10.1016/j.chemosphere.2009.07.079; Roberts AC, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00126; Sallinen V, 2009, J NEUROCHEM, V108, P719, DOI 10.1111/j.1471-4159.2008.05793.x; Shi XJ, 2008, TOXICOL APPL PHARM, V230, P23, DOI 10.1016/j.taap.2008.01.043; Slotkin TA, 2008, ENVIRON HEALTH PERSP, V116, P716, DOI 10.1289/ehp.11253; Spulber S, 2011, J NEUROSCI RES, V89, P142, DOI 10.1002/jnr.22534; Staddon JER, 2010, J EXP ANAL BEHAV, V94, P261, DOI 10.1901/jeab.2010.94-261; Stewart AM, 2013, BEHAV BRAIN RES, V236, P110, DOI 10.1016/j.bbr.2012.08.026; Sundstrom M, 2011, ENVIRON INT, V37, P178, DOI 10.1016/j.envint.2010.08.014; Tanimoto M, 2009, J NEUROSCI, V29, P2762, DOI 10.1523/JNEUROSCI.5530-08.2009; Ulhaq M, 2013, ENVIRON TOXICOL PHAR, V36, P423, DOI 10.1016/j.etap.2013.05.004; Wiggin TD, 2012, J NEUROPHYSIOL, V108, P925, DOI 10.1152/jn.00233.2012; Wong K, 2010, BEHAV BRAIN RES, V208, P450, DOI 10.1016/j.bbr.2009.12.023; Zeddies DG, 2005, J EXP BIOL, V208, P1363, DOI 10.1242/jeb.01534; Zhang L, 2011, ECOTOXICOLOGY, V20, P643, DOI 10.1007/s10646-011-0604-6; Zhang T, 2010, ENVIRON SCI TECHNOL, V44, P3572, DOI 10.1021/es1000159	69	56	56	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94227	10.1371/journal.pone.0094227	http://dx.doi.org/10.1371/journal.pone.0094227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740186	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000336863900038
J	Wang, X; Li, Y; Fang, G; Zhao, QC; Zeng, Q; Li, XM; Gong, HY; Li, YS				Wang, Xin; Li, Yang; Fang, Gen; Zhao, Qingchuan; Zeng, Qi; Li, Xuemei; Gong, Hanyu; Li, Yangsheng			Nitrite Promotes the Growth and Decreases the Lignin Content of indica Rice Calli: A Comprehensive Transcriptome Analysis of Nitrite-Responsive Genes during In Vitro Culture of Rice	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; GENOME-WIDE ANALYSIS; SECONDARY METABOLISM; NITRATE RESPONSE; SMALL AUXIN; RNA-SEQ; ARABIDOPSIS; EXPRESSION; SYSTEM; NUTRIENT	As both major macronutrients and signal molecules, nitrogen metabolites, such as nitrate and nitrite, play an important role in plant growth and development. In this study, the callus growth of indica rice cv. 9311 was significantly enhanced by nitrite, whereas the soluble protein content remained unchanged. The deep RNA sequencing technology (RNA-seq) showed that the transcriptional profiles of cv. 9311 calli were significantly changed after adding nitrite to the nitrate-free medium, and these nitrite-responsive genes were involved in a wide range of plant processes, particularly in the secondary metabolite pathways. Interestingly, most of the genes involved in phenylpropanoid-related pathways were coordinately down-regulated by nitrite, such as four cinnamoyl-CoA reductase, and these in turn resulted in the decrease of lignin content of indica calli. Furthermore, several candidate genes related to cell growth or stress responses were identified, such as genes coding for expansins, SMALL AUXIN UP RNA (SAUR) and HSP20s, and these suggested that nitrite could probably serve as a transcriptome signal to enhance the indica calli growth by regulation of various downstream genes expression. This study contributes to a better understanding of the function of nitrite during the process of plant tissue culture and could aid in the application of this technology to improved indica genetic transformation efficiency.	[Wang, Xin; Li, Yang; Fang, Gen; Zhao, Qingchuan; Zeng, Qi; Li, Xuemei; Gong, Hanyu; Li, Yangsheng] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Hubei, Peoples R China; [Wang, Xin] Chinese Acad Sci, Wuhan Bot Garden, CAS Key Lab Plant Germplasm Enhancement & Special, Wuhan, Hubei, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Li, YS (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Hubei, Peoples R China.	lysh2001@whu.edu.cn	li, yong/HDN-3885-2022; Li, Yuan/GXV-1310-2022; Li, Yang/GWM-7879-2022		National Program of Transgenic Variety Development of China [2011ZX08001-001, 2011ZX08001-004]; National Natural Science Foundation of China [31300227, 31271699]; Chinese Ministry of Education [313039]	National Program of Transgenic Variety Development of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Program of Transgenic Variety Development of China (Grant No. 2011ZX08001-001 and 2011ZX08001-004), National Natural Science Foundation of China (Grant No. 31300227 and 31271699) and Key Grant Project of Chinese Ministry of Education (Grant No. 313039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castaings L, 2011, J EXP BOT, V62, P1391, DOI 10.1093/jxb/erq375; Chae K, 2012, PLANT J, V71, P684, DOI 10.1111/j.1365-313X.2012.05024.x; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Choi D, 2006, PHYSIOL PLANTARUM, V126, P511, DOI 10.1111/j.1399-3054.2005.00612.x; Choi DS, 2003, PLANT CELL, V15, P1386, DOI 10.1105/tpc.011965; Fritz C, 2006, PLANT J, V46, P533, DOI 10.1111/j.1365-313X.2006.02715.x; Ge XJ, 2006, PLANT CELL REP, V25, P392, DOI 10.1007/s00299-005-0100-7; Goujon T, 2003, PLANTA, V217, P218, DOI 10.1007/s00425-003-0987-6; Gray J, 2012, PLANT SCI, V184, P112, DOI 10.1016/j.plantsci.2011.12.008; Jain M, 2006, GENOMICS, V88, P360, DOI 10.1016/j.ygeno.2006.04.008; Karthikeyan A, 2012, PLANT CELL TISS ORG, V109, P153, DOI 10.1007/s11240-011-0083-8; Karthikeyan A, 2011, PLANT SCI, V181, P258, DOI 10.1016/j.plantsci.2011.05.011; Krouk G, 2010, CURR OPIN PLANT BIOL, V13, P266, DOI 10.1016/j.pbi.2009.12.003; Lam HM, 2006, J INTEGR PLANT BIOL, V48, P873, DOI 10.1111/j.1744-7909.2006.00313.x; Lin YJ, 2005, PLANT CELL REP, V23, P540, DOI 10.1007/s00299-004-0843-6; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mokhele B, 2012, CAN J PLANT SCI, V92, P399, DOI [10.4141/CJPS2011-135, 10.4141/cjps2011-135]; Naoumkina MA, 2010, MOL PLANT PATHOL, V11, P829, DOI 10.1111/j.1364-3703.2010.00648.x; Nishimura A, 2005, P NATL ACAD SCI USA, V102, P11940, DOI 10.1073/pnas.0504220102; Nishimura A, 2006, NAT PROTOC, V1, P2796, DOI 10.1038/nprot.2006.469; Ogawa T, 1999, PLANT CELL REP, V18, P576, DOI 10.1007/s002990050625; Ozawa K, 2006, PLANT SCI, V170, P384, DOI 10.1016/j.plantsci.2005.09.015; Sakamoto A, 2004, FEBS LETT, V572, P27, DOI 10.1016/j.febslet.2004.07.005; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Shrawat AK, 2010, PLANT BIOTECHNOL, V27, P47, DOI 10.5511/plantbiotechnology.27.47; Shrawat AK, 2006, PLANT BIOTECHNOL J, V4, P575, DOI 10.1111/j.1467-7652.2006.00209.x; Shri M, 2013, PROTOPLASMA, V250, P631, DOI 10.1007/s00709-012-0439-x; Silva TD, 2010, PLANT CELL TISS ORG, V100, P1, DOI 10.1007/s11240-009-9616-9; Spartz AK, 2012, PLANT J, V70, P978, DOI 10.1111/j.1365-313X.2012.04946.x; Tsujimoto R, 2007, PLANT CELL PHYSIOL, V48, P484, DOI 10.1093/pcp/pcm019; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Vidal EA, 2008, CURR OPIN PLANT BIOL, V11, P521, DOI 10.1016/j.pbi.2008.07.003; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wagner A, 2013, PLANT MOL BIOL, V81, P105, DOI 10.1007/s11103-012-9985-z; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2004, PLANT PHYSIOL, V136, P2512, DOI 10.1104/pp.104.044610; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang RC, 2007, PLANT PHYSIOL, V145, P1735, DOI 10.1104/pp.107.108944; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Wang ZJ, 2012, PLANT MOL BIOL REP, V30, P1229, DOI 10.1007/s11105-012-0444-4; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Zhong RQ, 2009, PLANT SIGNAL BEHAV, V4, P1028, DOI 10.4161/psb.4.11.9875	45	7	9	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95105	10.1371/journal.pone.0095105	http://dx.doi.org/10.1371/journal.pone.0095105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740395	Green Submitted, gold, Green Published			2022-12-25	WOS:000336863900103
J	Zhang, L; Ding, ZX; Li, HY; Shen, Y				Zhang, Lin; Ding, Zhixuan; Li, Hongyu; Shen, Ying			3D Ear Identification Based on Sparse Representation	PLOS ONE			English	Article							FACE RECOGNITION; SHAPE	Biometrics based personal authentication is an effective way for automatically recognizing, with a high confidence, a person's identity. Recently, 3D ear shape has attracted tremendous interests in research field due to its richness of feature and ease of acquisition. However, the existing ICP (Iterative Closet Point)-based 3D ear matching methods prevalent in the literature are not quite efficient to cope with the one-to-many identification case. In this paper, we aim to fill this gap by proposing a novel effective fully automatic 3D ear identification system. We at first propose an accurate and efficient template-based ear detection method. By utilizing such a method, the extracted ear regions are represented in a common canonical coordinate system determined by the ear contour template, which facilitates much the following stages of feature extraction and classification. For each extracted 3D ear, a feature vector is generated as its representation by making use of a PCA-based local feature descriptor. At the stage of classification, we resort to the sparse representation based classification approach, which actually solves an l(1)-minimization problem. To the best of our knowledge, this is the first work introducing the sparse representation framework into the field of 3D ear identification. Extensive experiments conducted on a benchmark dataset corroborate the effectiveness and efficiency of the proposed approach. The associated Matlab source code and the evaluation results have been made publicly online available at http://sse.tongji.edu.cn/linzhang/ear/srcear/srcear.htm.	[Zhang, Lin; Ding, Zhixuan; Li, Hongyu; Shen, Ying] Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China	Tongji University	Shen, Y (corresponding author), Tongji Univ, Sch Software Engn, Shanghai 200092, Peoples R China.	yingshen@tongji.edu.cn		Zhang, Lin/0000-0002-4360-5523	Natural Science Foundation of China [61201394]; Shanghai Pujiang Program [13PJ1408700]; Shanghai Municipal Education Commission [12ZZ029]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work is supported by the Natural Science Foundation of China under grant no. 61201394, the Shanghai Pujiang Program under grant no. 13PJ1408700, and the Innovation Program of Shanghai Municipal Education Commission under grant no. 12ZZ029. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza A, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431221; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Burge M, 2000, INT C PATT RECOG, P822, DOI 10.1109/ICPR.2000.906202; Bustard JD, 2010, IEEE T SYST MAN CY A, V40, P486, DOI 10.1109/TSMCA.2010.2041652; Cadavid S, 2008, IEEE T INF FOREN SEC, V3, P709, DOI 10.1109/TIFS.2008.2007239; Chang K, 2003, IEEE T PATTERN ANAL, V25, P1160, DOI 10.1109/TPAMI.2003.1227990; Chen FL, 2013, IEEE T IMAGE PROCESS, V22, P4964, DOI 10.1109/TIP.2013.2280187; Chen H, 2005, WACV 2005: SEVENTH IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION, PROCEEDINGS, P123; Chen H, 2004, INT C PATT RECOG, P574, DOI 10.1109/ICPR.2004.1334594; Chen H, 2005, P CVPR WORKSH; Chen H, 2007, IEEE T PATTERN ANAL, V29, P718, DOI 10.1109/TPAMI.2007.1005; Choras M., 2005, ELECT LETT COMPUTER, V5, P84, DOI DOI 10.5565/REV/ELCVIA.108; Donoho DL, 2006, COMMUN PUR APPL MATH, V59, P797, DOI 10.1002/cpa.20132; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Harguess J, 2009, P CVPR WORKSH; He LH, 2012, PROC CVPR IEEE, P1146, DOI 10.1109/CVPR.2012.6247795; Heng Liu, 2013, 2013 5th International Conference on Intelligent Networking and Collaborative Systems, P731, DOI 10.1109/INCoS.2013.141; Huang D, 2011, LECT NOTES COMPUT SC, V6523, P206; Hurley DJ, 2005, COMPUT VIS IMAGE UND, V98, P491, DOI 10.1016/j.cviu.2004.11.001; Iannarelli A., 1989, FORENSIC IDENTIFICAT; Islam SMS, 2013, PATTERN RECOGN, V46, P613, DOI 10.1016/j.patcog.2012.09.016; Islam SMS, 2011, INT J COMPUT VISION, V95, P52, DOI 10.1007/s11263-011-0436-0; JAIN AK, 1999, BIOMETRICS PERSONAL; Jain Anil K., 2007, HDB BIOMETRICS; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kim SJ, 2007, IEEE J-STSP, V1, P606, DOI 10.1109/JSTSP.2007.910971; Kumar A, 2013, PATTERN RECOGN, V46, P73, DOI 10.1016/j.patcog.2012.06.020; Li S. Z., 2009, ENCY BIOMETRICS; Mairal J, 2010, J MACH LEARN RES, V11, P19; Malioutov DM, 2005, INT CONF ACOUST SPEE, P733; Mian AS, 2008, INT J COMPUT VISION, V79, P1, DOI 10.1007/s11263-007-0085-5; Moreno B., 1999, Proceedings IEEE 33rd Annual 1999 International Carnahan Conference on Security Technology (Cat. No.99CH36303), P469, DOI 10.1109/CCST.1999.797956; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Passalis G, 2007, 2007 IEEE CONFERENCE ON ADVANCED VIDEO AND SIGNAL BASED SURVEILLANCE, P39, DOI 10.1109/AVSS.2007.4425283; Tang HL, 2011, J SUPERCOMPUT, V58, P84, DOI 10.1007/s11227-010-0533-9; Theoharis T, 2008, PATTERN RECOGN, V41, P796, DOI 10.1016/j.patcog.2007.06.024; Wagner A, 2012, IEEE T PATTERN ANAL, V34, P372, DOI 10.1109/TPAMI.2011.112; Wang J.P., 2008, IEEE C COMP VIS PATT, V4, P1, DOI DOI 10.1109/CVPR.2008.4587647; Wright J, 2009, IEEE T PATTERN ANAL, V31, P210, DOI 10.1109/TPAMI.2008.79; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892; Xiaoxing Li, 2009, 2009 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P2575, DOI 10.1109/CVPRW.2009.5206613; Yan P, 2005, P CVPR WORKSH; Yan P, 2007, IEEE T PATTERN ANAL, V29, P1297, DOI 10.1109/TPAMI.2007.1067; Yang JC, 2009, PROC CVPR IEEE, P1794, DOI 10.1109/CVPRW.2009.5206757; Yang JM, 2012, PROC CVPR IEEE, P2296, DOI 10.1109/CVPR.2012.6247940; Yang JF, 2011, SIAM J SCI COMPUT, V33, P250, DOI 10.1137/090777761; Yuan L, 2012, PATTERN RECOGN LETT, V33, P182, DOI 10.1016/j.patrec.2011.09.041	48	9	9	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95506	10.1371/journal.pone.0095506	http://dx.doi.org/10.1371/journal.pone.0095506			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740247	gold, Green Published, Green Submitted			2022-12-25	WOS:000336863900151
J	Meraz, IM; Hearnden, CH; Liu, XW; Yang, M; Williams, L; Savage, DJ; Gu, JH; Rhudy, JR; Yokoi, K; Lavelle, EC; Serda, RE				Meraz, Ismail M.; Hearnden, Claire H.; Liu, Xuewu; Yang, Marie; Williams, Laura; Savage, David J.; Gu, Jianhua; Rhudy, Jessica R.; Yokoi, Kenji; Lavelle, Ed C.; Serda, Rita E.			Multivalent Presentation of MPL by Porous Silicon Microparticles Favors T Helper 1 Polarization Enhancing the Anti-Tumor Efficacy of Doxorubicin Nanoliposomes	PLOS ONE			English	Article							SUPPRESSOR-CELLS; ADAPTIVE IMMUNITY; DENDRITIC CELLS; BREAST-CANCER; DELIVERY; CARCINOMA; ADJUVANTS; IL-12; TH1	Porous silicon (pSi) microparticles, in diverse sizes and shapes, can be functionalized to present pathogen-associated molecular patterns that activate dendritic cells. Intraperitoneal injection of MPL-adsorbed pSi microparticles, in contrast to free MPL, resulted in the induction of local inflammation, reflected in the recruitment of neutrophils, eosinophils and proinflammatory monocytes, and the depletion of resident macrophages and mast cells at the injection site. Injection of microparticle-bound MPL resulted in enhanced secretion of the T helper 1 associated cytokines IFN-gamma and TNF-alpha by peritoneal exudate and lymph node cells in response to secondary stimuli while decreasing the anti-inflammatory cytokine IL-10. MPL-pSi microparticles independently exhibited anti-tumor effects and enhanced tumor suppression by low dose doxorubicin nanoliposomes. Intravascular injection of the MPL-bound microparticles increased serum IL-1 beta levels, which was blocked by the IL-1 receptor antagonist Anakinra. The microparticles also potentiated tumor infiltration by dendritic cells, cytotoxic T lymphocytes, and F4/80(+) macrophages, however, a specific reduction was observed in CD204(+) macrophages.	[Meraz, Ismail M.; Liu, Xuewu; Gu, Jianhua; Rhudy, Jessica R.; Yokoi, Kenji; Serda, Rita E.] Houston Methodist Res Inst, Houston, TX 77030 USA; [Hearnden, Claire H.; Yang, Marie; Williams, Laura; Lavelle, Ed C.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Adjuvant Res Grp, Dublin, Ireland; [Yang, Marie; Williams, Laura; Lavelle, Ed C.] Trinity Coll Dublin, CRANN, Dublin, Ireland; [Savage, David J.; Serda, Rita E.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Savage, David J.] Univ Texas Sch Med, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; Trinity College Dublin; Trinity College Dublin; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Serda, RE (corresponding author), Houston Methodist Res Inst, Houston, TX 77030 USA.	ritaserda@gmail.com	Lavelle, Ed/A-1716-2008; Savage, David/ABA-5389-2021; Yokoi, Kenji/J-1216-2014	Lavelle, Ed/0000-0002-3167-1080; Savage, MD, PhD, David/0000-0003-4690-5115	Houston Methodist and Science Foundation Ireland (SFI) [12/IA/1421]; Irish Health Research Board	Houston Methodist and Science Foundation Ireland (SFI)(Science Foundation Ireland); Irish Health Research Board	This research was supported by Houston Methodist and Science Foundation Ireland (SFI Investigators Award 12/IA/1421) and the Irish Health Research Board (Scholars Programme in Immunology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh D, 2014, CANCER RES, V74, P104, DOI 10.1158/0008-5472.CAN-13-1545; Blanco E, 2013, CANCER LETT, V334, P245, DOI 10.1016/j.canlet.2012.07.027; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002; Decuzzi P, 2009, J CONTROL RELEASE; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Godin B, 2012, ADV FUNCT MATER, V22, P4225, DOI 10.1002/adfm.201200869; Haabeth OAW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1239; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Le HK, 2009, INT IMMUNOPHARMACOL, V9, P900, DOI 10.1016/j.intimp.2009.03.015; Malvicini M, 2011, MOL ONCOL, V5, P242, DOI 10.1016/j.molonc.2011.03.007; Martin M, 2003, INFECT IMMUN, V71, P2498, DOI 10.1128/IAI.71.5.2498-2507.2003; Meraz IM, 2012, MOL PHARM; Mori A, 2012, EUR J IMMUNOL, V42, P2709, DOI 10.1002/eji.201242372; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Rimaniol AC, 2007, VACCINE, V25, P6784, DOI 10.1016/j.vaccine.2007.06.051; Savage DJ, 2013, CURR OPIN PHARM; Schmidt RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045186; Serda RE, 2010, SMALL; Serda RE, 2009, NANOSCALE, V1, P250, DOI 10.1039/b9nr00138g; Serda RE, 2009, BIOMATERIALS, V30, P2440, DOI 10.1016/j.biomaterials.2009.01.019; Serda RE, 2013, INT J NANOMED, V8, P1683, DOI 10.2147/IJN.S31756; Shen HF, 2013, CLIN CANCER RES, V19, P1806, DOI 10.1158/1078-0432.CCR-12-2764; Shigeoka M, 2013, CANCER SCI, V104, P1112, DOI 10.1111/cas.12188; Tanaka T, 2010, CANCER RES, V70, P3687, DOI 10.1158/0008-5472.CAN-09-3931; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Umemura N, 2008, J LEUKOCYTE BIOL, V83, P1136, DOI 10.1189/jlb.0907611	31	12	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94703	10.1371/journal.pone.0094703	http://dx.doi.org/10.1371/journal.pone.0094703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736547	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600086
J	Schoebel, CN; Auld, SKJR; Spaak, P; Little, TJ				Schoebel, Corine N.; Auld, Stuart K. J. R.; Spaak, Piet; Little, Tom J.			Effects of Juvenile Host Density and Food Availability on Adult Immune Response, Parasite Resistance and Virulence in a Daphnia-Parasite System	PLOS ONE			English	Article							GENETIC-VARIATION; FRESH-WATER; ENVIRONMENTAL-STRESS; POPULATION-DYNAMICS; LIFE-HISTORY; TRADE-OFFS; MAGNA; CONSEQUENCES; EVOLUTIONARY; DEPENDENCE	Host density can increase infection rates and reduce host fitness as increasing population density enhances the risk of becoming infected either through increased encounter rate or because host condition may decline. Conceivably, potential hosts could take high host density as a cue to up-regulate their defence systems. However, as host density usually covaries with food availability, it is difficult to examine the importance of host density in isolation. Thus, we performed two full-factorial experiments that varied juvenile densities of Daphnia magna (a freshwater crustacean) and food availability independently. We also included a simulated high-density treatment, where juvenile experimental animals were kept in filtered media that previously maintained Daphnia at high-density. Upon reaching adulthood, we exposed the Daphnia to their sterilizing bacterial parasite, Pasteuria ramosa, and examined how the juvenile treatments influenced the likelihood and severity of infection (Experiment I) and host immune investment (Experiment II). Neither juvenile density nor food treatments affected the likelihood of infection; however, well-fed hosts that were well-fed as juveniles produced more offspring prior to sterilization than their less well-fed counterparts. By contrast, parasite growth was independent of host juvenile resources or host density. Parasite-exposed hosts had a greater number of circulating haemocytes than controls (i.e., there was a cellular immune response), but the magnitude of immune response was not mediated by food availability or host density. These results suggest that density dependent effects on disease arise primarily through correlated changes in food availability: low food could limit parasitism and potentially curtail epidemics by reducing both the host's and parasite's reproduction as both depend on the same food.	[Schoebel, Corine N.] Swiss Fed Res Inst WSL, Dept Biodivers & Conservat Biol, Birmensdorf, Switzerland; [Schoebel, Corine N.; Spaak, Piet] Eawag, Dubendorf, Switzerland; [Schoebel, Corine N.; Spaak, Piet] ETH, Inst Integrat Biol, Zurich, Switzerland; [Auld, Stuart K. J. R.; Little, Tom J.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland; [Auld, Stuart K. J. R.] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Edinburgh; University of Stirling	Schoebel, CN (corresponding author), Swiss Fed Res Inst WSL, Dept Biodivers & Conservat Biol, Birmensdorf, Switzerland.	corine.schoebel@wsl.ch	Little, Tom J/B-7890-2009; Schoebel, Corine/D-2801-2013; Auld, Stuart KJR/N-1911-2019	Little, Tom J/0000-0002-8945-0416; Schoebel, Corine/0000-0001-9254-140X; Auld, Stuart KJR/0000-0001-6691-7442	Swiss National Science Foundation [3100 AO-116470]; Swiss ETH-Board (CESS-Gedihap); NERC; Wellcome Trust; NERC [NE/I026405/1] Funding Source: UKRI; Natural Environment Research Council [NE/I026405/1] Funding Source: researchfish	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss ETH-Board (CESS-Gedihap); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	For the present study CNS and PS were supported by the Swiss National Science Foundation (grant 3100 AO-116470; http://www.snf.ch/E/Pages/default.aspx); and the Swiss ETH-Board (CESS-Gedihap; http://www.cces.ethz.ch). SKRJA was funded by NERC (http://www.nerc.ac.uk/funding/available/fellowships/); and TJL by the Wellcome Trust (http://www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Auld SKJR, 2012, EVOLUTION, V66, P3287, DOI 10.1111/j.1558-5646.2012.01671.x; Auld SKJR, 2010, P ROY SOC B-BIOL SCI, V277, P3291, DOI 10.1098/rspb.2010.0772; Barber I, 2001, P ROY SOC B-BIOL SCI, V268, P71, DOI 10.1098/rspb.2000.1331; Boersma M, 1998, AM NAT, V152, P237, DOI 10.1086/286164; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; BOOTS M, 1993, FUNCT ECOL, V7, P528, DOI 10.2307/2390128; Brook BW, 2006, ECOLOGY, V87, P1445, DOI 10.1890/0012-9658(2006)87[1445:SOEFDD]2.0.CO;2; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; BURNS CW, 1995, OECOLOGIA, V101, P234, DOI 10.1007/BF00317289; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Cope NJ, 2004, AQUAT ECOL, V38, P83; Duncan AB, 2007, EVOLUTION, V61, P796, DOI 10.1111/j.1558-5646.2007.00072.x; Ebert D, 2000, OECOLOGIA, V122, P200, DOI 10.1007/PL00008847; Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606; Ebert D, 1996, PHILOS T ROY SOC B, V351, P1689, DOI 10.1098/rstb.1996.0151; Guinnee MA, 2007, J EVOLUTION BIOL, V20, P577, DOI 10.1111/j.1420-9101.2006.01253.x; Guinnee MA, 2004, AM NAT, V163, P880, DOI 10.1086/386553; Jokela J, 2005, OIKOS, V108, P156, DOI 10.1111/j.0030-1299.2005.13185.x; Jokela J, 1999, OECOLOGIA, V119, P320, DOI 10.1007/s004420050792; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Little TJ, 2008, PARASITOLOGY, V135, P303, DOI 10.1017/S0031182007003939; Lively CM, 2009, J EVOLUTION BIOL, V22, P2086, DOI 10.1111/j.1420-9101.2009.01824.x; Lively CM, 2006, ECOL LETT, V9, P1089, DOI 10.1111/j.1461-0248.2006.00969.x; Lively CM, 2010, ECOLOGY, V91, P3, DOI 10.1890/09-1158.1; Mitchell SE, 2005, P ROY SOC B-BIOL SCI, V272, P2601, DOI 10.1098/rspb.2005.3253; Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166; Neiman M, 2006, INVERTEBR BIOL, V125, P45, DOI 10.1111/j.1744-7410.2006.00038.x; Neiman M, 2013, EVOL ECOL, V27, P1117, DOI 10.1007/s10682-013-9632-4; Piesk M, 2013, ECOL ENTOMOL, V38, P346, DOI 10.1111/een.12024; Rowley AF, 1981, INVERTEBRATE BLOOD C; Sadd BM, 2006, P ROY SOC B-BIOL SCI, V273, P2571, DOI 10.1098/rspb.2006.3574; Schoebel CN, 2010, J EVOLUTION BIOL, V23, P2370, DOI 10.1111/j.1420-9101.2010.02097.x; SEITZ A, 1984, OECOLOGIA, V62, P94, DOI 10.1007/BF00377380; Seppala O, 2010, EVOLUTION, V64, P2397, DOI 10.1111/j.1558-5646.2010.00995.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Stjernman M, 2011, J EVOLUTION BIOL, V24, P2357, DOI 10.1111/j.1420-9101.2011.02363.x; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; TURCHIN P, 1992, ECOLOGY, V73, P289, DOI 10.2307/1938740; Vale PF, 2011, AM NAT, V177, P510, DOI 10.1086/659002; Wolinska J, 2009, TRENDS PARASITOL, V25, P236, DOI 10.1016/j.pt.2009.02.004	45	2	2	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94569	10.1371/journal.pone.0094569	http://dx.doi.org/10.1371/journal.pone.0094569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736707	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600074
J	Sensi, C; Simonelli, S; Zanotti, I; Tedeschi, G; Lusardi, G; Franceschini, G; Calabresi, L; Eberini, I				Sensi, Cristina; Simonelli, Sara; Zanotti, Ilaria; Tedeschi, Gabriella; Lusardi, Giulia; Franceschini, Guido; Calabresi, Laura; Eberini, Ivano			Distant Homology Modeling of LCAT and Its Validation through In Silico Targeting and In Vitro and In Vivo Assays	PLOS ONE			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; CANDIDA-RUGOSA LIPASE; LECITHIN/CHOLESTEROL ACYLTRANSFERASE; INTERFACIAL ACTIVATION; STRUCTURE PREDICTION; HUMAN-PLASMA; DEFICIENCY; MUTATIONS; IDENTIFICATION; LIPOPROTEIN	LCAT (lecithin: cholesterol acyltransferase) catalyzes the transacylation of a fatty acid of lecithin to cholesterol, generating a cholesteryl ester and lysolecithin. The knowledge of LCAT atomic structure and the identification of the amino acids relevant in controlling its structure and function are expected to be very helpful to understand the enzyme catalytic mechanism, as involved in HDL cholesterol metabolism. However - after an early report in the late '90 s - no recent advance has been made about LCAT three-dimensional structure. In this paper, we propose an LCAT atomistic model, built following the most up-to-date molecular modeling approaches, and exploiting newly solved crystallographic structures. LCAT shows the typical folding of the alpha/beta hydrolase superfamily, and its topology is characterized by a combination of alpha-helices covering a central 7-strand beta-sheet. LCAT presents a Ser/Asp/His catalytic triad with a peculiar geometry, which is shared with such other enzyme classes as lipases, proteases and esterases. Our proposed model was validated through different approaches. We evaluated the impact on LCAT structure of some point mutations close to the enzyme active site (Lys218Asn, Thr274Ala, Thr274Ile) and explained, at a molecular level, their phenotypic effects. Furthermore, we devised some LCAT modulators either designed through a de novo strategy or identified through a virtual high-throughput screening pipeline. The tested compounds were proven to be potent inhibitors of the enzyme activity.	[Sensi, Cristina; Eberini, Ivano] Univ Milan, Lab Biochim & Biofis Computaz, Milan, Italy; [Simonelli, Sara; Franceschini, Guido; Calabresi, Laura] Univ Milan, Dipartimento Sci Farmacol & Biomol, Ctr Enrica Grossi Paoletti, Milan, Italy; [Zanotti, Ilaria; Lusardi, Giulia] Univ Parma, Dipartimento Farm, I-43100 Parma, Italy; [Tedeschi, Gabriella] Univ Milan, Dipartimento Sci Vet & Sanita Pubbl, Milan, Italy	University of Milan; University of Milan; University of Parma; University of Milan	Eberini, I (corresponding author), Univ Milan, Lab Biochim & Biofis Computaz, Milan, Italy.	ivano.eberini@gmail.com	Tedeschi, Gabriella/I-6247-2017	Tedeschi, Gabriella/0000-0003-2082-6443; Zanotti, Ilaria/0000-0003-2701-6021; Calabresi, Laura/0000-0001-5042-9532; FRANCESCHINI, GUIDO/0000-0003-2687-1771	Universita degli Studi di Milano	Universita degli Studi di Milano	This research was supported by Universita degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Berglund P, 1998, J MOL CATAL B-ENZYM, V5, P283, DOI 10.1016/S1381-1177(98)00095-2; Calabresi L, 2005, ARTERIOSCL THROM VAS, V25, P1972, DOI 10.1161/01.ATV.0000175751.30616.13; Calabresi L, 2012, ATHEROSCLEROSIS, V222, P299, DOI 10.1016/j.atherosclerosis.2011.11.034; Campbell GR, 2007, VACCINE, V25, P8441, DOI 10.1016/j.vaccine.2007.09.070; Carlson L. A., 1979, LANCET, V2, P922; Congreve M, 2011, ADV PHARMACOL, V62, P1, DOI 10.1016/B978-0-12-385952-5.00011-7; Dehouck Y, 2009, BIOINFORMATICS, V25, P2537, DOI 10.1093/bioinformatics/btp445; Eberini I, 2011, J COMPUT AID MOL DES, V25, P743, DOI 10.1007/s10822-011-9455-8; Ericsson DJ, 2008, J MOL BIOL, V376, P109, DOI 10.1016/j.jmb.2007.10.079; FRANCESCHINI G, 1990, BIOCHIM BIOPHYS ACTA, V1043, P1, DOI 10.1016/0005-2760(90)90102-4; GJONE E, 1968, ACTA MED SCAND, V183, P107; GROCHULSKI P, 1994, BIOCHEMISTRY-US, V33, P3494, DOI 10.1021/bi00178a005; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; JAUHIAINEN M, 1986, J BIOL CHEM, V261, P7032; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Kryshtafovych A., 2013, PROTEINS; Kuhn P, 1998, BIOCHEMISTRY-US, V37, P13446, DOI 10.1021/bi9813983; Lin DS, 2010, ATHEROSCLEROSIS, V208, P155, DOI 10.1016/j.atherosclerosis.2009.07.031; MURAKAMI T, 1995, ARTERIOSCL THROM VAS, V15, P1819, DOI 10.1161/01.ATV.15.11.1819; Nakamura Y, 2004, BIOCHEMISTRY-US, V43, P14811, DOI 10.1021/bi0485629; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Papageorgiou AC, 2008, J MOL BIOL, V382, P1184, DOI 10.1016/j.jmb.2008.07.078; Peelman F, 1998, PROTEIN SCI, V7, P587, DOI 10.1002/pro.5560070307; Peelman F, 2001, J LIPID RES, V42, P471; Peelman F, 1999, PROTEIN ENG, V12, P71, DOI 10.1093/protein/12.1.71; Peelman F, 1997, EUR J BIOCHEM, V249, P708, DOI 10.1111/j.1432-1033.1997.t01-2-00708.x; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Simonelli S, 2013, BIOLOGICALS, V41, P446, DOI 10.1016/j.biologicals.2013.09.007; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; Wang JC, 1997, J BIOL CHEM, V272, P280; Wojciechowski M, 2004, J PHYS CHEM; Yang G, 1998, TETRAHEDRON LETT, V39, P2449, DOI 10.1016/S0040-4039(98)00238-X	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95044	10.1371/journal.pone.0095044	http://dx.doi.org/10.1371/journal.pone.0095044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736652	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600134
J	Liu, LQ; Richard, J; Kim, S; Wojcik, EJ				Liu, Liqiong; Richard, Jessica; Kim, Sunyoung; Wojcik, Edward J.			Small Molecule Screen for Candidate Antimalarials Targeting Plasmodium Kinesin-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FALCIPARUM DIHYDROOROTATE DEHYDROGENASE; TRITYL-L-CYSTEINE; ESCHERICHIA-COLI; APICOMPLEXAN PARASITES; CELL-CYCLE; HUMAN EG5; IN-VITRO; INHIBITORS; MALARIA; DISCOVERY	Plasmodium falciparum and vivax are responsible for the majority of malaria infections worldwide, resulting in over a million deaths annually. Malaria parasites now show measured resistance to all currently utilized drugs. Novel antimalarial drugs are urgently needed. The Plasmodium Kinesin-5 mechanoenzyme is a suitable "next generation" target. Discovered via small molecule screen experiments, the human Kinesin-5 has multiple allosteric sites that are "druggable." One site in particular, unique in its sequence divergence across all homologs in the superfamily and even within the same family, exhibits exquisite drug specificity. We propose that Plasmodium Kinesin-5 shares this allosteric site and likewise can be targeted to uncover inhibitors with high specificity. To test this idea, we performed a screen for inhibitors selective for Plasmodium Kinesin-5 ATPase activity in parallel with human Kinesin-5. Our screen of nearly 2000 compounds successfully identified compounds that selectively inhibit both P. vivax and falciparum Kinesin-5 motor domains but, as anticipated, do not impact human Kinesin-5 activity. Of note is a candidate drug that did not biochemically compete with the ATP substrate for the conserved active site or disrupt the microtubule-binding site. Together, our experiments identified MMV666693 as a selective allosteric inhibitor of Plasmodium Kinesin-5; this is the first identified protein target for the Medicines of Malaria Venture validated collection of parasite proliferation inhibitors. This work demonstrates that chemical screens against human kinesins are adaptable to homologs in disease organisms and, as such, extendable to strategies to combat infectious disease.	[Liu, Liqiong; Richard, Jessica; Kim, Sunyoung; Wojcik, Edward J.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wojcik, EJ (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	ewojci@lsuhsc.edu		Wojcik, Edward/0000-0002-3023-0312	National Institutes of Health [R01GM066328, R01GM097350]; Louisiana State University School of Graduate Studies; LSU School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097350, R01GM066328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University School of Graduate Studies; LSU School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM066328 (to E. W.) and R01GM097350 (to S. K.). This work was also supported by the Louisiana State University School of Graduate Studies (to J. R.) and the LSU School of Medicine (to L. L.).	Anthony MP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-316; Arnot DE, 2011, INT J PARASITOL, V41, P71, DOI 10.1016/j.ijpara.2010.07.012; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Biamonte MA, 2013, BIOORG MED CHEM LETT, V23, P2829, DOI 10.1016/j.bmcl.2013.03.067; Booker ML, 2010, J BIOL CHEM, V285, P33054, DOI 10.1074/jbc.M110.162081; Chakrabarti R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057302; Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; DeBonis S, 2004, MOL CANCER THER, V3, P1079; DeBonis S, 2008, J MED CHEM, V51, P1115, DOI 10.1021/jm070606z; Dempsey E, 2013, MOL BIOCHEM PARASIT, V188, P116, DOI 10.1016/j.molbiopara.2013.03.001; Duffy S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-408; El-Nassan HB, 2013, EUR J MED CHEM, V62, P614, DOI 10.1016/j.ejmech.2013.01.031; Francia ME, 2014, NAT REV MICROBIOL, V12, P125, DOI 10.1038/nrmicro3184; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gartner M, 2005, CHEMBIOCHEM, V6, P1173, DOI 10.1002/cbic.200500005; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; Goedken ER, 2012, J BIOMOL SCREEN, V17, P857, DOI 10.1177/1087057112447108; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Harris MT, 2013, ANTIMICROB AGENTS CH, V57, P3731, DOI 10.1128/AAC.00662-13; HENKEL RD, 1988, ANAL BIOCHEM, V169, P312, DOI 10.1016/0003-2697(88)90290-4; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Hyde JE, 2007, CURR DRUG TARGETS, V8, P31, DOI 10.2174/138945007779315524; Imwong M, 2011, J INFECT DIS, V203, P207, DOI 10.1093/infdis/jiq024; Indorato RL, 2013, BIOCHEM PHARMACOL, V86, P1441, DOI 10.1016/j.bcp.2013.09.003; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Kappes B, 2007, FUTURE MICROBIOL, V2, P409, DOI 10.2217/17460913.2.4.409; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Learman SS, 2009, BIOCHEMISTRY-US, V48, P1754, DOI 10.1021/bi801291q; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu LQ, 2011, J BIOL CHEM, V286, P6201, DOI 10.1074/jbc.M110.154989; Lockhart A, 1996, BIOCHEMISTRY-US, V35, P2365, DOI 10.1021/bi952318n; Magnusdottir A, 2009, NAT METHODS, V6, P477, DOI 10.1038/nmeth0709-477; Mahajan B, 2008, J BIOL CHEM, V283, P31871, DOI 10.1074/jbc.M800028200; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Nilsen A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005029; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Preuss J, 2012, J MED CHEM, V55, P7262, DOI 10.1021/jm300833h; Rackham MD, 2013, J MED CHEM, V56, P371, DOI 10.1021/jm301474t; Rickert KW, 2008, ARCH BIOCHEM BIOPHYS, V469, P220, DOI 10.1016/j.abb.2007.10.016; Sarli V, 2008, CLIN CANCER RES, V14, P7583, DOI 10.1158/1078-0432.CCR-08-0120; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Stock MF, 2001, METH MOL B, V164, P43; Tilley L, 2011, RSC DRUG DISCOV, V14, P33, DOI 10.1039/9781849733496-00033; Vyas VK, 2011, MINI-REV MED CHEM, V11, P1039; Wojcik EJ, 2013, GENE, V531, P133, DOI 10.1016/j.gene.2013.08.004; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107; Xue HY, 2003, MOL BIOCHEM PARASIT, V128, P21, DOI 10.1016/S0166-6851(03)00039-2; Yang L, 2008, BIOL PHARM BULL, V31, P1397, DOI 10.1248/bpb.31.1397; Yuthavong Y, 2012, P NATL ACAD SCI USA, V109, P16823, DOI 10.1073/pnas.1204556109; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang W, 2011, J PHYS CHEM B, V115, P784, DOI 10.1021/jp107255t; Zhang Y, 2013, J BIOL CHEM, V288, P34746, DOI 10.1074/jbc.M113.521955; Zilversmit MM, 2010, MOL BIOL EVOL, V27, P2198, DOI 10.1093/molbev/msq108	65	12	12	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16601	16614		10.1074/jbc.M114.551408	http://dx.doi.org/10.1074/jbc.M114.551408			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24737313	Green Published, hybrid			2022-12-25	WOS:000337965700060
J	Parker-Duffen, JL; Nakamura, K; Silver, M; Zuriaga, MA; MacLauchlan, S; Aprahamian, TR; Walsh, K				Parker-Duffen, Jennifer L.; Nakamura, Kazuto; Silver, Marcy; Zuriaga, Maria A.; MacLauchlan, Susan; Aprahamian, Tamar R.; Walsh, Kenneth			Divergent Roles for Adiponectin Receptor 1 (AdipoR1) and AdipoR2 in Mediating Revascularization and Metabolic Dysfunction in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INDUCED INSULIN-RESISTANCE; MICE LACKING ADIPONECTIN; HIGH-MOLECULAR-WEIGHT; ENDOTHELIAL-CELLS; SKELETAL-MUSCLE; STIMULATES ANGIOGENESIS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR EVENTS; GAMMA AGONIST	Adiponectin is a well described anti-inflammatory adipokine that is highly abundant in serum. Previous reports have found that adiponectin deficiency promotes cardiovascular and metabolic dysfunction in murine models, whereas its overexpression is protective. Two candidate adiponectin receptors, AdipoR1 and AdipoR2, are uncharacterized with regard to cardiovascular tissue homeostasis, and their in vivo metabolic functions remain controversial. Here we subjected AdipoR1- and AdipoR2-deficient mice to chronic hind limb ischemic surgery. Blood flow recovery in AdipoR1-deficient mice was similar to wild-type; however, revascularization in AdipoR2-deficient mice was severely attenuated. Treatment with adiponectin enhanced the recovery of wild-type mice but failed to rescue the impairment observed in AdipoR2-deficient mice. In view of this divergent receptor function in the hind limb ischemia model, AdipoR1-and AdipoR2-deficient mice were also evaluated in a model of diet-induced obesity. Strikingly, AdipoR1-deficient mice developed severe metabolic dysfunction compared with wild type, whereas AdipoR2-deficient mice were protected from diet-induced weight gain and metabolic perturbations. These data show that AdipoR2, but not AdipoR1, is functionally important in an in vivo model of ischemia-induced revascularization and that its expression is essential for the revascularization actions of adiponectin. These data also show that, in contrast to revascularization responses, AdipoR1, but not AdipoR2 deficiency, leads to diet-induced metabolic dysfunction, revealing that these receptors have highly divergent roles in vascular and metabolic homeostasis.	[Parker-Duffen, Jennifer L.; Nakamura, Kazuto; Silver, Marcy; Zuriaga, Maria A.; MacLauchlan, Susan; Aprahamian, Tamar R.; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Parker-Duffen, Jennifer L.; Walsh, Kenneth] Boston Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02118 USA; [Aprahamian, Tamar R.] Boston Univ, Sch Med, Dept Med, Renal Sect, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Walsh, K (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	Zuriaga, María/P-4616-2017	Zuriaga, María/0000-0003-0422-2965; MacLauchlan, Susan/0000-0001-9689-0826; Aprahamian, Tamar/0000-0001-9295-5995	National Institutes of Health [AG34972, HL81587, HL68758, K01 AR055965-02]; Pre-doctoral Training Grant in Cardiovascular Biology [HL007969]; Pre-doctoral Training Grant in Biomolecular Pharmacology [GM008541]; T32 Training Grant [HL007224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224, R01HL126141, T32HL007969, P01HL068758, P01HL081587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR055965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pre-doctoral Training Grant in Cardiovascular Biology; Pre-doctoral Training Grant in Biomolecular Pharmacology; T32 Training Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG34972, HL81587, and HL68758 (to K. W.), K01 AR055965-02 (to T. A.), and by Pre-doctoral Training Grants in Cardiovascular Biology HL007969 and Biomolecular Pharmacology GM008541 (to J. L. P.-D.).; A postdoctoral fellow on T32 Training Grant HL007224 (to the Whitaker Cardiovascular Institute).	Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Aprahamian T, 2009, J IMMUNOL, V182, P340, DOI 10.4049/jimmunol.182.1.340; Aprahamian TR, 2013, METABOLISM, V62, P1730, DOI 10.1016/j.metabol.2013.07.010; Bjursell M, 2007, DIABETES, V56, P583, DOI 10.2337/db06-1432; Cheng KKY, 2007, DIABETES, V56, P1387, DOI 10.2337/db06-1580; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Ding M, 2012, J MOL CELL CARDIOL, V52, P474, DOI 10.1016/j.yjmcc.2011.09.008; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Fasshauer M, 2004, FEBS LETT, V558, P27, DOI 10.1016/S0014-5793(03)01525-4; Higuchi A, 2010, ARTERIOSCL THROM VAS, V30, P46, DOI 10.1161/ATVBAHA.109.198465; Higuchi A, 2009, CIRC RES, V104, P1058, DOI 10.1161/CIRCRESAHA.109.194506; Ho DY, 2011, CIRCULATION, V124, P2303, DOI 10.1161/CIRCULATIONAHA.111.045187; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kondo M, 2009, J BIOL CHEM, V284, P1718, DOI 10.1074/jbc.M805301200; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu YF, 2007, ENDOCRINOLOGY, V148, P683, DOI 10.1210/en.2006-0708; Luo NL, 2013, ATHEROSCLEROSIS, V228, P124, DOI 10.1016/j.atherosclerosis.2013.02.026; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Ouchi N, 2003, HYPERTENSION, V42, P231, DOI 10.1161/01.HYP.0000083488.67550.B8; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; Patel SA, 2012, ENDOCRINOLOGY, V153, P5231, DOI 10.1210/en.2012-1368; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Rizvi YQ, 2013, VASC PHARMACOL, V59, P144, DOI 10.1016/j.vph.2013.09.001; Satoh H, 2005, DIABETES, V54, P1304, DOI 10.2337/diabetes.54.5.1304; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2008, FEBS LETT, V582, P1607, DOI 10.1016/j.febslet.2008.04.006; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Singh S, 2007, JAMA-J AM MED ASSOC, V298, P1189, DOI 10.1001/jama.298.10.1189; Wang YJ, 2014, CIRC RES, V114, P792, DOI 10.1161/CIRCRESAHA.114.302439; Wang YJ, 2012, ARTERIOSCL THROM VAS, V32, P934, DOI 10.1161/ATVBAHA.111.242164; Wong WT, 2011, CELL METAB, V14, P104, DOI 10.1016/j.cmet.2011.05.009; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang WS, 2002, DIABETES CARE, V25, P376, DOI 10.2337/diacare.25.2.376; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Zbinden S, 2007, AM J PHYSIOL-HEART C, V292, pH1891, DOI 10.1152/ajpheart.00537.2006; Zhang G, 2004, GENE THER, V11, P675, DOI 10.1038/sj.gt.3302210; Zhang P, 2009, ARTERIOSCL THROM VAS, V29, P67, DOI 10.1161/ATVBAHA.108.178061; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	56	25	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16200	16213		10.1074/jbc.M114.548115	http://dx.doi.org/10.1074/jbc.M114.548115			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742672	hybrid, Green Published			2022-12-25	WOS:000337965700025
J	Akazawa-Ogawa, Y; Takashima, M; Lee, YH; Ikegami, T; Goto, Y; Uegaki, K; Hagihara, Y				Akazawa-Ogawa, Yoko; Takashima, Mizuki; Lee, Young-Ho; Ikegami, Takahisa; Goto, Yuji; Uegaki, Koichi; Hagihara, Yoshihisa			Heat-induced Irreversible Denaturation of the Camelid Single Domain VHH Antibody Is Governed by Chemical Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody; Antibody Engineering; Protein Aggregation; Protein Chemical Modification; Protein Denaturation; Protein Folding; Protein Stability	DISULFIDE BOND; NONENZYMATIC DEAMIDATION; BIOPHYSICAL PROPERTIES; PROTEIN AGGREGATION; INACTIVATION; FRAGMENTS; IMMUNOGLOBULIN; ASPARAGINYL; RESIDUES; STABILIZATION	The variable domain of camelid heavy chain antibody (VHH) is highly heat-resistant and is therefore ideal for many applications. Although understanding the process of heat-induced irreversible denaturation is essential to improve the efficacy of VHH, its inactivation mechanism remains unclear. Here, we showed that chemical modifications predominantly governed the irreversible denaturation of VHH at high temperatures. After heat treatment, the activity of VHH was dependent only on the incubation time at 90 degrees C and was insensitive to the number of heating (90 degrees C)-cooling (20 degrees C) cycles, indicating a negligible role for folding/unfolding intermediates on permanent denaturation. The residual activity was independent of concentration; therefore, VHH lost its activity in a unimolecular manner, not by aggregation. A VHH mutant lacking Asn, which is susceptible to chemical modifications, had significantly higher heat resistance than did the wild-type protein, indicating the importance of chemical modifications to VHH denaturation.	[Akazawa-Ogawa, Yoko; Takashima, Mizuki; Uegaki, Koichi; Hagihara, Yoshihisa] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan; [Lee, Young-Ho; Ikegami, Takahisa; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Osaka University	Uegaki, K (corresponding author), Natl Inst Adv Ind Sci & Technol, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	k-uegaki@aist.go.jp; hagihara-kappael@aist.go.jp	HAGIHARA, Yoshihisa/K-4996-2016; Ikegami, Takahisa/I-9626-2017; Akazawa-Ogawa, Yoko/L-9333-2018	HAGIHARA, Yoshihisa/0000-0002-5980-1764; Ikegami, Takahisa/0000-0002-1429-1844; Akazawa-Ogawa, Yoko/0000-0001-5919-3036	National Institutes of Health from the NIGMS [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [25870407] Funding Source: KAKEN	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Lilian Kaede Komaba for critical reading of the manuscript. A part of the molecular graphics and analyses was performed with the UCSF Chimera package. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41-GM103311 from the NIGMS).	AHERN TJ, 1987, P NATL ACAD SCI USA, V84, P675, DOI 10.1073/pnas.84.3.675; AHERN TJ, 1985, SCIENCE, V228, P1280, DOI 10.1126/science.4001942; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; DAVIES RB, 1974, BIOCHEM J, V143, P115, DOI 10.1042/bj1430115; Demarest SJ, 2008, CURR OPIN DRUG DISC, V11, P675; Doering DS, 1996, BIOCHEMISTRY-US, V35, P12677, DOI 10.1021/bi9615699; Dolk E, 2005, PROTEINS, V59, P555, DOI 10.1002/prot.20378; DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Dunkelberger EB, 2012, J AM CHEM SOC, V134, P12658, DOI 10.1021/ja3039486; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Ewert S, 2002, BIOCHEMISTRY-US, V41, P3628, DOI 10.1021/bi011239a; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Frenken LGJ, 2000, J BIOTECHNOL, V78, P11, DOI 10.1016/S0168-1656(99)00228-X; GEIGER T, 1987, J BIOL CHEM, V262, P785; Hagihara Y, 2005, J BIOL CHEM, V280, P24752, DOI 10.1074/jbc.M503963200; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Hagihara Yoshihisa, 2012, Methods Mol Biol, V911, P399, DOI 10.1007/978-1-61779-968-6_24; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanson SRA, 2000, EXP EYE RES, V71, P195, DOI 10.1006/exer.2000.0868; HOROWITZ PM, 1993, ACS SYM SER, V516, P167; Jahn TR, 2008, ARCH BIOCHEM BIOPHYS, V469, P100, DOI 10.1016/j.abb.2007.05.015; Kabat EA, 1991, NIH PUBLICATION; Kim DY, 2012, PROTEIN ENG DES SEL, V25, P581, DOI 10.1093/protein/gzs055; KLIBANOV AM, 1983, ADV APPL MICROBIOL, V29, P1, DOI 10.1016/S0065-2164(08)70352-6; Ladenson RC, 2006, ANAL CHEM, V78, P4501, DOI 10.1021/ac058044j; Le Bon C, 1999, MACROMOLECULES, V32, P6120, DOI 10.1021/ma9905775; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Li B, 2003, J AM CHEM SOC, V125, P11486, DOI 10.1021/ja0360992; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Miller BR, 2010, PROTEIN ENG DES SEL, V23, P549, DOI 10.1093/protein/gzq028; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nilsson MR, 2002, PROTEIN SCI, V11, P342, DOI 10.1110/ps.48702; Omidfar K, 2007, BIOTECHNOL APPL BIOC, V46, P41, DOI 10.1042/BA20060104; PATEL K, 1990, PHARMACEUT RES, V7, P787, DOI 10.1023/A:1015999012852; Perez JMJ, 2001, BIOCHEMISTRY-US, V40, P74, DOI 10.1021/bi0009082; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Rodriguez-Rodriguez ER, 2012, J MOL BIOL, V423, P337, DOI 10.1016/j.jmb.2012.07.007; Renisio JG, 2002, PROTEINS, V47, P546, DOI 10.1002/prot.10096; Riha WE, 1996, CRIT REV FOOD SCI, V36, P225, DOI 10.1080/10408399609527724; Rombouts I, 2011, J AGR FOOD CHEM, V59, P1236, DOI 10.1021/jf103579u; Saerens D, 2005, J MOL BIOL, V352, P597, DOI 10.1016/j.jmb.2005.07.038; Saerens D, 2008, SENSORS-BASEL, V8, P4669, DOI 10.3390/s8084669; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Tomita S, 2011, BIOTECHNOL PROGR, V27, P855, DOI 10.1002/btpr.597; TOMIZAWA H, 1994, BIOCHEMISTRY-US, V33, P13032, DOI 10.1021/bi00248a012; van Boekel MAJS, 1999, INT DAIRY J, V9, P237, DOI 10.1016/S0958-6946(99)00068-0; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; Verma A, 2013, INFECT IMMUN, V81, P278, DOI 10.1128/IAI.00863-12; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Weatherill EE, 2012, PROTEIN ENG DES SEL, V25, P321, DOI 10.1093/protein/gzs021; Weijers M, 2003, PROTEIN SCI, V12, P2693, DOI 10.1110/ps.03242803; Wilmarth PA, 2006, J PROTEOME RES, V5, P2554, DOI 10.1021/pr050473a; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; WRIGHT HT, 1991, CRIT REV BIOCHEM MOL, V26, P1, DOI 10.1080/10409230490440532; ZALE SE, 1983, BIOTECHNOL BIOENG, V25, P2221, DOI 10.1002/bit.260250908; ZALE SE, 1986, BIOCHEMISTRY-US, V25, P5432, DOI 10.1021/bi00367a014; ZHAO MX, 1989, BIOORG CHEM, V17, P36, DOI 10.1016/0045-2068(89)90005-9; Zheng JY, 2006, INT J PHARM, V308, P46, DOI 10.1016/j.ijpharm.2005.10.024; Zhou YF, 2001, PROTEIN SCI, V10, P378, DOI 10.1110/ps.34201	64	27	27	8	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15666	15679		10.1074/jbc.M113.534222	http://dx.doi.org/10.1074/jbc.M113.534222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24739391	Green Published, hybrid			2022-12-25	WOS:000337465400048
J	Ghil, S; McCoy, KL; Hepler, JR				Ghil, Sungho; McCoy, Kelly L.; Hepler, John R.			Regulator of G Protein Signaling 2 (RGS2) and RGS4 Form Distinct G Protein-Dependent Complexes with Protease Activated-Receptor 1 (PAR1) in Live Cells	PLOS ONE			English	Article							COUPLED RECEPTORS; ALPHA; G-ALPHA(I1); SELECTIVITY; MECHANISM; SUBUNITS; ROLES	Protease-activated receptor 1 (PAR1) is a G-protein coupled receptor (GPCR) that is activated by natural proteases to regulate many physiological actions. We previously reported that PAR1 couples to G(i), G(q) and G(12) to activate linked signaling pathways. Regulators of G protein signaling (RGS) proteins serve as GTPase activating proteins to inhibit GPCR/G protein signaling. Some RGS proteins interact directly with certain GPCRs to modulate their signals, though cellular mechanisms dictating selective RGS/GPCR coupling are poorly understood. Here, using bioluminescence resonance energy transfer (BRET), we tested whether RGS2 and RGS4 bind to PAR1 in live COS-7 cells to regulate PAR1/G alpha-mediated signaling. We report that PAR1 selectively interacts with either RGS2 or RGS4 in a G protein-dependent manner. Very little BRET activity is observed between PAR1-Venus (PAR1-Ven) and either RGS2-Luciferase (RGS2-Luc) or RGS4-Luc in the absence of G alpha. However, in the presence of specific G alpha subunits, BRET activity was markedly enhanced between PAR1-RGS2 by G alpha(q/11), and PAR1-RGS4 by G alpha(o), but not by other G alpha subunits. G alpha(q/11)-YFP/RGS2-Luc BRET activity is promoted by PAR1 and is markedly enhanced by agonist (TFLLR) stimulation. However, PAR1-Ven/RGS-Luc BRET activity was blocked by a PAR1 mutant (R205A) that eliminates PAR1-G(q/11) coupling. The purified intracellular third loop of PAR1 binds directly to purified His-RGS2 or His-RGS4. In cells, RGS2 and RGS4 inhibited PAR1/G alpha-mediated calcium and MAPK/ERK signaling, respectively, but not RhoA signaling. Our findings indicate that RGS2 and RGS4 interact directly with PAR1 in G alpha-dependent manner to modulate PAR1/G alpha-mediated signaling, and highlight a cellular mechanism for selective GPCR/G protein/RGS coupling.	[Ghil, Sungho] Kyonggi Univ, Dept Life Sci, Suwon, South Korea; [McCoy, Kelly L.; Hepler, John R.] Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, Atlanta, GA 30322 USA	Kyonggi University; Emory University	Hepler, JR (corresponding author), Emory Univ, Sch Med, Rollins Res Ctr, Dept Pharmacol, Atlanta, GA 30322 USA.	jhepler@emory.edu			American Heart Association [0715465B]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [NRF-2012R1A1A2005207]; National Institutes of Health [R01NS37112, R01NS049195]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037112, R01NS049195] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by an American Heart Association Pre-doctoral Fellowship Grant 0715465B (KLM), by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (NRF-2012R1A1A2005207 to SG), and by grants from the National Institutes of Health (R01NS37112 and R01NS049195 awarded to JRH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Bernstein Leah S., 2003, V237, P195; Bockaert J, 2004, PHARMACOL THERAPEUT, V103, P203, DOI 10.1016/j.pharmthera.2004.06.004; BUHL AM, 1995, J BIOL CHEM, V270, P24631, DOI 10.1074/jbc.270.42.24631; Chen BX, 2014, J BIOL CHEM, V289, P1580, DOI 10.1074/jbc.M113.528273; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Day PW, 2004, METHOD ENZYMOL, V390, P295; Erdely HA, 2004, EUR J NEUROSCI, V19, P3125, DOI 10.1111/j.0953-816X.2004.03364.x; Georgoussi Z, 2006, CELL SIGNAL, V18, P771, DOI 10.1016/j.cellsig.2005.07.003; Ghil S, 2006, P NATL ACAD SCI USA, V103, P19158, DOI 10.1073/pnas.0609392103; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Hague C, 2005, J BIOL CHEM, V280, P27289, DOI 10.1074/jbc.M502365200; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Hollenberg MD, 2002, PHARMACOL REV, V54, P203, DOI 10.1124/pr.54.2.203; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Kehrl JH, 2002, INT J BIOCHEM CELL B, V34, P432, DOI 10.1016/S1357-2725(01)00141-8; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; McCoy KL, 2012, CELL SIGNAL, V24, P1351, DOI 10.1016/j.cellsig.2012.01.011; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; Mccoy KL, 2010, MOL PHARMACOL, V77, P1005, DOI 10.1124/mol.109.062018; Neitzel KL, 2006, SEMIN CELL DEV BIOL, V17, P383, DOI 10.1016/j.semcdb.2006.03.002; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Salim S, 2003, J BIOL CHEM, V278, P15842, DOI 10.1074/jbc.M210663200; Saugstad JA, 1998, J NEUROSCI, V18, P905; STRITTMATTER SM, 1994, J NEUROSCI, V14, P2327; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vellano CP, 2011, J BIOL CHEM, V286, P38659, DOI 10.1074/jbc.M111.274928; Verrall S, 1997, J BIOL CHEM, V272, P6898, DOI 10.1074/jbc.272.11.6898; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Zhang SA, 1998, J MOL CELL CARDIOL, V30, P269, DOI 10.1006/jmcc.1997.0591; Zhong HL, 2001, J PHARMACOL EXP THER, V297, P837	41	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95355	10.1371/journal.pone.0095355	http://dx.doi.org/10.1371/journal.pone.0095355			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743392	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100109
J	Liu, JW; Li, W; Wang, SW; Wu, YD; Li, ZL; Wang, WJ; Liu, RM; Ou, JS; Zhang, CX; Wang, SM				Liu, Jiawei; Li, Wen; Wang, Siwen; Wu, Yidan; Li, Zilun; Wang, Wenjian; Liu, Ruiming; Ou, Jingsong; Zhang, Chunxiang; Wang, Shenming			MiR-142-3p Attenuates the Migration of CD4(+) T Cells through Regulating Actin Cytoskeleton via RAC1 and ROCK2 in Arteriosclerosis Obliterans	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; ACTIVATION; ATHEROSCLEROSIS; EXPRESSION; REORGANIZATION; CHEMOKINE; PATHWAY	The migration of CD4(+) T cells plays an important role in arteriosclerosis obliterans (ASO). However, the molecular mechanisms involved in CD4(+) T cell migration are still unclear. The current study is aimed to determine the expression change of miR-142-3p in CD4(+) T cells from patients with ASO and investigate its role in CD4(+) T cell migration as well the potential mechanisms involved. We identified by qRT-PCR and in situ hybridization that the expression of miR-142-3p in CD4(+) T cells was significantly down-regulated in patients with ASO. Chemokine (C-X-C motif) ligand 12 (CXCL12), a common inflammatory chemokine under the ASO condition, was able to down-regulate the expression of miR-142-3p in cultured CD4(+) T cells. Up-regulation of miR-142-3p by lentivirus-mediated gene transfer had a strong inhibitory effect on CD4(+) T cell migration both in cultured human cells in vitro and in mouse aortas and spleens in vivo. RAC1 and ROCK2 were identified to be the direct target genes in human CD4(+) T cells, which are further confirmed by dual luciferase assay. MiR-142-3p had strong regulatory effects on actin cytoskeleton as shown by the actin staining in CD4(+) T cells. The results suggest that the expression of miR-142-3p is down-regulated in CD4(+) T cells from patients with ASO. The down-regulation of miR-142-3p could increase the migration of CD4(+) T cells to the vascular walls by regulation of actin cytoskeleton via its target genes, RAC1 and ROCK2.	[Liu, Jiawei; Wang, Siwen; Wu, Yidan; Li, Zilun; Wang, Wenjian; Liu, Ruiming; Ou, Jingsong; Wang, Shenming] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Vasc Surg, Guangzhou 510275, Guangdong, Peoples R China; [Li, Wen] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Gen Surg, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Chunxiang] Rush Univ, Rush Med Coll, Dept Pharmacol, Cardiovasc Res Ctr, Chicago, IL 60612 USA	Sun Yat Sen University; Sun Yat Sen University; Rush University	Zhang, CX (corresponding author), Rush Univ, Rush Med Coll, Dept Pharmacol, Cardiovasc Res Ctr, Chicago, IL 60612 USA.	chunxiang_zhang@rush.edu; shenmingwang@hotmail.com		zhang, chunxiang/0000-0001-8303-6495	National Natural Science Foundation of China [81270378]; Ministry of Health [254003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Health	This research was supported by the National Natural Science Foundation of China (Grant No. 81270378) and the Key Clinical Program of the Ministry of Health (Grant No. 254003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Younes S, 2000, CIRC RES, V86, P131, DOI 10.1161/01.RES.86.2.131; Ding S, 2012, ARTHRITIS RHEUM-US, V64, P2953, DOI 10.1002/art.34505; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Fenoglio C, 2011, NEUROSCI LETT, V504, P9, DOI 10.1016/j.neulet.2011.08.021; Gallo RM, 2012, J IMMUNOL, V189, P1689, DOI 10.4049/jimmunol.1101484; Kawakami S, 2010, MICROBES ENVIRON, V25, P15, DOI 10.1264/jsme2.ME09180; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Luchtefeld M, 2010, CIRCULATION, V122, P1621, DOI 10.1161/CIRCULATIONAHA.110.956730; Maqueda A, 2006, J CELL PHYSIOL, V207, P746, DOI 10.1002/jcp.20624; Marodon G, 2003, BLOOD, V101, P3416, DOI 10.1182/blood-2002-02-0578; Mendoza L, 2013, B MATH BIOL, V75, P1012, DOI 10.1007/s11538-013-9814-9; Miki H, 2002, SEIKAGAKU, V74, P1149; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Palin AC, 2013, J IMMUNOL, V190, P2682, DOI 10.4049/jimmunol.1202534; Rossi RL, 2011, NAT IMMUNOL, V12, P796, DOI 10.1038/ni.2057; Wang M, 2011, ARTERIOSCL THROM VAS, V31, P2046, DOI 10.1161/ATVBAHA.111.229559; Wei DS, 2012, ANN BIOMED ENG, V40, P1018, DOI 10.1007/s10439-011-0486-z; Wei YY, 2013, CIRCULATION, V127, P1609, DOI 10.1161/CIRCULATIONAHA.112.000736; Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067; Zhang XP, 2013, BIOCHEM BIOPH RES CO, V431, P404, DOI 10.1016/j.bbrc.2012.12.157	21	24	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95514	10.1371/journal.pone.0095514	http://dx.doi.org/10.1371/journal.pone.0095514			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743945	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100133
J	Yang, XA; Guo, MT; Wu, YH; Wu, QH; Zhang, RD				Yang, Xunan; Guo, Mengting; Wu, Yinghai; Wu, Qunhe; Zhang, Renduo			Removal of Emulsified Oil from Water by Fruiting Bodies of Macro-Fungus (Auricularia polytricha)	PLOS ONE			English	Article							WASTE-WATER; AQUEOUS-SOLUTIONS; CRUDE-OIL; ADSORPTION; MUSHROOMS; CHITOSAN; SORPTION; BIOSORPTION; KINETICS; SORBENT	The aim of this study was to investigate the feasibility of utilizing the fruiting bodies of a jelly macro-fungus Auricularia polytricha as adsorbents to remove emulsified oil from water. The effects of several factors, including temperature, initial pH, agitation speed, and adsorbent dosage, were taken into account. Results showed that the optimized conditions for adsorption of A. polytricha were a temperature of 35 degrees C, pH of 7.5, and agitation speed of 100 rpm. The adsorption kinetics were characterized by the pseudo-first order model, which showed the adsorption to be a fast physical process. The Langmuir-Freundlich isotherm described the adsorption very well and predicted the maximum adsorption capacity of 398 mg g(-1), under optimized conditions. As illustrated by scanning electron micrographs, the oil particles were adsorbed onto the hairs covering the bottom surface and could be desorbed by normal temperature volatilization. The material could be used as an emulsified oil adsorbent at least three times, retaining more than 95% of the maximum adsorption capacity. The results demonstrated that the fruiting bodies of A. polytricha can be a useful adsorbent to remove emulsified oil from water.	[Yang, Xunan; Guo, Mengting; Wu, Yinghai; Wu, Qunhe; Zhang, Renduo] Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangdong Prov Key Lab Environm Pollut Control &, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Yinghai] Minist Environm Protect, South China Inst Environm Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Wu, QH (corresponding author), Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangdong Prov Key Lab Environm Pollut Control &, Guangzhou 510275, Guangdong, Peoples R China.	eeswqh@mail.sysu.edu.cn; zhangrd@mail.sysu.edu.cn	Yang, Xunan/B-3454-2018	Yang, Xunan/0000-0003-1390-3033	Sun Yat-sen University; Chinese National Natural Science Foundation [51039007, 51179212]	Sun Yat-sen University; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Innovative doctorial program of Sun Yat-sen University (2013, http://graduate.sysu.edu.cn) and partly supported by grants from the Chinese National Natural Science Foundation (Nos. 51039007 and 51179212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad AL, 2005, WATER RES, V39, P2483, DOI 10.1016/j.watres.2005.03.035; Atun G, 1996, J ENVIRON SCI HEAL A, V31, P2055, DOI 10.1080/10934529609376474; Biswas N, 1973, THESIS U OTTAWA OTTA; Chi FH, 2006, J POLYM ENVIRON, V14, P411, DOI 10.1007/s10924-006-0027-2; Deschamps G, 2003, ENVIRON SCI TECHNOL, V37, P1013, DOI 10.1021/es020061s; Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385; Galli E, 2003, LETT APPL MICROBIOL, V37, P133, DOI 10.1046/j.1472-765X.2003.01354.x; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Huang HW, 2012, APPL MICROBIOL BIOT, V96, P829, DOI 10.1007/s00253-011-3846-6; Ibrahim S, 2010, BIOCHEM ENG J, V49, P78, DOI 10.1016/j.bej.2009.11.013; Ibrahim S, 2009, BIORESOURCE TECHNOL, V100, P5744, DOI 10.1016/j.biortech.2009.06.070; Langergren S., 1898, SVEN VETENSKAPSAKAD, V24, P1, DOI DOI 10.1007/BF01501332; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Mathialagan T, 2003, WATER QUAL RES J CAN, V38, P499, DOI 10.2166/wqrj.2003.032; MURALEEDHARAN TR, 1995, APPL ENVIRON MICROB, V61, P3507, DOI 10.1128/AEM.61.9.3507-3508.1995; Mysore D, 2005, WATER RES, V39, P2643, DOI 10.1016/j.watres.2005.04.034; Pan R, 2010, APPL MICROBIOL BIOT, V88, P997, DOI 10.1007/s00253-010-2821-y; Rajakovic V, 2007, J HAZARD MATER, V143, P494, DOI 10.1016/j.jhazmat.2006.09.060; Rajakovic-Ognjanovic V, 2008, J HAZARD MATER, V154, P558, DOI 10.1016/j.jhazmat.2007.10.066; Rao Ravella Sreenivas, 2008, Biotechnology Journal, V3, P510, DOI 10.1002/biot.200700201; SARKAR D, 1993, J COLLOID INTERF SCI, V157, P219, DOI 10.1006/jcis.1993.1179; Sidik SM, 2012, CHEM ENG J, V203, P9, DOI 10.1016/j.cej.2012.06.132; SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922; Sokker HH, 2011, J HAZARD MATER, V190, P359, DOI 10.1016/j.jhazmat.2011.03.055; Srinivasan A, 2010, BIORESOURCE TECHNOL, V101, P6594, DOI 10.1016/j.biortech.2010.03.079; Srinivasan A, 2010, J HAZARD MATER, V175, P695, DOI 10.1016/j.jhazmat.2009.10.065; STANG M, 1994, CHEM ENG PROCESS, V33, P307, DOI 10.1016/0255-2701(94)02000-0; Vimala R, 2009, J HAZARD MATER, V168, P376, DOI 10.1016/j.jhazmat.2009.02.062; Wahi R, 2013, SEP PURIF TECHNOL, V113, P51, DOI 10.1016/j.seppur.2013.04.015; Wang JL, 2009, BIOTECHNOL ADV, V27, P195, DOI 10.1016/j.biotechadv.2008.11.002; Yang YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033551; Zulfadhly Z, 2001, ENVIRON POLLUT, V112, P463, DOI 10.1016/S0269-7491(00)00136-6	32	18	20	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95162	10.1371/journal.pone.0095162	http://dx.doi.org/10.1371/journal.pone.0095162			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743498	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100078
J	Carita, RAC; Greco, CC; Denadai, BS				Correa Carita, Renato Aparecido; Greco, Camila Coelho; Denadai, Benedito Sergio			The Positive Effects of Priming Exercise on Oxygen Uptake Kinetics and High-Intensity Exercise Performance Are Not Magnified by a Fast-Start Pacing Strategy in Trained Cyclists	PLOS ONE			English	Article							O-2 UPTAKE; DOTO(2) KINETICS; SLOW COMPONENT; POWER; DURATION; SUBSEQUENT; RESPONSES; HUMANS; TIME	The purpose of this study was to determine both the independent and additive effects of prior heavy-intensity exercise and pacing strategies on the VO2 kinetics and performance during high-intensity exercise. Fourteen endurance cyclists (VO(2)max -62.8 +/- 8.5 mL.kg(-1).min(-1)) volunteered to participate in the present study with the following protocols: 1) incremental test to determine lactate threshold and VO(2)max; 2) four maximal constant-load tests to estimate critical power; 3) six bouts of exercise, using a fast-start (FS), even-start (ES) or slow-start (SS) pacing strategy, with and without a preceding heavy-intensity exercise session (i.e., 90% critical power). In all conditions, the subjects completed an all-out sprint during the final 60 s of the test as a measure of the performance. For the control condition, the mean response time was significantly shorter (p<0.001) for FS (27 +/- 4 s) than for ES (32 +/- 5 s) and SS (32 +/- 6 s). After the prior exercise, the mean response time was not significantly different among the paced conditions (FS=24 +/- 5 s; ES=25 +/- 5 s; SS=26 +/- 5 s). The end-sprint performance (i.e., mean power output) was only improved (similar to 3.2%, p<0.01) by prior exercise. Thus, in trained endurance cyclists, an FS pacing strategy does not magnify the positive effects of priming exercise on the overall VO2 kinetics and short-term high-intensity performance.	[Correa Carita, Renato Aparecido; Greco, Camila Coelho; Denadai, Benedito Sergio] Univ Estadual Paulista, IB, Human Performance Lab, Sao Paulo, Brazil	Universidade Estadual Paulista	Greco, CC (corresponding author), Univ Estadual Paulista, IB, Human Performance Lab, Sao Paulo, Brazil.	grecocc@rc.unesp.br	Denadai, Benedito S/A-7263-2012; Greco, Camila/F-8051-2012	Denadai, Benedito S/0000-0003-0775-1889; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey SJ, 2011, MED SCI SPORT EXER, V43, P457, DOI 10.1249/MSS.0b013e3181ef3dce; Bailey SJ, 2009, J APPL PHYSIOL, V107, P1743, DOI 10.1152/japplphysiol.00810.2009; Barker AR, 2010, J APPL PHYSIOL, V109, P491, DOI 10.1152/japplphysiol.00139.2010; Bishop D, 2002, MED SCI SPORT EXER, V34, P1041, DOI 10.1097/00005768-200206000-00022; Brown MR, 2010, J SCI MED SPORT, V13, P613, DOI 10.1016/j.jsams.2010.01.002; Bull AJ, 2000, MED SCI SPORT EXER, V32, P526, DOI 10.1097/00005768-200002000-00040; Burnley M, 2005, MED SCI SPORT EXER, V37, P838, DOI 10.1249/01.MSS.0000162617.18250.77; Burnley M, 2011, MED SCI SPORT EXER, V43, P2171, DOI 10.1249/MSS.0b013e31821ff26d; Campbell-O'Sullivan SP, 2002, J PHYSIOL-LONDON, V538, P931, DOI 10.1113/jphysiol.2001.013238; Caputo F, 2008, EUR J APPL PHYSIOL, V103, P47, DOI 10.1007/s00421-008-0670-5; Carter H, 2000, J APPL PHYSIOL, V89, P899, DOI 10.1152/jappl.2000.89.3.899; FOSTER C, 1993, MED SCI SPORT EXER, V25, P383; Foster C, 2003, MED SCI SPORT EXER, V35, P826, DOI 10.1249/01.MSS.0000065001.17658.68; Gaesser G A, 1996, Exerc Sport Sci Rev, V24, P35; Gerbino A, 1996, J APPL PHYSIOL, V80, P99, DOI 10.1152/jappl.1996.80.1.99; HILL DW, 1994, J SPORT MED PHYS FIT, V34, P23; Hill DW, 2002, MED SCI SPORT EXER, V34, P709, DOI 10.1097/00005768-200204000-00023; Jones AM, 2008, SCAND J MED SCI SPOR, V18, P615, DOI 10.1111/j.1600-0838.2007.00725.x; Jones AM, 2003, MED SCI SPORT EXER, V35, P2085, DOI 10.1249/01.MSS.0000099108.55944.C4; Jones AM, 2003, SPORTS MED, V33, P949, DOI 10.2165/00007256-200333130-00002; Jones AM, 2011, MED SCI SPORT EXER, V43, P2046, DOI 10.1249/MSS.0b013e31821fcfc1; Jones AM, 2010, MED SCI SPORT EXER, V42, P1876, DOI 10.1249/MSS.0b013e3181d9cf7f; LAMARRA N, 1987, J APPL PHYSIOL, V62, P2003, DOI 10.1152/jappl.1987.62.5.2003; MacDonald M, 1997, J APPL PHYSIOL, V83, P1318, DOI 10.1152/jappl.1997.83.4.1318; Messonnier L, 2006, INT J SPORTS MED, V27, P60, DOI 10.1055/s-2005-837507; Noakes TD, 2005, BRIT J SPORT MED, V39, P120, DOI 10.1136/bjsm.2003.010330; POOLE DC, 1988, ERGONOMICS, V31, P1265, DOI 10.1080/00140138808966766; Rossiter HB, 2002, J PHYSIOL-LONDON, V541, P991, DOI 10.1113/jphysiol.2001.012910; Rossiter HB, 2001, J PHYSIOL-LONDON, V537, P291, DOI 10.1111/j.1469-7793.2001.0291k.x; Spencer MR, 2001, MED SCI SPORT EXER, V33, P157; Timmons JA, 1997, AM J PHYSIOL-ENDOC M, V273, pE233, DOI 10.1152/ajpendo.1997.273.2.E233; Vanhatalo A, 2011, AM J PHYSIOL-REG I, V300, pR700, DOI 10.1152/ajpregu.00761.2010; Vanhatalo A, 2010, MED SCI SPORT EXER, V42, P563, DOI 10.1249/MSS.0b013e3181b71a4a	33	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95202	10.1371/journal.pone.0095202	http://dx.doi.org/10.1371/journal.pone.0095202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740278	gold, Green Submitted, Green Published			2022-12-25	WOS:000336863900115
J	Durisko, Z; Kemp, R; Mubasher, R; Dukas, R				Durisko, Zachary; Kemp, Rebecca; Mubasher, Rameeshay; Dukas, Reuven			Dynamics of Social Behavior in Fruit Fly Larvae	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; AGGREGATION; COMMUNITIES; PARASITOIDS; STRATEGIES; PHEROMONE; SIMULANS; BRAIN; MODEL; LIFE	We quantified the extent and dynamics of social interactions among fruit fly larvae over time. Both a wild-type laboratory population and a recently-caught strain of larvae spontaneously formed social foraging groups. Levels of aggregation initially increased during larval development and then declined with the wandering stage before pupation. We show that larvae aggregated more on hard than soft food, and more at sites where we had previously broken the surface of the food. Groups of larvae initiated burrowing sooner than solitary individuals, indicating that one potential benefit of larval aggregations is an improved ability to dig and burrow into the food substrate. We also show that two closely related species, D. melanogaster and D. simulans, differ in their tendency to aggregate, which may reflect different evolutionary histories. Our protocol for quantifying social behavior in larvae uncovered robust social aggregations in this simple model, which is highly amenable to neurogenetic analyses, and can serve for future research into the mechanisms and evolution of social behavior.	[Durisko, Zachary; Kemp, Rebecca; Mubasher, Rameeshay; Dukas, Reuven] McMaster Univ, Anim Behav Grp, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada; [Durisko, Zachary] Ctr Addict & Mental Hlth, Social Aetiol Mental Illness SAMI CIHR Training P, Toronto, ON, Canada	McMaster University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Durisko, Z (corresponding author), McMaster Univ, Anim Behav Grp, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada.	duriskzt@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ontario Innovation Trust; McMaster School of Graduate Studies	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust; McMaster School of Graduate Studies	This work was supported by the Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation, and Ontario Innovation Trust (RD) and McMaster School of Graduate Studies (ZD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W.C, 1931, ANIMAL AGGREGATION S; Allee WC, 1927, Q REV BIOL, V2, P367, DOI 10.1086/394281; Ardekani R, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0547; Ashburner M., 1989, DROSOPHILA LAB HDB; BARKER JSF, 1971, OECOLOGIA, V8, P139, DOI 10.1007/BF00345810; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Beltrami M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039393; BERTHOLF L. M., 1932, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGL PHYSIOL, V18, P32; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; CARTON Y, 1992, J INSECT BEHAV, V5, P161, DOI 10.1007/BF01049287; CARTON Y, 1985, BEHAV GENET, V15, P143, DOI 10.1007/BF01065895; Carton Y., 1986, GENETICS BIOL DROSOP; Costa J., 2006, OTHER INSECT SOC; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Durisko Z, 2014, J EXP BIOL, V217, P1193, DOI 10.1242/jeb.097683; Durisko Z, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1398; Dweck HKM, 2013, CURR BIOL, V23, P2472, DOI 10.1016/j.cub.2013.10.047; Fitzgerald TD, 1999, INFORMATION PROCESSING IN SOCIAL INSECTS, P379; FITZGERALD TD, 1976, SCIENCE, V194, P961, DOI 10.1126/science.982055; FITZGERALD TD, 1995, TENT CATERPILLARS; Fleury F, 2004, GENETICA, V120, P181, DOI 10.1023/B:GENE.0000017640.78087.9e; Foucaud J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0588; Fraenkel GS, 1961, ORIENTATION ANIMALS; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; Greenspan R.J., 2004, FLY PUSHING THEORY P; Huser A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047518; IBM Corp, 2011, IBM SPSS STAT WIND V; Iyengar BG, 2011, GENES BRAIN BEHAV, V10, P883, DOI 10.1111/j.1601-183X.2011.00729.x; Justice ED, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2174; Krebs C. J., 1999, ECOLOGICAL METHODOLO; Lefevre T, 2012, BIOL LETTERS, V8, P230, DOI 10.1098/rsbl.2011.0725; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; PARSONS PA, 1975, Q REV BIOL, V50, P151, DOI 10.1086/408437; Powell J. R., 1997, PROGR PROSPECTS EVOL; Reaume CJ, 2006, CURR BIOL, V16, pR623, DOI 10.1016/j.cub.2006.07.042; Roberts D. B., 1998, DROSOPHILA PRACTICAL; Robinson GE, 2005, NAT REV GENET, V6, P257, DOI 10.1038/nrg1575; Rohlfs M, 2005, MYCOLOGIA, V97, P996, DOI 10.3852/mycologia.97.5.996; Rohlfs M, 2005, ECOL ENTOMOL, V30, P556, DOI 10.1111/j.0307-6946.2005.00722.x; Rohlfs M, 2004, OECOLOGIA, V140, P654, DOI 10.1007/s00442-004-1629-9; Rohlfs Marko, 2005, Front Zool, V2, P2, DOI 10.1186/1742-9994-2-2; Saltz JB, 2011, EVOLUTION, V65, P2325, DOI 10.1111/j.1558-5646.2011.01295.x; Schneider J, 2012, P NATL ACAD SCI USA, V109, P17174, DOI 10.1073/pnas.1121252109; Simon AF, 2012, GENES BRAIN BEHAV, V11, P243, DOI 10.1111/j.1601-183X.2011.00740.x; Sokolowski MB, 2010, NEURON, V65, P780, DOI 10.1016/j.neuron.2010.03.007; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; Toth AL, 2007, TRENDS GENET, V23, P334, DOI 10.1016/j.tig.2007.05.001; Venu I, J EXP BIOL IN PRESS; Waddell S., 2010, DROSOPHILA NEUROBIOL; Wertheim B, 2005, ANNU REV ENTOMOL, V50, P321, DOI 10.1146/annurev.ento.49.061802.123329; Wilson E.O., 1975, P1; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xu J, 2008, NAT NEUROSCI, V11, P676, DOI 10.1038/nn.2119; Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483	55	46	47	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95495	10.1371/journal.pone.0095495	http://dx.doi.org/10.1371/journal.pone.0095495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740198	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900150
J	Lemay, P; Knowler, SP; Bouasker, S; Nedelec, Y; Platt, S; Freeman, C; Child, G; Barreiro, LB; Rouleau, GA; Rusbridge, C; Kibar, Z				Lemay, Philippe; Knowler, Susan P.; Bouasker, Samir; Nedelec, Yohann; Platt, Simon; Freeman, Courtenay; Child, Georgina; Barreiro, Luis B.; Rouleau, Guy A.; Rusbridge, Clare; Kibar, Zoha			Quantitative Trait Loci (QTL) Study Identifies Novel Genomic Regions Associated to Chiari-Like Malformation in Griffon Bruxellois Dogs	PLOS ONE			English	Article							OCCIPITAL BONE HYPOPLASIA; I-MALFORMATION	Chiari-like malformation (CM) is a developmental abnormality of the craniocervical junction that is common in the Griffon Bruxellois (GB) breed with an estimated prevalence of 65%. This disease is characterized by overcrowding of the neural parenchyma at the craniocervical junction and disturbance of cerebrospinal fluid (CSF) flow. The most common clinical sign is pain either as a direct consequence of CM or neuropathic pain as a consequence of secondary syringomyelia. The etiology of CM remains unknown but genetic factors play an important role. To investigate the genetic complexity of the disease, a quantitative trait locus (QTL) approach was adopted. A total of 14 quantitative skull and atlas measurements were taken and were tested for association to CM. Six traits were found to be associated to CM and were subjected to a whole-genome association study using the Illumina canine high density bead chip in 74 GB dogs (50 affected and 24 controls). Linear and mixed regression analyses identified associated single nucleotide polymorphisms (SNPs) on 5 Canis Familiaris Autosomes (CFAs): CFA2, CFA9, CFA12, CFA14 and CFA24. A reconstructed haplotype of 0.53 Mb on CFA2 strongly associated to the height of the cranial fossa (diameter F) and an haplotype of 2.5 Mb on CFA14 associated to both the height of the rostral part of the caudal cranial fossa (AE) and the height of the brain (FG) were significantly associated to CM after 10 000 permutations strengthening their candidacy for this disease (P = 0.0421, P = 0.0094 respectively). The CFA2 QTL harbours the Sall-1 gene which is an excellent candidate since its orthologue in humans is mutated in Townes-Brocks syndrome which has previously been associated to Chiari malformation I. Our study demonstrates the implication of multiple traits in the etiology of CM and has successfully identified two new QTL associated to CM and a potential candidate gene.	[Lemay, Philippe; Bouasker, Samir; Nedelec, Yohann; Barreiro, Luis B.; Kibar, Zoha] Univ Montreal, CHU St Justine Res Ctr, Montreal, PQ, Canada; [Knowler, Susan P.; Rusbridge, Clare] Fitzpatrick Referrals, Goldaming, Surrey, England; [Platt, Simon; Freeman, Courtenay] Univ Georgia, Coll Vet Med, Dept Small Anim Med & Surg, Athens, GA USA; [Child, Georgina] Small Anim Specialist Hosp, Sydney, NSW, Australia; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Rouleau, Guy A.] McGill Univ, Montreal, PQ, Canada; [Rusbridge, Clare] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford GU2 5XH, Surrey, England	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University System of Georgia; University of Georgia; McGill University; McGill University; University of Surrey	Kibar, Z (corresponding author), Univ Montreal, CHU St Justine Res Ctr, Montreal, PQ, Canada.	zoha.kibar@recherche-ste-justine.qc.ca	Fiumefreddo, Andrea/T-2977-2019; Barreiro, Luis/I-7772-2015; Knowler, Susan P/AAL-4595-2021; Rusbridge, Clare/A-3794-2019; Rusbridge, Clare/K-6560-2019	Knowler, Susan P/0000-0001-8727-8440; Rusbridge, Clare/0000-0002-3366-2110; Rusbridge, Clare/0000-0002-3366-2110; Barreiro, Luis/0000-0001-9456-367X; Platt, Simon/0000-0002-7818-1011	Syringomyelia DNA Research Fund; Griffon Bruxellois Club 1897; For the Love of Ollie Fund; Friends of Lola Fund; Griffon Bruxellois Club of New South Wales Australia; American Kennel Club; Canine Health Foundation [1004]; Foundation of Stars; CHU Sainte-Justine Foundation; "Fonds de Recherche du Quebec Sante"; Canadian Institutes for Health Research	Syringomyelia DNA Research Fund; Griffon Bruxellois Club 1897; For the Love of Ollie Fund; Friends of Lola Fund; Griffon Bruxellois Club of New South Wales Australia; American Kennel Club; Canine Health Foundation; Foundation of Stars; CHU Sainte-Justine Foundation; "Fonds de Recherche du Quebec Sante"(Fonds de la Recherche en Sante du Quebec); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	The cost of magnetic resonance imaging were mostly funded by Syringomyelia DNA Research Fund, The Griffon Bruxellois Club 1897; For the Love of Ollie Fund, Friends of Lola Fund, The Griffon Bruxellois Club of New South Wales Australia and the American Kennel Club, Canine Health Foundation Grant #1004. PL has a scholarship award from the Foundation of Stars and CHU Sainte-Justine Foundation. ZK has a salary award from the "Fonds de Recherche du Quebec Sante". ZK and CR are funded by the Canadian Institutes for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Carrera I, 2009, AM J VET RES, V70, P340, DOI 10.2460/ajvr.70.3.340; Cross HR, 2009, J SMALL ANIM PRACT, V50, P399, DOI 10.1111/j.1748-5827.2009.00799.x; Engels S, 2000, J MED GENET, V37, P458, DOI 10.1136/jmg.37.6.458; Freedman D, 2011, J VET INTERN MED, V25; Greenlee JDW, 2002, PEDIATRICS, V110, P1212, DOI 10.1542/peds.110.6.1212; Harrison SJ, 2012, DIS MODEL MECH, V5, P351, DOI 10.1242/dmm.002873; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kohlhase J, 1993, GENE REV; Lewis T, 2010, VET J, V183, P345, DOI 10.1016/j.tvjl.2009.10.022; Mateescu RG, 2008, AM J VET RES, V69, P1294, DOI 10.2460/ajvr.69.10.1294; Meadows J, 2000, J NEUROSURG, V92, P920, DOI 10.3171/jns.2000.92.6.0920; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Nishikawa M, 1997, J NEUROSURG, V86, P40, DOI 10.3171/jns.1997.86.1.0040; Pfahler S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049782; Propst EJ, 2005, LARYNGOSCOPE, V115, P1855, DOI 10.1097/01.mlg.0000177032.98386.20; Purcell S, 2009, PLINK WHOLE GENOME D; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANG ENV STAT COMP; Rusbridge C, 2004, J VET INTERN MED, V18, P673, DOI 10.1892/0891-6640(2004)18&lt;673:IOOBHC&gt;2.0.CO;2; Rusbridge C, 2003, VET REC, V153, P107, DOI 10.1136/vr.153.4.107; Rusbridge C, 2009, J SMALL ANIM PRACT, V50, P386, DOI 10.1111/j.1748-5827.2009.00744.x; Rusbridge C, 2000, J AM ANIM HOSP ASSOC, V36, P34, DOI 10.5326/15473317-36-1-34; Schmidt MJ, 2011, VET RADIOL ULTRASOUN, V52, P436, DOI 10.1111/j.1740-8261.2011.01825.x; Schoenebeck JJ, 2013, GENETICS, V193, P317, DOI 10.1534/genetics.112.145284; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Shaw TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033660; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; VEGA A, 1990, J NEUROL SCI, V99, P137, DOI 10.1016/0022-510X(90)90150-L	29	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e89816	10.1371/journal.pone.0089816	http://dx.doi.org/10.1371/journal.pone.0089816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740420	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900003
J	Sanchez-Ruiloba, L; Aicart-Ramos, C; Garcia-Guerra, L; Pose-Utrilla, J; Rodriguez-Crespo, I; Iglesias, T				Sanchez-Ruiloba, Lucia; Aicart-Ramos, Clara; Garcia-Guerra, Lucia; Pose-Utrilla, Julia; Rodriguez-Crespo, Ignacio; Iglesias, Teresa			Protein Kinase D Interacts with Neuronal Nitric Oxide Synthase and Phosphorylates the Activatory Residue Serine(1412)	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; D-MEDIATED PHOSPHORYLATION; INDEPENDENT ENOS ACTIVATION; PDZ DOMAIN; NO SYNTHASE; C-MU; TYROSINE PHOSPHORYLATION; ENDOTHELIAL-CELLS; ELECTRON-TRANSFER; GOLGI-APPARATUS	Neuronal Nitric Oxide Synthase (nNOS) is the biosynthetic enzyme responsible for nitric oxide (center dot NO) production in muscles and in the nervous system. This constitutive enzyme, unlike its endothelial and inducible counterparts, presents an N-terminal PDZ domain known to display a preference for PDZ-binding motifs bearing acidic residues at -2 position. In a previous work, we discovered that the C-terminal end of two members of protein kinase D family (PKD1 and PKD2) constitutes a PDZ-ligand. PKD1 has been shown to regulate multiple cellular processes and, when activated, becomes autophosphorylated at Ser(916), a residue located at -2 position of its PDZ-binding motif. Since nNOS and PKD are spatially enriched in postsynaptic densities and dendrites, the main objective of our study was to determine whether PKD1 activation could result in a direct interaction with nNOS through their respective PDZ-ligand and PDZ domain, and to analyze the functional consequences of this interaction. Herein we demonstrate that PKD1 associates with nNOS in neurons and in transfected cells, and that kinase activation enhances PKD1-nNOS co-immunoprecipitation and subcellular colocalization. However, transfection of mammalian cells with PKD1 mutants and yeast two hybrid assays showed that the association of these two enzymes does not depend on PKD1 PDZ-ligand but its pleckstrin homology domain. Furthermore, this domain was able to pull-down nNOS from brain extracts and bind to purified nNOS, indicating that it mediates a direct PKD1-nNOS interaction. In addition, using mass spectrometry we demonstrate that PKD1 specifically phosphorylates nNOS in the activatory residue Ser(1412), and that this phosphorylation increases nNOS activity and center dot NO production in living cells. In conclusion, these novel findings reveal a crucial role of PKD1 in the regulation of nNOS activation and synthesis of center dot NO, a mediator involved in physiological neuronal signaling or neurotoxicity under pathological conditions such as ischemic stroke or neurodegeneration.	[Sanchez-Ruiloba, Lucia; Garcia-Guerra, Lucia; Pose-Utrilla, Julia; Iglesias, Teresa] UAM, CSIC, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Aicart-Ramos, Clara; Rodriguez-Crespo, Ignacio] Univ Complutense Madrid, Dept Bioquim & Biol Mol 1, Madrid, Spain; [Sanchez-Ruiloba, Lucia; Garcia-Guerra, Lucia; Pose-Utrilla, Julia; Iglesias, Teresa] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, CIBERNED, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Complutense University of Madrid; CIBERNED; Instituto de Salud Carlos III	Rodriguez-Crespo, I (corresponding author), Univ Complutense Madrid, Dept Bioquim & Biol Mol 1, Madrid, Spain.	nacho@bbm1.ucm.es; tiglesias@iib.uam.es	Aicart-Ramos, Clara/C-7301-2016; pose, julia/ABG-7491-2020; Vacas, Teresa Iglesias/ABF-8663-2020; Rodriguez-Crespo, J. Ignacio/M-1966-2018	Aicart-Ramos, Clara/0000-0002-1114-4259; pose, julia/0000-0002-5009-344X; Vacas, Teresa Iglesias/0000-0002-4326-9005; Garcia, Lucia/0000-0002-8321-3137; Rodriguez-Crespo, J. Ignacio/0000-0002-2582-129X; Sanchez-Ruiloba, Lucia/0000-0001-5418-2290	Ministerio de Economia y Competitividad [SAF2011-26233, BFU2009-10442, BFU2012-37934]; Comunidad de Madrid [S2010/BMD-2331-Neurodegmodels-CM]; Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas - CIBERNED, Instituto de Salud Carlos III; CIBERNED; FPU predoctoral fellowship from Ministerio de Economia y Competitividad	Ministerio de Economia y Competitividad(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas - CIBERNED, Instituto de Salud Carlos III; CIBERNED(Instituto de Salud Carlos III); FPU predoctoral fellowship from Ministerio de Economia y Competitividad	This work was supported by the Ministerio de Economia y Competitividad [SAF2011-26233 to T.I., BFU2009-10442 and BFU2012-37934 to I.R-C.]; Comunidad de Madrid [S2010/BMD-2331-Neurodegmodels-CM to T. I.]; and Centro de Investigacion Biomedica en Red sobre Enfermedades Neurodegenerativas - CIBERNED, Instituto de Salud Carlos III, to T.I. Postdoctoral fellows L. S-R. and L. G-G. have been funded by research contracts from CIBERNED; Clara Aicart-Ramos is a recipient of a FPU predoctoral fellowship from Ministerio de Economia y Competitividad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Adams ME, 2010, J NEUROSCI, V30, P11004, DOI 10.1523/JNEUROSCI.1930-10.2010; Adams ME, 2001, J CELL BIOL, V155, P113, DOI 10.1083/jcb.200106158; Bisbal M, 2008, J NEUROSCI, V28, P9297, DOI 10.1523/JNEUROSCI.1879-08.2008; BREDT DS, 1991, NATURE, V351, P714, DOI 10.1038/351714a0; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Cabrera-Poch N, 2004, J BIOL CHEM, V279, P28592, DOI 10.1074/jbc.M312242200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202, DOI 10.1152/ajpendo.2000.279.5.E1202; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Cui H, 2007, J NEUROSCI, V27, P9901, DOI 10.1523/JNEUROSCI.1464-07.2007; Czondor K, 2009, MOL BIOL CELL, V20, P2108, DOI 10.1091/mbc.E08-09-0957; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ding G, 2007, J BIOL CHEM, V282, P27493, DOI 10.1074/jbc.M701641200; Doppler H, 2007, J BIOL CHEM, V282, P31873, DOI 10.1074/jbc.M703584200; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Doucet MV, 2012, PHARMACOL THERAPEUT, V133, P218, DOI 10.1016/j.pharmthera.2011.11.005; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Du C, 2009, CANCER RES, V69, P1117, DOI 10.1158/0008-5472.CAN-07-6270; Dudzinski DM, 2007, CARDIOVASC RES, V75, P247, DOI 10.1016/j.cardiores.2007.03.023; Eiseler T, 2010, J BIOL CHEM, V285, P18672, DOI 10.1074/jbc.M109.093880; Eiseler T, 2009, NAT CELL BIOL, V11, P545, DOI 10.1038/ncb1861; Firestein BL, 1999, J BIOL CHEM, V274, P10545, DOI 10.1074/jbc.274.15.10545; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Gerber NC, 1997, J BIOL CHEM, V272, P6285, DOI 10.1074/jbc.272.10.6285; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hausser A, 2005, NAT CELL BIOL, V7, P880, DOI 10.1038/ncb1289; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 2000, J BIOL CHEM, V275, P40048, DOI 10.1074/jbc.M005261200; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Jaggi M, 2005, CANCER RES, V65, P483; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; Kong HY, 2001, J NEUROSCI, V21, P176, DOI 10.1523/JNEUROSCI.21-01-00176.2001; Lopez-Menendez C, 2009, J CELL SCI, V122, P3554, DOI 10.1242/jcs.056473; Luo CX, 2011, NEUROSCI BULL, V27, P23, DOI 10.1007/s12264-011-1038-0; Matthews S, 1999, FEBS LETT, V457, P515, DOI 10.1016/S0014-5793(99)01090-X; Matthews SA, 2000, EMBO J, V19, P2935, DOI 10.1093/emboj/19.12.2935; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; McCabe TJ, 2000, J BIOL CHEM, V275, P6123, DOI 10.1074/jbc.275.9.6123; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Navarro-Lerida I, 2007, MOL BIOL CELL, V18, P2768, DOI 10.1091/mbc.E06-12-1102; Nhek S, 2010, MOL BIOL CELL, V21, P2327, DOI 10.1091/mbc.E10-02-0090; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Park JH, 2011, FREE RADICAL BIO MED, V51, P2217, DOI 10.1016/j.freeradbiomed.2011.09.021; Peterburs P, 2009, CANCER RES, V69, P5634, DOI 10.1158/0008-5472.CAN-09-0718; Pusapati GV, 2012, J BIOL CHEM, V287, P9473, DOI 10.1074/jbc.M112.339564; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rodriguez-Crespo I, 1999, J BIOL CHEM, V274, P21617, DOI 10.1074/jbc.274.31.21617; Rodriguez-Crespo I, 1998, ARCH BIOCHEM BIOPHYS, V359, P297, DOI 10.1006/abbi.1998.0928; RodriguezCrespo I, 1996, ARCH BIOCHEM BIOPHYS, V336, P151, DOI 10.1006/abbi.1996.0543; Rozengurt E, 2011, PHYSIOLOGY, V26, P23, DOI 10.1152/physiol.00037.2010; Saitoh F, 2004, J BIOL CHEM, V279, P29461, DOI 10.1074/jbc.M401471200; Sanchez-Blazquez P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011278; Sanchez-Ruiloba L, 2006, J BIOL CHEM, V281, P18888, DOI 10.1074/jbc.M603044200; Sartoretto JL, 2009, AM J PHYSIOL-HEART C, V297, pH1697, DOI 10.1152/ajpheart.00595.2009; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schepens J, 1997, FEBS LETT, V409, P53, DOI 10.1016/S0014-5793(97)00481-X; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Socodato R, 2012, J BIOL CHEM, V287, P38680, DOI 10.1074/jbc.M112.353961; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Storz P, 2003, J BIOL CHEM, V278, P17969, DOI 10.1074/jbc.M213224200; Stricker NL, 1997, NAT BIOTECHNOL, V15, P336, DOI 10.1038/nbt0497-336; Takahashi S, 2003, J BIOL CHEM, V278, P30821, DOI 10.1074/jbc.M304471200; Tiso M, 2005, J BIOL CHEM, V280, P39208, DOI 10.1074/jbc.M507775200; Tochio H, 1999, NAT STRUCT BIOL, V6, P417; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Waldron RT, 1999, J BIOL CHEM, V274, P9224, DOI 10.1074/jbc.274.14.9224; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang P, 2000, EUR J BIOCHEM, V267, P3116, DOI 10.1046/j.1432-1327.2000.01318.x; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Yen DHT, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-32; Yin DM, 2008, J NEUROSCI, V28, P8832, DOI 10.1523/JNEUROSCI.1291-08.2008; Yoo J, 2009, AM J PHYSIOL-CELL PH, V297, pC1576, DOI 10.1152/ajpcell.00184.2009; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200; Zhou L, 2009, NITRIC OXIDE-BIOL CH, V20, P223, DOI 10.1016/j.niox.2009.03.001; Ziegler S, 2011, MOL BIOL CELL, V22, P570, DOI 10.1091/mbc.E10-05-0427	85	15	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95191	10.1371/journal.pone.0095191	http://dx.doi.org/10.1371/journal.pone.0095191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740233	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900113
J	Barlow, LA; Cecile, J; Bauch, CT; Anand, M				Barlow, Lee-Ann; Cecile, Jacob; Bauch, Chris T.; Anand, Madhur			Modelling Interactions between Forest Pest Invasions and Human Decisions Regarding Firewood Transport Restrictions	PLOS ONE			English	Article							EMERALD ASH BORER; ASIAN LONGHORNED BEETLE; NORTH-AMERICA; COLEOPTERA; DISPERSAL; DYNAMICS; CERAMBYCIDAE; SPREAD; TREES	The invasion of nonnative, wood-boring insects such as the Asian longhorned beetle (A. glabripennis) and the emerald ash borer (A. planipennis) is a serious ecological and economic threat to Canadian deciduous and mixed-wood forests. Humans act as a major vector for the spread of these pests via firewood transport, although existing models do not explicitly capture human decision-making regarding firewood transport. In this paper we present a two-patch coupled human-environment system model that includes social influence and long-distance firewood transport and examines potential strategies for mitigating pest spread. We found that increasing concern regarding infestations (f) significantly reduced infestation. Additionally it resulted in multiple thresholds at which the intensity of infestation in a patch was decreased. It was also found that a decrease in the cost of firewood purchased in the area where it is supposed to be burned (Cl) resulted in an increased proportion of local-firewood strategists, and a 67% decrease in Cl from $6.75 to $4.50 was sufficient to eliminate crosspatch infestation. These effects are synergistic: increasing concern through awareness and education campaigns acts together with reduced firewood costs, thereby reducing the required threshold of both awareness and economic incentives. Our results indicate that the best management strategy includes a combination of public education paired with firewood subsidization.	[Barlow, Lee-Ann; Bauch, Chris T.] Univ Guelph, Dept Math Stat, Guelph, ON N1G 2W1, Canada; [Cecile, Jacob; Anand, Madhur] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada	University of Guelph; University of Guelph	Anand, M (corresponding author), Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada.	manand@uoguelph.ca			Natural Sciences and Engineering Council of Canada Discovery grants programs	Natural Sciences and Engineering Council of Canada Discovery grants programs	The work was funded by the Natural Sciences and Engineering Council of Canada Discovery grants programs (to MA and CB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackleh AS, 2007, THEOR POPUL BIOL, V71, P290, DOI 10.1016/j.tpb.2006.12.006; ANTONOVSKY MY, 1990, THEOR POPUL BIOL, V37, P343, DOI 10.1016/0040-5809(90)90043-U; Bauch CT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002452; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; BenDor TK, 2006, ECOL MODEL, V197, P221, DOI 10.1016/j.ecolmodel.2006.03.003; Gourley SA, 2011, SIAM REV, V53, P321, DOI 10.1137/100818510; Haack R. A., 2002, NEWSLETTER MICHIGAN, V47, P1; Haack RA, 2010, ANNU REV ENTOMOL, V55, P521, DOI 10.1146/annurev-ento-112408-085427; HOLLEY RA, 1975, ANN PROBAB, V3, P643, DOI 10.1214/aop/1176996306; Kang Y, 2011, J THEOR BIOL, V268, P84, DOI 10.1016/j.jtbi.2010.09.033; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; McKenney Daniel W., 2012, Arboriculture & Urban Forestry, V38, P81; Muirhead JR, 2006, DIVERS DISTRIB, V12, P71, DOI 10.1111/j.1366-9516.2006.00218.x; MURATORI S, 1989, APPL MATH MODEL, V13, P674, DOI 10.1016/0307-904X(89)90160-1; Nathan R, 2011, ECOL LETT, V14, P211, DOI 10.1111/j.1461-0248.2010.01573.x; Nowak DJ, 2001, J ECON ENTOMOL, V94, P116, DOI 10.1603/0022-0493-94.1.116; Poland TM, 2006, J FOREST, V104, P118; Rinaldi S, 2012, THEOR POPUL BIOL, V81, P1, DOI 10.1016/j.tpb.2011.08.002; Smith MT, 2004, ENVIRON ENTOMOL, V33, P435, DOI 10.1603/0046-225X-33.2.435; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; Woodall CW, 2005, FOREST ECOL MANAG, V216, P367, DOI 10.1016/j.foreco.2005.05.050	21	30	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e90511	10.1371/journal.pone.0090511	http://dx.doi.org/10.1371/journal.pone.0090511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736497	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600004
J	Brenneis, G; Scholtz, G				Brenneis, Georg; Scholtz, Gerhard			The Ventral Organs' of Pycnogonida (Arthropoda) Are Neurogenic Niches of Late Embryonic and Post-Embryonic Nervous System Development	PLOS ONE			English	Article							CRAYFISH CHERAX-DESTRUCTOR; ADULT DECAPOD CRUSTACEANS; CENTRAL OLFACTORY PATHWAY; DEVONIAN HUNSRUCK SLATE; SEA SPIDER ARTHROPODA; ACHAETE-SCUTE GENES; GERM BAND FORMATION; DROSOPHILA-MELANOGASTER; EUPERIPATOIDES-KANANGRENSIS; BRAIN-DEVELOPMENT	Early neurogenesis in arthropods has been in the focus of numerous studies, its cellular basis, spatio-temporal dynamics and underlying genetic network being by now comparably well characterized for representatives of chelicerates, myriapods, hexapods and crustaceans. By contrast, neurogenesis during late embryonic and/or post-embryonic development has received less attention, especially in myriapods and chelicerates. Here, we apply (i) immunolabeling, (ii) histology and (iii) scanning electron microscopy to study post-embryonic ventral nerve cord development in Pseudopallene sp., a representative of the sea spiders (Pycnogonida), the presumable sister group of the remaining chelicerates. During early post-embryonic development, large neural stem cells give rise to additional ganglion cell material in segmentally paired invaginations in the ventral ectoderm. These ectodermal cell regions - traditionally designated as `ventral organs' - detach from the surface into the interior and persist as apical cell clusters on the ventral ganglion side. Each cluster is a postembryonic neurogenic niche that features a tiny central cavity and initially still houses larger neural stem cells. The cluster stays connected to the underlying ganglionic somata cortex via an anterior and a posterior cell stream. Cell proliferation remains restricted to the cluster and streams, and migration of newly produced cells along the streams seems to account for increasing ganglion cell numbers in the cortex. The pycnogonid cluster-stream-systems show striking similarities to the lifelong neurogenic system of decapod crustaceans, and due to their close vicinity to glomerulus-like neuropils, we consider their possible involvement in post-embryonic (perhaps even adult) replenishment of olfactory neurons - as in decapods. An instance of a potentially similar post-embryonic/adult neurogenic system in the arthropod outgroup Onychophora is discussed. Additionally, we document two transient posterior ganglia in the ventral nerve cord of Pseudopallene sp. and evaluate this finding in light of the often discussed reduction of a segmented `opisthosoma' during pycnogonid evolution.	[Brenneis, Georg; Scholtz, Gerhard] Humboldt Univ, Inst Biol Vergleichende Zool, D-10099 Berlin, Germany	Humboldt University of Berlin	Brenneis, G (corresponding author), Humboldt Univ, Inst Biol Vergleichende Zool, D-10099 Berlin, Germany.	georg.brenneis@gmx.de	Brenneis, Georg/AAQ-9561-2021		Studienstiftung des deutschen Volkes; Deutscher Akademischer Austausch Dienst (DAAD); Deutsche Forschungsgemeinschaft [Scho 442/13-1]	Studienstiftung des deutschen Volkes; Deutscher Akademischer Austausch Dienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	GB was supported by the Studienstiftung des deutschen Volkes and the Deutscher Akademischer Austausch Dienst (DAAD). The project was funded by the Deutsche Forschungsgemeinschaft (Scho 442/13-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 1999, EVOL DEV, V1, P77, DOI 10.1046/j.1525-142x.1999.99014.x; Arango CP, 2007, CLADISTICS, V23, P255, DOI 10.1111/j.1096-0031.2007.00143.x; ARNAUD F, 1987, ADV MAR BIOL, V24, P1; Ax P., 1999, SYSTEM METAZOA; BATE CM, 1981, J EMBRYOL EXP MORPH, V61, P317; BATE CM, 1976, J EMBRYOL EXP MORPH, V35, P107; BAZIN F, 1970, Archives de Zoologie Experimentale et Generale, V111, P245; BAZIN F, 1971, Bulletin de la Societe Zoologique de France, V96, P87; BAZIN F, 1969, CR ACAD SCI D NAT, V269, P958; BAZIN F, 1968, CR ACAD SCI D NAT, V267, P356; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Beltz BS, 2011, EUR J NEUROSCI, V34, P870, DOI 10.1111/j.1460-9568.2011.07802.x; Benton JL, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-53; BERGSTROM J, 1980, Palaeontologische Zeitschrift, V54, P7; Bogomolova EV, 2007, RUSS J MAR BIOL+, V33, P145, DOI 10.1134/S1063074007030029; Bogomolova EV, 2011, RUSS J MAR BIOL+, V37, P348, DOI 10.1134/S106307401105004X; Bogomolova EV, 2003, ENTOMOL REV, V83, P222; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Boyan G, 2011, ARTHROPOD STRUCT DEV, V40, P334, DOI 10.1016/j.asd.2011.02.005; Breidbach O, 1996, MICROSC RES TECHNIQ, V35, P180, DOI 10.1002/(SICI)1097-0029(19961015)35:3&lt;180::AID-JEMT2&gt;3.0.CO;2-S; Brenneis G, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-32; Brenneis G, 2011, DEV GENES EVOL, V221, P309, DOI 10.1007/s00427-011-0382-4; Brenneis G, 2011, DEV GENES EVOL, V221, P329, DOI 10.1007/s00427-011-0381-5; BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8; Burris ZP, 2011, J MAR BIOL ASSOC UK, V91, P845, DOI 10.1017/S0025315410001554; CABRERA CV, 1987, CELL, V50, P425, DOI 10.1016/0092-8674(87)90496-X; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; CAYRE M, 1994, NATURE, V368, P57, DOI 10.1038/368057a0; Cayre M, 1996, J COMP NEUROL, V371, P300, DOI 10.1002/(SICI)1096-9861(19960722)371:2<300::AID-CNE9>3.0.CO;2-6; Cayre M, 2007, CHEM SENSES, V32, P385, DOI 10.1093/chemse/bjm010; da Silva PGC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039267; Chipman AD, 2006, DEV BIOL, V290, P337, DOI 10.1016/j.ydbio.2005.11.029; Damen WGM, 1998, P NATL ACAD SCI USA, V95, P10665, DOI 10.1073/pnas.95.18.10665; DOE CQ, 1985, DEV BIOL, V111, P193, DOI 10.1016/0012-1606(85)90445-2; DOE CQ, 1992, DEVELOPMENT, V116, P855; Doffinger C, 2010, DEV BIOL, V345, P105, DOI 10.1016/j.ydbio.2010.06.012; Doeffinger C, 2010, J COMP NEUROL, V518, P2612, DOI 10.1002/cne.22355; Dogiel V, 1913, Z WISS ZOOL ABT A, V107, P575; Dogiel V, 1911, Z WISS ZOOL ABT A, V99, P109; DOHLE W, 1976, ZOOMORPHOLOGIE, V84, P235, DOI 10.1007/BF01578696; DOHRN A, 1881, PANTOPODEN GOLFES NE; Dove H, 2003, DEVELOPMENT, V130, P2161, DOI 10.1242/dev.00442; Dufour MC, 2006, J COMP NEUROL, V495, P635, DOI 10.1002/cne.20909; Dunlop JA, 2010, ARTHROPOD STRUCT DEV, V39, P124, DOI 10.1016/j.asd.2010.01.003; Eriksson BJ, 2005, ARTHROPOD STRUCT DEV, V34, P407, DOI 10.1016/j.asd.2005.03.002; Eriksson BJ, 2003, J MORPHOL, V255, P1, DOI 10.1002/jmor.10034; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; Eriksson BJ, 2013, DEV GENES EVOL, V223, P237, DOI 10.1007/s00427-013-0442-z; Eriksson BJ, 2010, ARTHROPOD STRUCT DEV, V39, P478, DOI 10.1016/j.asd.2010.07.005; Fabritius-Vilpoux Kathia, 2008, Invertebrate Neuroscience, V8, P177, DOI 10.1007/s10158-008-0081-7; Gerberding M, 2001, DEV BIOL, V235, P397, DOI 10.1006/dbio.2001.0302; Gerberding M, 1997, INVERTEBR REPROD DEV, V32, P63, DOI 10.1080/07924259.1997.9672605; Gibert JM, 2000, EVOL DEV, V2, P194, DOI 10.1046/j.1525-142x.2000.00059.x; Grandel H, 2013, DEV GENES EVOL, V223, P131, DOI 10.1007/s00427-012-0425-5; Hanstrom B, 1928, VERGLEICHENDE ANATOM; Hanstrom B, 1919, THESIS STOCKHOLMS U; HARTENSTEIN V, 1987, ROUX ARCH DEV BIOL, V196, P473, DOI 10.1007/BF00399871; HARTENSTEIN V, 1984, ROUX ARCH DEV BIOL, V193, P308, DOI 10.1007/BF00848159; Harzsch S, 1998, J EXP BIOL, V201, P2465; Harzsch S, 2005, DEV GENES EVOL, V215, P53, DOI 10.1007/s00427-004-0451-z; HARZSCH S, 1994, ROUX ARCH DEV BIOL, V204, P93, DOI 10.1007/BF00361103; Harzsch S, 1999, J NEUROSCI, V19, P3472; Harzsch S, 2001, EVOL DEV, V3, P154, DOI 10.1046/j.1525-142x.2001.003003154.x; Harzsch S, 1996, J NEUROBIOL, V29, P384, DOI 10.1002/(SICI)1097-4695(199603)29:3<384::AID-NEU9>3.0.CO;2-5; Hedgpeth Joel W., 1947, SMITHSONIAN MISC COLL, V106, P1; Helfer H, 1935, PANTOPODA HGB KLASSE; Hoek P. P. C., 1881, CHALLENGER REPORT ZO, V3, P1, DOI DOI 10.5962/BHL.TITLE.13132; JUBERTHI.C, 1970, CR ACAD SCI D NAT, V270, P1028; Juberthie C., 1964, Annales de Speleologie, V19, P1; JUBERTHIEJUPEAU L, 1967, CR ACAD SCI D NAT, V264, P89; Kadner D, 2004, DEV GENES EVOL, V214, P367, DOI 10.1007/s00427-004-0419-z; King P., 1973, PYCNOGONIDS; Kuhl G, 2013, GEOL MAG, V150, P556, DOI 10.1017/S0016756812001033; Kux K, 2013, MECH DEVELOP, V130, P207, DOI 10.1016/j.mod.2013.02.003; Lehmann T, 2011, J MAR BIOL ASSOC UK, V91, P1081, DOI 10.1017/S0025315410002067; Manuel M, 2006, DEV GENES EVOL, V216, P481, DOI 10.1007/s00427-006-0095-2; Mayer G, 2009, P ROY SOC B-BIOL SCI, V276, P3571, DOI 10.1098/rspb.2009.0950; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Mittmann B, 2002, BIOL BULL-US, V203, P221, DOI 10.2307/1543407; MITTMANN B, 2003, THESIS HUMBOLDT U BE; Morgan T.H, 1891, STUDIES BIOLOGICAL L, V5, P1; NAKAMURA K, 1981, J NAT HIST, V15, P49, DOI 10.1080/00222938100770041; Oakley TH, 2013, MOL BIOL EVOL, V30, P215, DOI 10.1093/molbev/mss216; Okuda S., 1940, Journal of the Faculty of Science Hokkaido University Zoology, V7, P73; Pflugfelder O., 1948, Zoologische Jahrbuecher Jena Anatomie, V69, P443; Poschmann M, 2006, PALAEONTOLOGY, V49, P983, DOI 10.1111/j.1475-4983.2006.00583.x; PROKOP A, 1991, DEVELOPMENT, V111, P79; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Rehm P, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-19; Richter S, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-29; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Rota-Stabelli O, 2010, GENOME BIOL EVOL, V2, P425, DOI 10.1093/gbe/evq030; Sanchez S., 1958, Archives de Zoologie Experimentale et Generale, V96, P57; SANCHEZ SIMONE, 1959, ARCH ZOOL EXPTL ET GEN, V98, P1; SANDEMAN D, 1992, BIOL BULL, V183, P304, DOI 10.2307/1542217; Sandernan DC, 2011, ARTHROPOD STRUCT DEV, V40, P258, DOI 10.1016/j.asd.2011.03.001; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660; Schmidt M, 1997, BRAIN RES, V762, P131, DOI 10.1016/S0006-8993(97)00376-4; Schmidt M, 1999, BIOL BULL-US, V196, P127, DOI 10.2307/1542558; Schmidt M, 2001, J NEUROBIOL, V48, P181, DOI 10.1002/neu.1050; Schmidt M, 2007, CHEM SENSES, V32, P365, DOI 10.1093/chemse/bjm008; Schmidt M, 2007, J COMP NEUROL, V503, P64, DOI 10.1002/cne.21366; Schmidt M, 2011, J COMP NEUROL, V519, P2283, DOI 10.1002/cne.22657; SCHOLTZ G, 1995, BIOL BULL, V188, P157, DOI 10.2307/1542081; SCHOLTZ G, 1992, ROUX ARCH DEV BIOL, V202, P36, DOI 10.1007/BF00364595; SCHOLTZ G, 1990, PROC R SOC SER B-BIO, V239, P163, DOI 10.1098/rspb.1990.0013; Scholtz G, 2006, DEV GENES EVOL, V216, P395, DOI 10.1007/s00427-006-0085-4; Schurmann F.-W., 1987, P159; Sintoni S, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-1; Siveter DJ, 2004, NATURE, V431, P978, DOI 10.1038/nature02928; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; Song CK, 2009, ARTHROPOD STRUCT DEV, V38, P339, DOI 10.1016/j.asd.2008.12.004; Southall TD, 2009, EMBO J, V28, P3799, DOI 10.1038/emboj.2009.309; SPANA EP, 1995, DEVELOPMENT, V121, P3187; Spindler SR, 2010, DEV GENES EVOL, V220, P1, DOI 10.1007/s00427-010-0323-7; STOCK JH, 1978, ZOOL J LINN SOC-LOND, V63, P59, DOI 10.1111/j.1096-3642.1978.tb02090.x; Stollewerk A, 2006, INTEGR COMP BIOL, V46, P195, DOI 10.1093/icb/icj020; Stollewerk A, 2003, ARTHROPOD STRUCT DEV, V32, P5, DOI 10.1016/S1467-8039(03)00041-0; Stollewerk A, 2002, DEVELOPMENT, V129, P5339, DOI 10.1242/dev.00109; Stollewerk A, 2001, DEVELOPMENT, V128, P2673; Stollewerk Angelika, 2004, Front Zool, V1, P3, DOI 10.1186/1742-9994-1-3; Strausfeld NJ, 2006, ARTHROPOD STRUCT DEV, V35, P169, DOI 10.1016/j.asd.2006.06.002; Strausfeld NJ, 2006, P ROY SOC B-BIOL SCI, V273, P1857, DOI 10.1098/rspb.2006.3536; Strausfeld NJ, 2011, ARTHROPOD STRUCT DEV, V40, P276, DOI 10.1016/j.asd.2011.02.002; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Sullivan JM, 2007, J COMP NEUROL, V500, P574, DOI 10.1002/cne.21187; Sullivan JM, 2001, J EXP ZOOL, V290, P49, DOI 10.1002/jez.1035; Sullivan JM, 2005, J NEUROBIOL, V65, P157, DOI 10.1002/neu.20195; Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371; Ungerer P, 2008, P ROY SOC B-BIOL SCI, V275, P369, DOI 10.1098/rspb.2007.1391; Ungerer P, 2012, DEV BIOL, V371, P302, DOI 10.1016/j.ydbio.2012.08.025; Ungerer P, 2011, DEV BIOL, V357, P42, DOI 10.1016/j.ydbio.2011.05.662; Urbach R, 2003, ARTHROPOD STRUCT DEV, V32, P103, DOI 10.1016/S1467-8039(03)00042-2; von Reumont BM, 2012, MOL BIOL EVOL, V29, P1031, DOI 10.1093/molbev/msr270; Weller M, 2003, DEV GENES EVOL, V213, P554, DOI 10.1007/s00427-003-0362-4; WEYGOLDT P, 1979, Z ZOOL SYST EVOL, V17, P177; Wheeler SR, 2005, GENE EXPR PATTERNS, V5, P695, DOI 10.1016/j.modgep.2005.02.005; Wheeler SR, 2003, DEVELOPMENT, V130, P4373, DOI 10.1242/dev.00646; Wheeler WC, 1998, CLADISTICS, V14, P173, DOI 10.1111/j.1096-0031.1998.tb00331.x; Whitington PM, 2011, ARTHROPOD STRUCT DEV, V40, P193, DOI 10.1016/j.asd.2011.01.006; WHITINGTON PM, 1991, ROUX ARCH DEV BIOL, V199, P349, DOI 10.1007/BF01705928; WINTER G, 1980, Z ZOOL SYST EVOL, V18, P27; Wiren E, 1918, ZOOL BIDR UPPS, V6, P41; Zhao X, 2008, DEV NEUROBIOL, V68, P1487, DOI 10.1002/dneu.20669	145	16	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95435	10.1371/journal.pone.0095435	http://dx.doi.org/10.1371/journal.pone.0095435			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736377	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600180
J	Chen, TM; Leung, RKK; Zhou, Z; Liu, RC; Zhang, XX; Zhang, LJ				Chen, Tianmu; Leung, Ross Ka-kit; Zhou, Zi; Liu, Ruchun; Zhang, Xixing; Zhang, Lijie			Investigation of Key Interventions for Shigellosis Outbreak Control in China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; COMMON-SOURCE; TRANSMISSION; INFECTION; SURVIVAL; SONNEI; FLEXNERI; WATER; FOOD	Shigellosis is a major public health concern in China, where waterborne disease outbreaks are common. Shigellosis-containing strategies, mostly single or multiple interventions, are implemented by primary-level health departments. Systematic assessment of the effectiveness of these measures is scarce. To estimate the efficacy of commonly used intervention strategies, we developed a Susceptible-Exposed-Infectious/Asymptomatic-Recovered-Water model. No intervention was predicted to result in a total attack rate (TAR) of 90% of the affected population (95% confidence interval [CI]: 86.65-92.80) and duration of outbreak (DO) of 89 days, and the use of single-intervention strategies can be futile or even counter-productive. Prophylactics and water disinfection did not improve TAR or DO. School closure for up to 3 weeks did not help but only increased DO. Isolation alone significantly increased DO. Only antibiotics treatment could shorten the DO to 35 days with TAR unaffected. We observed that these intervention effects were additive when in combined usage under most circumstances. Combined intervention "Isolation+antibiotics+prophylactics+water disinfection'' was predicted to result in the lowest TAR (41.9%, 95% CI: 36.97-47.04%) and shortest DO (28 days). Our actual Shigellosis control implementation that also included school closure for 1 week, attained comparable results and the modeling produced an epidemic curve of Shigellosis highly similar to our actual outbreak data. This lends a strong support to the reality of our model that provides a possible reference for public health professionals to evaluate their strategies towards Shigellosis control.	[Chen, Tianmu; Liu, Ruchun; Zhang, Xixing] Changsha Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Changsha, Hunan, Peoples R China; [Leung, Ross Ka-kit] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China; [Zhou, Zi] Xiamen Univ, Sch Publ Hlth, Xiamen, Peoples R China; [Zhang, Lijie] Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China	Chinese University of Hong Kong; Xiamen University; Chinese Center for Disease Control & Prevention	Zhang, LJ (corresponding author), Chinese Ctr Dis Control & Prevent, Chinese Field Epidemiol Training Program, Beijing, Peoples R China.	cfetpzlj@126.com			Scientific Research Program of Health Depatrment of Hunan Province [B2012-138]; Scientific Research Program of Changsha Science and Technology Bureau [K1205028-31]	Scientific Research Program of Health Depatrment of Hunan Province; Scientific Research Program of Changsha Science and Technology Bureau	This work was partially supported by the Scientific Research Program of Health Depatrment of Hunan Province (B2012-138, http://www.21hospital.com/) and by the Scientific Research Program of Changsha Science and Technology Bureau (K1205028-31, http://www.cssti.cn/html/cskjw/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai ZG, 2011, DISCRETE CONT DYN-B, V15, P1, DOI 10.3934/dcdsb.2011.15.1; Bovee L, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-347; Brown ST, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-353; Chiou CS, 2001, J CLIN MICROBIOL, V39, P1048, DOI 10.1128/JCM.39.3.1048-1056.2001; DuPont HL, 2000, PRINCIPLES PRACTICE, P2363; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; He F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047239; ISLAM MS, 1993, APPL ENVIRON MICROB, V59, P652, DOI 10.1128/AEM.59.2.652-654.1993; Khan AI, 2006, EPIDEMIOL INFECT, V134, P605, DOI 10.1017/S0950268805005534; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; MARTIN DL, 1986, AM J EPIDEMIOL, V124, P299, DOI 10.1093/oxfordjournals.aje.a114388; MCFETERS GA, 1974, APPL MICROBIOL, V27, P823, DOI 10.1128/AEM.27.5.823-829.1974; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Qadri M H, 1995, J Family Community Med, V2, P36; SAMONIS G, 1994, EPIDEMIOL INFECT, V112, P235, DOI 10.1017/S0950268800057642; SWADDIWUDHIPONG W, 1995, J TROP MED HYG, V98, P145; Tang SY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010911; TAYLOR BC, 1964, J HYG-CAMBRIDGE, V62, P303, DOI 10.1017/S0022172400040018; Tien JH, 2010, B MATH BIOL, V72, P1506, DOI 10.1007/s11538-010-9507-6; World Health Organization (WHO), 2008, FOODB DIS OUTBR GUID; Wu FM, 2000, J FOOD PROTECT, V63, P568, DOI 10.4315/0362-028X-63.5.568; Wu JT, 2011, EXP BIOL MED, V236, P955, DOI 10.1258/ebm.2010.010271; Xiao GG, 2012, INDIAN PEDIATR, V49, P287, DOI 10.1007/s13312-012-0043-3; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	24	34	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95006	10.1371/journal.pone.0095006	http://dx.doi.org/10.1371/journal.pone.0095006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736407	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600122
J	Du, R; Yan, JB; Feng, QZ; Li, PP; Zhang, L; Chang, S; Li, SZ				Du, Ran; Yan, Jianbin; Feng, Quanzhou; Li, Peipei; Zhang, Lei; Chang, Sandra; Li, Shizhong			A Novel Wild-Type Saccharomyces cerevisiae Strain TSH1 in Scaling-Up of Solid-State Fermentation of Ethanol from Sweet Sorghum Stalks	PLOS ONE			English	Article							PHASE FERMENTATION; THERMOTOLERANT; TOLERANCE; ACID; FEEDSTOCK; BIOFUELS; SYSTEMS	The rising demand for bioethanol, the most common alternative to petroleum-derived fuel used worldwide, has encouraged a feedstock shift to non-food crops to reduce the competition for resources between food and energy production. Sweet sorghum has become one of the most promising non-food energy crops because of its high output and strong adaptive ability. However, the means by which sweet sorghum stalks can be cost-effectively utilized for ethanol fermentation in large-scale industrial production and commercialization remains unclear. In this study, we identified a novel Saccharomyces cerevisiae strain, TSH1, from the soil in which sweet sorghum stalks were stored. This strain exhibited excellent ethanol fermentative capacity and ability to withstand stressful solid-state fermentation conditions. Furthermore, we gradually scaled up from a 500-mL flask to a 127-m(3) rotary-drum fermenter and eventually constructed a 550-m(3) rotarydrum fermentation system to establish an efficient industrial fermentation platform based on TSH1. The batch fermentations were completed in less than 20 hours, with up to 96 tons of crushed sweet sorghum stalks in the 550-m(3) fermenter reaching 88% of relative theoretical ethanol yield (RTEY). These results collectively demonstrate that ethanol solid-state fermentation technology can be a highly efficient and low-cost solution for utilizing sweet sorghum, providing a feasible and economical means of developing non-food bioethanol.	[Du, Ran; Feng, Quanzhou; Li, Peipei; Zhang, Lei; Li, Shizhong] Tsinghua Univ, Inst Nucl & New Energy Technol, Beijing 100084, Peoples R China; [Yan, Jianbin] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Chang, Sandra] Beijing Engn Res Ctr Biofuels, Beijing, Peoples R China	Tsinghua University; Tsinghua University	Li, SZ (corresponding author), Tsinghua Univ, Inst Nucl & New Energy Technol, Beijing 100084, Peoples R China.	szli@mail.tsinghua.edu.cn	Yan, JianBin/AAE-3494-2022; Yan, Jianbin/GLT-7566-2022	Yan, Jianbin/0000-0001-7934-8808	Ministry of Science and Technology [2012DFG61720, 2011BAD22B03]; low carbon energy university alliance project; Public Science and Technology Research Funds Projects of Ocean [201005031]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); low carbon energy university alliance project; Public Science and Technology Research Funds Projects of Ocean	This work was financially supported by grants from the Ministry of Science and Technology (2012DFG61720, 2011BAD22B03), the low carbon energy university alliance project, and the Public Science and Technology Research Funds Projects of Ocean (201005031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque E, 2008, ENZYME MICROB TECH, V43, P214, DOI 10.1016/j.enzmictec.2007.08.006; Balat M, 2008, PROG ENERG COMBUST, V34, P551, DOI 10.1016/j.pecs.2007.11.001; Balat M, 2009, APPL ENERG, V86, P2273, DOI 10.1016/j.apenergy.2009.03.015; Bammert GF, 2000, ANTIMICROB AGENTS CH, V44, P1255, DOI 10.1128/AAC.44.5.1255-1265.2000; Basavaraj G, 2013, ENERG POLICY, V56, P501, DOI 10.1016/j.enpol.2013.01.012; Benjaphokee S, 2012, NEW BIOTECHNOL, V29, P379, DOI 10.1016/j.nbt.2011.07.002; BRYAN WL, 1985, T ASAE, V28, P268; Calvino M, 2012, CURR OPIN BIOTECH, V23, P323, DOI 10.1016/j.copbio.2011.12.002; Crago CL, 2010, ENERG POLICY, V38, P7404, DOI 10.1016/j.enpol.2010.08.016; Demirbas A, 2011, APPL ENERG, V88, P17, DOI 10.1016/j.apenergy.2010.07.016; Demirbas A, 2009, APPL ENERG, V86, pS108, DOI 10.1016/j.apenergy.2009.04.036; Eckhoff SR, 1983, ASAE TECH PAP, V83, P3558; EGG RP, 1993, BIOMASS BIOENERG, V5, P71, DOI 10.1016/0961-9534(93)90009-S; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Geng AL, 2010, INT J CHEM REACT ENG, V8; GIBBONS WR, 1986, APPL ENVIRON MICROB, V51, P115, DOI 10.1128/AEM.51.1.115-122.1986; Haber JE, 2012, GENETICS, V191, P33, DOI 10.1534/genetics.111.134577; Henk LL, 1996, APPL BIOCHEM BIOTECH, V57-8, P489, DOI 10.1007/BF02941729; Holker U, 2005, CURR OPIN MICROBIOL, V8, P301, DOI 10.1016/j.mib.2005.04.006; JASBERG BK, 1983, BIOTECHNOL BIOENG, P113; KARGI F, 1985, BIOTECHNOL BIOENG, V27, P1122, DOI 10.1002/bit.260270806; KARGI F, 1985, BIOTECHNOL BIOENG, V27, P34, DOI 10.1002/bit.260270106; Koh LP, 2008, BIOL CONSERV, V141, P2450, DOI 10.1016/j.biocon.2008.08.005; Koizumi T, 2013, RENEW SUST ENERG REV, V21, P102, DOI 10.1016/j.rser.2012.12.047; Krishna C, 2005, CRIT REV BIOTECHNOL, V25, P1, DOI 10.1080/07388550590925383; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P87, DOI 10.1016/B978-0-444-52149-1.00007-0; Kwon YJ, 2011, BIORESOURCE TECHNOL, V102, P11262, DOI 10.1016/j.biortech.2011.09.103; Lewis JG, 1997, J IND MICROBIOL BIOT, V18, P30, DOI 10.1038/sj.jim.2900347; Li SZ, 2013, APPL ENERG, V102, P260, DOI 10.1016/j.apenergy.2012.09.060; Lingle SE, 2013, BIOENERG RES, V6, P178, DOI 10.1007/s12155-012-9248-5; Linton JA, 2011, BIOMASS BIOENERG, V35, P3050, DOI 10.1016/j.biombioe.2011.04.007; Lu HZ, 2004, INT J SYST EVOL MICR, V54, P2431, DOI 10.1099/ijs.0.63257-0; Luttig M, 1997, BIOTECHNOL LETT, V19, P411, DOI 10.1023/A:1018327623422; Matsakas L, 2013, BIOMASS BIOENERG, V51, P91, DOI 10.1016/j.biombioe.2013.01.007; MCCLARY DO, 1959, J BACTERIOL, V78, P362, DOI 10.1128/JB.78.3.362-368.1959; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mitchell DA, 1992, SOLID SUBSTRATE CULT, P1; MORTIMER RK, 1986, GENETICS, V113, P35; Pandey A, 2003, BIOCHEM ENG J, V13, P81, DOI 10.1016/S1369-703X(02)00121-3; Raghavarao KSMS, 2003, BIOCHEM ENG J, V13, P127, DOI 10.1016/S1369-703X(02)00125-0; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shen F, 2009, ENERG FUEL, V23, P519, DOI 10.1021/ef800531e; Sree NK, 2000, BIORESOURCE TECHNOL, V72, P43, DOI 10.1016/S0960-8524(99)90097-4; Tanaka K, 2012, APPL ENVIRON MICROB, V78, P8161, DOI 10.1128/AEM.02356-12; Tsoularis A, 2002, MATH BIOSCI, V179, P21, DOI 10.1016/S0025-5564(02)00096-2; Wang EQ, 2010, APPL ENERG, V87, P2839, DOI 10.1016/j.apenergy.2009.05.032; Wu XR, 2010, IND CROP PROD, V31, P164, DOI 10.1016/j.indcrop.2009.10.006; Yu JL, 2010, APPL BIOCHEM BIOTECH, V160, P401, DOI 10.1007/s12010-008-8333-x; Yu JL, 2008, FUEL PROCESS TECHNOL, V89, P1056, DOI 10.1016/j.fuproc.2008.04.008; Zegada-Lizarazu W, 2012, BIOMASS BIOENERG, V40, P1, DOI 10.1016/j.biombioe.2012.01.048; Zheng DQ, 2011, BIORESOURCE TECHNOL, V102, P3020, DOI 10.1016/j.biortech.2010.09.122	52	23	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94480	10.1371/journal.pone.0094480	http://dx.doi.org/10.1371/journal.pone.0094480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736641	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600071
J	Lomonosova, YN; Shenkman, BS; Kalamkarov, GR; Kostrominova, TY; Nemirovskaya, TL				Lomonosova, Yulia N.; Shenkman, Boris S.; Kalamkarov, Grigorii R.; Kostrominova, Tatiana Y.; Nemirovskaya, Tatyana L.			L-arginine Supplementation Protects Exercise Performance and Structural Integrity of Muscle Fibers after a Single Bout of Eccentric Exercise in Rats	PLOS ONE			English	Article							MOUSE SKELETAL-MUSCLE; NITRIC-OXIDE; DOWNHILL EXERCISE; MU-CALPAIN; MDX MICE; CONTRACTIONS; EXPRESSION; DAMAGE; SOLEUS; ACTIVATION	Eccentric exercise is known to disrupt sarcolemmal integrity and induce damage of skeletal muscle fibers. We hypothesized that L-arginine (L-Arg; nitric oxide synthase (NOS) substrate) supplementation prior to a single bout of eccentric exercise would diminish exercise-induced damage. In addition, we used N-nitro-L-arginine methyl ester hydrochloride (L-NAME; NOS inhibitor) to clarify the role of native NOS activity in the development of exercise-induced muscle damage. Rats were divided into four groups: non-treated control (C), downhill running with (RA) or without (R) L-Arg supplementation and downhill running with L-NAME supplementation (RN). Twenty four hours following eccentric exercise seven rats in each group were sacrificed and soleus muscles were dissected and frozen for further analysis. The remaining seven rats in each group were subjected to the exercise performance test. Our experiments showed that L-Arg supplementation prior to a single bout of eccentric exercise improved subsequent exercise performance capacity tests in RA rats when compared with R, RN and C rats by 37%, 27% and 13%, respectively. This outcome is mediated by L-Arg protection against post-exercise damage of sarcolemma (2.26- and 0.87-fold less than R and RN groups, respectively), reduced numbers of damaged muscle fibers indicated by the reduced loss of desmin content in the muscle (15% and 25% less than R and RN groups, respectively), and diminished m-calpain mRNA up-regulation (42% and 30% less than R and RN groups, respectively). In conclusion, our study indicates that L-Arg supplementation prior to a single bout of eccentric exercise alleviates muscle fiber damage and preserves exercise performance capacity.	[Nemirovskaya, Tatyana L.] Moscow MV Lomonosov State Univ, Fac Basic Med, Moscow, Russia; [Lomonosova, Yulia N.; Shenkman, Boris S.; Nemirovskaya, Tatyana L.] RAS, Inst Biomed Problems, Moscow 117901, Russia; [Kalamkarov, Grigorii R.] RAS, Emanuel Inst Biochem Phys, Moscow 117901, Russia; [Kostrominova, Tatiana Y.] Indiana Univ Sch Med Northwest, Dept Anat & Cell Biol, Gary, IN USA	Lomonosov Moscow State University; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Russian Academy of Sciences; Emanuel Institute of Biochemical Physics	Nemirovskaya, TL (corresponding author), Moscow MV Lomonosov State Univ, Fac Basic Med, Moscow, Russia.	nemirovskaya@bk.ru	Shenkman, Boris/AAB-1536-2020; Kostrominova, Tatiana/AAS-2371-2020; Lomonosova, Yulia/ABG-2976-2020	Lomonosova, Yulia/0000-0003-0508-5480	Russian Foundation for Basic Research [11-0400787-a]; IUSM-NW	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); IUSM-NW	This work was supported by the Russian Foundation for Basic Research (project no. 11-0400787-a) and by funds from the IUSM-NW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer JD, 2006, FASEB J, V20, P738, DOI 10.1096/fj.05-4821fje; Armand AS, 2003, ACTA PHYSIOL SCAND, V179, P75, DOI 10.1046/j.1365-201X.2003.01187.x; ARMSTRONG RB, 1991, SPORTS MED, V12, P184, DOI 10.2165/00007256-199112030-00004; Barash IA, 2002, AM J PHYSIOL-REG I, V283, pR958, DOI 10.1152/ajpregu.00185.2002; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; Benedini-Elias PC, 2013, ACTA HISTOCHEM; Biral D, 2000, ACTA NEUROPATHOL, V100, P618, DOI 10.1007/s004010000231; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Brussee V, 1997, NEUROMUSCULAR DISORD, V7, P487, DOI 10.1016/S0960-8966(97)00115-6; Carlin KRM, 2006, J ANIM SCI, V84, P925, DOI 10.2527/2006.844925x; CARTER GT, 1994, HISTOL HISTOPATHOL, V9, P443; Choi SJ, 2010, AM J PHYSIOL-CELL PH, V299, pC1409, DOI 10.1152/ajpcell.00226.2010; Friden J, 1998, CELL TISSUE RES, V293, P165, DOI 10.1007/s004410051108; Friden J, 2001, ACTA PHYSIOL SCAND, V171, P321, DOI 10.1046/j.1365-201x.2001.00834.x; Gauche E, 2009, J ELECTROMYOGR KINES, V19, pE481, DOI 10.1016/j.jelekin.2009.01.006; Hayward R, 1999, MED SCI SPORT EXER, V31, P414, DOI 10.1097/00005768-199903000-00010; Heck TG, 2011, CELL BIOCHEM FUNCT, V29, P215, DOI 10.1002/cbf.1739; Hnia K, 2008, AM J PATHOL, V172, P1509, DOI 10.2353/ajpath.2008.071009; Huang CC, 2008, EXP GERONTOL, V43, P571, DOI 10.1016/j.exger.2008.03.002; Huang CC, 2009, CHINESE J PHYSIOL, V52, P306, DOI 10.4077/CJP.2009.AMH068; Ingalls CP, 1998, J APPL PHYSIOL, V85, P58, DOI 10.1152/jappl.1998.85.1.58; Isner-Horobeti ME, 2013, SPORTS MED, V43, P483, DOI 10.1007/s40279-013-0052-y; Karagounis LG, 2010, EUR J APPL PHYSIOL, V109, P839, DOI 10.1007/s00421-010-1427-5; Kerksick CM, 2013, FOOD CHEM TOXICOL; Knoblauch MA, 2013, OBESITY, V21, P135, DOI 10.1002/oby.20253; Koh TJ, 2000, AM J PHYSIOL-CELL PH, V279, pC806, DOI 10.1152/ajpcell.2000.279.3.C806; Kostek MC, 2007, PHYSIOL GENOMICS, V31, P42, DOI 10.1152/physiolgenomics.00151.2006; Kyparos A, 2001, CAN J APPL PHYSIOL, V26, P323, DOI 10.1139/h01-020; Lanteri R, 2006, MICROSURG, V26, P25, DOI 10.1002/micr.20206; Lass A, 2002, MOL PHARMACOL, V61, P1081, DOI 10.1124/mol.61.5.1081; LIEBER RL, 1994, J APPL PHYSIOL, V77, P1926, DOI 10.1152/jappl.1994.77.4.1926; Lieber RL, 1996, J APPL PHYSIOL, V80, P278, DOI 10.1152/jappl.1996.80.1.278; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lollo PCB, 2013, J SPORT SCI MED, V12, P461; Lomonosova YN, 2013, DOKL BIOCHEM BIOPHYS, V452, P271, DOI 10.1134/S1607672913050177; Lomonosova YN, 2012, FASEB J, V26, P4295, DOI 10.1096/fj.12-204412; Lynch GS, 1997, CELL CALCIUM, V22, P373, DOI 10.1016/S0143-4160(97)90022-1; LYNN R, 1994, J APPL PHYSIOL, V77, P1439, DOI 10.1152/jappl.1994.77.3.1439; Magalhaes J, 2013, APPL PHYSIOL NUTR ME, V38, P401, DOI 10.1139/apnm-2012-0226; MICHETTI M, 1995, BIOCHEM BIOPH RES CO, V207, P1009, DOI 10.1006/bbrc.1995.1285; Mikkelsen UR, 2013, EUR J APPL PHYSIOL, V113, P1883, DOI 10.1007/s00421-013-2606-y; Murphy RM, 2013, J PHYSIOL-LONDON, V591, P719, DOI 10.1113/jphysiol.2012.243279; Murphy RM, 2007, J APPL PHYSIOL, V103, P926, DOI 10.1152/japplphysiol.01422.2006; Murphy RM, 2006, J PHYSIOL-LONDON, V576, P595, DOI 10.1113/jphysiol.2006.114090; Murphy RM, 2011, J APPL PHYSIOL, V111, P1448, DOI 10.1152/japplphysiol.00441.2011; Murphy RM, 2010, CLIN EXP PHARMACOL P, V37, P385, DOI 10.1111/j.1440-1681.2009.05310.x; Murphy RM, 2009, J BIOL CHEM, V284, P7811, DOI 10.1074/jbc.M808655200; Nedergaard A, 2007, J APPL PHYSIOL, V103, P1513, DOI 10.1152/japplphysiol.01445.2006; OBOLENSKAYA MY, 1994, BIOCHEM BIOPH RES CO, V202, P571, DOI 10.1006/bbrc.1994.1966; Okada A, 2008, MUSCLE NERVE, V38, P1246, DOI 10.1002/mus.21110; Pye D, 2007, J PHYSIOL-LONDON, V581, P309, DOI 10.1113/jphysiol.2006.125930; Rattray B, 2013, EUR J APPL PHYSIOL, V113, P427, DOI 10.1007/s00421-012-2446-1; Roberts CK, 1999, AM J PHYSIOL-ENDOC M, V277, pE390, DOI 10.1152/ajpendo.1999.277.2.E390; Sakurai T, 2013, J PHYSIOL SCI, V63, P263, DOI 10.1007/s12576-013-0262-y; Schoenfeld BJ, 2012, J STRENGTH COND RES, V26, P1441, DOI 10.1519/JSC.0b013e31824f207e; Smith HK, 1997, INT J SPORTS MED, V18, P94, DOI 10.1055/s-2007-972602; Sosnowski P, 2012, J PHYSIOL BIOCHEM, V68, P1, DOI 10.1007/s13105-011-0111-5; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; Stupka N, 2001, J APPL PHYSIOL, V91, P1669, DOI 10.1152/jappl.2001.91.4.1669; Takekura H, 2001, J PHYSIOL-LONDON, V533, P571, DOI 10.1111/j.1469-7793.2001.0571a.x; Vanin AF, 2002, METHOD ENZYMOL, V359, P27; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Xiao DS, 2003, MOL CELL BIOCHEM, V252, P65, DOI 10.1023/A:1025517216681; Yang YF, 2006, J APPL PHYSIOL, V101, P1442, DOI 10.1152/japplphysiol.00438.2006; Yu JG, 2002, HISTOCHEM CELL BIOL, V118, P171, DOI 10.1007/s00418-002-0427-x; Zhang BT, 2012, J APPL PHYSIOL, V112, P2077, DOI 10.1152/japplphysiol.00770.2011; Zhang JYS, 2004, AM J PHYSIOL-CELL PH, V287, pC292, DOI 10.1152/ajpcell.00018.2004	67	20	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94448	10.1371/journal.pone.0094448	http://dx.doi.org/10.1371/journal.pone.0094448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736629	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600070
J	Valapala, M; Maji, S; Borejdo, J; Vishwanatha, JK				Valapala, Mallika; Maji, Sayantan; Borejdo, Julian; Vishwanatha, Jamboor K.			Cell Surface Translocation of Annexin A2 Facilitates Glutamate-induced Extracellular Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PLASMINOGEN ACTIVATION; INTRACELLULAR CALCIUM; MEMBRANE-BINDING; DEATH; PHOSPHORYLATION; EXCITOTOXICITY; DEGENERATION; RECEPTORS; APOPTOSIS	Glutamate-induced elevation in intracellular Ca2+ has been implicated in excitotoxic cell death. Neurons respond to increased glutamate levels by activating an extracellular proteolytic cascade involving the components of the plasmin-plasminogen system. AnxA2 is a Ca2+ -dependent phospholipid binding protein and serves as an extracellular proteolytic center by recruiting the tissue plasminogen activator and plasminogen and mediating the localized generation of plasmin. Ratiometric Ca2+ imaging and time-lapse confocal microscopy demonstrated glutamate-induced Ca2+ influx. We showed that glutamate translocated both endogenous and AnxA2-GFP to the cell surface in a process dependent on the activity of the NMDA receptor. Glutamate-induced translocation of AnxA2 is dependent on the phosphorylation of tyrosine 23 at the N terminus, and mutation of tyrosine 23 to a non-phosphomimetic variant inhibits the translocation process. The cell surface-translocated AnxA2 forms an active plasmin-generating complex, and this activity can be neutralized by a hexapeptide directed against the N terminus. These results suggest an involvement of AnxA2 in potentiating glutamate-induced cell death processes.	[Valapala, Mallika; Maji, Sayantan; Vishwanatha, Jamboor K.] Univ N Texas, Hlth Sci Ctr, Dept Mol & Med Genet, Ft Worth, TX 76107 USA; [Borejdo, Julian] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Vishwanatha, JK (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Mol & Med Genet, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	jamboor.vishwanatha@unthsc.edu	Maji, Sayantan/AAB-7080-2019; Maji, Sayantan/AAB-7070-2019	Vishwanatha, Jamboor/0000-0002-0266-6020	National Institute on Minority Health and Health Disparities [1P20 MD006882]; National Institute on Minority Health and Health Disparities [P20MD006882] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institute on Minority Health and Health Disparities Grant 1P20 MD006882 (to J. K. V.).	ANKARCRONA M, 1995, NEURON, V15, P961, DOI 10.1016/0896-6273(95)90186-8; Bellagamba C, 1997, J BIOL CHEM, V272, P3195, DOI 10.1074/jbc.272.6.3195; Blanchard S, 1996, J NEUROCHEM, V67, P805; Burghardt TP, 2006, BIOCHEMISTRY-US, V45, P4058, DOI 10.1021/bi052097d; CESARMAN GM, 1994, J BIOL CHEM, V269, P21198; Cheung NS, 1998, NEUROPHARMACOLOGY, V37, P1419, DOI 10.1016/S0028-3908(98)00123-3; Chintala SK, 2006, EXP EYE RES, V82, P5, DOI 10.1016/j.exer.2005.07.013; Delyfer MN, 2005, MOL VIS, V11, P688; Deshet N, 2008, J CELL PHYSIOL, V216, P632, DOI 10.1002/jcp.21441; Doble A, 1999, PHARMACOL THERAPEUT, V81, P163, DOI 10.1016/S0163-7258(98)00042-4; Ferreira IL, 1996, EUR J PHARMACOL, V302, P153, DOI 10.1016/0014-2999(96)00044-1; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; GLENNEY JR, 1985, FEBS LETT, V192, P79, DOI 10.1016/0014-5793(85)80047-8; GOULD KL, 1986, MOL CELL BIOL, V6, P2738, DOI 10.1128/MCB.6.7.2738; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hajjar KA, 2000, ANN NY ACAD SCI, V902, P265; He KL, 2008, J BIOL CHEM, V283, P19192, DOI 10.1074/jbc.M800100200; Jacovina AT, 2001, J BIOL CHEM, V276, P49350, DOI 10.1074/jbc.M106289200; Kim J, 2002, FRONT BIOSCI-LANDMRK, V7, pD341, DOI 10.2741/kim; Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085; Lin YH, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-7; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu J, 2007, MOL CELL BIOCHEM, V303, P211, DOI 10.1007/s11010-007-9477-7; Longstaff C, 2002, FRONT BIOSCI-LANDMRK, V7, pD244, DOI 10.2741/longstaf; Ma JX, 2000, J BIOL CHEM, V275, P12806, DOI 10.1074/jbc.275.17.12806; Menell JS, 1999, NEW ENGL J MED, V340, P994, DOI 10.1056/NEJM199904013401303; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Nixon E, 2012, INVEST OPHTH VIS SCI, V53, P4739, DOI 10.1167/iovs.12-9517; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Prasanna G, 2002, INVEST OPHTH VIS SCI, V43, P2704; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; REGNOUF F, 1995, J BIOL CHEM, V270, P27143, DOI 10.1074/jbc.270.45.27143; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Roda O, 2003, J BIOL CHEM, V278, P5702, DOI 10.1074/jbc.M207605200; Santos-Carvalho A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.160; Sattler R, 2000, J MOL MED, V78, P3, DOI 10.1007/s001090000077; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Shen Y, 2006, MOL NEUROBIOL, V34, P163, DOI 10.1385/MN:34:3:163; Strickland S, 1996, COLD SPRING HARB SYM, V61, P739; Syrovets T, 2004, CELL MOL LIFE SCI, V61, P873, DOI 10.1007/s00018-003-3348-5; Tchedre KT, 2008, INVEST OPHTH VIS SCI, V49, P2577, DOI 10.1167/iovs.07-1101; Valapala M, 2011, J BIOL CHEM, V286, P30911, DOI 10.1074/jbc.M111.271155; Valapala M, 2011, J CELL SCI, V124, P1453, DOI 10.1242/jcs.079236; Vorwerk CK, 1999, SURV OPHTHALMOL, V43, pS142, DOI 10.1016/S0039-6257(99)00017-X	45	19	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					15915	15926		10.1074/jbc.M113.511550	http://dx.doi.org/10.1074/jbc.M113.511550			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24742684	Green Published, hybrid			2022-12-25	WOS:000337965700003
J	Wu, D; Chen, LX; Sun, QR; Wu, XT; Jia, SJ; Meng, AM				Wu, Di; Chen, Luxi; Sun, Qingrui; Wu, Xiaotong; Jia, Shunji; Meng, Anming			Uracil-DNA Glycosylase Is Involved in DNA Demethylation and Required for Embryonic Development in the Zebrafish Embryo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair (BER); Zebrafish; DNA Demethylation; DNA Transcription; Embryo; DNA Glycosylase; Zygotic Genome Activation; Nuclear Reprogramming	ZYGOTIC PATERNAL GENOME; BASE EXCISION-REPAIR; ESCHERICHIA-COLI; 5-METHYLCYTOSINE-DNA GLYCOSYLASE; ACTIVE DEMETHYLATION; GENE ACTIVATION; METHYLATION; MOUSE; DEAMINASE; COMPLEX	Uracil-DNA glycosylase (Ung) is a component of the base excision repair process and has the ability to remove uracil from U:G mispairs in DNA. However, its implications in development of vertebrate embryos are poorly understood. In this study, we found that zebrafish uracil-DNA glycosylase a (Unga) is maternally expressed at high levels and accumulated in nuclei during cleavage and blastulation periods. Knockdown of unga in zebrafish embryos causes an increase of the global DNA methylation level concomitantly with a reduction of overall transcriptional activity in the nucleus, ultimately resulting in embryonic lethality during segmentation period. Conversely, unga overexpression is sufficient to reduce the global DNA methylation level, to increase H3K4me3 and H3K27me3 marks, and to activate genome transcription. Furthermore, overexpression of unga(D132A) mRNA, encoding a mutant Unga without DNA glycosylase activity, does not affect global DNA methylation level, indicating that its involvement in DNA demethylation is dependent on its glycosylase activity. These results together suggest that Unga is implicated in postfertilization genomic DNA demethylation, zygotic gene transcription, and normal embryonic development in zebrafish.	[Wu, Di; Chen, Luxi; Sun, Qingrui; Wu, Xiaotong; Jia, Shunji; Meng, Anming] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Ctr Life Sci, State Key Lab Biomembrane & Membrane Engn, Beijing 100084, Peoples R China	Tsinghua University	Meng, AM (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	mengam@mail.tsinghua.edu.cn	Wu, Xiaotong/AAH-4566-2021; Meng, Anming/A-4785-2012	Meng, Anming/0000-0001-7228-3431; Wu, Xiaotong/0000-0002-4109-9444	Major Science Programs of China [2011CB943800]; National Natural Science Foundation of China [31330052, 31221064]	Major Science Programs of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Science Programs of China Grant 2011CB943800 and by National Natural Science Foundation of China Grants 31330052 and 31221064.	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Detich N, 2003, J BIOL CHEM, V278, P27586, DOI 10.1074/jbc.M303740200; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fu YF, 2009, BLOOD, V113, P1340, DOI 10.1182/blood-2008-08-174854; Gongal PA, 2011, DEV BIOL, V355, P55, DOI 10.1016/j.ydbio.2011.04.018; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hamm S, 2008, BIOORG MED CHEM LETT, V18, P1046, DOI 10.1016/j.bmcl.2007.12.027; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jiang L, 2013, CELL, V153, P773, DOI 10.1016/j.cell.2013.04.041; Jin SG, 2008, DEV DYNAM, V237, P3435, DOI 10.1002/dvdy.21767; JOST JP, 1995, J BIOL CHEM, V270, P9734, DOI 10.1074/jbc.270.17.9734; Jost JP, 2002, FEBS LETT, V519, P128, DOI 10.1016/S0014-5793(02)02737-0; JOST JP, 1995, GENE, V157, P265, DOI 10.1016/0378-1119(95)00036-6; Kapoor A, 2005, FEBS LETT, V579, P5889, DOI 10.1016/j.febslet.2005.08.039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Le May N, 2012, MOL CELL, V47, P622, DOI 10.1016/j.molcel.2012.05.050; LINDAHL T, 1977, J BIOL CHEM, V252, P3286; Lindeman LC, 2011, DEV CELL, V21, P993, DOI 10.1016/j.devcel.2011.10.008; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; MacKay AB, 2007, GENOME, V50, P778, DOI 10.1139/G07-055; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mhanni AA, 2004, DEV GENES EVOL, V214, P412, DOI 10.1007/s00427-004-0418-0; Oates AC, 2001, BLOOD, V98, P1792, DOI 10.1182/blood.V98.6.1792; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Patra SK, 2008, CANCER METAST REV, V27, P315, DOI 10.1007/s10555-008-9118-y; Potok ME, 2013, CELL, V153, P759, DOI 10.1016/j.cell.2013.04.030; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Roy TW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm1031; Sanchez A, 2012, MOL CELL BIOL, V32, P4445, DOI 10.1128/MCB.01062-12; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Santos F, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-39; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; SLUPPHAUG G, 1993, NUCLEIC ACIDS RES, V21, P2579, DOI 10.1093/nar/21.11.2579; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Sousa MML, 2007, MOL ASPECTS MED, V28, P276, DOI 10.1016/j.mam.2007.04.006; Stancheva I, 2002, DEV BIOL, V243, P155, DOI 10.1006/dbio.2001.0560; Vanderlaan G, 2005, DEV BIOL, V282, P550, DOI 10.1016/j.ydbio.2005.04.010; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Visnes T, 2009, PHILOS T R SOC B, V364, P563, DOI 10.1098/rstb.2008.0186; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Yergeau DA, 2005, DEV BIOL, V283, P97, DOI 10.1016/j.ydbio.2005.04.006; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597	55	19	23	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15463	15473		10.1074/jbc.M114.561019	http://dx.doi.org/10.1074/jbc.M114.561019			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24739389	Green Published, hybrid			2022-12-25	WOS:000337465400029
J	Nolen, BM; Brand, RE; Prosser, D; Velikokhatnaya, L; Allen, PJ; Zeh, HJ; Grizzle, WE; Lomakin, A; Lokshin, AE				Nolen, Brian M.; Brand, Randall E.; Prosser, Denise; Velikokhatnaya, Liudmila; Allen, Peter J.; Zeh, Herbert J.; Grizzle, William E.; Lomakin, Aleksey; Lokshin, Anna E.			Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study	PLOS ONE			English	Article							CELL-ADHESION MOLECULE; OVARIAN-CANCER; DUCTAL ADENOCARCINOMA; TISSUE INHIBITOR; SCREENING TRIAL; CA-19-9; DIAGNOSIS; EXPRESSION; PROTEIN; CEA	Background: The clinical management of pancreatic cancer is severely hampered by the absence of effective screening tools. Methods: Sixty-seven biomarkers were evaluated in prediagnostic sera obtained from cases of pancreatic cancer enrolled in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). Results: The panel of CA 19-9, OPN, and OPG, identified in a prior retrospective study, was not effective. CA 19-9, CEA, NSE, bHCG, CEACAM1 and PRL were significantly altered in sera obtained from cases greater than 1 year prior to diagnosis. Levels of CA 19-9, CA 125, CEA, PRL, and IL-8 were negatively associated with time to diagnosis. A training/validation study using alternate halves of the PLCO set failed to identify a biomarker panel with significantly improved performance over CA 19-9 alone. When the entire PLCO set was used for training at a specificity (SP) of 95%, a panel of CA 19-9, CEA, and Cyfra 21-1 provided significantly elevated sensitivity (SN) levels of 32.4% and 29.7% in samples collected <1 and >1 year prior to diagnosis, respectively, compared to SN levels of 25.7% and 17.2% for CA 19-9 alone. Conclusions: Most biomarkers identified in previously conducted case/control studies are ineffective in prediagnostic samples, however several biomarkers were identified as significantly altered up to 35 months prior to diagnosis. Two newly derived biomarker combinations offered advantage over CA 19-9 alone in terms of SN, particularly in samples collected >1 year prior to diagnosis. However, the efficacy of biomarker-based tools remains limited at present. Several biomarkers demonstrated significant velocity related to time to diagnosis, an observation which may offer considerable potential for enhancements in early detection.	[Nolen, Brian M.; Prosser, Denise; Velikokhatnaya, Liudmila; Zeh, Herbert J.; Lokshin, Anna E.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA; [Brand, Randall E.] Univ Pittsburgh, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA USA; [Brand, Randall E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Allen, Peter J.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Zeh, Herbert J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Grizzle, William E.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Lomakin, Aleksey] MIT, Dept Phys, Cambridge, MA 02139 USA; [Lokshin, Anna E.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Lokshin, Anna E.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Lokshin, Anna E.] Univ Pittsburgh, Sch Med, Dept Ob Gyn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Alabama System; University of Alabama Birmingham; Massachusetts Institute of Technology (MIT); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lokshin, AE (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA.	lokshina@pitt.edu			NIH [2R01CA108990, U01CA117452, 5P30 CA047904 23]; NATIONAL CANCER INSTITUTE [P50CA101955, P30CA047904, U01CA117452, R01CA108990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding provided in the following NIH awards: 2R01CA108990, U01CA117452, and 5P30 CA047904 23. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura N, 2001, CANCER RES, V61, P6548; Ballehaninna UK, 2013, TUMOUR BIOL; Ben QW, 2011, ONCOL REP, V25, P709, DOI 10.3892/or.2011.1140; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloomston M, 2002, J SURG RES, V102, P35, DOI 10.1006/jsre.2001.6317; Boeck S, 2013, BRIT J CANCER, V108, P1684, DOI 10.1038/bjc.2013.158; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Brand RE, 2011, CLIN CANCER RES, V17, P805, DOI 10.1158/1078-0432.CCR-10-0248; Chari ST, 2005, GASTROENTEROLOGY, V129, P504, DOI 10.1053/j.gastro.2005.05.007; Chen JZ, 2007, J CHROMATOGR A, V1162, P117, DOI 10.1016/j.chroma.2007.03.096; Chen J, 2013, ONCOL LETT, V6, P43, DOI 10.3892/ol.2013.1326; Chen J, 2013, J CANCER RES CLIN, V139, P1117, DOI 10.1007/s00432-013-1422-4; Chen R, 2010, PANCREAS, V39, P981, DOI 10.1097/MPA.0b013e3181dac920; Damiano J, 2004, DIABETES METAB, V30, P203, DOI 10.1016/S1262-3636(07)70111-8; DIETEL M, 1986, J CANCER RES CLIN, V111, P257, DOI 10.1007/BF00389242; Douglas JB, 2010, CANCER EPIDEM BIOMAR, V19, P2298, DOI 10.1158/1055-9965.EPI-10-0400; Duraker N, 2007, J SURG ONCOL, V95, P142, DOI 10.1002/jso.20604; Ehmann M, 2007, PANCREAS, V34, P205, DOI 10.1097/01.mpa.0000250128.57026.b2; El-Mesallamy HO, 2013, PANCREAS, V42, P149, DOI 10.1097/MPA.0b013e3182550d9d; Faca VM, 2008, PLOS MED, V5, P953, DOI 10.1371/journal.pmed.0050123; Gonda TA, 2011, J PANCREAS, V12, P322; Goonetilleke KS, 2007, EJSO-EUR J SURG ONC, V33, P266, DOI 10.1016/j.ejso.2006.10.004; Gorelik E, 2005, CANCER EPIDEM BIOMAR, V14, P981, DOI 10.1158/1055-9965.EPI-04-0404; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Harsha HC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000046; Hawass NED, 1997, BRIT J RADIOL, V70, P360, DOI 10.1259/bjr.70.832.9166071; Howlader N, 2012, SEER CANC STAT REV 1; Kaur S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055171; Kleeff J, 2004, PANCREAS, V28, P25, DOI 10.1097/00006676-200401000-00004; Kommann M, 2000, ANN SURG, V231, P368, DOI 10.1097/00000658-200003000-00010; Koopmann J, 2004, CLIN CANCER RES, V10, P2386, DOI 10.1158/1078-0432.CCR-03-0165; Koopmann J, 2004, CANCER EPIDEM BIOMAR, V13, P487; Louhimo J, 2004, ONCOLOGY-BASEL, V66, P126, DOI 10.1159/000077438; Michaud D S, 2004, Minerva Chir, V59, P99; Michaud DS, 2007, CANCER EPIDEM BIOMAR, V16, P2101, DOI 10.1158/1055-9965.EPI-07-0182; Mroczko B, 2010, J CLIN LAB ANAL, V24, P256, DOI 10.1002/jcla.20395; Mroczko B, 2009, PANCREAS, V38, P613, DOI 10.1097/MPA.0b013e3181a488a0; O'Neal RL, 2013, HUM PATHOL, V44, P734, DOI 10.1016/j.humpath.2012.07.017; ONA FV, 1973, CANCER, V31, P324, DOI 10.1002/1097-0142(197302)31:2<324::AID-CNCR2820310208>3.0.CO;2-Y; Park HD, 2012, PROTEOMICS, V12, P3590, DOI 10.1002/pmic.201200101; Pelaez-Luna M, 2007, AM J GASTROENTEROL, V102, P2157, DOI 10.1111/j.1572-0241.2007.01480.x; Poruk KE, 2013, CURR MOL MED, V13, P340; Poruk KE, 2013, PANCREAS, V42, P193, DOI 10.1097/MPA.0b013e31825e354d; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; SCHMIEGEL WH, 1985, HEPATO-GASTROENTEROL, V32, P141; Shin EJ, 2012, GASTROENTEROL CLIN N, V41, P143, DOI 10.1016/j.gtc.2011.12.001; Simeone DM, 2007, PANCREAS, V34, P436, DOI 10.1097/MPA.0b013e3180333ae3; Skates SJ, 2012, INT J GYNECOL CANCER, V22, pS24, DOI 10.1097/IGC.0b013e318256488a; Sohn T A, 2000, Adv Surg, V34, P249; Strickland LA, 2009, J PATHOL, V218, P380, DOI 10.1002/path.2545; Syrigos KN, 1998, GUT, V42, P88, DOI 10.1136/gut.42.1.88; Tachezy M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039018; Tezel E, 2001, PANCREAS, V22, P122, DOI 10.1097/00006676-200103000-00003; Wigmore SJ, 2002, INT J ONCOL, V21, P881; Xie MJ, 2002, PANCREAS, V25, P234, DOI 10.1097/00006676-200210000-00004; Xu DH, 2010, J SURG ONCOL, V102, P469, DOI 10.1002/jso.21530; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484	58	57	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94928	10.1371/journal.pone.0094928	http://dx.doi.org/10.1371/journal.pone.0094928			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747429	Green Published, Green Submitted, gold			2022-12-25	WOS:000335226500045
J	Aizawa, M; Suzuki, Y; Suzuki, H; Pang, HH; Kihara, M; Nakata, J; Yamaji, K; Horikoshi, S; Tomino, Y				Aizawa, Masashi; Suzuki, Yusuke; Suzuki, Hitoshi; Pang, Huihua; Kihara, Masao; Nakata, Junichiro; Yamaji, Kenji; Horikoshi, Satoshi; Tomino, Yasuhiko			Uncoupling of Glomerular IgA Deposition and Disease Progression in Alymphoplasia Mice with IgA Nephropathy	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; CHEMOATTRACTANT PROTEIN (MCP)-1; CIRCULATING IMMUNE-COMPLEXES; STEROID PULSE THERAPY; FACTOR-KAPPA-B; BONE-MARROW; MESANGIAL CELLS; PERIPHERAL-BLOOD; O-GLYCOSYLATION; CELIAC-DISEASE	Previous clinical and experimental studies have indicated that cells responsible for IgA nephropathy (IgAN), at least in part, are localized in bone marrow (BM). Indeed, we have demonstrated that murine IgAN can be experimentally reconstituted by bone marrow transplantation (BMT) from IgAN prone mice in not only normal mice, but also in alymphoplasia mice (aly/aly) independent of IgA(+) cells homing to mucosa or secondary lymphoid tissues. The objective of the present study was to further assess whether secondary lymph nodes (LN) contribute to the progression of this disease. BM cells from the several lines of IgAN prone mice were transplanted into aly/aly and wild-type mice (B6). Although the transplanted aly/aly showed the same degree of mesangial IgA and IgG deposition and the same serum elevation levels of IgA and IgA-IgG immune-complexes (IC) as B6, even in extent, the progression of glomerular injury was observed only in B6. This uncoupling in aly/aly was associated with a lack of CD4(+) T cells and macrophage infiltration, although phlogogenic capacity to nephritogenic IC of renal resident cells was identical between both recipients. It is suggested that secondary LN may be required for the full progression of IgAN after nephritogenic IgA and IgA/IgG IC deposition.	[Aizawa, Masashi; Suzuki, Yusuke; Suzuki, Hitoshi; Pang, Huihua; Kihara, Masao; Nakata, Junichiro; Yamaji, Kenji; Horikoshi, Satoshi; Tomino, Yasuhiko] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan	Juntendo University	Tomino, Y (corresponding author), Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Tokyo, Japan.	yasu@juntendo.ac.jp			Ministry of Health, Labor and Welfare of Japan; Study Group on IgA Nephropathy in Japan; Grants-in-Aid for Scientific Research [26461240] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Study Group on IgA Nephropathy in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A part of this study was supported by research funds from Grant-in-Aid for Progressive Renal Disease Research, Research on Intractable Disease, from the Ministry of Health, Labor and Welfare of Japan and a grant from the Study Group on IgA Nephropathy in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa M, 2007, CONTRIB NEPHROL, V157, P164, DOI 10.1159/000102462; Allen AC, 2001, KIDNEY INT, V60, P969, DOI 10.1046/j.1523-1755.2001.060003969.x; BAKE AWLV, 1988, AM J KIDNEY DIS, V12, P410, DOI 10.1016/S0272-6386(88)80036-2; BAKE AWLV, 1989, J CLIN INVEST, V84, P1070, DOI 10.1172/JCI114269; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; BERGER J, 1968, J UROL NEPHROL, V74, P694; Chen YM, 2003, NEPHROL DIAL TRANSPL, V18, P2505, DOI 10.1093/ndt/gfg457; CLARKSON AR, 1984, CLIN NEPHROL, V21, P7; COPPO R, 1989, LAB INVEST, V60, P499; Couzi L, 2007, ARTHRITIS RHEUM, V56, P2362, DOI 10.1002/art.22654; deFijter JW, 1996, KIDNEY INT, V50, P952, DOI 10.1038/ki.1996.396; EMANCIPATOR SN, 1990, KIDNEY INT, V38, P1216, DOI 10.1038/ki.1990.337; ENDO Y, 1986, KIDNEY INT, V29, P557, DOI 10.1038/ki.1986.34; FEEHALLY J, 1986, KIDNEY INT, V30, P924, DOI 10.1038/ki.1986.274; Gharavi AG, 2000, NAT GENET, V26, P354, DOI 10.1038/81677; Gharavi AG, 2008, J AM SOC NEPHROL, V19, P1008, DOI 10.1681/ASN.2007091052; Glassock RJ, 2009, J CLIN INVEST, V119, P1450, DOI 10.1172/JCI39189; Gomez-Guerrero C, 2002, KIDNEY INT, V62, P2022, DOI 10.1046/j.1523-1755.2002.00653.x; Harper SJ, 1996, J CLIN PATHOL, V49, P38, DOI 10.1136/jcp.49.1.38; Hashimoto A, 2012, AM J PATHOL, V181, P1338, DOI 10.1016/j.ajpath.2012.06.038; Hiki Y, 2001, KIDNEY INT, V59, P1077, DOI 10.1046/j.1523-1755.2001.00591.x; IMAI H, 1985, KIDNEY INT, V27, P756, DOI 10.1038/ki.1985.76; Iwata Y, 2006, INTERNAL MED, V45, P1291, DOI 10.2169/internalmedicine.45.1837; JESSEN RH, 1992, LAB INVEST, V67, P379; Kajiyama T, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/819646; Kanamaru Y, 2003, NEPHRON EXP NEPHROL, V95, pE36, DOI 10.1159/000073022; Katafuchi R, 1998, CLIN NEPHROL, V49, P1; KATZ A, 1979, CLIN NEPHROL, V11, P39; Komatsu H, 2008, CLIN J AM SOC NEPHRO, V3, P1301, DOI 10.2215/CJN.00310108; Lopez-Franco O, 2002, AM J PATHOL, V161, P1497, DOI 10.1016/S0002-9440(10)64425-2; MOORTHY AV, 1978, JAMA-J AM MED ASSOC, V239, P2019, DOI 10.1001/jama.239.19.2019; NAKAMOTO Y, 1981, VIRCHOWS ARCH A, V392, P45, DOI 10.1007/BF00430547; Nakata J, 2013, NEPHROL DIAL TRANSPL, V28, P320, DOI 10.1093/ndt/gfs467; NICHOLLS KM, 1984, Q J MED, V53, P227; Nishie T, 2007, AM J PATHOL, V170, P447, DOI 10.2353/ajpath.2007.060559; Okazaki K, 2012, J AM SOC NEPHROL, V23, P1364, DOI 10.1681/ASN.2011121160; Ozawa Y, 2007, AM J PHYSIOL-RENAL, V292, pF330, DOI 10.1152/ajprenal.00059.2006; PESTKA JJ, 1989, FOOD CHEM TOXICOL, V27, P361, DOI 10.1016/0278-6915(89)90141-5; Saitoh A, 1998, J CLIN LAB ANAL, V12, P1, DOI 10.1002/(SICI)1098-2825(1998)12:1<1::AID-JCLA1>3.0.CO;2-F; Sakai H, 1997, NEPHROLOGY, V3, P91, DOI 10.1111/j.1440-1797.1997.tb00196.x; Sato D, 2012, NEPHROL DIAL TRANSPL, V27, P1090, DOI 10.1093/ndt/gfr403; Sato M, 2003, NEPHRON CLIN PRACT, V93, pC137, DOI 10.1159/000070233; SHIMIZU M, 1992, NEPHRON, V62, P328, DOI 10.1159/000187068; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; STAHL RAK, 1993, KIDNEY INT, V44, P1036, DOI 10.1038/ki.1993.346; Summers SA, 2009, J AM SOC NEPHROL, V20, P2518, DOI 10.1681/ASN.2009030337; Suzuki H, 2007, KIDNEY INT, V72, P319, DOI 10.1038/sj.ki.5002300; Suzuki H, 2005, J AM SOC NEPHROL, V16, P1289, DOI 10.1681/ASN.2004030219; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; Suzuki K, 2005, P NATL ACAD SCI USA, V102, P2482, DOI 10.1073/pnas.0409539102; Suzuki Y, 2003, J IMMUNOL, V170, P3243, DOI 10.4049/jimmunol.170.6.3243; Suzuki Y, 1998, KIDNEY INT, V54, P1166, DOI 10.1046/j.1523-1755.1998.00108.x; Suzuki Y, 2002, J IMMUNOL, V169, P4136, DOI 10.4049/jimmunol.169.8.4136; Suzuki Y, 2007, CONTRIB NEPHROL, V157, P70, DOI 10.1159/000102307; Takei T, 2002, AM J HUM GENET, V70, P781, DOI 10.1086/339077; Tomana M, 1999, J CLIN INVEST, V104, P73, DOI 10.1172/JCI5535; TOMINO Y, 1981, NEW ENGL J MED, V305, P1159; Tsuge T, 2003, INFLAMM RES, V52, P428, DOI 10.1007/s00011-003-1200-x; van Es LA, 2008, KIDNEY INT, V73, P1426, DOI 10.1038/ki.2008.66; VARIS J, 1993, J CLIN PATHOL, V46, P607, DOI 10.1136/jcp.46.7.607; Wilson C, 1996, RENAL RESPONSE GLOME, P1253; WOODROFFE AJ, 1982, SPRINGER SEMIN IMMUN, V5, P321, DOI 10.1007/BF01892091; Xie YS, 2004, KIDNEY INT, V65, P1135, DOI 10.1111/j.1523-1755.2004.00486.x	65	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95365	10.1371/journal.pone.0095365	http://dx.doi.org/10.1371/journal.pone.0095365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743510	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100111
J	Bild, DE; McClelland, R; Kaufman, JD; Blumenthal, R; Burke, GL; Carr, JJ; Post, WS; Register, TC; Shea, S; Szklo, M				Bild, Diane E.; McClelland, Robyn; Kaufman, Joel D.; Blumenthal, Roger; Burke, Gregory L.; Carr, J. Jeffrey; Post, Wendy S.; Register, Thomas C.; Shea, Steven; Szklo, Moyses			Ten-Year Trends in Coronary Calcification in Individuals without Clinical Cardiovascular Disease in the Multi-Ethnic Study of Atherosclerosis	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; ARTERY RISK DEVELOPMENT; HEART-DISEASE; YOUNG-ADULTS; MYOCARDIAL-INFARCTION; UNITED-STATES; CARDIA; REGRESSION; CALCIUM; MESA	Background: Coronary heart disease (CHD) incidence has declined significantly in the US, as have levels of major coronary risk factors, including LDL-cholesterol, hypertension and smoking, but whether trends in subclinical atherosclerosis mirror these trends is not known. Methods and Findings: To describe recent secular trends in subclinical atherosclerosis as measured by serial evaluations of coronary artery calcification (CAC) prevalence in a population over 10 years, we measured CAC using computed tomography (CT) and CHD risk factors in five serial cross-sectional samples of men and women from four race/ethnic groups, aged 55-84 and without clinical cardiovascular disease, who were members of Multi-Ethnic Study of Atherosclerosis (MESA) cohort from 2000 to 2012. Sample sizes ranged from 1062 to 4837. After adjusting for age, gender, and CT scanner, the prevalence of CAC increased across exams among African Americans, whose prevalence of CAC was 52.4% in 2000-02, 50.4% in 2003-04, 60.0% is 2005-06, 57.4% in 2007-08, and 61.3% in 2010-12 (p for trend <0.001). The trend was strongest among African Americans aged 55-64 [prevalence ratio for 2010-12 vs. 2000-02, 1.59 (95% confidence interval 1.06, 2.39); p = 0.005 for trend across exams]. There were no consistent trends in any other ethnic group. Risk factors generally improved in the cohort, and adjustment for risk factors did not change trends in CAC prevalence. Conclusions: There was a significant secular trend towards increased prevalence of CAC over 10 years among African Americans and no change in three other ethnic groups. Trends did not reflect concurrent general improvement in risk factors. The trend towards a higher prevalence of CAC in African Americans suggests that CHD risk in this population is not improving relative to other groups.	[Bild, Diane E.] NHLBI, Div Cardiovasc Sci, Bethesda, MD 20892 USA; [McClelland, Robyn] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Kaufman, Joel D.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Blumenthal, Roger; Post, Wendy S.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Post, Wendy S.; Szklo, Moyses] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Burke, Gregory L.; Register, Thomas C.] Wake Forest Sch Med, Winston Salem, NC USA; [Carr, J. Jeffrey] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Shea, Steven] Columbia Univ, New York, NY USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Wake Forest University; Vanderbilt University; Columbia University	Bild, DE (corresponding author), NHLBI, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA.	dbild@pcori.org	Blumenthal, Roger S/H-3223-2018; Carr, John/AAN-7531-2021; Kaufman, Joel/B-5761-2008	Blumenthal, Roger S/0000-0003-1910-3168; Carr, John/0000-0002-4398-8237; Register, Thomas/0000-0002-4078-0166; Szklo, Moyses/0000-0001-9433-6266; Kaufman, Joel/0000-0003-4174-9037	NCATS NIH HHS [UL1-TR-000040] Funding Source: Medline; NCRR NIH HHS [UL1-RR-025005] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Anderssen N, 1996, AM J EPIDEMIOL, V143, P351, DOI 10.1093/oxfordjournals.aje.a008749; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Bild DE, 1996, ANN EPIDEMIOL, V6, P235, DOI 10.1016/1047-2797(96)00005-1; BLANKENHORN D, 1961, AM J MED SCI, V242, P1, DOI 10.1097/00000441-196107000-00001; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Cohen JD, 2010, AM J CARDIOL, V106, P969, DOI 10.1016/j.amjcard.2010.05.030; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Dragano N, 2007, EUR J CARDIOV PREV R, V14, P568, DOI 10.1097/HJR.0b013e32804955c4; Fang Jing, 2011, Morbidity and Mortality Weekly Report, V60, P1377; Fryar CD, 2012, NCHS DATA BRIEF; Henein MY, 2011, INT J CARDIOL, V153, P31, DOI 10.1016/j.ijcard.2010.08.031; Hong MK, 2009, JACC-CARDIOVASC INTE, V2, P679, DOI 10.1016/j.jcin.2009.03.015; Jacobs DR, 1999, STAT MED, V18, P655, DOI 10.1002/(SICI)1097-0258(19990330)18:6<655::AID-SIM62>3.0.CO;2-U; Kaufman JD, 2012, AM J EPIDEMIOL, V176, P825, DOI 10.1093/aje/kws169; King DE, 2009, AM J MED, V122, P528, DOI 10.1016/j.amjmed.2008.11.013; Lopez-Jimenez F, 2009, CIRC-CARDIOVASC QUAL, V2, P443, DOI 10.1161/CIRCOUTCOMES.108.847202; Meigs JB, 2002, DIABETES CARE, V25, P1313, DOI 10.2337/diacare.25.8.1313; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; National Heart L, 2009, 2009 CHART BOOK CARD; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Nozue T, 2012, AM J CARDIOL, V109, P1247, DOI 10.1016/j.amjcard.2011.12.016; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Sangiorgi G, 1998, J AM COLL CARDIOL, V31, P126, DOI 10.1016/S0735-1097(97)00443-9; Schurgin S, 2001, DIABETES CARE, V24, P335, DOI 10.2337/diacare.24.2.335; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Tintut Y, 2001, CURR OPIN LIPIDOL, V12, P555, DOI 10.1097/00041433-200110000-00012; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yoon Sung Sug Sarah, 2010, NCHS Data Brief, P1	33	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94916	10.1371/journal.pone.0094916	http://dx.doi.org/10.1371/journal.pone.0094916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743658	gold, Green Submitted, Green Published			2022-12-25	WOS:000335309100050
J	Chien, CI; Chen, YW; Wu, YH; Chang, CY; Wang, TL; Wang, CC				Chien, Chin-I; Chen, Yu-Wei; Wu, Yi-Hua; Chang, Chih-Yao; Wang, Tzu-Ling; Wang, Chien-Chia			Functional Substitution of a Eukaryotic Glycyl-tRNA Synthetase with an Evolutionarily Unrelated Bacterial Cognate Enzyme	PLOS ONE			English	Article							THERMUS-THERMOPHILUS; GENE ENCODES; MITOCHONDRIAL; RECOGNITION; TRANSLATION; FEATURES; INTERRELATION; GLN-TRNA(GLN); DIVERGENCE; EXPRESSION	Two oligomeric types of glycyl-tRNA synthetase (GlyRS) are found in nature: a alpha(2) type and a alpha(2)beta(2) type. The former has been identified in all three kingdoms of life and often pairs with tRNA(Gly) that carries an A73 discriminator base, while the latter is found only in bacteria and chloroplasts and is almost always coupled with tRNA(Gly) that contains U73. In the yeast Saccharomyces cerevisiae, a single GlyRS gene, GRS1, provides both the cytoplasmic and mitochondrial functions, and tRNA(Gly) isoacceptors in both compartments possess A73. We showed herein that Homo sapiens and Arabidopsis thaliana cytoplasmic GlyRSs (both alpha(2)-type enzymes) can rescue both the cytoplasmic and mitochondrial defects of a yeast grs1(-) strain, while Escherichia coli GlyRS (a alpha(2)beta(2)-type enzyme) and A. thaliana organellar GlyRS (a (alpha beta)(2)-type enzyme) failed to rescue either defect of the yeast mull allele. However, a head-to-tail alpha beta fusion of E. coli GlyRS effectively supported the mitochondrial function. Our study suggests that a alpha(2)-type eukaryotic GlyRS may be functionally substituted with a alpha(2)beta(2)-type bacterial cognate enzyme despite their remote evolutionary relationships.	[Chien, Chin-I; Wu, Yi-Hua; Chang, Chih-Yao; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan; [Chen, Yu-Wei] Landseed Hosp, Dept Neurol, Ping Jen, Taiwan; [Wang, Tzu-Ling] Natl Hsinchu Univ Educ, Grad Inst Math & Sci Educ, Hsinchu, Taiwan	National Central University; National Tsing Hua University	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Jhongli, Taiwan.	dukewang@cc.ncu.edu.tw			National Science Council (Taipei, Taiwan) [NSC101-3113-B-008-001-MY3, NSC102-2311-B-008-004-MY3]; National Central University [NCU-LSH-102-A-002]; Landseed Hospital	National Science Council (Taipei, Taiwan)(Ministry of Science and Technology, Taiwan); National Central University; Landseed Hospital	This work was supported in part by grants (NSC101-3113-B-008-001-MY3 and NSC102-2311-B-008-004-MY3 to CCW) from the National Science Council (Taipei, Taiwan) and in part by a grant (NCU-LSH-102-A-002) from the National Central University and Landseed Hospital Joint Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev DE, 2012, NUCLEIC ACIDS RES, V40, P5602, DOI 10.1093/nar/gks182; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Bullard JN, 1999, J MOL BIOL, V288, P567, DOI 10.1006/jmbi.1999.2708; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang CP, 2012, NUCLEIC ACIDS RES, V40, P314, DOI 10.1093/nar/gkr724; Chang Chia-Pei, 2008, J Biol Chem, V283, P30699, DOI 10.1074/jbc.M805339200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Chen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033363; Chen SJ, 2011, ACS CHEM BIOL, V6, P1182, DOI 10.1021/cb200240a; Chen SJ, 2009, J BIOL CHEM, V284, P818, DOI 10.1074/jbc.M804378200; Chiu WC, 2010, MOL BIOL EVOL, V27, P1415, DOI 10.1093/molbev/msq025; Chiu WC, 2009, J BIOL CHEM, V284, P23954, DOI 10.1074/jbc.M109.031047; Duchene AM, 2001, J BIOL CHEM, V276, P15275, DOI 10.1074/jbc.M011525200; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Huang HY, 2006, J BIOL CHEM, V281, P31430, DOI 10.1074/jbc.M601869200; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; Liao CC, 2012, NUCLEIC ACIDS RES, V40, P9171, DOI 10.1093/nar/gks689; MarechalDrouard L, 1995, METHOD ENZYMOL, V260, P310, DOI 10.1016/0076-6879(95)60148-1; Mazauric MH, 1996, EUR J BIOCHEM, V241, P814, DOI 10.1111/j.1432-1033.1996.00814.x; Mazauric MH, 1999, BIOCHEMISTRY-US, V38, P13094, DOI 10.1021/bi991392t; Mazauric MH, 1998, EUR J BIOCHEM, V251, P744, DOI 10.1046/j.1432-1327.1998.2510744.x; NADA S, 1993, J BIOL CHEM, V268, P7660; Nameki N, 1997, J MOL BIOL, V268, P640, DOI 10.1006/jmbi.1997.0993; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; OSTREM DL, 1970, P NATL ACAD SCI USA, V67, P1967, DOI 10.1073/pnas.67.4.1967; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; TOTH MJ, 1986, J BIOL CHEM, V261, P6643; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Whelihan EF, 1997, EMBO J, V16, P2968, DOI 10.1093/emboj/16.10.2968; WILLIAMS J, 1995, NUCLEIC ACIDS RES, V23, P1307, DOI 10.1093/nar/23.8.1307	38	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94659	10.1371/journal.pone.0094659	http://dx.doi.org/10.1371/journal.pone.0094659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743154	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100038
J	Kikawa, K; Sakano, D; Shiraki, N; Tsuyama, T; Kume, K; Endo, F; Kume, S				Kikawa, Kazuhide; Sakano, Daisuke; Shiraki, Nobuaki; Tsuyama, Tomonori; Kume, Kazuhiko; Endo, Fumio; Kume, Shoen			Beneficial Effect of Insulin Treatment on Islet Transplantation Outcomes in Akita Mice	PLOS ONE			English	Article							BETA-CELL MASS; EMBRYONIC STEM-CELLS; GROWTH; HYPERGLYCEMIA; ACID; DIFFERENTIATION; DYSFUNCTION; INDUCTION; SCAFFOLDS; REVERSAL	Islet transplantation is a promising potential therapy for patients with type 1 diabetes. The outcome of islet transplantation depends on the transplantation of a sufficient amount of beta-cell mass. However, the initial loss of islets after transplantation is problematic. We hypothesized the hyperglycemic status of the recipient may negatively affect graft survival. Therefore, in the present study, we evaluated the effect of insulin treatment on islet transplantation involving a suboptimal amount of islets in Akita mice, which is a diabetes model mouse with an Insulin 2 gene missense mutation. Fifty islets were transplanted under the left kidney capsule of the recipient mouse with or without insulin treatment. For insulin treatment, sustained-release insulin implants were implanted subcutaneously into recipient mice 2 weeks before transplantation and maintained for 4 weeks. Islet transplantation without insulin treatment did not reverse hyperglycemia. In contrast, the group that received transplants in combination with insulin treatment exhibited improved fasting blood glucose levels until 18 weeks after transplantation, even after insulin treatment was discontinued. The group that underwent islet transplantation in combination with insulin treatment had better glucose tolerance than the group that did not undergo insulin treatment. Insulin treatment improved graft survival from the acute phase (i.e., 1 day after transplantation) to the chronic phase (i.e., 18 weeks after transplantation). Islet apoptosis increased with increasing glucose concentration in the medium or blood in both the in vitro culture and in vivo transplantation experiments. Expression profile analysis of grafts indicated that genes related to immune response, chemotaxis, and inflammatory response were specifically upregulated when islets were transplanted into mice with hyperglycemia compared to those with normoglycemia. Thus, the results demonstrate that insulin treatment protects islets from the initial rapid loss that is usually observed after transplantation and positively affects the outcome of islet transplantation in Akita mice.	[Kikawa, Kazuhide; Endo, Fumio] Kumamoto Univ, Grad Sch Med Sci, Dept Pediat, Chuo Ku, Kumamoto, Japan; [Kikawa, Kazuhide; Sakano, Daisuke; Shiraki, Nobuaki; Tsuyama, Tomonori; Kume, Kazuhiko; Kume, Shoen] Kumamoto Univ, Dept Stem Cell Biol, Inst Mol Embryol & Genet, Chuo Ku, Kumamoto, Japan; [Kume, Shoen] Kumamoto Univ, Program Leading Grad Sch, HIGO Hlth Life Sci Interdisciplinary & Glocal Ori, Chuo Ku, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Kume, S (corresponding author), Kumamoto Univ, Dept Stem Cell Biol, Inst Mol Embryol & Genet, Chuo Ku, Kumamoto, Japan.	skume@kumamoto-u.ac.jp	Kume, Shoen/M-4356-2016	Kume, Shoen/0000-0002-4292-205X; Kume, Kazuhiko/0000-0003-4232-1657; Sakano, Daisuke/0000-0001-5305-5556; shiraki, nobuaki/0000-0001-6708-9976	Funding Program for Next Generation World-Leading Researchers [LS099]; Japanese Society for the Promotion of Science; Realization of Regenerative Medicine; Program for Leading Graduate Schools "HIGO"; Ministry of Education, Culture, Sports, Science and Technology, Japan [21390280, 22790653]; MEXT, Japan; Grants-in-Aid for Scientific Research [26253059] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Realization of Regenerative Medicine; Program for Leading Graduate Schools "HIGO"; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the "Funding Program for Next Generation World-Leading Researchers'' (awarded to S.K., no. LS099), the Japanese Society for the Promotion of Science, the Realization of Regenerative Medicine (awarded to S.K.), the Program for Leading Graduate Schools "HIGO" (awarded to S.K.), Grants-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant no. 21390280, awarded to S.K. and #22790653 to D.S.), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; ArRajab A, 1996, PANCREAS, V13, P372, DOI 10.1097/00006676-199611000-00006; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Biarnes M, 2002, DIABETES, V51, P66, DOI 10.2337/diabetes.51.1.66; Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Deeds MC, 2011, LAB ANIM-UK, V45, P131, DOI 10.1258/la.2010.010090; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; FERRAND N, 1995, AM J PHYSIOL-CELL PH, V269, pC1250, DOI 10.1152/ajpcell.1995.269.5.C1250; Jamiolkowski Ryan M., 2012, Yale Journal of Biology and Medicine, V85, P37; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Jonas JC, 2009, DIABETES OBES METAB, V11, P65, DOI 10.1111/j.1463-1326.2009.01112.x; JUANG JH, 1994, DIABETES, V43, P1334, DOI 10.2337/diabetes.43.11.1334; Kataoka M, 2013, BIOCHEM BIOPH RES CO, V430, P1103, DOI 10.1016/j.bbrc.2012.12.030; KEYMEULEN B, 1993, TRANSPLANTATION, V56, P60, DOI 10.1097/00007890-199307000-00010; Koh A, 2010, TRANSPLANTATION, V89, P465, DOI 10.1097/TP.0b013e3181c478fd; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lai Y, 2009, ISLETS, V1, P19, DOI 10.4161/isl.1.1.8530; Linn T, 2006, CLIN EXP IMMUNOL, V144, P179, DOI 10.1111/j.1365-2249.2006.03066.x; Makhlouf L, 2003, TRANSPLANTATION, V76, P657, DOI 10.1097/01.TP.0000080881.75767.0E; Mathews CE, 2002, TRANSPLANTATION, V73, P1333, DOI 10.1097/00007890-200204270-00024; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matsumoto S, 2011, CELL TRANSPLANT, V20, P1641, DOI 10.3727/096368910X564058; Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360; McCall M, 2011, SURGERY, V150, P48, DOI 10.1016/j.surg.2011.02.023; McCall MD, 2012, TRANSPLANTATION, V94, P30, DOI 10.1097/TP.0b013e318257745d; Merino JF, 1997, DIABETOLOGIA, V40, P1004, DOI 10.1007/s001250050781; Mochida T, 2011, MOL GENET METAB, V103, P406, DOI 10.1016/j.ymgme.2011.05.002; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Movassat J, 1997, DIABETES, V46, P1445, DOI 10.2337/diabetes.46.9.1445; OHZATO H, 1993, TRANSPLANTATION, V56, P270, DOI 10.1097/00007890-199308000-00003; Posselt AM, 2010, TRANSPLANTATION, V90, P1595, DOI 10.1097/TP.0b013e3181fe1377; Saito Y, 2010, CELL TRANSPLANT, V19, P775, DOI 10.3727/096368910X508889; Sakata N, 2012, EXP DIABETES RES, DOI 10.1155/2012/256707; Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea; Shapiro AMJ, 2011, CURR OPIN ORGAN TRAN, V16, P627, DOI 10.1097/MOT.0b013e32834cfb84; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Talchai C, 2009, DIABETES OBES METAB, V11, P38, DOI 10.1111/j.1463-1326.2009.01115.x; Thyssen S, 2006, ENDOCRINOLOGY, V147, P2346, DOI 10.1210/en.2005-0396; Toque HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072277; Toso C, 2010, TRANSPL INT, V23, P259, DOI 10.1111/j.1432-2277.2009.00984.x; Wallace M, 2013, BBA-GEN SUBJECTS, V1830, P2583, DOI 10.1016/j.bbagen.2012.10.025; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; WANG PY, 1991, BIOMATERIALS, V12, P57, DOI 10.1016/0142-9612(91)90133-U; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887	48	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95451	10.1371/journal.pone.0095451	http://dx.doi.org/10.1371/journal.pone.0095451			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743240	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100119
J	Lim, CW; Su, Y; Yeo, SY; Ng, GM; Nguyen, VT; Zhong, L; Tan, RS; Poh, KK; Chai, P				Lim, Chi Wan; Su, Yi; Yeo, Si Yong; Ng, Gillian Maria; Vinh Tan Nguyen; Zhong, Liang; Tan, Ru San; Poh, Kian Keong; Chai, Ping			Automatic 4D Reconstruction of Patient-Specific Cardiac Mesh with 1-to-1 Vertex Correspondence from Segmented Contours Lines	PLOS ONE			English	Article							DEFORMABLE MODELS; FLUID-DYNAMICS; SHAPE MODEL; HEART; CONSTRUCTION; GENERATION; MOTION; AXIS	We propose an automatic algorithm for the reconstruction of patient-specific cardiac mesh models with 1-to-1 vertex correspondence. In this framework, a series of 3D meshes depicting the endocardial surface of the heart at each time step is constructed, based on a set of border delineated magnetic resonance imaging (MRI) data of the whole cardiac cycle. The key contribution in this work involves a novel reconstruction technique to generate a 4D (i.e., spatial-temporal) model of the heart with 1-to-1 vertex mapping throughout the time frames. The reconstructed 3D model from the first time step is used as a base template model and then deformed to fit the segmented contours from the subsequent time steps. A method to determine a tree-based connectivity relationship is proposed to ensure robust mapping during mesh deformation. The novel feature is the ability to handle intra-and inter-frame 2D topology changes of the contours, which manifests as a series of merging and splitting of contours when the images are viewed either in a spatial or temporal sequence. Our algorithm has been tested on five acquisitions of cardiac MRI and can successfully reconstruct the full 4D heart model in around 30 minutes per subject. The generated 4D heart model conforms very well with the input segmented contours and the mesh element shape is of reasonably good quality. The work is important in the support of downstream computational simulation activities.	[Lim, Chi Wan; Su, Yi; Yeo, Si Yong; Ng, Gillian Maria; Vinh Tan Nguyen] ASTAR, Inst High Performance Comp, Singapore, Singapore; [Zhong, Liang; Tan, Ru San] Natl Heart Ctr Singapore, Singapore, Singapore; [Poh, Kian Keong; Chai, Ping] Natl Univ Hlth Syst, Natl Univ Heart Ctr, Dept Cardiac, Singapore, Singapore; [Poh, Kian Keong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); National Heart Centre Singapore; National University of Singapore; National University of Singapore	Lim, CW (corresponding author), ASTAR, Inst High Performance Comp, Singapore, Singapore.	limcw@ihpc.a-star.edu.sg	Poh, Kian-Keong/AAS-2658-2021	ZHONG, LIANG/0000-0003-3608-4173; Tan, Ru San/0000-0003-2086-6517	National Medical Research Council in Singapore [NMRC/EDG/1037/2011]	National Medical Research Council in Singapore(National Medical Research Council, Singapore)	This work is supported by the National Medical Research Council Grant NMRC/EDG/1037/2011 in Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DC, 2007, MED IMAGE ANAL, V11, P648, DOI 10.1016/j.media.2007.06.011; Barequet G, 1996, COMPUT VIS IMAGE UND, V63, P251, DOI 10.1006/cviu.1996.0018; Corsi C, 2002, IEEE T MED IMAGING, V21, P1202, DOI 10.1109/TMI.2002.804418; Ecabert O, 2006, P SPIE, V6144; Ecabert O, 2008, IEEE T MED IMAGING, V27, P1189, DOI 10.1109/TMI.2008.918330; Frangi AF, 2002, IEEE T MED IMAGING, V21, P1151, DOI 10.1109/TMI.2002.804426; Frangi AF, 2001, IEEE T MED IMAGING, V20, P2, DOI 10.1109/42.906421; Haber I, 2000, MED IMAGE ANAL, V4, P335, DOI 10.1016/S1361-8415(00)00028-1; Kovacs SJ, 2001, PHILOS T ROY SOC A, V359, P1299, DOI 10.1098/rsta.2001.0832; Lamata P, 2011, MED IMAGE ANAL, V15, P801, DOI 10.1016/j.media.2011.06.010; Lorenz C, 2006, MED IMAGE ANAL, V10, P657, DOI 10.1016/j.media.2006.03.004; Lotjonen J, 2004, MED IMAGE ANAL, V8, P371, DOI 10.1016/j.media.2004.06.013; Lotjonen J, 1998, IEEE T MAGN, V34, P2228, DOI 10.1109/20.703860; Luo G, 2005, IEEE T INF TECHNOL B, V9, P430, DOI 10.1109/TITB.2005.847508; Max N., 1999, Journal of Graphics Tools, V4, P1, DOI 10.1080/10867651.1999.10487501; McQueen DM, 2000, COMPUT GRAPHICS-US, V34, P56, DOI 10.1145/563788.604453; Montagnat J, 2005, MED IMAGE ANAL, V9, P87, DOI 10.1016/j.media.2004.06.025; Park K, 2005, COMMUN ACM, V48, P43, DOI 10.1145/1042091.1042118; Petitjean C, 2011, MED IMAGE ANAL, V15, P169, DOI 10.1016/j.media.2010.12.004; Plank G, 2009, PHILOS T R SOC A, V367, P2257, DOI 10.1098/rsta.2009.0056; Prasad L, 2007, IMAGE VISION COMPUT, V25, P1557, DOI 10.1016/j.imavis.2006.06.025; Roussos G, 2005, J COMPUT APPL MATH, V180, P51, DOI 10.1016/j.cam.2004.10.002; Schenkel T, 2009, ANN BIOMED ENG, V37, P503, DOI 10.1007/s10439-008-9627-4; Sermesant M, 2003, MED IMAGE ANAL, V7, P475, DOI 10.1016/S1361-8415(03)00068-9; Skrinjar O, 2009, INT J BIOMEDICAL IMA, V2009; Su Y, 2006, INT J NUMER METH ENG, V65, P1472, DOI 10.1002/nme.1503; TAUBIN G, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P852, DOI 10.1109/ICCV.1995.466848; Taubin G., 1996, Computer Vision - ECCV '96. 4th Eurpean Conference on Computer Proceedings, P283, DOI 10.1007/BFb0015544; Vadakkumpadan F, 2012, IEEE ENG MED BIO, P4067, DOI 10.1109/EMBC.2012.6346860; Vadakkumpadan F, 2012, IEEE T MED IMAGING, V31, P1051, DOI 10.1109/TMI.2012.2184799; Wang X., 2008, P IEEE C COMP VIS PA, P1; Wang XX, 2007, LECT NOTES COMPUT SC, V4466, P60; Zhang ST, 2009, I S BIOMED IMAGING, P698, DOI 10.1109/ISBI.2009.5193143; Zhang YJ, 2012, MED IMAGE ANAL, V16, P1130, DOI 10.1016/j.media.2012.06.005; Zheng YF, 2008, IEEE T MED IMAGING, V27, P1668, DOI 10.1109/TMI.2008.2004421; Zhukov L, 2002, PROC SPIE, V4684, P1398, DOI 10.1117/12.467105	36	8	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e93747	10.1371/journal.pone.0093747	http://dx.doi.org/10.1371/journal.pone.0093747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743555	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100017
J	Moreno, S; Wodniecka, Z; Tays, W; Alain, C; Bialystok, E				Moreno, Sylvain; Wodniecka, Zofia; Tays, William; Alain, Claude; Bialystok, Ellen			Inhibitory Control in Bilinguals and Musicians: Event Related Potential (ERP) Evidence for Experience-Specific Effects	PLOS ONE			English	Article							WORKING-MEMORY; EXECUTIVE FUNCTIONS; COGNITIVE CONTROL; ERROR-DETECTION; CONFLICT; BRAIN; TASKS; PLASTICITY; COMPONENTS; CORTEX	Bilinguals and musicians exhibit behavioral advantages on tasks with high demands on executive functioning, particularly inhibitory control, but the brain mechanisms supporting these differences are unclear. Of key interest is whether these forms of experience influence cognition through similar or distinct information processing mechanisms. Here, we recorded event-related potentials (ERPs) in three groups - bilinguals, musicians, and controls - who completed a visual go-nogo task that involved the withholding of key presses to rare targets. Participants in each group achieved similar accuracy rates and responses times but the analysis of cortical responses revealed significant differences in ERP waveforms. Success in withholding a prepotent response was associated with enhanced stimulus-locked N2 and P3 wave amplitude relative to go trials. For nogo trials, there were altered timing-specific ERP differences and graded amplitude differences observed in the neural responses across groups. Specifically, musicians showed an enhanced early P2 response accompanied by reduced N2 amplitude whereas bilinguals showed increased N2 amplitude coupled with an increased late positivity wave relative to controls. These findings demonstrate that bilingualism and music training have differential effects on the brain networks supporting executive control over behavior.	[Moreno, Sylvain; Tays, William; Alain, Claude; Bialystok, Ellen] Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada; [Moreno, Sylvain; Alain, Claude] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Wodniecka, Zofia] Jagiellonian Univ, Dept Expt Psychol, Krakow, Poland; [Bialystok, Ellen] York Univ, Dept Psychol, Toronto, ON M3J 2R7, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; Jagiellonian University; York University - Canada	Moreno, S (corresponding author), Baycrest Ctr Geriatr Care, Rotman Res Inst, Toronto, ON, Canada.	smoreno@research.baycrest.org			Federal Economic Development Agency for Southern Ontario (FedDev Ontario); Natural Sciences and Engineering Research Council of Canada (NSERC) [A2559]; National Institutes of Health (NIH) [R01HD052523]; Foundation for Polish Science	Federal Economic Development Agency for Southern Ontario (FedDev Ontario); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This research was supported by the Federal Economic Development Agency for Southern Ontario (FedDev Ontario) to Sylvain Moreno, and grant A2559 from the Natural Sciences and Engineering Research Council of Canada (NSERC) and grant R01HD052523 from the National Institutes of Health (NIH) to Ellen Bialystok. During the work on the paper, Zofia Wodniecka was supported by a subsidy from Foundation for Polish Science (FOCUS program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2012, CEREB CORTEX, V22, P2076, DOI 10.1093/cercor/bhr287; Adesope OO, 2010, REV EDUC RES, V80, P207, DOI 10.3102/0034654310368803; Bialystok E, 2004, DEVELOPMENTAL SCI, V7, P325, DOI 10.1111/j.1467-7687.2004.00351.x; Bialystok E, 2004, PSYCHOL AGING, V19, P290, DOI 10.1037/0882-7974.19.2.290; Bialystok E., 2005, INT J BILINGUAL, V9, P103, DOI [10.1177/13670069050090010701, DOI 10.1177/13670069050090010701]; Bialystok E, 2001, BILINGUALISM DEV LAN, P24; Bialystok E, 2008, J EXP PSYCHOL LEARN, V34, P859, DOI 10.1037/0278-7393.34.4.859; Bialystok E, 2012, COGNITION, V122, P67, DOI 10.1016/j.cognition.2011.08.003; Bialystok Ellen, 2009, Psychol Sci Public Interest, V10, P89, DOI 10.1177/1529100610387084; Bialystok E, 2009, J EXP PSYCHOL HUMAN, V35, P565, DOI 10.1037/a0012735; Bokura H, 2001, CLIN NEUROPHYSIOL, V112, P2224, DOI 10.1016/S1388-2457(01)00691-5; Bugos JA, 2007, AGING MENT HEALTH, V11, P464, DOI 10.1080/13607860601086504; Carlson SM, 2008, DEVELOPMENTAL SCI, V11, P282, DOI 10.1111/j.1467-7687.2008.00675.x; Cattell R. B., 1950, HDB INDIVIDUAL GROUP; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001; Cowan Nelson, 1999, MODELS WORKING MEMOR; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Dunn BR, 1998, BRAIN COGNITION, V36, P355, DOI 10.1006/brcg.1998.0998; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; Elmer S, 2010, BRAIN RES, V1317, P147, DOI 10.1016/j.brainres.2009.12.052; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Federmeier KD, 2002, NEUROPSYCHOLOGIA, V40, P730, DOI 10.1016/S0028-3932(01)00193-2; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Gajewski PD, 2013, INT J PSYCHOPHYSIOL, V87, P273, DOI 10.1016/j.ijpsycho.2012.08.007; George EM, 2011, NEUROPSYCHOLOGIA, V49, P1083, DOI 10.1016/j.neuropsychologia.2011.02.001; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kok A, 2004, PSYCHOPHYSIOLOGY, V41, P9, DOI 10.1046/j.1469-8986.2003.00127.x; Lee YS, 2007, LEARN INSTR, V17, P336, DOI 10.1016/j.learninstruc.2007.02.010; Lefebvre CD, 2005, CLIN NEUROPHYSIOL, V116, P1665, DOI 10.1016/j.clinph.2005.03.015; Liotti M, 2005, CORTEX, V41, P377, DOI 10.1016/S0010-9452(08)70274-0; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luk G, 2012, LANG COGNITIVE PROC, V27, P1479, DOI 10.1080/01690965.2011.613209; Luk G, 2011, J NEUROSCI, V31, P16808, DOI 10.1523/JNEUROSCI.4563-11.2011; Luk G, 2010, BRAIN COGNITION, V74, P347, DOI 10.1016/j.bandc.2010.09.004; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Moreno S., 2013, HEAR RES, DOI [10.10.1016/j.heares.2013.09.012, DOI 10.10.1016/j.heares.2013.09.012]; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Moreno S, 2010, J NEUROLINGUIST, V23, P564, DOI 10.1016/j.jneuroling.2010.05.002; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Picton TW, 2000, CLIN NEUROPHYSIOL, V111, P53, DOI 10.1016/S1388-2457(99)00227-8; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rodriguez-Fornells A, 2005, J COGNITIVE NEUROSCI, V17, P422, DOI 10.1162/0898929053279559; Rodriguez-Fornells A, 2002, NATURE, V415, P1026, DOI 10.1038/4151026a; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Tao L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00123; Tays WJ, 2008, J COGNITIVE NEUROSCI, V20, P2250, DOI 10.1162/jocn.2008.20158; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584; Wodniecka Z, 2010, INT J BILING EDUC BI, V13, P575, DOI 10.1080/13670050.2010.488287; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI [10.1037/0033-295X.111.4.931, 10.1037/0033-295x.111.4.931]; Zendel BR, 2012, PSYCHOL AGING, V27, P410, DOI 10.1037/a0024816	59	60	63	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94169	10.1371/journal.pone.0094169	http://dx.doi.org/10.1371/journal.pone.0094169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3IK	24743321	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100027
J	Park, A; Won, ST; Pentecost, M; Bartkowski, W; Lee, B				Park, Arnold; Won, Sohui T.; Pentecost, Mickey; Bartkowski, Wojciech; Lee, Benhur			CRISPR/Cas9 Allows Efficient and Complete Knock-In of a Destabilization Domain-Tagged Essential Protein in a Human Cell Line, Allowing Rapid Knockdown of Protein Function	PLOS ONE			English	Article							TREACHER-COLLINS-SYNDROME; TCOF1 GENE-PRODUCT; CRISPR-CAS9 SYSTEM; CAS9; SPECIFICITY; TCOF1/TREACLE; NUCLEASES; NICKASES; RECEPTOR	Although modulation of protein levels is an important tool for study of protein function, it is difficult or impossible to knockdown or knockout genes that are critical for cell growth or viability. For such genes, a conditional knockdown approach would be valuable. The FKBP protein-based destabilization domain (DD)-tagging approach, which confers instability to the tagged protein in the absence of the compound Shield-1, has been shown to provide rapid control of protein levels determined by Shield-1 concentration. Although a strategy to knock-in DD-tagged protein at the endogenous loci has been employed in certain parasite studies, partly due to the relative ease of knock-in as a result of their mostly haploid lifecycles, this strategy has not been demonstrated in diploid or hyperploid mammalian cells due to the relative difficulty of achieving complete knock-in in all alleles. The recent advent of CRISPR/Cas9 homing endonuclease-mediated targeted genome cleavage has been shown to allow highly efficient homologous recombination at the targeted locus. We therefore assessed the feasibility of using CRISPR/Cas9 to achieve complete knock-in to DD-tag the essential gene Treacher Collins-Franceschetti syndrome 1 (TCOF1) in human 293T cells. Using a double antibiotic selection strategy to select clones with at least two knock-in alleles, we obtained numerous complete knock-in clones within three weeks of initial transfection. DD-TCOF1 expression in the knock-in cells was Shield-1 concentration-dependent, and removal of Shield-1 resulted in destabilization of DD-TCOF1 over the course of hours. We further confirmed that the tagged TCOF1 retained the nucleolar localization of the wild-type untagged protein, and that destabilization of DD-TCOF1 resulted in impaired cell growth, as expected for a gene implicated in ribosome biogenesis. CRISPR/Cas9-mediated homologous recombination to completely knock-in a DD tag likely represents a generalizable and efficient strategy to achieve rapid modulation of protein levels in mammalian cells.	[Park, Arnold; Pentecost, Mickey; Bartkowski, Wojciech; Lee, Benhur] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA; [Won, Sohui T.; Lee, Benhur] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA	University of California System; University of California Los Angeles; Icahn School of Medicine at Mount Sinai	Lee, B (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90024 USA.	Benhur.Lee@mssm.edu	Lee, Benhur/A-8554-2016	Lee, Benhur/0000-0003-0760-1709; Won, Taylor/0000-0002-4821-0854; Park, Arnold/0000-0001-8916-2230	National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award [GM007185]; NIH [T32 AI060567]; NIH Ruth L. Kirschstein National Research Service Award [F32 AI100498]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060567, F32AI100498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	AP was supported by the National Institutes of Health (NIH) Ruth L. Kirschstein National Research Service Award GM007185. MP was supported by NIH T32 AI060567 as well as the NIH Ruth L. Kirschstein National Research Service Award F32 AI100498. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bowman M, 2012, EUR J HUM GENET, V20, P769, DOI 10.1038/ejhg.2012.2; Child MA, 2013, NAT CHEM BIOL, V9, P651, DOI 10.1038/nchembio.1315; Cho SW, 2014, GENOME RES, V24, P132, DOI 10.1101/gr.162339.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; de Azevedo MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040981; Dixon J, 2000, HUM MOL GENET, V9, P1473, DOI 10.1093/hmg/9.10.1473; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Dixon MJ, 1996, HUM MOL GENET, V5, P1391, DOI 10.1093/hmg/5.Supplement_1.1391; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gonzales B, 2005, HUM MOL GENET, V14, P2035, DOI 10.1093/hmg/ddi208; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Lin CI, 2009, BIOCHEM BIOPH RES CO, V386, P396, DOI 10.1016/j.bbrc.2009.06.050; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Miyazaki Y, 2012, J AM CHEM SOC, V134, P3942, DOI 10.1021/ja209933r; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakai D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002566; Sakai D, 2009, INT J BIOCHEM CELL B, V41, P1229, DOI 10.1016/j.biocel.2008.10.026; Sellmyer MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043297; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trainor PA, 2009, EUR J HUM GENET, V17, P275, DOI 10.1038/ejhg.2008.221; Valdez BC, 2004, P NATL ACAD SCI USA, V101, P10709, DOI 10.1073/pnas.0402492101; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	35	34	36	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95101	10.1371/journal.pone.0095101	http://dx.doi.org/10.1371/journal.pone.0095101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743236	Green Submitted, gold, Green Published			2022-12-25	WOS:000335309100071
J	Wang, F; Akashi, K; Murakami, Y; Inoue, Y; Furuta, T; Yamada, H; Ohtomo, K; Kiryu, S				Wang, Fang; Akashi, Ken; Murakami, Yoshinori; Inoue, Yusuke; Furuta, Toshihiro; Yamada, Haruyasu; Ohtomo, Kuni; Kiryu, Shigeru			Detection of Lung Tumors in Mice Using a 1-Tesla Compact Magnetic Resonance Imaging System	PLOS ONE			English	Article							MOUSE LUNG; COMPUTED-TOMOGRAPHY; KINASE INHIBITOR; CANCER; MRI; ADENOCARCINOMA; MODEL; PROGRESSION; STRATEGIES; RADIATION	Due to their small size, lung tumors in rodents are typically investigated using high-field magnetic resonance (MR) systems (4.7 T or higher) to achieve higher signal-to-noise ratios, although low-field MR systems are less sensitive to susceptibility artifacts caused by air in the lung. We investigated the feasibility of detecting lung tumors in living, freely breathing mice with a 1-T compact permanent magnet MR system. In total, 4 mice were used, and MR images of mouse lungs were acquired using a T1-weighted three-dimensional fast low-angle shot sequence without cardiac or respiratory gating. The delineation and size of lung tumors were assessed and compared with histopathological findings. Submillimeter lesions were demonstrated as hyperintense, relative to the surrounding lung parenchyma, and were delineated clearly. Among the 13 lesions validated in histopathological sections, 11 were detected in MR images; the MR detection rate was thus 84.6%. A strong correlation was obtained in size measurements between MR images and histological sections. Thus, a dedicated low-field MR system can be used to detect lung tumors in living mice noninvasively without gating.	[Wang, Fang; Furuta, Toshihiro; Yamada, Haruyasu; Kiryu, Shigeru] Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, Tokyo, Japan; [Wang, Fang] Shandong Univ, Qi Lu Hosp, Dept Radiol, Jinan 250100, Peoples R China; [Akashi, Ken; Murakami, Yoshinori] Univ Tokyo, Inst Med Sci, Div Mol Pathol, Minato Ku, Tokyo, Japan; [Inoue, Yusuke] Kitasato Univ, Sch Med, Dept Diagnost Radiol, Minami Ku, Sagamihara, Kanagawa 228, Japan; [Ohtomo, Kuni] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Shandong University; University of Tokyo; Kitasato University; University of Tokyo	Kiryu, S (corresponding author), Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, Tokyo, Japan.	kiryu-tky@umin.ac.jp	Kiryu, Shigeru/B-6867-2019	Kiryu, Shigeru/0000-0003-1440-9483; Furuta, Toshihiro/0000-0003-0025-7677				Balaban R S, 2001, ILAR J, V42, P248; Bankson JA, 2008, J MAGN RESON IMAGING, V27, P57, DOI 10.1002/jmri.21221; BELINSKY SA, 1992, CANCER RES, V52, P3164; Carreno BM, 2009, CLIN CANCER RES, V15, P3277, DOI 10.1158/1078-0432.CCR-08-2502; Cassidy PJ, 2004, J MAGN RESON IMAGING, V19, P229, DOI 10.1002/jmri.10454; de Kemp RA, 2010, J NUCL MED, V51, p18S, DOI 10.2967/jnumed.109.068148; Degrassi A, 2010, MOL CANCER THER, V9, P673, DOI 10.1158/1535-7163.MCT-09-0726; Garbow JR, 2008, CLIN CANCER RES, V14, P1363, DOI 10.1158/1078-0432.CCR-07-1757; Garbow JR, 2004, CANCER RES, V64, P2740, DOI 10.1158/0008-5472.CAN-03-3258; Hayashi Naoto, 2004, Magn Reson Med Sci, V3, P27, DOI 10.2463/mrms.3.27; Huang MQ, 2004, MAGN RESON IMAGING, V22, P645, DOI 10.1016/j.mri.2004.01.041; Inoue Y, 2006, J MAGN RESON IMAGING, V24, P901, DOI 10.1002/jmri.20713; Kennel SJ, 2000, MED PHYS, V27, P1101, DOI 10.1118/1.598974; Kirsch DG, 2010, INT J RADIAT ONCOL, V76, P973, DOI 10.1016/j.ijrobp.2009.11.038; Kiryu S, 2010, MAGN RESON IMAGING, V28, P273, DOI 10.1016/j.mri.2009.10.005; Konar M, 2011, VET RADIOL ULTRASOUN, V52, pS5, DOI 10.1111/j.1740-8261.2010.01780.x; Krupnick AS, 2012, NAT PROTOC, V7, P128, DOI 10.1038/nprot.2011.424; Kubo S, 2006, MAGN RESON MED, V56, P698, DOI 10.1002/mrm.21006; Liu J, 2002, SURG ONCOL, V11, P217, DOI 10.1016/S0960-7404(02)00053-1; Malkinson AM, 2001, LUNG CANCER, V32, P265, DOI 10.1016/S0169-5002(00)00232-4; Michael L.., 1986, MAGNETIC RESONANCE I, V4, P6; Olson JD, 2012, RADIAT RES, V178, P321, DOI 10.1667/RR2800.1; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; Rosen Y, 2006, INT J CANCER, V119, P365, DOI 10.1002/ijc.21857; Schuster DP, 2004, AM J RESP CELL MOL, V30, P129, DOI 10.1165/rcmb.2003-0213TR; Tidwell VK, 2012, MAGN RESON MED, V67, P572, DOI 10.1002/mrm.22951; Umutlu L, 2012, J MAGN RESON IMAGING, V36, P714, DOI 10.1002/jmri.23702; Wang DL, 2004, MAGN RESON MED, V52, P927, DOI 10.1002/mrm.20217; Zhou XZ, 2008, COMPARATIVE MED, V58, P276	30	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94945	10.1371/journal.pone.0094945	http://dx.doi.org/10.1371/journal.pone.0094945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743153	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100054
J	Chen, XH; Wei, P; Wang, XT; Zong, MH; Lou, WY				Chen, Xiao-Hong; Wei, Ping; Wang, Xiao-Ting; Zong, Min-Hua; Lou, Wen-Yong			A Novel Carbonyl Reductase with Anti-Prelog Stereospecificity from Acetobacter sp CCTCC M209061: Purification and Characterization	PLOS ONE			English	Article							ALCOHOL-DEHYDROGENASE; ASYMMETRIC REDUCTION; ISOCITRATE DEHYDROGENASE; EFFICIENT SYNTHESIS; 4-(TRIMETHYLSILYL)-3-BUTYN-2-ONE; SPECIFICITY; STABILITY; CLONING; NAD	A novel carbonyl reductase (AcCR) catalyzing the asymmetric reduction of ketones to enantiopure alcohols with anti-Prelog stereoselectivity was found in Acetobacter sp. CCTCC M209061 and enriched 27.5-fold with an overall yield of 0.4% by purification. The enzyme showed a homotetrameric structure with an apparent molecular mass of 104 kDa and each subunit of 27 kDa. The gene sequence of AcCR was cloned and sequenced, and a 762 bp gene fragment was obtained. Either NAD(H) or NADP(H) can be used as coenzyme. For the reduction of 4'-chloroacetophenone, the K-m value for NADH was around 25-fold greater than that for NADPH (0.66 mM vs 0.026 mM), showing that AcCR preferred NADPH over NADH. However, when NADH was used as cofactor, the response of AcCR activity to increasing concentration of 4'-chloroacetophenone was clearly sigmoidal with a Hill coefficient of 3.1, suggesting that the enzyme might possess four substrate-binding sites cooperating with each other The V-max value for NADH-linked reduction was higher than that for NADPH-linked reduction (0.21 mM/min vs 0.17 mM/min). For the oxidation of isopropanol, the similar enzymological properties of AcCR were found using NAD(+) or NADP(+) as cofactor. Furthermore, a broad range of ketones such as aryl ketones, alpha-ketoesters and aliphatic ketones could be enantioselectively reduced into the corresponding chiral alcohols by this enzyme with high activity.	[Chen, Xiao-Hong; Wei, Ping; Lou, Wen-Yong] S China Univ Technol, Coll Light Ind & Food Sci, Lab Appl Biocatalysis, Guangzhou, Guangdong, Peoples R China; [Wang, Xiao-Ting; Zong, Min-Hua; Lou, Wen-Yong] S China Univ Technol, State Key Lab Pulp & Paper Engn, Guangzhou, Guangdong, Peoples R China	South China University of Technology; South China University of Technology	Lou, WY (corresponding author), S China Univ Technol, Coll Light Ind & Food Sci, Lab Appl Biocatalysis, Guangzhou, Guangdong, Peoples R China.	wylou@scut.edu.cn	Lou, Wen-Yong/AAL-8087-2020	Lou, Wen-Yong/0000-0003-3474-3446	National Science Fund for Excellent Young Scholars [21222606]; NSFC [21376096]; Key Program of Guangdong Natural Science Foundation [S2013020013049]; Foundation for the Author of National Excellent Doctoral Dissertation of China [201504]; Fundamental Research Funds for SCUT [2013ZG0003]	National Science Fund for Excellent Young Scholars; NSFC(National Natural Science Foundation of China (NSFC)); Key Program of Guangdong Natural Science Foundation; Foundation for the Author of National Excellent Doctoral Dissertation of China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Fundamental Research Funds for SCUT	This study was partially supported by the National Science Fund for Excellent Young Scholars (21222606), the NSFC (21376096), the Key Program of Guangdong Natural Science Foundation (S2013020013049), the Foundation for the Author of National Excellent Doctoral Dissertation of China (201504) and the Fundamental Research Funds for SCUT (2013ZG0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler JJ, 2000, LANGMUIR, V16, P7255, DOI 10.1021/la000363c; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao H, 2011, BIORESOURCE TECHNOL, V102, P1733, DOI 10.1016/j.biortech.2010.08.072; CHEN AJ, 1993, J BIOL CHEM, V268, P11002; Chen XH, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-110; Clark JS, 2006, TETRAHEDRON, V62, P73, DOI 10.1016/j.tet.2005.09.144; Gao C, 2013, BIORESOURCE TECHNOL, V137, P111, DOI 10.1016/j.biortech.2013.02.115; HUMMEL W, 1990, APPL MICROBIOL BIOT, V34, P15, DOI 10.1007/BF00170916; Jakoblinnert A, 2013, J BIOTECHNOL, V165, P52, DOI 10.1016/j.jbiotec.2013.02.006; Kawano S, 2011, BIOSCI BIOTECH BIOCH, V75, P1055, DOI 10.1271/bbb.100528; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYLAND ML, 1989, FEMS MICROBIOL LETT, V58, P165; Ma HM, 2012, ADV SYNTH CATAL, V354, P1765, DOI 10.1002/adsc.201100366; Nakamura K, 2003, TETRAHEDRON-ASYMMETR, V14, P2659, DOI 10.1016/S0957-4166(03)00526-3; Ni Y, 2012, BIOTECHNOL ADV, V30, P1279, DOI 10.1016/j.biotechadv.2011.10.007; Nie Y, 2011, ORG BIOMOL CHEM, V9, P4070, DOI 10.1039/c0ob00938e; Prelog V., 1964, PURE APPL CHEM, V9, P119, DOI DOI 10.1351/PAC196409010119; Richter N, 2011, ENZYME MICROB TECH, V48, P472, DOI 10.1016/j.enzmictec.2011.02.004; Rocha-Martin J, 2012, BIORESOURCE TECHNOL, V103, P343, DOI 10.1016/j.biortech.2011.10.018; Sheldon RA, 2012, CHEM SOC REV, V41, P1437, DOI 10.1039/c1cs15219j; Singh A, 2009, PROCESS BIOCHEM, V44, P986, DOI 10.1016/j.procbio.2009.04.020; Soni P, 2007, PROCESS BIOCHEM, V42, P1632, DOI 10.1016/j.procbio.2007.09.007; Tanaka N, 1996, STRUCTURE, V4, P33, DOI 10.1016/S0969-2126(96)00007-X; TEZUKA T, 1983, PLANT PHYSIOL, V72, P959, DOI 10.1104/pp.72.4.959; Wang LJ, 2011, BIORESOURCE TECHNOL, V102, P7023, DOI 10.1016/j.biortech.2011.04.046; Wang NQ, 2013, J MOL CATAL B-ENZYM, V92, P1, DOI 10.1016/j.molcatb.2013.03.007; Weckbecker A, 2006, BIOCATAL BIOTRANSFOR, V24, P380, DOI 10.1080/10242420600893827; Weckbecker A, 2010, ADV BIOCHEM ENG BIOT, V120, P195, DOI 10.1007/10_2009_55; WERMUTH B, 1981, J BIOL CHEM, V256, P1206; Xiao ZJ, 2009, BIORESOURCE TECHNOL, V100, P5560, DOI 10.1016/j.biortech.2009.06.006; Xie Y, 2010, BIORESOURCE TECHNOL, V101, P1054, DOI 10.1016/j.biortech.2009.09.003; Xu GC, 2012, ACS CATAL, V2, P2566, DOI 10.1021/cs300430g; Yamada-Nodera K, 2007, J BIOSCI BIOENG, V103, P174, DOI 10.1263/jbb.103.174; Zhang BB, 2008, J MOL CATAL B-ENZYM, V54, P122, DOI 10.1016/j.molcatb.2007.12.018; Zhang RZ, 2011, BIORESOURCE TECHNOL, V102, P483, DOI 10.1016/j.biortech.2010.08.060; Zhang ZJ, 2011, BIOPROC BIOSYST ENG, V34, P315, DOI 10.1007/s00449-010-0473-z	36	14	14	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94543	10.1371/journal.pone.0094543	http://dx.doi.org/10.1371/journal.pone.0094543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740089	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900052
J	Heaton, MP; Leymaster, KA; Kalbfleisch, TS; Kijas, JW; Clarke, SM; McEwan, J; Maddox, JF; Basnayake, V; Petrik, DT; Simpson, B; Smith, TPL; Chitko-McKown, CG				Heaton, Michael P.; Leymaster, Kreg A.; Kalbfleisch, Theodore S.; Kijas, James W.; Clarke, Shannon M.; McEwan, John; Maddox, Jillian F.; Basnayake, Veronica; Petrik, Dustin T.; Simpson, Barry; Smith, Timothy P. L.; Chitko-McKown, Carol G.		Int Sheep Genomics Consortium	SNPs for Parentage Testing and Traceability in Globally Diverse Breeds of Sheep	PLOS ONE			English	Article							PATERNITY ANALYSIS; MARKERS; NUCLEOTIDE; EXCLUSION; SEQUENCE; CATTLE	DNA-based parentage determination accelerates genetic improvement in sheep by increasing pedigree accuracy. Single nucleotide polymorphism (SNP) markers can be used for determining parentage and to provide unique molecular identifiers for tracing sheep products to their source. However, the utility of a particular "parentage SNP'' varies by breed depending on its minor allele frequency (MAF) and its sequence context. Our aims were to identify parentage SNPs with exceptional qualities for use in globally diverse breeds and to develop a subset for use in North American sheep. Starting with genotypes from 2,915 sheep and 74 breed groups provided by the International Sheep Genomics Consortium (ISGC), we analyzed 47,693 autosomal SNPs by multiple criteria and selected 163 with desirable properties for parentage testing. On average, each of the 163 SNPs was highly informative (MAF >= 0.3) in 48 +/- 5 breed groups. Nearby polymorphisms that could otherwise confound genetic testing were identified by whole genome and Sanger sequencing of 166 sheep from 54 breed groups. A genetic test with 109 of the 163 parentage SNPs was developed for matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. The scoring rates and accuracies for these 109 SNPs were greater than 99% in a panel of North American sheep. In a blinded set of 96 families (sire, dam, and non-identical twin lambs), each parent of every lamb was identified without using the other parent's genotype. In 74 ISGC breed groups, the median estimates for probability of a coincidental match between two animals (P-I), and the fraction of potential adults excluded from parentage (P-E) were 1.1x10(-39) and 0.999987, respectively, for the 109 SNPs combined. The availability of a well-characterized set of 163 parentage SNPs facilitates the development of high-throughput genetic technologies for implementing accurate and economical parentage testing and traceability in many of the world's sheep breeds.	[Heaton, Michael P.; Leymaster, Kreg A.; Smith, Timothy P. L.; Chitko-McKown, Carol G.] USMARC, Clay Ctr, NE 68933 USA; [Kalbfleisch, Theodore S.] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Kijas, James W.] CSIRO, Div Anim Food & Hlth Sci, Brisbane, Qld, Australia; [Clarke, Shannon M.; McEwan, John] AgResearch, Invermay Agr Ctr, Mosgiel, New Zealand; [Maddox, Jillian F.] Meat & Livestock Australia, North Sydney, Australia; [Basnayake, Veronica; Petrik, Dustin T.; Simpson, Barry] GeneSeek, Lincoln, NE USA	University of Louisville; Commonwealth Scientific & Industrial Research Organisation (CSIRO); AgResearch - New Zealand	Heaton, MP (corresponding author), USMARC, Clay Ctr, NE 68933 USA.	mike.heaton@ars.usda.gov	Kijas, James W/A-4656-2011; McEwan, John/A-1143-2008; Barendse, William J/D-8608-2011; Cemal, Ibrahim/AAC-2783-2020; Kalbfleisch, Theodore/AAN-5407-2021; Simianer, Henner/A-6574-2015; Arranz, Juan-Jose/H-1225-2015	Kijas, James W/0000-0002-1417-8278; McEwan, John/0000-0003-4801-6207; Barendse, William J/0000-0002-5464-0658; Simianer, Henner/0000-0002-7551-3797; Arranz, Juan-Jose/0000-0001-9058-131X; Clarke, Shannon/0000-0002-4615-8917; Heaton, Michael/0000-0003-1386-1208; Drogemuller, Cord/0000-0001-9773-522X; Kalbfleisch, Theodore/0000-0002-2370-8189; MacHugh, David/0000-0002-8112-4704; ciani, elena/0000-0001-5673-0975	United States Department of Agriculture, Agricultural Research Service; KY IDeA Networks of Biomedical Research Excellence (Cooper PI) NIH/NIGMS [5P20GM103436-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); KY IDeA Networks of Biomedical Research Excellence (Cooper PI) NIH/NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this research was provided by the United States Department of Agriculture, Agricultural Research Service. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the USDA. USDA is an equal opportunity provider and employer. TSK was supported in part by the KY IDeA Networks of Biomedical Research Excellence (Cooper PI) NIH/NIGMS 5P20GM103436-13. This work was conducted in part using the resources of the University of Louisville's research computing group and the Cardinal Research Cluster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, Proc Natl Acad Sci U S A, V83, P4; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Bell A, 2013, SUCCESS RAT IN PRESS; Chakraborty R, 1996, J FORENSIC SCI, V41, P671; CHAKRABORTY R, 1988, GENETICS, V118, P527; Clarke SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093392; Consortium ISG, 2013, ISGC SNP LOC PAR ASS; Ding CM, 2009, METHODS MOL BIOL, V578, P245, DOI 10.1007/978-1-60327-411-1_16; Dodds KG, 2005, J ANIM SCI, V83, P2271; Double MC, 1997, MOL ECOL, V6, P1155, DOI 10.1046/j.1365-294X.1997.00291.x; Fisher PJ, 2009, J DAIRY SCI, V92, P369, DOI 10.3168/jds.2008-1086; GELDERMANN H, 1986, J ANIM SCI, V63, P1759, DOI 10.2527/jas1986.6361759x; Hayes BJ, 2011, J DAIRY SCI, V94, P2114, DOI 10.3168/jds.2010-3896; Heaton MP, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-23; Heaton MP, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-25; Heaton MP, 2005, JAVMA-J AM VET MED A, V226, P1311, DOI 10.2460/javma.2005.226.1311; Heaton MP, 2003, MAMM GENOME, V14, P765, DOI 10.1007/s00335-003-2283-y; Heaton MP, 2002, MAMM GENOME, V13, P272, DOI 10.1007/s00335-001-2146-3; Holt CL, 2000, FORENSIC SCI INT, V112, P91, DOI 10.1016/S0379-0738(00)00169-9; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; JONES DA, 1972, J FORENSIC SCI SOC, V12, P355, DOI 10.1016/S0015-7368(72)70695-7; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; LEYMASTER KA, 1991, J ANIM SCI, V69, P993; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Nachman MW, 2000, GENETICS, V156, P297; Rendo F, 2011, FORENSIC SCI INT-GEN, V5, P333, DOI 10.1016/j.fsigen.2010.09.009; Rosa AJM, 2013, SMALL RUMINANT RES, V113, P62, DOI 10.1016/j.smallrumres.2013.03.021; Souza CA, 2012, GENET MOL RES, V11, P1217, DOI 10.4238/2012.May.8.4; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; Werner FAO, 2004, ANIM GENET, V35, P44, DOI 10.1046/j.1365-2052.2003.01071.x; Whittaker JC, 2003, GENETICS, V164, P781	33	73	79	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94851	10.1371/journal.pone.0094851	http://dx.doi.org/10.1371/journal.pone.0094851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740156	Green Published, gold			2022-12-25	WOS:000336863900075
J	Kitahara, MV; Lin, MF; Foret, S; Huttley, G; Miller, DJ; Chen, CA				Kitahara, Marcelo V.; Lin, Mei-Fang; Foret, Sylvain; Huttley, Gavin; Miller, David J.; Chen, Chaolun Allen			The "Naked Coral'' Hypothesis Revisited - Evidence for and Against Scleractinian Monophyly	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; DNA-SEQUENCE EVOLUTION; MAXIMUM-LIKELIHOOD; MOLECULAR PHYLOGENY; UNIVERSAL PRIMERS; GENE ORDER; CNIDARIA; ANTHOZOA; PROTEIN; MODEL	The relationship between Scleractinia and Corallimorpharia, Orders within Anthozoa distinguished by the presence of an aragonite skeleton in the former, is controversial. Although classically considered distinct groups, some phylogenetic analyses have placed the Corallimorpharia within a larger Scleractinia/Corallimorpharia clade, leading to the suggestion that the Corallimorpharia are "naked corals'' that arose via skeleton loss during the Cretaceous from a Scleractinian ancestor. Scleractinian paraphyly is, however, contradicted by a number of recent phylogenetic studies based on mt nucleotide (nt) sequence data. Whereas the "naked coral'' hypothesis was based on analysis of the sequences of proteins encoded by a relatively small number of mt genomes, here a much-expanded dataset was used to reinvestigate hexacorallian phylogeny. The initial observation was that, whereas analyses based on nt data support scleractinian monophyly, those based on amino acid (aa) data support the "naked coral'' hypothesis, irrespective of the method and with very strong support. To better understand the bases of these contrasting results, the effects of systematic errors were examined. Compared to other hexacorallians, the mt genomes of "Robust'' corals have a higher (A+T) content, codon usage is far more constrained, and the proteins that they encode have a markedly higher phenylalanine content, leading us to suggest that mt DNA repair may be impaired in this lineage. Thus the "naked coral'' topology could be caused by high levels of saturation in these mitochondrial sequences, long-branch effects or model violations. The equivocal results of these extensive analyses highlight the fundamental problems of basing coral phylogeny on mitochondrial sequence data.	[Kitahara, Marcelo V.] Univ Fed Sao Paulo, Dept Ciencias Mar, Sao Paulo, Brazil; [Kitahara, Marcelo V.] Univ Sao Paulo, Ctr Biol Marinha CEBIMar, Sao Paulo, Brazil; [Lin, Mei-Fang; Miller, David J.] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; [Lin, Mei-Fang; Chen, Chaolun Allen] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Lin, Mei-Fang; Foret, Sylvain; Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Foret, Sylvain] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Huttley, Gavin] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Chen, Chaolun Allen] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Chen, Chaolun Allen] Acad Sinica, Taiwan Int Grad Program TIGP Biodivers, Taipei 115, Taiwan	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; James Cook University; Academia Sinica - Taiwan; James Cook University; Australian National University; Australian National University; John Curtin School of Medical Research; National Taiwan University; Academia Sinica - Taiwan	Miller, DJ (corresponding author), James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia.	david.miller@jcu.edu.au; cac@gate.sinica.edu.tw	FORET, Sylvain/B-9207-2012; Huttley, Gavin A/G-5169-2015; Lin, MeiFang/AAE-9913-2020; Kitahara, Marcelo Visentini/D-5560-2011	Huttley, Gavin A/0000-0001-7224-2074; Kitahara, Marcelo Visentini/0000-0003-4011-016X; Miller, David/0000-0003-0291-9531	National Science Council (NSC); Academia Sinica; Australian Research Council; Sao Paulo Funding Agency (FAPESP) [2012/21583-1]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Australian Research Council(Australian Research Council); Sao Paulo Funding Agency (FAPESP)	This study was supported by grants from the National Science Council (NSC) and Academia Sinica (Thematic Grants 2005-2010) to CAC, from the Australian Research Council to DJM and SF, and from Sao Paulo Funding Agency (FAPESP grant 2012/21583-1) to MVK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi J, 2000, J MOL EVOL, V50, P348, DOI 10.1007/s002399910038; Aranda M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-501; Barbeitos MS, 2010, P NATL ACAD SCI USA, V107, P11877, DOI 10.1073/pnas.0914380107; Barry D., 1987, STAT SCI, V2, P191, DOI DOI 10.1214/SS/1177013353; Beagley CT, 1998, GENETICS, V148, P1091; Beaten MJ, 1998, J MOL EVOL, V47, P697, DOI 10.1007/PL00006429; Boussau B, 2006, SYSTEMATIC BIOL, V55, P756, DOI 10.1080/10635150600975218; Brugler MR, 2007, MOL PHYLOGENET EVOL, V42, P776, DOI 10.1016/j.ympev.2006.08.016; Chen CA, 2000, MAR BIOTECHNOL, V2, P146; Chen CH, 2008, MAR BIOTECHNOL, V10, P538, DOI 10.1007/s10126-008-9093-x; Chen C, 2008, MOL PHYLOGENET EVOL, V46, P19, DOI 10.1016/j.ympev.2007.09.013; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; Culligan KM, 2000, NUCLEIC ACIDS RES, V28, P463, DOI 10.1093/nar/28.2.463; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, P345; Dower JF, 2001, FISH OCEANOGR, V10, P268, DOI 10.1046/j.1365-2419.2001.00162.x; Emblem A, 2011, MOL PHYLOGENET EVOL, V61, P495, DOI 10.1016/j.ympev.2011.07.012; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Fischer E, 2012, BIOGEOCHEMISTRY, V110, P31, DOI 10.1007/s10533-012-9719-y; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fukami H, 2005, CORAL REEFS, V24, P410, DOI 10.1007/s00338-005-0023-3; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; Galtier N, 1998, MOL BIOL EVOL, V15, P871, DOI 10.1093/oxfordjournals.molbev.a025991; Gil M, 2013, MOL BIOL EVOL, V30, P1270, DOI 10.1093/molbev/mst034; GOLDMAN N, 1993, J MOL EVOL, V36, P182, DOI 10.1007/BF00166252; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harrison GL, 2004, MOL BIOL EVOL, V21, P974, DOI 10.1093/molbev/msh065; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huang DW, 2008, J MOL EVOL, V66, P167, DOI 10.1007/s00239-008-9069-5; Huang DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034459; Huang DW, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-37; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huttley G, 2009, AUST J ZOOL, V57, P167, DOI 10.1071/ZO09049; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Kitahara MV, 2013, ZOOL SCR, V42, P201, DOI 10.1111/j.1463-6409.2012.00575.x; Kitahara MV, 2012, INVERTEBR SYST, V26, P303, DOI 10.1071/IS11053; Kitahara MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011490; Kitahara MV, 2010, SYST BIODIVERS, V8, P91, DOI 10.1080/14772000903571088; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Knight RD, 2001, GENOME BIOL, V2, P4; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Kosiol C, 2006, THESIS U CAMBRIDGE C; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le Goff-Vitry MC, 2004, MOL PHYLOGENET EVOL, V30, P167, DOI 10.1016/S1055-7903(03)00162-3; Lin MF, 2012, MOL PHYLOGENET EVOL, V65, P323, DOI 10.1016/j.ympev.2012.06.011; Lin MF, 2011, ZOOL STUD, V50, P513; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Park E, 2012, MOL PHYLOGENET EVOL, V62, P329, DOI 10.1016/j.ympev.2011.10.008; Park E, 2011, GENE, V486, P81, DOI 10.1016/j.gene.2011.07.003; Peden J., 2005, CODONW VERSION 1 4 2; Phillips MJ, 2010, SYST BIOL, V59, P90, DOI 10.1093/sysbio/syp079; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; PONTKINGDON GA, 1995, NATURE, V375, P109, DOI 10.1038/375109b0; REAKAKUDLA ML, 1997, BIODIVERSITY, V2, P83; Reed JK, 2002, HYDROBIOLOGIA, V471, P43, DOI 10.1023/A:1016588901551; Riemann-Zuerneck K., 2003, Zoologische Verhandelingen (Leiden), V345, P367; Roberts JM, 2009, COLD-WATER CORALS: THE BIOLOGY AND GEOLOGY OF DEEP-SEA CORAL HABITATS, P20, DOI 10.1017/CBO9780511581588.003; Rodolfo-Metalpa R, 2010, BIOGEOSCIENCES, V7, P289, DOI 10.5194/bg-7-289-2010; Rodriguez-Ezpeleta N, 2007, SYST BIOL, V56, P389, DOI 10.1080/10635150701397643; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Rosenberg MS, 2003, MOL BIOL EVOL, V20, P610, DOI 10.1093/molbev/msg067; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Shearer TL, 2002, MOL ECOL, V11, P2475, DOI 10.1046/j.1365-294X.2002.01652.x; Sheffield NC, 2009, SYST BIOL, V58, P381, DOI 10.1093/sysbio/syp037; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; Sinniger F, 2007, J MOL EVOL, V64, P196, DOI 10.1007/s00239-006-0015-0; Stampar SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086612; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Stephenson TA, 1921, Q J MICROSC SCI, V65, P493; Stolarski J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-316; Stolarski Jaroslaw, 1995, Acta Palaeontologica Polonica, V40, P19; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57, DOI DOI 10.1016/J.MARPOLBUL.2009.11.011; Tseng CC, 2005, CORAL REEFS, V24, P502, DOI 10.1007/s00338-005-0499-x; Van Den Bussche RA, 1998, MOL PHYLOGENET EVOL, V10, P408, DOI 10.1006/mpev.1998.0531; van Oppen MJH, 1999, MOL BIOL EVOL, V16, P1812, DOI 10.1093/oxfordjournals.molbev.a026094; van Oppen MJH, 2002, J MOL EVOL, V55, P1, DOI 10.1007/s00239-001-0075-0; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yap VB, 2010, MOL BIOL EVOL, V27, P726, DOI 10.1093/molbev/msp232	93	38	38	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94774	10.1371/journal.pone.0094774	http://dx.doi.org/10.1371/journal.pone.0094774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740380	Green Published, Green Accepted, gold			2022-12-25	WOS:000336863900064
J	Siewe, B; Wallace, J; Rygielski, S; Stapleton, JT; Martin, J; Deeks, SG; Landay, A				Siewe, Basile; Wallace, Jennillee; Rygielski, Sonya; Stapleton, Jack T.; Martin, Jeffrey; Deeks, Steven G.; Landay, Alan			Regulatory B Cells Inhibit Cytotoxic T Lymphocyte (CTL) Activity and Elimination of Infected CD4 T Cells after In Vitro Reactivation of HIV Latent Reservoirs	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; IMMUNE-RESPONSES; B10 CELLS; VIVO; REPLICATION; SUPPRESSION; MECHANISMS; EXPRESSION; BLOCKADE	During HIV infection, IL-10/IL-10 receptor and programmed death-1 (PD-1)/programmed death-1-ligand (PD-L1) interactions have been implicated in the impairment of cytotoxic T lymphocyte (CTL) activity. Despite antiretroviral therapy (ART), attenuated anti-HIV CTL functions present a major hurdle towards curative measures requiring viral eradication. Therefore, deeper understanding of the mechanisms underlying impaired CTL is crucial before HIV viral eradication is viable. The generation of robust CTL activity necessitates interactions between antigen-presenting cells (APC), CD4(+) and CD8(+) T cells. We have shown that in vitro, IL-10(hi)PD-L1(hi) regulatory B cells (Bregs) directly attenuate HIV-specific CD8(+)-mediated CTL activity. Bregs also modulate APC and CD4(+) T cell function; herein we characterize the Breg compartment in uninfected (HIVNEG), HIV-infected "elite controllers" (HIVEC), ART-treated (HIVART), and viremic (HIVvir), subjects, and in vitro, assess the impact of Bregs on anti-HIV CTL generation and activity after reactivation of HIV latent reservoirs using suberoylanilide hydroxamic acid (SAHA). We find that Bregs from HIVEC and HIVART subjects exhibit comparable IL-10 expression levels significantly higher than HIVNEG subjects, but significantly lower than HIVVIR subjects. Bregs from HIVEC and HIVART subjects exhibit comparable PD-L1 expression, significantly higher than in HIVVIR and HIVNEG subjects. SAHA-treated Breg-depleted PBMC from HIVEC and HIVART subjects, displayed enhanced CD4(+) T-cell proliferation, significant upregulation of antigen-presentation molecules, increased frequency of CD107a(+) and HIV-specific CD8(+) T cells, associated with efficient elimination of infected CD4(+) T cells, and reduction in integrated viral DNA. Finally, IL-10-R and PD-1 antibody blockade partially reversed Breg-mediated inhibition of CD4(+) T-cell proliferation. Our data suggest that, possibly, via an IL-10 and PD-L1 synergistic mechanism; Bregs likely inhibit APC function and CD4(+) T-cell proliferation, leading to anti-HIV CTL attenuation, hindering viral eradication.	[Siewe, Basile; Wallace, Jennillee; Rygielski, Sonya; Landay, Alan] Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Stapleton, Jack T.] Iowa City Vet Affairs Med Ctr, Iowa City, IA USA; [Stapleton, Jack T.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Stapleton, Jack T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Stapleton, Jack T.] Univ Iowa, Dept Immunol, Iowa City, IA 52242 USA; [Martin, Jeffrey; Deeks, Steven G.] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Landay, Alan] Univ Utrecht, Fac Sci, Div Pharmacol, Utrecht Inst Pharmaceut Sci,FC Donders Chair, Utrecht, Netherlands	Rush University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; University of Iowa; University of Iowa; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Utrecht University	Siewe, B (corresponding author), Rush Univ, Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA.	basile_siewe@rush.edu		Deeks, Steven/0000-0001-6371-747X; Stapleton, Jack/0000-0002-2302-9055	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development; National Institutes of Health [RO1 AI-58740]; National Institutes of Health -Developmental Center for AIDS Research [P30 AI-082151-01, P01 AI-076174-01A1]; Delaney AIDS Research Enterprise (DARE) [U19AI096109]; National Institute of Allergy and Infectious Diseases (NIAID) [K24 AI069994]; UCSF CFAR [P30 AI027763]; UCSF CTSI [UL1 RR024131]; Center for AIDS Prevention Studies [P30 MH62246]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI058740, U19AI096109, P30AI082151, UM1AI106701, P01AI076174, UM1AI068636, K24AI069994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000207] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health -Developmental Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Delaney AIDS Research Enterprise (DARE); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCSF CFAR; UCSF CTSI; Center for AIDS Prevention Studies; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by grants from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Merit Review Grant JTS), the National Institutes of Health (RO1 AI-58740 to JTS) and National Institutes of Health -Developmental Center for AIDS Research P30 AI-082151-01 and P01 AI-076174-01A1, by the Delaney AIDS Research Enterprise (DARE; U19AI096109), National Institute of Allergy and Infectious Diseases (NIAID) (K24 AI069994), the UCSF CFAR (P30 AI027763), the UCSF CTSI (UL1 RR024131), and the Center for AIDS Prevention Studies (P30 MH62246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2012, ONCOIMMUNOLOGY, V1, P1430, DOI 10.4161/onci.21175; Ahmed KA, 2012, J LEUKOCYTE BIOL, V92, P289, DOI 10.1189/jlb.1211631; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Bouaziz JD, EUR J IMMUNOL, V40, P2686; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Das A, 2012, J IMMUNOL, V189, P3925, DOI 10.4049/jimmunol.1103139; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Hersperger AR, 2011, CURR OPIN HIV AIDS, V6, P169, DOI 10.1097/COH.0b013e3283454c39; Hersperger AR, 2011, BLOOD, V117, P3799, DOI 10.1182/blood-2010-12-322727; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Margolis DM, 2013, CURR OPIN HIV AIDS, V8, P230, DOI 10.1097/COH.0b013e32835ef089; Matsushita T, 2010, J IMMUNOL, V185, P2240, DOI 10.4049/jimmunol.1001307; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; McIlroy D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00052; Migueles SA, 2012, IMMUNITY, V36, P320, DOI 10.1016/j.immuni.2012.03.006; Morva A, 2012, BLOOD, V119, P106, DOI 10.1182/blood-2011-06-360768; Palmer BE, 2013, J IMMUNOL, V190, P211, DOI 10.4049/jimmunol.1201108; Porichis F, CURR HIV AIDS REP; Said EA, NAT MED, V16, P452; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Siewe B, 2013, J LEUKOC BIOL; Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Trautmann L, 2007, CURR OPIN HIV AIDS, V2, P219, DOI 10.1097/COH.0b013e3280ebb5c9; van de Veen W, 2013, J ALLERGY CLIN IMMUN, V131, P1204, DOI 10.1016/j.jaci.2013.01.014; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501	38	32	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e92934	10.1371/journal.pone.0092934	http://dx.doi.org/10.1371/journal.pone.0092934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739950	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900014
J	Sinha, AK; AbdElgawad, H; Giblen, T; Zinta, G; De Rop, M; Asard, H; Blust, R; De Boeck, G				Sinha, Amit Kumar; AbdElgawad, Hamada; Giblen, Terri; Zinta, Gaurav; De Rop, Michelle; Asard, Han; Blust, Ronny; De Boeck, Gudrun			Anti-Oxidative Defences Are Modulated Differentially in Three Freshwater Teleosts in Response to Ammonia-Induced Oxidative Stress	PLOS ONE			English	Article							HIGH ENVIRONMENTAL AMMONIA; TROUT ONCORHYNCHUS-MYKISS; SALMO-SALAR L; RAINBOW-TROUT; LIPID-PEROXIDATION; SUBLETHAL AMMONIA; FREE-RADICALS; PRIMARY CULTURES; SEA BASS; TOXICITY	Oxidative stress and the antioxidant response induced by high environmental ammonia (HEA) were investigated in the liver and gills of three freshwater teleosts differing in their sensitivities to ammonia. The highly ammonia-sensitive salmonid Oncorhynchus mykiss (rainbow trout), the less ammonia sensitive cyprinid Cyprinus carpio (common carp) and the highly ammonia-resistant cyprinid Carassius auratus (goldfish) were exposed to 1 mM ammonia (as NH4HCO3) for 0 h (control), 3 h, 12 h, 24 h, 48 h, 84 h and 180 h. Results show that HEA exposure increased ammonia accumulation significantly in the liver of all the three fish species from 24 h-48 h onwards which was associated with an increment in oxidative stress, evidenced by elevation of xanthine oxidase activity and levels of hydrogen peroxide (H2O2) and malondialdehyde (MDA). Unlike in trout, H2O2 and MDA accumulation in carp and goldfish liver was restored to control levels (84 h-180 h); which was accompanied by a concomitant increase in superoxide dismutase (SOD), catalase (CAT), ascorbate peroxidase activity and reduced ascorbate content. Many of these defence parameters remained unaffected in trout liver, while components of the glutathione redox cycle (reduced glutathione, glutathione peroxidase and glutathione reductase) enhanced to a greater extent. The present findings suggest that trout rely mainly on glutathione dependent defensive mechanism while carp utilize SOD, CAT and ascorbate as anti-oxidative sentinels. Hepatic cells of goldfish appear to utilize each of these protective systems, and showed more effective anti-oxidative compensatory responses towards HEA than carp, while trout were least effective. The present work also indicates that HEA exposure resulted in a relatively mild oxidative stress in the gills of all three species. This probably explains the almost complete lack of anti-oxidative responses in branchial tissue. This research suggests that oxidative stress, as well as the antioxidant potential clearly differ between salmonid and cyprinid species.	[Sinha, Amit Kumar; Giblen, Terri; De Rop, Michelle; Blust, Ronny; De Boeck, Gudrun] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium; [AbdElgawad, Hamada; Zinta, Gaurav; Asard, Han] Univ Antwerp, Dept Biol, Mol Plant Physiol & Biotechnol Grp, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Sinha, AK (corresponding author), Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium.	sinha_cife@rediffmail.com	De Boeck, Gudrun/A-1938-2015; Zinta, Gaurav/A-1530-2015; AbdElgawad, Hamada/N-2488-2017	De Boeck, Gudrun/0000-0003-0941-3488; Zinta, Gaurav/0000-0002-5503-8618; Sinha, Amit Kumar/0000-0003-0419-7640; AbdElgawad, Hamada/0000-0001-9764-9006	Fonds Wetenschappelijk Onderzoek - Vlaanderen [FWO 1121310N]	Fonds Wetenschappelijk Onderzoek - Vlaanderen(FWO)	This work was supported by the Fonds Wetenschappelijk Onderzoek - Vlaanderen [FWO 1121310N]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; ALESSIO HM, 1988, J APPL PHYSIOL, V64, P1333, DOI 10.1152/jappl.1988.64.4.1333; Aniagu SO, 2006, ENVIRON MOL MUTAGEN, V47, P616, DOI 10.1002/em.20247; ARILLO A, 1981, ECOTOX ENVIRON SAFE, V5, P316, DOI 10.1016/0147-6513(81)90006-3; Basha PS, 2003, ECOTOX ENVIRON SAFE, V56, P218, DOI 10.1016/S0147-6513(03)00028-9; Benli ACK, 2008, CHEMOSPHERE, V72, P1355, DOI 10.1016/j.chemosphere.2008.04.037; Brusilow SW, 2002, MEDICINE, V81, P240, DOI 10.1097/00005792-200205000-00007; Cheung CCC, 2001, AQUAT TOXICOL, V52, P189, DOI 10.1016/S0166-445X(00)00145-4; Ching BY, 2009, AQUAT TOXICOL, V95, P203, DOI 10.1016/j.aquatox.2009.09.004; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Dorval J, 2003, TOXICOL APPL PHARM, V192, P191, DOI 10.1016/S0041-008X(03)00281-3; Dosdat A, 2003, AQUAT LIVING RESOUR, V16, P509, DOI 10.1016/j.aquliv.2003.08.001; DOWDEN BOBBY F., 1965, J WATER POLLUT CONTR FED, V37, P1308; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; DROTAR A, 1985, PLANT SCI, V42, P35, DOI 10.1016/0168-9452(85)90025-1; Erdogan O, 2005, COMP BIOCHEM PHYS C, V141, P145, DOI 10.1016/j.cca.2005.05.013; Eyckmans M, 2011, AQUAT TOXICOL, V103, P112, DOI 10.1016/j.aquatox.2011.02.010; FAN P, 1993, BRAIN RES, V632, P225, DOI 10.1016/0006-8993(93)91157-N; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Foss A, 2004, AQUACULTURE, V237, P179, DOI 10.1016/j.aquaculture.2004.03.013; FREEMAN BA, 1982, LAB INVEST, V47, P412; Guerriero G, 2002, COMP BIOCHEM PHYS A, V132, P205, DOI 10.1016/S1095-6433(01)00549-9; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hamilton MC, 2005, ENVIRON SCI TECHNOL, V39, P8622, DOI 10.1021/es050898y; Hansen BH, 2006, CHEMOSPHERE, V65, P1707, DOI 10.1016/j.chemosphere.2006.04.088; HASAN MR, 1986, AQUACULTURE, V54, P97, DOI 10.1016/0044-8486(86)90261-9; Hegazi M.M.A., 2011, EGYPT J AQUAT BIOL F, V15, P15; Hegazi MM, 2010, AQUAT TOXICOL, V99, P118, DOI 10.1016/j.aquatox.2010.04.007; Hermenegildo C, 1996, NEUROCHEM RES, V21, P1237, DOI 10.1007/BF02532401; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ip YK, 2004, PHYSIOL BIOCHEM ZOOL, V77, P390, DOI 10.1086/383510; Ip YK, 2004, J COMP PHYSIOL B, V174, P565, DOI 10.1007/s00360-004-0445-1; Ip YK, 2001, J COMP PHYSIOL B, V171, P357; Jena SD, 2009, VET RES COMMUN, V33, P421, DOI 10.1007/s11259-008-9188-x; Ji LL, 1999, P SOC EXP BIOL MED, V222, P283, DOI 10.1046/j.1525-1373.1999.d01-145.x; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; Kelley EE, 2010, FREE RADICAL BIO MED, V48, P493, DOI 10.1016/j.freeradbiomed.2009.11.012; Knoph MB, 1996, COMP BIOCHEM PHYS A, V113, P375, DOI 10.1016/0300-9629(95)02078-0; KNOPH MB, 1994, AQUAT TOXICOL, V30, P295, DOI 10.1016/0166-445X(94)00046-8; Kosenko E, 1999, FREE RADICAL BIO MED, V26, P1369, DOI 10.1016/S0891-5849(98)00339-6; Kosenko E, 2003, BRAIN RES, V981, P193, DOI 10.1016/S0006-8993(03)03035-X; Le Ruyet JP, 1998, COMP BIOCHEM PHYS A, V119, P511, DOI 10.1016/S1095-6433(97)00458-3; Lemarie G, 2004, AQUACULTURE, V229, P479, DOI 10.1016/S0044-8486(03)00392-2; Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; MARCAIDA G, 1992, FEBS LETT, V296, P67, DOI 10.1016/0014-5793(92)80404-5; McKenzie DJ, 2003, COMP BIOCHEM PHYS A, V135, P515, DOI 10.1016/S1095-6433(03)00116-8; Murshed R, 2008, ANAL BIOCHEM, V383, P320, DOI 10.1016/j.ab.2008.07.020; Murthy CRK, 2001, J NEUROSCI RES, V66, P282, DOI 10.1002/jnr.1222; Murthy CRK, 2000, NEUROCHEM INT, V37, P255, DOI 10.1016/S0197-0186(00)00028-0; Norenberg MD, 2007, METAB BRAIN DIS, V22, P219, DOI 10.1007/s11011-007-9062-5; Ozer N, 1998, J BIOCHEM BIOPH METH, V36, P95, DOI 10.1016/S0165-022X(97)00051-1; Person-Le Ruyet J, 2003, J FISH BIOL, V62, P879, DOI 10.1046/j.1095-8649.2003.00073.x; PersonLeRuyet J, 1997, AQUACULTURE, V154, P155, DOI 10.1016/S0044-8486(97)00052-5; Pinto W, 2007, AQUAC RES, V38, P1198, DOI 10.1111/j.1365-2109.2007.01788.x; Prieto AI, 2009, ENVIRON TOXICOL, V24, P563, DOI 10.1002/tox.20458; Randall D. J., 2002, Marine Pollution Bulletin, V45, P17, DOI 10.1016/S0025-326X(02)00227-8; Rau MA, 2004, COMP BIOCHEM PHYS C, V137, P335, DOI 10.1016/j.cca.2004.03.001; Rose C, 2002, METAB BRAIN DIS, V17, P251, DOI 10.1023/A:1021945515514; SCHENONE G, 1982, ECOTOX ENVIRON SAFE, V6, P479, DOI 10.1016/0147-6513(82)90029-X; Sinha AK, 2013, J EXP BIOL, V216, P2917, DOI 10.1242/jeb.084574; Sinha AK, 2013, AQUAT TOXICOL, V130, P86, DOI 10.1016/j.aquatox.2013.01.003; Sinha AK, 2012, AQUAT TOXICOL, V114, P153, DOI 10.1016/j.aquatox.2012.02.027; Sinha AK, 2012, AQUAT TOXICOL, V109, P33, DOI 10.1016/j.aquatox.2011.11.002; Soderberg RW, 1992, J APPL AQUACULTURE, V1, P83; Stephensen E, 2002, COMP BIOCHEM PHYS C, V133, P435, DOI 10.1016/S1532-0456(02)00129-1; Strobel C, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-144; SUGIHARA N, 1994, TOXICOL APPL PHARM, V126, P124, DOI 10.1006/taap.1994.1098; Sun HJ, 2012, J HAZARD MATER, V221, P213, DOI 10.1016/j.jhazmat.2012.04.036; Sun HJ, 2011, BIOCHEM SYST ECOL, V39, P536, DOI 10.1016/j.bse.2011.08.001; THURSTON RV, 1981, ENVIRON SCI TECHNOL, V15, P837, DOI 10.1021/es00089a012; Tomasso J.R., 1994, REV FISH SCI, V2, P291, DOI [10.1080/10641269409388560, DOI 10.1080/10641269409388560]; Tsui TKN, 2004, J EXP BIOL, V207, P1977, DOI 10.1242/jeb.00905; Valavanidis A, 2006, ECOTOX ENVIRON SAFE, V64, P178, DOI 10.1016/j.ecoenv.2005.03.013; VERDOUW H, 1978, WATER RES, V12, P399, DOI 10.1016/0043-1354(78)90107-0; Walsh PJ, 2007, COMP BIOCHEM PHYS A, V147, P332, DOI 10.1016/j.cbpa.2006.09.001; Weinstein D.I., 1998, AQUACULTURE, V165, P81, DOI DOI 10.1016/S0044-8486(98)00251-8; Wicks BJ, 2002, COMP BIOCHEM PHYS A, V132, P275, DOI 10.1016/S1095-6433(02)00034-X; Wilkie MP, 2011, J EXP BIOL, V214, P4107, DOI 10.1242/jeb.057513; Wilkie MP, 1997, COMP BIOCHEM PHYS A, V118, P39, DOI 10.1016/S0300-9629(96)00407-0; WINSTON GW, 1991, AQUAT TOXICOL, V19, P137, DOI 10.1016/0166-445X(91)90033-6; Winzer K, 2002, AQUAT TOXICOL, V56, P275, DOI 10.1016/S0166-445X(01)00215-6; WRIGHT PA, 1995, J EXP BIOL, V198, P127; Wright PA, 2009, J EXP BIOL, V212, P2303, DOI 10.1242/jeb.023085; Zhao YY, 2009, ENVIRON TOXICOL PHAR, V27, P195, DOI 10.1016/j.etap.2008.10.005	88	94	104	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95319	10.1371/journal.pone.0095319	http://dx.doi.org/10.1371/journal.pone.0095319			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740135	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900128
J	Cai, B; Li, CH; Huang, J				Cai, Bin; Li, Cheng-Hui; Huang, Jian			Systematic Identification of Cell-Wall Related Genes in Populus Based on Analysis of Functional Modules in Co-Expression Network	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; CELLULOSE; BIOSYNTHESIS; CONSERVATION; COMPLEXES; SND1	The identification of novel genes relevant to plant cell wall (PCW) biosynthesis in Populus is a highly important and challenging problem. We surveyed candidate Populus cell wall genes using a non-targeted approach. First, a genome-wide Populus gene co-expression network (PGCN) was constructed using microarray data available in the public domain. Module detection was then performed, followed by gene ontology (GO) enrichment analysis, to assign the functional category to these modules. Based on GO annotation, the modules involved in PCW biosynthesis were then selected and analyzed in detail to annotate the candidate PCW genes in these modules, including gene annotation, expression of genes in different tissues, and so on. We examined the overrepresented cis-regulatory elements (CREs) in the gene promoters to understand the possible transcriptionally co-regulated relationships among the genes within the functional modules of cell wall biosynthesis. PGCN contains 6,854 nodes (genes) with 324,238 edges. The topological properties of the network indicate scale-free and modular behavior. A total of 435 modules were identified; among which, 67 modules were identified by overrepresented GO terms. Six modules involved in cell wall biosynthesis were identified. Module 9 was mainly involved in cellular polysaccharide metabolic process in the primary cell wall, whereas Module 4 comprises genes involved in secondary cell wall biogenesis. In addition, we predicted and analyzed 10 putative CREs in the promoters of the genes in Module 4 and Module 9. The non-targeted approach of gene network analysis and the data presented here can help further identify and characterize cell wall related genes in Populus.	[Cai, Bin; Huang, Jian] Soochow Univ, Coll Med, Dept Genet, Suzhou, Jiangsu, Peoples R China; [Li, Cheng-Hui] Suzhou Polytech Inst Agr, Dept Hort, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Huang, J (corresponding author), Soochow Univ, Coll Med, Dept Genet, Suzhou, Jiangsu, Peoples R China.	huangjian79@suda.edu.cn			Chinese National Natural Science Foundation [31000569, 31201607]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was supported by Chinese National Natural Science Foundation (31000569 and 31201607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Bray D, 2003, SCIENCE, V301, P1864, DOI 10.1126/science.1089118; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ha MA, 2002, PHYTOCHEMISTRY, V61, P7, DOI 10.1016/S0031-9422(02)00199-1; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Holland N, 2000, PLANT PHYSIOL, V123, P1313, DOI 10.1104/pp.123.4.1313; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kimura S, 1999, PLANT CELL, V11, P2075, DOI 10.1105/tpc.11.11.2075; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mao LY, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-346; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Persson S, 2007, P NATL ACAD SCI USA, V104, P15566, DOI 10.1073/pnas.0706592104; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Ruan JH, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-8; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Tuskan GA, 2004, PLANT BIOLOGY, V6, P2, DOI 10.1055/s-2003-44715; Wang S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-138; Yang XD, 2011, BUILD SIMUL-CHINA, V4, P181, DOI 10.1007/s12273-011-0047-2; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhong RQ, 2006, PLANT CELL, V18, P3158, DOI 10.1105/tpc.106.047399; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325	28	24	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95176	10.1371/journal.pone.0095176	http://dx.doi.org/10.1371/journal.pone.0095176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736620	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600151
J	Huang, L; Hu, F; Xie, XL; Harder, J; Fernandes, K; Zeng, XY; Libby, R; Gan, L				Huang, Liang; Hu, Fang; Xie, Xiaoling; Harder, Jeffery; Fernandes, Kimberly; Zeng, Xiang-yun; Libby, Richard; Gan, Lin			Pou4f1 and Pou4f2 Are Dispensable for the Long-Term Survival of Adult Retinal Ganglion Cells in Mice	PLOS ONE			English	Article							FAMILY TRANSCRIPTION FACTOR; BCL-2 TRANSGENIC MICE; DOMAIN FACTOR BRN-3B; GENE-EXPRESSION; SENSORY DIFFERENTIATION; TRIGEMINAL GANGLION; BH3-ONLY PROTEINS; NEURONAL DEATH; AXON OUTGROWTH; VISUAL-SYSTEM	Purpose: To investigate the role of Pou4f1 and Pou4f2 in the survival of adult retinal ganglion cells (RGCs). Methods: Conditional alleles of Pou4f1 and Pou4f2 were generated (Pou4f1(loxP) and Pou4f2(loxP) respectively) for the removal of Pou4f1 and Pou4f2 in adult retinas. A tamoxifen-inducible Cre was used to delete Pou4f1 and Pou4f2 in adult mice and retinal sections and flat mounts were subjected to immunohistochemistry to confirm the deletion of both alleles and to quantify the changes in the number of RGCs and other retinal neurons. To determine the effect of loss of Pou4f1 and Pou4f2 on RGC survival after axonal injury, controlled optic nerve crush (CONC) was performed and RGC death was assessed. Results: Pou4f1 and Pou4f2 were ablated two weeks after tamoxifen treatment. Retinal interneurons and Muller glial cells are not affected by the ablation of Pou4f1 or Pou4f2 or both. Although the deletion of both Pou4f1 and Pou4f2 slightly delays the death of RGCs at 3 days post-CONC in adult mice, it does not affect the cell death progress afterwards. Moreoever, deletion of Pou4f1 or Pou4f2 or both has no impact on the long-term viability of RGCs at up to 6 months post-tamoxifen treatment. Conclusion: Pou4f1 and Pou4f2 are involved in the acute response to damage to RGCs but are dispensable for the long-term survival of adult RGC in mice.	[Huang, Liang; Hu, Fang; Xie, Xiaoling; Harder, Jeffery; Fernandes, Kimberly; Libby, Richard; Gan, Lin] Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14627 USA; [Huang, Liang; Hu, Fang; Xie, Xiaoling; Harder, Jeffery; Fernandes, Kimberly; Libby, Richard; Gan, Lin] Univ Rochester, Sch Med & Dent, Dept Ophthalmol, Rochester, NY USA; [Huang, Liang; Hu, Fang; Zeng, Xiang-yun] Gannan Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Ganzhou, Jiangxi, Peoples R China; [Gan, Lin] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China	University of Rochester; University of Rochester; Gannan Medical University; Hangzhou Normal University	Gan, L (corresponding author), Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14627 USA.	lin_gan@urmc.rochester.edu	Huang, Liang/AAH-1887-2021	Huang, Liang/0000-0002-8615-2595; Libby, Richard/0000-0003-2844-7632	National Institute of Health [1R21EY023104]; National Natural Science Foundation of China [81271006, 81060081, 81241124, 81360155]; Hangzhou City Health Science Foundation [20120633B25]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [T32EY007125, R21EY023104, R01EY018606] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou City Health Science Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by National Institute of Health grant 1R21EY023104, National Natural Science Foundation of China grant 81271006, 81060081, 81241124 and 81360155, Hangzhou City Health Science Foundation grant No. 20120633B25, and the Research to Prevent Blindness challenge grant to the Department of Ophthalmology at the University of Rochester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Bonfanti L, 1996, J NEUROSCI, V16, P4186; Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Budhram-Mahadeo VS, 2006, NUCLEIC ACIDS RES, V34, P6640, DOI 10.1093/nar/gkl878; Budram-Mahadeo V, 2002, ONCOGENE, V21, P6123, DOI 10.1038/sj.onc.1205842; Cenni MC, 1996, EUR J NEUROSCI, V8, P1735, DOI 10.1111/j.1460-9568.1996.tb01317.x; Chierzi S, 1999, J NEUROSCI, V19, P8367; Ding Q, 2009, J NEUROSCI, V29, P3992, DOI 10.1523/JNEUROSCI.5237-08.2009; Dykes IM, 2011, J NEUROSCI, V31, P9789, DOI 10.1523/JNEUROSCI.0901-11.2011; Dykes IM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-3; Eng SR, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-3; Eng SR, 2004, DEVELOPMENT, V131, P3859, DOI 10.1242/dev.01260; Eng SR, 2001, J NEUROSCI, V21, P541, DOI 10.1523/JNEUROSCI.21-02-00541.2001; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Erkman L, 2000, NEURON, V28, P779, DOI 10.1016/S0896-6273(00)00153-7; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Huang EJ, 1999, DEVELOPMENT, V126, P2869; Hudson CD, 2005, J BIOL CHEM, V280, P11851, DOI 10.1074/jbc.M408679200; Lei L, 2006, DEV BIOL, V300, P758, DOI 10.1016/j.ydbio.2006.08.062; Li Y, 2000, EXP EYE RES, V71, P209, DOI 10.1006/exer.2000.0873; Libby RT, 2005, PLOS GENET, V1, P17, DOI 10.1371/journal.pgen.0010004; Liu XH, 2001, J BIOL CHEM, V276, P46326, DOI 10.1074/jbc.M108930200; Malik JMI, 2005, MOL THER, V11, P373, DOI 10.1016/j.ymthe.2004.11.014; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Napankangas U, 2003, MOL BRAIN RES, V120, P30, DOI 10.1016/j.molbrainres.2003.09.016; Nickells RW, 1996, J GLAUCOMA, V5, P345; Nickells RW, 2004, BRAIN RES BULL, V62, P439, DOI 10.1016/j.brainresbull.2003.07.007; Pan L, 2005, DEVELOPMENT, V132, P703, DOI 10.1242/dev.01646; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Perez-Sanchez C, 2002, NUCLEIC ACIDS RES, V30, P4872, DOI 10.1093/nar/gkf610; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Semaan SJ, 2010, ASN NEURO, V2, DOI 10.1042/AN20100003; Smith MD, 1998, J BIOL CHEM, V273, P16715, DOI 10.1074/jbc.273.27.16715; Vahava O, 1998, SCIENCE, V279, P1950, DOI 10.1126/science.279.5358.1950; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Wang SW, 2002, DEVELOPMENT, V129, P467; Wang SW, 2000, MOL CELL NEUROSCI, V16, P141, DOI 10.1006/mcne.2000.0860; Weiss S, 2003, MOL CELL BIOL, V23, P7957, DOI 10.1128/MCB.23.22.7957-7964.2003; White FA, 1998, J NEUROSCI, V18, P1428; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868; XIANG MQ, 1993, NEURON, V11, P689, DOI 10.1016/0896-6273(93)90079-7; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zou M, 2012, DEV BIOL, V364, P114, DOI 10.1016/j.ydbio.2012.01.021	52	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94173	10.1371/journal.pone.0094173	http://dx.doi.org/10.1371/journal.pone.0094173			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736625	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600050
J	Lhorente, JP; Gallardo, JA; Villanueva, B; Carabano, MJ; Neira, R				Paul Lhorente, Jean; Gallardo, Jose A.; Villanueva, Beatriz; Carabano, Maria J.; Neira, Roberto			Disease Resistance in Atlantic Salmon (Salmo salar): Coinfection of the Intracellular Bacterial Pathogen Piscirickettsia salmonis and the Sea Louse Caligus rogercresseyi	PLOS ONE			English	Article							INFECTIOUS-PANCREATIC-NECROSIS; AMEBIC GILL DISEASE; LICE LEPEOPHTHEIRUS-SALMONIS; ONCORHYNCHUS-MYKISS WALBAUM; RAINBOW-TROUT; GENETIC-VARIATION; POST-SMOLTS; COHO SALMON; INCREASE RESISTANCE; CAUSATIVE AGENT	Background: Naturally occurring coinfections of pathogens have been reported in salmonids, but their consequences on disease resistance are unclear. We hypothesized that 1) coinfection of Caligus rogercresseyi reduces the resistance of Atlantic salmon to Piscirickettsia salmonis; and 2) coinfection resistance is a heritable trait that does not correlate with resistance to a single infection. Methodology: In total, 1,634 pedigreed Atlantic salmon were exposed to a single infection (SI) of P. salmonis (primary pathogen) or coinfection with C. rogercresseyi (secondary pathogen). Low and high level of coinfection were evaluated (LC = 44 copepodites per fish; HC = 88 copepodites per fish). Survival and quantitative genetic analyses were performed to determine the resistance to the single infection and coinfections. Main Findings: C. rogercresseyi significantly increased the mortality in fish infected with P. salmonis (SI mortality = 251/545; LC mortality = 544/544 and HC mortality = 545/545). Heritability estimates for resistance to P. salmonis were similar and of medium magnitude in all treatments (h(SI)(2) = 0.23 +/- 0.07; h(LC)(2) = 0.17 +/- 0.08; h(HC)(2) = 0.24 +/- 0.07). A large and significant genetic correlation with regard to resistance was observed between coinfection treatments (r(g) LC-HC = 0.99 +/- 0.01) but not between the single and coinfection treatments (r(g) SI-LC = -0.14 +/- 0.33; r(g) SI-HC = 0.32 +/- 0.34). Conclusions/Significance: C. rogercresseyi, as a secondary pathogen, reduces the resistance of Atlantic salmon to the pathogen P. salmonis. Resistance to coinfection of Piscirickettsia salmonis and Caligus rogercresseyi in Atlantic salmon is a heritable trait. The absence of a genetic correlation between resistance to a single infection and resistance to coinfection indicates that different genes control these processes. Coinfection of different pathogens and resistance to coinfection needs to be considered in future research on salmon farming, selective breeding and conservation.	[Paul Lhorente, Jean; Neira, Roberto] Aquainnovo SA, Puerto Montt, Chile; [Gallardo, Jose A.] Pontificia Univ Catolica Valparaiso, Valparaiso, Chile; [Villanueva, Beatriz; Carabano, Maria J.] INIA, Dept Mejora Genet Anim, Madrid, Spain; [Neira, Roberto] Univ Chile, Fac Ciencias Agron, Dept Prod Anim, Santiago, Chile	Pontificia Universidad Catolica de Valparaiso; Universidad de Chile	Gallardo, JA (corresponding author), Pontificia Univ Catolica Valparaiso, Valparaiso, Chile.	jose.gallardo@ucv.cl	Neira, Roberto/H-3964-2013; Carabaño, Maria/L-1927-2019; Gallardo, José/F-3261-2010	Neira, Roberto/0000-0002-9434-5290; Gallardo, José/0000-0002-7717-8726; Carabano, Maria/0000-0002-3087-9170	INNOVA-CHILE of CORFO [206-5047, 07CN13PBT-61]; Ministerio de Economia y Competitividad, Spain [CGL2012-39861-C02-02]	INNOVA-CHILE of CORFO; Ministerio de Economia y Competitividad, Spain	This study was financed by INNOVA-CHILE of CORFO through the projects: 1) Consorcio empresarial de genetica y desarrollo biotecnologico para la industria salmonera (No 206-5047), and 2) Desarrollo de una nueva metodologia para la identificacion y seleccion de salmonidos geneticamente resistentes al ectoparasito Caligus rogercresseyi (07CN13PBT-61). This study is a collaborative work of different institutions belonging to "Red de genetica e inmunologia para el control de patogenos en Acuicultura" (RED CYTED No 11RT0420). BV received funding from the Ministerio de Economia y Competitividad, Spain (project CGL2012-39861-C02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2003, ARCH VIROL, V148, P1507, DOI 10.1007/s00705-003-0116-7; Araya A, 2012, AQUAC RES, V43, P1904, DOI 10.1111/j.1365-2109.2011.02991.x; Boxshall GA, 2000, CONTRIB ZOOL, V69, P137, DOI 10.1163/18759866-0690102015; Bustos PA, 2011, AQUACULTURE, V310, P281, DOI 10.1016/j.aquaculture.2010.11.001; Byrne N, 2008, FISH SHELLFISH IMMUN, V24, P489, DOI 10.1016/j.fsi.2007.08.010; Connors BM, 2010, J APPL ECOL, V47, P1365, DOI 10.1111/j.1365-2664.2010.01887.x; Costello MJ, 2006, TRENDS PARASITOL, V22, P475, DOI 10.1016/j.pt.2006.08.006; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; CVITANICH JD, 1991, J FISH DIS, V14, P121, DOI 10.1111/j.1365-2761.1991.tb00584.x; Densmore CL, 2004, J AQUAT ANIM HEALTH, V16, P73, DOI 10.1577/H03-039.1; DORSON M, 1995, VET RES, V26, P361; Drangsholt TMK, 2012, AQUACULTURE, V324, P312, DOI 10.1016/j.aquaculture.2011.11.007; Ducrocq V., 2010, 9 WORLD C GEN LIV PR; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fast MD, 2006, FISH SHELLFISH IMMUN, V21, P228, DOI 10.1016/j.fsi.2005.11.010; Finstad B, 2000, AQUAC RES, V31, P795, DOI 10.1046/j.1365-2109.2000.00511.x; FRYER JL, 1992, INT J SYST BACTERIOL, V42, P120, DOI 10.1099/00207713-42-1-120; Fryer JL, 2003, J FISH DIS, V26, P251, DOI 10.1046/j.1365-2761.2003.00460.x; FRYER JL, 1990, FISH PATHOL, V25, P107, DOI 10.3147/jsfp.25.107; GAGGERO A, 1995, J FISH DIS, V18, P277, DOI 10.1111/j.1365-2761.1995.tb00303.x; Gharbi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-20; Gilmour A.R., 1999, ASREML REFERENCE MAN; Gjedrem T., 1995, Aquaculture Research, V26, P129, DOI 10.1111/j.1365-2109.1995.tb00892.x; Gjerde B, 2009, AQUACULTURE, V287, P52, DOI 10.1016/j.aquaculture.2008.10.028; Gjoen HM, 1997, AQUACULTURE, V158, P277, DOI 10.1016/S0044-8486(97)00203-2; Glover KA, 2005, AQUACULTURE, V245, P19, DOI 10.1016/j.aquaculture.2004.11.047; Gomez D, 2011, AQUACULTURE, V318, P15, DOI 10.1016/j.aquaculture.2011.04.023; Gonzalez L, 2000, AQUACULTURE, V183, P13, DOI 10.1016/S0044-8486(99)00282-3; Guy DR, 2009, AQUACULTURE, V290, P229, DOI 10.1016/j.aquaculture.2009.02.015; Henryon M, 2005, AQUACULTURE, V250, P621, DOI 10.1016/j.aquaculture.2004.12.022; Henryon M, 2002, AQUACULTURE, V209, P59, DOI 10.1016/S0044-8486(01)00729-3; Holten-Andersen L, 2012, PLOS ONE; Johansen LH, 2001, DIS AQUAT ORGAN, V47, P109, DOI 10.3354/dao047109; Johansen LH, 2009, AQUACULTURE, V290, P9, DOI 10.1016/j.aquaculture.2009.02.002; JOHNSON DL, 1995, J DAIRY SCI, V78, P449, DOI 10.3168/jds.S0022-0302(95)76654-1; Jones SRM., 2011, J AQUAC RES DEV, DOI [10.4172/2155-9546.s2-003, DOI 10.4172/2155-9546.S2-003]; Kjoglum S, 2008, AQUAC RES, V39, P498, DOI 10.1111/j.1365-2109.2008.01904.x; Kolstad K, 2005, AQUACULTURE, V247, P145, DOI 10.1016/j.aquaculture.2005.02.009; Krkosek M, 2007, SCIENCE, V318, P1772, DOI 10.1126/science.1148744; Krkosek M, 2011, ECOL APPL, V21, P897, DOI 10.1890/09-1861.1; Leal J, 2007, SALMOCIENCIA, V2, P34; Leeds TD, 2010, J ANIM SCI, V88, P1936, DOI 10.2527/jas.2009-2538; MacKinnon BM, 1998, ICES J MAR SCI, V55, P188, DOI 10.1006/jmsc.1997.0361; Yanez JM, 2013, AQUACULTURE, V414, P155, DOI 10.1016/j.aquaculture.2013.08.009; MULCAHY D, 1976, AM FISH SOC FISH HLT, V5, P5; Mustafa A, 2000, J FISH DIS, V23, P337, DOI 10.1046/j.1365-2761.2000.00235.x; Mustafa A, 1999, CAN J ZOOL, V77, P1332, DOI 10.1139/cjz-77-8-1332; Norris A, 2008, J FISH DIS, V31, P913, DOI 10.1111/j.1365-2761.2008.00982.x; Nowak BF, 2010, J FISH DIS, V33, P683, DOI 10.1111/j.1365-2761.2010.01158.x; Odegard J, 2007, AQUACULTURE, V271, P173, DOI 10.1016/j.aquaculture.2007.06.006; Odegard J, 2006, AQUACULTURE, V259, P116, DOI 10.1016/j.aquaculture.2006.05.034; Odegard J, 2011, AQUAC RES, V42, P103, DOI 10.1111/j.1365-2109.2010.02669.x; Lhorente JP, 2012, AQUACULTURE, V324, P55, DOI 10.1016/j.aquaculture.2011.10.046; Perry GML, 2004, AQUACULTURE, V235, P263, DOI 10.1016/j.aquaculture.2004.03.002; Pike A.W., 1999, ADV PARASIT, V44, P223; Rozas M., 2007, SALMOCIENCIA, V2, P43; Saint-Jean SR, 2007, FISH SHELLFISH IMMUN, V23, P390, DOI 10.1016/j.fsi.2006.11.012; SAS INSTITUTE INC, 1993, US GUID STAT VERS 6; Sernapesca, 2012, INF SAN SALM CTR MAR; Silverstein JT, 2009, J ANIM SCI, V87, P860, DOI 10.2527/jas.2008-1157; Skaala O, 2014, MAR BIOL RES, V10, P279, DOI 10.1080/17451000.2013.810756; Smith PA, 1999, DIS AQUAT ORGAN, V37, P165, DOI 10.3354/dao037165; Storset A, 2007, AQUACULTURE, V272, pS62, DOI 10.1016/j.aquaculture.2007.08.011; Tadiso TM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-141; Tafalla C, 2006, AQUACULTURE, V256, P15, DOI 10.1016/j.aquaculture.2006.01.027; Taylor RS, 2007, AQUACULTURE, V272, pS94, DOI 10.1016/j.aquaculture.2007.08.007; Tully O, 2002, PARASITOLOGY, V124, pS165, DOI 10.1017/S0031182002001889; Valdes-Donoso P, 2013, J FISH DIS, V36, P353, DOI 10.1111/jfd.12070; VILAS MP, 1994, B EUR ASSOC FISH PAT, V14, P1; Weber GM, 2008, N AM J AQUACULT, V70, P425, DOI 10.1577/A07-059.1; WITHLER RE, 1990, T AM FISH SOC, V119, P1003, DOI 10.1577/1548-8659(1990)119&lt;1003:GVIRTB&gt;2.3.CO;2; Zagmutt-Vergara FJ, 2005, DIS AQUAT ORGAN, V64, P163, DOI 10.3354/dao064163	73	58	58	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95397	10.1371/journal.pone.0095397	http://dx.doi.org/10.1371/journal.pone.0095397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736323	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600179
J	Olivier-Van Stichelen, S; Dehennaut, V; Buzy, A; Zachayus, JL; Guinez, C; Mir, AM; El Yazidi-Belkoura, I; Copin, MC; Boureme, D; Loyaux, D; Ferrara, P; Lefebvre, T				Olivier-Van Stichelen, Stephanie; Dehennaut, Vanessa; Buzy, Armelle; Zachayus, Jean-Luc; Guinez, Celine; Mir, Anne-Marie; El Yazidi-Belkoura, Ikram; Copin, Marie-Christine; Boureme, Didier; Loyaux, Denis; Ferrara, Pascual; Lefebvre, Tony			O-GlcNAcylation stabilizes beta-catenin through direct competition with phosphorylation at threonine 41	FASEB JOURNAL			English	Article						Wnt signaling; cancer; ETD-MS/MS	INCIDENT COLORECTAL-CANCER; CARBOHYDRATE-METABOLISM; GLCNAC GLYCOSYLATION; LACTIC-ACID; CELL-GROWTH; PATHWAY; ACTIVATION; MUTATIONS; TUMORS; RISK	Dysfunctions in Wnt signaling increase beta-catenin stability and are associated with cancers, including colorectal cancer. In addition, beta-catenin degradation is decreased by nutrient-dependent O-GlcNAcylation. Human colon tumors and colons from mice fed high-carbohydrate diets exhibited higher amounts of beta-catenin and O-GlcNAc relative to healthy tissues and mice fed a standard diet, respectively. Administration of the O-GlcNAcase inhibitor thiamet G to mice also increased colonic expression of beta-catenin. By ETD-MS/MS, we identified 4 O-GlcNAcylation sites at the N terminus of beta-catenin (S23/T40/T41/T112). Furthermore, mutation of serine and threonine residues within the D box of beta-catenin reduced O-GlcNAcylation by 75%. Interestingly, elevating O-GlcNAcylation in human colon cell lines drastically reduced phosphorylation at T41, a key residue of the D box responsible for beta-catenin stability. Analyses of beta-catenin O-GlcNAcylation mutants reinforced T41 as the most crucial residue that controls the beta-catenin degradation rate. Finally, inhibiting O-GlcNAcylation decreased the beta-catenin/beta-catenin interaction necessary for mucosa integrity, whereas O-GlcNAcase silencing improved this interaction. These results suggest that O-GlcNAcylation regulates not only the stability of beta-catenin, but also affects its localization at the level of adherens junctions. Accordingly, we propose that O-GlcNAcylation of beta-catenin is a missing link between the glucose metabolism deregulation observed in metabolic disorders and the development of cancer.	[Olivier-Van Stichelen, Stephanie; Dehennaut, Vanessa; Guinez, Celine; Mir, Anne-Marie; El Yazidi-Belkoura, Ikram; Lefebvre, Tony] Univ Lille 1, CNRS, Unit Struct & Funct Glycobiol, UMR 8576,IFR 147, F-59655 Villeneuve Dascq, France; [Buzy, Armelle; Zachayus, Jean-Luc; Boureme, Didier; Loyaux, Denis; Ferrara, Pascual] Sanofi Aventis Res & Dev, Exploratory Unit Syst Biol, Toulouse, France; [Copin, Marie-Christine] Univ Lille 2, Tumor Bank, Reg Reference Ctr Canc, Ctr Hosp Reg Univ Lille CHRU, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Sanofi-Aventis; Sanofi France; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Lefebvre, T (corresponding author), Univ Lille 1, CNRS, Unit Struct & Funct Glycobiol, UMR 8576,IFR 147, F-59655 Villeneuve Dascq, France.	tony.lefebvre@univ-lille1.fr	El Yazidi-Belkoura, Ikram/AAE-8805-2022; dehennaut, vanessa/I-7435-2018; Lefebvre, Tony/AAW-9169-2021; Lefebvre, Tony/AAZ-1724-2021; olivier-van stichelen, Stephanie/AAH-9328-2021	dehennaut, vanessa/0000-0001-6421-0793; Lefebvre, Tony/0000-0001-9883-2240; olivier-van stichelen, Stephanie/0000-0002-2033-5241; EL YAZIDI-BELKOURA, IKRAM/0000-0002-5323-7509	Ligue Contre le Cancer/Comite du Nord; Association pour la Recherche sur le Cancer; Region Nord-Pas de Calais (Cancer Regional Program), Lille 1 University; Centre National de la Recherche Scientifique; Ligue Contre le Cancer	Ligue Contre le Cancer/Comite du Nord(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Region Nord-Pas de Calais (Cancer Regional Program), Lille 1 University(Region Hauts-de-France); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ligue Contre le Cancer(Ligue nationale contre le cancer)	The authors thank Prof. D. Vocadlo (Simon Fraser University, Burnaby, BC, Canada), who provided NButGT and Ac-5SGlcNAc; Dr. C. Couturier (Biology Institute of Lille, France), who provided the HA-ubiquitin expression; Dr. C. Liu (University of Kentucky, Lexington, KY, USA), who provided pCS2+beta-catenin-2XFlag (WT and TM); the Site de Recherche Integree sur le Cancer ONCOLille, and the Tumor Bank [Regional Reference Center in Cancer, Centre Hospitalier Regional Universitaire (CHRU)] of Lille (Lille, France) for providing colon tumor tissues and matching tumor-adjacent normal tissues; and Michelle Bond [National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), U.S. National Institutes of Health, Bethesda, MD, USA] for editing the English in the manuscript and for helpful comments. This work was supported by the Ligue Contre le Cancer/Comite du Nord, the Association pour la Recherche sur le Cancer, the Region Nord-Pas de Calais (Cancer Regional Program), Lille 1 University, and the Centre National de la Recherche Scientifique. V. D. is the recipient of a postdoctoral fellowship from the Ligue Contre le Cancer. The authors declare no conflicts of interest.	Ahmed RL, 2006, CANCER-AM CANCER SOC, V107, P28, DOI 10.1002/cncr.21950; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cori CF, 1925, J BIOL CHEM, V64, P11; Cori CF, 1925, J BIOL CHEM, V65, P397; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Dossus L, 2008, BEST PRACT RES CL EN, V22, P551, DOI 10.1016/j.beem.2008.08.003; Fardini Y, 2013, FRONT ENDOCRINOL, V4, DOI 10.3389/fendo.2013.00099; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Guinez C, 2008, FASEB J, V22, P2901, DOI 10.1096/fj.07-102509; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hatsell S, 2003, J BIOL CHEM, V278, P37745, DOI 10.1074/jbc.M301346200; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Khaw KT, 2004, CANCER EPIDEM BIOMAR, V13, P915; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Lefebvre T, 2004, J CELL BIOCHEM, V93, P999, DOI 10.1002/jcb.20242; Legoix P, 1999, ONCOGENE, V18, P4044, DOI 10.1038/sj.onc.1202800; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu CM, 1999, P NATL ACAD SCI USA, V96, P6273, DOI 10.1073/pnas.96.11.6273; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma F, 2014, GENE, V535, P191, DOI 10.1016/j.gene.2013.11.035; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Olivier-Van Stichelen Stephanie, 2012, Am J Physiol Endocrinol Metab, V302, pE417, DOI 10.1152/ajpendo.00390.2011; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shevchenko A, 1997, RAPID COMMUN MASS SP, V11, P1015, DOI 10.1002/(SICI)1097-0231(19970615)11:9<1015::AID-RCM958>3.0.CO;2-H; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Su YY, 2008, MOL CELL, V32, P652, DOI 10.1016/j.molcel.2008.10.023; van Noort M, 2002, EXP CELL RES, V276, P264, DOI 10.1006/excr.2002.5520; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Winer IS, 2006, J BIOL CHEM, V281, P26181, DOI 10.1074/jbc.M604217200; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278	43	93	97	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3325	3338		10.1096/fj.13-243535	http://dx.doi.org/10.1096/fj.13-243535			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24744147	Green Published			2022-12-25	WOS:000340265400005
J	Singh, M; Kaur, R; Lee, MJ; Pickering, RT; Sharma, VM; Puri, V; Kandror, KV				Singh, Maneet; Kaur, Rajween; Lee, Mi-Jeong; Pickering, R. Taylor; Sharma, Vishva Mitra; Puri, Vishwajeet; Kandror, Konstantin V.			Fat-specific Protein 27 Inhibits Lipolysis by Facilitating the Inhibitory Effect of Transcription Factor Egr1 on Transcription of Adipose Triglyceride Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; LIPID DROPLETS; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; FSP27; METABOLISM; STORAGE; EXPRESSION; PROMOTES; TISSUE	Lipolysis in fat tissue represents a major source of circulating fatty acids. Previously, we have found that lipolysis in adipocytes is controlled by early growth response transcription factor Egr1 that directly inhibits transcription of adipose triglyceride lipase, ATGL (Chakrabarti, P., Kim, J. Y., Singh, M., Shin, Y. K., Kim, J., Kumbrink, J., Wu, Y., Lee, M. J., Kirsch, K. H., Fried, S. K., and Kandror, K. V. (2013) Mol. Cell. Biol. 33, 3659-3666). Here we demonstrate that knockdown of the lipid droplet protein FSP27 (a.k.a. CIDEC) in human adipocytes increases expression of ATGL at the level of transcription, whereas overexpression of FSP27 has the opposite effect. FSP27 suppresses the activity of the ATGL promoter in vitro, and the proximal Egr1 binding site is responsible for this effect. FSP27 co-immunoprecipitates with Egr1 and increases its association with and inhibition of the ATGL promoter. Knockdown of Egr1 attenuates the inhibitory effect of FSP27. These results provide a new model of transcriptional regulation of ATGL.	[Singh, Maneet; Kaur, Rajween; Lee, Mi-Jeong; Pickering, R. Taylor; Sharma, Vishva Mitra; Puri, Vishwajeet; Kandror, Konstantin V.] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Puri, V (corresponding author), Boston Univ, Sect Endocrinol Diabet & Nutr, Dept Med, Sch Med, 650 Albany St, Boston, MA 02118 USA.	vpuri@bu.edu; kkandror@bu.edu	Lee, Mi-Jeong/GXV-9843-2022; Lee, Mi-Jeong/ABE-1084-2020	Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Kandror, Konstantin/0000-0002-8601-9313; Pickering, Richard/0000-0002-5243-4068	National Institutes of Health [DK52057, AG039612, R56DK094815, 8KL2TR000158, UL1-TR000157]; American Diabetes Association [7-11-BS-76]; Allen Foundation; Boston Nutrition and Obesity Research Center Pilot Grant [P30DK046200]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000157, KL2TR000158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052057, R01DK052057, R56DK094815, P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG039612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Allen Foundation; Boston Nutrition and Obesity Research Center Pilot Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Grants DK52057 and AG039612 from the National Institutes of Health, Grant 7-11-BS-76 from the American Diabetes Association, and a research award from the Allen Foundation (to K. V. K.); National Institutes of Health Grants R56DK094815 and 8KL2TR000158 (from the parent grant UL1-TR000157 to the Clinical and Translational Science Institute, Boston University); and Boston Nutrition and Obesity Research Center Pilot Grant P30DK046200 (to V. P.).	Ahmadian M, 2009, DIABETES, V58, P855, DOI 10.2337/db08-1644; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Chakrabarti P, 2013, MOL CELL BIOL, V33, P3659, DOI 10.1128/MCB.01584-12; Chakrabarti P, 2010, DIABETES, V59, P775, DOI 10.2337/db09-1602; Coen PM, 2012, TRENDS ENDOCRIN MET, V23, P391, DOI 10.1016/j.tem.2012.05.009; Coleman RA, 2011, CHEM REV, V111, P6359, DOI 10.1021/cr100404w; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kim JY, 2008, AM J PHYSIOL-ENDOC M, V294, pE654, DOI 10.1152/ajpendo.00104.2007; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Li D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-446; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Oliver P, 2012, INT J OBESITY, V36, P225, DOI 10.1038/ijo.2011.92; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Ranjit S, 2011, J LIPID RES, V52, P221, DOI 10.1194/jlr.M008771; Rubio-Cabezas O, 2009, EMBO MOL MED, V1, P280, DOI 10.1002/emmm.200900037; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang WS, 2012, NAT MED, V18, P235, DOI 10.1038/nm.2614; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Yang XY, 2013, MOL ENDOCRINOL, V27, P116, DOI 10.1210/me.2012-1178; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Zimmermann R, 2009, BBA-MOL CELL BIOL L, V1791, P494, DOI 10.1016/j.bbalip.2008.10.005	54	42	44	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14481	14487		10.1074/jbc.C114.563080	http://dx.doi.org/10.1074/jbc.C114.563080			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24742676	Green Published, hybrid			2022-12-25	WOS:000337248100005
J	Luo, JJ; Song, ZY; Yu, SL; Cui, D; Wang, BL; Ding, FR; Li, S; Dai, YP; Li, N				Luo, Junjie; Song, Zhiyuan; Yu, Shengli; Cui, Dan; Wang, Benli; Ding, Fangrong; Li, Song; Dai, Yunping; Li, Ning			Efficient Generation of Myostatin (MSTN) Biallelic Mutations in Cattle Using Zinc Finger Nucleases	PLOS ONE			English	Article							MUSCLE GROWTH; SOMATIC-CELLS; GENE CAUSES; CLEAVAGE; DELETION; DESIGN; REPAIR; CALVES; MICE	Genetically engineered zinc-finger nucleases (ZFNs) are useful for marker-free gene targeting using a one-step approach. We used ZFNs to efficiently disrupt bovine myostatin (MSTN), which was identified previously as the gene responsible for double muscling in cattle. The mutation efficiency of bovine somatic cells was approximately 20%, and the biallelic mutation efficiency was 8.3%. To evaluate the function of the mutated MSTN locus before somatic cell nuclear transfer, MSTN mRNA and protein expression was examined in four mutant cell colonies. We generated marker-gene-free cloned cattle, in which the MSTN biallelic mutations consisted of a 6-bp deletion in one of the alleles and a 117-bp deletion and 9-bp insertion in the other allele, resulting in at least four distinct mRNA splice variants. In the MSTN mutant cattle, the total amount of MSTN protein with the C-terminal domain was reduced by approximately 50%, and hypertrophied muscle fibers of the quadriceps and the double-muscled phenotype appeared at one month of age. Our proof-of-concept study is the first to produce MSTN mutations in cattle, and may allow the development of genetically modified strains of double-muscled cattle.	[Luo, Junjie; Song, Zhiyuan; Yu, Shengli; Cui, Dan; Wang, Benli; Dai, Yunping; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Ding, Fangrong; Li, Song; Dai, Yunping] Beijing GeneProt Biotechnol Co Ltd, Beijing, Peoples R China; [Li, Ning] Yunnan Agr Univ, Coll Anim Sci, Kunming, Peoples R China	China Agricultural University; Yunnan Agricultural University	Dai, YP (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	daiyunping@sina.com; ninglcau@cau.edu.cn		Luo, Junjie/0000-0002-8987-0533	National Major Development Program of Transgenic Breeding [2013ZX08007-002]; National Program 863 of Bioreactor Major Project; Beijing Gene Protein Biotechnology Co., Ltd.	National Major Development Program of Transgenic Breeding; National Program 863 of Bioreactor Major Project; Beijing Gene Protein Biotechnology Co., Ltd.	This study was supported by grants from the National Major Development Program of Transgenic Breeding (2013ZX08007-002) and the National Program 863 of Bioreactor Major Project. Beijing Gene Protein Biotechnology Co., Ltd., provided support in the form of salaries for authors YPD, FRD and SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bibikova M, 2002, GENETICS, V161, P1169; Carroll D, 2006, NAT PROTOC, V1, P1329, DOI 10.1038/nprot.2006.231; Catipovic B, 2004, NEW ENGL J MED, V351, P1030; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Gong GC, 2004, SCI CHINA SER C, V47, P470, DOI 10.1360/03yc0224; Gong GC, 2004, MOL REPROD DEV, V69, P278, DOI 10.1002/mrd.20130; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Lee HJ, 2010, GENOME RES, V20, P81, DOI 10.1101/gr.099747.109; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Mani M, 2005, BIOCHEM BIOPH RES CO, V335, P447, DOI 10.1016/j.bbrc.2005.07.089; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Orlando SJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq512; ROSENKRANS CF, 1991, CELL IMMUNOL, V133, P187, DOI 10.1016/0008-8749(91)90190-M; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Smith J, 1999, NUCLEIC ACIDS RES, V27, P674, DOI 10.1093/nar/27.2.674; Szabo G, 1998, MAMM GENOME, V9, P671, DOI 10.1007/s003359900843; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Valerie K, 2003, ONCOGENE, V22, P5792, DOI 10.1038/sj.onc.1206679; Wheeler TL, 2001, J ANIM SCI, V79, P3069; Yu SL, 2011, CELL RES, V21, P1638, DOI 10.1038/cr.2011.153	27	38	47	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95225	10.1371/journal.pone.0095225	http://dx.doi.org/10.1371/journal.pone.0095225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743319	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100090
J	Ratovoson, R; Raharimanga, V; Rakotosamimanana, N; Ravaloson, B; Ratsitorahina, M; Randremanana, R; Ramarokoto, H; Rajatonirina, S; Rasolofo, V; Richard, V				Ratovoson, Rila; Raharimanga, Voamalala; Rakotosamimanana, Niaina; Ravaloson, B.; Ratsitorahina, Maherisosa; Randremanana, Rindra; Ramarokoto, Herimanana; Rajatonirina, Soatiana; Rasolofo, Voahangy; Richard, Vincent			Increase in the Number of Tuberculosis Cases Treated following Tuberculin Skin Testing in First-Year Schoolchildren in Madagascar	PLOS ONE			English	Article							CHILDREN; TRANSMISSION; IMPACT; YIELD	Background: Tuberculosis continues to cause unacceptably high levels of disease and death worldwide. Active preventive strategies are required to improve tuberculosis control and to increase the number of cases treated in developing countries. The aim of this study was to evaluate the utility of the tuberculin skin test (TST) in first-year schoolchildren as a means of increasing the number of tuberculosis cases detected through the screening of close contacts. Methods: All members of the households of 90 schoolchildren assigned to three groups on the basis of TST category (<= 5 mm, [5-15) mm, >= 15 mm) were screened for sputum smear-positive pulmonary tuberculosis. The percentage detection of tuberculosis in close contacts was compared between TST categories. Results: We identified 433 close contacts of the 90 schoolchildren, who were then evaluated for tuberculosis. We identified 11 cases of pulmonary tuberculosis among the close contacts (7 already on treatment and 4 previously undiagnosed): 0 in TST category <= 5 mm, 3 in TST category [5-15) mm and 8 in TST category >= 15 mm). This approach increased the detection of tuberculosis cases by a factor of 1.6 in first-year schoolchildren of the TST >= 5 mm group. Conclusion: TST in first-year schoolchildren is a potentially effective method for improving the detection of tuberculosis in close contacts.	[Ratovoson, Rila; Raharimanga, Voamalala; Ratsitorahina, Maherisosa; Randremanana, Rindra; Rajatonirina, Soatiana; Richard, Vincent] Pasteur Inst Antananarivo, Epidemiol Unit, Antananarivo, Madagascar; [Rakotosamimanana, Niaina; Ramarokoto, Herimanana; Rasolofo, Voahangy] Pasteur Inst Antananarivo, Mycobacteria Unit, Antananarivo, Madagascar; [Ravaloson, B.] Minist Hlth, TB Treatment Ctr, Antananarivo, Madagascar; [Richard, Vincent] Pasteur Inst Dakar, Epidemiol Unit, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Richard, V (corresponding author), Pasteur Inst Antananarivo, Epidemiol Unit, Antananarivo, Madagascar.	vrichard@pasteur.sn		Rakotosamimanana, Niaina/0000-0002-2352-9797; Ratovoson, Rila/0000-0002-3867-6343; Vincent, RICHARD/0000-0002-6961-1753	Pasteur Institute of Madagascar	Pasteur Institute of Madagascar	The study was supported by grants from the Pasteur Institute of Madagascar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Chan PC, 2008, INT J TUBERC LUNG D, V12, P1401; Classen CN, 1999, THORAX, V54, P136, DOI 10.1136/thx.54.2.136; CURRY FJ, 1971, CHEST, V59, P590, DOI 10.1378/chest.59.6.590; Driver CR, 2002, PUBLIC HEALTH REP, V117, P366, DOI 10.1016/S0033-3549(04)50173-5; KARALLIEDDE S, 1987, TUBERCLE, V68, P33, DOI 10.1016/0041-3879(87)90005-5; Lagrange PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073579; Molicotti P, 2014, J INFECT DEV COUNTR, V8, P24, DOI 10.3855/jidc.3295; Moonan PK, 2005, INT J TUBERC LUNG D, V9, P322; Murthy M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071470; Raharimanga V, 2012, TROP MED INT HLTH TM; Randremanana RV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-21; Randremanana RV, 2009, TROP MED INT HEALTH, V14, P429, DOI 10.1111/j.1365-3156.2009.02239.x; Saito M, 2004, INT J TUBERC LUNG D, V8, P842; Soren K, 1999, PEDIATR INFECT DIS J, V18, P949, DOI 10.1097/00006454-199911000-00002; SULLAM PM, 1986, AM J PUBLIC HEALTH, V76, P1109, DOI 10.2105/AJPH.76.9.1109; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; World Health Organization, 2013, TUBERCULOSIS	18	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95494	10.1371/journal.pone.0095494	http://dx.doi.org/10.1371/journal.pone.0095494			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743554	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100126
J	Sheng, KC; Herrero, LJ; Taylor, A; Hapel, AJ; Mahalingam, S				Sheng, Kuo-Ching; Herrero, Lara J.; Taylor, Adam; Hapel, Andrew J.; Mahalingam, Suresh			IL-3 and CSF-1 Interact to Promote Generation of CD11c(+) IL-10-Producing Macrophages	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; DENDRITIC CELLS; GENE-EXPRESSION; HUMAN MONOCYTES; MAST-CELL; MULTI-CSF; FACTOR-I; INTERLEUKIN-3; DIFFERENTIATION; PROLIFERATION	Unraveling the mechanisms of hematopoiesis regulated by multiple cytokines remains a challenge in hematology. IL-3 is an allergic cytokine with the multilineage potential, while CSF-1 is produced in the steady state with restricted lineage coverage. Here, we uncovered an instructive role of CSF-1 in IL-3-mediated hematopoiesis. CSF-1 significantly promoted IL-3-driven CD11c(+) cell expansion and dampened basophil and mast cell generation from C57BL/6 bone marrow. Further studies indicated that the CSF-1/CSF-1R axis contributed significantly to IL-3-induced CD11c(+) cell generation through enhancing c-Fos-associated monopoiesis. CD11c(+) cells induced by IL-3 or IL-3/CSF-1 were competent in cellular maturation and endocytosis. Both IL-3 and IL-3/CSF-1 cells lacked classical dendritic cell appearance and resembled macrophages in morphology. Both populations produced a high level of IL-10, in addition to IL-1, IL-6 and TNF alpha, in response to LPS, and were relatively poor T cell stimulators. Collectively, these findings reveal a role for CSF-1 in mediating the IL-3 hematopoietic pathway through monopoiesis, which regulates expansion of CD11c(+) macrophages.	[Sheng, Kuo-Ching; Herrero, Lara J.; Taylor, Adam; Mahalingam, Suresh] Griffith Univ, Inst Glyc, Nathan, Qld 4111, Australia; [Hapel, Andrew J.] Australian Natl Univ, John Curtin Sch Med Res, Div Mol Med, Canberra, ACT 0200, Australia	Griffith University; Australian National University; John Curtin School of Medical Research	Sheng, KC (corresponding author), Griffith Univ, Inst Glyc, Gold Coast Campus, Nathan, Qld 4111, Australia.	k.sheng@griffith.edu.au; s.mahalingam@griffith.edu.au	Herrero, Lara/A-4628-2015	Herrero, Lara/0000-0002-5661-9828	Australian National Health and Medical Research Council [APP1012292]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by a grant from the Australian National Health and Medical Research Council to SM (Grant ID APP1012292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki I, 1996, EUR J IMMUNOL, V26, P1388, DOI 10.1002/eji.1830260631; BARTELMEZ SH, 1985, J CELL PHYSIOL, V122, P362, DOI 10.1002/jcp.1041220305; Baumeister T, 2003, J INVEST DERMATOL, V121, P280, DOI 10.1046/j.1523-1747.2003.12380.x; BREEN FN, 1990, BRIT J HAEMATOL, V74, P138, DOI 10.1111/j.1365-2141.1990.tb02556.x; Buelens C, 2002, BLOOD, V99, P993, DOI 10.1182/blood.V99.3.993; Caux C, 1996, BLOOD, V87, P2376, DOI 10.1182/blood.V87.6.2376.bloodjournal8762376; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Drutman SB, 2012, J IMMUNOL, V188, P3603, DOI 10.4049/jimmunol.1102741; Ebner S, 2002, J IMMUNOL, V168, P6199, DOI 10.4049/jimmunol.168.12.6199; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; HAPEL AJ, 1985, BLOOD, V65, P1453, DOI 10.1182/blood.V65.6.1453.bloodjournal6561453; Jack GD, 2009, BLOOD, V114, P2172, DOI 10.1182/blood-2008-11-191536; KAWANO Y, 1991, BLOOD, V77, P2118; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; METCALF D, 1986, BLOOD, V68, P46; Morris C F, 1990, Immunol Ser, V49, P177; MORRIS CF, 1990, BRIT J HAEMATOL, V74, P131, DOI 10.1111/j.1365-2141.1990.tb02555.x; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; NAKAHATA T, 1986, NATURE, V324, P65, DOI 10.1038/324065a0; NAKAMURA T, 1991, CELL GROWTH DIFFER, V2, P267; NIEMEYER CM, 1989, BLOOD, V73, P945; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; Reddy EP, 2000, ONCOGENE, V19, P2532, DOI 10.1038/sj.onc.1203594; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Shen T, 2008, INT IMMUNOL, V20, P1201, DOI 10.1093/intimm/dxn077; Sheng KC, 2008, J IMMUNOL, V181, P2455, DOI 10.4049/jimmunol.181.4.2455; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Sudo T, 1995, ONCOGENE, V11, P2469; Zhang L, 2011, BLOOD, V118, P2266, DOI 10.1182/blood-2011-01-331157	31	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95208	10.1371/journal.pone.0095208	http://dx.doi.org/10.1371/journal.pone.0095208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743235	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100087
J	Valzania, L; Romani, P; Tian, L; Li, S; Cavaliere, V; Pennacchio, F; Gargiulo, G				Valzania, Luca; Romani, Patrizia; Tian, Ling; Li, Sheng; Cavaliere, Valeria; Pennacchio, Francesco; Gargiulo, Giuseppe			A Polydnavirus ANK Protein Acts as Virulence Factor by Disrupting the Function of Prothoracic Gland Steroidogenic Cells	PLOS ONE			English	Article							NIGRICEPS VIERECK HYMENOPTERA; VIRESCENS F LEPIDOPTERA; EXPRESSION; LARVAE; HOST; STRATEGIES; FAMILY; DEATH; ALG-2; ALIX	Polydnaviruses are obligate symbionts integrated as proviruses in the genome of some ichneumonoid wasps that parasitize lepidopteran larvae. Polydnavirus free viral particles, which are injected into the host at oviposition, express virulence factors that impair immunity and development. To date, most studies have focused on the molecular mechanisms underpinning immunosuppression, whereas how viral genes disrupt the endocrine balance remains largely uninvestigated. Using Drosophila as a model system, the present report analyzes the function of a member of the ankyrin gene family of the bracovirus associated with Toxoneuron nigriceps, a larval parasitoid of the noctuid moth Heliothis virescens. We found that the TnBVank1 expression in the Drosophila prothoracic gland blocks the larval-pupal molt. This phenotype can be rescued by feeding the larvae with 20-hydroxyecdysone. The localization of the TnBVANK1 is restricted to the cytoplasm where it interacts with Hrs and Alix marked endosomes. Collectively, our data demonstrate that the TnBVANK1 protein acts as a virulence factor that causes the disruption of ecdysone biosynthesis and developmental arrest by impairing the vesicular traffic of ecdysteroid precursors in the prothoracic gland steroidogenic cells.	[Valzania, Luca; Romani, Patrizia; Cavaliere, Valeria; Gargiulo, Giuseppe] Univ Bologna, Dipartimento Farm & Biotecnol, Bologna, Italy; [Tian, Ling; Li, Sheng] Inst Plant Physiol & Ecol, Key Lab Insect Dev & Evolutionary Biol, Shanghai, Peoples R China; [Pennacchio, Francesco] Univ Naples Federico II, Dipartimento Agr, Lab Entomol E Tremblay, Portici, NA, Italy	University of Bologna; Chinese Academy of Sciences; University of Naples Federico II	Gargiulo, G (corresponding author), Univ Bologna, Dipartimento Farm & Biotecnol, Bologna, Italy.	giuseppe.gargiulo@unibo.it	Romani, Patrizia/AAN-3509-2020; Cavaliere, Valeria/P-1509-2015	GARGIULO, GIUSEPPE/0000-0003-3974-2557; CAVALIERE, VALERIA/0000-0002-3264-499X; Valzania, Luca/0000-0002-8955-3554; PENNACCHIO, Francesco/0000-0002-8794-9328	MIUR (Prin); University of Bologna (RFO); University of Bologna; MIUR; European Funds for the Regional Development (FESR)	MIUR (Prin)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); University of Bologna (RFO); University of Bologna; MIUR(Ministry of Education, Universities and Research (MIUR)); European Funds for the Regional Development (FESR)	This article is based on work supported by grants from MIUR (Prin 2008-2010 to GG e FP), University of Bologna (RFO 2008; 2009 to GG), a fellowship from University of Bologna to LV and PON R&C 2007-2013 grant financed by MIUR in cooperation with the European Funds for the Regional Development (FESR), project GenopomPro, coordinated by the University of Napoli Federico II, Department of Agriculture (to FP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bissig C, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016816; Bitra K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002722; BRAND AH, 1993, DEVELOPMENT, V118, P401; Drezen JM, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P15, DOI 10.1016/B978-0-12-384858-1.00002-3; Duchi S, 2010, CELL MOL LIFE SCI, V67, P1699, DOI 10.1007/s00018-010-0273-2; Falabella P, 2006, ARCH INSECT BIOCHEM, V61, P157, DOI 10.1002/arch.20120; Falabella P, 2007, J GEN VIROL, V88, P92, DOI 10.1099/vir.0.82306-0; Florentin A, 2012, J CELL BIOL, V196, P513, DOI 10.1083/jcb.201107133; FRIEND DS, 1981, HISTOCHEM J, V13, P535, DOI 10.1007/BF01002709; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gilbert LI, 2005, VITAM HORM, V73, P31, DOI 10.1016/S0083-6729(05)73002-8; Gueguen G, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003580; Hackney JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049105; HAY BA, 1994, DEVELOPMENT, V120, P2121; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Kroemer JA, 2005, J VIROL, V79, P7617, DOI 10.1128/JVI.79.12.7617-7628.2005; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; McGrail M, 1997, DEVELOPMENT, V124, P2409; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Moeller ME, 2013, DEVELOPMENT, V140, P4730, DOI 10.1242/dev.099739; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; Parvy JP, 2005, DEV BIOL, V282, P84, DOI 10.1016/j.ydbio.2005.02.028; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; PENNACCHIO F, 1993, ARCH INSECT BIOCHEM, V24, P65, DOI 10.1002/arch.940240202; Pennacchio F, 1997, INSECT BIOCHEM MOLEC, V27, P439, DOI 10.1016/S0965-1748(97)00016-7; Pennacchio F, 2002, EXPTL BIOL REV, P123; Pennacchio F, 1998, J INSECT PHYSIOL, V44, P845, DOI 10.1016/S0022-1910(98)00016-X; Pruijssers AJ, 2009, J EXP BIOL, V212, P2998, DOI 10.1242/jeb.030635; Quicke D. L. J., 1997, PARASITIC WASPS; Rodenburg KW, 2005, BBA-MOL CELL BIOL L, V1736, P10, DOI 10.1016/j.bbalip.2005.07.002; Romani P, 2009, GENETICS, V181, P165, DOI 10.1534/genetics.108.096008; Shia M, 2008, VIROLOGY, V375, P374, DOI 10.1016/j.virol.2008.02.027; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Strand MR, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P139, DOI 10.1016/B978-0-12-384858-1.00011-4; Strand MR, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P149, DOI 10.1016/B978-0-12-384858-1.00012-6; Strand MR, 2010, INSECT VIROLOGY, P171; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Tsuda M, 2006, FEBS LETT, V580, P3296, DOI 10.1016/j.febslet.2006.05.005; Volkoff AN, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P33, DOI 10.1016/B978-0-12-384858-1.00003-5; Warren JT, 2006, DEV DYNAM, V235, P315, DOI 10.1002/dvdy.20626; Webb B.A., 2000, VIRUS TAXONOMY, P253; Webb BA, 2005, COMPREHENSIVE MOL IN, V6, P323, DOI DOI 10.1016/B0-44-451924-6/00086-7; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zinchuk Vadim, 2008, Curr Protoc Cell Biol, VChapter 4, DOI 10.1002/0471143030.cb0419s39	51	12	14	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95104	10.1371/journal.pone.0095104	http://dx.doi.org/10.1371/journal.pone.0095104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743267	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100072
J	Chikina, MD; Sealfon, SC				Chikina, Maria D.; Sealfon, Stuart C.			Increasing Consistency of Disease Biomarker Prediction Across Datasets	PLOS ONE			English	Article							SURROGATE VARIABLE ANALYSIS; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; MICROARRAY; METAANALYSIS; INTEGRATION; SIGNATURE; PATHWAYS; CRITERIA	Microarray studies with human subjects often have limited sample sizes which hampers the ability to detect reliable biomarkers associated with disease and motivates the need to aggregate data across studies. However, human gene expression measurements may be influenced by many non-random factors such as genetics, sample preparations, and tissue heterogeneity. These factors can contribute to a lack of agreement among related studies, limiting the utility of their aggregation. We show that it is feasible to carry out an automatic correction of individual datasets to reduce the effect of such 'latent variables' (without prior knowledge of the variables) in such a way that datasets addressing the same condition show better agreement once each is corrected. We build our approach on the method of surrogate variable analysis but we demonstrate that the original algorithm is unsuitable for the analysis of human tissue samples that are mixtures of different cell types. We propose a modification to SVA that is crucial to obtaining the improvement in agreement that we observe. We develop our method on a compendium of multiple sclerosis data and verify it on an independent compendium of Parkinson's disease datasets. In both cases, we show that our method is able to improve agreement across varying study designs, platforms, and tissues. This approach has the potential for wide applicability to any field where lack of inter-study agreement has been a concern.	[Chikina, Maria D.] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Sealfon, Stuart C.] Mt Sinai Sch Med, Ctr Translat Syst Biol, Dept Neurol, New York, NY USA; [Sealfon, Stuart C.] Mt Sinai Sch Med, Dept Neurol, New York, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Chikina, MD (corresponding author), Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA.	mchikina@pitt.edu	Hatzis, Christos/M-3867-2015	Hatzis, Christos/0000-0002-8120-2290; SEALFON, Stuart/0000-0001-5791-1217	NIH/NINDS [5T32NS051147-05]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS051147] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH/NINDS grant 5T32NS051147-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Achiron A, 2010, NEUROBIOL DIS, V38, P201, DOI 10.1016/j.nbd.2009.12.029; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Arasappan D, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-65; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Borozan I, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-305; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Bushnell SE, 2012, NEUROLOGY, V79, P531, DOI 10.1212/WNL.0b013e318259e123; Chakraborty S, 2012, BIOINFORMATICS, V28, P799, DOI 10.1093/bioinformatics/bts022; Choi H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-364; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Eysenck H J, 1995, J Eval Clin Pract, V1, P29, DOI 10.1111/j.1365-2753.1995.tb00005.x; EYSENCK HJ, 1994, BRIT MED J, V309, P789, DOI 10.1136/bmj.309.6957.789; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; Gandhi KS, 2010, HUM MOL GENET, V19, P2134, DOI 10.1093/hmg/ddq090; Gilli F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008962; Goldenberg Marvin M, 2012, P T, V37, P175; Gurevich M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-46; Hecker M, 2012, PHARMACOGENOMICS J, V12, P360, DOI 10.1038/tpj.2011.12; Hecker M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029648; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Kang DD, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1071; Kotelnikova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002365; Kuhn A, 2011, NAT METHODS, V8, P945, DOI [10.1038/NMETH.1710, 10.1038/nmeth.1710]; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2008, P NATL ACAD SCI USA, V105, P18718, DOI 10.1073/pnas.0808709105; Lu SY, 2010, BIOINFORMATICS, V26, P333, DOI 10.1093/bioinformatics/btp669; Manoli T, 2006, BIOINFORMATICS, V22, P2500, DOI 10.1093/bioinformatics/btl424; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Riveros C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014176; Satoh J, 2006, J NEUROIMMUNOL, V174, P108, DOI 10.1016/j.jneuroim.2006.02.004; Stevens JR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-57; Teschendorff AE, 2011, BIOINFORMATICS, V27, P1496, DOI 10.1093/bioinformatics/btr171; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Zhang FL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016795; Zhang M, 2009, BIOINFORMATICS, V25, P1662, DOI 10.1093/bioinformatics/btp295; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059	41	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e91272	10.1371/journal.pone.0091272	http://dx.doi.org/10.1371/journal.pone.0091272			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740471	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000336863900007
J	Soloski, MJ; Crowder, LA; Lahey, LJ; Wagner, CA; Robinson, WH; Aucott, JN				Soloski, Mark J.; Crowder, Lauren A.; Lahey, Lauren J.; Wagner, Catriona A.; Robinson, William H.; Aucott, John N.			Serum Inflammatory Mediators as Markers of Human Lyme Disease Activity	PLOS ONE			English	Article							HUMORAL INNATE IMMUNITY; BORRELIA-BURGDORFERI; RHEUMATOID-ARTHRITIS; ERYTHEMA MIGRANS; CYTOKINES; CHEMOKINES; SKIN; MANIFESTATIONS; PENTRAXINS; HEPATITIS	Chemokines and cytokines are key signaling molecules that orchestrate the trafficking of immune cells, direct them to sites of tissue injury and inflammation and modulate their states of activation and effector cell function. We have measured, using a multiplex-based approach, the levels of 58 immune mediators and 7 acute phase markers in sera derived from of a cohort of patients diagnosed with acute Lyme disease and matched controls. This analysis identified a cytokine signature associated with the early stages of infection and allowed us to identify two subsets (mediator-high and mediator-low) of acute Lyme patients with distinct cytokine signatures that also differed significantly (p < 0.0005) in symptom presentation. In particular, the T cell chemokines CXCL9 (MIG), CXCL10 (IP-10) and CCL19 (MIP3B) were coordinately increased in the mediator-high group and levels of these chemokines could be associated with seroconversion status and elevated liver function tests (p = 0.027 and p = 0.021 respectively). There was also upregulation of acute phase proteins including CRP and serum amyloid A. Consistent with the role of CXCL9/CXCL10 in attracting immune cells to the site of infection, CXCR3+ CD4 T cells are reduced in the blood of early acute Lyme disease (p = 0.01) and the decrease correlates with chemokine levels (p = 0.0375). The levels of CXCL9/10 did not relate to the size or number of skin lesions but elevated levels of serum CXCL9/CXCL10 were associated with elevated liver enzymes levels. Collectively these results indicate that the levels of serum chemokines and the levels of expression of their respective chemokine receptors on T cell subsets may prove to be informative biomarkers for Lyme disease and related to specific disease manifestations.	[Soloski, Mark J.] Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA; [Aucott, John N.] Johns Hopkins Univ, Sch Med, Dept Med, Div Internal Med, Baltimore, MD 21205 USA; [Lahey, Lauren J.; Wagner, Catriona A.; Robinson, William H.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Palo Alto, CA 94304 USA; [Lahey, Lauren J.; Wagner, Catriona A.; Robinson, William H.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Crowder, Lauren A.] Lyme Dis Res Fdn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Soloski, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Rheumatol, Baltimore, MD 21205 USA.	mski@jhmi.edu; jaucott@jhmi.edu		Crowder, Lauren/0000-0002-7261-1236; Robinson, William/0000-0003-4385-704X; Wagner, Catriona/0000-0002-4949-6612	National Institute of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health [P30AR05350]; Stabler Foundation; Ira Fine Discovery Fund; Lyme Research Alliance; Lyme Disease Research Foundation, Inc.; Brennan Family; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053503] Funding Source: NIH RePORTER	National Institute of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Stabler Foundation; Ira Fine Discovery Fund; Lyme Research Alliance; Lyme Disease Research Foundation, Inc.; Brennan Family; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Arthritis And Musculoskeletal And Skin Diseases of the National Institutes of Health under Award Number P30AR05350, the Stabler Foundation (www.stablerfoundation.org), the Ira Fine Discovery Fund (http://www.drirafinediscoveryfund.com/), the Lyme Research Alliance (www.lymeresearchalliance.org) and the Lyme Disease Research Foundation, Inc. (www.lymemd.org). The authors would like to acknowledge vision, support and funding from the Brennan Family. The Brennan family has no commercial affiliation, company affiliation, or competing interests that could affect the transparency of this manuscript. The funders of this publication had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, MMWR Recomm Rep, V46, P1; [Anonymous], 2000, HLTH PEOPL 2010 UND; Aucott J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-79; Bacon R. M., 2007, Morbidity and Mortality Weekly Report, V56, P573; Bockenstedt LK, 2012, J CLIN INVEST, V122, P2652, DOI 10.1172/JCI58813; Bode JG, 2012, EUR J CELL BIOL, V91, P496, DOI 10.1016/j.ejcb.2011.09.008; Borchers AT, 2009, SEMIN IMMUNOPATHOL, V31, P309, DOI 10.1007/s00281-009-0167-2; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Campbell GL, 1998, AM J EPIDEMIOL, V148, P1018, DOI 10.1093/oxfordjournals.aje.a009568; Centers for Disease Control and Prevention (CDC), 2013, MMWR Morb Mortal Wkly Rep, V62, P669; Chandra PE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3383; Coyle BS, 1996, J INFECT DIS, V173, P1260, DOI 10.1093/infdis/173.5.1260; Dandache P, 2008, INFECT DIS CLIN N AM, V22, P235, DOI 10.1016/j.idc.2007.12.012; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; DURAY PH, 1989, RHEUM DIS CLIN N AM, V15, P691; Embers ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029914; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hastey CJ, 2012, J IMMUNOL, V188, P5612, DOI 10.4049/jimmunol.1103735; Hodzic E, 2008, ANTIMICROB AGENTS CH, V52, P1728, DOI 10.1128/AAC.01050-07; Horowitz HW, 1996, HEPATOLOGY, V23, P1412, DOI 10.1002/hep.510230617; Hughes-Austin JM, 2013, ANN RHEUM DIS, V72, P901, DOI 10.1136/annrheumdis-2012-201505; Jones KL, 2008, CLIN INFECT DIS, V46, P85, DOI 10.1086/524022; Kazakoff M A, 1993, Arch Fam Med, V2, P409, DOI 10.1001/archfami.2.4.409; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Lee EY, 2009, AUTOIMMUN REV, V8, P379, DOI 10.1016/j.autrev.2008.12.002; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Lindstrom TM, 2010, SCAND J CLIN LAB INV, V70, P79, DOI 10.3109/00365513.2010.493406; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Manfredi AA, 2008, CURR OPIN IMMUNOL, V20, P538, DOI 10.1016/j.coi.2008.05.004; Moschovakis GL, 2012, EUR J IMMUNOL, V42, P1949, DOI 10.1002/eji.201242614; Mullegger RR, 2007, INFECT IMMUN, V75, P4621, DOI 10.1128/IAI.00263-07; Roe B, 2007, J INFECT DIS, V196, P1053, DOI 10.1086/520935; Rupprecht TA, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-42; Salazar JC, 2003, J IMMUNOL, V171, P2660, DOI 10.4049/jimmunol.171.5.2660; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; Shin JJ, 2007, ARTHRITIS RHEUM-US, V56, P1325, DOI 10.1002/art.22441; Steere AC, 2004, NAT REV IMMUNOL, V4, P143, DOI 10.1038/nri1267; Steere AC, 2003, NEW ENGL J MED, V348, P2472, DOI 10.1056/NEJM200306123482423; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Strle K, 2012, ARTHRITIS RHEUM-US, V64, P1497, DOI 10.1002/art.34383; Strle K, 2011, AM J PATHOL, V178, P2726, DOI 10.1016/j.ajpath.2011.02.018; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Wormser GP, 2006, NEW ENGL J MED, V354, P2794, DOI 10.1056/NEJMcp061181; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 2000, CLIN INFECT DIS, V31, pS1, DOI 10.1086/314053; Zaidi SA, 2002, CLIN INFECT DIS, V34, P1206, DOI 10.1086/339871; Zanchi AC, 2007, DIGEST DIS SCI, V52, P2629, DOI 10.1007/s10620-006-9405-9	50	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93243	10.1371/journal.pone.0093243	http://dx.doi.org/10.1371/journal.pone.0093243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740099	gold, Green Published			2022-12-25	WOS:000336863900017
J	Zhang, J; Nielsen, SE; Grainger, TN; Kohler, M; Chipchar, T; Farr, DR				Zhang, Jian; Nielsen, Scott E.; Grainger, Tess N.; Kohler, Monica; Chipchar, Tim; Farr, Daniel R.			Sampling Plant Diversity and Rarity at Landscape Scales: Importance of Sampling Time in Species Detectability	PLOS ONE			English	Article							RICHNESS; OBSERVER; MODELS; EXTRAPOLATION; DISTRIBUTIONS; RAREFACTION; SURVIVAL; DORMANCY; FOREST	Documenting and estimating species richness at regional or landscape scales has been a major emphasis for conservation efforts, as well as for the development and testing of evolutionary and ecological theory. Rarely, however, are sampling efforts assessed on how they affect detection and estimates of species richness and rarity. In this study, vascular plant richness was sampled in 356 quarter hectare time-unlimited survey plots in the boreal region of northeast Alberta. These surveys consisted of 15,856 observations of 499 vascular plant species (97 considered to be regionally rare) collected by 12 observers over a 2 year period. Average survey time for each quarter-hectare plot was 82 minutes, ranging from 20 to 194 minutes, with a positive relationship between total survey time and total plant richness. When survey time was limited to a 20-minute search, as in other Alberta biodiversity methods, 61 species were missed. Extending the survey time to 60 minutes, reduced the number of missed species to 20, while a 90-minute cut-off time resulted in the loss of 8 species. When surveys were separated by habitat type, 60 minutes of search effort sampled nearly 90% of total observed richness for all habitats. Relative to rare species, time-unlimited surveys had similar to 65% higher rare plant detections post-20 minutes than during the first 20 minutes of the survey. Although exhaustive sampling was attempted, observer bias was noted among observers when a subsample of plots was re-surveyed by different observers. Our findings suggest that sampling time, combined with sample size and observer effects, should be considered in landscape-scale plant biodiversity surveys.	[Zhang, Jian; Nielsen, Scott E.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Grainger, Tess N.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Kohler, Monica; Chipchar, Tim; Farr, Daniel R.] Alberta Biodivers Monitoring Inst, Edmonton, AB, Canada	University of Alberta; University of Toronto	Zhang, J (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	zjian@ualberta.ca	Zhang, Jian/A-7878-2008; Nielsen, Scott/O-7482-2019; Nielsen, Scott/C-2842-2013	Zhang, Jian/0000-0003-0589-6267; Nielsen, Scott/0000-0002-9754-0630; Nielsen, Scott/0000-0002-9754-0630	Ecological Monitoring Committee for the Lower Athabasca (EMCLA); Canada's Oil Sands Innovation Alliance, oil sands companies active in the Lower Athabasca Planning Region; Alberta Biodiversity Monitoring Institute (ABMI)	Ecological Monitoring Committee for the Lower Athabasca (EMCLA); Canada's Oil Sands Innovation Alliance, oil sands companies active in the Lower Athabasca Planning Region; Alberta Biodiversity Monitoring Institute (ABMI)	This study was supported by the Ecological Monitoring Committee for the Lower Athabasca (EMCLA), Canada's Oil Sands Innovation Alliance, oil sands companies active in the Lower Athabasca Planning Region, and the Alberta Biodiversity Monitoring Institute (ABMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABMI (Alberta Biodiversity Monitoring Institute), 2010, TERR FIELD DAT COLL; Alexander HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052762; Alexander HM, 1997, ECOLOGY, V78, P1230, DOI 10.2307/2265872; Archaux F, 2006, J VEG SCI, V17, P299, DOI 10.1111/j.1654-1103.2006.tb02449.x; Archaux F, 2009, J VEG SCI, V20, P603, DOI 10.1111/j.1654-1103.2009.01079.x; Beck J, 2010, METHODS ECOL EVOL, V1, P38, DOI 10.1111/j.2041-210X.2009.00003.x; Beckingham J. D., 1996, FIELD GUIDE ECOSITES; Boutin S, 2009, FOREST ECOL MANAG, V258, pS168, DOI 10.1016/j.foreco.2009.08.024; Braunisch V, 2010, ECOGRAPHY, V33, P826, DOI 10.1111/j.1600-0587.2009.05891.x; Brose U, 2003, ECOLOGY, V84, P2364, DOI 10.1890/02-0558; Brown J. H., 1995, MACROECOLOGY; CHAO A, 1984, SCAND J STAT, V11, P265; Chao A, 2005, SPECIES RICHNESS EST; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chen GK, 2013, J ECOL, V101, P183, DOI 10.1111/1365-2745.12021; Chen GK, 2009, J ECOL, V97, P1383, DOI 10.1111/j.1365-2745.2009.01560.x; Chiarucci A, 2012, J VEG SCI, V23, P1003, DOI 10.1111/jvs.12003; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Ellison AM, 2007, ENVIRON ENTOMOL, V36, P766, DOI 10.1603/0046-225X(2007)36[766:RIOTAA]2.0.CO;2; Faber-Langendoen D, 2012, NATURESERVE CONSERVA; Garrard GE, 2008, AUSTRAL ECOL, V33, P986, DOI 10.1111/j.1442-9993.2008.01869.x; Garrard GE, 2013, METHODS ECOL EVOL, V4, P45, DOI 10.1111/j.2041-210x.2012.00257.x; Gotelli Nicholas J., 2011, P39; Gu WD, 2004, BIOL CONSERV, V116, P195, DOI 10.1016/S0006-3207(03)00190-3; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Hsieh T. C., 2013, INEXT ONLINE INTERPO; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Kery M, 2004, J ECOL, V92, P686, DOI 10.1111/j.0022-0477.2004.00885.x; Kery M, 2004, CONSERV BIOL, V18, P570, DOI 10.1111/j.1523-1739.2004.00105.x; Klimes L, 2001, J VEG SCI, V12, P699, DOI 10.2307/3236910; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; LYNCH JF, 1974, CONDOR, V76, P370, DOI 10.2307/1365812; Moore JL, 2011, ECOL APPL, V21, P601, DOI 10.1890/10-0590.1; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Nielsen SE, 2009, BIODIVERS CONSERV, V18, P2961, DOI 10.1007/s10531-009-9619-1; Nielsen SE, 2013, TARGETED RARE PLANT; NILSSON IN, 1985, J ECOL, V73, P65, DOI 10.2307/2259768; Oksanen J., 2017, R PACKAGE VERSION 26; PALMER MW, 1991, ECOLOGY, V72, P1512, DOI 10.2307/1941127; R Core Team, 2016, R FDN STAT COMP; RAVEN PH, 1992, SCIENCE, V258, P1099, DOI 10.1126/science.258.5085.1099; Scott WA, 2003, PLANT ECOL, V165, P101, DOI 10.1023/A:1021441331839; Shefferson RP, 2001, ECOLOGY, V82, P145, DOI 10.2307/2680092; Stohlgren T.J., 2007, MEASURING PLANT DIVE; Swart NC, 2012, NAT CLIM CHANGE, V2, P134, DOI 10.1038/nclimate1421; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Whittaker R. J., 1998, ISLAND BIOGEOGRAPHY; Xu H, 2012, J VEG SCI, V23, P1006, DOI 10.1111/j.1654-1103.2012.01423.x	49	27	27	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95334	10.1371/journal.pone.0095334	http://dx.doi.org/10.1371/journal.pone.0095334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740179	gold, Green Published			2022-12-25	WOS:000336863900130
J	Goswami, G; Powell, BM; Vatsa, M; Singh, R; Noore, A				Goswami, Gaurav; Powell, Brian M.; Vatsa, Mayank; Singh, Richa; Noore, Afzel			FR-CAPTCHA: CAPTCHA Based on Recognizing Human Faces	PLOS ONE			English	Article							RECOGNITION	A Completely Automated Public Turing test to tell Computers and Humans Apart (CAPTCHA) is designed to distinguish humans from machines. Most of the existing tests require reading distorted text embedded in a background image. However, many existing CAPTCHAs are either too difficult for humans due to excessive distortions or are trivial for automated algorithms to solve. These CAPTCHAs also suffer from inherent language as well as alphabet dependencies and are not equally convenient for people of different demographics. Therefore, there is a need to devise other Turing tests which can mitigate these challenges. One such test is matching two faces to establish if they belong to the same individual or not. Utilizing face recognition as the Turing test, we propose FR-CAPTCHA based on finding matching pairs of human faces in an image. We observe that, compared to existing implementations, FR-CAPTCHA achieves a human accuracy of 94% and is robust against automated attacks.	[Goswami, Gaurav; Vatsa, Mayank; Singh, Richa] Indraprastha Inst Informat Technol, Delhi, India; [Powell, Brian M.; Noore, Afzel] W Virginia Univ, Morgantown, WV 26506 USA	Indraprastha Institute of Information Technology Delhi; West Virginia University	Vatsa, M (corresponding author), Indraprastha Inst Informat Technol, Delhi, India.	mayank@iiitd.ac.in	Vatsa, Mayank/AAR-7199-2020; Singh, Richa/M-9961-2017; Goswami, Gaurav/ABH-9597-2020; Vatsa, Mayank/I-5050-2013	Vatsa, Mayank/0000-0001-5952-2274; Singh, Richa/0000-0003-4060-4573; Goswami, Gaurav/0000-0001-5607-7654; Vatsa, Mayank/0000-0001-5952-2274				Bursztein E, 2010, P IEEE S SECUR PRIV, P399, DOI 10.1109/SP.2010.31; Datta R, 2009, IEEE T INF FOREN SEC, V4, P504, DOI 10.1109/TIFS.2009.2022709; Elson J, 2007, CCS'07: PROCEEDINGS OF THE 14TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P366; Golle P., 2008, CCS'08: PROCEEDINGS OF THE 15TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY, P535; Goswami G, 2014, FUTURE GENER COMP SY, V31, P59, DOI 10.1016/j.future.2012.08.013; Grother PJ, 2010, NIST INTERAGENCY REP; Johnston RA, 2009, MEMORY, V17, P577, DOI 10.1080/09658210902976969; Kluever KA, 2009, S US PRIV SEC, P14; Martinez A. M., 1998, TECHNICAL REPORT; Ruiz-del-Solar J, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/184617; Schlaikjer Andy, 2007, 07014 LTICMU; Shirali-Shahreza S, 2008, 2008 3RD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEM AND KNOWLEDGE ENGINEERING, VOLS 1 AND 2, P205, DOI 10.1109/ISKE.2008.4730926; Sinha P, 2006, P IEEE, V94, P1948, DOI 10.1109/JPROC.2006.884093; Stavrou A, 2005, COMPUT NETW, V48, P781, DOI 10.1016/j.comnet.2005.01.005; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379; Zhu B, 2010, PROCEEDINGS OF THE 17TH ACM CONFERENCE ON COMPUTER AND COMMUNICATIONS SECURITY (CCS'10), P187, DOI 10.1145/1866307.1866329	17	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e91708	10.1371/journal.pone.0091708	http://dx.doi.org/10.1371/journal.pone.0091708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736523	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600005
J	Itariu, BK; Zeyda, M; Prager, G; Stulnig, TM				Itariu, Bianca K.; Zeyda, Maximilian; Prager, Gerhard; Stulnig, Thomas M.			Insulin-Like Growth Factor 1 Predicts Post-Load Hypoglycemia following Bariatric Surgery: A Prospective Cohort Study	PLOS ONE			English	Article							GASTRIC BYPASS-SURGERY; IGF-I; HYPERINSULINEMIC HYPOGLYCEMIA; LONG-TERM; CANCER RISK; NESIDIOBLASTOSIS; GLUCOSE; PANCREATECTOMY; SENSITIVITY; RESISTANCE	Postprandial hypoglycemia is a complication following gastric bypass surgery, which frequently remains undetected. Severe hypoglycemic episodes, however, put patients at risk, e. g., for syncope. A major cause of hypoglycemia following gastric bypass is hyperinsulinemic nesidioblastosis. Since pancreatic islets in nesidioblastosis overexpress insulin-like growth factor 1 (IGF-1) receptor a and administration of recombinant IGF-1 provokes hypoglycemia, our main objective was to investigate the occurrence of post-load hypoglycemia one year after bariatric surgery and its relation to pre- and post-operative IGF-1 serum concentrations. We evaluated metabolic parameters including 2 h 75 g oral glucose tolerance test (OGTT) and measured IGF-1 serum concentration in thirty-six non-diabetic patients (29 f/7 m), aged 41.3 +/- 2.0 y with a median (IQR) BMI of 30.9 kg/m(2) (27.5-34.3 kg/m(2)), who underwent elective bariatric surgery (predominantly gastric bypass, 83%) at our hospital. Post-load hypoglycemia as defined by a 2 h glucose concentration <60 mg/dl was detected in 50% of patients. Serum insulin and C-peptide concentration during the OGTT and HOMA-IR (homeostatic model assessment-insulin resistance) were similar in hypoglycemic and euglycemic patients. Strikingly, pre- and post-operative serum IGF-1 concentrations were significantly higher in hypoglycemic patients (p = 0.012 and p = 0.007 respectively). IGF-1 serum concentration before surgery negatively correlated with 2 h glucose concentration during the OGTT (rho = -0.58, p = 0.0003). Finally, IGF-1 serum concentrations before and after surgery significantly predicted post-load hypoglycemia with odds ratios of 1.28 (95% CI: 1.03-1.55, p = 0.029) and 1.18 (95% CI:1.03-1.33, p = 0.015), respectively, for each 10 ng/ml increment. IGF-1 serum concentration could be a valuable biomarker to identify patients at risk for hypoglycemia following bariatric surgery independently of a diagnostic OGFTT. Thus, IGF-1 testing could help to prevent a significant complication of gastric bypass surgery.	[Itariu, Bianca K.; Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Dept Med 3, Div Endocrinol & Metab, Vienna, Austria; [Itariu, Bianca K.; Zeyda, Maximilian; Stulnig, Thomas M.] Med Univ Vienna, Christian Doppler Lab Cardiometab Immunotherapy, Vienna, Austria; [Prager, Gerhard] Med Univ Vienna, Dept Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Stulnig, TM (corresponding author), Med Univ Vienna, Dept Med 3, Div Endocrinol & Metab, Vienna, Austria.	thomas.stulnig@meduniwien.ac.at	Itariu, Bianca-Karla/AAD-6317-2019	Zeyda, Maximilian/0000-0001-5000-1974; Stulnig, Thomas/0000-0003-3300-6161; Itariu, Bianca/0000-0001-8100-1715	Austrian National Bank [12735]; European Community [201608]; Federal Ministry of Economy, Family and Youth; National Foundation for Research, Technology and Development	Austrian National Bank; European Community(European Commission); Federal Ministry of Economy, Family and Youth; National Foundation for Research, Technology and Development	This work was supported by the Austrian National Bank Project no. 12735; the European Community's 7th Framework Programme (FP7/2007-2013) under grant agreement no. 201608 and the Federal Ministry of Economy, Family and Youth; and the National Foundation for Research, Technology and Development (all to T. M. S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Anderwald CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077326; Anderwald CH, 2012, DIABETES CARE, V35, P2580, DOI 10.2337/dc12-0197; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Buchwald H, 2013, OBES SURG, V23, P427, DOI 10.1007/s11695-012-0864-0; Chaput JP, 2009, INT J OBESITY, V33, P46, DOI 10.1038/ijo.2008.221; Chernausek SD, 2007, J CLIN ENDOCR METAB, V92, P902, DOI 10.1210/jc.2006-1610; Clancy TE, 2006, J GASTROINTEST SURG, V10, P1116, DOI 10.1016/j.gassur.2006.04.008; Clemmons DR, 2004, HORMONE RES S1, V62, P77; Cox DJ, 2000, DIABETES CARE, V23, P163, DOI 10.2337/diacare.23.2.163; Cui YF, 2011, J GASTROINTEST SURG, V15, P1879, DOI 10.1007/s11605-011-1585-8; Friedrich N, 2012, DIABETES CARE, V35, P768, DOI 10.2337/dc11-1833; Goldfine AB, 2007, J CLIN ENDOCR METAB, V92, P4678, DOI 10.1210/jc.2007-0918; Gram IT, 2006, INT J OBESITY, V30, P1623, DOI 10.1038/sj.ijo.0803324; Hirsch FF, 2012, OBES SURG, V22, P910, DOI 10.1007/s11695-012-0589-0; Holdstock C, 2008, INT J OBESITY, V32, P1640, DOI 10.1038/ijo.2008.157; Itariu BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054634; Itariu BK, 2012, AM J CLIN NUTR, V96, P1137, DOI 10.3945/ajcn.112.037432; Karlsson J, 2007, INT J OBESITY, V31, P1248, DOI 10.1038/sj.ijo.0803573; Key TJ, 2010, LANCET ONCOL, V11, P530, DOI 10.1016/S1470-2045(10)70095-4; Khoo CM, 2013, ANN SURG; Kim SH, 2009, OBES SURG, V19, P1550, DOI 10.1007/s11695-009-9893-8; Laron Z, 1999, J CLIN ENDOCR METAB, V84, P4397, DOI 10.1210/jc.84.12.4397; Laron Z, 2001, J CLIN PATHOL-MOL PA, V54, P311; Li JB, 2004, WORLD J GASTROENTERO, V10, P255; Marsk R, 2010, DIABETOLOGIA, V53, P2307, DOI 10.1007/s00125-010-1798-5; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mitchell JE, 2013, OBESITY, V21, P665, DOI 10.1002/oby.20066; Mittempergher F, 2013, OBES SURG, V23, P594, DOI 10.1007/s11695-012-0820-z; Moreira RO, 2008, OBES SURG, V18, P1618, DOI 10.1007/s11695-008-9569-9; Neff KJ, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-8; Ogiwara Y, 2010, ENDOCR J, V57, P325, DOI 10.1507/endocrj.K09E-370; Parsaik Ajay K, 2012, J Diabetes Sci Technol, V6, P1107; Patti ME, 2010, DIABETOLOGIA, V53, P2276, DOI 10.1007/s00125-010-1884-8; Patti ME, 2005, DIABETOLOGIA, V48, P2236, DOI 10.1007/s00125-005-1933-x; Pellitero S, 2013, EUR J ENDOCRINOL, V169, P695, DOI 10.1530/EJE-13-0209; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Roddam AW, 2008, ANN INTERN MED, V149, P461, DOI 10.7326/0003-4819-149-7-200810070-00006; Roslin M, 2011, SURG ENDOSC, V25, P1926, DOI 10.1007/s00464-010-1489-9; ROTH DA, 1965, DIABETES, V14, P526, DOI 10.2337/diab.14.8.526; Rumilla KM, 2009, MODERN PATHOL, V22, P239, DOI 10.1038/modpathol.2008.169; Service GJ, 2005, NEW ENGL J MED, V353, P249, DOI 10.1056/NEJMoa043690; Sesti G, 2005, DIABETES CARE, V28, P120, DOI 10.2337/diacare.28.1.120; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Zoidis E, 2011, MOL CELL BIOCHEM, V348, P33, DOI 10.1007/s11010-010-0634-z	47	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94613	10.1371/journal.pone.0094613	http://dx.doi.org/10.1371/journal.pone.0094613			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736741	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600076
J	Mogre, V; Abedandi, R; Salifu, ZS				Mogre, Victor; Abedandi, Robert; Salifu, Zenabankara S.			Distorted Self-Perceived Weight Status and Underestimation of Weight Status in Diabetes Mellitus Type 2 Patients	PLOS ONE			English	Article							BODY-WEIGHT; OVERWEIGHT; OBESITY; PERCEPTION; HYPERTENSION; PREVALENCE; RISK; CARE; ADULTS; MISPERCEPTION	Objectives: Diabetes mellitus type 2 (DM 2) patients' self-perception of their weight status is very critical in diabetes care. We sought to investigate perception of weight status in a sample of 200 DM 2 patients attending an outpatient clinic at a Teaching Hospital and compared it with their BMI-measured weight status, with a focus on underestimation of their weight status. Factors associated with underestimation of weight status in this sample were also explored. Methods: Using a cross-sectional design, anthropometric and clinical variables were assessed using appropriate tools. Questionnaires were used to collect socio-demographic data and self-perception of weight status. Self-perceived weight status was compared to BMI-measured weight status by cross-tabulation, Kappa statistics of agreement and chi(2) for trend analysis. Both univariate and multiple logistic regression analysis were conducted to identify factors associated with underestimation of weight status. Results: The prevalence of general overweight/obesity and abdominal obesity was 32.0% (n = 64) and 58.0% (n = 116) respectively. Generally, 58.0% (n = 116) of the participants had a distorted weight perceived weight status in which 77.6% (n = 90) underestimated their weight status. Factors associated with underestimation of weight status were being overweight/obese (AOR = 22.9, 95% CI = 8.30-63.07, p<0.001), not married (AOR = 3.7, 95% CI = 1.50-9.17, p = 0.005) and never tried to lose weight (AOR = 6.9, 95% CI = 2.35-19.97, p<0.001). Participants aged over 40 years and those being hyperglycaemic were not significantly associated to underestimation of weight status. Conclusion: We found a substantial discordance between BMI-measured and self-perceived weight status. Factors that were associated with underestimation of weight status were being; overweight/obese, not married and never tried to lose weight. Diabetes patients should be provided with information about weight guidelines.	[Mogre, Victor] Univ Dev Studies, Sch Med & Hlth Sci, Dept Human Biol, Tamale, Ghana; [Abedandi, Robert; Salifu, Zenabankara S.] Univ Dev Studies, Sch Med & Hlth Sci, Dept Allied Hlth Sci, Tamale, Ghana	University for Development Studies; University for Development Studies	Mogre, V (corresponding author), Univ Dev Studies, Sch Med & Hlth Sci, Dept Human Biol, Tamale, Ghana.	vmogre@uds.edu.gh	Mogre, Victor/H-2883-2019	Mogre, Victor/0000-0003-0230-5783				Akhuemokhan IK., 2008, MERA DIABETES INT, P17; Alwan H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-467; Arauz-Pacheco C, 2002, DIABETES CARE, V25, P134, DOI 10.2337/diacare.25.1.134; Ask AS, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-33; Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Berraho M, 2012, PAN AFR MED J, V11; Bhanji S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-363; Blokstra A, 1999, INT J OBESITY, V23, P7, DOI 10.1038/sj.ijo.0800803; Burke MA, 2010, OBESITY, V18, P1226, DOI 10.1038/oby.2009.369; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chalmers J, 1999, J HYPERTENS, V17, P151; Danquah I, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-210; Daousi C, 2006, POSTGRAD MED J, V82, P280, DOI 10.1136/pmj.2005.039032; DEVANEY B, 1989, AM J AGR ECON, V71, P932, DOI 10.2307/1242670; Duncan DT, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-20; Faber M, 2005, ETHNIC DIS, V15, P238; Fadupin G T, 2004, Afr J Med Med Sci, V33, P381; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Funnel MM, 2009, DIABETES CARE, V32, pS87, DOI 10.2337/dc09-S087; Galuska DA, 1999, JAMA-J AM MED ASSOC, V282, P1576, DOI 10.1001/jama.282.16.1576; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gill G, 2009, DIABETOLOGIA, V52, P8, DOI 10.1007/s00125-008-1167-9; GORYNSKI P, 1989, J CLIN EPIDEMIOL, V42, P1149, DOI 10.1016/0895-4356(89)90112-1; Gregory CO, 2008, OBESITY, V16, P979, DOI 10.1038/oby.2008.22; Grundy SM, 1998, AM J CLIN NUTR, V67, p563S, DOI 10.1093/ajcn/67.3.563S; Harada Tetsuo, 2007, Journal of Physiological Anthropology, V26, P201, DOI 10.2114/jpa2.26.201; Hussin DK, 2011, ALEX J MED, V47, P365, DOI 10.1016/j.ajme.2011.07.013; Initiative NOE, 1998, CLIN GUID ID EV TREA; Johnson-Taylor WL, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-9; Jung RT, 1997, BRIT MED BULL, V53, P307, DOI 10.1093/oxfordjournals.bmb.a011615; Kamath A., 2011, INT J BIOL MED RES, V2, P636; Klein R, 1996, ARCH INTERN MED, V156, P622, DOI 10.1001/archinte.156.6.622; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; Maximova K, 2008, INT J OBESITY, V32, P1008, DOI 10.1038/ijo.2008.15; McTigue K, 2006, DIABETES CARE, V29, P695, DOI 10.2337/diacare.29.03.06.dc05-2459; Meisinger C, 2006, AM J CLIN NUTR, V84, P483, DOI 10.1093/ajcn/84.3.483; Mogre V, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/2049-3258-71-30; Mohan V, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/409083; Nakade M, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-11; Ojofeitimi E. O., 2007, Pakistan Journal of Nutrition, V6, P502; Okosun IS, 2003, OBES RES, V11, P1010, DOI 10.1038/oby.2003.139; Pinkney J, 2002, BMJ-BRIT MED J, V325, P232, DOI 10.1136/bmj.325.7358.232; Polonsky WH, 2010, DIABETES RES CLIN PR, V88, P151, DOI 10.1016/j.diabres.2010.02.008; Powell TM, 2010, ARCH INTERN MED, V170, P1695, DOI 10.1001/archinternmed.2010.314; Skinner AC, 2008, DIABETES CARE, V31, P227, DOI 10.2337/dc07-1214; Smolak L, 1999, INT J EAT DISORDER, V25, P263, DOI 10.1002/(SICI)1098-108X(199904)25:3&lt;263::AID-EAT3&gt;3.0.CO;2-V; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Tuei Vivian C, 2010, Diabetes Metab Res Rev, V26, P433, DOI 10.1002/dmrr.1106; TURNER RC, 1993, J HYPERTENS, V11, P309; Unadike BC, 2011, NIGER J CLIN PRACT, V14, P300, DOI 10.4103/1119-3077.86772; WHO, 2000, OB PREV MAN GLOB EP; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2008, WAIST CIRCUMFERENCE; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Young-Hyman D, 2000, OBES RES, V8, P241, DOI 10.1038/oby.2000.28	55	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95165	10.1371/journal.pone.0095165	http://dx.doi.org/10.1371/journal.pone.0095165			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736567	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600147
J	Rinehart, M; Grab, S; Rohan, L; Katz, D; Wax, A				Rinehart, Matthew; Grab, Sheila; Rohan, Lisa; Katz, David; Wax, Adam			Analysis of Vaginal Microbicide Film Hydration Kinetics by Quantitative Imaging Refractometry	PLOS ONE			English	Article							SPATIAL FOURIER-ANALYSIS; DRUG-DELIVERY; MICROSCOPY; DYNAMICS; CELLS	We have developed a quantitative imaging refractometry technique, based on holographic phase microscopy, as a tool for investigating microscopic structural changes in water-soluble polymeric materials. Here we apply the approach to analyze the structural degradation of vaginal topical microbicide films due to water uptake. We implemented transmission imaging of 1-mm diameter film samples loaded into a flow chamber with a 1.5x2 mm field of view. After water was flooded into the chamber, interference images were captured and analyzed to obtain high resolution maps of the local refractive index and subsequently the volume fraction and mass density of film material at each spatial location. Here, we compare the hydration dynamics of a panel of films with varying thicknesses and polymer compositions, demonstrating that quantitative imaging refractometry can be an effective tool for evaluating and characterizing the performance of candidate microbicide film designs for anti-HIV drug delivery.	[Rinehart, Matthew; Katz, David; Wax, Adam] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Grab, Sheila; Rohan, Lisa] Univ Pittsburgh, Sch Pharm, Magee Womens Res Inst, Pittsburgh, PA USA; [Katz, David] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA	Duke University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Duke University	Rinehart, M (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	matt.rinehart@duke.edu		Wax, Adam/0000-0002-1827-5112	National Science Foundation [MRI-1039562]; National Institutes of Health [RO1 HD072702, DAIDS IPCP U19 AI082639]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD072702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI082639] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from the National Science Foundation (MRI-1039562) and the National Institutes of Health (RO1 HD072702 and DAIDS IPCP U19 AI082639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil A, 2011, DRUG DELIV TRANSL RE, V1, P209, DOI 10.1007/s13346-011-0022-6; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; BERK DA, 1993, BIOPHYS J, V65, P2428, DOI 10.1016/S0006-3495(93)81326-2; CONRAD; Follow-on African Consortium for Tenofovir Studies (FACTS); United States Agency for International Development (USAID), 2013, SAF EFF TEN GEL PREV; DAVIES HG, 1952, NATURE, V169, P541, DOI 10.1038/169541a0; Dobaria NB, 2009, AAPS PHARMSCITECH, V10, P951, DOI 10.1208/s12249-009-9288-0; FRANKMAN O, 1975, J INT MED RES, V3, P292, DOI 10.1177/030006057500300412; Garg S, 2005, PHARM RES-DORDR, V22, P584, DOI 10.1007/s11095-005-2490-1; Garg S, 2010, ANTIVIR RES, V88, pS19, DOI 10.1016/j.antiviral.2010.09.010; Geonnotti AR, 2006, BIOPHYS J, V91, P2121, DOI 10.1529/biophysj.106.086322; Ghiglia D.C., 1998, 2 DIMENSIONAL PHASE, V1st; Ham AS, 2012, PHARM RES-DORDR, V29, P1897, DOI 10.1007/s11095-012-0715-7; HUNTLEY JM, 1993, APPL OPTICS, V32, P3047, DOI 10.1364/AO.32.003047; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Katz DF, 2011, DRUG DELIV TRANSL RE, V1, P256, DOI 10.1007/s13346-011-0029-z; Kolin DL, 2006, BIOPHYS J, V91, P3061, DOI 10.1529/biophysj.106.082768; LEE P I, 1987, Journal of Controlled Release, V6, P207, DOI 10.1016/0168-3659(87)90077-0; Machado RM, 2013, J PHARM SCI-US, V102, P2069, DOI 10.1002/jps.23577; Miller-Chou BA, 2003, PROG POLYM SCI, V28, P1223, DOI 10.1016/S0079-6700(03)00045-5; National Institute of Allergy and Infectious Diseases (NIAID); Microbicide Trials Network, 2000, SAF EFF TEN 1 GEL TE; Neurath AR, 2003, BMC INFECT DIS, V3, DOI 10.1186/1471-2334-3-27; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Rappaz B, 2005, OPT EXPRESS, V13, P9361, DOI 10.1364/OPEX.13.009361; Rinehart MT, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3665439; Rustomjee R, 1999, AIDS, V13, P1511, DOI 10.1097/00002030-199908200-00011; Shaked NT, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3290242; Shaked NT, 2009, OPT EXPRESS, V17, P15585, DOI 10.1364/OE.17.015585; Stone A., 2010, MICROBICIDES WAYS FO; Tasoglu S, 2013, PHYS FLUIDS, V25, DOI 10.1063/1.4793598; TSAY TT, 1991, BIOPHYS J, V60, P360, DOI 10.1016/S0006-3495(91)82061-6; Younus Pasha M, 2012, LAT AM J PHARM, V31	31	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95005	10.1371/journal.pone.0095005	http://dx.doi.org/10.1371/journal.pone.0095005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736376	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600121
J	Stafford-Banks, CA; Rotenberg, D; Johnson, BR; Whitfield, AE; Ullman, DE				Stafford-Banks, Candice A.; Rotenberg, Dorith; Johnson, Brian R.; Whitfield, Anna E.; Ullman, Diane E.			Analysis of the Salivary Gland Transcriptome of Frankliniella occidentalis	PLOS ONE			English	Article							ADULT FEMALE MOSQUITO; PROTEOMIC ANALYSIS; ANNOTATED CATALOG; VECTOR COMPETENCE; PLANT PENETRATION; FEEDING-BEHAVIOR; GLUCOSE-OXIDASE; RUSSIAN WHEAT; PEA APHID; PROTEINS	Saliva is known to play a crucial role in insect feeding behavior and virus transmission. Currently, little is known about the salivary glands and saliva of thrips, despite the fact that Frankliniella occidentalis (Pergande) (the western flower thrips) is a serious pest due to its destructive feeding, wide host range, and transmission of tospoviruses. As a first step towards characterizing thrips salivary gland functions, we sequenced the transcriptome of the primary salivary glands of F. occidentalis using short read sequencing (Illumina) technology. A de novo-assembled transcriptome revealed 31,392 high quality contigs with an average size of 605 bp. A total of 12,166 contigs had significant BLASTx or tBLASTx hits (E <= 1.0E(-6)) to known proteins, whereas a high percentage (61.24%) of contigs had no apparent protein or nucleotide hits. Comparison of the F. occidentalis salivary gland transcriptome (sialotranscriptome) against a published F. occidentalis full body transcriptome assembled from Roche-454 reads revealed several contigs with putative annotations associated with salivary gland functions. KEGG pathway analysis of the sialotranscriptome revealed that the majority (18 out of the top 20 predicted KEGG pathways) of the salivary gland contig sequences match proteins involved in metabolism. We identified several genes likely to be involved in detoxification and inhibition of plant defense responses including aldehyde dehydrogenase, metalloprotease, glucose oxidase, glucose dehydrogenase, and regucalcin. We also identified several genes that may play a role in the extra-oral digestion of plant structural tissues including beta-glucosidase and pectin lyase; and the extra-oral digestion of sugars, including alpha-amylase, maltase, sucrase, and alpha-glucosidase. This is the first analysis of a sialotranscriptome for any Thysanopteran species and it provides a foundational tool to further our understanding of how thrips interact with their plant hosts and the viruses they transmit.	[Stafford-Banks, Candice A.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Rotenberg, Dorith; Whitfield, Anna E.] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA; [Johnson, Brian R.; Ullman, Diane E.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of California System; University of California Davis; Kansas State University; University of California System; University of California Davis	Stafford-Banks, CA (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	canstafford@ucdavis.edu		Rotenberg, Dorith/0000-0002-9018-8822	College of Agricultural and Environmental Sciences; Henry A. Jastro Research Award; Department of Plant Pathology, University of California, Davis; NIFA/AFRI CAP [GRANT11454594]	College of Agricultural and Environmental Sciences; Henry A. Jastro Research Award; Department of Plant Pathology, University of California, Davis(University of California System); NIFA/AFRI CAP	This work was supported by the College of Agricultural and Environmental Sciences, the Henry A. Jastro Research Award, and the graduate program of the Department of Plant Pathology, University of California, Davis. This work was also supported by the NIFA/AFRI CAP grant: Advancing innovative technologies and integrated strategies for sustainable management of thrips-transmitted tospoviruses Grant Number GRANT11454594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti N, 2000, J INSECT PHYSL, V58, P391; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Andersen JF, 2009, J PROTEOME RES, V8, P1474, DOI 10.1021/pr8008429; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Arca B, 2007, INSECT BIOCHEM MOLEC, V37, P107, DOI 10.1016/j.ibmb.2006.10.007; Assumpcao TCF, 2008, INSECT BIOCHEM MOLEC, V38, P213, DOI 10.1016/j.ibmb.2007.11.001; Backus EA, 2012, J INSECT PHYSIOL, V58, P949, DOI 10.1016/j.jinsphys.2012.04.011; Badillo-Vargas IE, 2012, J VIROL, V86, P8793, DOI 10.1128/JVI.00285-12; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Calvo E, 2008, INSECT BIOCHEM MOLEC, V38, P499, DOI 10.1016/j.ibmb.2007.12.006; Calvo E, 2006, INSECT BIOCHEM MOLEC, V36, P570, DOI 10.1016/j.ibmb.2006.04.005; CAMPBELL BC, 1985, ARCH INSECT BIOCHEM, V2, P203, DOI 10.1002/arch.940020208; Carolan JC, 2009, PROTEOMICS, V9, P2457, DOI 10.1002/pmic.200800692; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Celorio-Mancera MD, 2009, ARCH INSECT BIOCHEM, V70, P122, DOI 10.1002/arch.20282; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Cherqui A, 2000, J INSECT PHYSIOL, V46, P1177, DOI 10.1016/S0022-1910(00)00037-8; CHILDERS CC, 1991, ANN ENTOMOL SOC AM, V84, P272, DOI 10.1093/aesa/84.3.272; Christodoulou DC, 2001, CURR PROTOCOL MOL BI; Colebatch G, 2002, INSECT BIOCHEM MOLEC, V32, P1065, DOI 10.1016/S0965-1748(02)00044-9; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cooper WR, 2013, ANN ENTOMOL SOC AM, V106, P86, DOI 10.1603/AN12096; Cooper WR, 2010, ENVIRON ENTOMOL, V39, P223, DOI 10.1603/EN09079; Cristofoletti PT, 2003, J INSECT PHYSL, P49; Decrem Y, 2008, FEBS J, V275, P1485, DOI 10.1111/j.1742-4658.2008.06308.x; Del Bene G, 1999, INT J INSECT MORPHOL, V28, P301, DOI 10.1016/S0020-7322(99)00033-1; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; DELBENE G, 1991, INT J INSECT MORPHOL, V20, P15, DOI 10.1016/0020-7322(91)90024-4; Eberhard SH, 2007, J INSECT PHYSIOL, V53, P126, DOI 10.1016/j.jinsphys.2006.11.001; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Francischetti IMB, 2003, BIOCHEM BIOPH RES CO, V305, P869, DOI 10.1016/S0006-291X(03)00857-X; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Giebultowicz J, 2009, MOLECULES, V14, P2363, DOI 10.3390/molecules14072363; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Harrewijn P, 1996, ENTOMOL EXP APPL, V79, P345, DOI 10.1007/BF00186293; HEMING BS, 1978, J MORPHOL, V156, P1, DOI 10.1002/jmor.1051560102; Hosseininaveh V, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.7001; Jia LG, 1996, TOXICON, V34, P1269, DOI 10.1016/S0041-0101(96)00108-0; Kindt F, 2003, J INSECT PHYSIOL, V49, P183, DOI 10.1016/S0022-1910(02)00255-X; Kirk William D. J., 1997, P119; KUMAR NKK, 1995, J ECON ENTOMOL, V88, P1057, DOI 10.1093/jee/88.4.1057; Lewis T., 1973, THRIPS THEIR BIOL EC; MA R, 1990, J INSECT PHYSIOL, V36, P507, DOI 10.1016/0022-1910(90)90102-L; MARINOTTI O, 1990, INSECT BIOCHEM, V20, P619, DOI 10.1016/0020-1790(90)90074-5; MCALLAN JW, 1961, CAN J ZOOLOG, V39, P305, DOI 10.1139/z61-034; McAuslane HJ, 1997, J CHEM ECOL, V23, P2861, DOI 10.1023/A:1022575313325; Miles PW, 1999, BIOL REV, V74, P41, DOI 10.1017/S0006323198005271; MITCHELL FL, 1995, NATO ADV SCI INST SE, V276, P175; Montero-Astua M., 2012, THESIS KANSAS STATE; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nagata T, 1999, J GEN VIROL, V80, P507, DOI 10.1099/0022-1317-80-2-507; Nagata T, 2002, J GEN VIROL, V83, P663, DOI 10.1099/0022-1317-83-3-663; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Plyusnin A, 2012, VIRUS TAXONOMY, P725; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rotenberg D, 2010, INSECT MOL BIOL, V20, P1; Rotenberg D, 2009, PHYTOPATHOLOGY, V99, P404, DOI 10.1094/PHYTO-99-4-0404; Shackel KA, 2005, ARCH INSECT BIOCHEM, V58, P69, DOI 10.1002/arch.20033; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; Su YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039303; ULLMAN DE, 1989, INT J INSECT MORPHOL, V18, P289, DOI 10.1016/0020-7322(89)90011-1; ULLMAN DE, 1992, PHYTOPATHOLOGY, V82, P1333, DOI 10.1094/Phyto-82-1333; Ullman Diane E., 1993, Phytopathology, V83, P1374; van de Wetering F, 1998, ENTOMOL EXP APPL, V88, P9, DOI 10.1046/j.1570-7458.1998.00340.x; van de Wetering F, 1999, ENTOMOL EXP APPL, V93, P105, DOI 10.1046/j.1570-7458.1999.00567.x; Watanabe H, 1997, INSECT BIOCHEM MOLEC, V27, P305, DOI 10.1016/S0965-1748(97)00003-9; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Will T, 2006, J EXP BOT, V57, P729, DOI 10.1093/jxb/erj089; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Wright MK, 2006, J INSECT PHYSIOL, V52, P717, DOI 10.1016/j.jinsphys.2006.03.012; Zeng F, 2000, COMP BIOCHEM PHYS A, V126, P101, DOI 10.1016/S1095-6433(00)00193-8	78	53	55	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94447	10.1371/journal.pone.0094447	http://dx.doi.org/10.1371/journal.pone.0094447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736614	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600069
J	Pankratz, S; Bittner, S; Herrmann, AM; Schuhmann, MK; Ruck, T; Meuth, SG; Wiendl, H				Pankratz, Susann; Bittner, Stefan; Herrmann, Alexander M.; Schuhmann, Michael K.; Ruck, Tobias; Meuth, Sven G.; Wiendl, Heinz			Human CD4(+)HLA-G(+) regulatory T cells are potent suppressors of graft-versus-host disease in vivo	FASEB JOURNAL			English	Article						human leukocyte antigen G; immune tolerance; humanized mouse model; membrane potential of tT(reg) cells	CYCLIC ADENOSINE-MONOPHOSPHATE; HUMAN PERIPHERAL-BLOOD; CENTRAL-NERVOUS-SYSTEM; HLA-G EXPRESSION; MULTIPLE-SCLEROSIS; EX-VIVO; ACTIVATION; TOLERANCE; FOXP3; INFLAMMATION	CD4(+) T cells expressing the immunotolerizing molecule HLA-G have been described as a unique human thymus-derived regulatory T (tT(reg)) cell subset involved in immunoregulation and parenchymal homeostasis during infectious and autoimmune inflammation. We compared properties and molecular characteristics of human CD4(+) HLA-G(+) with those of CD4(+) CD25(+) FoxP3-expressing tT(reg) cells using in vitro studies of T-cell receptor (TCR) signaling, single-cell electrophysiology, and functional in vivo studies. Both tT(reg) populations are characterized by alterations in proximal-signaling pathways on TCR stimulation and a hyperpolarization of the plasma membrane when compared to conventional CD4(+) T cells. However, both clearly differ in phenotype and pattern of secreted cytokines, which results in distinct mechanisms of suppression: While CD4(+) HLA-G(+) cells secrete high levels of inhibitory molecules (IL-10, soluble HLA-G, IL-35), CD4(+) CD25(+) FoxP3(+) cells express these molecules at significantly lower levels and seem to exert their function mainly in a contact-dependent manner via cyclic adenosine-monophosphate. Finally we demonstrate that human CD4(+) HLA-G(+) tT(reg) cells significantly ameliorated graft-versus-host disease in a humanized mouse model as a first proof of their in vivo relevance. Our data further characterize and establish CD4(+) HLA-G(+) cells as a potent human tT(reg) population that can modulate polyclonal adaptive immune responses in vivo and thus being a promising candidate for potential clinical applications in the future.	[Pankratz, Susann; Bittner, Stefan; Herrmann, Alexander M.; Ruck, Tobias; Meuth, Sven G.; Wiendl, Heinz] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Meuth, Sven G.] Univ Munster, Dept Neuropathophysiol, Inst Physiol 1, D-48149 Munster, Germany; [Schuhmann, Michael K.] Univ Wurzburg, Dept Neurol, Wurzburg, Germany	University of Munster; University of Munster; University of Wurzburg	Wiendl, H (corresponding author), Univ Munster, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	heinz.wiendl@ukmuenster.de	Ruck, Tobias/AAH-4627-2021; Meuth, Sven G/HHM-8941-2022; Ruck, Tobias/AAQ-3703-2020; Wiendl, Heinz/AAX-6041-2021	Meuth, Sven G/0000-0003-2571-3501; Ruck, Tobias/0000-0001-6332-8650; Eichler (born Pankratz), Susann/0000-0003-3321-3232; Bittner, Stefan/0000-0003-2179-3655; Wiendl, Heinz/0000-0003-4310-3432	Innovative Medizinische Forschung [IMF Bl111316]; Competence Network for Multiple Sclerosis - Federal Ministry of Education and Research [FKZ 01GI0907]; German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)] [CRC Transregio 128-A9, CRC Transregio 128-B1, WI 1722/6-1]; DFG, Cells-in-Motion Cluster of Excellence, University of Munster [EXC 1003-CiM]	Innovative Medizinische Forschung; Competence Network for Multiple Sclerosis - Federal Ministry of Education and Research; German Research Foundation [Deutsche Forschungsgemeinschaft (DFG)](German Research Foundation (DFG)); DFG, Cells-in-Motion Cluster of Excellence, University of Munster	The authors are grateful to Prof. Dr. Jerzy-Roch Nofer (Center for Laboratory Medicine, University Hospital Munster, Munster, Germany) for GPT measurements, Prof. Dr. Lydia M. Sorokin (Institute for Physiological Chemistry and Pathobiochemistry, Munster University, Munster, Germany) for providing the purified anti-CD3 mAb, and the Department of Transfusion Medicine (University of Munster, Munster, Germany) for providing the fresh LRS chambers. This work was supported by Innovative Medizinische Forschung (IMF Bl111316) to S. B. and S. G. M.; the Competence Network for Multiple Sclerosis, funded by the Federal Ministry of Education and Research (FKZ 01GI0907), to H. W.; the German Research Foundation [Deutsche Forschungsgemeinschaft (DFG), CRC Transregio 128-A9, B1. and WI 1722/6-1] to H. W.; and by the DFG, Cells-in-Motion Cluster of Excellence (EXC 1003-CiM), University of Munster, to S. B., S. G. M., and H. W. All authors approved the final manuscript and had input in revising it for intellectual content and style. The authors declare no conflicts of interest.	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Bacchetta R, 2006, J CLIN INVEST, V116, P1713, DOI 10.1172/JCI25112; Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bartelt RR, 2013, WIRES SYST BIOL MED, V5, P101, DOI 10.1002/wsbm.1194; Becker C, 2009, BLOOD, V114, P1263, DOI 10.1182/blood-2009-02-206730; Bittner S, 2010, BRAIN PATHOL, V20, P999, DOI 10.1111/j.1750-3639.2010.00407.x; Bittner S, 2009, BRAIN, V132, P2501, DOI 10.1093/brain/awp163; Bodor J, 2012, EUR J IMMUNOL, V42, P1375, DOI 10.1002/eji.201141578; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Costantino CM, 2008, EUR J IMMUNOL, V38, P921, DOI 10.1002/eji.200738104; Costantino CM, 2008, J CLIN IMMUNOL, V28, P697, DOI 10.1007/s10875-008-9236-x; Crellin NK, 2007, BLOOD, V109, P2014, DOI 10.1182/blood-2006-07-035279; de Andres C, 2007, J NEUROIMMUNOL, V182, P204, DOI 10.1016/j.jneuroim.2006.09.012; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Feger U, 2007, CLIN EXP IMMUNOL, V147, P412, DOI 10.1111/j.1365-2249.2006.03271.x; Feger U, 2007, BLOOD, V110, P568, DOI 10.1182/blood-2006-11-057125; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Goodman WA, 2012, CRIT REV IMMUNOL, V32, P65, DOI 10.1615/CritRevImmunol.v32.i1.40; Huang YH, 2011, CELL MOL LIFE SCI, V68, P407, DOI 10.1007/s00018-010-0582-5; Huang YH, 2009, ANN NEUROL, V66, P171, DOI 10.1002/ana.21705; Huang YH, 2009, J LEUKOCYTE BIOL, V86, P273, DOI 10.1189/jlb.1008649; Jonuleit H, 2002, J EXP MED, V196, P255, DOI 10.1084/jem.20020394; Jonuleit H, 2005, METH MOLEC MED, V109, P285; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Klein M, 2012, J IMMUNOL, V188, P1091, DOI 10.4049/jimmunol.1102045; Li C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003140; Marek N, 2010, HUM IMMUNOL, V71, P666, DOI 10.1016/j.humimm.2010.05.002; Meuth SG, 2005, PFLUG ARCH EUR J PHY, V450, P111, DOI 10.1007/s00424-004-1377-z; Meuth SG, 2008, J BIOL CHEM, V283, P14559, DOI 10.1074/jbc.M800637200; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Moes N, 2010, GASTROENTEROLOGY, V139, P770, DOI 10.1053/j.gastro.2010.06.006; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Olson BM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00315; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Schmetterer KG, 2012, FASEB J, V26, P2253, DOI 10.1096/fj.11-193672; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Stephens LA, 2001, EUR J IMMUNOL, V31, P1247, DOI 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M; Strasser SI, 2000, HEPATOLOGY, V32, P1265, DOI 10.1053/jhep.2000.20067; Tsang JYS, 2006, J LEUKOCYTE BIOL, V80, P145, DOI 10.1189/jlb.0605344; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Xiao L, 2013, CHINESE MED J-PEKING, V126, P2652, DOI 10.3760/cma.j.issn.0366-6999.20122228; Zozulya AL, 2008, NAT CLIN PRACT NEURO, V4, P384, DOI 10.1038/ncpneuro0832	47	44	47	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2014	28	8					3435	3445		10.1096/fj.14-251074	http://dx.doi.org/10.1096/fj.14-251074			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AN0HM	24744146				2022-12-25	WOS:000340265400014
J	Anton, R; Bauer, SM; Keck, PRWEF; Laufer, S; Rothbauer, U				Anton, Roman; Bauer, Silke M.; Keck, Peter R. W. E. F.; Laufer, Stefan; Rothbauer, Ulrich			A p38 Substrate-Specific MK2-EGFP Translocation Assay for Identification and Validation of New p38 Inhibitors in Living Cells: A Comprising Alternative for Acquisition of Cellular p38 Inhibition Data	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MAP KINASE; BIOLOGICAL EVALUATION; NUCLEAR EXPORT; PATHWAY; SCREEN; DIBENZOSUBERONES; CHEMOTYPES; DISCOVERY; STRESSES	The fundamental role of p38 mitogen-activated protein kinases (MAPKs) in inflammation underlines their importance as therapeutic targets for various inflammatory medical conditions, including infectious, vascular, neurobiological and autoimmune disease. Although decades of research have yielded several p38 inhibitors, most clinical trials have failed, due to lack of selectivity and efficacy in vivo. This underlines the continuous need to screen for novel structures and chemotypes of p38 inhibitors. Here we report an optimized MK2-EGFP translocation assay in a semi-automated image based High Content Analysis (HCA) system to screen a combinatorial library of 3362 proprietary compounds with extensive variations of chemotypes. By determining the levels of redistribution of MK2-EGFP upon activation of the Rac/p38 pathway in combination with compound treatment, new candidates were identified, which modulate p38 activity in living cells. Based on integrated analysis of TNF alpha release from human whole blood, biochemical kinase activity assays and JNK3 selectivity testing, we show that this cell based assay reveals a high overlap and predictability for cellular efficacy, selectivity and potency of tested compounds. As a result we disclose a new comprehensive short-list of subtype inhibitors which are functional in the low nanomolar range and might provide the basis for further lead-optimization. In accordance to previous reports, we demonstrate that the MK2-EGFP translocation assay is a suitable primary screening approach for p38-MAPK drug development and provide an attractive labor- and cost saving alternative to other cell based methods including determination of cytokine release from hPBMCs or whole blood.	[Anton, Roman; Rothbauer, Ulrich] Univ Tubingen, NMI Nat & Med Sci Inst, Reutlingen, Germany; [Anton, Roman; Rothbauer, Ulrich] Univ Tubingen, Tubingen, Germany; [Bauer, Silke M.; Keck, Peter R. W. E. F.; Laufer, Stefan] Univ Tubingen, Inst Pharm, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Laufer, S (corresponding author), Univ Tubingen, Inst Pharm, Tubingen, Germany.	stefan.laufer@uni-tuebingen.de; ulrich.rothbauer@uni-tuebingen.de	Rothbauer, Ulrich/C-7712-2018	Rothbauer, Ulrich/0000-0001-5923-8986; Anton, Roman/0000-0002-9036-0012; Laufer, Stefan/0000-0001-6952-1486	Ministry of Science, Research and the Arts of Baden-Wuertemberg, Germany [V.1.4.-H3-1403-74]	Ministry of Science, Research and the Arts of Baden-Wuertemberg, Germany	This work was supported by the Ministry of Science, Research and the Arts of Baden-Wuertemberg, Germany (V.1.4.-H3-1403-74). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2011, J BIOL CHEM, V286, P7619, DOI 10.1074/jbc.M110.158477; Anton R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026257; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bracht C, 2010, CHEMMEDCHEM, V5, P1134, DOI 10.1002/cmdc.201000114; Buhler S, 2011, J MED CHEM, V54, P3283, DOI 10.1021/jm101623p; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dambach DM, 2005, CURR TOP MED CHEM, V5, P929, DOI 10.2174/1568026054985911; Diller DJ, 2005, CURR TOP MED CHEM, V5, P953, DOI 10.2174/1568026054985948; Engel K, 1998, EMBO J, V17, P3363, DOI 10.1093/emboj/17.12.3363; Fischer S, 2013, J MED CHEM, V56, P241, DOI 10.1021/jm301539x; Fischer S, 2011, EXPERT OPIN THER PAT, V21, P1843, DOI 10.1517/13543776.2011.636737; Bonilla-Hernan MG, 2011, RHEUMATOLOGY, V50, P1542, DOI 10.1093/rheumatology/ker192; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Goettert M, 2011, J PHARMACEUT BIOMED, V55, P236, DOI 10.1016/j.jpba.2011.01.014; Goettert M, 2010, ANAL BIOCHEM, V406, P233, DOI 10.1016/j.ab.2010.07.007; Goldstein DM, 2005, CURR TOP MED CHEM, V5, P1017, DOI 10.2174/1568026054985939; GRISWOLD DE, 1987, BIOCHEM PHARMACOL, V36, P3463, DOI 10.1016/0006-2952(87)90327-3; Henriksen U, 2008, COMB CHEM HIGH T SCR, V11, P537, DOI 10.2174/138620708785204081; Herlaar E, 1999, MOL MED TODAY, V5, P439, DOI 10.1016/S1357-4310(99)01544-0; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Koeberle SC, 2012, J MED CHEM, V55, P5868, DOI 10.1021/jm300327h; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Laufer S, 2008, ORG BIOMOL CHEM, V6, P437, DOI 10.1039/b717605h; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Martz KE, 2012, J MED CHEM, V55, P7862, DOI 10.1021/jm300951u; Meng WY, 2002, J BIOL CHEM, V277, P37401, DOI 10.1074/jbc.C200418200; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Repici M, 2006, ADV EXP MED BIOL, V588, P145; Ross S, 2006, ASSAY DRUG DEV TECHN, V4, P397, DOI 10.1089/adt.2006.4.397; Trask OJ, 2009, METHODS MOL BIOL, V565, P159, DOI 10.1007/978-1-60327-258-2_8; Trask OJ, 2006, METHOD ENZYMOL, V414, P419, DOI 10.1016/S0076-6879(06)14023-9; Wang XS, 1997, J BIOL CHEM, V272, P23668, DOI 10.1074/jbc.272.38.23668; Williams RG, 2006, METHOD ENZYMOL, V414, P364, DOI 10.1016/S0076-6879(06)14021-5; Yong HY, 2009, EXPERT OPIN INV DRUG, V18, P1893, DOI 10.1517/13543780903321490; Young PR, 2013, J BIOMOL SCREEN, V18, P1156, DOI 10.1177/1087057113497401; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95641	10.1371/journal.pone.0095641	http://dx.doi.org/10.1371/journal.pone.0095641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743242	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100151
J	Basu, A; Dasari, V; Mishra, RK; Khosla, S				Basu, Amitava; Dasari, Vasanthi; Mishra, Rakesh K.; Khosla, Sanjeev			The CpG Island Encompassing the Promoter and First Exon of Human DNMT3L Gene Is a PcG/TrX Response Element (PRE)	PLOS ONE			English	Article							POLYCOMB GROUP PROTEINS; DE-NOVO METHYLATION; HETEROCHROMATIN PROTEIN-1; DNA METHYLATION; MECHANISMS; DROSOPHILA; SET	DNMT3L, a member of DNA methyltransferases family, is present only in mammals. As it provides specificity to the action of de novo methyltransferases, DNMT3A and DNMT3B and interacts with histone H3, DNMT3L has been invoked as the molecule that can read the histone code and translate it into DNA methylation. It plays an important role in the initiation of genomic imprints during gametogenesis and in nuclear reprogramming. With important functions attributed to it, it is imperative that the DNMT3L expression is tightly controlled. Previously, we had identified a CpG island within the human DNMT3L promoter and first exon that showed loss of DNA methylation in cancer samples. Here we show that this Differentially Methylated CpG island within DNMT3L (DNMT3L DMC) acts to repress transcription, is a Polycomb/Trithorax Response Element (PRE) and interacts with both PRC1 and PRC2 Polycomb repressive complexes. In addition, it adopts inactive chromatin conformation and is associated with other inactive chromatin-specific proteins like SUV39H1 and HP1. The presence of DNMT3L DMC also influences the adjacent promoter to adopt repressive histone post-translational modifications. Due to its association with multiple layers of repressive epigenetic modifications, we believe that PRE within the DNMT3L DMC is responsible for the tight regulation of DNMT3L expression and the aberrant epigenetic modifications of this region leading to DNMT3L overexpression could be the reason of nuclear programming during carcinogenesis.	[Basu, Amitava; Khosla, Sanjeev] Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India; [Dasari, Vasanthi; Mishra, Rakesh K.] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Khosla, S (corresponding author), Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India.	sanjuk@cdfd.org.in	Mishra, Rakesh K/F-3496-2010	Mishra, Rakesh K/0000-0001-6636-7380	Department of Biotechnology, Govt of India	Department of Biotechnology, Govt of India(Department of Biotechnology (DBT) India)	Department of Biotechnology, Govt of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapola U, 2004, BIOCHEM J, V380, P205; Arima T, 2006, DEV BIOL, V297, P361, DOI 10.1016/j.ydbio.2006.05.003; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; Ginjala V, 2002, J BIOL CHEM, V277, P5707, DOI 10.1074/jbc.C100552200; Gokul G, 2007, EPIGENETICS-US, V2, P80, DOI 10.4161/epi.2.2.3692; Gokul G, 2009, EPIGENETICS-US, V4, P322, DOI 10.4161/epi.4.5.9239; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hames B.D., 1998, GEL ELECTROPHORESIS, V4th ed.; Hashimoto H, 2010, EPIGENOMICS-UK, V2, P657, DOI 10.2217/EPI.10.44; Hata K, 2002, DEVELOPMENT, V129, P1983; Hwang KK, 2001, P NATL ACAD SCI USA, V98, P11423, DOI 10.1073/pnas.211303598; Imhof Axel, 2006, Briefings in Functional Genomics & Proteomics, V5, P222, DOI 10.1093/bfgp/ell030; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Krouwels IM, 2005, J CELL BIOL, V170, P537, DOI 10.1083/jcb.200502154; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lynch MD, 2012, EMBO J, V31, P317, DOI 10.1038/emboj.2011.399; Mahmoudi T, 2001, ONCOGENE, V20, P3055, DOI 10.1038/sj.onc.1204330; Manderwad GP, 2010, ARCH PATHOL LAB MED, V134, P1193, DOI 10.1043/2009-0417-OA.1; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Nestorov P, 2013, CURR TOP DEV BIOL, V104, P243, DOI 10.1016/B978-0-12-416027-9.00008-5; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; REUTER G, 1990, NATURE, V344, P219, DOI 10.1038/344219a0; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schotta G, 2003, GENETICA, V117, P149, DOI 10.1023/A:1022923508198; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Schwartz YB, 2004, COLD SPRING HARB SYM, V69, P301, DOI 10.1101/sqb.2004.69.301; Shiota M, 2010, ENDOCR-RELAT CANCER, V17, P455, DOI 10.1677/ERC-09-0321; Siegal ML, 1996, GENETICS, V144, P715; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Sultana H, 2011, NUCLEIC ACIDS RES, V39, P3543, DOI 10.1093/nar/gkq1297; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Voie A, 1997, CELL BIOL LAB HDB, V3, P510; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Zhang DY, 2011, CHROMOSOMA, V120, P97, DOI 10.1007/s00412-010-0294-5	46	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e93561	10.1371/journal.pone.0093561	http://dx.doi.org/10.1371/journal.pone.0093561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743422	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100015
J	Gupta, A; Rezvani, R; Lapointe, M; Poursharifi, P; Marceau, P; Tiwari, S; Tchernof, A; Cianflone, K				Gupta, Abhishek; Rezvani, Reza; Lapointe, Marc; Poursharifi, Pegah; Marceau, Picard; Tiwari, Sunita; Tchernof, Andre; Cianflone, Katherine			Downregulation of Complement C3 and C3aR Expression in Subcutaneous Adipose Tissue in Obese Women	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; INCREASED ENERGY-EXPENDITURE; BODY-FAT MASS; INSULIN-RESISTANCE; GENE-EXPRESSION; METABOLIC SYNDROME; DEFICIENT MICE; BINDING-SITES; SERUM C3; IN-VIVO	Background: The central component of the complement system, C3, is associated with obesity, metabolic syndrome and cardiovascular disease however the underlying reasons are unknown. In the present study we evaluated gene expression of C3, the cleavage product C3a/C3adesArg and its cognate receptor C3aR in subcutaneous and omental adipose tissue in women. Methods: Women (n = 140, 21-69 years, BMI 19.5-79 kg/m(2)) were evaluated for anthropometric and blood parameters, and adipose tissue gene expression. Results: Subjects were separated into groups (n = 34-36) according to obesity: normal/overweight (<= 30 kg/m(2)), obese I (<= 45 kg/m(2)), obese II (<= 51 kg/m(2)), and obese III (<= 80 kg/m(2)). Overall, while omental expression remained unchanged, subcutaneous C3 and C3aR gene expression decreased with increasing adiposity (2-way ANOVA, p<0.01), with a concomitant decrease in SC/OM ratio (p<0.001). In subcutaneous adipose, both C3 and C3aR expression correlated with apoB, and apoA1 and inversely with waist circumference and blood pressure, while C3aR also correlated with glucose (p<0.05-0.0001). While omental C3aR expression did not correlate with any factor, omental C3 correlated with waist circumference, glucose and apoB (all p<0.05). Further, while plasma C3a/C3adesArg increased and adiponectin decreased with increasing BMI, both correlated (C3a negatively and adiponectin positively) with subcutaneous C3 and C3aR expression (p<0.05-0.001) or less). Conclusions: The obesity-induced down-regulation of complement C3 and C3aR which is specific to subcutaneous adipose tissue, coupled to the strong correlations with multiple anthropometric, plasma and adipokine variables support a potential role for complement in immunometabolism.	[Gupta, Abhishek; Rezvani, Reza; Lapointe, Marc; Poursharifi, Pegah; Marceau, Picard; Tchernof, Andre; Cianflone, Katherine] Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Gupta, Abhishek; Tiwari, Sunita] King Georges Med Univ, Dept Physiol, Lucknow, Uttar Pradesh, India	Laval University; King George's Medical University	Cianflone, K (corresponding author), Univ Laval, Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	katherine.cianflone@criucpq.ulaval.ca	Rezvani, Reza/M-7642-2019; Poursharifi, Pegah/K-4420-2019	Rezvani, Reza/0000-0003-3585-9854; Poursharifi, Pegah/0000-0002-7804-4359; Tchernof, Andre/0000-0002-2587-1000; Lapointe, Marc/0000-0003-0461-2576	Canadian Institutes of Health Research (CIHR); CIHR Hope scholarship; Obesity Training Program; CRIUCPQ; Ethicon-Endosurgery/Johnson Johnson	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR Hope scholarship(Canadian Institutes of Health Research (CIHR)); Obesity Training Program; CRIUCPQ; Ethicon-Endosurgery/Johnson Johnson	This study was supported by a grant from the Canadian Institutes of Health Research (CIHR to KC). K. Cianflone holds a Canada Research Chair in Adipose Tissue. A. Gupta holds a CIHR Hope scholarship. R. Rezvani and P. Poursharifi are supported by grants from the Obesity Training Program and the CRIUCPQ. A. Tchernof is the recipient of an Industrial Research Institute Chair in Bariatric and Metabolic Surgery at IUCPQ, Laval University (sponsored by Ethicon-Endosurgery/Johnson & Johnson). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Arumugam TV, 2004, SHOCK, V21, P401, DOI 10.1097/00024382-200405000-00002; Busch C, 2013, MOL IMMUNOL, V53, P363, DOI 10.1016/j.molimm.2012.09.001; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Cianflone K, 2003, BBA-BIOMEMBRANES, V1609, P127, DOI 10.1016/S0005-2736(02)00686-7; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Engstrom G, 2005, DIABETOLOGIA, V48, P2525, DOI 10.1007/s00125-005-0021-6; Fisette A, 2013, IMMUNOBIOLOGY, V218, P127, DOI 10.1016/j.imbio.2012.04.001; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fujita T, 2013, DIABETES-METAB RES, V29, P220, DOI 10.1002/dmrr.2380; Gabrielsson BG, 2003, OBES RES, V11, P699, DOI 10.1038/oby.2003.100; Gauvreau D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060795; Insenser M, 2012, MOL CELL ENDOCRINOL, V363, P10, DOI 10.1016/j.mce.2012.07.001; Kalant D, 2000, J LIPID RES, V41, P1963; Kalant D, 2005, J BIOL CHEM, V280, P23936, DOI 10.1074/jbc.M406921200; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Lewis RD, 2011, AM J PATHOL, V179, P1601, DOI 10.1016/j.ajpath.2011.06.015; Lim J, 2013, FASEB J, V27, P822, DOI 10.1096/fj.12-220582; Linton SM, 1999, MOL IMMUNOL, V36, P905, DOI 10.1016/S0161-5890(99)00113-3; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; MacLaren RE, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-3; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Maslowska M, 2005, VITAM HORM, V70, P309, DOI 10.1016/S0083-6729(05)70010-8; Mogilenko DA, 2012, J BIOL CHEM, V287, P5954, DOI 10.1074/jbc.M111.289322; Muscari A, 2007, DIABETES CARE, V30, P2362, DOI 10.2337/dc07-0637; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Onat A, 2011, CLIN CHIM ACTA, V412, P1171, DOI 10.1016/j.cca.2011.03.005; Onat A, 2010, METABOLISM, V59, P628, DOI 10.1016/j.metabol.2009.09.006; Ozata M, 2002, J CLIN ENDOCR METAB, V87, P853, DOI 10.1210/jc.87.2.853; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; Phillips CM, 2012, ATHEROSCLEROSIS, V220, P513, DOI 10.1016/j.atherosclerosis.2011.11.007; Volp ACP, 2012, NUTRITION, V28, P544, DOI 10.1016/j.nut.2011.08.014; Roy C, 2008, AM J PHYSIOL-ENDOC M, V294, pE1051, DOI 10.1152/ajpendo.00689.2007; Roy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062531; Saleh J, 1998, J LIPID RES, V39, P884; Samaras K, 2010, OBESITY, V18, P884, DOI 10.1038/oby.2009.443; Scantlebury T, 1998, J BIOL CHEM, V273, P20903, DOI 10.1074/jbc.273.33.20903; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Smith JD, 2011, WILD ENVIRON MED, V22, P107, DOI 10.1016/j.wem.2011.01.003; Sun JZ, 1999, PROTEIN SCI, V8, P2304; van Greevenbroek MMJ, 2012, INT J CARDIOL, V154, P158, DOI 10.1016/j.ijcard.2010.09.017; van Oostrom AJHHM, 2007, ATHEROSCLEROSIS, V190, P167, DOI 10.1016/j.atherosclerosis.2006.01.009; Ward PA, 2008, J LEUKOCYTE BIOL, V83, P467, DOI 10.1189/jlb.0607376; Wernstedt I, 2006, ENDOCRINOLOGY, V147, P2690, DOI 10.1210/en.2005-1133; Wlazlo N, 2012, METABOLISM, V61, P1787, DOI 10.1016/j.metabol.2012.05.015; Xia Z, 2002, J BIOL CHEM, V277, P45874, DOI 10.1074/jbc.M207281200; Xia ZN, 2004, J BIOL CHEM, V279, P4051, DOI 10.1074/jbc.M311319200; Xia ZN, 2003, METABOLISM, V52, P1360, DOI 10.1016/S0026-0495(03)00254-3; Yavuz S, 2010, PEDIATR DERMATOL, V27, P504, DOI 10.1111/j.1525-1470.2010.01255.x	51	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95478	10.1371/journal.pone.0095478	http://dx.doi.org/10.1371/journal.pone.0095478			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743347	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100123
J	Layton, KKS; Martel, AL; Hebert, PDN				Layton, Kara K. S.; Martel, Andre L.; Hebert, Paul D. N.			Patterns of DNA Barcode Variation in Canadian Marine Molluscs	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; MITOCHONDRIAL-DNA; BIOLOGICAL IDENTIFICATIONS; SPECIES COMPLEX; GENES; PHYLOGEOGRAPHY; EVOLUTION; SEQUENCES; BIVALVIA; ECOLOGY	Background: Molluscs are the most diverse marine phylum and this high diversity has resulted in considerable taxonomic problems. Because the number of species in Canadian oceans remains uncertain, there is a need to incorporate molecular methods into species identifications. A 648 base pair segment of the cytochrome c oxidase subunit I gene has proven useful for the identification and discovery of species in many animal lineages. While the utility of DNA barcoding in molluscs has been demonstrated in other studies, this is the first effort to construct a DNA barcode registry for marine molluscs across such a large geographic area. Methodology/Principal Findings: This study examines patterns of DNA barcode variation in 227 species of Canadian marine molluscs. Intraspecific sequence divergences ranged from 0-26.4% and a barcode gap existed for most taxa. Eleven cases of relatively deep (>2%) intraspecific divergence were detected, suggesting the possible presence of overlooked species. Structural variation was detected in COI with indels found in 37 species, mostly bivalves. Some indels were present in divergent lineages, primarily in the region of the first external loop, suggesting certain areas are hotspots for change. Lastly, mean GC content varied substantially among orders (24.5%-46.5%), and showed a significant positive correlation with nearest neighbour distances. Conclusions/Significance: DNA barcoding is an effective tool for the identification of Canadian marine molluscs and for revealing possible cases of overlooked species. Some species with deep intraspecific divergence showed a biogeographic partition between lineages on the Atlantic, Arctic and Pacific coasts, suggesting the role of Pleistocene glaciations in the subdivision of their populations. Indels were prevalent in the barcode region of the COI gene in bivalves and gastropods. This study highlights the efficacy of DNA barcoding for providing insights into sequence variation across a broad taxonomic group on a large geographic scale.	[Layton, Kara K. S.; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Martel, Andre L.] Canadian Museum Nat, Gatineau, PQ, Canada	University of Guelph	Layton, KKS (corresponding author), Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada.	klayton@uoguelph.ca	Layton, Kara/AAC-6007-2019; Hebert, Paul DN/C-4161-2013	Hebert, Paul DN/0000-0002-3081-6700; Layton, Kara/0000-0002-4302-3048	Natural Sciences and Engineering Research Council (NSERC) through the Canadian Healthy Oceans Network; government of Canada through Genome Canada; Ontario Genomics Institute; Indian and Northern Affairs Canada	Natural Sciences and Engineering Research Council (NSERC) through the Canadian Healthy Oceans Network(Natural Sciences and Engineering Research Council of Canada (NSERC)); government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; Indian and Northern Affairs Canada	This research was funded, in part, by the Natural Sciences and Engineering Research Council (NSERC) through the Canadian Healthy Oceans Network and a Discovery Grant to PDNH. Sequence analysis was enabled by funding from the government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life Project. Field work was aided by a Northern Scientific Training Program grant to KKSL from Indian and Northern Affairs Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; Bouchet Philippe, 2006, P31; Boyle EE, 2013, MAR BIOL, V160, P413, DOI 10.1007/s00227-012-2099-y; Carr CM, 2010, PLOS ONE, V6; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1658/1100-9233(2003)014[0927:VAPORF]2.0.CO;2; Dodson JJ, 2007, MOL ECOL, V16, P5030, DOI 10.1111/j.1365-294X.2007.03559.x; Drent J, 2004, FUNCT ECOL, V18, P349, DOI 10.1111/j.0269-8463.2004.00839.x; Garrido-Ramos MA, 1998, GENOME, V41, P818, DOI 10.1139/gen-41-6-818; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; GILMER RW, 1990, AM MALACOL BULL, V8, P67; Harrell Jr FE, 2012, HMISC HARRELL MISCEL; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hellberg ME, 1999, MOL BIOL EVOL, V16, P839, DOI 10.1093/oxfordjournals.molbev.a026168; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hunt Brian, 2010, PLoS ONE, V5, P1, DOI 10.1371/journal.pone.0009835; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Jarnegren J, 2007, MAR BIOL, V152, P43, DOI 10.1007/s00227-007-0651-y; Johnson SB, 2008, J SHELLFISH RES, V27, P43, DOI 10.2983/0730-8000(2008)27[43:DBOLLR]2.0.CO;2; Jones M, 2011, PLOS ONE, V6; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Kyriakou Eleni, 2010, BMC Research Notes, V3, P222, DOI 10.1186/1756-0500-3-222; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Mardulyn P, 1999, MOL PHYLOGENET EVOL, V12, P282, DOI 10.1006/mpev.1999.0618; Marko PB, 2009, J BIOGEOGR, V36, P1861, DOI 10.1111/j.1365-2699.2009.02114.x; Metz EC, 1998, P NATL ACAD SCI USA, V95, P10676, DOI 10.1073/pnas.95.18.10676; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mikkelsen NT, 2007, ZOOL SCR, V36, P455, DOI 10.1111/j.1463-6409.2006.00289.x; Milani L, 2013, GENOME BIOL EVOL, V5, P1408, DOI 10.1093/gbe/evt101; Naughton KM, 2009, INVERTEBR SYST, V23, P348, DOI 10.1071/IS08021; Passamonti M, 2003, GENETICS, V164, P603; Passamonti M, 2009, DNA CELL BIOL, V28, P79, DOI 10.1089/dna.2008.0807; Petersen GH, 1999, POLAR BIOL, V22, P322; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Remigio EA, 2003, MOL PHYLOGENET EVOL, V29, P641, DOI 10.1016/S1055-7903(03)00140-4; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; TAYLOR EB, 1994, MOL ECOL, V3, P235, DOI 10.1111/j.1365-294X.1994.tb00057.x; Theologidis I, 2008, EVOLUTION, V62, P959, DOI 10.1111/j.1558-5646.2008.00329.x; Thomaz D, 1996, P ROY SOC B-BIOL SCI, V263, P363, DOI 10.1098/rspb.1996.0056; VERMEIJ GJ, 1991, PALEOBIOLOGY, V17, P281, DOI 10.1017/S0094837300010617; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MOL ECOL RESOUR, V8, P1202, DOI 10.1111/j.1755-0998.2008.02332.x; Wares JP, 2001, EVOLUTION, V55, P2455; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Zou SM, 2012, MAR BIOTECHNOL, V14, P21, DOI 10.1007/s10126-011-9384-5; Zou SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026619; Zouros E, 2013, EVOL BIOL, V40, P1, DOI 10.1007/s11692-012-9195-2	52	105	113	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95003	10.1371/journal.pone.0095003	http://dx.doi.org/10.1371/journal.pone.0095003			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743320	Green Submitted, Green Published, gold			2022-12-25	WOS:000335309100058
J	Lockett, AD; Brown, MB; Santos-Falcon, N; Rush, NI; Oueini, H; Oberle, AJ; Bolanis, E; Fragoso, MA; Petrusca, DN; Serban, KA; Schweitzer, KS; Presson, RG; Campos, M; Petrache, I				Lockett, Angelia D.; Brown, Mary Beth; Santos-Falcon, Nieves; Rush, Natalia I.; Oueini, Houssam; Oberle, Amber J.; Bolanis, Esther; Fragoso, Miryam A.; Petrusca, Daniela N.; Serban, Karina A.; Schweitzer, Kelly S.; Presson, Robert G., Jr.; Campos, Michael; Petrache, Irina			Active Trafficking of Alpha 1 Antitrypsin across the Lung Endothelium	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN; CAPILLARY ENDOTHELIUM; TUNNELING NANOTUBULES; IMMUNE-RESPONSES; LAVAGE FLUID; CANCER-CELLS; TRANSCYTOSIS; RECEPTOR; ALPHA(1)-ANTITRYPSIN	The homeostatic lung protective effects of alpha-1 antitrypsin (A1AT) may require the transport of circulating proteinase inhibitor across an intact lung endothelial barrier. We hypothesized that uninjured pulmonary endothelial cells transport A1AT to lung epithelial cells. Purified human A1AT was rapidly taken up by confluent primary rat pulmonary endothelial cell monolayers, was secreted extracellularly, both apically and basolaterally, and was taken up by adjacent rat lung epithelial cells co-cultured on polarized transwells. Similarly, polarized primary human lung epithelial cells took up basolaterally-, but not apically-supplied A1AT, followed by apical secretion. Evidence of A1AT transcytosis across lung microcirculation was confirmed in vivo by two-photon intravital microscopy in mice. Time-lapse confocal microscopy indicated that A1AT colocalized with Golgi in the endothelium whilst inhibition of the classical secretory pathway with tunicamycin significantly increased intracellular retention of A1AT. However, inhibition of Golgi secretion promoted non-classical A1AT secretion, associated with microparticle release. Polymerized A1AT or A1AT supplied to endothelial cells exposed to soluble cigarette smoke extract had decreased transcytosis. These results suggest previously unappreciated pathways of A1AT bidirectional uptake and secretion from lung endothelial cells towards the alveolar epithelium and airspaces. A1AT trafficking may determine its functional bioavailablity in the lung, which could be impaired in individuals exposed to smoking or in those with A1AT deficiency.	[Lockett, Angelia D.; Rush, Natalia I.; Oueini, Houssam; Oberle, Amber J.; Bolanis, Esther; Petrusca, Daniela N.; Serban, Karina A.; Schweitzer, Kelly S.; Petrache, Irina] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Brown, Mary Beth] Indiana Univ, Sch Hlth & Rehabil Sci, Dept Phys Therapy, Indianapolis, IN USA; [Presson, Robert G., Jr.] Indiana Univ, Sch Med, Dept Anesthesia, Indianapolis, IN 46202 USA; [Santos-Falcon, Nieves; Fragoso, Miryam A.; Campos, Michael] Univ Miami, Div Pulm & Crit Care Med, Miami, FL USA; [Petrache, Irina] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Lockett, AD (corresponding author), Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA.	anlocket@iu.edu	Petrache, Irina/AAZ-9648-2020; Campos, Michael/X-2025-2019	Campos, Michael/0000-0001-5485-9062	VA Merit Award; NIH [R01HL077328-08]; NHLBI, NIH [R01HL077328-07S1-]; Baxter Healthcare; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105772, R01HL077328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001150] Funding Source: NIH RePORTER	VA Merit Award(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Baxter Healthcare; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	Funding for this project came from the following sources: 1. VA Merit Award http://www.research.va.gov/funding; 2. NIH R01HL077328-08-http://grants.nih.gov/grants/oer.htm; 3. NHLBI Diversity Supplement, NIH R01HL077328-07S1- http://grants.nih.gov/grants/oer.htm; 4. Baxter Healthcare-www.baxterhealthcare.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2008, CELL MOL IMMUNOL, V5, P261, DOI 10.1038/cmi.2008.32; Ahmed KA, 2011, J CELL MOL MED, V15, P1458, DOI 10.1111/j.1582-4934.2010.01008.x; Alam S, 2011, AM J RESP CELL MOL, V45, P261, DOI 10.1165/rcmb.2010-0328OC; Aldonyte R, 2008, COPD, V5, P153, DOI 10.1080/15412550802092936; Bebawy M, 2009, LEUKEMIA, V23, P1643, DOI 10.1038/leu.2009.76; Bergsmedh A, 2001, P NATL ACAD SCI USA, V98, P6407, DOI 10.1073/pnas.101129998; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Chung KF, 2001, EUR RESPIR J, V18, p50S, DOI 10.1183/09031936.01.00229701; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; Churg A, 2008, AM J RESP CELL MOL B; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; DEHOUCK B, 1994, J CELL BIOL, V126, P465, DOI 10.1083/jcb.126.2.465; Ferkol T, 2000, AM J RESP CRIT CARE, V161, P944, DOI 10.1164/ajrccm.161.3.9907018; GHITESCU L, 1986, J CELL BIOL, V102, P1304, DOI 10.1083/jcb.102.4.1304; JANOFF A, 1979, SCIENCE, V206, P1313, DOI 10.1126/science.316187; JANOFF A, 1985, AM REV RESPIR DIS, V132, P417; JOHNSON LG, 1989, J APPL PHYSIOL, V66, P2772, DOI 10.1152/jappl.1989.66.6.2772; Kaetzel CS, 2001, CURR BIOL, V11, pR35, DOI 10.1016/S0960-9822(00)00041-5; Levchenko A, 2005, P NATL ACAD SCI USA, V102, P1933, DOI 10.1073/pnas.0401851102; Lockett AD, 2013, AM J RESP CELL MOL, V49, P143, DOI 10.1165/rcmb.2012-0515OC; MILICI AJ, 1987, J CELL BIOL, V105, P2603, DOI 10.1083/jcb.105.6.2603; Mills K, 2001, CLIN CHEM, V47, P2012; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; NEWTON CR, 1988, NUCLEIC ACIDS RES, V16, P8233, DOI 10.1093/nar/16.17.8233; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; OLSEN GN, 1975, J CLIN INVEST, V55, P427, DOI 10.1172/JCI107947; Pasquier J, 2012, J BIOL CHEM, V287, P7374, DOI 10.1074/jbc.M111.312157; Petrache I, 2006, AM J PATHOL, V169, P1155, DOI 10.2353/ajpath.2006.060058; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Presson RG, 2011, AM J PATHOL, V179, P75, DOI 10.1016/j.ajpath.2011.03.048; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; RICHARDSON J, 1976, LAB INVEST, V35, P307; Sherer NM, 2008, TRENDS CELL BIOL, V18, P414, DOI 10.1016/j.tcb.2008.07.003; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sohrab S, 2009, FASEB J, V23, P3149, DOI 10.1096/fj.09-129304; Stevens T, 1999, AM J PHYSIOL-LUNG C, V277, pL119, DOI 10.1152/ajplung.1999.277.1.L119; Stockley RA, 2004, THORAX, V59, P363, DOI 10.1136/thx.2004.023572; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; VAUGHAN L, 1982, BIOCHIM BIOPHYS ACTA, V701, P339, DOI 10.1016/0167-4838(82)90237-0; Vogel LK, 2000, FEBS LETT, V473, P297, DOI 10.1016/S0014-5793(00)01548-9; Vogel SM, 2001, AM J PHYSIOL-LUNG C, V281, pL1512, DOI 10.1152/ajplung.2001.281.6.L1512; Waschbisch A, 2009, J NEUROIMMUNOL, V209, P131, DOI 10.1016/j.jneuroim.2009.02.005; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Yamanouchi H, 1998, EUR RESPIR J, V11, P120, DOI 10.1183/09031936.98.11010120; Zhang QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003097	47	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e93979	10.1371/journal.pone.0093979	http://dx.doi.org/10.1371/journal.pone.0093979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743137	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100022
J	Longinetti, E; Santacatterina, M; El-Khatib, Z				Longinetti, Elisa; Santacatterina, Michele; El-Khatib, Ziad			Gender Perspective of Risk Factors Associated with Disclosure of HIV Status, a Cross-Sectional Study in Soweto, South Africa	PLOS ONE			English	Article							SEROSTATUS DISCLOSURE; ANTIRETROVIRAL TREATMENT; SEXUAL PARTNERS; WOMEN; PREDICTORS; INFECTION; BARRIERS; PEOPLE; STIGMA; BEHAVIOR	Background: Human Immunodeficiency Virus (HIV) status disclosure has been shown to provide several benefits, both at the individual and societal levels. Aim: To determine risk factors associated with disclosing HIV status among antiretroviral therapy (ART) recipients in South Africa. Setting: A cross-sectional study on risk factors for viremia and drug resistance took place at two outpatient HIV clinics in 2008, at a large hospital located in Soweto, South Africa. Methods: We conducted a secondary data analysis on socio-economic characteristics and HIV status disclosure to anyone, focusing on gender differences. Descriptive and multivariable logistic regression analyses were performed to model the associations between risk factors and HIV status disclosure. Additionally, descriptive analysis was conducted to describe gender differences of HIV status disclosure to partner, parents, parents in law, partner, child, family, employer, and other. Patients: A total of 883 patients were interviewed. The majority were women (73%) with median age of 39 years. Results: Employed patients were less likely to disclose than unemployed (odds ratio (OR) 0.36; 95% confidence interval (CI) 0.1-1.0; p = 0.05)). Women with higher income were more likely to disclose (OR 3.25; 95% CI 0.90-11.7; p = 0.07) than women with lower income, while men with higher income were less likely (OR 0.20; 95% CI 0.02-1.99; p = 0.17) than men with lower income. Men were more likely than women to disclose to their partner (p<0.01), and to partner and family (p<0.01), women were more likely than men to disclose to child and family (p<0.01), to child, family and others (p = 0.01). Conclusion: Being employed imposed a risk factor for HIV status disclosure, additionally we found an interaction effect of gender and income on disclosure. Interventions designed to reduce workplace discrimination and gender-sensitive interventions promoting disclosure are strongly recommended.	[Longinetti, Elisa] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Santacatterina, Michele] Karolinska Inst, Inst Environm Med IMM, Biostat Unit, Stockholm, Sweden; [El-Khatib, Ziad] Karolinska Inst, Dept Publ Hlth Sci, Hlth Syst & Policy Res Grp Global Hlth, Stockholm, Sweden; [El-Khatib, Ziad] Univ Quebec Abitibi Temiscamingue, Rouyn Noranda, PQ, Canada	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Quebec; University Quebec Abitibi-Temiscamingue	El-Khatib, Z (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Hlth Syst & Policy Res Grp Global Hlth, Stockholm, Sweden.	ziad.khatib@gmail.com	El-Khatib, Ziad/B-5161-2017; Santacatterina, Michele/AAL-5050-2020	El-Khatib, Ziad/0000-0003-0756-7280; Santacatterina, Michele/0000-0003-0599-3876; El-Khatib, Ziad/0000-0002-0711-5404; Longinetti, Elisa/0000-0002-4789-7172	Karolinska Institutet faculty fund; Swedish International Development Agency; Stanford Fogarty International Collaboration; Sven Gard Foundation for Virology, Stockholm	Karolinska Institutet faculty fund; Swedish International Development Agency; Stanford Fogarty International Collaboration; Sven Gard Foundation for Virology, Stockholm	The original study was funded by a Karolinska Institutet faculty fund (http://ki.se/ki/jsp/polopoly.jsp?d = 13467&l=en), the Swedish International Development Agency (http://www.sida.se/english/), the Stanford Fogarty International Collaboration (http://med.stanford.edu/rmg/funding/internalfunding. html), and the Sven Gard Foundation for Virology, Stockholm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaynew Y, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-8; Akani CI, 2006, TROP DOCT, V36, P87, DOI 10.1258/004947506776593378; Anglewicz P, 2011, AIDS CARE, V23, P998, DOI 10.1080/09540121.2010.542130; [Anonymous], 2014, WORLD AIDS DAY 2014; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Arnold EM, 2008, AIDS CARE, V20, P80, DOI 10.1080/09540120701449138; Asander AS, 2004, INT J SOC WELF, V13, P77, DOI 10.1111/j.1369-6866.2004.00299.x; Berger BE, 2001, RES NURS HEALTH, V24, P518, DOI 10.1002/nur.10011; Bouillon K, 2007, AIDS, V21, pS89, DOI 10.1097/01.aids.0000255091.29050.13; Bunn JY, 2007, AIDS EDUC PREV, V19, P198, DOI 10.1521/aeap.2007.19.3.198; Crepaz N, 2003, AIDS CARE, V15, P379, DOI 10.1080/0954012031000105432; Dageid W, 2012, CULT HEALTH SEX, V14, P925, DOI 10.1080/13691058.2012.710337; Dave SS, 2006, SEX TRANSM INFECT, V82, P117, DOI 10.1136/sti.2005.015396; Deribe K, 2010, SAHARA J-J SOC ASP H, V7, P30, DOI 10.1080/17290376.2010.9724953; Deribe K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-81; Duru OK, 2006, AIDS BEHAV, V10, P495, DOI 10.1007/s10461-006-9089-3; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; Franke MF, 2010, AIDS BEHAV, V14, P189, DOI 10.1007/s10461-008-9474-1; Gielen A C, 2000, Matern Child Health J, V4, P111, DOI 10.1023/A:1009522321240; Jung AC, 1998, J GEN INTERN MED, V13, P131, DOI 10.1046/j.1525-1497.1998.00031.x; Kalichman SC, 1999, HEALTH PSYCHOL, V18, P281, DOI 10.1037/0278-6133.18.3.281; KEOGH P, 1994, SOC SCI MED, V38, P1047, DOI 10.1016/0277-9536(94)90221-6; KING G, 2001, POLITICAL ANAL, V0009; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Kleinbaum D. G., 2002, LOGISTIC REGRESSION; Lemma F, 2007, AIDS 2008 17 INT AID; Lim Vivien K G, 2003, J Occup Health Psychol, V8, P235, DOI 10.1037/1076-8998.8.4.235; MAARTENS G, 2008, SO AFRICAN HIV CLIN; Maman S, 2004, GENDER DIMENSIONS HI; MCGRATH JW, 1993, SOC SCI MED, V36, P429, DOI 10.1016/0277-9536(93)90405-S; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Ndiaye C, 2008, World Health Popul, V10, P43; Niccolai LM, 1999, SEX TRANSM DIS, V26, P281, DOI 10.1097/00007435-199905000-00008; O'Brien ME, 2003, SEX TRANSM DIS, V30, P731, DOI 10.1097/01.OLQ.0000079049.73800.C2; Pagano M, 2000, PRINCIPLE BIOSTATIST; Patel R, 2012, AIDS CARE, V24, P358, DOI 10.1080/09540121.2011.608786; Reda AA, 2013, AIDS CARE, V25, P956, DOI 10.1080/09540121.2012.748868; Rosen Sydney, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P200, DOI 10.1177/1545109708320684; SCHOEPF BG, 1993, SOC SCI MED, V37, P1401, DOI 10.1016/0277-9536(93)90170-9; Skogmar S, 2006, AIDS CARE, V18, P725, DOI 10.1080/09540120500307248; Sowell RL, 2003, HEALTH EDUC RES, V18, P32, DOI 10.1093/her/18.1.32; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Strachan ED, 2007, PSYCHOSOM MED, V69, P74, DOI 10.1097/01.psy.0000249900.34885.46; WHO, 2012, GEND IN HIV; WHO, 2000, OP HIV AIDS EP; Wingood GM, 2000, HEALTH EDUC BEHAV, V27, P539, DOI 10.1177/109019810002700502; Wong LH, 2009, JAIDS-J ACQ IMM DEF, V50, P215, DOI 10.1097/QAI.0b013e3181900172; World Health Organization, 2010, SCAL PRIOR HIV AIDS	50	20	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95440	10.1371/journal.pone.0095440	http://dx.doi.org/10.1371/journal.pone.0095440			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3IK	24743189	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100118
J	Day, CL; Moshi, ND; Abrahams, DA; van Rooyen, M; O'rie, T; de Kock, M; Hanekom, WA				Day, Cheryl L.; Moshi, Noella D.; Abrahams, Deborah A.; van Rooyen, Michele; O'rie, Terrence; de Kock, Marwou; Hanekom, Willem A.			Patients with Tuberculosis Disease Have Mycobacterium tuberculosis-Specific CD8 T Cells with a Pro-Apoptotic Phenotype and Impaired Proliferative Capacity, Which Is Not Restored following Treatment	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ANTIMICROBIAL ACTIVITY; LATENT INFECTION; IFN-GAMMA; CD127 EXPRESSION; MEMORY; LYMPHOCYTES; ANTIGENS; HIV; FREQUENCIES	CD8 T cells play a critical role in control of chronic viral infections; however, the role of these cells in containing persistent bacterial infections, such as those caused by Mycobacterium tuberculosis (Mtb), is less clear. We assessed the phenotype and functional capacity of CD8 T cells specific for the immunodominant Mtb antigens CFP-10 and ESAT-6, in patients with pulmonary tuberculosis (TB) disease, before and after treatment, and in healthy persons with latent Mtb infection (LTBI). In patients with TB disease, CFP-10/ESAT-6-specific IFN-gamma(+) CD8 T cells had an activated, pro-apoptotic phenotype, with lower Bcl-2 and CD127 expression, and higher Ki67, CD57, and CD95 expression, than in LTBI. When CFP-10/ESAT-6-specific IFN-gamma(+) CD8 T cells were detectable, expression of distinct combinations of these markers was highly sensitive and specific for differentiating TB disease from LTBI. Successful treatment of disease resulted in changes of these markers, but not in restoration of CFP-10/ESAT-6-specific CD8 or CD4 memory T cell proliferative capacity. These data suggest that high mycobacterial load in active TB disease is associated with activated, short-lived CFP-10/ESAT-6-specific CD8 T cells with impaired functional capacity that is not restored following treatment. By contrast, LTBI is associated with preservation of long-lived CFP-10/ESAT-6-specific memory CD8 T cells that maintain high Bcl-2 expression and which may readily proliferate.	[Day, Cheryl L.; Moshi, Noella D.; Abrahams, Deborah A.; van Rooyen, Michele; O'rie, Terrence; de Kock, Marwou; Hanekom, Willem A.] Univ Cape Town, SATVI, Observatory, South Africa; [Day, Cheryl L.; Moshi, Noella D.; Abrahams, Deborah A.; van Rooyen, Michele; O'rie, Terrence; de Kock, Marwou; Hanekom, Willem A.] Univ Cape Town, Inst Infect Dis & Mol Med, Sch Child & Adolescent Hlth, Observatory, South Africa; [Day, Cheryl L.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Day, Cheryl L.] Emory Univ, Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Day, Cheryl L.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA	University of Cape Town; University of Cape Town; Emory University; Emory University; Rollins School Public Health; Emory University	Day, CL (corresponding author), Univ Cape Town, SATVI, Observatory, South Africa.	cheryl.day@emory.edu	Day, Cheryl/GQQ-9720-2022; Day, Cheryl L/J-9844-2012	Day, Cheryl L/0000-0002-6497-4846; Hanekom, Willem/0000-0003-3070-6154	National Institute of Allergy and Infectious Diseases at the National Institutes of Health [R01 AI083156]; Emory Center for AIDS Research [P30 AI050409]; KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); Mandela Rhodes Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083156, P30AI050409] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Emory Center for AIDS Research; KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH); Mandela Rhodes Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (grant number R01 AI083156 to C. L. D.); Emory Center for AIDS Research (grant number P30 AI050409); a Collaborative Grant from the KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) to N.D.M.; and a Mandela Rhodes Foundation fellowship to N.D.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2007, INFECT IMMUN, V75, P5210, DOI 10.1128/IAI.00624-07; Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Boudet F, 1996, J IMMUNOL, V156, P2282; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Brookes RH, 2003, EUR J IMMUNOL, V33, P3293, DOI 10.1002/eji.200324109; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Caccamo N, 2006, J IMMUNOL, V177, P1780, DOI 10.4049/jimmunol.177.3.1780; Caccamo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005528; Carranza C, 2006, AM J RESP CRIT CARE, V173, P238, DOI 10.1164/rccm.200503-411OC; Caruso AM, 1999, J IMMUNOL, V162, P5407; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chen CY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000392; Cho S, 2000, P NATL ACAD SCI USA, V97, P12210, DOI 10.1073/pnas.210391497; Crawley AM, 2012, SEMIN IMMUNOL, V24, P231, DOI 10.1016/j.smim.2012.02.006; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; FLORY CM, 1992, J LEUKOCYTE BIOL, V51, P225, DOI 10.1002/jlb.51.3.225; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; Glynn JR, 2010, J INFECT DIS, V201, P704, DOI 10.1086/650529; Golden-Mason L, 2006, HEPATOLOGY, V44, P1098, DOI 10.1002/hep.21365; Govender L, 2010, VACCINE, V29, P51, DOI 10.1016/j.vaccine.2010.10.022; Grayson JM, 2002, J IMMUNOL, V169, P3760, DOI 10.4049/jimmunol.169.7.3760; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hirsch CS, 2005, J CLIN IMMUNOL, V25, P353, DOI 10.1007/s10875-005-4841-4; Hirsch CS, 1999, J INFECT DIS, V179, P945, DOI 10.1086/314667; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kale J, 2012, CELL, V151, P1179, DOI 10.1016/j.cell.2012.11.013; Klein MR, 2001, J INFECT DIS, V183, P928, DOI 10.1086/319267; Kremer L, 2000, INFECT IMMUN, V68, P4264, DOI 10.1128/IAI.68.7.4264-4273.2000; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; LEVETON C, 1989, INFECT IMMUN, V57, P390, DOI 10.1128/IAI.57.2.390-395.1989; Lewinsohn DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067016; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lewinsohn DM, 2001, J IMMUNOL, V166, P439, DOI 10.4049/jimmunol.166.1.439; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Pathan AA, 2000, EUR J IMMUNOL, V30, P2713, DOI 10.1002/1521-4141(200009)30:9<2713::AID-IMMU2713>3.0.CO;2-4; Qiu YQ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002984; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Rozot V, 2013, EUR J IMMUNOL, V43, P1568, DOI 10.1002/eji.201243262; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Shams H, 2004, J IMMUNOL, V173, P1966, DOI 10.4049/jimmunol.173.3.1966; Shin H, 2007, CURR OPIN IMMUNOL, V19, P408, DOI 10.1016/j.coi.2007.06.004; Slyker JA, 2012, J VIROL, V86, P11373, DOI 10.1128/JVI.00790-12; Smith SM, 2000, INFECT IMMUN, V68, P7144, DOI 10.1128/IAI.68.12.7144-7148.2000; Sousa AO, 2000, P NATL ACAD SCI USA, V97, P4204, DOI 10.1073/pnas.97.8.4204; Stegelmann F, 2005, J IMMUNOL, V175, P7474, DOI 10.4049/jimmunol.175.11.7474; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Tang ST, 2011, J IMMUNOL, V186, P1068, DOI 10.4049/jimmunol.1002212; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Vasconcelos JR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002699; Wang XTZ, 2003, IMMUNITY, V18, P631, DOI 10.1016/S1074-7613(03)00116-X; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Yi JS, 2010, IMMUNOLOGY, V129, P474, DOI 10.1111/j.1365-2567.2010.03255.x; YOSHINO T, 1994, BLOOD, V83, P1856; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010	70	31	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94949	10.1371/journal.pone.0094949	http://dx.doi.org/10.1371/journal.pone.0094949			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740417	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900085
J	Eakin, K; Baratz-Goldstein, R; Pick, CG; Zindel, O; Balaban, CD; Hoffer, ME; Lockwood, M; Miller, J; Hoffer, BJ				Eakin, Katharine; Baratz-Goldstein, Renana; Pick, Chiam G.; Zindel, Ofra; Balaban, Carey D.; Hoffer, Michael E.; Lockwood, Megan; Miller, Jonathan; Hoffer, Barry J.			Efficacy of N-Acetyl Cysteine in Traumatic Brain Injury	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; COGNITIVE DEFICITS; ACETYLCYSTEINE; MODEL; STRESS; ACID	In this study, using two different injury models in two different species, we found that early post-injury treatment with N-Acetyl Cysteine (NAC) reversed the behavioral deficits associated with the TBI. These data suggest generalization of a protocol similar to our recent clinical trial with NAC in blast-induced mTBI in a battlefield setting [1], to mild concussion from blunt trauma. This study used both weight drop in mice and fluid percussion injury in rats. These were chosen to simulate either mild or moderate traumatic brain injury (TBI). For mice, we used novel object recognition and the Y maze. For rats, we used the Morris water maze. NAC was administered beginning 30-60 minutes after injury. Behavioral deficits due to injury in both species were significantly reversed by NAC treatment. We thus conclude NAC produces significant behavioral recovery after injury. Future preclinical studies are needed to define the mechanism of action, perhaps leading to more effective therapies in man.	[Eakin, Katharine; Lockwood, Megan; Miller, Jonathan; Hoffer, Barry J.] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA; [Baratz-Goldstein, Renana; Pick, Chiam G.; Zindel, Ofra] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Balaban, Carey D.] Univ Pittsburgh, Dept Otolaryngol Neurobiol Commun Sci & Disorders, Pittsburgh, PA 15260 USA; [Hoffer, Michael E.] Naval Med Ctr San Diego, Dept Otolaryngol, Spatial Orientat Ctr, San Diego, CA USA; [Hoffer, Barry J.] Taipei Med Univ, Grad Program Neuroregenerat, Taipei, Taiwan	Case Western Reserve University; Tel Aviv University; Sackler Faculty of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Defense; United States Navy; Naval Medical Center San Diego; Taipei Medical University	Hoffer, BJ (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH 44106 USA.	barry.hoffer@case.edu	Balaban, Carey/O-6586-2019; Balaban, Carey/I-3467-2017	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Miller, Jonathan/0000-0001-5441-1751	Lincoln Master Clinician in Neurosurgery Award [USPHS] [NS070825]; National Science Council of Taiwan [NSC98-2314-B-038-011-MY3, NSC101-2321-B-038-005]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070825] Funding Source: NIH RePORTER	Lincoln Master Clinician in Neurosurgery Award [USPHS]; National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Lincoln Master Clinician in Neurosurgery Award to JM, [USPHS grant #NS070825]; and the National Science Council of Taiwan [#NSC98-2314-B-038-011-MY3], [NSC101-2321-B-038-005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Bergold P, 2012, J NEUROTRAUM, V29, pA109; Chen G, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/716458; Comper P, 2005, BRAIN INJURY, V19, P863, DOI 10.1080/02699050400025042; Cuzzocrea S, 2000, BRIT J PHARMACOL, V130, P1219, DOI 10.1038/sj.bjp.0703421; De Vries H, 1996, PHARMACOL REV, V49, P143; Dix SL, 1999, BEHAV BRAIN RES, V99, P191, DOI 10.1016/S0166-4328(98)00079-5; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Duarte JMD, 2012, BIOL PSYCHIAT, V71, P1006, DOI 10.1016/j.biopsych.2011.07.035; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Farr SA, 2003, J NEUROCHEM, V84, P1173, DOI 10.1046/j.1471-4159.2003.01580.x; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Franzblau M, 2013, MED HYPOTHESES, V81, P842, DOI 10.1016/j.mehy.2013.09.012; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Hart AM, 2004, NEUROSCIENCE, V125, P91, DOI 10.1016/j.neuroscience.2003.12.040; Hicdonmez T, 2006, NEUROCHEM RES, V31, P473, DOI 10.1007/s11064-006-9040-z; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Khan M, 2004, J NEUROSCI RES, V76, P519, DOI 10.1002/jnr.20087; Lante F, 2008, HIPPOCAMPUS, V18, P602, DOI 10.1002/hipo.20421; Lappas M, 2003, J CLIN ENDOCR METAB, V88, P1723, DOI 10.1210/jc.2002-021677; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Pahan K, 1998, FREE RADICAL BIO MED, V24, P39, DOI 10.1016/S0891-5849(97)00137-8; Prabhu A, 2009, ANN VASC SURG, V23, P645, DOI 10.1016/j.avsg.2008.12.005; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Santangelo F, 2003, CURR MED CHEM, V10, P2599, DOI 10.2174/0929867033456567; Sekhon B, 2003, BRAIN RES, V971, P1, DOI 10.1016/S0006-8993(03)02244-3; Stipanuk MH, 2006, J NUTR, V136, p1652S, DOI 10.1093/jn/136.6.1652S; Tang Y, 1997, P NATL ACAD SCI USA, V94, P12667, DOI 10.1073/pnas.94.23.12667; Tsai SY, 2009, P NATL ACAD SCI USA, V106, P22468, DOI 10.1073/pnas.0909089106; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; West CA, 2007, ACTA NEUROCHIR SUPPL, V100, P29; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	40	69	71	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e90617	10.1371/journal.pone.0090617	http://dx.doi.org/10.1371/journal.pone.0090617			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740427	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000336863900004
J	Fernando, B; Morrison, Z; Kalra, D; Cresswell, K; Sheikh, A				Fernando, Bernard; Morrison, Zoe; Kalra, Dipak; Cresswell, Kathrin; Sheikh, Aziz			Approaches to Recording Drug Allergies in Electronic Health Records: Qualitative Study	PLOS ONE			English	Article							PREVENTION; MANAGEMENT; HOSPITALS; MEDICINE; CARE	Background: Drug allergy represent an important subset of adverse drug reactions that is worthy of attention because many of these reactions are potentially preventable with use of computerised decision support systems. This is however dependent on the accurate and comprehensive recording of these reactions in the electronic health record. The objectives of this study were to understand approaches to the recording of drug allergies in electronic health record systems. Materials and Methods: We undertook a case study comprising of 21 in-depth interviews with a purposefully selected group of primary and secondary care clinicians, academics, and members of the informatics and drug regulatory communities, observations in four General Practices and an expert group discussion with 15 participants from the Allergy and Respiratory Expert Resource Group of the Royal College of General Practitioners. Results: There was widespread acceptance among healthcare professionals of the need for accurate recording of drug allergies and adverse drug reactions. Most drug reactions were however likely to go unreported to and/or unrecognised by healthcare professionals and, even when recognised and reported, not all reactions were accurately recorded. The process of recording these reactions was not standardised. Conclusions: There is considerable variation in the way drug allergies are recorded in electronic health records. This limits the potential of computerised decision support systems to help alert clinicians to the risk of further reactions. Inaccurate recording of information may in some instances introduce new problems as patients are denied treatments that they are erroneously believed to be allergic to.	[Fernando, Bernard; Morrison, Zoe; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, EHlth Res Grp, Edinburgh, Midlothian, Scotland; [Kalra, Dipak] UCL, Ctr Hlth Informat & Multiprofess Educ, London, England; [Cresswell, Kathrin] Univ Edinburgh, Sch Hlth Social Sci, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland; [Sheikh, Aziz] Harvard Univ, Sch Med, Boston, MA USA; [Sheikh, Aziz] Harvard Univ, Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, Sch Med, Boston, MA 02115 USA	University of Edinburgh; University of London; University College London; University of Edinburgh; University of Edinburgh; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, EHlth Res Grp, Edinburgh, Midlothian, Scotland.	Aziz.Sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009; Kalra, D/H-6661-2019	Sheikh, Aziz/0000-0001-7022-3056; Kalra, D/0000-0001-5254-4067	Medical Research Council [MR/K006584/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aronson JK, 2003, BRIT MED J, V327, P1222, DOI 10.1136/bmj.327.7425.1222; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Catwell L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000126; Coiera E, 2004, BRIT MED J, V328, P1197, DOI 10.1136/bmj.328.7449.1197; Coleman J, 2010, EPRESCRIBING DECISIO; CORNFORD T, 1994, OMEGA-INT J MANAGE S, V22, P491, DOI 10.1016/0305-0483(94)90030-2; Cresswell K, 2013, INT J MED INFORM, V82, pE73, DOI 10.1016/j.ijmedinf.2012.10.007; Cresswell KM, 2008, J ALLERGY CLIN IMMUN, V121, P1112, DOI 10.1016/j.jaci.2007.12.1180; Crowe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-100; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; Demoly P, 1999, ALLERGY, V54, P999, DOI 10.1034/j.1398-9995.1999.00247.x; DOH RCGP BMA, 2011, GOOD PRACT GUID GP E, Vv4; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Hug BL, 2010, J GEN INTERN MED, V25, P31, DOI 10.1007/s11606-009-1141-3; Jha AK, 2011, NEW ENGL J MED, V365, P1756, DOI 10.1056/NEJMp1109398; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Kohane IS, 2012, NEW ENGL J MED, V367, P2538, DOI 10.1056/NEJMe1213371; Microsoft, 2009, DES GUID DISPL ADV D; Microsoft, 2010, DISPL CLIN STAT DES; Mirakian R, 2009, CLIN EXP ALLERGY, V39, P43, DOI 10.1111/j.1365-2222.2008.03155.x; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Simpson CR, 2007, CLIN EXP ALLERGY, V37, P1586, DOI 10.1111/j.1365-2222.2007.02830.x; Tsang C, 2011, FAM PRACT	25	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93047	10.1371/journal.pone.0093047	http://dx.doi.org/10.1371/journal.pone.0093047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740090	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900016
J	Wojcik, J; Schwabedal, J; Clewley, R; Shilnikov, AL				Wojcik, Jeremy; Schwabedal, Justus; Clewley, Robert; Shilnikov, Andrey L.			Key Bifurcations of Bursting Polyrhythms in 3-Cell Central Pattern Generators	PLOS ONE			English	Article							SYNCHRONIZATION; OSCILLATORS; PLASTICITY; PRINCIPLES; NETWORKS; CIRCUITS; ROLES	We identify and describe the key qualitative rhythmic states in various 3-cell network motifs of a multifunctional central pattern generator (CPG). Such CPGs are neural microcircuits of cells whose synergetic interactions produce multiple states with distinct phase-locked patterns of bursting activity. To study biologically plausible CPG models, we develop a suite of computational tools that reduce the problem of stability and existence of rhythmic patterns in networks to the bifurcation analysis of fixed points and invariant curves of a Poincare return maps for phase lags between cells. We explore different functional possibilities for motifs involving symmetry breaking and heterogeneity. This is achieved by varying coupling properties of the synapses between the cells and studying the qualitative changes in the structure of the corresponding return maps. Our findings provide a systematic basis for understanding plausible biophysical mechanisms for the regulation of rhythmic patterns generated by various CPGs in the context of motor control such as gait-switching in locomotion. Our analysis does not require knowledge of the equations modeling the system and provides a powerful qualitative approach to studying detailed models of rhythmic behavior. Thus, our approach is applicable to a wide range of biological phenomena beyond motor control.	[Wojcik, Jeremy] Appl Technol Associates, Albuquerque, NM USA; [Schwabedal, Justus; Clewley, Robert; Shilnikov, Andrey L.] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA; [Clewley, Robert; Shilnikov, Andrey L.] Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA; [Shilnikov, Andrey L.] Lobachevsky State Univ Nizhni Novgorod, Dept Computat Math & Cybernet, Nizhnii Novgorod, Russia	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Lobachevsky State University of Nizhni Novgorod	Shilnikov, AL (corresponding author), Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA.	ashilnikov@gsu.edu	shilnikov, andrey/AAX-5100-2020	shilnikov, andrey/0000-0002-4879-4327	DFG [SCHW 1685/1-1]; National Science Foundation (NSF) [DMS-1009591]; MESRF [14.740.11.0919]; RFFI [11-01-00001]; GSU Brains and Behavior Program; Direct For Mathematical & Physical Scien [1009591] Funding Source: National Science Foundation	DFG(German Research Foundation (DFG)); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); MESRF; RFFI(Russian Foundation for Basic Research (RFBR)); GSU Brains and Behavior Program; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	JS was supported by the DFG (SCHW 1685/1-1). The Ph.D. studies of JW were funded by National Science Foundation (NSF) grant DMS-1009591. AS was in part supported by NSF grant DMS-1009591, MESRF project 14.740.11.0919, RFFI 11-01-00001 as well as the GSU Brains and Behavior Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwin P, 2008, PHYSICA D, V237, P454, DOI 10.1016/j.physd.2007.09.015; BAL T, 1988, J COMP PHYSIOL A, V163, P715, DOI 10.1007/BF00604049; Belykh I, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.188101; Belykh I, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.078102; Best J, 2005, SIAM J APPL DYN SYST, V4, P1107, DOI 10.1137/050625540; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; BULLOCH AGM, 1992, TRENDS NEUROSCI, V15, P422, DOI 10.1016/0166-2236(92)90004-R; Calabrese RL, 2011, INTEGR COMP BIOL, V51, P845, DOI 10.1093/icb/icr074; Calin-Jageman RJ, 2007, J NEUROPHYSIOL, V98, P2382, DOI 10.1152/jn.00572.2007; CANAVIER CC, 1994, J NEUROPHYSIOL, V72, P872, DOI 10.1152/jn.1994.72.2.872; Clewley R, 2006, PYDSTOOL INTEGRATED; Clewley R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002628; Dror R, 1999, BIOL CYBERN, V80, P11, DOI 10.1007/s004220050501; Frost WN, 1996, P NATL ACAD SCI USA, V93, P422, DOI 10.1073/pnas.93.1.422; Jahl S, 2010, PHYS REV E, V81; Jalil S, 2013, J CHAOS, V6; Jalil S, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.036214; Katz PS, 2007, COLD SPRING HARB MON, V49, P251; Koch H, 2011, INTEGR COMP BIOL, V51, P856, DOI 10.1093/icb/icr099; Kopell N, 2004, P NATL ACAD SCI USA, V101, P15482, DOI 10.1073/pnas.0406343101; Kopell N, 1988, NEURAL CONTROL RHYTH; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; KRISTAN WB, 1976, J EXP BIOL, V65, P643; Kristan WB, 2008, CURR BIOL, V18, pR928, DOI 10.1016/j.cub.2008.07.081; Lamb Damon G, 2011, Neural Syst Circuits, V1, P13, DOI 10.1186/2042-1001-1-13; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MARDER E, 1994, CURR BIOL, V4, P752, DOI 10.1016/S0960-9822(00)00169-X; Marder E, 2012, NEURON, V76, P1, DOI 10.1016/j.neuron.2012.09.010; Masino MA, 2002, J NEUROPHYSIOL, V87, P1603, DOI 10.1152/jn.00338.2001; Masino MA, 2002, J NEUROPHYSIOL, V87, P1572, DOI 10.1152/jn.00336.2001; Matsuoka K, 1987, BIOL CYBERN, V1, P1; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newcomb JM, 2012, P NATL ACAD SCI USA, V109, P10669, DOI 10.1073/pnas.1201877109; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; Rabinovich MI, 2006, REV MOD PHYS, V78, P1213, DOI 10.1103/RevModPhys.78.1213; Rubin J, 2000, NEURAL COMPUT, V12, P597, DOI 10.1162/089976600300015727; Rubin JE, 2012, J MATH NEUROSCI, V2, DOI 10.1186/2190-8567-2-4; Sakurai A, 2011, CURR BIOL, V21, P1036, DOI 10.1016/j.cub.2011.04.040; Schultheiss B, 2012, PHASE RESPONSE CURVE; Selverston AI, 1985, MODEL NEURAL NETWORK; Sherwood WE, 2011, J COMPUT NEUROSCI, V30, P323, DOI 10.1007/s10827-010-0259-y; Shilnikov A, 2004, INT J BIFURCAT CHAOS, V14, P2143, DOI 10.1142/S0218127404010539; SHILNIKOV A, 2012, J NONLINEAR DYNAMICS, V68, P305; Shilnikov A, 2008, CHAOS, V18, DOI 10.1063/1.2959850; Shilnikov L.P., 1998, METHODS QUALITATIV 1; Shilnikov LP, 2001, METHODS QUALITATIV 2; Skinner F K, 1994, J Comput Neurosci, V1, P69, DOI 10.1007/BF00962719; Skinner FK, 1999, J NEUROPHYSIOL, V81, P1274, DOI 10.1152/jn.1999.81.3.1274; SOMERS D, 1993, BIOL CYBERN, V68, P393, DOI 10.1007/BF00198772; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Van Vreeswijk C, 1994, J Comput Neurosci, V1, P313; Wojcik J, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056209	53	44	44	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e92918	10.1371/journal.pone.0092918	http://dx.doi.org/10.1371/journal.pone.0092918			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24739943	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900013
J	Chen, LH; Wang, PH; Yang, YJ; He, J				Chen, Lihua; Wang, Pinghua; Yang, Yuanjun; He, Jia			Constitutive Model of Single Root System's Resistance to Tensile Stress - Taking Pinus tabulaeformis, Betula platyphylla, Quercus mongolica and Larix gmelinii as Experimental Objects	PLOS ONE			English	Article							REINFORCEMENT; SOIL; STRENGTH	A constitutive model for the stress-strain relationship of single forest root system was developed in order to provide theoretical foundations for the mechanisms of soil-reinforcement by root system and offer a reliable basis for the analysis of root tensile strength character. This study started a general form of linear and non-linear stress-strain relation that was mathematically defined by four boundary conditions observed in typical tensile tests of single roots. The parameters of the model were determined by experiment data and had definite physical meaning. The model was verified by experiment data, which showed that the calculated values were in good agreement with the experimental single root tensile test results. The constitutive model was validated and found to be feasible for modeling single root tensile stress.	[Chen, Lihua; Wang, Pinghua; Yang, Yuanjun; He, Jia] Beijing Forest Univ, Key Lab Soil & Water Conservat & Desertificat Com, Minist Educ, Sch Water & Soil Conservat, Beijing, Peoples R China	Beijing Forestry University	Chen, LH (corresponding author), Beijing Forest Univ, Key Lab Soil & Water Conservat & Desertificat Com, Minist Educ, Sch Water & Soil Conservat, Beijing, Peoples R China.	c_lihua@bjfu.edu.cn			Project of Study and Demonstration of Construction Technology on Water Conservation Forest System in Three-North Area [2011BAD38B05]; National Natural Science Foundation of China [30872067, 30901162]; Ministry of Education of China [20090014110002]	Project of Study and Demonstration of Construction Technology on Water Conservation Forest System in Three-North Area; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This study was funded by Project of Study and Demonstration of Construction Technology on Water Conservation Forest System in Three-North Area (No. 2011BAD38B05); National Natural Science Foundation of China (No. 30872067; No. 30901162) and Doctoral Fund of Ministry of Education of China (No. 20090014110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L. H., 2008, MECH ROOT SOIL; [陈丽华 CHEN Lihua], 2007, [山地学报, Journal of Mountain Science], V25, P224; [程洪 CHENG Hong], 2006, [水土保持通报, Bulletin of Soil and Water Conservation], V26, P97; Cofie P, 2001, SOIL TILL RES, V63, P51, DOI 10.1016/S0167-1987(01)00225-2; De Baets S, 2008, PLANT SOIL, V305, P207, DOI 10.1007/s11104-008-9553-0; Hubble TCT, 2010, ECOL ENG, V36, P292, DOI 10.1016/j.ecoleng.2009.04.006; Ji JN, 2012, CATENA, V92, P139, DOI 10.1016/j.catena.2011.12.008; Liu XP, 2006, SCI SOIL WATER CONSE, V4, P66, DOI [10.3969/j.issn.1672-3007.2006.02.012, DOI 10.3969/J.ISSN.1672-3007.2006.02.012]; Mickovski SB, 2009, SOIL SCI SOC AM J, V73, P1276, DOI 10.2136/sssaj2008.0172; Pollen N, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003801; Schwarz M, 2010, ECOL ENG, V36, P285, DOI 10.1016/j.ecoleng.2009.06.014; Song WF, 2007, J SW FORESTRY COLL, V27, P8, DOI [10.3969/j.issn.2095-1914.2007.05.003, DOI 10.3969/J.ISSN.2095-1914.2007.05.003]; Stokes A, 2008, SLOPE STABILITY EROS, P65, DOI [DOI 10.1007/978-1-4020-6676-4_4, 10.1007/978-1-4020-6676-4_4]; Thorne CR., 1990, VEGETATION EROSION, P125; Tosi M, 2007, GEOMORPHOLOGY, V87, P268, DOI 10.1016/j.geomorph.2006.09.019; WU TH, 1995, WATER RESOUR RES, V31, P2097; Wu TH, 2007, DEV PLANT SOIL SCI, V103, P21	17	4	4	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93066	10.1371/journal.pone.0093066	http://dx.doi.org/10.1371/journal.pone.0093066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736724	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600014
J	Chen, SY; Ye, T; Hao, L; Chen, H; Wang, SJ; Fan, ZF; Guo, LY; Zhou, T				Chen, Shanyi; Ye, Ting; Hao, Lu; Chen, Hui; Wang, Shaojie; Fan, Zaifeng; Guo, Liyun; Zhou, Tao			Infection of Apple by Apple Stem Grooving Virus Leads to Extensive Alterations in Gene Expression Patterns but No Disease Symptoms	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; NICOTIANA-BENTHAMIANA; SUBGENOMIC RNAS; RESPONSES; GENOME; TRANSCRIPTION; GRAPEVINE; TISSUES; COMMON	To understand the molecular basis of viral diseases, transcriptome profiling has been widely used to correlate host gene expression change patterns with disease symptoms during viral infection in many plant hosts. We used infection of apple by Apple stem grooving virus (ASGV), which produces no disease symptoms, to assess the significance of host gene expression changes in disease development. We specifically asked the question of whether such asymptomatic infection is attributed to limited changes in host gene expression. Using RNA-seq, we identified a total of 184 up-regulated and 136 down-regulated genes in apple shoot cultures permanently infected by ASGV in comparison with virus-free shoot cultures. As in most plant hosts showing disease symptoms during viral infection, these differentially expressed genes encode known or putative proteins involved in cell cycle, cell wall biogenesis, response to biotic and abiotic stress, development and fruit ripening, phytohormone function, metabolism, signal transduction, transcription regulation, translation, transport, and photosynthesis. Thus, global host gene expression changes do not necessarily lead to virus disease symptoms. Our data suggest that the general approaches to correlate host gene expression changes under viral infection conditions to specific disease symptom, based on the interpretation of transcription profiling data and altered individual gene functions, may have limitations depending on particular experimental systems.	[Zhou, Tao] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Zhou, T (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	taozhoucau@cau.edu.cn		Guo, Li-yun/0000-0002-1688-5726	Earmarked Fund for Modern Agro-industry Technology Research System [CARS-28]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]; Special Fund for Agro-Scientific Research in the Public Interest [201203076-02]	Earmarked Fund for Modern Agro-industry Technology Research System; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Special Fund for Agro-Scientific Research in the Public Interest	This research was supported by the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-28), Program for Changjiang Scholars and Innovative Research Team in University (IRT1042) and Special Fund for Agro-Scientific Research in the Public Interest ( No. 201203076-02) administered by the Chinese Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Romero P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-92; Allie F, 2013, EUR J PLANT PATHOL, V137, P765, DOI 10.1007/s10658-013-0286-4; Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Babu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-325; Baebler S, 2009, MOL PLANT PATHOL, V10, P263, DOI 10.1111/j.1364-3703.2008.00530.x; Benjamini Y, 2001, ANN STAT, V29, P1165; Cembali T, 2003, CROP PROT, V22, P1149, DOI 10.1016/S0261-2194(03)00156-X; Chen ZR, 2008, MOL PLANT PATHOL, V9, P809, DOI 10.1111/J.1364-3703.2008.00505.X; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Espinoza C, 2007, FUNCT INTEGR GENOMIC, V7, P95, DOI 10.1007/s10142-006-0031-6; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Gambino G, 2012, J EXP BOT, V63, P5919, DOI 10.1093/jxb/ers244; Hanssen IM, 2011, PLANT PHYSIOL, V156, P301, DOI 10.1104/pp.111.173906; Hirata H, 2003, J GEN VIROL, V84, P2579, DOI 10.1099/vir.0.19179-0; Itaya A, 2002, MOL PLANT MICROBE IN, V15, P990, DOI 10.1094/MPMI.2002.15.10.990; Jia MA, 2012, MOL PLANT PATHOL, V13, P251, DOI 10.1111/j.1364-3703.2011.00743.x; King AMQ, 2012, VIRUS TAXONOMY CLASS, P931; Komatsu K, 2012, VIRUS RES, V167, P8, DOI 10.1016/j.virusres.2012.02.019; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu JZ, 2013, PLANT J, V74, P110, DOI 10.1111/tpj.12108; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Marathe R, 2004, PLANT MOL BIOL, V55, P501, DOI 10.1007/s11103-004-0439-0; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OHIRA K, 1995, J GEN VIROL, V76, P2305, DOI 10.1099/0022-1317-76-9-2305; PLESE N, 1975, Phytopathologische Zeitschrift, V82, P315; Satoh K, 2010, J GEN VIROL, V91, P294, DOI 10.1099/vir.0.015990-0; Shimizu T, 2007, MOL PLANT MICROBE IN, V20, P247, DOI 10.1094/MPMI-20-3-0247; Shimizu T, 2009, ARCH VIROL, V154, P959, DOI 10.1007/s00705-009-0397-6; Tatineni S, 2009, VIROLOGY, V385, P521, DOI 10.1016/j.virol.2008.12.024; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; WANG MC, 1999, INTEGRATING RESULTS; Wen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073725; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Yanase H., 1983, ACTA HORTIC, V130, P117, DOI DOI 10.17660/ACTAHORTIC.1983.130.20; Yang CL, 2007, MOL PLANT MICROBE IN, V20, P358, DOI 10.1094/MPMI-20-4-0358; YOSHIKAWA N, 1992, VIROLOGY, V191, P98, DOI 10.1016/0042-6822(92)90170-T	39	18	20	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95239	10.1371/journal.pone.0095239	http://dx.doi.org/10.1371/journal.pone.0095239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736405	Green Submitted, Green Published, gold			2022-12-25	WOS:000336922600161
J	Ilie, G; Mann, RE; Boak, A; Adlaf, EM; Hamilton, H; Asbridge, M; Rehm, J; Cusimano, MD				Ilie, Gabriela; Mann, Robert E.; Boak, Angela; Adlaf, Edward M.; Hamilton, Hayley; Asbridge, Mark; Rehm, Juergen; Cusimano, Michael D.			Suicidality, Bullying and Other Conduct and Mental Health Correlates of Traumatic Brain Injury in Adolescents	PLOS ONE			English	Article							RISK BEHAVIOR; CHILDREN; SCHOOL; QUESTIONNAIRE-12; CONCUSSION; SYMPTOMS; VALIDITY	Objective: Our knowledge on the adverse correlates of traumatic brain injuries (TBI), including non-hospitalized cases, among adolescents is limited to case studies. We report lifetime TBI and adverse mental health and conduct behaviours associated with TBI among adolescents from a population-based sample in Ontario. Method and Findings: Data were derived from 4,685 surveys administered to adolescents in grades 7 through 12 as part of the 2011 population-based cross-sectional Ontario Student Drug Use and Health Survey (OSDUHS). Lifetime TBI was defined as head injury that resulted in being unconscious for at least 5 minutes or being retained in the hospital for at least one night, and was reported by 19.5% (95% CI: 17.3,21.9) of students. When holding constant sex, grade, and complex sample design, students with TBI had significantly greater odds of reporting elevated psychological distress (AOR = 1.52), attempting suicide (AOR = 3.39), seeking counselling through a crisis help-line (AOR = 2.10), and being prescribed medication for anxiety, depression, or both (AOR = 2.45). Moreover, students with TBI had higher odds of being victimized through bullying at school (AOR = 1.70), being cyber-bullied (AOR = 2.05), and being threatened with a weapon at school (AOR = 2.90), compared with students who did not report TBI. Students with TBI also had higher odds of victimizing others and engaging in numerous violent as well as nonviolent conduct behaviours. Conclusions: Significant associations between TBI and adverse internalizing and externalizing behaviours were found in this large population-based study of adolescents. Those who reported lifetime TBI were at a high risk for experiencing mental and physical health harms in the past year than peers who never had a head injury. Primary physicians should be vigilant and screen for potential mental heath and behavioural harms in adolescent patients with TBI. Efforts to prevent TBI during adolescence and intervene at an early stage may reduce injuries and comorbid problems in this age group.	[Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Mann, Robert E.; Boak, Angela; Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Adlaf, Edward M.; Hamilton, Hayley; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mann, Robert E.; Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Mann, Robert E.; Asbridge, Mark] Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Dalhousie University; Dalhousie University	Ilie, G (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Cusimano, Michael/X-4059-2019; Ilie, Gabriela/AAM-9122-2021; Cusimano, Michael/GWR-1025-2022; Ilie, Gabriela/J-6066-2014	Ilie, Gabriela/0000-0002-1602-6374	Canadian Institute of Health Research (CIHR)'s Team Grant in Traumatic Brain Injury and Violence [FRN: 103946]; Ontario Neurotrauma Foundation; AUTO21, a member of the Networks of Centres of Excellence program; Natural Sciences and Engineering Research Council; Social Sciences and Humanities Research Council; Industry Canada; Ontario Ministry of Health and Long-Term Care	Canadian Institute of Health Research (CIHR)'s Team Grant in Traumatic Brain Injury and Violence(Canadian Institutes of Health Research (CIHR)); Ontario Neurotrauma Foundation; AUTO21, a member of the Networks of Centres of Excellence program; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Industry Canada; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This work was financially supported by the Canadian Institute of Health Research (CIHR)'s Team Grant in Traumatic Brain Injury and Violence (FRN: 103946) and by the Ontario Neurotrauma Foundation. Additional funding was obtained from a grant from AUTO21, a member of the Networks of Centres of Excellence program that is administered and funded by the Natural Sciences and Engineering Research Council, the Social Sciences and Humanities Research Council, in partnership with Industry Canada, and ongoing funding support from the Ontario Ministry of Health and Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, JAMA-J AM MED ASSOC, V308, P2327; Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Baguley IJ, 2006, J HEAD TRAUMA REHAB, V21, P45, DOI 10.1097/00001199-200601000-00005; Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Dicker BG, 1989, HEAD TRAUMA REHABIL, V4, P73; Dooley JJ, 2008, BRAIN INJURY, V22, P836, DOI 10.1080/02699050802425444; Due P, 2005, EUR J PUBLIC HEALTH, V15, P128, DOI 10.1093/eurpub/cki105; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Finkelstein E., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; FRANCES ALLEN, 2000, DSM 4 CLASSIFICATION; French DJ, 2004, EUR CHILD ADOLES PSY, V13, P1, DOI 10.1007/s00787-004-0345-7; Gainer RB, ATTEMPTED SUICIDE IS; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Hux D, 1998, BRAIN INJURY, V12, P667; Ilie G, MENTAL HLTH SU UNPUB; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Laird RD, 2005, DEV PSYCHOPATHOL, V17, P127, DOI 10.1017/S0954579405050078; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; May A, 2011, ASSESSMENT, V18, P379, DOI 10.1177/1073191110374285; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Paglia-Boak A., 2011, CAMH RES DOCUMENT SE, V32; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Public Health Canada, 2011, BULL PREV SCH; Sharp NL, 2006, DISABIL REHABIL, V28, P767, DOI 10.1080/09638280500386668; Simpson G, 2005, J NERV MENT DIS, V193, P680, DOI 10.1097/01.nmd.0000180743.65943.c8; Tait RJ, 2003, AUST NZ J PSYCHIAT, V37, P374, DOI 10.1046/j.1440-1614.2003.01133.x; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Tate RL, 2004, BRAIN INJURY OUTCOME; Tonks J, 2010, NEUROPSYCHOL REHABIL, V20, P922, DOI 10.1080/09602011.2010.519209; Willer B, 2004, INJURY PREV, V10, P144, DOI 10.1136/ip.2003.005017	37	51	51	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94936	10.1371/journal.pone.0094936	http://dx.doi.org/10.1371/journal.pone.0094936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736613	gold, Green Published			2022-12-25	WOS:000336922600110
J	Zhang, XR; Zhang, J; Li, W; Liu, L; Sun, BS; Guo, ZH; Shi, CH; Zhao, YQ				Zhang, Xiangrong; Zhang, Ji; Li, Wei; Liu, Li; Sun, Baoshan; Guo, Zhenghong; Shi, Caihong; Zhao, Yuqing			In Vitro Metabolism of 20(R)-25-Methoxyl-Dammarane-3, 12, 20-Triol from Panax notoginseng in Human, Monkey, Dog, Rat, and Mouse Liver Microsomes	PLOS ONE			English	Article							NATURAL-PRODUCT; CANCER; 20(S)-25-METHOXYL-DAMMARANE-3-BETA; 12-BETA; PLASMA	In The present study characterized in vitro metabolites of 20(R)-25-methoxyl-dammarane-3 beta, 12 beta, 20-triol (20(R)-25-OCH3-PPD) in mouse, rat, dog, monkey and human liver microsomes. 20(R)-25-OCH3-PPD was incubated with liver microsomes in the presence of NADPH. The reaction mixtures and the metabolites were identified on the basis of their mass profiles using LC-Q/TOF and were quantified using triple quadrupole instrument by multiple reaction monitoring. A total of 7 metabolites (M1-M7) of the phase I metabolites were detected in all species. 25(R)-OCH3-PPD was metabolized by hydroxylation, dehydrogenation, and O-demethylation. Enzyme kinetic of 20(R)-25-OCH3-PPD metabolism was evaluated in rat and human hepatic microsomes. Incubations studies with selective chemical inhibitors demonstrated that the metabolism of 20(R)-25-OCH3-PPD was primarily mediated by CYP3A4. We conclude that 20(R)-25-OCH3-PPD was metabolized extensively in mammalian species of mouse, rat, dog, monkey, and human. CYP3A4-catalyzed oxygenation metabolism played an important role in the disposition of 25(R)-OCH3-PPD, especially at the C-20 hydroxyl group.	[Zhang, Xiangrong; Li, Wei; Sun, Baoshan; Guo, Zhenghong; Shi, Caihong; Zhao, Yuqing] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Shenyang, Liaoning, Peoples R China; [Zhang, Ji; Liu, Li] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China; [Zhao, Yuqing] Shenyang Pharmaceut Univ, Key Lab Res & Design, Drug Targets Based Minist Educ, Shenyang, Liaoning, Peoples R China	Shenyang Pharmaceutical University; China Pharmaceutical University; Shenyang Pharmaceutical University	Zhao, YQ (corresponding author), Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Shenyang, Liaoning, Peoples R China.	yuqingzhao@syphu.edu.cn	Sun, Baoshan/B-9196-2016	Sun, Baoshan/0000-0002-9762-3313	National Science and Technology Major Project; Key New Drug Creation and Manufacturing Program [2009ZX09102-114]; National Nature Science Foundation of China [81273389, 81302662]; Liaoning Province Education Administration [L2012364]	National Science and Technology Major Project; Key New Drug Creation and Manufacturing Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Liaoning Province Education Administration	This work is mainly supported by National Science and Technology Major Project and "Key New Drug Creation and Manufacturing Program" (2009ZX09102-114), National Nature Science Foundation of China (Admission No. 81273389, 81302662, http://www.nsfc.gov.cn) and Liaoning Province Education Administration (No. L2012364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; Dang HX, 2009, PROG NEURO-PSYCHOPH, V33, P1417, DOI 10.1016/j.pnpbp.2009.07.020; Hao M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002697; Helms Steve, 2004, Altern Med Rev, V9, P259; Li L, 2012, DRUG METAB DISPOS, V40, P2041, DOI 10.1124/dmd.112.046995; Shi CH, 2013, XENOBIOTICA, V43, P868, DOI 10.3109/00498254.2013.789149; Wang W, 2008, BRIT J CANCER, V98, P792, DOI 10.1038/sj.bjc.6604227; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041586; Wang W, 2009, LUNG CANCER, V65, P306, DOI 10.1016/j.lungcan.2008.11.016; Wang W, 2009, CANCER LETT, V278, P241, DOI 10.1016/j.canlet.2009.01.005; Yoo JH, 2010, CANCER LETT, V289, P99, DOI 10.1016/j.canlet.2009.08.008; Zhang LH, 2013, BBA-GEN SUBJECTS, V1830, P4148, DOI 10.1016/j.bbagen.2013.04.008; Zhang X, 2009, XENOBIOTICA, V39, P457, DOI 10.1080/00498250902810951; Zhang X, 2007, J CHROMATOGR B, V858, P65, DOI 10.1016/j.jchromb.2007.08.021; Zhao JM, 2011, BIOORG MED CHEM LETT, V21, P1027, DOI 10.1016/j.bmcl.2010.12.035; Zhao Y, 2007, MED CHEM, V3, P51, DOI 10.2174/157340607779317508	16	13	14	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94962	10.1371/journal.pone.0094962	http://dx.doi.org/10.1371/journal.pone.0094962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736630	Green Published, gold, Green Submitted			2022-12-25	WOS:000336922600112
J	Zhou, FJ; Roy, B; Dunlap, JR; Enganti, R; von Arnim, AG				Zhou, Fujun; Roy, Bijoyita; Dunlap, John R.; Enganti, Ramya; von Arnim, Albrecht G.			Translational Control of Arabidopsis Meristem Stability and Organogenesis by the Eukaryotic Translation Factor eIF3h	PLOS ONE			English	Article							STEM-CELL FATE; SHOOT APICAL MERISTEM; RIBOSOMAL-PROTEINS; RECEPTOR KINASE; MESSENGER-RNA; GENE-EXPRESSION; H-SUBUNIT; INITIATION; WUSCHEL; REINITIATION	Essentially all aboveground plant tissues develop from the stem cells in the primary shoot apical meristem. Proliferation of the stem cell population in the Arabidopsis shoot apical meristem is tightly controlled by a feedback loop formed primarily by the homeodomain transcription factor WUSCHEL (WUS) and the CLAVATA ligand-receptor system. In this study, it is shown that mutation of a translation initiation factor, eIF3h, causes a tendency to develop a strikingly enlarged shoot apical meristem with elevated and ectopic expression of WUS and CLAVATA3 (CLV3). Many of the mRNAs that function in apical meristem maintenance possess upstream open reading frames (uORFs), translational attenuators that render translation partially dependent on eIF3h. Specifically, the mRNA for the receptor kinase, CLV1, is undertranslated in the eif3h mutant as shown by transient and transgenic expression assays. Concordant phenotypic observations include defects in organ polarity and in translation of another uORF-containing mRNA, ASYMMETRIC LEAVES 1 (AS1), in eif3h. In summary, the expression of developmental regulatory mRNAs is attenuated by uORFs, and this attenuation is balanced in part by the translation initiation factor, eIF3h. Thus, translational control plays a key role in Arabidopsis stem cell regulation and organogenesis.	[Zhou, Fujun; von Arnim, Albrecht G.] Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN 37996 USA; [Roy, Bijoyita; Enganti, Ramya; von Arnim, Albrecht G.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN USA; [Dunlap, John R.] Univ Tennessee, Div Biol, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	von Arnim, AG (corresponding author), Univ Tennessee, Genome Sci & Technol Program, Knoxville, TN 37996 USA.	vonarnim@utk.edu		Enganti, Ramya/0000-0001-7283-1389; von Arnim, Albrecht/0000-0003-3472-3357; Roy, Bijoyita/0000-0003-1061-5482	DOE Energy Biosciences Program [DEFG02- 96ER20223]; BARD [IS3901-06C]	DOE Energy Biosciences Program; BARD	This work was supported by a grant from the DOE Energy Biosciences Program (DEFG02- 96ER20223). Partial stipend support for FZ was provided by BARD grant IS3901-06C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichinger E, 2012, ANNU REV PLANT BIOL, V63, P615, DOI 10.1146/annurev-arplant-042811-105555; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brand U, 2002, PLANT PHYSIOL, V129, P565, DOI 10.1104/pp.001867; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Burks EA, 2001, J BIOL CHEM, V276, P2122, DOI 10.1074/jbc.M007236200; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Cheng YF, 2007, PLANT CELL, V19, P2430, DOI 10.1105/tpc.107.053009; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Echevarria-Zomeno S, 2013, INT J MOL SCI, V14, P4670, DOI 10.3390/ijms14034670; GALLIE DR, 1993, PLANT CELL REP, V13, P119, DOI 10.1007/BF00235304; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Green KA, 2005, PLANT CELL, V17, P691, DOI 10.1105/tpc.104.026179; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; Horiguchi G, 2012, PLANT SCI, V191, P24, DOI 10.1016/j.plantsci.2012.04.008; Horiguchi G, 2011, PLANT J, V65, P724, DOI 10.1111/j.1365-313X.2010.04457.x; Ivanov PA, 1997, VIROLOGY, V232, P32, DOI 10.1006/viro.1997.8525; Kim BH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r60; Kim TH, 2004, PLANT CELL, V16, P3341, DOI 10.1105/tpc.104.026880; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; KOZAK M, 1986, P NATL ACAD SCI USA, V83, P2850, DOI 10.1073/pnas.83.9.2850; Kwon CS, 2005, GENE DEV, V19, P992, DOI 10.1101/gad.1276305; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Mandel T, 2014, DEVELOPMENT, V141, P830, DOI 10.1242/dev.104687; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Muench DG, 2012, WIRES RNA, V3, P178, DOI 10.1002/wrna.1104; Nimchuk ZL, 2011, CURR BIOL, V21, P345, DOI 10.1016/j.cub.2011.01.039; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pinon V, 2008, DEVELOPMENT, V135, P1315, DOI 10.1242/dev.016469; Rayson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031917; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rosado A, 2012, P NATL ACAD SCI USA, V109, P19537, DOI 10.1073/pnas.1214774109; Roy B, 2010, RNA, V16, P748, DOI 10.1261/rna.2056010; Schepetilnikov M, 2013, EMBO J, V32, P1087, DOI 10.1038/emboj.2013.61; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schuetz M, 2008, PLANT PHYSIOL, V148, P870, DOI 10.1104/pp.108.119396; Schutte BC, 1997, BIOTECHNIQUES, V22, P40, DOI 10.2144/97221bm06; Subramanian C, 2006, PLANT J, V48, P138, DOI 10.1111/j.1365-313X.2006.02851.x; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Szakonyi D, 2011, PLANT SIGNAL BEHAV, V6, P712, DOI 10.4161/psb.6.5.15070; Tiruneh BS, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-123; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; Vaughn JN, 2012, RNA, V18, P368, DOI 10.1261/rna.031179.111; von Arnim A. G., 2013, ARABIDOPSIS BOOK, pe0165; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Yadav RK, 2010, DEVELOPMENT, V137, P3581, DOI 10.1242/dev.054973; Yamamoto YY, 2009, PLANT J, V60, P350, DOI 10.1111/j.1365-313X.2009.03958.x; Yamamoto YY, 2003, PLANT J, V35, P273, DOI 10.1046/j.1365-313X.2003.01797.x; Yao Y, 2008, DEVELOPMENT, V135, P1325, DOI 10.1242/dev.017913; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhou F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-193	57	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95396	10.1371/journal.pone.0095396	http://dx.doi.org/10.1371/journal.pone.0095396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736281	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600178
J	Charman, M; Colbourne, TR; Pietrangelo, A; Kreplak, L; Ridgway, ND				Charman, Mark; Colbourne, Terry R.; Pietrangelo, Antonietta; Kreplak, Laurent; Ridgway, Neale D.			Oxysterol-binding Protein (OSBP)-related Protein 4 (ORP4) Is Essential for Cell Proliferation and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cholesterol; Lipid Transport; Phospholipid; RNA Interference (RNAi); Oxysterol-binding Protein; Phosphatidylinositol 4-Phosphate; Vimentin	STEROL-BINDING; SPHINGOMYELIN SYNTHESIS; ENDOPLASMIC-RETICULUM; DEPENDENT ACTIVATION; CERAMIDE TRANSPORT; PLASMA-MEMBRANE; INTERACTS; APOPTOSIS; OSBP; 25-HYDROXYCHOLESTEROL	Oxysterol-binding protein (OSBP) and OSBP-related proteins (ORPs) comprise a large gene family with sterol/lipid transport and regulatory activities. ORP4 (OSBP2) is a closely related paralogue of OSBP, but its function is unknown. Here we show that ORP4 binds similar sterol and lipid ligands as OSBP and other ORPs but is uniquely required for the proliferation and survival of cultured cells. Recombinant ORP4L and a variant without a pleckstrin homology (PH) domain (ORP4S) bind 25-hydroxycholesterol and extract and transfer cholesterol between liposomes. Two conserved histidine residues in the OSBP homology domain ORP4 are essential for binding phosphatidylinositol 4-phosphate but not sterols. The PH domain of ORP4L also binds phosphatidylinositol 4-phosphate in the Golgi apparatus. However, in the context of ORP4L, the PH domain is required for normal organization of the vimentin network. Unlike OSBP, RNAi silencing of all ORP4 variants (including a partial PH domain truncation termed ORP4M) in HEK293 and HeLa cells resulted in growth arrest but not cell death. ORP4 silencing in non-transformed intestinal epithelial cells (IEC)-18 caused apoptosis characterized by caspase 3 and poly(ADP-ribose) polymerase processing, DNA cleavage, and JNK phosphorylation. IEC-18 transformed with oncogenic H-Ras have increased expression of ORP4L and ORP4S proteins and are resistant to the growth-inhibitory effects of ORP4 silencing. Results suggest that ORP4 promotes the survival of rapidly proliferating cells.	[Charman, Mark; Colbourne, Terry R.; Pietrangelo, Antonietta; Ridgway, Neale D.] Dalhousie Univ, Dept Pediat, Halifax, NS B3H 4R2, Canada; [Charman, Mark; Colbourne, Terry R.; Pietrangelo, Antonietta; Ridgway, Neale D.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 4R2, Canada; [Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Ridgway, ND (corresponding author), Dalhousie Univ, Atlantic Res Ctr, 5849 Univ Ave,POB 15000, Halifax, NS B3H 4R2, Canada.	nridgway@dal.ca		Ridgway, Neale/0000-0002-0441-6228; kreplak, laurent/0000-0001-9370-9809	Heart and Stroke Foundation of Canada; Canadian Institutes of Health Research [MOP-15284]; Nova Scotia Health Research Foundation	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation	This work was supported by grants from The Heart and Stroke Foundation of Canada and Canadian Institutes of Health Research Grant MOP-15284 (to N. D. R.).; Recipient of a studentship from the Nova Scotia Health Research Foundation.	Alfaro G, 2011, TRAFFIC, V12, P1521, DOI 10.1111/j.1600-0854.2011.01265.x; Banerji S, 2010, MOL BIOL CELL, V21, P4141, DOI 10.1091/mbc.E10-05-0424; Beh CT, 2001, GENETICS, V157, P1117; Burgett AWG, 2011, NAT CHEM BIOL, V7, P639, DOI 10.1038/nchembio.625; de Saint-Jean M, 2011, J CELL BIOL, V195, P965, DOI 10.1083/jcb.201104062; Dirsch VM, 2003, CANCER RES, V63, P8869; DUKE RC, 1983, P NATL ACAD SCI-BIOL, V80, P6361, DOI 10.1073/pnas.80.20.6361; Garcia-Prieto C, 2013, J BIOL CHEM, V288, P3240, DOI 10.1074/jbc.M112.384776; Goto A, 2012, MOL BIOL CELL, V23, P3624, DOI 10.1091/mbc.E12-04-0283; Helbig L, 2011, J BIOL CHEM, V286, P12991, DOI 10.1074/jbc.M110.190645; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; Johansson M, 2005, MOL BIOL CELL, V16, P5480, DOI 10.1091/mbc.E05-03-0189; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lopez-Anton N, 2006, J BIOL CHEM, V281, P33078, DOI 10.1074/jbc.M607904200; Maeda K, 2013, NATURE, V501, P257, DOI 10.1038/nature12430; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Muller IM, 2005, MOL PHARMACOL, V67, P1684, DOI 10.1124/mol.104.004234; Ngo M, 2009, MOL BIOL CELL, V20, P1388, DOI 10.1091/mbc.E08-09-0905; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Nishimura T, 2005, GENES CELLS, V10, P793, DOI 10.1111/j.1365-2443.2005.00879.x; Perry RJ, 2005, BBA-MOL CELL BIOL L, V1734, P220, DOI 10.1016/j.bbalip.2005.04.001; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; RAK J, 1995, J CELL BIOL, V131, P1587, DOI 10.1083/jcb.131.6.1587; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Ridgway ND, 2010, SUBCELL BIOCHEM, V51, P159, DOI 10.1007/978-90-481-8622-8_6; Rudy A, 2008, J NAT PROD, V71, P482, DOI 10.1021/np070534e; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; Tong J, 2013, STRUCTURE, V21, P1203, DOI 10.1016/j.str.2013.05.007; Udagawa O, 2014, GENES CELLS, V19, P13, DOI 10.1111/gtc.12105; Vihervaara T, 2011, CHEM PHYS LIPIDS, V164, P443, DOI 10.1016/j.chemphyslip.2011.03.002; Wang C, 2002, BIOCHEM J, V361, P461, DOI 10.1042/0264-6021:3610461; Wyles JP, 2007, EXP CELL RES, V313, P1426, DOI 10.1016/j.yexcr.2007.01.018; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	36	63	64	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15705	15717		10.1074/jbc.M114.571216	http://dx.doi.org/10.1074/jbc.M114.571216			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742681	hybrid, Green Published			2022-12-25	WOS:000337465400051
J	Bull, JJ; Vegge, CS; Schmerer, M; Chaudhry, WN; Levin, BR				Bull, James J.; Vegge, Christina Skovgaard; Schmerer, Matthew; Chaudhry, Waqas Nasir; Levin, Bruce R.			Phenotypic Resistance and the Dynamics of Bacterial Escape from Phage Control	PLOS ONE			English	Article							ESCHERICHIA-COLI; EVOLUTIONARY DYNAMICS; THERAPY; SUCCESS; POPULATION; INFECTION; COMMUNITY; GROWTH; MODEL	The canonical view of phage - bacterial interactions in dense, liquid cultures is that the phage will eliminate most of the sensitive cells; genetic resistance will then ascend to restore high bacterial densities. Yet there are various mechanisms by which bacteria may remain sensitive to phages but still attain high densities in their presence - because bacteria enter a transient state of reduced adsorption. Importantly, these mechanisms may be cryptic and inapparent prior to the addition of phage yet result in a rapid rebound of bacterial density after phage are introduced. We describe mathematical models of these processes and suggest how different types of this 'phenotypic' resistance may be elucidated. We offer preliminary in vitro studies of a previously characterized E. coli model system and Campylobacter jejuni illustrating apparent phenotypic resistance. As phenotypic resistance may be specific to the receptors used by phages, awareness of its mechanisms may identify ways of improving the choice of phages for therapy. Phenotypic resistance can also explain several enigmas in the ecology of phage-bacterial dynamics. Phenotypic resistance does not preclude the evolution of genetic resistance and may often be an intermediate step to genetic resistance.	[Bull, James J.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Bull, James J.] Univ Texas Austin, Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Bull, James J.; Schmerer, Matthew] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Vegge, Christina Skovgaard] Univ Copenhagen, Dept Vet Dis Biol, Frederiksberg, Denmark; [Chaudhry, Waqas Nasir; Levin, Bruce R.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Chaudhry, Waqas Nasir] Natl Univ Sci & Technol, Atta Ur Rahman Sch Appl Biosci, Islamabad, Pakistan	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Copenhagen; Emory University; National University of Sciences & Technology - Pakistan	Bull, JJ (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	bull@utexas.edu			NIH [GM57756, GM 091875]; Higher Education Commission Pakistan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057756, R01GM091875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higher Education Commission Pakistan(Higher Education Commission of Pakistan); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH GM57756 (JJB) and GM 091875 (BRL), Higher Education Commission Pakistan (WNC). JJB is also supported as the Miescher Regents Professor (U. Texas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bikard D, 2012, CURR OPIN IMMUNOL, V24, P15, DOI 10.1016/j.coi.2011.10.005; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Bull JJ, 2006, J THEOR BIOL, V241, P928, DOI 10.1016/j.jtbi.2006.01.027; Bull JJ, 2012, ANTIMICROB AGENTS CH, V56, P949, DOI 10.1128/AAC.05842-11; Bull JJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-35; Bull JJ, 2010, VIROLOGY, V398, P79, DOI 10.1016/j.virol.2009.11.040; Bull JJ, 2006, P R SOC B, V273, P2703, DOI 10.1098/rspb.2006.3640; CAMPBELL A, 1961, EVOLUTION, V15, P153, DOI 10.2307/2406076; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; Davidson CJ, 2008, ANNU REV GENET, V42, P253, DOI 10.1146/annurev.genet.42.110807.091601; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gallet R, 2012, EVOLUTION, V66, P3485, DOI 10.1111/j.1558-5646.2012.01690.x; Hansen VM, 2007, BMC MICROBIOLOGY, V7, P90; HORNE MT, 1970, SCIENCE, V168, P992, DOI 10.1126/science.168.3934.992-a; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; LEVIN BR, 1977, AM NAT, V111, P3, DOI 10.1086/283134; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Levin BR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003312; LI K, 1961, J GEN MICROBIOL, V24, P355, DOI 10.1099/00221287-24-3-355; Mushtaq N, 2004, ANTIMICROB AGENTS CH, V48, P1503, DOI 10.1128/AAC.48.5.1503-1508.2004; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; R Development Core Team, 2012, R LANG ENV STAT COMP; Schrag SJ, 1996, AM NAT, V148, P348, DOI 10.1086/285929; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; Sorensen MCH, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00011; SPANAKIS E, 1987, J GEN MICROBIOL, V133, P353; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Wei Y, 2010, P ROY SOC B-BIOL SCI, V277, P3247, DOI 10.1098/rspb.2010.0651; Weitz JS, 2008, THEOR ECOL, V1, P13, DOI 10.1007/s12080-007-0001-1	32	73	75	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94690	10.1371/journal.pone.0094690	http://dx.doi.org/10.1371/journal.pone.0094690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743264	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100041
J	Kayigamba, FR; Bakker, MI; Lammers, J; Mugisha, V; Bagiruwigize, E; Asiimwe, A; van der Loeff, MFS				Kayigamba, Felix R.; Bakker, Mirjam I.; Lammers, Judith; Mugisha, Veronicah; Bagiruwigize, Emmanuel; Asiimwe, Anita; van der Loeff, Maarten F. Schim			Provider-Initiated HIV Testing and Counselling in Rwanda: Acceptability among Clinic Attendees and Workers, Reasons for Testing and Predictors of Testing	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SOUTH-AFRICA; HEALTH-CARE; ROUTINE; BOTSWANA; OUTPATIENT; SETTINGS	Introduction: Routine provider-initiated HIV testing and counselling (PITC) may increase HIV testing rates, but whether PITC is acceptable to health facility (HF) attendees is unclear. In the course of a PITC intervention study in Rwanda, we assessed the acceptability of PITC, reasons for being or not being tested and factors associated with HIV testing. Methods: Attendees were systematically interviewed in March 2009 as they left the HF, regarding knowledge and acceptability of PITC, history of testing and reasons for being tested or not. Subsequently, PITC was introduced in 6 of the 8 HFs and a second round of interviews was conducted. Independent factors associated with testing were analysed using logistic regression. Randomly selected health care workers (HCWs) were also interviewed. Results: 1772 attendees were interviewed. Over 95% agreed with the PITC policy, both prior to and after implementation of PITC policy. The most common reasons for testing were the desire to know one's HIV status and having been offered an HIV test by an HCW. The most frequent reasons for not being tested were known HIV status and test not being offered. In multivariable analysis, PITC, age >= 15 years, and not having been previously tested were factors significantly associated with testing. Although workload was increased by PITC, HIV testing rates increased and HCWs overwhelmingly supported the policy. Conclusion: Among attendees and HCWs in Rwandan clinics, the acceptability of PITC was very high. PITC appeared to increase testing rates and may be helpful in prevention and early access to treatment.	[Kayigamba, Felix R.] INTERACT, Kigali, Rwanda; [Bakker, Mirjam I.] Royal Trop Inst, KIT Biomed Res, NL-1105 AZ Amsterdam, Netherlands; [Lammers, Judith] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Mugisha, Veronicah] Columbia Univ, Mailman Sch Publ Hlth, ICAP, Kigali, Rwanda; [Bagiruwigize, Emmanuel] Minist Hlth, Ruhengeri Hosp, Kigali, Rwanda; [Asiimwe, Anita] Minist Hlth, Kigali, Rwanda; [van der Loeff, Maarten F. Schim] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim] AMC, Ctr Infect & Immun Amsterdam CINIMA, Amsterdam, Netherlands; [van der Loeff, Maarten F. Schim] Publ Hlth Serv Amsterdam GGD, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Public Health Service Amsterdam	Kayigamba, FR (corresponding author), INTERACT, Kigali, Rwanda.	fkaigamba@gmail.com			Infectious Disease Network for Treatment and Research in Africa (INTERACT); Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research; European Union [SANTE/2006/105-316]	Infectious Disease Network for Treatment and Research in Africa (INTERACT); Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research; European Union(European Commission)	Both financial and technical support for this study were provided by the Infectious Disease Network for Treatment and Research in Africa (INTERACT), an organization funded by the Netherlands Organization for Scientific Research/Netherlands Foundation for the Advancement of Tropical Research (http://www.nwo.nl/over-nwo/organisatie/nwo-onderdelen/wotro W07.05.201.00; URL: http://www.nwo.nl/nwohome.nsf/pages/NWOA_6MMGNF) and the European Union (SANTE/2006/105-316; URL: http://ec.europa.eu/europeaid/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, UNAIDS REP GLOB AIDS; April MD, 2010, B WORLD HEALTH ORGAN, V88, P703, DOI 10.2471/BLT.09.073049; Bassett IV, 2007, JAIDS-J ACQ IMM DEF, V46, P181, DOI 10.1097/QAI.0b013e31814277c8; Bassett IV, 2010, CLIN INFECT DIS, V50, pS77, DOI 10.1086/651477; Bayer R, 2011, NEW ENGL J MED, V365, P1265, DOI 10.1056/NEJMp1108657; Becker J, 2009, PAN AFR MED J, V3, P1; Bock NN, 2008, INT J TUBERC LUNG D, V12, pS69; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Cockcroft Anne, 2007, BMC Int Health Hum Rights, V7, P5, DOI 10.1186/1472-698X-7-5; Corneli A, 2008, INT J TUBERC LUNG D, V12, pS79; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; Evans C, 2009, INT J NURS STUD, V46, P723, DOI 10.1016/j.ijnurstu.2008.11.003; Hardon A, 2011, MED ANTHROPOL, V30, P183, DOI 10.1080/01459740.2011.552455; Kharsany ABM, 2010, AIDS CARE, V22, P533, DOI 10.1080/09540120903254005; Matovu JKB, 2007, TROP MED INT HEALTH, V12, P1315, DOI 10.1111/j.1365-3156.2007.01923.x; Nakanjako D, 2007, AIDS BEHAV, V11, P753, DOI 10.1007/s10461-006-9180-9; National Institute of Statistics of Rwanda (NISR) [Rwanda] Ministry of Health (MOH) [ Rwanda] and ICF International, 2010, RWAND DEM HLTH SURV; Njeru MK, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-87; Obermeyer CM, 2007, AM J PUBLIC HEALTH, V97, P1762, DOI 10.2105/AJPH.2006.096263; Odhiambo J, 2008, INT J TUBERC LUNG D, V12, pS63; Pope DS, 2008, JAIDS-J ACQ IMM DEF, V48, P190, DOI 10.1097/QAI.0b013e3181775926; Pope DS, 2010, AIDS CARE, V22, P238, DOI 10.1080/09540120903040594; Roura M, 2013, AIDS, V27, P617, DOI 10.1097/QAD.0b013e32835b7048; Silvestri DM, 2011, JAIDS-J ACQ IMM DEF, V56, pE9, DOI 10.1097/QAI.0b013e3181fdb629; Steen TW, 2007, JAIDS-J ACQ IMM DEF, V44, P484, DOI 10.1097/QAI.0b013e318030ffa9; Titus MJ, 2009, INT J GYNECOL OBSTET, V106, P137, DOI 10.1016/j.ijgo.2009.03.026; Topp SM, 2011, B WORLD HEALTH ORGAN, V89, P328, DOI 10.2471/BLT.10.084442; Topp SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011522; Ujiji OA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-151; Van Rie A, 2008, INT J TUBERC LUNG D, V12, pS73; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; Waxman MJ, 2007, AIDS PATIENT CARE ST, V21, P981, DOI 10.1089/apc.2007.0075; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; World Health Organization, 2007, GUID PROV IN HIV TES	34	20	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95459	10.1371/journal.pone.0095459	http://dx.doi.org/10.1371/journal.pone.0095459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AG3IK	24743295	gold, Green Published, Green Submitted			2022-12-25	WOS:000335309100120
J	Christiansen, HM; Lin, V; Tanaka, S; Velikanov, A; Mollet, HF; Wintner, SP; Fordham, SV; Fisk, AT; Hussey, NE				Christiansen, Heather M.; Lin, Victor; Tanaka, Sho; Velikanov, Anatoly; Mollet, Henry F.; Wintner, Sabine P.; Fordham, Sonja V.; Fisk, Aaron T.; Hussey, Nigel E.			The Last Frontier: Catch Records of White Sharks (Carcharodon carcharias) in the Northwest Pacific Ocean	PLOS ONE			English	Article							PELAGIC SHARKS; CONSERVATION; MOVEMENTS; MIGRATION; BEHAVIOR; MANAGEMENT; BIOLOGY; PATTERNS; CAPTURE; HABITAT	White sharks are highly migratory apex predators, globally distributed in temperate, sub-tropical, and tropical waters. Knowledge of white shark biology and ecology has increased recently based on research at known aggregation sites in the Indian, Atlantic, and Northeast Pacific Oceans; however, few data are available for the Northwest Pacific Ocean. This study provides a meta-analysis of 240 observations of white sharks from the Northwest Pacific Ocean between 1951 and 2012. Records comprise reports of bycatch in commercial fisheries, media accounts, personal communications, and documentation of shark-human interactions from Russia (n = 8), Republic of Korea (22), Japan (129), China (32), Taiwan (45), Philippines (1) and Vietnam (3). Observations occurred in all months, excluding October-January in the north (Russia and Republic of Korea) and July-August in the south (China, Taiwan, Philippines, and Vietnam). Population trend analysis indicated that the relative abundance of white sharks in the region has remained relatively stable, but parameterization of a 75% increase in observer effort found evidence of a minor decline since 2002. Reliably measured sharks ranged from 126-602 cm total length (TL) and 16-2530 kg total weight. The largest shark in this study (602 cm TL) represents the largest measured shark on record worldwide. For all countries combined the sex ratio was non-significantly biased towards females (1:1.1; n = 113). Of 60 females examined, 11 were confirmed pregnant ranging from the beginning stages of pregnancy (egg cases) to near term (140 cm TL embryos). On average, 6.0 +/- 2.2 embryos were found per litter (maximum of 10) and gestation period was estimated to be 20 months. These observations confirm that white sharks are present in the Northwest Pacific Ocean year-round. While acknowledging the difficulties of studying little known populations of a naturally low abundance species, these results highlight the need for dedicated research to inform regional conservation and management planning.	[Christiansen, Heather M.; Fisk, Aaron T.; Hussey, Nigel E.] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada; [Tanaka, Sho] Tokai Univ, Sch Marine Sci & Technol, Shimizu, Shizuoka, Japan; [Velikanov, Anatoly] Sakhalin Res Inst Fisheries & Oceanog, Div Marine & Freshwater Biol Resources, Yuzhno Sakhalinsk, Russia; [Mollet, Henry F.] Moss Landing Marine Labs, Moss Landing, CA 95039 USA; [Mollet, Henry F.] Monterey Bay Aquarium, Monterey, CA USA; [Wintner, Sabine P.] KwaZulu Natal Sharks Board, Umhlanga Rocks, South Africa; [Wintner, Sabine P.] Univ KwaZulu Natal, Biomed Resource Unit, Durban, South Africa; [Fordham, Sonja V.] Shark Advocates Int Project Ocean Fdn, Washington, DC USA	University of Windsor; Tokai University; Research lnstitute of Fisheries & Oceanography; Moss Landing Marine Laboratories; Monterey Bay Aquarium Research Institute; University of Kwazulu Natal	Christiansen, HM (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON N9B 3P4, Canada.	mccannh@uwindsor.ca	Hussey, Nigel E/F-9699-2015		Canada Research Chair program NSERC Ocean Tracking Network; University of Windsor	Canada Research Chair program NSERC Ocean Tracking Network; University of Windsor	Support for this project was provided in part by Canada Research Chair program NSERC Ocean Tracking Network to ATF. HMC was supported in part by scholarships and graduate assistantships from the University of Windsor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 1994, MAR FISH REV, V56, P24; [Anonymous], 2004, MARINE FISHERIES REV; [Anonymous], 2010, INT WHIT SHARK S FEB; Antonov J.I., 2010, NOAA ATLAS NESDIS, V2, P184, DOI DOI 10.13140/2.1.1115.4889; Awruch CA, 2008, MAR ECOL PROG SER, V355, P277, DOI 10.3354/meps07227; Barker MJ, 2005, AQUAT CONSERV, V15, P325, DOI 10.1002/aqc.660; Blower DC, 2012, MAR ECOL PROG SER, V455, P229, DOI 10.3354/meps09659; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bonfil R, 2010, AQUAT BIOL, V8, P115, DOI 10.3354/ab00217; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce Barry D., 2012, P225; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Camhi MD, 2009, CONSERVATION STATUS; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Castro Jose I., 2012, P85; Cliff G, 1996, GREAT WHITE SHARKS, P351, DOI 10.1016/B978-012415031-7/50033-1; Cliff G, 2000, S AFR J SCI, V96, P365; Cliff G, 2011, MAR FRESHWATER RES, V62, P700, DOI 10.1071/MF10182; Cooke Steven J., 2008, Endangered Species Research, V4, P165, DOI 10.3354/esr00063; De Maddalena A., 2012, MEDITERRANEAN GREAT; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Dolganov VN, 2012, RUSS J MAR BIOL+, V38, P88, DOI 10.1134/S106307401201004X; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Domeier Michael L., 2012, P199; Domeier Michael L., 2012, P133; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Dudley Sheldon F.J., 2012, P511; Duffy Clinton A.J., 2012, P301; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Ellis R, 1991, GREAT WHITE SHARK; Ezcurra JM., 2012, OXYGEN CONSUMPTION R, P17; Ezcurra Juan M., 2012, P3; Fergusson IK, 1996, GREAT WHITE SHARKS, P321, DOI 10.1016/B978-012415031-7/50031-8; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Francis Malcolm P., 2012, P319; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; Gallagher AJ, 2011, CURR ISSUES TOUR, V14, P797, DOI 10.1080/13683500.2011.585227; Gubili C, 2011, P ROY SOC B-BIOL SCI, V278, P1679, DOI 10.1098/rspb.2010.1856; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Han JB, 2010, ANN ZOOL FENN, V47, P15, DOI 10.5735/086.047.0102; Hussey Nigel E., 2012, P27; Jorgensen Salvador J., 2012, P159; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; Kyne PM, 2012, CONSERVATION STATUS, P156; Lee IC, 2013, FISHERIES AGENCYS NE; Lowe CG, 2012, GLOBAL PERSPECTIVES, P405; MacNeil MA, 2012, J FISH BIOL, V80, P991, DOI 10.1111/j.1095-8649.2012.03257.x; Malcolm H, 2001, REPORT ENV AUSTR MAR; McPherson JM, 2009, DIVERS DISTRIB, V15, P880, DOI 10.1111/j.1472-4642.2009.00596.x; Mizuno Ayako W., 2001, Mammal Study, V26, P109, DOI 10.3106/mammalstudy.26.109; Mollet HF, 2000, FISH B-NOAA, V98, P299; Mollet HF, 1996, GREAT WHITE SHARKS, P91, DOI 10.1016/B978-012415031-7/50011-2; Moriyasu S, 1972, KUROSHIO ITS PHYS AS, P353; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; NAKANO H, 1987, JPN J ICHTHYOL, V33, P414, DOI 10.1007/BF02904106; Nakaya K, 1996, FISHERIES SCI, V62, P830, DOI 10.2331/fishsci.62.830; NAKAYA K, 1994, FISHERIES SCI, V60, P515, DOI 10.2331/fishsci.60.515; Nasby-Lucas Nicole, 2012, P381; Norman J. R., 1937, GIANT FISHES WHALES; Park KA, 2011, KOREAN J REMOTE SENS, V27, P663, DOI 10.7780/kjrs.2011.27.6.663; Paterson R., 1986, Australian Fisheries, V45, P12; Payne MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030105; Pratt HL, 1996, GREAT WHITE SHARKS, P131, DOI 10.1016/B978-012415031-7/50014-8; Robbins Rachel L., 2012, P287; Saidi B, 2005, CYBIUM, V29, P303; Santana-Morales Omar, 2012, P187; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Skomal Gregory B., 2012, P405; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Strong WR, 1996, GREAT WHITE SHARKS, P401, DOI 10.1016/B978-012415031-7/50038-0; Tanaka S, 2011, MAR FRESHWATER RES, V62, P548, DOI 10.1071/MF10130; Techera EJ, 2011, MAR POLICY, V35, P73, DOI 10.1016/j.marpol.2010.08.003; Towner AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071197; Towner AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066035; Uchida S, 1996, GREAT WHITE SHARKS, P139, DOI 10.1016/B978-012415031-7/50015-X; Uchida S, 1987, JPN GROUP ELASMOBRAN, V24, P4; Velikanov A.Ya., 2010, J ICHTHYOL, V50, P347, DOI [10.1134/S0032945210040089, DOI 10.1134/S0032945210040089]; Vianna GMS, 2012, BIOL CONSERV, V145, P267, DOI 10.1016/j.biocon.2011.11.022; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Weltz K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068554; WENG K, 2013, J MAR BIOL, V2013, pNIL1, DOI DOI 10.1155/2013/598745; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8	88	17	19	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94407	10.1371/journal.pone.0094407	http://dx.doi.org/10.1371/journal.pone.0094407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740299	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900043
J	Nobre, LS; Garcia-Serres, R; Todorovic, S; Hildebrandt, P; Teixeira, M; Latour, JM; Saraiva, LM				Nobre, Ligia S.; Garcia-Serres, Ricardo; Todorovic, Smilja; Hildebrandt, Peter; Teixeira, Miguel; Latour, Jean-Marc; Saraiva, Ligia M.			Escherichia coli RIC Is Able to Donate Iron to Iron-Sulfur Clusters	PLOS ONE			English	Article							RESONANCE RAMAN; 4FE-4S CLUSTERS; DIIRON PROTEINS; 2FE-2S CLUSTER; YTFE PROTEIN; NITRIC-OXIDE; BIOSYNTHESIS; REPAIR; ISCU; MOSSBAUER	Escherichia coli RIC (Repair of Iron Centers) is a diiron protein previously reported to be involved in the repair of iron-sulfur proteins damaged by oxidative or nitrosative stresses, and proposed to act as an iron donor. This possible role of RIC was now examined specifically by evaluating its ability to donate iron ions to apo-iron-sulfur proteins, determining the iron binding constants and assessing the lability of its iron ions. We show, by UV-visible, EPR and resonance Raman spectroscopies that RIC may participate in the synthesis of an iron-sulfur cluster in the apo-forms of the spinach ferredoxin and IscU when in the presence of the sulfide donating system IscS and L-cysteine. Iron binding assays allowed determining the as-isolated and fully reduced RIC dissociation constants for the ferric and ferrous iron of 10(-27) M and 10(-13) M, respectively. Mossbauer studies revealed that the RIC iron ions are labile, namely when the center is in the mixed-valence redox form as compared with the (mu-oxo) diferric one. Altogether, these results suggest that RIC is capable of delivering iron for the formation of iron-sulfur clusters.	[Nobre, Ligia S.; Todorovic, Smilja; Teixeira, Miguel; Saraiva, Ligia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, P-2780156 Oeiras, Portugal; [Hildebrandt, Peter] Tech Univ Berlin, Inst Chem, FG Biophys Chem, Berlin, Germany; [Garcia-Serres, Ricardo; Latour, Jean-Marc] Univ Grenoble 1, CEA Grenoble, CEA,CBM, CNRS,UMR 5249,Equipe Physicochim Met Biol,DSV,iRT, F-38041 Grenoble, France	Universidade Nova de Lisboa; Technical University of Berlin; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Teixeira, M (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Av Republ EAN, P-2780156 Oeiras, Portugal.	miguel@itqb.unl.pt; lst@itqb.unl.pt	Teixeira, Miguel/A-9098-2011; Todorovic, Smilja M/F-7612-2010; García-Serres, Ricardo/E-4344-2012; Teixeira, Miguel/M-1509-2019; Saraiva, Ligia M/H-8537-2012; Hildebrandt, Peter/J-5658-2014	Teixeira, Miguel/0000-0003-4124-6237; Todorovic, Smilja M/0000-0002-0219-6743; García-Serres, Ricardo/0000-0001-5203-0568; Teixeira, Miguel/0000-0003-4124-6237; Saraiva, Ligia M/0000-0002-0675-129X; Hildebrandt, Peter/0000-0003-1030-5900; Nobre, Ligia/0000-0002-3060-2593	FCT [PTDC/BBB-BQB/0937/2012, PTDC/QUI-BIOQ/111080/2009]; Fundacao para a Ciencia e Tecnologia fellowship [SFRH/SRFH/BPD/69325/2010];  [PEst-OE/EQB/LA0004/2011]	FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao para a Ciencia e Tecnologia fellowship; 	The work was funded by PEst-OE/EQB/LA0004/2011, FCT projects PTDC/BBB-BQB/0937/2012 (LMS), PTDC/QUI-BIOQ/111080/2009 (MT) and by the following Fundacao para a Ciencia e Tecnologia fellowship SFRH/SRFH/BPD/69325/2010 (LN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Agar JN, 2000, J AM CHEM SOC, V122, P2136, DOI 10.1021/ja9944195; ALIVERTI A, 1995, FEBS LETT, V368, P220, DOI 10.1016/0014-5793(95)00648-S; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Crouse BR, 1996, BIOCHEMISTRY-US, V35, P16222, DOI 10.1021/bi9620114; CZERNUSZEWICZ RS, 1994, J AM CHEM SOC, V116, P7134, DOI 10.1021/ja00095a017; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Ding HG, 2000, P NATL ACAD SCI USA, V97, P5146, DOI 10.1073/pnas.97.10.5146; Ding HG, 2004, BIOCHEM J, V379, P433, DOI 10.1042/BJ20031702; FISCHER DS, 1964, CLIN CHEM, V10, P21, DOI 10.1016/0009-8981(64)90210-4; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; FOX BG, 1993, J AM CHEM SOC, V115, P3688, DOI 10.1021/ja00062a039; FU WG, 1991, FEBS LETT, V284, P165, DOI 10.1016/0014-5793(91)80676-T; FU WG, 1992, J BIOL CHEM, V267, P15502; Gavrilenko NA, 2008, J ANAL CHEM+, V63, P1038, DOI 10.1134/S106193480811004X; Harrington JC, 2009, INFECT IMMUN, V77, P1945, DOI 10.1128/IAI.01365-08; Iannuzzi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021992; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Justino MC, 2007, J BIOL CHEM, V282, P10352, DOI 10.1074/jbc.M610656200; Justino M, 2009, BIOMETALS, V22, P99, DOI 10.1007/s10534-008-9191-2; Justino MC, 2006, FEMS MICROBIOL LETT, V257, P278, DOI 10.1111/j.1574-6968.2006.00179.x; Justino MC, 2005, J BIOL CHEM, V280, P2636, DOI 10.1074/jbc.M411070200; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kurtz DM, 1997, J BIOL INORG CHEM, V2, P159, DOI 10.1007/s007750050120; Layer G, 2006, J BIOL CHEM, V281, P16256, DOI 10.1074/jbc.M513569200; Leal SS, 2004, J BIOL INORG CHEM, V9, P987, DOI 10.1007/s00775-004-0599-z; Lu JX, 2008, BIOCHEM J, V409, P535, DOI 10.1042/BJ20071166; Mathevon C, 2007, P NATL ACAD SCI USA, V104, P13295, DOI 10.1073/pnas.0704338104; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; Overton TW, 2008, J BACTERIOL, V190, P2004, DOI 10.1128/JB.01733-07; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; RAWLINGS J, 1974, P NATL ACAD SCI USA, V71, P125, DOI 10.1073/pnas.71.1.125; SAGE JT, 1989, J AM CHEM SOC, V111, P7239, DOI 10.1021/ja00200a052; SCHWARZENBACH G, 1963, HELV CHIM ACTA, V46, P1390, DOI 10.1002/hlca.19630460434; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Shu LJ, 1998, J BIOL INORG CHEM, V3, P392, DOI 10.1007/s007750050249; Skovran E, 2004, J BACTERIOL, V186, P7626, DOI 10.1128/JB.186.22.7626-7634.2004; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Todorovic S, 2008, J BIOL INORG CHEM, V13, P765, DOI 10.1007/s00775-008-0362-y; Tokumoto U, 2002, J BIOCHEM, V131, P713, DOI 10.1093/oxfordjournals.jbchem.a003156; Xing G, 2006, BIOCHEMISTRY-US, V45, P5393, DOI 10.1021/bi0519607; YEGOROV DY, 1993, FREE RADICAL BIO MED, V15, P565, DOI 10.1016/0891-5849(93)90158-Q	42	23	23	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95222	10.1371/journal.pone.0095222	http://dx.doi.org/10.1371/journal.pone.0095222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740378	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900120
J	Sugahara, M				Sugahara, Michihiro			A Technique for High-Throughput Protein Crystallization in Ionically Cross-Linked Polysaccharide Gel Beads for X-Ray Diffraction Experiments	PLOS ONE			English	Article							ANGLE NEUTRON-SCATTERING; CRYSTAL-MOUNTING METHOD; AGAROSE-GEL; LYSOZYME CRYSTALS; PHYSICOCHEMICAL CHARACTERIZATION; STABILITY IMPROVEMENT; OSMOTIC SHOCK; CRYSTALLOGRAPHY; GROWTH; CRYOCRYSTALLOGRAPHY	A simple technique for high-throughput protein crystallization in ionically cross-linked polysaccharide gel beads has been developed for contactless handling of crystals in X-ray crystallography. The method is designed to reduce mechanical damage to crystals caused by physical contact between crystal and mount tool and by osmotic shock during various manipulations including cryoprotection, heavy-atom derivatization, ligand soaking, and diffraction experiments. For this study, protein crystallization in alginate and kappa-carrageenan gel beads was performed using six test proteins, demonstrating that proteins could be successfully crystallized in gel beads. Two complete diffraction data sets from lysozyme and ID70067 protein crystals in gel beads were collected at 100 K without removing the crystals; the results showed that the crystals had low mosaicities. In addition, crystallization of glucose isomerase was carried out in alginate gel beads in the presence of synthetic zeolite molecular sieves (MS), a hetero-epitaxic nucleant; the results demonstrated that MS can reduce excess nucleation of this protein in beads. To demonstrate heavy-atom derivatization, lysozyme crystals were successfully derivatized with K2PtBr6 within alginate gel beads. These results suggest that gel beads prevent serious damage to protein crystals during such experiments.	RIKEN SPring 8 Ctr, Sayo, Hyogo, Japan	RIKEN	Sugahara, M (corresponding author), RIKEN SPring 8 Ctr, Sayo, Hyogo, Japan.	msuga@spring8.or.jp			RIKEN; Japan Society for the Promotion of Science [25650026]	RIKEN; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a 'Strategic Programs for R&D' contribution from RIKEN and by a 'Grant in Aid for Scientific Research' from Japan Society for the Promotion of Science (KAKENHI No. 25650026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai H, 2003, CELL BIOCHEM BIOPHYS, V39, P23, DOI 10.1385/CBB:39:1:23; Aishima J, 2010, ACTA CRYSTALLOGR D, V66, P1032, DOI 10.1107/S0907444910028192; Alkire RW, 2013, J APPL CRYSTALLOGR, V46, P525, DOI 10.1107/S0021889813003348; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bowler MW, 2010, ACTA CRYSTALLOGR D, V66, P855, DOI 10.1107/S0907444910019591; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Chinte U, 2005, J APPL CRYSTALLOGR, V38, P412, DOI 10.1107/S0021889805005029; Elbert DL, 1999, LANGMUIR, V15, P5355, DOI 10.1021/la9815749; Garcia-Ruiz JM, 2004, CRYSTAL GROWTH - FROM FUNDAMENTALS TO TECHNOLOGY, P369, DOI 10.1016/B978-044451386-1/50019-2; Garcia-Ruiz JM, 2001, J CRYST GROWTH, V232, P165, DOI 10.1016/S0022-0248(01)01146-0; Garcia-Ruiz JM, 2001, J CRYST GROWTH, V232, P596, DOI 10.1016/S0022-0248(01)01083-1; Gavira JA, 2002, ACTA CRYSTALLOGR D, V58, P1653, DOI 10.1107/S0907444902014609; Gavira JA, 2002, ACTA CRYSTALLOGR D, V58, P1147, DOI 10.1107/S0907444902006959; Han Q, 2000, ACTA CRYSTALLOGR D, V56, P772, DOI 10.1107/S0907444900005096; Hasenaka H, 2009, J CRYST GROWTH, V312, P73, DOI 10.1016/j.jcrysgro.2009.09.031; Hilgart MC, 2011, J SYNCHROTRON RADIAT, V18, P717, DOI 10.1107/S0909049511029918; Hirata K, 2010, AIP CONF PROC, V1234, P901, DOI 10.1063/1.3463362; Kitago Y, 2005, ACTA CRYSTALLOGR D, V61, P1013, DOI 10.1107/S0907444905012734; Kitago Y, 2010, J APPL CRYSTALLOGR, V43, P341, DOI 10.1107/S0021889809054272; Kriminski S, 2003, ACTA CRYSTALLOGR D, V59, P697, DOI 10.1107/S0907444903002713; Li YF, 2012, RSC ADV, V2, P4857, DOI 10.1039/c2ra20511d; Lopez-Jaramillo FJ, 2002, ACTA CRYSTALLOGR D, V58, P209, DOI 10.1107/S090744490101914X; Lopez-Jaramillo FJ, 2001, J APPL CRYSTALLOGR, V34, P365, DOI 10.1107/S0021889801003697; Lorber B, 2009, PROG BIOPHYS MOL BIO, V101, P13, DOI 10.1016/j.pbiomolbio.2009.12.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; ROBERT MC, 1988, J CRYST GROWTH, V90, P358, DOI 10.1016/0022-0248(88)90332-6; Sankalia MG, 2006, J PHARM SCI-US, V95, P1994, DOI 10.1002/jps.20665; Sankalia MG, 2006, INT J PHARMACEUT, V312, P1, DOI 10.1016/j.ijpharm.2005.11.048; Sauter C, 2009, J APPL CRYSTALLOGR, V42, P279, DOI 10.1107/S0021889809003446; Song JH, 2007, J SYNCHROTRON RADIAT, V14, P191, DOI 10.1107/S0909049507004803; Sugahara M, 2008, ACTA CRYSTALLOGR D, V64, P686, DOI 10.1107/S0907444908009980; Sugahara M, 2011, CRYST GROWTH DES, V11, P110, DOI 10.1021/cg100987g; Sugiyama S, 2012, J AM CHEM SOC, V134, P5786, DOI 10.1021/ja301584y; Sugiyama S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.025502; TANAKA H, 1984, BIOTECHNOL BIOENG, V26, P53, DOI 10.1002/bit.260260111; THIESSEN KJ, 1994, ACTA CRYSTALLOGR D, V50, P491, DOI 10.1107/S0907444994001332; Thorne RE, 2003, J APPL CRYSTALLOGR, V36, P1455, DOI 10.1107/S0021889803018375; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Vidal O, 1998, J CRYST GROWTH, V192, P271, DOI 10.1016/S0022-0248(98)00415-1; Vidal O, 1998, J CRYST GROWTH, V192, P257, DOI 10.1016/S0022-0248(98)00416-3; Watanabe N, 2006, ACTA CRYSTALLOGR D, V62, P891, DOI 10.1107/S0907444906010432; Willaert R, 2005, ACTA CRYSTALLOGR D, V61, P1280, DOI 10.1107/S0907444905021566; Xie XL, 2001, PROTEIN SCI, V10, P2419, DOI 10.1110/ps.ps.36701; Yoshizaki I, 2002, J CRYST GROWTH, V237, P295, DOI 10.1016/S0022-0248(01)01890-5	45	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95017	10.1371/journal.pone.0095017	http://dx.doi.org/10.1371/journal.pone.0095017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740192	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900094
J	Tong, HH; Lambert, G; Li, YX; Thurman, JM; Stahl, GL; Douthitt, K; Clancy, C; He, YJ; Bowman, AS				Tong, Hua Hua; Lambert, Garrett; Li, Yong Xing; Thurman, Joshua M.; Stahl, Gregory L.; Douthitt, Kelsey; Clancy, Caitlin; He, Yujuan; Bowman, Andrew S.			Deletion of the Complement C5a Receptor Alleviates the Severity of Acute Pneumococcal Otitis Media following Influenza A Virus Infection in Mice	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL COLONIZATION; PHENOTYPE VARIANTS; OPACITY PHENOTYPE; CYTOKINE GENES; MIDDLE-EAR; FACTOR B; PATHOGENESIS; ACTIVATION	There is considerable evidence that influenza A virus (IAV) promotes adherence, colonization, and superinfection by S. pneumoniae (Spn) and contributes to the pathogenesis of otitis media (OM). The complement system is a critical innate immune defense against both pathogens. To assess the role of the complement system in the host defense and the pathogenesis of acute pneumococcal OM following IAV infection, we employed a well-established transtympanically-induced mouse model of acute pneumococcal OM. We found that antecedent IAV infection enhanced the severity of acute pneumococcal OM. Mice deficient in complement C1qa (C1qa(-/-)) or factor B (Bf(-/-)) exhibited delayed viral and bacterial clearance from the middle ear and developed significant mucosal damage in the eustachian tube and middle ear. This indicates that both the classical and alternative complement pathways are critical for the oto-immune defense against acute pneumococcal OM following influenza infection. We also found that Spn increased complement activation following IAV infection. This was characterized by sustained increased levels of anaphylatoxins C3a and C5a in serum and middle ear lavage samples. In contrast, mice deficient in the complement C5a receptor (C5aR) demonstrated enhanced bacterial clearance and reduced severity of OM. Our data support the concept that C5a-C5aR interactions play a significant role in the pathogenesis of acute pneumococcal OM following IAV infection. It is possible that targeting the C5a-C5aR axis might prove useful in attenuating acute pneumococcal OM in patients with influenza infection.	[Tong, Hua Hua; Lambert, Garrett; Li, Yong Xing; Douthitt, Kelsey; Clancy, Caitlin; He, Yujuan] Ohio State Univ, Dept Otolaryngol, Coll Med & Publ Hlth, Columbus, OH 43210 USA; [Thurman, Joshua M.] Univ Colorado Denver, Dept Med, Aurora, CO USA; [Stahl, Gregory L.] Harvard Univ, Sch Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [He, Yujuan] Chongqing Med Univ, Dept Clin Lab Med, Chongqing, Sichuan, Peoples R China; [Bowman, Andrew S.] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Harvard Medical School; Chongqing Medical University; University System of Ohio; Ohio State University	Tong, HH (corresponding author), Ohio State Univ, Dept Otolaryngol, Coll Med & Publ Hlth, Columbus, OH 43210 USA.	tong.1@osu.edu	Bowman, Andrew/V-5035-2019; Bowman, Andrew S/B-4321-2012	Bowman, Andrew S/0000-0002-0738-8453; Stahl, Gregory/0000-0002-4805-8119; Thurman, Joshua Michael/0000-0002-3476-9956	National Institute on Deafness and Other Communication Disorders, National Institutes of Health [R01DC009235]; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [R01 DK076690]; National Institutes of Health [HL56086, AI089781, HL056653]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056086, R29HL056653, R56HL056086, R01HL056653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI089781, R01AI089781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009235] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was supported by Award Number R01DC009235 from the National Institute on Deafness and Other Communication Disorders (HHT), National Institutes of Health, R01 DK076690 from the National Institute of Diabetes and Digestive and Kidney Diseases (JMT), National Institutes of Health, and HL56086, AI089781, HL056653 (GLS) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON JS, 1982, INFECT IMMUN, V36, P289, DOI 10.1128/IAI.36.1.289-296.1982; ANDERSSON B, 1981, INFECT IMMUN, V32, P311, DOI 10.1128/IAI.32.1.311-317.1981; Bakaletz LO, 2010, J LEUKOCYTE BIOL, V87, P213, DOI 10.1189/jlb.0709518; BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Bluestone CD, 1996, PEDIATR INFECT DIS J, V15, P281, DOI 10.1097/00006454-199604000-00002; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Garcia CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064443; GIEBINK GS, 1987, ANN OTO RHINOL LARYN, V96, P199, DOI 10.1177/000348948709600212; GIEBINK GS, 1980, INFECT IMMUN, V30, P445; Harada T, 1985, AURIS NASUS LARYNX S, V12, P188; He YJ, 2013, INT J PEDIATR OTORHI, V77, P911, DOI 10.1016/j.ijporl.2013.03.004; Heikkinen T, 1999, NEW ENGL J MED, V340, P260, DOI 10.1056/NEJM199901283400402; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Li Q, 2011, INFECT IMMUN, V79, P2578, DOI 10.1128/IAI.00168-11; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; Long JP, 2003, INFECT IMMUN, V71, P5531, DOI 10.1128/IAI.71.10.5531-5540.2003; MacArthur CJ, 2006, HEARING RES, V219, P12, DOI 10.1016/j.heares.2006.05.012; Marom T, 2012, CURR ALLERGY ASTHM R, V12, P551, DOI 10.1007/s11882-012-0303-2; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Melhus A, 2000, INFECT IMMUN, V68, P4024, DOI 10.1128/IAI.68.7.4024-4031.2000; Mina MJ, 2013, INFECT IMMUN, V81, P625, DOI 10.1128/IAI.01460-12; Mozdzanowska K, 2006, VIROLOGY, V352, P418, DOI 10.1016/j.virol.2006.05.008; Narkio-Makela M, 2000, LARYNGOSCOPE, V110, P1745; Narkio-Makela M, 2001, CLIN EXP IMMUNOL, V124, P369, DOI 10.1046/j.1365-2249.2001.01523.x; O'Brien KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017377; Ohta R, 2011, MICROBIOL IMMUNOL, V55, P191, DOI 10.1111/j.1348-0421.2011.00309.x; Pettigrew MM, 2011, J CLIN MICROBIOL, V49, P3750, DOI 10.1128/JCM.01186-11; Ricklin D, 2013, ADV EXP MED BIOL, V735, P1, DOI 10.1007/978-1-4614-4118-2_1; Ricklin D, 2013, J IMMUNOL, V190, P3839, DOI 10.4049/jimmunol.1203200; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riedemann NC, 2003, J LEUKOCYTE BIOL, V74, P966, DOI 10.1189/jlb.0403137; Sabirov A, 2008, VACCINE, V26, P1501, DOI 10.1016/j.vaccine.2008.01.029; Sarma JV, 2012, CELL HEALTH CYTOSKEL, V4, P73, DOI 10.2147/CHC.S27233; Short KR, 2013, INFECT IMMUN, V81, P645, DOI 10.1128/IAI.01278-12; Short KR, 2011, J INFECT DIS, V204, P1857, DOI 10.1093/infdis/jir618; TANNOCK GA, 1984, INFECT IMMUN, V43, P457, DOI 10.1128/IAI.43.2.457-462.1984; Tong HH, 2002, INFECT IMMUN, V70, P4292, DOI 10.1128/IAI.70.8.4292-4301.2002; Tong HH, 2001, INFECT IMMUN, V69, P602, DOI 10.1128/IAI.69.1.602-606.2001; Tong HH, 2000, ANN OTO RHINOL LARYN, V109, P1021, DOI 10.1177/000348940010901106; Tong HH, 2010, INFECT IMMUN, V78, P976, DOI 10.1128/IAI.01012-09; Vernatter J, 2013, CURR OPIN INFECT DIS, V26, P277, DOI 10.1097/QCO.0b013e3283608419; Woehrl B, 2011, J CLIN INVEST, V121, P3943, DOI 10.1172/JCI57522; Yan CG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00368; YELLON RF, 1991, LARYNGOSCOPE, V101, P165	47	15	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95160	10.1371/journal.pone.0095160	http://dx.doi.org/10.1371/journal.pone.0095160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740152	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900111
J	Ding, F; Huang, Y; Sun, WJ; Jiang, GF; Chen, Y				Ding, Fan; Huang, Yao; Sun, Wenjuan; Jiang, Guangfu; Chen, Yue			Decomposition of Organic Carbon in Fine Soil Particles Is Likely More Sensitive to Warming than in Coarse Particles: An Incubation Study with Temperate Grassland and Forest Soils in Northern China	PLOS ONE			English	Article							LAND-USE; MATTER DECOMPOSITION; MICROBIAL BIOMASS; SIZE FRACTIONS; WATER-CONTENT; RESPIRATION; CLIMATE; DEPENDENCE; STABILIZATION; TEXTURE	It is widely recognized that global warming promotes soil organic carbon (SOC) decomposition, and soils thus emit more CO2 into the atmosphere because of the warming; however, the response of SOC decomposition to this warming in different soil textures is unclear. This lack of knowledge limits our projection of SOC turnover and CO2 emission from soils after future warming. To investigate the CO2 emission from soils with different textures, we conducted a 107-day incubation experiment. The soils were sampled from temperate forest and grassland in northern China. The incubation was conducted over three short-term cycles of changing temperature from 5 degrees C to 30 degrees C, with an interval of 5 degrees C. Our results indicated that CO2 emissions from sand (>50 mu m), silt (2-50 mu m), and clay (<2 mu m) particles increased exponentially with increasing temperature. The sand fractions emitted more CO2 (CO2-C per unit fraction-C) than the silt and clay fractions in both forest and grassland soils. The temperature sensitivity of the CO2 emission from soil particles, which is expressed as Q(10), decreased in the order clay>silt>sand. Our study also found that nitrogen availability in the soil facilitated the temperature dependence of SOC decomposition. A further analysis of the incubation data indicated a power-law decrease of Q(10) with increasing temperature. Our results suggested that the decomposition of organic carbon in fine-textured soils that are rich in clay or silt could be more sensitive to warming than those in coarse sandy soils and that SOC might be more vulnerable in boreal and temperate regions than in subtropical and tropical regions under future warming.	[Ding, Fan; Huang, Yao; Sun, Wenjuan; Jiang, Guangfu; Chen, Yue] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Ding, Fan; Jiang, Guangfu; Chen, Yue] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, WJ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	sunwj@ibcas.ac.cn	Huang, Yao/O-6832-2014; Ding, Fan/A-3049-2015; Huang, Yao/GQH-3308-2022; huang, yao/GWR-5388-2022	Ding, Fan/0000-0002-7938-1015; Huang, Yao/0000-0002-0192-1421; sun, wenjuan/0000-0002-9667-1882	National Natural Science Foundation of China [41075108]; Ministry of Science and Technology of China [2010CB950604]; CAS Strategic Priority Research Program [XDA05050507]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); CAS Strategic Priority Research Program	This work was jointly supported by the National Natural Science Foundation of China (Grant No. 41075108), the Ministry of Science and Technology of China (2010CB950604) and the CAS Strategic Priority Research Program (Grant No. XDA05050507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TH, 2010, SOIL BIOL BIOCHEM, V42, P2039, DOI 10.1016/j.soilbio.2010.06.026; Arevalo CBM, 2012, SOIL SCI SOC AM J, V76, P241, DOI 10.2136/sssaj2011.0126; Baldock JA, 2000, ORG GEOCHEM, V31, P697, DOI 10.1016/S0146-6380(00)00049-8; Balesdent J., 1996, Mass spectrometry of soils., P83; BALESDENT J, 1987, SOIL BIOL BIOCHEM, V19, P25, DOI 10.1016/0038-0717(87)90120-9; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bosatta E, 1999, SOIL BIOL BIOCHEM, V31, P1889, DOI 10.1016/S0038-0717(99)00105-4; BOUYOUCOS GJ, 1962, AGRON J, V54, P464, DOI 10.2134/agronj1962.00021962005400050028x; Bremner J. M., 1996, Methods of soil analysis. Part 3 - chemical methods., P1085; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Chang XF, 2012, SOIL SCI, V177, P554, DOI 10.1097/SS.0b013e31826bdd5d; Chapman SK, 2012, SOIL SCI SOC AM J, V76, P2221, DOI 10.2136/sssaj2012.0163; Chen XP, 2010, SOIL BIOL BIOCHEM, V42, P2282, DOI 10.1016/j.soilbio.2010.08.030; Chivenge P, 2011, AGR ECOSYST ENVIRON, V140, P361, DOI 10.1016/j.agee.2010.12.004; Christensen BT, 2001, EUR J SOIL SCI, V52, P345, DOI 10.1046/j.1365-2389.2001.00417.x; CHRISTENSON B, 1987, SCAND J INFECT DIS, V19, P429, DOI 10.3109/00365548709021675; Conant RT, 2008, ECOLOGY, V89, P2384, DOI 10.1890/08-0137.1; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Cusack DF, 2013, SOIL BIOL BIOCHEM, V57, P192, DOI 10.1016/j.soilbio.2012.07.012; Cusack DF, 2010, GLOBAL CHANGE BIOL, V16, P2555, DOI 10.1111/j.1365-2486.2009.02131.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Dieckow J, 2009, EUR J SOIL SCI, V60, P240, DOI 10.1111/j.1365-2389.2008.01101.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Feng W, 2013, BIOGEOCHEM, V112, P1; Fierer N, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002644; Follett RF, 2007, SOIL SCI, V172, P189, DOI 10.1097/ss.0b013e31803403de; Franzluebbers AJ, 1999, SOIL BIOL BIOCHEM, V31, P1083, DOI 10.1016/S0038-0717(99)00022-X; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Hamdi S, 2013, SOIL BIOL BIOCHEM, V58, P115, DOI 10.1016/j.soilbio.2012.11.012; Hartley IP, 2008, SOIL BIOL BIOCHEM, V40, P1567, DOI 10.1016/j.soilbio.2008.01.007; HASSINK J, 1994, SOIL BIOL BIOCHEM, V26, P1221, DOI 10.1016/0038-0717(94)90147-3; Huang Y, 2004, SOIL BIOL BIOCHEM, V36, P973, DOI 10.1016/j.soilbio.2004.02.009; Jackson ML, 1969, SOIL CHEM ANAL ADV C, P20; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; Kirschbaum MUF, 2008, FOREST ECOL MANAG, V255, P2990, DOI 10.1016/j.foreco.2008.02.005; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kogel-Knabner I, 2008, J PLANT NUTR SOIL SC, V171, P61, DOI 10.1002/jpln.200700048; Lagomarsino A, 2012, PEDOBIOLOGIA, V55, P101, DOI 10.1016/j.pedobi.2011.12.002; Lang M, 2011, J SOIL SEDIMENT, V11, P15, DOI 10.1007/s11368-010-0260-0; Leifeld J, 2005, BIOGEOCHEMISTRY, V75, P433, DOI 10.1007/s10533-005-2237-4; Li LJ, 2010, BIOL FERT SOILS, V46, P653, DOI 10.1007/s00374-010-0463-y; LINN DM, 1984, SOIL SCI SOC AM J, V48, P1267, DOI 10.2136/sssaj1984.03615995004800060013x; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Ludwig B, 2003, EUR J SOIL SCI, V54, P117, DOI 10.1046/j.1365-2389.2003.00496.x; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Manjaiah KM, 2010, CURR SCI INDIA, V98, P915; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Natali SM, 2011, GLOBAL CHANGE BIOL, V17, P1394, DOI 10.1111/j.1365-2486.2010.02303.x; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; Sessitsch A, 2001, APPL ENVIRON MICROB, V67, P4215, DOI 10.1128/AEM.67.9.4215-4224.2001; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Sposito G, 1999, P NATL ACAD SCI USA, V96, P3358, DOI 10.1073/pnas.96.7.3358; Suseela V, 2012, GLOBAL CHANGE BIOL, V18, P336, DOI 10.1111/j.1365-2486.2011.02516.x; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Tian QX, 2014, SOIL BIOL BIOCHEM, V68, P329, DOI 10.1016/j.soilbio.2013.10.015; TIESSEN H, 1983, SOIL SCI SOC AM J, V47, P509, DOI 10.2136/sssaj1983.03615995004700030023x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Xu X, 2012, SOIL BIOL BIOCHEM, V50, P142, DOI 10.1016/j.soilbio.2012.03.007; Yang XM, 2009, CAN J SOIL SCI, V89, P413, DOI 10.4141/cjss08063; Zhou T, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000850; Zinn YL, 2005, SOIL TILL RES, V84, P28, DOI 10.1016/j.still.2004.08.007; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	71	22	24	11	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95348	10.1371/journal.pone.0095348	http://dx.doi.org/10.1371/journal.pone.0095348			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736659	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600172
J	Hassani, K; Shio, MT; Martel, C; Faubert, D; Olivier, M				Hassani, Kasra; Shio, Marina Tiemi; Martel, Caroline; Faubert, Denis; Olivier, Martin			Absence of Metalloprotease GP63 Alters the Protein Content of Leishmania Exosomes	PLOS ONE			English	Article							MEMBRANE-VESICLES; INFLAMMATORY RESPONSE; TYROSINE PHOSPHATASES; STATISTICAL-MODEL; EXPRESSION; INFECTION; CLEAVAGE; CELL; MACROPHAGES; RESISTANCE	Protozoan parasites of Leishmania genus are able to successfully infect their host macrophage due to multiple virulence strategies that result in its deactivation. Recent studies suggest Leishmania GP63 to be a critical virulence factor in modulation of many macrophage molecules, including protein tyrosine phosphatases (PTPs) and transcription factors (TFs). Additionally, we and others recently reported that Leishmania-released exosomes can participate in pathogenesis. Exosomes are 40-100 nm vesicles that are freed by many eukaryotic cells. To better understand the GP63-dependent immune modulation of the macrophage by Leishmania parasites and their exosomes, we compared the immunomodulatory properties of Leishmania major (WT) and L. major gp63(-/-) (KO) as well as their exosomes in vitro and in vivo. Importantly, we observed that Leishmania exosomes can modulate macrophage PTPs and TFs in a GP63-dependent manner. In addition, our qRT-PCR analyses showed that WT parasites were able to downregulate multiple genes involved in the immune response, especially cytokines and pattern recognition receptors. KO parasites showed a strongly reduced modulatory capacity compared to WT parasites. Furthermore, comparison of WT versus KO exosomes also showed divergences in alteration of gene expression, especially of chemokine receptors. In parallel, studying the in vivo inflammatory recruitment using a murine air pouch model, we found that exosomes have stronger proinflammatory properties than parasites and preferentially induce the recruitment of neutrophils. Finally, comparative proteomics of WT and KO exosomes surprisingly revealed major differences in their protein content, suggesting a role for GP63 in Leishmania exosomal protein sorting. Collectively our data clearly establish the crucial role of GP63 in dampening the innate inflammatory response during early Leishmania infection, and also provides new insights in regard to the role and biology of exosomes in Leishmania host-parasite interactions.	[Hassani, Kasra; Shio, Marina Tiemi; Martel, Caroline; Olivier, Martin] McGill Univ, Dept Med, Montreal, PQ, Canada; [Hassani, Kasra; Shio, Marina Tiemi; Martel, Caroline; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Hassani, Kasra; Shio, Marina Tiemi; Martel, Caroline; Olivier, Martin] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Faubert, Denis] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada	McGill University; McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Olivier, M (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	martin.olivier@mcgill.ca	Shio, Marina Tiemi/E-6466-2019	Shio, Marina Tiemi/0000-0002-2494-6816; Hassani, Kasra/0000-0003-0750-5629	Canadian Institutes of Health [MOP-12671]; Canadian Institute of Health Research CIHR; Fonds de Recherche en Sante du Quebec (FRSQ); Fonds de Recherche du Quebec - Nature et Technologies (FQRNT); Research Institute of the McGill University Health Centre (MUHC); Centre for Host-Parasite Interactions (CHPI)	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canadian Institute of Health Research CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Fonds de Recherche du Quebec - Nature et Technologies (FQRNT); Research Institute of the McGill University Health Centre (MUHC); Centre for Host-Parasite Interactions (CHPI)	This study was supported by Canadian Institutes of Health Research grant no. MOP-12671 to MO (www.cihr-irsc.gc.ca). Research in MO's laboratory is supported by operating grants from the Canadian Institute of Health Research CIHR), Fonds de Recherche en Sante du Quebec (FRSQ) and Fonds de Recherche du Quebec - Nature et Technologies (FQRNT). KH is the recipient of studentships from the Research Institute of the McGill University Health Centre (MUHC) and Centre for Host-Parasite Interactions (CHPI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Dayyeh I, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000305; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bhatia VN, 2009, ANAL CHEM, V81, P9819, DOI 10.1021/ac901335x; Bisset LR, 2005, CURR OPIN PULM MED, V11, P35, DOI 10.1097/01.mcp.0000144502.50149.e0; BONIFACINO JS, 2006, CURRENT PROTOCOLS CE; BOUVIER J, 1990, BIOCHEMISTRY-US, V29, P10113, DOI 10.1021/bi00495a015; Brittingham A, 1999, INFECT IMMUN, V67, P4477, DOI 10.1128/IAI.67.9.4477-4484.1999; BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102; Contreras I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001148; Deatherage B. L., 2012, INFECT IMMUN; Forget G, 2005, J BIOL CHEM, V280, P30542, DOI 10.1074/jbc.M414126200; Forget G, 2006, INFECT IMMUN, V74, P6272, DOI 10.1128/IAI.00853-05; Gomez MA, 2010, VIRULENCE, V1, P314, DOI 10.4161/viru.1.4.12194; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Gregory DJ, 2008, EUR J IMMUNOL, V38, P1071, DOI 10.1002/eji.200737586; Halle M, 2009, J BIOL CHEM, V284, P6893, DOI 10.1074/jbc.M805861200; Hassani K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018724; Havlis J, 2003, ANAL CHEM, V75, P1300, DOI 10.1021/ac026136s; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Kaparakis M, 2010, CELL MICROBIOL, V12, P372, DOI 10.1111/j.1462-5822.2009.01404.x; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Markova B, 2005, METHODS, V35, P22, DOI 10.1016/j.ymeth.2004.07.004; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; McGwire BS, 2003, INFECT IMMUN, V71, P1008, DOI 10.1128/IAI.71.2.1008-1010.2003; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oliveira DL, 2010, INFECT IMMUN, V78, P1601, DOI 10.1128/IAI.01171-09; Olivier M, 2012, MICROBES INFECT; RADZIOCH D, 1991, J LEUKOCYTE BIOL, V50, P263, DOI 10.1002/jlb.50.3.263; Santarem N, 2013, J PROTEOMICS, V84, P106, DOI 10.1016/j.jprot.2013.03.012; Shakoory B, 2004, J INTERF CYTOK RES, V24, P271, DOI 10.1089/107999004323065057; Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004; Silverman J. M., 2010, J IMMUNOL; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Torrecilhas ACT, 2009, MICROBES INFECT, V11, P29, DOI 10.1016/j.micinf.2008.10.003; Yao CQ, 2007, EUKARYOT CELL, V6, P1905, DOI 10.1128/EC.00073-07; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1	43	66	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95007	10.1371/journal.pone.0095007	http://dx.doi.org/10.1371/journal.pone.0095007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736445	gold, Green Submitted, Green Published			2022-12-25	WOS:000336922600123
J	Thomsen, CR; Uldbjerg, N; Hvidman, L; Atladottir, HO; Henriksen, TB; Milidou, I				Thomsen, Christine Rohr; Uldbjerg, Niels; Hvidman, Lone; Atladottir, Hjordis Osk; Henriksen, Tine Brink; Milidou, Ioanna			Seasonal Variation of Dystocia in a Large Danish Cohort	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; RISK-FACTORS; EPIDURAL ANALGESIA; CESAREAN DELIVERY; NULLIPAROUS WOMEN; SPONTANEOUS LABOR; HIGH PREVALENCE; PREECLAMPSIA; PREGNANCY; DETERMINANTS	Background: Dystocia is one of the most frequent causes of cesarean delivery in nulliparous women. Despite this, its causes are largely unknown. Vitamin D receptor (VDR) has been found in the myometrium. Thus, it is possible that vitamin D affects the contractility of the myometrium and may be involved in the pathogenesis of dystocia. Seasonal variation of dystocia in areas with distinct seasonal variation in sunlight exposure, like Denmark, could imply that vitamin D may play a role. This study examined whether there was seasonal variation in the incidence of dystocia in a Danish population. Method: We used information from a cohort of 34,261 nulliparous women with singleton pregnancies, spontaneous onset of labor between 37 and 42 completed gestational weeks, and vertex fetal presentation. All women gave birth between 1992 and 2010 at the Department of Obstetrics and Gynecology, Aarhus University Hospital, Skejby. Logistic regression combined with cubic spline was used to estimate the seasonal variation for each outcome after adjusting for calendar time. Results: No evidence for seasonal variation was found for any of the outcomes: acute cesarean delivery due to dystocia (p = 0.44); instrumental vaginal delivery due to dystocia (p = 0.69); oxytocin augmentation due to dystocia (p = 0.46); and overall dystocia (p = 0.91). Conclusion: No seasonal variation in the incidence of dystocia was observed in a large cohort of Danish women. This may reflect no association between vitamin D and dystocia, or alternatively that other factors with seasonal variation and influence on the occurrence of dystocia attenuate such an association.	[Thomsen, Christine Rohr; Uldbjerg, Niels; Hvidman, Lone] Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark; [Atladottir, Hjordis Osk; Henriksen, Tine Brink] Aarhus Univ Hosp, Dept Pediat, DK-8000 Aarhus, Denmark; [Henriksen, Tine Brink; Milidou, Ioanna] Aarhus Univ Hosp, Inst Clin Med, Perinatal Epidemiol Res Unit, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Thomsen, CR (corresponding author), Aarhus Univ Hosp, Dept Obstet & Gynecol, DK-8000 Aarhus, Denmark.	christineantonsen@yahoo.dk	Uldbjerg, Niels/O-2038-2016	Uldbjerg, Niels/0000-0002-6449-6426; Milidou, Ioanna/0000-0003-2640-7848	Danish Council for Independent Research; Aarhus University Research Foundation; Grosserer L.F. Foghts Foundation; Direktor Jacob Madsen & Hustru Olga Madsens Foundation; Aase og Ejnar Danielsens Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Aarhus University Research Foundation; Grosserer L.F. Foghts Foundation; Direktor Jacob Madsen & Hustru Olga Madsens Foundation; Aase og Ejnar Danielsens Foundation	The Aarhus Birth Cohort is funded by The Danish Council for Independent Research (http://fivu.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research/the-danish-council-for-independent-research) and Aarhus University Research Foundation (http://auff.au.dk/en). This project is a result of a grant from Grosserer L.F. Foghts Foundation (www.foghtsfond.dk), Direktor Jacob Madsen & Hustru Olga Madsens Foundation, and Aase og Ejnar Danielsens Foundation (www.danielsensfond.dk). The Aarhus University Research Foundation has supplied a scholarship to Christine Rohr Thomsen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetrics and Gynecology Committee on Practice Bulletins-Obstetrics, 2003, Obstet Gynecol, V102, P1445; Andersen R, 2013, EUR J CLIN NUTR, V67, P270, DOI 10.1038/ejcn.2013.3; Atladottir HO, 2007, EPIDEMIOLOGY, V18, P240, DOI 10.1097/01.ede.0000254064.92806.13; Bassir M, 2001, ACTA PAEDIATR, V90, P577, DOI 10.1080/080352501750197755; Boyle A, 2013, OBSTET GYNECOL, V122, P33, DOI 10.1097/AOG.0b013e3182952242; Brunvand L, 1998, ACTA OBSTET GYN SCAN, V77, P303, DOI 10.1034/j.1600-0412.1998.770309.x; Christensen AL, 2011, COMPUT METH PROG BIO, V104, P333, DOI 10.1016/j.cmpb.2011.07.016; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1357, DOI 10.1111/aogs.12000; Fraser WD, 2002, OBSTET GYNECOL, V99, P409, DOI 10.1016/S0029-7844(01)01755-0; Fu X, 2000, ACTA OBSTET GYN SCAN, V79, P174, DOI 10.1034/j.1600-0412.2000.079003174.x; Gifford DS, 2000, OBSTET GYNECOL, V95, P589, DOI 10.1016/S0029-7844(99)00575-X; Haugen M, 2009, EPIDEMIOLOGY, V20, P720, DOI 10.1097/EDE.0b013e3181a70f08; HEDEGAARD M, 1993, BMJ-BRIT MED J, V307, P234, DOI 10.1136/bmj.307.6898.234; Hollis BW, 2013, CALCIFIED TISSUE INT, V92, P128, DOI 10.1007/s00223-012-9607-4; Kimlin MG, 2008, MOL ASPECTS MED, V29, P453, DOI 10.1016/j.mam.2008.08.005; Kjaergaard Hanne, 2008, BMC Pregnancy Childbirth, V8, P45, DOI 10.1186/1471-2393-8-45; Kjaergaard H, 2009, ACTA OBSTET GYN SCAN, V88, P402, DOI 10.1080/00016340902811001; Magnus P, 2001, BRIT J OBSTET GYNAEC, V108, P1116, DOI 10.1111/j.1471-0528.2003.00273.x; Merewood A, 2009, J CLIN ENDOCR METAB, V94, P940, DOI 10.1210/jc.2008-1217; Moller N, 1999, SANDBJERG GUIDELINE; Papandreou L, 2004, EUR J OBSTET GYN R B, V115, P17, DOI 10.1016/j.ejogrb.2003.11.032; Rejnmark L, 2011, CLIN ENDOCRINOL, V74, P37, DOI 10.1111/j.1365-2265.2010.03894.x; Rudra CB, 2005, J MATERN-FETAL NEO M, V18, P319, DOI 10.1080/14767050500275838; Sachan A, 2005, AM J CLIN NUTR, V81, P1060; Selin L, 2008, ACTA OBSTET GYN SCAN, V87, P216, DOI 10.1080/00016340701837744; Sheiner E, 2002, ACTA OBSTET GYN SCAN, V81, P222, DOI 10.1034/j.1600-0412.2002.810306.x; SIMPSON RU, 1985, J BIOL CHEM, V260, P8882; SMITH PL, 1979, AM STAT, V33, P57, DOI 10.2307/2683222; TANBO T, 1995, OBSTET GYNECOL, V86, P188, DOI 10.1016/0029-7844(95)00159-O; ULDBJERG N, 1983, AM J OBSTET GYNECOL, V147, P662, DOI 10.1016/0002-9378(83)90446-5; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; Vienonen A, 2004, J SOC GYNECOL INVEST, V11, P104, DOI 10.1016/j.jsgi.2003.09.003; Visser M, 2003, J CLIN ENDOCR METAB, V88, P5766, DOI 10.1210/jc.2003-030604; Zhang J, 2001, AM J OBSTET GYNECOL, V185, P128, DOI 10.1067/mob.2001.113874; Zhang J, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.058; Zhang J, 2010, OBSTET GYNECOL, V116, P1281, DOI 10.1097/AOG.0b013e3181fdef6e	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94432	10.1371/journal.pone.0094432	http://dx.doi.org/10.1371/journal.pone.0094432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736600	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600068
J	Belogurov, A; Kudriaeva, A; Kuzina, E; Smirnov, I; Bobik, T; Ponomarenko, N; Kravtsova-Ivantsiv, Y; Ciechanover, A; Gabibov, A				Belogurov, Alexey, Jr.; Kudriaeva, Anna; Kuzina, Ekaterina; Smirnov, Ivan; Bobik, Tatyana; Ponomarenko, Natalia; Kravtsova-Ivantsiv, Yelena; Ciechanover, Aaron; Gabibov, Alexander			Multiple Sclerosis Autoantigen Myelin Basic Protein Escapes Control by Ubiquitination during Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; PEPTIDES; ENCEPHALOMYELITIS; PATHWAY; OLIGODENDROCYTES; ELECTROPHORESIS; AUTOANTIBODIES; SUSCEPTIBILITY; PURIFICATION; DESTRUCTION	The vast majority of cellular proteins are degraded by the 26S proteasome after their ubiquitination. Here, we report that the major component of the myelin multilayered membrane sheath, myelin basic protein (MBP), is hydrolyzed by the 26S proteasome in a ubiquitin-independent manner both in vitro and in mammalian cells. As a proteasomal substrate, MBP reveals a distinct and physiologically relevant concentration range for ubiquitin-independent proteolysis. Enzymatic deimination prevents hydrolysis of MBP by the proteasome, suggesting that an abnormally basic charge contributes to its susceptibility toward proteasome-mediated degradation. To our knowledge, our data reveal the first case of a pathophysiologically important autoantigen as a ubiquitin-independent substrate of the 26S proteasome.	[Belogurov, Alexey, Jr.; Kudriaeva, Anna; Kuzina, Ekaterina; Smirnov, Ivan; Bobik, Tatyana; Ponomarenko, Natalia; Gabibov, Alexander] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117871, Russia; [Belogurov, Alexey, Jr.; Gabibov, Alexander] Russian Acad Sci, Inst Gene Biol, Moscow 117334, Russia; [Kuzina, Ekaterina; Smirnov, Ivan; Gabibov, Alexander] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119991, Russia; [Kravtsova-Ivantsiv, Yelena; Ciechanover, Aaron] Technion Israel Inst Technol, Canc & Vasc Biol Ctr, Rappaport Fac Med, IL-31096 Haifa, Israel; [Kravtsova-Ivantsiv, Yelena; Ciechanover, Aaron] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Lomonosov Moscow State University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology	Ciechanover, A (corresponding author), Technion Israel Inst Technol, Canc & Vasc Biol Ctr, Rappaport Fac Med, IL-31096 Haifa, Israel.	c_tzachy@netvision.net.il; gabibov@mx.ibch.ru	Smirnov, Ivan/N-5635-2017; Kudriaeva, Anna/P-5893-2017; Belogurov, Alexey/L-5859-2017; Bobik, Tatyana/E-6742-2014; Ciechanover, Aaron J/C-9166-2017	Smirnov, Ivan/0000-0002-0384-6568; Kudriaeva, Anna/0000-0003-1163-9929; Belogurov, Alexey/0000-0002-2033-9621; Bobik, Tatyana/0000-0002-4113-9442; Kuzina, Ekaterina/0000-0002-5468-0262	Russian Scientific Foundation [14-14-00585]; Russian Foundation for Basic Research [12-04-33258, 12-04-01609-a]; Russian Federation [CPi 2445.2013.4]; Skolkovo program; RFBR [10-04-00673, 13-04-40277-H]; Scientific School Support Program "Chemical Basis of Biocatalysis" [2046.2012.4]; Presidium of the Russian Academy of Sciences [24]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Israel Science Foundation; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [1775/12]; European Union Treat PolyQ Network; Deutsch-Israelische Projektkooperation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation); Skolkovo program; RFBR(Russian Foundation for Basic Research (RFBR)); Scientific School Support Program "Chemical Basis of Biocatalysis"; Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Israel Science Foundation(Israel Science Foundation); I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); European Union Treat PolyQ Network; Deutsch-Israelische Projektkooperation	This work was supported by Russian Scientific Foundation Project 14-14-00585 "Molecular mechanism and physiological significance of the ubiquitin-independent proteasomal degradation of the proteins," which was supported in part by Russian Foundation for Basic Research Grant 12-04-33258, 12-04-01609-a, and Fellowship of President of Russian Federation C Pi 2445.2013.4 (to A. B.). This work was also supported in part by the Skolkovo program and RFBR 10-04-00673, 13-04-40277-H, the Scientific School Support Program "Chemical Basis of Biocatalysis" 2046.2012.4, the programs of the Presidium of the Russian Academy of Sciences "Peculiarities of Antigen Degradation in Autoimmune Neurodegeneration," " Nanotechnologies and Nanomaterials" 24 (Federal Special Research Programs "Fundamental Science for Medicine"), and "Molecular and Cellular Biology" (to A. G.). This work was also supported by grants from the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, the Israel Science Foundation, the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (Grant 1775/12), the European Union Treat PolyQ Network, and the Deutsch-Israelische Projektkooperation (to A. C.).	Aggarwal S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001577; Akaishi T, 1996, BRAIN RES, V722, P139, DOI 10.1016/0006-8993(96)00212-0; BARBARESE E, 1981, P NATL ACAD SCI-BIOL, V78, P1953, DOI 10.1073/pnas.78.3.1953; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Belogurov AA, 2013, FASEB J, V27, P222, DOI 10.1096/fj.12-213975; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; D'Souza CA, 2006, NEUROCHEM RES, V31, P1045, DOI 10.1007/s11064-006-9116-9; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gross-Mesilaty S, 1998, P NATL ACAD SCI USA, V95, P8058, DOI 10.1073/pnas.95.14.8058; Happel P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01806; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Huber EM, 2012, ANGEW CHEM INT EDIT, V51, P8708, DOI 10.1002/anie.201201616; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Jurewicz A, 1998, J IMMUNOL, V160, P3056; KARIN N, 1994, J EXP MED, V180, P2227, DOI 10.1084/jem.180.6.2227; Kim JK, 2003, MOL CELL PROTEOMICS, V2, P453, DOI 10.1074/mcp.M200050-MCP200; KONO DH, 1988, J EXP MED, V168, P213, DOI 10.1084/jem.168.1.213; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; KRISTENSSON K, 1986, NATURE, V322, P544, DOI 10.1038/322544a0; LAATSCH RH, 1962, J EXP MED, V115, P777, DOI 10.1084/jem.115.4.777; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; MONFERRAN CG, 1986, MOL CELL BIOCHEM, V70, P131; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Musse AA, 2008, DIS MODEL MECH, V1, P229, DOI 10.1242/dmm.000729; OKSENBERG JR, 1993, NATURE, V362, P68, DOI 10.1038/362068a0; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5374, DOI 10.1021/bi9925569; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Rani N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1752; REISFELD RA, 1962, NATURE, V195, P281, DOI 10.1038/195281a0; Rivers TM, 1935, J EXP MED, V61, P689, DOI 10.1084/jem.61.5.689; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171	39	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17758	17766		10.1074/jbc.M113.544247	http://dx.doi.org/10.1074/jbc.M113.544247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24739384	hybrid, Green Published			2022-12-25	WOS:000338018100039
J	Yokom, AL; Morishima, Y; Lau, M; Su, M; Glukhova, A; Osawa, Y; Southworth, DR				Yokom, Adam L.; Morishima, Yoshihiro; Lau, Miranda; Su, Min; Glukhova, Alisa; Osawa, Yoichi; Southworth, Daniel R.			Architecture of the Nitric-oxide Synthase Holoenzyme Reveals Large Conformational Changes and a Calmodulin-driven Release of the FMN Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NO COMPLEX-FORMATION; CRYO-EM STRUCTURE; ELECTRON-TRANSFER; REDUCTASE DOMAIN; HEME REDUCTION; CATALYSIS; MICROSCOPY; ACTIVATION; OXYGENASE; VISUALIZATION	Nitric-oxide synthase (NOS) is required in mammals to generate NO for regulating blood pressure, synaptic response, and immune defense. NOS is a large homodimer with well characterized reductase and oxygenase domains that coordinate a multistep, interdomain electron transfer mechanism to oxidize L-arginine and generate NO. Ca2+-calmodulin (CaM) binds between the reductase and oxygenase domains to activate NO synthesis. Although NOS has long been proposed to adopt distinct conformations that alternate between interflavin and FMN-heme electron transfer steps, structures of the holoenzyme have remained elusive and the CaM-bound arrangement is unknown. Here we have applied single particle electron microscopy (EM) methods to characterize the full-length of the neuronal isoform (nNOS) complex and determine the structural mechanism of CaM activation. We have identified that nNOS adopts an ensemble of open and closed conformational states and that CaM binding induces a dramatic rearrangement of the reductase domain. Our three-dimensional reconstruction of the intact nNOS-CaM complex reveals a closed conformation and a cross-monomer arrangement with the FMN domain rotated away from the NADPH-FAD center, toward the oxygenase dimer. This work captures, for the first time, the reductase-oxygenase structural arrangement and the CaM-dependent release of the FMN domain that coordinates to drive electron transfer across the domains during catalysis.	[Yokom, Adam L.; Southworth, Daniel R.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Morishima, Yoshihiro; Lau, Miranda; Osawa, Yoichi] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Yokom, Adam L.; Glukhova, Alisa] Univ Michigan, Program Chem Biol, Ann Arbor, MI 48109 USA; [Su, Min; Southworth, Daniel R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Southworth, DR (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	dsouth@umich.edu		Glukhova, Alisa/0000-0003-4146-965X	American Heart Association; National Institutes of Health [GM077430]; University of Michigan Protein Folding Diseases Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Protein Folding Diseases Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an American Heart Association Scientist Development Grant, National Institutes of Health Grant GM077430 (to Y. O.), and the University of Michigan Protein Folding Diseases Initiative.	ABUSOUD HM, 1993, P NATL ACAD SCI USA, V90, P10769, DOI 10.1073/pnas.90.22.10769; ABUSOUD HM, 1994, J BIOL CHEM, V269, P32047; Adak S, 2001, J BIOL CHEM, V276, P23246, DOI 10.1074/jbc.M102509200; Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Bender AT, 2000, J BIOL CHEM, V275, P26018, DOI 10.1074/jbc.275.34.26018; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Bogdan C, 2001, NAT IMMUNOL; BREDT DS, 1990, P NATL ACAD SCI USA, V87, P682, DOI 10.1073/pnas.87.2.682; Craig DH, 2002, J BIOL CHEM, V277, P33987, DOI 10.1074/jbc.M203118200; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Daff S, 2010, NITRIC OXIDE-BIOL CH, V23, P1, DOI 10.1016/j.niox.2010.03.001; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gachhui R, 1996, J BIOL CHEM, V271, P20594, DOI 10.1074/jbc.271.34.20594; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; Ghosh S, 1999, J BIOL CHEM, V274, P24100, DOI 10.1074/jbc.274.34.24100; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Haque MM, 2012, J BIOL CHEM, V287, P30105, DOI 10.1074/jbc.M112.339697; Ilagan RP, 2009, BIOCHEMISTRY-US, V48, P3864, DOI 10.1021/bi8021087; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; Iyanagi T, 2012, ARCH BIOCHEM BIOPHYS, V528, P72, DOI 10.1016/j.abb.2012.09.002; Knudsen GM, 2003, J BIOL CHEM, V278, P31814, DOI 10.1074/jbc.M303267200; Li HY, 2008, J BIOL CHEM, V283, P34762, DOI 10.1074/jbc.M806949200; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Miller RT, 1999, BIOCHEM BIOPH RES CO, V265, P184, DOI 10.1006/bbrc.1999.1643; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Panda K, 2001, J BIOL CHEM, V276, P23349, DOI 10.1074/jbc.M100687200; Panda SP, 2013, ARCH BIOCHEM BIOPHYS, V533, P88, DOI 10.1016/j.abb.2013.03.004; PARADIES HH, 1979, J BIOL CHEM, V254, P7495; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Roman LJ, 2006, J BIOL CHEM, V281, P23111, DOI 10.1074/jbc.M603671200; Roman LJ, 2000, J BIOL CHEM, V275, P29225, DOI 10.1074/jbc.M004766200; Rozhkova EA, 2002, J BIOL CHEM, V277, P16888, DOI 10.1074/jbc.M200642200; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Siddhanta U, 1996, J BIOL CHEM, V271, P7309, DOI 10.1074/jbc.271.13.7309; Smith BC, 2013, P NATL ACAD SCI USA, V110, pE3577, DOI 10.1073/pnas.1313331110; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Southworth DR, 2008, MOL CELL, V32, P631, DOI 10.1016/j.molcel.2008.10.024; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tejero J, 2010, J BIOL CHEM, V285, P25941, DOI 10.1074/jbc.M110.126797; Tiso M, 2007, BIOCHEMISTRY-US, V46, P14418, DOI 10.1021/bi701646k; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; Xia CW, 2009, J BIOL CHEM, V284, P30708, DOI 10.1074/jbc.M109.031682; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007	48	33	33	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 13	2014	289	24					16855	16865		10.1074/jbc.M114.564005	http://dx.doi.org/10.1074/jbc.M114.564005			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9GQ	24737326	Green Published, hybrid			2022-12-25	WOS:000338016200023
J	Shibasaki, K; Ikenaka, K; Tamalu, F; Tominaga, M; Ishizaki, Y				Shibasaki, Koji; Ikenaka, Kazuhiro; Tamalu, Fuminobu; Tominaga, Makoto; Ishizaki, Yasuki			A Novel Subtype of Astrocytes Expressing TRPV4 (Transient Receptor Potential Vanilloid 4) Regulates Neuronal Excitability via Release of Gliotransmitters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-EVOKED ACTIVATION; CATION CHANNEL; ATP RELEASE; SYNAPTIC-TRANSMISSION; ASTROGLIAL NETWORKS; CALCIUM TRANSIENTS; NEURAL-ACTIVITY; HIPPOCAMPUS; ENDFEET; STRETCH	Astrocytes play active roles in the regulation of synaptic transmission. Neuronal excitation can evoke Ca2+ transients in astrocytes, and these Ca2+ transients can modulate neuronal excitability. Although only a subset of astrocytes appears to communicate with neurons, the types of astrocytes that can regulate neuronal excitability are poorly characterized. We found that similar to 30% of astrocytes in the brain express transient receptor potential vanilloid 4 (TRPV4), indicating that astrocytic subtypes can be classified on the basis of their expression patterns. When TRPV4(+) astrocytes are activated by ligands such as arachidonic acid, the activation propagates to neighboring astrocytes through gap junctions and by ATP release from the TRPV4(+) astrocytes. After activation, both TRPV4(+) and TRPV4(-) astrocytes release glutamate, which acts as an excitatory gliotransmitter to increase synaptic transmission through type 1 metabotropic glutamate receptor (mGluR). Our results indicate that TRPV4(+) astrocytes constitute a novel subtype of the population and are solely responsible for initiating excitatory gliotransmitter release to enhance synaptic transmission. We propose that TRPV4(+) astrocytes form a core of excitatory glial assembly in the brain and function to efficiently increase neuronal excitation in response to endogenous TRPV4 ligands.	[Shibasaki, Koji; Ishizaki, Yasuki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma 3718511, Japan; [Ikenaka, Kazuhiro] Natl Inst Nat Sci, Div Neurobiol Neuroinformat, Okazaki, Aichi 4448787, Japan; [Tominaga, Makoto] Natl Inst Nat Sci, Div Cell Signaling, Natl Inst Physiol Sci, Okazaki, Aichi 4448787, Japan; [Tominaga, Makoto] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Ikenaka, Kazuhiro; Tominaga, Makoto] Grad Univ Adv Studies, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Tamalu, Fuminobu] Saitama Med Univ, Dept Physiol, Moroyama, Saitama 3500495, Japan	Gunma University; National Institutes of Natural Sciences (NINS) - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Graduate University for Advanced Studies - Japan; Saitama Medical University	Shibasaki, K (corresponding author), Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma 3718511, Japan.	shibasaki@gunma-u.ac.jp	Tamalu, Fuminobu/AAE-4580-2020; Shibasaki, Koji/U-8674-2018; Ishizaki, Yasuki/AAB-1209-2020	Tamalu, Fuminobu/0000-0002-2756-8822; Shibasaki, Koji/0000-0003-2330-1749; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology [21200012, 20399554, 24111507, 26111702, 26117502, 23650159, 18077012]; Uehara Memorial Foundation; Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation [13C2]; Takeda Science Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-aid for Scientific Research (KAKENHI Projects 21200012, 20399554, 24111507, and 26111702 "Brain Environment" and 26117502 "glial assembly" (to K. S.), 23650159 (to Y. I.), and 18077012 (to M. T.)) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, by grants from the Uehara Memorial Foundation, Sumitomo Foundation, Brain Science Foundation, Narishige Neuroscience Research Foundation, and Salt Science Research Foundation no. 13C2 (all to K. S.), and by a grant from the Takeda Science Foundation (to K. S. and Y. I.).	Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Benfenati V, 2011, P NATL ACAD SCI USA, V108, P2563, DOI 10.1073/pnas.1012867108; Butenko O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039959; Cao X, 2013, NAT MED, V19, P773, DOI 10.1038/nm.3162; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Gevaert T, 2007, J CLIN INVEST, V117, P3453, DOI 10.1172/JCI31766; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Guler AD, 2002, J NEUROSCI, V22, P6408; Kang N, 2005, J NEUROPHYSIOL, V94, P4121, DOI 10.1152/jn.00448.2005; Kettenmann H. R. B., 2005, NEUROGLIA, P135; Koizumi S, 2003, P NATL ACAD SCI USA, V100, P11023, DOI 10.1073/pnas.1834448100; Lee HU, 2013, GLIA, V61, P210, DOI 10.1002/glia.22427; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Mandadi S, 2009, PFLUG ARCH EUR J PHY, V458, P1093, DOI 10.1007/s00424-009-0703-x; Mihara H, 2011, J PHYSIOL-LONDON, V589, P3471, DOI 10.1113/jphysiol.2011.207829; Mihara H, 2010, J NEUROSCI, V30, P16536, DOI 10.1523/JNEUROSCI.4426-10.2010; Mishima T, 2010, J NEUROSCI, V30, P3093, DOI 10.1523/JNEUROSCI.5065-09.2010; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Newman EA, 2003, TRENDS NEUROSCI, V26, P536, DOI 10.1016/S0166-2236(03)00237-6; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Pannasch U, 2013, TRENDS NEUROSCI, V36, P405, DOI 10.1016/j.tins.2013.04.004; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Piet R, 2007, J NEUROSCI, V27, P4027, DOI 10.1523/JNEUROSCI.0462-07.2007; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Sasaki T, 2012, P NATL ACAD SCI USA, V109, P20720, DOI 10.1073/pnas.1213458109; Sasaki T, 2011, CEREB CORTEX, V21, P1889, DOI 10.1093/cercor/bhq256; Sasaki T, 2011, SCIENCE, V331, P599, DOI 10.1126/science.1197598; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shi M, 2013, ACTA NEUROPATHOL, V126, P725, DOI 10.1007/s00401-013-1166-x; Shibasaki K, 2007, GENE EXPR PATTERNS, V7, P57, DOI 10.1016/j.modgep.2006.05.008; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shibasaki K, 2013, BIOCHEM BIOPH RES CO, V441, P327, DOI 10.1016/j.bbrc.2013.10.046; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Takayama Y., 2014, FASEB J IN PRESS; Theodosis DT, 2008, PHYSIOL REV, V88, P983, DOI 10.1152/physrev.00036.2007; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Wissenbach U, 2000, FEBS LETT, V485, P127, DOI 10.1016/S0014-5793(00)02212-2	45	72	72	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14470	14480		10.1074/jbc.M114.557132	http://dx.doi.org/10.1074/jbc.M114.557132			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24737318	hybrid, Green Published			2022-12-25	WOS:000337248100004
J	Suzuki, H; Ohto, U; Higaki, K; Mena-Barragan, T; Aguilar-Moncayo, M; Mellet, CO; Nanba, E; Fernandez, JMG; Suzuki, Y; Shimizu, T				Suzuki, Hironori; Ohto, Umeharu; Higaki, Katsumi; Mena-Barragan, Teresa; Aguilar-Moncayo, Matilde; Ortiz Mellet, Carmen; Nanba, Eiji; Garcia Fernandez, Jose M.; Suzuki, Yoshiyuki; Shimizu, Toshiyuki			Structural Basis of Pharmacological Chaperoning for Human beta-Galactosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; MUTANT ENZYME; CHEMICAL CHAPERONES; GM1 GANGLIOSIDOSIS; GENE-MUTATIONS; FABRY DISEASE; THERAPY; PURIFICATION; REPLACEMENT; GLUCOSIDASE	G(M1) gangliosidosis and Morquio B disease are autosomal recessive diseases caused by the defect in the lysosomal beta-galactosidase (beta-Gal), frequently related to misfolding and subsequent endoplasmic reticulum-associated degradation. Pharmacological chaperone (PC) therapy is a newly developed molecular therapeutic approach by using small molecule ligands of the mutant enzyme that are able to promote the correct folding and prevent endoplasmic reticulum-associated degradation and promote trafficking to the lysosome. In this report, we describe the enzymological properties of purified recombinant human beta-Gal(WT) and two representative mutations in GM1 gangliosidosis Japanese patients, beta-Gal(R201C) and beta-Gal(151T). We have also evaluated the PC effect of two competitive inhibitors of beta-Gal. Moreover, we provide a detailed atomic view of the recognition mechanism of these compounds in comparison with two structurally related analogues. All compounds bind to the active site of beta-Gal with the sugar-mimicking moiety making hydrogen bonds to active site residues. Moreover, the binding affinity, the enzyme selectivity, and the PC potential are strongly affected by the mono-or bicyclic structure of the core as well as the orientation, nature, and length of the exocyclic substituent. These results provide understanding on the mechanism of action of beta-Gal selective chaperoning by newly developed PC compounds.	[Suzuki, Hironori; Ohto, Umeharu; Shimizu, Toshiyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Higaki, Katsumi; Nanba, Eiji] Tottori Univ, Res Ctr Biosci & Technol, Div Funct Genom, Yonago, Tottori 6838503, Japan; [Mena-Barragan, Teresa; Aguilar-Moncayo, Matilde; Ortiz Mellet, Carmen] Univ Seville, Fac Chem, Dept Organ Chem, E-41012 Seville, Spain; [Garcia Fernandez, Jose M.] Univ Seville, CSIC, Inst Chem Res IIQ, E-41092 Seville, Spain; [Suzuki, Yoshiyuki] Int Univ Hlth & Welf Grad Sch, Otawara, Tochigi 3248501, Japan; [Shimizu, Toshiyuki] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Tottori University; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); International University of Health & Welfare; Japan Science & Technology Agency (JST)	Shimizu, T (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1130033, Japan.	shimizu@mol.f.u-tokyo.ac.jp	Fernandez, Jose M Garcia/D-8105-2011; Mellet, Carmen Ortiz/C-7993-2011; Aguilar-Moncayo, Matilde/K-8113-2014	Fernandez, Jose M Garcia/0000-0002-6827-0387; Mellet, Carmen Ortiz/0000-0002-7676-7721; Aguilar-Moncayo, Matilde/0000-0003-3652-2639	Ministry of Education, Culture, Science, Sports, and Technology of Japan; Ministry of Health, Labor and Welfare of Japan [H20-Kokoro-022, H22-Nanji-Ippan-002]; Japan Science and Technology Agency [AS232Z00009G]; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Spanish Ministerio de Economia y Competitividad [SAF2010-15670, CTQ2010-15848]; Fundacion Ramon Areces; Junta de Andalucia; European Regional Development Funds (FEDER); Eurpean Social Funds (FSE); Center for Research, Technology and Innovation of the University of Seville (CITIUS);  [13680918];  [14207106]	Ministry of Education, Culture, Science, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Spanish Ministerio de Economia y Competitividad(Spanish Government); Fundacion Ramon Areces; Junta de Andalucia(Junta de Andalucia); European Regional Development Funds (FEDER)(European Commission); Eurpean Social Funds (FSE); Center for Research, Technology and Innovation of the University of Seville (CITIUS); ; 	This work was supported by Grants-in-Aid from the Ministry of Education, Culture, Science, Sports, and Technology of Japan (to U. O. and T. S.) and Grants 13680918 and 14207106 (to Y. S.), Ministry of Health, Labor and Welfare of Japan H20-Kokoro-022 and H22-Nanji-Ippan-002, and Japan Science and Technology Agency Grant AS232Z00009G (to Y. S.), grants from the Takeda Science Foundation and Mochida Memorial Foundation for Medical and Pharmaceutical Research (to U. O. and T. S.), and Spanish Ministerio de Economia y Competitividad contracts SAF2010-15670 and CTQ2010-15848, the Fundacion Ramon Areces, the Junta de Andalucia, the European Regional Development Funds (FEDER), the Eurpean Social Funds (FSE), and the Center for Research, Technology and Innovation of the University of Seville (CITIUS).	Aguilar M, 2008, CHEMBIOCHEM, V9, P2612, DOI 10.1002/cbic.200800451; Aguilar-Moncayo M, 2012, CHEM COMMUN, V48, P6514, DOI 10.1039/c2cc32065g; Aguilar-Moncayo M, 2011, ORG BIOMOL CHEM, V9, P3698, DOI 10.1039/c1ob05234a; ALPERS DH, 1969, GASTROENTEROLOGY, V56, P985; ASP NG, 1972, ANAL BIOCHEM, V47, P527, DOI 10.1016/0003-2697(72)90147-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benito JM, 2011, EXPERT OPIN THER PAT, V21, P885, DOI 10.1517/13543776.2011.569162; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Callahan JW, 1999, BBA-MOL BASIS DIS, V1455, P85, DOI 10.1016/S0925-4439(99)00075-7; Coelho C. J., 1999, CLIN BIOCHEM, V32, P1801; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; DISTLER JJ, 1973, J BIOL CHEM, V248, P6772; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan JQ, 2008, BIOL CHEM, V389, P1, DOI 10.1515/BC.2008.009; Guce AI, 2011, CHEM BIOL, V18, P1521, DOI 10.1016/j.chembiol.2011.10.012; Higaki K, 2011, HUM MUTAT, V32, P843, DOI 10.1002/humu.21516; Hofer D, 2009, HUM MUTAT, V30, P1214, DOI 10.1002/humu.21031; Kuno S, 2013, CARBOHYD RES, V368, P8, DOI 10.1016/j.carres.2012.12.010; Luan Z, 2009, CHEMBIOCHEM, V10, P2780, DOI 10.1002/cbic.200900442; Matsuda J, 2003, P NATL ACAD SCI USA, V100, P15912, DOI 10.1073/pnas.2536657100; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ogawa S, 2002, BIOORGAN MED CHEM, V10, P1967, DOI 10.1016/S0968-0896(02)00005-6; Ohto U, 2012, J BIOL CHEM, V287, P1801, DOI 10.1074/jbc.M111.293795; OSHIMA A, 1991, AM J HUM GENET, V49, P1091; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parenti G, 2009, EMBO MOL MED, V1, P268, DOI 10.1002/emmm.200900036; Perez VMD, 2000, J ORG CHEM, V65, P136, DOI 10.1021/jo991242o; Platt FM, 2008, ACTA PAEDIATR, V97, P88, DOI 10.1111/j.1651-2227.2008.00656.x; Sanchez-Fernandez EM, 2012, CHEM-EUR J, V18, P8527, DOI 10.1002/chem.201200279; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Suzuki Y., 2013, ONLINE METABOLIC MOL; Suzuki Y, 2013, BRAIN DEV-JPN, V35, P515, DOI 10.1016/j.braindev.2012.12.002; Suzuki Y, 2009, PERSPECT MED CHEM, V3, P7; Takai T, 2013, MOL THER, V21, P526, DOI 10.1038/mt.2012.263; Usui K, 2012, ACTA CRYSTALLOGR F, V68, P73, DOI 10.1107/S1744309111047920; YOSHIDA K, 1991, AM J HUM GENET, V49, P435	37	49	52	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14560	14568		10.1074/jbc.M113.529529	http://dx.doi.org/10.1074/jbc.M113.529529			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24737316	Green Published, hybrid			2022-12-25	WOS:000337248100014
J	Reekie, J; Donovan, B; Guy, R; Hocking, JS; Jorm, L; Kaldor, JM; Mak, DB; Preen, D; Pearson, S; Roberts, CL; Stewart, L; Wand, H; Ward, J; Liu, B				Reekie, Joanne; Donovan, Basil; Guy, Rebecca; Hocking, Jane S.; Jorm, Louisa; Kaldor, John M.; Mak, Donna B.; Preen, David; Pearson, Sallie; Roberts, Christine L.; Stewart, Louise; Wand, Handan; Ward, James; Liu, Bette			Hospitalisations for Pelvic Inflammatory Disease Temporally Related to a Diagnosis of Chlamydia or Gonorrhoea: A Retrospective Cohort Study	PLOS ONE			English	Article							CLINICAL HEALTH PEACH; INFECTION; WOMEN; TRACHOMATIS; AUSTRALIA; ADOLESCENTS; POPULATION; PREVENTION; SEQUELAE; TRIAL	Objectives: The presence and severity of pelvic inflammatory disease (PID) symptoms are thought to vary by microbiological etiology but there is limited empirical evidence. We sought to estimate and compare the rates of hospitalisation for PID temporally related to diagnoses of gonorrhoea and chlamydia. Methods: All women, aged 15-45 years in the Australian state of New South Wales (NSW), with a diagnosis of chlamydia or gonorrhoea between 01/07/2000 and 31/12/2008 were followed by record linkage for up to one year after their chlamydia or gonorrhoea diagnosis for hospitalisations for PID. Standardised incidence ratios compared the incidence of PID hospitalisations to the age-equivalent NSW population. Results: A total of 38,193 women had a chlamydia diagnosis, of which 483 were hospitalised for PID; incidence rate (IR) 13.9 per 1000 person-years of follow-up (PYFU) (95% CI 12.6-15.1). In contrast, 1015 had a gonorrhoea diagnosis, of which 45 were hospitalised for PID (IR 50.8 per 1000 PYFU, 95% CI 36.0-65.6). The annual incidence of PID hospitalisation temporally related to a chlamydia or gonorrhoea diagnosis was 27.0 (95% CI 24.4-29.8) and 96.6 (95% CI 64.7-138.8) times greater, respectively, than the age-equivalent NSW female population. Younger age, socio-economic disadvantage, having a diagnosis prior to 2005 and having a prior birth were also associated with being hospitalised for PID. Conclusions: Chlamydia and gonorrhoea are both associated with large increases in the risk of PID hospitalisation. Our data suggest the risk of PID hospitalisation is much higher for gonorrhoea than chlamydia; however, further research is needed to confirm this finding.	[Reekie, Joanne; Donovan, Basil; Guy, Rebecca; Kaldor, John M.; Wand, Handan; Ward, James] UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Donovan, Basil] Sydney Hosp, Sydney Sexual Hlth Ctr, Sydney, NSW, Australia; [Hocking, Jane S.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Jorm, Louisa] Univ Western Sydney, Ctr Hlth Res, Sydney, NSW, Australia; [Mak, Donna B.] Univ Notre Dame, Sch Med, Fremantle, WA, Australia; [Preen, David] Univ Western Australia, Ctr Hlth Serv & Res, Crawley, WA, Australia; [Pearson, Sallie] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Pearson, Sallie] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Roberts, Christine L.] Univ Sydney, Kolling Inst Med Res, Sydney, NSW 2006, Australia; [Stewart, Louise] Curtin Univ, Ctr Populat Hlth Res, Perth, WA 6845, Australia; [Ward, James] Baker IDI, Alice Springs, NT, Australia; [Liu, Bette] UNSW Australia, Sch Publ Hlth & Community Med, Sydney, NSW, Australia; [Liu, Bette] Sax Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; University of Melbourne; Western Sydney University; University of Notre Dame Australia; University of Western Australia; University of Sydney; University of Sydney; University of Sydney; Kolling Institute of Medical Research; Curtin University; Baker Heart and Diabetes Institute; University of New South Wales Sydney; University of Sydney	Reekie, J (corresponding author), UNSW Australia, Kirby Inst, Sydney, NSW, Australia.	jreekie@kirby.unsw.edu.au	Stewart, Louise M/I-3753-2013; Donovan, Basil J/K-1246-2012; Hocking, Jane/AAD-5203-2021; Jorm, Louisa/AAN-6874-2020; Ward, James/ABD-1439-2020; Preen, David B/H-5663-2014	Stewart, Louise M/0000-0003-2015-6320; Donovan, Basil J/0000-0001-8851-4126; Hocking, Jane/0000-0001-9329-8501; Jorm, Louisa/0000-0003-0390-661X; Ward, James/0000-0002-2892-4542; Preen, David B/0000-0002-2982-2169; Mak, Donna/0000-0003-3215-4330; Guy, Rebecca/0000-0002-2929-4634	National Health and Medical Research Council (NHMRC) [1020628]; NHMRC	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by the National Health and Medical Research Council (NHMRC) grant #1020628. BD, RG, JH, JK, CR, and BL are all supported by NHMRC Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2012, SEX HEALTH, V9, P399, DOI 10.1071/SH11183; Ansari Z, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-475; Australian Bureau of Statistics, 2012, AUSTR SOC TRENDS SEX; Australian Bureau of Statistics, 2011, 2011 CENS POP HOUS A; Bakken IJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-130; Centers for Disease Control and Prevention, 2012, SEX TRANSM DIS SURV; Chen MY, 2004, INT J STD AIDS, V15, P762, DOI 10.1258/0956462042395113; Davies B, 2013, SEX TRANSM DIS, V40, P230, DOI 10.1097/OLQ.0b013e31827b9d75; Department of Health and Aged Care & National Key Centre for Social Applications of Geographical Information Systems (GISCA), 2001, MEAS REM ACC REM IND; European Centre for Disease Prevention and Control, 2012, SEX TRANSM INF EUR 1; Gray-Swain MR, 2006, CURR OPIN OBSTET GYN, V18, P503, DOI 10.1097/01.gco.0000242952.87125.69; Guy R, 2012, SEX HEALTH, V9, P205, DOI 10.1071/SH11074; Herzog SA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-187; Kong FYS, 2011, MED J AUSTRALIA, V194, P249, DOI 10.5694/j.1326-5377.2011.tb02957.x; Liu B, 2013, SEX TRANSM INFECT, V89, P45, DOI 10.1136/sextrans-2011-050252; Low N, 2006, SEX TRANSM INFECT, V82, P212, DOI 10.1136/sti.2005.017186; McKinley S, 2000, HEART LUNG, V29, P237, DOI 10.1067/mhl.2000.106940; Ness RB, 2006, SEX TRANSM DIS, V33, P137, DOI 10.1097/01.olq.0000187205.67390.d1; Ness RB, 2002, AM J OBSTET GYNECOL, V186, P929, DOI 10.1067/mob.2002.121625; Ness RB, 2008, SEX TRANSM DIS, V35, P129, DOI 10.1097/OLQ.0b013e3181557c25; Oakeshott P., 2010, BRIT MED J, V340, pc1642, DOI [10.1136/bmj.c1642, DOI 10.1136/BMJ.C1642]; Risser WL, 2012, INT J STD AIDS, V23, P457, DOI 10.1258/ijsa.2011.011362; Scholes D, 2012, SEX TRANSM DIS, V39, P81, DOI 10.1097/OLQ.0b013e31823e3009; Short VL, 2009, CLIN INFECT DIS, V48, P41, DOI 10.1086/594123; SOPER DE, 1994, AM J OBSTET GYNECOL, V170, P1008, DOI 10.1016/S0002-9378(94)70094-X; Statistics ABo, 2006, CENS POP HOUS SOC IN; The Kirby Institute, 2012, BLOODB VIR SEX TRANS; The Kirby Institute, 2012, HIV VIR HEP SEX TRAN; WASHINGTON AE, 1991, JAMA-J AM MED ASSOC, V266, P2581, DOI 10.1001/jama.266.18.2581; WASSERHEIT JN, 1986, ANN INTERN MED, V104, P187, DOI 10.7326/0003-4819-104-2-187; WESTROM L, 1992, SEX TRANSM DIS, V19, P185, DOI 10.1097/00007435-199207000-00001; WHO, 2010, INT STAT CLASS DIS R	32	22	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94361	10.1371/journal.pone.0094361	http://dx.doi.org/10.1371/journal.pone.0094361			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743388	gold, Green Published			2022-12-25	WOS:000335309100030
J	Zain, SM; Mohamed, R; Cooper, DN; Razali, R; Rampal, S; Mahadeva, S; Chan, WK; Anwar, A; Rosli, NSM; Mahfudz, AS; Cheah, PL; Basu, RC; Mohamed, Z				Zain, Shamsul Mohd; Mohamed, Rosmawati; Cooper, David N.; Razali, Rozaimi; Rampal, Sanjay; Mahadeva, Sanjiv; Chan, Wah-Kheong; Anwar, Arif; Rosli, Nurul Shielawati Mohamed; Mahfudz, Anis Shafina; Cheah, Phaik-Leng; Basu, Roma Choudhury; Mohamed, Zahurin			Genome-Wide Analysis of Copy Number Variation Identifies Candidate Gene Loci Associated with the Progression of Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							PANCREATIC-POLYPEPTIDE; NATURAL-HISTORY; NEUROPEPTIDE-Y; FOOD-INTAKE; EXPRESSION; OBESITY; SYSTEM; METABOLISM; RECEPTOR; COMMON	Between 10 and 25% of individuals with non-alcoholic fatty liver disease (NAFLD) develop hepatic fibrosis leading to cirrhosis and hepatocellular carcinoma (HCC). To investigate the molecular basis of disease progression, we performed a genome-wide analysis of copy number variation (CNV) in a total of 49 patients with NAFLD [10 simple steatosis and 39 nonalcoholic steatohepatitis (NASH)] and 49 matched controls using high-density comparative genomic hybridization (CGH) microarrays. A total of 11 CNVs were found to be unique to individuals with simple steatosis, whilst 22 were common between simple steatosis and NASH, and 224 were unique to NASH. We postulated that these CNVs could be involved in the pathogenesis of NAFLD progression. After stringent filtering, we identified four rare and/or novel CNVs that may influence the pathogenesis of NASH. Two of these CNVs, located at 13q12.11 and 12q13.2 respectively, harbour the exportin 4 (XPO4) and phosphodiesterase 1B (PDE1B) genes which are already known to be involved in the etiology of liver cirrhosis and HCC. Cross-comparison of the genes located at these four CNV loci with genes already known to be associated with NAFLD yielded a set of genes associated with shared biological processes including cell death, the key process involved in 'second hit' hepatic injury. To our knowledge, this pilot study is the first to provide CNV information of potential relevance to the NAFLD spectrum. These data could prove invaluable in predicting patients at risk of developing NAFLD and more importantly, those who will subsequently progress to NASH.	[Zain, Shamsul Mohd; Mohamed, Zahurin] Univ Malaya, Fac Med, Pharmacogen Lab, Kuala Lumpur, Malaysia; [Zain, Shamsul Mohd; Mohamed, Zahurin] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia; [Mohamed, Rosmawati; Mahadeva, Sanjiv; Chan, Wah-Kheong] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF10 3AX, S Glam, Wales; [Razali, Rozaimi; Anwar, Arif; Rosli, Nurul Shielawati Mohamed] Univ Malaya, Sengen Sdn Bhd, Kuala Lumpur, Malaysia; [Rampal, Sanjay] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Mahfudz, Anis Shafina] Univ Teknol MARA, Fac Med, Med Imaging Unit, Selangor, Malaysia; [Cheah, Phaik-Leng] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Basu, Roma Choudhury] Univ Malaya, Med Ctr, Clin Invest Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Cardiff University; Universiti Malaya; Universiti Malaya; Universiti Teknologi MARA; Universiti Malaya; Universiti Malaya	Zain, SM (corresponding author), Univ Malaya, Fac Med, Pharmacogen Lab, Kuala Lumpur, Malaysia.	soulz712@gmail.com; ros@ummc.edu.my	Cooper, David N/H-4384-2011; Razali, Rozaimi/AAF-9115-2021; Zain, Shamsul Mohd/U-8718-2019; RAZALI, ROZAIMI/O-8694-2017; ZAIN, SHAMSUL MOHD/N-6995-2013; Chan, Wah Kheong/AGA-6636-2022; Chan, Wah-Kheong/H-2329-2016; Mohamed, Zahurin/C-1112-2010; Mahfudz, Anis Shafina/G-8815-2014; Rampal, Sanjay/B-9691-2010; Mahadeva, Sanjiv/E-1711-2011	Cooper, David N/0000-0002-8943-8484; Razali, Rozaimi/0000-0002-8996-3975; Zain, Shamsul Mohd/0000-0002-3441-6659; RAZALI, ROZAIMI/0000-0002-8996-3975; ZAIN, SHAMSUL MOHD/0000-0002-3441-6659; Chan, Wah Kheong/0000-0002-9105-5837; Chan, Wah-Kheong/0000-0002-9105-5837; Mohamed, Zahurin/0000-0002-4396-0517; Mahfudz, Anis Shafina/0000-0002-6432-2194; Rampal, Sanjay/0000-0002-0105-6407; Mahadeva, Sanjiv/0000-0001-5824-0590	High Impact Research Ministry of Higher Education (HIRMOHE) of Malaysia [E000049-20001]	High Impact Research Ministry of Higher Education (HIRMOHE) of Malaysia	This work was supported by High Impact Research Ministry of Higher Education (HIRMOHE) of Malaysia Grant E000049-20001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almon RR, 2012, GENE REGUL SYST BIO, V6, P151, DOI 10.4137/GRSB.S10371; Ashla AA, 2010, HEPATOL RES, V40, P594, DOI 10.1111/j.1872-034X.2010.00646.x; Bae JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019091; Bloomfeld RS, 1999, PHYSIOL BEHAV, V66, P203, DOI 10.1016/S0031-9384(98)00266-2; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Caldwell S, 2010, DIGEST DIS, V28, P162, DOI 10.1159/000282081; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chang ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-109; Clarke AJ, 2010, EUR J HUM GENET, V18, P859, DOI 10.1038/ejhg.2010.35; Curtis C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-588; Dong D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031540; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Hernaez R, 2012, GASTROENT HEPAT-BARC, V35, P32, DOI 10.1016/j.gastrohep.2011.08.002; Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jou J, 2008, SEMIN LIVER DIS, V28, P370, DOI 10.1055/s-0028-1091981; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P814; Liang XT, 2011, J GASTROEN HEPATOL, V26, P544, DOI 10.1111/j.1440-1746.2010.06434.x; Lin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008488; Lionel AC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002464; Liu N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-231; Liu YL, 2008, INT J OBESITY, V32, P1712, DOI 10.1038/ijo.2008.160; Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1; Na K, 2013, INT J CANCER, V133, P408, DOI 10.1002/ijc.28020; Nagashima S, 2011, J ATHEROSCLER THROMB, V18, P190, DOI 10.5551/jat.6478; Nguyen DQ, 2008, GENOME RES, V18, P1711, DOI 10.1101/gr.077289.108; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Quiroga AD, 2012, HEPATOLOGY, V56, P2188, DOI 10.1002/hep.25961; Rappaport N, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat018; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Royo F., 2013, British Journal of Medicine and Medical Research, V3, P1773; Ruhl CE, 2005, CLIN GASTROENTEROL H, V3, P1260, DOI 10.1016/S1542-3565(05)00743-3; Sanyal Arun J, 2002, Gastroenterology, V123, P1705, DOI 10.1053/gast.2002.36572; Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607; Zain SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058538; Zain SM, 2012, HUM GENET, V131, P1145, DOI 10.1007/s00439-012-1141-y; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang H, 2013, EXP THER MED, V5, P119, DOI 10.3892/etm.2012.750; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011	53	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95604	10.1371/journal.pone.0095604	http://dx.doi.org/10.1371/journal.pone.0095604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743702	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000335309100145
J	Greig, J; Thurtle, N; Cooney, L; Ariti, C; Ahmed, AO; Ashagre, T; Ayela, A; Chukwumalu, K; Criado-Perez, A; Gomez-Restrepo, C; Meredith, C; Neri, A; Stellmach, D; Sani-Gwarzo, N; Nasidi, A; Shanks, L; Dargan, PI				Greig, Jane; Thurtle, Natalie; Cooney, Lauren; Ariti, Cono; Ahmed, Abdulkadir Ola; Ashagre, Teshome; Ayela, Anthony; Chukwumalu, Kingsley; Criado-Perez, Alison; Gomez-Restrepo, Camilo; Meredith, Caitlin; Neri, Antonio; Stellmach, Darryl; Sani-Gwarzo, Nasir; Nasidi, Abdulsalami; Shanks, Leslie; Dargan, Paul I.			Association of Blood Lead Level with Neurological Features in 972 Children Affected by an Acute Severe Lead Poisoning Outbreak in Zamfara State, Northern Nigeria	PLOS ONE			English	Article							EXPOSURE; ENCEPHALOPATHY; CADMIUM; THERAPY; FALL	Background: In 2010, Medecins Sans Frontieres (MSF) investigated reports of high mortality in young children in Zamfara State, Nigeria, leading to confirmation of villages with widespread acute severe lead poisoning. In a retrospective analysis, we aimed to determine venous blood lead level (VBLL) thresholds and risk factors for encephalopathy using MSF programmatic data from the first year of the outbreak response. Methods and Findings: We included children aged <= 5 years with VBLL >= 45 mu g/dL before any chelation and recorded neurological status. Odds ratios (OR) for neurological features were estimated; the final model was adjusted for age and baseline VBLL, using random effects for village of residence. 972 children met inclusion criteria: 885 (91%) had no neurological features; 34 (4%) had severe features; 47 (5%) had reported recent seizures; and six (1%) had other neurological abnormalities. The geometric mean VBLLs for all groups with neurological features were >100 mu g/dL vs 65.9 mu g/dL for those without neurological features. The adjusted OR for neurological features increased with increasing VBLL: from 2.75, 95%CI 1.27-5.98 (80-99.9 mu g/dL) to 22.95, 95%CI 10.54-49.96 (>= 120 mu g/dL). Neurological features were associated with younger age (OR 4.77 [95% CI 2.50-9.11] for 1-<2 years and 2.69 [95% CI 1.15-6.26] for 2-<3 years, both vs 3-5 years). Severe neurological features were seen at VBLL,105 mg/dL only in those with malaria. Interpretation: Increasing VBLL (from >= 80 mu g/dL) and age 1-<3 years were strongly associated with neurological features; in those tested for malaria, a positive test was also strongly associated. These factors will help clinicians managing children with lead poisoning in prioritising therapy and developing chelation protocols.	[Greig, Jane] Med Sans Frontieres, Manson Unit, London, England; [Thurtle, Natalie; Cooney, Lauren; Shanks, Leslie; Dargan, Paul I.] Med Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands; [Ariti, Cono] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Ahmed, Abdulkadir Ola; Ashagre, Teshome; Ayela, Anthony; Chukwumalu, Kingsley; Criado-Perez, Alison; Gomez-Restrepo, Camilo; Meredith, Caitlin; Stellmach, Darryl] Med Sans Frontieres, Nigeria Miss, Sokoto, Niger; [Neri, Antonio] Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA; [Stellmach, Darryl] Univ Oxford, Inst Social & Cultural Anthropol, Oxford, England; [Sani-Gwarzo, Nasir] Fed Minist Hlth, Dept Publ Hlth, Abuja, Nigeria; [Nasidi, Abdulsalami] Nigeria Ctr Dis Control, Abuja, Nigeria; [Dargan, Paul I.] Guys & St Thomas NHS Fdn Trust, London, England; [Dargan, Paul I.] Kings Coll London, London, England	Doctors Without Borders; Doctors Without Borders; University of London; London School of Hygiene & Tropical Medicine; Centers for Disease Control & Prevention - USA; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Greig, J (corresponding author), Med Sans Frontieres, Manson Unit, London, England.	Jane.Greig@london.msf.org	Stellmach, Darryl/AAL-1276-2021	Stellmach, Darryl/0000-0003-3845-6874; Dargan, Paul/0000-0002-3433-9622; Greig, Jane/0000-0003-2732-0023	M�decins Sans Fronti�res [OCA_pilot_00_Greig, OCA011-33, OCA_ERB_011_31_Greig] Funding Source: researchfish	M�decins Sans Fronti�res		Agency for Toxic Substances and Disease Registry, 2007, TOX PROF LEAD; [Anonymous], 2012, NIG MAL IND SURV 201; Berg KK, 2006, MMWR DISPATCH, V55, P1; BETTS PR, 1973, BMJ-BRIT MED J, V1, P402, DOI 10.1136/bmj.1.5850.402; Biya O., 2010, Morbidity and Mortality Weekly Report, V59, P846; Bland JM, 2010, INT J NURS STUD, V47, P931, DOI 10.1016/j.ijnurstu.2009.10.001; Bornschein RL, 2000, PEDIATR RES, V48, P593; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Brown MJ, 2010, EUR J PUBLIC HEALTH, V20, P288, DOI 10.1093/eurpub/ckp164; Centers for Disease Control, 2002, MAN EL BLOOD LEAD LE; Cheesbrough M, 2006, DISTRICT LAB PRACTIC, V1st, DOI [10.1017/cbo9780511543470, DOI 10.1017/CBO9780511543470]; CHISOLM JJ, 1957, PEDIATRICS, V19, P2; CHISOLM JJ, 1956, PEDIATRICS, V18, P943; Coffin R, 1996, J PEDIAT, V69, P198; Den Hond E, 2002, J HUM HYPERTENS, V16, P563, DOI 10.1038/sj.jhh.1001452; Dooyema CA, 2012, ENVIRON HEALTH PERSP, V120, P601, DOI 10.1289/ehp.1103965; GENNART JP, 1992, AM J EPIDEMIOL, V135, P1208, DOI 10.1093/oxfordjournals.aje.a116227; Gerr F, 2002, AM J IND MED, V42, P98, DOI 10.1002/ajim.10096; GREENGARD J, 1965, J PEDIATR-US, V66, P707, DOI 10.1016/S0022-3476(65)80004-X; Haefliger P, 2009, ENVIRON HEALTH PERSP, V117, P1535, DOI 10.1289/ehp.0900696; He KM, 2009, SCI TOTAL ENVIRON, V407, P3986, DOI 10.1016/j.scitotenv.2009.03.018; Kaul B, 1999, ENVIRON HEALTH PERSP, V107, P917, DOI 10.2307/3454481; Kelly CA, 2004, ANN EMERG MED, V44, P108, DOI 10.1016/j.annemergmed.2004.03.028; Lanphear BP, 2000, PUBLIC HEALTH REP, V115, P521, DOI 10.1093/phr/115.6.521; Li P, 2009, J HAZARD MATER, V168, P591, DOI 10.1016/j.jhazmat.2009.03.031; Lo YC, 2012, ENVIRON HEALTH PERSP, V120, P1450, DOI 10.1289/ehp.1104793; McDonald JM, 1942, J AMER MED ASSOC, V119, P870, DOI 10.1001/jama.1942.02830280016004; Mielke HW, 2012, ENVIRON INT, V43, P48, DOI 10.1016/j.envint.2012.03.005; MSF Ethics Review Board, 2013, STAND OP PROC; National Academy of Sciences, 1972, PAT POP REP CH UNPUB; Neri A, 2013, INT J ENV HLTH RES; NRIAGU JO, 1983, NEW ENGL J MED, V308, P660, DOI 10.1056/NEJM198303173081123; Onalaja AO, 2000, ENVIRON HEALTH PERSP, V108, P23, DOI 10.2307/3454630; Parry J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3433; PAYTON M, 1994, AM J EPIDEMIOL, V140, P821, DOI 10.1093/oxfordjournals.aje.a117330; Plumlee GS, 2013, ENVIRON HEALTH PERSP, V121, P744, DOI 10.1289/ehp.1206051; Rogan WJ, 2001, NEW ENGL J MED, V344, P1421, DOI 10.1056/NEJM200105103441902; RUMMO JH, 1979, ARCH ENVIRON HEALTH, V34, P120, DOI 10.1080/00039896.1979.10667381; SCARBOROUGH J, 1984, J HIST MED ALL SCI, V39, P469, DOI 10.1093/jhmas/39.4.469; Selevan SG, 2003, NEW ENGL J MED, V348, P1527, DOI 10.1056/NEJMoa020880; U. S. Environmental Protection Agency, 2005, GUID SEL AG GROUPS M; Uetani M, 2006, BIOMETALS, V19, P521, DOI 10.1007/s10534-005-5619-0; USA Massachusetts Medical Society, 2001, Morbidity and Mortality Weekly Report, V50, P457; van der Kuijp TJ, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-61; WALDRON T, 1978, LANCET, V2, P1315; Watts J, 2009, LANCET, V374, P868, DOI 10.1016/S0140-6736(09)61612-3; World Health Organisation, 2010, CHILDH LEAD POIS; Zhao TT, 2013, CLIN BIOCHEM, V46, P612, DOI 10.1016/j.clinbiochem.2013.02.007	48	30	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93716	10.1371/journal.pone.0093716	http://dx.doi.org/10.1371/journal.pone.0093716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740291	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000336863900025
J	Haagensen, AMJ; Sorensen, DB; Sandoe, P; Matthews, LR; Birck, MM; Fels, JJ; Astrup, A				Haagensen, Annika Maria Juul; Sorensen, Dorte Bratbo; Sandoe, Peter; Matthews, Lindsay R.; Birck, Malene Muusfeldt; Fels, Johannes Josef; Astrup, Arne			High Fat, Low Carbohydrate Diet Limit Fear and Aggression in Gottingen Minipigs	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; SOCIAL-BEHAVIOR; GUT MICROBIOTA; YOUNG-ADULTS; CHOLESTEROL; BRAIN; PIGS; ASSOCIATION; HOSTILITY; DISEASE	High fat, low carbohydrate diets have become popular, as short-term studies show that such diets are effective for reducing body weight, and lowering the risk of diabetes and cardiovascular disease. There is growing evidence from both humans and other animals that diet affects behaviour and intake of fat has been linked, positively and negatively, with traits such as exploration, social interaction, anxiety and fear. Animal models with high translational value can help provide relevant and important information in elucidating potential effects of high fat, low carbohydrate diets on human behaviour. Twenty four young, male Gottingen minipigs were fed either a high fat/cholesterol, low carbohydrate diet or a low fat, high carbohydrate/sucrose diet in contrast to a standard low fat, high carbohydrate minipig diet. Spontaneous behaviour was observed through video recordings of home pens and test-related behaviours were recorded during tests involving animal-human contact and reaction towards a novel object. We showed that the minipigs fed a high fat/cholesterol, low carbohydrate diet were less aggressive, showed more non-agonistic social contact and had fewer and less severe skin lesions and were less fearful of a novel object than minipigs fed low fat, high carbohydrate diets. These results found in a porcine model could have important implications for general health and wellbeing of humans and show the potential for using dietary manipulations to reduce aggression in human society.	[Haagensen, Annika Maria Juul; Sorensen, Dorte Bratbo] Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet Dis Biol, Frederiksberg, Denmark; [Sandoe, Peter] Univ Copenhagen, Dept Food & Resource Econ, Frederiksberg, Denmark; [Sandoe, Peter] Univ Copenhagen, Dept Large Anim Sci, Frederiksberg, Denmark; [Matthews, Lindsay R.] Lindsay R Matthews & Associates Res Int, Scerne Di Pineto, Italy; [Matthews, Lindsay R.] Univ Auckland, Dept Psychol, Auckland, New Zealand; [Birck, Malene Muusfeldt; Astrup, Arne] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Frederiksberg, Denmark; [Fels, Johannes Josef] Novo Nordisk AS, Malov, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Auckland; University of Copenhagen; Novo Nordisk	Sorensen, DB (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Expt Anim Models, Dept Vet Dis Biol, Frederiksberg, Denmark.	brat@sund.ku.dk	Sandøe, Peter/E-8758-2015; Astrup, Arne/B-1407-2015	Sandøe, Peter/0000-0003-0397-3273; Sorensen, Dorte Bratbo/0000-0002-6144-1710; Astrup, Arne/0000-0001-8968-8996	Centre for Applied Laboratory Animal Research; Danish Council for Strategic Research [2101-06-0034]	Centre for Applied Laboratory Animal Research; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was supported by the Centre for Applied Laboratory Animal Research and the Danish Council for Strategic Research (Grant Number: 2101-06-0034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrup A, 2011, AM J CLIN NUTR, V93, P684, DOI 10.3945/ajcn.110.004622; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Birck MM, 2011, AM J PHYSIOL-HEART C, V300, pH1595, DOI 10.1152/ajpheart.01253.2010; Bollen P, 1998, SCAND J LAB ANIM SCI, V25, P23; Bollen PJA, 2002, 32 SCAND LAS S GARD; BRAMBLETT C A, 1981, Primates, V22, P96, DOI 10.1007/BF02382560; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Broom DM, 2009, ANIM BEHAV, V78, P1037, DOI 10.1016/j.anbehav.2009.07.027; Coccaro E, 2012, BRAIN BEHAV IMMUN S1, V26, pS28; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; D'Eath RB, 2002, BEHAVIOUR, V139, P1175, DOI 10.1163/15685390260437326; Dalmau A, 2009, APPL ANIM BEHAV SCI, V117, P173, DOI 10.1016/j.applanim.2008.12.014; DeWall CN, 2011, AGGRESSIVE BEHAV, V37, P73, DOI 10.1002/ab.20366; Golomb BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032175; Greenwood CE, 2001, J PSYCHIATR NEUROSCI, V26, P182; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; Gunnarsson S, 2009, LIVEST SCI, V123, P306, DOI 10.1016/j.livsci.2008.12.002; Haagensen AMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079429; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Held S, 2001, ANIM WELFARE, V10, pS209; HilakiviClarke L, 1996, LIFE SCI, V58, P1653, DOI 10.1016/0024-3205(96)00140-3; Hooper L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002137.pub3; Hu T, 2012, AM J EPIDEMIOL, V176, pS44, DOI 10.1093/aje/kws264; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2546, DOI 10.1001/jama.283.19.2546; Iribarren C, 2004, EUR J CLIN NUTR, V58, P24, DOI 10.1038/sj.ejcn.1601739; Janczak AM, 2003, APPL ANIM BEHAV SCI, V81, P13, DOI 10.1016/S0168-1591(02)00252-6; Johansen T, 2001, COMPARATIVE MED, V51, P150; Kanter MM, 2012, ADV NUTR, V3, P711, DOI 10.3945/an.111.001321; KAPLAN JR, 1991, PSYCHOSOM MED, V53, P634, DOI 10.1097/00006842-199111000-00005; KAPLAN JR, 1994, PSYCHOSOM MED, V56, P479, DOI 10.1097/00006842-199411000-00001; Larsen MO, 2006, AM J PHYSIOL-ENDOC M, V290, pE670, DOI 10.1152/ajpendo.00251.2005; Lewis CRG, 2008, LIVEST SCI, V116, P338, DOI 10.1016/j.livsci.2008.02.014; Lieberman HR, 2005, BRAIN RES BULL, V66, P149, DOI 10.1016/j.brainresbull.2005.04.011; LORE R, 1986, AGGRESSIVE BEHAV, V12, P409, DOI 10.1002/1098-2337(1986)12:6<409::AID-AB2480120603>3.0.CO;2-6; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Pond WG, 2008, J NUTR, V138, P282, DOI 10.1093/jn/138.2.282; Ramsden CE, 2013, J BRIT MED, P346; Re S, 2008, VET RES COMMUN, V32, P225, DOI 10.1007/s11259-007-9021-y; Rodriguez-Estevez V, 2010, APPL ANIM BEHAV SCI, V127, P28, DOI 10.1016/j.applanim.2010.08.010; Rosado B, 2010, APPL ANIM BEHAV SCI, V123, P124, DOI 10.1016/j.applanim.2010.01.009; Schook L, 2005, ANIM BIOTECHNOL, V16, P183, DOI 10.1080/10495390500265034; Smulders D, 2006, PHYSIOL BEHAV, V89, P438, DOI 10.1016/j.physbeh.2006.07.002; Solnick SJ, 2012, INJURY PREV, V18, P259, DOI 10.1136/injuryprev-2011-040117; Sondergaard LV, 2007, SCAND J LAB ANIM SCI, V34, P91; Sparks DL, 2008, J ALZHEIMERS DIS, V15, P641; Spensley JC, 1995, APPL ANIM BEHAV SCI, V44, P257; Stewart CL, 2010, ANIM WELFARE, V19, P349; STOLBA A, 1989, ANIM PROD, V48, P419, DOI 10.1017/S0003356100040411; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Swindle MM, 1998, SCAND J LAB ANIM SCI, V25, P11; Tsutsumi H, 2001, LAB ANIM-UK, V35, P236, DOI 10.1258/0023677011911688	51	29	30	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93821	10.1371/journal.pone.0093821	http://dx.doi.org/10.1371/journal.pone.0093821			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740321	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900027
J	Kimber, ST; Brown, T; Fox, KR				Kimber, Scott T.; Brown, Tom; Fox, Keith R.			A Mutant of Uracil DNA Glycosylase That Distinguishes between Cytosine and 5-Methylcytosine	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; ESCHERICHIA-COLI; MUTATIONAL ANALYSIS; STRUCTURAL BASIS; ENZYME; THYMINE; MECHANISM; CATALYSIS; RESIDUES; BINDING	We demonstrate that a mutant of uracil DNA glycosylase (N123D:L191A) distinguishes between cytosine and methylcytosine. Uracil DNA glycosylase (UDG) efficiently removes uracil from DNA in a reaction in which the base is flipped into the enzyme's active site. Uracil is selected over cytosine by a pattern of specific hydrogen bonds, and thymine is excluded by steric clash of its 5-methyl group with Y66. The N123D mutation generates an enzyme that excises cytosine. This N123D: L191A mutant excises C when it is mispaired with A or opposite an abasic site, but not when it is paired with G. In contrast no cleavage is observed with any substrates that contain 5-methylcytosine. This enzyme may offer a new approach for discriminating between cytosine and 5-methylcytosine.	[Kimber, Scott T.; Fox, Keith R.] Univ Southampton, Ctr Biol Sci, Southampton, Hants, England; [Brown, Tom] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England	University of Southampton; University of Oxford	Fox, KR (corresponding author), Univ Southampton, Ctr Biol Sci, Southampton, Hants, England.	k.r.fox@soton.ac.uk	Brown, Tom/C-9185-2016	Brown, Tom/0000-0002-6538-3036	BBSRC; Biotechnology and Biological Sciences Research Council [975723] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	STK was supported by a BBSRC research studentship www.bbsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJELLAND S, 1994, J BIOL CHEM, V269, P30489; BOITEUX S, 1990, J BIOL CHEM, V265, P3916; CEDAR H, 1979, NUCLEIC ACIDS RES, V6, P2125, DOI 10.1093/nar/6.6.2125; Drohat AC, 2000, BIOCHEMISTRY-US, V39, P11865, DOI 10.1021/bi000922e; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11876, DOI 10.1021/bi9910880; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Handa P, 2002, NUCLEIC ACIDS RES, V30, P3086, DOI 10.1093/nar/gkf425; Jiang YL, 2002, BIOCHEMISTRY-US, V41, P11236, DOI 10.1021/bi026226r; Jiang YL, 2002, BIOCHEMISTRY-US, V41, P11248, DOI 10.1021/bi026227j; Jiang YL, 2001, J BIOL CHEM, V276, P42347, DOI 10.1074/jbc.M106594200; Kavli B, 1996, EMBO J, V15, P3442, DOI 10.1002/j.1460-2075.1996.tb00710.x; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Krosky DJ, 2005, BIOCHEMISTRY-US, V44, P5949, DOI 10.1021/bi050084u; Krosky DJ, 2004, BIOCHEMISTRY-US, V43, P4188, DOI 10.1021/bi036303y; Kwon K, 2003, CHEM BIOL, V10, P351, DOI 10.1016/S1074-5521(03)00077-2; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; NEDDERMANN P, 1994, P NATL ACAD SCI USA, V91, P1642, DOI 10.1073/pnas.91.5.1642; Panayotou G, 1998, J BIOL CHEM, V273, P45, DOI 10.1074/jbc.273.1.45; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; ROY R, 1994, BIOCHEMISTRY-US, V33, P15131, DOI 10.1021/bi00254a024; SAVVA R, 1995, NATURE, V373, P487, DOI 10.1038/373487a0; Seibert E, 2002, BIOCHEMISTRY-US, V41, P10976, DOI 10.1021/bi026121o; SHAPIRO R, 1973, J BIOL CHEM, V248, P4060; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; TYE BK, 1977, P NATL ACAD SCI USA, V74, P154, DOI 10.1073/pnas.74.1.154; Werner RM, 2000, BIOCHEMISTRY-US, V39, P12585, DOI 10.1021/bi001532v; Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017	31	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95394	10.1371/journal.pone.0095394	http://dx.doi.org/10.1371/journal.pone.0095394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740413	Green Published, gold, Green Accepted			2022-12-25	WOS:000336863900139
J	Mor, SM; DeMaria, A; Naumova, EN				Mor, Siobhan M.; DeMaria, Alfred, Jr.; Naumova, Elena N.			Hospitalization Records as a Tool for Evaluating Performance of Food- and Water-Borne Disease Surveillance Systems: A Massachusetts Case Study	PLOS ONE			English	Article							STANDARDIZED INFECTION RATIO; PUBLIC-HEALTH SURVEILLANCE; FOODBORNE ILLNESS; COMMUNICABLE DISEASE; DISCHARGE DATA; CRYPTOSPORIDIOSIS; GASTROENTERITIS; GIARDIASIS; WINBUGS; BURDEN	We outline a framework for evaluating food- and water-borne surveillance systems using hospitalization records, and demonstrate the approach using data on salmonellosis, campylobacteriosis and giardiasis in persons aged >= 65 years in Massachusetts. For each infection, and for each reporting jurisdiction, we generated smoothed standardized morbidity ratios (SMR) and surveillance to hospitalization ratios (SHR) by comparing observed surveillance counts with expected values or the number of hospitalized cases, respectively. We examined the spatial distribution of SHR and related this to the mean for the entire state. Through this approach municipalities that deviated from the typical experience were identified and suspected of under-reporting. Regression analysis revealed that SHR was a significant predictor of SMR, after adjusting for population age-structure. This confirms that the spatial "signal" depicted by surveillance is in part influenced by inconsistent testing and reporting practices since municipalities that reported fewer cases relative to the number of hospitalizations had a lower relative risk (as estimated by SMR). Periodic assessment of SHR has potential in assessing the performance of surveillance systems.	[Mor, Siobhan M.] Univ Sydney, Fac Vet Sci, Farm Anim & Vet Publ Hlth, Sydney, NSW 2006, Australia; [Mor, Siobhan M.] Univ Sydney, Sch Publ Hlth, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Mor, Siobhan M.; Naumova, Elena N.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Bur Infect Dis, Boston, MA 02111 USA; [DeMaria, Alfred, Jr.] Massachusetts Dept Publ Hlth, Boston, MA USA; [Naumova, Elena N.] Tufts Univ, Sch Engn, Dept Civil & Environm Engn, Medford, MA 02155 USA	University of Sydney; University of Sydney; Massachusetts Department of Public Health; Tufts University; Massachusetts Department of Public Health; Tufts University	Mor, SM (corresponding author), Univ Sydney, Fac Vet Sci, Farm Anim & Vet Publ Hlth, Sydney, NSW 2006, Australia.	siobhan.mor@sydney.edu.au; elena.naumova@tufts.edu	Naumova, Elena/AAP-3395-2020	Naumova, Elena/0000-0002-9562-4734; Mor, Siobhan/0000-0003-0121-2016	National Institute of Environmental Health Sciences [ES 013171]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013171] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding for this research was provided by the National Institute of Environmental Health Sciences (ES 013171). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer TH, 2001, JAMA-J AM MED ASSOC, V285, P313, DOI 10.1001/jama.285.3.313; Bureau of Communicable Disease Control, 2006, GUID SURV REP CONTR; Calderwood MS, 2010, PUBLIC HEALTH REP, V125, P843, DOI 10.1177/003335491012500611; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P453; Chui KKH, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-444; Chui KKH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-447; Cohen SA, 2008, ENVIRON RES, V108, P185, DOI 10.1016/j.envres.2008.06.009; Collier SA, 2010, INT C EM INF DIS ATL; Craun Gunther F., 2006, Journal of Water and Health, V4, P241, DOI 10.2166/wh.2006.025; Effler P, 1999, JAMA-J AM MED ASSOC, V282, P1845, DOI 10.1001/jama.282.19.1845; FISHER ES, 1990, AM J PUBLIC HEALTH, V80, P1487, DOI 10.2105/AJPH.80.12.1487; Flint JA, 2005, CLIN INFECT DIS, V41, P698, DOI 10.1086/432064; Gerba CP, 1996, INT J FOOD MICROBIOL, V30, P113, DOI 10.1016/0168-1605(96)00996-8; German R R, 2001, MMWR Recomm Rep, V50, P1; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Gustafson TL, 2006, INFECT CONT HOSP EP, V27, P427, DOI 10.1086/503019; Helms M, 2006, CLIN INFECT DIS, V42, P498, DOI 10.1086/499813; Jhung MA, 2009, CLIN INFECT DIS, V49, P949, DOI 10.1086/605086; Kasatpibal Nongyao, 2009, Clin Epidemiol, V1, P67; Kirk MD, 2010, CLIN INFECT DIS, V50, P397, DOI 10.1086/649878; KOOBATIAN TJ, 1991, ANN NEUROL, V30, P618, DOI 10.1002/ana.410300418; Lawson A. B., 2003, DIS MAPPING WINBUGS; Lawson AB, 2001, STAT MED, V20, P2183, DOI 10.1002/sim.933; Lawson AB, 2000, STAT MED, V19, P2217; Lazarus R, 2009, J AM MED INFORM ASSN, V16, P18, DOI 10.1197/jamia.M2848; Love D, 2008, J PUBLIC HEALTH MAN, V14, P533, DOI 10.1097/01.PHH.0000338365.66704.7d; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Madsen KM, 1998, INFECT CONT HOSP EP, V19, P175; Mor SM, 2009, CLIN INFECT DIS, V48, P698, DOI 10.1086/597033; Narong MN, 2003, AM J INFECT CONTROL, V31, P274, DOI 10.1067/mic.2003.65; Naumova EN, 2000, PUBLIC HEALTH REP, V115, P436, DOI 10.1093/phr/115.5.436; Rea V., 2009, Morbidity and Mortality Weekly Report, V58, P169; Reynolds KA, 2008, REV ENVIRON CONTAM T, V192, P117, DOI 10.1007/978-0-387-71724-1_4; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scharff RL, 2012, J FOOD PROTECT, V75, P123, DOI 10.4315/0362-028X.JFP-11-058; SCHRAMM MM, 1991, PUBLIC HEALTH REP, V106, P95; Sickbert-Bennett EE, 2011, EMERG INFECT DIS, V17, P23, DOI 10.3201/eid1701.100660; Stone PW, 2007, AM J INFECT CONTROL, V35, P145, DOI 10.1016/j.ajic.2006.11.001; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Trevejo RT, 2003, AM J EPIDEMIOL, V157, P48, DOI 10.1093/aje/kwf155; Yokoe DS, 1999, EMERG INFECT DIS, V5, P779, DOI 10.3201/eid0506.9906	41	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e93744	10.1371/journal.pone.0093744	http://dx.doi.org/10.1371/journal.pone.0093744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI4VW	24740304	Green Published, gold			2022-12-25	WOS:000336863900026
J	Zhao, XM; Liu, C; Li, QY; Hu, WB; Zhou, MT; Nie, HY; Zhang, YX; Peng, ZC; Zhao, P; Xia, QY				Zhao, Xiao-Ming; Liu, Chun; Li, Qiong-Yan; Hu, Wen-Bo; Zhou, Meng-Ting; Nie, Hong-Yi; Zhang, Yin-Xia; Peng, Zhang-Chuan; Zhao, Ping; Xia, Qing-You			Basic Helix-Loop-Helix Transcription Factor Bmsage Is Involved in Regulation of fibroin H-chain Gene via Interaction with SGF1 in Bombyx mori	PLOS ONE			English	Article							SECRETES RECOMBINANT PROTEINS; FORK HEAD; SILK GLAND; TRANSGENIC SILKWORM; SERICIN LAYER; EXPRESSION; BINDING; DNA; TISSUE; CONTAINS	Silk glands are specialized in the synthesis of several secretory proteins. Expression of genes encoding the silk proteins in Bombyx mori silk glands with strict territorial and developmental specificities is regulated by many transcription factors. In this study, we have characterized B. mori sage, which is closely related to sage in the fruitfly Drosophila melanogaster. It is termed Bmsage; it encodes transcription factor Bmsage, which belongs to the Mesp subfamily, containing a basic helix-loop-helix motif. Bmsage transcripts were detected specifically in the silk glands of B. mori larvae through RT-PCR analysis. Immunoblotting analysis confirmed the Bmsage protein existed exclusively in B. mori middle and posterior silk gland cells. Bmsage has a low level of expression in the 4th instar molting stages, which increases gradually in the 5th instar feeding stages and then declines from the wandering to the pupation stages. Quantitative PCR analysis suggested the expression level of Bmsage in a high silk strain was higher compared to a lower silk strain on day 3 of the larval 5th instar. Furthermore, far western blotting and co-immunoprecipitation assays showed the Bmsage protein interacted with the fork head transcription factor silk gland factor 1 (SGF1). An electrophoretic mobility shift assay showed the complex of Bmsage and SGF1 proteins bound to the A and B elements in the promoter of fibroin H-chain gene(fib-H), respectively. Luciferase reporter gene assays confirmed the complex of Bmsage and SGF1 proteins increased the expression of fib-H. Together, these results suggest Bmsage is involved in the regulation of the expression of fib-H by being together with SGF1 in B. mori PSG cells.	[Zhao, Xiao-Ming; Liu, Chun; Li, Qiong-Yan; Hu, Wen-Bo; Zhou, Meng-Ting; Nie, Hong-Yi; Zhang, Yin-Xia; Peng, Zhang-Chuan; Zhao, Ping; Xia, Qing-You] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Zhao, Xiao-Ming; Liu, Chun; Li, Qiong-Yan; Hu, Wen-Bo; Zhou, Meng-Ting; Nie, Hong-Yi; Zhang, Yin-Xia; Peng, Zhang-Chuan; Zhao, Ping; Xia, Qing-You] Southwest Univ, Coll Biotechnol, Minist Agr, Key Sericultural Lab, Chongqing, Peoples R China	Southwest University - China; Ministry of Agriculture & Rural Affairs; Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	zhao, xiaoming/GNM-5551-2022	Zhao, Xiaoming/0000-0003-2237-3417	National Hi-Tech Research and Development Program of China [2011AA100306]; Program for New Century Excellent Talents [NCET-11-0699]; National Natural Science Foundation of China [31000545, 31372380]; Chongqing City Board of Education1/4boolean AND [CY120101]	National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chongqing City Board of Education1/4boolean AND	This work was supported by grants from the National Hi-Tech Research and Development Program of China (No. 2011AA100306 to Q-YX), Program for New Century Excellent Talents (No. NCET-11-0699 to CL), the National Natural Science Foundation of China (No. 31000545 and No. 31372380 to CL) and Chongqing City Board of Education1/4 boolean AND No. CY120101 to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Bitra K, 2009, GENE, V448, P74, DOI 10.1016/j.gene.2009.08.003; Bobrovnik SA, 2003, J BIOCHEM BIOPH METH, V57, P213, DOI 10.1016/S0165-022X(03)00145-3; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; DURAND B, 1992, MOL CELL BIOL, V12, P5768, DOI 10.1128/MCB.12.12.5768; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FUKUTA M, 1993, J BIOL CHEM, V268, P19471; GOLDSMITH MR, 1984, ANNU REV GENET, V18, P443, DOI 10.1146/annurev.ge.18.120184.002303; Hino R, 2006, BIOMATERIALS, V27, P5715, DOI 10.1016/j.biomaterials.2006.07.028; Hoskins RA, 2007, SCIENCE, V316, P1625, DOI 10.1126/science.1139816; HUI CC, 1990, J MOL BIOL, V213, P651, DOI 10.1016/S0022-2836(05)80253-0; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; ISHIZAKI H, 1994, INT J DEV BIOL, V38, P301; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; Julien E, 2002, INSECT BIOCHEM MOLEC, V32, P377, DOI 10.1016/S0965-1748(01)00170-9; Kethidi DR, 2004, J BIOL CHEM, V279, P19634, DOI 10.1074/jbc.M311647200; Kimoto M, 2012, DEV GENES EVOL, V222, P351, DOI 10.1007/s00427-012-0418-4; Kokubo H, 1996, DEV GENES EVOL, V206, P80, DOI 10.1007/s004270050033; Li MY, 2011, SCIENCE, V333, P53, DOI 10.1126/science.1207018; Liu QX, 2000, DEV BIOL, V225, P437, DOI 10.1006/dbio.2000.9836; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340; Markova EP, 2003, COMP BIOCHEM PHYS B, V134, P535, DOI 10.1016/S1096-4959(03)00004-6; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019; Ohno K, 2013, J BIOL CHEM, V288, P31581, DOI 10.1074/jbc.M113.514471; Pan MH, 2007, IN VITRO CELL DEV-AN, V43, P101, DOI 10.1007/s11626-006-9009-x; Park D, 2008, MOL CELL BIOL, V28, P410, DOI 10.1128/MCB.01104-07; Saga Y, 1996, DEVELOPMENT, V122, P2769; SUZUKI Y, 1990, DEV GROWTH DIFFER, V32, P179; SUZUKI Y, 1986, P NATL ACAD SCI USA, V83, P9522, DOI 10.1073/pnas.83.24.9522; Takiya S, 2005, NUCLEIC ACIDS RES, V33, P786, DOI 10.1093/nar/gki228; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomita M, 2007, TRANSGENIC RES, V16, P449, DOI 10.1007/s11248-007-9087-x; TSUDA M, 1983, P NATL ACAD SCI-BIOL, V80, P7442, DOI 10.1073/pnas.80.24.7442; TURNER FR, 1977, DEV BIOL, V57, P403, DOI 10.1016/0012-1606(77)90225-1; Wang Y, 2007, DEV GENES EVOL, V217, P715, DOI 10.1007/s00427-007-0184-x; WEIGEL D, 1989, CELL, V57, P645, DOI 10.1016/0092-8674(89)90133-5; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Zhao AC, 2010, TRANSGENIC RES, V19, P29, DOI 10.1007/s11248-009-9295-7	44	27	35	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94091	10.1371/journal.pone.0094091	http://dx.doi.org/10.1371/journal.pone.0094091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740008	gold, Green Submitted, Green Published			2022-12-25	WOS:000336863900033
J	Fernando, MR; Reyes, JL; Iannuzzi, J; Leung, G; McKay, DM				Fernando, Maria Ruweka; Reyes, Jose Luis; Iannuzzi, Jordan; Leung, Gabriella; McKay, Derek Mark			The Pro-Inflammatory Cytokine, Interleukin-6, Enhances the Polarization of Alternatively Activated Macrophages	PLOS ONE			English	Article							IL-6; EXPRESSION; PHAGOCYTOSIS; PLASTICITY; BLOCKADE	Macrophages are important innate immune cells that are associated with two distinct phenotypes: a pro-inflammatory (or classically activated) subset with prototypic macrophage functions such as inflammatory cytokine production and bactericidal activity, and an anti-inflammatory (or alternatively activated (AAM)) subset linked with wound healing and tissue repair processes. In this study, we examined the effect of interlukein-6 on human and murine macrophage polarization. The results indicate that despite being commonly associated with pro-inflammatory functions and being implicated in the pathogenesis/pathophysiology of numerous inflammatory diseases, interleukin-6 can enhance the polarization of AAMs, based on increased expression of hallmark markers: arginase-1, Ym1 and CD206; this effect required the AAM differentiating cytokines, IL-4 and IL-13. Co-treatment of AAMs with IL-6 resulted in spontaneous release of IL-10, suppressed LPS-induced nitric oxide production and inhibited cytokine production by activated CD4(+) T cells - immunoregulatory features not observed in the 'parent' IL-4+IL-13-induced AAM. The effect of IL-6 required signal transducer and activator of transcription (STAT)-3, was partially dependent on up-regulation of the IL4R alpha chain, and was independent of autocrine IL-10. In the presence of IFN gamma, IL-6 promoted the production of IL-1 beta and TNF alpha suggesting that this cytokine can enhance the phenotype to which a macrophage has committed. This finding may explain the pleiotrophic nature of IL-6, where it is associated with the perpetuation and enhancement of disease in inflammatory situations, but is also necessary for resolution of inflammation and adequate wound healing to occur in others. Thus, the potential benefit of IL-6 in promoting an AAM, with its' anti-inflammatory and wound healing ability, may need to be considered in immunotherapies aimed at in vivo modulation or inhibition of IL-6.	[Fernando, Maria Ruweka; Reyes, Jose Luis; Iannuzzi, Jordan; Leung, Gabriella; McKay, Derek Mark] Univ Calgary, Dept Physiol & Pharmacol, Calvin Phoebe & Joan Snyder Inst Chron Dis, Gastrointestinal Res Grp,Inflammat Res Network, Calgary, AB, Canada	University of Calgary	McKay, DM (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calvin Phoebe & Joan Snyder Inst Chron Dis, Gastrointestinal Res Grp,Inflammat Res Network, Calgary, AB, Canada.	dmckay@ucalgary.ca	McKay, Derek/HCH-3240-2022; Reyes, Jose Luis/D-8322-2018	Leung, Gabriella/0000-0002-8754-1621; Reyes, Jose Luis/0000-0003-0089-0261	Crohn's and Colitis Foundation of Canada; Canadian Institutes for Health Research (CHIR)/Canadian Digestive Health Foundation (CDHF); Alberta Innovates-Health Solutions (AI-HS); AI-HS; CIHR/Janssen/Canadian Association of Gastroenterology (CAG); CAG; Canada Research Chair in Intestinal Immunophysiology	Crohn's and Colitis Foundation of Canada; Canadian Institutes for Health Research (CHIR)/Canadian Digestive Health Foundation (CDHF); Alberta Innovates-Health Solutions (AI-HS); AI-HS; CIHR/Janssen/Canadian Association of Gastroenterology (CAG); CAG; Canada Research Chair in Intestinal Immunophysiology	This work was funded by an operating grant from the Crohn's and Colitis Foundation of Canada to DM. MF is recipient of Graduate Studentships from the Canadian Institutes for Health Research (CHIR)/Canadian Digestive Health Foundation (CDHF) and Alberta Innovates-Health Solutions (AI-HS). GL is a recipient of an AI-HS graduate studentship and J-L. Reyes is a recipient of post-doctoral fellowships from AI-HS and CIHR/Janssen/Canadian Association of Gastroenterology (CAG). JI is a recipient of a CAG Summer Studentship. DM is an AI-HS Scientist and recipient of a Canada Research Chair (Tier 1) in Intestinal Immunophysiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli W, 2001, EUR J IMMUNOL, V31, P2751, DOI 10.1002/1521-4141(200109)31:9&lt;2751::AID-IMMU2751&gt;3.0.CO;2-4; Antignano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021893; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Horsnell WGC, 2010, IMMUNOBIOLOGY, V215, P704, DOI 10.1016/j.imbio.2010.05.011; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kostek MC, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-106; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Mircic M, 2009, DRUG TODAY, V45, P189, DOI 10.1358/dot.2009.45.3.1343794; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Muzes G, 2012, WORLD J GASTROENTERO, V18, P5848, DOI 10.3748/wjg.v18.i41.5848; Nagy ZS, 2013, IMMUNOBIOLOGY, V218, P1336, DOI 10.1016/j.imbio.2013.06.011; Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Prescott D, 2011, AM J PHYSIOL-GASTR L, V301, pG487, DOI 10.1152/ajpgi.00042.2011; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004970; Smolen JS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1969; Smyth D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038441; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Stout RD, 2004, J LEUKOCYTE BIOL, V76, P509, DOI 10.1189/jlb.0504272; Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073; Taams LS, 2005, HUM IMMUNOL, V66, P222, DOI 10.1016/j.humimm.2004.12.006; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368	38	152	157	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94188	10.1371/journal.pone.0094188	http://dx.doi.org/10.1371/journal.pone.0094188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736635	gold, Green Published, Green Submitted			2022-12-25	WOS:000336922600051
J	Langa, J; Sousa, C; Sidat, M; Kroeger, K; McLellan-Lemal, E; Belani, H; Patel, S; Shodell, D; Shodell, M; Benech, I; Needle, R				Langa, Judite; Sousa, Cesar; Sidat, Mohsin; Kroeger, Karen; McLellan-Lemal, Eleanor; Belani, Hrishikesh; Patel, Shama; Shodell, Daniel; Shodell, Michael; Benech, Irene; Needle, Richard			HIV Risk Perception and Behavior among Sex Workers in Three Major Urban Centers of Mozambique	PLOS ONE			English	Article							RAPID ASSESSMENT; CONDOM USE; INFECTION; DURBAN	HIV risk perceptions and behaviors of 236 commercial sex workers from three major Mozambican urban centers were studied using the International Rapid Assessment, Response and Evaluation (I-RARE) methodology. All were offered HIV testing and, in Maputo, syphilis testing was offered as well. Sixty-three of the 236 opted for HIV testing, with 30 (48%) testing positive for HIV. In Maputo, all 30 receiving HIV tests also had syphilis testing, with 6 (20%) found to be positive. Results include interview excerpts and qualitative results using I-RARE methodology and AnSWR-assisted analyses of the interviews and focus group sessions.	[Langa, Judite; Shodell, Daniel] Ctr Dis Control & Prevent, Maputo, Mozambique; [Sousa, Cesar; Sidat, Mohsin] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique; [Kroeger, Karen; McLellan-Lemal, Eleanor; Belani, Hrishikesh; Patel, Shama; Benech, Irene] Ctr Dis Control & Prevent, Atlanta, GA USA; [Shodell, Michael] Long Isl Univ, New York, NY 11201 USA; [Needle, Richard] Off Global Aids Coordinator, Washington, DE USA	Eduardo Mondlane University; Centers for Disease Control & Prevention - USA	Shodell, M (corresponding author), Long Isl Univ, New York, NY 11201 USA.	gnr8@cdc.gov	McLellan-Lemal, Eleanor/J-9720-2012	McLellan-Lemal, Eleanor/0000-0002-1884-9315; Sidat, Mohsin/0000-0002-8378-2014	CDC Mozambique	CDC Mozambique	This study was supported by CDC Mozambique with PEPFAR funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral S, 2012, LANCET INFECT DIS; Basu I, 2004, JAIDS-J ACQ IMM DEF, V36, P845, DOI 10.1097/00126334-200407010-00012; Boily MC, 2013, AIDS; Burdick de Piedrasanta M, 2005, CORRIDOR HOPE HIV AI; Deering KN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S6-S11; Hallett TB, 2007, STUD FAMILY PLANN, V38, P1, DOI 10.1111/j.1728-4465.2007.00111.x; INS INE & ICF Macro, 2010, INQ NAC PREV RISC CO; Kummels I, 2005, IBEROAMERICA, V5, P7; Machungo F, 2002, INT J STD AIDS, V13, P326, DOI 10.1258/0956462021925153; Mangueira J., 2009, REG WORKSH VULN POP; Manopaiboon C, 2013, INT J STD AIDS; National AIDS Council, 2009, REP MOZ TRIANG PROJ; Needle RH, 2003, AM J PUBLIC HEALTH, V93, P970, DOI 10.2105/AJPH.93.6.970; Needle R, 2008, SOC SCI MED, V67, P1447, DOI 10.1016/j.socscimed.2008.06.031; O'Connell K, 2009, INT RAPID ASSESSMENT; Olusegun Odu BK, 2013, RES J ORG PSYCHOL ED, V2, P44; Parry C, 2008, DRUG ALCOHOL DEPEN, V95, P45, DOI 10.1016/j.drugalcdep.2007.12.005; Parry CDH, 2009, AIDS BEHAV, V13, P849, DOI 10.1007/s10461-008-9367-3; Parry CDH, 2009, SUBST USE MISUSE, V44, P886, DOI 10.1080/10826080802487028; Sobela F, 2009, JAIDS-J ACQ IMM DEF, V51, P216, DOI 10.1097/QAI.0b013e31819c170f; Strotman R, 2005, ANSWR ANAL SOFTWARE; Syvertsen JL, 2013, CULT HLTH SEX; Trotter RT, 2001, METHODOLOGICAL MODEL; Varga C A, 1997, Afr J Reprod Health, V1, P74, DOI 10.2307/3583277; Wang C, 2007, SEX TRANSM INFECT, V83, P534, DOI 10.1136/sti.2007.027151; World Health Organization, 2011, PREV HIV SEX WORK SU; Zuma Khangelani, 2010, Afr J Reprod Health, V14, P47	27	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94838	10.1371/journal.pone.0094838	http://dx.doi.org/10.1371/journal.pone.0094838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AI5PW	24736653	gold, Green Published			2022-12-25	WOS:000336922600094
J	Taylor, DR; Alaghband-Zadeh, J; Cross, GF; Omar, S; le Roux, CW; Vincent, RP				Taylor, David R.; Alaghband-Zadeh, Jamshid; Cross, Gemma F.; Omar, Sohail; le Roux, Carel W.; Vincent, Royce P.			Urine Bile Acids Relate to Glucose Control in Patients with Type 2 Diabetes Mellitus and a Body Mass Index Below 30 kg/m(2)	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; CHOLESTEROL 7-ALPHA-HYDROXYLASE GENE; INSULIN-RESISTANCE; BARIATRIC SURGERY; RECEPTOR FXR; LIFE-STYLE; IKK-BETA; OBESITY; PLASMA; MECHANISMS	Bile acids are important endocrine signalling molecules, modulating glucose homeostasis through activation of cell surface and nuclear receptors. Bile acid metabolism is altered in type 2 diabetes mellitus; however, whether this is of pathogenic consequence is not fully established. In this study urinary bile acid excretion in individuals with type 2 diabetes and matched healthy volunteers was assessed. Urinary bile acid excretion in type 2 diabetes patients was considered in the context of prevailing glycaemia and the patient body mass index. Urine bile acids were measured by liquid chromatography-tandem mass spectrometry, allowing individual quantification of 15 bile acid species. Urinary bile acid excretion in patients with type 2 diabetes who were normal weight (BMI 18.5-24.9 kg/m(2)) and overweight (BMI 25-29.9 kg/m(2)) were elevated compared to healthy normal weight volunteers, both p<0.0001. In obese (BMI >= 30 kg/m(2)) type 2 diabetes patients, urinary bile acid excretion was significantly lower than in the normal and overweight type 2 diabetes groups (both p<0.01). Total bile acid excretion positively correlated with HbA1c in normal (rs=0.85, p=<0.001) and overweight (rs = 0.61, p = 0.02) but not obese type 2 diabetes patients (rs = -0.08, p = 0.73). The glycaemia-associated increases in urine bile acid excretion in normal weight and overweight type 2 diabetes seen in this study may represent compensatory increases in bile acid signalling to maintain glucose homeostasis. As such alterations appear blunted by obesity; further investigation of weight-dependent effects of bile acid signalling on type 2 diabetes pathogenesis is warranted.	[Taylor, David R.; Alaghband-Zadeh, Jamshid; Cross, Gemma F.; Omar, Sohail; le Roux, Carel W.; Vincent, Royce P.] Kings Coll Hosp London, Dept Clin Biochem, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Taylor, DR (corresponding author), Kings Coll Hosp London, Dept Clin Biochem, London, England.	davidtaylor8@nhs.net		Vincent, Royce P/0000-0003-0743-4189; Taylor, David/0000-0003-1385-3961				ANDERSEN E, 1988, EUR J CLIN INVEST, V18, P166, DOI 10.1111/j.1365-2362.1988.tb02408.x; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BENNION LJ, 1977, NEW ENGL J MED, V296, P1365, DOI 10.1056/NEJM197706162962401; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cai S, 2009, J CHROMATOGR B, V877, P3619, DOI 10.1016/j.jchromb.2009.08.044; Chen LH, 2010, J PHARMACOL EXP THER, V334, P164, DOI 10.1124/jpet.110.166892; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Glicksman C, 2010, ANN CLIN BIOCHEM, V47, P482, DOI 10.1258/acb.2010.010040; Guidone C, 2006, DIABETES, V55, P2025, DOI 10.2337/db06-0068; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Handelsman Y, 2011, DIABETES CARE, V34, pS244, DOI 10.2337/dc11-s237; Ikegawa S, 1996, BIOMED CHROMATOGR, V10, P313, DOI 10.1002/(SICI)1099-0801(199611)10:6<313::AID-BMC603>3.0.CO;2-F; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kumar DP, 2012, BIOCHEM BIOPH RES CO, V427, P600, DOI 10.1016/j.bbrc.2012.09.104; Laferrere B, 2011, INT J OBESITY, V35, pS22, DOI 10.1038/ijo.2011.143; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Leibson CL, 2001, DIABETES CARE, V24, P1584, DOI 10.2337/diacare.24.9.1584; Li Lei O, 2010, Mol Endocrinol, V24, P657, DOI 10.1210/me.2009-0152; Li TG, 2006, HEPATOLOGY, V43, P1202, DOI 10.1002/hep.21183; Li TG, 2012, J BIOL CHEM, V287, P1861, DOI 10.1074/jbc.M111.305789; Li TG, 2010, J LIPID RES, V51, P832, DOI 10.1194/jlr.M002782; Mannucci E, 2010, J ENDOCRINOL INVEST, V33, P147, DOI [10.3275/6497, 10.1007/BF03346573]; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Polyzogopoulou EV, 2003, DIABETES, V52, P1098, DOI 10.2337/diabetes.52.5.1098; Popescu IR, 2010, FEBS LETT, V584, P2845, DOI 10.1016/j.febslet.2010.04.068; Prawitt J, 2011, CURR DIABETES REP, V11, P160, DOI 10.1007/s11892-011-0187-x; Roberts RE, 2011, CLIN ENDOCRINOL, V74, P67, DOI 10.1111/j.1365-2265.2010.03886.x; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Shang Q, 2010, AM J PHYSIOL-GASTR L, V298, pG419, DOI 10.1152/ajpgi.00362.2009; SIMKO V, 1987, HEPATOLOGY, V7, P115, DOI 10.1002/hep.1840070123; Simonen M, 2012, OBES SURG, V22, P1473, DOI 10.1007/s11695-012-0673-5; Staels B, 2009, DIABETES CARE, V32, pS237, DOI 10.2337/dc09-S355; Steiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025006; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Tagliacozzi D, 2003, CLIN CHEM LAB MED, V41, P1633, DOI 10.1515/CCLM.2003.247; Takikawa H, 1984, Gastroenterol Jpn, V19, P104; Taylor NF, 2006, METH MOL B, V324, P159; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Verdich C, 2001, INT J OBESITY, V25, P1206, DOI 10.1038/sj.ijo.0801655; Vincent RP, 2013, ANN CLIN BIOCHEM, V50, P360, DOI 10.1177/0004563212473450; Watanabe M, 2011, J BIOL CHEM, V286, P26913, DOI 10.1074/jbc.M111.248203; Wu TZ, 2013, J CLIN ENDOCR METAB, V98, pE718, DOI 10.1210/jc.2012-3961; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	49	19	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e93540	10.1371/journal.pone.0093540	http://dx.doi.org/10.1371/journal.pone.0093540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736330	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600020
J	Weathington, NM; Snavely, CA; Chen, BB; Zhao, J; Zhao, YT; Mallampalli, RK				Weathington, Nathaniel M.; Snavely, Courtney A.; Chen, Bill B.; Zhao, Jing; Zhao, Yutong; Mallampalli, Rama K.			Glycogen Synthase Kinase-3 beta Stabilizes the Interleukin (IL)-22 Receptor from Proteasomal Degradation in Murine Lung Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE LYMPHOID-CELLS; ACTIN POLYMERIZATION; TH17 CELLS; IL-22; UBIQUITINATION; PHOSPHORYLATES; CORTACTIN; PATHWAY; ERK	Signaling through the interleukin (IL)-22 cytokine axis provides essential immune protection in the setting of extracellular infection as part of type 17 immunity. Molecular regulation of IL-22 receptor (IL-22R) protein levels is unknown. In murine lung epithelia, IL-22R is a relatively short-lived protein (t(1/2) similar to 1.5 h) degraded by the ubiquitin proteasome under normal unstimulated conditions, but its degradation is accelerated by IL-22 treatment. Lys(449) within the intracellular C-terminal domain of the IL-22R serves as a ubiquitin acceptor site as disruption of this site by deletion or site-directed mutagenesis creates an IL-22R variant that, when expressed in cells, is degradation-resistant and not ubiquitinated. Glycogen synthase kinase (GSK)-3 beta phosphorylates the IL-22R within a consensus phosphorylation signature at Ser(410) and Ser(414), and IL-22 treatment of cells triggers GSK-3 beta inactivation. GSK-3 beta overexpression results in accumulation of IL-22R protein, whereas GSK-3 beta depletion in cells reduces levels of the receptor. Mutagenesis of IL-22R at Ser(410) and Ser(414) results in receptor variants that display reduced phosphorylation levels and are more labile as compared with wild-type IL-22R when expressed in cells. Further, the cytoskeletal protein cortactin, which is important for epithelial spreading and barrier formation, is phosphorylated and activated at the epithelial cell leading edge after treatment with IL-22, but this effect is reduced after GSK-3 beta knockdown. These findings reveal the ability of GSK-3 beta to modulate IL-22R protein stability that might have significant implications for cyto-protective functions and therapeutic targeting of the IL-22 signaling axis.	[Weathington, Nathaniel M.; Snavely, Courtney A.; Chen, Bill B.; Zhao, Jing; Zhao, Yutong; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Zhao, Yutong; Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Mallampalli, RK (corresponding author), Univ Pittsburgh, UPMC Montefiore, Dept Med, Div Pulm Allergy & Crit Care Med, NW 628, Pittsburgh, PA 15213 USA.	mallampallirk@upmc.edu			United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; United States Department of Veterans Affairs; National Institutes of Health R01 [HL096376, HL097376, HL098174, HL081784, UH2 HL123502, P01 HL114453, HL116472, HL01916]; American Heart Association [12SDG9050005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098174, R01HL096376, P01HL114453, R01HL097376, R01HL081784, UH2HL123502, R01HL112791, R01HL116472] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); United States Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, and a Merit Review Award from the United States Department of Veterans Affairs (to R. K. M. and N.M.W.). This work was also supported, in part, by National Institutes of Health R01 Grants HL096376, HL097376, HL098174, HL081784, UH2 HL123502, and P01 HL114453 (to R. K. M.), HL116472 (to B. B. C.), and HL01916 (to Y.Z.), and an American Heart Association Award 12SDG9050005 (to J.Z.).	Aujla SJ, 2009, J MOL MED, V87, P451, DOI 10.1007/s00109-009-0448-1; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bougneres L, 2004, J CELL BIOL, V166, P225, DOI 10.1083/jcb.200402073; Chen BB, 2013, NAT IMMUNOL, V14, P470, DOI 10.1038/ni.2565; Chen BB, 2009, MOL CELL BIOL, V29, P3062, DOI 10.1128/MCB.01824-08; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Filali M, 2002, J BIOL CHEM, V277, P33398, DOI 10.1074/jbc.M107977200; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Jiang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027464; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kumar KGS, 2003, EMBO J, V22, P5480; Kwiek NC, 2007, CELL SIGNAL, V19, P593, DOI 10.1016/j.cellsig.2006.08.009; Lejeune D, 2002, J BIOL CHEM, V277, P33676, DOI 10.1074/jbc.M204204200; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Litovchick L, 2004, MOL CELL BIOL, V24, P8970, DOI 10.1128/MCB.24.20.8970-8980.2004; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Surjit M, 2007, CELL CYCLE, V6, P580, DOI 10.4161/cc.6.5.3899; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zhao J, 2012, NAT IMMUNOL, V13, P651, DOI 10.1038/ni.2341; Zhao J, 2012, J BIOL CHEM, V287, P19105, DOI 10.1074/jbc.M112.339507; Zou CB, 2011, J BIOL CHEM, V286, P28019, DOI 10.1074/jbc.M111.253385; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377; Zwiers A, 2012, J IMMUNOL, V188, P1573, DOI 10.4049/jimmunol.1101494	31	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 20	2014	289	25					17610	17619		10.1074/jbc.M114.551747	http://dx.doi.org/10.1074/jbc.M114.551747			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ9HE	24742671	hybrid, Green Published			2022-12-25	WOS:000338018100026
J	Chi, YC; Armstrong, GS; Jones, DNM; Eisenmesser, EZ; Liu, CW				Chi, Ying-Chih; Armstrong, Geoffrey S.; Jones, David N. M.; Eisenmesser, Elan Z.; Liu, Chang-Wei			Residue Histidine 50 Plays a Key Role in Protecting alpha-Synuclein from Aggregation at Physiological pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mutant; Nuclear Magnetic Resonance; Parkinson Disease; Protein Aggregation; Synuclein	FAMILIAL PARKINSONS-DISEASE; IN-VITRO; FIBRIL FORMATION; E46K MUTATION; MICE; IMPACT; NMR; PATHOGENESIS; BINDING; DUPLICATION	alpha-Synuclein (Syn) aggregation is involved in the pathogenesis of Parkinson disease (PD). Recently, substitution of histidine 50 in Syn with a glutamine, H50Q, was identified as a new familial PD mutant. Here, nuclear magnetic resonance (NMR) studies revealed that the H50Q substitution causes an increase of the flexibility of the C-terminal region. This finding provides direct evidence that this PD-causing mutant can mediate long range effects on the sampling of Syn conformations. In vitro aggregation assays showed that substitution of His-50 with Gln, Asp, or Ala promotes Syn aggregation, whereas substitution with the positively charged Arg suppresses Syn aggregation. Histidine carries a partial positive charge at neutral pH, and so our result suggests that positively charged His-50 plays a role in protecting Syn from aggregation under physiological conditions.	[Chi, Ying-Chih; Eisenmesser, Elan Z.; Liu, Chang-Wei] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Aurora, CO 80045 USA; [Jones, David N. M.] Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA; [Armstrong, Geoffrey S.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Jones, DNM (corresponding author), Univ Colorado, Dept Pharmacol, Sch Med, Aurora, CO 80045 USA.	david.jones@ucdenver.edu; elan.eisenmesser@ucdenver.edu; changwei.liu@ucdenver.edu			National Institutes of Health [5R01NS72397]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01NS72397 (to C.-W.L.).	Appel-Cresswell S, 2013, MOVEMENT DISORD, V28, P811, DOI 10.1002/mds.25421; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200; Bussell R, 2001, J BIOL CHEM, V276, P45996, DOI 10.1074/jbc.M106777200; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chatterjee A, 2005, J CHEM SCI, V117, P3, DOI 10.1007/BF02704356; Choi W, 2004, FEBS LETT, V576, P363, DOI 10.1016/j.febslet.2004.09.038; Coelho-Cerqueira E, 2013, FEBS J, V280, P4915, DOI 10.1111/febs.12471; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Ghosh D, 2013, BIOCHEMISTRY-US, V52, P6925, DOI 10.1021/bi400999d; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hoyer W, 2004, BIOCHEMISTRY-US, V43, P16233, DOI 10.1021/bi048453u; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Izawa Y, 2012, BRAIN BEHAV, V2, P595, DOI 10.1002/brb3.86; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Liu CW, 2005, J BIOL CHEM, V280, P22670, DOI 10.1074/jbc.M501508200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Norris EH, 2004, CURR TOP DEV BIOL, V60, P17; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Sasakawa H, 2007, BIOCHEM BIOPH RES CO, V363, P795, DOI 10.1016/j.bbrc.2007.09.048; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Ulrih NP, 2008, BBA-MOL BASIS DIS, V1782, P581, DOI 10.1016/j.bbadis.2008.07.004; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wakamatsu M, 2008, NEUROBIOL AGING, V29, P574, DOI 10.1016/j.neurobiolaging.2006.11.017; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wise-Scira O, 2013, ACS CHEM NEUROSCI, V4, P498, DOI 10.1021/cn3002027; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	48	17	17	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15474	15481		10.1074/jbc.M113.544049	http://dx.doi.org/10.1074/jbc.M113.544049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742669	Green Published, hybrid			2022-12-25	WOS:000337465400030
J	Morimoto, R; Shindou, H; Tarui, M; Shimizu, T				Morimoto, Ryo; Shindou, Hideo; Tarui, Megumi; Shimizu, Takao			Rapid Production of Platelet-activating Factor Is Induced by Protein Kinase C alpha-mediated Phosphorylation of Lysophosphatidylcholine Acyltransferase 2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Catalysis; Inflammation; Macrophages; Membrane Lipids; Phosphorylation; Protein Kinase C (PKC); Platelet-activating Factor; Lysophospholipid Acyltransferase	CYTOSOLIC PHOSPHOLIPASE A(2); POLYUNSATURATED FATTY-ACIDS; LYSO-PAF ACETYLTRANSFERASE; FACTOR-ACETYLHYDROLASE; CELL-DEATH; RECEPTOR; CLONING; BINDING; IDENTIFICATION; BIOSYNTHESIS	Platelet-activating factor (PAF), a potent proinflammatory lipid mediator, is synthesized rapidly in response to extracellular stimuli by the activation of acetyl-CoA:lyso-PAF acetyltransferase (lyso-PAFAT). We have reported previously that lyso-PAFAT activity is enhanced in three distinct ways in mouse macrophages: rapid activation (30 s) after PAF stimulation and minutes to hours after LPS stimulation. Lysophosphatidylcholine acyltransferase 2 (LPCAT2) was later identified as a Ca2+-dependent lyso-PAFAT. However, the mechanism of rapid lyso-PAFAT activation within 30 s has not been elucidated. Here we show a new signaling pathway for rapid biosynthesis of PAF that is mediated by phosphorylation of LPCAT2 at Ser-34. Stimulation by either PAF or ATP resulted in PKC-mediated phosphorylation of LPCAT2 to enhance lyso-PAFAT activity and rapid PAF production. Biochemical analyses showed that the phosphorylation of Ser-34 resulted in augmentation of V-max with minimal K-m change. Our results offer an answer for the previously unknown mechanism of rapid PAF production.	[Morimoto, Ryo; Shindou, Hideo; Tarui, Megumi; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Shinjuku Ku, Tokyo 1628655, Japan; [Morimoto, Ryo; Shimizu, Takao] Univ Tokyo, Dept Biochem & Mol Biol, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; [Shindou, Hideo] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; Japan Science & Technology Agency (JST)	Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Tokyo 1628655, Japan.	hshindou-tky@umin.net	Shimizu, Takao/AAV-7052-2021	Morimoto, Ryo/0000-0002-5497-4666	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; National Center for Global Health and Medicine [24-001, 25-201]; Takeda Science Foundation; Cell Science Research Foundation; CREST, the Japan Science and Technology Agency; Gushinkai	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); CREST, the Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Gushinkai	This work was supported by a grant-in-aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; by National Center for Global Health and Medicine grant 24-001, 25-201; and by the Takeda Science Foundation (to T. S.).; Supported by the Takeda Science Foundation and The Cell Science Research Foundation.; Supported by CREST, the Japan Science and Technology Agency, Gushinkai, and The Cell Science Research Foundation.	BALLESTER R, 1985, J BIOL CHEM, V260, P5194; Bitencourt CS, 2013, J CELL MOL MED, V17, P1554, DOI 10.1111/jcmm.12118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSSOLINO F, 1994, J BIOL CHEM, V269, P2877; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hattori M, 1995, J BIOL CHEM, V270, P31345, DOI 10.1074/jbc.270.52.31345; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; JAMESKRACKE MR, 1994, J PHARMACOL EXP THER, V271, P824; Jonsson F, 2012, BLOOD, V119, P2533, DOI 10.1182/blood-2011-07-367334; Jonsson F, 2011, J CLIN INVEST, V121, P1484, DOI 10.1172/JCI45232; Karasawa K, 1996, J BIOCHEM-TOKYO, V120, P838; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; Koeberle A, 2012, FASEB J, V26, P169, DOI 10.1096/fj.11-184879; Koeberle A, 2010, FASEB J, V24, P4929, DOI 10.1096/fj.10-162818; Kume K, 1997, J BIOL CHEM, V272, P22898, DOI 10.1074/jbc.272.36.22898; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; NIETO ML, 1988, J BIOL CHEM, V263, P2217; NIETO ML, 1988, J BIOL CHEM, V263, P4607; Nixon AB, 1999, J BIOL CHEM, V274, P5469, DOI 10.1074/jbc.274.9.5469; OHNO S, 1990, J BIOL CHEM, V265, P6296; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Shindou H, 2000, BIOCHEM BIOPH RES CO, V271, P812, DOI 10.1006/bbrc.2000.2723; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; TJOELKER LW, 1995, J BIOL CHEM, V270, P25481, DOI 10.1074/jbc.270.43.25481; Tokuoka SM, 2013, BIOCHEM BIOPH RES CO, V436, P306, DOI 10.1016/j.bbrc.2013.05.099; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; WYKLE RL, 1980, J BIOL CHEM, V255, P256; Yamashita A, 1997, J BIOCHEM-TOKYO, V122, P1	44	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15566	15576		10.1074/jbc.M114.558874	http://dx.doi.org/10.1074/jbc.M114.558874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24742674	Green Published, hybrid			2022-12-25	WOS:000337465400039
J	Hikosaka, K; Ikutani, M; Shito, M; Kazuma, K; Gulshan, M; Nagai, Y; Takatsu, K; Konno, K; Tobe, K; Kanno, H; Nakagawa, T				Hikosaka, Keisuke; Ikutani, Masashi; Shito, Masayuki; Kazuma, Kohei; Gulshan, Maryam; Nagai, Yoshinori; Takatsu, Kiyoshi; Konno, Katsuhiro; Tobe, Kazuyuki; Kanno, Hitoshi; Nakagawa, Takashi			Deficiency of Nicotinamide Mononucleotide Adenylyltransferase 3 (Nmnat3) Causes Hemolytic Anemia by Altering the Glycolytic Flow in Mature Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEBER CONGENITAL AMAUROSIS; PYRUVATE-KINASE DEFICIENCY; SUBCELLULAR COMPARTMENTATION; ADENINE-DINUCLEOTIDE; AXONAL DEGENERATION; ENZYMATIC-SYNTHESIS; NAD SYNTHESIS; METABOLISM; MUTATIONS; MICE	NAD biosynthesis is of substantial interest because of its important roles in regulating various biological processes. Nicotinamide mononucleotide adenylyltransferase 3 (Nmnat3) is considered a mitochondria-localized NAD synthesis enzyme involved in de novo and salvage pathways. Although the biochemical properties of Nmnat3 are well documented, its physiological function in vivo remains unclear. In this study, we demonstrated that Nmnat3 was localized in the cytoplasm of mature erythrocytes and critically regulated their NAD pool. Deficiency of Nmnat3 in mice caused splenomegaly and hemolytic anemia, which was associated with the findings that Nmnat3-deficient erythrocytes had markedly lower ATP levels and shortened lifespans. However, the NAD level in other tissues were not apparently affected by the deficiency of Nmnat3. LC-MS/MS-based metabolomics revealed that the glycolysis pathway in Nmnat3-deficient erythrocytes was blocked at a glyceraldehyde 3-phosphate dehydrogenase (GAPDH) step because of the shortage of the coenzyme NAD. Stable isotope tracer analysis further demonstrated that deficiency of Nmnat3 resulted in glycolysis stall and a shift to the pentose phosphate pathway. Our findings indicate the critical roles of Nmnat3 in maintenance of the NAD pool in mature erythrocytes and the physiological impacts at its absence in mice.	[Hikosaka, Keisuke; Gulshan, Maryam; Nakagawa, Takashi] Toyama Univ, Frontier Res Core Life Sci, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan; [Ikutani, Masashi; Nagai, Yoshinori; Takatsu, Kiyoshi] Toyama Univ, Dept Immunobiol & Pharmacol Genet, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan; [Gulshan, Maryam; Tobe, Kazuyuki] Toyama Univ, Dept Internal Med 1, Grad Sch Med & Pharmaceut Sci Res, Toyama 9300194, Japan; [Kazuma, Kohei; Konno, Katsuhiro] Toyama Univ, Inst Nat Med, Toyama 9300194, Japan; [Shito, Masayuki; Kanno, Hitoshi] Tokyo Womens Med Univ, Dept Transfus Med & Cell Proc, Grad Sch Med, Tokyo 1628666, Japan; [Kanno, Hitoshi] Tokyo Womens Med Univ, Dept Adv Biomed Engn & Sci, Grad Sch Med, Tokyo 1628666, Japan; [Takatsu, Kiyoshi] Toyama Prefectural Inst Pharmaceut Res, Kosugi, Toyama 9390363, Japan; [Nagai, Yoshinori] PRESTO, JST, Kawaguchi, Saitama 3320012, Japan	University of Toyama; University of Toyama; University of Toyama; University of Toyama; Tokyo Women's Medical University; Tokyo Women's Medical University; Japan Science & Technology Agency (JST)	Nakagawa, T (corresponding author), Toyama Univ, 2630 Sugitani, Toyama 9300194, Japan.	nakagawa@med.u-toyama.ac.jp	Nakagawa, Takashi/F-3015-2010	Nakagawa, Takashi/0000-0001-5539-7605; Konno, Katsuhiro/0000-0002-1949-1845	Sumitomo Foundation; Kanae Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation;  [24609019];  [24116511]; Grants-in-Aid for Scientific Research [25461609, 24590577] Funding Source: KAKEN	Sumitomo Foundation; Kanae Foundation for the Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Takeda Science Foundation(Takeda Science Foundation (TSF)); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-aid for Young Scientists (A) (24609019) and a Grant-in-Aid for Scientific Research on Innovative Areas (24116511) (to T. N.). This work was also supported by grants from The Sumitomo Foundation, Kanae Foundation for the Promotion of Medical Science, Astellas Foundation for Research on Metabolic Disorders, and the Takeda Science Foundation (to T. N.).	Aizawa S, 2005, EXP HEMATOL, V33, P1292, DOI 10.1016/j.exphem.2005.07.008; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Climent Fernando, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P95; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; Darghouth D, 2011, BLOOD, V117, pE57, DOI 10.1182/blood-2010-07-299636; Di Stefano M, 2010, BLOOD CELL MOL DIS, V45, P33, DOI 10.1016/j.bcmd.2010.04.003; Di Stefano M, 2013, FEBS J, V280, P4711, DOI 10.1111/febs.12433; Dolle C, 2013, FEBS J, V280, P3530, DOI 10.1111/febs.12304; Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361; Felici R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076938; Gilley J, 2013, J NEUROSCI, V33, P13410, DOI 10.1523/JNEUROSCI.1534-13.2013; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; Guarente L, 2013, GENE DEV, V27, P2072, DOI 10.1101/gad.227439.113; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Hicks AN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047869; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; KANNO H, 1995, BLOOD, V86, P3205, DOI 10.1182/blood.V86.8.3205.bloodjournal8683205; KIRTLEY ME, 1977, MOL CELL BIOCHEM, V18, P141, DOI 10.1007/BF00280279; Koenekoop RK, 2012, NAT GENET, V44, P1035, DOI 10.1038/ng.2356; Lau C, 2009, FRONT BIOSCI-LANDMRK, V14, P410, DOI 10.2741/3252; Liu J, 2011, CURR OPIN HEMATOL, V18, P133, DOI 10.1097/MOH.0b013e32834521f3; LIU RH, 1995, NUCLEIC ACIDS RES, V23, P3742, DOI 10.1093/nar/23.18.3742; LOKEN MR, 1987, BLOOD, V69, P255; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Manodori AB, 2002, J LAB CLIN MED, V140, P161, DOI 10.1067/mlc.2002.126504; MICHELI V, 1990, ARCH BIOCHEM BIOPHYS, V283, P40, DOI 10.1016/0003-9861(90)90609-3; MICHELI V, 1991, ADV EXP MED BIOL, V307, P139; Micheli V, 1997, METHOD ENZYMOL, V280, P211; MIWA S, 1993, AM J HEMATOL, V42, P31, DOI 10.1002/ajh.2830420108; MORIMOTO M, 1995, BLOOD, V86, P4323, DOI 10.1182/blood.V86.11.4323.bloodjournal86114323; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; NOBLE NA, 1989, BLOOD, V74, P475; Orsomando G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053271; Palmieri F, 2009, J BIOL CHEM, V284, P31249, DOI 10.1074/jbc.M109.041830; Perrault I, 2012, NAT GENET, V44, P975, DOI 10.1038/ng.2357; PITTMAN JG, 1966, J CLIN INVEST, V45, P165, DOI 10.1172/JCI105328; PREISS J, 1957, J BIOL CHEM, V225, P759; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; SESTINI S, 1993, ARCH BIOCHEM BIOPHYS, V302, P206, DOI 10.1006/abbi.1993.1200; Song EK, 2011, J BIOL CHEM, V286, P44480, DOI 10.1074/jbc.M111.307645; Sporty JL, 2008, J SEP SCI, V31, P3202, DOI 10.1002/jssc.200800238; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Tyan YC, 2005, J PROTEOME RES, V4, P748, DOI 10.1021/pr0497780; VANDENBOS C, 1993, EXP HEMATOL, V21, P350; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	63	50	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14796	14811		10.1074/jbc.M114.554378	http://dx.doi.org/10.1074/jbc.M114.554378			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24739386	Green Published, hybrid			2022-12-25	WOS:000337248100035
J	Shi, JR; Njai, R; Wells, E; Collins, J; Wilkins, M; Dooyema, C; Sinclair, J; Gao, HJ; Rainey, JJ				Shi, Jianrong; Njai, Rashid; Wells, Eden; Collins, Jim; Wilkins, Melinda; Dooyema, Carrie; Sinclair, Julie; Gao, Hongjiang; Rainey, Jeanette J.			Knowledge, Attitudes, and Practices of Nonpharmaceutical Interventions following School Dismissals during the 2009 Influenza A H1N1 Pandemic in Michigan, United States	PLOS ONE			English	Article							PUBLIC-SCHOOLS; CLOSURE; DECISIONS; OUTBREAK	Background: Many schools throughout the United States reported an increase in dismissals due to the 2009 influenza A H1N1 pandemic (pH1N1). During the fall months of 2009, more than 567 school dismissals were reported from the state of Michigan. In December 2009, the Michigan Department of Community Health, in collaboration with the United States Centers for Disease Control and Prevention, conducted a survey to describe the knowledge, attitudes, and practices (KAPs) of households with school-aged children and classroom teachers regarding the recommended use of nonpharmaceutical interventions (NPIs) to slow the spread of influenza. Methods: A random sample of eight elementary schools (kindergarten through 5th grade) was selected from each of the eight public health preparedness regions in the state. Within each selected school, a single classroom was randomly identified from each grade (K-5), and household caregivers of the classroom students and their respective teachers were asked to participate in the survey. Results: In total, 26% (2,188/8,280) of household caregivers and 45% (163/360) of teachers from 48 schools (of the 64 sampled) responded to the survey. Of the 48 participating schools, 27% (13) experienced a school dismissal during the 2009 fall term. Eighty-seven percent (1,806/2,082) of caregivers and 80% (122/152) of teachers thought that the 2009 influenza A H1N1 pandemic was severe, and >90% of both groups indicated that they told their children/students to use NPIs, such as washing hands more often and covering coughs with tissues, to prevent infection with influenza. Conclusions: Knowledge and instruction on the use of NPIs appeared to be high among household caregivers and teachers responding to the survey. Nevertheless, public health officials should continue to explain the public health rationale for NPIs to reduce pandemic influenza. Ensuring this information is communicated to household caregivers and teachers through trusted sources is essential.	[Njai, Rashid; Dooyema, Carrie; Sinclair, Julie; Gao, Hongjiang; Rainey, Jeanette J.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Global Migrat & Quarantine, Atlanta, GA USA; [Wells, Eden] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Wilkins, Melinda] Michigan State Univ, Program Publ Hlth, E Lansing, MI 48824 USA; [Collins, Jim] Michigan Dept Community Hlth, Bur Epidemiol, Lansing, MI USA; [Shi, Jianrong] Eagle Med Serv, San Antonio, TX 78257 USA	Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan; Michigan State University; MDHHS - Michigan Department of Health & Human Services	Shi, JR (corresponding author), Eagle Med Serv, San Antonio, TX 78257 USA.	hku3@cdc.gov	Wilkins, Melinda/AAZ-1114-2021		Epidemic Intelligence Service (EIS) Training Program at the United States Centers for Disease Control and Prevention	Epidemic Intelligence Service (EIS) Training Program at the United States Centers for Disease Control and Prevention	This survey was supported by the Epidemic Intelligence Service (EIS) Training Program at the United States Centers for Disease Control and Prevention (http://www.cdc.gov/eis/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto NJ, 2010, AM J PREV MED, V39, P395, DOI 10.1016/j.amepre.2010.07.011; Agolory SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050916; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Centers for Disease Control and Prevention, 2007, INT PREP PLANN GUID; Centers for Disease Control and Prevention, 2009, CDC GUID STAT LOC PU; Centers for Disease Control and Prevention (CDC), 2009, CDC HLTH UPD SCH K 1; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Dooyema CA, 2014, J SCHOOL HEALTH, V84, P56, DOI 10.1111/josh.12113; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; Harvard School of Public Health`, 2009, SURV FINDS MAN AM HA; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Jarquin VG, 2011, EMERG INFECT DIS, V17, P751, DOI [10.3201/eid1704.100906, 10.3201/eid1706.100906]; Johnson AJ, 2008, EMERG INFECT DIS, V14, P1024, DOI 10.3201/eid1407.080096; Klaiman T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-73; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; McVernon J, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-257; Michigan Pandemic Influenza Coordinating Committee, 2010, 2009 INFL A H1N1 PAN; Miller JR, 2013, J SCHOOL HEALTH, V83, P281, DOI 10.1111/josh.12028; Nasrullah M, 2012, INT J INFECT DIS, V16, pE382, DOI 10.1016/j.ijid.2012.01.010; Stebbins S, 2010, J PUBLIC HEALTH MAN, V16, P316, DOI 10.1097/PHH.0b013e3181cb4368; The Community Guide Task Force, 2012, EM PREP RESP SCH DIS; Timperio C. G., 2009, Morbidity and Mortality Weekly Report, V58, P1405	22	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2014	9	4							e94290	10.1371/journal.pone.0094290	http://dx.doi.org/10.1371/journal.pone.0094290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG2DP	24747300	Green Submitted, gold, Green Published			2022-12-25	WOS:000335226500022
J	Isaias, IU; Dipaola, M; Michi, M; Marzegan, A; Volkmann, J; Roidi, MLR; Frigo, CA; Cavallari, P				Isaias, Ioannis Ugo; Dipaola, Mariangela; Michi, Marlies; Marzegan, Alberto; Volkmann, Jens; Roidi, Marina L. Rodocanachi; Frigo, Carlo Albino; Cavallari, Paolo			Gait Initiation in Children with Rett Syndrome	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; MOVEMENT; LOCOMOTION; TRANSITION; MUTATIONS; BALANCE	Rett syndrome is an X-linked neurodevelopmental condition mainly characterized by loss of spoken language and a regression of purposeful hand use, with the development of distinctive hand stereotypies, and gait abnormalities. Gait initiation is the transition from quiet stance to steady-state condition of walking. The associated motor program seems to be centrally mediated and includes preparatory adjustments prior to any apparent voluntary movement of the lower limbs. Anticipatory postural adjustments contribute to postural stability and to create the propulsive forces necessary to reach steady-state gait at a predefined velocity and may be indicative of the effectiveness of the feedforward control of gait. In this study, we examined anticipatory postural adjustments associated with gait initiation in eleven girls with Rett syndrome and ten healthy subjects. Muscle activity (tibialis anterior and soleus muscles), ground reaction forces and body kinematic were recorded. Children with Rett syndrome showed a distinctive impairment in temporal organization of all phases of the anticipatory postural adjustments. The lack of appropriate temporal scaling resulted in a diminished impulse to move forward, documented by an impairment in several parameters describing the efficiency of gait start: length and velocity of the first step, magnitude and orientation of centre of pressure-centre of mass vector at the instant of (swing-) toe off. These findings were related to an abnormal muscular activation pattern mainly characterized by a disruption of the synergistic activity of antagonistic pairs of postural muscles. This study showed that girls with Rett syndrome lack accurate tuning of feedforward control of gait.	[Isaias, Ioannis Ugo; Volkmann, Jens] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Isaias, Ioannis Ugo; Dipaola, Mariangela; Michi, Marlies; Marzegan, Alberto; Cavallari, Paolo] Univ Milan, Dept Pathophysiol & Transplantat, LAMB Pierfranco & Luisa Mariani, Milan, Italy; [Dipaola, Mariangela; Frigo, Carlo Albino] Politecn Milan, Biomed Technol Lab, TBM Lab, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Roidi, Marina L. Rodocanachi] Fdn Don Carlo Gnocchi IRCSS, Milan, Italy	University of Wurzburg; University of Milan; Polytechnic University of Milan	Isaias, IU (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany.	Isaias_I@ukw.de	Cavallari, Paolo/C-5145-2012; Isaias, Ioannis Ugo/F-4492-2014; Marzegan, Alberto/AAA-8480-2020; Volkmann, Jens/AAK-7570-2020; Frigo, Carlo Albino/AAA-7060-2021	Cavallari, Paolo/0000-0003-3160-9030; Isaias, Ioannis Ugo/0000-0002-3552-5144; Marzegan, Alberto/0000-0002-8389-7655; Frigo, Carlo Albino/0000-0003-0948-6089; Volkmann, Jens/0000-0002-9570-593X	Fondazione Mariani for Child Neurology; Associazione Italiana Sindrome di Rett	Fondazione Mariani for Child Neurology; Associazione Italiana Sindrome di Rett	This study was supported by Fondazione Mariani for Child Neurology and the Associazione Italiana Sindrome di Rett. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Antonietti A., 2005, CICLO EVOLUTIVO DISA, V8, P257; Berstein N., 1967, COORDINATION REGULAT; BRENIERE Y, 1986, J BIOMECH, V19, P1035, DOI 10.1016/0021-9290(86)90120-X; BRENIERE Y, 1989, J MOTOR BEHAV, V21, P20; BRENIERE Y, 1987, J MOTOR BEHAV, V19, P62, DOI 10.1080/00222895.1987.10735400; Caderby T, 2013, GAIT POSTURE, V37, P144, DOI 10.1016/j.gaitpost.2012.06.012; CARLSOO S, 1966, ACTA ANAT, V65, P1; Carpinella I, 2007, IEEE T NEUR SYS REH, V15, P543, DOI 10.1109/TNSRE.2007.908933; Colvin L, 2003, ARCH DIS CHILD, V88, P38, DOI 10.1136/adc.88.1.38; CRENNA P, 1991, J PHYSIOL-LONDON, V437, P635, DOI 10.1113/jphysiol.1991.sp018616; DAN B, 2008, POSTURE KEY ISSUE DE, P148; DAS P, 1988, NEUROSCIENCE, V25, P1023, DOI 10.1016/0306-4522(88)90055-3; Downs J, 2008, PEDIATRICS, V121, P540, DOI 10.1542/peds.2007-1641; Engerstrom I W, 1990, Acta Paediatr Scand Suppl, V369, P1; Ferrari A, 2008, GAIT POSTURE, V28, P207, DOI 10.1016/j.gaitpost.2007.11.009; FORSSBERG H, 1985, EXP BRAIN RES, V57, P480; Forssberg H., 1991, NEUROBIOLOGICAL BASI, P259; GAHERY Y, 1987, ARCH ITAL BIOL, V125, P345; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hayes KC, 1990, POSTURE GAIT CONTROL, VII, P255; JIAN YC, 1993, GAIT POSTURE, V1, P9, DOI DOI 10.1016/0966-6362(93)90038-3; Ledebt A, 1998, EXP BRAIN RES, V120, P9, DOI 10.1007/s002210050372; LEPERS R, 1995, EXP BRAIN RES, V107, P118; Lotan M, 2006, THESCIENTIFICWORLDJO, V6, P1314, DOI 10.1100/tsw.2006.187; Malouin F, 2000, GAIT POSTURE, V11, P239, DOI 10.1016/S0966-6362(00)00051-5; Malouin F, 1996, SOC NEUROSCI, V802, P8; Malouin F, 1994, SOC NEUROSCI, V241, P3; MANN RA, 1979, J BONE JOINT SURG AM, V61, P232, DOI 10.2106/00004623-197961020-00011; Martin M, 2002, PHYS THER, V82, P566, DOI 10.1093/ptj/82.6.566; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; McIlroy WE, 1999, GAIT POSTURE, V9, P190, DOI 10.1016/S0966-6362(99)00013-2; Mutsaarts M, 2005, MOTOR CONTROL, V9, P439, DOI 10.1123/mcj.9.4.439; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; NISSAN M, 1990, J BIOMED ENG, V12, P165, DOI 10.1016/0141-5425(90)90139-E; Polovina S, 2010, COLLEGIUM ANTROPOL, V34, P981; Rett A, 1966, Wien Med Wochenschr, V116, P723; Rosenbaum DA, 1984, TUTORIALS LEARNING M, P219; Sorsdahl AB, 2010, BMC PEDIATR, V27, P10; Stackhouse C, 2007, GAIT POSTURE, V26, P301, DOI 10.1016/j.gaitpost.2006.09.076; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8; Zatsiorsky V., 1983, BIOMECHANICS 8 B, V56, P1152	44	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e92736	10.1371/journal.pone.0092736	http://dx.doi.org/10.1371/journal.pone.0092736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743294	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100010
J	Xu, XH; Wu, XB; Wu, SB; Liu, HB; Chen, R; Li, Y				Xu, Xue-Hu; Wu, Xiao-Bing; Wu, Shang-Biao; Liu, Hai-Bo; Chen, Rong; Li, Yong			Identification of miRNAs Differentially Expressed in Clinical Stages of Human Colorectal Carcinoma-An Investigation in Guangzhou, China	PLOS ONE			English	Article							HUMAN COLON-CANCER; MICRORNA GENES; TRANSFORMATION; PROGRESSION; SIGNATURES; MIR-145; TARGET; MIR-31; RNAS; PCR	Aberrant expression of microRNAs (miRNAs) has been implicated in human cancer, including colorectal cancer (CRC). Such dysregulated miRNAs may have potential as diagnostic markers or therapeutic targets. However, the nature of an association between these miRNAs and clinical stages of CRC is still not clear. To this end, we performed a miRNA profiling of 1547 distinct human miRNAs using 31 samples of tumor and paired normal mucosa obtained from 31 CRC patients. Based on statistical analyses of profiling data, we identified 569 miRNAs that were significantly dysregulated in CRC relative to normal tissues (P<0.05). Among the 569 dysregulated miRNAs, downregulation of 17 was associated with stages II, III, and IV colon and rectal cancers (separate or combined), according to our criteria. We also assessed the potential of these dysregulated miRNAs as diagnostic biomarkers for CRC patients who were without metastasis, and the value of the dysregulated miRNAs for predicting metastasis, lymph node and distant. Their distinct expression patterns in colon and rectal cancers were also examined. Although our findings cannot be immediately applied toward clinical diagnosis, our new study model for determining and assessing the biomarker potential of dysregulated miRNAs should be useful in further research in detection of human CRC.	[Xu, Xue-Hu; Wu, Xiao-Bing; Wu, Shang-Biao; Chen, Rong; Li, Yong] Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Liu, Hai-Bo] Guangzhou Med Univ, Affiliated Hosp 3, Dept Expt Res, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Xu, XH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China.	Dr.xu.generalsurgery@gmail.com			Guangdong provincial Department of Science and Technology [2011A080300002, 2011B090400526]; Science and Information Technology of Guangzhou [2010J-E141]	Guangdong provincial Department of Science and Technology; Science and Information Technology of Guangzhou	This work was supported by Guangdong provincial Department of Science and Technology (2011A080300002 and 2011B090400526); Science and Information Technology of Guangzhou (2010J-E141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen WC, 2012, EXP THER MED, V3, P1039, DOI 10.3892/etm.2012.531; Figueredo A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005390.pub2; Hamfjord J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034150; He XQ, 2012, MOL MED, V18, P1491, DOI 10.2119/molmed.2012.00304; Kong YW, 2012, LANCET ONCOL, V13, pE249, DOI 10.1016/S1470-2045(12)70073-6; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kuo TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031587; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma YL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2276; Olaru AV, 2011, INFLAMM BOWEL DIS, V17, P221, DOI 10.1002/ibd.21359; Piepoli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033663; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schee K, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-505; Schimanski CC, 2009, WORLD J GASTROENTERO, V15, P2089, DOI 10.3748/wjg.15.2089; Suzuki H, 2011, CANCER RES, V71, P5646, DOI 10.1158/0008-5472.CAN-11-1076; Wang QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044398; Xi YG, 2006, CLIN CANCER RES, V12, P2014, DOI 10.1158/1078-0432.CCR-05-1853; Xia HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044206; Xu RS, 2013, INT J ONCOL, V42, P676, DOI 10.3892/ijo.2012.1746; Yin Y, 2013, BBA-GENE REGUL MECH, V1829, P239, DOI 10.1016/j.bbagrm.2012.11.006; Zhu L, 2012, MED ONCOL, V29, P1037, DOI 10.1007/s12032-011-9975-z	27	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94060	10.1371/journal.pone.0094060	http://dx.doi.org/10.1371/journal.pone.0094060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743265	Green Published, Green Submitted, gold			2022-12-25	WOS:000335309100025
J	Dong, JF; Zhang, SM; Ma, J; Liu, HM; Du, YY; Liu, YH				Dong, JunFeng; Zhang, ShengMin; Ma, Jun; Liu, HaoMing; Du, YingYing; Liu, YongHui			Preparation, Characterization, and In Vitro Cytotoxicity Evaluation of a Novel Anti-Tuberculosis Reconstruction Implant	PLOS ONE			English	Article							HYDROXYAPATITE COMPOSITE SCAFFOLDS; SPINAL TUBERCULOSIS; MECHANICAL-PROPERTIES; LACTIDE COMPOSITE; VIVO EVALUATION; BONE; FABRICATION; DEGRADATION; BIOACTIVITY; RIFAMPICIN	Background: Reconstruction materials currently used in clinical for osteoarticular tuberculosis (TB) are unsatisfactory due to a variety of reasons. Rifampicin (RFP) is a well-known and highly effective first-line anti-tuberculosis (anti-TB) drug. Poly-DL-lactide (PDLLA) and nano-hydroxyapatite (nHA) are two promising materials that have been used both for orthopedic reconstruction and as carriers for drug release. In this study we report the development of a novel anti-TB implant for osteoarticular TB reconstruction using a combination of RFP, PDLLA and nHA. Methods: RFP, PDLLA and nHA were used as starting materials to produce a novel anti-TB activity implant by the solvent evaporation method. After manufacture, the implant was characterized and its biodegradation and drug release profile were tested. The in vitro cytotoxicity of the implant was also evaluated in pre-osteoblast MC3T3-E1 cells using multiple methodologies. Results: A RFP/PDLLA/nHA composite was successfully synthesized using the solvent evaporation method. The composite has a loose and porous structure with evenly distributed pores. The production process was steady and no chemical reaction occurred as proved by Fourier Transform Infrared Spectroscopy (FTIR) and X-Ray Diffraction (XRD). Meanwhile, the composite blocks degraded and released drug for at least 12 weeks. Evaluation of in vitro cytotoxicity in MC3T3-E1 cells verified that the synthesized composite blocks did not affect cell growth and proliferation. Conclusion: It is feasible to manufacture a novel bioactive anti-TB RFP/PDLLA/nHA composite by the solvent evaporation method. The composite blocks showed appropriate properties such as degradation, drug release and biosafety to MC3T3-E1 cells. In conclusion, the novel composite blocks may have great potential for clinical applications in repairing bone defects caused by osteoarticular TB.	[Dong, JunFeng; Zhang, ShengMin; Ma, Jun; Liu, HaoMing; Du, YingYing; Liu, YongHui] Huazhong Univ Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China; [Dong, JunFeng; Zhang, ShengMin; Ma, Jun] Huazhong Univ Sci & Technol, Dept Biomed Engn, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, SM (corresponding author), Huazhong Univ Sci & Technol, Adv Biomat & Tissue Engn Ctr, Wuhan 430074, Peoples R China.	smzhang@mail.hust.edu.cn	Ma, Jun/K-2084-2012; Liu, Yong/GWQ-6163-2022	Ma, Jun/0000-0001-5167-1750; 	National Basic Research Program of China (973 Program) [2012CB933601]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This project was supported in part by the National Basic Research Program of China (973 Program, 2012CB933601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Z, 2011, ANTIMICROB AGENTS CH, V55, P1527, DOI 10.1128/AAC.01524-10; Aydin E, 2011, J MATER SCI-MATER M, V22, P2413, DOI 10.1007/s10856-011-4435-z; Bahna P, 2007, INT J ANTIMICROB AG, V29, P593, DOI 10.1016/j.ijantimicag.2006.12.013; Barbosa MC, 2013, MAT SCI ENG C-MATER, V33, P2620, DOI 10.1016/j.msec.2013.02.027; Bemer-Melchior P, 2000, J ANTIMICROB CHEMOTH, V46, P571, DOI 10.1093/jac/46.4.571; Chen L, 2011, COMPOS SCI TECHNOL, V71, P1842, DOI 10.1016/j.compscitech.2011.08.015; Chen L, 2013, J MECH BEHAV BIOMED, V22, P41, DOI 10.1016/j.jmbbm.2013.03.008; Chlopek J, 2009, POLYM DEGRAD STABIL, V94, P1479, DOI 10.1016/j.polymdegradstab.2009.05.010; Dong JF, 2014, EXPERT OPIN DRUG DEL, V11, P299, DOI 10.1517/17425247.2014.872625; Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X; Garg RK, 2011, J SPINAL CORD MED, V34, P440, DOI 10.1179/2045772311Y.0000000023; Gauthier O, 1999, J MATER SCI-MATER M, V10, P199, DOI 10.1023/A:1008949910440; Ge ZH, 2008, EUR SPINE J, V17, P1482, DOI 10.1007/s00586-008-0778-7; Guillaume M, 2012, MED MALADIES INFECT, V42, P414, DOI 10.1016/j.medmal.2012.07.018; Guillaume O, 2012, J CONTROL RELEASE, V162, P492, DOI 10.1016/j.jconrel.2012.08.003; Hasegawa S, 2005, J BIOMED MATER RES A, V75A, P567, DOI 10.1002/jbm.a.30460; Hasegawa S, 2007, J BIOMED MATER RES A, V81A, P930, DOI 10.1002/jbm.a.31109; Jain AK, 2007, CLIN ORTHOP RELAT R, P39, DOI 10.1097/BLO.0b013e318065b7c3; Jain AK, 2012, INT ORTHOP, V36, P285, DOI 10.1007/s00264-011-1296-5; Javerliat I, 2007, ANN VASC SURG, V21, P603, DOI 10.1016/j.avsg.2007.06.005; Jing Z, 2003, J CONTROL RELEASE, V92, P227, DOI 10.1016/S0168-3659(03)00372-9; Jones WL, 2011, BIOFOULING, V27, P207, DOI 10.1080/08927014.2011.554977; Khoo Larry T, 2003, Spine J, V3, P130, DOI 10.1016/S1529-9430(02)00410-2; Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026; Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152; Onyebujoh P, 2005, B WORLD HEALTH ORGAN, V83, P857; Ravelingien M, 2010, EUR J PHARM BIOPHARM, V76, P366, DOI 10.1016/j.ejpb.2010.08.010; Ren J, 2008, J MATER SCI-MATER M, V19, P1075, DOI 10.1007/s10856-007-3181-8; Russias J, 2006, MAT SCI ENG C-BIO S, V26, P1289, DOI 10.1016/j.msec.2005.08.004; Sun F, 2011, ACTA BIOMATER, V7, P3813, DOI 10.1016/j.actbio.2011.07.002; Tan QG, 2011, INT J MOL SCI, V12, P890, DOI 10.3390/ijms12020890; Teng XR, 2007, J BIOMED MATER RES B, V81B, P185, DOI 10.1002/jbm.b.30652; Vagaska B, 2010, PHYSIOL RES, V59, P309, DOI 10.33549/physiolres.931776; van Ingen J, 2011, CLIN INFECT DIS, V52, pE194, DOI 10.1093/cid/cir184; Wan T, 2005, BIO-MED MATER ENG, V15, P333; Wang RG, 2012, MACROMOLECULES, V45, P6830, DOI 10.1021/ma301183k; World Health Organization, 2004, WORLD HLTH REP 2004; Zhang SM, 2005, CURR APPL PHYS, V5, P516, DOI 10.1016/j.cap.2005.01.023	38	5	6	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94937	10.1371/journal.pone.0094937	http://dx.doi.org/10.1371/journal.pone.0094937			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740373	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900083
J	Du, JK; Li, PP; Liu, HL; Lu, DY; Liang, H; Dou, YH				Du, Jikun; Li, Peipei; Liu, Helu; Lu, Dongyue; Liang, Hong; Dou, Yuhong			Phenotypic and Molecular Characterization of Multidrug Resistant Klebsiella pneumoniae Isolated from a University Teaching Hospital, China	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; LEVEL CARBAPENEM RESISTANCE; INTENSIVE-CARE-UNIT; EXTENDED-SPECTRUM; MULTIPLEX PCR; RISK-FACTORS; NEW-YORK; GENES; AMPC; STRAINS	The multidrug-resistant rate of Klebsiella pneumoniae has risen rapidly worldwide. To better understand the multidrug resistance situation and molecular characterization of Klebsiella pneumoniae, a total of 153 Klebsiella pneumoniae isolates were collected, and drug susceptibility test was performed to detect its susceptibility patterns to 13 kinds of antibiotics. Phenotypic tests for carbapenemases ESBLs and AmpC enzyme-producing strains were performed to detect the resistance phenotype of the isolates. Then PCR amplification and sequencing analysis were performed for the drug resistance determinants. The results showed that 63 strains harbored bla(CTX-M) gene, and 14 strains harbored bla(DHA) gene. Moreover, there were 5 strains carrying bla(KPC) gene, among which 4 strains carried bla(CTX-M), bla(DHA) and bla(KPC) genes, and these 4 strains were also resistant to imipenem. Our data indicated that drug-resistant Klebsiella pneumoniae were highly prevalent in the hospital. Thus it is warranted that surveillance of epidemiology of those resistant isolates should be a cause for concern, and appropriate drugs should be chosen.	[Du, Jikun; Li, Peipei; Liu, Helu; Lu, Dongyue; Liang, Hong; Dou, Yuhong] Guangzhou Med Univ, Shenzhen Shajing Affiliated Hosp, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Dou, YH (corresponding author), Guangzhou Med Univ, Shenzhen Shajing Affiliated Hosp, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China.	douyuhong@126.com	du, jikun/G-3990-2013		Shenzhen Science and Technique Project [201302173]; Baoan Key Medical Subject Construction Program	Shenzhen Science and Technique Project; Baoan Key Medical Subject Construction Program	This work was supported by grants from the Shenzhen Science and Technique Project (No. 201302173) and the Baoan Key Medical Subject Construction Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boll EJ, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-201; Chia JH, 2010, MICROB DRUG RESIST, V16, P317, DOI 10.1089/mdr.2009.0048; Clinical and Laboratory Standards Insitute, 2009, M100S22 CLSI; Coelho A, 2012, INT J ANTIMICROB AG, V39, P514, DOI 10.1016/j.ijantimicag.2012.01.006; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Correa L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-80; Coudron PE, 2003, J CLIN MICROBIOL, V41, P772, DOI 10.1128/JCM.41.2.772-777.2003; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Espedido BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059920; Fabbri G, 2013, INT J ENV RES PUB HE, V10, P808, DOI 10.3390/ijerph10030808; Fisher MA, 2009, J MED MICROBIOL, V58, P774, DOI 10.1099/jmm.0.006171-0; Gao Wei, 2009, Zhongguo Kangshengsu Zazhi, V34, P48; Gootz TD, 2009, ANTIMICROB AGENTS CH, V53, P1998, DOI 10.1128/AAC.01355-08; Huang TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062774; Kaczmarek FM, 2006, ANTIMICROB AGENTS CH, V50, P3396, DOI 10.1128/AAC.00285-06; Kawakami S, 2000, Kansenshogaku Zasshi, V74, P24; Krishnamurthy V, 2013, J CLIN DIAGN RES, V7, P1975; Lee CH, 2011, ANTIMICROB AGENTS CH, V55, P4058, DOI 10.1128/AAC.00259-11; Lomaestro BM, 2006, CLIN INFECT DIS, V43, pE26, DOI 10.1086/505598; Manchanda V, 2003, J ANTIMICROB CHEMOTH, V51, P415, DOI 10.1093/jac/dkg098; Marchaim D, 2008, ANTIMICROB AGENTS CH, V52, P1413, DOI 10.1128/AAC.01103-07; Marchaim D, 2010, ANTIMICROB AGENTS CH, V54, P5099, DOI 10.1128/AAC.00565-10; Messai Y, 2008, PATHOL BIOL, V56, P319, DOI 10.1016/j.patbio.2008.05.008; Oliver A, 2001, ANTIMICROB AGENTS CH, V45, P616, DOI 10.1128/AAC.45.2.616-620.2001; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pessoa-Silva CL, 2003, J HOSP INFECT, V53, P198, DOI 10.1053/jhin.2002.1373; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Sanchez GV, 2013, EMERG INFECT DIS, V19, P133, DOI 10.3201/eid1901.120310; Schlesinger J, 2005, ANTIMICROB AGENTS CH, V49, P1150, DOI 10.1128/AAC.49.3.1150-1156.2005; Struve C, 2004, ENVIRON MICROBIOL, V6, P584, DOI 10.1111/j.1462-2920.2004.00590.x; Turner MS, 2009, J ANTIMICROB CHEMOTH, V64, P960, DOI 10.1093/jac/dkp338; Veras DL, 2011, CURR MICROBIOL, V62, P1610, DOI 10.1007/s00284-011-9899-z; Yang Q, 2011, CHIN J LAB MED, V34, P984; Younes A, 2011, J ANTIMICROB CHEMOTH, V66, P313, DOI 10.1093/jac/dkq453; [虞涛 Yu Tao], 2011, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V34, P254; [张永标 Zhang Yongbiao], 2004, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V24, P577; Zhuo C, 2012, CHIN J INFECT CHEMOT, V12, P174	41	33	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95181	10.1371/journal.pone.0095181	http://dx.doi.org/10.1371/journal.pone.0095181			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740167	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900112
J	He, XP; Cao, Y; Wang, LH; Han, YL; Zhong, XY; Zhou, GX; Cai, YP; Zhang, HF; Gao, P				He, Xiaoping; Cao, Yang; Wang, Lihua; Han, Yingli; Zhong, Xiuying; Zhou, Guixiang; Cai, Yongping; Zhang, Huafeng; Gao, Ping			Human Fibroblast Reprogramming to Pluripotent Stem Cells Regulated by the miR19a/b-PTEN Axis	PLOS ONE			English	Article							SOMATIC-CELLS; C-MYC; EMBRYONIC STEM; MOUSE; INDUCTION; EXPRESSION; MICRORNAS; GENERATION; ADULT; MICE	Induction of pluripotent stem cells (iPSC) by defined transcription factors is the recognized canonical means for somatic reprogramming, however, it remains incompletely understood how individual transcription factors affect cell fate decisions during the reprogramming process. Here, we report induction of fibroblast reprogramming by various transcriptional factors is mediated by a miR19a/b-PTEN axis. cMyc, one of the four Yamanaka factors known to stimulate both somatic cell reprogramming and tumorigenesis, induced the expression of multiple mircoRNAs, miR-17 similar to 92 cluster in particular, in the early stage of reprogramming of human fibroblasts. Importantly, miR-17 similar to 92 cluster could greatly enhance human fibroblast reprogramming induced by either the four Yamanaka factors (Oct4, Sox2, Klf4, and cMyc, or 4F) or the first three transcriptional factors (Oct4, Sox2, and Klf4, or 3F). Among members of this microRNA cluster, miR-19a/b exhibited the most potent effect on stimulating fibroblst reprogramming to iPSCs. Additional studies revealed that miR-19a/b enhanced iPSC induction efficiency by targeted inhibition of phosphatase and tensin homolog (PTEN), a renowned tumor suppressor whose loss-of-function mutations were found in multiple human malignancies. Our results thus demonstrate an important role of miR-19a/b-PTEN axis in the reprogramming of human fibroblasts, illustrating that the somatic reprogramming process and its underlying regulation pathways are intertwined with oncogenic signaling in human malignancies.	[He, Xiaoping; Cao, Yang; Wang, Lihua; Han, Yingli; Zhong, Xiuying; Zhang, Huafeng; Gao, Ping] Univ Sci & Technol China, Sch Life Sci, Innovat Ctr Cell Biol, Hefei 230026, Peoples R China; [Zhou, Guixiang] Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Peoples R China; [Cai, Yongping] Anhui Univ, Sch Med, Dept Pathol, Hefei 230039, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui University	Gao, P (corresponding author), Univ Sci & Technol China, Sch Life Sci, Innovat Ctr Cell Biol, Hefei 230026, Peoples R China.	pgao2@ustc.edu.cn	Zhang, Huafeng/A-7188-2012		Chinese Academy of Sciences [XDA01010404]; National Basic Key Research Program of China [2014CB910600, 2012CB910104, 2011CBA01103]; National Nature Science Foundation of China [31171385, 81372148, 31071257]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Key Research Program of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported in part by Chinese Academy of Sciences (XDA01010404), National Basic Key Research Program of China (2014CB910600, 2012CB910104 and 2011CBA01103), National Nature Science Foundation of China (31171385, 81372148 and 31071257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Chou BK, 2013, CELL STEM CELL, V13, P261, DOI 10.1016/j.stem.2013.08.004; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Frenzel Anna, 2010, Genes Cancer, V1, P660, DOI 10.1177/1947601910377488; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Guo XD, 2013, CELL RES, V23, P142, DOI 10.1038/cr.2012.180; Jamerson MH, 2004, J MAMMARY GLAND BIOL, V9, P27, DOI 10.1023/B:JOMG.0000023586.69263.0b; Jiang X, 2012, CANCER CELL, V22, P524, DOI 10.1016/j.ccr.2012.08.028; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/nmeth.1393, 10.1038/NMETH.1393]; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tong M, 2011, CELL RES, V21, P1634, DOI 10.1038/cr.2011.143; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Ye D, 2012, STEM CELLS, V30, P1645, DOI 10.1002/stem.1149; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu Y, 2014, STEM CELLS, V32, P349, DOI 10.1002/stem.1447	40	10	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95213	10.1371/journal.pone.0095213	http://dx.doi.org/10.1371/journal.pone.0095213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740298	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900117
J	Jia, HC; Jiang, BJ; Wu, CX; Lu, WC; Hou, WS; Sun, S; Yan, HR; Han, TF				Jia, Hongchang; Jiang, Bingjun; Wu, Cunxiang; Lu, Wencheng; Hou, Wensheng; Sun, Shi; Yan, Hongrui; Han, Tianfu			Maturity Group Classification and Maturity Locus Genotyping of Early-Maturing Soybean Varieties from High-Latitude Cold Regions	PLOS ONE			English	Article							TIME; GENES; RESPONSES; CLONING; GROWTH; E1	Background: With the migration of human beings, advances of agricultural sciences, evolution of planting patterns and global warming, soybeans have expanded to both tropical and high-latitude cold regions (HCRs). Unlike other regions, HCRs have much more significant and diverse photoperiods and temperature conditions over seasons or across latitudes, and HCR soybeans released there show rich diversity in maturity traits. However, HCR soybeans have not been as well classified into maturity groups (MGs) as other places. Therefore, it is necessary to identify MGs in HCRs and to genotype the maturity loci. Methods: Local varieties were collected from the northern part of Northeast China and the far-eastern region of Russia. Maturity group reference (MGR) soybeans of MGs MG000, MG00, and MG0 were used as references during field experiments. Both local varieties and MGR soybeans were planted for two years (2010-2011) in Heihe (N 50 degrees 15', E 127 degrees 27', H 168.5 m), China. The days to VE (emergence), R1 (beginning bloom) and R7 (beginning maturity) were recorded and statistically analyzed. Furthermore, some varieties were further genotyped at four molecularly-identified maturity loci E1, E2, E3 and E4. Results: The HCR varieties were classified into MG0 or even more early-maturing. In Heihe, some varieties matured much earlier than MG000, which is the most early-maturing known MG, and clustered into a separate group. We designated the group as MG0000, following the convention of MGs. HCR soybeans had relatively stable days to beginning bloom from emergence. The HCR varieties diversified into genotypes of E1, E2, E3 and E4. These loci had different effects on maturity. Conclusion: HCRs diversify early-maturing MGs of soybean. MG0000, a new MG that matures much earlier than known MGs, was developed. HCR soybean breeding should focus more on shortening post-flowering reproductive growth. E1, E2, E3, and E4 function differentially.	[Jia, Hongchang; Jiang, Bingjun; Wu, Cunxiang; Hou, Wensheng; Sun, Shi; Han, Tianfu] Chinese Acad Agr Sci, Inst Crop Sci, Key Lab Soybean Biol Beijing, Minist Agr MOA, Beijing 100193, Peoples R China; [Jia, Hongchang; Lu, Wencheng; Yan, Hongrui] Heilongjiang Acad Agr Sci, Heihe Branch, Heihe, Heilongjiang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Heilongjiang Academy of Agricultural Sciences	Yan, HR (corresponding author), Heilongjiang Acad Agr Sci, Heihe Branch, Heihe, Heilongjiang, Peoples R China.	hhyhr@sina.com; hantianfu@caas.cn	Jiang, Bingjun/GWQ-4354-2022		China Agriculture Research System [CARS-04]; Natural Science Foundation of China [31201232]; CAAS Innovation Project	China Agriculture Research System; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAAS Innovation Project	This project was supported by the China Agriculture Research System (CARS-04), the Natural Science Foundation of China (31201232, http://www.nsfc.gov.cn), and the CAAS Innovation Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliprandini LF, 2009, CROP SCI, V49, P801, DOI 10.2135/cropsci2008.07.0390; [Anonymous], ACTA AGRONOMICA SINI; Bai X, 2004, HEILONGJIANG AGR SCI, P52; BERNARD RL, 1972, CROP SCI, V12, P235, DOI 10.2135/cropsci1972.0011183X001200020028x; BERNARD RL, 1971, CROP SCI, V11, P242, DOI 10.2135/cropsci1971.0011183X001100020022x; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Boerma H. R., 2004, SOYBEANS IMPROVEMENT; Bonato ER, 1999, GENET MOL BIOL, V22, P229, DOI 10.1590/S1415-47571999000200016; Buzzell R. I., 1980, SOYBEAN GENETICS NEW, V7, P26, DOI DOI 10.1093/JHERED/ESP113; BUZZELL RI, 1971, CAN J GENET CYTOL, V13, P703, DOI 10.1139/g71-100; Cheng LR, 2011, THEOR APPL GENET, V123, P421, DOI 10.1007/s00122-011-1594-8; Cober ER, 2010, CROP SCI, V50, P524, DOI 10.2135/cropsci2009.04.0174; Cober ER, 2001, CROP SCI, V41, P698, DOI 10.2135/cropsci2001.413698x; Egli DB, 2011, AGRON J, V103, P743, DOI 10.2134/agronj2010.0508; Fehr W. R., 1977, 80 IOW STAT U COOP E; Gai J., 2001, ACTA AGRONOMICA SINI, V27, P286; Han TianFu, 1995, Soybean Science, V14, P283; Han TianFu, 1995, Acta Botanica Sinica, V37, P863; Han TianFu, 1998, Acta Agronomica Sinica, V24, P550; Hao G., 1992, Acta Agronomica Sinica, V18, P275; Hartwig E. E., 1987, Soybean Genetics Newsletter, V14, P14; HARTWIG EE, 1970, TROP SCI, V12, P47; Husson F., 2017, FACTOMINER MULTIVARI, V1, P38; Jiang BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077474; Liu B, 2008, GENETICS, V180, P995, DOI 10.1534/genetics.108.092742; Lu W, 2011, CHINA SEED IND, P59; MCBLAIN BA, 1987, J HERED, V78, P160, DOI 10.1093/oxfordjournals.jhered.a110349; Napompeth, 1997, SOYBEAN FEEDS WORLD, P69; Nedoluzhko AV, 2007, CYTOL GENET+, V41, P190, DOI 10.3103/S0095452707030097; R Core Team R, 2022, R LANG ENV STAT COMP; RAY JD, 1995, CROP SCI, V35, P1001, DOI 10.2135/cropsci1995.0011183X003500040012x; SUMMERFIELD RJ, 1992, ANN BOT-LONDON, V69, P101, DOI 10.1093/oxfordjournals.aob.a088314; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Tomkins JP, 1996, CROP SCI, V36, P1144, DOI 10.2135/cropsci1996.0011183X003600050013x; Wang G. X., 1981, Scientia Agricultura Sinica, P39; Wang Y, 1999, CHINA SEEDS, V5, P48; Wang Ying, 2008, Acta Agronomica Sinica, V34, P1160, DOI 10.3724/SP.J.1006.2008.01160; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; Whigham DK, 1978, AGRONOMIC CHARACTERI, P77; Wu CunXiang, 2012, Acta Agronomica Sinica, V38, P1977; Xia ZJ, 2012, PLANT SYST EVOL, V298, P1217, DOI 10.1007/s00606-012-0628-2; Xia ZJ, 2012, P NATL ACAD SCI USA, V109, pE2155, DOI 10.1073/pnas.1117982109; Zhang LX, 2007, CROP MANAGEMENT, DOI 10.1094/CM-2007-0927-1001-RS	44	35	45	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94139	10.1371/journal.pone.0094139	http://dx.doi.org/10.1371/journal.pone.0094139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740097	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900034
J	Myczko, L; Rosin, ZM; Skorka, P; Tryjanowski, P				Myczko, Lukasz; Rosin, Zuzanna M.; Skorka, Piotr; Tryjanowski, Piotr			Urbanization Level and Woodland Size Are Major Drivers of Woodpecker Species Richness and Abundance	PLOS ONE			English	Article							GREAT SPOTTED WOODPECKERS; PATCH SIZE; FOREST MANAGEMENT; BIRD; LANDSCAPE; DENDROCOPOS; SUCCESS; MIDDLE; CONSERVATION; INDICATORS	Urbanization is a process globally responsible for loss of biodiversity and for biological homogenization. Urbanization may have a direct negative impact on species behaviour and indirect effects on species populations through alterations of their habitats, for example patch size and habitat quality. Woodpeckers are species potentially susceptible to urbanization. These birds are mostly forest specialists and the development of urban areas in former forests may be an important factor influencing their richness and abundance, but documented examples are rare. In this study we investigated how woodpeckers responded to changes in forest habitats as a consequence of urbanization, namely size and isolation of habitat patches, and other within-patch characteristics. We selected 42 woodland patches in a gradient from a semi-natural rural landscape to the city centre of Poznan (Western Poland) in spring 2010. Both species richness and abundance of woodpeckers correlated positively to woodland patch area and negatively to increasing urbanization. Abundance of woodpeckers was also positively correlated with shrub cover and percentage of deciduous tree species. Furthermore, species richness and abundance of woodpeckers were highest at moderate values of canopy openness. Ordination analyses confirmed that urbanization level and woodland patch area were variables contributing most to species abundance in the woodpecker community. Similar results were obtained in presence-absence models for particular species. Thus, to sustain woodpecker species within cities it is important to keep woodland patches large, multi-layered and rich in deciduous tree species.	[Myczko, Lukasz; Skorka, Piotr; Tryjanowski, Piotr] Poznan Univ Life Sci, Inst Zool, Poznan, Poland; [Rosin, Zuzanna M.] Adam Mickiewicz Univ, Fac Biol, Dept Cell Biol, Poznan, Poland	Poznan University of Life Sciences; Adam Mickiewicz University	Myczko, L (corresponding author), Poznan Univ Life Sci, Inst Zool, Poznan, Poland.	lukasz.myczko@up.poznan.pl	Skórka, Piotr/B-7218-2009; Rosin, Zuzanna Maria/AGK-4907-2022; Rosin, Zuzanna Maria/C-3824-2017	Skórka, Piotr/0000-0002-3221-296X; Rosin, Zuzanna Maria/0000-0002-7565-7547; Rosin, Zuzanna Maria/0000-0002-7565-7547; Skorka, Piotr/0000-0002-7486-2928; Tryjanowski, Piotr/0000-0002-8358-0797; Myczko, Lukasz/0000-0002-9305-2306				Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; BEISSINGER SR, 1982, CONDOR, V84, P75, DOI 10.2307/1367825; Bellamy PE, 1996, J APPL ECOL, V33, P249, DOI 10.2307/2404747; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Bolger DT, 2001, BIOL CONSERV, V102, P213, DOI 10.1016/S0006-3207(01)00028-3; Borda-de-Agua L, 2011, LANDSCAPE ECOL, V26, P253, DOI 10.1007/s10980-010-9546-2; Chiesura A, 2004, LANDSCAPE URBAN PLAN, V68, P129, DOI 10.1016/j.landurbplan.2003.08.003; Dorresteijn I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065236; Drever MC, 2008, BIOL CONSERV, V141, P624, DOI 10.1016/j.biocon.2007.12.004; Duit A, 2009, J ENVIRON DEV, V18, P42, DOI DOI 10.1177/1070496508329302; Erritzoe J, 2003, ACTA ORNITHOL, V38, P77, DOI 10.3161/068.038.0204; Estades CF, 2001, LANDSCAPE ECOL, V16, P161, DOI 10.1023/A:1011197432467; Gaston K. J., 2010, URBAN ECOLOGY; Gilbert O.L., 1989, ECOLOGY URBAN HABITA; Grahn P, 1994, EUR REGION PLANN, V56, P89; Haddad NM, 1999, ECOL APPL, V9, P612, DOI 10.1890/1051-0761(1999)009[0612:CADEOI]2.0.CO;2; HANSKI I, 1997, METAPOPULATION BIOL; Hines JE, 2006, PRESENCE3 0 SOFTWARE; Kilgo JC, 2012, J WILDLIFE MANAGE, V76, P328, DOI 10.1002/jwmg.282; Kociolek AV, 2011, CONSERV BIOL, V25, P241, DOI 10.1111/j.1523-1739.2010.01635.x; Kosinski Z, 2006, ANN ZOOL FENN, V43, P198; Kosinski Z, 2007, POL J ECOL, V55, P519; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; LEPS J, 2003, MULTIVARIATE ANAL EC; Levins R., 1970, SOME MATH PROBLEMS B, P77; Li F, 2005, LANDSCAPE URBAN PLAN, V72, P325, DOI 10.1016/j.landurbplan.2004.04.002; MacKenzie D.I., 2005, OCCUPANCY ESTIMATION; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; Matsuoka RH, 2008, LANDSCAPE URBAN PLAN, V84, P7, DOI 10.1016/j.landurbplan.2007.09.009; Mazgajski TD, 2006, ANN ZOOL FENN, V43, P211; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Mertler C.A., 2002, ADV MULTIVARIATE STA; Michalek Klaus G., 2003, BWP Update, V5, P101; Mikusinski G, 2001, CONSERV BIOL, V15, P208, DOI 10.1046/j.1523-1739.2001.99236.x; Mikusinski G, 1998, CONSERV BIOL, V12, P200, DOI 10.1046/j.1523-1739.1998.96310.x; Mikusinski G, 2006, ANN ZOOL FENN, V43, P86; Mikusinski Grzegorz, 1997, Vogelwelt, V118, P277; Mortberg UM, 2001, LANDSCAPE ECOL, V16, P193, DOI 10.1023/A:1011190902041; Myczko L, 2011, J AVIAN BIOL, V42, P429, DOI 10.1111/j.1600-048X.2011.05326.x; Pakkala T, 2006, ANN ZOOL FENN, V43, P137; Pasinelli G, 2007, BIODIVERS CONSERV, V16, P1283, DOI 10.1007/s10531-007-9162-x; Przybylska K, 2012, ACTA ORNITHOL, V47, P37, DOI 10.3161/000164512X653908; Quinn GP, 2002, EXPT DESIGN DATA ANA, DOI DOI 10.1017/CBO9780511806384; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rickman JK, 2003, ECOGRAPHY, V26, P777, DOI 10.1111/j.0906-7590.2003.03345.x; ROBINSON SK, 1995, SCIENCE, V267, P1987, DOI 10.1126/science.267.5206.1987; Robles H, 2012, CONSERV BIOL, V26, P284, DOI 10.1111/j.1523-1739.2011.01816.x; Roland J, 2000, ECOLOGY, V81, P1642, DOI 10.1890/0012-9658(2000)081[1642:APBDEO]2.0.CO;2; Sandstrom UG, 2006, LANDSCAPE URBAN PLAN, V77, P39, DOI 10.1016/j.landurbplan.2005.01.004; Seress G, 2012, J AVIAN BIOL, V43, P403, DOI 10.1111/j.1600-048X.2012.05527.x; Sisk TD, 1997, ECOL APPL, V7, P1170, DOI 10.1890/1051-0761(1997)007[1170:BAIPWM]2.0.CO;2; TOROK J, 1990, HOLARCTIC ECOL, V13, P257; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Virkkala R, 2006, ANN ZOOL FENN, V43, P82; Wesolowski T, 2005, ACTA ORNITHOL, V40, P53, DOI 10.3161/068.040.0111	56	24	27	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e94218	10.1371/journal.pone.0094218	http://dx.doi.org/10.1371/journal.pone.0094218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740155	Green Submitted, Green Published, gold			2022-12-25	WOS:000336863900037
J	Rasid, O; Meulenbroeks, C; Grone, A; Zaiss, D; Sijts, A				Rasid, Orhan; Meulenbroeks, Chantal; Grone, Andrea; Zaiss, Dietmar; Sijts, Alice			Enhanced Inflammatory Potential of CD4(+) T-Cells That Lack Proteasome Immunosubunit Expression, in a T-Cell Transfer-Based Colitis Model	PLOS ONE			English	Article							KAPPA-B-ALPHA; SELECTIVE INHIBITOR; IMMUNOPROTEASOME; 20S; DEGRADATION; ACTIVATION; DISEASE; PROTEIN; TH1	Proteasomes play a fundamental role in intracellular protein degradation and therewith regulate a variety of cellular processes. Exposure of cells to (pro) inflammatory cytokines upregulates the expression of three inducible catalytic proteasome subunits, the immunosubunits, which incorporate into newly assembled proteasome complexes and alter the catalytic activity of the cellular proteasome population. Single gene-deficient mice lacking one of the three immunosubunits are resistant to dextran sulfate sodium (DSS)-induced colitis development and, likewise, inhibition of one single immunosubunit protects mice against the development of DSS-induced colitis. The observed diminished disease susceptibility has been attributed to altered cytokine production and CD4(+) T-cell differentiation in the absence of immunosubunits. To further test whether the catalytic activity conferred by immunosubunits plays an essential role in CD4(+) T-cell function and to distinguish between the role of immunosubunits in effector T-cells versus inflamed tissue, we used a T-cell transfer-induced colitis model. Naive wt or immunosubunit-deficient CD4(+) T-cells were adoptively transferred into RAG1(-/-) and immunosubunit-deficient RAG1(-/-) mice and colitis development was determined six weeks later. While immunosubunit expression in recipient mice had no effect on colitis development, transferred immunosubunit-deficient T-cells were more potent in inducing colitis and produced more proinflammatory IL17 than wt T-cells. Taken together, our data show that modifications in proteasome-mediated proteolysis in T-cells, conferred by lack of immunosubunit incorporation, do not attenuate but enhance CD4(+) T-cell-induced inflammation.	[Rasid, Orhan; Meulenbroeks, Chantal; Zaiss, Dietmar; Sijts, Alice] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Grone, Andrea] Univ Utrecht, Fac Vet Med, Dept Pathol, Utrecht, Netherlands	Utrecht University; Utrecht University	Zaiss, D (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	Dietmar.Zaiss@ed.ac.uk; e.j.a.m.sijts@uu.nl		Rasid, Orhan/0000-0002-7040-9587; Sijts, Alice/0000-0003-3815-4788; Zaiss, Dietmar M.W./0000-0003-3596-7062	European Federation of Immunological Sciences-Immunology Letters Short-term fellowship; European Union [280873 ADITEC]; University of Utrecht	European Federation of Immunological Sciences-Immunology Letters Short-term fellowship; European Union(European Commission); University of Utrecht	The word here presented was supported by an European Federation of Immunological Sciences-Immunology Letters Short-term fellowship to OR, European Union's Seventh Framework Programme, Grant Agreement 280873 ADITEC to AS, and an University of Utrecht stimulus grant to DZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Basler M, 2014, EMBO MOL MED, V6, P226, DOI 10.1002/emmm.201303543; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; Caudill CM, 2006, J IMMUNOL, V176, P4075, DOI 10.4049/jimmunol.176.7.4075; Coombes JL, 2005, IMMUNOL REV, V204, P184, DOI 10.1111/j.0105-2896.2005.00250.x; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dahlmann B, 2001, BIOCHIMIE, V83, P295, DOI 10.1016/S0300-9084(01)01240-8; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Hensley SE, 2010, J IMMUNOL, V184, P4115, DOI 10.4049/jimmunol.0903003; Joeris T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039827; Kalim KW, 2012, J IMMUNOL, V189, P4182, DOI 10.4049/jimmunol.1201183; Kincaid EZ, 2012, NAT IMMUNOL, V13, P129, DOI 10.1038/ni.2203; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pickering AM, 2010, BIOCHEM J, V432, P585, DOI 10.1042/BJ20100878; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; Qureshi N, 2012, BBA-MOL CELL RES, V1823, P2087, DOI 10.1016/j.bbamcr.2012.06.016; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Sijts EJAM, 2011, CELL MOL LIFE SCI, V68, P1491, DOI 10.1007/s00018-011-0657-y; TRAENCKNER EBM, 1994, EMBO J, V13, P5433, DOI 10.1002/j.1460-2075.1994.tb06878.x; van Helden MJG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023769; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Zaiss DMW, 2008, INFECT IMMUN, V76, P1207, DOI 10.1128/IAI.01134-07; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023; Zaiss DMW, 2011, J IMMUNOL, V187, P2302, DOI 10.4049/jimmunol.1101003	26	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95378	10.1371/journal.pone.0095378	http://dx.doi.org/10.1371/journal.pone.0095378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	24740379	Green Published, gold, Green Submitted			2022-12-25	WOS:000336863900137
J	Xiao, JQ; Liu, XH; Hou, B; Yao, Y; Deng, K; Feng, M; Xing, B; Lian, W; Wang, RZ; Feng, F				Xiao, Jian-Qi; Liu, Xiao-Hai; Hou, Bo; Yao, Yong; Deng, Kan; Feng, Min; Xing, Bin; Lian, Wei; Wang, Ren-Zhi; Feng, Feng			Correlations of Pituitary Tumor Transforming Gene Expression with Human Pituitary Adenomas: A Meta-Analysis	PLOS ONE			English	Article							PTTG EXPRESSION; CAUSES ANEUPLOIDY; CLONAL ORIGIN; OVEREXPRESSION; HYPOPLASIA; HORMONE	Objective: Pituitary tumor transforming gene (PTTG) is an important paracrine growth factor involved in early lactotrope transformation and early onset of angiogenesis in pituitary hyperplasia. Emerging evidences have shown that PTTG expression may contribute to the etiology of pituitary adenomas; but individually published studies showed inconclusive results. This meta-analysis aimed to derive a more precise estimation of the correlations of PTTG expression with human pituitary adenomas. Methods: A range of electronic databases were searched: MEDLINE (1966 similar to 2013), the Cochrane Library Database (Issue 12, 2013), EMBASE (1980 similar to 2013), CINAHL (1982 similar to 2013), Web of Science (1945 similar to 2013) and the Chinese Biomedical Database (CBM) (1982 similar to 2013) without language restrictions. Meta-analysis was performed using the STATA 12.0 software. Crude odds ratio (OR) or standard mean difference (SMD) with its corresponding 95% confidence interval (95% CI) were calculated. Results: Twenty-four clinical cohort studies were included with a total of 1,464 pituitary adenomas patients. The meta-analysis results revealed that patients with invasive pituitary adenomas had higher positive expression of PTTG than those of non-invasive patients (OR = 6.68, 95% CI = 3.72-11.99, P<0.001). We also found a significant difference in microvessel density between invasive and non-invasive patients (SMD = 1.81, 95% CI = 0.39-3.23, P = 0.013). However, there were no significant difference in PTTG expression between functional and non-functional patients with pituitary adenomas (OR = 1.11, 95% CI = 0.58-2.10, P = 0.753). No publication bias was detected in this meta-analysis (all P>0.05). Conclusion: This present meta-analysis suggests that PTTG expression may be associated with tumor invasiveness and microvessel density of pituitary adenomas, while no correlations with functional status was found.	[Xiao, Jian-Qi; Liu, Xiao-Hai; Yao, Yong; Deng, Kan; Feng, Min; Xing, Bin; Lian, Wei; Wang, Ren-Zhi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China; [Xiao, Jian-Qi; Liu, Xiao-Hai; Hou, Bo; Yao, Yong; Deng, Kan; Feng, Min; Xing, Bin; Lian, Wei; Wang, Ren-Zhi; Feng, Feng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Hou, Bo; Feng, Feng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Radiol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Wang, RZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China.	wangrz@126.com; cjr.fengfeng@vip.163.com		George, Tipoe/0000-0002-2603-0625; So, Kwok-Fai/0000-0003-4039-4246	National Natural Science Foundation of China [81072084, 81100869]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Grant No. 81072084 and 81100869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JM, 1990, J CLIN INVEST, V86, P336, DOI 10.1172/JCI114705; Biggerstaff BJ, 2008, STAT MED, V27, P6093, DOI 10.1002/sim.3428; Chesnokova V, 2005, MOL ENDOCRINOL, V19, P2371, DOI 10.1210/me.2005-0137; Chesnokova V, 2008, P NATL ACAD SCI USA, V105, P17498, DOI 10.1073/pnas.0804810105; Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974; Chesnokova V, 2013, P NATL ACAD SCI USA, V110, pE3331, DOI 10.1073/pnas.1310589110; Cristina C, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-4; Cuny T, 2013, EUR J ENDOCRINOL, V168, P533, DOI 10.1530/EJE-12-0763; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Donangelo I, 2006, ENDOCRINOLOGY, V147, P4781, DOI 10.1210/en.2006-0544; Dworakowska D, 2009, BEST PRACT RES CL EN, V23, P525, DOI 10.1016/j.beem.2009.05.004; Fedele M, 2013, TUM CTR NERV SYST, V10, P161; Filippella M, 2006, CLIN ENDOCRINOL, V65, P536, DOI 10.1111/j.1365-2265.2006.02630.x; Gagliano T, 2013, PITUITARY, V16, P91, DOI 10.1007/s11102-012-0380-1; Gruppetta M, 2013, PITUITARY, V16, P545, DOI 10.1007/s11102-012-0454-0; He XL, 2008, MOD PRACT MED, V20; Heaney AP, 2002, J CLIN INVEST, V109, P277, DOI 10.1172/JCI200214264; HERMAN V, 1990, J CLIN ENDOCR METAB, V71, P1427, DOI 10.1210/jcem-71-6-1427; Hsueh C, 2013, CLIN ENDOCRINOL, V78, P303, DOI 10.1111/cen.12007; [胡静芳 Hu Jingfang], 2006, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V26, P193; Hunter JAC, 2003, EUR J ENDOCRINOL, V148, P203, DOI 10.1530/eje.0.1480203; Ishikawa H, 2001, J CLIN ENDOCR METAB, V86, P867, DOI 10.1210/jc.86.2.867; JACOBY LB, 1990, J NEUROSURG, V73, P731, DOI 10.3171/jns.1990.73.5.0731; Jaffrain-Rea M- L, 2013, TUM CTR NERV SYST, V10, P189; Jia W, 2013, TUMOR BIOL, V34, P1559, DOI 10.1007/s13277-013-0686-2; Li AJ, 2007, CHIN J CLIN NEUROSUR, V12, P418; Li J, 2008, CHIN J MINIM INVAS N, V13, P71; Li YY, 2006, PRACTICAL CLIN MED, V7, P10; Tena-Suck ML, 2008, ANN DIAGN PATHOL, V12, P275, DOI 10.1016/j.anndiagpath.2008.02.001; Liu JN, 2004, PRACT CLIN MED, V9, P172; McCabe CJ, 2003, CLIN ENDOCRINOL, V58, P141, DOI 10.1046/j.1365-2265.2003.01598.x; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI200320401; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Minematsu T, 2006, ENDOCR PATHOL, V17, P143, DOI 10.1385/EP:17:2:143; Mo K, 2011, J MINIMALLY INVASIVE, V6, P94; Monsalves E, 2014, J CLIN ENDOCR METAB; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Perez-Castro C, 2012, PHYSIOL REV, V92, P1, DOI 10.1152/physrev.00003.2011; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Raverot G, 2010, J CLIN ENDOCR METAB, V95, P1708, DOI 10.1210/jc.2009-1191; Salehi F, 2010, INT J SURG PATHOL, V18, P5, DOI 10.1177/1066896909356105; Sanchez-Tejada L, 2013, ENDOCRINOL NUTR, V60, P358, DOI 10.1016/j.endonu.2012.09.005; Shen YL, 2012, ANAT RES, V34, P202; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Tfelt-Hansen J, 2006, CLIN MED RES, V4, P130, DOI 10.3121/cmr.4.2.130; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Wang F, 2005, CHIN J CLIN NEUROSUR, V10; Wang YS, 2008, CHIN J CLIN NEUROSUR, V13, P279; Wierinckx A, 2007, ENDOCR-RELAT CANCER, V14, P887, DOI 10.1677/ERC-07-0062; Wu JS, 2010, ZHEJIANG MED J, V32, P1290; Xiong ZY, 2006, CHIN J CLIN NEUROSUR, V11, P531; Yu R, 2000, J BIOL CHEM, V275, P36502, DOI 10.1074/jbc.C000546200; Yu R, 2003, ENDOCRINOLOGY, V144, P4991, DOI 10.1210/en.2003-0305; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zhang X, 1999, J CLIN ENDOCR METAB, V84, P761, DOI 10.1210/jc.84.2.761; Zhang Y, 2012, CHIN J LAB DIAGN, V16, P1671; Zhou C, 2013, ONCOGENE; Zhou CQ, 2008, ENDOCR-RELAT CANCER, V15, P817, DOI 10.1677/ERC-08-0060; Zhou J, 2008, J XIANNING U MED SCI, V22, P102; 孙慧莉, 2013, [中国老年学杂志, Chinese Journal of Gerontology], V33, P176	60	134	137	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 4	2014	9	3							e90396	10.1371/journal.pone.0090396	http://dx.doi.org/10.1371/journal.pone.0090396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4FD	24740309	Green Published, gold, Green Submitted			2022-12-25	WOS:000332475500046
J	Kim, H; Choi, K; Kang, H; Lee, SY; Chi, SW; Lee, MS; Song, J; Im, D; Choi, Y; Cho, SC				Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Lee, So-Young; Chi, Seung-Wook; Lee, Min-Sung; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan			Identification of a Novel Function of CX-4945 as a Splicing Regulator	PLOS ONE			English	Article							PROTEIN-KINASE CK2; PRE-MESSENGER-RNA; SERINE-RICH; SR PROTEINS; IN-VIVO; DISEASE; PHOSPHORYLATION; INHIBITOR; FAMILY; PURIFICATION	Alternative splicing is a nearly ubiquitous versatile process that controls gene expression and creates numerous protein isoforms with different functions from a single gene. The significance of alternative splicing has been confirmed by the increasing number of human diseases that are caused by misregulation of splicing events. Very few compounds, however, have been reported to act as inhibitors of alternative splicing, and their potential clinical use needs to be evaluated. Here, we report that CX-4945, a previously well-characterized inhibitor of casein kinase 2 (CK2) and a molecule currently in clinical trials (Phase II) for cancer treatment, regulates splicing in mammalian cells in a CK2-independent manner. Transcriptome-wide analysis using exon array also showed a widespread alteration in alternative splicing of numerous genes. We found that CX-4945 potently inhibits the Cdc2-like kinases (Clks) in vitro and in turn, leads to suppression of the phosphorylation of serine/arginine-rich (SR) proteins in mammalian cells. Surprisingly, the overall efficacy of CX-4945 on Clks (IC50 = 3-90 nM) was stronger than that of TG-003, the strongest inhibitor reported to date. Of the Clks, Clk2 was most strongly inhibited by CX-4945 in an ATP-competitive manner. Our research revealed an unexpected activity of the drug candidate CX-4945 as a potent splicing modulator and also suggested a potential application for therapy of diseases caused by abnormal splicing.	[Kim, Hyeongki; Choi, Kwangman; Kang, Hyunju; Song, Jaehyoung; Im, Donghwa; Choi, Yura; Cho, Sungchan] Korea Res Inst Biosci & Biotechnol, Targeted Med Res Ctr, Cheongwon, Chungbuk, South Korea; [Kim, Hyeongki; Cho, Sungchan] Univ Sci & Technol, Dept Biomol Sci, Taejon, South Korea; [Lee, So-Young] Minist Food & Drug Safety, Int Cooperat Off, Cheongwon, Chungbuk, South Korea; [Chi, Seung-Wook; Lee, Min-Sung] Korea Res Inst Biosci & Biotechnol, BioMed Prote Res Ctr, Cheongwon, Chungbuk, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ministry of Food & Drug Safety (MFDS), Republic of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Cho, SC (corresponding author), Korea Res Inst Biosci & Biotechnol, Targeted Med Res Ctr, Cheongwon, Chungbuk, South Korea.	sungchan@kribb.re.kr		Shin, Ju-Young/0000-0003-1010-7525	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2003182]; KRIBB Research Initiative Program	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; KRIBB Research Initiative Program	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2003182) and KRIBB Research Initiative Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KA, 2008, ADV ENZYME REGUL, V48, P179, DOI 10.1016/j.advenzreg.2008.04.002; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Cabrejos ME, 2004, J CELL BIOCHEM, V93, P2, DOI 10.1002/jcb.20209; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chabot B, 1996, TRENDS GENET, V12, P472, DOI 10.1016/0168-9525(96)10037-8; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Coombs TC, 2013, BIOORG MED CHEM LETT, V23, P3654, DOI 10.1016/j.bmcl.2013.02.096; DAHMUS ME, 1981, J BIOL CHEM, V256, P3319; Dalma-Weiszhausz DD, 2006, METHOD ENZYMOL, V410, P3, DOI 10.1016/S0076-6879(06)10001-4; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Dredge BK, 2001, NAT REV NEUROSCI, V2, P43, DOI 10.1038/35049061; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Ferguson AD, 2011, FEBS LETT, V585, P104, DOI 10.1016/j.febslet.2010.11.019; FU XD, 1995, RNA, V1, P663; Guerra B, 2008, CURR MED CHEM, V15, P1870, DOI 10.2174/092986708785132933; GUI JF, 1994, P NATL ACAD SCI USA, V91, P10824, DOI 10.1073/pnas.91.23.10824; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kim E, 2008, RNA BIOL, V5, P17, DOI 10.4161/rna.5.1.5944; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Kuroyanagi N, 1998, BIOCHEM BIOPH RES CO, V242, P357, DOI 10.1006/bbrc.1997.7913; Levinson N, 2006, RNA, V12, P925, DOI 10.1261/rna.8306; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Misteli T, 1998, J CELL BIOL, V143, P297, DOI 10.1083/jcb.143.2.297; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Nayler O, 1997, BIOCHEM J, V326, P693, DOI 10.1042/bj3260693; Ng B, 2004, J ALLERGY CLIN IMMUN, V114, P1463, DOI 10.1016/j.jaci.2004.09.006; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pilch B, 2001, CANCER RES, V61, P6876; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Sanford J R, 2003, Prog Mol Subcell Biol, V31, P33; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Soret J, 2005, P NATL ACAD SCI USA, V102, P8764, DOI 10.1073/pnas.0409829102; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Venkatachalam CM, 2003, J MOL GRAPH MODEL, V21, P289, DOI 10.1016/S1093-3263(02)00164-X; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Younis I, 2010, MOL CELL BIOL, V30, P1718, DOI 10.1128/MCB.01301-09; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837	53	78	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e94978	10.1371/journal.pone.0094978	http://dx.doi.org/10.1371/journal.pone.0094978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743259	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100056
J	Wang, Q; Tikhonenko, M; Bozack, SN; Lydic, TA; Yan, L; Panchy, NL; Mcsorley, KM; Faber, MS; Yan, YQ; Boulton, ME; Grant, MB; Busik, JV				Wang, Qi; Tikhonenko, Maria; Bozack, Svetlana N.; Lydic, Todd A.; Yan, Lily; Panchy, Nicholas L.; Mcsorley, Kelly M.; Faber, Matthew S.; Yan, Yuanqing; Boulton, Michael E.; Grant, Maria B.; Busik, Julia V.			Changes in the Daily Rhythm of Lipid Metabolism in the Diabetic Retina	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; CIRCADIAN CLOCK; MOLECULAR CLOCKS; LIVER; MOUSE; TIME; MELATONIN; INSULIN; PROTEIN-1; SYSTEM	Disruption of circadian regulation was recently shown to cause diabetes and metabolic disease. We have previously demonstrated that retinal lipid metabolism contributed to the development of diabetic retinopathy. The goal of this study was to determine the effect of diabetes on circadian regulation of clock genes and lipid metabolism genes in the retina and retinal endothelial cells (REC). Diabetes had a pronounced inhibitory effect on the negative clock arm with lower amplitude of the period (per) 1 in the retina; lower amplitude and a phase shift of per2 in the liver; and a loss of cryptochrome (cry) 2 rhythmic pattern in suprachiasmatic nucleus (SCN). The positive clock arm was increased by diabetes with higher amplitude of circadian locomotor output cycles kaput (CLOCK) and brain and muscle aryl-hydrocarbon receptor nuclear translocator-like 1 (bmal1) and phase shift in bmal1 rhythmic oscillations in the retina; and higher bmal1 amplitude in the SCN. Peroxisome proliferator-activated receptor (PPAR) alpha exhibited rhythmic oscillation in retina and liver; PPAR gamma had lower amplitude in diabetic liver; sterol regulatory element-binding protein (srebp) 1c had higher amplitude in the retina but lower in the liver in STZ-induced diabetic animals. Both of Elongase (Elovl) 2 and Elovl4 had a rhythmic oscillation pattern in the control retina. Diabetic retinas lost Elovl4 rhythmic oscillation and had lower amplitude of Elovl2 oscillations. In line with the in vivo data, circadian expression levels of CLOCK, bmal1 and srebp1c had higher amplitude in rat REC (rREC) isolated from diabetic rats compared with control rats, while PPAR gamma and Elovl2 had lower amplitude in diabetic rREC. In conclusion, diabetes causes dysregulation of circadian expression of clock genes and the genes controlling lipid metabolism in the retina with potential implications for the development of diabetic retinopathy.	[Wang, Qi; Bozack, Svetlana N.; Mcsorley, Kelly M.; Faber, Matthew S.; Busik, Julia V.] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Tikhonenko, Maria; Panchy, Nicholas L.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Lydic, Todd A.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Yan, Lily] Michigan State Univ, Dept Psychol Social Sci, E Lansing, MI 48824 USA; [Yan, Yuanqing; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA; [Boulton, Michael E.] Indiana Univ, Dept Ophthalmol, Indianapolis, IN 46204 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis	Busik, JV (corresponding author), Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA.	busik@msu.edu	Busik, Julia V/A-2698-2010; Lydic, Todd A./ADB-0177-2022	Busik, Julia V/0000-0003-3453-7124; Yan, Lily/0000-0002-6261-2542; Faber, Matthew/0000-0002-5583-5115	National Institutes of Health (NIH) [EY016077]; MEAS [MICL02163, EY07739, EY12601, EY021626, DK090730]; NATIONAL EYE INSTITUTE [R01EY016077, R01EY007739, R01EY012601, R21EY021626, R29EY007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEAS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) Grants EY016077; and MEAS grant MICL02163 to JVB, EY07739 and EY12601 to MBG, EY021626 to MEB and DK090730 to MBG and JVB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Ando H, 2009, DIABETOLOGIA, V52, P329, DOI 10.1007/s00125-008-1194-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bhatwadekar AD, 2013, DIABETES, V62, P273, DOI 10.2337/db12-0172; Botolin D, 2003, J BIOL CHEM, V278, P6959, DOI 10.1074/jbc.M212846200; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Bugianesi E, 2005, HEPATOLOGY, V42, P987, DOI 10.1002/hep.20920; Busik J, 2009, DIABETES, V58, pA229; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Busik JV, 2009, J EXP MED, V206, P2897, DOI 10.1084/jem.20090889; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Deng X, 2007, J BIOL CHEM, V282, P17517, DOI 10.1074/jbc.M702228200; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dinet V, 2007, J PINEAL RES, V42, P83, DOI 10.1111/j.1600-079X.2006.00387.x; Grace MS, 1996, BRAIN RES, V735, P93; Herichova I, 2005, MOL CELL BIOCHEM, V270, P223, DOI 10.1007/s11010-005-5323-y; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Hofmann K, 2013, HORM METAB RES, V45, P629, DOI 10.1055/s-0033-1343462; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; Kohsaka A, 2007, TRENDS ENDOCRIN MET, V18, P4, DOI 10.1016/j.tem.2006.11.005; Kudo T, 2004, DIABETOLOGIA, V47, P1425, DOI 10.1007/s00125-004-1461-0; Kuriyama K, 2004, FEBS LETT, V572, P206, DOI 10.1016/j.febslet.2004.07.036; Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Maeda A, 2006, INVEST OPHTH VIS SCI, V47, P4050, DOI 10.1167/iovs.06-0183; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Matsumoto E, 2010, J BIOL CHEM, V285, P33028, DOI 10.1074/jbc.M109.089391; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Monteleone P, 2008, NEUROSCI LETT, V435, P30, DOI 10.1016/j.neulet.2008.02.003; Mulligan JD, 2008, EXP GERONTOL, V43, P146, DOI 10.1016/j.exger.2007.10.011; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oishi K, 2005, BIOCHEM J, V386, P575, DOI 10.1042/BJ20041150; Oishi K, 2004, BIOCHEM BIOPH RES CO, V317, P330, DOI 10.1016/j.bbrc.2004.03.055; Organisciak DT, 2000, INVEST OPHTH VIS SCI, V41, P3694; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pavan B, 2006, BIOCHEM BIOPH RES CO, V350, P169, DOI 10.1016/j.bbrc.2006.09.015; Paxinos G, 1999, CHEMOARCHITECTONIC A; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Peschke E, 2008, J PINEAL RES, V45, P439, DOI 10.1111/j.1600-079X.2008.00612.x; Prasai MJ, 2008, DIABETES VASC DIS RE, V5, P89, DOI 10.3132/dvdr.2008.015; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sakamoto K, 2000, NEUROREPORT, V11, P3995, DOI 10.1097/00001756-200012180-00018; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Stamenkovic JA, 2012, METABOLISM, V61, P978, DOI 10.1016/j.metabol.2011.11.013; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Straume M, 2004, METHOD ENZYMOL, V383, P149; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Xue JF, 2010, FITOTERAPIA, V81, P173, DOI 10.1016/j.fitote.2009.08.020; Yamazaki S, 1999, J BIOL RHYTHM, V14, P197, DOI 10.1177/074873099129000605; Yang GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038117; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	61	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e95028	10.1371/journal.pone.0095028	http://dx.doi.org/10.1371/journal.pone.0095028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736612	Green Published, Green Submitted, gold			2022-12-25	WOS:000336922600131
J	Tan, YW; Ge, GH; Pan, TL; Wen, DF; Gan, JH				Tan, Youwen; Ge, Guohong; Pan, Tengli; Wen, Danfeng; Gan, Jianhe			A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease	PLOS ONE			English	Article							CIRCULATING MICRORNAS; HEPATIC STEATOSIS; EXPRESSION LEVELS; RT-PCR; STEATOHEPATITIS; FIBROSIS; MIR-122; INJURY; INFLAMMATION; CARCINOMA	Background: The invasive nature of liver biopsy makes the histopathological diagnosis of non-alcoholic fatty liver disease (NAFLD) difficult and its diagnostic performance unsatisfactory. The present study aimed to identify a serum microRNA (miRNA) expression profile that could serve as a novel diagnostic biomarker for NAFLD. Methods: Serum miRNA expression was investigated using three cohorts comprising 465 participants (healthy controls and NAFLD patients) recruited between August 2010 and June 2013. miRNA expression was initially screened by Illumina sequencing using serum samples pooled from 20 patients and 20 controls. Quantitative reverse transcriptase polymerase chain reaction assay was then used to evaluate the expression of selected miRNAs. A logistic regression model was constructed using a training cohort (n = 242) and validated using another cohort (n = 183). The area under the receiver operating characteristic curve (AUC) was used to evaluate diagnostic accuracy. Results: We identified an miRNA panel (hsa-miR-122-5p, hsa-miR-1290, hsa-miR-27b-3p, and hsa-miR-192-5p) with a high diagnostic accuracy for NAFLD. The satisfactory diagnostic performance of the miRNA panel remained regardless of the NAFLD activity score (NAS) status. There was significant difference between the AUC values of the miRNA panel and those of ALT (AUC = 0.786, 95% CI = 0.717-0.855; P = 0.142) and FIB-4 (AUC = 0.795, 95% CI = 0.730-0.860; sensitivity = 69.9%, specificity = 83.7%. Conclusion: We identified a serum microRNA panel with considerable clinical value in NAFLD diagnosis. The results indicate that the miRNA panel is a more sensitive and specific biomarker for NAFLD than ALT and FIB-4.	[Tan, Youwen; Gan, Jianhe] Soochow Univ, Affiliated Hosp 1, Dept Infect Dis, Suzhou, Peoples R China; [Tan, Youwen; Ge, Guohong; Pan, Tengli; Wen, Danfeng] Zhenjiang Affiliated Jiangsu Univ, Hosp 3, Dept Hepatosis, Zhenjiang, Peoples R China	Soochow University - China	Gan, JH (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Infect Dis, Suzhou, Peoples R China.	ganjianhe@aliyun.com			Natural Science Foundation of Jiangsu Province, China [BK2011151]; Medical Project of Health Department Jiangsu Province [H201248]; Social Development Project of Zhenjiang City [SH201346]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Medical Project of Health Department Jiangsu Province; Social Development Project of Zhenjiang City	This work was supported by the Natural Science Foundation of Jiangsu Province, China (BK2011151) (http://www.jstd.gov.cn/), Medical Project of Health Department Jiangsu Province (H201248) (http://www.jswst.gov.cn/), and the Social Development Project of Zhenjiang City (SH201346) (http://kjj.zhenjiang.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Blanco-Calvo M, 2012, SENSORS-BASEL, V12, P9349, DOI 10.3390/s120709349; Castera L, 2013, NAT REV GASTRO HEPAT, V10, P666, DOI 10.1038/nrgastro.2013.175; Castera L, 2010, LANCET, V375, P1419, DOI 10.1016/S0140-6736(09)62195-4; Cazanave SC, 2011, J LIPID RES, V52, P1517, DOI 10.1194/jlr.M014654; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen WJ, 2012, ATHEROSCLEROSIS, V222, P314, DOI 10.1016/j.atherosclerosis.2012.01.020; Chen YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066577; Chen YP, 2013, LIVER INT, V33, P1257, DOI 10.1111/liv.12196; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Chiang YP, 2012, PATHOL ONCOL RES, V18, P585, DOI 10.1007/s12253-011-9480-x; De Minicis S, 2013, CURR PHARM DESIGN, V19, P5239; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fan JG, 2011, J DIGEST DIS, V12, P38, DOI 10.1111/j.1751-2980.2010.00476.x; Fernandez-Hernando C, 2013, ARTERIOSCL THROM VAS, V33, P178, DOI 10.1161/ATVBAHA.112.300144; Ge Yan, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P908, DOI 10.3969/j.issn.1672-7347.2011.09.017; Geng L, 2013, ONCOGENE; Giordano S, 2013, HEPATOLOGY, V57, P840, DOI 10.1002/hep.26095; Gougelet A, 2013, M S-MED SCI, V29, P861, DOI 10.1051/medsci/20132910013; Gougelet A, 2013, WORLD J GASTROENTERO, V19, P440, DOI 10.3748/wjg.v19.i4.440; He Y, 2012, CELL SIGNAL, V24, P2268, DOI 10.1016/j.cellsig.2012.07.023; Hsu Shu-Hao, 2013, Curr Pathobiol Rep, V1, P53; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Iino I, 2013, CANCER SCI, V104, P624, DOI 10.1111/cas.12122; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kotronen A, 2009, GASTROENTEROLOGY, V137, P865, DOI 10.1053/j.gastro.2009.06.005; Lewis AP, 2010, BIOCHEM SOC T, V38, P1553, DOI 10.1042/BST0381553; Li A, 2013, CLIN CANCER RES, V19, P5252, DOI 10.1158/1078-0432.CCR-13-1899; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McDaniel K, 2014, J CELL MOL MED, V18, P197, DOI 10.1111/jcmm.12223; Mottin CC, 2004, OBES SURG, V14, P635, DOI 10.1381/096089204323093408; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Poynard Thierry, 2005, Comp Hepatol, V4, P10; Shimamura T, 2008, J IMMUNOL, V181, P4656, DOI 10.4049/jimmunol.181.7.4656; Singaravelu R, 2014, HEPATOLOGY, V59, P98, DOI 10.1002/hep.26634; Wang XW, 2012, GASTROENTEROLOGY, V142, P1431, DOI 10.1053/j.gastro.2012.04.007; Zhang H, 2012, WORLD J GASTROENTERO, V18, P5188, DOI 10.3748/wjg.v18.i37.5188; Zhang Y, 2010, CLIN CHEM, V56, P1830, DOI 10.1373/clinchem.2010.147850; Zheng L, 2010, J GASTROEN HEPATOL, V25, P156, DOI 10.1111/j.1440-1746.2009.05949.x	42	197	207	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e105192	10.1371/journal.pone.0105192	http://dx.doi.org/10.1371/journal.pone.0105192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	24736723	Green Submitted, Green Published, gold			2022-12-25	WOS:000342687200058
J	Ou, X; Liu, ML; Luo, HR; Dong, LQ; Liu, F				Ou, Xiang; Liu, Meilian; Luo, Hairong; Dong, Lily Q.; Liu, Feng			Ursolic Acid Inhibits Leucine-Stimulated mTORC1 Signaling by Suppressing mTOR Localization to Lysosome	PLOS ONE			English	Article							AMINO-ACIDS; RAG GTPASES; TSC1-TSC2 COMPLEX; MAMMALIAN TARGET; SKELETAL-MUSCLE; ACTIVATION; GROWTH; CELL; PATHWAY; RAPTOR	Ursolic acid (UA), a pentacyclic triterpenoid widely found in medicinal herbs and fruits, has been reported to possess a wide range of beneficial properties including anti-hyperglycemia, anti-obesity, and anti-cancer. However, the molecular mechanisms underlying the action of UA remain largely unknown. Here we show that UA inhibits leucine-induced activation of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway in C2C12 myotubes. The UA-mediated inhibition of mTORC1 is independent of Akt, tuberous sclerosis complex 1/2 (TSC1/2), and Ras homolog enriched in brain (Rheb), suggesting that UA negatively regulates mTORC1 signaling by targeting at a site downstream of these mTOR regulators. UA treatment had no effect on the interaction between mTOR and its activator Raptor or inhibitor Deptor, but suppressed the binding of RagB to Raptor and inhibited leucine-induced mTOR lysosomal localization. Taken together, our study identifies UA as a direct negative regulator of the mTORC1 signaling pathway and suggests a novel mechanism by which UA exerts its beneficial function.	[Ou, Xiang; Liu, Meilian; Luo, Hairong; Liu, Feng] Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha, Hunan, Peoples R China; [Ou, Xiang; Liu, Meilian; Luo, Hairong; Liu, Feng] Cent S Univ, Xiangya Hosp 2, Key Lab Diabet Immunol, Ctr Diabet, Changsha, Hunan, Peoples R China; [Ou, Xiang; Liu, Meilian; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	Central South University; Central South University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Liu, F (corresponding author), Cent S Univ, Xiangya Hosp 2, Metab Syndrome Res Ctr, Changsha, Hunan, Peoples R China.	liuf@uthscsa.edu	Liu, Feng/CAG-8962-2022		NIH RO1 grant [DK100697]; National Nature Science Foundation of China [81130015]; National Basic Research Program of China [2014CB910500]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100697] Funding Source: NIH RePORTER	NIH RO1 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an NIH RO1 grant (DK100697, http://grants.nih.gov/grants/funding/r01.htm), a grant from the National Nature Science Foundation of China (81130015, http://www.nsfc.gov.cn/nsfc/cen/00/download.html), and a grant from the National Basic Research Program of China (2014CB910500, http://www.most.gov.cn/kjjh/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqahtani A, 2013, CURR MED CHEM, V20, P908; Atherton PJ, 2010, AMINO ACIDS, V38, P1533, DOI 10.1007/s00726-009-0377-x; Babcock JT, 2011, CURR DRUG TARGETS, V12, P1223; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Gao N, 2012, BRIT J PHARMACOL, V165, P1813, DOI 10.1111/j.1476-5381.2011.01684.x; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Howell JJ, 2013, BIOCHEM SOC T, V41, P906, DOI 10.1042/BST20130041; Howell JJ, 2011, TRENDS ENDOCRIN MET, V22, P94, DOI 10.1016/j.tem.2010.12.003; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kimball SR, 1999, J BIOL CHEM, V274, P11647, DOI 10.1074/jbc.274.17.11647; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee J, 2010, CHEM-BIOL INTERACT, V188, P635, DOI 10.1016/j.cbi.2010.09.019; Leng SL, 2013, INT J CANCER, V133, P2781, DOI 10.1002/ijc.28301; Li Y, 2010, MOL NUTR FOOD RES, V54, P1609, DOI 10.1002/mnfr.200900564; Liobikas J, 2011, J NAT PROD, V74, P1640, DOI 10.1021/np200060p; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Liu ZQ, 2002, J CLIN ENDOCR METAB, V87, P5553, DOI 10.1210/jc.2002-020424; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shanmugam MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032476; Wang AP, 2011, J BIOL CHEM, V286, P60, DOI 10.1074/jbc.M110.188144; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang TT, 2009, NEUROSCI LETT, V465, P177, DOI 10.1016/j.neulet.2009.08.026; Yeh CT, 2010, MOL NUTR FOOD RES, V54, P1285, DOI 10.1002/mnfr.200900414; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zou J, 2011, DEV CELL, V20, P97, DOI 10.1016/j.devcel.2010.11.020	46	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2014	9	4							e95393	10.1371/journal.pone.0095393	http://dx.doi.org/10.1371/journal.pone.0095393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4VW	25003527	Green Published, Green Submitted, gold			2022-12-25	WOS:000336863900138
J	Yin, YW; Li, JC; Gao, D; Chen, YX; Li, BH; Wang, JZ; Liu, Y; Liao, SQ; Zhang, MJ; Gao, CY; Zhang, LL				Yin, Yan-Wei; Li, Jing-Cheng; Gao, Dong; Chen, Yan-Xiu; Li, Bing-Hu; Wang, Jing-Zhou; Liu, Yun; Liao, Shao-Qiong; Zhang, Ming-Jie; Gao, Chang-Yue; Zhang, Li-Li			Influence of ATP-Binding Cassette Transporter 1 R219K and M883I Polymorphisms on Development of Atherosclerosis: A Meta-Analysis of 58 Studies	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; ABCA1 GENE; A1 GENE; ARTERY-DISEASE; LOW HDL; RISK; VARIANTS; ASSOCIATION; LEVEL	Background: Numerous epidemiological studies have evaluated the associations between ATP-binding cassette transporter 1 (ABCA1) R219K (rs2230806) and M883I (rs4149313) polymorphisms and atherosclerosis (AS), but results remain controversial. The purpose of the present study is to investigate whether these two polymorphisms facilitate the susceptibility to AS using a meta-analysis. Methods: PubMed, Embase, Web of Science, Medline, Cochrane database, Clinicaltrials.gov, Current Controlled Trials, Chinese Clinical Trial Registry, CBMdisc, CNKI, Google Scholar and Baidu Library were searched to get the genetic association studies. All statistical analyses were done with Stata 11.0. Results: Forty-seven articles involving 58 studies were included in the final meta-analysis. For the ABCA1 R219K polymorphism, 42 studies involving 12,551 AS cases and 19,548 controls were combined showing significant association between this variant and AS risk (for K allele vs. R allele: OR = 0.77, 95% CI = 0.71-0.84, P < 0.01; for K/K vs. R/R: OR = 0.60, 95% CI = 0.51-0.71, P < 0.01; for K/K vs. R/K+R/R: OR = 0.69, 95% CI = 0.60-0.80, P < 0.01; for K/K+R/K vs. R/R: OR = 0.74, 95% CI = 0.66-0.83, P < 0.01). For the ABCA1 M883I polymorphism, 16 studies involving 4,224 AS cases and 3,462 controls were combined. There was also significant association between the variant and AS risk (for I allele vs. M allele: OR = 0.85, 95% CI = 0.77-0.95, P < 0.01). Conclusions: The present meta-analysis suggested that the ABCA1 R219K and M883I polymorphisms were associated with the susceptibility to AS. However, due to the high heterogeneity in the meta-analysis, the results should be interpreted with caution.	[Yin, Yan-Wei; Li, Jing-Cheng; Gao, Dong; Li, Bing-Hu; Wang, Jing-Zhou; Liu, Yun; Liao, Shao-Qiong; Zhang, Ming-Jie; Gao, Chang-Yue; Zhang, Li-Li] Third Mil Med Univ, Dept Neurol, Inst Surg Res, Daping Hosp, Chongqing, Peoples R China; [Chen, Yan-Xiu] Liaocheng Hosp, Dept Neurol, Brain Hosp, Liaocheng, Shandong, Peoples R China	Army Medical University	Zhang, LL (corresponding author), Third Mil Med Univ, Dept Neurol, Inst Surg Res, Daping Hosp, Chongqing, Peoples R China.	zhanglilidoctor@hotmail.com	zhang, xuan/B-9476-2016	zhang, xuan/0000-0001-8775-1699	Natural Science Foundation Project of CQ CSTC [CSTC2012JJJQ10003]; National Natural Science Foundation of China [NSFC 81271282]	Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation Project of CQ CSTC (CSTC2012JJJQ10003 to Li-li Zhang) and National Natural Science Foundation of China (NSFC 81271282 to Jing-cheng Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrikovics H, 2006, CEREBROVASC DIS, V21, P254, DOI 10.1159/000091223; [Anonymous], 2008, CAUS DEATH 2008; Balcerzyk A, 2008, DIS MARKERS, V24, P81, DOI 10.1155/2008/789291; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brousseau ME, 2001, ATHEROSCLEROSIS, V154, P607, DOI 10.1016/S0021-9150(00)00722-X; Cenarro A, 2003, J MED GENET, V40, P163, DOI 10.1136/jmg.40.3.163; Cha Z, 2006, J TROPICAL MED, V6, P510; Chang YF, 2005, THESIS CAPITAL MED U, P1; Clee SM, 2001, CIRCULATION, V103, P1198; [崔翰斌 Cui Hanbin], 2005, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V26, P572; Doosti M, 2010, TRANSL RES, V155, P185, DOI 10.1016/j.trsl.2009.12.002; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evans D, 2003, J MOL MED-JMM, V81, P264, DOI 10.1007/s00109-003-0426-y; Frikke-Schmidt R, 2008, ARTERIOSCL THROM VAS, V28, P180, DOI 10.1161/ATVBAHA.107.153858; [郭茜 Guo Qian], 2010, [中国糖尿病杂志, Chinese Journal of Diabetes], V18, P827; [郭志刚 GUO Zhigang], 2007, [广东医学, Guangdong Medical Journal], V28, P378; Guyatt GH, BMJ, V336, P924; Harada T, 2003, ATHEROSCLEROSIS, V169, P105, DOI 10.1016/S0021-9150(03)00135-7; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Jensen Majken K, 2007, Atherosclerosis, V195, pe172, DOI 10.1016/j.atherosclerosis.2007.01.025; Katzov H, 2004, HUM MUTAT, V23, P358, DOI 10.1002/humu.20012; Kitjaroentham A, 2007, ARCH MED RES, V38, P834, DOI 10.1016/j.arcmed.2007.06.010; Li J, 2012, XIN ZANG ZHI, V24, P185; Li J, 2009, CLIN EXP PHARMACOL P, V36, P567, DOI 10.1111/j.1440-1681.2008.05119.x; Li Y, 2005, THESIS CHINA U GEOSC, P1; Li Y, 2012, MOL BIOL REP, V39, P1809, DOI 10.1007/s11033-011-0922-z; Liu XB, 2011, T AM MATH SOC, V363, P2939, DOI 10.1090/S0002-9947-2011-05091-9; Ma XY, 2011, ATHEROSCLEROSIS, V215, P428, DOI 10.1016/j.atherosclerosis.2011.01.008; [毛颖 MAO Ying], 2011, [中国循环杂志, Chinese Circulation Journal], V26, P23; Martin M, 2006, INT J CARDIOL, V110, P267, DOI 10.1016/j.ijcard.2005.08.020; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nebel A, 2007, ATHEROSCLEROSIS, V193, P458, DOI 10.1016/j.atherosclerosis.2006.09.022; Porchay-Balderelli I, 2009, METABOLISM, V58, P74, DOI 10.1016/j.metabol.2008.08.009; Shi WY, 2009, PRACTICAL PREVENTIVE, V16, P1057; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun Ping, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P627; Tan JHH, 2003, HUM GENET, V113, P106, DOI 10.1007/s00439-003-0943-3; Tsai CT, 2007, CARDIOLOGY, V107, P321, DOI 10.1159/000099069; Wang B, 2012, J CARDIOVASCULAR PUL, V31, P716; Wang LJ, 2004, QUALITY TEXTILES FOR QUALITY LIFE, VOLS 1-4, P449; Wang SH, 2008, PREVENTION TREATMENT, V8, P18; [王秀萍 WANG Xiuping], 2006, [临床心血管病杂志, Journal of Clinical Cardiology], V22, P516; [王旭东 Wang Xudong], 2004, [临床心血管病杂志, Journal of Clinical Cardiology], V20, P215; WANG YF, 2009, NONFERROUS METALS SM, V1, P18; Wang YM, 2006, J CHENGDU MED COLL, V1, P102; Wells G. A., 2011, NEWCASTLE OTTAWA SCA; Whiting BM, 2005, AM HEART J, V150, P243, DOI 10.1016/j.ahj.2004.08.034; Woll PS, 2005, CLIN CHEM, V51, P907, DOI 10.1373/clinchem.2004.047126; WU YF, 2006, CHINESE J CLIN REHAB, V10, P7; Xia ZH, 2012, ACTA MED SINICA, V25, P1; [肖志杰 Xiao Zhijie], 2004, [中华神经科杂志, Chinese Journal of Neurology], V37, P516; Xu H, 2011, CHIN J LAB DIAGN, V15, P1104; Xue JH, 2012, CHINESE J INTEGRATIV, V10, P574; Yi Y, 2011, THESIS ZUNYI MED U, P1; Yu B, 2008, J TONGJI U MED SCI, V29, P64; Yuan TY, 2011, CHIN J INTEGR MED CA, V9, P62; Zhang L. F., 2008, CHIN J GERIATR HEART, V10, P270, DOI DOI 10.18307/2008.0301; Zhang T, 2010, SHAANXI MED J, V39, P1596; Zhang XX, 2008, PREVENTION TREATMENT, V8, P304; [赵水平 Zhao Shuiping], 2004, [中华心血管病杂志, Chinese Journal of Cardiology], V32, P712	64	27	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86480	10.1371/journal.pone.0086480	http://dx.doi.org/10.1371/journal.pone.0086480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466114	Green Submitted, Green Published, gold			2022-12-25	WOS:000330288000104
J	Tan, Y; Liu, TR; Hu, SW; Tian, D; Li, C; Zhong, JK; Sun, HG; Luo, TT; Lai, WY; Guo, ZG				Tan, Ying; Liu, Ting Rong; Hu, Shui Wang; Tian, Di; Li, Chen; Zhong, Jian Kai; Sun, Hai Ge; Luo, Tian Tian; Lai, Wen Yan; Guo, Zhi-Gang			Acute Coronary Syndrome Remodels the Protein Cargo and Functions of High-Density Lipoprotein Subfractions	PLOS ONE			English	Article							CHOLESTEROL EFFLUX; PROTEOMIC ANALYSIS; DYSFUNCTIONAL HDL; APOLIPOPROTEIN-E; MACROPHAGES; DISEASE; ATHEROSCLEROSIS; INFLAMMATION; HEMOGLOBIN; ACTIVATION	Objectives: This study examined alterations in the functions and proteome of high-density lipoprotein (HDL) subfractions (HDL2 and HDL3) isolated from patients with acute coronary syndrome (ACS) compared with control subjects. Methods: We measured HDL subfraction cholesterol efflux capacity, inflammatory index (HII), paraoxonase-1 (PON1) activity, and lipid hydroperoxide (LOOH) levels in both male age-matched controls and the ACS group (n = 40/group). Additionally, proteomic analysis was used to monitor changes in the HDL subfraction proteome between controls and ACS subjects. Results: Both HDL2 and HDL3 from ACS patients had greater HII and LOOH levels compared with controls (P<0.001); PON1 activity and cholesterol efflux capacity in both HDL2 and HDL3 from the ACS group were significantly less than those of controls (P<0.001). Using proteomic analysis, we demonstrated that, compared with the control group, nine proteins were selectively enriched in HDL3 from subjects with ACS, and ras-related protein Rab-7b was decreased in HDL3. Additionally, in the ACS subjects, 12 proteins were decreased in HDL2 and 4 proteins were increased in HDL2. Conclusions: Functional HDL subfractions shifted to dysfunctional HDL subfractions during ACS, and the functional impairment was linked to remodeled protein cargo in HDL subfractions from ACS patients.	[Tan, Ying; Liu, Ting Rong; Tian, Di; Li, Chen; Zhong, Jian Kai; Sun, Hai Ge; Luo, Tian Tian; Lai, Wen Yan; Guo, Zhi-Gang] Southern Med Univ, Nanfang Hosp, Div Cardiol, Guangzhou, Guangdong, Peoples R China; [Hu, Shui Wang] Southern Med Univ, Lab Pathophysiol, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Guo, ZG (corresponding author), Southern Med Univ, Nanfang Hosp, Div Cardiol, Guangzhou, Guangdong, Peoples R China.	guozhigang126@126.com			Natural Science Foundation of Guangdong Province of China [10151051501000073]; Special Doctor Station Foundation of the University of the Education Department of China [20104433110006]	Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Special Doctor Station Foundation of the University of the Education Department of China	This work was supported by the Natural Science Foundation of Guangdong Province of China (10151051501000073) and the Special Doctor Station Foundation of the University of the Education Department of China (20104433110006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwaili K, 2012, BBA-MOL CELL BIOL L, V1821, P405, DOI 10.1016/j.bbalip.2011.07.013; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Arab K, 2004, ANAL BIOCHEM, V325, P158, DOI 10.1016/j.ab.2003.10.022; Beltowski J, 2005, PHARMACOL RES, V51, P523, DOI 10.1016/j.phrs.2005.01.007; Berrougui H, 2007, J LIPID RES, V48, P328, DOI 10.1194/jlr.M600167-JLR200; Charles-Schoeman C, 2009, ARTHRITIS RHEUM-US, V60, P2870, DOI 10.1002/art.24802; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; Degoma EM, 2008, J AM COLL CARDIOL, V51, P2199, DOI 10.1016/j.jacc.2008.03.016; Di Filippo C, 2006, CARDIOVASC DRUG REV, V24, P77; Dodani S, 2008, INT J CARDIOL, V129, P125, DOI 10.1016/j.ijcard.2007.12.019; Duffy D, 2009, NAT REV CARDIOL, V6, P455, DOI 10.1038/nrcardio.2009.94; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Guo ZG, 2012, CHEM PHYS LIPIDS, V165, P32, DOI 10.1016/j.chemphyslip.2011.10.005; Julia Z, 2010, J LIPID RES, V51, P3350, DOI 10.1194/jlr.P009746; Karlsson H, 2005, PROTEOMICS, V5, P1431, DOI 10.1002/pmic.200401010; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Lehrke M, 2007, J AM COLL CARDIOL, V49, P442, DOI 10.1016/j.jacc.2006.09.034; Li XA, 1998, BIOCHEM BIOPH RES CO, V244, P249, DOI 10.1006/bbrc.1998.8248; Lin CY, 1999, J LIPID RES, V40, P1618; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Nabais S, 2009, PROGNOSTIC IMPACT HE; Nagy E, 2009, ARTERIOSCLER THROMB, V30, P1347; Navab M, 2006, NAT CLIN PRACT ENDOC, V2, P504, DOI 10.1038/ncpendmet0245; Navab M, 2009, J LIPID RES, V50, P1538, DOI 10.1194/jlr.M800539-JLR200; Ortiz-Munoz G, 2009, FASEB J, V23, P3129, DOI 10.1096/fj.08-127928; Ostos MA, 2001, ARTERIOSCL THROM VAS, V21, P1023, DOI 10.1161/01.ATV.21.6.1023; Previsdomini M, 2007, AM J CARDIOL, V100, P579, DOI 10.1016/j.amjcard.2007.03.065; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Schultz JR, 1993, PROTEIN COMPOSITION; Shao BH, 2006, CURR OPIN CARDIOL, V21, P322, DOI 10.1097/01.hco.0000231402.87232.aa; Song ZQ, 2010, ATHEROSCLEROSIS, V211, P90, DOI 10.1016/j.atherosclerosis.2010.01.046; Stewart CR, 2005, BIOCHEMISTRY-US, V44, P9108, DOI 10.1021/bi050497v; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Watanabe J, 2009, J BIOL CHEM, V284, P18292, DOI 10.1074/jbc.M109.017202; Watson CE, 2011, J LIPID RES, V52, P361, DOI 10.1194/jlr.M011098; YAMAMOTO N, 1991, J IMMUNOL, V147, P273; Yao M, 2009, J IMMUNOL, V183, P1751, DOI 10.4049/jimmunol.0900249	38	197	207	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2014	9	4							e94264	10.1371/journal.pone.0094264	http://dx.doi.org/10.1371/journal.pone.0094264			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5PW	24736723	Green Submitted, gold, Green Published			2022-12-25	WOS:000336922600055
J	Gong, YH; Han, TG; Chen, W; Dib, HH; Yang, GA; Zhuang, RS; Chen, YQ; Tong, XY; Yin, XX; Lu, ZX				Gong, Yanhong; Han, Tieguang; Chen, Wei; Dib, Hassan H.; Yang, Guoan; Zhuang, Runsen; Chen, Yuqi; Tong, Xinyue; Yin, Xiaoxv; Lu, Zuxun			Prevalence of Anxiety and Depressive Symptoms and Related Risk Factors among Physicians in China: A Cross-Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; WORK HOURS; BURNOUT; SLEEP; CARE; PERCEPTIONS; WORKPLACE; DOCTORS; STRESS	Background: Physicians' poor mental health not only hinders their professional performance and affects the quality of healthcare provided but also adversely affects patients' health outcomes. Few studies in China have evaluated the mental health of physicians. The purposes of this study are to quantify Chinese physicians' anxiety and depressive symptoms as well as evaluate associated risk factors. Methods: In our study, 2641 physicians working in public hospitals in Shenzhen in southern China were recruited and interviewed by using a structured questionnaire along with validated scales testing anxiety and depressive symptoms. Multivariable logistic regression models were used to identify risk factors for anxiety and depressive symptoms. Results: An estimated 25.67% of physicians had anxiety symptoms, 28.13% had depressive symptoms, and 19.01% had both anxiety and depressive symptoms. More than 10% of the participants often experienced workplace violence and 63.17% sometimes encountered it. Among our study population, anxiety and depressive symptoms were associated with poor self-reported physical health, frequent workplace violence, lengthy working hours (more than 60 hours a week), frequent night shifts (twice or more per week), and lack of regular physical exercise. Conclusions: Our study demonstrates that anxiety and depressive symptoms are common among physicians in China, and the doctor-patient relationship issue is particularly stressful. Interventions implemented to minimize workload, improve doctor-patient relationships, and assist physicians in developing healthier lifestyles are essential to combat anxiety and depressive symptoms among physicians, which may improve their professional performance.	[Gong, Yanhong; Tong, Xinyue; Yin, Xiaoxv; Lu, Zuxun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430074, Peoples R China; [Han, Tieguang; Yang, Guoan; Zhuang, Runsen; Chen, Yuqi] Shenzhen Hlth Educ & Promot Ctr, Shenzhen, Guangdong, Peoples R China; [Chen, Wei] Laiwu Municipal Ctr Dis Control & Prevent, Dept Occupat Hlth, Laiwu, Guangdong, Peoples R China; [Dib, Hassan H.] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Huazhong University of Science & Technology; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Yin, XX (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430074, Peoples R China.	hnyinxiaoxv@126.com; zuxunlu@yahoo.com	Dib, Hassan/M-7694-2015; Tian, Hua/GPP-4477-2022	Dib, Hassan/0000-0002-9508-0909; Gong, Yufeng/0000-0002-1396-527X	Shenzhen Health Education and Promotion Center	Shenzhen Health Education and Promotion Center	This project was funded by the Shenzhen Health Education and Promotion Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Little Y, 2007, BRIT MED J, V334, P777, DOI 10.1136/bmj.39154.516667.BE; Amaddeo F, 2007, EPIDEMIOL PSICHIAT S, V16, P16, DOI 10.1017/S1121189X00004565; Arnetz BB, 2001, SOC SCI MED, V52, P203, DOI 10.1016/S0277-9536(00)00220-3; Averina M, 2005, SOC PSYCH PSYCH EPID, V40, P511, DOI 10.1007/s00127-005-0918-x; Aytac S, 2012, WORK, V41, P3026, DOI 10.3233/WOR-2012-0559-3026; Bannai A, 2014, SCAND J WORK ENV HEA, V40, P5, DOI 10.5271/sjweh.3388; Coomber S, 2002, BRIT J ANAESTH, V89, P873, DOI 10.1093/bja/aef273; Costa G, 2003, THEOR ISS ERGON SCI, V4, P263, DOI DOI 10.1080/14639220210158880; Devi S, 2011, LANCET, V377, P454, DOI 10.1016/S0140-6736(11)60145-1; Donisi Valeria, 2013, Psychiatry Res, V209, P691, DOI 10.1016/j.psychres.2013.02.031; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; General Administration of Sport of China, 2008, B STAT PHYS EX CHIN; GLASS DC, 1993, J CONSULT CLIN PSYCH, V61, P147, DOI 10.1037/0022-006X.61.1.147; Harma M, 1996, APPL ERGON, V27, P25, DOI 10.1016/0003-6870(95)00046-1; Henwood T, 2012, J CLIN NURS, V21, P1746, DOI 10.1111/j.1365-2702.2011.03994.x; Iacovides A, 2003, J AFFECT DISORDERS, V75, P209, DOI 10.1016/S0165-0327(02)00101-5; Kong LP, 2013, J CLIN NURS, V22, P1163, DOI 10.1111/jocn.12090; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Li JA, 2006, SOC SCI MED, V62, P1066, DOI 10.1016/j.socscimed.2005.07.011; Liu Y, 2013, J CLIN NURS, V22, P80, DOI 10.1111/jocn.12010; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Lloyd S, 1994, J Emerg Med, V12, P559; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; MCKNIGHT JD, 1995, J CONSULT CLIN PSYCH, V63, P490, DOI 10.1037/0022-006X.63.3.490; Merecz D, 2009, INT J OCCUP MED ENV, V22, P243, DOI 10.2478/v10001-009-0027-2; National Health and Family Planning Commission of the People's Republic of China, 2012, STAT B DEV HLTH SERV; Ofili AN, 2004, OCCUP MED-OXFORD, V54, P400, DOI 10.1093/occmed/kqh081; Osborn DPJ, 2003, INT J GERIATR PSYCH, V18, P623, DOI 10.1002/gps.896; POMERLEAU OF, 1990, CIBA F SYMP, V152, P225; Ribeiro JD, 2012, J AFFECT DISORDERS, V136, P743, DOI 10.1016/j.jad.2011.09.049; Ruitenburg MM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-292; RUSSELL GFM, 1983, BRIT J CLIN PHARMACO, V15, pS147, DOI 10.1111/j.1365-2125.1983.tb05859.x; Schwenk TL, 2008, J CLIN PSYCHIAT, V69, P617, DOI 10.4088/JCP.v69n0414; Shen LL, 2012, INT J PSYCHIAT MED, V44, P257, DOI 10.2190/PM.44.3.f; Shrive Fiona M, 2006, BMC Med Res Methodol, V6, P57, DOI 10.1186/1471-2288-6-57; Sun W, 2012, J OCCUP HEALTH, V54, P1, DOI 10.1539/joh.11-0169-OA; Takahashi M, 2012, J OCCUP ENVIRON MED, V54, P1078, DOI 10.1097/JOM.0b013e31826230b7; Tsai YC, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-199; Vaglum P, 1999, J AFFECT DISORDERS, V52, P153, DOI 10.1016/S0165-0327(98)00081-0; Virtanen M, 2012, EXPERT REV NEUROTHER, V12, P497, DOI [10.1586/ERN.12.29, 10.1586/ern.12.29]; Wada K, 2011, INT J BEHAV MED, V18, P384, DOI 10.1007/s12529-010-9132-7; Wallace JE, 2012, HEALTH-LONDON, V16, P3, DOI 10.1177/1363459310371080; Wang Fang P, 2012, MED SOC, V25, P74; Wang JN, 2010, INT ARCH OCC ENV HEA, V83, P905, DOI 10.1007/s00420-010-0508-4; Wang ZY, 1984, SHANGHAI ARCH PSYCHI, P71; Zhao M, 2011, MED LAW, V30, P401; Zhengyu W., 1984, SHANGHAI ARCH PSYCHI, P73; [朱大方 Zhu Dafang], 2010, [中国公共卫生, China Public Health], V26, P429; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	50	156	164	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2014	9	7							e103242	10.1371/journal.pone.0103242	http://dx.doi.org/10.1371/journal.pone.0103242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0QO	24743634	Green Submitted, Green Published, gold			2022-12-25	WOS:000339551100099
J	Gong, YF; Tian, H; Wang, LJ; Yu, SP; Ru, SG				Gong, Yufeng; Tian, Hua; Wang, Lijia; Yu, Suping; Ru, Shaoguo			An Integrated Approach Combining Chemical Analysis and an In Vivo Bioassay to Assess the Estrogenic Potency of a Municipal Solid Waste Landfill Leachate in Qingdao	PLOS ONE			English	Article							GOLDFISH CARASSIUS-AURATUS; ENDOCRINE-DISRUPTING CHEMICALS; EELPOUT ZOARCES-VIVIPARUS; PERCH PERCA-FLUVIATILIS; YEAST 2-HYBRID ASSAY; PUBLIC REFUSE DUMP; WATER TREATMENT; TREATMENT-PLANT; BISPHENOL-A; CONTAMINATED SEDIMENTS	Various adverse effects related to landfill leachate have made leachates an important issue in past decades, and it has been demonstrated that landfill leachate is an important source of environmental estrogens. In this study, we employed chemical analysis of some already evaluated estrogenic substances, in combination with a bioassay using several specific biomarkers (e.g., plasma vitellogenin and sex steroids, enzyme activity of gonad gamma-glutamyl transpeptidase, and gonadosomatic index) to evaluate the estrogenic activities in outlets from different stages of the leachate treatment process. The results indicated that 5 environmental estrogens (4-t-octylphenol, bisphenol A, di-ethyl phthalate, di-n-butyl phthalate, and diethylhexyl phthalate) were detected by a gas chromatography-mass spectrometry, and the concentrations in leachate samples were 6153 ng/L, 3642 ng/L, 2139 ng/L, 5900 ng/L, and 9422 ng/L, respectively. Leachate (1:200 diluted) induced the synthesis of plasma vitellogenin and led to decreased enzyme activity of gonad gamma-glutamyl transpeptidase and gonadosomatic index in male goldfish (Carassius auratus) after a 28-day exposure, while increased circulating 17b-estradiol level was also observed in males exposed to treated effluent. Although the target EEs were partially removed with removal rates varying from 87.2% to 99.77% by the "membrane bioreactor+ reverse osmosis+ aeration zeolite biofilter'' treatment process, the treated effluent is still estrogenic to fish. The method combined chemical techniques with the responses of test organisms allowing us to identify the group of estrogen-like chemicals so that we were able to evaluate the overall estrogenic effects of a complex mixture, avoiding false negative assessments.	[Gong, Yufeng; Tian, Hua; Yu, Suping; Ru, Shaoguo] Ocean Univ China, Marine Life Sci Coll, Qingdao, Peoples R China; [Wang, Lijia] Qingdao Chengtou Xiaojianxi Leachate Treatment Co, Qingdao, Peoples R China	Ocean University of China	Ru, SG (corresponding author), Ocean Univ China, Marine Life Sci Coll, Qingdao, Peoples R China.	rusg@ouc.edu.cn	Dib, Hassan/M-7694-2015; Tian, Hua/GPP-4477-2022	Dib, Hassan/0000-0002-9508-0909; Gong, Yufeng/0000-0002-1396-527X	Natural Science Foundation of China [31170322]; Natural Science Foundation of Jiangsu Province [BK2011165]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by Natural Science Foundation of China (31170322), www.nsfc.gov.cn and Natural Science Foundation of Jiangsu Province (BK2011165), www.jsnsf.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1; Asakura H, 2004, WASTE MANAGE, V24, P613, DOI 10.1016/j.wasman.2004.02.004; Asakura H, 2009, WASTE MANAGE, V29, P1852, DOI 10.1016/j.wasman.2008.11.030; Asakura Hiroshi, 2007, Environmental Sciences, V14, P79; Baderna D, 2011, ENVIRON RES, V111, P603, DOI 10.1016/j.envres.2011.01.015; Behnisch PA, 2001, CHEMOSPHERE, V43, P977, DOI 10.1016/S0045-6535(00)00458-6; Blankvoort BMG, 2005, ENVIRON TOXICOL PHAR, V19, P263, DOI 10.1016/j.etap.2004.08.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cardinali M, 2004, REPROD TOXICOL, V18, P597, DOI 10.1016/j.reprotox.2004.03.001; CARNEVALI O, 1993, J ENDOCRINOL, V137, P383, DOI 10.1677/joe.0.1370383; CARNEVALI O, 1992, GEN COMP ENDOCR, V88, P406, DOI 10.1016/0016-6480(92)90235-C; Chang H, 2011, WATER RES, V45, P732, DOI 10.1016/j.watres.2010.08.046; Christiansen LB, 1998, MAR ENVIRON RES, V46, P137, DOI 10.1016/S0141-1136(97)00047-0; Coors A, 2003, ENVIRON SCI TECHNOL, V37, P3430, DOI 10.1021/es0300158; Diniz MS, 2009, ECOTOXICOLOGY, V18, P1011, DOI 10.1007/s10646-009-0392-4; Dinizi MS, 2010, J ENVIRON SCI, V22, P1613, DOI 10.1016/S1001-0742(09)60297-7; Dizer H, 2002, ENVIRON TOXICOL, V17, P105, DOI 10.1002/tox.10038; Folmar LC, 2002, AQUAT TOXICOL, V60, P101, DOI 10.1016/S0166-445X(01)00276-4; Furhacker M, 2000, CHEMOSPHERE, V41, P751, DOI 10.1016/S0045-6535(99)00466-X; GERBERHUBER S, 1987, NUCLEIC ACIDS RES, V15, P4737, DOI 10.1093/nar/15.12.4737; Giam C.S., 1984, Handbook of Environmental Chemistry, V3C, P67; Gunnarsson L, 2009, SCI TOTAL ENVIRON, V407, P5235, DOI 10.1016/j.scitotenv.2009.06.018; He PJ, 2009, SCI TOTAL ENVIRON, V407, P4928, DOI 10.1016/j.scitotenv.2009.05.036; Jobling S, 1996, ENVIRON TOXICOL CHEM, V15, P194, DOI [10.1002/etc.5620150218, 10.1897/1551-5028(1996)015&lt;0194:IOTGIR&gt;2.3.CO;2]; Jobling S, 1998, IDENTIFICATION OESTR; Jonsson S, 2003, WATER RES, V37, P609, DOI 10.1016/S0043-1354(02)00304-4; Joseph L, 2011, WATER RES, V45, P4056, DOI 10.1016/j.watres.2011.05.015; Kawagoshi Y, 2003, J ENVIRON MONITOR, V5, P269, DOI 10.1039/b210962j; Kawagoshi Y, 2002, J ENVIRON MONITOR, V4, P1040, DOI 10.1039/b206161a; Kime DE, 1999, AQUACULTURE, V177, P345, DOI 10.1016/S0044-8486(99)00097-6; Kjeldsen P, 2002, CRIT REV ENV SCI TEC, V32, P297, DOI 10.1080/10643380290813462; Klauck CR, 2013, WASTE MANAGE RES, V31, P1148, DOI 10.1177/0734242X13502388; KOMEN J, 1989, AQUACULTURE, V78, P349, DOI 10.1016/0044-8486(89)90111-7; Korner W, 2000, CHEMOSPHERE, V40, P1131, DOI 10.1016/S0045-6535(99)00362-8; Kurata Y, 2008, J MATER CYCLES WASTE, V10, P144, DOI 10.1007/s10163-008-0200-x; Lei L, 2006, JPN J ENV TOXICOL, V9, P11; Leusch FDL, 2006, ECOTOX ENVIRON SAFE, V65, P403, DOI 10.1016/j.ecoenv.2005.07.020; Li CR, 2009, ENVIRON MONIT ASSESS, V150, P397, DOI 10.1007/s10661-008-0238-1; Liu ZH, 2009, SCI TOTAL ENVIRON, V407, P731, DOI 10.1016/j.scitotenv.2008.08.039; Lu GH, 2010, CHEMOSPHERE, V80, P982, DOI 10.1016/j.chemosphere.2010.05.038; Lu GH, 2011, ECOTOXICOLOGY, V20, P974, DOI 10.1007/s10646-011-0660-y; Marin MG, 2004, MAR POLLUT BULL, V48, P835, DOI 10.1016/j.marpolbul.2004.02.037; Ministry of Environmental Protection of The People's Republic of China, 2011, CHIN ENV STAT ANN BO; MIURA T, 1991, ZOOL SCI, V8, P63; Muller M, 2008, ENVIRON TOXICOL CHEM, V27, P1649, DOI [10.1897/07-519.1, 10.1897/07-519]; Nakamura D, 2010, TOXICOL LETT, V194, P16, DOI 10.1016/j.toxlet.2010.02.002; Noaksson E, 2005, AQUAT TOXICOL, V75, P162, DOI 10.1016/j.aquatox.2005.07.011; Noaksson E, 2003, SCI TOTAL ENVIRON, V305, P87, DOI 10.1016/S0048-9697(02)00503-X; Noaksson E, 2001, TOXICOL APPL PHARM, V174, P160, DOI 10.1006/taap.2001.9194; Pan ZB, 2012, J KOREAN SOC APPL BI, V55, P219, DOI 10.1007/s13765-012-1014-z; Pivato A, 2006, WASTE MANAGE, V26, P1148, DOI 10.1016/j.wasman.2005.10.008; Purdom C.E., 1994, Chemistry and Ecology, V8, P275, DOI 10.1080/02757549408038554; Rasmussen TH, 2005, AQUAT TOXICOL, V72, P177, DOI 10.1016/j.aquatox.2004.12.003; Rasmussen TH, 2004, COMP BIOCHEM PHYS C, V139, P1, DOI 10.1016/j.cca.2004.08.016; Ribecco C, 2012, AQUAT TOXICOL, V109, P133, DOI 10.1016/j.aquatox.2011.12.002; Ribecco C, 2011, AQUAT TOXICOL, V104, P308, DOI 10.1016/j.aquatox.2011.05.005; Safe SH, 1998, ENVIRON HEALTH PERSP, V106, P1051, DOI 10.2307/3434151; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Sisinno CLS, 2000, B ENVIRON CONTAM TOX, V64, P107, DOI 10.1007/s001289910017; Sole M, 2003, COMP BIOCHEM PHYS C, V136, P145, DOI 10.1016/S1532-0456(03)00192-3; SUMPTER JP, 1995, ENVIRON HEALTH PERSP, V103, P173, DOI 10.2307/3432529; Svenson A, 2004, J ENVIRON SCI HEAL A, V39, P2817, DOI [10.1081/LESA-200033857, 10.1081/ESE-200033857]; ter Veld MGR, 2006, J AGR FOOD CHEM, V54, P4407, DOI 10.1021/jf052864f; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thorpe KL, 2003, ENVIRON SCI TECHNOL, V37, P1142, DOI 10.1021/es0201348; Tian H, 2010, COMP BIOCHEM PHYS C, V152, P107, DOI 10.1016/j.cbpc.2010.03.004; Tian H, 2010, AQUAT TOXICOL, V98, P67, DOI 10.1016/j.aquatox.2010.01.011; Tian H, 2009, COMP BIOCHEM PHYS C, V150, P231, DOI 10.1016/j.cbpc.2009.04.014; Toft G, 2001, ECOTOX ENVIRON SAFE, V48, P76, DOI 10.1006/eesa.2000.1985; Tyler CR, 1999, ENVIRON TOXICOL CHEM, V18, P337, DOI 10.1002/etc.5620180234; WALLACE RA, 1985, J BIOL CHEM, V260, P1268; Wang RM, 2013, ENVIRON SCI POLLUT R, V20, P8612, DOI 10.1007/s11356-013-1817-4; Wen RS, 2013, AQUAT TOXICOL, V132, P165, DOI 10.1016/j.aquatox.2013.02.010; Yasuhara A, 1999, WASTE MANAGE RES, V17, P186, DOI 10.1177/0734242X9901700304; Yasuhara A, 1997, J CHROMATOGR A, V774, P321, DOI 10.1016/S0021-9673(97)00078-2; Zhang XN, 2013, GEN COMP ENDOCR, V193, P158, DOI 10.1016/j.ygcen.2013.08.003; Zheng G, 2004, CHIN J IND MED, V17, P273	77	156	164	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2014	9	4							e95597	10.1371/journal.pone.0095597	http://dx.doi.org/10.1371/journal.pone.0095597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3IK	24743634	Green Published, gold, Green Submitted			2022-12-25	WOS:000335309100144
J	Wang, Y; Yan, HJ; Zhou, SY; Wang, YS; Qi, H; Deng, CY; Li, FR				Wang, Yun; Yan, Hong-Jie; Zhou, Shu-Yan; Wang, Yun-Shuang; Qi, Hui; Deng, Chun-Yan; Li, Fu-Rong			The Immunoregulation Effect of Alpha 1-Antitrypsin Prolong beta-Cell Survival after Transplantation	PLOS ONE			English	Article							ISLET TRANSPLANTATION; REDUCES INFLAMMATION; ALLOGRAFT-REJECTION; ALPHA(1)-ANTITRYPSIN; INHIBITOR	Islet transplantation has considerable potential as a cure for diabetes. However, the difficulties that arise from inflammation and the immunological rejection of transplants must be addressed for islet transplantation to be successful. Alpha 1-antitrypsin (AAT) inhibits the damage on beta cells caused by inflammatory reactions and promotes beta-cell survival and proliferation. This protein also induces specific immune tolerance to transplanted beta cells. However, whether the expression of AAT in beta cells themselves could eliminate or decrease immunological rejection of transplants is not clear. Therefore, we established a beta cell line (NIT-hAAT) that stably expresses human AAT. Interestingly, in a cytotoxic T lymphocyte (CTL)-killing assay, we found that hAAT reduced apoptosis and inflammatory cytokine production in NIT-1 cells and regulated the Th1/Th2 cytokine balance in vitro. In vivo transplantation of NIT-hAAT cells into mice with diabetes showed hAAT inhibited immunological rejection for a short period of time and increased the survival of transplanted beta cells. This study demonstrated that hAAT generated remarkable immunoprotective and immunoregulation effects in a model of beta cell islet transplantation for diabetes model.	[Wang, Yun] Ningxia Med Univ, Gen Hosp, Dept Cardiac Surg, Yinchuan, Peoples R China; [Wang, Yun; Yan, Hong-Jie; Zhou, Shu-Yan; Wang, Yun-Shuang; Qi, Hui; Deng, Chun-Yan; Li, Fu-Rong] Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Key Lab Stem Cell & Cellular Therapy, Shenzhen, Peoples R China; [Li, Fu-Rong] Shenzhen Inst Gerontol, Shenzhen, Peoples R China	Ningxia Medical University; Jinan University	Li, FR (corresponding author), Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Key Lab Stem Cell & Cellular Therapy, Shenzhen, Peoples R China.	frli62@163.com			National 973 Program of China [2007CB516811]; National Natural Science Foundation of China [30772042, 81270857]; Science and Technology Project of Shenzhen [JCYJ20120618153743791, GJHZ20120618153934353]	National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Shenzhen	This work was supported by the National 973 Program of China (No. 2007CB516811), The National Natural Science Foundation of China (No. 30772042 and No. 81270857), and The Science and Technology Project of Shenzhen (No. JCYJ20120618153743791, GJHZ20120618153934353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi R, 2004, J IMMUNOL, V172, P767, DOI 10.4049/jimmunol.172.2.767; Bertuzzi F, 2004, J CLIN ENDOCR METAB, V89, P5724, DOI 10.1210/jc.2004-0659; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Brantly M, 2002, AM J RESP CELL MOL, V27, P652, DOI 10.1165/rcmb.F250; BRANTLY ML, 1991, CHEST, V100, P703, DOI 10.1378/chest.100.3.703; Churg A, 2001, LAB INVEST, V81, P1119, DOI 10.1038/labinvest.3780324; HAMAGUCHI K, 1991, DIABETES, V40, P842, DOI 10.2337/diabetes.40.7.842; Jie ZJ, 2003, CHINESE MED J-PEKING, V116, P1678; Kalis M, 2010, ISLETS, V2, P185, DOI 10.4161/isl.2.3.11654; Koulmanda M, 2012, P NATL ACAD SCI USA, V109, P15443, DOI 10.1073/pnas.1018366109; Lewis EC, 2005, P NATL ACAD SCI USA, V102, P12153, DOI 10.1073/pnas.0505579102; Lewis EC, 2008, P NATL ACAD SCI USA, V105, P16236, DOI 10.1073/pnas.0807627105; Lu YQ, 2006, HUM GENE THER, V17, P625, DOI 10.1089/hum.2006.17.625; Ludvigsson J, 2010, CURR DIABETES REP, V10, P370, DOI 10.1007/s11892-010-0138-y; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Ottaviani S, 2011, TRANSL RES, V157, P332, DOI 10.1016/j.trsl.2010.12.014; Ozeri E, 2012, J IMMUNOL, V189, P146, DOI 10.4049/jimmunol.1101340; Petrache L, 2006, AM J RESP CRIT CARE, V173, P1222, DOI 10.1164/rccm.200512-1842OC; Pott GB, 2009, J LEUKOCYTE BIOL, V85, P886, DOI 10.1189/jlb.0208145; Robertson RP, 2010, DIABETES, V59, P1285, DOI 10.2337/db09-1846; Shahaf G, 2011, MOL MED, V17, P1000, DOI 10.2119/molmed.2011.00145; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Slobedman B, 2009, J VIROL, V83, P9618, DOI 10.1128/JVI.01098-09; Tawara I, 2012, P NATL ACAD SCI USA, V109, P564, DOI 10.1073/pnas.1117665109; Walters S, 2009, J IMMUNOL, V182, P793, DOI 10.4049/jimmunol.182.2.793; Wei P, 2012, BIOCHEM BIOPH RES CO, V418, P330, DOI 10.1016/j.bbrc.2012.01.021; Weir GC, 2009, CURR DIABETES REP, V9, P100, DOI 10.1007/s11892-009-0018-5; Ye J, 2013, IMMUNOL LETT, V150, P61, DOI 10.1016/j.imlet.2013.01.009; Zhang B, 2007, DIABETES, V56, P1316, DOI 10.2337/db06-1273	29	59	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2014	9	4							e94548	10.1371/journal.pone.0094548	http://dx.doi.org/10.1371/journal.pone.0094548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI5LS	24740145	gold, Green Published			2022-12-25	WOS:000336909100095
J	Wang, YW; Shi, DB; Chen, X; Gao, C; Gao, P				Wang, Ya-Wen; Shi, Duan-Bo; Chen, Xu; Gao, Chao; Gao, Peng			Clinicopathological Significance of MicroRNA-214 in Gastric Cancer and Its Effect on Cell Biological Behaviour	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR ANGIOGENESIS; TARGETING PTEN; EXPRESSION; PROLIFERATION; GROWTH; INVASIVENESS; PROGRESSION; SURVIVAL; INVASION	Accumulating evidence indicates that numerous microRNAs are involved in the tumorigenesis and progression of gastric cancer, while the clinical significance of microRNA-214 in gastric cancer is poorly understood and the exact role of microRNA-214 in gastric cancer remains obscure. In the present study, expression levels of microRNA-214 in 80 gastric carcinoma tissues, 18 nontumourous gastric tissues, and 4 types of gastric cancer cell lines were quantified by reverse transcription followed by real-time quantitative polymerase chain reaction (RT-qPCR), and the relationship between microRNA-214 expression and cliniopathological characteristics including prognosis was explored. To investigate the potential role of microRNA-214 in gastric cancer cell biological behaviour, we performed cell proliferation, apoptosis, migration and invasion assays in four gastric cancer cell lines and an immortalized gastric cell line in vitro. Our results showed that microRNA-214 was dramatically downregulated in gastric cancer tissues and gastric cancer cell lines, compared with nontumourous gastric tissues. Stepwise downregulation of microRNA-214 expression was observed among nontumourous gastric mucosa, nonmetastasis gastric cancer tissues, and metastasis gastric cancer tissues. The expression of microRNA-214 was significantly inversely correlated with lymph node metastasis and tumour size but had no correlation with the patient's prognosis. Ectopic expression of microRNA-214 could inhibit cell migration and invasion ability in SGC7901 and MKN45 gastric cancer cells. And knockdown of microRNA-214 significantly facilitated cell proliferation, migration and invasion in a cell-specific manner in MKN28, BGC823 and GES-1 cells. Colony stimulating factor 1 (CSF1) was identified as a target gene of microRNA-214. In summary, our data demonstrated that microRNA-214 is a promising novel biomarker for lymph node metastasis in patients with gastric cancer. And we identified that downregulation of microRNA-214 may regulate the proliferation, invasion and migration of gastric cancer cells by directly targeting CSF1.	[Wang, Ya-Wen; Shi, Duan-Bo; Chen, Xu; Gao, Chao; Gao, Peng] Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Peoples R China	Shandong University	Gao, P (corresponding author), Shandong Univ, Sch Med, Dept Pathol, Jinan 250100, Peoples R China.	gaopeng@sdu.edu.cn			National Natural Science Foundation of China [81172351, 81372856]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172351 and 81372856). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligeti S, 2011, FERTIL STERIL, V95, P2464, DOI 10.1016/j.fertnstert.2011.03.026; BAIOCCHI G, 1991, CANCER, V67, P990, DOI 10.1002/1097-0142(19910215)67:4<990::AID-CNCR2820670422>3.0.CO;2-8; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Dai XZ, 2011, CHINESE SCI BULL, V56, P3301, DOI 10.1007/s11434-011-4717-3; Derfoul A, 2011, CARCINOGENESIS, V32, P1607, DOI 10.1093/carcin/bgr184; Espinosa I, 2011, AM J PATHOL, V179, P2100, DOI 10.1016/j.ajpath.2011.06.021; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Gao P, 2011, J HEPATOL, V54, P1177, DOI 10.1016/j.jhep.2010.09.023; Gill K, 2001, FERTIL STERIL, V76, P1005, DOI 10.1016/S0015-0282(01)02735-2; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Motoyama K, 2010, INT J ONCOL, V36, P1089, DOI 10.3892/ijo_00000590; Mroczko B, 2007, CLIN CHIM ACTA, V380, P208, DOI 10.1016/j.cca.2007.02.037; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Okazaki T, 2005, J IMMUNOL, V174, P7531, DOI 10.4049/jimmunol.174.12.7531; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng RQ, 2012, J BIOL CHEM, V287, P14301, DOI 10.1074/jbc.M111.337642; Penna E, 2011, EMBO J, V30, P1990, DOI 10.1038/emboj.2011.102; Qiang R, 2011, INT J BIOCHEM CELL B, V43, P632, DOI 10.1016/j.biocel.2011.01.002; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; Wang HJ, 2009, J DIGEST DIS, V10, P258, DOI 10.1111/j.1751-2980.2009.00394.x; Wu WKK, 2010, ONCOGENE, V29, P5761, DOI 10.1038/onc.2010.352; Xing AY, 2013, EXP MOL PATHOL, V95, P91, DOI 10.1016/j.yexmp.2013.05.003; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Yang ZZ, 2009, IUBMB LIFE, V61, P1075, DOI 10.1002/iub.252; Zhang BG, 2012, ONCOL REP, V27, P1019, DOI 10.3892/or.2012.1645; Zhang C, 2012, ADV ENG FORUM, V2-3, P7, DOI 10.4028/www.scientific.net/AEF.2-3.7; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94	28	59	63	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91307	10.1371/journal.pone.0091307	http://dx.doi.org/10.1371/journal.pone.0091307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24740145	Green Published, Green Submitted, gold			2022-12-25	WOS:000332839300110
